PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hegazy, AM; Yamada, D; Kobayashi, M; Kohno, S; Ueno, M; Ali, MAE; Ohta, K; Tadokoro, Y; Ino, Y; Todo, T; Soga, T; Takahashi, C; Hirao, A				Hegazy, Ahmed M.; Yamada, Daisuke; Kobayashi, Masahiko; Kohno, Susumu; Ueno, Masaya; Ali, Mohamed A. E.; Ohta, Kumiko; Tadokoro, Yuko; Ino, Yasushi; Todo, Tomoki; Soga, Tomoyoshi; Takahashi, Chiaki; Hirao, Atsushi			Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; brain tumor; drug screening; mammalian target of rapamycin (mTOR); mitochondria	CANCER-CELLS; INITIATING CELLS; STEM-CELLS; MITOCHONDRIAL; TUMORIGENICITY; IDENTIFICATION; BIOGENESIS; ACTIVATION; GROWTH; MTORC1	Although abnormal metabolic regulation is a critical determinant of cancer cell behavior, it is still unclear how an altered balance between ATP production and consumption contributes to malignancy. Here we show that disruption of this energy balance efficiently suppresses aggressive malignant gliomas driven by mammalian target of rapamycin complex 1 (mTORC1) hyperactivation. In a mouse glioma model, mTORC1 hyperactivation induced by conditional Tsc1 deletion increased numbers of glioma-initiating cells (GICs) in vitro and in vivo. Metabolic analysis revealed that mTORC1 hyperactivation enhanced mitochondrial biogenesis, as evidenced by elevations in oxygen consumption rate and ATP production. Inhibition of mitochondrial ATP synthetase was more effective in repressing sphere formation by Tsc1-deficient glioma cells than that by Tsc1-competent glioma cells, indicating a crucial function for mitochondrial bioenergetic capacity in GIC expansion. To translate this observation into the development of novel therapeutics targeting malignant gliomas, we screened drug libraries for small molecule compounds showing greater efficacy in inhibiting the proliferation/survival of Tsc1-deficient cells compared with controls. We identified several compounds able to preferentially inhibit mitochondrial activity, dramatically reducing ATP levels and blocking glioma sphere formation. In human patient-derived glioma cells, nigericin, which reportedly suppresses cancer stem cell properties, induced AMPK phosphorylation that was associated with mTORC1 inactivation and induction of autophagy and led to a marked decrease in sphere formation with loss of GIC marker expression. Furthermore, malignant characteristics of human glioma cells were markedly suppressed by nigericin treatment in vivo. Thus, targeting mTORC1-driven processes, particularly those involved in maintaining a cancer cell's energy balance, may be an effective therapeutic strategy for glioma patients.	[Hegazy, Ahmed M.; Yamada, Daisuke; Kobayashi, Masahiko; Ueno, Masaya; Ali, Mohamed A. E.; Ohta, Kumiko; Tadokoro, Yuko; Hirao, Atsushi] Kanazawa Univ, Canc Res Inst, Div Mol Genet, Kanazawa, Ishikawa 9200934, Japan; [Kohno, Susumu; Takahashi, Chiaki] Kanazawa Univ, Canc Res Inst, Div Oncol & Mol Biol, Canc & Stem Cell Res Program, Kanazawa, Ishikawa 9200934, Japan; [Ino, Yasushi; Todo, Tomoki] Univ Tokyo, Inst Med Sci, Lab Innovat Canc Therapy, Minato Ku, Tokyo 1088639, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata 9970017, Japan; [Yamada, Daisuke] Niigata Univ Pharm & Appl Sci, Div Pharmacol, Niigata, Niigata 9568603, Japan	Kanazawa University; Kanazawa University; University of Tokyo; Keio University; Niigata University	Hirao, A (corresponding author), Kanazawa Univ, Div Mol Genet, Canc & Stem Cell Res Program, Canc Res Inst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	ahirao@staff.kanazawa-u.ac.jp	UENO, Masaya/D-8464-2015	UENO, Masaya/0000-0001-9177-8640; Ahmed, Mohamed/0000-0002-8789-8567	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED); Egyptian Ministry of Higher Education and Mission Sector; Japan Society for the Promotion of Science (JSPS) KAKENHI [JP25340028]; Grants-in-Aid for Scientific Research [15H01509] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Egyptian Ministry of Higher Education and Mission Sector; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT)/Project for Cancer Research and Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a scholarship from the Egyptian Ministry of Higher Education and Mission Sector.; Supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP25340028.	Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Deng CC, 2013, INT J BIOCHEM CELL B, V45, P1997, DOI 10.1016/j.biocel.2013.06.023; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; HAYASHI JI, 1992, SOMAT CELL MOLEC GEN, V18, P123, DOI 10.1007/BF01233159; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoshii T, 2014, J BIOCHEM, V156, P73, DOI 10.1093/jb/mvu037; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Korkolopoulou P, 2012, HISTOPATHOLOGY, V61, P293, DOI 10.1111/j.1365-2559.2012.04236.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Manago A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.263; MORAIS R, 1994, CANCER RES, V54, P3889; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Rigobello MP, 2002, BRIT J PHARMACOL, V136, P1162, DOI 10.1038/sj.bjp.0704823; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Tamase A, 2009, P NATL ACAD SCI USA, V106, P17163, DOI 10.1073/pnas.0905016106; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Tanaka S, 2015, J NEURO-ONCOL, V121, P239, DOI 10.1007/s11060-014-1630-z; The WHO, 2020, CLASSIFICATION TUMOU; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamada D, 2014, J BIOCHEM, V155, P227, DOI 10.1093/jb/mvt112; Yang JF, 2011, J SURG RES, V168, P97, DOI 10.1016/j.jss.2009.06.025; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	42	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21496	21509		10.1074/jbc.M116.734756	http://dx.doi.org/10.1074/jbc.M116.734756			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27519418	Green Published, hybrid			2022-12-26	WOS:000385999200017
J	Zhou, RB; Lu, HM; Liu, J; Shi, JY; Zhu, J; Lu, QQ; Yin, DC				Zhou, Ren-Bin; Lu, Hui-Meng; Liu, Jie; Shi, Jian-Yu; Zhu, Jing; Lu, Qin-Qin; Yin, Da-Chuan			A Systematic Analysis of the Structures of Heterologously Expressed Proteins and Those from Their Native Hosts in the RCSB PDB Archive	PLOS ONE			English	Article							MEAN-SQUARE DISTANCE; STRUCTURE ALIGNMENT; SECONDARY STRUCTURE; DYNAMICS; CRYSTALLOGRAPHY; TECHNOLOGY; SELECTION; CONTACTS; PACKING; BINDING	Recombinant expression of proteins has become an indispensable tool in modern day research. The large yields of recombinantly expressed proteins accelerate the structural and functional characterization of proteins. Nevertheless, there are literature reported that the recombinant proteins show some differences in structure and function as compared with the native ones. Now there have been more than 100,000 structures (from both recombinant and native sources) publicly available in the Protein Data Bank (PDB) archive, which makes it possible to investigate if there exist any proteins in the RCSB PDB archive that have identical sequence but have some difference in structures. In this paper, we present the results of a systematic comparative study of the 3D structures of identical naturally purified versus recombinantly expressed proteins. The structural data and sequence information of the proteins were mined from the RCSB PDB archive. The combinatorial extension (CE), FATCAT-flexible and TM-Align methods were employed to align the protein structures. The root-mean-square distance (RMSD), TM-score, P-value, Z-score, secondary structural elements and hydrogen bonds were used to assess the structure similarity. A thorough analysis of the PDB archive generated five-hundred-seventeen pairs of native and recombinant proteins that have identical sequence. There were no pairs of proteins that had the same sequence and significantly different structural fold, which support the hypothesis that expression in a heterologous host usually could fold correctly into their native forms.	[Zhou, Ren-Bin; Lu, Hui-Meng; Shi, Jian-Yu; Zhu, Jing; Lu, Qin-Qin; Yin, Da-Chuan] Northwestern Polytech Univ, Inst Special Environm Biophys, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian, Shaanxi, Peoples R China; [Liu, Jie] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China	Northwestern Polytechnical University; Xidian University	Yin, DC (corresponding author), Northwestern Polytech Univ, Inst Special Environm Biophys, Sch Life Sci, Key Lab Space Biosci & Biotechnol, Xian, Shaanxi, Peoples R China.	yindc@nwpu.edu.cn	LU, HUI-MENG/A-1717-2018; Shi, Jian-Yu/S-4485-2019	LU, HUI-MENG/0000-0002-5334-1402; Shi, Jian-Yu/0000-0002-2303-273X	National Natural Science Foundation of China [31170816]; Natural Science Foundation of Shaanxi Province(CN) [2014JQ4140]; Fundamental Research Funds for the Central Universities of China [3102014JCQ15002, 3102015ZY081, 3102015ZY082, 3102015BJ(II)ZS011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(CN)(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	Funded by National Natural Science Foundation of China, Grant numbers: 31170816, DCY, URLs:http://fund.sciencenet.cn/index.php/search/project?name=&person=&no=31170816&company=&subject=&money1=&money2=&startTime=1999&endTime=2016&subcategory=&redract_url=&submit.x=34&submit.y=17&submit=advSearch, Natural Science Foundation of Shaanxi Province(CN), Grant numbers: 2014JQ4140, DCY, Fundamental Research Funds for the Central Universities of China, Grant numbers: 3102014JCQ15002, QQL, Fundamental Research Funds for the Central Universities of China, Grant numbers: 3102015ZY081, HML, Fundamental Research Funds for the Central Universities of China, Grant numbers: 3102015ZY082, HML, and Fundamental Research Funds for the Central Universities of China, Grant numbers: 3102015BJ(II)ZS011, JZ.	Andrec M, 2007, PROTEINS, V69, P449, DOI 10.1002/prot.21507; Andrell J, 2013, MOL MEMBR BIOL, V30, P52, DOI 10.3109/09687688.2012.703703; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burra PV, 2009, P NATL ACAD SCI USA, V106, P10505, DOI 10.1073/pnas.0812152106; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Carugo O, 2003, J APPL CRYSTALLOGR, V36, P125, DOI 10.1107/S0021889802020502; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Casadevall N, 2002, NEPHROL DIAL TRANSPL, V17, P42, DOI 10.1093/ndt/17.suppl_5.42; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Derreumaux S, 2001, NUCLEIC ACIDS RES, V29, P2314, DOI 10.1093/nar/29.11.2314; EIGENBROT C, 1992, PROTEINS, V14, P75, DOI 10.1002/prot.340140109; Ferrer-Miralles N, 2015, METHODS MOL BIOL, V1258, P1, DOI 10.1007/978-1-4939-2205-5_1; Furnham N, 2006, NAT STRUCT MOL BIOL, V13, P184, DOI 10.1038/nsmb0306-184; Garbuzynskiy SO, 2005, PROTEINS, V60, P139, DOI 10.1002/prot.20491; Ghosh M, 1998, J BACTERIOL, V180, P4781, DOI 10.1128/JB.180.18.4781-4789.1998; Gibrat J, 1997, BIOPHYS J; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; Greives N, 2014, P NATL ACAD SCI USA, V111, P10197, DOI 10.1073/pnas.1407545111; Guo YX, 2013, INT SURG, V98, P82, DOI 10.9738/CC171.1; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hua L, 2014, PROTEIN EXPRES PURIF, V102, P52, DOI 10.1016/j.pep.2014.08.004; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kim HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009180; Kondrashov DA, 2008, PROTEINS, V70, P353, DOI 10.1002/prot.21499; KOSSIAKOFF AA, 1992, PROTEINS, V14, P65, DOI 10.1002/prot.340140108; Levitt M, 1998, P NATL ACAD SCI USA, V95, P5913, DOI 10.1073/pnas.95.11.5913; Ma JZ, 2014, ADV PROTEIN CHEM STR, V94, P121, DOI 10.1016/B978-0-12-800168-4.00005-6; Merlin M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/136419; Nagaich U, 2015, J ADV PHARM TECHNOL, V6, P147, DOI 10.4103/2231-4040.166456; Orlova MA, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1225, DOI 10.1023/B:BIRY.0000009137.75375.d2; Paul MJ, 2013, CURR PHARM DESIGN, V19, P5478, DOI 10.2174/1381612811319310003; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Rosano GL, 2014, RECOMBINANT PROTEIN, P7; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rupa P, 2003, BIOTECHNOL LETT, V25, P1917, DOI 10.1023/B:BILE.0000003987.60659.ea; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Sigoillot C, 2004, APPL MICROBIOL BIOT, V64, P346, DOI 10.1007/s00253-003-1468-3; Sikic Kresimir, 2010, Open Biochem J, V4, P83, DOI 10.2174/1874091X01004010083; Soumpasis DM, 2012, COMPUTATION BIOMOLEC; Stark A, 2003, J MOL BIOL, V326, P1307, DOI 10.1016/S0022-2836(03)00045-7; Su XD, 2015, CRYSTALLOGR REV, V21, P122, DOI 10.1080/0889311X.2014.973868; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01448; Weaver T, 1998, J MOL BIOL, V280, P431, DOI 10.1006/jmbi.1998.1862; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zacharias J, 2014, J CHEM INF MODEL, V54, P2166, DOI 10.1021/ci5000856; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	50	44	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161254	10.1371/journal.pone.0161254	http://dx.doi.org/10.1371/journal.pone.0161254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517583	Green Submitted, gold, Green Published			2022-12-26	WOS:000381382100065
J	Ahmad, S; Lee, SY; Kong, HG; Jo, EJ; Choi, HK; Khan, R; Lee, SW				Ahmad, Shabir; Lee, Seung Yeup; Kong, Hyun Gi; Jo, Eun Jeong; Choi, Hye Kyung; Khan, Raees; Lee, Seon-Woo			Genetic Determinants for Pyomelanin Production and Its Protective Effect against Oxidative Stress in Ralstonia solanacearum	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; PSEUDOMONAS-AERUGINOSA; FUNGAL MELANINS; PIGMENT; SUSCEPTIBILITY; VIRULENCE; BIOSYNTHESIS; MELANIZATION; EXPRESSION; CLONING	Ralstonia solanacearum is a soil-borne plant pathogen that infects more than 200 plant species. Its broad host range and long-term survival under different environmental stress conditions suggest that it uses a variety of mechanisms to protect itself against various types of biotic and abiotic stress. R. solanacearum produces a melanin-like brown pigment in the stationary phase when grown in minimal medium containing tyrosine. To gain deeper insight into the genetic determinants involved in melanin production, transposon-inserted mutants of R. solanacearum strain SL341 were screened for strains with defective melanin-producing capability. In addition to one mutant already known to be involved in pyomelanin production (viz., strain SL341D, with disruption of the hydroxphenylpyruvate dioxygenase gene), we identified three other mutants with disruption in the regulatory genes rpoS, hrpG, and oxyR, respectively. Wild-type SL341 produced pyomelanin in minimal medium containing tyrosine whereas the mutant strains did not. Likewise, homogentisate, a major precursor of pyomelanin, was detected in the culture filtrate of the wild-type strain but not in those of the mutant strains. A gene encoding hydroxyphenylpyruvate dioxygenase exhibited a significant high expression in wild type SL341 compared to other mutant strains, suggesting that pyomelanin production is regulated by three different regulatory proteins. However, analysis of the gene encoding homogentisate dioxygenase revealed no significant difference in its relative expression over time in the wild-type SL341 and mutant strains, except for SL341D, at 72 h incubation. The pigmented SL341 strain also exhibited a high tolerance to hydrogen peroxide stress compared with the non-pigmented SL341D strain. Our study suggests that pyomelanin production is controlled by several regulatory factors in R. solanacearum to confer protection under oxidative stress.	[Ahmad, Shabir; Lee, Seung Yeup; Kong, Hyun Gi; Jo, Eun Jeong; Choi, Hye Kyung; Khan, Raees; Lee, Seon-Woo] Dong A Univ, Dept Appl Biosci, Busan 49315, South Korea	Dong A University	Lee, SW (corresponding author), Dong A Univ, Dept Appl Biosci, Busan 49315, South Korea.	seonlee@dau.ac.kr	Lee, Seung Yeup/GSJ-3887-2022	Lee, Seon-Woo/0000-0001-6142-7612; KHAN, RAEES/0000-0002-8324-5702	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01110501]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This research was carried out with support of Next-Generation BioGreen 21 Program (Project No. PJ01110501), Rural Development Administration, Republic of Korea.	ARONSON JN, 1965, J BACTERIOL, V90, P38, DOI 10.1128/JB.90.1.38-46.1965; Battesti A, 2011, ANNU REV MICROBIOL, V65, P189, DOI 10.1146/annurev-micro-090110-102946; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Chai LYA, 2010, IMMUNOBIOLOGY, V215, P915, DOI 10.1016/j.imbio.2009.10.002; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; Colburn-Clifford JM, 2010, APPL ENVIRON MICROB, V76, P7392, DOI 10.1128/AEM.01742-10; COYNE VE, 1992, APPL ENVIRON MICROB, V58, P2861, DOI 10.1128/AEM.58.9.2861-2865.1992; DENOYA CD, 1994, J BACTERIOL, V176, P5312, DOI 10.1128/JB.176.17.5312-5319.1994; Drewnowska JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125428; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flores-Cruz Z, 2011, APPL ENVIRON MICROB, V77, P6426, DOI 10.1128/AEM.05813-11; Flores-Cruz Z, 2009, MOL PLANT MICROBE IN, V22, P773, DOI 10.1094/MPMI-22-7-0773; Fogarty RV, 1996, ENZYME MICROB TECH, V19, P311, DOI 10.1016/0141-0229(96)00002-6; Garcia-Rivera J, 2001, MED MYCOL, V39, P353, DOI 10.1080/mmy.39.4.353.357; Han HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128967; Hayward A. C., 1994, PSEUDOMONAS SOLANACE; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Hernandez-Romero D, 2005, APPL ENVIRON MICROB, V71, P6808, DOI 10.1128/AEM.71.11.6808-6815.2005; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Jeong Y, 2007, PLANT DIS, V91, P1277, DOI 10.1094/PDIS-91-10-1277; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; OGUNNARIWO J, 1975, J MED MICROBIOL, V8, P199, DOI 10.1099/00222615-8-1-199; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Prota G., 1992, MELANINS MELANOGENES; Riley PA, 1997, INT J BIOCHEM CELL B, V29, P1235, DOI 10.1016/S1357-2725(97)00013-7; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaad N. W., 2001, LAB GUIDE IDENTIFICA, V3rd, P1; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; SEN M, 1965, J GEN MICROBIOL, V41, P1; SICHEL G, 1991, FREE RADICAL BIO MED, V11, P1, DOI 10.1016/0891-5849(91)90181-2; Turick CE, 2010, PROPERTIES FUNCTION; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; van Elsas JD, 2001, CAN J MICROBIOL, V47, P842, DOI 10.1139/cjm-47-9-842; Vasse J, 2000, MOL PLANT MICROBE IN, V13, P259, DOI 10.1094/MPMI.2000.13.3.259; WALLIS FM, 1978, PHYSIOL PLANT PATHOL, V13, P307, DOI 10.1016/0048-4059(78)90047-4; Wan X, 2009, APPL MICROBIOL BIOT, V82, P261, DOI 10.1007/s00253-008-1742-5; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120923; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; WHITE LP, 1958, NATURE, V182, P1427, DOI 10.1038/1821427a0; Wu J, 2015, PHYSIOL MOL PLANT P, V90, P57, DOI 10.1016/j.pmpp.2015.03.003; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang Y, 2008, FEMS MICROBIOL LETT, V280, P219, DOI 10.1111/j.1574-6968.2008.01070.x; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	55	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160845	10.1371/journal.pone.0160845	http://dx.doi.org/10.1371/journal.pone.0160845			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513990	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100079
J	Baumann, CW; Liu, HMM; Thompson, LV				Baumann, Cory W.; Liu, Haiming M.; Thompson, LaDora V.			Denervation-Induced Activation of the Ubiquitin-Proteasome System Reduces Skeletal Muscle Quantity Not Quality	PLOS ONE			English	Article							EXTENSOR DIGITORUM LONGUS; RECEPTOR GENE-EXPRESSION; CONTRACTILE PROPERTIES; PROTEIN-DEGRADATION; MESSENGER-RNA; RING FINGER-1; IN-VIVO; ATROPHY; MYOSIN; DIHYDROPYRIDINE	It is well known that the ubiquitin-proteasome system is activated in response to skeletal muscle wasting and functions to degrade contractile proteins. The loss of these proteins inevitably reduces skeletal muscle size (i. e., quantity). However, it is currently unknown whether activation of this pathway also affects function by impairing the muscle's intrinsic ability to produce force (i. e., quality). Therefore, the purpose of this study was twofold, (1) document how the ubiquitin-proteasome system responds to denervation and (2) identify the physiological consequences of these changes. To induce soleus muscle atrophy, C57BL6 mice underwent tibial nerve transection of the left hindlimb for 7 or 14 days (n = 6-8 per group). At these time points, content of several proteins within the ubiquitin-proteasome system were determined via Western blot, while ex vivo whole muscle contractility was specifically analyzed at day 14. Denervation temporarily increased several key proteins within the ubiquitin-proteasome system, including the E3 ligase MuRF1 and the proteasome subunits 19S, alpha 7 and beta 5. These changes were accompanied by reductions in absolute peak force and power, which were offset when expressed relative to physiological cross-sectional area. Contrary to peak force, absolute and relative forces at submaximal stimulation frequencies were significantly greater following 14 days of denervation. Taken together, these data represent two keys findings. First, activation of the ubiquitin-proteasome system is associated with reductions in skeletal muscle quantity rather than quality. Second, shortly after denervation, it appears the muscle remodels to compensate for the loss of neural activity via changes in Ca2+ handling.	[Baumann, Cory W.; Liu, Haiming M.; Thompson, LaDora V.] Univ Minnesota, Sch Med, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Thompson, LV (corresponding author), Univ Minnesota, Sch Med, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA.	thomp067@umn.edu			National Institutes of Health [T32-AG029796]; NATIONAL INSTITUTE ON AGING [T32AG029796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a National Institutes of Health training grant (T32-AG029796: Functional Proteomics of Aging). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agbulut O, 2009, AM J PHYSIOL-CELL PH, V296, pC205, DOI 10.1152/ajpcell.00408.2008; Attaix Didier, 2003, P219, DOI 10.1079/9780851996790.0219; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Batt JAE, 2013, JOVE-J VIS EXP, DOI 10.3791/50657; Baumann CW, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12081; Baumann CW, 2016, MUSCLE NERV IN PRESS; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Boudriau S, 1996, MUSCLE NERVE, V19, P1383, DOI 10.1002/(SICI)1097-4598(199611)19:11<1383::AID-MUS2>3.0.CO;2-8; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Chen CNJ, 2014, J MUSCLE RES CELL M, V35, P191, DOI 10.1007/s10974-014-9385-x; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; FINOL HJ, 1981, J PHYSIOL-LONDON, V319, P81, DOI 10.1113/jphysiol.1981.sp013893; Furuya N, 2014, AUTOPHAGY, V10, P631, DOI 10.4161/auto.27785; GOLDMAN D, 1988, NEURON, V1, P329, DOI 10.1016/0896-6273(88)90081-5; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Graber TG, 2015, J GERONTOL A-BIOL, V70, P1045, DOI 10.1093/gerona/glu163; Graber TG, 2015, AGE, V37, DOI 10.1007/s11357-015-9773-1; Graber TG, 2013, J GERONTOL A-BIOL, V68, P1326, DOI 10.1093/gerona/glt032; Gregorio CC, 2005, J MUSCLE RES CELL M, V26, P389, DOI 10.1007/s10974-005-9021-x; Greising SM, 2011, J APPL PHYSIOL, V110, P109, DOI 10.1152/japplphysiol.00852.2010; Ingalls CP, 2004, J APPL PHYSIOL, V96, P1619, DOI 10.1152/japplphysiol.00084.2003; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jagoe RT, 2001, CURR OPIN CLIN NUTR, V4, P183, DOI 10.1097/00075197-200105000-00003; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Magnusson C, 2005, EUR J NEUROSCI, V21, P577, DOI 10.1111/j.1460-9568.2005.03855.x; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; MENDEZ J, 1960, METABOLISM, V9, P184; Midrio M, 1997, PFLUG ARCH EUR J PHY, V434, P398, DOI 10.1007/s004240050413; Midrio M, 2006, EUR J APPL PHYSIOL, V98, P1, DOI 10.1007/s00421-006-0256-z; Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670; Nagpal P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046427; Nakao R, 2015, MUSCLE NERVE, V51, P276, DOI 10.1002/mus.24310; Ozawa J, 2013, BIOMED RES-TOKYO, V34, P251; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Polge C, 2011, FASEB J, V25, P3790, DOI 10.1096/fj.11-180968; Radzyukevich TL, 2004, AM J PHYSIOL-CELL PH, V287, pC1445, DOI 10.1152/ajpcell.00518.2003; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Saeki Y, 2012, METHODS MOL BIOL, V832, P315, DOI 10.1007/978-1-61779-474-2_22; SALONEN V, 1985, MUSCLE NERVE, V8, P125, DOI 10.1002/mus.880080208; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; SHIH HT, 1990, J CLIN INVEST, V85, P781, DOI 10.1172/JCI114504; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Thompson LV, 2006, J APPL PHYSIOL, V101, P1581, DOI 10.1152/japplphysiol.00426.2006; Viguie CA, 1997, ANAT REC, V248, P346; Warren GL, 1999, J PHYSIOL-LONDON, V515, P609, DOI 10.1111/j.1469-7793.1999.609ac.x; WEBSTER DMS, 1985, CAN J PHYSIOL PHARM, V63, P681, DOI 10.1139/y85-113; Yampolsky P, 2010, EUR J NEUROSCI, V31, P646, DOI 10.1111/j.1460-9568.2010.07096.x; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	55	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160839	10.1371/journal.pone.0160839	http://dx.doi.org/10.1371/journal.pone.0160839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513942	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100078
J	Del-Prado, R; Divakar, PK; Lumbsch, HT; Crespo, AM				Del-Prado, Ruth; Divakar, Pradeep Kumar; Lumbsch, H. Thorsten; Crespo, Ana M.			Hidden Genetic Diversity in an Asexually Reproducing Lichen Forming Fungal Group	PLOS ONE			English	Article							GENUS MELANOHALEA PARMELIACEAE; SPECIES PAIR CONCEPT; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; BAYESIAN-INFERENCE; ASCOMYCOTA; DELIMITATION; DNA; COMPLEX; TREE	Asexual species with vegetative propagation of both symbiont partners (soredia) in lichens may harbor lower species diversity because they may indeed represent evolutionary dead ends or clones. In this study we aim to critically examine species boundaries in the sorediate lichen forming fungi Parmotrema reticulatum-Parmotrema pseudoreticulatum complex applying coalescent-based approaches and other recently developed DNA-based methods. To this end, we gathered 180 samples from Africa, Asia, Australasia, Europe, North and South America and generated sequences of internal transcribed spacer of nuclear ribosomal DNA (ITS) and DNA replication licensing factor MCM7 (MCM7). The dataset was analysed using different approaches such as traditional phylogeny-maximum likelihood and Bayesian-genetic distances, automatic barcode gap discovery and coalescent-based methods-PTP, GMYC, spedeSTEM and *Beast-in order to test congruence among results. Additionally, the divergence times were also estimated to elucidate diversification events. Delimitations inferred from the different analyses are comparable with only minor differences, and following a conservative approach we propose that the sampled specimens of the P. reticulatum-P. pseudoreticulatum complex belong to at least eight distinct species-level lineages. Seven are currently classified under P. reticulatum and one as P. pseudoreticulatum. In this work we discuss one of only few examples of cryptic species that have so far been found in sorediate reproducing lichen forming fungi. Additionally our estimates suggest a recent origin of the species complex-during the Miocene. Consequently, the wide distribution of several of the cryptic species has to be explained by intercontinental long-distance dispersal events.	[Del-Prado, Ruth; Divakar, Pradeep Kumar; Crespo, Ana M.] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Madrid, Spain; [Lumbsch, H. Thorsten] Field Museum, Sci & Educ, Chicago, IL USA	Complutense University of Madrid; Field Museum of Natural History (Chicago)	Del-Prado, R (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Madrid, Spain.	rpradomi@farm.ucm.es	Divakar, Pradeep K/E-5603-2014; Crespo, Ana/N-6236-2014	Divakar, Pradeep K/0000-0002-0300-0124; Crespo, Ana/0000-0002-5271-0157; Lumbsch, Thorsten/0000-0003-1512-835X; DEL PRADO, RUTH/0000-0002-7497-2510	Spanish Ministerio de Ciencia e Innovacion [CGL2013-4248P]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (CGL2013-4248P).; The project was funded by CGL2013-4248P. Sequencing was performed in the Centro de Genomica y Proteomica del Parque Cientifico de Madrid, where Maria Isabel Garcia Saez is especially thanked. We also thank anonymous reviewers for providing valuable feedback that improved the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altermann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097556; de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Arguello A, 2007, BIOL J LINN SOC, V91, P455, DOI 10.1111/j.1095-8312.2007.00810.x; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Molina MC, 2011, ORG DIVERS EVOL, V11, P331, DOI 10.1007/s13127-011-0060-4; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CLAUZADE G, 1985, B SOC BOTANIQUE CTR, V7, P1; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Crespo A, 2002, MYCOL RES, V106, P788, DOI 10.1017/S095375620200610X; Crespo A, 2001, TAXON, V50, P807, DOI 10.2307/1223708; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Molina MD, 2011, LICHENOLOGIST, V43, P585, DOI 10.1017/S0024282911000521; Del-Prado R, 2013, TAXON, V62, P928, DOI 10.12705/625.22; Del-Prado R, 2011, LICHENOLOGIST, V43, P569, DOI 10.1017/S0024282911000582; Del-Prado R, 2010, MOL PHYLOGENET EVOL, V56, P125, DOI 10.1016/j.ympev.2010.04.014; Divakar P.K., 2005, PARMELIOID LICHENS I; Divakar PK, 2005, LICHENOLOGIST, V37, P55, DOI 10.1017/S0024282904014586; Divakar PK, 2005, LICHENOLOGIST, V37, P37, DOI 10.1017/S0024282904014641; Divakar PK, 2012, AM J BOT, V99, P2014, DOI 10.3732/ajb.1200258; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyer PS, 2011, CURR OPIN MICROBIOL, V14, P649, DOI 10.1016/j.mib.2011.10.001; Elix J. A, 1994, FLORA AUSTR, V55, P1; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Ene IV, 2014, NAT REV MICROBIOL, V12, P239, DOI 10.1038/nrmicro3236; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Hale BW, 1999, BRYOLOGIST, V102, P462, DOI 10.2307/3244234; HALE ME, 1990, BRYOLOGIST, V93, P23, DOI 10.2307/3243542; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kraichak E, 2015, SCI REP-UK, V5, DOI 10.1038/srep10028; Kroken S, 2001, MYCOLOGIA, V93, P38, DOI 10.2307/3761604; Kueck Ulrich, 2009, Fungal Biology Reviews, V23, P86, DOI 10.1016/j.fbr.2009.10.004; Leavitt S.D., 2015, RECENT ADV LICHENOLO, P11, DOI 10.1007/978-81-322-2235-4_2; Leavitt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085240; Leavitt SD, 2013, MYCOKEYS, P1, DOI 10.3897/mycokeys.7.4508; Leavitt SD, 2012, BIOL J LINN SOC, V107, P920, DOI 10.1111/j.1095-8312.2012.01978.x; Leavitt SD, 2013, MOL PHYLOGENET EVOL, V66, P138, DOI 10.1016/j.ympev.2012.09.013; Leavitt SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-176; Leavitt SD, 2011, MOL PHYLOGENET EVOL, V60, P317, DOI 10.1016/j.ympev.2011.05.012; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Llimona X., 2001, BOCCONEA, V14, P1; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lumbsch HT, 2011, FUNGAL DIVERS, V50, P59, DOI 10.1007/s13225-011-0123-z; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Mason-Gamer RJ, 2004, SYST BIOL, V53, P25, DOI 10.1080/10635150490424402; MATTSSON JE, 1989, TAXON, V38, P238, DOI 10.2307/1220840; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Miralles A, 2011, ZOOL SCR, V40, P16, DOI 10.1111/j.1463-6409.2010.00453.x; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otalora MAG, 2010, AM J BOT, V97, P216, DOI 10.3732/ajb.0900064; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paradis E, 2006; Parnmen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052245; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Poelt J., 1970, NEUE FOLGE, V4, P187; POELT VJ, 1972, BOT NOTISER, V125, P77; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prieto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065576; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2007, TRACER V1 4; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmitt I, 2009, PERSOONIA, V23, P35, DOI 10.3767/003158509X470602; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tavares C. N, 1945, PORTUGALIAE ACTA B B, V1, P1; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; TEHLER A, 1982, TAXON, V31, P708, DOI 10.2307/1219689; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Varga J, 2014, MYCOPATHOLOGIA, V178, P349, DOI 10.1007/s11046-014-9795-8; Yang ZH, 2014, MOL BIOL EVOL, V31, P3125, DOI 10.1093/molbev/msu279; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	84	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161031	10.1371/journal.pone.0161031	http://dx.doi.org/10.1371/journal.pone.0161031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513649	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100111
J	Yao, YT; Wang, XH; Zeng, ZZ; Liu, YW; Peng, SS; Zhu, ZC; Piao, SL				Yao, Yitong; Wang, Xuhui; Zeng, Zhenzhong; Liu, Yongwen; Peng, Shushi; Zhu, Zaichun; Piao, Shilong			The Effect of Afforestation on Soil Moisture Content in Northeastern China	PLOS ONE			English	Article							SEMIARID LOESS PLATEAU; CARBON SEQUESTRATION; WATER YIELD; LAND-USE; VEGETATION CHANGES; PLANTED FORESTS; LEAF-AREA; RESPONSES; TREES; CONSERVATION	Widespread afforestation programs sequester carbon from the atmosphere and mitigate the rising of atmospheric carbon dioxide (CO2). Meanwhile, afforestation carbon sequestration may cost soil water. However, changes in soil moisture content (SMC) after large-scale afforestation or reforestation have rarely been quantified. In this study, we measured changes in SMC following afforestation using a paired plots method with data from 757 plots in Northeastern China. We found a marginally significant decline in soil moisture content of the top 1-m soil (SMC0-1m) after afforestation (P = 0.08) at the regional scale. The SMC responses to afforestation also vary across species. For example, significant SMC decrease are found for Populus spp. plantations (P < 0.05) and plantations of Pinus sylvestris var. mongolica (P < 0.05). Splitting the first meter of the soil profile into different depth intervals revealed that SMC declined significantly in shallow layers (0-30 cm) for Populus spp. and Pinus sylvestris var. mongolica. We also found that when SMC in the control exceeded a specific threshold, SMC for all five tree species considered tended to decrease, suggesting that the effects of afforestation on soil hydrology vary across different regions.	[Yao, Yitong; Wang, Xuhui; Zeng, Zhenzhong; Liu, Yongwen; Peng, Shushi; Zhu, Zaichun; Piao, Shilong] Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China	Peking University	Piao, SL (corresponding author), Peking Univ, Coll Urban & Environm Sci, Sino French Inst Earth Syst Sci, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn	wang, xuhui/H-8605-2019; Liu, Yongwen/O-7330-2015; Zeng, Zhenzhong/A-2212-2019; PENG, Shushi/AAS-2603-2020; Zhu, Zaichun/I-5374-2014; Zhu, Zaichun/ABD-2040-2021; Peng, Shushi/J-4779-2014	wang, xuhui/0000-0003-0818-9816; Liu, Yongwen/0000-0002-9664-303X; Zeng, Zhenzhong/0000-0001-6851-2756; PENG, Shushi/0000-0001-5098-726X; Zhu, Zaichun/0000-0001-5235-5194; Zhu, Zaichun/0000-0001-5235-5194; Peng, Shushi/0000-0001-5098-726X	National Natural Science Foundation of China [41561134016, 41530528]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (41561134016 and 41530528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral A, 2004, BIOMASS BIOENERG, V27, P41, DOI 10.1016/j.biombioe.2003.11.004; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Brown AE, 2005, J HYDROL, V310, P28, DOI 10.1016/j.jhydrol.2004.12.010; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, PROG PHYS GEOG, V31, P389, DOI 10.1177/0309133307081290; Chen LD, 2007, CATENA, V70, P200, DOI 10.1016/j.catena.2006.08.007; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang S, 2007, J ENVIRON MANAGE, V85, P672, DOI 10.1016/j.jenvman.2006.09.014; Farley KA, 2005, GLOBAL CHANGE BIOL, V11, P1565, DOI 10.1111/j.1365-2486.2005.01011.x; Figueroa JD, 2008, INT J GREENH GAS CON, V2, P9, DOI 10.1016/S1750-5836(07)00094-1; Gazal RM, 2006, AGR FOREST METEOROL, V137, P56, DOI 10.1016/j.agrformet.2006.03.002; Huang MB, 2003, HYDROL PROCESS, V17, P2599, DOI 10.1002/hyp.1281; Jackson RB, 2005, SCIENCE, V310, P1944, DOI 10.1126/science.1119282; Jackson RB, 2000, ECOL APPL, V10, P470, DOI 10.1890/1051-0761(2000)010[0470:BCOVCA]2.0.CO;2; Jackson RB, 2007, CARBON WATER TRADEOF; Jackson RB, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044006; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jarvis P.G., 1983, ENCY PLANT PHYSL D, P233, DOI DOI 10.1007/978-3-642-68156-1_9; Jiao JY, 2012, RESTOR ECOL, V20, P240, DOI 10.1111/j.1526-100X.2010.00756.x; Jin TT, 2011, HYDROL EARTH SYST SC, V15, P2519, DOI 10.5194/hess-15-2519-2011; Kim Y, 2007, J HYDROMETEOROL, V8, P534, DOI 10.1175/JHM612.1; Legates DR, 2011, PROG PHYS GEOG, V35, P65, DOI 10.1177/0309133310386514; Li, 2009, SCI SOIL WATER CONSE, V4, P009; Li S, 2014, HYDROL PROCESS, V28, P5573, DOI 10.1002/hyp.10018; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Mu XM, 2007, HYDROL PROCESS, V21, P2124, DOI 10.1002/hyp.6391; Mulia R, 2006, PLANT SOIL, V281, P71, DOI 10.1007/s11104-005-3770-6; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nosetto MD, 2006, J ARID ENVIRON, V67, P142, DOI 10.1016/j.jaridenv.2005.12.008; Nosetto MD, 2012, AGR ECOSYST ENVIRON, V154, P2, DOI 10.1016/j.agee.2011.01.008; Payn T, 2015, FOREST ECOL MANAG, V352, P57, DOI 10.1016/j.foreco.2015.06.021; Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Scheffer M, 2005, GLOBAL CHANGE BIOL, V11, P1003, DOI 10.1111/j.1365-2486.2005.00962.x; Song LN, 2016, AGR WATER MANAGE, V164, P281, DOI 10.1016/j.agwat.2015.10.018; Spracklen DV, 2012, NATURE, V489, P282, DOI 10.1038/nature11390; State Forestry Administration of the People's Republic of China, 2009, 7 NAT FOR RES INV RE; Sun G, 2006, J HYDROL, V328, P548, DOI 10.1016/j.jhydrol.2005.12.013; van Dijk AIJM, 2007, FOREST ECOL MANAG, V251, P1, DOI 10.1016/j.foreco.2007.06.010; Wang S, 2012, HYDROL EARTH SYST SC, V16, P2883, DOI 10.5194/hess-16-2883-2012; Xi BY, 2013, AGR WATER MANAGE, V117, P83, DOI 10.1016/j.agwat.2012.11.006; Xu XY, 2011, J FOREST RES-JPN, V16, P144, DOI 10.1007/s10310-010-0220-y; Yang H, 2004, GEOFORUM, V35, P507, DOI 10.1016/j.geoforum.2003.10.002; [杨建伟 Yang Jianwe], 2006, [生态学报, Acta Ecologica Sinica], V26, P558; Yang L, 2014, CATENA, V115, P123, DOI 10.1016/j.catena.2013.12.005; Yang L, 2012, J HYDROL, V475, P111, DOI 10.1016/j.jhydrol.2012.09.041; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; Zhang X, 2005, J ARID ENVIRON, V60, P567, DOI 10.1016/j.jaridenv.2004.07.008; Zhang XP, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006711; Zhao WZ, 2001, ACTA PEDOLOGICA SINI, V39, P113; Zheng X, 2012, AGR WATER MANAGE, V109, P94, DOI 10.1016/j.agwat.2012.02.010	55	27	29	6	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160776	10.1371/journal.pone.0160776	http://dx.doi.org/10.1371/journal.pone.0160776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513001	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100071
J	Nagle, MW; Latourelle, JC; Labadorf, A; Dumitriu, A; Hadzi, TC; Beach, TG; Myers, RH				Nagle, Michael W.; Latourelle, Jeanne C.; Labadorf, Adam; Dumitriu, Alexandra; Hadzi, Tiffany C.; Beach, Thomas G.; Myers, Richard H.			The 4p16.3 Parkinson Disease Risk Locus Is Associated with GAK Expression and Genes Involved with the Synaptic Vesicle Membrane	PLOS ONE			English	Article							G-ASSOCIATED KINASE; CLATHRIN; IDENTIFICATION; LOCALIZATION; RECRUITMENT; MUTATIONS; ALIGNMENT; AUXILIN; PRODUCT	Genome-wide association studies (GWAS) have identified the GAK/DGKQ/IDUA region on 4p16.3 among the top three risk loci for Parkinson's disease (PD), but the specific gene and risk mechanism are unclear. Here, we report transcripts containing the 3' clathrin-binding domain of GAK identified by RNA deep-sequencing in post-mortem human brain tissue as having increased expression in PD. Furthermore, carriers of 4p16.3 PD GWAS risk SNPs show decreased expression of one of these transcripts, GAK25 (Gencode Transcript 009), which correlates with the expression of genes functioning in the synaptic vesicle membrane. Together, these findings provide strong evidence for GAK clathrin-binding-and J-domain transcripts' influence on PD pathogenicity, and for a role for GAK in regulating synaptic function in PD.	[Nagle, Michael W.; Latourelle, Jeanne C.; Labadorf, Adam; Dumitriu, Alexandra; Hadzi, Tiffany C.; Myers, Richard H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Nagle, Michael W.; Myers, Richard H.] Boston Univ, Sch Med, Grad Program Mol Translat Med, Boston, MA 02118 USA; [Nagle, Michael W.; Latourelle, Jeanne C.; Labadorf, Adam; Dumitriu, Alexandra; Myers, Richard H.] Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA; [Labadorf, Adam; Myers, Richard H.] Boston Univ, Bioinformat Program, Coll Arts & Sci, Boston, MA 02118 USA; [Beach, Thomas G.] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA	Boston University; Boston University; Boston University; Boston University; Banner Research; Banner Health; Banner Sun Health Research Institute	Myers, RH (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; Myers, RH (corresponding author), Boston Univ, Sch Med, Grad Program Mol Translat Med, Boston, MA 02118 USA.; Myers, RH (corresponding author), Boston Univ, Sch Med, Genome Sci Inst, Boston, MA 02118 USA.; Myers, RH (corresponding author), Boston Univ, Bioinformat Program, Coll Arts & Sci, Boston, MA 02118 USA.	rmyers@bu.edu		Nagle, Michael/0000-0002-4677-7582	Cogan Foundation; National Institutes of Health [R01-NS076843]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS072026] Funding Source: NIH RePORTER	Cogan Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Cogan Foundation and National Institutes of Health [R01-NS076843] (Characterization of the role of cyclin G-associated kinase in Parkinson disease). M.W.N., R.H.M., J.C.L., A.L., A.D., and T.C.H. were supported by these grants.	Alexa A, 2010, TOPGO TOPGO ENRICHME; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], [No title captured]; Beach TG, 2008, CELL TISSUE BANK, V9, P229, DOI 10.1007/s10561-008-9067-2; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Bellucci A, 2012, BRAIN RES, V1476, P183, DOI 10.1016/j.brainres.2012.04.014; Belluzzi E, 2012, BIOCHEM SOC T, V40, P1111, DOI 10.1042/BST20120124; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; Dumitriu A, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/614212; Dumitriu A, 2011, HUM MOL GENET, V20, P1478, DOI 10.1093/hmg/ddr026; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee DW, 2005, J CELL SCI, V118, P4311, DOI 10.1242/jcs.02548; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsumine H, 1997, AM J HUM GENET, V60, P588; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Pienaar IS, 2012, MOL NEUROBIOL, V45, P126, DOI 10.1007/s12035-011-8226-9; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Zhang CX, 2005, TRAFFIC, V6, P1103, DOI 10.1111/j.1600-0854.2005.00346.x	44	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160925	10.1371/journal.pone.0160925	http://dx.doi.org/10.1371/journal.pone.0160925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508417	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400066
J	PrayGod, G; Mukerebe, C; Magawa, R; Jeremiah, K; Torok, ME				PrayGod, George; Mukerebe, Crispin; Magawa, Ruth; Jeremiah, Kidola; Torok, M. Estee			Indoor Air Pollution and Delayed Measles Vaccination Increase the Risk of Severe Pneumonia in Children: Results from a Case-Control Study in Mwanza, Tanzania	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; YOUNG-CHILDREN; ETIOLOGY; DISEASE; AGE	Background Mortality due to severe pneumonia during childhood in resource-constrained settings is high, but data to provide basis for interventions to improve survival are limited. The objective of this study was to determine the risk factors for severe pneumonia in children aged under five years old in Mwanza, Tanzania. Methods We conducted a case-control study of children aged 2 to 59 months at Sekou-Toure regional hospital in Mwanza City, north-western, Tanzania from May 2013 to March 2014. Cases were children with severe pneumonia and controls were children with other illnesses. Data on demography, social-economical status, nutritional status, environmental factors, vaccination status, vitamin A supplementation and deworming, and nasopharyngeal carriage were collected and analysed using logistic regression. Results 117 patients were included in the study. Of these, 45 were cases and 72 controls. Cases were younger than controls, but there were no differences in social-economic or nutritional status between the two groups. In multiple regression, we found that an increased risk of severe pneumonia was associated with cooking indoors (OR 5.5, 95% CI: 1.4, 22.1), and delayed measles vaccination (OR 3.9, 95% CI: 1.1, 14.8). The lack of vitamin A supplementation in the preceding six month and Enterobacter spp nasopharyngeal carriage were not associated with higher risk of severe pneumonia. Age >= 24 months (OR 0.2, 95% CI: 0.04, 0.8) and not receiving antibiotics before referral (OR 0.3, 95% CI 0.1, 0.9) were associated with lower risk for severe pneumonia. Conclusions Indoor air pollution and delayed measles vaccination increase the risk for severe pneumonia among children aged below five years. Interventions to reduce indoor air pollution and to promote timely administration of measles vaccination are urgently needed to reduce the burden of severe pneumonia in children in Tanzania	[PrayGod, George; Mukerebe, Crispin; Magawa, Ruth; Jeremiah, Kidola] Natl Inst Med Res, Mwanza Med Res Ctr, Mwanza, Tanzania; [Torok, M. Estee] Univ Cambridge, Dept Med, Cambridge, England	National Institute of Medical Research; University of Cambridge	PrayGod, G (corresponding author), Natl Inst Med Res, Mwanza Med Res Ctr, Mwanza, Tanzania.	gpraygod@yahoo.com	; PrayGod, George/L-7098-2018	Jeremiah, Kidola/0000-0001-7900-9689; Torok, Mili Estee/0000-0001-9098-8590; PrayGod, George/0000-0002-0329-4839	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust [087540]; National Institute for Medical Research in Tanzania; Academy of Medical Sciences; Health Foundation; Academy of Medical Sciences (AMS) [AMS-CSF4-Torok] Funding Source: researchfish	Training Health Researchers into Vocational Excellence in East Africa (THRiVE) - Wellcome Trust; National Institute for Medical Research in Tanzania; Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Health Foundation; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This study was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540 funded by the Wellcome Trust. GP, CM, RM and KJ are supported by theNational Institute for Medical Research in Tanzania. MET is a Clinician Scientist Fellow funded by the Academy of Medical Sciences and the Health Foundation. The funders had no role in study design, data collection, analysis and interpretation, decision to publish, or preparation of the manuscript.; This study was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540 funded by the Wellcome Trust. The funding body had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The Director General of the National Institute for Medical Research, Tanzania is thanked for providing permission to publish this paper.	Ashraf S, 2013, INT J EPIDEMIOL, V42, P194, DOI 10.1093/ije/dys233; Baron M, 1999, MANUAL CLIN MICROBIO; Bruce NG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S8; DEFRANCISCO A, 1993, INT J EPIDEMIOL, V22, P1174, DOI 10.1093/ije/22.6.1174; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS132, DOI 10.1093/cid/cir1068; Hildenwall H, 2016, TROP MED INT HEALTH, V21, P149, DOI 10.1111/tmi.12635; Infante-Rivard C, 2003, AM J EPIDEMIOL, V157, P176, DOI 10.1093/aje/kwf174; Kirkwood BR, 2004, ESSENTIAL MED STAT; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Miller E, 2003, ARCH DIS CHILD, V88, P222, DOI 10.1136/adc.88.3.222; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) Ministry of Health (MoH) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2016, TANZ DEM HLTH SURV M; MTANGO FDE, 1992, TROP MED PARASITOL, V43, P229; NBS & ICF Macro, 2011, TANZ DEM HLTH SURV 2; PrayGod G, 2013, J NUTR, V143, P735, DOI 10.3945/jn.112.168997; Rothman K.J., 1998, MORDEN EPIDEMIOLOGY; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sankoh O, 2014, INT J EPIDEMIOL, V43, P645, DOI 10.1093/ije/dyu101; SHAH N, 1994, J TROP PEDIATRICS, V40, P201, DOI 10.1093/tropej/40.4.201; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Sigauque B, 2009, J TROP PEDIATRICS, V55, P379, DOI 10.1093/tropej/fmp030; Smith KR, 2000, THORAX, V55, P518, DOI 10.1136/thorax.55.6.518; Walker CLF, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010402; World Health Organization, 2010, GLOB ER MEASL REP SE; World Health Organization, 2006, CHILD GROWTH STAND; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zar HJ, 2014, PEDIATR PULM, V49, P430, DOI 10.1002/ppul.23030	29	15	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160804	10.1371/journal.pone.0160804	http://dx.doi.org/10.1371/journal.pone.0160804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508389	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400056
J	Thaler, MA; Feurer, R; Thaler, C; Sonntag, N; Schleef, M; Rondak, IC; Poppert, H				Thaler, Markus Alexander; Feurer, Regina; Thaler, Christoph; Sonntag, Natalie; Schleef, Michael; Rondak, Ina-Christine; Poppert, Holger			Activated Protein C Resistance Does Not Increase Risk for Recurrent Stroke or Death in Stroke Patients	PLOS ONE			English	Article							FACTOR-V-LEIDEN; INHERITED PROTHROMBOTIC CONDITIONS; ISCHEMIC CEREBROVASCULAR-DISEASE; COAGULATION-FACTOR-V; YOUNG-ADULTS; COMPETING RISKS; VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; MULTISTATE MODELS; MUTATION	Background Activated protein C (APC) resistance is the most common inherited prothrombotic disorder. The role of APC resistance in ischemic stroke is controversially discussed. Objectives The aim of this single center follow up study was to investigate the effect of APC resistance on stroke recurrence and survival in stroke patients. Patients/Methods We retrospectively identified 966 patients who had had an ischemic stroke or transitory ischemic attack (TIA) and in whom laboratory tests for APC resistance had been conducted. These patients were contacted to determine the primary outcomes of recurrent ischemic stroke or death. Results A total of 858 patients with an average follow up time of 8.48 years were included. APC resistance did not influence cumulative incidence functions for stroke free and total survival. In multivariate analyses, crude and adjusted hazard ratios for recurrent stroke as well as for death where not significantly increased in patients with APC resistance. This also applies to the subgroups of young patients, patients with cryptogenic stroke and patients with atrial fibrillation. Conclusion APC-resistance is not a risk factor for subsequent stroke or death in patients with a first ischemic stroke or TIA. Testing for APC-resistance in stroke patients therefore cannot be routinely recommended.	[Thaler, Markus Alexander; Schleef, Michael] Tech Univ Munich, Klinikum Rechts Isar, Inst Klin Chem & Pathobiochem, Munich, Germany; [Feurer, Regina; Thaler, Christoph; Sonntag, Natalie; Poppert, Holger] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, Munich, Germany; [Rondak, Ina-Christine] Tech Univ Munich, Klinikum Rechts Isar, Inst Med Stat & Epidemiol, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich	Poppert, H (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, Munich, Germany.	poppert@gmx.de		Poppert, Holger/0000-0003-2189-7681				AALEN O, 1978, ANN STAT, V6, P534, DOI 10.1214/aos/1176344198; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; [Anonymous], 2014, R LANG ENV STAT COMP; Austin H, 2002, STROKE, V33, P2762, DOI 10.1161/01.STR.0000038094.79901.3B; Aznar J, 2004, THROMB HAEMOSTASIS, V91, P1031, DOI 10.1160/TH03-11-0690; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Biswas A, 2009, THROMB RES, V124, P397, DOI 10.1016/j.thromres.2009.02.015; Blinkenberg EO, 2010, EUR J HUM GENET, V18, P862, DOI 10.1038/ejhg.2010.33; Bolaman Z, 2009, AM J MED SCI, V337, P11, DOI 10.1097/MAJ.0b013e3181753b86; Bushnell C D, 2001, J Stroke Cerebrovasc Dis, V10, P279, DOI 10.1053/jscd.2001.123777; Bushnell CD, 2000, STROKE, V31, P3067, DOI 10.1161/01.STR.31.12.3067; Cushman M, 1998, THROMB HAEMOSTASIS, V79, P912; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; de Lau LML, 2010, EXPERT REV NEUROTHER, V10, P1321, DOI 10.1586/ERN.10.104; De Stefano V, 1998, BLOOD, V91, P3562, DOI 10.1182/blood.V91.10.3562.3562_3562_3565; de Wreede LC, 2011, J STAT SOFTW, V38, P1; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Dragoni F, 2011, THROMB RES, V127, P85, DOI 10.1016/j.thromres.2010.11.013; Feurer R, 2010, EUR J NEUROL, V17, P1339, DOI 10.1111/j.1468-1331.2010.03015.x; Gray B, 2013, CMPRSK SUBDISTRIBUTI; Grossmann R, 2002, BLOOD COAGUL FIBRIN, V13, P583, DOI 10.1097/00001721-200210000-00002; Haller B, 2013, LIFETIME DATA ANAL, V19, P33, DOI 10.1007/s10985-012-9230-8; Hamedani AG, 2013, J STROKE CEREBROVASC, V22, P419, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.007; Hamzi Khalil, 2011, Indian J Hum Genet, V17, P212, DOI 10.4103/0971-6866.92105; Hankey GJ, 2001, STROKE, V32, P1793, DOI 10.1161/01.STR.32.8.1793; Kheradmand Ehsan, 2014, Adv Biomed Res, V3, P80, DOI 10.4103/2277-9175.127993; KONTULA K, 1995, THROMB HAEMOSTASIS, V73, P558; Lalouschek W, 2005, STROKE, V36, P1405, DOI 10.1161/01.STR.0000170635.45745.b8; Longstreth WT, 1998, STROKE, V29, P577, DOI 10.1161/01.STR.29.3.577; Lopaciuk S, 2001, CLIN APPL THROMB-HEM, V7, P346, DOI 10.1177/107602960100700418; Madonna P, 2002, STROKE, V33, P51, DOI 10.1161/hs0102.100483; Margaglione M, 1999, ARTERIOSCL THROM VAS, V19, P1751, DOI 10.1161/01.ATV.19.7.1751; Mojiminiyi OA, 2008, MED PRIN PRACT, V17, P136, DOI 10.1159/000112968; Morris JG, 2010, STROKE, V41, P2985, DOI 10.1161/STROKEAHA.110.595199; Moskau S, 2010, NEUROL RES, V32, P519, DOI 10.1179/016164109X12464612122533; Nabavi DG, 1998, J NEUROL, V245, P653, DOI 10.1007/s004150050262; Pezzini A, 2005, STROKE, V36, P533, DOI 10.1161/01.STR.0000155741.31499.c2; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rey R C, 2001, J Stroke Cerebrovasc Dis, V10, P128, DOI 10.1053/jscd.2001.25464; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; Sanchez J, 1997, HAEMOSTASIS, V27, P9; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Slooter AJC, 2005, J THROMB HAEMOST, V3, P1213, DOI 10.1111/j.1538-7836.2005.01442.x; Soare Angela Mirela, 2010, J Med Life, V3, P412; Supanc V, 2014, J STROKE CEREBROVASC, V23, pE171, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.025; They-They TP, 2012, J MOL NEUROSCI, V46, P210, DOI 10.1007/s12031-011-9580-9; Voetsch B, 2000, THROMB HAEMOSTASIS, V83, P229; Weber R, 2005, NERVENARZT, V76, P193, DOI 10.1007/s00115-004-1789-1; Yaghi Shadi, 2014, Neurol Clin Pract, V4, P386; Zeller J A, 2006, Hamostaseologie, V26, P309; Zunker P, 2001, J NEUROL, V248, P701, DOI 10.1007/s004150170117	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160382	10.1371/journal.pone.0160382	http://dx.doi.org/10.1371/journal.pone.0160382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508300	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400028
J	Cockburn, D; Wilkens, C; Dilokpimol, A; Nakai, H; Lewinska, A; Abou Hachem, M; Svensson, B				Cockburn, Darrell; Wilkens, Casper; Dilokpimol, Adiphol; Nakai, Hiroyuki; Lewinska, Anna; Abou Hachem, Maher; Svensson, Birte			Using Carbohydrate Interaction Assays to Reveal Novel Binding Sites in Carbohydrate Active Enzymes	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; GLYCOSIDE HYDROLASE; ANGSTROM RESOLUTION; SUGAR TONGS; CLOSTRIDIUM-CELLULOLYTICUM; POLYSACCHARIDE RECOGNITION; OLIGOSACCHARIDE BINDING; BARLEY ALPHA-AMYLASE-1	Carbohydrate active enzymes often contain auxiliary binding sites located either on independent domains termed carbohydrate binding modules (CBMs) or as so-called surface binding sites (SBSs) on the catalytic module at a certain distance from the active site. The SBSs are usually critical for the activity of their cognate enzyme, though they are not readily detected in the sequence of a protein, but normally require a crystal structure of a complex for their identification. A variety of methods, including affinity electrophoresis (AE), insoluble polysaccharide pulldown (IPP) and surface plasmon resonance (SPR) have been used to study auxiliary binding sites. These techniques are complementary as AE allows monitoring of binding to soluble polysaccharides, IPP to insoluble polysaccharides and SPR to oligosaccharides. Here we show that these methods are useful not only for analyzing known binding sites, but also for identifying new ones, even without structural data available. We further verify the chosen assays discriminate between known SBS/CBM containing enzymes and negative controls. Altogether 35 enzymes are screened for the presence of SBSs or CBMs and several novel binding sites are identified, including the first SBS ever reported in a cellulase. This work demonstrates that combinations of these methods can be used as a part of routine enzyme characterization to identify new binding sites and advance the study of SBSs and CBMs, allowing them to be detected in the absence of structural data.	[Cockburn, Darrell; Wilkens, Casper; Dilokpimol, Adiphol; Nakai, Hiroyuki; Lewinska, Anna; Abou Hachem, Maher; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, Enzyme & Prot Chem, Lyngby, Denmark	Technical University of Denmark	Svensson, B (corresponding author), Tech Univ Denmark, Dept Syst Biol, Enzyme & Prot Chem, Lyngby, Denmark.	bis@bio.dtu.dk	Wilkens, Casper/AAP-4214-2021; Dilokpimol, Adiphol/AAO-9940-2021; Cockburn, Darrell/F-6172-2011; Wilkens, Casper/R-1070-2016; Wilkens, Casper/GRR-1975-2022; Abou Hachem, Maher/M-4772-2019	Cockburn, Darrell/0000-0001-6791-6599; Wilkens, Casper/0000-0001-7692-067X; Abou Hachem, Maher/0000-0001-8250-1842; Dilokpimol, Adiphol/0000-0002-7208-507X; Svensson, Birte/0000-0002-2993-8196	Danish Council for Independent Research \ Natural Sciences, FNU [09-072151]; Technical University of Denmark; FNU	Danish Council for Independent Research \ Natural Sciences, FNU; Technical University of Denmark; FNU(Danish Natural Science Research Council)	BS received grant number 09-072151 from The Danish Council for Independent Research vertical bar Natural Sciences, FNU (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council/the-danish-council-for-independent-research-natural-sciences). DC received an H. C. Orsted post-doctoral fellowship from the Technical University of Denmark (www.dtu.dk). CW received joint PhD funding from FNU and the Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bozonnet S, 2007, FEBS J, V274, P5055, DOI 10.1111/j.1742-4658.2007.06024.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christiansen C, 2009, FEBS LETT, V583, P1159, DOI 10.1016/j.febslet.2009.02.045; Cockburn D, 2015, INT J BIOL MACROMOL, V75, P338, DOI 10.1016/j.ijbiomac.2015.01.054; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Cockburn D, 2013, SPR CARB CH, V39, P204, DOI 10.1039/9781849737173-00204; Cuyvers S, 2012, ANAL BIOCHEM, V420, P90, DOI 10.1016/j.ab.2011.09.005; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Cuyvers S, 2011, APPL MICROBIOL BIOT, V92, P539, DOI 10.1007/s00253-011-3343-y; Cuyvers S, 2011, FEBS J, V278, P1098, DOI 10.1111/j.1742-4658.2011.08023.x; De Vos D, 2006, BIOCHEMISTRY-US, V45, P4797, DOI 10.1021/bi052193e; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Fan LH, 2012, P NATL ACAD SCI USA, V109, P13260, DOI 10.1073/pnas.1209856109; Feng L, 2015, BIOCHEMISTRY-US, V54, P6207, DOI 10.1021/acs.biochem.5b00228; GIBSON RM, 1987, CARLSBERG RES COMMUN, V52, P373, DOI 10.1007/BF02907525; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Hernandez-Gomez MC, 2015, FEBS LETT, V589, P2297, DOI 10.1016/j.febslet.2015.07.009; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Jahn M, 2003, CHEM COMMUN, P1327, DOI 10.1039/b302380j; Jalak J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108181; Kanai R, 2004, BIOCHEMISTRY-US, V43, P14047, DOI 10.1021/bi048489m; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; LARSON SB, 1994, J MOL BIOL, V235, P1560, DOI 10.1006/jmbi.1994.1107; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Lin YC, 2011, J AM CHEM SOC, V133, P16617, DOI 10.1021/ja206692g; Lo Leggio L, 2001, FEBS LETT, V509, P303, DOI 10.1016/S0014-5793(01)03177-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; LOYTER A, 1966, J BIOL CHEM, V241, P2611; Ludwiczek ML, 2007, J MOL BIOL, V373, P337, DOI 10.1016/j.jmb.2007.07.057; Lyhne-Iversen L, 2006, ACTA CRYSTALLOGR F, V62, P849, DOI 10.1107/S174430910603096X; Mikami B, 1999, J MOL BIOL, V285, P1235, DOI 10.1006/jmbi.1998.2379; Mori H, 2001, EUR J BIOCHEM, V268, P6545, DOI 10.1046/j.0014-2956.2001.02609.x; Nakai H, 2010, BIOCHIMIE, V94, P1; Nakai H, 2010, FEBS J, V277, P3538, DOI 10.1111/j.1742-4658.2010.07763.x; Nakai H, 2009, FEBS J, V276, P7353, DOI 10.1111/j.1742-4658.2009.07445.x; Nielsen JW, 2012, ARCH BIOCHEM BIOPHYS, V528, P1, DOI 10.1016/j.abb.2012.08.005; Nielsen MM, 2009, BIOCHEMISTRY-US, V48, P7686, DOI 10.1021/bi900795a; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Patrick WM, 2010, FEBS J, V277, P4549, DOI 10.1111/j.1742-4658.2010.07869.x; Payan F, 2003, J PROTEIN CHEM, V22, P275, DOI 10.1023/A:1025072520607; QIAN MX, 1995, PROTEIN SCI, V4, P747; Ragunath C, 2008, J MOL BIOL, V384, P1232, DOI 10.1016/j.jmb.2008.09.089; RAHA M, 1992, J BACTERIOL, V174, P6644, DOI 10.1128/JB.174.20.6644-6652.1992; Ramasubbu N, 2004, EUR J BIOCHEM, V271, P2517, DOI 10.1111/j.1432-1033.2004.04182.x; Ramasubbu N, 2003, J MOL BIOL, V325, P1061, DOI 10.1016/S0022-2836(02)01326-8; Rejzek M, 2011, MOL BIOSYST, V7, P718, DOI 10.1039/c0mb00204f; Robert X, 2005, J BIOL CHEM, V280, P32968, DOI 10.1074/jbc.M505515200; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; ROBERTS PJP, 1960, BIOCHEM J, V76, P246, DOI 10.1042/bj0760246; Ruzanski C, 2013, J BIOL CHEM, V288, P28581, DOI 10.1074/jbc.M113.497867; SCANNAPIECO FA, 1990, BIOCHEM BIOPH RES CO, V173, P1109, DOI 10.1016/S0006-291X(05)80900-3; Schmidt A, 1999, BIOCHEMISTRY-US, V38, P2403, DOI 10.1021/bi982108l; Seo EunSeong, 2010, Journal of Applied Glycoscience, V57, P157; Shim JH, 2009, J BACTERIOL, V191, P4835, DOI 10.1128/JB.00176-09; Simpson PJ, 2000, J BIOL CHEM, V275, P41137, DOI 10.1074/jbc.M006948200; SOGAARD M, 1993, J BIOL CHEM, V268, P22480; STOFFER B, 1993, BIOCHEM J, V292, P197, DOI 10.1042/bj2920197; Strobel KL, 2015, J BIOL CHEM, V290, P22818, DOI 10.1074/jbc.M115.673467; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; Tomme P, 2000, ENZYME MICROB TECH, V27, P453, DOI 10.1016/S0141-0229(00)00246-5; Tranier S, 2005, BIOLOGIA, V60, P37; Vandermarliere E, 2008, BIOCHEM J, V410, P71, DOI 10.1042/BJ20071128; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Wilkens C, 2016, APPL MICROBIOL BIOT, V100, P6265, DOI 10.1007/s00253-016-7417-8; Wilkens C, 2016, FEBS LETT, V590, P118, DOI 10.1002/1873-3468.12027; Yaniv Oren, 2012, Methods Mol Biol, V908, P101, DOI 10.1007/978-1-61779-956-3_10	73	13	13	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160112	10.1371/journal.pone.0160112	http://dx.doi.org/10.1371/journal.pone.0160112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504624	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200023
J	Liu, R; Li, N; Lin, Y; Wang, M; Peng, YD; Lewi, K; Wang, QH				Liu, Rui; Li, Na; Lin, Yi; Wang, Mei; Peng, Yongde; Lewi, Keidren; Wang, Qinghua			Glucagon Like Peptide-1 Promotes Adipocyte Differentiation via the Wnt4 Mediated Sequestering of Beta-Catenin	PLOS ONE			English	Article							PROGLUCAGON GENE-EXPRESSION; ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTIONAL CONTROL; CELL PROLIFERATION; ADIPOGENESIS; MECHANISMS; DISEASE; MICE; MASS	Glucagon-like peptide-1 (GLP-1) plays a role in the regulation of adipogenesis; however, the precise underlying molecular mechanism has not been fully defined. Wnt was recently identified as an important regulator of adipogenesis. This study aimed to investigate the involvement of the Wnt signaling pathway in the effects of GLP-1 on adipocyte differentiation. 3T3-L1 cells were induced to differentiate. The changes in the expression levels of adipogenic transcription factors and Wnts and the phosphorylation level and subcellular localization of beta-catenin were quantified after GLP-1 treatment. GLP-1 stimulated adipocyte differentiation and lipid accumulation, which were accompanied by the expression of adipocyte marker genes. The expression of Wnt4 was upregulated in the process of adipocyte differentiation, which was further enhanced by treatment with GLP-1. beta-catenin, an important mediator of the Wnt pathway, was immediately dephosphorylated and translocated from cytoplasm to nucleus when differentiation was induced. In the presence of GLP-1, however, beta-catenin was redirected to the cell plasma membrane leading to its decreased accumulation in the nucleus. Knockdown of Wnt4 blocked the effect of GLP-1 on the cellular localization of beta-catenin and expression level of adipogenic transcription factors. Our findings showed that GLP-1 promoted adipogenesis through the modulation of the Wnt4/beta-catenin signaling pathway, suggesting that the GLP-1-Wnt beta-catenin system might be a new target for the treatment of metabolic disease.	[Liu, Rui; Wang, Qinghua] Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai 200040, Peoples R China; [Li, Na; Lin, Yi; Wang, Mei; Peng, Yongde] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Endocrinol, Shanghai 200080, Peoples R China; [Lewi, Keidren; Wang, Qinghua] Univ Toronto, Keenan Res Ctr Biomed Sci, Div Endocrinol & Metab, St Michaels Hosp,Dept Physiol, Toronto, ON M5B 1W8, Canada; [Lewi, Keidren; Wang, Qinghua] Univ Toronto, Div Endocrinol & Metab, Keenan Res Ctr Biomed Sci, St Michaels Hosp,Dept Med, Toronto, ON M5B 1W8, Canada	Fudan University; Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Liu, R (corresponding author), Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai 200040, Peoples R China.	ruiliu1221@126.com	Wang, Qinghua/GVT-3252-2022	Liu, Rui/0000-0002-8321-1617	National Nature Science Foundation [81200622, 81100616, 81100589]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation (grant numbers 81200622, 81100616, and 81100589).	Ailhaud G, 2006, CR BIOL, V329, P570, DOI 10.1016/j.crvi.2005.12.012; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Bays Harold, 2006, Expert Rev Cardiovasc Ther, V4, P871; Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Challa TD, 2012, J BIOL CHEM, V287, P6421, DOI 10.1074/jbc.M111.310342; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Dubois SG, 2006, OBESITY, V14, P1543, DOI 10.1038/oby.2006.178; Dubuisson O, 2011, ENDOCRINOLOGY, V152, P3648, DOI 10.1210/en.2011-0225; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Heller C, 2011, AM J PHYSIOL-ENDOC M, V301, pE864, DOI 10.1152/ajpendo.00144.2011; HISSIN PJ, 1982, J CLIN INVEST, V70, P780, DOI 10.1172/JCI110674; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Liu R, 2013, HORM METAB RES, V45, P646, DOI 10.1055/s-0033-1343472; Liu R, 2010, BIOCHEM BIOPH RES CO, V403, P172, DOI 10.1016/j.bbrc.2010.10.131; Liu SH, 2012, AM J PHYSIOL-ENDOC M, V303, pE740, DOI 10.1152/ajpendo.00328.2011; Liu ZY, 2008, J BIOL CHEM, V283, P8723, DOI 10.1074/jbc.M706105200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Ni ZY, 2003, J BIOL CHEM, V278, P1380, DOI 10.1074/jbc.M206006200; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004; Shao WJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1263, DOI 10.1152/ajpendo.00600.2012; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zuo Y, 2006, J BIOL CHEM, V281, P7960, DOI 10.1074/jbc.M510682200	40	12	15	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160212	10.1371/journal.pone.0160212	http://dx.doi.org/10.1371/journal.pone.0160212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504979	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200026
J	Klocko, AL; Borejsza-Wysocka, E; Brunner, AM; Shevchenko, O; Aldwinckle, H; Strauss, SH				Klocko, Amy L.; Borejsza-Wysocka, Ewa; Brunner, Amy M.; Shevchenko, Olga; Aldwinckle, Herb; Strauss, Steven H.			Transgenic Suppression of AGAMOUS Genes in Apple Reduces Fertility and Increases Floral Attractiveness	PLOS ONE			English	Article							MADS-BOX GENES; DOUBLE FLOWERS; C-FUNCTION; RNA; INVASIVENESS; INTERFERENCE; RESISTANCE; EVOLUTION; PRUNUS; MALUS	We investigated the ability of RNA interference (RNAi) directed against two co-orthologs of AGAMOUS (AG) from Malus domestica (domestic apple, MdAG) to reduce the risks of invasiveness and provide genetic containment of transgenes, while also promoting the attractiveness of flowers for ornamental usage. Suppression of two MdAG-like genes, MdMADS15 and MdMADS22, led to the production of trees with highly showy, polypetalous flowers. These "double-flowers" had strongly reduced expression of both MdAG-like genes. Members of the two other clades within in the MdAG subfamily showed mild to moderate differences in gene expression, or were unchanged, with the level of suppression approximately proportional to the level of sequence identity between the gene analyzed and the RNAi fragment. The double-flowers also exhibited reduced male and female fertility, had few viable pollen grains, a decreased number of stigmas, and produced few viable seeds after cross-pollination. Despite these floral alterations, RNAi-AG trees with double-flowers set full-sized fruit. Suppression or mutation of apple AG-like genes appears to be a promising method for combining genetic containment with improved floral attractiveness.	[Klocko, Amy L.; Shevchenko, Olga; Strauss, Steven H.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Borejsza-Wysocka, Ewa; Aldwinckle, Herb] Cornell Univ, Sch Integrat Plant Sci, Sect Plant Pathol & Plant Microbe Biol, Geneva, NY USA; [Brunner, Amy M.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA	Oregon State University; Cornell University; Virginia Polytechnic Institute & State University	Strauss, SH (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	steven.strauss@oregonstate.edu	Klocko, Amy/AAB-2661-2019		United States Department of Agriculture ARS Nursery and Floriculture Initiative; J. Frank Schmidt Family Charitable Foundation; USDA ARS Nursery and Floriculture Initiative	United States Department of Agriculture ARS Nursery and Floriculture Initiative; J. Frank Schmidt Family Charitable Foundation; USDA ARS Nursery and Floriculture Initiative	This work was funded by the United States Department of Agriculture ARS Nursery and Floriculture Initiative (to SHS) and the J. Frank Schmidt Family Charitable Foundation (to SHS).; We thank the USDA ARS Nursery and Floriculture Initiative and the J. Frank Schmidt Family Charitable Foundation for funding, the greenhouse staff of Oregon State University for care of the apple trees, and Gary Brown and Pauline Spaine of USDA APHIS for regulatory oversight. We also thank Dr. Barb Lachenbruch of Oregon State University for access to the Keyence digital microscope, and Dr. Lailiang Cheng of Cornell University for qPCR advice, and for providing primer sequences and reaction conditions for the apple ACT housekeeping gene.	[Agriculture USDo APHIS], 2015, AGRICULTURE USDO; Ahmed F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023443; Barceloux DG, 2008, MEDICAL TOXICOLOGY O; Bolarinwa IF, 2015, FOOD CHEM, V170, P437, DOI 10.1016/j.foodchem.2014.08.083; Borejsza-Wysocka EE, 1999, ACTA HORTIC, V489, P259; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Culley TM, 2007, BIOSCIENCE, V57, P956, DOI 10.1641/B571108; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Dubois A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009288; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elorriaga E, 2014, TREE GENET GENOMES, V10, P1583, DOI 10.1007/s11295-014-0781-6; Fourquin C, 2012, PLANT J, V71, P990, DOI 10.1111/j.1365-313X.2012.05046.x; Galimba KD, 2012, P NATL ACAD SCI USA, V109, pE2267, DOI 10.1073/pnas.1203686109; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Ireland HS, 2013, PLANT J, V73, P1044, DOI 10.1111/tpj.12094; Ito T, 2004, NATURE, V430, P356, DOI 10.1038/nature02733; Klocko AL, 2016, NAT BIOTECHNOL IN PR; Knight TM, 2011, BIOSCIENCE, V61, P816, DOI 10.1525/bio.2011.61.10.11; Koornneef J, 1980, ARABIDOPSIS INFORMAT, V17, P11; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Krens FA, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00286; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu ZX, 2013, PLANT CELL REP, V32, P227, DOI 10.1007/s00299-012-1357-2; NYBOM H, 1990, THEOR APPL GENET, V79, P153, DOI 10.1007/BF00225944; Ogren TL, 2004, ALLERGY FREE GARDENI; Pan IL, 2010, J EXP BOT, V61, P1795, DOI 10.1093/jxb/erq046; Pandolfini T, 2009, NUTRIENTS, V1, P168, DOI 10.3390/nu1020168; Peterson R, 2010, INTEGR J PLANT BIOL, V1, pe13, DOI DOI 10.4081/PB.2010.E13; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; Ranney T.G., 2004, COMBINED P INT PLANT, V54, P604; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shulaev V, 2008, PLANT PHYSIOL, V147, P985, DOI 10.1104/pp.107.115618; Sun YK, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0288-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian Y, 2015, GENE, V555, P277, DOI 10.1016/j.gene.2014.11.018; Tyson RC, 2011, ECOL MODEL, V222, P2084, DOI 10.1016/j.ecolmodel.2011.03.039; van der Linden CG, 2002, J EXP BOT, V53, P1025, DOI 10.1093/jexbot/53.371.1025; Vanblaere T, 2014, PLANT BIOTECHNOL J, V12, P2, DOI 10.1111/pbi.12110; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vining KJ, 2012, HORTSCIENCE, V47, P1210, DOI 10.21273/HORTSCI.47.9.1210; Waltz E, 2015, NAT BIOTECHNOL, V33, P326, DOI 10.1038/nbt0415-326c; Waltz E, 2015, NAT BIOTECHNOL, V33, P12, DOI 10.1038/nbt0115-12; Zhang CS, 2012, PLANT PHYSIOL, V159, P1319, DOI 10.1104/pp.112.197228	46	22	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0159421	10.1371/journal.pone.0159421	http://dx.doi.org/10.1371/journal.pone.0159421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500731	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500008
J	Melade, J; McCulloch, S; Ramasindrazana, B; Lagadec, E; Turpin, M; Pascalis, H; Goodman, SM; Markotter, W; Dellagi, K				Melade, Julien; McCulloch, Stewart; Ramasindrazana, Beza; Lagadec, Erwan; Turpin, Magali; Pascalis, Herve; Goodman, Steven M.; Markotter, Wanda; Dellagi, Koussay			Serological Evidence of Lyssaviruses among Bats on Southwestern Indian Ocean Islands	PLOS ONE			English	Article							INSECTIVOROUS BATS; DUVENHAGE VIRUS; RABIES; ANTIBODIES; PARAMYXOVIRUSES; EPIDEMIOLOGY; DIVERSITY; EMERGENCE; MAMMALS	We provide serological evidence of lyssavirus circulation among bats on southwestern Indian Ocean (SWIO) islands. A total of 572 bats belonging to 22 species were collected on Anjouan, Mayotte, La Reunion, Mauritius, Mahe and Madagascar and screened by the Rapid Fluorescent Focus Inhibition Test for the presence of neutralising antibodies against the two main rabies related lyssaviruses circulating on the African continent: Duvenhage lyssavirus (DUVV) and Lagos bat lyssavirus (LBV), representing phylogroups I and II, respectively. A total of 97 and 42 sera were able to neutralise DUVV and LBV, respectively. No serum neutralised both DUVV and LBV but most DUVV-seropositive bats (n = 32/220) also neutralised European bat lyssavirus 1 (EBLV-1) but not Rabies lyssavirus (RABV), the prototypic lyssavirus of phylogroup I. These results highlight that lyssaviruses belonging to phylogroups I and II circulate in regional bat populations and that the putative phylogroup I lyssavirus is antigenically closer to DUVV and EBLV-1 than to RABV. Variation between bat species, roost sites and bioclimatic regions were observed. All brain samples tested by RTPCR specific for lyssavirus RNA were negative.	[Melade, Julien; Ramasindrazana, Beza; Lagadec, Erwan; Turpin, Magali; Pascalis, Herve; Dellagi, Koussay] Ctr Rech & Veille Malad Emergentes Ocean Indien C, Plateforme Rech CYROI, St Clotilde, Reunion, France; [Melade, Julien; Ramasindrazana, Beza; Lagadec, Erwan; Turpin, Magali; Pascalis, Herve; Dellagi, Koussay] Univ La Reunion, CNRS 9192, UMR PIMIT Proc Infect Milieu Insulaire Trop, Plateforme Rech CYROI,IRD 249,INSERM U1187, St Denis, Reunion, France; [Melade, Julien; Ramasindrazana, Beza; Lagadec, Erwan; Turpin, Magali; Pascalis, Herve; Dellagi, Koussay] IRD, St Clotilde, Reunion, France; [McCulloch, Stewart; Markotter, Wanda] Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, Sch Med,Fac Hlth Sci, Pretoria, South Africa; [Ramasindrazana, Beza; Goodman, Steven M.] Assoc Vahatra, Antananarivo, Madagascar; [Ramasindrazana, Beza] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Goodman, Steven M.] Field Museum Nat Hist, Chicago, IL 60605 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Institut de Recherche pour le Developpement (IRD); University of Pretoria; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Field Museum of Natural History (Chicago)	Dellagi, K (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien C, Plateforme Rech CYROI, St Clotilde, Reunion, France.; Dellagi, K (corresponding author), Univ La Reunion, CNRS 9192, UMR PIMIT Proc Infect Milieu Insulaire Trop, Plateforme Rech CYROI,IRD 249,INSERM U1187, St Denis, Reunion, France.; Dellagi, K (corresponding author), IRD, St Clotilde, Reunion, France.; Markotter, W (corresponding author), Univ Pretoria, Ctr Viral Zoonoses, Dept Med Virol, Sch Med,Fac Hlth Sci, Pretoria, South Africa.	wanda.markotter@up.ac.za; koussay.dellagi@gmail.com	Pascalis, Herve/M-9410-2019; RAMASINDRAZANA, Beza/AGY-9255-2022; Mélade, Julien/GQQ-0118-2022; Pascalis, Herve/F-5726-2014	Pascalis, Herve/0000-0002-6822-7311; Pascalis, Herve/0000-0002-6822-7311; Abid, sayda/0000-0003-2488-1431; McCulloch, Stewart/0000-0001-6656-769X; Markotter, Wanda/0000-0002-7550-0080; RAMASINDRAZANA, Beza/0000-0002-8838-949X	CRVOI; European Regional Development Funds FEDER POCT "Pathogenes associes a la Faune Sauvage Ocean Indien" project [31189]; FEDER-POCT ParamyxOI project [33857]; National Research Foundation, South Africa [91496, 85786]; ECOSAN/CNRS-INEE "Batman"; "RUN-Emerge, European Commission FP7 Regpot Capacity program"; Fonds de Cooperation regionale, Prefecture de La Reunion; Field Museum of Natural History, Chicago, through the Dr. Ralph and Marian Falk Medical Research Trust	CRVOI; European Regional Development Funds FEDER POCT "Pathogenes associes a la Faune Sauvage Ocean Indien" project; FEDER-POCT ParamyxOI project; National Research Foundation, South Africa(National Research Foundation - South Africa); ECOSAN/CNRS-INEE "Batman"; "RUN-Emerge, European Commission FP7 Regpot Capacity program"; Fonds de Cooperation regionale, Prefecture de La Reunion; Field Museum of Natural History, Chicago, through the Dr. Ralph and Marian Falk Medical Research Trust	This work was supported by funding from CRVOI and from the European Regional Development Funds FEDER POCT "Pathogenes associes a la Faune Sauvage Ocean Indien" project (No 31189), and FEDER-POCT ParamyxOI project (No 33857), as well as the National Research Foundation, South Africa (UID 91496, and 85786). Sampling on Mayotte was supported by ECOSAN/CNRS-INEE "Batman". B. Ramasindrazana's postdoctoral fellowship at CRVOI was funded by "RUN-Emerge, European Commission FP7 Regpot Capacity program", the "Fonds de Cooperation regionale, Prefecture de La Reunion", and The Field Museum of Natural History, Chicago, through the Dr. Ralph and Marian Falk Medical Research Trust.	Andriamandimby SF, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-77; Nguyen ATK, 2014, EMERG INFECT DIS, V20, P161, DOI 10.3201/eid2001.130813; [Anonymous], 2014, GUIDELINES PUBLIC HL; Anthony E.L.P., 1988, P47; Arguin PM, 2002, EMERG INFECT DIS, V8, P258, DOI 10.3201/eid0803.010330; Badrane H, 2001, J VIROL, V75, P3268, DOI 10.1128/JVI.75.7.3268-3276.2001; Banyard AC, 2014, VIRUSES-BASEL, V6, P2974, DOI 10.3390/v6082974; BENMANSOUR A, 1991, J VIROL, V65, P4198, DOI 10.1128/JVI.65.8.4198-4203.1991; BOURHY H, 1993, VIROLOGY, V194, P70, DOI 10.1006/viro.1993.1236; Brookes SM, 2006, DEV BIOLOGICALS, V125, P185; Brookes SM, 2005, VACCINE, V23, P4101, DOI 10.1016/j.vaccine.2005.03.037; Coertse J, 2010, J CLIN MICROBIOL, V48, P3949, DOI 10.1128/JCM.01256-10; Dietrich M, 2014, MOL ECOL, V23, P2783, DOI 10.1111/mec.12777; Escobar LE, 2015, REV INST MED TROP SP, V57, P63, DOI 10.1590/S0036-46652015000100009; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gomard Y, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw037; Goodman S.M., 2011, BATS MADAGASCAR, P129; Goodman SM, 2013, ATLAS SELECTED LAND; Goodman Steven M, 2015, Zootaxa, V3936, P538, DOI 10.11646/zootaxa.3936.4.4; Gould AR, 1998, VIRUS RES, V54, P165, DOI 10.1016/S0168-1702(98)00025-2; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Hanlon CA, 2005, VIRUS RES, V111, P44, DOI 10.1016/j.virusres.2005.03.009; Hayman DTS, 2008, EMERG INFECT DIS, V14, P926, DOI 10.3201/eid1406.071421; ICTV, 2014, VIR TAX 2014 REL; Johnson N, 2014, VIRUSES-BASEL, V6, P1911, DOI 10.3390/v6051911; KEMP GE, 1972, AM J TROP MED HYG, V21, P356, DOI 10.4269/ajtmh.1972.21.356; Kgaladi J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002511; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kulzmin IV, 2008, EMERG INFECT DIS, V14, P1887, DOI 10.3201/eid1412.080750; Kuzmin IV, 2008, J CLIN MICROBIOL, V46, P1451, DOI 10.1128/JCM.00016-08; Kuzmin IV, 2011, VECTOR-BORNE ZOONOT, V11, P1465, DOI 10.1089/vbz.2011.0663; Malerczyk C, 2014, HUM VACC IMMUNOTHER, V10, P2799, DOI 10.4161/21645515.2014.972741; Markotter W, 2013, J WILDLIFE DIS, V49, P1000, DOI 10.7589/2012-10-257; Marston DA, 2012, EMERG INFECT DIS, V18, P664, DOI 10.3201/eid1804.111553; Melade J, 2016, SCI REP-UK, V6, DOI 10.1038/srep23752; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; R Core Team, 2021, R LANGUAGE ENV STAT; Racey P.A., 1988, P31; Ramasindrazana B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145709; Reynes Jean-Marc, 2011, Adv Prev Med, V2011, P727821, DOI 10.4061/2011/727821; Reynes JM, 2004, EMERG INFECT DIS, V10, P2231, DOI 10.3201/eid1012.040459; Tortosa P, 2012, INFECT GENET EVOL, V12, P1333, DOI 10.1016/j.meegid.2012.03.024; van Thiel PPAM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000428; Webber BJ, 2014, MMWR-MORBID MORTAL W, V63, P749; WHO, 2013, WHO TECH REP SER, V984, P1; Wilkinson DA, 2014, J VIROL, V88, P8268, DOI 10.1128/JVI.01211-14; Wilkinson DA, 2012, VIRUS RES, V170, P159, DOI 10.1016/j.virusres.2012.08.022	47	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160553	10.1371/journal.pone.0160553	http://dx.doi.org/10.1371/journal.pone.0160553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501458	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500030
J	van Schie, SNS; Sengupta, RN; Herschlag, D				van Schie, Sabine N. S.; Sengupta, Raghuvir N.; Herschlag, Daniel			Differential Assembly of Catalytic Interactions within the Conserved Active Sites of Two Ribozymes	PLOS ONE			English	Article							GROUP-I RIBOZYME; METAL-ION COORDINATION; FREE-ENERGY LANDSCAPE; INDUCED-FIT MECHANISM; CONFORMATIONAL-CHANGE; TETRAHYMENA RIBOZYME; TRANSFER-RNA; PHOSPHOROTHIOATE ANALOGS; GUANOSINE NUCLEOPHILE; SENSING RIBOSWITCH	Molecular recognition is central to biology and a critical aspect of RNA function. Yet structured RNAs typically lack the preorganization needed for strong binding and precise positioning. A striking example is the group I ribozyme from Tetrahymena, which binds its guanosine substrate (G) orders of magnitude slower than diffusion. Binding of G is also thermodynamically coupled to binding of the oligonucleotide substrate (S) and further work has shown that the transition from E.G to E.S.G accompanies a conformational change that allows G to make the active site interactions required for catalysis. The group I ribozyme from Azoarcus has a similarly slow association rate but lacks the coupled binding observed for the Tetrahymena ribozyme. Here we test, using G analogs and metal ion rescue experiments, whether this absence of coupling arises from a higher degree of preorganization within the Azoarcus active site. Our results suggest that the Azoarcus ribozyme forms cognate catalytic metal ion interactions with G in the E.G complex, interactions that are absent in the Tetrahymena E.G complex. Thus, RNAs that share highly similar active site architectures and catalyze the same reactions can differ in the assembly of transition state interactions. More generally, an ability to readily access distinct local conformational states may have facilitated the evolutionary exploration needed to attain RNA machines that carry out complex, multi-step processes.	[van Schie, Sabine N. S.; Sengupta, Raghuvir N.; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [van Schie, Sabine N. S.] Leiden Univ, Leiden Inst Chem, NL-2333 CC Leiden, Netherlands; [Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Stanford ChEM H Chem Engn & Med Human Hlth, Stanford, CA 94305 USA	Stanford University; Leiden University; Leiden University - Excl LUMC; Stanford University; Stanford University; Stanford University	Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Stanford ChEM H Chem Engn & Med Human Hlth, Stanford, CA 94305 USA.	herschla@stanford.edu			National Institutes of Health [GM049243, 5 T32 GM007276]; National Institutes of Health (NIH) [GM049243]; NIH training grant [5 T32 GM007276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049243, T32GM007276, R37GM049243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM049243 (https://www.nih.gov/) to DH, and National Institutes of Health Training Grant 5 T32 GM007276 (https://www.nih.gov/) to RNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Institutes of Health (NIH) to D.H. (GM049243); R.N.S. was supported in part by a NIH training grant (5 T32 GM007276). We thank members of the Herschlag laboratory for helpful discussions.	AURUP H, 1994, NUCLEIC ACIDS RES, V22, P20, DOI 10.1093/nar/22.1.20; Benz-Moy TL, 2011, BIOCHEMISTRY-US, V50, P8733, DOI 10.1021/bi2008245; Chanfreau G, 1996, EMBO J, V15, P3466, DOI 10.1002/j.1460-2075.1996.tb00713.x; Chen WJ, 2014, CURR OPIN STRUC BIOL, V24, P141, DOI 10.1016/j.sbi.2014.01.009; CHRISTIAN EL, 2005, HDB RNA BIOCH; Christian EL, 2005, HDB RNA BIOCH, P319; COHN M, 1982, J BIOL CHEM, V257, P7646; Dai Q, 2007, ORG LETT, V9, P3057, DOI 10.1021/ol071129h; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; ECKSTEIN F, 1983, ANGEW CHEM INT EDIT, V22, P423, DOI 10.1002/anie.198304233; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; Frank J, 2010, ANNU REV BIOCHEM, V79, P381, DOI 10.1146/annurev-biochem-060408-173330; Frederiksen JK, 2009, METHODS, V49, P148, DOI 10.1016/j.ymeth.2009.07.005; Gleitsman KR, 2014, RNA, V20, P1732, DOI 10.1261/rna.044362.114; Guo ZJ, 2009, NAT STRUCT MOL BIOL, V16, P1154, DOI 10.1038/nsmb.1672; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8299, DOI 10.1021/bi00083a034; Hougland JL, 2006, COLD SPRING HARB MON, V43, P133; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; Huang H, 2014, NAT CHEM BIOL, V10, P686, DOI [10.1038/NCHEMBIO.1561, 10.1038/nchembio.1561]; Karbstein K, 2003, P NATL ACAD SCI USA, V100, P2300, DOI 10.1073/pnas.252749799; Karbstein K, 2002, BIOCHEMISTRY-US, V41, P11171, DOI 10.1021/bi0202631; Kim HY, 2008, THESIS; Kuo L, 2004, INORG CHIM ACTA, V357, P3934, DOI 10.1016/j.ica.2004.06.060; Kuo LY, 2001, BBA-GENE STRUCT EXPR, V1522, P158, DOI 10.1016/S0167-4781(01)00327-X; Kuo LY, 1996, NUCLEIC ACIDS RES, V24, P3722, DOI 10.1093/nar/24.19.3722; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Liberman JA, 2012, WIRES RNA, V3, P369, DOI 10.1002/wrna.114; Lipchock SV, 2008, P NATL ACAD SCI USA, V105, P5699, DOI 10.1073/pnas.0712016105; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; Martick M, 2006, CELL, V126, P309, DOI 10.1016/j.cell.2006.06.036; MCCONNELL TS, 1993, P NATL ACAD SCI USA, V90, P8362, DOI 10.1073/pnas.90.18.8362; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Ottink OM, 2007, RNA, V13, P2202, DOI 10.1261/rna.635307; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Sengupta RN, 2016, RNA, V22, P32, DOI 10.1261/rna.053710.115; Serganov A, 2012, ANNU REV BIOPHYS, V41, P343, DOI 10.1146/annurev-biophys-101211-113224; Shan S, 2001, BIOCHEMISTRY-US, V40, P5161, DOI 10.1021/bi002887h; Shan SO, 1999, BIOCHEMISTRY-US, V38, P10958, DOI 10.1021/bi990388e; Shan SO, 1999, BIOCHEMISTRY-US, V38, P10976, DOI 10.1021/bi9903897; Shan SO, 1999, P NATL ACAD SCI USA, V96, P12299, DOI 10.1073/pnas.96.22.12299; Shan SO, 2002, RNA, V8, P861, DOI 10.1017/S1355838202020216; SIGLER PB, 1975, ANNU REV BIOPHYS BIO, V4, P477, DOI 10.1146/annurev.bb.04.060175.002401; Sripathi KN, 2014, RNA, V20, P1112, DOI 10.1261/rna.044982.114; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Strauss-Soukup JK, 2000, J MOL BIOL, V302, P339, DOI 10.1006/jmbi.2000.4056; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Voorhees RM, 2013, ANNU REV BIOCHEM, V82, P203, DOI 10.1146/annurev-biochem-113009-092313; Wang SL, 1999, BIOCHEMISTRY-US, V38, P14363, DOI 10.1021/bi9913202; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013	54	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160457	10.1371/journal.pone.0160457	http://dx.doi.org/10.1371/journal.pone.0160457			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501145	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500026
J	Li, B; Zhang, YP; Li, JJ; Yao, GX; Pan, HQ; Hu, GL; Chen, C; Zhang, HL; Li, ZC				Li, Ben; Zhang, Yanpei; Li, Jinjie; Yao, Guoxin; Pan, Huiqiao; Hu, Guanglong; Chen, Chao; Zhang, Hongliang; Li, Zichao			Fine Mapping of Two Additive Effect Genes for Awn Development in Rice (Oryza sativa L.)	PLOS ONE			English	Article							LOOP-HELIX PROTEIN; DOMESTICATED RICE; IDENTIFICATION; ENCODES; CULTIVATION; POPULATION; GLABERRIMA; TRANSITION; RUFIPOGON; TRAITS	Awns, important domestication and agronomic traits in rice (Oryza sativa L.), are conferred by polygenes and the environment. Near isogenic line (NIL) pairs BM33 and BM38 were constructed from crosses between awnless japonica cv Nipponbare as recurrent parent, and lines SLG or Funingxiaohongmang (awned japonica accessions), respectively, as donors. In order to study the genetic and molecular mechanism of awning, two unknown, independent genes with additive effects were identified in a cross between the NILs. To map and clone the two genes, a BC4F4 population of 8,103 individuals and a BC4F6 population of 11,206 individuals were constructed. Awn3-1 was fine mapped to a 101.13 kb genomic region between Indel marker In316 and SNP marker S9-1 on chromosome 3. Nine predicted genes in the interval were annotated in the Rice Annotation Project Database (RAP-DB), and Os03g0418600 was identified as the most likely candidate for Awn3-1 through sequence comparisons and RT-PCR assays. Awn4-2 was fine mapped to a 62.4 kb genomic region flanked by simple sequence repeat (SSR) marker M1126 and Indel maker In73 on chromosome 4L. This region contained the previously reported gene An-1 that regulates awn development. Thus, An-1 may be the candidate gene of Awn4-2. These results will facilitate cloning of the awn genes and thereby provide an understanding of the molecular basis of awn development.	[Li, Zichao] China Agr Univ, Minist Educ, Key Lab Crop Heterosis & Utilizat, Beijing 100193, Peoples R China; China Agr Univ, Beijing Key Lab Crop Genet Improvement, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University	Li, ZC (corresponding author), China Agr Univ, Minist Educ, Key Lab Crop Heterosis & Utilizat, Beijing 100193, Peoples R China.	lizichao@cau.edu.cn	pan, huiqiao/A-5785-2015; Li, Zichao/AAS-8954-2021	Li, Zichao/0000-0002-3186-1132	National Science Foundation of China [31271689]; China National Key Technologies RD Program [2015BAD02B00, 2013BAD01B02-15]; 948 project of the Ministry Of Agriculture [2011-G2B, 2011-G1 (2)-25]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Key Technologies RD Program(National Key Technology R&D Program); 948 project of the Ministry Of Agriculture	This study was supported by National Science Foundation of China (31271689), China National Key Technologies R&D Program (2015BAD02B00 and 2013BAD01B02-15), and 948 project of the Ministry Of Agriculture (2011-G2B and 2011-G1 (2)-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Robert A McIntosh, University of Sydney, for critical reading of the manuscript and suggestions for revision. This study was supported by National Science Foundation of China (31271689), China National Key Technologies R&D Program (2015BAD02B00 and 2013BAD01B02-15), and 948 project of the Ministry Of Agriculture (2011-G2B and 2011-G1 (2)-25).	Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Furuta T, 2015, G3-GENES GENOM GENET, V5, P2267, DOI 10.1534/g3.115.020834; Gutierrez AG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-6; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; GRUNDBACHER FJ, 1963, BOT REV, V29, P366, DOI 10.1007/BF02860824; Gu BG, 2015, MOL PLANT, V8, P1635, DOI 10.1016/j.molp.2015.08.001; Hu GL, 2011, CHINESE SCI BULL, V56, P835, DOI 10.1007/s11434-010-4181-5; Hua L, 2015, PLANT CELL, V27, P1875, DOI 10.1105/tpc.15.00260; Ishii T, 2013, NAT GENET, V45, P462, DOI 10.1038/ng.2567; Jin Feng-Xue, 2009, Journal of Crop Science and Biotechnology, V12, P9; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Lu XC, 2008, PLANT BIOLOGY, V10, P365, DOI 10.1111/j.1438-8677.2008.00033.x; Luo JH, 2013, PLANT CELL, V25, P3360, DOI 10.1105/tpc.113.113589; Ma Y, 2015, CELL, V160, P1209, DOI 10.1016/j.cell.2015.01.046; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sato S, 1996, BREEDING SCI, V46, P321; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Toriba T, 2014, PLANT J, V77, P616, DOI 10.1111/tpj.12411; [王军 Wang Jun], 2013, [华北农学报, Acta Agriculturae Boreali-Sinica], V28, P7; Xiong LX, 1999, THEOR APPL GENET, V98, P243, DOI 10.1007/s001220051064; Yao GuoXin, 2010, Journal of China Agricultural University, V15, P1; ZHANG QF, 1994, P NATL ACAD SCI USA, V91, P8675, DOI 10.1073/pnas.91.18.8675; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	32	1	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160792	10.1371/journal.pone.0160792	http://dx.doi.org/10.1371/journal.pone.0160792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494628	gold, Green Published, Green Submitted			2022-12-26	WOS:000381369500083
J	Mediero, A; Wilder, T; Reddy, VSR; Cheng, Q; Tovar, N; Coelho, PG; Witek, L; Whatling, C; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Reddy, Vishnu S. R.; Cheng, Qian; Tovar, Nick; Coelho, Paulo G.; Witek, Lukasz; Whatling, Carl; Cronstein, Bruce N.			Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism	FASEB JOURNAL			English	Article						antiplatelet drugs; A(2A)R; bone regeneration; 3-D HA; -TCP scaffolds	ACTIVE METABOLITE; P2X7 RECEPTORS; A(2A) RECEPTOR; A2A RECEPTOR; PROTEIN-2; REGENERATION; INFLAMMATION; SUPPRESSION; ACTIVATION; EXPRESSION	As many as 10% of bone fractures heal poorly, and large bone defects resulting from trauma, tumor, or infection may not heal without surgical intervention. Activation of adenosine A(2A) receptors (A(2A)Rs) stimulates bone formation. Ticagrelor and dipyridamole inhibit platelet function by inhibiting P2Y(12) receptors and platelet phosphodiesterase, respectively, but share the capacity to inhibit cellular uptake of adenosine and thereby increase extracellular adenosine levels. Because dipyridamole promotes bone regeneration by an A(2A)R-mediated mechanism we determined whether ticagrelor could regulate the cells involved in bone homeostasis and regeneration in a murine model and whether inhibition of P2Y(12) or indirect A(2A)R activation via adenosine was involved. Ticagrelor, dipyridamole and the active metabolite of clopidogrel (CAM), an alternative P2Y(12) antagonist, inhibited osteoclast differentiation and promoted osteoblast differentiation in vitro. A(2A)R blockade abrogated the effects of ticagrelor and dipyridamole on osteoclast and osteoblast differentiation whereas A(2B)R blockade abrogated the effects of CAM. Ticagrelor and CAM, when applied to a 3-dimentional printed resorbable calcium-triphosphate/hydroxyapatite scaffold implanted in a calvarial bone defect, promoted significantly more bone regeneration than the scaffold alone and as much bone regeneration as BMP-2, a growth factor currently used to promote bone regeneration. These results suggest novel approaches to targeting adenosine receptors in the promotion of bone regeneration.Mediero, A., Wilder, T., Reddy, V. S. R., Cheng, Q., Tovar, N., Coelho, P. G., Witek, L., Whatling, C., Cronstein, B. N. Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism.	[Mediero, Aranzazu] Univ Autonoma Madrid, Inst Invest Sanitaria, Bone & Joint Res Unit, Fdn Jimenez Diaz, Madrid, Spain; [Wilder, Tuere; Cheng, Qian; Cronstein, Bruce N.] NYU, Dept Med, Div Translat Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Reddy, Vishnu S. R.; Tovar, Nick; Coelho, Paulo G.; Witek, Lukasz] NYU Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Whatling, Carl] AstraZeneca R&D, Cardiovasc & Metab Dis Innovat Med Unit, Translat Sci, Molndal, Sweden	Autonomous University of Madrid; Fundacion Jimenez Diaz; New York University; NYU Langone Medical Center; New York University; AstraZeneca	Cronstein, BN (corresponding author), NYU Sch Med, Div Translat Med, Dept Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020; Witek, Lukasz/AAU-5689-2020; Coelho, Paulo G/B-2999-2014	Witek, Lukasz/0000-0003-1458-6527; Coelho, Paulo G/0000-0001-8347-6124; Cronstein, Bruce/0000-0002-4295-7383; Pintor, Jesus/0000-0002-9191-7679; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR54897, AR046121]; NIH National Heart, Lung, and Blood Institute [RC1HL100815]; NYU-HHC Clinical and Translational Science Institute [UL1TR000038]; NYU Georgia Family Support Program [9NIH/NCI 5 P30CA16087-310]; AstraZeneca; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121, R01AR056672, R01AR068593, R56AR056672, R01AR054897] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NYU-HHC Clinical and Translational Science Institute; NYU Georgia Family Support Program; AstraZeneca(AstraZeneca); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR56672, AR54897, and AR046121 to B.N.C.) and the NIH National Heart, Lung, and Blood Institute (Grant RC1HL100815 to B.N.C.); the NYU-HHC Clinical and Translational Science Institute (Grant UL1TR000038 to B.N.C.) and the NYU Georgia Family Support Program (Grant 9NIH/NCI 5 P30CA16087-310 to B.N.C.); and by a grant from AstraZeneca. A.M. and B.N.C. have filed a patent on the use of adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending) and a patent on the use of antibodies against Netrin-1 for the treatment of bone diseases. B.N.C. holds patents numbers 5,932,558; 6,020,321; 6,555,545; 7,795,427; adenosine A<INF>1</INF>R and A<INF>2B</INF>R antagonists to treat fatty liver (pending); adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). B.N.C. is a consultant for Bristol-Myers Squibb, AstraZeneca, Novartis, CanFite Biopharmaceuticals, Cypress Laboratories, Regeneron (Westat, DSMB), Endocyte, Protalex, Allos, Inc., Savient, Gismo Therapeutics, Antares Pharmaceutical, Medivector, King Pharmaceutical, Celizome, Tap Pharmaceuticals, Prometheus Laboratories, Sepracor, Amgen, Combinatorx, Kyowa Hakka, Hoffman-LaRoche, and Avidimer Therapeutics. B.N.C. has stock in CanFite Biopharmaceuticals. The remaining authors declare no conflicts of interest.	Armstrong D, 2014, J CARDIOVASC PHARM T, V19, P209, DOI 10.1177/1074248413511693; Bonello L, 2014, J AM COLL CARDIOL, V63, P872, DOI 10.1016/j.jacc.2013.09.067; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cattaneo M, 2014, J AM COLL CARDIOL, V63, P2503, DOI 10.1016/j.jacc.2014.03.031; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI 10.1055/s-0029-1215875; Gartland A, 2012, FRONT BIOSCI-LANDMRK, V17, P16, DOI 10.2741/3912; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Ishack S, 2017, J BIOMED MATER RES B, V105, P366, DOI 10.1002/jbm.b.33561; Kanakaris Nikolaos K, 2008, J Surg Orthop Adv, V17, P133; Korcok J, 2004, J BONE MINER RES, V19, pS418; Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2013, TRENDS ENDOCRIN MET, V24, P290, DOI 10.1016/j.tem.2013.02.001; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040; Montesinos MC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1914; Moriyama K, 2010, J BIOL CHEM, V285, P39271, DOI 10.1074/jbc.M109.098293; Noe L, 2010, CURR MED CHEM, V17, P2897, DOI 10.2174/092986710792065018; Nylander S, 2013, J THROMB HAEMOST, V11, P1867, DOI 10.1111/jth.12360; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pereillo JM, 2002, DRUG METAB DISPOS, V30, P1288, DOI 10.1124/dmd.30.11.1288; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; SAVI P, 1992, BIOCHEM PHARMACOL, V44, P527, DOI 10.1016/0006-2952(92)90445-O; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Siddiqui NA, 2013, CURR STEM CELL RES T, V8, P192; Silva NRFA, 2011, J PROSTHODONT, V20, P93, DOI 10.1111/j.1532-849X.2010.00623.x; Spiro AS, 2010, J ORTHOP RES, V28, P785, DOI 10.1002/jor.21044; Sterling JA, 2014, CURR OSTEOPOROS REP, V12, P48, DOI 10.1007/s11914-014-0187-2; Su XM, 2012, J CLIN INVEST, V122, P3579, DOI 10.1172/JCI38576; Syberg S, 2012, J BONE MINER RES, V27, P2373, DOI 10.1002/jbmr.1690; Szpalski C, 2012, J CRANIOFAC SURG, V23, P638, DOI 10.1097/SCS.0b013e31824db8d4; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; van Giezen JJJ, 2012, J CARDIOVASC PHARM T, V17, P164, DOI 10.1177/1074248411410883; Wesselius A, 2011, FRONT BIOSCI-LANDMRK, V16, P2572, DOI 10.2741/3873; Wiebe SH, 1999, CELL PHYSIOL BIOCHEM, V9, P323, DOI 10.1159/000016326; Witek L, 2013, J ADV CERAM, V2, P274, DOI 10.1007/s40145-013-0072-y; Wittfeldt A, 2013, J AM COLL CARDIOL, V61, P723, DOI 10.1016/j.jacc.2012.11.032; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0	52	28	30	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3887	3900		10.1096/fj.201600616R	http://dx.doi.org/10.1096/fj.201600616R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27511945	Green Published			2022-12-26	WOS:000386474700023
J	Ardehed, A; Johansson, D; Sundqvist, L; Schagerstrom, E; Zagrodzka, Z; Kovaltchouk, NA; Bergstrom, L; Kautsky, L; Rafajlovic, M; Pereyra, RT; Johannesson, K				Ardehed, Angelica; Johansson, Daniel; Sundqvist, Lisa; Schagerstrom, Ellen; Zagrodzka, Zuzanna; Kovaltchouk, Nikolaj A.; Bergstrom, Lena; Kautsky, Lena; Rafajlovic, Marina; Pereyra, Ricardo T.; Johannesson, Kerstin			Divergence within and among Seaweed Siblings (Fucus vesiculosus and F. radicans) in the Baltic Sea	PLOS ONE			English	Article							POPULATION-STRUCTURE; MORPHOLOGICAL VARIATION; PHAEOPHYCEAE; HETEROKONTOPHYTA; SERRATUS; HYBRIDIZATION; FUCACEAE; DIFFERENTIATION; EVANESCENS; SPECIATION	Closely related taxa provide significant case studies for understanding evolution of new species but may simultaneously challenge species identification and definition. In the Baltic Sea, two dominant and perennial brown algae share a very recent ancestry. Fucus vesiculosus invaded this recently formed postglacial sea 8000 years ago and shortly thereafter Fucus radicans diverged from this lineage as an endemic species. In the Baltic Sea both species reproduce sexually but also recruit fully fertile new individuals by asexual fragmentation. Earlier studies have shown local differences in morphology and genetics between the two taxa in the northern and western Bothnian Sea, and around the island of Saaremaa in Estonia, but geographic patterns seemin conflict with a single origin of F. radicans. To investigate the relationship between northern and Estonian distributions, we analysed the genetic variation using 9 microsatellite loci in populations from eastern Bothnian Sea, Archipelago Sea and the Gulf of Finland. These populations are located in between earlier studied populations. However, instead of bridging the disparate genetic gap between N-W Bothnian Sea and Estonia, as expected from a simple isolation-by-distance model, the new populations substantially increased overall genetic diversity and showed to be strongly divergent from the two earlier analysed regions, showing signs of additional distinct populations. Contrasting earlier findings of increased asexual recruitment in low salinity in the Bothnian Sea, we found high levels of sexual reproduction in some of the Gulf of Finland populations that inhabit extremely low salinity. The new data generated in this study supports the earlier conclusion of two reproductively isolated but very closely related species. However, the new results also add considerable genetic and morphological complexity within species. This makes species separation at geographic scales more demanding and suggests a need for more comprehensive approaches to further disentangle the intriguing relationship and history of the Baltic Sea fucoids.	[Ardehed, Angelica; Johansson, Daniel] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Ardehed, Angelica; Johansson, Daniel; Sundqvist, Lisa; Zagrodzka, Zuzanna; Rafajlovic, Marina; Pereyra, Ricardo T.; Johannesson, Kerstin] Univ Gothenburg, Ctr Marine Evolutionary Biol, Gothenburg, Sweden; [Sundqvist, Lisa] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Schagerstrom, Ellen; Kautsky, Lena] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Zagrodzka, Zuzanna; Pereyra, Ricardo T.; Johannesson, Kerstin] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden; [Kovaltchouk, Nikolaj A.] Russian Acad Sci, Komarov Bot Inst, St Petersburg, Russia; [Bergstrom, Lena] Swedish Univ Agr Sci, Dept Aquat Resources, Oregrund, Sweden; [Rafajlovic, Marina] Univ Gothenburg, Dept Phys, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; Stockholm University; University of Gothenburg; Russian Academy of Sciences; Komarov Botanical Institute, Russian Academy of Sciences; Swedish University of Agricultural Sciences; University of Gothenburg	Johannesson, K (corresponding author), Univ Gothenburg, Ctr Marine Evolutionary Biol, Gothenburg, Sweden.; Johannesson, K (corresponding author), Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden.	Kerstin.Johannesson@gu.se	Johannesson, Kerstin/X-7994-2019; Rafajlovic, Marina/ABB-8142-2021; Zagrodzka, Zuzanna/AAE-4541-2021; Sundqvist, Lisa/G-7270-2015	Johannesson, Kerstin/0000-0003-0176-7986; Rafajlovic, Marina/0000-0003-2177-4622; Bergstrom, Lena/0000-0002-8059-8764; Sundqvist, Lisa/0000-0001-6200-2894; Schagerstrom, Ellen/0000-0003-2085-0013	C.F. Lundstrom foundation; Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (Formas); Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (VR); BONUS (Art 185) - EU; BONUS (Art 185) - Formas	C.F. Lundstrom foundation; Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (Formas); Centre of Marine Evolutionary Biology at University of Gothenburg - Swedish Research Council (VR); BONUS (Art 185) - EU; BONUS (Art 185) - Formas	The authors acknowledge financial support from C.F. Lundstrom foundation, Centre of Marine Evolutionary Biology (www.cemeb.gu.se) at University of Gothenburg supported by the Swedish Research Councils (Formas and VR), and support to the project BAMBI from BONUS (Art 185) funded jointly by EU and Formas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Helena Forslund, Jens Perus, Jessica Oremus, Tomas Meier and Annika Lindstrom who contributed to different parts of the fieldwork. We also kindly acknowledge the financial support from C.F. Lundstrom foundation, Centre of Marine Evolutionary Biology (www.cemeb.gu.se) at University of Gothenburg supported by the Swedish Research Councils (Formas and VR), and support to the project BAMBI from BONUS (Art 185) funded jointly by EU and Formas.	Andrejev O, 2004, BOREAL ENVIRON RES, V9, P1; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Ardehed A, 2015, ECOL EVOL, V5, P4233, DOI 10.1002/ece3.1629; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; BACK S, 1993, ANN BOT FENN, V30, P275; BAKER HG, 1967, EVOLUTION, V21, P853, DOI 10.1111/j.1558-5646.1967.tb03440.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom L, 2005, J PHYCOL, V41, P1025, DOI 10.1111/j.1529-8817.2005.00125.x; Bergstrom L, 2003, BOT MAR, V46, P125, DOI 10.1515/BOT.2003.013; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Canovas FG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-371; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Coyer JA, 2007, J EVOLUTION BIOL, V20, P2322, DOI 10.1111/j.1420-9101.2007.01411.x; Coyer JA, 2006, MOL PHYLOGENET EVOL, V39, P209, DOI 10.1016/j.ympev.2006.01.019; Coyer JA, 2002, P ROY SOC B-BIOL SCI, V269, P1829, DOI 10.1098/rspb.2002.2093; Coyer JA, 2003, MOL ECOL, V12, P1817, DOI 10.1046/j.1365-294X.2003.01850.x; Durrant HMS, 2014, CONSERV BIOL, V28, P438, DOI 10.1111/cobi.12203; Engel CR, 2003, MOL ECOL NOTES, V3, P180, DOI 10.1046/j.1471-8286.2003.00390.x; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Feistel R, 2010, OCEAN SCI, V6, P3, DOI 10.5194/os-6-3-2010; Forslund H, 2013, MAR BIOL RES, V9, P262, DOI 10.1080/17451000.2012.731694; Forslund H, 2012, MAR BIOL RES, V8, P322, DOI 10.1080/17451000.2011.637565; Goudet J., 2005, PCAGEN 1 2 1; Gunnarsson K, 2012, MAR BIOL RES, V8, P87, DOI 10.1080/17451000.2011.594890; Gylle AM, 2011, J PHYCOL, V47, P98, DOI 10.1111/j.1529-8817.2010.00928.x; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Johannesson K, 2011, J PHYCOL, V47, P990, DOI 10.1111/j.1529-8817.2011.01032.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kemppainen P, 2009, J EVOLUTION BIOL, V22, P2000, DOI 10.1111/j.1420-9101.2009.01810.x; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; McCarthy MA, 1997, ECOL MODEL, V103, P99, DOI 10.1016/S0304-3800(97)00104-X; Panova M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-687; Pereyra RT, 2013, J EVOLUTION BIOL, V26, P1727, DOI 10.1111/jeb.12170; Pereyra RT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-70; Perrin C, 2007, EUR J PHYCOL, V42, P219, DOI 10.1080/09670260701336554; Pritchard JK, 2000, GENETICS, V155, P945; Raberg S, 2007, ESTUAR COAST SHELF S, V73, P249, DOI 10.1016/j.ecss.2007.01.005; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Reichel K, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0388-z; Rothausler E, 2015, LIMNOL OCEANOGR, V60, P2173, DOI 10.1002/lno.10195; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruuskanen A, 1999, OPHELIA, V50, P43, DOI 10.1080/00785326.1999.10409388; Schagerstrom E, 2014, ESTUAR COAST SHELF S, V149, P187, DOI 10.1016/j.ecss.2014.08.022; Serrao EA, 1999, J PHYCOL, V35, P254, DOI 10.1046/j.1529-8817.1999.3520254.x; Serrao EA, 1996, OECOLOGIA, V107, P1, DOI 10.1007/BF00582229; Sundqvist L, 2016, ECOL EVOL, V6, P3461, DOI 10.1002/ece3.2096; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Tatarenkov A, 2007, J PHYCOL, V43, P675, DOI 10.1111/j.1529-8817.2007.00369.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Voipio A., 1981, BALTIC SEA; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westerbom M, 2002, MAR BIOL, V140, P991, DOI 10.1007/s00227-001-0765-6	52	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161266	10.1371/journal.pone.0161266	http://dx.doi.org/10.1371/journal.pone.0161266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525655	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100050
J	Ma, W; Waffo-Teguo, P; Jourdes, M; Li, H; Teissedre, PL				Ma, Wen; Waffo-Teguo, Pierre; Jourdes, Michael; Li, Hua; Teissedre, Pierre-Louis			Chemical Affinity between Tannin Size and Salivary Protein Binding Abilities: Implications for Wine Astringency	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; GRAPE SEEDS; RED WINE; POLYMERIC PROCYANIDINS; BY-PRODUCTS; PROANTHOCYANIDINS; CHROMATOGRAPHY; VARIETIES; PHASE; QUANTIFICATION	Astringency perception, as an essential parameter for high-quality red wine, is principally elicited by condensed tannins in diversified chemical structures. Condensed tannins, which are also known as proanthocyanidins (PAs), belong to the flavonoid class of polyphenols and are incorporated by multiple flavan-3-ols units according to their degree of polymerization (DP). However, the influence of DP size of PAs on astringency perception remains unclear for decades. This controversy was mainly attributed to the lack of efficient strategies to isolate the PAs in non-galloylated forms and with individual degree size from grape/ wine. In the present study, the astringency intensity of purified and identified grape oligomeric tannins (DP ranged from 1 to 5) was firstly explored. A novel non-solid phase strategy was used to rapidly exclude the galloylated PAs from the non-galloylated PAs and fractionate the latter according to their DP size. Then, a series of PAs with individual DP size and galloylation were purified by an approach of preparative hydrophilic interaction chromatography. Furthermore, purified compounds were identified by both normal phase HPLC-FLD and reverse phase UHPLC-ESI-Q-TOF. Finally, the contribution of the astringency perception of the individual purified tannins was examined with a salivary protein binding ability test. The results were observed by HPLC-FLD and quantified by changes in PA concentration remaining in the filtrate. In summary, a new approach without a solid stationary phase was developed to isolate PAs according to their DP size. And a positive relationship between the DP of PAs and salivary protein affinity was revealed.	[Ma, Wen; Li, Hua] Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China; [Ma, Wen; Li, Hua] Northwest A&F Univ, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China; [Ma, Wen; Waffo-Teguo, Pierre; Jourdes, Michael; Teissedre, Pierre-Louis] Univ Bordeaux, ISVV, EA 4577, Unite Rech OENOL, F-33882 Villenave Dornon, France; [Ma, Wen; Waffo-Teguo, Pierre; Jourdes, Michael; Teissedre, Pierre-Louis] INRA, ISVV, USC OENOL 1366, F-33882 Villenave Dornon, France	Northwest A&F University - China; Northwest A&F University - China; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Li, H (corresponding author), Northwest A&F Univ, Coll Enol, Yangling, Shaanxi, Peoples R China.; Li, H (corresponding author), Northwest A&F Univ, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China.; Teissedre, PL (corresponding author), Univ Bordeaux, ISVV, EA 4577, Unite Rech OENOL, F-33882 Villenave Dornon, France.; Teissedre, PL (corresponding author), INRA, ISVV, USC OENOL 1366, F-33882 Villenave Dornon, France.	lihuawine@nwsuaf.edu.cn; pierre-louis.teissedre@u-bordeaux.fr	Teissedre, Pierre-Louis/I-6885-2016	TEISSEDRE, Pierre-Louis/0000-0002-0115-5456; Ma, Wen/0000-0003-2765-6301	China Scholarship Council, China	China Scholarship Council, China(China Scholarship Council)	Wen Ma was supported by a grant from China Scholarship Council, China.	Bindon K, 2014, J AGR FOOD CHEM, V62, P11582, DOI 10.1021/jf503922h; Cala O, 2010, FASEB J, V24, P4281, DOI 10.1096/fj.10-158741; Cheah KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098921; Chen SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126457; Cheynier V, 1998, METHOD ENZYMOL, P178; Chira K, 2011, MOLECULES, V16, P1519, DOI 10.3390/molecules16021519; de Freitas VAP, 1998, PHYTOCHEMISTRY, V49, P1435, DOI 10.1016/S0031-9422(98)00107-1; Gabetta B, 2000, FITOTERAPIA, V71, P162, DOI 10.1016/S0367-326X(99)00161-6; Gu LW, 2002, J AGR FOOD CHEM, V50, P4852, DOI 10.1021/jf020214v; Kelm MA, 2006, J AGR FOOD CHEM, V54, P1571, DOI 10.1021/jf0525941; Kennedy JA, 2003, J CHROMATOGR A, V995, P99, DOI 10.1016/S0021-9673(03)00420-5; Ky I, 2014, MOLECULES, V19, P482, DOI 10.3390/molecules19010482; Labarbe B, 1999, J AGR FOOD CHEM, V47, P2719, DOI 10.1021/jf990029q; LEA AGH, 1992, BASIC LIFE SCI, V59, P827; Li HJ, 2008, J MASS SPECTROM, V43, P1353, DOI 10.1002/jms.1411; Li HJ, 2007, ANAL CHEM, V79, P1739, DOI 10.1021/ac061823v; Liu X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151276; Lorrain B, 2013, FOOD CHEM, V140, P76, DOI 10.1016/j.foodchem.2013.02.048; Ma W, 2014, TRENDS FOOD SCI TECH, V40, P6, DOI 10.1016/j.tifs.2014.08.001; Pechamat L, 2014, J AGR FOOD CHEM, V62, P1701, DOI 10.1021/jf4052754; Peleg H, 1999, J SCI FOOD AGR, V79, P1123, DOI 10.1002/(SICI)1097-0010(199906)79:8<1123::AID-JSFA336>3.3.CO;2-4; Peynaud E., 2013, LE GOUT DU VIN; Rendeiro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063535; Gonzalez-Centeno MR, 2012, J AGR FOOD CHEM, V60, P11850, DOI 10.1021/jf303047k; Ribereau-Gayon P., 2006, HDB ENOLOGY MICROBIO, VVolume 1, P327, DOI [10.1002/0470010398, DOI 10.1002/0470010398]; Robbins RJ, 2012, J AOAC INT, V95, P1153, DOI 10.5740/jaoacint.12-162; Schwarz B, 2008, EUR FOOD RES TECHNOL, V227, P1693, DOI 10.1007/s00217-008-0895-x; Spranger I, 2008, FOOD CHEM, V108, P519, DOI 10.1016/j.foodchem.2007.11.004; Sun BS, 1999, J CHROMATOGR A, V841, P115, DOI 10.1016/S0021-9673(99)00281-2; Sun BS, 1998, J AGR FOOD CHEM, V46, P1390, DOI 10.1021/jf970753d; Waterhouse AL, 2000, AM J ENOL VITICULT, V51, P383; Xiao JS, 2008, J AGR FOOD CHEM, V56, P2096, DOI 10.1021/jf072679x; Zeng L, 2016, RAPID COMMUN MASS SP, V30, P81, DOI 10.1002/rcm.7416	33	24	25	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161095	10.1371/journal.pone.0161095	http://dx.doi.org/10.1371/journal.pone.0161095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518822	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100046
J	Togo, Y; Takahashi, K; Saito, K; Kiso, H; Tsukamoto, H; Huang, B; Yanagita, M; Sugai, M; Harada, H; Komori, T; Shimizu, A; MacDougall, M; Bessho, K				Togo, Yumiko; Takahashi, Katsu; Saito, Kazuyuki; Kiso, Honoka; Tsukamoto, Hiroko; Huang, Boyen; Yanagita, Motoko; Sugai, Manabu; Harada, Hidemitsu; Komori, Toshihisa; Shimizu, Akira; MacDougall, Mary; Bessho, Kazuhisa			Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; RECOMBINANT ECTODYSPLASIN; STEM-CELLS; MOUSE; TEETH; EXPRESSION; CBFA1; ABNORMALITIES; ACTIVATOR; PREVENTS	Supernumerary teeth and tooth agenesis are common morphological anomalies in humans. We previously obtained evidence that supernumerary maxillary incisors form as a result of the successive development of the rudimentary maxillary incisor tooth germ in Usag-1 null mice. The development of tooth germs is arrested in Runx2 null mice, and such mice also exhibit lingual epithelial buds associated with the upper molars and incisors. The aim of this study is to investigate the potential crosstalk between Usag-1 and Runx2 during tooth development. In the present study, three interesting phenomena were observed in double null Usag-1(-/-)/Runx2(-/-) mice: the prevalence of supernumerary teeth was lower than in Usag-1 null mice; tooth development progressed further compared than in Runx2 null mice; and the frequency of molar lingual buds was lower than in Runx2 null mice. Therefore, we suggest that RUNX2 and USAG-1 act in an antagonistic manner. The lingual bud was completely filled with odontogenic epithelial Sox2-positive cells in the Usag-1(+/+)/Runx2(-/-) mice, whereas almost no odontogenic epithelial Sox2-positive cells contributed to supernumerary tooth formation in the rudimentary maxillary incisors of the Usag-1(-/-)/Runx2(+/+) mice. Our findings suggest that RUNX2 directly or indirectly prevents the differentiation and/or proliferation of odontogenic epithelial Sox2-positive cells. We hypothesize that RUNX2 inhibits the bone morphogenetic protein (BMP) and/ or Wnt signaling pathways regulated by USAG-1, whereas RUNX2 expression is induced by BMP signaling independently of USAG-1.	[Togo, Yumiko; Takahashi, Katsu; Saito, Kazuyuki; Kiso, Honoka; Tsukamoto, Hiroko; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Huang, Boyen] Charles Sturt Univ, Sch Dent & Hlth Sci, Fac Sci, Orange, NSW 2800, Australia; [Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [Sugai, Manabu] Univ Fukui, Dept Mol Genet, Div Med, Fac Med Sci, Eiheiji, Fukui 9101193, Japan; [Harada, Hidemitsu] Iwate Med Univ, Div Dev Biol & Regenerat Med, Dept Anat, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan; [Komori, Toshihisa] Nagasaki Univ, Dept Cell Biol, Unit Basic Med Sci, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528588, Japan; [Shimizu, Akira] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept Expt Therapeut, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan; [MacDougall, Mary] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Inst Oral Hlth Res, Birmingham, AL 35294 USA	Kyoto University; Charles Sturt University; Kyoto University; University of Fukui; Iwate Medical University; Nagasaki University; Kyoto University; University of Alabama System; University of Alabama Birmingham	Takahashi, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	takahask@kuhp.kyoto-u.ac.jp	Huang, Boyen/I-7768-2014; Huang, Boyen/GRE-5912-2022; Yanagita, Motoko/AAJ-7731-2021; Huang, Boyen/AAR-3348-2020; Harada, Hidemitsu/P-5692-2017; MacDougall, Mary/ABG-8212-2021	Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Huang, Boyen/0000-0002-1246-7447; Harada, Hidemitsu/0000-0002-9724-8568; Yanagita, Motoko/0000-0002-0339-9008; Sugai, Manabu/0000-0003-1668-7647	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R D) FS stage [AS231Z01061G, AS242Z02645Q];  [22592213];  [25463081]; Grants-in-Aid for Scientific Research [24390073, 25293069] Funding Source: KAKEN	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R D) FS stage; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research(C) Nos. 22592213 and 25463081 and A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R& D) FS stage: AS231Z01061G and AS242Z02645Q. KT received all of the above funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; Callea M, 2012, BMJ CASE REP, V5; Camilleri S, 2006, EUR J ORAL SCI, V114, P361, DOI 10.1111/j.1600-0722.2006.00399.x; Casal ML, 2007, AM J HUM GENET, V81, P1050, DOI 10.1086/521988; Chen S, 2002, CONNECT TISSUE RES, V43, P338, DOI 10.1080/03008200290000691; Chen S, 2009, J DENT RES, V88, P904, DOI 10.1177/0022034509342873; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; FITZGERALD LR, 1973, ARCH ORAL BIOL, V18, P381, DOI 10.1016/0003-9969(73)90162-3; Fleischmannova J, 2008, EUR J ORAL SCI, V116, P1, DOI 10.1111/j.1600-0722.2007.00504.x; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Huang B, 2013, ORAL DIS, V19, P144, DOI 10.1111/j.1601-0825.2012.01963.x; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jiang HP, 1999, MECH DEVELOP, V81, P169, DOI 10.1016/S0925-4773(98)00232-9; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; KAUFMAN MH, 1995, J ANAT, V186, P607; Kiso H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096938; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kowalczyk C, 2011, J BIOL CHEM, V286, P30769, DOI 10.1074/jbc.M111.267997; Kurosaka H, 2011, STEM CELLS, V29, P1792, DOI 10.1002/stem.722; Lagronova-Churava S, 2013, J EXP ZOOL PART B, V320B, P307, DOI 10.1002/jez.b.22502; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murashima-Suginami A, 2008, BIOCHEM BIOPH RES CO, V369, P1012, DOI 10.1016/j.bbrc.2008.02.135; Murashima-Suginami A, 2007, BIOCHEM BIOPH RES CO, V359, P549, DOI 10.1016/j.bbrc.2007.05.148; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Nakamura T, 2008, J BIOL CHEM, V283, P4825, DOI 10.1074/jbc.M708388200; Ohazama A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004092; Otsu K, 2011, J CELL PHYSIOL, V226, P2527, DOI 10.1002/jcp.22597; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pispa J, 2004, DEV DYNAM, V231, P432, DOI 10.1002/dvdy.20138; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Takahashi K, 2013, GENE THERAPY TOOLS P, P727; Tucker AS, 2004, DEV BIOL, V268, P185, DOI 10.1016/j.ydbio.2003.12.019; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2009, DEVELOPMENT, V136, P1939, DOI 10.1242/dev.033803; Wang XP, 2005, J DENT RES, V84, P138, DOI 10.1177/154405910508400206; Yamamoto H, 2005, ARCH ORAL BIOL, V50, P189, DOI 10.1016/j.archoralbio.2004.11.010; Yanagita M, 2006, KIDNEY INT, V70, P989, DOI 10.1038/sj.ki.5001731; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhang ZY, 2009, SCIENCE, V323, P1232, DOI 10.1126/science.1167418; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	52	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161067	10.1371/journal.pone.0161067	http://dx.doi.org/10.1371/journal.pone.0161067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518316	Green Submitted, gold, Green Published			2022-12-26	WOS:000381382100042
J	Bates, MA; Brandenberger, C; Langohr, II; Kumagai, K; Lock, AL; Harkema, JR; Holian, A; Pestka, JJ				Bates, Melissa A.; Brandenberger, Christina; Langohr, Ingeborg I.; Kumagai, Kazuyoshi; Lock, Adam L.; Harkema, Jack R.; Holian, Andrij; Pestka, James J.			Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption	PLOS ONE			English	Article							DIETARY FISH-OIL; ZEALAND MIXED MICE; GROWTH-FACTOR-BETA; MURINE LUPUS; EICOSAPENTAENOIC ACID; ALVEOLAR MACROPHAGES; APOPTOTIC CELLS; OMEGA-3 LIPIDS; RAPID METHOD; FATTY-ACIDS	Occupational exposure to respirable crystalline silica (cSiO(2), quartz) is etiologically linked to systemic lupus erythematosus (lupus) and other human autoimmune diseases (ADs). In the female NZBWF1 mouse, a widely used animal model that is genetically prone to lupus, short-term repeated intranasal exposure to cSiO(2) triggers premature initiation of autoimmune responses in the lungs and kidneys. In contrast to cSiO(2)'s triggering action, consumption of the omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA) prevents spontaneous onset of autoimmunity in this mouse strain. The aim of this study was to test the hypothesis that consumption of DHA will prevent cSiO(2)-triggered autoimmunity in the female NZBWF1 mouse. Mice (6 wk old) were fed isocaloric AIN-93G diets containing 0.0, 0.4, 1.2 or 2.4% DHA. Two wk after initiating feeding, mice were intranasally instilled with 1 mg cSiO(2) once per wk for 4 wk and maintained on experimental diets for an additional 12 wk. Mice were then sacrificed and the lung, blood and kidney assessed for markers of inflammation and autoimmunity. DHA was incorporated into lung, red blood cells and kidney from diet in a concentration-dependent fashion. Dietary DHA dose-dependently suppressed cSiO(2)-triggered perivascular leukocyte infiltration and ectopic lymphoid tissue neogenesis in the lung. DHA consumption concurrently inhibited cSiO(2)-driven elevation of proinflammatory cytokines, B-cell proliferation factors, IgG and anti-dsDNA Ig in both bronchoalveolar lavage fluid and plasma. DHA's prophylactic effects were further mirrored in reduced proteinuria and glomerulonephritis in cSiO(2)-treated mice. Taken together, these results reveal that DHA consumption suppresses cSiO(2) triggering of autoimmunity in female NZBWF1 mice as manifested in the lung, blood and kidney. Our findings provide novel insight into how dietary modulation of the lipidome might be used to prevent or delay triggering of AD by cSiO(2). Such knowledge opens the possibility of developing practical, low-cost preventative strategies to reduce the risk of initiating AD and subsequent flaring in cSiO(2)-exposed individuals. Additional research in this model is required to establish the mechanisms by which DHA suppresses cSiO(2)-induced autoimmunity and to ascertain unique lipidome signatures predictive of susceptibility to cSiO(2)-triggered AD.	[Bates, Melissa A.; Pestka, James J.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Bates, Melissa A.; Harkema, Jack R.; Pestka, James J.] Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA; [Brandenberger, Christina] Hannover Med Sch, Inst Funct & Appl Anat, D-30625 Hannover, Germany; [Langohr, Ingeborg I.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Studies, Baton Rouge, LA 70803 USA; [Kumagai, Kazuyoshi] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Lock, Adam L.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Holian, Andrij] Univ Montana, Ctr Environm Hlth Sci, Missoula, MT 59812 USA	Michigan State University; Michigan State University; Hannover Medical School; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Michigan State University; Michigan State University; University of Montana System; University of Montana	Pestka, JJ (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.; Pestka, JJ (corresponding author), Michigan State Univ, Inst Integrat Toxicol, E Lansing, MI 48824 USA.	pestka@msu.edu	Langohr, Ingeborg M/H-5570-2019; Lock, Adam/HCH-4180-2022	Langohr, Ingeborg M/0000-0001-7366-4391; Holian, Andrij/0000-0003-0072-4538	National Institute of Environmental Health Sciences [ES021265]; Lupus Foundation of America (JP)	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Lupus Foundation of America (JP)	This work was supported by grants from the National Institute of Environmental Health Sciences (ES021265, JP, http://www.niehs.nih.gov/) and the Lupus Foundation of America (JP, http://www.lupus.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3843; Bates MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125481; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004; Bhattacharya A, 2003, J AM COLL NUTR, V22, P388, DOI 10.1080/07315724.2003.10719322; Biswas R, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/304180; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; Brandenberger C, 2015, PART FIBRE TOXICOL, V12, DOI 10.1186/s12989-015-0110-8; Brandenberger C, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-26; Brown JM, 2005, AM J PHYSIOL-LUNG C, V289, pL990, DOI 10.1152/ajplung.00078.2005; Brown JM, 2004, INHAL TOXICOL, V16, P133, DOI 10.1080/08958370490270936; Brown JM, 2003, CLIN EXP IMMUNOL, V131, P415, DOI 10.1046/j.1365-2249.2003.02094.x; BURTON GW, 1981, LIPIDS, V16, P946, DOI 10.1007/BF02535005; Calder PC, 2015, JPEN-PARENTER ENTER, V39, p18S, DOI 10.1177/0148607115595980; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2010, CLIN NUTR, V29, P5, DOI 10.1016/j.clnu.2009.11.003; CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534; Chandrasekar B, 1996, NUTR RES, V16, P489, DOI 10.1016/0271-5317(96)00030-9; CHANDRASEKAR B, 1995, J AUTOIMMUN, V8, P381, DOI 10.1006/jaut.1995.0030; Clarke Tainya C, 2015, Natl Health Stat Report, P1; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Cohen PL, 2003, CURRENT PROTOCOLS IM, V52, DOI [10.1016/B978-0-12-394596-9.00010-X, DOI 10.1016/B978-0-12-394596-9.00010-X]; Cooper GS, 2002, INT IMMUNOPHARMACOL, V2, P303, DOI 10.1016/S1567-5769(01)00181-3; Costenbader KH, 2012, AUTOIMMUN REV, V11, P604, DOI 10.1016/j.autrev.2011.10.022; Duffy EM, 2004, J RHEUMATOL, V31, P1551; Finckh A, 2006, ARTHRITIS RHEUM-US, V54, P3648, DOI 10.1002/art.22210; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gomez-Puerta JA, 2013, AUTOIMMUN REV, V12, P1129, DOI 10.1016/j.autrev.2013.06.016; Gonzalez ML, 2000, J IMMUNOL, V164, P1071, DOI 10.4049/jimmunol.164.2.1071; Halade GV, 2010, J IMMUNOL, V184, P5280, DOI 10.4049/jimmunol.0903282; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Harris WS, 2008, LIPIDS, V43, P805, DOI 10.1007/s11745-008-3215-0; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Huang WN, 2016, INT J RHEUM DIS, V19, P1310, DOI 10.1111/1756-185X.12826; KELLEY VE, 1985, J IMMUNOL, V134, P1914; Kim YJ, 2006, LIFE SCI, V78, P2523, DOI 10.1016/j.lfs.2005.10.034; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Lacher SE, 2010, INHAL TOXICOL, V22, P77, DOI 10.3109/08958370902929969; Li Y, 2010, ARCH IMMUNOL THER EX, V58, P355, DOI 10.1007/s00005-010-0093-y; Lock AL, 2013, J DAIRY SCI, V96, P6650, DOI 10.3168/jds.2013-6892; Madaio MP, 2003, CLIN EXP IMMUNOL, V131, P396, DOI 10.1046/j.1365-2249.2003.02112.x; Magna M, 2015, SCAND J IMMUNOL, V82, P218, DOI 10.1111/sji.12335; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; MORROW PE, 1988, FUND APPL TOXICOL, V10, P369, DOI 10.1016/0272-0590(88)90284-9; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; NIAID Autoimmune Diseases Coordinating Committee, 2005, NIAID REP C; NIEHS, 2012, AUTOIMMUNE DIS; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; OBERDORSTER G, 1992, EXP LUNG RES, V18, P87, DOI 10.3109/01902149209020653; Parks CG, 2002, ARTHRITIS RHEUM-US, V46, P1840, DOI 10.1002/art.10368; Parks CG, 2014, INT J MOL SCI, V15, P14269, DOI 10.3390/ijms150814269; Paschoal VA, 2013, LIPIDS, V48, P93, DOI 10.1007/s11745-012-3726-6; Pestka JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100255; Pfau JC, 2004, TOXICOLOGY, V195, P167, DOI 10.1016/j.tox.2003.09.011; Plourde M, 2007, APPL PHYSIOL NUTR ME, V32, P619, DOI 10.1139/H07-034; Pollard KM, 2010, CHEM RES TOXICOL, V23, P455, DOI 10.1021/tx9003787; PRICKETT JD, 1983, ARTHRITIS RHEUM, V26, P133, DOI 10.1002/art.1780260203; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROBINSON DR, 1986, ARTHRITIS RHEUM, V29, P539, DOI 10.1002/art.1780290412; ROBINSON DR, 1985, PROSTAGLANDINS, V30, P51, DOI 10.1016/S0090-6980(85)80010-1; Sang A, 2012, PROG MOL BIOL TRANSL, V105, P321, DOI 10.1016/B978-0-12-394596-9.00010-X; Schumann J, 2016, EUR J PHARMACOL, V785, P18, DOI 10.1016/j.ejphar.2015.04.057; Schwartz N, 2014, CURR OPIN RHEUMATOL, V26, P502, DOI 10.1097/BOR.0000000000000089; SLAVIN RE, 1985, HUM PATHOL, V16, P393, DOI 10.1016/S0046-8177(85)80233-1; SPURNEY RF, 1994, PROSTAGLANDINS, V48, P331, DOI 10.1016/0090-6980(94)90032-9; Stussman BJ, 2012, NATL HLTH STAT REP, P1; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; VACEK PM, 1991, FUND APPL TOXICOL, V17, P614, DOI 10.1016/0272-0590(91)90211-L; Venkatraman JT, 1999, J AM COLL NUTR, V18, P602, DOI 10.1080/07315724.1999.10718895; WALTON AJE, 1991, ANN RHEUM DIS, V50, P463, DOI 10.1136/ard.50.7.463; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473; Winwood RJ, 2013, OCL OILS FAT CROP LI, V20, DOI 10.1051/ocl/2013030; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156; Yan D, 1998, TOXICOL APPL PHARM, V148, P261, DOI 10.1006/taap.1997.8326	78	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160622	10.1371/journal.pone.0160622	http://dx.doi.org/10.1371/journal.pone.0160622			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513935	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100051
J	Cao, KAL; Costello, ME; Lakis, VA; Bartolo, F; Chua, XY; Brazeilles, R; Rondeau, P				Cao, Kim-Anh Le; Costello, Mary-Ellen; Lakis, Vanessa Anne; Bartolo, Francois; Chua, Xin-Yi; Brazeilles, Remi; Rondeau, Pascale			MixMC: A Multivariate Statistical Framework to Gain Insight into Microbial Communities	PLOS ONE			English	Article							RARE BIOSPHERE; GUT; SELECTION; WRINKLES; OBESITY; LEAD; DIET	Culture independent techniques, such as shotgun metagenomics and 16S rRNA amplicon sequencing have dramatically changed the way we can examine microbial communities. Recently, changes in microbial community structure and dynamics have been associated with a growing list of human diseases. The identification and comparison of bacteria driving those changes requires the development of sound statistical tools, especially if microbial biomarkers are to be used in a clinical setting. We present mixMC, a novel multivariate data analysis framework for metagenomic biomarker discovery. mixMC accounts for the compositional nature of 16S data and enables detection of subtle differences when high inter-subject variability is present due to microbial sampling performed repeatedly on the same subjects, but in multiple habitats. Through data dimension reduction the multivariate methods provide insightful graphical visualisations to characterise each type of environment in a detailed manner. We applied mixMC to 16S microbiome studies focusing on multiple body sites in healthy individuals, compared our results with existing statistical tools and illustrated added value of using multivariate methodologies to fully characterise and compare microbial communities.	[Cao, Kim-Anh Le; Costello, Mary-Ellen; Lakis, Vanessa Anne] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Bartolo, Francois] Univ Toulouse, Inst Math Toulouse, UMR CNRS INSA 5219, Toulouse, France; [Chua, Xin-Yi] Inst Mol Biosci, Queensland Facil Adv Bioinformat, Brisbane, Qld, Australia; [Brazeilles, Remi; Rondeau, Pascale] Danone Nutr Res, Palaiseau, France; [Costello, Mary-Ellen] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld 4102, Australia	University of Queensland; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Queensland; Danone Nutricia; Queensland University of Technology (QUT)	Cao, KAL (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia.	k.lecao@uq.edu.au			Australian Cancer Research Foundation (ACRF) for the Diamantina Individualised Oncology Care Centre at The University of Queensland Diamantina Institute; National Health and Medical Research Council (NHMRC) [APP1087415]; Agence Nationale de la Recherche (ANR) [ANR-10-BTBR-05-02]	Australian Cancer Research Foundation (ACRF) for the Diamantina Individualised Oncology Care Centre at The University of Queensland Diamantina Institute; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	KALC was supported in part by the Australian Cancer Research Foundation (ACRF) for the Diamantina Individualised Oncology Care Centre at The University of Queensland Diamantina Institute and the National Health and Medical Research Council (NHMRC) Career Development fellowship (APP1087415). FB was supported by the Agence Nationale de la Recherche (ANR) for the SYNTHACS project (ANR-10-BTBR-05-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors confirm that there is no competing interest or financial disclosure to Danone Nutricia Research. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Ban YG, 2015, BIOINFORMATICS, V31, P3322, DOI 10.1093/bioinformatics/btv364; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Costello ME, 2015, ARTHRITIS RHEUMATOL, V67, P686, DOI 10.1002/art.38967; DOLEDEC S, 1987, ACTA OECOL-OEC GEN, V8, P403; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Filzmoser P, 2009, ENVIRONMETRICS, V20, P621, DOI 10.1002/env.966; Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gonzlez I., 2013, BIODATA MIN, V5, P19; Gower J.C., 1998, PRINCIPAL COORDINATE; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kalivodova A, 2015, J CHEMOMETR, V29, P21, DOI 10.1002/cem.2657; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Le Cao K. -A., 2016, MIXOMICS OMICS DATA; Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118; Liquet B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-325; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovell D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004075; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MANDAL S, 2015, MICROBIAL ECOLOGY HL, V26; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Paulson J., 2015, METAGENOMESEQ STAT A; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Straube J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134540; Templ M., 2011, ROBCOMPOSITIONS R PA, DOI 10.1002/9781119976462.ch25; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ward DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039315; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Westerhuis JA, 2010, METABOLOMICS, V6, P119, DOI 10.1007/s11306-009-0185-z; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	52	88	89	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160169	10.1371/journal.pone.0160169	http://dx.doi.org/10.1371/journal.pone.0160169			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513472	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100028
J	Ribas-Deulofeu, L; Denis, V; De Palmas, S; Kuo, CY; Hsieh, HJ; Chen, CA				Ribas-Deulofeu, Lauriane; Denis, Vianney; De Palmas, Stephane; Kuo, Chao-Yang; Hsieh, Hernyi Justin; Chen, Chaolun Allen			Structure of Benthic Communities along the Taiwan Latitudinal Gradient	PLOS ONE			English	Article							CORAL-REEF ECOSYSTEMS; CHINWAN INNER BAY; CLIMATE-CHANGE; WATER-QUALITY; OCEAN ACIDIFICATION; SPECIES-DIVERSITY; SOUTHERN TAIWAN; ALGAL TURFS; PHASE-SHIFT; RESILIENCE	The distribution and the structure of benthic assemblages vary with latitude. However, few studies have described benthic communities along large latitudinal gradients, and patterns of variation are not fully understood. Taiwan, lying between 21.90 degrees N and 25.30 degrees N, is located at the center of the Philippine-Japan arc and lies at the northern margin of coral reef development. A wide range of habitats is distributed along this latitudinal gradient, from extensive fringing coral reefs at the southern coast to non-reefal communities at the north. In this study, we examined the structure of benthic communities around Taiwan, by comparing its assemblages in four regions, analyzing the effects of the latitudinal gradient, and highlighting regional characteristics. A total of 25 sites, 125 transects, and 2,625 photographs were used to analyze the benthic communities. Scleractinian corals present an obvious gradient of increasing diversity from north to south, whereas macro-algae diversity is higher on the north-eastern coast. At the country scale, Taiwanese coral communities were dominated by turf algae (49%). At the regional scale, we observed an important heterogeneity that may be caused by local disturbances and habitat degradation that smooths out regional differences. In this context, our observations highlight the importance of managing local stressors responsible for reef degradation. Overall, this study provides an important baseline upon which future changes in benthic assemblages around Taiwan can be assessed.	[Ribas-Deulofeu, Lauriane; De Palmas, Stephane] Natl Taiwan Normal Univ, Dept Life Sci, Taipei 11677, Taiwan; [Ribas-Deulofeu, Lauriane; De Palmas, Stephane; Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei 11529, Taiwan; [Ribas-Deulofeu, Lauriane; De Palmas, Stephane; Chen, Chaolun Allen] Natl Taiwan Normal Univ, Taipei 11529, Taiwan; [Ribas-Deulofeu, Lauriane; Denis, Vianney; De Palmas, Stephane; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Denis, Vianney; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan; [Kuo, Chao-Yang] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Hsieh, Hernyi Justin] Penghu Marine Biol Res Ctr, Makong 880, Penghu, Taiwan	National Taiwan Normal University; Academia Sinica - Taiwan; National Taiwan Normal University; Academia Sinica - Taiwan; National Taiwan University; James Cook University	Chen, CA (corresponding author), Acad Sinica, Taiwan Int Grad Program, Biodivers Program, Taipei 11529, Taiwan.; Chen, CA (corresponding author), Natl Taiwan Normal Univ, Taipei 11529, Taiwan.; Denis, V; Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan.; Denis, V; Chen, CA (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan.	vianneydenis@ntu.edu.tw; cac@gate.sinica.edu.tw	, de PALMAS Stéphane/AAS-8982-2021; Denis, Vianney/E-6868-2013; Ribas-Deulofeu, Lauriane/AAC-2793-2022	, de PALMAS Stéphane/0000-0002-2567-1789; Denis, Vianney/0000-0002-0914-5586; Ribas-Deulofeu, Lauriane/0000-0001-9005-5547	Academia Sinica [AS-100-TP2-A02-3, AS-104-SS-A03]; Ministry of Science and Technology of Taiwan [104-2611-M-002-020-MY2]; National Science Council [100-2811-B-001-074]; Taiwan International Graduate Program; Aide a la Mobilite Internationale des Etudiants, Conseil General, Ile de France	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Taiwan International Graduate Program; Aide a la Mobilite Internationale des Etudiants, Conseil General, Ile de France	This work was funded by AS-100-TP2-A02-3, Academia Sinica (http://www.sinica.edu.tw/main_e.shtml), to CAC; AS-104-SS-A03, Academia Sinica (http://www.sinica.edu.tw/main_e.shtml), to CAC; 104-2611-M-002-020-MY2, Ministry of Science and Technology of Taiwan (http://www.most.gov.tw/), to VD; 100-2811-B-001-074, National Science Council (http://www.most.gov.tw/), to VD; National Science Council (http://www.most.gov.tw/) to LRD; Taiwan International Graduate Program (http://tigp.sinica.edu.tw/) to LRD and SDP; and Aide a la Mobilite Internationale des Etudiants, Conseil General, Ile de France (http://www.iledefrance.fr/aides-regionales-appels-projets/aide-mobilite-etudiants-amie), to LRD.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Angulo-Valdes JA, 2010, MAR POLICY, V34, P635, DOI 10.1016/j.marpol.2009.12.002; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Beger M, 2014, DIVERS DISTRIB, V20, P245, DOI 10.1111/ddi.12140; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Benayahu Y, 2004, ZOOL STUD, V43, P548; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L, 2002, REEFS RISK SO ASIA; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chang Jui-Sheng, 2010, Bulletin of Fisheries Research Agency, P11; Chang KH, 1991, RESOURCE INVESTIGATI; Chang YC, 2008, ECOL MODEL, V211, P153, DOI 10.1016/j.ecolmodel.2007.09.001; CHEN C.A., 2009, KUROSHIO SCI, V3, P15; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Chen CC, 2005, MAR ECOL PROG SER, V304, P91, DOI 10.3354/meps304091; Chen CLA, 1999, ZOOL STUD, V38, P119; Chen CTA, 2004, MAR CHEM, V87, P73, DOI 10.1016/j.marchem.2004.01.006; Chiang YM, 1987, DISTRIBUTION SEAWEED, P71; Connell SD, 2014, MAR ECOL PROG SER, V495, P299, DOI 10.3354/meps10513; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Dai C, 2009, SCLERACTINIA FAUNA T; Dai C.-F., 1991, ATOLL RES B, V354, P1, DOI [10.5479/si.00775630.354.1, DOI 10.5479/SI.00775630.354.1]; Dai C-F, 1998, J NATL PARK, V8, P79; DAI CF, 1993, PSZNI MAR ECOL, V14, P185; Dai CF, 1999, J NATL PARK, V9, P111; Dai CF, 2004, GCRM REPORT E CHINA, V3, P153; Dai CF, 2002, P IUCN WCPA EA4 TAIP, P265; Dai CF, 1997, STATUS CORAL REEFS P, P123; Dalton SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075873; Denis V, 2013, CORAL REEFS, V32, P503, DOI 10.1007/s00338-013-1019-z; Denis V, 2015, MAR BIODIVERS, V45, P619, DOI 10.1007/s12526-014-0299-z; Denis V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054330; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gattuso JP, 1999, AM ZOOL, V39, P160; Goldberg J., 2004, STATUS CORAL REEFS W, V2004, P67; Haraguchi H., 2008, KUROSHIO SCI, V2, P41; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2011, REG ENVIRON CHANGE, V11, pS215, DOI 10.1007/s10113-010-0189-2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hsieh HJ, 2008, CORAL REEFS, V27, P599, DOI 10.1007/s00338-008-0378-3; Hsieh HJ, 2007, AQUAT CONSERV, V17, P619, DOI 10.1002/aqc.826; Hsieh HYJ, 2011, ZOOL STUD, V50, P443; Hsieh HJ, 2001, CORAL REEFS, V20, P316, DOI 10.1007/s003380100169; Hsieh HJ., 2008, THESIS; Huang DW, 2015, MAR BIODIVERS, V45, P157, DOI 10.1007/s12526-014-0236-1; Huang YCA, 2011, MAR ECOL PROG SER, V423, P83, DOI 10.3354/meps08944; Huang YCA, 2012, MAR POLLUT BULL, V64, P851, DOI 10.1016/j.marpolbul.2012.01.012; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JOHANNES RE, 1983, MAR ECOL PROG SER, V11, P105, DOI 10.3354/meps011105; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Kleypas JA, 1999, AM ZOOL, V39, P146; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044364; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lee CS, 2006, NAT HAZARDS, V37, P87, DOI 10.1007/s11069-005-4658-8; Lee H.-J., 1997, J OCEANOGR, V53, P467; Lee HJ, 1999, CONT SHELF RES, V19, P871, DOI 10.1016/S0278-4343(99)00006-0; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Liao MH, 2007, ZOOL STUD, V46, P520; Lin CC, 1969, ACTA GEOL TAIWAN, V13, P126; Liu C.-M., 2010, CLIMATE CHANGE IMPAC; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Liu PJ, 2009, MAR ENVIRON RES, V68, P106, DOI 10.1016/j.marenvres.2009.04.009; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; Meng PJ, 2008, ENVIRON POLLUT, V156, P67, DOI 10.1016/j.envpol.2007.12.039; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mok HK, 2008, KUROSHIO SCI, V2, P21; Muir PR, 2015, SCIENCE, V348, P1135, DOI 10.1126/science.1259911; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; Reaser JK, 2000, CONSERV BIOL, V14, P1500, DOI 10.1046/j.1523-1739.2000.99145.x; Rogelj J, 2011, NAT CLIM CHANGE, V1, P413, DOI 10.1038/NCLIMATE1258; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; Schuhmacher H., 1988, P379; Shao KT, 2008, 2008 TAIWAN SPECIES, P249; Smale DA, 2010, ESTUAR COAST SHELF S, V86, P83, DOI 10.1016/j.ecss.2009.10.016; TAIRA K, 1975, TECTONOPHYSICS, V28, pT1, DOI 10.1016/0040-1951(75)90057-8; Teng WH, 2006, NAT HAZARDS, V37, P191, DOI 10.1007/s11069-005-4667-7; Tew KS, 2014, MAR POLLUT BULL, V85, P641, DOI 10.1016/j.marpolbul.2013.11.022; Tkachenko KS, 2007, MAR BIOL, V151, P185, DOI 10.1007/s00227-006-0467-1; Tu JY, 2009, J CLIMATE, V22, P3617, DOI 10.1175/2009JCLI2411.1; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Work TM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002989; Wu ShaoHong, 2012, Proceedings of the International Academy of Ecology and Environmental Sciences, V2, P1; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474	97	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160601	10.1371/journal.pone.0160601	http://dx.doi.org/10.1371/journal.pone.0160601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513665	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000381381100048
J	Yamanashi, H; Ngoc, MQ; Huy, TV; Suzuki, M; Tsujino, A; Toizumi, M; Takahashi, K; Thiem, VD; Anh, DD; Anh, NTH; Tho, LH; Maeda, T; Cox, SE; Yoshida, LM; Ariyoshi, K				Yamanashi, Hirotomo; Mai Quang Ngoc; Tran Van Huy; Suzuki, Motoi; Tsujino, Akira; Toizumi, Michiko; Takahashi, Kensuke; Vu Dinh Thiem; Dang Duc Anh; Nguyen Thi Hien Anh; Le Huu Tho; Maeda, Takahiro; Cox, Sharon E.; Yoshida, Lay-Myint; Ariyoshi, Koya			Population-Based Incidence Rates of First-Ever Stroke in Central Vietnam	PLOS ONE			English	Article							30-DAY CASE-FATALITY; RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; SYSTEMATIC ANALYSIS; BLOOD-PRESSURE; GLOBAL BURDEN; DISEASE; TRENDS; SURVEILLANCE; INSURANCE	Introduction Stroke incidence data with methodologically acceptable design in Southeast Asia countries is limited. This study aimed to determine incidence of age-, sex- and subtype-specific first-ever stroke (FES) in Vietnam. Methods We conducted a hospital-based retrospective study, targeting all stroke cases hospitalized at a solo-provider hospital in our study site of Nha Trang from January 2009 to December 2011 with International Classification of Diseases, 10th revision (ICD-10) codes I60-69. We calculated positive predictive values (PPVs) of each ICD-10-coded stroke by conducting a detailed case review of 190 randomly selected admissions with ICD-10 codes of I60-I69. These PPVs were then used to estimate annual incident stroke cases from the computerized database. National census data in 2009 was used as a denominator. Results 2,693 eligible admissions were recorded during the study period. The crude annual incidence rate of total FES was 90.2 per 100,000 population (95% CI 81.1-100.2). The age-adjusted incidence of FES was 115.7 (95% CI 95.9-139.1) when adjusted to the WHO world populations. Importantly, age-adjusted intracerebral hemorrhage was as much as one third of total FES: 36.9 (95% CI 26.1-51.0). Conclusions We found a considerable proportion of FES in Vietnam to be attributable to intracerebral hemorrhage, which is as high or exceeding levels seen in high-income countries. A high prevalence of improperly treated hypertension in Vietnam may underlie the high prevalence of intracerebral hemorrhagic stroke in this population.	[Yamanashi, Hirotomo; Suzuki, Motoi; Takahashi, Kensuke; Ariyoshi, Koya] Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Med, Sakamoto, Nagasaki, Japan; [Yamanashi, Hirotomo; Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Isl & Community Med, Goto, Nagasaki, Japan; [Mai Quang Ngoc; Tran Van Huy] Khanh Hoa Gerenral Hosp, Dept Geriatr, Nha Trang, Khanh Hoa, Vietnam; [Tsujino, Akira] Univ Grad Sch Biomed Sci, Dept Neurol & Strokol, Sakamoto, Nagasaki, Japan; [Toizumi, Michiko; Yoshida, Lay-Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki, Japan; [Vu Dinh Thiem; Dang Duc Anh; Nguyen Thi Hien Anh] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Le Huu Tho] Khanh Hoa Hlth Serv, Nha Trang, Khanh Hoa, Vietnam; [Maeda, Takahiro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Community Med, Sakamoto, Nagasaki, Japan; [Cox, Sharon E.] Nagasaki Univ, Sch Trop Med & Global Hlth, Sakamoto, Nagasaki, Japan; [Cox, Sharon E.] London Sch Hyg & Trop Med, London, England	Nagasaki University; Nagasaki University; Nagasaki University; National Institute of Hygiene & Epidemiology (NIHE); Nagasaki University; Nagasaki University; University of London; London School of Hygiene & Tropical Medicine	Ariyoshi, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Inst Trop Med, Dept Clin Med, Sakamoto, Nagasaki, Japan.	kari@nagasaki-u.ac.jp	Toizumi, Michiko/AAA-7450-2019; Cox, Sharon E/ABA-7986-2020; Van Tran, Huy/AAK-8750-2021	Toizumi, Michiko/0000-0002-8401-9344; Cox, Sharon E/0000-0002-9908-2936; Van Tran, Huy/0000-0001-5515-5745; Vu, Thiem/0000-0001-6168-4555; YOSHIDA, LAYMYINT/0000-0002-7567-3248; Suzuki, Motoi/0000-0002-8340-0880	Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Research and development (AMED); JSPS KAKENHI [JP15K19230]; Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Research and development (AMED); JSPS KAKENHI [JP15K19230]	Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Initiative for Global Research Network on Infectious Diseases from Japan Agency for Medical Research and development (AMED), and JSPS KAKENHI Grant Number JP15K19230.	Ahmad OB, 2003, AGE STANDARDIZATION; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; [Anonymous], 2010, 2009 POPULATION HOUS; Corbin DOC, 2004, STROKE, V35, P1254, DOI 10.1161/01.STR.0000127371.24658.df; Corso G, 2009, NEUROEPIDEMIOLOGY, V32, P186, DOI 10.1159/000195688; Do N, 2014, J KOREAN MED SCI, V29, P919, DOI 10.3346/jkms.2014.29.7.919; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Feigin V, 2004, LANCET, V363, P1920, DOI 10.1016/S0140-6736(04)16436-2; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Kim HC, 2005, HYPERTENSION, V46, P393, DOI 10.1161/01.HYP.0000177118.46049.e6; Kirkman MA, 2009, ACTA NEUROL BELG, V109, P114; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lavados PM, 2005, LANCET, V365, P2206, DOI 10.1016/S0140-6736(05)66779-7; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Minelli C, 2007, STROKE, V38, P2906, DOI 10.1161/STROKEAHA.107.484139; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngo Anh D, 2010, BMC Res Notes, V3, P78, DOI 10.1186/1756-0500-3-78; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Sedova P, 2015, J STROKE CEREBROVASC, V24, P2032, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.019; Son PT, 2012, J HUM HYPERTENS, V26, P268, DOI 10.1038/jhh.2011.18; Spolaore P, 2005, STROKE, V36, P1031, DOI 10.1161/01.STR.0000160755.94884.4a; Sridharan SE, 2009, STROKE, V40, P1212, DOI 10.1161/STROKEAHA.108.531293; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Thorvaldsen P, 1997, STROKE, V28, P500, DOI 10.1161/01.STR.28.3.500; Truelsen T, 2007, LANCET NEUROL, V6, P134, DOI 10.1016/S1474-4422(06)70686-X; Tsiskaridze A, 2004, STROKE, V35, P2523, DOI 10.1161/01.STR.0000144683.96048.98; Van Minh H, 2006, J HUM HYPERTENS, V20, P109, DOI 10.1038/sj.jhh.1001942; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	31	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160665	10.1371/journal.pone.0160665	http://dx.doi.org/10.1371/journal.pone.0160665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513471	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000381381100055
J	Komatsu, Y; Derwish, L; Hirasawa, K				Komatsu, Yumiko; Derwish, Leena; Hirasawa, Kensuke			IRF1 Downregulation by Ras/MEK Is Independent of Translational Control of IRF1 mRNA	PLOS ONE			English	Article							FACTOR-I; TRANSCRIPTION FACTOR; NEGATIVE REGULATION; ANTIVIRAL RESPONSE; ALPHA-INTERFERON; ONCOGENIC RAS; IFN-BETA; ACTIVATION; GENES; PHOSPHORYLATION	Oncogenic activation of Ras/MEK downregulates the expression of interferon regulatory factor 1 (IRF1), which is a prerequisite for oncolytic viruses to replicate in cancer cells [1]. Moreover, restoration of IRF1 expression is essential to induce apoptosis of cancer cells treated with a MEK inhibitor [2]. However, the molecular mechanisms that underlie IRF1 downregulation by Ras/MEK remain unclear. In this study, we determined whether Ras/MEK activation modulates IRF1 expression at its translational level. MEK inhibition increased the activity of IRF1 promoter construct in Ras transformed NIH3T3 cells and wild type MEF, but not in IRF1 deficient MEF, indicating that IRF1 protein is required for the transcriptional activation of IRF1. By conducting reporter analysis using IRF1 5'- and 3'- UTR constructs, we determined that cis elements on 5'- and 3'-UTR of IRF1 mRNA are not involved in the IRF1 regulation by Ras/MEK. We further compared the recruitment of ribo-somes to IRF1 mRNA in RasV12 cells treated with or without the MEK inhibitor by conducting polysome analysis. No difference was observed in the polysomal distribution of IRF1 mRNA between RasV12 cells treated with and without the MEK inhibitor. These results suggest that regulation of IRF1 translation is independent of IRF1 downregulation by Ras/MEK.	[Komatsu, Yumiko; Derwish, Leena; Hirasawa, Kensuke] Mem Univ Newfoundland, Fac Med, Div BioMed Sci, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada	Memorial University Newfoundland	Hirasawa, K (corresponding author), Mem Univ Newfoundland, Fac Med, Div BioMed Sci, 300 Prince Philip Dr, St John, NF A1B 3V6, Canada.	kensuke@mun.ca		Derwish, Leena/0000-0002-8054-6569	Canadian Institutes of Health Research [RNL126468]; Research and Development Corporation of Newfoundland and Labrador [5404.1033104]; Canadian Breast Cancer Foundation [208641]; Canadian Institutes for Health Research (CIHR); Regional Development Corporation of Newfoundland and Labrador (RDC); Canadian Breast Cancer Foundation (CBCF)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research and Development Corporation of Newfoundland and Labrador; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Regional Development Corporation of Newfoundland and Labrador (RDC); Canadian Breast Cancer Foundation (CBCF)	This work was supported by Canadian Institutes of Health Research (www.cihr-irsc.gc.ca, grant number RNL126468), Research and Development Corporation of Newfoundland and Labrador (http://www.rdc.org/, grant number 5404.1033104) and Canadian Breast Cancer Foundation (http://www.cbcf.org/Pages/default.aspx, grant number 208641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants (to K. H.) from the Canadian Institutes for Health Research (CIHR), the Regional Development Corporation of Newfoundland and Labrador (RDC) and the Canadian Breast Cancer Foundation (CBCF).	AbuSara N, 2015, CANCER LETT, V357, P575, DOI 10.1016/j.canlet.2014.12.017; [Anonymous], 1993, CELL, V75, P83; AU WC, 1992, NUCLEIC ACIDS RES, V20, P2877, DOI 10.1093/nar/20.11.2877; Battcock SA, 2006, J VIROL, V80, P4422, DOI 10.1128/JVI.80.9.4422-4430.2006; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CHANG CH, 1992, IMMUNOGENETICS, V35, P378; Christian SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044267; Christian SL, 2009, J VIROL, V83, P6717, DOI 10.1128/JVI.02213-08; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dutia BM, 1999, VIROLOGY, V261, P173, DOI 10.1006/viro.1999.9834; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gandin V, 2014, JOVE-J VIS EXP, DOI 10.3791/51455; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Hobart M, 1997, J IMMUNOL, V158, P4260; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; KIRCHHOFF S, 1993, NUCLEIC ACIDS RES, V21, P2881, DOI 10.1093/nar/21.12.2881; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Komatsu Y, 2015, GENOM DATA, V4, P84, DOI 10.1016/j.gdata.2015.03.012; Komatsu Y, 2015, ONCOGENE, V34, P3985, DOI 10.1038/onc.2014.331; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Kroger A, 2003, ONCOGENE, V22, P1045, DOI 10.1038/sj.onc.1206260; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; Nair S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003999; Noser JA, 2007, MOL THER; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Robichaud N, 2015, ONCOGENE, V34, P2032, DOI 10.1038/onc.2014.146; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; TANAKA N, 1994, CANCER LETT, V83, P191, DOI 10.1016/0304-3835(94)90318-2; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Ueki IF, 2013, J EXP MED, V210, P1929, DOI 10.1084/jem.20121401; Wang F, 2012, CARDIOVASC RES, V93, P190, DOI 10.1093/cvr/cvr260; WEINBERG RA, 1989, CANCER RES, V49, P3713; White LC, 1996, IMMUNITY, V5, P365, DOI 10.1016/S1074-7613(00)80262-9; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46	51	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160529	10.1371/journal.pone.0160529	http://dx.doi.org/10.1371/journal.pone.0160529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508303	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400037
J	Muvva, C; Patra, S; Venkatesan, S				Muvva, Charuvaka; Patra, Sanjukta; Venkatesan, Subramanian			MMpI: A WideRange of Available Compounds of Matrix Metalloproteinase Inhibitors	PLOS ONE			English	Article							DATABASE; DESIGN	Matrix metalloproteinases (MMPs) are a family of zinc-dependent proteinases involved in the regulation of the extracellular signaling and structural matrix environment of cells and tissues. MMPs are considered as promising targets for the treatment of many diseases. Therefore, creation of database on the inhibitors of MMP would definitely accelerate the research activities in this area due to its implication in above-mentioned diseases and associated limitations in the first and second generation inhibitors. In this communication, we report the development of a new MMpI database which provides resourceful information for all researchers working in this field. It is a web-accessible, unique resource that contains detailed information on the inhibitors of MMP including small molecules, peptides and MMP Drug Leads. The database contains entries of similar to 3000 inhibitors including similar to 72 MMP Drug Leads and similar to 73 peptide based inhibitors. This database provides the detailed molecular and structural details which are necessary for the drug discovery and development. The MMpI database contains physical properties, 2D and 3D structures (mol2 and pdb format files) of inhibitors of MMP. Other data fields are hyperlinked to PubChem, ChEMBL, BindingDB, DrugBank, PDB, MEROPS and PubMed. The database has extensive searching facility with MMpI ID, IUPAC name, chemical structure and with the title of research article. The MMP inhibitors provided in MMpI database are optimized using Python-based Hierarchical Environment for Integrated Xtallography (Phenix) software. MMpI Database is unique and it is the only public database that contains and provides the complete information on the inhibitors of MMP.	[Muvva, Charuvaka; Venkatesan, Subramanian] CSIR, Cent Leather Res Inst, Chem Lab, Madras, Tamil Nadu, India; [Muvva, Charuvaka] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Patra, Sanjukta] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Academy of Scientific & Innovative Research (AcSIR); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Venkatesan, S (corresponding author), CSIR, Cent Leather Res Inst, Chem Lab, Madras, Tamil Nadu, India.	subuchem@hotmail.com		Muvva, Charuvaka/0000-0001-5521-213X	Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC0121]; Department of Biotechnology (DBT) NER-Twinning project, New Delhi, India [BT/272/NE/TBP/2011]	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT) NER-Twinning project, New Delhi, India	This work was supported by the Council of Scientific and Industrial Research (CSIR), (GENESIS, BSC0121 and OSDD projects) and Department of Biotechnology (DBT) NER-Twinning project (No. BT/272/NE/TBP/2011), New Delhi, India.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bachmann LH, 1999, SEX TRANSM DIS, V26, P272, DOI 10.1097/00007435-199905000-00006; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Devel L, 2010, BIOCHIMIE, V92, P1501, DOI 10.1016/j.biochi.2010.07.017; Eckhard U, 2016, MATRIX BIOL, V49, P37, DOI 10.1016/j.matbio.2015.09.003; Ertl P, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-1; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Keeling J, 2008, MICROSC RES TECHNIQ, V71, P371, DOI 10.1002/jemt.20565; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Ndinguri MW, 2012, MOLECULES, V17, P14230, DOI 10.3390/molecules171214230; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Peterson JT, 2004, HEART FAIL REV, V9, P63, DOI 10.1023/B:HREV.0000011395.11179.af; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030; Sela-Passwell N, 2011, EXPERT OPIN DRUG DIS, V6, P527, DOI 10.1517/17460441.2011.560936; Sela-Passwell N, 2010, BBA-MOL CELL RES, V1803, P29, DOI 10.1016/j.bbamcr.2009.04.010; Whittaker M, 1999, CHEM REV, V99, P2735, DOI 10.1021/cr9804543	23	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159321	10.1371/journal.pone.0159321	http://dx.doi.org/10.1371/journal.pone.0159321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509041	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400007
J	Hamimi, C; David, A; Versmisse, P; Weiss, L; Bruel, T; Zucman, D; Appay, V; Moris, A; Ungeheuer, MN; Lascoux-Combe, C; Barre-Sinoussi, F; Muller-Trutwin, M; Boufassa, F; Lambotte, O; Pancino, G; Saez-Cirion, A				Hamimi, Chiraz; David, Annie; Versmisse, Pierre; Weiss, Laurence; Bruel, Timothee; Zucman, David; Appay, Victor; Moris, Arnaud; Ungeheuer, Marie-Noelle; Lascoux-Combe, Caroline; Barre-Sinoussi, Franocise; Muller-Trutwin, Michaela; Boufassa, Faroudy; Lambotte, Olivier; Pancino, Gianfranco; Saez-Cirion, Asier		ANRS CO21 CODEX Cohort	Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 Particles	PLOS ONE			English	Article							CD8(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; DC-SIGN; LONG-TERM; EX-VIVO; RESPONSES; REPLICATION; RESTRICTION; NONPROGRESSORS; SAMHD1	HIV controllers (HICs), rare HIV-1 infected individuals able to control viral replication without antiretroviral therapy, are characterized by an efficient polyfunctional and cytolytic HIV-specific CD8+ T cell response. The mechanisms underlying the induction and maintenance of such response in many HICs despite controlled viremia are not clear. Dendritic cells play a crucial role in the generation and reactivation of T cell responses but scarce information is available on those cells in HICs. We found that monocyte derived dendritic cells (MDDCs) from HICs are less permissive to HIV-1 infection than cells from healthy donors. In contrast MDDCs from HICs are particularly efficient at capturing HIV-1 particles when compared to cells from healthy donors or HIV-1 patients with suppressed viral load on antiretroviral treatment. MDDCs from HICs expressed on their surface high levels of syndecan-3, DC-SIGN and MMR, which could cooperate to facilitate HIV-1 capture. The combination of low susceptibility to HIV-1 infection but enhanced capacity to capture particles might allow MDDCs from HICs to preserve their function from the deleterious effect of infection while facilitating induction of HIV-specific CD8+ T cells by cross-presentation in a context of low viremia.	[Hamimi, Chiraz; Versmisse, Pierre; Weiss, Laurence; Barre-Sinoussi, Franocise; Pancino, Gianfranco] Inst Pasteur, Regulat Infect Retrovirales, Paris, France; [David, Annie; Muller-Trutwin, Michaela; Saez-Cirion, Asier] Inst Pasteur, HIV Inflammat & Persistance, Paris, France; [Weiss, Laurence] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Weiss, Laurence] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bruel, Timothee; Lambotte, Olivier] Univ Paris 11, UMR 1184, Le Kremlin Bicetre, France; [Bruel, Timothee; Lambotte, Olivier] CEA, DSV iMETI, Div Immunovirol, IDMIT, Fontenay Aux Roses, France; [Zucman, David] Hop Foch, Serv Med Interne, Suresnes, France; [Appay, Victor; Moris, Arnaud] Sorbonne Univ, Univ Paris 06, DHU FAST, CR7,CIMI Paris, Paris, France; [Appay, Victor; Moris, Arnaud] CIMI Paris, INSERM, U1135, Paris, France; [Moris, Arnaud] CIMI Paris, CNRS, ERL 8255, Paris, France; [Ungeheuer, Marie-Noelle] Inst Pasteur, Plateforme Invest Clin & Acces Ressources Biol IC, Paris, France; [Lascoux-Combe, Caroline] Hop St Louis, AP HP, Dept Infect Dis, Paris, France; [Boufassa, Faroudy] Fac Med Paris Sud, INSERM, U1018, Le Kremlin Bicetre, France; [Lambotte, Olivier] Ctr Immunol Viral Infect & Autoimmune Dis, U1184, INSERM, Le Kremlin Bicetre, France; [Lambotte, Olivier] Hop Univ Paris Sud, APHP, Serv Med Interne, Immunol Clin, Le Kremlin Bicetre, France; [Hamimi, Chiraz] CIMI, INSERM, U1135, Paris, France; [Bruel, Timothee] Inst Pasteur, Dept Virol, Virus & Immun Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Saez-Cirion, A (corresponding author), Inst Pasteur, HIV Inflammat & Persistance, Paris, France.	asier.saez-cirion@pasteur.fr	Bruel, Timothée/AAI-4632-2020; Lambotte, Olivier/GRT-0160-2022; Appay, Victor/M-4830-2017; WEISS, Laurence/B-1373-2012; Saez-Cirion, Asier/A-8640-2008; Appay, Victor/AAM-7701-2021	Saez-Cirion, Asier/0000-0003-2406-7536; SCHWARTZ, OLIVIER/0000-0002-0729-1475; Bruel, Timothee/0000-0002-3952-4261; Appay, Victor/0000-0001-5434-3963; Muller-Trutwin, Michaela/0000-0002-3854-2396; Moris, Arnaud/0000-0002-5052-1678	French National Agency of AIDS and Viral Hepatitis Research (ANRS) [10311 09398]; Universite Pierre et Marie Curie; Sidaction	French National Agency of AIDS and Viral Hepatitis Research (ANRS); Universite Pierre et Marie Curie; Sidaction	This study received financial support from the French National Agency of AIDS and Viral Hepatitis Research (ANRS, 10311 09398). CH was a Ph.D. student funded by the Universite Pierre et Marie Curie and Sidaction. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Buzon MJ, 2011, J VIROL, V85, P9646, DOI 10.1128/JVI.05327-11; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Harman AN, 2011, BLOOD, V118, P298, DOI 10.1182/blood-2010-07-297721; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lai J, 2009, J BIOL CHEM, V284, P11027, DOI 10.1074/jbc.M809698200; Lecuroux C, 2014, J VIROL, V88, P176, DOI 10.1128/JVI.02098-13; MACATONIA SE, 1990, IMMUNOLOGY, V71, P38; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Martin-Gayo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004930; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moris A, 2004, BLOOD, V103, P2648, DOI 10.1182/blood-2003-07-2532; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Palmer P, 2007, EUR CYTOKINE NETW, V18, P108, DOI 10.1684/ecn.2007.0093; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2013, IMMUNOL REV, V254, P281, DOI 10.1111/imr.12076; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Singh SK, 2009, MOL IMMUNOL, V47, P164, DOI 10.1016/j.molimm.2009.09.026; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Unger WWJ, 2012, J CONTROL RELEASE, V160, P88, DOI 10.1016/j.jconrel.2012.02.007; van Montfoort N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00182; Vingert B, 2012, J VIROL, V86, P10661, DOI 10.1128/JVI.00056-12; Vingert B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000780; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Xu RH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000768	42	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160251	10.1371/journal.pone.0160251	http://dx.doi.org/10.1371/journal.pone.0160251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505169	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200029
J	Pfeuty, B; Thommen, Q				Pfeuty, Benjamin; Thommen, Quentin			Adaptive Benefits of Storage Strategy and Dual AMPK/TOR Signaling in Metabolic Stress Response	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; FLUCTUATING ENVIRONMENTS; SKELETAL-MUSCLE; CELL-GROWTH; NUTRIENT; NETWORKS; PATHWAYS; ADAPTATION	Cellular metabolism must ensure that supply of nutrient meets the biosynthetic and bioenergetic needs. Cells have therefore developed sophisticated signaling and regulatory pathways in order to cope with dynamic fluctuations of both resource and demand and to regulate accordingly diverse anabolic and catabolic processes. Intriguingly, these pathways are organized around a relatively small number of regulatory hubs, such as the highly conserved AMPK and TOR kinase families in eukaryotic cells. Here, the global metabolic adaptations upon dynamic environment are investigated using a prototypical model of regulated metabolism. In this model, the optimal enzyme profiles as well as the underlying regulatory architecture are identified by combining perturbation and evolutionary methods. The results reveal the existence of distinct classes of adaptive strategies, which differ in the management of storage reserve depending on the intensity of the stress and in the regulation of ATP-producing reaction depending on the nature of the stress. The regulatory architecture that optimally implements these adaptive features is characterized by a crosstalk between two specialized signaling pathways, which bears close similarities with the sensing and regulatory properties of AMPK and TOR pathways.	[Pfeuty, Benjamin; Thommen, Quentin] Univ Lille Sci & Technol, CNRS, Lab Phys Lasers Atomes & Mol, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Pfeuty, B (corresponding author), Univ Lille Sci & Technol, CNRS, Lab Phys Lasers Atomes & Mol, Villeneuve Dascq, France.	Benjamin.Pfeuty@univ-lille1.fr	Thommen, Quentin/AAB-8700-2020; pfeuty, benjamin/R-6825-2018	Thommen, Quentin/0000-0002-0373-9199; 	LABEX CEMPI [ANR-11-LABX-0007]	LABEX CEMPI	This work was supported by ANR-11-LABX-0007 operated by the French National Research Agency (ANR) (http://www.agence-nationale-recherche.fr/, BP QT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported by LABEX CEMPI (ANR-11-LABX-0007) operated by the French National Research Agency (ANR).	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Berkhout J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01417; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Chubukov V, 2012, P NATL ACAD SCI USA, V109, P5127, DOI 10.1073/pnas.1114235109; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; De Jong A., EVOLUTIONARY COMPUTA; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Diderich JA, 1999, MICROBIOL-SGM, V145, P3447, DOI 10.1099/00221287-145-12-3447; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Geisel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027033; Gottstein W, 2014, BIOSYSTEMS, V117, P68, DOI 10.1016/j.biosystems.2013.12.006; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Ingalls BP, 2003, J THEOR BIOL, V222, P23, DOI 10.1016/S0022-5193(03)00011-0; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Khonsari AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126244; Klipp E, 2002, EUR J BIOCHEM, V269, P5406, DOI 10.1046/j.1432-1033.2002.03223.x; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Liebermeister W, 2005, J THEOR BIOL, V234, P423, DOI 10.1016/j.jtbi.2004.12.010; Liebermeister W, 2004, BIOSYSTEMS, V76, P261, DOI 10.1016/j.biosystems.2004.05.022; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lipan O, 2005, P NATL ACAD SCI USA, V102, P7063, DOI 10.1073/pnas.0403790102; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Neyfakh AA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-23; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oyarzun DA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0671; Oyarzun DA, 2012, J THEOR BIOL, V295, P139, DOI 10.1016/j.jtbi.2011.11.017; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Reznik E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003195; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Steuer R, 2009, ADV CHEM PHYS; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Troein C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000855; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Waldherr S, 2015, J THEOR BIOL, V365, P469, DOI 10.1016/j.jtbi.2014.10.035; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653; Yuan HX, 2013, MOL CELL, V49, P379, DOI 10.1016/j.molcel.2013.01.019; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	48	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160247	10.1371/journal.pone.0160247	http://dx.doi.org/10.1371/journal.pone.0160247			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505075	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200028
J	Tandon, P; James, MT; Abraldes, JG; Karvellas, CJ; Ye, F; Pannu, N				Tandon, Puneeta; James, Matthew T.; Abraldes, Juan G.; Karvellas, Constantine J.; Ye, Feng; Pannu, Neesh			Relevance of New Definitions to Incidence and Prognosis of Acute Kidney Injury in Hospitalized Patients with Cirrhosis: A Retrospective Population-Based Cohort Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SERUM CREATININE VALUE; RIFLE CRITERIA; 1.5 MG/DL; MORTALITY; OUTCOMES; RISK; CLASSIFICATION; INCREASES; NETWORK	Background The implementation of new serum creatinine (SCr)-based criteria for acute kidney injury (AKI) has brought to light several areas of uncertainty in patients with cirrhosis. Study Design Population-based cohort study. Setting & Participants Adults with cirrhosis hospitalized between 2002-2012. Predictor We aimed to address the prognostic implications of the new AKI criteria in cirrhosis. Outcomes Baseline kidney function was defined from all outpatient SCr within 3 months before hospitalization. Cox proportional hazards models were fit to examine associations between AKI, renal recovery and all-cause mortality. Results 4,733 patients were studied. The 30-day mortality was higher for participants with AKI (43.9% vs 8.5%; p-value<0.001), and increased with AKI severity. The highest incidence of AKI occurred when the lowest SCr within the three months prior to admission was used to define baseline. The hazard ratio for mortality using the lowest SCr within 3 months and the closest pre-admission SCr (definition suggested by the recent consensus guideline) were similar, validating the use of the latter measure. As compared to patients without AKI, stage 1 AKI with maximum SCr <= 132 mmol/L remained associated with a 3.5-fold increased hazard of death at 30 days (95% CI 2.6 to 4.7). Limitations As an observational study, the results were vulnerable to residual confounding and ascertainment bias in the use of laboratory data to identify AKI. We did not have access to liver function or disease etiology variables and were unable to adjust for these in our analyses. Conclusions These results confirm the graded relationship between AKI severity, renal recovery, and mortality and further clarify previously discordant reports about the prognostic relevance of new AKI criteria in patients with cirrhosis.	[Tandon, Puneeta; Abraldes, Juan G.; Karvellas, Constantine J.] Univ Alberta, Div Gastroenterol, Cirrhosis Care Clin, Edmonton, AB, Canada; [Tandon, Puneeta; Abraldes, Juan G.; Karvellas, Constantine J.] Univ Alberta, Dept Med, CEGIIR, Edmonton, AB, Canada; [James, Matthew T.] Univ Calgary, Div Nephrol, Calgary, AB, Canada; [Karvellas, Constantine J.] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Ye, Feng; Pannu, Neesh] Univ Alberta, Div Nephrol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Calgary; University of Alberta; University of Alberta	Pannu, N (corresponding author), Univ Alberta, Div Nephrol, Edmonton, AB, Canada.	neesh.pannu@ualberta.ca		Gonzalez-Abraldes, Juan/0000-0003-3421-937X; Karvellas, Constantine/0000-0002-1555-1089	Canadian Institutes of Health Research (CIHR); CRIO team grant from Alberta Innovates-Health Solutions	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CRIO team grant from Alberta Innovates-Health Solutions	This study was funded by an operating grant from the Canadian Institutes of Health Research (CIHR). The Interdisciplinary Chronic Disease Collaboration (ICDC) is funded through a CRIO team grant from Alberta Innovates-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli P, 2015, J HEPATOL; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Belcher JM, 2013, CLIN GASTROENTEROL H, V11, P1550, DOI 10.1016/j.cgh.2013.03.018; Belcher JM, 2013, HEPATOLOGY, V57, P753, DOI 10.1002/hep.25735; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fagundes C, 2015, J HEPATOL, V62, P743, DOI 10.1016/j.jhep.2014.11.039; Fagundes C, 2013, J HEPATOL, V59, P474, DOI 10.1016/j.jhep.2013.04.036; Fede G, 2012, J HEPATOL, V56, P810, DOI 10.1016/j.jhep.2011.10.016; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hoste EA, 2004, CONTRIB NEPHROL, V144, P1; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Israelsen ME, 2015, J GASTROEN HEPATOL, V30, P236, DOI 10.1111/jgh.12709; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Pannu N, 2013, CLIN J AM SOC NEPHRO, V8, P194, DOI 10.2215/CJN.06480612; Pannu N, 2011, AM J KIDNEY DIS, V58, P206, DOI 10.1053/j.ajkd.2011.01.028; Piano S, 2015, J HEPATOL, V62, P744, DOI 10.1016/j.jhep.2014.12.001; Piano S, 2013, J HEPATOL, V59, P482, DOI 10.1016/j.jhep.2013.03.039; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Sawhney S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006497; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Thakar CV, 2013, ADV CHRONIC KIDNEY D, V20, P67, DOI 10.1053/j.ackd.2012.10.003; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Uchino S, 2006, CRIT CARE MED, V34, P1913, DOI 10.1097/01.CCM.0000224227.70642.4F; Wong F, 2015, J HEPATOL, V62, P741, DOI 10.1016/j.jhep.2014.10.047; Wong F, 2013, GASTROENTEROLOGY, V145, P1280, DOI 10.1053/j.gastro.2013.08.051; Wong F, 2011, GUT, V60, P702, DOI 10.1136/gut.2010.236133	35	41	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160394	10.1371/journal.pone.0160394	http://dx.doi.org/10.1371/journal.pone.0160394			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504876	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200034
J	Hayashimoto, N; Inoue, T; Morita, H; Yasuda, M; Ueno, M; Kawai, K; Itoh, T				Hayashimoto, Nobuhito; Inoue, Takashi; Morita, Hanako; Yasuda, Masahiko; Ueno, Masami; Kawai, Kenji; Itoh, Toshio			Survey and Experimental Infection of Enteropathogenic Escherichia coli in Common Marmosets (Callithrix jacchus)	PLOS ONE			English	Article							PCR	Common marmosets (Callithrix jacchus) are frequently used for biomedical research but can be afflicted with diarrhea-a serious and potentially lethal health problem. Enteropathogenic Escherichia coli (EPEC) is thought to be the causative pathogen of hemorrhagic typhlocolitis in common marmosets, but the actual incidence of the disease and the relationship between EPEC and hematochezia are unknown. This study investigated the prevalence of EPEC infection in common marmosets and the association between EPEC and hematochezia. A total of 230 stool or rectal swab samples were collected from 230 common marmosets (98 clinically healthy, 85 diarrhea, and 47 bloody stool samples) and tested by culture-based detection and PCR amplification of VT1, VT2, LT, ST, eae, and bfp genes. Healthy animals were divided into three groups (n = 4 each for high and low concentration groups and n = 2 as negative control), and those in the experimental groups were perorally inoculated with a 2-ml of suspension of EPEC R811 strain adjusted to 5 x 10(8) (high concentration) and 5 x 10(4) (low concentration) CFU/ml. Two animals in each group were examined 3 and 14 days post-inoculation (DPI). EPEC was detected in 10 of 98 clinically healthy samples (10.2%), 17 of 85 diarrhea samples (20%), and all 47 bloody stool samples (100%), with a significant difference detected between presence of EPEC and sample status (P < 0.01). Acute hematochezia was observed in all animals of the high-concentration group but not in other groups at 1 or 2 DPI. A histopathological examination revealed the attachment of gram-negative bacilli to epithelial apical membranes and desquamated epithelial cells in the cecum of animals in the high-concentration group at 3 DPI. These findings suggest that EPEC is a causative agent of hemorrhagic typhlocolitis in common marmosets.	[Hayashimoto, Nobuhito; Morita, Hanako; Ueno, Masami] Cent Inst Expt Anim, ICLAS Monitoring Ctr, Kawasaki Ku, 3-25-12 Tonomachi, Kawasaki, Kanagawa, Japan; [Inoue, Takashi; Itoh, Toshio] Cent Inst Expt Anim, Marmoset Res Dept, Kawasaki Ku, 3-25-12 Tonomachi, Kawasaki, Kanagawa, Japan; [Yasuda, Masahiko; Kawai, Kenji] Cent Inst Expt Anim, Pathol Anal Ctr, Kawasaki Ku, 3-25-12 Tonomachi, Kawasaki, Kanagawa, Japan		Hayashimoto, N (corresponding author), Cent Inst Expt Anim, ICLAS Monitoring Ctr, Kawasaki Ku, 3-25-12 Tonomachi, Kawasaki, Kanagawa, Japan.	nobuh@ciea.or.jp		Inoue, Takashi/0000-0003-4691-7255	Japan Society for the Promotion of Science KAKENHI [24500449]; Central Institute for Experimental Animals	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Central Institute for Experimental Animals	This study was partially supported by a Japan Society for the Promotion of Science KAKENHI (grant no. 24500449, [https://www.jsps.go.jp/j-grantsinaid/]) that was given to NH. The rest part of this study was supported by internal research funds of Central Institute for Experimental Animals that was given to NH.; This study was partially supported by a Japan Society for the Promotion of Science KAKENHI (grant no. 24500449). The authors thank Dr. Atsushi Iguchi, Miyazaki University, for performing O antigen genotyping of the isolates.	Bruck WM, 2003, J PEDIATR GASTR NUTR, V37, P273, DOI 10.1097/00005176-200309000-00014; Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007; Carvalho VM, 2003, J CLIN MICROBIOL, V41, P1225, DOI 10.1128/JCM.41.3.1225-1234.2003; Franck SM, 1998, J CLIN MICROBIOL, V36, P1795, DOI 10.1128/JCM.36.6.1795-1797.1998; Hartland EL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00015; Hayashimoto N, 2015, GENOME ANNOUNC, V3, P5; HOLM S, 1979, SCAND J STAT, V6, P65; Iguchi A, 2015, J CLIN MICROBIOL, V53, P2427, DOI 10.1128/JCM.00321-15; Katoh Rei, 2002, Kansenshogaku Zasshi, V76, P721; Lever MS, 2008, INT J EXP PATHOL, V89, P171, DOI 10.1111/j.1365-2613.2008.00581.x; Ludlage E, 2003, COMPARATIVE MED, V53, P369; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Ochoa TJ, 2011, CURR OPIN INFECT DIS, V24, P478, DOI 10.1097/QCO.0b013e32834a8b8b; Sasseville V G, 2012, Vet Pathol, V49, P1057, DOI 10.1177/0300985812461655; Thomson JA, 1996, LAB ANIM SCI, V46, P275	15	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160116	10.1371/journal.pone.0160116	http://dx.doi.org/10.1371/journal.pone.0160116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501144	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500013
J	Okuda, K; Fu, HY; Matsuzaki, T; Araki, R; Tsuchida, S; Thanikachalam, PV; Fukuta, T; Asai, T; Yamato, M; Sanada, S; Asanuma, H; Asano, Y; Asakura, M; Hanawa, H; Hao, H; Oku, N; Takashima, S; Kitakaze, M; Sakata, Y; Minamino, T				Okuda, Keiji; Fu, Hai Ying; Matsuzaki, Takashi; Araki, Ryo; Tsuchida, Shota; Thanikachalam, Punniyakoti V.; Fukuta, Tatsuya; Asai, Tomohiro; Yamato, Masaki; Sanada, Shoji; Asanuma, Hiroshi; Asano, Yoshihiro; Asakura, Masanori; Hanawa, Haruo; Hao, Hiroyuki; Oku, Naoto; Takashima, Seiji; Kitakaze, Masafumi; Sakata, Yasushi; Minamino, Tetsuo			Targeted Therapy for Acute Autoimmune Myocarditis with Nano-Sized Liposomal FK506 in Rats	PLOS ONE			English	Article							GIANT-CELL MYOCARDITIS; CARDIAC DYSFUNCTION; GENE-EXPRESSION; MODEL; ACTIVATION; IMMUNOSUPPRESSION; RECEPTOR	Immunosuppressive agents are used for the treatment of immune-mediated myocarditis; however, the need to develop a more effective therapeutic approach remains. Nano-sized liposomes may accumulate in and selectively deliver drugs to an inflammatory lesion with enhanced vascular permeability. The aims of this study were to investigate the distribution of liposomal FK506, an immunosuppressive drug encapsulated within liposomes, and the drug's effects on cardiac function in a rat experimental autoimmune myocarditis (EAM) model. We prepared polyethylene glycol-modified liposomal FK506 (mean diameter: 109.5 +/- 4.4 nm). We induced EAM by immunization with porcine myosin and assessed the tissue distribution of the nano-sized beads and liposomal FK506 in this model. After liposomal or free FK506 was administered on days 14 and 17 after immunization, the cytokine expression in the rat hearts along with the histological findings and hemodynamic parameters were determined on day 21. Ex vivo fluorescent imaging revealed that intravenously administered fluorescent-labeled nano-sized beads had accumulated in myocarditic but not normal hearts on day 14 after immunization and thereafter. Compared to the administration of free FK506, FK506 levels were increased in both the plasma and hearts of EAM rats when liposomal FK506 was administered. The administration of liposomal FK506 markedly suppressed the expression of cytokines, such as interferon-gamma and tumor necrosis factor-alpha, and reduced inflammation and fibrosis in the myocardium on day 21 compared to free FK506. The administration of liposomal FK506 also markedly ameliorated cardiac dysfunction on day 21 compared to free FK506. Nano-sized liposomes may be a promising drug delivery system for targeting myocarditic hearts with cardioprotective agents.	[Okuda, Keiji; Fu, Hai Ying; Matsuzaki, Takashi; Araki, Ryo; Tsuchida, Shota; Yamato, Masaki; Sanada, Shoji; Asano, Yoshihiro; Sakata, Yasushi] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka, Japan; [Thanikachalam, Punniyakoti V.] Int Med Univ, Dept Pharmaceut Chem, Kuala Lumpur, Malaysia; [Fukuta, Tatsuya; Asai, Tomohiro; Oku, Naoto] Univ Shizuoka, Grad Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka, Japan; [Asanuma, Hiroshi] Meiji Univ Integrat Med, Dept Internal Med, Nantan, Kyoto, Japan; [Asakura, Masanori; Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Clin Res & Dev, Suita, Osaka, Japan; [Hanawa, Haruo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Hao, Hiroyuki] Nihon Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Takashima, Seiji] Osaka Univ, Grad Sch Med, Dept Med Biochem, Suita, Osaka, Japan; [Minamino, Tetsuo] Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, Miki, Kagawa, Japan	Osaka University; International Medical University Malaysia; University of Shizuoka; National Cerebral & Cardiovascular Center - Japan; Niigata University; Nihon University; Osaka University; Kagawa University	Minamino, T (corresponding author), Kagawa Univ, Fac Med, Dept Cardiorenal & Cerebrovasc Med, Miki, Kagawa, Japan.	minamino@med.kagawa-u.ac.jp		Sakata, Yasushi/0000-0002-5618-4721; Thanikachalam, Punniyakoti Veeraveedu/0000-0002-4249-7962; Fukuta, Tatsuya/0000-0001-8878-8602	Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a grant from Japan Science and Technology Agency (JST) and a Grant-in-Aid for Challenging Exploratory Research from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2004, AUTOIMMUN REV, V3, P476, DOI 10.1016/j.autrev.2004.08.009; Barbarino JM, 2013, PHARMACOGENET GENOM, V23, P563, DOI 10.1097/FPC.0b013e328364db84; Chang H, 2008, CIRC J, V72, P813, DOI 10.1253/circj.72.813; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Francis GE, 1996, J DRUG TARGET, V3, P321, DOI 10.3109/10611869608996824; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Fuse K, 2001, CLIN EXP IMMUNOL, V124, P346, DOI 10.1046/j.1365-2249.2001.01510.x; Hanawa H, 2002, CLIN SCI, V103, P623, DOI 10.1042/cs1030623; HANAWA H, 1992, CLIN IMMUNOL IMMUNOP, V62, P321, DOI 10.1016/0090-1229(92)90110-A; Ishii T, 2013, FASEB J, V27, P1362, DOI 10.1096/fj.12-221325; Ishii T, 2013, BIOCHEM BIOPH RES CO, V430, P1201, DOI 10.1016/j.bbrc.2012.12.080; Kandolin R, 2013, CIRC-HEART FAIL, V6, P15, DOI 10.1161/CIRCHEARTFAILURE.112.969261; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Kinugasa F, 2008, BIOL PHARM BULL, V31, P1723, DOI 10.1248/bpb.31.1723; KODAMA M, 1993, AM HEART J, V126, P1385, DOI 10.1016/0002-8703(93)90538-K; KODAMA M, 1990, CLIN IMMUNOL IMMUNOP, V57, P250, DOI 10.1016/0090-1229(90)90039-S; KODAMA M, 1991, CIRC RES, V69, P1042, DOI 10.1161/01.RES.69.4.1042; Kumar A, 1999, AM J PHYSIOL-REG I, V276, pR265, DOI 10.1152/ajpregu.1999.276.1.R265; Madni A, 2014, J PHARM PHARM SCI, V17, P401, DOI 10.18433/J3CP55; Matia I, 2010, EUR J VASC ENDOVASC, V39, P478, DOI 10.1016/j.ejvs.2009.11.016; Matsumoto Y, 2012, CELL IMMUNOL, V279, P70, DOI 10.1016/j.cellimm.2012.09.011; Moffatt SD, 1999, TRANSPLANTATION, V67, P1205, DOI 10.1097/00007890-199905150-00001; Muller LK, 2015, BIOCHEM BIOPH RES CO, V468, P411, DOI 10.1016/j.bbrc.2015.08.088; Nehoff H, 2014, INT J NANOMED, V9, P2539, DOI 10.2147/IJN.S47129; Noutsias M, 2011, EUR J HEART FAIL, V13, P611, DOI 10.1093/eurjhf/hfr014; Okura Y, 1997, J MOL CELL CARDIOL, V29, P491, DOI 10.1006/jmcc.1996.0293; Sagar S, 2012, LANCET, V379, P738, DOI 10.1016/S0140-6736(11)60648-X; Sakuma S, 2000, BRIT J PHARMACOL, V130, P1655, DOI 10.1038/sj.bjp.0703472; Takahama H, 2013, CARDIOVASC DRUG THER, V27, P125, DOI 10.1007/s10557-012-6437-6; Takahama H, 2009, J AM COLL CARDIOL, V53, P709, DOI 10.1016/j.jacc.2008.11.014; Watanabe K, 2001, CIRCULATION, V104, P1098, DOI 10.1161/hc3501.096190; Watanabe R, 2008, TRANSL RES, V152, P119, DOI 10.1016/j.trsl.2008.07.006; Yang WI, 2014, CIRC J, V78, P1197, DOI 10.1253/circj.CJ-13-1235	35	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160944	10.1371/journal.pone.0160944	http://dx.doi.org/10.1371/journal.pone.0160944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501378	Green Published, gold			2022-12-26	WOS:000381373500068
J	Singchat, W; Hitakomate, E; Rerkarmnuaychoke, B; Suntronpong, A; Fu, BY; Bodhisuwan, W; Peyachoknagul, S; Yang, FT; Koontongkaew, S; Srikulnath, K				Singchat, Worapong; Hitakomate, Ekarat; Rerkarmnuaychoke, Budsaba; Suntronpong, Aorarat; Fu, Beiyuan; Bodhisuwan, Winai; Peyachoknagul, Surin; Yang, Fengtang; Koontongkaew, Sittichai; Srikulnath, Kornsorn			Genomic Alteration in Head and Neck Squamous Cell Carcinoma (HNSCC) Cell Lines Inferred from Karyotyping, Molecular Cytogenetics, and Array Comparative Genomic Hybridization	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; COPY NUMBER GAIN; IN-SITU HYBRIDIZATION; TYROSINE PHOSPHATASE PTPRD; HUMAN OVARIAN-CANCER; PROSTATE-CANCER; CHROMOSOME-ABERRATIONS; SOLID TUMORS; EXPRESSION; WWOX	Genomic alteration in head and neck squamous cell carcinoma (HNSCC) was studied in two cell line pairs (HN30-HN31 and HN4-HN12) using conventional C-banding, multiplex fluorescence in situ hybridization (M-FISH), and array comparative genomic hybridization (array CGH). HN30 and HN4 were derived from primary lesions in the pharynx and base of tongue, respectively, and HN31 and HN12 were derived from lymph-node metastatic lesions belonging to the same patients. Gain of chromosome 1, 7, and 11 were shared in almost all cell lines. Hierarchical clustering revealed that HN31 was closely related to HN4, which shared eight chromosome alteration cases. Large C-positive heterochromatins were found in the centromeric region of chromosome 9 in HN31 and HN4, which suggests complex structural amplification of the repetitive sequence. Array CGH revealed amplification of 7p22.3p11.2, 8q11.23q12.1, and 14q32.33 in all cell lines involved with tumorigenesis and inflammation genes. The amplification of 2p21 (SIX3), 11p15.5 (H19), and 11q21q22.3 (MAML2, PGR, TRPC6, and MMP family) regions, and deletion of 9p23 (PTPRD) and 16q23.1 (WWOX) regions were identified in HN31 and HN12. Interestingly, partial loss of PTPRD (9p23) and WWOX (16q23.1) genes was identified in HN31 and HN12, and the level of gene expression tended to be the down-regulation of PTPRD, with no detectable expression of the WWOX gene. This suggests that the scarcity of PTPRD and WWOX genes might have played an important role in progression of HNSCC, and could be considered as a target for cancer therapy or a biomarker in molecular pathology.	[Singchat, Worapong; Suntronpong, Aorarat; Peyachoknagul, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Lab Anim Cytogenet & Comparat Gen, Dept Genet, Fac Sci, 50 Ngamwongwan, Bangkok 10900, Thailand; [Hitakomate, Ekarat; Koontongkaew, Sittichai] Thammasat Univ, Fac Dent, Pathum Thani 12121, Thailand; [Rerkarmnuaychoke, Budsaba] Mahidol Univ, Ramathibodi Hosp, Dept Pathol, Fac Med, Bangkok 10400, Thailand; [Fu, Beiyuan; Yang, Fengtang] Wellcome Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Bodhisuwan, Winai] Kasetsart Univ, Dept Stat, Fac Sci, 50 Ngamwongwan, Bangkok 10900, Thailand; [Peyachoknagul, Surin; Srikulnath, Kornsorn] Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand	Kasetsart University; Thammasat University; Mahidol University; Wellcome Trust Sanger Institute; Kasetsart University; Kasetsart University	Srikulnath, K (corresponding author), Kasetsart Univ, Lab Anim Cytogenet & Comparat Gen, Dept Genet, Fac Sci, 50 Ngamwongwan, Bangkok 10900, Thailand.; Srikulnath, K (corresponding author), Kasetsart Univ, Natl Res Univ, Ctr Adv Studies Trop Nat Resources, Bangkok, Thailand.	kornsorn.s@ku.ac.th	Yang, Fan/GYU-4249-2022; Bodhisuwan, Winai/Q-3240-2019; Srikulnath, Kornsorn/GLU-1326-2022	Srikulnath, Kornsorn/0000-0002-5985-7258; Singchat, Worapong/0000-0002-7083-6159; Hitakomate, Ekarat/0000-0002-0158-3485; Bodhisuwan, Winai/0000-0003-3207-9019; Yang, Fengtang/0000-0002-3573-2354	Kasetsart University Research and Development Institute (KURDI), Thailand [33.58]; Kasetsart University, Thailand [PM4/2558]; Science Research Fund (ScRF) [ScRF-S19-2558]; Postgraduate Studentship (ScKUPGS) from Faculty of Science, Kasetsart University [0513.10701/2262]; Fellowship of Capacity Building for Kasetsart University on Internationalization [0513.10109/1757]; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, (CASTNAR, NRU-KU, Thailand) [6/2558]; National Research Council of Thailand (NRCT) [006/2558]; Wellcome Trust [WT098051]	Kasetsart University Research and Development Institute (KURDI), Thailand; Kasetsart University, Thailand; Science Research Fund (ScRF); Postgraduate Studentship (ScKUPGS) from Faculty of Science, Kasetsart University; Fellowship of Capacity Building for Kasetsart University on Internationalization; Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, (CASTNAR, NRU-KU, Thailand); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was financially supported by Kasetsart University Research and Development Institute (KURDI) (No. 33.58), Kasetsart University, Thailand; Professor Motivation (PM) (No. PM4/2558), Science Research Fund (ScRF) (No. ScRF-S19-2558), and Postgraduate Studentship (ScKUPGS) from Faculty of Science, Kasetsart University (No. 0513.10701/2262); the Fellowship of Capacity Building for Kasetsart University on Internationalization (No. 0513.10109/1757); Center for Advanced Studies in Tropical Natural Resources, National Research University-Kasetsart University, (CASTNAR, NRU-KU, Thailand) (No. 6/2558); and the National Research Council of Thailand (NRCT) (No. 006/2558). The Cytogenetics Core Facility at the Wellcome Trust Sanger Institute is funded by the Wellcome Trust (No. WT098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Ambatipudi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017250; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Andrade VP, 2015, MOL ONCOL, V9, P772, DOI 10.1016/j.molonc.2014.12.005; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Braakhuis BJM, 2002, HEAD NECK-J SCI SPEC, V24, P198, DOI 10.1002/hed.10042.abs; Brauswetter D, 2016, VIRCHOWS ARCH, V468, P579, DOI 10.1007/s00428-016-1905-1; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; CARDINALI M, 1995, INT J CANCER, V61, P98, DOI 10.1002/ijc.2910610117; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Croce CM, 1999, J CLIN ONCOL, V17, P1618, DOI 10.1200/JCO.1999.17.5.1618; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dolloff NG, 2005, ONCOGENE, V24, P6848, DOI 10.1038/sj.onc.1208815; Ekizoglu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115353; Engehausen DG, 2005, ANTICANCER RES, V25, P1607; Feigenberg Tomer, 2013, ISRN Obstet Gynecol, V2013, P137509, DOI 10.1155/2013/137509; Ferreiro JF, 2015, HAEMATOLOGICA, V100, pE275, DOI 10.3324/haematol.2015.124305; FOULKES WD, 1993, BRIT J CANCER, V67, P268, DOI 10.1038/bjc.1993.51; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Garnis C, 2004, ORAL ONCOL, V40, P511, DOI 10.1016/j.oraloncology.2003.10.006; Geigl JB, 2006, NAT PROTOC, V1, P1172, DOI 10.1038/nprot.2006.160; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Gooding RP, 1999, BRIT J HAEMATOL, V106, P669, DOI 10.1046/j.1365-2141.1999.01602.x; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Guilbert A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-125; Hensen EF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-168; Hezova Renata, 2007, Biomedical Papers (Olomouc), V151, P11; Higaki E, 2016, GASTRIC CANCER, V19, P63, DOI 10.1007/s10120-014-0449-9; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jarmuz-Szymczak M, 2013, MOL BIOL REP, V40, P4161, DOI 10.1007/s11033-013-2496-4; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kanata K, 2005, J HARD TISSUE BIOL, V14, P251, DOI [10.2485/jhtb.14.251, DOI 10.2485/JHTB.14.251]; Kohn L, 2015, APPL IMMUNOHISTO M M, V23, P334, DOI 10.1097/PAI.0000000000000087; Kontos CK, 2010, BRIT J CANCER, V102, P1384, DOI 10.1038/sj.bjc.6605654; Koontongkaew S, 2012, MED ONCOL, V29, P690, DOI 10.1007/s12032-011-9871-6; Koontongkaew S, 2009, CELL BIOL INT, V33, P165, DOI 10.1016/j.cellbi.2008.10.009; Kornberg LJ, 1998, HEAD NECK-J SCI SPEC, V20, P745, DOI 10.1002/(SICI)1097-0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z; Kost-Alimova M, 2004, GENE CHROMOSOME CANC, V40, P316, DOI 10.1002/gcc.20054; Krum Everson A., 2008, Rev. Bras. Hematol. Hemoter., V30, P253, DOI 10.1590/S1516-84842008000300016; Kuroki T, 2004, CLIN CANCER RES, V10, P2459, DOI 10.1158/1078-0432.CCR-03-0096; Kurscheid S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0583-7; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv WJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/108458; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Majidzadeh-A Keivan, 2011, BMC Res Notes, V4, P215, DOI 10.1186/1756-0500-4-215; Mao L, 1996, CANCER RES, V56, P5128; Matouk I, 2005, CANC THER, V3, P249; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Meehan M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-6; Mesquita B, 2013, BREAST CANCER RES TR, V138, P37, DOI 10.1007/s10549-013-2408-2; Mo ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071816; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Mohan M, 2014, ONCOL REV, V8, P13, DOI 10.4081/oncol.2014.244; Muthuswami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077553; Nakamura M, 2003, CANCER RES, V63, P737; Nguyen DP, 2014, BJU INT, V113, P986, DOI 10.1111/bju.12452; Oba-Shinjo Sueli M, 2008, Cancer Immun, V8, P7; Ohana P, 2002, INT J CANCER, V98, P645, DOI 10.1002/ijc.10243; Ohana P, 1999, FEBS LETT, V454, P81, DOI 10.1016/S0014-5793(99)00780-2; Ortiz B, 2014, P NATL ACAD SCI USA, V111, P8149, DOI 10.1073/pnas.1401952111; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Pruegsanusak K, 2012, ASIAN PAC J CANCER P, V13, P885, DOI 10.7314/APJCP.2012.13.3.885; Qin LX, 2002, WORLD J GASTROENTERO, V8, P769, DOI 10.3748/wjg.v8.i5.769; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sasaki H, 2015, ONCOL LETT, V9, P709, DOI 10.3892/ol.2014.2719; Satih S, 2010, OMICS, V14, P231, DOI 10.1089/omi.2009.0124; Schrock MS, 2015, EXP BIOL MED, V240, P296, DOI 10.1177/1535370214561590; Seneviratne D, 2015, GASTROENTEROLOGY, V148, P181, DOI 10.1053/j.gastro.2014.09.019; Seo AN, 2015, TUMOR BIOL, V36, P9813, DOI 10.1007/s13277-015-3726-2; Sethi S, 2009, DIAGN MOL PATHOL, V18, P81, DOI 10.1097/PDM.0b013e3181804b82; Shlush Liran I, 2015, Am Soc Clin Oncol Educ Book, pe662, DOI 10.14694/EdBook_AM.2015.35.e662; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Squire JA, 2002, HEAD NECK-J SCI SPEC, V24, P874, DOI 10.1002/hed.10122; Srikulnath K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134829; Stein L, 2010, THYROID, V20, P475, DOI 10.1089/thy.2009.0008; Stella F, 2014, BLOOD CELL MOL DIS, V53, P110, DOI 10.1016/j.bcmd.2014.05.006; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Supikamolseni A, 2015, GENET MOL RES, V14, P13981, DOI 10.4238/2015.October.29.18; Trempus CS, 2011, MOL CARCINOGEN, V50, P981, DOI 10.1002/mc.20768; Tsukasaki K, 2001, ONCOGENE, V20, P3301, DOI 10.1038/sj.onc.1204421; Vatanasapt P., 2012, Journal of the Medical Association of Thailand, V95, P182; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Vincent-Chong VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054705; Von Holstein SL, 2012, ONCOL REP, V27, P1413, DOI 10.3892/or.2012.1676; Walsh Jarrett E, 2007, Curr Treat Options Oncol, V8, P227, DOI 10.1007/s11864-007-0032-2; Wattanapanitch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106952; Yan HC, 2015, MOL MED REP, V12, P1783, DOI 10.3892/mmr.2015.3640; Yan L, 2015, ONCOGENE, V34, P3076, DOI 10.1038/onc.2014.236; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, HISTOL HISTOPATHOL, V23, P877, DOI 10.14670/HH-23.877; Zhang P, 2014, AM J PATHOL, V184, P1323, DOI 10.1016/j.ajpath.2014.01.028; Zhang SG, 2010, MOL BIOL REP, V37, P381, DOI 10.1007/s11033-009-9817-7; Zhang YL, 2015, INT J CLIN EXP MED, V8, P15127	105	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160901	10.1371/journal.pone.0160901	http://dx.doi.org/10.1371/journal.pone.0160901			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501229	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500066
J	Ye, SY; Krauss, KW; Brix, H; Wei, MJ; Olsson, L; Yu, XY; Ma, XY; Wang, J; Yuan, HM; Zhao, GM; Ding, XG; Moss, RF				Ye, Siyuan; Krauss, Ken W.; Brix, Hans; Wei, Mengjie; Olsson, Linda; Yu, Xueyang; Ma, Xueying; Wang, Jin; Yuan, Hongming; Zhao, Guangming; Ding, Xigui; Moss, Rebecca F.			Inter-Annual Variability of Area-Scaled Gaseous Carbon Emissions from Wetland Soils in the Liaohe Delta, China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; YELLOW-RIVER ESTUARY; LAND-USE CHANGE; METHANE EMISSIONS; NITROUS-OXIDE; SUAEDA-SALSA; MARSH ECOSYSTEM; NET SOURCE; FLUXES; RESPIRATION	Global management of wetlands to suppress greenhouse gas (GHG) emissions, facilitate carbon (C) sequestration, and reduce atmospheric CO2 concentrations while simultaneously promoting agricultural gains is paramount. However, studies that relate variability in CO2 and CH4 emissions at large spatial scales are limited. We investigated three-year emissions of soil CO2 and CH4 from the primary wetland types of the Liaohe Delta, China, by focusing on a total wetland area of 3287 km(2). One percent is Suaeda salsa, 24% is Phragmites australis, and 75% is rice. While S. salsa wetlands are under somewhat natural tidal influence, P. australis and rice are managed hydrologically for paper and food, respectively. Total C emissions from CO2 and CH4 from these wetland soils were 2.9 Tg C/year, ranging from 2.5 to 3.3 Tg C/year depending on the year assessed. Primary emissions were from CO2 (similar to 98%). Photosynthetic uptake of CO2 would mitigate most of the soil CO2 emissions, but CH4 emissions would persist. Overall, CH4 fluxes were high when soil temperatures were > 18 degrees C and pore water salinity < 18 PSU. CH4 emissions from rice habitat alone in the Liaohe Delta represent 0.2% of CH4 carbon emissions globally from rice. With such a large area and interannual sensitivity in soil GHG fluxes, management practices in the Delta and similar wetlands around the world have the potential not only to influence local C budgeting, but also to influence global biogeochemical cycling.	[Ye, Siyuan; Wei, Mengjie; Yu, Xueyang; Ma, Xueying; Wang, Jin; Yuan, Hongming; Zhao, Guangming; Ding, Xigui] China Geol Survey, Qingdao Inst Marine Geol, Key Lab Coastal Wetland Biogeosci, Qingdao 266071, Peoples R China; [Ye, Siyuan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Geol, Qingdao 266061, Peoples R China; [Krauss, Ken W.] US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA; [Brix, Hans; Olsson, Linda] Aarhus Univ, Dept Biosci, DK-8000 Aarhus C, Denmark; [Brix, Hans; Olsson, Linda] Aarhus Univ, Sinodanish Ctr Educ & Res, DK-8000 Aarhus C, Denmark; [Moss, Rebecca F.] USGS Wetland & Aquat Res Ctr, Cherokee Nation Technol Solut, Lafayette, LA 70506 USA	China Geological Survey; Qingdao Institute of Marine Geology (QIMG); Qingdao National Laboratory for Marine Science & Technology; United States Department of the Interior; United States Geological Survey; Aarhus University; Aarhus University	Krauss, KW (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Lafayette, LA 70506 USA.	kraussk@usgs.gov	Brix, Hans/C-5208-2008; Brix, Hans/AAN-5367-2020	Brix, Hans/0000-0003-2771-2983; Brix, Hans/0000-0003-2771-2983	Ministry of Land and Resources Program of China [201111023]; Marine Safeguard Project [GZH201200503]; China Geological Survey Projects [121201005000150004, 1212010611402]; National Natural Science Foundation of China [40872167, 41240022]; Sino-Danish Centre for Education and Research; United States Geological Survey (Climate and Land Use Change R & D and LandCarbon Programs); China Geological Survey [CH-02.0600]	Ministry of Land and Resources Program of China; Marine Safeguard Project; China Geological Survey Projects(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-Danish Centre for Education and Research; United States Geological Survey (Climate and Land Use Change R & D and LandCarbon Programs); China Geological Survey(China Geological Survey)	This work was funded by grants from the Ministry of Land and Resources Program of China (Grant No. 201111023), Marine Safeguard Project (Grant No. GZH201200503), China Geological Survey Projects (Grant Nos. 121201005000150004, 1212010611402), National Natural Science Foundation of China (Grant Nos. 40872167 and 41240022), the Sino-Danish Centre for Education and Research, and by in-kind contributions from the China Geological Survey (Project Annex No. 6, CH-02.0600) and United States Geological Survey (Climate and Land Use Change R & D and LandCarbon Programs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer D, 2010, PRINC PRIMER CLIM, P1; BARTLETT KB, 1987, BIOGEOCHEMISTRY, V4, P183, DOI 10.1007/BF02187365; Bridgham SD, 2006, WETLANDS, V26, P889, DOI 10.1672/0277-5212(2006)26[889:TCBONA]2.0.CO;2; Brix H, 2001, AQUAT BOT, V69, P313, DOI 10.1016/S0304-3770(01)00145-0; Brix H, 2014, ECOL ENG, V73, P760, DOI 10.1016/j.ecoleng.2014.09.099; Chen Q, 2015, J GEOSCI ENV PROT, V3, P26; Chen QF, 2013, INT BIODETER BIODEGR, V85, P646, DOI 10.1016/j.ibiod.2013.04.009; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Ciais P., 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CB09781107415324.015; Craft C, 2007, LIMNOL OCEANOGR, V52, P1220, DOI 10.4319/lo.2007.52.3.1220; Dinsmore KJ, 2009, PLANT SOIL, V318, P229, DOI 10.1007/s11104-008-9832-9; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Ehhalt D, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P239; Gleason RA, 2011, ECOL APPL, V21, pS65, DOI 10.1890/09-0216.1; Global Carbon Project, 2013, METH BUDG TRENDS 201; Hatala JA, 2012, AGR ECOSYST ENVIRON, V150, P1, DOI 10.1016/j.agee.2012.01.009; Hendriks DMD, 2007, BIOGEOSCIENCES, V4, P411, DOI 10.5194/bg-4-411-2007; Hertel TW, 2010, BIOSCIENCE, V60, P223, DOI 10.1525/bio.2010.60.3.8; Holm GO, 2016, WETLANDS, V36, P401, DOI 10.1007/s13157-016-0746-7; Huang GH, 2005, J ENVIRON SCI HEAL A, V40, P1227, DOI 10.1081/ESE-200055666; Johnson R. A., 1988, APPL MULTIVARIATE ST; Kim H, 2009, ENVIRON SCI TECHNOL, V43, P961, DOI 10.1021/es802681k; Knox SH, 2015, GLOBAL CHANGE BIOL, V21, P750, DOI 10.1111/gcb.12745; Krauss KW, 2012, PLANT SOIL, V358, P265, DOI 10.1007/s11104-012-1182-y; Krauss KW, 2012, WETLANDS, V32, P73, DOI 10.1007/s13157-011-0246-8; Lal R, 2008, PHILOS T R SOC B, V363, P815, DOI 10.1098/rstb.2007.2185; Livingston G., 1995, BIOGENIC TRACE GASES, P14; Mao R, 2014, WETLANDS, V34, P189, DOI 10.1007/s13157-013-0497-7; Matson PA, 1995, BIOGENIC TRACE GASES; MCKEE KL, 1988, AM J BOT, V75, P1352, DOI 10.2307/2444458; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Megonigal JP, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001594; Meijide A, 2011, BIOGEOSCIENCES, V8, P3809, DOI 10.5194/bg-8-3809-2011; Middleton BA, 2001, J ECOL, V89, P818, DOI 10.1046/j.0022-0477.2001.00602.x; Mitsch WJ, 2013, LANDSCAPE ECOL, V28, P583, DOI 10.1007/s10980-012-9758-8; Mou XJ, 2011, J ENVIRON SCI, V23, P958, DOI 10.1016/S1001-0742(10)60530-X; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Neubauer SC, 2000, MAR ECOL PROG SER, V199, P13, DOI 10.3354/meps199013; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Olsson L, 2015, BIOGEOSCIENCES, V12, P4965, DOI 10.5194/bg-12-4965-2015; Pangala SR, 2013, NEW PHYTOL, V197, P524, DOI 10.1111/nph.12031; Petrescu AMR, 2015, P NATL ACAD SCI USA, V112, P4594, DOI 10.1073/pnas.1416267112; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Song HL, 2016, WETLANDS, V36, pS113, DOI 10.1007/s13157-014-0587-1; Song WeiMin, 2015, Journal of Geophysical Research: Biogeosciences, V120, P1475, DOI 10.1002/2015JG003043; Sun ZG, 2013, CHEMOSPHERE, V90, P856, DOI 10.1016/j.chemosphere.2012.10.004; Tian HQ, 2016, NATURE, V531, P225, DOI 10.1038/nature16946; Tong C, 2013, ESTUAR COAST, V36, P633, DOI 10.1007/s12237-013-9596-1; Whalen SC, 2005, ENVIRON ENG SCI, V22, P73, DOI 10.1089/ees.2005.22.73; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; WMO, 2014, WMO1130; Xu XW, 2014, ECOL ENG, V73, P469, DOI 10.1016/j.ecoleng.2014.09.087; Yan XY, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003182; Yu KW, 2006, CHEMOSPHERE, V62, P905, DOI 10.1016/j.chemosphere.2005.05.033; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zhang HJ, 2010, CHEMOSPHERE, V79, P754, DOI 10.1016/j.chemosphere.2010.02.039; Zhu LH, 2010, J GEOGR SCI, V20, P31, DOI 10.1007/s11442-010-0031-2; Zhu XY, 2014, ATMOS ENVIRON, V92, P478, DOI 10.1016/j.atmosenv.2014.04.061; Zona D, 2016, P NATL ACAD SCI USA, V113, P40, DOI 10.1073/pnas.1516017113; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	64	12	13	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160612	10.1371/journal.pone.0160612	http://dx.doi.org/10.1371/journal.pone.0160612			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501148	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500039
J	Rensvold, JW; Krautkramer, KA; Dowell, JA; Denu, JM; Pagliarini, DJ				Rensvold, Jarred W.; Krautkramer, Kimberly A.; Dowell, James A.; Denu, John M.; Pagliarini, David J.			Iron Deprivation Induces Transcriptional Regulation of Mitochondrial Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACKING TRANSFERRIN RECEPTOR; HISTONE MODIFICATIONS; CHROMATIN REGULATION; SULFUR PROTEINS; GENE-EXPRESSION; DISEASE; DEFICIENCY; METABOLISM; HYPOXIA; CANCER	Mitochondria are essential organelles that adapt to stress and environmental changes. Among the nutrient signals that affect mitochondrial form and function is iron, whose depletion initiates a rapid and reversible decrease in mitochondrial biogenesis through unclear means. Here we demonstrate that, unlike the canonical iron-induced alterations to transcript stability, loss of iron dampens the transcription of genes encoding mitochondrial proteins with no change to transcript half-life. Using mass spectrometry, we demonstrate that these transcriptional changes are accompanied by dynamic alterations to histone acetylation and methylation levels that are largely reversible upon readministration of iron. Moreover, histone deacetylase inhibition abrogates the decreased histone acetylation observed upon iron deprivation and restores normal transcript levels at genes encoding mitochondrial proteins. Collectively, we demonstrate that deprivation of an essential nutrient induces transcriptional repression of organellar biogenesis involving epigenetic alterations.	[Rensvold, Jarred W.; Denu, John M.; Pagliarini, David J.] Morgridge Inst Res, 2268 Discovery Bldg,330 N Orchard St, Madison, WI 53715 USA; [Krautkramer, Kimberly A.; Dowell, James A.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53715 USA; [Krautkramer, Kimberly A.; Dowell, James A.; Denu, John M.] Univ Wisconsin, Wisconsin Inst Discovery, Madison, WI 53715 USA; [Pagliarini, David J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pagliarini, DJ (corresponding author), Morgridge Inst Res, 2268 Discovery Bldg,330 N Orchard St, Madison, WI 53715 USA.	dpagliarini@morgridge.org	Krautkramer, Kimberly/AAR-7014-2020	Krautkramer, Kimberly/0000-0002-9227-0977; Pagliarini, David J./0000-0002-0001-0087	Searle Scholars Award, a Shaw Scientist Award, Department of Agriculture Hatch Award [WIS01671]; National Institutes of Health [R01DK098672]; National Institutes of Health Molecular Biosciences Training Grant [T32GM007215]; University of Wisconsin-Madison, College of Agricultural and Life Sciences Louis and Elsa Thomsen Distinguished Graduate Fellowship; National Institutes of Health Molecular and Applied Nutrition Training Program Grant [T32DK007665]; National Institutes of Health University of Wisconsin Medical Scientist Training Program [T32GM008692]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098672, T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, T32GM007215, R01GM115591] Funding Source: NIH RePORTER	Searle Scholars Award, a Shaw Scientist Award, Department of Agriculture Hatch Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Molecular Biosciences Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison, College of Agricultural and Life Sciences Louis and Elsa Thomsen Distinguished Graduate Fellowship; National Institutes of Health Molecular and Applied Nutrition Training Program Grant; National Institutes of Health University of Wisconsin Medical Scientist Training Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Searle Scholars Award, a Shaw Scientist Award, Department of Agriculture Hatch Award WIS01671, and National Institutes of Health Grant R01DK098672 (to D. J. P.); National Institutes of Health Molecular Biosciences Training Grant T32GM007215 and a University of Wisconsin-Madison, College of Agricultural and Life Sciences Louis and Elsa Thomsen Distinguished Graduate Fellowship (to J. W. R.); and National Institutes of Health Molecular and Applied Nutrition Training Program Grant T32DK007665 and National Institutes of Health University of Wisconsin Medical Scientist Training Program Grant T32GM008692 (to K. A. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen GFG, 2013, EMBO REP, V14, P1127, DOI 10.1038/embor.2013.168; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Chervona Y, 2012, FREE RADICAL BIO MED, V53, P1041, DOI 10.1016/j.freeradbiomed.2012.07.020; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Eisenstein RS, 2003, J NUTR, V133, p1510S, DOI 10.1093/jn/133.5.1510S; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Frey PA, 2012, ACS CHEM BIOL, V7, P1477, DOI 10.1021/cb300323q; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Goldenthal MJ, 2004, MOL CELL BIOCHEM, V262, P1, DOI 10.1023/B:MCBI.0000038228.85494.3b; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kaplan CD, 2009, CHEM REV, V109, P4536, DOI 10.1021/cr9001676; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Labbe K, 2014, ANNU REV CELL DEV BI, V30, P357, DOI 10.1146/annurev-cellbio-101011-155756; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Martinez-Reyes I, 2016, MOL CELL, V61, P199, DOI 10.1016/j.molcel.2015.12.002; Matak P, 2016, P NATL ACAD SCI USA, V113, P3428, DOI 10.1073/pnas.1519473113; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Ponka P, 1999, INT J BIOCHEM CELL B, V31, P1111, DOI 10.1016/S1357-2725(99)00070-9; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Quiros PM, 2015, NAT REV MOL CELL BIO, V16, P345, DOI 10.1038/nrm3984; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Rouault TA, 2015, NAT CHEM BIOL, V11, P442, DOI 10.1038/nchembio.1843; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; von Haehling S, 2015, NAT REV CARDIOL, V12, P659, DOI 10.1038/nrcardio.2015.109; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023; Yao MY, 2014, AM J PHYSIOL-LUNG C, V307, pL829, DOI 10.1152/ajplung.00081.2014; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	63	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20827	+		10.1074/jbc.M116.727701	http://dx.doi.org/10.1074/jbc.M116.727701			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27497435	hybrid, Green Published			2022-12-26	WOS:000385406200001
J	Forny, P; Schumann, A; Mustedanagic, M; Mathis, D; Wulf, MA; Nagele, N; Langhans, CD; Zhakupova, A; Heeren, J; Scheja, L; Fingerhut, R; Peters, HL; Hornemann, T; Thony, B; Kolker, S; Burda, P; Froese, DS; Devuyst, O; Baumgartner, MR				Forny, Patrick; Schumann, Anke; Mustedanagic, Merima; Mathis, Deborah; Wulf, Marie-Angela; Nagele, Nadine; Langhans, Claus-Dieter; Zhakupova, Assem; Heeren, Joerg; Scheja, Ludger; Fingerhut, Ralph; Peters, Heidi L.; Hornemann, Thorsten; Thony, Beat; Koelker, Stefan; Burda, Patricie; Froese, D. Sean; Devuyst, Olivier; Baumgartner, Matthias R.			Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; ammonia; enzyme mutation; inborn error of metabolism; metabolic disease; mitochondrial disease; genotype-phenotype correlation; knock-in mouse model; methylmalonic aciduria; vitamin B12 metabolism	CHAIN FATTY-ACIDS; MITOCHONDRIAL DYSFUNCTION; PROPIONIC ACIDURIA; ORGANIC ACIDURIAS; LIPOCALIN 2; ACIDEMIA; DISEASE; MUT; IDENTIFICATION; METABOLISM	Methylmalonic aciduria (MMAuria), caused by deficiency of methylmalonyl-CoA mutase (MUT), usually presents in the newborn period with failure to thrive and metabolic crisis leading to coma or even death. Survivors remain at risk of metabolic decompensations and severe long term complications, notably renal failure and neurological impairment. We generated clinically relevant mouse models of MMAuria using a constitutive Mut knock-in (KI) allele based on the p.Met700Lys patient mutation, used homozygously (KI/KI) or combined with a knockout allele (KO/KI), to study biochemical and clinical MMAuria disease aspects. Transgenic Mut(ki/ki) and Mut(ko/ki) mice survive post-weaning, show failure to thrive, and show increased methylmalonic acid, propionylcarnitine, odd chain fatty acids, and sphingoid bases, a new potential biomarker of MMAuria. Consistent with genetic dosage, Mut(ko/ki) mice have lower Mut activity, are smaller, and show higher metabolite levels than Mut(ki/ki) mice. Further, Mut(ko/ki) mice exhibit manifestations of kidney and brain damage, including increased plasma urea, impaired diuresis, elevated biomarkers, and changes in brain weight. On a high protein diet, mutant mice display disease exacerbation, including elevated blood ammonia, and catastrophic weight loss, which, in Mut(ki/ki) mice, is rescued by hydroxocobalamin treatment. This study expands knowledge of MMAuria, introduces the discovery of new biomarkers, and constitutes the first in vivo proof of principle of cobalamin treatment in mut-type MMAuria.	[Forny, Patrick; Schumann, Anke; Mustedanagic, Merima; Thony, Beat; Burda, Patricie; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp Zurich, Div Metab, CH-8032 Zurich, Switzerland; [Forny, Patrick; Schumann, Anke; Fingerhut, Ralph; Thony, Beat; Burda, Patricie; Froese, D. Sean; Baumgartner, Matthias R.] Univ Childrens Hosp Zurich, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Mathis, Deborah] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland; [Fingerhut, Ralph] Univ Childrens Hosp Zurich, Swiss Newborn Screening Lab, CH-8032 Zurich, Switzerland; [Forny, Patrick; Schumann, Anke; Hornemann, Thorsten; Froese, D. Sean; Devuyst, Olivier; Baumgartner, Matthias R.] Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, CH-8006 Zurich, Switzerland; [Forny, Patrick; Devuyst, Olivier; Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Schumann, Anke; Nagele, Nadine; Devuyst, Olivier] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Wulf, Marie-Angela] Univ Zurich Hosp, Inst Neuropathol, CH-8006 Zurich, Switzerland; [Zhakupova, Assem; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, CH-8006 Zurich, Switzerland; [Langhans, Claus-Dieter; Koelker, Stefan] Univ Childrens Hosp, Div Child Neurol & Inherited Metab Dis, D-69120 Heidelberg, Germany; [Heeren, Joerg; Scheja, Ludger] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Peters, Heidi L.] Murdoch Childrens Res Inst, Metab Res, Parkville, Vic 3052, Australia	University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Murdoch Children's Research Institute	Baumgartner, MR (corresponding author), Univ Childrens Hosp Zurich, Div Metab, CH-8032 Zurich, Switzerland.	matthias.baumgartner@kispi.uzh.ch	Froese, D. Sean Sean/AAW-6899-2021; Forny, Patrick/I-8387-2016; peters, heidi/GWD-0358-2022; Froese, Sean/J-6665-2017; Baumgartner, Matthias/Q-2855-2017; Fingerhut, Ralph/AAY-5061-2021	Froese, D. Sean Sean/0000-0003-1557-3517; Forny, Patrick/0000-0003-1877-2976; Froese, Sean/0000-0003-1557-3517; Baumgartner, Matthias/0000-0002-9270-0826; Fingerhut, Ralph/0000-0002-9674-8931; Peters, Heidi/0000-0001-7189-5874; Mathis, Deborah/0000-0002-2326-7782; Devuyst, Olivier/0000-0003-3744-4767; Thony, Beat/0000-0002-8420-4769	Rare Disease Initiative Zurich; clinical research priority program for rare diseases of the University of Zurich; Swiss National Science Foundation [31003A_138521, 310030-146490]; Wolferman-Nageli Foundation; European Community [305608]; Swiss National Science Foundation MD-PhD fellowship (Swiss National Science Foundation) [323530_145248]	Rare Disease Initiative Zurich; clinical research priority program for rare diseases of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wolferman-Nageli Foundation; European Community(European Commission); Swiss National Science Foundation MD-PhD fellowship (Swiss National Science Foundation)	This work was supported by the Rare Disease Initiative Zurich (radiz), a clinical research priority program for rare diseases of the University of Zurich; the Swiss National Science Foundation Grant 31003A_138521; the Wolferman-Nageli Foundation; the European Community's Seventh Framework Programme FP7/2007-2013 Grant 305608 (EURenOmics) (to O. D.); the Swiss National Science Foundation Project Grant 310030-146490 (to O. D.); and a Swiss National Science Foundation MD-PhD fellowship (Swiss National Science Foundation Grant 323530_145248; to P. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Acquaviva C, 2005, HUM MUTAT, V25, P167, DOI 10.1002/humu.20128; Ballhausen D, 2009, NEUROSCIENCE, V164, P578, DOI 10.1016/j.neuroscience.2009.08.028; Baumgartner MR, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0130-8; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Buck NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044974; Chandler RJ, 2008, HUM GENE THER, V19, P53, DOI 10.1089/hum.2007.0118; Chandler RJ, 2010, MOL THER, V18, P11, DOI 10.1038/mt.2009.247; Chandler RJ, 2009, FASEB J, V23, P1252, DOI 10.1096/fj.08-121848; Coker M, 1996, J INHERIT METAB DIS, V19, P743, DOI 10.1007/BF01799166; Cosson MA, 2009, MOL GENET METAB, V97, P172, DOI 10.1016/j.ymgme.2009.03.006; de Keyzer Y, 2009, PEDIATR RES, V66, P91, DOI 10.1203/PDR.0b013e3181a7c270; Ferreira AC, 2015, PROG NEUROBIOL, V131, P120, DOI 10.1016/j.pneurobio.2015.06.005; Forny P, 2016, HUM MUTAT, V37, P745, DOI 10.1002/humu.23013; Forny P, 2014, HUM MUTAT, V35, P1449, DOI 10.1002/humu.22633; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; HILLMAN RE, 1974, PEDIATR RES, V8, P941, DOI 10.1203/00006450-197412000-00005; Horster F, 2009, J INHERIT METAB DIS, V32, P630, DOI 10.1007/s10545-009-1189-6; Horster F, 2007, PEDIATR RES, V62, P225; Kolker S, 2015, J INHERIT METAB DIS, V38, P1041, DOI 10.1007/s10545-015-9839-3; Kolker S, 2013, J INHERIT METAB DIS, V36, P635, DOI 10.1007/s10545-013-9600-8; Kolker S, 2005, CELL MOL LIFE SCI, V62, P621, DOI 10.1007/s00018-005-4463-2; Kolker S, 2003, J BIOL CHEM, V278, P47388, DOI 10.1074/jbc.M308861200; Lempp TJ, 2007, MOL GENET METAB, V90, P284, DOI 10.1016/j.ymgme.2006.10.002; Malvagia S, 2015, CLIN CHIM ACTA, V450, P342, DOI 10.1016/j.cca.2015.09.012; Malyszko J, 2008, RENAL FAILURE, V30, P625, DOI 10.1080/08860220802134607; Manoli I, 2013, P NATL ACAD SCI USA, V110, P13552, DOI 10.1073/pnas.1302764110; MATSUI SM, 1983, NEW ENGL J MED, V308, P857, DOI 10.1056/NEJM198304143081501; Merinero B, 2008, J INHERIT METAB DIS, V31, P55, DOI 10.1007/s10545-007-0667-y; Morath MA, 2008, J INHERIT METAB DIS, V31, P35, DOI 10.1007/s10545-007-0571-5; Naude PJW, 2012, FASEB J, V26, P2811, DOI 10.1096/fj.11-202457; Nicolaides P, 1998, ARCH DIS CHILD, V78, P508, DOI 10.1136/adc.78.6.508; OBERHOLZ.VG, 1967, ARCH DIS CHILD, V42, P492, DOI 10.1136/adc.42.225.492; Okun JG, 2002, J BIOL CHEM, V277, P14674, DOI 10.1074/jbc.M200997200; Othman A, 2015, ATHEROSCLEROSIS, V240, P216, DOI 10.1016/j.atherosclerosis.2015.03.011; PERRY TL, 1977, PEDIATR RES, V11, P1192, DOI 10.1203/00006450-197712000-00005; Peters H, 2003, J BIOL CHEM, V278, P52909, DOI 10.1074/jbc.M310533200; Peters HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040609; Scheja L, 2008, LIPIDS, V43, P1039, DOI 10.1007/s11745-008-3220-3; Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957; WENDEL U, 1991, PEDIATR RES, V29, P403, DOI 10.1203/00006450-199104000-00015; Ziesch B, 2012, J INHERIT METAB DIS, V35, P983, DOI 10.1007/s10545-012-9458-1	44	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20563	20573		10.1074/jbc.M116.747717	http://dx.doi.org/10.1074/jbc.M116.747717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27519416	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000384574800022
J	Liu, K; Lv, JL; Dai, YC; Zhang, H; Cao, YF				Liu, Ke; Lv, Jialong; Dai, Yunchao; Zhang, Hong; Cao, Yingfei			Cross-Species Extrapolation of Models for Predicting Lead Transfer from Soil to Wheat Grain	PLOS ONE			English	Article							TRITICUM-AESTIVUM; HEAVY-METAL; SENSITIVITY DISTRIBUTION; BIOAVAILABILITY MODEL; ACUTE TOXICITY; CADMIUM; NICKEL; ACCUMULATION; PLANT; ZINC	The transfer of Pb from the soil to crops is a serious food hygiene security problem in China because of industrial, agricultural, and historical contamination. In this study, the characteristics of exogenous Pb transfer from 17 Chinese soils to a popular wheat variety (Xiaoyan 22) were investigated. In addition, bioaccumulation prediction models of Pb in grain were obtained based on soil properties. The results of the analysis showed that pH and OC were the most important factors contributing to Pb uptake by wheat grain. Using a cross-species extrapolation approach, the Pb uptake prediction models for cultivar Xiaoyan 22 in different soil Pb levels were satisfactorily applied to six additional non-modeled wheat varieties to develop a prediction model for each variety. Normalization of the bioaccumulation factor (BAF) to specific soil physico-chemistry is essential, because doing so could significantly reduce the intra-species variation of different wheat cultivars in predicted Pb transfer and eliminate the influence of soil properties on ecotoxicity parameters for organisms of interest. Finally, the prediction models were successfully verified against published data (including other wheat varieties and crops) and used to evaluate the ecological risk of Pb for wheat in contaminated agricultural soils.	[Liu, Ke; Lv, Jialong; Dai, Yunchao; Zhang, Hong; Cao, Yingfei] Northwest A&F Univ, Coll Nat Resources & Environm, Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Lv, JL (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Minist Agr, Key Lab Plant Nutr & Agrienvironm Northwest China, Yangling, Peoples R China.	ljlll@nwsuaf.edu.cn			Ministry of Agriculture of the People's Republic of China [200903015]	Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This research was supported by the Ministry of Agriculture of the People's Republic of China (No. 200903015); http://www.moa.gov.cn/, Chinese special fund.; We would like to express our gratitude to Professor Wenxiang HE and Dongli LIANG for assistance with this paper. We declare that there is no conflict of interest. This research was supported by the Ministry of Agriculture of the People's Republic of China (No. 200903015).	Ahmed AB, 2010, AFR J AGR RES, V5, P2795; Antoniadis V, 2008, CHEMOSPHERE, V71, P759, DOI 10.1016/j.chemosphere.2007.10.015; Baize D, 2009, AGRON SUSTAIN DEV, V29, P297, DOI 10.1051/agro:2008057; Bermudez GMA, 2011, J HAZARD MATER, V193, P264, DOI 10.1016/j.jhazmat.2011.07.058; Boussen S, 2013, GEODERMA, V192, P227, DOI 10.1016/j.geoderma.2012.08.029; Castaldi P, 2009, GEODERMA, V151, P241, DOI 10.1016/j.geoderma.2009.04.009; CHAMBERLAIN AC, 1983, ATMOS ENVIRON, V17, P693, DOI 10.1016/0004-6981(83)90416-X; Chlopecka A, 1996, WATER AIR SOIL POLL, V87, P297, DOI 10.1007/BF00696843; Deleebeeck NME, 2008, ECOTOX ENVIRON SAFE, V70, P67, DOI 10.1016/j.ecoenv.2007.05.002; Deleebeeck NME, 2007, ECOTOX ENVIRON SAFE, V67, P1, DOI 10.1016/j.ecoenv.2006.10.001; Deleebeeck NME, 2009, WATER RES, V43, P1935, DOI 10.1016/j.watres.2009.01.019; Ding CF, 2016, J HAZARD MATER, V303, P21, DOI 10.1016/j.jhazmat.2015.10.027; Feng JF, 2012, ENVIRON GEOCHEM HLTH, V34, P605, DOI 10.1007/s10653-012-9454-2; Huang ML, 2008, SCI TOTAL ENVIRON, V405, P54, DOI 10.1016/j.scitotenv.2008.07.004; Jamali MK, 2009, J HAZARD MATER, V164, P1386, DOI 10.1016/j.jhazmat.2008.09.056; James K, 2009, ENVIRON TOXICOL CHEM, V23, P691; Krauss M, 2002, J PLANT NUTR SOIL SC, V165, P3, DOI 10.1002/1522-2624(200202)165:1<3::AID-JPLN3>3.0.CO;2-B; Li YK, 1983, ANAL METHODS AGR CHE; Li ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103633; Liang ZF, 2013, ECOTOX ENVIRON SAFE, V93, P180, DOI 10.1016/j.ecoenv.2013.04.003; Liu K, 2015, ECOTOX ENVIRON SAFE, V113, P207, DOI 10.1016/j.ecoenv.2014.12.005; Liu W., 2014, ENVIRON SCI POLLUT R, V22, P8432; Liu WX, 2009, B ENVIRON CONTAM TOX, V82, P343, DOI 10.1007/s00128-008-9575-6; Liu WT, 2010, J ENVIRON MANAGE, V91, P781, DOI 10.1016/j.jenvman.2009.10.009; Martinez E, 2008, SOIL TILL RES, V99, P232, DOI 10.1016/j.still.2008.02.001; Nan ZR, 2002, WATER AIR SOIL POLL, V133, P205, DOI 10.1023/A:1012962604095; Raimondo S, 2008, ENVIRON TOXICOL CHEM, V27, P2599, DOI 10.1897/08-157.1; Rodrigues SM, 2012, PLANT SOIL, V361, P329, DOI 10.1007/s11104-012-1249-9; Rooney CP, 2007, ENVIRON POLLUT, V145, P596, DOI 10.1016/j.envpol.2006.04.008; Schlekat CE, 2010, SCI TOTAL ENVIRON, V408, P6148, DOI 10.1016/j.scitotenv.2010.09.012; Tlustos P, 2006, PLANT SOIL ENVIRON, V52, P16, DOI 10.17221/3341-PSE; Van Sprang PA, 2009, SCI TOTAL ENVIRON, V407, P5373, DOI 10.1016/j.scitotenv.2009.06.029; Wang XQ, 2012, ECOLOGICAL THRESHOLD; Wang ZW, 2011, J SCI FOOD AGR, V91, P377, DOI 10.1002/jsfa.4196; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080855; Zhang Hong-zhen, 2010, Huanjing Kexue, V31, P488; Zhang ZW, 1998, SCI TOTAL ENVIRON, V220, P137, DOI 10.1016/S0048-9697(98)00252-6; Zhao FJ, 2004, ENVIRON POLLUT, V131, P461, DOI 10.1016/j.envpol.2004.02.011	38	13	15	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160552	10.1371/journal.pone.0160552	http://dx.doi.org/10.1371/journal.pone.0160552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518712	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100017
J	Silva, RNAE; Wijtzes, A; van de Bongardt, D; van de Looij-Jansen, P; Bannink, R; Raat, H				Avelar e Silva, Raquel Nogueira; Wijtzes, Anne; van de Bongardt, Daphne; van de Looij-Jansen, Petra; Bannink, Rienke; Raat, Hein			Early Sexual Intercourse: Prospective Associations with Adolescents Physical Activity and Screen Time	PLOS ONE			English	Article							HEALTH-RISK BEHAVIORS; SPORTS PARTICIPATION; SCHOOL-STUDENTS; DOUBLE-STANDARD; SUBSTANCE USE; AGE; US; TELEVISION; PREDICTORS; INITIATION	Objectives To assess the prospective associations of physical activity behaviors and screen time with early sexual intercourse initiation (i.e., before 15 years) in a large sample of adolescents. Methods We used two waves of data from the Rotterdam Youth Monitor, a longitudinal study conducted in the Netherlands. The analysis sample consisted of 2,141 adolescents aged 12 to 14 years (mean age at baseline =12.2 years, SD=0.43). Physical activity (e.g., sports outside school), screen time (e.g., computer use), and early sexual intercourse initiation were assessed by means of self- report questionnaires. Logistic regression models were tested to assess the associations of physical activity behaviors and screen time (separately and simultaneously) with early sexual intercourse initiation, controlling for confounders (i.e., socio-demographics and substance use). Interaction effects with gender were tested to assess whether these associations differed significantly between boys and girls. Results The only physical activity behavior that was a significant predictor of early sexual intercourse initiation was sports club membership. Adolescent boys and girls who were members of a sports club) were more likely to have had early sex (OR=2.17; 95% CI=1.33, 3.56. Significant gender interaction effects indicated that boys who watched TV >= 2 hours/day ( OR=2.00; 95% CI=1.08, 3.68) and girls who used the computer >= 2 hours/ day (OR=3.92; 95% CI=1.76, 8.69) were also significantly more likely to have engaged in early sex. Conclusion These findings have implications for professionals in general pediatric healthcare, sexual health educators, policy makers, and parents, who should be aware of these possible prospective links between sports club membership, TV watching (for boys), and computer use ( for girls), and early sexual intercourse initiation. However, continued research on determinants of adolescents' early sexual initiation is needed to further contribute to the strategies for improving adolescents' healthy sexual development and behaviors.	[Avelar e Silva, Raquel Nogueira; Wijtzes, Anne; Bannink, Rienke; Raat, Hein] Univ Rotterdam, Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van de Bongardt, Daphne] Univ Amsterdam, Res Inst Child Dev & Educ Res Prior Area YIELD, Amsterdam, Netherlands; [van de Looij-Jansen, Petra] Municipal Rotterdam, Dept Res & Business Intelligence, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Amsterdam	Silva, RNAE; Raat, H (corresponding author), Univ Rotterdam, Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	r.nogueiraavelaresilva@erasmusmc.nl; h.raat@erasmusmc.nl	van de Bongardt, Daphne/AAA-8686-2021; Nogueira Avelar e Silva, Raquel/F-5081-2019	van de Bongardt, Daphne/0000-0001-5777-9201; Nogueira Avelar e Silva, Raquel/0000-0001-7895-0936	Coordination for the Improvement of Higher Education Personnel (CAPES) [7974/13-2]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The PhD project of RNAS, of which the present study was a part, was funded by the Coordination for the Improvement of Higher Education Personnel (CAPES), grant number 7974/13-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannink R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094026; Barnes GM, 2007, J YOUTH ADOLESCENCE, V36, P697, DOI 10.1007/s10964-006-9075-0; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bersamin M, 2008, J MARRIAGE FAM, V70, P97, DOI 10.1111/j.1741-3737.2007.00464.x; Boislard PMA, 2011, J ADOLESCENCE, V34, P289, DOI 10.1016/j.adolescence.2010.05.002; BRONFENBRENNER U, 1994, PSYCHOL REV, V101, P568, DOI 10.1037/0033-295X.101.4.568; Brown JD, 2006, PEDIATRICS, V117, P1018, DOI 10.1542/peds.2005-1406; Ciairano S, 2006, J CLIN CHILD ADOLESC, V35, P275, DOI 10.1207/s15374424jccp3502_11; Collins RL, 2004, PEDIATRICS, V114, pE280, DOI 10.1542/peds.2003-1065-L; Council on Communication and Media, 2013, PEDIATRICS; Crawford M, 2003, J SEX RES, V40, P13, DOI 10.1080/00224490309552163; Daniels SR, 2015, PEDIATRICS, V136, pE275, DOI 10.1542/peds.2015-1558; De Graaf H, 2012, SEX ONDER JE 25E SEK; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Dodge B, 2005, AM J HEALTH BEHAV, V29, P172, DOI 10.5993/AJHB.29.2.8; Faurie C, 2004, EVOL HUM BEHAV, V25, P1, DOI 10.1016/S1090-5138(03)00064-3; Habel MA, 2010, PERSPECT SEX REPRO H, V42, P244, DOI 10.1363/4224410; Kaestle CE, 2005, AM J EPIDEMIOL, V161, P774, DOI 10.1093/aje/kwi095; Kastbom AA, 2016, ADOLESC HEALTH MED T, V7, P1, DOI 10.2147/AHMT.S95493; Kastbom AA, 2015, ACTA PAEDIATR, V104, P91, DOI 10.1111/apa.12803; Kreager DA, 2009, SOC PSYCHOL QUART, V72, P143, DOI 10.1177/019027250907200205; Kulig K, 2003, ARCH PEDIAT ADOL MED, V157, P905, DOI 10.1001/archpedi.157.9.905; Lara AS, 2015, J PEDIAT ADOLESCENT, V15, P1, DOI [10.1016/j.jpag.2015.11.012., DOI 10.1016/J.JPAG.2015.11.012]; Longmore MA, 2004, SOC PSYCHOL QUART, V67, P279, DOI 10.1177/019027250406700304; Lyons H, 2013, ARCH SEX BEHAV, V42, P585, DOI 10.1007/s10508-012-0051-3; Lyons H, 2011, J SEX RES, V48, P437, DOI 10.1080/00224499.2010.506679; Miller KE, 1998, J HEALTH SOC BEHAV, V39, P108, DOI 10.2307/2676394; Mongraw-Chaffin ML, 2015, LANCET DIABETES ENDO, V3, P437, DOI 10.1016/S2213-8587(15)00086-8; Neal SE, 2015, INT PERSPECT SEX R H, V41, P210, DOI 10.1363/4121015; Nelson MC, 2006, PEDIATRICS, V117, P1281, DOI 10.1542/peds.2005-1692; PAGE R. M., 1998, J HLTH ED, V29, P186, DOI DOI 10.1080/10556699.1998.10603332; Parkes A, 2013, J ADOLESCENCE, V36, P1121, DOI 10.1016/j.adolescence.2013.08.019; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Pedersen S, 2004, PSYCHOL WOMEN QUART, V28, P412, DOI 10.1111/j.1471-6402.2004.00158.x; Peltzer K, 2015, W INDIAN MED J, V64, P351, DOI 10.7727/wimj.2014.025; Radtke T, 2013, EUR J APPL PHYSIOL, V113, P1213, DOI 10.1007/s00421-012-2542-2; Rice E, 2015, ARCH SEX BEHAV, V44, P755, DOI 10.1007/s10508-014-0366-3; Rissel CE, 2003, AUST NZ J PUBL HEAL, V27, P131, DOI 10.1111/j.1467-842X.2003.tb00800.x; Sandfort TGM, 2008, AM J PUBLIC HEALTH, V98, P155, DOI 10.2105/AJPH.2006.097444; Schalet Amy, 2000, BODY SOC, V6, P75, DOI DOI 10.1177/1357034X00006001006; Shneyderman Y, 2013, HEALTH EDUC BEHAV, V40, P400, DOI 10.1177/1090198112447800; Siegel DM, 1998, J ADOLESCENT HEALTH, V23, P20, DOI 10.1016/S1054-139X(97)00274-7; Siziya S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-6; Statistics Netherlands, 2004, STAND OND 2003; Sung J, 2013, KOREAN J FAM MED, V34, P115, DOI 10.4082/kjfm.2013.34.2.115; Taliaferro LA, 2010, J SCHOOL HEALTH, V80, P399, DOI 10.1111/j.1746-1561.2010.00520.x; UNICEF UNAIDS UNFPA ILO WHO and The World Bank, 2011, OPP CRIS PREV HIV EA, P1; Van de Bongardt D, 2013, SOC INT ED J, V7, P76; van de Bongardt D, 2014, J ADOLESCENT HEALTH, V55, P388, DOI 10.1016/j.jadohealth.2014.02.017; Vuori MT, 2012, SCAND J PUBLIC HEALT, V40, P61, DOI 10.1177/1403494811423429; Weaver H., 2005, SEX ED, V5, P171, DOI [DOI 10.1080/14681810500038889, 10.1080/14681810500038889]; WHO, 2016, PHYS ACT ITS IMP HLT; WHO, 2012, AD YOUTHS, P3; Zimmer-Gembeck MJ, 2008, DEV REV, V28, P153, DOI 10.1016/j.dr.2007.06.001	54	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0158648	10.1371/journal.pone.0158648	http://dx.doi.org/10.1371/journal.pone.0158648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513323	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100010
J	Gonzalez-Pinto, A; Gonzalez-Ortega, I; Alberich, S; de Azua, SR; Bernardo, M; Bioque, M; Cabrera, B; Corripio, I; Arango, C; Lobo, A; Sanchez-Torres, AM; Cuesta, MJ				Gonzalez-Pinto, Ana; Gonzalez-Ortega, Itxaso; Alberich, Susana; de Azua, Sonia Ruiz; Bernardo, Miguel; Bioque, Miquel; Cabrera, Bibiana; Corripio, Iluminada; Arango, Celso; Lobo, Antonio; Sanchez-Torres, Ana M.; Cuesta, Manuel J.		PEPs Grp	Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History	PLOS ONE			English	Article							1ST-EPISODE SCHIZOPHRENIA-PATIENTS; BIPOLAR DISORDER; BRAIN STRUCTURE; ANTIPSYCHOTIC-DRUGS; CLINICAL-TRIAL; FOLLOW-UP; HIGH-RISK; CONSENSUS; SIBLINGS; SPECTRUM	The objective of this study is to investigate cognitive performance in a first-episode psychosis sample, when stratifying the interaction by cannabis use and familial or non-familial psychosis. Hierarchical-regression models were used to analyse this association in a sample of 268 first-episode psychosis patients and 237 controls. We found that cannabis use was associated with worse working memory, regardless of family history. However, cannabis use was clearly associated with worse cognitive performance in patients with no family history of psychosis, in cognitive domains including verbal memory, executive function and global cognitive index, whereas cannabis users with a family history of psychosis performed better in these domains. The main finding of the study is that there is an interaction between cannabis use and a family history of psychosis in the areas of verbal memory, executive function and global cognition: that is, cannabis use is associated with a better performance in patients with a family history of psychosis and a worse performance in those with no family history of psychosis. In order to confirm this hypothesis, future research should explore the actual expression of the endocannabinoid system in patients with and without a family history of psychosis.	[Gonzalez-Pinto, Ana; Gonzalez-Ortega, Itxaso; Alberich, Susana; de Azua, Sonia Ruiz; Bernardo, Miguel; Bioque, Miquel; Cabrera, Bibiana; Corripio, Iluminada; Arango, Celso; Lobo, Antonio] Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain; [Gonzalez-Pinto, Ana; Gonzalez-Ortega, Itxaso; Alberich, Susana; de Azua, Sonia Ruiz] Univ Basque Country, Dept Psychiat, Araba Univ Hosp, Vitoria, Spain; [Bernardo, Miguel; Bioque, Miquel; Cabrera, Bibiana] Hosp Clin Barcelona, Barcelona Clin, Schizophrenia Unit, Inst Neurosci, Barcelona, Spain; [Bernardo, Miguel] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Corripio, Iluminada] Univ Autonoma Barcelona, Dept Psychiat, IIB SANT PAU, Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Arango, Celso] Univ Complutense, IiSGM, Gregorio Maranon Gen Univ Hospital, Child & Adolescent Psychiat Dept,Sch Med, Madrid, Spain; [Lobo, Antonio] Univ Zaragoza, Zaragoza, Spain; [Lobo, Antonio] Aragon Inst Hlth Sci IIS Aragon, Zaragoza, Spain; [Sanchez-Torres, Ana M.; Cuesta, Manuel J.] Navarre Hosp Complex, Dept Psychiat, Pamplona, Spain; [Sanchez-Torres, Ana M.; Cuesta, Manuel J.] Navarre Inst Hlth Res, IdiSNA, Pamplona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University Hospital of Araba; University of Basque Country; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Complutense University of Madrid; University of Zaragoza; Servicio Navarro de Salud - Osasunbidea	Gonzalez-Pinto, A (corresponding author), Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain.; Gonzalez-Pinto, A (corresponding author), Univ Basque Country, Dept Psychiat, Araba Univ Hosp, Vitoria, Spain.	anamaria.gonzalez-pintoarrillaga@osakidetza.net	de Azúa, Sonia Ruiz/AAB-8923-2020; Alonso-Solis, Anna/AAB-1460-2020; Bernardo, Miquel/P-3049-2015; Parellada, Mara/AAQ-1272-2021; Ibanez, Angela/A-5854-2017; Bobes, Julio/AAH-4365-2019; Balanzá-Martínez, Vicent/C-3073-2011; Vieta, Eduard/I-6330-2013; Contreras, Fernando/S-5217-2017; Sarro, Salvador/E-7806-2010; Cuesta, Manuel J./C-4357-2008	de Azúa, Sonia Ruiz/0000-0002-9876-2526; Bernardo, Miquel/0000-0001-8748-6717; Parellada, Mara/0000-0001-7977-3601; Ibanez, Angela/0000-0003-2751-0150; Bobes, Julio/0000-0003-2187-4033; Balanzá-Martínez, Vicent/0000-0001-7772-7396; Vieta, Eduard/0000-0002-0548-0053; Alberich, Susana/0000-0002-4945-3428; Contreras, Fernando/0000-0003-2929-2804; Bioque, Miquel/0000-0001-6887-7149; Corripio, Iluminada/0000-0003-2562-711X; CABRERA, BIBIANA/0000-0002-7749-5449; mane santacana, anna/0000-0003-2127-349X; Meseguer, Ana/0000-0003-0273-7164; Sarro, Salvador/0000-0003-1835-2189; Mezquida, Gisela/0000-0002-6080-2203; Gonzalez-Pinto, Ana Maria/0000-0002-2568-5179; Albacete Belzunces, Auria/0000-0003-4156-4972; Gonzalez-Ortega, Itxaso/0000-0001-7074-4353; Cuesta, Manuel J./0000-0003-0250-5718; Alonso, Anna/0000-0002-5393-9391; Sanchez-Torres, Ana Maria/0000-0002-9505-2406	Spanish Ministry of Economy and Competitiveness [ISCIII 2009-2011:PI 080208]; Instituto de Salud Carlos III-European Fund for Regional Development [PI10/01430, PI10/01746, PI11/01977, PI11/02708, 2011/1064, PI12/02077, PI13/02252, PI13/00451, PI14/01900, PI11/02831]; Centre for Biomedical Research in the Mental Health Network (CIBERSAM); Health Department of the Government of Navarre [11/101, 87/2014]; Government of Catalonia, Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement [2014SGR441]; Contract FI-DGR from the Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR [2015 FI_B2 00100]; Esther Koplowitz Centre (Barcelona); Department of Education, Linguistic Policy and Culture of the Basque Country Government; Basque Foundation for Health Innovation and Research (BIOEF); Madrid Regional Government [S2010/BMD-2422 AGES]; European Union Structural Funds; European Union [FP7-HEALTH-2009-2.2.1-2-241909, FP7-HEALTH-2009-2.2.1-3-242114, FP7-HEALTH-2013-2.2.1-2-603196, FP7-HEALTH-2013-2.2.1-2-602478]; Alicia Koplowitz Foundation; Mutua Madrilena Foundation; University of the Basque Country [GIC10/80, GIC12/84]; Stanley Research Foundation [03-RC-003]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Instituto de Salud Carlos III-European Fund for Regional Development; Centre for Biomedical Research in the Mental Health Network (CIBERSAM); Health Department of the Government of Navarre; Government of Catalonia, Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement; Contract FI-DGR from the Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR; Esther Koplowitz Centre (Barcelona); Department of Education, Linguistic Policy and Culture of the Basque Country Government; Basque Foundation for Health Innovation and Research (BIOEF); Madrid Regional Government; European Union Structural Funds(European Commission); European Union(European Commission); Alicia Koplowitz Foundation; Mutua Madrilena Foundation; University of the Basque Country; Stanley Research Foundation	The authors would like to thank the following institutions for their funding contributions: the Spanish Ministry of Economy and Competitiveness (Ref. ISCIII 2009-2011:PI 080208), the Instituto de Salud Carlos III-European Fund for Regional Development (PI10/01430, PI10/01746, PI11/01977, PI11/02708, 2011/1064, PI12/02077, PI13/02252, PI13/00451 and PI14/01900, PI11/02831), the Centre for Biomedical Research in the Mental Health Network (CIBERSAM), the Health Department of the Government of Navarre (11/101 and 87/2014), the Government of Catalonia, Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (2014SGR441), the Contract FI-DGR-2013 from the Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR (2015 FI_B2 00100 to GM), the Esther Koplowitz Centre (Barcelona), local grants from the Department of Education, Linguistic Policy and Culture of the Basque Country Government, the Basque Foundation for Health Innovation and Research (BIOEF), Madrid Regional Government (S2010/BMD-2422 AGES), European Union Structural Funds and European Union Seventh Framework Program under grant agreements FP7-HEALTH-2009-2.2.1-2-241909 (Project EU-GEI), FP7-HEALTH-2009-2.2.1-3-242114 (Project OPTiMISE), FP7-HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and FP7-HEALTH-2013-2.2.1-2-602478 (Project METSY), Alicia Koplowitz Foundation, Mutua Madrilena Foundation, and the University of the Basque Country (GIC10/80, GIC12/84). The psychiatric research department at Araba University Hospital is supported by the Stanley Research Foundation (03-RC-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew-Blais J, 2013, COGN NEUROPSYCHIATRY, V18, P44, DOI 10.1080/13546805.2012.676309; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold C, 2015, SCHIZOPHR RES, V168, P231, DOI 10.1016/j.schres.2015.07.051; Becker TM, 2008, NEUROPSYCHOPHARMACOL, V33, P2619, DOI 10.1038/sj.npp.1301673; Benedet M.J., 1998, TAVEC TEST APRENDIZA; Bernardo M, 2013, REV PSIQUIATR SALUD, V6, P4, DOI 10.1016/j.rpsm.2012.11.001; Bertelsen M, 2008, ARCH GEN PSYCHIAT, V65, P762, DOI 10.1001/archpsyc.65.7.762; Bioque M, 2013, NEUROPSYCHOPHARMACOL, V38, P2568, DOI 10.1038/npp.2013.165; Bora E, 2014, ACTA PSYCHIAT SCAND, V130, P1, DOI 10.1111/acps.12261; Bora E, 2009, BRIT J PSYCHIAT, V195, P475, DOI 10.1192/bjp.bp.108.055731; Conners C.K., 2004, CONTINUOUS PERFORMAN; Cuesta MJ, 2015, SCHIZOPHR RES, V164, P65, DOI 10.1016/j.schres.2015.02.022; Cunha PJ, 2013, SCHIZOPHR RES, V147, P209, DOI 10.1016/j.schres.2013.04.009; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; Davidson M, 2009, AM J PSYCHIAT, V166, P675, DOI 10.1176/appi.ajp.2008.08060806; Derks EM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-71; Dickinson D, 2011, SCHIZOPHRENIA BULL, V37, P1157, DOI 10.1093/schbul/sbq018; Eack SM, 2010, SCHIZOPHRENIA BULL, V36, P1081, DOI 10.1093/schbul/sbp026; Ferraro L, 2013, SCHIZOPHR RES, V150, P129, DOI 10.1016/j.schres.2013.07.046; First M.B., 1997, ENTREVISTA CLINICA E; Fis NP, 2008, EUR CHILD ADOLES PSY, V17, P424, DOI 10.1007/s00787-008-0684-x; Galderisi S, 2009, SCHIZOPHR RES, V115, P104, DOI 10.1016/j.schres.2009.09.022; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Golden C.J., 1978, STROOP COLOR WORD TE; Gonzalez-Pinto A, 2011, SCHIZOPHRENIA BULL, V37, P631, DOI 10.1093/schbul/sbp126; Gonzalez-Pinto A, 2010, J AFFECT DISORDERS, V124, P250, DOI 10.1016/j.jad.2009.11.005; Greenwood TA, 2007, ARCH GEN PSYCHIAT, V64, P1242, DOI 10.1001/archpsyc.64.11.1242; Groom MJ, 2008, SCHIZOPHR RES, V99, P85, DOI 10.1016/j.schres.2007.11.008; Gur RE, 2007, AM J PSYCHIAT, V164, P813, DOI 10.1176/appi.ajp.164.5.813; Heaton R.K., 1993, WISCONSIN CARD SORTI; Hill SK, 2013, AM J PSYCHIAT, V170, P1275, DOI 10.1176/appi.ajp.2013.12101298; Hollingshead AB, 1958, CLASS MENTAL ILLNESS; Hughes C, 2005, ACTA PSYCHIAT SCAND, V111, P185, DOI 10.1111/j.1600-0447.2004.00392.x; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kern RS, 2008, AM J PSYCHIAT, V165, P214, DOI 10.1176/appi.ajp.2007.07010043; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Rodriguez-Sanchez JM, 2010, SCHIZOPHR RES, V124, P142, DOI 10.1016/j.schres.2010.08.017; Maziade M, 2011, SCHIZOPHRENIA BULL, V37, P1218, DOI 10.1093/schbul/sbq026; Meier MH, 2012, P NATL ACAD SCI USA, V109, pE2657, DOI 10.1073/pnas.1206820109; Meijer J, 2012, ACTA PSYCHIAT SCAND, V125, P66, DOI 10.1111/j.1600-0447.2011.01777.x; Norman RMG, 2007, J NERV MENT DIS, V195, P846, DOI 10.1097/NMD.0b013e318156f8e2; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Pagliaccio D, 2015, JAMA PSYCHIAT, V72, P994, DOI 10.1001/jamapsychiatry.2015.1054; Pena-Casanova J, 1990, TEST BARCELONA; Rabin RA, 2011, SCHIZOPHR RES, V128, P111, DOI 10.1016/j.schres.2011.02.017; Rais M, 2008, AM J PSYCHIAT, V165, P490, DOI 10.1176/appi.ajp.2007.07071110; Rais M, 2010, EUR NEUROPSYCHOPHARM, V20, P855, DOI 10.1016/j.euroneuro.2010.08.008; Rapp C, 2012, CURR PHARM DESIGN, V18, P5070, DOI 10.2174/138161212802884861; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ringen PA, 2010, PSYCHOL MED, V40, P1337, DOI 10.1017/S0033291709991620; Robles O, 2008, BIOL PSYCHIAT, V63, P498, DOI 10.1016/j.biopsych.2007.05.016; Robson PJ, 2014, DRUG TEST ANAL, V6, P24, DOI 10.1002/dta.1529; Smith MJ, 2014, SCHIZOPHRENIA BULL, V40, P287, DOI 10.1093/schbul/sbt176; Solowij N, 2013, SCHIZOPHR RES, V143, P179, DOI 10.1016/j.schres.2012.10.040; van Winkel R, 2011, NEUROPSYCHOPHARMACOL, V36, P2529, DOI 10.1038/npp.2011.141; van Winkel R, 2011, ARCH GEN PSYCHIAT, V68, P148, DOI 10.1001/archgenpsychiatry.2010.152; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 1997, WECHSLER ADULT INTEL; Yucel M, 2012, SCHIZOPHRENIA BULL, V38, P316, DOI 10.1093/schbul/sbq079; Zalla T, 2004, PSYCHIAT RES, V121, P207, DOI 10.1016/S0165-1781(03)00252-X; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057; Zilles D, 2009, EUR ARCH PSY CLIN N, V259, P309, DOI 10.1007/s00406-009-0001-9	65	17	17	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160949	10.1371/journal.pone.0160949	http://dx.doi.org/10.1371/journal.pone.0160949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513670	Green Published, gold			2022-12-26	WOS:000381381100093
J	Hong, SM; Park, IS; Kim, YB; Hong, SJ; Lee, B				Hong, Seok Min; Park, Il-Seok; Kim, Yong Bok; Hong, Seok Jin; Lee, Byungho			Analysis of the Prevalence of and Factors Associated with Hearing Loss in Korean Adolescents	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; LEISURE NOISE EXPOSURE; THRESHOLD SHIFTS; NATIONAL-HEALTH; US; CHILDREN; PLAYERS; ADULTS; RISK; POPULATION	Background Hearing loss can lead to a number of disabilities, subsequently reducing the quality of life. In general, hearing thresholds of adolescents are better than adults and the elderly. However, occasionally, adolescents acquire hearing loss for a number of reasons. In this study, our goal was to estimate the prevalence of hearing loss in the Korean population and to investigate the factors related to hearing thresholds in adolescents. Methods A cross-sectional study was conducted using data from the Korean National Health and Nutrition Examination Survey (KNHANES) between 2010 and 2012. We enrolled a total of 1,658 participants, ages 13 to 18 years. We investigated the prevalence of hearing loss and the factors associated with hearing thresholds at various frequencies (0.5, 1, 2, 3, 4, and 6 KHz). Results Weighted prevalence of unilateral and bilateral hearing loss in Korean adolescents was 2.2% and 0.4%, respectively. Weighted prevalence of hearing thresholds >= 20 dB at speech and high frequencies were 3.1% and 5.0%, respectively, for unilateral hearing loss and 0.7% and 1.9%, respectively, for bilateral. Age group, tympanometric data, and household income were significantly related to unilateral or bilateral hearing thresholds >= 20 dB at speech frequencies. Earphone use in noisy places was associated with bilateral hearing thresholds >= 20 dB at high frequencies. Conclusions The prevalence of hearing loss in Korean adolescents was 2.6% using the general standard threshold associated with hearing loss. However, the prevalence of hearing thresholds >= 20 dB for speech and high frequencies was much higher. The results from this study provide an estimate of hearing loss in adolescents and suggest the need for early detection and hearing preservation programs among adolescents.	[Hong, Seok Min; Park, Il-Seok; Kim, Yong Bok; Hong, Seok Jin] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Hwaseong, South Korea; [Lee, Byungho] Yes Hosp, Dept Internal Med, Yongin, South Korea	Hallym University	Hong, SM (corresponding author), Hallym Univ, Dongtan Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Hwaseong, South Korea.	thecell@medimail.co.kr	Hong, Seok-Jin/GVT-2415-2022	Hong, Seok-Jin/0000-0002-9061-0552				Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Biassoni EC, 2014, NOISE HEALTH, V16, P331, DOI 10.4103/1463-1741.140515; Carter L, 2014, EAR HEARING, V35, P491, DOI 10.1097/01.aud.0000451498.92871.20; Cone BK, 2010, EAR HEARING, V31, P202, DOI 10.1097/AUD.0b013e3181c62263; Cruickshanks KJ, 1998, JAMA-J AM MED ASSOC, V279, P1715, DOI 10.1001/jama.279.21.1715; Dehnert K, 2015, INT J AUDIOL, V54, P665, DOI 10.3109/14992027.2015.1030510; Elzouki Abdelaziz Y., 2012, TXB CLIN PEDIAT, P602; Fligor BJ, 2004, EAR HEARING, V25, P513, DOI 10.1097/00003446-200412000-00001; Henderson E, 2011, PEDIATRICS, V127, pE39, DOI 10.1542/peds.2010-0926; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Kim MG, 2009, YONSEI MED J, V50, P771, DOI 10.3349/ymj.2009.50.6.771; Lee GJC, 2014, INT J AUDIOL, V53, P462, DOI 10.3109/14992027.2014.893376; Lutman M. E., 1998, ADV NOISE RES BIOL E, VI, P170; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Mahomed F, 2013, EAR HEARING, V34, P745, DOI 10.1097/01.aud.0000436255.53747.a4; MeyerBisch C, 1996, AUDIOLOGY, V35, P121; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Peng JH, 2007, J OTOLARYNGOL, V36, P181, DOI 10.2310/7070.2007.0032; Schlauch RS, 2012, AM J AUDIOL, V21, P106, DOI 10.1044/1059-0889(2012/11-0012); Schlauch RS, 2009, HDB CLIN AUDIOLOGY, V6, P30; Schmuziger N, 2006, INT J AUDIOL, V45, P46, DOI 10.1080/14992020500377089; Shargorodsky J, 2010, JAMA-J AM MED ASSOC, V304, P772, DOI 10.1001/jama.2010.1124; Swanepoel D, 2010, TELEMED J E-HEALTH, V16, P557, DOI 10.1089/tmj.2009.0143; Tharpe A, 1993, INT J PEDIATR OTORHI, V21, P41; Williams W, 2015, NOISE HEALTH, V17, P358, DOI 10.4103/1463-1741.165066; World Health Organization, MILL PEOPL WORLD HAV	27	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159981	10.1371/journal.pone.0159981	http://dx.doi.org/10.1371/journal.pone.0159981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513659	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100021
J	Mhimbira, F; Hella, J; Maroa, T; Kisandu, S; Chiryamkubi, M; Said, K; Mhalu, G; Mkopi, A; Mutayoba, B; Reither, K; Gagneux, S; Fenner, L				Mhimbira, Francis; Hella, Jerry; Maroa, Thomas; Kisandu, Shadrack; Chiryamkubi, Magreth; Said, Khadija; Mhalu, Grace; Mkopi, Abdallah; Mutayoba, Beatrice; Reither, Klaus; Gagneux, Sebastien; Fenner, Lukas			Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; EARLY DEATH; COMMUNITY; MORTALITY; ADULTS; TB; EPIDEMIOLOGY; MANAGEMENT; INFECTION; MALAWI	Introduction Decentralization of Directly Observed Treatment (DOT) for tuberculosis (TB) to the community (home-based DOT) has improved the coverage of TB treatment and reduced the burden to the health care facilities (facility-based DOT). We aimed to compare TB treatment outcomes in home-based and facility-based DOT under programmatic conditions in an urban setting with a high TB burden. Methodology A retrospective analysis of a cohort of adult TB patients (>= 15 years) routinely notified between 2010 and 2013 in two representative TB sub-districts in the Temeke district, Dar es Salaam, Tanzania. We assessed differences in treatment outcomes by calculating Risk Ratios (RRs). We used logistic regression to assess the association between DOT and treatment outcomes. Results Data of 4,835 adult TB patients were analyzed, with a median age of 35 years, 2,943 (60.9%) were men and TB/HIV co-infection prevalence of 39.9%. A total of 3,593 (74.3%) patients were treated under home-based DOT. Patients on home-based DOT were more likely to die compared to patients on facility-based DOT (RR 2.04, 95% Confidence Interval [95% CI]: 1.52-2.73), and more likely to complete TB treatment (RR 1.14, 95% CI: 1.06-1.23), but less likely to have a successful treatment outcome (RR 0.94, 95% CI: 0.92-0.97). Home-based DOT was preferred by women (adjusted Odds Ratio [aOR] 1.55, 95% CI: 1.34-1.80, p<0.001), older people (aOR 1.01 for each year increase, 95% CI: 1.00-1.02, p = 0.001) and patients with extra-pulmonary TB (aOR 1.45, 95% CI: 1.16-1.81, p = 0.001), but less frequently by patients on a retreatment regimen (aOR 0.12, 95% CI: 0.08-0.19, p<0.001). Conclusions/significance TB patients under home-based DOT had more frequently risk factors of death such as older age, HIV infection and sputum smear-negative TB, and had higher mortality compared to patients under facility-based DOT. Further operational research is needed to monitor the implementation of DOT under programmatic conditions.	[Mhimbira, Francis; Hella, Jerry; Maroa, Thomas; Kisandu, Shadrack; Said, Khadija; Mhalu, Grace; Mkopi, Abdallah; Reither, Klaus; Fenner, Lukas] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Mhimbira, Francis; Hella, Jerry; Said, Khadija; Mhalu, Grace; Reither, Klaus; Gagneux, Sebastien; Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Mhimbira, Francis; Hella, Jerry; Said, Khadija; Mhalu, Grace; Reither, Klaus; Gagneux, Sebastien; Fenner, Lukas] Univ Basel, Basel, Switzerland; [Chiryamkubi, Magreth; Mutayoba, Beatrice] Minist Hlth Community Dev Gender Elderly & Childr, Natl TB & Leprosy Programme, Dar Es Salaam, Tanzania; [Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	Ifakara Health Institute; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Bern	Mhimbira, F; Fenner, L (corresponding author), Ifakara Hlth Inst, Dar Es Salaam, Tanzania.; Mhimbira, F; Fenner, L (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Mhimbira, F; Fenner, L (corresponding author), Univ Basel, Basel, Switzerland.; Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	fmhimbira@ihi.or.tz; Lukas.fenner@unibas.ch	Gagneux, Sebastien/ABE-7909-2020; Hella, Jerry/I-6738-2017	Hella, Jerry/0000-0003-2392-8592; Fenner, Lukas/0000-0003-3309-4835; Gagneux, Sebastien/0000-0001-7783-9048; Reither, Klaus/0000-0001-6195-8237; Mhimbira, Francis/0000-0001-8989-6832	Rudolf Geigy Foundation, Basel, Switzerland; "Amt fur Ausbildungsbeitrage" of Basel, Switzerland; National TB Programme; Ifakara Health Institute (IHI)	Rudolf Geigy Foundation, Basel, Switzerland; "Amt fur Ausbildungsbeitrage" of Basel, Switzerland; National TB Programme; Ifakara Health Institute (IHI)	LF received funding from Rudolf Geigy Foundation, Basel, Switzerland (http://www.geigystiftung.ch/en/). FM was supported by Ifakara Health Institute (www.ihi.or.tz) and "Amt fur Ausbildungsbeitrage" of Basel, Switzerland (http://www.hochschulen.bs.ch/ueber-uns/organisation/amtausbildungsbeitraege.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the assistance and support by the National TB Programme and the District TB coordinators of the Temeke District, Dar es Salaam, Tanzania. This work was supported by the Rudolf Geigy Foundation, Basel, Switzerland, and the Ifakara Health Institute (IHI). FM was also supported by the "Amt fur Ausbildungsbeitrage", Basel, Switzerland.	Bigna JJR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132394; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Connolly C, 1998, INT J TUBERC LUNG D, V2, P919; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Egwaga Saidi, 2008, Patient Prefer Adherence, V2, P1; Egwaga S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-80; Field N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0679-9; Frieden TR, 2007, B WORLD HEALTH ORGAN, V85, P407, DOI 10.2471/BLT.06.038927; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Hosford JD, 2015, TUBERCULOSIS, V95, P112, DOI 10.1016/j.tube.2014.10.006; Kabali C, 2013, TUBERCULOSIS, V93, P461, DOI 10.1016/j.tube.2013.01.001; Kang'ombe CT, 2004, INT J TUBERC LUNG D, V8, P829; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Leone S, 2010, INT J INFECT DIS, V14, pE283, DOI 10.1016/j.ijid.2009.05.016; Liu XQ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001876; Lwilla F, 2003, TROP MED INT HEALTH, V8, P204, DOI 10.1046/j.1365-3156.2003.00999.x; Maher D, 2003, TUBERCULOSIS, V83, P177, DOI 10.1016/S1472-9792(02)00066-5; Metcalfe JZ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001877; Naidoo K, 2012, ANN INTERN MED, V157, P313, DOI 10.7326/0003-4819-157-5-201209040-00004; National Bureau of Statistics, 2013, 2012 POP HOUS CENS; NTLP, 2013, MAN MAN TUB LEPR, VSixth Edition; NTLP MoHSW, 2015, NAT TUB LEPR 2014 AN; PATH, 2013, SUBC DMPA DMPA SC TR; Pepper DJ, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0076-5; PMORALG, 2014, DAR SAL REG SOC PROF; Sharma SK, 2005, INDIAN J MED RES, V121, P550; van den Boogaard J, 2009, INT J TUBERC LUNG D, V13, P1524; van den Broek J, 1998, INT J TUBERC LUNG D, V2, P547; Van Deun A, 2012, PUBLIC HEALTH ACTION, V2, P3, DOI 10.5588/pha.12.0007; Vijay S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021008; VOLMINK J, 2003, COCHRANE DATABASE SY; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Wandwalo E, 2006, HEALTH POLICY, V78, P284, DOI 10.1016/j.healthpol.2005.11.010; Wandwalo Eliud, 2005, Cost Eff Resour Alloc, V3, P6, DOI 10.1186/1478-7547-3-6; WHO, 2013, HDB LAB DIAGN TUB SP; *WHO, 2015, THE END TB STRAT; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2013, DEFINITIONS REPORTIN; Wright CM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0945-5; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	43	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161171	10.1371/journal.pone.0161171	http://dx.doi.org/10.1371/journal.pone.0161171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513331	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000381381100126
J	Snider, NT; Portney, DA; Willcockson, HH; Maitra, D; Martin, HC; Greenson, JK; Omary, MB				Snider, Natasha T.; Portney, Daniel A.; Willcockson, Helen H.; Maitra, Dhiman; Martin, Hope C.; Greenson, Joel K.; Omary, M. Bishr			Ethanol and Acetaminophen Synergistically Induce Hepatic Aggregation and TCH346Insensitive Nuclear Translocation of GAPDH	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-DEATH; OXIDATIVE STRESS; CGP 3466B; MOLECULAR-MECHANISMS; NITROSYLATION; MITOCHONDRIA; DISEASE; TCH346	The glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) signals during cellular stress via several post-translational modifications that change its folding properties, protein-protein interactions and sub-cellular localization. We examined GAPDH properties in acute mouse liver injury due to ethanol and/or acetaminophen (APAP) treatment. Synergistic robust and time-dependent nuclear accumulation and aggregation of GAPDH were observed only in combined, but not individual, ethanol/APAP treatments. The small molecule GAPDH-targeting compound TCH346 partially attenuated liver damage possibly via mitochondrial mechanisms, and independent of nuclear accumulation and aggregation of GAPDH. These findings provide a novel potential mechanism for hepatotoxicity caused by combined alcohol and acetaminophen exposure.	[Snider, Natasha T.; Willcockson, Helen H.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Portney, Daniel A.; Maitra, Dhiman; Martin, Hope C.; Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Greenson, Joel K.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Vet Adm Ann Arbor Hlth Care Syst, Ann Arbor, MI 48105 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Snider, NT (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	ntsnider@med.unc.edu		, dhiman/0000-0002-8775-2963; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health (NIH) [R01 DK52951, K01 DK093776, R03 DK102450, P30 DK034933, P30 DK034987]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, K01DK093776, R03DK102450, R01DK052951, P30DK034987, R25DK088752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) grants R01 DK52951 [M.B.O.], K01 DK093776 and R03 DK102450 [N.T.S.], and institutional grants P30 DK034933 to the University of Michigan and P30 DK034987 to the University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018; Agarwal R, 2011, J PHARMACOL EXP THER, V337, P110, DOI 10.1124/jpet.110.176321; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Andringa G, 2000, EUR J NEUROSCI, V12, P3033, DOI 10.1046/j.1460-9568.2000.00181.x; Andringa G, 2003, NEUROBIOL DIS, V14, P205, DOI 10.1016/S0969-9961(03)00125-6; Andringa G, 2000, ADV RES NEURODEGENER, V8, P215; Bunchorntavakul C, 2013, CLIN LIVER DIS, V17, P587, DOI 10.1016/j.cld.2013.07.005; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ghibelli L, 1999, FASEB J, V13, P2031, DOI 10.1096/fasebj.13.14.2031; Groeneveld GJ, 2004, AMYOTROPH LATERAL SC, V5, P220, DOI 10.1080/14660820410019530; Gu XS, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002110; Guha P, 2016, P NATL ACAD SCI USA, V113, P1417, DOI 10.1073/pnas.1524860113; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Lee SB, 2012, J CELL BIOL, V199, P65, DOI 10.1083/jcb.201205015; Leisner TM, 2013, ONCOGENE, V32, P4017, DOI 10.1038/onc.2012.408; Lu ZP, 2011, EMBO REP, V12, P840, DOI 10.1038/embor.2011.121; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Meinen S, 2011, EMBO MOL MED, V3, P465, DOI 10.1002/emmm.201100151; Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2015, J BIOL CHEM, V290, P14493, DOI 10.1074/jbc.M114.635607; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Samson AL, 2014, J BIOL CHEM, V289, P26922, DOI 10.1074/jbc.M114.570275; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; Summar ML, 2004, HYPERTENSION, V43, P186, DOI 10.1161/01.HYP.0000112424.06921.52; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; Weerasinghe SVW, 2014, AM J PHYSIOL-GASTR L, V307, pG355, DOI 10.1152/ajpgi.00303.2013; Yu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065468; Yuan LY, 2013, CLIN LIVER DIS, V17, P507, DOI 10.1016/j.cld.2013.07.002	50	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160982	10.1371/journal.pone.0160982	http://dx.doi.org/10.1371/journal.pone.0160982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513663	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100102
J	Verhaert, N; Walraevens, J; Desloovere, C; Wouters, J; Gerard, JM				Verhaert, Nicolas; Walraevens, Joris; Desloovere, Christian; Wouters, Jan; Gerard, Jean-Marc			Direct Acoustic Stimulation at the Lateral Canal: An Alternative Route to the Inner Ear?	PLOS ONE			English	Article							MIXED HEARING-LOSS; ROUND WINDOW MEMBRANE; PAROXYSMAL POSITIONAL VERTIGO; BONE-CONDUCTION STIMULATION; COCHLEAR STIMULATION; STAPES FIXATION; VIBRANT SOUNDBRIDGE; OSSICULAR CHAIN; TEMPORAL BONES; MIDDLE EARS	Severe to profound mixed hearing loss is associated with hearing rehabilitation difficulties. Recently, promising results for speech understanding were obtained with a direct acoustic cochlear implant (DACI). The surgical implantation of a DACI with standard coupling through a stapedotomy can however be regarded as challenging. Therefore, in this experimental study, the feasibility of direct acoustic stimulation was investigated at an anatomically and surgically more accessible inner ear site. DACI stimulation of the intact, blue-lined and opened lateral semicircular canal (LC) was investigated and compared with standard oval window (OW) coupling. Additionally, stapes footplate fixation was induced. Round window (RW) velocity, as a measure of the performance of the device and its coupling efficiency, was determined in fresh-frozen human cadaver heads. Using single point laser Doppler vibrometry, RW velocity could reliably be measured in low and middle frequency range, and equivalent sound pressure level (L-E) output was calculated. Results for the different conditions obtained in five heads were analyzed in subsequent frequency ranges. Comparing the difference in RW membrane velocity showed higher L-E in the LC opened condition [mean: 103 equivalent dB SPL], than in LC intact or blue-lined conditions [63 and 74 equivalent dB SPL, respectively]. No difference was observed between the LC opened and the standard OW condition. Inducing stapes fixation, however, led to a difference in the low frequency range of L-E compared to LC opened. In conclusion, this feasibility study showed promising results for direct acoustic stimulation at this specific anatomically and surgically more accessible inner ear site. Future studies are needed to address the impact of LC stimulation on cochlear micromechanics and on the vestibular system like dizziness and risks of hearing loss.	[Verhaert, Nicolas; Wouters, Jan] KU Leuven Univ Leuven, Dept Neurosci, ExpORL, Leuven, Belgium; [Verhaert, Nicolas; Desloovere, Christian] Univ Hosp Leuven, Dept Otolaryngol Head & Neck Surg, Leuven, Belgium; [Walraevens, Joris] Cochlear Technol Ctr Belgium, Mechelen, Belgium; [Gerard, Jean-Marc] Cleveland Clin Abu Dhabi, Dept ENT & Head & Neck Surg, Abu Dhabi, U Arab Emirates	KU Leuven; KU Leuven; University Hospital Leuven; Cleveland Clinic Foundation	Verhaert, N (corresponding author), KU Leuven Univ Leuven, Dept Neurosci, ExpORL, Leuven, Belgium.; Verhaert, N (corresponding author), Univ Hosp Leuven, Dept Otolaryngol Head & Neck Surg, Leuven, Belgium.	nicolas.verhaert@kuleuven.be			Research Foundation Flanders; Research Council of the University Hospitals Leuven; IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders) [110722]; Cochlear Ltd.; Cochlear Ltd	Research Foundation Flanders(FWO); Research Council of the University Hospitals Leuven; IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Cochlear Ltd.; Cochlear Ltd	Nicolas Verhaert was supported by the Research Foundation Flanders and the Research Council of the University Hospitals Leuven. Part of this research was supported by the IWT (Institute for the Promotion of Innovation by Science and Technology in Flanders), project 110722, and partially by Cochlear Ltd. Joris Walraevens is an employee of Cochlear Ltd who provided support in the form of salaries for author Joris Walraevens, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The specific roles of this author is articulated in the 'author contributions' section.	Agrawal SK, 2001, ANN NY ACAD SCI, V942, P300; Asai M, 1999, ACTA OTO-LARYNGOL, V119, P356; ASTM, 2005, INT F2504 05 STAND P; Baumgartner WD, 2010, ADV OTO-RHINO-LARYNG, V69, P38, DOI 10.1159/000318521; Bernhard H, 2011, IEEE T BIO-MED ENG, V58, P420, DOI 10.1109/TBME.2010.2087756; Charpiot A, 2010, OTOL NEUROTOL, V31, P237, DOI 10.1097/MAO.0b013e3181ca85a2; Chatzimichalis M, 2012, AUDIOL NEURO-OTOL, V17, P299, DOI 10.1159/000339214; Coulson C J, 2013, Cochlear Implants Int, V14, P98, DOI 10.1179/1754762811Y.0000000018; Deveze A, 2010, OTOL NEUROTOL, V31, P1027, DOI 10.1097/MAO.0b013e3181edb6d1; FARRIOR JB, 1985, LARYNGOSCOPE, V95, P1029; Gostian A, 2014, IMPACT COUPLING TECH, P111; Grossohmichen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119601; Haeusler R, 2008, AUDIOL NEURO-OTOL, V13, P247, DOI 10.1159/000115434; Kitahara T, 2014, OTOL NEUROTOL, V35, P981, DOI 10.1097/MAO.0000000000000306; LEMPERT J, 1952, AMA ARCH OTOLARYNGOL, V56, P101; Lenarz T, 2014, AUDIOL NEURO-OTOL, V19, P164, DOI 10.1159/000358004; Lenarz T, 2013, OTOL NEUROTOL, V34, P1215, DOI 10.1097/MAO.0b013e318298aa76; Luers JC, 2013, OTOL NEUROTOL, V34, P1005, DOI 10.1097/MAO.0b013e3182990d2b; Lupo JE, 2012, OTOL NEUROTOL, V33, P425, DOI 10.1097/MAO.0b013e318245cecb; Maier H, 2013, HEARING RES, V301, P115, DOI 10.1016/j.heares.2012.12.010; Martin C, 2009, OTOL NEUROTOL, V30, P1196, DOI 10.1097/MAO.0b013e3181c34898; Mattingly JK, 2015, OTOL NEUROTOL, V36, P1403, DOI 10.1097/MAO.0000000000000814; Merchant SN, 2008, OTOL NEUROTOL, V29, P282, DOI 10.1097/mao.0b013e318161ab24; Nakajima HH, 2005, HEARING RES, V204, P60, DOI 10.1016/j.heares.2005.01.002; Nakajima HH, 2009, JARO-J ASSOC RES OTO, V10, P23, DOI 10.1007/s10162-008-0150-y; Olson ES, 1999, NATURE, V402, P526, DOI 10.1038/990092; Parnes LS, 1996, OTOLARYNG CLIN N AM, V29, P333; Pau HW, 2010, OTOL NEUROTOL, V31, P225, DOI 10.1097/MAO.0b013e3181cc07fd; Pennings RJE, 2010, OTOL NEUROTOL, V31, P998, DOI 10.1097/MAO.0b013e3181e8fc21; Pisano DV, 2012, AUDIOL NEURO-OTOL, V17, P338, DOI 10.1159/000339653; Ramakrishna J, 2012, OTOL NEUROTOL, V33, P640, DOI 10.1097/MAO.0b013e31824bae56; Rosnow R. L., 2005, BEGINNING BEHAV RES; Rosowski JJ, 2007, AUDIOL NEURO-OTOL, V12, P265, DOI 10.1159/000101474; Schwab B, 2012, OTOL NEUROTOL, V33, P804, DOI 10.1097/MAO.0b013e3182595471; Shambaugh G E Jr, 1979, Am J Otol, V1, P1; Smouha EE, 1999, OTOLARYNG HEAD NECK, V120, P146, DOI 10.1016/S0194-5998(99)70398-0; Stenfelt S, 2004, HEARING RES, V198, P10, DOI 10.1016/j.heares.2004.07.008; Stenfelt S, 2004, J ACOUST SOC AM, V115, P797, DOI 10.1121/1.1639903; Stenfelt S, 2015, HEARING RES, V329, P41, DOI 10.1016/j.heares.2014.12.003; Stieger C, 2013, HEARING RES, V301, P105, DOI 10.1016/j.heares.2012.11.005; Tringali S, 2010, AUDIOL NEURO-OTOL, V15, P291, DOI 10.1159/000283006; Verhaert N, 2015, EAR HEARING, V36, P320, DOI 10.1097/AUD.0000000000000117; Verhaert N, 2013, OTOL NEUROTOL, V34, P1201, DOI 10.1097/MAO.0b013e31829ce7d2; Verhaert N, 2011, OTOL NEUROTOL, V32, P639, DOI 10.1097/MAO.0b013e318212023c; Vincent R, 2002, OTOL NEUROTOL, V23, P866, DOI 10.1097/00129492-200211000-00010; WELLING DB, 1995, OTOLARYNG CLIN N AM, V28, P207; WEVER EG, 1948, ARCH OTOLARYNGOL, V48, P19; Whittemore KR, 2004, HEARING RES, V187, P85, DOI 10.1016/S0378-5955(03)00332-0; Zwartenkot JW, 2014, OTOL NEUROTOL, V35, P221, DOI 10.1097/MAO.0000000000000258	49	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160819	10.1371/journal.pone.0160819	http://dx.doi.org/10.1371/journal.pone.0160819			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500399	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500057
J	Zhang, YJ; Liu, ZT; Zhou, W				Zhang, Yajun; Liu, Zongtian; Zhou, Wen		Natl Nat Sci Fdn China NSFC	Event Recognition Based on Deep Learning in Chinese Texts	PLOS ONE			English	Article							EXTRACTION; PRODUCTS; RANKING; CORTEX	Event recognition is the most fundamental and critical task in event-based natural language processing systems. Existing event recognition methods based on rules and shallow neural networks have certain limitations. For example, extracting features using methods based on rules is difficult; methods based on shallow neural networks converge too quickly to a local minimum, resulting in low recognition precision. To address these problems, we propose the Chinese emergency event recognition model based on deep learning (CEERM). Firstly, we use a word segmentation system to segment sentences. According to event elements labeled in the CEC 2.0 corpus, we classify words into five categories: trigger words, participants, objects, time and location. Each word is vectorized according to the following six feature layers: part of speech, dependency grammar, length, location, distance between trigger word and core word and trigger word frequency. We obtain deep semantic features of words by training a feature vector set using a deep belief network (DBN), then analyze those features in order to identify trigger words by means of a back propagation neural network. Extensive testing shows that the CEERM achieves excellent recognition performance, with a maximum F-measure value of 85.17%. Moreover, we propose the dynamic-supervised DBN, which adds supervised fine-tuning to a restricted Boltzmann machine layer by monitoring its training performance. Test analysis reveals that the new DBN improves recognition performance and effectively controls the training time. Although the F-measure increases to 88.11%, the training time increases by only 25.35%.	[Zhang, Yajun; Liu, Zongtian; Zhou, Wen; Natl Nat Sci Fdn China NSFC] Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China	Shanghai University	Zhang, YJ (corresponding author), Shanghai Univ, Sch Comp Engn & Sci, Shanghai, Peoples R China.	zyj1985email@163.com			National Natural Science Foundation of China (NSFC) [61305053, 61273328, 71203135]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (NSFC), No. 61305053, No. 61273328, and No. 71203135.	Ahn D., 2006, P WORKSH ANN REAS TI, P1; Bengio, 2011, P ICML, DOI DOI 10.1177/1753193411430810; Bombieri N, 2011, IEEE T COMPUT, V60, P1730, DOI 10.1109/TC.2010.187; Boytcheva S., 2003, 10 C EUR CHAPT ASS C, P41; Cao YG, 2011, J BIOMED INFORM, V44, P277, DOI 10.1016/j.jbi.2011.01.004; Carpineto C, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2071389.2071390; Carreira-Perpinan M.A., 2005, P ARTIFICIAL INTELLI, VR5:, P33; Che W, 2010, P 23 INT C COMP LING, P13, DOI DOI 10.1007/S00466-010-0527-8; Chien HL, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P786; Comas PR, 2012, ACM T INFORM SYST, V30, DOI 10.1145/2328967.2328972; Ding Xiao, 2011, RES SENTENCE LEVEL C; Erhan D, 2010, J MACH LEARN RES, V11, P625; Gagie T, 2012, THEOR COMPUT SCI, V426, P25, DOI 10.1016/j.tcs.2011.12.002; He RF, 2012, EXPERT SYST APPL, V39, P2375, DOI 10.1016/j.eswa.2011.08.084; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; Hinton G.E., 2012, P ADV NEURAL INFORM, V25, P2447; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hinton GE, 1999, IEE CONF PUBL, P1, DOI 10.1049/cp:19991075; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Jianfeng Fu, 2010, Information Technology Journal, V9, P184, DOI 10.3923/itj.2010.184.187; [姜吉发 Jiang Jifa], 2005, [计算机工程, Computer Engineering], V31, P96; Kim S, 2011, INFORM PROCESS MANAG, V47, P593, DOI 10.1016/j.ipm.2010.12.002; Lee CS, 2003, EXPERT SYST APPL, V25, P431, DOI 10.1016/S0957-4174(03)00062-9; Lee TS, 2003, J OPT SOC AM A, V20, P1434, DOI 10.1364/JOSAA.20.001434; Lee TS, 1998, VISION RES, V38, P2429, DOI 10.1016/S0042-6989(97)00464-1; Li Feng, 2008, BREAKING EVENTS INFO; Li Pei-Feng, 2016, Journal of Software, V27, P280, DOI 10.13328/j.cnki.jos.004833; [梁晗 LIANG Han], 2006, [中文信息学报, Journal of Chinese Information Processing], V20, P40; [刘宗田 LIU Zong-tian], 2009, [计算机科学, Computer Science], V36, P189; Miwa Makoto, 2010, Journal of Bioinformatics and Computational Biology, V8, P131, DOI 10.1142/S0219720010004586; Nivre J., 2005, MSI REPORT 5133, P1; Ozgencil N.E., 2006, P AAAI WORKSH EV EXT, P7; Paltoglou G, 2010, INFORM SCIENCES, V180, P2763, DOI 10.1016/j.ins.2010.03.020; Pitler E, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P544; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shen M, 2012, IMPROVED METHOD FEAT, P496; Tan Hongye, 2008, RESEARCH ON CHINESE; Wang W, 2010, LECT NOTES COMPUT SC, V6184, P644, DOI 10.1007/978-3-642-14246-8_62; Wen Z, 2007, EVENT BASED KNOWLEDG, P498; Weng J., 2015, INT J INTELLIGENT SC, V05, P112, DOI DOI 10.4236/IJIS.2015.52011; Yao Y, 2015, INFORM SCIENCES, V302, P70, DOI 10.1016/j.ins.2014.12.038; Yen SJ, 2013, INFORM SCIENCES, V224, P77, DOI 10.1016/j.ins.2012.10.014; Yu XH, 1997, NEURAL NETWORKS, V10, P517, DOI 10.1016/S0893-6080(96)00102-5; Zhou D, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379777	45	9	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160147	10.1371/journal.pone.0160147	http://dx.doi.org/10.1371/journal.pone.0160147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501231	Green Submitted, gold, Green Published			2022-12-26	WOS:000381373500014
J	Li, FQ; Wang, R; Qu, C; Fu, NN; Luo, C; Xu, YH				Li, Fengqi; Wang, Ran; Qu, Cheng; Fu, Ningning; Luo, Chen; Xu, Yihua			Sequencing and Characterization of the Invasive Sycamore Lace Bug Corythucha ciliata (Hemiptera: Tingidae) Transcriptome	PLOS ONE			English	Article							STEPHANITIS-PYRIOIDES SCOTT; GENOME ANNOTATION; MICROSATELLITES; IDENTIFICATION; SIMILARITY; PACKAGE; REGIONS; SAY	The sycamore lace bug, Corythucha ciliata (Hemiptera: Tingidae), is an invasive forestry pest rapidly expanding in many countries. This pest poses a considerable threat to the urban forestry ecosystem, especially to Platanus spp. However, its molecular biology and biochemistry are poorly understood. This study reports the first C. ciliata transcriptome, encompassing three different life stages (Nymphs, adults female (AF) and adults male (AM)). In total, 26.53 GB of clean data and 60,879 unigenes were obtained from three RNAseq libraries. These unigenes were annotated and classified by Nr (NCBI non-redundant protein sequences), Nt (NCBI non-redundant nucleotide sequences), Pfam (Protein family), KOG/COG (Clusters of Orthologous Groups of proteins), Swiss-Prot (A manually annotated and reviewed protein sequence database), and KO (KEGG Ortholog database). After all pairwise comparisons between these three different samples, a large number of differentially expressed genes were revealed. The dramatic differences in global gene expression profiles were found between distinct life stages (nymphs and AF, nymphs and AM) and sex difference (AF and AM), with some of the significantly differentially expressed genes (DEGs) being related to metamorphosis, digestion, immune and sex difference. The different express of unigenes were validated through quantitative Real-Time PCR (qRT-PCR) for 16 randomly selected unigenes. In addition, 17,462 potential simple sequence repeat molecular markers were identified in these transcriptome resources. These comprehensive C. ciliata transcriptomic information can be utilized to promote the development of environmentally friendly methodologies to disrupt the processes of metamorphosis, digestion, immune and sex differences.	[Li, Fengqi; Wang, Ran; Qu, Cheng; Fu, Ningning; Luo, Chen; Xu, Yihua] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing 100097, Peoples R China	Beijing Academy of Agriculture & Forestry	Luo, C (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing 100097, Peoples R China.	Luochen1010@126.com			Project of science and technology of Beijing City [Z151100001115002]	Project of science and technology of Beijing City	This work was funded by the Project of science and technology of Beijing City (grant No. Z151100001115002).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battisti R. de, 1985, Frustula Entomologica, V7-8, P125; D' AGUILAR J., 1977, B SOC ENTOMOLOGIQUE, V82, P2; Drew W, 1977, TINGOIDEA OKLAHOMA H, P29; Foster SP, 1997, ANNU REV ENTOMOL, V42, P123, DOI 10.1146/annurev.ento.42.1.123; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Halbert S. E., 1998, ENTOMOL CIRCULAR, V387, P1; Heidemann O, 1908, P ENT SOC WASH; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Izri A, 2015, JAMA DERMATOL, V151, P909, DOI 10.1001/jamadermatol.2015.0577; Ju RT, 2009, ENTOMOL NEWS, V120, P409, DOI 10.3157/021.120.0410; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Maceljski M., 1972, Acta ent Jugosl, V8, P105; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; MENN JJ, 1989, J AGR FOOD CHEM, V37, P271, DOI 10.1021/jf00085a062; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nair S, 2012, J ENTOMOL SCI, V47, P247; Oszi B., 2006, Applied Ecology and Environmental Research, V4, P135; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRADO C E, 1990, Revista Chilena de Entomologia, V18, P53; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reese J, 2013, J GENOMICS, V2, P54; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozen S, 2000, Methods Mol Biol, V132, P365; Sharma PC, 2007, TRENDS BIOTECHNOL, V25, P490, DOI 10.1016/j.tibtech.2007.07.013; Stolle E, 2013, GENOME BIOL EVOL, V5, P151, DOI 10.1093/gbe/evs133; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Streito Jean-Claude, 2006, Entomologiste (Paris), V62, P31; Tian CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11042; Wade O, 1917, SYCAMORE LACE BUG CO, V116, P16; Wang Fulian, 2008, Scientia Silvae Sinicae, V44, P137; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Xie W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04088; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yang WY, 2014, FLA ENTOMOL, V97, P1070, DOI 10.1653/024.097.0310; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	40	3	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160609	10.1371/journal.pone.0160609	http://dx.doi.org/10.1371/journal.pone.0160609			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494615	gold, Green Submitted, Green Published			2022-12-26	WOS:000381369500065
J	Miccoll, L; Delgado, R; Guerra, P; Versace, F; Rodriguez-Ruiz, S; Fernandez-Santaella, MC				Miccoll, Laura; Delgado, Rafael; Guerra, Pedro; Versace, Francesco; Rodriguez-Ruiz, Sonia; Carmen Fernandez-Santaella, M.			Affective Pictures and the Open Library of Affective Foods (OLAF): Tools to Investigate Emotions toward Food in Adults	PLOS ONE			English	Article							IMAGE DATABASE; SPANISH; VALIDATION	Recently, several sets of standardized food pictures have been created, supplying both food images and their subjective evaluations. However, to date only the OLAF (Open Library of Affective Foods), a set of food images and ratings we developed in adolescents, has the specific purpose of studying emotions toward food. Moreover, some researchers have argued that food evaluations are not valid across individuals and groups, unless feelings toward food cues are compared with feelings toward intense experiences unrelated to food, that serve as benchmarks. Therefore the OLAF presented here, comprising a set of original food images and a group of standardized highly emotional pictures, is intended to provide valid between-group judgments in adults. Emotional images (erotica, mutilations, and neutrals from the International Affective Picture System/IAPS) additionally ensure that the affective ratings are consistent with emotion research. The OLAF depicts high-calorie sweet and savory foods and low-calorie fruits and vegetables, portraying foods within natural scenes matching the IAPS features. An adult sample evaluated both food and affective pictures in terms of pleasure, arousal, dominance, and food craving, following standardized affective rating procedures. The affective ratings for the emotional pictures corroborated previous findings, thus confirming the reliability of evaluations for the food images. Among the OLAF images, high-calorie sweet and savory foods elicited the greatest pleasure, although they elicited, as expected, less arousal than erotica. The observed patterns were consistent with research on emotions and confirmed the reliability of OLAF evaluations. The OLAF and affective pictures constitute a sound methodology to investigate emotions toward food within a wider motivational framework. The OLAF is freely accessible at digibug. ugr. es.	[Miccoll, Laura; Delgado, Rafael; Guerra, Pedro; Rodriguez-Ruiz, Sonia; Carmen Fernandez-Santaella, M.] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain; [Versace, Francesco] Univ Oklahoma, Stephenson Canc Ctr, Oklahoma Tobacco Res Ctr, Dept Family & Prevent Med, Oklahoma City, OK USA	University of Granada; University of Oklahoma System; University of Oklahoma Health Sciences Center	Miccoll, L (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain.	lauramiccoli@ugr.es	Guerra, Pedro/ABF-1291-2020; Fernández, María Carmen/H-5469-2011; Delgado Rodríguez, Rafael F./L-5176-2018; Guerra, Pedro/ABH-1639-2020	Fernández, María Carmen/0000-0001-7094-1138; Delgado Rodríguez, Rafael F./0000-0003-4971-6643; Guerra, Pedro/0000-0003-0614-629X; Miccoli, Laura/0000-0002-2523-3746; Versace, Francesco/0000-0002-2107-6683	Spanish Ministry of Economy and Competitiveness/MINECO [PSI2013-43777-P]; Regional Ministry of Economy, Innovation, and Science of the Junta de Andalucia, Spain [P12.SEJ.391]	Spanish Ministry of Economy and Competitiveness/MINECO; Regional Ministry of Economy, Innovation, and Science of the Junta de Andalucia, Spain	The research was funded by grants from 1) the Spanish Ministry of Economy and Competitiveness/MINECO (grant code: PSI2013-43777-P; https://sede.micinn.gob.es/stfls/eSede/Ficheros/2014/AnexoII_Presel_PRP_Proyectos_Excelencia_2013.pdf) and 2) the Regional Ministry of Economy, Innovation, and Science of the Junta de Andalucia, Spain (grant code: P12.SEJ.391; http://investigacion.ugr.es/pages/proyectos/2012/anexo_i_resolucion_proyectos_concedidos/!). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Munoz MA, 2010, MOTIV EMOTION, V34, P93, DOI 10.1007/s11031-009-9145-1; Bartoshuk LM, 2006, PHILOS T R SOC B, V361, P1137, DOI 10.1098/rstb.2006.1853; BIRCH LL, 1992, NUTR REV, V50, P249, DOI 10.1111/j.1753-4887.1992.tb01341.x; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Bradley M.M., 2007, HDB EMOTION ELICITAT, P29; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cepeda-Benito A, 2000, BEHAV RES THER, V38, P1125, DOI 10.1016/S0005-7967(99)00141-2; Charbonnier L, 2016, APPETITE, V96, P166, DOI 10.1016/j.appet.2015.08.041; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; Ferrando PJ, 2000, PSICOTHEMA, V12, P383; Ferrari V, 2017, COGNITION EMOTION, V31, P552, DOI 10.1080/02699931.2016.1140020; Foroni F, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00051; Fresan A, 2013, ACTAS ESP PSIQUIATRI, V41, P227; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Hendrikse JJ, 2015, OBES REV, V16, P424, DOI 10.1111/obr.12265; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Lang P. J., 2008, A8 U FLOR GAIN; Marchewka A, 2014, BEHAV RES METHODS, V46, P596, DOI 10.3758/s13428-013-0379-1; Meule A., 2013, FRONT PSYCHOL, V4, P1, DOI [DOI 10.3389/fpsyg.2013.00669, DOI 10.3389/FPSYG.2013.00669]; Miccoli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114515; Molto J, 2013, AN PSICOL-SPAIN, V29, P965, DOI 10.6018/analesps.29.3.153591; Nijs Ilse M T, 2008, Eat Behav, V9, P462, DOI 10.1016/j.eatbeh.2008.07.009; Pallister E, 2008, CLIN PSYCHOL REV, V28, P366, DOI 10.1016/j.cpr.2007.07.001; Ribeiro RL, 2005, REV BRAS PSIQUIATR, V27, P208, DOI 10.1590/S1516-44462005000300009; Schneider W, 2002, E PRIME 2 0 USERS GU; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Stockburger J, 2009, NEUROIMAGE, V47, P1819, DOI 10.1016/j.neuroimage.2009.04.071; Versace F, 2015, OBES REV, V16, P702, DOI 10.1111/obr.12301; Versace F, 2015, SOC COGN AFFECT NEUR; Vila J., 2001, REV PSICOLOG A GEN A, V54, P635, DOI DOI 10.6018/analesps.29.3.153591; Wardle J, 2006, FRONT NUTR SCI, P375, DOI 10.1079/9780851990323.0375; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wessa M., 2010, Z KL PSYCH PSYCHOTH, V39, P77, DOI [10.1026/1616-3443/a000036, DOI 10.1026/1616-3443/A000036]	35	30	30	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0158991	10.1371/journal.pone.0158991	http://dx.doi.org/10.1371/journal.pone.0158991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513636	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100013
J	Ueberschlag, SL; Seay, JR; Roberts, AH; DeSpirito, PC; Stith, JM; Folz, RJ; Carter, KA; Weiss, EP; Zavorsky, GS				Ueberschlag, Seteena L.; Seay, James R.; Roberts, Alexandra H.; DeSpirito, Pamela C.; Stith, Jeremy M.; Folz, Rodney J.; Carter, Kathleen A.; Weiss, Edward P.; Zavorsky, Gerald S.			The Effect of Protandim (R) Supplementation on Athletic Performance and Oxidative Blood Markers in Runners	PLOS ONE			English	Article							LIPID-PEROXIDATION; STRESS; RESPONSES; CARCINOGENESIS; INDUCTION; ENZYMES; MUSCLE; TRIAL; TIME	The purpose of this study determined if oral supplementation of Protandim (R) (a nutraceutical) for 90 days improved 5-km running performance and reduced serum thiobarbituric acid-reacting substances (TBARS) at rest, an indicator of oxidative stress. Secondary objectives were to measure whole blood superoxide dismutase (SOD), glutathione (GSH), and glutathione peroxidase (GPX), at rest and 10 minutes after completion of the race before and after supplementation as well as quality of life. In a double-blind, randomized, placebo controlled trial, 38 runners [mean (SD) = 34 (7) yrs; BMI = 22 (2) kg/m(2)] received either 90 days of Protandim (R) [1 pill a day, n = 19)] or placebo (n = 19). Randomization was done in blocks of two controlling for sex and 5-km baseline performance. A 5-km race was performed at baseline and after 90 days of supplementation, with blood samples taken before and 10-min after each race. Fasting blood samples were acquired at baseline, after 30, 60, and 90 days of supplementation. TBARS, SOD, GPX, and GSH were assayed in an out-of-state accredited lab. Running performance was not altered by Protandim (R) or placebo [20.3 (2.1) minutes, with an -8 (33) seconds change in 5-km time regardless of group]. There was no change in TBARS, SOD, or GPX (at rest) after three months of Protandim (R) supplementation compared to placebo. However, in a subgroup >= 35 years of age, there was a 2-fold higher increase in SOD in those taking Protandim (R) for three months compared to those on placebo (p = 0.038). The mean post-race change in TBARS (compared to pre-race) increased by about 20% in half of the subjects, but was not altered between groups, even after three months of supplementation. Quality of life was also not different between the two conditions. In conclusion, Protandim (R) did not (1) alter 5-km running time, (2) lower TBARS at rest (3) raise antioxidant enzyme concentrations compared to placebo (with exception of SOD in those >= 35 years old) or, (4) affect quality of life compared to placebo.	[Ueberschlag, Seteena L.; Seay, James R.; Roberts, Alexandra H.; Carter, Kathleen A.] Univ Louisville, Dept Hlth & Sport Sci, Louisville, KY 40292 USA; [DeSpirito, Pamela C.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Stith, Jeremy M.] Univ Kentucky, Dept Clin Sci, Lexington, KY USA; [Folz, Rodney J.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Weiss, Edward P.] St Louis Univ, Dept Nutr & Dietet, St Louis, MO 63103 USA; [Zavorsky, Gerald S.] Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA	University of Louisville; University of Louisville; University of Kentucky; Case Western Reserve University; Saint Louis University; University System of Georgia; Georgia State University	Zavorsky, GS (corresponding author), Georgia State Univ, Dept Resp Therapy, Atlanta, GA 30303 USA.	zavorsky@gsu.edu	Weiss, Edward P/P-1682-2017; Roberts, Alexandra/AAD-8422-2020; Roberts, Alexandra H/I-5763-2017; Zavorsky, Gerald S./I-7753-2013; Zavorsky, Gerald S./AAI-1422-2021	Roberts, Alexandra/0000-0003-4823-9718; Roberts, Alexandra H/0000-0003-4823-9718; Zavorsky, Gerald S./0000-0002-4473-1601; Zavorsky, Gerald S./0000-0002-4473-1601	LifeVantage	LifeVantage	GSZ was the principal investigator for the grant from LifeVantage that funded graduate student stipends. LifeVantage also paid for equipment, supplies, independent blood analyses, conferences, and publication fees. LifeVantage had no role in study design or data collection. They did, however, have access to the de-identified raw data of which an independent statistician hired by them verified our analyses. In a sub-analysis that their statistician performed, they showed that SOD increased in subjects equal to and greater than 35 years of age. While age related changes in SOD with supplementation was not made a priori, we added the results to the manuscript and discuss the ramifications of performing unplanned statistical tests in the manuscript. LifeVantage also received the manuscript draft as per agreement and provided some suggestions for improvement. GSZ accepted some of their suggestions on improvement, including the reporting of the unplanned age-related changes in SOD with supplementation.	Arent SM, 2010, J STRENGTH COND RES, V24, P1117, DOI 10.1519/JSC.0b013e3181cb70b8; Arent SM, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-11; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Burnham EL, 2012, AM J PHYSIOL-LUNG C, V302, P1688, DOI [10.1152/ajplung.00171.2011, 10.1152/ajplung.00297.2011]; Chandwaney R, 1998, AGE, V21, P109, DOI 10.1007/s11357-998-0017-5; CLEMENS MR, 1987, CHEM PHYS LIPIDS, V45, P251, DOI 10.1016/0009-3084(87)90068-5; EINSELE H, 1987, ARCH TOXICOL, V60, P163, DOI 10.1007/BF00296972; Fatouros IG, 2004, MED SCI SPORT EXER, V36, P2065, DOI 10.1249/01.MSS.0000147632.17450.FF; Feairheller Deborah L, 2011, J Exerc Physiol Online, V14, P49; Hadley M, 2013, MAXIMUM PERFORMANCE; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Jeukendrup AE, 2005, MED SCI SPORT EXER, V37, P1820, DOI 10.1249/01.mss.0000175095.56646.4b; Ji L, 2000, FREE RADICALS EXERCI, P35; Joddar B, 2011, FREE RADICAL BIO MED, V50, P700, DOI 10.1016/j.freeradbiomed.2010.12.008; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; Margonis K, 2007, FREE RADICAL BIO MED, V43, P901, DOI 10.1016/j.freeradbiomed.2007.05.022; Marzatico F, 1997, J SPORT MED PHYS FIT, V37, P235; MATSUO M, 2000, FREE RADICALS EXERCI, P1; Michailidis Y, 2007, MED SCI SPORT EXER, V39, P1107, DOI 10.1249/01.mss.0b013e318053e7ba; Mullins AL, 2013, BIOMARKERS, V18, P446, DOI 10.3109/1354750X.2013.810668; Nelson SK, 2006, FREE RADICAL BIO MED, V40, P341, DOI 10.1016/j.freeradbiomed.2005.08.043; Nuzzo R, 2014, NATURE, V506, P150, DOI 10.1038/506150a; Qureshi Muhammad Muddasir, 2010, Journal of Dietary Supplements, V7, P159, DOI 10.3109/19390211.2010.482041; Scalzo R, 2014, FASEB J, V28, pLB399; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Slattery KM, 2014, MED SCI SPORT EXER, V46, P1114, DOI 10.1249/MSS.0000000000000222; Tan XL, 2009, LUNG CANCER, V65, P129, DOI 10.1016/j.lungcan.2009.01.002; Velmurugan K, 2009, FREE RADICAL BIO MED, V46, P430, DOI 10.1016/j.freeradbiomed.2008.10.050; Veskoukis AS, 2009, FREE RADICAL BIO MED, V47, P1371, DOI 10.1016/j.freeradbiomed.2009.07.014	30	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160559	10.1371/journal.pone.0160559	http://dx.doi.org/10.1371/journal.pone.0160559			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513339	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100045
J	Wang, P; Wang, H; Li, XT; Liu, Y; Zhao, CB; Zhu, DL				Wang, Peng; Wang, Hu; Li, Xiaotao; Liu, Ying; Zhao, Chengbin; Zhu, Daling			SRCIN1 Suppressed Osteosarcoma Cell Proliferation and Invasion	PLOS ONE			English	Article							P140CAP; EXPRESSION; METASTASIS; MICRORNAS; PROGNOSIS; MIGRATION; PROTEIN; CANCER	SRCIN1 (SRC kinase signalling inhibitor 1) is a new tumor suppressor gene. Previous studies showed that SRCIN1 played a tumor suppressor role in the development of lung cancer and breast cancer. However, the role of SRCIN1 in osteosarcoma is still unknown. In this study, we demonstrated that SRCIN1 was downregulated in osteosarcoma cell lines compared with osteoblastic cell line. Moreover, SRCIN1 was downregulated in osteosarcoma tissues compared with the adjacent tissues. Further investigation revealed that overexpression of SRCIN1 inhibited the osteosarcoma cell line MG-63 proliferation. This effect was confirmed by measuring the ki-67 and PCNA expression. SRCIN1 overexpression promoted E-cadherin expression and suppressed N-cadherin, Vimentin and Snail expression, suggesting that SRCIN1 overexpression inhibited EMT of the osteosarcoma cell. In addition, ectopic expression of SRCIN1 inhibited the MG-63 cell colony formation and invasion. These data suggested that SRCIN1 acted as a tumor suppressor gene in the development of osteosarcoma.	[Wang, Peng; Zhao, Chengbin] Harbin Med Univ, Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China; [Wang, Hu] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Orthoped, Shantou 515041, Guangdong, Peoples R China; [Li, Xiaotao] Jiamusi Univ, Affiliated Hosp 1, Dept Orthoped, Jiamusi 154000, Heilongjiang, Peoples R China; [Liu, Ying] Harbin Med Univ, Clin Med Grade 4, Harbin 150001, Heilongjiang, Peoples R China; [Zhu, Daling] Harbin Med Univ Daqing, Coll Pharm, Dept Biopharmaceut Sci, Daqing 163319, Peoples R China; [Zhu, Daling] Biopharmaceut Key Lab Heilongjiang Prov, Harbin 150081, Peoples R China	Harbin Medical University; Shantou University; Jiamusi University; Harbin Medical University; Harbin Medical University	Zhao, CB (corresponding author), Harbin Med Univ, Hosp 4, Dept Orthoped, Harbin 150001, Heilongjiang, Peoples R China.; Zhu, DL (corresponding author), Harbin Med Univ Daqing, Coll Pharm, Dept Biopharmaceut Sci, Daqing 163319, Peoples R China.; Zhu, DL (corresponding author), Biopharmaceut Key Lab Heilongjiang Prov, Harbin 150081, Peoples R China.	chengbinzhao1@163.com; dalingz@yahoo.com			Postdoctoral Fund of Heilongjiang Province [LBH-Z15147]	Postdoctoral Fund of Heilongjiang Province	This study was supported by the Postdoctoral Fund of Heilongjiang Province (No. LBH-Z15147). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao MH, 2014, EUR J CANCER, V50, P1013, DOI 10.1016/j.ejca.2013.12.024; Damiano L, 2012, ONCOGENE, V31, P624, DOI 10.1038/onc.2011.257; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Di Stefano P, 2007, EMBO J, V26, P2843, DOI 10.1038/sj.emboj.7601724; Di Stefano P, 2011, AM J CANCER RES, V1, P663; Gao Y, 2014, BIOCHEM BIOPH RES CO, V444, P230, DOI 10.1016/j.bbrc.2014.01.061; Geng S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091566; Hong QN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0037-1; Iwasaki T, 2015, INT J ONCOL, V46, P1543, DOI 10.3892/ijo.2015.2867; Kennedy S, 2008, BRIT J CANCER, V98, P1641, DOI 10.1038/sj.bjc.6604365; Lv HL, 2014, MOL MED REP, V10, P2912, DOI 10.3892/mmr.2014.2582; Miao JL, 2013, TUMOR BIOL, V34, P2093, DOI 10.1007/s13277-013-0940-7; Niu GF, 2015, CELL PROLIFERAT, V48, P348, DOI 10.1111/cpr.12187; Niu GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119225; Sharma N, 2013, AM J CANCER RES, V3, P290; Tang J, 2014, CELL PROLIFERAT, V47, P427, DOI 10.1111/cpr.12129; van der Deen M, 2013, J BIOL CHEM, V288, P21307, DOI 10.1074/jbc.M112.445890; Wang GB, 2015, TUMOR BIOL, V36, P4715, DOI 10.1007/s13277-015-3120-0; Wang L, 2015, TUMOR BIOL, V36, P3911, DOI 10.1007/s13277-014-3034-2; Wang XH, 2014, MOL MED REP, V10, P855, DOI 10.3892/mmr.2014.2260; Zhang C, 2014, INT J CLIN EXP PATHO, V7, P4194; Zhang C, 2014, INT J MOL SCI, V15, P6544, DOI 10.3390/ijms15046544; Zhang J, 2015, CLIN CHIM ACTA, V444, P9, DOI 10.1016/j.cca.2015.01.025	23	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0155518	10.1371/journal.pone.0155518	http://dx.doi.org/10.1371/journal.pone.0155518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513473	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100002
J	Zhou, J; Wu, FZ; Yang, WQ; Tan, B; Xu, ZF; Zhang, J; Duan, F; Liu, H; Justine, MF				Zhou, Jiao; Wu, Fuzhong; Yang, Wanqin; Tan, Bo; Xu, Zhenfeng; Zhang, Jian; Duan, Fei; Liu, Hui; Justine, Meta Francis			The Mass Loss and Humification of Stumps and Roots in Masson Pine Plantations Based on Log File Records	PLOS ONE			English	Article							COARSE WOODY DEBRIS; LITTER DECOMPOSITION; ORGANIC-MATTER; NUTRIENT RELEASE; LEAF-LITTER; FOREST; NITROGEN; DYNAMICS; CARBON; PLANT	Stumps account for a large proportion of coarse woody debris in managed forests, but their decay dynamics are poorly understood. The loss of mass and the degree of humification of the above-ground woody debris, below-ground woody debris, bark and root system (R1, 10 mm >= diameter > 0 mm; R2, 25 mm >= diameter > 10 mm; 100 mm >= R3 > 25 mm; R4 > 100 mm) of Masson pine (Pinus massoniana) stump systems were evaluated in southwestern China in a chronosequence of plantations cut 1-15 years prior to the study. The results indicated that above-ground woody debris decomposed more quickly than below-ground woody debris and bark, whereas the degree of humification followed the opposite trend. Compared with one-year stumps, the mass losses of 15-year stump systems were 60.4% for above-ground woody debris, 42.1% for below-ground woody debris, 47.3% for bark, 69.9% for R1, 47.3% for R2, 51.0% for R3, and 83.2% for R4. In contrast, below-ground woody debris showed a greater degree of humification compared with other components in the stump system. Among the root system, fine roots (R1, diameter <= 10 mm) had the largest k value (0.09), whereas the decay rate of coarser roots (R2, R3, R4; diameter > 10 mm) increased with increasing root diameter. However, coarse roots showed a larger degree of humification (0.2-0.6) than fine roots (0.3-0.4). These results suggest that below-ground woody debris and coarse roots may display a higher degree of humification, showing greater short-term contributions to overall humification when compared with the other components in the stump system.	[Zhou, Jiao; Wu, Fuzhong; Yang, Wanqin; Tan, Bo; Xu, Zhenfeng; Zhang, Jian; Duan, Fei; Liu, Hui; Justine, Meta Francis] Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Inst Ecol & Forestry, Chengdu 611130, Peoples R China; [Wu, Fuzhong; Yang, Wanqin; Tan, Bo; Xu, Zhenfeng; Zhang, Jian; Justine, Meta Francis] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Yang, WQ (corresponding author), Sichuan Agr Univ, Long Term Res Stn Alpine Forest Ecosyst, Inst Ecol & Forestry, Chengdu 611130, Peoples R China.	scyangwq@163.com		Francis Justine, Meta/0000-0001-7895-4961	National Science Foundation of China [31270498]; National Key Technologies R & D Program of China [2011BAC09B05]; Post-doctoral Foundation of China [2012T50782]; Sichuan Youth Science & Technology Foundation [2012JQ0008]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R & D Program of China(National Key Technology R&D Program); Post-doctoral Foundation of China(China Postdoctoral Science Foundation); Sichuan Youth Science & Technology Foundation	The project was supported by National Science Foundation of China (31270498), the National Key Technologies R & D Program of China (2011BAC09B05), the Post-doctoral Foundation of China (2012T50782) and the Sichuan Youth Science & Technology Foundation (2012JQ0008).	Adani F, 2004, CHEMOSPHERE, V56, P13, DOI 10.1016/j.chemosphere.2004.01.040; ALLISON F. E., 1963, SOIL SCI SOC AMER PROC, V27, P309; AMARANTHUS M, 1994, CAN J FOREST RES, V24, P2157, DOI 10.1139/x94-278; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; CAMIRE C, 1991, PLANT SOIL, V138, P123, DOI 10.1007/BF00011814; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen H, 2001, CAN J FOREST RES, V31, P246, DOI 10.1139/cjfr-31-2-246; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Cornelissen JHC, 2012, AMBIO, V41, P231, DOI 10.1007/s13280-012-0304-3; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; FAHEY TJ, 1983, ECOL MONOGR, V53, P51, DOI 10.2307/1942587; FAHEY TJ, 1988, FOREST SCI, V34, P744; FOGEL R, 1977, CAN J BOT, V55, P1632, DOI 10.1139/b77-190; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Ganjegunte GK, 2004, FOREST ECOL MANAG, V187, P197, DOI 10.1016/S0378-1127(03)00332-3; Garrett LG, 2008, FOREST ECOL MANAG, V255, P3839, DOI 10.1016/j.foreco.2008.03.031; Garrett LG, 2010, FOREST ECOL MANAG, V260, P1389, DOI 10.1016/j.foreco.2010.07.041; Gorissen A, 1996, PLANT SOIL, V187, P289, DOI 10.1007/BF00017094; GRIER CC, 1978, CAN J FOREST RES, V8, P198, DOI 10.1139/x78-031; Guo LB, 2006, FOREST ECOL MANAG, V228, P145, DOI 10.1016/j.foreco.2006.02.043; Hakkila P., 1989, UTILIZATION RESIDUAL; Harmon M.E., 1996, GUIDELINES MEASUREME; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Harmon ME, 2000, CAN J FOREST RES, V30, P76, DOI 10.1139/cjfr-30-1-76; HENDRICK RL, 1993, CAN J FOREST RES, V23, P2507, DOI 10.1139/x93-312; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Hunter MD, 2003, PEDOBIOLOGIA, V47, P101, DOI 10.1078/0031-4056-00174; Ikeya K, 2003, SOIL SCI PLANT NUTR, V49, P47, DOI 10.1080/00380768.2003.10409978; Janisch JE, 2005, ECOSCIENCE, V12, P151, DOI 10.2980/i1195-6860-12-2-151.1; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Kononova M. M., 1961, SOIL ORGANIC MATTER; Kueppers LM, 2004, OECOLOGIA, V141, P641, DOI 10.1007/s00442-004-1689-x; Lear DH, 2011, CAN J FOREST RES, V25, P361; Li Zhou, 2007, Journal of Forestry Research (Harbin), V18, P48, DOI 10.1007/s11676-007-0009-9; Ludovici KH, 2006, CAN J FOREST RES, V36, P105, DOI 10.1139/X05-227; Martin-Neto L, 1998, GEODERMA, V81, P305, DOI 10.1016/S0016-7061(97)00089-X; McCay TS, 2004, FOREST ECOL MANAG, V189, P387, DOI 10.1016/j.foreco.2003.09.005; MEGONIGAL JP, 1988, AM J BOT, V75, P1334, DOI 10.2307/2444456; MEREDITH DS, 1973, ANNU REV PHYTOPATHOL, V11, P313, DOI 10.1146/annurev.py.11.090173.001525; Ni XY, 2015, GEODERMA, V241, P136, DOI 10.1016/j.geoderma.2014.11.018; Ni XY, 2014, CAN J SOIL SCI, V94, P453, DOI 10.4141/CJSS2013-121; Olajuyigbe SO, 2011, FOREST ECOL MANAG, V262, P1109, DOI 10.1016/j.foreco.2011.06.010; Olesen P. O., 1971, TREE IMPROV, V3, P1; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Ono K, 2011, PLANT SOIL, V338, P171, DOI 10.1007/s11104-010-0397-z; Palviainen M, 2015, FOREST ECOL MANAG, V358, P1, DOI 10.1016/j.foreco.2015.08.036; Palviainen M, 2010, FOREST ECOL MANAG, V260, P1478, DOI 10.1016/j.foreco.2010.07.046; Penman J., 2003, GOOD PRACTICE GUIDAN; Persson T, 2013, FOREST ECOL MANAG, V290, P1, DOI 10.1016/j.foreco.2012.09.024; Ponge JF, 2013, SOIL BIOL BIOCHEM, V57, P1048, DOI 10.1016/j.soilbio.2012.07.019; Richardson J. S. C., 2002, BIOENERGY SUSTAINABL; Shorohova E, 2008, CAN J FOREST RES, V38, P2414, DOI 10.1139/X08-083; Shorohova E, 2016, EUR J FOREST RES, V135, P593, DOI 10.1007/s10342-016-0957-8; Shorohova E, 2012, FOREST ECOL MANAG, V263, P74, DOI 10.1016/j.foreco.2011.09.006; Song Sen, 2008, Zhiwu Shengtai Xuebao, V32, P1227, DOI 10.3773/j.issn.1005-264x.2008.06.003; Stevenson FJ., 1983, HUMUS CHEM GENESIS C; Wang H, 2010, PALAEOGEOGR PALAEOCL, V286, P171, DOI 10.1016/j.palaeo.2009.12.015; Wang W, 2014, PLANT SOIL, V374, P677, DOI 10.1007/s11104-013-1902-y; Weatherall A, 2006, BIOMASS BIOENERG, V30, P1060, DOI 10.1016/j.biombioe.2005.12.016; You SJ, 1999, SCI TOTAL ENVIRON, V227, P155, DOI 10.1016/S0048-9697(99)00024-8; Zeng DH, 2010, APPL SOIL ECOL, V44, P133, DOI 10.1016/j.apsoil.2009.11.002; Zhao M, 2005, FOREST ECOL MANAG, V207, P295, DOI 10.1016/j.foreco.2004.10.049; [赵玉涛 Zhao Yutao], 2002, [山地学报, Journal of mountain science], V20, P12; Zhou LW, 2012, FUNGAL ECOL, V5, P230, DOI 10.1016/j.funeco.2011.09.005	66	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160913	10.1371/journal.pone.0160913	http://dx.doi.org/10.1371/journal.pone.0160913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512999	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100089
J	Stilp, CE; Kluender, KR				Stilp, Christian E.; Kluender, Keith R.			Stimulus Statistics Change Sounds from Near-Indiscriminable to Hyperdiscriminable	PLOS ONE			English	Article							MISMATCH NEGATIVITY MMN; HUMAN AUDITORY-CORTEX; SPEECH-PERCEPTION; SENSORY MEMORY; ADAPTATION; INFORMATION; NEURONS; DISCRIMINATION; REPRESENTATION; SENSITIVITY	Objects and events in the sensory environment are generally predictable, making most of the energy impinging upon sensory transducers redundant. Given this fact, efficient sensory systems should detect, extract, and exploit predictability in order to optimize sensitivity to less predictable inputs that are, by definition, more informative. Not only are perceptual systems sensitive to changes in physical stimulus properties, but growing evidence reveals sensitivity both to relative predictability of stimuli and to co- occurrence of stimulus attributes within stimuli. Recent results revealed that auditory perception rapidly reorganizes to efficiently capture covariance among stimulus attributes. Acoustic properties per se were perceptually abandoned, and sounds were instead processed relative to patterns of cooccurrence. Here, we show that listeners' ability to distinguish sounds from one another is driven primarily by the extent to which they are consistent or inconsistent with patterns of covariation among stimulus attributes and, to a lesser extent, whether they are heard frequently or infrequently. When sounds were heard frequently and deviated minimally from the prevailing pattern of covariance among attributes, they were poorly discriminated from one another. In stark contrast, when sounds were heard rarely and markedly violated the pattern of covariance, they became hyperdiscriminable with discrimination performance beyond apparent limits of the auditory system. Plausible cortical candidates underlying these dramatic changes in perceptual organization are discussed. These findings support efficient coding of stimulus statistical structure as a model for both perceptual and neural organization.	[Stilp, Christian E.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Kluender, Keith R.] Purdue Univ, Dept Speech Language & Hearing Sci, W Lafayette, IN 47907 USA	University of Louisville; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Stilp, CE (corresponding author), Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA.	christian.stilp@louisville.edu			National Institutes on Deafness and Other Communicative Disorders [F31 DC009532, RC1 DC010601]	National Institutes on Deafness and Other Communicative Disorders	This research was partially supported by grants from the National Institutes on Deafness and Other Communicative Disorders to the first (F31 DC009532) and second (RC1 DC010601) authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN O, 1987, BIOL PSYCHOL, V24, P197, DOI 10.1016/0301-0511(87)90002-0; Anderson JL, 2003, LANG SPEECH, V46, P155, DOI 10.1177/00238309030460020601; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Assmann Peter, 2004, VVolume 18, P231; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Attneave F., 1959, APPL INFORM THEORY P; Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Barlow H. B, 1961, SENS COMMUN, P53; Barlow HB, 1989, COMPUTING NEURON, P54; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; Caclin A, 2006, J COGNITIVE NEUROSCI, V18, P1959, DOI 10.1162/jocn.2006.18.12.1959; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chechik G, 2012, P NATL ACAD SCI USA, V109, P18968, DOI 10.1073/pnas.1111242109; Chevillet M, 2011, J NEUROSCI, V31, P9345, DOI 10.1523/JNEUROSCI.1448-11.2011; Clayards M, 2008, COGNITION, V108, P804, DOI 10.1016/j.cognition.2008.04.004; Escera C, 2014, PSYCHOPHYSIOLOGY, V51, P111, DOI 10.1111/psyp.12156; Geisler WS, 2008, ANN REV PSYCH; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Hebb Donald O., 1949, ORG BEHAV; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; HOLM S, 1979, SCAND J STAT, V6, P65; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kluender K. R., 2008, SENSES COMPREHENSIVE, P829, DOI DOI 10.1016/B978-012370880-9.00067-0; Kluender KR, 1998, J ACOUST SOC AM, V104, P3568, DOI 10.1121/1.423939; Kluender KR, 2003, SPEECH COMMUN, V41, P59, DOI 10.1016/S0167-6393(02)00093-6; Kluender KR, 1999, J ACOUST SOC AM, V105, P503, DOI 10.1121/1.424587; Kluender KR, 2013, VOWEL INHERENT SPECT, P117; KLUENDER KR, 2006, HDB PSYCHOLINGUISTIC, P153, DOI DOI 10.1016/B978-012369374-7/50007-9; Lisker L, 1978, SR54 HASK LAB STAT R, P127; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Maravall M, 2013, PRINCIPLES OF NEURAL CODING, P357; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Nelken I, 2013, ADV EXP MED BIOL, V787, P411, DOI 10.1007/978-1-4614-1590-9_45; Opolko F., 1989, MCGILL U MASTER SAMP; Paavilainen P, 2001, PSYCHOPHYSIOLOGY, V38, P359, DOI 10.1017/S0048577201000920; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; REPP BH, 1982, PSYCHOL BULL, V92, P81, DOI 10.1037/0033-2909.92.1.81; Rosch E., 1987, COGNITION CATEGORIZA, P27; SAMS M, 1983, BIOL PSYCHOL, V17, P41, DOI 10.1016/0301-0511(83)90065-0; Samson EW, 1951, FUNDAMENTAL NATURAL, pE5079; SANGER TD, 1989, NEURAL NETWORKS, V2, P459, DOI 10.1016/0893-6080(89)90044-0; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; Simpson AJR, 2014, J NEUROSCI, V34, P1963, DOI 10.1523/JNEUROSCI.4274-13.2013; Stilp CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030845; Stilp CE, 2011, J ACOUST SOC AM, V130, pEL352, DOI 10.1121/1.3647264; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P21914, DOI 10.1073/pnas.1009020107; Tian B, 2004, J NEUROPHYSIOL, V92, P2993, DOI 10.1152/jn.00472.2003; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Werker JF, 2012, CURR DIR PSYCHOL SCI, V21, P221, DOI 10.1177/0963721412449459; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108	63	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0161001	10.1371/journal.pone.0161001	http://dx.doi.org/10.1371/journal.pone.0161001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KR	27508391	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400074
J	McAteer, KM; Corrigan, F; Thornton, E; Turner, RJ; Vink, R				McAteer, Kelly M.; Corrigan, Frances; Thornton, Emma; Turner, Renee Jade; Vink, Robert			Short and Long Term Behavioral and Pathological Changes in a Novel Rodent Model of Repetitive Mild Traumatic Brain Injury	PLOS ONE			English	Article							INTERNATIONAL-CONFERENCE; CLINICAL PRESENTATION; RECURRENT CONCUSSION; CONSENSUS STATEMENT; ANIMAL-MODELS; AXONAL INJURY; TAU-PROTEIN; FOOTBALL; SPORT; NEUROINFLAMMATION	A history of concussion, particularly repeated injury, has been linked to an increased risk for the development of neurodegenerative diseases, particularly chronic traumatic encephalopathy (CTE). CTE is characterized by abnormal accumulation of hyperphosphorylated tau and deficits in learning and memory. As yet the mechanisms associated with the development of CTE are unknown. Accordingly, the aim of the current study was to develop and characterize a novel model of repetitive mTBI that accurately reproduces the key short and long-term functional and histopathological features seen clinically. Forty male Sprague-Dawley rats were randomly assigned to receive 0, 1 or 3x mTBI spaced five days apart using a modified version of the Marmarou impact-acceleration diffuse-TBI model to deliver 110G of linear force. Functional outcomes were assessed six and twelve weeks post-injury, with histopathology assessed twenty-four hours and twelve weeks post-injury. Repetitive mTBI resulted in mild spatial and recognition memory deficits as reflected by increased escape latency on the Barnes maze and decreased time spent in the novel arm of the Y maze. There was a trend towards increased anxiety-like behavior, with decreased time spent in the inner portion of the open field. At 24 hours and 12 weeks post injury, repetitive mTBI animals showed increased tau phosphorylation and microglial activation within the cortex. Increases in APP immunoreactivity were observed in repetitive mTBI animals at 12 weeks indicating long-term changes in axonal integrity. This novel model of repetitive mTBI with its persistent cognitive deficits, neuroinflammation, axonal injury and tau hyperphosphorylation, thus represents a clinically relevant experimental approach to further explore the underlying pathogenesis of CTE.	[McAteer, Kelly M.; Corrigan, Frances; Thornton, Emma; Turner, Renee Jade] Univ Adelaide, Sch Med, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia	University of Adelaide; University of South Australia	Corrigan, F (corresponding author), Univ Adelaide, Sch Med, Adelaide Ctr Neurosci Res, Adelaide, SA, Australia.	frances.corrigan@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Corrigan, Frances/0000-0001-6150-8893	National Health and Medical Research Council [APP1068712]; Australian National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council: APP1068712; consultations.nhmrc.gov.au (RV). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This work was supported, in part, by a grant from the Australian National Health and Medical Research Council.	Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barth JT, 2001, J ATHL TRAINING, V36, P253; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feuillette S, 2010, J NEUROCHEM, V113, P895, DOI 10.1111/j.1471-4159.2010.06663.x; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; Gerson JE, 2016, J NEUROTRAUMA; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gould TD, 2009, NEUROMETHODS, V42, P1, DOI 10.1007/978-1-60761-303-9_1; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guzel A, 2010, AM J EMERG MED, V28, P399, DOI 10.1016/j.ajem.2008.12.025; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Hovda DA, 1993, INTRACRANIAL PRESSUR, VVIII, P469; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; King T, 2013, J SCI MED SPORT, V16, P302, DOI 10.1016/j.jsams.2012.09.003; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Luo Jian, 2014, Front Neurol, V5, P12, DOI 10.3389/fneur.2014.00012; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Miyasaka T, 2010, FEBS LETT, V584, P3227, DOI 10.1016/j.febslet.2010.06.014; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Noble JM, 2013, NEUROPSYCHOL REV, V23, P273, DOI 10.1007/s11065-013-9239-0; Ojo JO, 2016, J NEUROPATHOLOGY EXP; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Seifert T, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0568-6; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Thies E, 2007, J NEUROSCI, V27, P2896, DOI 10.1523/JNEUROSCI.4674-06.2007; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	69	51	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160220	10.1371/journal.pone.0160220	http://dx.doi.org/10.1371/journal.pone.0160220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505027	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000381374200027
J	Coric, VM; Simic, TP; Pekmezovic, TD; Basta-Jovanovic, GM; Radojevic, ARS; Radojevic-Skodric, SM; Matic, MG; Dragicevic, DP; Radic, TM; Bogdanovic, LM; Dzamic, ZM; Pljesa-Ercegovac, MS				Coric, Vesna M.; Simic, Tatjana P.; Pekmezovic, Tatjana D.; Basta-Jovanovic, Gordana M.; Radojevic, Ana R. Savic; Radojevic-Skodric, Sanja M.; Matic, Marija G.; Dragicevic, Dejan P.; Radic, Tanja M.; Bogdanovic, Ljiljana M.; Dzamic, Zoran M.; Pljesa-Ercegovac, Marija S.			Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; OCCUPATIONAL-EXPOSURE; GENE POLYMORPHISMS; P1 POLYMORPHISMS; BLADDER-CANCER; HUMAN KIDNEY; GSTT1; SUSCEPTIBILITY; POPULATION; ENZYMES	The aim of this study was to evaluate specific glutathione S-transferase (GST) gene variants as determinants of risk in patients with clear cell renal cell carcinoma (cRCC), independently or simultaneously with established RCC risk factors, as well as to discern whether phenotype changes reflect genotype-associated risk. GSTA1, GSTM1, GSTP1 and GSTT1 genotypes were determined in 199 cRCC patients and 274 matched controls. Benzo(a) pyrene diolepoxide (BPDE)-DNA adducts were determined in DNA samples obtained from cRCC patients by ELISA method. Significant association between GST genotype and risk of cRCC development was found for the GSTM1-null and GSTP1-variant genotype (p = 0.02 and p<0.001, respectively). Furthermore, 22% of all recruited cRCC patients were carriers of combined GSTM1-null, GSTT1-active, GSTA1-low activity and GSTP1-variant genotype, exhibiting 9.32-fold elevated cRCC risk compared to the reference genotype combination (p = 0.04). Significant association between GST genotype and cRCC risk in smokers was found only for the GSTP1 genotype, while GSTM1-null/GSTP1-variant/GSTA1 low-activity genotype combination was present in 94% of smokers with cRCC, increasing the risk of cRCC up to 7.57 (p = 0.02). Furthermore, cRCC smokers with GSTM1-null genotype had significantly higher concentration of BPDE-DNA adducts in comparison with GSTM1-active cRCC smokers (p = 0.05). GSTM1, GSTT1, GSTA1 and GSTP1 polymorphisms might be associated with the risk of cRCC, with special emphasis on GSTM1-null and GSTP1-variant genotypes. Combined GSTM1-null, GSTT1-active, GSTA1 low activity and GSTP1-variant genotypes might be considered as "risk-carrying genotype combination" in cRCC.	[Coric, Vesna M.; Simic, Tatjana P.; Radojevic, Ana R. Savic; Matic, Marija G.; Pljesa-Ercegovac, Marija S.] Inst Med & Clin Biochem, Belgrade, Serbia; [Pekmezovic, Tatjana D.] Inst Epidemiol, Belgrade, Serbia; [Basta-Jovanovic, Gordana M.; Radojevic-Skodric, Sanja M.; Bogdanovic, Ljiljana M.] Inst Pathol, Belgrade, Serbia; [Dragicevic, Dejan P.; Dzamic, Zoran M.] Clin Ctr Serbia, Urol Clin, Belgrade, Serbia; [Coric, Vesna M.; Simic, Tatjana P.; Pekmezovic, Tatjana D.; Basta-Jovanovic, Gordana M.; Radojevic, Ana R. Savic; Radojevic-Skodric, Sanja M.; Matic, Marija G.; Dragicevic, Dejan P.; Radic, Tanja M.; Bogdanovic, Ljiljana M.; Dzamic, Zoran M.; Pljesa-Ercegovac, Marija S.] Univ Belgrade, Fac Med, Belgrade 11001, Serbia	University of Belgrade; Clinical Centre of Serbia; University of Belgrade	Pljesa-Ercegovac, MS (corresponding author), Inst Med & Clin Biochem, Belgrade, Serbia.; Pljesa-Ercegovac, MS (corresponding author), Univ Belgrade, Fac Med, Belgrade 11001, Serbia.	m.pljesa.ercegovac@gmail.com	Pljesa-Ercegovac, Marija/AFS-8309-2022	Coric, Vesna/0000-0003-0227-821X; Simic, Tatjana/0000-0001-8683-5129	Ministry of Education, Science and Technological Development of Republic of Serbia [OI175052, III41027]	Ministry of Education, Science and Technological Development of Republic of Serbia	This study was supported by Grant OI175052 and III41027 provided by Ministry of Education, Science and Technological Development of Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman SZ, 1996, CANCER LETT, V107, P229, DOI 10.1016/0304-3835(96)04832-X; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Ahmad ST, 2012, DNA CELL BIOL, V31, P636, DOI 10.1089/dna.2011.1392; Bruning T, 1997, ARCH TOXICOL, V71, P596, DOI 10.1007/s002040050432; Bruning T, 1999, OCCUP MED-OXFORD, V49, P299, DOI 10.1093/occmed/49.5.299; Buzio L, 2003, OCCUP ENVIRON MED, V60, P789, DOI 10.1136/oem.60.10.789; Cheng HY, 2012, RENAL FAILURE, V34, P1052, DOI 10.3109/0886022X.2012.708380; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Coric V, 2010, J MED BIOCHEM, V29, P204, DOI 10.2478/v10011-010-0025-8; De Martino M, 2010, J UROLOGY, V183, P878, DOI 10.1016/j.juro.2009.11.032; DEKANT W, 1993, TOXICOL LETT, V67, P151, DOI 10.1016/0378-4274(93)90052-Y; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Eble J.N., 2006, PATHOLOGY GENETICS T; Escudier B, 2014, BRIT J CANCER, V110, P2821, DOI 10.1038/bjc.2014.244; Filiadis I, 2000, BJU INT, V86, P794, DOI 10.1046/j.1464-410x.2000.00940.x; Green T, 1997, CHEM-BIOL INTERACT, V105, P99, DOI 10.1016/S0009-2797(97)00040-9; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; International Agency for Research on Cancer, 1993, BERYLLIUM CADMIUM ME; Jia CY, 2014, TUMOR BIOL, V35, P3867, DOI 10.1007/s13277-013-1513-5; Jung I, 2000, Cancer Control, V7, P325; Karami S, 2008, CARCINOGENESIS, V29, P1567, DOI 10.1093/carcin/bgn153; Liu R, 2012, ASIAN PAC J CANCER P, V13, P3109, DOI 10.7314/APJCP.2012.13.7.3109; Longuemaux S, 1999, CANCER RES, V59, P2903; Manevich Y, 2013, FREE RADICAL BIO MED, V54, P62, DOI 10.1016/j.freeradbiomed.2012.10.556; Matic M, 2013, UROL ONCOL-SEMIN ORI, V31, P1184, DOI 10.1016/j.urolonc.2011.08.005; Oniki K, 2008, PHARMACOGENET GENOM, V18, P275, DOI 10.1097/FPC.0b013e3282f56176; Ping J, 2006, TOXICOL SCI, V89, P438, DOI 10.1093/toxsci/kfj037; Pljesa-Ercegovac M, 2008, UROL ONCOL-SEMIN ORI, V26, P175, DOI 10.1016/j.urolonc.2007.02.007; Polimanti R, 2013, GENE, V512, P102, DOI 10.1016/j.gene.2012.09.113; Protzel C, 2012, EUR UROL SUPPL, V11, P52, DOI 10.1016/j.eursup.2012.05.002; Salinas-Sanchez AS, 2012, UROL ONCOL-SEMIN ORI, V30, P864, DOI 10.1016/j.urolonc.2010.10.001; Searchfield L, 2011, HISTOPATHOLOGY, V58, P180, DOI 10.1111/j.1365-2559.2010.03733.x; Simic T, 2006, AMINO ACIDS, V30, P495, DOI 10.1007/s00726-006-0329-7; Simic T, 2002, WORLD J UROL, V20, P385, DOI 10.1007/s00345-002-0302-3; Simic T, 2001, UROL RES, V29, P38, DOI 10.1007/s002400000158; Sobin LH., 2010, TNM CLASSIFICATION M; Sweeney C, 2000, CANCER EPIDEM BIOMAR, V9, P449; Thevenin AF, 2011, PROTEIN SCI, V20, P834, DOI 10.1002/pro.609; Wiencke JK, 2002, ONCOGENE, V21, P7376, DOI 10.1038/sj.onc.1205799; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; Yang XJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001673	42	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160570	10.1371/journal.pone.0160570	http://dx.doi.org/10.1371/journal.pone.0160570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500405	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500031
J	Drumonde-Neves, J; Franco-Duarte, R; Lima, T; Schuller, D; Pais, C				Drumonde-Neves, Joao; Franco-Duarte, Ricardo; Lima, Teresa; Schuller, Dorit; Pais, Celia			Yeast Biodiversity in Vineyard Environments Is Increased by Human Intervention	PLOS ONE			English	Article							NON-SACCHAROMYCES YEASTS; SPONTANEOUS FERMENTATIONS; GRAPE VARIETIES; WINE; IDENTIFICATION; POPULATIONS; REGION; DIVERSITY; DYNAMICS; ECOLOGY	One hundred and five grape samples were collected during two consecutive years from 33 locations on seven oceanic islands of the Azores Archipelago. Grape samples were obtained from vineyards that were either abandoned or under regular cultivation involving common viticultural interventions, to evaluate the impact of regular human intervention on grape yeast biota diversity in vineyards. A total of 3150 yeast isolates were obtained and 23 yeast species were identified. The predominant species were Hanseniaspora uvarum, Pichia terricola, Starmerella bacillaris and Issatchenkia hanoiensis. The species Barnettozyma californica, Candida azymoides and Pichia cecembensis were reported in grapes or wine-associated environments for the first time. A higher biodiversity was found in active vineyards where regular human intervention takes place (Shannon index: 1.89 and 1.53 in the first and second years, respectively) when compared to the abandoned ones (Shannon index: 0.76 and 0.31). This finding goes against the assumptions that human intervention can destroy biodiversity and lead to homogeneity in the environment. Biodiversity indices were considerably lower in the year with the heaviest rainfall. This study is the first to report on the grape yeast communities from several abandoned vineyards that have undergone no human intervention.	[Drumonde-Neves, Joao; Lima, Teresa] Univ Azores, CITAA Res Ctr Agr Technol Azores, Angra Do Heroismo, Portugal; [Drumonde-Neves, Joao; Franco-Duarte, Ricardo; Schuller, Dorit; Pais, Celia] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal	Universidade dos Acores; Universidade do Minho	Franco-Duarte, R (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	ricardofilipeduarte@bio.uminho.pt	Pais, Célia/A-9186-2010; Franco-Duarte, Ricardo/I-6594-2015	Pais, Célia/0000-0001-5959-290X; Franco-Duarte, Ricardo/0000-0002-2333-6127; Lima, Teresa/0000-0002-0354-1190	Azorean Government [M321/006/F/2008]; PROEMPREGO; ERDF through the COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT [FCOMP-01-0124-008775, PTDC/AGR-ALI/103392/2008, PTDC/AGR-ALI/121062/2010, UID/BIA/04050/2013, POCI-01-0145-FEDER-007569]; Fundação para a Ciência e a Tecnologia [PTDC/AGR-ALI/121062/2010, PTDC/AGR-ALI/103392/2008] Funding Source: FCT	Azorean Government; PROEMPREGO; ERDF through the COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	Joao Drumonde Neves is the recipient of a fellowship of the Azorean Government (M321/006/F/2008) and PROEMPREGO. This work was supported by the strategic programme UID/BIA/04050/2013 (POCI-01-0145-FEDER-007569) funded by national funds through the FCT I.P. and by the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI), and by national funds through FCT by the projects FCOMP-01-0124-008775, PTDC/AGR-ALI/103392/2008 and PTDC/AGR-ALI/121062/2010.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baffi MA, 2011, ANN MICROBIOL, V61, P75, DOI 10.1007/s13213-010-0099-z; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Beltran G, 2002, SYST APPL MICROBIOL, V25, P287, DOI 10.1078/072320202320386479; Bhadra B, 2007, FEMS YEAST RES, V7, P579, DOI 10.1111/j.1567-1364.2007.00215.x; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Borges P., 2009, ECOSSISTEMAS BEM EST; Cabras P, 1999, J AGR FOOD CHEM, V47, P3854, DOI 10.1021/jf990005j; Cadez N, 2010, FEMS YEAST RES, V10, P619, DOI 10.1111/j.1567-1364.2010.00635.x; Calhelha RC, 2006, FOOD MICROBIOL, V23, P393, DOI 10.1016/j.fm.2005.04.008; Chavan P, 2009, FOOD MICROBIOL, V26, P801, DOI 10.1016/j.fm.2009.05.005; Clavijo A, 2010, INT J FOOD MICROBIOL, V143, P241, DOI 10.1016/j.ijfoodmicro.2010.08.010; Combina M, 2005, J APPL MICROBIOL, V98, P1055, DOI 10.1111/j.1365-2672.2005.02540.x; Combina M, 2005, INT J FOOD MICROBIOL, V99, P237, DOI 10.1016/j.ijfoodmicro.2004.08.017; Comitini F, 2006, LETT APPL MICROBIOL, V42, P248, DOI 10.1111/j.1472-765X.2005.01837.x; Comitini F, 2008, ANN MICROBIOL, V58, P489, DOI 10.1007/BF03175547; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V148, P23, DOI 10.1016/j.ijfoodmicro.2011.04.021; Cordero-Bueso G, 2011, INT J FOOD MICROBIOL, V145, P132, DOI 10.1016/j.ijfoodmicro.2010.11.040; De La Torre MJ, 1998, MICROBIOS, V96, P165; Di Maro E, 2007, INT J FOOD MICROBIOL, V117, P201, DOI 10.1016/j.ijfoodmicro.2007.04.007; Esteve-Zarzoso B, 1999, INT J SYST BACTERIOL, V49, P329, DOI 10.1099/00207713-49-1-329; Fleet GH, 2002, BIODIVERSITY AND BIOTECHNOLOGY OF WINE YEASTS, P1; Gayevskiy V, 2012, ISME J, V6, P1281, DOI 10.1038/ismej.2011.195; Guerra E, 1999, IND ALIMENT-ITALY, P9; Guzzon R, 2011, S AFR J ENOL VITIC, V32, P242; Hong YA, 2013, FOOD MICROBIOL, V34, P207, DOI 10.1016/j.fm.2012.12.011; JACKSON DI, 1993, AM J ENOL VITICULT, V44, P409; Jolly N. P., 2003, South African Journal of Enology and Viticulture, V24, P35; Lederer MA, 2013, ACTA AGR SCAND B-S P, V63, P89, DOI 10.1080/09064710.2012.723738; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Li EH, 2011, WORLD J MICROB BIOT, V27, P2475, DOI 10.1007/s11274-011-0711-9; LONGO E, 1991, AM J ENOL VITICULT, V42, P141; Medeiros C. A., 1994, FINISTERRA, VXXIX, P199; Milanovic V, 2013, INT J FOOD MICROBIOL, V161, P240, DOI 10.1016/j.ijfoodmicro.2012.12.019; Nemcova K, 2014, SLOVAKIA, V60, P103; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P2765, DOI 10.1128/AEM.01864-06; Ocon E, 2010, EUR FOOD RES TECHNOL, V230, P885, DOI 10.1007/s00217-010-1233-7; PARISH ME, 1985, AM J ENOL VITICULT, V36, P165; PIELOU E C, 1969, P286; Raspor P, 2006, INT J FOOD MICROBIOL, V109, P97, DOI 10.1016/j.ijfoodmicro.2006.01.017; Rementeria A, 2003, INT J FOOD MICROBIOL, V86, P201, DOI 10.1016/S0168-1605(03)00289-7; Renouf V, 2005, AUST J GRAPE WINE R, V11, P316, DOI 10.1111/j.1755-0238.2005.tb00031.x; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; Settanni L, 2012, J BIOSCI BIOENG, V114, P606, DOI 10.1016/j.jbiosc.2012.07.010; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Sun HH, 2009, ANN MICROBIOL, V59, P69, DOI 10.1007/BF03175601; Sun Y, 2014, ANTON LEEUW INT J G, V105, P533, DOI 10.1007/s10482-013-0105-0; Swiegers JH, 2005, AUST J GRAPE WINE R, V11, P139, DOI 10.1111/j.1755-0238.2005.tb00285.x; Tristezza M, 2013, FOOD MICROBIOL, V36, P335, DOI 10.1016/j.fm.2013.07.001; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14	53	31	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160579	10.1371/journal.pone.0160579	http://dx.doi.org/10.1371/journal.pone.0160579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500638	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500033
J	Sedlacik, J; Frolich, A; Spallek, J; Forkert, ND; Faizy, TD; Werner, F; Knopp, T; Krause, D; Fiehler, J; Buhk, JH				Sedlacik, Jan; Froelich, Andreas; Spallek, Johanna; Forkert, Nils D.; Faizy, Tobias D.; Werner, Franziska; Knopp, Tobias; Krause, Dieter; Fiehler, Jens; Buhk, Jan-Hendrik			Magnetic Particle Imaging for High Temporal Resolution Assessment of Aneurysm Hemodynamics	PLOS ONE			English	Article								Purpose The purpose of this work was to demonstrate the capability of magnetic particle imaging (MPI) to assess the hemodynamics in a realistic 3D aneurysm model obtained by additive manufacturing. MPI was compared with magnetic resonance imaging (MRI) and dynamic digital subtraction angiography (DSA). Materials and Methods The aneurysm model was of saccular morphology (7 mm dome height, 5 mm cross-section, 3-4 mm neck, 3.5 mm parent artery diameter) and connected to a peristaltic pump delivering a physiological flow (250 mL/min) and pulsation rate (70/min). High-resolution (4 h long) 4D phase contrast flow quantification (4D pc-fq) MRI was used to directly assess the hemodynamics of the model. Dynamic MPI, MRI, and DSA were performed with contrast agent injections (3 mL volume in 3 s) through a proximally placed catheter. Results and Discussion 4D pc-fq measurements showed distinct pulsatile flow velocities (20-80 cm/s) as well as lower flow velocities and a vortex inside the aneurysm. All three dynamic methods (MPI, MRI, and DSA) also showed a clear pulsation pattern as well as delayed contrast agent dynamics within the aneurysm, which is most likely caused by the vortex within the aneurysm. Due to the high temporal resolution of MPI and DSA, it was possible to track the contrast agent bolus through the model and to estimate the average flow velocity (about 60 cm/s), which is in accordance with the 4D pc-fq measurements. Conclusions The ionizing radiation free, 4D high resolution MPI method is a very promising tool for imaging and characterization of hemodynamics in human. It carries the possibility of overcoming certain disadvantages of other modalities like considerably lower temporal resolution of dynamic MRI and limited 2D characteristics of DSA. Furthermore, additive manufacturing is the key for translating powerful pre-clinical techniques into the clinic.	[Sedlacik, Jan; Froelich, Andreas; Faizy, Tobias D.; Fiehler, Jens; Buhk, Jan-Hendrik] Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany; [Spallek, Johanna; Krause, Dieter] Hamburg Univ Technol, Dept Prod Dev & Mech Engn Design, Hamburg, Germany; [Forkert, Nils D.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Forkert, Nils D.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Werner, Franziska; Knopp, Tobias] Univ Med Ctr Hamburg Eppendorf, Sect Biomed Imaging, Hamburg, Germany; [Werner, Franziska; Knopp, Tobias] Hamburg Univ Technol, Inst Biomed Imaging, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hamburg University of Technology; University of Calgary; University of Calgary; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hamburg University of Technology	Sedlacik, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neuroradiol, Hamburg, Germany.	j.sedlacik@uke.de	Knopp, Tobias/AAH-1644-2019; Forkert, Nils Daniel/K-6273-2012; Krause, Dieter/ABD-8315-2021	Knopp, Tobias/0000-0002-1589-8517; Forkert, Nils Daniel/0000-0003-2556-3224; Spallek, Johanna/0000-0002-4387-4504; Krause, Dieter/0000-0002-1253-1699	German Research Foundation [AD125/5-4]; Forschungszentrum Medizintechnik Hamburg; Philips Healthcare; Philips AlluraClarity Angiography system; Department of Radiology (University Medical Center Hamburg-Eppendorf, Hamburg, Germany)	German Research Foundation(German Research Foundation (DFG)); Forschungszentrum Medizintechnik Hamburg; Philips Healthcare; Philips AlluraClarity Angiography system; Department of Radiology (University Medical Center Hamburg-Eppendorf, Hamburg, Germany)	The German Research Foundation (dfg.de) funded the magnetic particle imaging scanner (grant no. AD125/5-4). The Forschungszentrum Medizintechnik Hamburg (fmthh.de) funded the project for 3D printing of aneurysms. Philips Healthcare supports and realized the "Hermann-Zeumer Research Laboratory" including a Philips AlluraClarity Angiography system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Prof. Gerhard Adam and colleagues of the Department of Radiology (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) for acquiring the funding of the MPI scanner and the associated research group. We also wish to thank Dr. Andre Kemmling (Neuroradiology, University Hospital Schleswig-Holstein, Lubeck, Germany) for his work in conceptualizing the manufacturing of aneurysm models.	Anderson JR, 2016, J NEUROINTERV SURG, V8, P517, DOI 10.1136/neurintsurg-2015-011686; Bonnefous O, 2012, MED PHYS, V39, P6264, DOI 10.1118/1.4754299; Brinjikji W, 2016, AM J NEURORADIOL, V37, P615, DOI 10.3174/ajnr.A4575; Chueh JY, 2009, AM J NEURORADIOL, V30, P1159, DOI 10.3174/ajnr.A1543; Ferguson RM, 2015, IEEE T MED IMAGING, V34, P1077, DOI 10.1109/TMI.2014.2375065; Frolich AMJ, 2016, AM J NEURORADIOL, V37, P120, DOI 10.3174/ajnr.A4486; Gleich B, 2005, NATURE, V435, P1214, DOI 10.1038/nature03808; Haegele J, 2012, RADIOLOGY, V265, P933, DOI 10.1148/radiol.12120424; Jeong W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/782801; Kaul MG, 2015, ROFO-FORTSCHR RONTG, V187, P347, DOI 10.1055/s-0034-1399344; Knopp T, 2015, ADV MATH PHYS, V2015, DOI 10.1155/2015/472818; Knox K, 2005, CATHETER CARDIO INTE, V65, P47, DOI 10.1002/ccd.20333; Kono K, 2013, NEUROL MED-CHIR, V53, P347, DOI 10.2176/nmc.53.347; Lim RP, 2008, AM J NEURORADIOL, V29, P1847, DOI 10.3174/ajnr.A1252; Markl M, 2012, J MAGN RESON IMAGING, V36, P1015, DOI 10.1002/jmri.23632; Pereira VM, 2013, AM J NEURORADIOL, V34, P808, DOI 10.3174/ajnr.A3322; Salamon J, 2016, INT WORKSH MAGN PART, P122; Schonfeld MH, 2016, CLIN NEURORADIOL, V26, P57, DOI 10.1007/s00062-014-0330-6; van Ooij P, 2012, NMR BIOMED, V25, P14, DOI 10.1002/nbm.1706; Weber A, 2016, PHYS MED BIOL, V61, P475, DOI 10.1088/0031-9155/61/2/475; Weizenecker J, 2009, PHYS MED BIOL, V54, pL1, DOI 10.1088/0031-9155/54/5/L01; Wirtz D, 2016, 6 INT WORKSH MAGN PA, P172; Zheng B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14055	23	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160097	10.1371/journal.pone.0160097	http://dx.doi.org/10.1371/journal.pone.0160097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494610	Green Published, gold			2022-12-26	WOS:000381369500020
J	Tatler, AL; Goodwin, AT; Gbolahan, O; Saini, G; Porte, J; John, AE; Clifford, RL; Violette, SM; Weinreb, PH; Parfrey, H; Wolters, PJ; Gauldie, J; Kolb, M; Jenkins, G				Tatler, Amanda L.; Goodwin, Amanda T.; Gbolahan, Olumide; Saini, Gauri; Porte, Joanne; John, Alison E.; Clifford, Rachel L.; Violette, Shelia M.; Weinreb, Paul H.; Parfrey, Helen; Wolters, Paul J.; Gauldie, Jack; Kolb, Martin; Jenkins, Gisli			Amplification of TGF beta Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-CELLS; LUNG FIBROSIS; ACTIVATION; INTEGRIN-ALPHA-V-BETA-6; INFLAMMATION; TGF-BETA-1; MICE; INHIBITION; EXPRESSION	Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease with poor survival rates and limited treatment options. Upregulation of alpha v beta 6 integrins within the alveolar epithelial cells is a characteristic feature of IPF and correlates with poor patient survival. The profibrotic cytokine TGF beta 1 can upregulate alpha v beta 6 integrin expression but the molecular mechanisms driving this effect have not previously been elucidated. We confirm that stimulation with exogenous TGF beta 1 increases expression of the integrin beta 6 subunit gene (ITGB6) and alpha v beta 6 integrin cell surface expression in a time-and concentration-dependent manner. TGF beta 1-induced ITGB6 expression occurs via transcriptional activation of the ITGB6 gene, but does not result from effects on ITGB6 mRNA stability. Basal expression of ITGB6 in, and alpha v beta 6 integrins on, lung epithelial cells occurs via homeostatic alpha v beta 6-mediated TGF beta 1 activation in the absence of exogenous stimulation, and can be amplified by TGF beta 1 activation. Fundamentally, we show for the first time that TGF beta 1-induced ITGB6 expression occurs via canonical Smad signalling since dominant negative constructs directed against Smad3 and 4 inhibit ITGB6 transcriptional activity. Furthermore, disruption of a Smad binding site at -798 in the ITGB6 promoter abolishes TGF beta 1-induced ITGB6 transcriptional activity. Using chromatin immunoprecipitation we demonstrate that TGF beta 1 stimulation of lung epithelial cells results in direct binding of Smad3, and Smad4, to the ITGB6 gene promoter within this region. Finally, using an adenoviral TGF beta 1 over-expression model of pulmonary fibrosis we demonstrate that Smad3 is crucial for TGF beta 1-induced alpha v beta 6 integrin expression within the alveolar epithelium in vivo. Together, these data confirm that a homeostatic, autocrine loop of alpha v beta 6 integrin activated TGF beta 1-induced ITGB6 gene expression regulates epithelial basal alpha v beta 6 integrin expression, and demonstrates that this occurs via Smad-dependent transcriptional regulation at a single Smad binding site in the promoter of the beta 6 subunit gene. Active TGF beta 1 amplifies this pathway both in vitro and in vivo, which may promote fibrosis.	[Tatler, Amanda L.; Goodwin, Amanda T.; Gbolahan, Olumide; Saini, Gauri; Porte, Joanne; John, Alison E.; Clifford, Rachel L.; Jenkins, Gisli] Univ Nottingham, Div Resp Med City, Nottingham, England; [Violette, Shelia M.; Weinreb, Paul H.] Biogen, Cambridge, MA USA; [Parfrey, Helen] Univ Cambridge, Dept Pathol, Cambridge, England; [Wolters, Paul J.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Gauldie, Jack; Kolb, Martin] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	University of Nottingham; Biogen; University of Cambridge; University of California System; University of California San Francisco; McMaster University	Tatler, AL (corresponding author), Univ Nottingham, Div Resp Med City, Nottingham, England.	Amanda.tatler@nottingham.ac.uk	Jenkins, Gisli/R-8143-2017; tatler, amanda/I-2620-2019	Jenkins, Gisli/0000-0002-7929-2119; tatler, amanda/0000-0002-4644-4614; Clifford, Rachel/0000-0002-8677-452X; Goodwin, Amanda/0000-0002-1488-6549; Weinreb, Paul/0000-0002-0802-0052; John, Alison/0000-0002-0453-3221	Wellcome Trust; NC3Rs; Medical Research Foundation [MRF-091-0004-RG-TATLE] Funding Source: researchfish; National Institute for Health Research [ACF-2014-12-002] Funding Source: researchfish; National Centre for the Replacement [G1100564/1, NC/K500501/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement	In addition to research grants provided by the Wellcome Trust and NC3Rs (held by GJ), and a personal fellowship (held by ALT), two co-authors are employees of Biogen Idec. This funder provided support in the form of salaries for SMV and PHW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Clifford RL, 2008, J BIOL CHEM, V283, P35337, DOI 10.1074/jbc.M803342200; Das PM, 2004, BIOTECHNIQUES, V37, P961, DOI 10.2144/04376RV01; Giacomini MM, 2012, EXP CELL RES, V318, P716, DOI 10.1016/j.yexcr.2012.01.020; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Huang YC, 2014, TOXICOL IND HEALTH, V30, P182, DOI 10.1177/0748233712452606; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; John AE, 2013, J NUCL MED, V54, P2146, DOI 10.2967/jnumed.113.120592; Joshi D, 2013, LIVER TRANSPLANT, V19, P383, DOI 10.1002/lt.23613; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V327, P393, DOI 10.1016/j.bbrc.2004.12.032; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Navaratnam V, 2011, THORAX, V66, P462, DOI 10.1136/thx.2010.148031; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Saini G, 2015, EUR RESP J; SHEPPARD D, 1992, J BIOL CHEM, V267, P17409; Tatler AL, 2016, J BIOL CHEM, V291, P9540, DOI 10.1074/jbc.M115.692368; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; van Almen GC, 2011, AGING CELL, V10, P769, DOI 10.1111/j.1474-9726.2011.00714.x; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Xu MY, 2009, AM J PATHOLOGY; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zhao JS, 2002, AM J PHYSIOL-LUNG C, V282, pL585, DOI 10.1152/ajplung.00151.2001	29	24	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0158047	10.1371/journal.pone.0158047	http://dx.doi.org/10.1371/journal.pone.0158047			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494713	Green Published, gold, Green Submitted			2022-12-26	WOS:000381369500003
J	Han, YF; Shewan, AM; Thorn, P				Han, Yanfeng; Shewan, Annette M.; Thorn, Peter			HCO(3)(-)Transport through Anoctamin/Transmembrane Protein ANO1/TMEM16A in Pancreatic Acinar Cells Regulates Luminal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bicarbonate; epithelial cell; exocytosis; ion channel; pancreas; secretion; transporter	CYTOSOLIC CA2+; TMEM16A; EXOCYTOSIS; SECRETION; CHANNEL; BICARBONATE; EXPRESSION	The identification of ANO1/TMEM16A as the likely calcium-dependent chloride channel of exocrine glands has led to a more detailed understanding of its biophysical properties. This includes a calcium-dependent change in channel selectivity and evidence that HCO3-permeability can be significant. Here we use freshly isolated pancreatic acini that preserve the luminal structure to measure intraluminal pH and test the idea that ANO1/TMEM16A contributes to luminal pH balance. Our data show that, under physiologically relevant stimulation with 10 pm cholesystokinin, the luminal acid load that results from the exocytic fusion of zymogen granules is significantly blunted by HCO3-buffer in comparison with HEPES, and that this is blocked by the specific TMEM16A inhibitor T16inh-A01. Furthermore, in a model of acute pancreatitis, we observed substantive luminal acidification and provide evidence that ANO1/TMEM16A acts to attenuate this pH shift. We conclude that ANO1/TMEM16A is a significant pathway in pancreatic acinar cells for HCO3-secretion into the lumen.	[Han, Yanfeng; Thorn, Peter] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Shewan, Annette M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Thorn, Peter] Univ Sydney, Charles Perkins Ctr, John Hopkins Dr, Sydney, NSW 2050, Australia	University of Queensland; University of Queensland; University of Sydney	Thorn, P (corresponding author), Univ Sydney, Charles Perkins Ctr, John Hopkins Dr, Sydney, NSW 2050, Australia.	p.thorn@sydney.edu.au	Shewan, Annette/B-3251-2011; Thorn, peter/F-7030-2010	Shewan, Annette/0000-0003-4936-9207; Thorn, peter/0000-0002-3228-770X; Han, Yanfeng/0000-0001-8423-0409	Australian Research Council [DP110100642]; National Health and Medical Research Council [APP1021764, APP1059426]; National Breast Cancer Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation	This work was supported by Australian Research Council Grant DP110100642 (to P. T.) and National Health and Medical Research Council Grants APP1021764 and APP1059426 (to P. T.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a National Breast Cancer Foundation Early Career Researcher fellowship.	Behrendorff N, 2010, GASTROENTEROLOGY, V139, P1711, DOI 10.1053/j.gastro.2010.07.051; Boedtkjer DMB, 2015, BRIT J PHARMACOL, V172, P4158, DOI 10.1111/bph.13201; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; DUTTA SK, 1979, DIGEST DIS SCI, V24, P529, DOI 10.1007/BF01489321; Freedman SD, 2001, GASTROENTEROLOGY, V121, P950, DOI 10.1053/gast.2001.27992; GILLESPIE JI, 1989, Q J EXP PHYSIOL CMS, V74, P883, DOI 10.1113/expphysiol.1989.sp003359; Hegyi P, 2011, GUT, V60, P544, DOI 10.1136/gut.2010.218461; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Ishikawa T, 1996, J MEMBRANE BIOL, V153, P147, DOI 10.1007/s002329900118; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Kidd JF, 2001, PFLUG ARCH EUR J PHY, V441, P489, DOI 10.1007/s004240000451; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Low JT, 2010, J CELL SCI, V123, P3201, DOI 10.1242/jcs.071225; MUALLEM S, 1990, J BIOL CHEM, V265, P12806; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Ni YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086734; Novak I, 2013, FRONT PHYSIOL, V4, P1; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pena-Munzenmayer G, 2015, J BIOL CHEM, V290, P10677, DOI 10.1074/jbc.M114.612895; Peters CJ, 2015, P NATL ACAD SCI USA, V112, P3547, DOI 10.1073/pnas.1502291112; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sohma Y, 2001, JOP, V2, P198; Terashima H, 2013, P NATL ACAD SCI USA, V110, P19354, DOI 10.1073/pnas.1312014110; Thorn P, 2005, J PHYSIOL-LONDON, V563, P433, DOI 10.1113/jphysiol.2004.077230; THORN P, 1992, J GEN PHYSIOL, V100, P11, DOI 10.1085/jgp.100.1.11; Thorn P, 2004, P NATL ACAD SCI USA, V101, P6774, DOI 10.1073/pnas.0400336101; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu YW, 2014, J GEN PHYSIOL, V144, P113, DOI 10.1085/jgp.201411179; ZHANG GH, 1992, J MEMBRANE BIOL, V129, P311	32	17	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20345	20352		10.1074/jbc.M116.750224	http://dx.doi.org/10.1074/jbc.M116.750224			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27510033	hybrid, Green Published			2022-12-26	WOS:000384574800006
J	Kouwenberg, M; Jacobs, CWM; van der Vlag, J; Hilbrands, LB				Kouwenberg, M.; Jacobs, C. W. M.; van der Vlag, J.; Hilbrands, L. B.			Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; T-CELLS; IL-10 PRODUCTION; IN-VITRO; DIFFERENTIATION; ACTIVATION; EXPRESSION; LITHIUM; LIPOPOLYSACCHARIDE	Introduction Tolerogenic dendritic cells (DCs) have the potential to prolong graft survival after transplantation. Tolerogenic DCs are in general characterized by a low expression of co-stimulatory molecule and a high IL-10: IL-12 production ratio. Based on promising results with earlier used alternatively activated DCs, we aimed to generate in culture potentially tolerogenic DC by simultaneously blocking GSK3 by lithium chloride (LiCl) and stimulating TLR2 by PAM(3)CysSerLys(4). Materials and Methods Bone marrow-derived LiClPAM(3) DCs were generated by the addition of LiCl 24 hours before harvesting, and one hour later PAM(3)CysSerLys(4). The phenotype of the DCs was assessed by determining the expression of co-stimulatory molecules in flow cytometry and cytokine production in ELISA, whereas their functional properties were tested in a mixed lymphocyte reaction. A fully MHC mismatched heterotopic heart transplant preceded by infusion of donor-derived LiClPAM(3) DC was performed to assess the tolerogenic potential of LiClPAM(3) DCs in vivo. Results LiClPAM(3) DCs displayed a tolerogenic phenotype accompanied with a low expression of co-stimulatory molecules and a high IL-10:IL-12 production ratio. However, in mixed lymphocyte reaction, LiClPAM(3) DCs appeared superior in T cell stimulation, and induced Th1 and Th17 differentiation. Moreover, mice pretreated with LiClPAM(3) DC displayed a reduced graft survival. Analysis of LiClPAM(3) DC culture supernatant revealed high levels of CXCL-1, which was also found in supernatants of co-cultures of LiClPAM(3) DC and T cells. Nevertheless, we could not show a role for CXCL-1 in T cell proliferation or activation in vitro. Discussion LiClPAM(3) DCs display in vitro a tolerogenic phenotype with a high IL-10:IL-12 ratio, but appeared to be highly immunogenic, since allograft rejection was accelerated. As yet unidentified LiClPAM(3) DC-derived factors, may explain the immunogenic character of LiCl-PAM(3) DCs in vivo.	[Kouwenberg, M.; Jacobs, C. W. M.; van der Vlag, J.; Hilbrands, L. B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen	Hilbrands, LB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands.	luuk.hilbrands@radboudumc.nl	Hilbrands, Luuk/B-4921-2011; Van der Vlag, Johan/E-4636-2010; Kouwenberg, Margreet/P-8827-2015	Hilbrands, Luuk/0000-0002-4935-9765; Van der Vlag, Johan/0000-0001-7843-5918; Kouwenberg, Margreet/0000-0003-1992-920X	NWO ZonMw AGIKO Radboud PhD programm [92003567]	NWO ZonMw AGIKO Radboud PhD programm	Funding provided by NWO ZonMw AGIKO 92003567 Radboud PhD programm 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Albayrak A, 2013, INT IMMUNOPHARMACOL, V16, P35, DOI 10.1016/j.intimp.2013.03.018; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Beurel E, 2010, TRENDS IMMUNOL, V31, P24, DOI 10.1016/j.it.2009.09.007; CORRY RJ, 1973, TRANSPLANT P, V5, P733; Cortes-Vieyra R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132867; Daniel V, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0111-2; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Dieker J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0617-2; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd; Ferreira GB, 2011, DIABETES-METAB RES, V27, P933, DOI 10.1002/dmrr.1275; Fransen JH, 2009, ARTHRITIS RHEUM-US, V60, P2304, DOI 10.1002/art.24719; FREVERT CW, 1995, J IMMUNOL, V154, P335; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Guha S, 2011, BASIC RES CARDIOL, V106, P773, DOI 10.1007/s00395-011-0189-5; Hill EV, 2015, EUR J IMMUNOL, V45, P1103, DOI 10.1002/eji.201444661; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jiga LP, 2004, TRANSPLANTATION, V77, P1761, DOI 10.1097/01.TP.0000131165.37177.6E; Kalantari T, 2014, CLIN EXP IMMUNOL, V176, P180, DOI 10.1111/cei.12266; Katancik JA, 2000, CYTOKINE, V12, P1480, DOI 10.1006/cyto.2000.0742; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Leuenberger T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100871; Lu LN, 1997, TRANSPLANTATION, V64, P1808, DOI 10.1097/00007890-199712270-00031; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morelli AE, 2014, CURR OPIN ORGAN TRAN, V19, P348, DOI 10.1097/MOT.0000000000000097; Noh KJ, 2012, J NANOMATER, V2012, DOI 10.1155/2012/475430; Owen JL, 2011, CELL IMMUNOL, V270, P172, DOI 10.1016/j.cellimm.2011.05.004; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Salazar L, 2007, EUR CYTOKINE NETW, V18, P78, DOI 10.1684/ecn.2007.0089; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Slack EC, 2007, EUR J IMMUNOL, V37, P1600, DOI 10.1002/eji.200636830; Stroopinsky D, 2009, EUR J IMMUNOL, V39, P2703, DOI 10.1002/eji.200839097; Tai NW, 2011, CLIN IMMUNOL, V139, P336, DOI 10.1016/j.clim.2011.03.003; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Tsao NN, 2015, ANTIMICROB AGENTS CH, V59, P1530, DOI 10.1128/AAC.04261-14; Van Brussel I, 2014, AUTOIMMUN REV, V13, P138, DOI 10.1016/j.autrev.2013.09.008; Wang HZ, 2011, J IMMUNOL, V186, P675, DOI 10.4049/jimmunol.1001473; Wang Y, 2009, BRIT J PHARMACOL, V157, P1004, DOI 10.1111/j.1476-5381.2009.00284.x; Woltman AM, 2000, EUR J IMMUNOL, V30, P1807, DOI 10.1002/1521-4141(200007)30:7<1807::AID-IMMU1807>3.0.CO;2-N; Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x; Yung Raymond, 2007, Immun Ageing, V4, P8, DOI 10.1186/1742-4933-4-8; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	51	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159986	10.1371/journal.pone.0159986	http://dx.doi.org/10.1371/journal.pone.0159986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525971	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100010
J	Cheng, MH; Tam, CN; Choy, KW; Tsang, WH; Tsang, SL; Pang, CP; Song, YQ; Sham, MH				Cheng, Man Hei; Tam, Chung Nga; Choy, Kwong Wai; Tsang, Wai Hung; Tsang, Sze Lan; Pang, Chi Pui; Song, You Qiang; Sham, Mai Har			A gamma A-Crystallin Mouse Mutant Secc with Small Eye, Cataract and Closed Eyelid	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; LENS; MUTATIONS; AGGREGATION; GENE; MICROPHTHALMIA; ABLATION	Cataract is the most common cause of visual loss in humans. A spontaneously occurred, autosomal dominant mouse mutant Secc, which displayed combined features of small eye, cataract and closed eyelid was discovered in our laboratory. In this study, we identified the mutation and characterized the cataract phenotype of this novel Secc mutant. The Secc mutant mice have eyelids that remain half-closed throughout their life. The mutant lens has a significant reduction in size and with opaque spots clustered in the centre. Histological analysis showed that in the core region of the mutant lens, the fiber cells were disorganized and clefts and vacuoles were observed. The cataract phenotype was evident from new born stage. We identified the Secc mutation by linkage analysis using whole genome microsatellite markers and SNP markers. The Secc locus was mapped at chromosome 1 flanked by SNPs rs3158129 and rs13475900. Based on the chromosomal position, the candidate cataract locus gamma-crystallin gene cluster (Cryg) was investigated by sequencing. A single base deletion (299delG) in exon 3 of Cryga which led to a frame-shift of amino acid sequence from position 91 was identified. As a result of this mutation, the sequences of the 3rd and 4th Greek-key motifs of the gamma A-crystallin are replaced with an unrelated C-terminal peptide of 75 residues long. Coincidentally, the point mutation generated a HindIII restriction site, allowing the identification of the Cryga(Secc) mutant allele by RFLP. Western blot analysis of 3-week old lenses showed that the expression of gamma-crystallins was reduced in the Cryga(Secc) mutant. Furthermore, in cell transfection assays using Cryga(Secc) mutant cDNA expression constructs in 293T, COS-7 and human lens epithelial B3 cell lines, the mutant gamma A-crystallins were enriched in the insoluble fractions and appeared as insoluble aggregates in the transfected cells. In conclusion, we have demonstrated that the Secc mutation leads to the generation of Cryga(Secc) proteins with reduced solubility and prone to form aggregates within lens cells. Accumulation of mutant proteins in the lens fibers would lead to cataract formation in the Secc mutant.	[Cheng, Man Hei; Tam, Chung Nga; Tsang, Wai Hung; Tsang, Sze Lan; Song, You Qiang; Sham, Mai Har] Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China; [Choy, Kwong Wai] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Song, You Qiang; Sham, Mai Har] Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Sham, MH (corresponding author), Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.; Sham, MH (corresponding author), Li Ka Shing Fac Med, Ctr Reprod Dev & Growth, Pokfulam, Hong Kong, Peoples R China.	mhsham@hku.hk	Sham, Mai Har/AAX-3781-2020; Choy, Richard/AAW-8230-2020	Sham, Mai Har/0000-0003-1179-7839; Choy, Richard/0000-0002-3616-6200; Song, You-Qiang/0000-0001-9407-2256	Hong Kong Research Grant Council General Research Fund [HKU 7685/06M]	Hong Kong Research Grant Council General Research Fund(Hong Kong Research Grants Council)	Funded by Hong Kong Research Grant Council General Research Fund (HKU 7685/06M).	Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chang CK, 2016, J BIOMOLECULAR STRUC, V19, P1; Fan JG, 2005, MOL VIS, V11, P76; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Furuta Y, 1998, GENE DEV, V12, P3764, DOI 10.1101/gad.12.23.3764; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; Graw J, 1999, PROG RETIN EYE RES, V18, P235, DOI 10.1016/S1350-9462(98)00018-4; Graw JC, 2004, INVEST OPHTH VIS SCI, V45, P1202, DOI 10.1167/iovs.03-0811; Harrington V, 2007, MOL VIS, V13, P1680; Heude E, 2015, HUM MOL GENET, V24, P1670, DOI 10.1093/hmg/ddu579; Jablonski M, 2004, MOL VIS, V10, P577; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P3923, DOI 10.1167/iovs.06-1284; Klopp N, 1998, GENOMICS, V52, P152, DOI 10.1006/geno.1998.5417; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Loster J, 1997, MOL GEN GENET, V257, P97, DOI 10.1007/s004380050628; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Pande A, 2001, P NATL ACAD SCI USA, V98, P6116, DOI 10.1073/pnas.101124798; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Ponce A, 2005, MOL VIS, V11, P752; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Serebryany E, 2016, PROTEIN SCI, V25, P1115, DOI 10.1002/pro.2924; Song SH, 2008, MOL VIS, V14, P1282; Sundberg JP, 2010, VET PATHOL, V47, P1100, DOI 10.1177/0300985810374837; Tan FG, 2004, INVEST OPHTH VIS SCI, V45, P863, DOI 10.1167/iovs.03-0708; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Wang KS, 2005, MAMM GENOME, V16, P332, DOI 10.1007/s00335-004-2444-7; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Yamada R, 2003, DEVELOPMENT, V130, P1759, DOI 10.1242/dev.00399; Zhang Y, 2007, MOL VIS, V13, P2289	33	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160691	10.1371/journal.pone.0160691	http://dx.doi.org/10.1371/journal.pone.0160691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513760	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100058
J	Kammoun, M; Picard, B; Astruc, T; Gagaoua, M; Aubert, D; Bonnet, M; Blanquet, V; Cassar-Malek, I				Kammoun, Malek; Picard, Brigitte; Astruc, Thierry; Gagaoua, Mohammed; Aubert, Denise; Bonnet, Muriel; Blanquet, Veronique; Cassar-Malek, Isabelle			The Invalidation of HspB1 Gene in Mouse Alters the Ultrastructural Phenotype of Muscles	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-B-CRYSTALLIN; SKELETAL-MUSCLE; STRESS-RESPONSE; HSP22 HSPB8; EXPRESSION; EXERCISE; HEAT-SHOCK-PROTEIN-27; DYNAMICS; TISSUE	Even though abundance of Hsp27 is the highest in skeletal muscle, the relationships between the expression of HspB1 (encoding Hsp27) and muscle characteristics are not fully understood. In this study, we have analysed the effect of Hsp27 inactivation on mouse development and phenotype. We generated a mouse strain devoid of Hsp27 protein by homologous recombination of the HspB1 gene. The HspB1(-/-) mouse was viable and fertile, showing neither apparent morphological nor anatomical alterations. We detected a gender dimorphism with marked effects in males, a lower body weight (P < 0.05) with no obvious changes in the growth rate, and a lower plasma lipids profile (cholesterol, HDL and triglycerides, 0.001 < P < 0.05). The muscle structure of the animals was examined by optical microscopy and transmission electron microscopy. Not any differences in the characteristics of muscle fibres (contractile and metabolic type, shape, perimeter, cross-sectional area) were detected except a trend for a higher proportion of small fibres. Different myosin heavy chains electrophoretic profiles were observed in the HspB1(-/-) mouse especially the presence of an additional isoform. Electron microscopy revealed ultrastructural abnormalities in the myofibrillar structure of the HspB1-/- mouse mutant mice (e.g. destructured myofibrils and higher gaps between myofibrils) especially in the m. Soleus. Combined with our previous data, these findings suggest that Hsp27 could directly impact the organization of muscle cytoskeleton at the molecular and ultrastructural levels.	[Kammoun, Malek; Picard, Brigitte; Gagaoua, Mohammed; Bonnet, Muriel; Cassar-Malek, Isabelle] INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France; [Kammoun, Malek; Picard, Brigitte; Bonnet, Muriel; Cassar-Malek, Isabelle] Clermont Univ, VetAgro Sup, Herbivores UMR1213, BP 10448, F-63000 Clermont Ferrand, France; [Astruc, Thierry] INRA, Qual Prod Animaux UR0370, F-63122 St Genes Champanelle, France; [Gagaoua, Mohammed] Univ Freres Mentouri Constantine, INATAA, Equipe Maquav, Constantine, Algeria; [Aubert, Denise] Univ Lyon 1, CNRS, INRA, Ecole Normale Super Lyon,Inst Genom Fonct Lyon, F-69364 Lyon, France; [Blanquet, Veronique] INRA, Genet Mol Anim UMR1061, F-87060 Limoges, France	INRAE; VetAgro Sup; VetAgro Sup; INRAE; Universite Constantine; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); INRAE	Cassar-Malek, I (corresponding author), INRA, Herbivores UMR1213, F-63122 St Genes Champanelle, France.; Cassar-Malek, I (corresponding author), Clermont Univ, VetAgro Sup, Herbivores UMR1213, BP 10448, F-63000 Clermont Ferrand, France.	isabelle.cassar-malek@clermont.inra.fr	, Cassar-Malek/AAW-6386-2020; Gagaoua, Mohammed/HGD-3831-2022; Bonnet, Muriel/M-6265-2017; Gagaoua, Mohammed/H-3221-2016	, Cassar-Malek/0000-0001-7407-1408; Bonnet, Muriel/0000-0001-7193-3543; Gagaoua, Mohammed/0000-0001-6913-3379; Aubert, Denise/0000-0002-1442-3384	INRA Phase Division	INRA Phase Division	INRA Phase Division funded the study (http://www.phase.inra.fr/en/).	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; ARRIGO AP, 1988, MOL CELL BIOL, V8, P5059, DOI 10.1128/MCB.8.12.5059; ASHMORE CR, 1974, GROWTH, V38, P501; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DD, 2007, GENESIS, V45, P667, DOI 10.1002/dvg.20340; Chaze T, 2008, PROTEOMICS, V8, P4236, DOI 10.1002/pmic.200701101; Cobley JN, 2014, FREE RADICAL BIO MED, V70, P23, DOI 10.1016/j.freeradbiomed.2014.02.004; Crowe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077383; Dubinska-Magiera M, 2014, FEBS LETT, V588, P517, DOI 10.1016/j.febslet.2014.01.005; Eroglu B, 2014, DEV BIOL, V386, P448, DOI 10.1016/j.ydbio.2013.12.038; Folkesson M, 2013, ACTA PHYSIOL, V209, P26, DOI 10.1111/apha.12124; Fontaine JM, 2005, BIOCHEM BIOPH RES CO, V337, P1006, DOI 10.1016/j.bbrc.2005.09.148; Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Guay J, 1997, J CELL SCI, V110, P357; Hao XM, 2007, CELL STRESS CHAPERON, V12, P364, DOI 10.1379/CSC-308.1; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Huey KA, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00398; Kammoun M, 2014, EUROPEAN J HISTOCHEM, V58; Kammoun M, 2013, COMPUT STRUCT BIOTEC, V6, DOI 10.5936/csbj.201303008; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kargul J, 2012, INT J BIOCHEM CELL B, V44, P1587, DOI 10.1016/j.biocel.2012.06.022; Kim M, 2002, MOL REPROD DEV, V61, P3, DOI 10.1002/mrd.1125; Koh TJ, 2004, AM J PHYSIOL-CELL PH, V286, pC713, DOI 10.1152/ajpcell.00341.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Liu HY, 2012, J ANIM SCI, V90, P25, DOI 10.2527/jas.53724; MacKenzie TC, 2005, J GENE MED, V7, P50, DOI 10.1002/jgm.649; Magnol L, 2011, ANIMAL, V5, P663, DOI 10.1017/S1751731110002405; Meunier B, 2010, HISTOCHEM CELL BIOL, V134, P307, DOI 10.1007/s00418-010-0733-7; Miana-Mena FJ, 2002, P NATL ACAD SCI USA, V99, P3234, DOI 10.1073/pnas.052023599; Middleton RC, 2013, EXP CELL RES, V319, P860, DOI 10.1016/j.yexcr.2013.01.002; Morrow G, 2015, CELL STRESS CHAPERON, V20, P207, DOI 10.1007/s12192-014-0561-0; Morrow G, 2012, INT J BIOCHEM CELL B, V44, P1613, DOI 10.1016/j.biocel.2012.03.009; Morton JP, 2009, SPORTS MED, V39, P643, DOI 10.2165/00007256-200939080-00003; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Neufer PD, 1996, J BIOL CHEM, V271, P24089, DOI 10.1074/jbc.271.39.24089; Pappas CT, 2015, P NATL ACAD SCI USA, V112, P13573, DOI 10.1073/pnas.1508273112; Paulsen G, 2009, J APPL PHYSIOL, V107, P570, DOI 10.1152/japplphysiol.00209.2009; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Perng MD, 1999, J CELL SCI, V112, P2099; Picard B, 1998, HISTOCHEM J, V30, P473, DOI 10.1023/A:1003207922944; Picard B, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4020017; Picard B, 2011, ELECTROPHORESIS, V32, P1804, DOI 10.1002/elps.201100118; Stope MB, 2012, WORLD J UROL, V30, P327, DOI 10.1007/s00345-012-0843-z; Tucker NR, 2009, EXP CELL RES, V315, P3176, DOI 10.1016/j.yexcr.2009.06.030; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Zhang Q, 2012, MOL BIOL REP, V39, P953, DOI 10.1007/s11033-011-0821-3; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	53	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0158644	10.1371/journal.pone.0158644	http://dx.doi.org/10.1371/journal.pone.0158644			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512988	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100009
J	Soriano, JM; Villegas, D; Aranzana, MJ; del Moral, LFG; Royo, C				Miguel Soriano, Jose; Villegas, Dolors; Jose Aranzana, Maria; Garcia del Moral, Luis F.; Royo, Conxita			Genetic Structure of Modern Durum Wheat Cultivars and Mediterranean Landraces Matches with Their Agronomic Performance	PLOS ONE			English	Article							POPULATION-STRUCTURE; LINKAGE DISEQUILIBRIUM; GLUTEN STRENGTH; YIELD FORMATION; DIVERSITY; MARKERS; ADAPTATION; COMPONENTS; DISPERSAL; VARIETIES	A collection of 172 durum wheat landraces from 21 Mediterranean countries and 20 modern cultivars were phenotyped in 6 environments for 14 traits including phenology, biomass, yield and yield components. The genetic structure of the collection was ascertained with 44 simple sequence repeat markers that identified 448 alleles, 226 of them with a frequency lower than 5%, and 10 alleles per locus on average. In the modern cultivars all the alleles were fixed in 59% of the markers. Total genetic diversity was H-T = 0.7080 and the genetic differentiation value was G(ST) = 0.1730. STRUCTURE software allocated 90.1% of the accessions in five subpopulations, one including all modern cultivars, and the four containing landrace related to their geographic origin: eastern Mediterranean, eastern Balkans and Turkey, western Balkans and Egypt, and western Mediterranean. Mean yield of subpopulations ranged from 2.6 t ha(-1) for the western Balkan and Egyptian landraces to 4.0 t ha(-1) for modern cultivars, with the remaining three subpopulations showing similar values of 3.1 t ha(-1). Modern cultivars had the highest number of grains m-2 and harvest index, and the shortest cycle length. The diversity was lowest in modern cultivars (H-T = 0.4835) and highest in landraces from the western Balkans and Egypt (H-T = 0.6979). Genetic diversity and AMOVA indicated that variability between subpopulations was much lower (17%) than variability within them (83%), though all subpopulations had similar biomass values in all growth stages. A dendrogram based on simple sequence repeat data matched with the clusters obtained by STRUCTURE, improving this classification for some accessions that have a large admixture. landraces included in the subpopulation from the eastern Balkans and Turkey were separated into two branches in the dendrogram drawn with phenotypic data, suggesting a different origin for the landraces collected in Serbia and Macedonia. The current study shows a reliable relationship between genetic and phenotypic population structures, and the connection of both with the geographic origin of the landraces.	[Miguel Soriano, Jose; Villegas, Dolors; Royo, Conxita] Inst Recerca & Tecnol Agroalimentaries, Field Crops Programme, Lleida, Spain; [Jose Aranzana, Maria] Ctr Recerca Agrigen, Plant & Anim Genom Programme, Barcelona, Spain; [Garcia del Moral, Luis F.] Univ Granada, Inst Biotechnol, Dept Plant Physiol, Granada, Spain	IRTA; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Granada	Soriano, JM (corresponding author), Inst Recerca & Tecnol Agroalimentaries, Field Crops Programme, Lleida, Spain.	josemiguel.soriano@irta.cat	Villegas, Dolors/I-7205-2013; Soriano Soriano, Jose Miguel/E-7894-2018; Royo, Conxita/J-3362-2017; Aranzana, Maria Jose/H-7799-2015	Villegas, Dolors/0000-0003-2961-6346; Soriano Soriano, Jose Miguel/0000-0003-1965-6504; Royo, Conxita/0000-0001-7939-1451; Aranzana, Maria Jose/0000-0002-0240-8021	Ministerio de Economia y competitividad [AGL-2006-09226-C02-01]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria	Ministerio de Economia y competitividad(Spanish Government); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria(Instituto de Investigacion Agropecuaria (INIA))	The research was funded by the Ministerio de Economia y competitividad project AGL-2006-09226-C02-01, and Dr. Jose Miguel Soriano is funded by Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (http://www.mineco.gob.es/).	Achtar S, 2010, RUSS J GENET+, V46, P1320, DOI 10.1134/S1022795410110074; Al Khanjari S, 2007, GENET RESOUR CROP EV, V54, P1291, DOI 10.1007/s10722-006-9110-8; Annicchiarico P, 2009, PLANT BREEDING, V128, P164, DOI 10.1111/j.1439-0523.2008.01557.x; ANNICCHIARICO P, 1995, HEREDITAS, V122, P163, DOI 10.1111/j.1601-5223.1995.00163.x; Borner A, 1997, THEOR APPL GENET, V95, P1133, DOI 10.1007/s001220050673; CARRILLO JM, 1990, PLANT BREEDING, V104, P325, DOI 10.1111/j.1439-0523.1990.tb00443.x; CHEN HB, 1994, CROP SCI, V34, P1628, DOI 10.2135/cropsci1994.0011183X003400060037x; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; COLLAKU A, 1994, PLANT BREEDING, V112, P40, DOI 10.1111/j.1439-0523.1994.tb01274.x; Culley TM, 2002, AM J BOT, V89, P460, DOI 10.3732/ajb.89.3.460; Dedkova OS, 2009, RUSS J GENET+, V45, P1082, DOI 10.1134/S1022795409090099; Doyle J. J., 1987, PHYTOCHEM B, P11; Eujayl I, 2002, THEOR APPL GENET, V104, P399, DOI 10.1007/s001220100738; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feldman M., 2001, WORLD WHEAT BOOK HIS, P3; Fufa H, 2005, EUPHYTICA, V145, P133, DOI 10.1007/s10681-005-0626-3; Garcia del Moral LF, 2003, AGRON J, V95, P266, DOI 10.2134/agronj2003.0266; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Khan MK, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv083; KYZERIDIS N, 1995, J AGRON CROP SCI, V174, P133, DOI 10.1111/j.1439-037X.1995.tb00204.x; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Landjeva S, 2006, GENET RESOUR CROP EV, V53, P1605, DOI 10.1007/s10722-005-8718-4; Le Couviour F, 2011, THEOR APPL GENET, V123, P715, DOI 10.1007/s00122-011-1621-9; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Mac Key J., 2005, DURUM WHEAT BREEDING, VVolume 1, P3; Maccaferri M, 2008, THEOR APPL GENET, V117, P1225, DOI 10.1007/s00122-008-0857-5; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2003, THEOR APPL GENET, V107, P783, DOI 10.1007/s00122-003-1319-8; Maccaferri Marco, 2006, Plant Genetic Resources Characterization and Utilization, V4, P79, DOI 10.1079/PGR2006117; Mantovani P, 2008, MOL BREEDING, V22, P629, DOI 10.1007/s11032-008-9205-3; Melnikova NV, 2010, GENET RESOUR CROP EV, V57, P587, DOI 10.1007/s10722-009-9497-0; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Moragues M, 2006, FIELD CROP RES, V95, P194, DOI 10.1016/j.fcr.2005.02.009; Moragues M, 2007, GENET RESOUR CROP EV, V54, P1133, DOI 10.1007/s10722-006-9005-8; Nazco R, 2014, J AGR SCI-CAMBRIDGE, V152, P379, DOI 10.1017/S0021859613000117; Nazco R, 2014, GENET RESOUR CROP EV, V61, P1219, DOI 10.1007/s10722-014-0104-7; Nazco R, 2012, EUPHYTICA, V185, P1, DOI 10.1007/s10681-011-0588-6; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pritchard JK, 2000, GENETICS, V155, P945; RASCIO A, 1992, PLANT PHYSIOL, V98, P908, DOI 10.1104/pp.98.3.908; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Royo C, 2008, AGRON J, V100, P352, DOI 10.2134/agronj2007.0060; Royo C, 2006, CEREAL RES COMMUN, V34, P1021, DOI 10.1556/CRC.34.2006.2-3.233; Royo C, 2014, GENET RESOUR CROP EV, V61, P1345, DOI 10.1007/s10722-014-0116-3; Royo C, 2010, FIELD CROP RES, V119, P91, DOI 10.1016/j.fcr.2010.06.020; Ruiz M, 2012, CROP SCI, V52, P2262, DOI 10.2135/cropsci2012.02.0081; Sahri A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0264-2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Talas F, 2011, PLANT BREEDING, V130, P398, DOI 10.1111/j.1439-0523.2011.01867.x; Teklu Y, 2006, GENET RESOUR CROP EV, V53, P1115, DOI 10.1007/s10722-005-1146-7; Villegas D, 2001, ANN BOT-LONDON, V88, P617, DOI 10.1006/anbo.2001.1512; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang DD, 2010, PLANT GENOME-US, V3, P117, DOI 10.3835/plantgenome2010.03.0004	60	62	63	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160983	10.1371/journal.pone.0160983	http://dx.doi.org/10.1371/journal.pone.0160983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513751	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100103
J	Nagai, T; Doi, S; Nakashima, A; Irifuku, T; Sasaki, K; Ueno, T; Masaki, T				Nagai, Takuo; Doi, Shigehiro; Nakashima, Ayumu; Irifuku, Taisuke; Sasaki, Kensuke; Ueno, Toshinori; Masaki, Takao			Linagliptin Ameliorates MethylglyoxalInduced Peritoneal Fibrosis in Mice	PLOS ONE			English	Article							GLUCOSE DEGRADATION-PRODUCT; TO-MESENCHYMAL TRANSITION; GLYCATION END-PRODUCTS; MESOTHELIAL CELLS; GLYOXALASE SYSTEM; DIALYSIS PATIENTS; DPP-4 INHIBITION; RENAL INJURY; RAT MODEL; MEMBRANE	Recent studies have reported increases of methylglyoxal (MGO) in peritoneal dialysis patients, and that MGO-mediated inflammation plays an important role in the development of peritoneal fibrosis through production of transforming growth factor-beta 1 (TGF-beta 1). Linagliptin, a dipeptidyl peptidase-4 inhibitor, exerts anti-inflammatory effects independent of blood glucose levels. In this study, we examined whether linagliptin suppresses MGO-induced peritoneal fibrosis in mice. Male C57/BL6 mice were divided into three groups: control, MGO injection plus saline, and MGO injection plus linagliptin (n = 6 per group). Peritoneal fibrosis was induced by daily intraperitoneal injection of saline containing 40 mmol/L MGO for 21 days. Saline was administered intraperitoneally to the control group. Linagliptin (10 mg/kg) or saline were administrated by once-daily oral gavage from 3 weeks before starting MGO injections. Immunohistochemical staining revealed that linagliptin suppressed expression of a-smooth muscle actin and fibroblast-specific protein-1, deposition of type I and III collagen, and macrophage (F4/80) infiltration. Peritoneal equilibration testing showed improved peritoneal functions in mice treated with linagliptin. Peritoneal injection of MGO increased plasma levels of glucagon-like peptide-1 (GLP-1) in mice, and a further increase was observed in linagliptin-treated mice. Although MGO increased plasma glucose levels, linagliptin did not decrease plasma glucose levels. Moreover, linagliptin reduced the TGF-beta 1 concentration in the peritoneal fluid of MGO-treated mice. GLP-1 receptor (GLP-1R) was expressed in monocytes/macrophages and linagliptin suppressed GLP-1R expression in MGO-injected mice. These results suggest that oral administration of linagliptin ameliorates MGO-induced peritoneal fibrosis.	[Nagai, Takuo; Doi, Shigehiro; Nakashima, Ayumu; Irifuku, Taisuke; Sasaki, Kensuke; Ueno, Toshinori; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan	Hiroshima University	Doi, S (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	sdoi@hiroshima-u.ac.jp	Doi, Shigehiro/AAQ-2655-2020; Nakashima, Ayumu/N-9158-2017; Nakashima, Ayumu/CAF-0274-2022	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; SASAKI, KENSUKE/0000-0001-5899-0885	Ryokufukai; Japanese Association of Dialysis Physicians	Ryokufukai; Japanese Association of Dialysis Physicians	This work was supported by a grant from Ryokufukai and the Japanese Association of Dialysis Physicians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou S, 2003, BIOCHEM SOC T, V31, P1394; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Chaykovska L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027861; DOBBIE JW, 1989, BLOOD PURIFICAT, V7, P74, DOI 10.1159/000169580; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; GANDHI VC, 1980, ARCH INTERN MED, V140, P1201, DOI 10.1001/archinte.140.9.1201; Ha H, 2001, KIDNEY INT, V59, P463, DOI 10.1046/j.1523-1755.2001.059002463.x; Hirahara I, 2009, NEPHROL DIAL TRANSPL, V24, P437, DOI 10.1093/ndt/gfn495; Honda K, 1999, NEPHROL DIAL TRANSPL, V14, P1541, DOI 10.1093/ndt/14.6.1541; Inagi R, 1999, FEBS LETT, V463, P260, DOI 10.1016/S0014-5793(99)01642-7; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kang DH, 1999, PERITON DIALYSIS INT, V19, P221; Katagiri D, 2013, J AM SOC NEPHROL, V24, P2034, DOI 10.1681/ASN.2013020134; Kitamura M, 2012, CHEM-BIOL INTERACT, V195, P95, DOI 10.1016/j.cbi.2011.11.002; Klein T, 2014, MED MOL MORPHOL, V47, P137, DOI 10.1007/s00795-013-0053-9; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Kodera R, 2014, BIOCHEM BIOPH RES CO, V443, P828, DOI 10.1016/j.bbrc.2013.12.049; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; Lenski M, 2011, J MOL CELL CARDIOL, V51, P906, DOI 10.1016/j.yjmcc.2011.08.001; Linden T, 2002, KIDNEY INT, V62, P697, DOI 10.1046/j.1523-1755.2002.00490.x; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Maessen DEM, 2015, CLIN SCI, V128, P839, DOI 10.1042/CS20140683; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; MCLELLAN AC, 1994, CLIN SCI, V87, P21, DOI 10.1042/cs0870021; Nakamoto Hidetomo, 2002, Adv Perit Dial, V18, P119; Rabbani N, 2012, AMINO ACIDS, V42, P1133, DOI 10.1007/s00726-010-0783-0; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Takahashi S, 2009, NEPHRON EXP NEPHROL, V112, pE59, DOI 10.1159/000213896; Terasaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070933; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; THROCKMORTON DC, 1995, KIDNEY INT, V48, P111, DOI 10.1038/ki.1995.274; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Yang AH, 2003, KIDNEY INT, V63, P1530, DOI 10.1046/j.1523-1755.2003.00861.x	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160993	10.1371/journal.pone.0160993	http://dx.doi.org/10.1371/journal.pone.0160993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513960	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100106
J	Perez-Lara, E; Semagn, K; Chen, H; Iqbal, M; N'Diaye, A; Kamran, A; Navabi, A; Pozniak, C; Spaner, D				Perez-Lara, Enid; Semagn, Kassa; Chen, Hua; Iqbal, Muhammad; N'Diaye, Amidou; Kamran, Atif; Navabi, Alireza; Pozniak, Curtis; Spaner, Dean			QTLs Associated with Agronomic Traits in the Cutler x AC Barrie Spring Wheat Mapping Population Using Single Nucleotide Polymorphic Markers	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; ARRAYS TECHNOLOGY DART; MOLECULAR MARKERS; GENETIC-ANALYSIS; DWARFING GENES; RESISTANCE; VERNALIZATION; YIELD; IMPROVEMENT; SELECTION	We recently reported three earliness per se quantitative trait loci (QTL) associated with flowering and maturity in a recombinant inbred lines (RILs) population derived from a cross between the spring wheat (Triticum aestivum L.) cultivars 'Cutler' and 'AC Barrie' using 488 microsatellite and diversity arrays technology (DArT) markers. Here, we present QTLs associated with flowering time, maturity, plant height, and grain yield using high density single nucleotide polymorphic (SNP) markers in the same population. A mapping population of 158 RILs and the two parents were evaluated at five environments for flowering, maturity, plant height and grain yield under field conditions, at two greenhouse environments for flowering, and genotyped with a subset of 1809 SNPs out of the 90K SNP array and 2 functional markers (Ppd-D1 and Rht-D1). Using composite interval mapping on the combined phenotype data across all environments, we identified a total of 19 QTLs associated with flowering time in greenhouse (5), and field (6) conditions, maturity (5), grain yield (2) and plant height (1). We mapped these QTLs on 8 chromosomes and they individually explained between 6.3 and 37.8% of the phenotypic variation. Four of the 19 QTLs were associated with multiple traits, including a QTL on 2D associated with flowering, maturity and grain yield; two QTLs on 4A and 7A associated with flowering and maturity, and another QTL on 4D associated with maturity and plant height. However, only the QTLs on both 2D and 4D had major effects, and they mapped adjacent to well-known photoperiod response Ppd-D1 and height reducing Rht-D1 genes, respectively. The QTL on 2D reduced flowering and maturity time up to 5 days with a yield penalty of 436 kg ha(-1), while the QTL on 4D reduced plant height by 13 cm, but increased maturity by 2 days. The high density SNPs allowed us to map eight moderate effect, two major effect, and nine minor effect QTLs that were not identified in our previous study using microsatellite and DArT markers. Results from this study provide additional information to wheat researchers developing early maturing and short stature spring wheat cultivars.	[Perez-Lara, Enid; Semagn, Kassa; Chen, Hua; Iqbal, Muhammad; Spaner, Dean] Univ Alberta, Agr Forestry Ctr 4 10, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [N'Diaye, Amidou; Pozniak, Curtis] Univ Saskatchewan, Ctr Crop Dev, 51 Campus Dr, Saskatoon, SK S7N 5A8, Canada; [N'Diaye, Amidou; Pozniak, Curtis] Univ Saskatchewan, Dept Plant Sci, 51 Campus Dr, Saskatoon, SK S7N 5A8, Canada; [Kamran, Atif] Univ Punjab, Dept Bot, Seed Ctr, New Campus, Lahore 54590, Pakistan; [Navabi, Alireza] Univ Guelph, Dept Plant Agr, Crop Sci Bldg, Guelph, ON N1G 2W1, Canada; [Iqbal, Muhammad] Natl Agr Res Ctr, Natl Inst Genom & Adv Biotechnol, Pk Rd, Islamabad 45500, Pakistan	University of Alberta; University of Saskatchewan; University of Saskatchewan; University of Punjab; University of Guelph; National Agricultural Research Council - Pakistan	Spaner, D (corresponding author), Univ Alberta, Agr Forestry Ctr 4 10, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	dspaner@ualberta.ca	Semagn, Kassa/S-8858-2017	Semagn, Kassa/0000-0001-6486-5685; Perez-Lara, Enid/0000-0002-9672-0226; N'Diaye, Amidou/0000-0001-7769-7801; Iqbal, Muhammad/0000-0002-7519-6023; Spaner, Dean/0000-0002-2088-5104	University of Alberta wheat breeding program from the Alberta Crop Industry Development Fund; Alberta Wheat Commission; Agriculture and Agri-Food Canada; NSERC Collaborative Grant; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Genome Canada; Genome Prairie; Genome Alberta; Alberta Innovates; Canadian Wheat Board fellowship (CWB); Chinese Government Scholarship; Pakistani Government Fellowships; Western Grains Research Foundation Endowment Fund; Core Program check-off funds	University of Alberta wheat breeding program from the Alberta Crop Industry Development Fund; Alberta Wheat Commission; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); NSERC Collaborative Grant; Saskatchewan Ministry of Agriculture; Western Grains Research Foundation; Genome Canada(Genome Canada); Genome Prairie; Genome Alberta; Alberta Innovates; Canadian Wheat Board fellowship (CWB); Chinese Government Scholarship; Pakistani Government Fellowships; Western Grains Research Foundation Endowment Fund; Core Program check-off funds	This research was supported by grants to the University of Alberta wheat breeding program from the Alberta Crop Industry Development Fund, Alberta Wheat Commission, Agriculture and Agri-Food Canada, Western Grains Research Foundation Endowment Fund and Core Program check-off funds, and an NSERC Collaborative Grant to DS. This work was conducted in part within the project "Canadian Triticum Advancement Through Genomics (CTAG)." The authors would like to acknowledge CTAG funding provided by the Saskatchewan Ministry of Agriculture, Western Grains Research Foundation, Agriculture and Agri-Food Canada, Genome Canada, Genome Prairie, Genome Alberta and Alberta Innovates. The study was also supported by a Canadian Wheat Board fellowship (CWB) to the sixth (AK), and a Chinese Government Scholarship to the third (HC) author, and Pakistani Government Fellowships to the fourth (MI) and sixth (AK) authors.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Asif M, 2015, CROP SCI, V55, P1129, DOI 10.2135/cropsci2014.01.0080; Babu RC, 2003, CROP SCI, V43, P1457, DOI 10.2135/cropsci2003.1457; Bai CH, 2013, J EXP BOT, V64, P1745, DOI 10.1093/jxb/ert041; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Boopathi NM, 2013, RICE SCI, V20, P25, DOI 10.1016/S1672-6308(13)60104-3; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chee PW, 2001, CROP SCI, V41, P295, DOI 10.2135/cropsci2001.412295x; Chen F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-199; Chen H, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0373-7; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dubcovsky J, 1998, THEOR APPL GENET, V97, P968, DOI 10.1007/s001220050978; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evans L., 1998, FEEDING 10 BILLION P; GALIBA G, 1995, THEOR APPL GENET, V90, P1174, DOI 10.1007/BF00222940; Ginot F, 1996, NUCLEIC ACIDS RES, V24, P540, DOI 10.1093/nar/24.3.540; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Gupta Pushpendra Kumar, 2007, Journal of Zhejiang University-Science B, V8, P807, DOI 10.1631/jzus.2007.B0807; HALEY CS, 1997, GENOME MAPPING PRACT, P49; HU GX, 1993, DNA CELL BIOL, V12, P763, DOI 10.1089/dna.1993.12.763; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Iqbal M, 2006, CAN J PLANT SCI, V86, P995, DOI 10.4141/P06-002; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kamran A, 2013, THEOR APPL GENET, V126, P1965, DOI 10.1007/s00122-013-2110-0; Kolb FL, 2001, CROP SCI, V41, P611, DOI 10.2135/cropsci2001.413611x; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; LAW CN, 1978, HEREDITY, V41, P185, DOI 10.1038/hdy.1978.87; Law CN, 1997, NEW PHYTOL, V137, P19, DOI 10.1046/j.1469-8137.1997.00814.x; Lorieux M, 2012, MOL BREEDING, V30, P1231, DOI 10.1007/s11032-012-9706-y; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCaig TN, 1996, CAN J PLANT SCI, V76, P337, DOI 10.4141/cjps96-059; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Preston JC, 2008, PLANT PHYSIOL, V146, P265, DOI 10.1104/pp.107.109561; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Randhawa HS, 2013, PLANT BREEDING, V132, P458, DOI 10.1111/pbr.12057; SCARTH R, 1983, HEREDITY, V51, P607, DOI 10.1038/hdy.1983.73; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Semagn K, 2007, CROP SCI, V47, P294, DOI 10.2135/cropsci2006.02.0095; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Semagn K, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue5-fulltext-14; Tanio M, 2007, BREEDING SCI, V57, P65, DOI 10.1270/jsbbs.57.65; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; UTZ HF, 2003, PLABQTL COMPUTER PRO; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wilhelm EP, 2009, THEOR APPL GENET, V118, P285, DOI 10.1007/s00122-008-0898-9; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yu M, 2014, J INTEGR AGR, V13, P1835, DOI 10.1016/S2095-3119(13)60655-3; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zych K, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0475-6	68	32	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160623	10.1371/journal.pone.0160623	http://dx.doi.org/10.1371/journal.pone.0160623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513976	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100052
J	Qirjazi, E; McArthur, E; Nash, DM; Dixon, SN; Weir, MA; Vasudev, A; Jandoc, R; Gula, LJ; Oliver, MJ; Wald, R; Garg, AX				Qirjazi, Elena; McArthur, Eric; Nash, Danielle M.; Dixon, Stephanie N.; Weir, Matthew A.; Vasudev, Akshya; Jandoc, Racquel; Gula, Lorne J.; Oliver, Matthew J.; Wald, Ron; Garg, Amit X.			Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; QT INTERVAL PROLONGATION; ANTIDEPRESSANT USE; CARDIAC-ARREST; SAFETY; CLARITHROMYCIN; SELECTION; OUTCOMES; TORSADE; MODELS	Background The risk of ventricular arrhythmia with citalopram and escitalopram is controversial. In this study we investigated the association between these two drugs and the risk of ventricular arrhythmia. Methods We conducted a population-based retrospective cohort study of older adults (mean age 76 years) from 2002 to 2012 in Ontario, Canada, newly prescribed citalopram (n = 137 701) or escitalopram (n = 38 436), compared to those prescribed referent antidepressants sertraline or paroxetine (n = 96 620). After inverse probability of treatment weighting using a propensity score, the baseline characteristics of the comparison groups were similar. The primary outcome was a hospital encounter with ventricular arrhythmia within 90 days of a new prescription, assessed using hospital diagnostic codes. The secondary outcome was all-cause mortality within 90 days. Results Citalopram was associated with a higher risk of a hospital encounter with ventricular arrhythmia compared with referent antidepressants (0.06% vs. 0.04%, relative risk [RR] 1.53, 95% confidence intervals [CI] 1.03 to 2.29), and a higher risk of mortality (3.49% vs. 3.12%, RR 1.12, 95% CI 1.06 to 1.18). Escitalopram was not associated with a higher risk of ventricular arrhythmia compared with the referent antidepressants (0.03% vs. 0.04%, RR 0.84, 95% CI 0.42 to 1.68), but was associated with a higher risk of mortality (2.86% vs. 2.63%, RR 1.09, 95% CI 1.01 to 1.18). Conclusion Among older adults, initiation of citalopram compared to two referent antidepressants was associated with a small but statistically significant increase in the 90-day risk of a hospital encounter for ventricular arrhythmia.	[Qirjazi, Elena; Weir, Matthew A.; Garg, Amit X.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [McArthur, Eric; Nash, Danielle M.; Dixon, Stephanie N.; Jandoc, Racquel; Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Dixon, Stephanie N.; Weir, Matthew A.; Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Vasudev, Akshya] Univ Western Ontario, Div Geriatr Psychiat, Dept Psychiat, London, ON, Canada; [Vasudev, Akshya] Univ Western Ontario, Div Clin Pharmacol, Dept Med, London, ON, Canada; [Oliver, Matthew J.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; [Wald, Ron] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Wald, Ron] Univ Toronto, Div Nephrol, Dept Med, Toronto, ON, Canada	Western University (University of Western Ontario); University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Garg, AX (corresponding author), Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada.; Garg, AX (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Garg, AX (corresponding author), Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada.	amit.garg@lhsc.on.ca	Gula, Lorne/G-3298-2011; Weir, Matthew/G-3354-2011; Garg, Amit X/G-3295-2011		annual grant from Ontario Ministry of Health and Long-Term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry at Western University; Lawson Health Research Institute; Dr. Adam Linton Chair in Kidney Health Analytics; Lilibeth Caberto Kidney Clinical Research Unit	annual grant from Ontario Ministry of Health and Long-Term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario; Schulich School of Medicine and Dentistry at Western University; Lawson Health Research Institute; Dr. Adam Linton Chair in Kidney Health Analytics; Lilibeth Caberto Kidney Clinical Research Unit	The Institute for Clinical Evaluative Sciences (ICES) is a non-profit research corporation funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of the material in the current report are based on data and information compiled and provided by the Canadian Institute of Health Information (CIHI). The research was conducted at the ICES Western facility, which receives financial support from the Academic Medical Organization of Southwestern Ontario, the Schulich School of Medicine and Dentistry at Western University and the Lawson Health Research Institute. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, the Ontario MOHLTC or CIHI is intended or should be inferred. Dr. Amit Garg was supported by the Dr. Adam Linton Chair in Kidney Health Analytics. Research personnel who worked on this project were supported by the Lilibeth Caberto Kidney Clinical Research Unit.	ALGRA A, 1991, CIRCULATION, V83, P1888, DOI 10.1161/01.CIR.83.6.1888; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; BOYER WF, 1992, J CLIN PSYCHIAT, V53, P61; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Canada Health, 2012, ANT CIPR ESC UPD INF; Canada Health, 2012, CEL CIT ASS ABN HEAR; Castro VM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f288; Czaja AS, 2013, PHARMACOEPIDEM DR S, V22, P607, DOI 10.1002/pds.3420; De Bruin ML, 2005, J CLIN EPIDEMIOL, V58, P1325, DOI 10.1016/j.jclinepi.2005.04.009; de Gregorio C, 2011, INT J CARDIOL, V148, P226, DOI 10.1016/j.ijcard.2009.05.060; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; EDWARDS JG, 1989, PSYCHOPHARMACOLOGY, V97, P96, DOI 10.1007/BF00443420; Fleet JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-81; Food US and Administration Drug, 2011, FDA DRUG SAF COMM AB; Food US and Administration Drug, 2012, FDA DRUG SAF COMM RE; Friberg LE, 2006, BRIT J CLIN PHARMACO, V61, P177, DOI 10.1111/j.1365-2125.2005.02546.x; Funk KA, 2013, ANN PHARMACOTHER, V47, P1330, DOI 10.1177/1060028013501994; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Hennessy S, 2010, PHARMACOEPIDEM DR S, V19, P555, DOI 10.1002/pds.1869; Howland RH, 2011, J PSYCHOSOC NURS MEN, V49, P13, DOI 10.3928/02793695-20111011-01; IMS Institute for Health Informatics, US MED US REV 2011; Isbister GK, 2006, INTENS CARE MED, V32, P1060, DOI 10.1007/s00134-006-0183-9; Jain AK, 2012, KIDNEY INT, V81, P1248, DOI 10.1038/ki.2012.18; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Joffe MM, 2004, AM STAT, V58, P272, DOI 10.1198/000313004X5824; KUHS H, 1990, PSYCHOPHARMACOLOGY, V102, P379, DOI 10.1007/BF02244107; Lam RW, 2013, J PSYCHIATR NEUROSCI, V38, pE5, DOI 10.1503/jpn.120256; Leonard CE, 2011, PHARMACOEPIDEM DR S, V20, P903, DOI 10.1002/pds.2181; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Li DQ, 2015, CAN MED ASSOC J, V187, P174, DOI 10.1503/cmaj.140950; Mamdani MM, 2000, AM J PSYCHIAT, V157, P360, DOI 10.1176/appi.ajp.157.3.360; Marcum ZA, 2012, AM J GERIATR PHARMAC, V10, P264, DOI 10.1016/j.amjopharm.2012.05.002; Newman SC, 2008, CAN J PSYCHIAT, V53, P704, DOI 10.1177/070674370805301011; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Patel NH, 2013, AM J THER, V20, pE720, DOI 10.1097/MJT.0b013e3182192d6e; Petersen T, 2002, PROG NEURO-PSYCHOPH, V26, P177, DOI 10.1016/S0278-5846(01)00250-0; Quan H, 2008, HEALTH SERV RES, V43, P1424, DOI 10.1111/j.1475-6773.2007.00822.x; Sala Michela, 2009, Ther Adv Cardiovasc Dis, V3, P29, DOI 10.1177/1753944708096282; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Tamariz L, 2012, PHARMACOEPIDEM DR S, V21, P148, DOI 10.1002/pds.2340; Tseng PT, 2012, GEN HOSP PSYCHIAT, V34, pe13; Uchida M, 2015, J DEV BEHAV PEDIATR, V36, P434, DOI 10.1097/DBP.0000000000000188; van Haelst IMM, 2014, J CLIN PSYCHIAT, V75, P15, DOI 10.4088/JCP.13m08397; Vieweg WVR, 2012, AM J MED, V125, P859, DOI 10.1016/j.amjmed.2011.12.002; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Weir MA, 2011, ARCH INTERN MED, V171, P703, DOI 10.1001/archinternmed.2011.103; Wenzel-Seifert K, 2011, DTSCH ARZTEBL INT, V108, P687, DOI 10.3238/arztebl.2011.0687; Zhang YY, 2011, ARCH INTERN MED, V171, P1727, DOI 10.1001/archinternmed.2011.433; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]; Zivin K, 2013, AM J PSYCHIAT, V170, P642, DOI 10.1176/appi.ajp.2013.12030408	53	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160768	10.1371/journal.pone.0160768	http://dx.doi.org/10.1371/journal.pone.0160768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513855	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100068
J	Silva, WD; Millar, JG; Hanks, LM; Bento, JMS				Silva, Weliton D.; Millar, Jocelyn G.; Hanks, Lawrence M.; Bento, Jose Mauricio S.			10-Methyldodecanal, a Novel Attractant Pheromone Produced by Males of the South American Cerambycid Beetle Eburodacrys vittata	PLOS ONE			English	Article							AGGREGATION PHEROMONES; SEX-PHEROMONE; IDENTIFICATION; PHENOLOGY	We report the identification, synthesis, and field bioassay of a novel attractant pheromone produced by males of Eburodacrys vittata (Blanchard), a South American cerambycid beetle in the subfamily Cerambycinae. Headspace volatiles from males contained a sex-specific compound, identified as 10-methyldodecanal. In a field bioassay conducted in Brazil, significant numbers of males and females were caught in traps baited with synthesized racemic 10-methyldodecanal, consistent with the aggregation-sex pheromones produced by males of many cerambycine species. This compound represents a new structural class of cerambycid pheromones, and it is the first pheromone identified for a species in the tribe Eburiini.	[Silva, Weliton D.; Bento, Jose Mauricio S.] Univ Sao Paulo, Dept Entomol & Acarol, Sao Paulo, Brazil; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Millar, Jocelyn G.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Hanks, Lawrence M.] Univ Illinois, Dept Entomol, Urbana, IL USA	Universidade de Sao Paulo; University of California System; University of California Riverside; University of California System; University of California Riverside; University of Illinois System; University of Illinois Urbana-Champaign	Silva, WD (corresponding author), Univ Sao Paulo, Dept Entomol & Acarol, Sao Paulo, Brazil.	wdsilv@gmail.com	Silva, Weliton D./N-9410-2019; Bento, José Maurício Simões/A-9759-2008; Silva, Weliton D/J-5080-2015	Silva, Weliton D./0000-0001-9035-204X; Bento, José Maurício Simões/0000-0001-8655-5178; Silva, Weliton D/0000-0001-9035-204X; Millar, Jocelyn/0000-0001-7639-9001	United States Department of Agriculture, Animal Plant Health Inspection Service, Plant Protection and Quarantine grant [14-8130-1422-CA, 15-8130-1422-CA]; Instituto Nacional de Ciencia e Tecnologia de Semioquimicos na Agricultura [2008/57701-2, 573761/2008-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/26936-2]; Alphawood Foundation of Chicago; National Science Foundation [CHE-0320922]; National Institutes of Health [S10RR023677]	United States Department of Agriculture, Animal Plant Health Inspection Service, Plant Protection and Quarantine grant; Instituto Nacional de Ciencia e Tecnologia de Semioquimicos na Agricultura; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Alphawood Foundation of Chicago; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by United States Department of Agriculture, Animal Plant Health Inspection Service, Plant Protection and Quarantine (www.aphis.usda.gov) grant numbers 14-8130-1422-CA and 15-8130-1422-CA (to JGM and LMH), Instituto Nacional de Ciencia e Tecnologia de Semioquimicos na Agricultura (http://inct.cnpq.br) grant numbers 2008/57701-2 and 573761/2008-6 (to JMSB), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) grant number 2013/26936-2 (to WDS), and Alphawood Foundation of Chicago (www.alphawoodfoundation.org) (to LMH). The Bruker Avance 600 MHz NMR spectrometer was obtained with National Science Foundation (www.nsf.gov) grant number CHE-0320922 and National Institutes of Health (www.nih.gov/) grant number S10RR023677 to UC Riverside. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berti Filho E., 1997, SCI FOR, V52, P51; Botero JP, 2015, EUR J TAXON, V148, P1, DOI 10.5852/ejt.2015.148; Carde RT, 2014, J CHEM ECOL, V40, P519, DOI 10.1007/s10886-014-0465-6; Costa C, 2000, MONGR TERC MILENIO, V1, P99; Costa Lima A., 1955, INSETOS BRASIL; Fonseca MG, 2010, J CHEM ECOL, V36, P1132, DOI 10.1007/s10886-010-9850-y; GOODLAND R, 1971, J ECOL, V59, P411, DOI 10.2307/2258321; Graham EE, 2012, J ECON ENTOMOL, V105, P837, DOI 10.1603/EC12053; Graham EE, 2010, J ECON ENTOMOL, V103, P641, DOI 10.1603/EC10013; Hanks LM, 2007, J CHEM ECOL, V33, P889, DOI 10.1007/s10886-007-9275-4; Hanks LM, 2014, ANN ENTOMOL SOC AM, V107, P211, DOI 10.1603/AN13067; Hanks LM, 2013, CHEMOECOLOGY, V23, P21, DOI 10.1007/s00049-012-0116-8; Hanks LM, 2016, SEMIOCHEMIC IN PRESS; Millar JG, 2016, CERAMBYCIDA IN PRESS; Mitchell RF, 2015, J CHEM ECOL, V41, P431, DOI 10.1007/s10886-015-0571-0; Mitchell RF, 2013, CHEMOECOLOGY, V23, P121, DOI 10.1007/s00049-012-0122-x; Mitchell RF, 2011, ENTOMOL EXP APPL, V141, P71, DOI 10.1111/j.1570-7458.2011.01167.x; Monne MA, 2005, ZOOTAXA, P1, DOI 10.11646/zootaxa.946.1.1; Ray AM, 2015, J ECON ENTOMOL, V108, P1860, DOI 10.1093/jee/tov170; Ray AM, 2012, J CHEM ECOL, V38, P1151, DOI 10.1007/s10886-012-0181-z; SAS Institute Inc, 2011, SAS STAT 9 3 US GUID; Schmeelk TC, 2016, J EC ENTOLO IN PRESS; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SVACHA P, 2014, HDB ZOOLOGY ARTHROPO, V3, P77	24	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160727	10.1371/journal.pone.0160727	http://dx.doi.org/10.1371/journal.pone.0160727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512985	Green Published, gold			2022-12-26	WOS:000381381100062
J	dos Santos, LF; Silva, RJS; do Amaral, DOJ; de Paula, MFB; Falcao, LL; Legavre, T; Alves, RM; Marcellino, LH; Micheli, F				dos Santos, Lucas Ferraz; Santana Silva, Raner Jose; Jordao do Amaral, Daniel Oliveira; Barbosa de Paula, Marcia Fabiana; Falcao, Loeni Ludke; Legavre, Thierry; Alves, Rafael Moyses; Marcellino, Lucilia Helena; Micheli, Fabienne			Selection of Reference Genes for Expression Study in Pulp and Seeds of Theobroma grandiflorum (Willd. ex Spreng.) Schum	PLOS ONE			English	Article							INTERNAL CONTROL; PLANT; PCR; ORIGIN; RNA	Cupuassu (Theobroma grandiflorum [Willd. ex Spreng.] Schum) is a species of high economic importance in Brazil with great potential at international level due to the multiple uses of both its seeds and pulp in the industry of sweets and cosmetics. For this reason, the cupuassu breeding program focused on the selection of genotypes with high pulp and seed quality-selection associated with the understanding of the mechanisms involved in fruit formation. Gene expression is one of the most used approaches related to such understanding. In this sense, quantitative real-time PCR (qPCR) is a powerful tool, since it rapidly and reliably quantifies gene expression levels across different experimental conditions. The analysis by qPCR and the correct interpretation of data depend on signal normalization using reference genes, i.e. genes presenting a uniform pattern of expression in the analyzed samples. Here, we selected and analyzed the expression of five genes from cupuassu (ACP, ACT, GAPDH, MDH, TUB) to be used as candidates for reference genes on pulp and seed of young, maturing and mature cupuassu fruits. The evaluation of the gene expression stability was obtained using the NormFinder, geNorm and BestKeeper programs. In general, our results indicated that the GAPDH and MDH genes constituted the best combination as reference genes to analyze the expression of cupuassu samples. To our knowledge, this is the first report of reference gene definition in cupuassu, and these results will support subsequent analysis related to gene expression studies in cupuassu plants subjected to different biotic or abiotic conditions as well as serve as a tool for diversity analysis based on pulp and seed quality.	[dos Santos, Lucas Ferraz; Santana Silva, Raner Jose; Jordao do Amaral, Daniel Oliveira; Barbosa de Paula, Marcia Fabiana; Micheli, Fabienne] Univ Estadual Santa Cruz, Dept Ciencias Biol, CBG, Rodovia Ilheus Itabuna,Km 16, BR-45662900 Ilheus, BA, Brazil; [Falcao, Loeni Ludke; Marcellino, Lucilia Helena] Embrapa Recursos Genet & Biotecnol, BR-70770917 Brasilia, DF, Brazil; [Legavre, Thierry; Micheli, Fabienne] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Alves, Rafael Moyses] Embrapa Amazonia Oriental, BR-66095903 Belem, Para, Brazil; [Barbosa de Paula, Marcia Fabiana] Univ Fed Mato Grosso, ICS, Av Alexandre Ferronato 1200, Sinop, MT, Brazil	Universidade Estadual de Santa Cruz; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); CIRAD; Universite de Montpellier; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso	Micheli, F (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, CBG, Rodovia Ilheus Itabuna,Km 16, BR-45662900 Ilheus, BA, Brazil.; Micheli, F (corresponding author), CIRAD, UMR AGAP, F-34398 Montpellier, France.	fabienne.micheli@cirad.fr	Micheli, Fabienne/AAL-9895-2021; Marcellino, Lucilia/N-1967-2016	Marcellino, Lucilia/0000-0002-0430-2490; Micheli, Fabienne/0000-0002-9031-362X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [DTE0038/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401924/2012-2, 501715/2013-4]; CNPq [PQ1]; FAPESB [DTE0038/2013]; CAPES-EMBRAPA "Theobroma"	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); CAPES-EMBRAPA "Theobroma"	LFS was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Project CAPES-EMBRAPA "Theobroma"); RJSS was supported by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB, project noDTE0038/2013); DOJA and MFBP were supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, projects 401924/2012-2 and 501715/2013-4, respectively). LHM was the beneficiary of Cirad funds for three monthstraining at Cirad (Action Incitative). FM was supported by a CNPq Productivity Grant (PQ1). The studies were supported by CAPES-EMBRAPA "Theobroma" and FAPESB (noDTE0038/2013) projects, both coordinated by FM.	ALVES R.M., 2008, REV BRAS FRUTIC, V30, P696; Alves RM, 2006, MOL ECOL NOTES, V6, P1219, DOI 10.1111/j.1471-8286.2006.01496.x; Alves RM, 2013, REV BRAS FRUTIC, V35, P818, DOI 10.1590/S0100-29452013000300019; Amil-Ruiz F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070603; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Bastolla F., 2007, SELECAO AVALIACAO GE; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Calzavara BBG, 1984, FRUTICULTURA TROPICA; Carvalho AV, 2008, CIENCIA TECNOL ALIME, V28, P986, DOI 10.1590/S0101-20612008000400035; Carvalho K, 2010, ANAL BIOCHEM, V402, P197, DOI 10.1016/j.ab.2010.03.038; Centeno DC, 2011, PLANT CELL, V23, P162, DOI 10.1105/tpc.109.072231; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Clement C. R., 2010, Diversity, V2, P72; Cohen Kelly de Oliveira, 2005, Food Sci. Technol (Campinas), V25, P182, DOI 10.1590/S0101-20612005000100030; Das Lalita, 2012, BMC Res Notes, V5, P395, DOI 10.1186/1756-0500-5-395; Dehydrogenase Is Critical for Embryo Development and Heterotrophic Metabolism in Arabidopsis, 2014, PLANT PHYSIOL, V164, P1175, DOI [10.1104/pp.113.233866, DOI 10.1104/PP.113.233866]; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; dos Santos LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151074; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Hibbeler S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-18; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Maia M. C. C., 2011, Pesquisa Florestal Brasileira, V31, P123, DOI 10.4336/2011.pfb.31.66.123; Mariot RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120854; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Olias P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099678; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Petersen J, 2003, J MOL EVOL, V57, P16, DOI 10.1007/s00239-002-2441-y; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinheiro TT, 2011, GENET MOL RES, V10, P3291, DOI 10.4238/2011.November.17.4; Reddy PS., 2015, PLANT GENE, V1, P35, DOI [DOI 10.1016/J.PLGENE.2015.02.001, 10.1016/j.plgene.2015.02.001]; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Santana RJS, 2011, C NAC CIENC BIOL REC, P387; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang ZA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10343; Zaffagnini M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00450; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160646	10.1371/journal.pone.0160646	http://dx.doi.org/10.1371/journal.pone.0160646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501324	Green Published, gold			2022-12-26	WOS:000381373500041
J	Martinez, H; Garcia, IA; Sampieri, L; Alvarez, C				Martinez, Hernan; Garcia, Iris A.; Sampieri, Luciana; Alvarez, Cecilia			Spatial-Temporal Study of Rab1b Dynamics and Function at the ER-Golgi Interface	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADP-RIBOSYLATION FACTOR; GTP-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; BREFELDIN-A; INTERMEDIATE COMPARTMENT; CIS-GOLGI; VESICULAR TRANSPORT; MEMBRANE-PROTEIN; FACTOR GBF1	The GTPase Rab1b is involved in ER to Golgi transport, with multiple Rab1b effectors (located at ERES, VTCs and the Golgi complex) being required for its function. In this study, we performed live-cell dual-expression studies to analyze the dynamics of Rab1b and some effectors located at the ERES-Golgi interface. Rab1b occupied widely distributed mobile punctate and tubular structures, displaying a transient overlaps with its effectors and showing that these overlaps occurred at the same time in spatially distinct steps of ER to Golgi transport. In addition, we assessed Rab1b dynamics during cargo sorting by analyzing the concentration at ERES of a Golgi protein (SialT2-CFP) during Brefeldin A washout (BFA WO). Rab1b was associated to most of the ERES structures, but at different times during BFA WO, and recurrently SialT2-CFP was sorted in the ERES-Rab1b positive structures. Furthermore, we reveal for first time that Rab1b localization time at ERES depended on GBF1, a Rab1b effector that acts as the guanine nucleotide exchange factor of Arf1, and that Rab1b membrane association/dissociation dynamics at ERES was dependent on the GBF1 membrane association and activity, which strongly suggests that GBF1 activity modulates Rab1b membrane cycling dynamic.	[Martinez, Hernan; Garcia, Iris A.; Sampieri, Luciana; Alvarez, Cecilia] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin Inmunol CIBCI CONICET, RA-5000 Cordoba, Argentina	National University of Cordoba	Alvarez, C (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin Inmunol CIBCI CONICET, RA-5000 Cordoba, Argentina.	calvarez@fcq.unc.edu.ar		Sampieri, Luciana/0000-0002-1269-4463	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); FONCYT [PICT-0043]; Secyt (UNC); CONICET; INC	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT(FONCyT); Secyt (UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INC	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), FONCYT (Prestamo BID 2012. PICT-0043), and Secyt (UNC) to CA as PI. CONICET and INC granted fellowships to HM, LS, and IAG, respectively. CA is member of CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2009, OPT EXPRESS, V17, P6829, DOI 10.1364/OE.17.006829; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Colanzi A, 2013, P NATL ACAD SCI USA, V110, P9794, DOI 10.1073/pnas.1222413110; Cox R, 2004, MOL BIOL CELL, V15, P1487, DOI 10.1091/mbc.E03-06-0443; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; Dukhovny A, 2008, J CELL SCI, V121, P865, DOI 10.1242/jcs.019463; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Garcia Iris A, 2011, Cell Logist, V1, P159; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Giraudo CG, 2003, J BIOL CHEM, V278, P40262, DOI 10.1074/jbc.M305455200; Guo Y., 2013, CELL LOGIST, V3, P27687, DOI [10.4161/cl.27687, DOI 10.4161/CL.27687]; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kirshner H, 2013, J MICROSC-OXFORD, V249, P13, DOI 10.1111/j.1365-2818.2012.03675.x; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Marie M, 2012, J CELL SCI, V125, P5403, DOI 10.1242/jcs.108100; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Martinez-Martinez N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111685; Mochizuki Y, 2013, J BIOL CHEM, V288, P1009, DOI 10.1074/jbc.M112.395087; Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792; SARASTE J, 1995, J CELL SCI, V108, P1541; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Slavin I, 2011, EUR J CELL BIOL, V90, P301, DOI 10.1016/j.ejcb.2010.10.001; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Spanfo S, 1999, J BIOL CHEM, V274, P17705, DOI 10.1074/jbc.274.25.17705; Stephens DJ, 2000, J CELL SCI, V113, P2177; Sztul E, 2009, FEBS LETT, V583, P3770, DOI 10.1016/j.febslet.2009.10.083; Szul T, 2005, TRAFFIC, V6, P374, DOI 10.1111/j.1600-0854.2005.00282.x; Tenorio MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135260; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Uliana AS, 2006, TRAFFIC, V7, P604, DOI 10.1111/j.1600-0854.2006.00413.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	51	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160838	10.1371/journal.pone.0160838	http://dx.doi.org/10.1371/journal.pone.0160838			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500526	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500058
J	Donner, J; Kaukonen, M; Anderson, H; Moller, F; Kyostila, K; Sankari, S; Hytonen, M; Giger, U; Lohi, H				Donner, Jonas; Kaukonen, Maria; Anderson, Heidi; Moller, Fredrik; Kyostila, Kaisa; Sankari, Satu; Hytonen, Marjo; Giger, Urs; Lohi, Hannes			Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders	PLOS ONE			English	Article							PRIMARY LENS LUXATION; FACTOR-VII DEFICIENCY; DOG BREEDS; HYPERURICOSURIA; CATALASE; DISEASES; TERRIERS; MODEL	Background The growing number of identified genetic disease risk variants across dog breeds challenges the current state-of-the-art of population screening, veterinary molecular diagnostics, and genetic counseling. Multiplex screening of such variants is now technologically feasible, but its practical potential as a supportive tool for canine breeding, disease diagnostics, pet care, and genetics research is still unexplored. Results To demonstrate the utility of comprehensive genetic panel screening, we tested nearly 7000 dogs representing around 230 breeds for 93 disease-associated variants using a custom-designed genotyping microarray (the MyDogDNA1panel test). In addition to known breed disease-associated mutations, we discovered 15 risk variants in a total of 34 breeds in which their presence was previously undocumented. We followed up on seven of these genetic findings to demonstrate their clinical relevance. We report additional breeds harboring variants causing factor VII deficiency, hyperuricosuria, lens luxation, von Willebrand's disease, multifocal retinopathy, multidrug resistance, and rod-cone dysplasia. Moreover, we provide plausible molecular explanations for chondrodysplasia in the Chinook, cerebellar ataxia in the Norrbottenspitz, and familiar nephropathy in the Welsh Springer Spaniel. Conclusions These practical examples illustrate how genetic panel screening represents a comprehensive, efficient and powerful diagnostic and research discovery tool with a range of applications in veterinary care, disease research, and breeding. We conclude that several known disease alleles are more widespread across different breeds than previously recognized. However, careful follow up studies of any unexpected discoveries are essential to establish genotype-phenotype correlations, as is readiness to provide genetic counseling on their implications for the dog and its breed.	[Donner, Jonas; Anderson, Heidi; Moller, Fredrik; Lohi, Hannes] Genoscoper Labs Oy, Helsinki, Finland; [Kaukonen, Maria; Kyostila, Kaisa; Hytonen, Marjo; Lohi, Hannes] Univ Helsinki, Res Programs Unit Mol Neurol, Helsinki, Finland; [Kaukonen, Maria; Kyostila, Kaisa; Hytonen, Marjo; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Kaukonen, Maria; Kyostila, Kaisa; Hytonen, Marjo; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Sankari, Satu] Univ Helsinki, Dept Equine & Small Anim Med, Helsinki, Finland; [Giger, Urs] Univ Penn, Med Genet Sect, Philadelphia, PA 19104 USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Pennsylvania	Donner, J (corresponding author), Genoscoper Labs Oy, Helsinki, Finland.	jonas.donner@genoscoper.com	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Hytonen, Marjo/0000-0003-1976-5874; Kaukonen, Maria/0000-0002-2146-4694; Donner, Jonas/0000-0002-9874-8484	Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Finnish Cultural Foundation; Academy of Finland; National Institutes of Health [OD010939]	Jane and Aatos Erkko Foundation; Biocentrum Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was partly supported by the Jane and Aatos Erkko Foundation (http://www.jaes.fi/; to HL), Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/; to HL), the Finnish Cultural Foundation (http://www.skr.fi; to KK), the Academy of Finland (http://www.aka.fi/fi/; to HL), and National Institutes of Health grant number OD010939 - Animal Models of Human Genetic Disease (http://www.nih.gov; to UG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannasch D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000246; Brons AK, 2013, J VET INTERN MED, V27, P1400, DOI 10.1111/jvim.12176; Callan MB, 2006, J THROMB HAEMOST, V4, P2616, DOI 10.1111/j.1538-7836.2006.02203.x; Davidson AG, 2007, J VET INTERN MED, V21, P394, DOI 10.1892/0891-6640(2007)21[394:GCOARH]2.0.CO;2; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Farrell Lindsay L, 2015, Canine Genet Epidemiol, V2, P3, DOI 10.1186/s40575-015-0014-9; Finnigan DF, 2007, J VET INTERN MED, V21, P458, DOI 10.1892/0891-6640(2007)21[458:ANMOTC]2.0.CO;2; Forman OP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064627; FUKUDA K, 1982, ACTA HISTOCHEM CYTOC, V15, P685, DOI 10.1267/ahc.15.685; Genoscoper Laboratories Oy, MYDOGDNA TECHN SHEET; Gilliam D, 2014, J VET INTERN MED, V28, P871, DOI 10.1111/jvim.12355; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Gultekin GI, 2012, J VET INTERN MED, V26, P935, DOI 10.1111/j.1939-1676.2012.00958.x; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hytonen MK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006037; Kaae JA, 2007, J VET INTERN MED, V21, P976, DOI 10.1892/0891-6640(2007)21[976:HFVDIT]2.0.CO;2; Karmi N, 2010, J VET INTERN MED, V24, P1337, DOI 10.1111/j.1939-1676.2010.0631.x; Karmi N, 2010, AM J VET RES, V71, P909, DOI 10.2460/ajvr.71.8.909; Kramer JW, 2004, VET PATHOL, V41, P221, DOI 10.1354/vp.41-3-221; Kyostila K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075621; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Mealey KL, 2001, PHARMACOGENETICS, V11, P727, DOI 10.1097/00008571-200111000-00012; Miyadera K, 2012, MAMM GENOME, V23, P40, DOI 10.1007/s00335-011-9361-3; Nakamura K, 2000, INT J BIOCHEM CELL B, V32, P1183, DOI 10.1016/S1357-2725(00)00057-1; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; [School of Veterinary Medicine University of Pennsylvania PennGen-Section of Medical Genetics], LIST CAN FEL HER DIS; Slutsky J, 2013, VET J, V197, P182, DOI 10.1016/j.tvjl.2013.02.021; Suomen Kennelliitto ry, KOIRANET JAL; [University of Sydney Faculty of Veterinary Science], ONL MEND INH AN; Zangerl B, 2010, MOL VIS, V16, P2791; Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317	32	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161005	10.1371/journal.pone.0161005	http://dx.doi.org/10.1371/journal.pone.0161005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525650	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100029
J	Banica, T; Schwarzkopf, DS				Banica, Theodora; Schwarzkopf, D. Samuel			Induction of Kanizsa Contours Requires Awareness of the Inducing Context	PLOS ONE			English	Article							ILLUSORY CONTOURS; SUBJECTIVE CONTOURS; PHANTOM SURFACE; VISUAL-CORTEX; PERCEPTION; DEPTH; ORIENTATION; ATTENTION; SHAPE; REAL	It remains unknown to what extent the human visual system interprets information about complex scenes without conscious analysis. Here we used visualmasking techniques to assess whether illusory contours (Kanizsa shapes) are perceived when the inducing context creating this illusion does not reach awareness. In the first experiment we tested perception directly by having participants discriminate the orientation of an illusory contour. In the second experiment, we exploited the fact that the presence of an illusory contour enhances performance on a spatial localization task. Moreover, in the latter experiment we also used a different masking method to rule out the effect of stimulus duration. Our results suggest that participants do not perceive illusory contours when they are unaware of the inducing context. This is consistent with theories of a multistage, recurrent process of perceptual integration. Our findings thus challenge some reports, including those fromneurophysiological experiments in anaesthetized animals. Furthermore, we discuss the importance to test the presence of the phenomenal percept directly with appropriatemethods.	[Banica, Theodora; Schwarzkopf, D. Samuel] UCL, Expt Psychol, 26 Bedford Way, London, England; [Schwarzkopf, D. Samuel] UCL, Inst Cognit Neurosci, 17 Queen Sq, London, England	University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Expt Psychol, 26 Bedford Way, London, England.; Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London, England.	s.schwarzkopf@ucl.ac.uk			European Research Council [310829]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by the European Research Council, 310829 (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BL, 2007, PSYCHOL REV, V114, P470, DOI 10.1037/0033-295X.114.2.470; Axelrod V, 2014, CONSCIOUS COGN, V27, P233, DOI 10.1016/j.concog.2014.05.004; Bahrami B, 2008, PERCEPTION, V37, P1520, DOI 10.1068/p5999; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Clifford CWG, 2005, CURR BIOL, V15, P574, DOI 10.1016/j.cub.2005.01.055; Conci M, 2009, NEUROPSYCHOLOGIA, V47, P726, DOI 10.1016/j.neuropsychologia.2008.11.029; Cox MA, 2013, P NATL ACAD SCI USA, V110, P17095, DOI 10.1073/pnas.1310806110; Falconbridge M, 2010, J VISION, V10, DOI 10.1167/10.8.21; Ffytche DH, 1996, NEUROIMAGE, V3, P104, DOI 10.1006/nimg.1996.0012; FRISBY JP, 1975, PERCEPTION, V4, P349, DOI 10.1068/p040349; GELLATLY ARH, 1980, PERCEPTION, V9, P599, DOI 10.1068/p090599; Gillam B, 1999, VISION RES, V39, P109, DOI 10.1016/S0042-6989(98)00052-2; GROSOF DH, 1993, NATURE, V365, P550, DOI 10.1038/365550a0; Hakkinen J, 2001, VISION RES, V41, P187, DOI 10.1016/S0042-6989(00)00231-5; HALPERN DF, 1981, PERCEPTION, V10, P199, DOI 10.1068/p100199; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; Haynes JD, 2005, NEURON, V46, P811, DOI 10.1016/j.neuron.2005.05.012; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Heider B, 2000, EUR J NEUROSCI, V12, P4117, DOI 10.1046/j.1460-9568.2000.00293.x; Hesselmann G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00584; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Kogo N, 2010, PSYCHOL REV, V117, P406, DOI 10.1037/a0019076; Kok P, 2014, CURR BIOL, V24, P1531, DOI 10.1016/j.cub.2014.05.042; Lau JSF, 2012, J VISION, V12, DOI 10.1167/12.6.15; Lee TS, 2001, P NATL ACAD SCI USA, V98, P1907, DOI 10.1073/pnas.031579998; Ling S, 2009, PSYCHOL SCI, V20, P1348, DOI 10.1111/j.1467-9280.2009.02446.x; LIU L, 1994, NATURE, V367, P66, DOI 10.1038/367066a0; Mattingley JB, 1997, SCIENCE, V275, P671, DOI 10.1126/science.275.5300.671; Mendola JD, 1999, J NEUROSCI, V19, P8560; Montaser-Kouhsari L, 2007, J NEUROSCI, V27, P2186, DOI 10.1523/JNEUROSCI.4173-06.2007; Moore CM, 1997, J EXP PSYCHOL HUMAN, V23, P339, DOI 10.1037/0096-1523.23.2.339; Moors P, 2016, PSYCHOL SCI, V27, P945, DOI 10.1177/0956797616642525; Moors P, 2016, ATTEN PERCEPT PSYCHO, V78, P902, DOI 10.3758/s13414-015-1043-x; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Mudrik L, 2011, PSYCHOL SCI, V22, P764, DOI 10.1177/0956797611408736; MUISE JG, 1993, PERCEPTION, V22, P623, DOI 10.1068/p220623; Newell BR, 2014, BEHAV BRAIN SCI, V37, P1, DOI 10.1017/S0140525X12003214; Pan YX, 2012, J NEUROSCI, V32, P6760, DOI 10.1523/JNEUROSCI.6140-11.2012; PARKS TE, 1994, PERCEPTION, V23, P857, DOI 10.1068/p230857; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; PETERHANS E, 1991, TRENDS NEUROSCI, V14, P112, DOI 10.1016/0166-2236(91)90072-3; Ramsden BM, 2001, CEREB CORTEX, V11, P648, DOI 10.1093/cercor/11.7.648; REYNOLDS RI, 1981, PERCEPTION, V10, P107, DOI 10.1068/p100107; Ringach DL, 1996, VISION RES, V36, P3037, DOI 10.1016/0042-6989(96)00062-4; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rubin N, 2001, PERCEPTION, V30, P339, DOI 10.1068/p3173; Schurger A, 2015, P NATL ACAD SCI USA, V112, pE2083, DOI 10.1073/pnas.1418730112; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Schwarzkopf DS, 2011, P ROY SOC B-BIOL SCI, V278, P2207, DOI 10.1098/rspb.2010.1909; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Sobel KV, 2003, VISION RES, V43, P1533, DOI 10.1016/S0042-6989(03)00178-0; Stanley DA, 2003, NEURON, V37, P323, DOI 10.1016/S0896-6273(02)01148-0; Sterzer P, 2008, J VISION, V8, DOI 10.1167/8.15.10; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Vandenbroucke ARE, 2014, J COGNITIVE NEUROSCI, V26, P955, DOI 10.1162/jocn_a_00530; Varin D., 1971, RIV PSICOL, V65, P101; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Vuilleumier P, 1998, NEUROREPORT, V9, P2481, DOI 10.1097/00001756-199808030-00010; Vuilleumier P, 2001, NEUROPSYCHOLOGIA, V39, P597, DOI 10.1016/S0028-3932(00)00148-2; Vul E, 2006, NAT NEUROSCI, V9, P873, DOI 10.1038/nn1723; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Wokke ME, 2013, PSYCHOL SCI, V24, P63, DOI 10.1177/0956797612449175; Yang JK, 2015, J VISION, V15, DOI 10.1167/15.14.6; Zhan CA, 2008, CEREB CORTEX, V18, P1029, DOI 10.1093/cercor/bhm139; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	67	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161177	10.1371/journal.pone.0161177	http://dx.doi.org/10.1371/journal.pone.0161177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518569	gold, Green Published, Green Submitted			2022-12-26	WOS:000381382100058
J	Peden, AE; Franklin, RC; Leggat, PA				Peden, Amy E.; Franklin, Richard C.; Leggat, Peter A.			The Hidden Tragedy of Rivers: A Decade of Unintentional Fatal Drowning in Australia	PLOS ONE			English	Article							PREVENTION; DEATHS; MORTALITY; CHILDREN; INJURY; WATER	Objective(s) Describe unintentional drowning deaths in rivers, creeks and streams (rivers) in Australia and identify risk factors to inform prevention. Design & Setting This study is a cross-sectional, total population audit of all unintentional fatal drownings in Australian rivers between 1-July-2002 and 30-June-2012 using Australian coronial data. A modified Bonferroni test has been applied, deeming statistical significance p<0.03 and p<0.04 respectively. Results Rivers (n = 770; 26.6%) were the leading location among the 2,892 people who died from unintentional fatal drowning. This is a rate of 0.37 / 100,000 people / annum. Within river drowning deaths common groups include; males (80.4%), adults (85.3%), adults who have consumed alcohol (25.5%), people who fell in (21.3%), people involved in non-aquatic transport incidents (18.2%) and locals (74.0%). Children were 1.75 times more likely than adults (p<0.04) to drown in rivers as a result of a fall and adults 1.50 times more likely to drown in rivers as a result of watercraft incidents when compared to children. When compared to males, females were 2.27 and 4.45 times respectively more likely to drown in rivers as a result of incidents involving non-aquatic transport (p<0.04) and being swept away by floodwaters (p<0.04). Males were 2.66 and 4.27 times respectively more likely to drown in rivers as a result of watercraft incidents (p<0.04) and as a result of jumping in (p<0.04) when compared to females. Conclusion(s) While rivers are the leading location for drowning in Australia, little is understood about the risks. This study has identified key groups (males, adults, locals) and activities. While males were more likely to drown, the risk profile for females differed.	[Peden, Amy E.; Franklin, Richard C.] Royal Life Saving Soc Australia, Sydney, NSW, Australia; [Peden, Amy E.; Franklin, Richard C.; Leggat, Peter A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Sch Publ Hlth & Trop Med, Townsville, Qld, Australia; [Leggat, Peter A.] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Populat Hlth, Canberra, ACT, Australia	James Cook University; Australian National University	Peden, AE (corresponding author), Royal Life Saving Soc Australia, Sydney, NSW, Australia.; Peden, AE (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Sch Publ Hlth & Trop Med, Townsville, Qld, Australia.	apeden@rlssa.org.au	Peden, Amy E/AAO-5342-2020; Franklin, Richard Charles/H-1731-2012	Peden, Amy E/0000-0002-6424-1511; Franklin, Richard Charles/0000-0003-1864-4552; Leggat, Peter/0000-0002-8749-014X	Royal Life Saving Society-Australia; Australian Government	Royal Life Saving Society-Australia; Australian Government(Australian GovernmentCGIAR)	This research is supported by the Royal Life Saving Society-Australia to aid in the reduction of drowning. Research at the Royal Life Saving Society-Australia is supported by the Australian Government.	Australian Bureau of Statistics, 2013, 2011 CENS QUICKSTATS; Australian Bureau of Statistics, 2006, 2006 CENS QUICKSTATS; Australian Bureau of Statistics, 2006, 3101 0 AUSTR DEM STA; Australian Bureau of Statistics, 2014, 31010 AUSTR BUR STAT; Australian Government, 2015, AUSTR HERITAGE STRAT, P7; Australian Government Department of Health, 2015, DOCT LOC 2010; Australian Government-Australian Law Reform Commission, 2015, 84 ALRC AUSTR GOV; Australian Water Safety Council, 2008, GUID WAT SAF ESS LOC; Australian Water Safety Council, 2012, AUSTR WAT SAF STRAT; Beattie N, 2008, RURAL REMOTE HEALTH, V8; Bessereau J, 2015, INT J INJ CONTROL SA, DOI [10.1080/17457300, DOI 10.1080/17457300.]; Brenner RA, 2003, PEDIATRICS, V112, P440, DOI 10.1542/peds.112.2.440; Bugeja L, 2012, INT J INJ CONTROL SA, P1; Claesson A, 2008, RESUSCITATION, V76, P381, DOI 10.1016/j.resuscitation.2007.09.003; Driscoll TR, 2004, INJURY PREV, V10, P107, DOI 10.1136/ip.2003.004390; Franklin RC., 2006, EVALUATION OF BRONZE; Franklin RC, 2010, MED J AUSTRALIA, V192, P123, DOI 10.5694/j.1326-5377.2010.tb03448.x; Howland J, 1996, AM J PUBLIC HEALTH, V86, P93, DOI 10.2105/AJPH.86.1.93; ICECI Coordination and Maintenance Group, 2004, INT CLASS EXT CAUS I; KEMP A, 1992, BRIT MED J, V304, P1143, DOI 10.1136/bmj.304.6835.1143; Keppel G, 1991, DESIGN ANAL RES HDB; Kugelberg FC, 2007, FORENSIC SCI INT, V165, P10, DOI 10.1016/j.forsciint.2006.05.004; Leggat PA, 2009, J TRAVEL MED, V16, P243, DOI 10.1111/j.1708-8305.2009.00302.x; Lin CY, 2015, INJURY PREV, V21, pE43, DOI 10.1136/injuryprev-2013-041110; Lippmann JM, 2012, MED J AUSTRALIA, V197, P230, DOI 10.5694/mja11.10988; Liu H, 2013, MED J AUSTRALIA, V203, P24; Lu TH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-30; Lunetta P, 2002, INJ PREV, V8, P342, DOI 10.1136/ip.8.4.342; Marchant J, 2008, MED J AUSTRALIA, V188, P484, DOI 10.5694/j.1326-5377.2008.tb01725.x; Mitchell Rebecca, 2004, Aust J Rural Health, V12, P246, DOI 10.1111/j.1440-1854.2004.00628.x; Mitchell RJ, 2010, INJURY PREV, V16, P261, DOI 10.1136/ip.2009.024307; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Morrongiello BA, 2010, AM J LIFESTYLE MED, V4, P65, DOI 10.1177/1559827609348475; Nakayama H, 2003, HAWAII MED J, V62, P165; National Centre for Classification in Health Australia, 2004, ICD 10 AM TAB LIST D; Newman LM, 1998, ANN EMERG MED, V32, P687, DOI 10.1016/S0196-0644(98)70068-X; PEARN J, 1977, MED J AUSTRALIA, V1, P616, DOI 10.5694/j.1326-5377.1977.tb130960.x; Peden AE, 2016, INJURY PREV, V22, P202, DOI 10.1136/injuryprev-2015-041750; Peden AE, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav031; Prameprart M, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2471, DOI 10.1177/1010539513488796; Queensland Floods Commission of Inquiry, 2012, QUEENSL FLOODS COMM; Rahman A, 2006, Int J Inj Contr Saf Promot, V13, P101, DOI 10.1080/17457300500172941; Royal Life Saving Society-Australia, 2014, ROYAL LIF SAV SOC AU; Smith GS, 2001, JAMA-J AM MED ASSOC, V286, P2974, DOI 10.1001/jama.286.23.2974; SPSS Inc, 2010, IBM SPSS STAT 20 0; Thompson DC, 2001, POOL FENCING PREVENT; Turner Cathy, 2003, Inj Control Saf Promot, V10, P123, DOI 10.1076/icsp.10.3.123.14560; Vinet F, 2012, NAT HAZARDS, V61, P1179, DOI 10.1007/s11069-011-9975-5; WILSON M, 1985, ETHOL SOCIOBIOL, V6, P59, DOI 10.1016/0162-3095(85)90041-X; Wintemute GJ, 2013, WEST J EMERG MED, V14, P200, DOI 10.5811/westjem.2012.1.11717; World Health Organization (WHO), 2014, GLOB REP DROWN PREV; Zhu YC, 2015, SE ASIAN J TROP MED, V46, P1112; Zhu YC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2010-0	53	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160709	10.1371/journal.pone.0160709	http://dx.doi.org/10.1371/journal.pone.0160709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517313	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000381382100021
J	Hope, ES; McKenney, DW; Pedlar, JH; Stocks, BJ; Gauthier, S				Hope, Emily S.; McKenney, Daniel W.; Pedlar, John H.; Stocks, Brian J.; Gauthier, Sylvie			Wildfire Suppression Costs for Canada under a Changing Climate	PLOS ONE			English	Article							FOREST-FIRE; BOREAL FOREST; MODELS; IMPACT; MANAGEMENT; RISKS; PRECIPITATION; TEMPERATURE; MOISTURE; REGIMES	Climate-influenced changes in fire regimes in northern temperate and boreal regions will have both ecological and economic ramifications. We examine possible future wildfire area burned and suppression costs using a recently compiled historical (i.e.,1980-2009) fire management cost database for Canada and several Intergovernmental Panel on Climate Change (IPCC) climate projections. Area burned was modelled as a function of a climate moisture index (CMI), and fire suppression costs then estimated as a function of area burned. Future estimates of area burned were generated from projections of the CMI under two emissions pathways for four General Circulation Models (GCMs); these estimates were constrained to ecologically reasonable values by incorporating a minimum fire return interval of 20 years. Total average annual national fire management costs are projected to increase to just under $1 billion (a 60% real increase from the 1980-2009 period) under the low greenhouse gas emissions pathway and $1.4 billion (119% real increase from the base period) under the high emissions pathway by the end of the century. For many provinces, annual costs that are currently considered extreme (i.e., occur once every ten years) are projected to become commonplace (i.e., occur once every two years or more often) as the century progresses. It is highly likely that evaluations of current wildland fire management paradigms will be necessary to avoid drastic and untenable cost increases as the century progresses.	[Hope, Emily S.; McKenney, Daniel W.; Pedlar, John H.] Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada; [Stocks, Brian J.] BJ Stocks Wildfire Invest Ltd, Sault Ste Marie, ON, Canada; [Gauthier, Sylvie] Nat Resources Canada, Canadian Forest Serv, Laurentian Forestry Ctr, Ste Foy, PQ, Canada	Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre; Natural Resources Canada; Canadian Forest Service	McKenney, DW (corresponding author), Nat Resources Canada, Canadian Forest Serv, Great Lakes Forestry Ctr, Sault Ste Marie, ON, Canada.	dan.mckenney@canada.ca	Gauthier, Sylvie/J-3923-2019	Gauthier, Sylvie/0000-0001-6720-0195; Hope, Emily/0000-0001-8560-6092	Wildfire Investigations Ltd.	Wildfire Investigations Ltd.	These authors have no support or funding to report. BJ. Stocks Wildfire Investigations Ltd. provided support in the form of salaries for authors [BJS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2014, R LANG ENV STAT COMP; Boulanger Y, 2014, CAN J FOREST RES, V44, P365, DOI 10.1139/cjfr-2013-0372; Brown TJ, 2004, CLIMATIC CHANGE, V62, P365, DOI 10.1023/B:CLIM.0000013680.07783.de; Calkin DE, 2005, J FOREST, V103, P179, DOI 10.1093/jof/103.4.179; Casbeer DW, 2006, INT J SYST SCI, V37, P351, DOI 10.1080/00207720500438480; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; de Groot W, 2003, INT WILDLAND FIRE SU, P8; Fitch RA, 2013, FOREST RESTORATION T; Flannigan M. D., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P847, DOI 10.1007/s11027-005-9020-7; Flannigan MD, 2005, CLIMATIC CHANGE, V72, P1, DOI 10.1007/s10584-005-5935-y; Flannigan MD, 2000, SCI TOTAL ENVIRON, V262, P221, DOI 10.1016/S0048-9697(00)00524-6; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Fritzsche J, 2011, 16002X STAT CAN; Gauthier S, 2015, CAN J FOREST RES, V45, P553, DOI 10.1139/cjfr-2014-0125; Gebert KM, 2007, WEST J APPL FOR, V22, P188, DOI 10.1093/wjaf/22.3.188; Girardin MP, 2015, CLIMATIC CHANGE, V130, P587, DOI 10.1007/s10584-015-1373-7; Girardin MP, 2013, FOREST ECOL MANAG, V294, P238, DOI 10.1016/j.foreco.2012.07.005; Girardin MP, 2009, J APPL METEOROL CLIM, V48, P517, DOI 10.1175/2008JAMC1996.1; Gorte R.W., 2013, RISING COST WILDFIRE; Hennessy K., 2005, CLIMATE CHANGE IMPAC; Heon J, 2014, P NATL ACAD SCI USA, V111, P13888, DOI 10.1073/pnas.1409316111; Hogg EH, 1997, AGR FOREST METEOROL, V84, P115, DOI 10.1016/S0168-1923(96)02380-5; HOGG EH, 1994, CAN J FOREST RES, V24, P1835, DOI 10.1139/x94-237; HUTCHINSON MF, 1995, INT J GEOGR INF SYST, V9, P385, DOI 10.1080/02693799508902045; Intergovernmental Panel on Climate Change (IPCC), REPR CONC PATHW; Jiang P, 2013, J HYDROL, V479, P75, DOI 10.1016/j.jhydrol.2012.11.041; Johnston JS, 2012, WILDFIRE POLICY LAW, P158; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Liang JJ, 2008, INT J WILDLAND FIRE, V17, P650, DOI 10.1071/WF07010; Littell JS, 2016, GLOBAL CHANGE BIOL, V22, P2353, DOI 10.1111/gcb.13275; Magnussen S, 2012, INT J WILDLAND FIRE, V21, P328, DOI 10.1071/WF11026; MARTELL DL, 1994, FOREST CHRON, V70, P164, DOI 10.5558/tfc70164-2; McAlpine RS, 1999, INT J WILDLAND FIRE, V9, P203, DOI 10.1071/WF00007; McKenney D, 2013, FOREST CHRON, V89, P659, DOI 10.5558/tfc2013-118; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Mitchell RJ, 2014, FOREST ECOL MANAG, V327, P316, DOI 10.1016/j.foreco.2013.12.003; Natural Resources Canada, FIR HIST DAT; Pedlar JH, 2015, J APPL METEOROL CLIM, V54, P506, DOI 10.1175/JAMC-D-14-0045.1; Pindyck R.S., 1998, ECONOMETRIC MODELS E, V4th edition; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; Podur J, 2010, ECOL MODEL, V221, P1301, DOI 10.1016/j.ecolmodel.2010.01.013; Prestemon JP, 2008, FOREST SCI, V54, P381; PRICE C, 1994, J CLIMATE, V7, P1484, DOI 10.1175/1520-0442(1994)007<1484:TIOACC>2.0.CO;2; Price D.T., 2011, NORX421 NAT RES CAN, P104; Rocca ME, 2014, FOREST ECOL MANAG, V327, P290, DOI 10.1016/j.foreco.2014.04.005; Sanford T, 2014, NAT CLIM CHANGE, V4, P164, DOI 10.1038/nclimate2148; Spracklen DV, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010966; STOCKS BJ, 1993, FOREST CHRON, V69, P290, DOI 10.5558/tfc69290-3; Stocks BJ, 2013, EVALUATING CURRENT F, DOI DOI 10.1111/j.1467-9868.2010.00749.x; Stocks BJ., 2016, FORESTRY CH IN PRESS; Terando A, 2012, J CLIMATE, V25, P473, DOI 10.1175/2011JCLI4168.1; Terrier A, 2013, ECOL APPL, V23, P21, DOI 10.1890/12-0425.1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wang YH, 2010, ECOL MODEL, V221, P122, DOI 10.1016/j.ecolmodel.2008.12.007; Wotton B., 2006, FIRE MANAGEMENT CANA; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; WOTTON BM, 1993, FOREST CHRON, V69, P187, DOI 10.5558/tfc69187-2; Xiao JF, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/044003; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	60	37	37	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0157425	10.1371/journal.pone.0157425	http://dx.doi.org/10.1371/journal.pone.0157425			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513660	Green Published, gold			2022-12-26	WOS:000381381100004
J	Lin, TT; Wu, CC; Yang, YH; Lin, LY; Lin, JL; Chen, PC; Hwang, JJ				Lin, Ting-Tse; Wu, Chih-Chen; Yang, Yao-Hsu; Lin, Lian-Yu; Lin, Jiunn-Lee; Chen, Pau-Chung; Hwang, Juey-Jen			Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis	PLOS ONE			English	Article							INTENSIVE GLYCEMIC CONTROL; GLUCOSE CONTROL; KIDNEY-DISEASE; TYPE-2; INSULIN; PHARMACOKINETICS; ASSOCIATION; STATEMENT; COMPLICATIONS; EPIDEMIOLOGY	Background Diabetes and chronic kidney disease (CKD) are a high-stakes combination for cardiovascular disease. Patients with decreased kidney function and end-stage renal disease ( ESRD) have increased risk of hypoglycemia when attaining better glycemic control, leading to higher risk of myocardial infarction (MI). For these patients, which kinds of anti-hyperglycemic agents would be associated with higher risk of MI is not clear. Methods We identified patients from a nation-wide database called Registry for Catastrophic Illness, which encompassed almost 100% of the patients receiving dialysis therapy in Taiwan from 1995 to 2008. Patients with diabetes and ESRD were selected as the study cohort. Propensity score adjustment and Cox's proportional hazards regression model were used to estimate the hazard ratios (HRs) for new-onset MI. Results Among 15,161 patients, 39% received insulin, 40% received sulfonylureas, 18% received meglitinides and 3% received thiazolidinedione (TZD). After a median follow-up of 1,357 days, the incidence of MI was significant increase in patients taking sulfonylureas (HR =1.523, 95% confidence interval [CI]=1.331-1.744), meglitinides ( HR=1.251, 95% CI=1.048-1.494) and TZD (HR=1.515, 95% CI=1.071-2.145) by using patients receiving insulin therapy as the reference group. The risk of MI remains higher in other three groups in subgroup analyses. Conclusions In conclusion, among diabetic patients with ESRD undergoing dialysis, the use of sulfonylureas, meglitinides and TZD are associated with higher risk of new-onset MI as compared with insulin.	[Lin, Ting-Tse; Wu, Chih-Chen] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lin, Ting-Tse] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Lin, Lian-Yu; Lin, Jiunn-Lee; Hwang, Juey-Jen] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University	Lin, LY; Hwang, JJ (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	hspenos@gmail.com; jueyhwang@ntu.edu.tw	Chen, Pau-Chung/H-5686-2011; 楊, 曜旭/A-3450-2019	Chen, Pau-Chung/0000-0002-6242-5974; 楊, 曜旭/0000-0002-8080-0504; WU, CHIH-CHENG/0000-0002-9690-6573; LIN, TING-TSE/0000-0002-8810-5127; LIN, LIAN-YU/0000-0001-7505-6429; Hwang, Juey-Jen/0000-0001-6437-0455				Abe M, 2011, CURR DRUG METAB, V12, P57, DOI 10.2174/138920011794520053; ADROGUE HJ, 1992, KIDNEY INT, V42, P1266, DOI 10.1038/ki.1992.414; Alvestrand A, 1997, KIDNEY INT, V52, pS48; Berkowitz SA, 2014, JAMA INTERN MED, V174, P1955, DOI 10.1001/jamainternmed.2014.5294; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Chou MT, 2013, INT J CARDIOL, V167, P2719, DOI 10.1016/j.ijcard.2012.06.108; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hasslacher C, 2003, DIABETES CARE, V26, P886, DOI 10.2337/diacare.26.3.886; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inoue T, 2003, CLIN NEPHROL, V60, P90; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jonsson A, 1998, EUR J CLIN PHARMACOL, V53, P429, DOI 10.1007/s002280050403; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Levin SR, 2000, DIABETES CARE, V23, P1478, DOI 10.2337/diacare.23.10.1478; Lin TT, 2015, KIDNEY INT, V88, P378, DOI 10.1038/ki.2015.96; Nagai T, 2003, DIABETES RES CLIN PR, V59, P191, DOI 10.1016/S0168-8227(02)00242-5; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nye HJ, 2011, NEPHRON CLIN PRACT, V118, pC380, DOI 10.1159/000323739; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; Salpeter SR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002967.pub4; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Snyder RW, 2004, SEMIN DIALYSIS, V17, P365, DOI 10.1111/j.0894-0959.2004.17346.x; Sobngwi E, 2010, DIABETES CARE, V33, P1409, DOI 10.2337/dc09-2176; Thompson-Culkin K, 2002, J INT MED RES, V30, P391, DOI 10.1177/147323000203000405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WEINRAUCH LA, 1978, ARCH INTERN MED, V138, P399, DOI 10.1001/archinte.138.3.399; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	35	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160436	10.1371/journal.pone.0160436	http://dx.doi.org/10.1371/journal.pone.0160436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513562	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100038
J	Yang, TH; Lu, SC; Lin, WJ; Zhao, K; Zhao, CF; An, KN; Jou, IM; Lee, PY; Kuo, LC; Su, FC				Yang, Tai-Hua; Lu, Szu-Ching; Lin, Wei-Jr; Zhao, Kristin; Zhao, Chunfeng; An, Kai-Nan; Jou, I-Ming; Lee, Pei-Yuan; Kuo, Li-Chieh; Su, Fong-Chin			Assessing Finger Joint Biomechanics by Applying Equal Force to Flexor Tendons In Vitro Using a Novel Simultaneous Approach	PLOS ONE			English	Article							MOMENT ARMS; HUMAN HAND; MUSCLES; THUMB; COORDINATION; MOVEMENTS; EXCURSION; PATTERNS; FLEXION; MODEL	Background The flexor digitorum superficialis (FDS) and flexor digitorum profundus (FDP) are critical for finger flexion. Although research has recently focused on these tendons' coactivity, their contributions in different tasks remain unclear. This study created a novel simultaneous approach to investigate the coactivity between the tendons and to clarify their contributions in different tasks. Methods Ten human cadaveric hands were mounted on our custom frame with the FDS and FDP of the third finger looped through a mechanical pulley connected to a force transducer. Joint range of motion, tendon excursion and loading force were recorded during individual joint motion and free joint movement from rest to maximal flexion. Each flexor tendon's moment arm was then calculated. Results In individual motions, we found that the FDP contributed more than the FDS in proximal interphalangeal ( PIP) joint motion, with an overall slope of 1.34 and all FDP-to-FDS excursion (P/S) ratios greater than 1.0 with force increase. However, the FDP contributed less than the FDS in metacarpophalangeal (MCP) joint motion, with an overall slope of 0.95 and P/S ratios smaller than 1.0 throughout the whole motion except between 1.9% and 13.1% force. In free joint movement, the FDP played a greater role than the FDS, with an overall ratio of 1.37 and all P/S ratios greater than 1.0. Conclusions The new findings include differences in finger performance and excursion amounts between the FDS and FDP throughout flexion. Such findings may provide the basis for new hand models and treatments.	[Yang, Tai-Hua; Lu, Szu-Ching; Lin, Wei-Jr; Lee, Pei-Yuan; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan, Taiwan; [Jou, I-Ming] Natl Cheng Kung Univ, Dept Orthoped, Tainan, Taiwan; [Yang, Tai-Hua; Lin, Wei-Jr; Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Zhao, Kristin] Mayo Clin, Dept Phys Med & Rehabil, Rehabil Med Res Ctr, Rochester, MN USA; [Yang, Tai-Hua; Lu, Szu-Ching; Zhao, Chunfeng; An, Kai-Nan] Mayo Clin, Div Orthoped Res, Biomech & Tendon & Soft Tissue Biol Lab, Rochester, MN USA; [Lee, Pei-Yuan] Show Chwan Mem Hosp, Dept Orthoped, Changhua, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Mayo Clinic; Mayo Clinic; Show Chwan Memorial Hospital	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Kuo, LC (corresponding author), Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan, Taiwan.; Su, FC (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	jkkuo@mail.ncku.edu.tw; fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011; Kuo, Li-Chieh/ABC-3826-2021	SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0001-7728-0096; Kuo, Li-Chieh/0000-0002-5644-655X; Yang, Tai-Hua/0000-0001-5068-2570	National Science Council, Taiwan [NSC100-2627-B-006-017]; Asian Institute of TeleSurgery (AITS), Chang Bing Show Chwan Memorial Hospital, TAIWAN	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Asian Institute of TeleSurgery (AITS), Chang Bing Show Chwan Memorial Hospital, TAIWAN	This study was supported by a grant from National Science Council grant NSC100-2627-B-006-017, Taiwan.; The authors gratefully acknowledge the Asian Institute of TeleSurgery (AITS), Chang Bing Show Chwan Memorial Hospital, TAIWAN, for their support and help. This study was supported by a grant from National Science Council grant NSC100-2627-B-006-017, TAIWAN.	ABRAHAMSSON SO, 1994, ACTA ORTHOP SCAND, V65, P548, DOI 10.3109/17453679409000912; An KN, 2007, J BIOMECH, V40, P713, DOI 10.1016/j.jbiomech.2006.10.008; AN KN, 1985, J ORTHOP RES, V3, P202, DOI 10.1002/jor.1100030210; AN KN, 1979, J BIOMECH, V12, P775, DOI 10.1016/0021-9290(79)90163-5; AN KN, 1983, J BIOMECH, V16, P419, DOI 10.1016/0021-9290(83)90074-X; ARMSTRONG TJ, 1978, J BIOMECH, V11, P119, DOI 10.1016/0021-9290(78)90004-0; BACKHOUSE KM, 1954, J ANAT, V88, P133; BECKER JC, 1988, IEEE T BIO-MED ENG, V35, P110, DOI 10.1109/10.1348; Birglen L, 2004, IEEE T ROBOTIC AUTOM, V20, P211, DOI 10.1109/TRA.2004.824641; BRAND PW, 1981, J HAND SURG-AM, V6, P209, DOI 10.1016/S0363-5023(81)80072-X; Bright D, 1976, T ORTHOP RES SOC, V1, P240; BROOK N, 1995, MED ENG PHYS, V17, P54, DOI 10.1016/1350-4533(95)90378-O; CHAO EY, 1976, J BIOMECH, V9, P387, DOI 10.1016/0021-9290(76)90116-0; CHAO EY, 1978, J ENG MECH DIV-ASCE, V104, P255; Chiu HY, 1998, J HAND SURG-BRIT EUR, V23B, P788, DOI 10.1016/S0266-7681(98)80098-3; DARLING WG, 1994, J BIOMECH, V27, P479, DOI 10.1016/0021-9290(94)90023-X; DARLING WG, 1990, J NEUROPHYSIOL, V63, P1098, DOI 10.1152/jn.1990.63.5.1098; Dennerlein JT, 1999, J ORTHOPAED RES, V17, P178, DOI 10.1002/jor.1100170205; Franko OI, 2011, J BIOMECH, V44, P1987, DOI 10.1016/j.jbiomech.2011.04.025; Goehler CM, 2010, J BIOMECH, V43, P1553, DOI 10.1016/j.jbiomech.2010.01.032; GREENWALD D, 1994, J HAND SURG-AM, V19A, P626, DOI 10.1016/0363-5023(94)90272-0; HIROSE S, 1978, MECH MACH THEORY, V13, P351, DOI 10.1016/0094-114X(78)90059-9; Kamper DG, 2002, J BIOMECH, V35, P1581, DOI 10.1016/S0021-9290(02)00229-4; Kaufmann Robert A, 2007, Am J Orthop (Belle Mead NJ), V36, pE128; Ketchum L D, 1978, J Hand Surg Am, V3, P205; Kociolek AM, 2011, J BIOMECH, V44, P1967, DOI 10.1016/j.jbiomech.2011.05.002; Kuo LC, 2009, J ELECTROMYOGR KINES, V19, P829, DOI 10.1016/j.jelekin.2008.07.008; Kuo PL, 2006, J BIOMECH, V39, P2934, DOI 10.1016/j.jbiomech.2005.10.028; Kursa K, 2006, J ORTHOP RES, V24, P763, DOI 10.1002/jor.20110; LANDSMEE.JM, 1965, ACTA ANAT, V60, P330; LANDSMEER J M, 1961, Acta Morphol Neerl Scand, V3, P287; Lee SW, 2009, IEEE T BIO-MED ENG, V56, P2253, DOI 10.1109/TBME.2009.2019119; Li K, 2010, J BIOMECH, V43, P2618, DOI 10.1016/j.jbiomech.2010.05.003; Li ZM, 2001, J BIOMECH, V34, P1097, DOI 10.1016/S0021-9290(01)00061-6; Li ZM, 2000, CLIN BIOMECH, V15, P203, DOI 10.1016/S0268-0033(99)00058-3; LONG C, 1964, J BONE JOINT SURG AM, V46, P1683, DOI 10.2106/00004623-196446080-00005; Nikanjarn M, 2007, HUM MOVEMENT SCI, V26, P1, DOI 10.1016/j.humov.2006.09.002; Nimbarte Ashish D, 2008, J Orthop Surg Res, V3, P27, DOI 10.1186/1749-799X-3-27; Odhner LU, 2015, INT J ROBOT RES, V34, P1347, DOI 10.1177/0278364914558494; Odhner LU, 2014, INT J ROBOT RES, V33, P736, DOI 10.1177/0278364913514466; Odhner LU, 2013, EXPT ROBOTICS, P27; Odhner LU, 2012, P IEEE INT C ROB AUT; Pearlman JL, 2004, J ORTHOP RES, V22, P306, DOI 10.1016/j.orthres.2003.08.001; Peck FH, 1998, J HAND SURG-BRIT EUR, V23B, P41, DOI 10.1016/S0266-7681(98)80216-7; Sancho-Bru JL, 2001, J BIOMECH, V34, P1491, DOI 10.1016/S0021-9290(01)00106-3; SCHUIND F, 1992, J HAND SURG-AM, V17A, P291, DOI 10.1016/0363-5023(92)90408-H; Spanjer SAJ, 2012, 2 ASME IFTOMM INT C; Tanaka Tatsuro, 2005, J Hand Ther, V18, P330, DOI 10.1197/j.jht.2005.04.001; Towles JD, 2004, J HAND SURG-AM, V29A, P1056, DOI 10.1016/j.jhsa.2004.07.005; Valero-Cuevas FJ, 1998, J BIOMECH, V31, P693, DOI 10.1016/S0021-9290(98)00082-7; Valero-Cuevas FJ, 2000, J NEUROPHYSIOL, V83, P1469, DOI 10.1152/jn.2000.83.3.1469; Valero-Cuevas FJ, 2000, J BIOMECH, V33, P1601, DOI 10.1016/S0021-9290(00)00131-7; Van Ee CA, 2000, J BIOMECH ENG-T ASME, V122, P9, DOI 10.1115/1.429621; WEHBE MA, 1987, AM J OCCUP THER, V41, P164, DOI 10.5014/ajot.41.3.164	54	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160301	10.1371/journal.pone.0160301	http://dx.doi.org/10.1371/journal.pone.0160301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513744	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000381381100031
J	Zeng, ZC; Liu, CM; Luo, SJ; Chen, J; Gong, ES				Zeng, Zicong; Liu, Chengmei; Luo, Shunjing; Chen, Jun; Gong, Ersheng			The Profile and Bioaccessibility of Phenolic Compounds in Cereals Influenced by Improved Extrusion Cooking Treatment	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; RICE; BARLEY; ACIDS; BIOAVAILABILITY; POLYPHENOLS; PRODUCTS; HEALTH; GRAINS; BRAN	The aim of this study was to investigate the effect of Improved Extrusion Cooking Treatment (IECT) on the phenolics and its bioaccessibility in cereals, represented by brown rice, wheat, and oat. Data showed that total phenolic content and total antioxidant activity in free form were significantly decreased, while the bound form was increased after IECT. After IECT, the total free phenolic acids of brown rice and wheat were significantly decreased by 5.88% and 45.66%, respectively, while the total bound phenolic acids of brown rice, wheat, and oat were significantly increased by 6.45%, 8.78%, and 9.10%, respectively. Brown rice provided the most bioaccessible phenolics and antioxidant compounds, followed by oat and wheat. IECT significantly decreased the bioaccessible phenolics of brown rice and oat by 31.09% and 30.95%, while it had minimal effect on the bioaccessible phenolics of wheat. These results showed that IECT greatly affected the phenolics and its bioaccessibiltiy of cereals, with the effect depending on cereal matrix and the sensitivity of free and bound phenolics. Furthermore, bioaccessible phenolic acids of raw and processed cereals were considerably low, and it slightly contributed to the bioaccessible phenolics.	[Zeng, Zicong; Liu, Chengmei; Luo, Shunjing; Chen, Jun; Gong, Ersheng] Nanchang Univ, State Key Lab Food Sci & Technol, 235 Nanjing East Rd, Nanchang, Jiangxi, Peoples R China	Nanchang University	Luo, SJ (corresponding author), Nanchang Univ, State Key Lab Food Sci & Technol, 235 Nanjing East Rd, Nanchang, Jiangxi, Peoples R China.	luoshunjing@aliyun.com	Gong, Er Sheng/Q-8339-2018; jun, chen/GRX-7622-2022	Gong, Er Sheng/0000-0003-1141-9547; 	National Natural Science Foundation of China [31271953]; Ganpo Outstanding Talents 555 Projects [18000007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ganpo Outstanding Talents 555 Projects	Author (CM Liu) was financially supported by the National Natural Science Foundation of China (31271953), http://www.nsfc.gov.cn/; and Ganpo Outstanding Talents 555 Projects (18000007), http://xxgk.jiangxi.gov.cn/bmgkxx/srst/gzdt/gggs/201008/t20100807_243823.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Estrada BA, 2014, FOOD CHEM, V152, P46, DOI 10.1016/j.foodchem.2013.11.093; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Altan A, 2009, INT J FOOD SCI TECH, V44, P1263, DOI 10.1111/j.1365-2621.2009.01956.x; Anson NM, 2009, J CEREAL SCI, V49, P296, DOI 10.1016/j.jcs.2008.12.001; Bouayed J, 2011, FOOD CHEM, V128, P14, DOI 10.1016/j.foodchem.2011.02.052; Dobberstein D, 2010, J AGR FOOD CHEM, V58, P8927, DOI 10.1021/jf101514j; Hithamani G, 2014, J AGR FOOD CHEM, V62, P11170, DOI 10.1021/jf503450u; Hithamani G, 2014, FOOD CHEM, V164, P55, DOI 10.1016/j.foodchem.2014.04.107; Hole AS, 2013, J AGR FOOD CHEM, V61, P2739, DOI 10.1021/jf3045236; Hole AS, 2012, J AGR FOOD CHEM, V60, P6369, DOI 10.1021/jf300410h; Kern SM, 2003, J AGR FOOD CHEM, V51, P6050, DOI 10.1021/jf0302299; Liu CM, 2011, J CEREAL SCI, V54, P473, DOI 10.1016/j.jcs.2011.09.001; Liu RH, 2007, J CEREAL SCI, V46, P207, DOI 10.1016/j.jcs.2007.06.010; Masisi K, 2016, FOOD CHEM, V196, P90, DOI 10.1016/j.foodchem.2015.09.021; Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z; Miller NJ, 1997, FREE RADICAL RES, V26, P195, DOI 10.3109/10715769709097799; Qiu Y, 2010, FOOD CHEM, V121, P140, DOI 10.1016/j.foodchem.2009.12.021; Sharma P, 2012, FOOD CHEM, V131, P1406, DOI 10.1016/j.foodchem.2011.10.009; Shih MC, 2009, FOOD CHEM, V117, P114, DOI 10.1016/j.foodchem.2009.03.084; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Ti HH, 2015, FOOD CHEM, V178, P186, DOI 10.1016/j.foodchem.2015.01.087; Tian S, 2004, J AGR FOOD CHEM, V52, P4808, DOI 10.1021/jf049446f; Tomas-Barberan FA, 2012, J AGR FOOD CHEM, V60, P8773, DOI 10.1021/jf300671j; Wang W, 2015, FOOD CHEM, V171, P40, DOI 10.1016/j.foodchem.2014.08.095; Yen GC, 2011, EUR J PHARM SCI, V44, P281, DOI 10.1016/j.ejps.2011.08.006; Yu LL, 2002, FOOD CHEM, V78, P457, DOI 10.1016/S0308-8146(02)00156-5; Zielinski H, 2006, MOL NUTR FOOD RES, V50, P824, DOI 10.1002/mnfr.200500258	27	44	45	5	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161086	10.1371/journal.pone.0161086	http://dx.doi.org/10.1371/journal.pone.0161086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513581	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100119
J	Fock, HO; Kraus, G				Fock, Heino O.; Kraus, Gerd			From Metaphors to Formalism: A Heuristic Approach to Holistic Assessments of Ecosystem Health	PLOS ONE			English	Article							MULTICRITERIA DECISION-ANALYSIS; GOOD ENVIRONMENTAL STATUS; SUSTAINABILITY ASSESSMENT; MARINE ECOSYSTEMS; ECOLOGICAL STATUS; RISK-ASSESSMENT; INDICATORS; FRAMEWORK; SCIENCE; MANAGEMENT	Environmental policies employ metaphoric objectives such as ecosystem health, resilience and sustainable provision of ecosystem services, which influence corresponding sustainability assessments by means of normative settings such as assumptions on system description, indicator selection, aggregation of information and target setting. A heuristic approach is developed for sustainability assessments to avoid ambiguity and applications to the EU Marine Strategy Framework Directive (MSFD) and OSPAR assessments are presented. For MSFD, nineteen different assessment procedures have been proposed, but at present no agreed assessment procedure is available. The heuristic assessment framework is a functional-holistic approach comprising an ex-ante/ex-post assessment framework with specifically defined normative and systemic dimensions (EAEPNS). The outer normative dimension defines the ex-ante/ex-post framework, of which the latter branch delivers one measure of ecosystem health based on indicators and the former allows to account for the multi-dimensional nature of sustainability (social, economic, ecological) in terms of modeling approaches. For MSFD, the ex-ante/ex-post framework replaces the current distinction between assessments based on pressure and state descriptors. The exante and the ex-post branch each comprise an inner normative and a systemic dimension. The inner normative dimension in the ex-post branch considers additive utility models and likelihood functions to standardize variables normalized with Bayesian modeling. Likelihood functions allow precautionary target setting. The ex-post systemic dimension considers a posteriori indicator selection by means of analysis of indicator space to avoid redundant indicator information as opposed to a priori indicator selection in deconstructive-structural approaches. Indicator information is expressed in terms of ecosystem variability by means of multivariate analysis procedures. The application to the OSPAR assessment for the southern North Sea showed, that with the selected 36 indicators 48% of ecosystem variability could be explained. Tools for the ex-ante branch are risk and ecosystem models with the capability to analyze trade-offs, generating model output for each of the pressure chains to allow for a phasing-out of human pressures. The Bayesian measure of ecosystem health is sensitive to trends in environmental features, but robust to ecosystem variability in line with state space models. The combination of the ex-ante and ex-post branch is essential to evaluate ecosystem resilience and to adopt adaptive management. Based on requirements of the heuristic approach, three possible developments of this concept can be envisioned, i.e. a governance driven approach built upon participatory processes, a science driven functional-holistic approach requiring extensive monitoring to analyze complete ecosystem variability, and an approach with emphasis on ex-ante modeling and ex-post assessment of well-studied subsystems.	[Fock, Heino O.; Kraus, Gerd] ThunenInst Sea Fisheries, Hamburg, Germany		Fock, HO (corresponding author), ThunenInst Sea Fisheries, Hamburg, Germany.	Heino.fock@thuenen.de		Fock, Heino/0000-0003-2902-3559	Federal Ministry of Research and Education (BMBF) [FKZ 03F0671A]; BMBF [FKZ 03F0671A]	Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Research and Education (BMBF; www.bmbf.de). Project name:'NOAH - Assessment of seafloor state in the German North Sea', Grant number FKZ 03F0671A. The work was carried out within NOAH, but authors sere not funded through the project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work has been supported through the BMBF funded project 'NOAH-Assessment of seafloor state in the German North Sea' (FKZ 03F0671A). The comments of three anonymous reviewers and Howard Browman on an earlier version of this manuscript are gratefully acknowledged.	Andersen JH, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00055; Arkema KK, 2012, AM FISH S S, V79, P9; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; Bebbington J, 2007, ECOL ECON, V61, P224, DOI 10.1016/j.ecolecon.2006.10.021; Bertram C, 2014, MAR POLICY, V43, P307, DOI 10.1016/j.marpol.2013.06.016; Bhatia R, 2008, ENVIRON HEALTH PERSP, V116, P991, DOI 10.1289/ehp.11132; Binder C. R., 2010, Building sustainable rural futures: the added value of systems approaches in times of change and uncertainty. 9th European IFSA Symposium, Vienna, Austria, 4-7 July 2010, P801; Black M, 1962, MODELS METAPHORS; Blanchard JL, 2010, ICES J MAR SCI, V67, P732, DOI 10.1093/icesjms/fsp282; Bohringer C, 2007, ECOL ECON, V63, P1, DOI 10.1016/j.ecolecon.2007.03.008; Booysen F, 2002, SOC INDIC RES, V59, P115, DOI 10.1023/A:1016275505152; Borja A, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00072; Borja A, 2013, MAR POLLUT BULL, V76, P16, DOI 10.1016/j.marpolbul.2013.08.042; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Borja A, 2010, MAR POLLUT BULL, V60, P1143, DOI 10.1016/j.marpolbul.2010.06.026; Bossel H, 2002, CONSERV ECOL, V5; Calbick KS, 2011, EVALUATING NATL ENV; Calow P., 1992, Journal of Aquatic Ecosystem Health, V1, P1, DOI 10.1007/BF00044403; Carolan M.S, 2008, CRIT SOCIOL, V34, P725, DOI DOI 10.1177/0896920508093365; Carolan MS, 2006, SOC NATUR RESOUR, V19, P921, DOI 10.1080/08941920600902112; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carstensen J, 2007, MAR POLLUT BULL, V55, P3, DOI 10.1016/j.marpolbul.2006.08.016; Carstensen J, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00033; CIS working Group, 2013, COMM IMPL STRAT; Claussen U., 2011, COMMON UNDERSTANDING; Costanza Robert, 1999, Aquatic Ecology, V33, P105, DOI 10.1023/A:1009930313242; Costanza R, 2012, ECOL ENG, V45, P24, DOI 10.1016/j.ecoleng.2012.03.023; Costanza Robert, 1992, P239; CPMR, 2014, TECHN PAP CPMR GEN S; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Deutsch L, 2003, ECOL ECON, V44, P205, DOI 10.1016/S0921-8009(02)00274-4; Ebert U, 2004, J ENVIRON ECON MANAG, V47, P270, DOI 10.1016/j.jeem.2003.09.001; Environment Canada U. S. Environmemntal Protection Agency, 2014, STAT GREAT LAK 2011; Ewing B., 2010, CALCULATION METHODOL, V2010; FAO, 1999, IND SUST DEV MAR CAP; Fischherz B, 2010, METAPHORS SUSTAINABI; Fock H, 2011, HUM ECOL RISK ASSESS, V17, P187, DOI 10.1080/10807039.2011.538634; Fock HO, 2014, J SEA RES, V85, P325, DOI 10.1016/j.seares.2013.06.004; Fock HO, 2011, ENVIRON SCI POLICY, V14, P289, DOI 10.1016/j.envsci.2010.11.005; Froese R, 2015, MAR POLICY, V51, P230, DOI 10.1016/j.marpol.2014.07.012; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; Gasparatos A, 2009, ACCOUNT FORUM, V33, P245, DOI 10.1016/j.accfor.2008.07.006; Grant Michigan Sea, 2009, TACKL WICK PROBL INT; Greenstreet S.P.R., 2012, ICES J MAR SCI, V69, P343, DOI DOI 10.1093/ICESJMS/FSR201; Greenstreet SPR, 2012, ICES J MAR SCI, V69, P1789, DOI 10.1093/icesjms/fss148; Greenstreet SPR, 2012, ICES J MAR SCI, V69, P8, DOI 10.1093/icesjms/fsr188; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hatton-Ellis T, 2008, AQUAT CONSERV, V18, P111, DOI 10.1002/aqc.947; HELCOM, 2010, EC HLTH BALT SEA 200, V122; HELCOM, 2014, 462014 HELCOM HOD; HELCOM, 2013, HELCOM COR IND FIN R; Held L, 2008, METHODS STAT INFEREN; Herrick C, 2000, SCI TECHNOL HUM VAL, V25, P309, DOI 10.1177/016224390002500303; Heslenfeld P, 2008, ICES J MAR SCI, V65, P1392, DOI 10.1093/icesjms/fsn159; Hilborn R, 2003, SCI MAR, V67, P15, DOI 10.3989/scimar.2003.67s115; HILBORN R, 1997, MONOGRAPHS POPULATIO; Hobbs NT, 2006, ECOL APPL, V16, P5, DOI 10.1890/04-0645; Hoffman R. R., 1980, COGNITION FIGURATIVE, P393; Hull RB, 2003, ENVIRON MANAGE, V31, P1, DOI 10.1007/s00267-002-2812-6; Hurlbert SH, 1997, AUST J ECOL, V22, P369, DOI 10.1111/j.1442-9993.1997.tb00687.x; Johnson D, 2008, ICES J MAR SCI, V65, P1387, DOI 10.1093/icesjms/fsn154; Jorgensen SE, 2005, HANDBOOK OF ECOLOGICAL INDICATORS FOR ASSESSMENT OF ECOSYSTEM HEALTH, P5; Jorgensen SE, 2005, HANDBOOK OF ECOLOGICAL INDICATORS FOR ASSESSMENT OF ECOSYSTEM HEALTH, P1; Kailiponi P, 2010, PROCEDIA ENGINEER, V3, P163, DOI 10.1016/j.proeng.2010.07.016; Kates RW, 2001, SCIENCE, V292, P641, DOI 10.1126/science.1059386; Kates RW, 2003, P NATL ACAD SCI USA, V100, P8062, DOI 10.1073/pnas.1231331100; Keller EF, 2005, BIOSCIENCE, V55, P1069, DOI 10.1641/0006-3568(2005)055[1069:EOAM]2.0.CO;2; Kershner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025248; Kiker GA, 2005, INTEGR ENVIRON ASSES, V1, P95, DOI 10.1897/IEAM_2004a-015.1; Kirkebooen G, 2009, MAKING ESSENTIAL CHO, P169, DOI DOI 10.1057/9780230236837; Knights AM, 2013, ECOL APPL, V23, P755, DOI 10.1890/12-1137.1; Kruse J, 2011, METAPHERNANALYSEN RE; Kueffer C, 2014, BIOSCIENCE, V64, P719, DOI 10.1093/biosci/biu084; Lackey RT, 2007, CONSERV BIOL, V21, P12, DOI 10.1111/j.1523-1739.2006.00639.x; Lackey RT, 2001, BIOSCIENCE, V51, P437, DOI 10.1641/0006-3568(2001)051[0437:VPAEH]2.0.CO;2; Lakoff G., 1980, METAPHORS WE LIVE; Larson B., 2011, METAPHORS ENV SUSTAI; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Levin R, 1998, ECOSYST HEALTH, P53; Levin SA, 2005, BIOSCIENCE, V55, P1075, DOI 10.1641/0006-3568(2005)055[1075:SATEOC]2.0.CO;2; Linkov I, 2006, ENVIRON INT, V32, P1072, DOI 10.1016/j.envint.2006.06.013; Loreau M, 2010, MONOGR POPUL BIOL, V46, P1; Lu Y., 2015, COMPUT OPTIM APPL, V1, P1, DOI DOI 10.1126/SCIADV.1400039; Mangel M, 1986, NAT RESOUR MODEL, V1, P1; Mars MM, 2012, ORGAN DYN, V41, P271, DOI 10.1016/j.orgdyn.2012.08.002; Mayer AL, 2008, ENVIRON INT, V34, P277, DOI 10.1016/j.envint.2007.09.004; Mee LD, 2008, MAR POLLUT BULL, V56, P187, DOI 10.1016/j.marpolbul.2007.09.038; Menzie CA, 2012, INTEGR ENVIRON ASSES, V8, P401, DOI 10.1002/ieam.1279; Metaphor Black M., 1955, P ARISTOTELIAN SOC, V55, P273; MIKKELSON G.M., 1997, PERSPECTIVES SCI, V5, P481; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Mollmann C, 2009, GLOBAL CHANGE BIOL, V15, P1377, DOI 10.1111/j.1365-2486.2008.01814.x; Mori K, 2012, ENVIRON IMPACT ASSES, V32, P94, DOI 10.1016/j.eiar.2011.06.001; Moser K. S., 2000, FORUM QUALITATIVE SO, V1, P87; Nardo M., 2005, HDB CONSTRUCTING COM, V2005/3, DOI DOI 10.1787/533411815016; Ness B., 2007, ECOL ECON, V60, P498, DOI [DOI 10.1016/J.ECOLECON.2006.07.023, 10.1016/j.ecolecon.2006.07.023]; Niemeijer D., 2002, ENVIRON SCI POLICY, V5, P91, DOI [DOI 10.1016/S1462-9011(02)00026-6, 10.1016/S1462-9011(02)00026-6]; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Norgaard RB, 2010, ECOL ECON, V69, P1219, DOI 10.1016/j.ecolecon.2009.11.009; Ojaveer H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019231; OSPAR, 2010, QUAL STAT REP 2010; OSPAR Commission, 2009, EV OSPAR SYST EC QUA; OSPAR Commission, 2009, REP UTR WORKSH REG A; Parris TM, 2003, P NAT AC SC US, V100, P8063; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Patricio J, 2014, DELIVERABLE; Pickett STA, 2002, ECOSYSTEMS, V5, P1, DOI 10.1007/s10021-001-0051-y; Pinter L, 2012, ECOL INDIC, V17, P20, DOI 10.1016/j.ecolind.2011.07.001; Prins T, 2014, COHERENT GEOGRAPHIC; Probst WN, 2012, ICES J MAR SCI, V69, P670, DOI 10.1093/icesjms/fss015; Proctor JD, 2005, BIOSCIENCE, V55, P1065, DOI 10.1641/0006-3568(2005)055[1065:ECAM]2.0.CO;2; Rapport D., 1998, ECOSYST HEALTH, P3; Rapport D, 1998, ECOSYST HEALTH, P34; Rapport D., 1998, ECOSYST HEALTH, P18; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Rapport DJ, 2009, ENCY LIFE SUPPORT SY, P325; Raymond CM, 2013, BIOSCIENCE, V63, P536, DOI 10.1525/bio.2013.63.7.7; Reed M, 2005, ECOL SOC, V10, DOI 10.5751/ES-01296-1001r03; Reis S, 2015, PUBLIC HEALTH, V129, P1383, DOI 10.1016/j.puhe.2013.07.006; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Rickels W, 2014, ENVIRON RES LETT, V9, P15; Ross N, 1997, CAN GEOGR-GEOGR CAN, V41, P114, DOI 10.1111/j.1541-0064.1997.tb01152.x; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; Sarewitz D, 2004, ENVIRON SCI POLICY, V7, P385, DOI 10.1016/j.envsci.2004.06.001; Schernewski G, 2015, MAR POLICY, V51, P305, DOI 10.1016/j.marpol.2014.09.002; Schluter M., 2015, PRINCIPLES BUILDING, P251, DOI [10.1017/CBO9781316014240.011, DOI 10.1017/CBO9781316014240.011]; Schmitt R, 2005, QUAL REP, V10, P358; Schon DA, 1993, METAPHOR THOUGHT, DOI DOI 10.1017/CBO9781139173865.011; Schoon M.L, 2015, PRINCIPLES BUILDING, P32, DOI [10.1017/CBO9781316014240.003, DOI 10.1017/CBO9781316014240.003]; Selkoe Kimberly, 2015, Ecosystem Health and Sustainability, V1, P17, DOI 10.1890/EHS14-0024.1; Shear H, 2005, DEV APPL ECOSYSTEM H, P105; Sherman BH, 2000, MAR POLLUT B, V41, P1; Shin YJ, 2010, ICES J MAR SCI, V67, P692, DOI 10.1093/icesjms/fsp294; Singh RK, 2009, ECOL INDIC, V9, P189, DOI 10.1016/j.ecolind.2008.05.011; Smith C, 2014, CONCEPTUAL MODELS EF, V1.1; Stefan D, 2011, 3 INT WORKSH SOFTW R; Stelzenmuller V, 2015, ICES J MAR SCI, V72, P1022, DOI 10.1093/icesjms/fsu206; Strauss S., 2009, COMMUNICATING BIOL S, P153; Tett P, 2013, MAR ECOL PROG SER, V494, P1, DOI 10.3354/meps10539; Triantaphyllou E, 1998, ENCY ELECT ELECT ENG, V15, P175; van Leeuwen J, 2014, MAR POLICY, V50, P325, DOI 10.1016/j.marpol.2014.03.004; Visbeck M, 2014, MAR POLICY, V48, P184, DOI 10.1016/j.marpol.2014.03.005; von Winterfeldt D, 1973, MULTIATTRIBUTE UTILI; Voss R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107811; Waas T, 2014, SUSTAINABILITY-BASEL, V6, P5512, DOI 10.3390/su6095512; Walker B, 2002, CONSERV ECOL, V6; Wells PG, 2005, HANDBOOK OF ECOLOGICAL INDICATORS FOR ASSESSMENT OF ECOSYSTEM HEALTH, P395; Wiek A, 2005, ENVIRON IMPACT ASSES, V25, P589, DOI 10.1016/j.eiar.2004.09.009; Xu W, 2001, AGR ECOSYST ENVIRON, V83, P215, DOI 10.1016/S0167-8809(00)00159-6; Yigitcanlar Tan, 2010, Sustainability, V2, P321, DOI 10.3390/su2010321; Zacharias MA, 2001, AQUAT CONSERV, V11, P59, DOI 10.1002/aqc.429	154	3	3	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159481	10.1371/journal.pone.0159481	http://dx.doi.org/10.1371/journal.pone.0159481			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KR	27509185	gold, Green Submitted, Green Published			2022-12-26	WOS:000381380400009
J	Lee, KE; Moon, CM; Yoon, HJ; Kim, BS; Chang, JY; Son, HM; Ryu, MS; Kim, SE; Shim, KN; Jung, HK; Jung, SA				Lee, Ko Eun; Moon, Chang Mo; Yoon, Hai-Jeon; Kim, Bom Sahn; Chang, Ji Young; Son, Hyo Moon; Ryu, Min Sun; Kim, Seong-Eun; Shim, Ki-Nam; Jung, Hye-Kyung; Jung, Sung-Ae			Background Colonic F-18-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma	PLOS ONE			English	Article							METABOLIC SYNDROME; INSULIN-RESISTANCE; INCREASED RISK; OBESITY; CANCER; RIFAXIMIN; PET/CT; DYSLIPIDEMIA; INFLAMMATION; POPULATION	F-18-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) scan is used to evaluate various kinds of tumors. While most studies on PET findings of the colon focus on the colonic uptake pattern, studies regarding background colonic uptake on PET scan are rare. The purpose of this study was to identify the association between the background colonic uptake and the presence of colorectal adenoma (CRA), which is a frequent precancerous lesion. We retrospectively reviewed the medical records of 241 patients with gynecologic malignancy who had received PET or PET/computed tomography (CT) scan and colonoscopy at the same period as a baseline evaluation. Background colonic F-18-FDG uptake was visually graded and the maximal standardized uptake values (SUVmax) of 7 different bowel segments were averaged. In univariate analysis, older age at diagnosis (>= 50 years, p = 0.034), overweight (BMI >= 23 kg/m(2), p = 0.010), hypercholesterolemia (>= 200 mg/dL, p = 0.027), and high grade background colonic uptake (p = 0.009) were positively associated with the prevalence of CRA. By multiple logistic regression, high grade background colonic uptake was independently predictive of CRA (odds ratio = 2.25, p = 0.021). The proportion of CRA patients significantly increased as background colonic uptake grade increased from 1 to 4 (trend p = 0.015). Out of the 138 patients who underwent PET/CT, the proportion of CRA patients in the group with high SUVmax (>2.25) was significantly higher than in the low SUVmax group (27.5% vs. 11.6%, p = 0.031). In conclusion, high grade of background colonic F-18-FDG uptake is significantly associated with the prevalence of CRA.	[Lee, Ko Eun; Moon, Chang Mo; Chang, Ji Young; Son, Hyo Moon; Ryu, Min Sun; Kim, Seong-Eun; Shim, Ki-Nam; Jung, Hye-Kyung; Jung, Sung-Ae] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Yoon, Hai-Jeon; Kim, Bom Sahn] Ewha Womans Univ, Sch Med, Dept Nucl Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Moon, CM (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea.; Kim, BS (corresponding author), Ewha Womans Univ, Sch Med, Dept Nucl Med, Seoul, South Korea.	mooncm27@ewha.ac.kr; kbomsahn@ewha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2014R1A1A2058325, NRF-2012M3A9B6055379]; Ewha Womans University Research Grant	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Ewha Womans University Research Grant	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number, NRF-2014R1A1A2058325) and (grant number, NRF-2012M3A9B6055379) and the Ewha Womans University Research Grant of 2014.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Aronchick CA, 2000, GASTROINTEST ENDOSC, V52, P346, DOI 10.1067/mge.2000.108480; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Bird CL, 1998, AM J EPIDEMIOL, V147, P670, DOI 10.1093/oxfordjournals.aje.a009508; Cook GJR, 2004, SEMIN NUCL MED, V34, P122, DOI 10.1053/j.semnuclmed.2003.12.003; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Dulal S, 2014, CANCER J, V20, P225, DOI 10.1097/PPO.0000000000000050; DuPont HL, 2016, ALIMENT PHARM THER, V43, P3, DOI 10.1111/apt.13434; Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004; FALK PM, 1994, DIS COLON RECTUM, V37, P153, DOI 10.1007/BF02047538; Franquet E, 2014, NUCL MED COMMUN, V35, P1026, DOI 10.1097/MNM.0000000000000170; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6; Gutman F, 2005, AM J ROENTGENOL, V185, P495, DOI 10.2214/ajr.185.2.01850495; Kaaks R, 2001, P NUTR SOC, V60, P91, DOI 10.1079/PNS200070; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kang HW, 2010, AM J GASTROENTEROL, V105, P178, DOI 10.1038/ajg.2009.541; Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398; Kei Pin Lin, 2010, AJR Am J Roentgenol, V194, pW401, DOI 10.2214/AJR.09.3703; Kim BC, 2012, CANCER CAUSE CONTROL, V23, P727, DOI 10.1007/s10552-012-9942-9; Kim Seok ki, 1999, Clin Positron Imaging, V2, P273, DOI 10.1016/S1095-0397(99)00030-8; Kim Y, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-4; Liu CS, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-51; Nagata N, 2014, INT J CANCER, V135, P2273, DOI 10.1002/ijc.28872; Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727; Oh JR, 2010, AM J ROENTGENOL, V195, P1404, DOI 10.2214/AJR.10.4663; Siddiqui AA, 2011, AM J MED SCI, V341, P227, DOI 10.1097/MAJ.0b013e3181df9055; Tatlidil R, 2002, RADIOLOGY, V224, P783, DOI 10.1148/radiol.2243011214; Valk PE, 1999, ARCH SURG-CHICAGO, V134, P503, DOI 10.1001/archsurg.134.5.503; Xu DB, 2014, GASTROENTEROLOGY, V146, P484, DOI 10.1053/j.gastro.2013.10.026; Yang MH, 2013, AM J GASTROENTEROL, V108, P833, DOI 10.1038/ajg.2013.64; Yasuda S, 2001, J NUCL MED, V42, P989; Yoon HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141473; Yun KE, 2013, CANCER RES, V73, P4020, DOI 10.1158/0008-5472.CAN-12-3477	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160886	10.1371/journal.pone.0160886	http://dx.doi.org/10.1371/journal.pone.0160886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509022	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400060
J	Liu, Y; Sun, CF; Li, Q; Cai, QF				Liu, Yu; Sun, Changfeng; Li, Qiang; Cai, Qiufang			A Picea crassifolia Tree-Ring Width-Based Temperature Reconstruction for the Mt. Dongda Region, Northwest China, and Its Relationship to Large-Scale Climate Forcing	PLOS ONE			English	Article							NORTHEASTERN TIBETAN PLATEAU; MEAN MAXIMUM TEMPERATURE; NORTHERN-HEMISPHERE; INNER-MONGOLIA; ANNUAL PRECIPITATION; PINUS-TABULAEFORMIS; PAST MILLENNIUM; VARIABILITY; AD; OSCILLATION	The historical May-October mean temperature since 1831 was reconstructed based on tree-ring width of Qinghai spruce (Picea crassifolia Kom.) collected on Mt. Dongda, North of the Hexi Corridor in Northwest China. The regression model explained 46.6% of the variance of the instrumentally observed temperature. The cold periods in the reconstruction were 1831-1889, 1894-1901, 1908-1934 and 1950-1952, and the warm periods were 1890-1893, 1902-1907, 1935-1949 and 1953-2011. During the instrumental period (1951-2011), an obvious warming trend appeared in the last twenty years. The reconstruction displayed similar patterns to a temperature reconstruction from the east-central Tibetan Plateau at the inter-decadal timescale, indicating that the temperature reconstruction in this study was a reliable proxy for Northwest China. It was also found that the reconstruction series had good consistency with the Northern Hemisphere temperature at a decadal timescale. Multi-taper method spectral analysis detected some low-and high-frequency cycles (2.3-2.4-year, 2.8-year, 3.4-3.6-year, 5.0-year, 9.9-year and 27.0-year). Combining these cycles, the relationship of the low-frequency change with the Pacific Decadal Oscillation (PDO), North Atlantic Oscillation (NAO) and Southern Oscillation (SO) suggested that the reconstructed temperature variations may be related to large-scale atmospheric-oceanic variations. Major volcanic eruptions were partly reflected in the reconstructed temperatures after high-pass filtering; these events promoted anomalous cooling in this region. The results of this study not only provide new information for assessing the long-term temperature changes in the Hexi Corridor of Northwest China, but also further demonstrate the effects of large-scale atmospheric-oceanic circulation on climate change in Northwest China.	[Liu, Yu; Sun, Changfeng] Xi An Jiao Tong Univ, Dept Earth & Environm Sci, Sch Human Settlements & Civil Engn, Xian 710049, Peoples R China; [Liu, Yu; Sun, Changfeng; Li, Qiang; Cai, Qiufang] Chinese Acad Sci, State Key Lab Loess & Quaternary Geol, Inst Earth Environm, Xian 710061, Peoples R China; [Liu, Yu; Li, Qiang] Beijing Normal Univ, JCGCS, Beijing 100875, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Beijing Normal University	Liu, Y (corresponding author), Xi An Jiao Tong Univ, Dept Earth & Environm Sci, Sch Human Settlements & Civil Engn, Xian 710049, Peoples R China.; Liu, Y (corresponding author), Chinese Acad Sci, State Key Lab Loess & Quaternary Geol, Inst Earth Environm, Xian 710061, Peoples R China.; Liu, Y (corresponding author), Beijing Normal Univ, JCGCS, Beijing 100875, Peoples R China.	liuyu@loess.llqg.ac.cn	Sun, Changfeng/X-2375-2019; Liu, Yu/AAA-6165-2019	Sun, Changfeng/0000-0001-8648-8120; liu, yu/0000-0002-1402-0737	National Basic Research Program of China [2013CB955903]; Chinese Academy of Sciences [KZZD-EW-04-01]; State Key Laboratory of Loess and Quaternary Geology Foundation 366 [SKLLQG1317]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Loess and Quaternary Geology Foundation 366	This work was jointly supported by the National Basic Research Program of China (2013CB955903), the Chinese Academy of Sciences (KZZD-EW-04-01), and the State Key Laboratory of Loess and Quaternary Geology Foundation 366 (SKLLQG1317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Ammann CM, 2007, CLIMATIC CHANGE, V85, P71, DOI 10.1007/s10584-007-9276-x; Bai DZ, 2012, IMPACT FACTORS GROWT; Bao G, 2012, CHINESE SCI BULL, V57, P4765, DOI 10.1007/s11434-012-5547-7; Bao G, 2012, PALAEOGEOGR PALAEOCL, V313, P162, DOI 10.1016/j.palaeo.2011.10.017; Briffa KR, 2002, HOLOCENE, V12, P759, DOI 10.1191/0959683602hl588rp; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Cai Q, 2014, CLIM PAST, V10, P509, DOI 10.5194/cp-10-509-2014; Cai QF, 2013, QUATERN INT, V283, P3, DOI 10.1016/j.quaint.2012.03.034; Chen F, 2011, J ARID ENVIRON, V75, P1121, DOI 10.1016/j.jaridenv.2011.06.010; Chen F, 2013, BOREAS, V42, P1008, DOI 10.1111/bor.12017; Chen ZJ, 2013, QUATERN INT, V283, P21, DOI 10.1016/j.quaint.2012.07.005; Chen ZS, 2017, THEOR APPL CLIMATOL, V128, P945, DOI 10.1007/s00704-016-1752-7; Cook E.R., 2013, METHODS DENDROCHRONO; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 2004, QUATERNARY SCI REV, V23, P2063, DOI 10.1016/j.quascirev.2004.08.013; D'Arrigo R, 2005, CLIM DYNAM, V24, P227, DOI [10.1007/s00382-004-0502-1, 10.1007/s00382-004-0502-l]; D'Arrigo R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006352; D'Arrigo RD, 1999, CLIMATIC CHANGE, V41, P1, DOI 10.1023/A:1005370210796; Duan JP, 2012, CLIM DYNAM, V39, P919, DOI 10.1007/s00382-011-1232-9; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Fan ZX, 2008, INT J CLIMATOL, V28, P1879, DOI 10.1002/joc.1689; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Feldstein SB, 2003, Q J ROY METEOR SOC, V129, P901, DOI 10.1256/qj.02.76; Fritts H. C., 1976, TREE RINGS CLIMATE; Anonymous, 2008, P97, DOI 10.1007/978-3-540-79242-0_1; Gervais BR, 2001, HOLOCENE, V11, P499, DOI 10.1191/095968301678302940; Gou XH, 2014, QUATERNARY RES, V81, P508, DOI 10.1016/j.yqres.2013.09.005; [郭小芹 GUO Xiao-qin], 2011, [中国沙漠, Journal of Desert Research], V31, P1323; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Huang SP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019781; Jia PQ, 2001, PLATEAU METEOROLOGY, V20, P225; [贾文雄 JIA Wenxiong], 2008, [中国沙漠, Journal of Desert Research], V28, P1151; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Lei Y, 2014, CHINESE SCI BULL, V59, P3449, DOI 10.1007/s11434-014-0410-7; Li BF, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017953; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI [10.1038/nclimate1936, 10.1038/NCLIMATE1936]; Liang EY, 2007, CHINESE SCI BULL, V52, P2715, DOI 10.1007/s11434-007-0351-5; Liu N, 2015, PALAEOGEOGR PALAEOCL, V438, P113, DOI 10.1016/j.palaeo.2015.08.003; Liu N, 2013, INT J BIOMETEOROL, V57, P169, DOI 10.1007/s00484-012-0544-8; Liu Y, 2006, SCI CHINA SER D, V49, P408, DOI 10.1007/s11430-006-0408-3; Liu Y, 2014, QUATERNARY SCI REV, V93, P67, DOI 10.1016/j.quascirev.2014.03.023; Liu Y, 2013, PALAEOGEOGR PALAEOCL, V388, P145, DOI 10.1016/j.palaeo.2013.08.011; Liu Y, 2011, CHINESE SCI BULL, V56, P2986, DOI 10.1007/s11434-011-4713-7; Liu Y, 2010, WATER RES, V44, P2781, DOI 10.1016/j.watres.2010.02.013; Liu Y, 2009, SCI CHINA SER D, V52, P348, DOI 10.1007/s11430-009-0025-z; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Melvin TM, 2014, DENDROCHRONOLOGIA, V32, P7, DOI 10.1016/j.dendro.2013.06.002; Peng JJ, 2013, QUATERN INT, V283, P63, DOI 10.1016/j.quaint.2012.07.007; Qiu MX, 1984, ACTA PHYTOECOLOGICA, V8, P235; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Shao X, 2010, QUATERNARY SCI REV, V29, P2111, DOI 10.1016/j.quascirev.2010.05.005; Shi F, 2013, CLIM RES, V56, P231, DOI 10.3354/cr01156; Shi N, 1989, METEOROLOGICAL MONTH, V15, P8; Siebert L, 2012, GLOBAL VOLCANISM PRO; Song J, 1998, INT J CLIMATOL, V18, P1345, DOI 10.1002/(SICI)1097-0088(1998100)18:12<1345::AID-JOC322>3.0.CO;2-J; Stokes M.A., 1996, INTRO TREE RING DATI; Sun JQ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009626; Sun JY, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017290; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tian QH, 2012, SCI CHINA EARTH SCI, V55, P770, DOI 10.1007/s11430-012-4375-6; TIBSHIRANI R, 1986, ANN STAT, V14, P1335, DOI 10.1214/aos/1176350158; Wang B., 2006, ASIAN MONSOON, P1; Watanabe M, 2004, J CLIMATE, V17, P4674, DOI 10.1175/JCLI-3228.1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Yang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057638; Yin XL, 2008, ARID METEOROLOGY, V26, P90; Zhang QB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017425; Zhang Y, 2011, INT J CLIMATOL, V31, P371, DOI 10.1002/joc.2085; Zhu HF, 2013, QUATERN INT, V283, P134, DOI 10.1016/j.quaint.2012.04.011	75	11	13	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160963	10.1371/journal.pone.0160963	http://dx.doi.org/10.1371/journal.pone.0160963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509206	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400072
J	Granot, Y; Tal, O; Rosset, S; Skorecki, K				Granot, Yaron; Tal, Omri; Rosset, Saharon; Skorecki, Karl			On the Apportionment of Population Structure	PLOS ONE			English	Article							CELL-LINE PANEL; GENETIC-STRUCTURE; DIVERSITY; DIFFERENTIATION; CLASSIFICATION; RELATIVES; DISTANCE	Measures of population differentiation, such as F-ST, are traditionally derived from the partition of diversity within and between populations. However, the emergence of population clusters from multilocus analysis is a function of genetic structure (departures from panmixia) rather than of diversity. If the populations are close to panmixia, slight differences between the mean pairwise distance within and between populations (low F-ST) can manifest as strong separation between the populations, thus population clusters are often evident even when the vast majority of diversity is partitioned within populations rather than between them. For any given F-ST value, clusters can be tighter (more panmictic) or looser (more stratified), and in this respect higher F-ST does not always imply stronger differentiation. In this study we propose a measure for the partition of structure, denoted E-ST, which is more consistent with results from clustering schemes. Crucially, our measure is based on a statistic of the data that is a good measure of internal structure, mimicking the information extracted by unsupervised clustering or dimensionality reduction schemes. To assess the utility of our metric, we ranked various human (HGDP) population pairs based on F-ST and E-ST and found substantial differences in ranking order. E-ST ranking seems more consistent with population clustering and classification and possibly with geographic distance between populations. Thus, E-ST may at times outperform F-ST in identifying evolutionary significant differentiation.	[Granot, Yaron; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Granot, Yaron; Skorecki, Karl] Technion Israel Inst Technol, Res Inst, Haifa, Israel; [Granot, Yaron; Skorecki, Karl] Rambam Med Ctr, Haifa, Israel; [Tal, Omri] Max Planck Inst Math Sci, Inselstr 22-26, D-04103 Leipzig, Germany; [Rosset, Saharon] Tel Aviv Univ, Sch Math Sci, Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rambam Health Care Campus; Technion Israel Institute of Technology; Max Planck Society; Tel Aviv University	Granot, Y (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel.; Granot, Y (corresponding author), Technion Israel Inst Technol, Res Inst, Haifa, Israel.; Granot, Y (corresponding author), Rambam Med Ctr, Haifa, Israel.	yarongranot@hotmail.com			Israel Science Foundation [189/05]; Beutler Fund at Rambam Medical Center	Israel Science Foundation(Israel Science Foundation); Beutler Fund at Rambam Medical Center	We thank Alan Templeton for helpful advice, Tat Dat Tran for assisting with one of the proofs in the appendix, Lior Lesch for software support, Sagi Abelson for help with the MATLAB script and two anonymous reviewers. KS wishes to acknowledge the Israel Science Foundation (grant 189/05) and the Beutler Fund at Rambam Medical Center for research support.	Cann HM, 2002, SCIENCE, V296, P261; Darwin C., 1871, P423; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Gao XY, 2009, HUM HERED, V68, P182, DOI 10.1159/000224638; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HUDSON RR, 1992, GENETICS, V132, P583; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Tal O, 2013, BIOSYSTEMS, V111, P18, DOI 10.1016/j.biosystems.2012.07.005; Tal O, 2012, J THEOR BIOL, V293, P206, DOI 10.1016/j.jtbi.2011.10.005; Waples RS, 1991, FNWC194 NOAA NMFS US; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Witherspoon DJ, 2007, GENETICS, V176, P351, DOI 10.1534/genetics.106.067355; Wright S., 1978, EVOLUTION GENETIC PO	22	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160413	10.1371/journal.pone.0160413	http://dx.doi.org/10.1371/journal.pone.0160413			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505172	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200037
J	Lee, A; Lin, A; Shah, K; Singh, H; Miller, V; Rao, SG				Lee, Amanda; Lin, Abraham; Shah, Kajol; Singh, Harpreet; Miller, Vandana; Rao, Shubha Gururaja			Optimization of Non-Thermal Plasma Treatment in an In Vivo Model Organism	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; CELL-DEATH; DROSOPHILA; HEMATOPOIESIS; SYSTEM; OZONE; FLY	Non-thermal plasma is increasingly being recognized for a wide range of medical and biological applications. However, the effect of non-thermal plasma on physiological functions is not well characterized in in vivo model systems. Here we use a genetically amenable, widely used model system, Drosophila melanogaster, to develop an in vivo system, and investigate the role of non-thermal plasma in blood cell differentiation. Although the blood system in Drosophila is primitive, it is an efficient system with three types of hemocytes, functioning during different developmental stages and environmental stimuli. Blood cell differentiation in Drosophila plays an essential role in tissue modeling during embryogenesis, morphogenesis and also in innate immunity. In this study, we optimized distance and frequency for a direct non-thermal plasma application, and standardized doses to treat larvae and adult flies so that there is no effect on the viability, fertility or locomotion of the organism. We discovered that at optimal distance, time and frequency, application of plasma induced blood cell differentiation in the Drosophila larval lymph gland. We articulate that the augmented differentiation could be due to an increase in the levels of reactive oxygen species (ROS) upon non-thermal plasma application. Our studies open avenues to use Drosophila as a model system in plasma medicine to study various genetic disorders and biological processes where non-thermal plasma has a possible therapeutic application.	[Lee, Amanda; Lin, Abraham; Miller, Vandana] Drexel Univ, Coll Engn, AJ Drexel Plasma Inst, Camden, NJ 08103 USA; [Shah, Kajol; Singh, Harpreet; Rao, Shubha Gururaja] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Rao, SG (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA.	shubha.gururajarao@drexelmed.edu	Lin, Abraham/AAW-8059-2020; Singh, Harpreet/M-9822-2019	Lin, Abraham/0000-0003-0097-3323; Singh, Harpreet/0000-0002-6135-1897; Gururaja Rao, Shubha/0000-0003-2234-1917; Miller, Vandana/0000-0002-2323-2299	Clinical and Translational Research Institute grant; Commonwealth Universal Research Enhancement Program grant; American Heart Association National Scientist Development grant [11SDG7230059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL133050] Funding Source: NIH RePORTER	Clinical and Translational Research Institute grant; Commonwealth Universal Research Enhancement Program grant; American Heart Association National Scientist Development grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by a Clinical and Translational Research Institute grant (HS) (http://drexel.edu/medicine/Research/Clinical-andTranslational-Research-Institute/), a Commonwealth Universal Research Enhancement Program grant (HS) (https://www.portal.state.pa.us/portal/server.pt/community/health_research_program_cure/14189), and an American Heart Association National Scientist Development grant (11SDG7230059) (http://my.americanheart.org/professional/Research/FundingOpportunities/SupportingInformation/Scientist-Development-Grant_UCM_443318_Article.jsp#.VpgFhPkrK8E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KV, 2003, NAT GENET, V33, P285, DOI 10.1038/ng1105; Arjunan K.P., 2011, PLASMA MED, V1, P279, DOI DOI 10.1615/PlasmaMed.2012006389; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Chernets N, 2014, TISSUE ENG A; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Danil D., 2009, NEW J PHYS, V11; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Graves DB, 2014, PHYS PLASMAS, V21, DOI 10.1063/1.4892534; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Kuchenbecker M, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/4/045212; Kvam E, 2012, ANTIMICROB AGENTS CH, V56, P2028, DOI 10.1128/AAC.05642-11; Lee OJ, 2016, J TISSUE ENG REGEN M, V10, P348, DOI 10.1002/term.2074; Lin A, 2015, PLASMA PROCESSES POL; Lin A, 2015, PLASMA PROCESS POLYM, V12, P1117, DOI 10.1002/ppap.201400232; Lu X, 2016, PHYS REP, V630, P1, DOI 10.1016/j.physrep.2016.03.003; Lunov O, 2014, SCI REP-UK, V4, DOI 10.1038/srep07129; Miles WO, 2011, DIS MODEL MECH, V4, P753, DOI 10.1242/dmm.006908; Nagaraj R, 2012, GENE DEV, V26, P2027, DOI 10.1101/gad.183061.111; Niemi K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813817; Osei-Owusu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132594; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Poonalagu D, 2016, MOLECULAR IDENTITY O; Schlegel J, 2013, CLIN PLASMA MED, V1, P2, DOI 10.1016/j.cpme.2013.08.001; Schmidt A, 2015, J BIOL CHEM, V290, P6731, DOI 10.1074/jbc.M114.603555; Shen ZY, 2003, INT J MOL MED, V11, P479; Singh H, 2012, MITOCHONDRION, V12, P230, DOI 10.1016/j.mito.2011.09.004; Steinbeck MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082143; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Voter KZ, 2001, INHAL TOXICOL, V13, P465, DOI 10.1080/08958370151131837	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160676	10.1371/journal.pone.0160676	http://dx.doi.org/10.1371/journal.pone.0160676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505063	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200055
J	Liebig, T; Jassogne, L; Rahn, E; Laderach, P; Poehling, HM; Kucel, P; Van Asten, P; Avelino, J				Liebig, Theresa; Jassogne, Laurence; Rahn, Eric; Laderach, Peter; Poehling, Hans-Michael; Kucel, Patrick; Van Asten, Piet; Avelino, Jacques			Towards a Collaborative Research: A Case Study on Linking Science to Farmers' Perceptions and Knowledge on Arabica Coffee Pests and Diseases and Its Management	PLOS ONE			English	Article							CLIMATE-CHANGE; AGROFORESTRY SYSTEMS; INSECT PESTS; BERRY BORER; CROP PESTS; SHADE; QUALITY; KENYA; L.; RESISTANCE	The scientific community has recognized the importance of integrating farmer's perceptions and knowledge (FPK) for the development of sustainable pest and disease management strategies. However, the knowledge gap between indigenous and scientific knowledge still contributes to misidentification of plant health constraints and poor adoption of management solutions. This is particularly the case in the context of smallholder farming in developing countries. In this paper, we present a case study on coffee production in Uganda, a sector depending mostly on smallholder farming facing a simultaneous and increasing number of socio-ecological pressures. The objectives of this study were (i) to examine and relate FPK on Arabica Coffee Pests and Diseases (CPaD) to altitude and the vegetation structure of the production systems; (ii) to contrast results with perceptions from experts and (iii) to compare results with field observations, in order to identify constraints for improving the information flow between scientists and farmers. Data were acquired by means of interviews and workshops. One hundred and fifty farmer households managing coffee either at sun exposure, under shade trees or inter-cropped with bananas and spread across an altitudinal gradient were selected. Field sampling of the two most important CPaD was conducted on a subset of 34 plots. The study revealed the following findings: (i) Perceptions on CPaD with respect to their distribution across altitudes and perceived impact are partially concordant among farmers, experts and field observations (ii) There are discrepancies among farmers and experts regarding management practices and the development of CPaD issues of the previous years. (iii) Field observations comparing CPaD in different altitudes and production systems indicate ambiguity of the role of shade trees. According to the locality-specific variability in CPaD pressure as well as in FPK, the importance of developing spatially variable and relevant CPaD control practices is proposed.	[Liebig, Theresa; Rahn, Eric; Laderach, Peter] Ctr Int Agr Trop, Cali, Colombia; [Liebig, Theresa; Jassogne, Laurence; Rahn, Eric; Van Asten, Piet] Int Inst Trop Agr, Kampala, Uganda; [Liebig, Theresa; Poehling, Hans-Michael] Leibniz Univ Hannover, Sect Phytomed, Inst Hort Prod Syst, Hannover, Germany; [Rahn, Eric] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Kucel, Patrick] Natl Agr Res Org, Natl Coffee Res Inst NaCORRI, Mukono, Uganda; [Avelino, Jacques] Ctr Int Cooperat Agr Res Dev CIRAD, UPR Bioagresseurs, Montpellier, France; [Avelino, Jacques] Trop Agr Res & Higher Educ Ctr CATIE, Dept Res & Dev, Turrialba, Costa Rica; [Avelino, Jacques] Interamer Inst Cooperat Agr, San Jose, Costa Rica; [Avelino, Jacques] Reg Cooperat Program Technol Dev & Modernizat Cof, Guatemala City, Guatemala	Alliance; International Center for Tropical Agriculture - CIAT; Leibniz University Hannover; Swiss Federal Institutes of Technology Domain; ETH Zurich; CIRAD; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza	Liebig, T (corresponding author), Ctr Int Agr Trop, Cali, Colombia.	theresa.liebig@gmail.com	Avelino, Jacques/C-5624-2009	Avelino, Jacques/0000-0003-1983-9431; van Asten, Piet/0000-0003-0584-3552; Liebig, Theresa/0000-0002-8160-0539; Laderach, Peter/0000-0001-8708-6318	German Federal Ministry for Economic Cooperation and Development (BMZ) / German Society for International Cooperation (GIZ) [8157483]	German Federal Ministry for Economic Cooperation and Development (BMZ) / German Society for International Cooperation (GIZ)	This research was supported by the German Federal Ministry for Economic Cooperation and Development (BMZ) / German Society for International Cooperation (GIZ) (Prime Agreement No 8157483) and conducted under the CGIAR research program on Climate Change, Agriculture and Food Security (CCAFS) (http://www.bmz.de/de/index.html and https://www.giz.de/de/html/index.html). Funding was received by the international institute for tropical agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RI, 2015, CROP PROT, V72, P97, DOI 10.1016/j.cropro.2015.02.010; [Anonymous], STARGAZER WELL FORMA; [Anonymous], 2014, R LANG ENV STAT COMP; Avelino J, 2005, J SCI FOOD AGR, V85, P1869, DOI 10.1002/jsfa.2188; Avelino J., 2011, ECOSYSTEMS SERVICES, P91; Avelino J, 2015, FOOD SECUR, V7, P303, DOI 10.1007/s12571-015-0446-9; Baker PS, 2007, SCAA C HAND LONG BEA; Bedimo JAM, 2008, PHYTOPATHOLOGY, V98, P1320, DOI 10.1094/PHYTO-98-12-1320; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; BELLON MR, 1995, HUM ORGAN, V54, P263, DOI 10.17730/humo.54.3.98460132152k434l; Bentley J. W., 1999, Agriculture and Human Values, V16, P75, DOI 10.1023/A:1007558919244; Bosselmann AS, 2009, AGR ECOSYST ENVIRON, V129, P253, DOI 10.1016/j.agee.2008.09.004; Bottenberg H, 1995, INT J PEST MANAGE, V41, P195, DOI 10.1080/09670879509371948; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Cerdan CR, 2012, AGR SYST, V110, P119, DOI 10.1016/j.agsy.2012.03.014; CHITERE PO, 1993, INT J PEST MANAGE, V39, P126, DOI 10.1080/09670879309371776; Craparo ACW, 2015, AGR FOREST METEOROL, V207, P1, DOI 10.1016/j.agrformet.2015.03.005; DaMatta Fábio M., 2007, Braz. J. Plant Physiol., V19, P485, DOI 10.1590/S1677-04202007000400014; Damon A, 2000, B ENTOMOL RES, V90, P453, DOI 10.1017/S0007485300000584; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; Decazy F, 2003, J FOOD SCI, V68, P2356, DOI 10.1111/j.1365-2621.2003.tb05772.x; Dossa EL, 2008, AGROFOREST SYST, V72, P103, DOI 10.1007/s10457-007-9075-4; Egonyu JP, 2015, AFR ENTOMOL, V23, P68, DOI 10.4001/003.023.0109; Fishel F.M., 2015, GLOBAL INCREASE COUN; Funk C., 2012, US GEOLOGICAL SURVEY, V3062; Gichimu BM, 2008, 10 AFCA C KAMP UG; GRIFFITHS E, 1971, ANN APPL BIOL, V67, P45, DOI 10.1111/j.1744-7348.1971.tb02907.x; HAMILTON AC, 1981, VEGETATIO, V45, P107, DOI 10.1007/BF00119220; Heong K., 1985, SYSTEMS ANALYSIS IN; Heong KL, 2002, AGR ECOSYST ENVIRON, V92, P137, DOI 10.1016/S0167-8809(01)00304-8; Heong KL, 1997, J APPL COMMUN, V82, P3; Hijmans R.J., 2010, GADM DATABASE GLOBAL; Hill DS, 1975, AGR INSECT PESTS TRO; Hindorf H, 2011, J ADV RES, V2, P109, DOI 10.1016/j.jare.2010.08.006; Jansen K., 1998, POLITICAL ECOLOGY MO; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jassogne L., 2013, OXFAM POLICY PRACTIC, V9, P51, DOI DOI 10.1080/14735903.2012.714576; Jonsson M, 2015, J PEST SCI, V88, P281, DOI 10.1007/s10340-014-0615-1; Joshi RC, 2000, INT J PEST MANAGE, V46, P43, DOI 10.1080/096708700227561; Kutywayo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073432; Laderach P, 2010, TECHNICAL REPORT; Laderach P., 2008, TALL AD CAMB CLIM CO; Laderach P, 2011, CLIM CHANG MANAG, P703, DOI 10.1007/978-3-642-14776-0_42; Leichenko R. M., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P1, DOI 10.1023/A:1015860421954; Lenth R. V., 2015, ISMEANS LEAST SQUARE; Lin BB, 2010, AGR FOREST METEOROL, V150, P510, DOI 10.1016/j.agrformet.2009.11.010; Lopez-Bravo DF, 2012, CROP PROT, V38, P21, DOI 10.1016/j.cropro.2012.03.011; Mahiri I. O., 1998, Journal of International Development, V10, P527, DOI 10.1002/(SICI)1099-1328(199806)10:4&lt;527::AID-JID543&gt;3.0.CO;2-S; Manu-Aduening JA, 2007, ANN APPL BIOL, V151, P189, DOI 10.1111/j.1744-7348.2007.00156.x; Matovu J, 2013, AFRICAN CROP SCI C P, V11, P221; McCook S, 2015, PHYTOPATHOLOGY, V105, P1164, DOI 10.1094/PHYTO-04-15-0085-RVW; Mugagga F, 2012, CATENA, V90, P39, DOI 10.1016/j.catena.2011.11.004; Muller RA, 2008, COFFEE GROWING PROCE, P491; Murphy S, 2008, INTEGRATED STEM BORE; Muschler RG, 2001, AGROFOREST SYST, V51, P131, DOI 10.1023/A:1010603320653; Musoli PC, 1993, AGR UGANDA, VII, P376; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Norton G. W., 1999, Agriculture and Human Values, V16, P431, DOI 10.1023/A:1007608019218; Nyeko P, 2002, CROP PROT, V21, P929, DOI 10.1016/S0261-2194(02)00068-6; Obopile M, 2008, CROP PROT, V27, P1220, DOI 10.1016/j.cropro.2008.03.003; Ochou GO, 1998, INT J PEST MANAGE, V44, P5, DOI 10.1080/096708798228455; Ovalle-Rivera O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124155; Price L. L., 2001, Agriculture and Human Values, V18, P153, DOI 10.1023/A:1011163307355; Rahn E, 2014, MITIG ADAPT STRAT GL, V19, P1119, DOI 10.1007/s11027-013-9467-x; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Roling NG, 2004, NJAS-WAGEN J LIFE SC, V52, P211; Rubia EG, 1996, CROP PROT, V15, P327, DOI 10.1016/0261-2194(95)00080-1; Rutherford M, 2006, PESTS DIS COFFEE E A; Sanco D, 2012, EU PESTICIDES DATABA; Schluter T, 2008, GEOLOGICAL ATLAS OF; Schroth G, 2000, AGROFOREST SYST, V50, P199, DOI 10.1023/A:1006468103914; Segura HR, 2004, J ECON ENTOMOL, V97, P1491, DOI 10.1603/0022-0493-97.5.1491; Siles P, 2010, J HYDROL, V395, P39, DOI 10.1016/j.jhydrol.2010.10.005; Songa JM, 2002, INT J PEST MANAGE, V48, P1, DOI 10.1080/09670870110052077; Sontheimer S, 1999, CONDUCTING PRA PARTI; Talbot John M., 2004, GROUNDS AGREEMENT PO; Tanzubil PB, 1997, INT J PEST MANAGE, V43, P133, DOI 10.1080/096708797228825; TAPLEY R. G., 1960, BULL ENT RES, V51, P279, DOI 10.1017/S0007485300057990; Teodoro AV, 2010, ENVIRON ENTOMOL, V39, P1744, DOI 10.1603/EN10092; Trutmann P., 1996, Agriculture and Human Values, V13, P64, DOI 10.1007/BF01530524; Vaast P, 2006, J SCI FOOD AGR, V86, P197, DOI 10.1002/jsfa.2338; Valencia V, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00428.1; Van Asten PJA, 2009, EXP AGR, V45, P1, DOI 10.1017/S0014479708006984; Van Mele P, 2001, INT J PEST MANAGE, V47, P7, DOI 10.1080/09670870150215559; Verchot L. V., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P901, DOI 10.1007/s11027-007-9105-6; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wyckhuys KAG, 2007, AGR HUM VALUES, V24, P307, DOI 10.1007/s10460-007-9068-y; Yang X B, 2001, GLOB CHANGE HUM HLTH, V2, P90, DOI [10.1023/A:1015086831467, DOI 10.1023/A:1015086831467]; YOSHIDA M, 1987, HUM TOXICOL, V6, P403, DOI 10.1177/096032718700600511; Youm O, 1998, INT J PEST MANAGE, V44, P123, DOI 10.1080/096708798228437	92	27	27	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159392	10.1371/journal.pone.0159392	http://dx.doi.org/10.1371/journal.pone.0159392			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504826	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200006
J	Neasta, J; Fiorenza, A; He, DY; Phamluong, K; Kiely, PA; Ron, D				Neasta, Jeremie; Fiorenza, Anna; He, Dao-Yao; Phamluong, Khanhky; Kiely, Patrick A.; Ron, Dorit			Activation of the cAMP Pathway Induces RACK1-Dependent Binding of beta-Actin to BDNF Promoter	PLOS ONE			English	Article							PROTEIN-KINASE-C; RNA-POLYMERASE-II; NUCLEAR ACTIN; PHOSPHODIESTERASE PDE4D5; CELL-MIGRATION; RACK1; TRANSCRIPTION; DYNAMICS; RECEPTOR; EXPRESSION	RACK1 is a scaffolding protein that contributes to the specificity and propagation of several signaling cascades including the cAMP pathway. As such, RACK1 participates in numerous cellular functions ranging from cell migration and morphology to gene transcription. To obtain further insights on the mechanisms whereby RACK1 regulates cAMP-dependent processes, we set out to identify new binding partners of RACK1 during activation of the cAMP signaling using a proteomics strategy. We identified beta-actin as a direct RACK1 binding partner and found that the association between beta-actin and RACK1 is increased in response to the activation of the cAMP pathway. Furthermore, we show that cAMP-dependent increase in BDNF expression requires filamentous actin. We further report that beta-actin associates with the BDNF promoter IV upon the activation of the cAMP pathway and present data to suggest that the association of beta-actin with BDNF promoter IV is RACK1-dependent. Taken together, our data suggest that beta-actin is a new RACK1 binding partner and that the RACK1 and beta-actin association participate in the cAMP-dependent regulation of BDNF transcription.	[Neasta, Jeremie; Fiorenza, Anna; He, Dao-Yao; Phamluong, Khanhky; Ron, Dorit] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA; [Kiely, Patrick A.] Univ Limerick, Hlth Res Inst, Grad Entry Med Sch, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Neasta, Jeremie] Univ Montpellier, Fac Pharm, Lab Pharmacol, Montpellier, France; [He, Dao-Yao] C&M Biolabs, Richmond, CA USA	University of California System; University of California San Francisco; University of Limerick; University of Limerick; Universite de Montpellier	Ron, D (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94115 USA.	dorit.ron@ucsf.edu		Fiorenza, Anna/0000-0001-7546-2347; Neasta, Jeremie/0000-0002-7801-4176	National Institutes of Health [NIH-NIAAA R01 AA016848, NIH-NIAAA R37 AA016848, NIH-NIAAA P50 AA017072]; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; Science Foundation Ireland [13/CDA/2228]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA016848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health NIH-NIAAA R01 AA016848 (DR), NIH-NIAAA R37 AA016848 (DR), NIH-NIAAA P50 AA017072 (DR), the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (DR) and Science Foundation Ireland (13/CDA/2228) (PK). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Belin BJ, 2013, MOL BIOL CELL, V24, P982, DOI 10.1091/mbc.E12-09-0685; Belyantseva IA, 2009, P NATL ACAD SCI USA, V106, P9703, DOI 10.1073/pnas.0900221106; Bird RJ, 2010, BIOCHEM J, V432, P207, DOI 10.1042/BJ20101010; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Ceci M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035034; Cheever TR, 2013, INT REV CEL MOL BIO, V301, P157, DOI 10.1016/B978-0-12-407704-1.00004-X; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; He DY, 2002, MOL PHARMACOL, V62, P272, DOI 10.1124/mol.62.2.272; Hendzel MJ, 2014, CURR OPIN CELL BIOL, V28, P84, DOI 10.1016/j.ceb.2014.04.003; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hutchins BI, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc1; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; Miller LD, 2004, ONCOGENE, V23, P5682, DOI 10.1038/sj.onc.1207735; Neasta J, 2012, J BIOL CHEM, V287, P322, DOI 10.1074/jbc.M111.272195; Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083; Percipalle P, 2013, NUCLEUS-AUSTIN, V4, P43, DOI 10.4161/nucl.22798; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Ron D, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-53; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen X, 2013, TRENDS CELL BIOL; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Thornton C, 2004, J BIOL CHEM, V279, P31357, DOI 10.1074/jbc.M402316200; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Welch MD, 1999, TRENDS CELL BIOL, V9, P423, DOI 10.1016/S0962-8924(99)01651-7; Weston L, 2012, J CELL SCI, V125, P3519, DOI 10.1242/jcs.099523; Yaka R, 2003, J BIOL CHEM, V278, P9630, DOI 10.1074/jbc.M209141200; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160948	10.1371/journal.pone.0160948	http://dx.doi.org/10.1371/journal.pone.0160948			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505161	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200083
J	Teye, K; Numata, S; Ishii, N; Krol, RP; Tsuchisaka, A; Hamada, T; Koga, H; Karashima, T; Ohata, C; Tsuruta, D; Saya, H; Haftek, M; Hashimoto, T				Teye, Kwesi; Numata, Sanae; Ishii, Norito; Krol, Rafal P.; Tsuchisaka, Atsunari; Hamada, Takahiro; Koga, Hiroshi; Karashima, Tadashi; Ohata, Chika; Tsuruta, Daisuke; Saya, Hideyuki; Haftek, Marek; Hashimoto, Takashi			Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents	PLOS ONE			English	Article							KERATINOCYTES IN-VITRO; HOMING RECEPTOR CD44; GROWTH-FACTOR; BIVATUZUMAB MERTANSINE; HYDROGEN-PEROXIDE; CANCER-CELLS; HUMAN SKIN; VARIANT; BINDING; ISOFORMS	CD44, a cell surface proteoglycan, is involved in many biological events. CD44 transcripts undergo complex alternative splicing, resulting in many functionally distinct isoforms. To date, however, the nature of these isoforms in human epidermis has not been adequately determined. In this study, we isolated all CD44 transcripts from normal human epidermis, and studied how their expressions are regulated. By RT-PCR, we found that a number of different CD44 transcripts were expressed in human epidermis, and we obtained all these transcripts from DNA bands in agarose and acrylamide gels by cloning. Detailed sequence analysis revealed 18 CD44 transcripts, 3 of which were novel. Next, we examined effects of 10 different agents on the expression of CD44 transcripts in cultured human keratinocytes, and found that several agents, particularly epidermal growth factor, hydrogen peroxide, phorbol 12-myristate 13-acetate, retinoic acid, calcium and fetal calf serum differently regulated their expressions in various patterns. Furthermore, normal and malignant keratinocytes were found to produce different CD44 transcripts upon serum stimulation and subsequent starvation, suggesting that specific CD44 isoforms are involved in tumorigenesis via different CD44-mediated biological pathways.	[Teye, Kwesi; Numata, Sanae; Ishii, Norito; Krol, Rafal P.; Tsuchisaka, Atsunari; Hamada, Takahiro; Koga, Hiroshi; Karashima, Tadashi; Ohata, Chika; Hashimoto, Takashi] Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan; [Teye, Kwesi; Numata, Sanae; Ishii, Norito; Krol, Rafal P.; Tsuchisaka, Atsunari; Hamada, Takahiro; Koga, Hiroshi; Karashima, Tadashi; Ohata, Chika; Hashimoto, Takashi] Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan; [Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Osaka, Japan; [Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Haftek, Marek] Univ Lyon 1, EA 4169, Lyon, France; [Haftek, Marek] CNRS, Lyon, France	Kurume University; Kurume University; Osaka Metropolitan University; Keio University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS)	Hashimoto, T (corresponding author), Kurume Univ, Sch Med, Dept Dermatol, Kurume, Fukuoka 8300011, Japan.; Hashimoto, T (corresponding author), Kurume Univ, Inst Cutaneous Cell Biol, Kurume, Fukuoka 8300011, Japan.	hashimot@med.kurume-u.ac.jp	Hashimoto, Takashi/H-6947-2019; Saya, Hideyuki/J-4325-2013	Hashimoto, Takashi/0000-0002-0144-3255; Teye, Kwesi/0000-0002-0543-3724; Saya, Hideyuki/0000-0001-6610-1902	Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology [26860904]	Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology	This study was supported by Grants-in-Aid for Scientific Research (grant numbers 26860904), and Supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens T, 2001, J INVEST DERMATOL, V116, P93, DOI 10.1046/j.1523-1747.2001.00236.x; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Biddle A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057314; Bikle DD, 2004, J CELL BIOCHEM, V92, P436, DOI 10.1002/jcb.20095; Bikle DD, 2001, MOL CELL ENDOCRINOL, V177, P161, DOI 10.1016/S0303-7207(01)00452-X; Bitoux M.-A.L., 2009, OPEN DERMATOL J, V3, P32, DOI [10.2174/1874372200903010032, DOI 10.2174/1874372200903010032]; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bourguignon LYW, 2014, AM J PATHOL, V184, P1912, DOI 10.1016/j.ajpath.2014.03.010; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chiricozzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090284; Chou YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093692; Clemmensen A, 2009, EXP DERMATOL, V18, P979, DOI 10.1111/j.1600-0625.2009.00921.x; Denning MF, 2004, INT J BIOCHEM CELL B, V36, P1141, DOI 10.1016/j.biocel.2003.12.004; DENNING MF, 1995, CELL GROWTH DIFFER, V6, P149; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; Downing MT, 1997, HISTOCHEM J, V29, P735, DOI 10.1023/A:1026417202351; ELIAS P M, 1987, Dermatologica (Basel), V175, P28; ELIAS PM, 1981, LAB INVEST, V44, P531; Erfani E, 2016, INT J BIOL MARKER, V31, pE53, DOI 10.5301/jbm.5000165; FORSBERG UH, 1989, IMMUNOGENETICS, V29, P405, DOI 10.1007/BF00375870; FRANCKE U, 1983, SOMAT CELL GENET, V9, P333, DOI 10.1007/BF01539142; GARLICK JA, 1994, J INVEST DERMATOL, V103, P554, DOI 10.1111/1523-1747.ep12396847; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; GOETTE DK, 1976, ARCH DERMATOL, V112, P1788, DOI 10.1001/archderm.1976.01630370068017; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Haftek M, 2008, J DERMATOL SCI, V51, P135, DOI 10.1016/j.jdermsci.2008.03.007; HAGGERTY JG, 1992, J INVEST DERMATOL, V99, P374, DOI 10.1111/1523-1747.ep12616087; Harari PM, 2000, CLIN CANCER RES, V6, P323; Harfouche G, 2010, STEM CELLS, V28, P1639, DOI 10.1002/stem.485; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Heider KH, 2004, CANCER IMMUNOL IMMUN, V53, P567, DOI 10.1007/s00262-003-0494-4; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Hiraga T, 2013, CANCER RES, V73, P4112, DOI 10.1158/0008-5472.CAN-12-3801; HOFMANN M, 1993, CANCER RES, V53, P1516; Hogan KA, 2013, CYTOKINE, V64, P652, DOI 10.1016/j.cyto.2013.09.004; Iozzo RV, 2000, PROTEOGLYCANS STRUCT, P61; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Kaya G, 2012, J NUTR HEALTH AGING, V16, P285, DOI 10.1007/s12603-012-0041-0; Kaya G, 2006, PLOS MED, V3, P2291, DOI 10.1371/journal.pmed.0030493; Kaya G, 2007, DERMATOLOGY, V215, P284, DOI 10.1159/000107621; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; KITAJIMA Y, 1988, CANCER RES, V48, P964; Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207; Lehmann B, 2009, EXP DERMATOL, V18, P97, DOI 10.1111/j.1600-0625.2008.00810.x; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Li Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016483; Loo AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049215; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; McKnight B, 2015, J DRUGS DERMATOL, V14, P1147; MILSTONE LM, 1994, J CELL SCI, V107, P3183; Miyake H, 1998, J UROLOGY, V160, P1562, DOI 10.1016/S0022-5347(01)62613-2; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Mukherjee S, 2006, CLIN INTERV AGING, V1, P327, DOI 10.2147/ciia.2006.1.4.327; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Petersen AB, 2000, J PHOTOCH PHOTOBIO B, V59, P123, DOI 10.1016/S1011-1344(00)00149-4; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Riechelmann H, 2008, ORAL ONCOL, V44, P823, DOI 10.1016/j.oraloncology.2007.10.009; RODRIGUEZ C, 1995, INT J CANCER, V64, P347, DOI 10.1002/ijc.2910640512; Sandjeu Y, 2009, J PHYSIOL PHARMACOL, V60, P23; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seiter S, 1996, VIRCHOWS ARCH, V428, P141; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Simon JC, 1996, EUR J CANCER, V32A, P1394, DOI 10.1016/0959-8049(96)00196-7; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; Szabo Imre, 2004, Clin Dev Immunol, V11, P233, DOI 10.1080/17402520400001710; THOMAS L, 1993, J INVEST DERMATOL, V100, P115, DOI 10.1111/1523-1747.ep12462776; Tijink BM, 2006, CLIN CANCER RES, V12, P6064, DOI 10.1158/1078-0432.CCR-06-0910; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; TSUKAMOTO T, 1989, Keio Journal of Medicine, V38, P277; VANWEERING DHJ, 1993, PCR METH APPL, V3, P100; Yang HS, 2011, EXP MOL MED, V43, P622, DOI 10.3858/emm.2011.43.11.070; Yoshida GJ, 2014, BIOCHEM BIOPH RES CO, V443, P622, DOI 10.1016/j.bbrc.2013.12.016; Zbytek B, 2008, J INVEST DERMATOL, V128, P2271, DOI 10.1038/jid.2008.62; Zheng XY, 2006, BIOTECHNOL PROGR, V22, P1294, DOI 10.1021/bp060121o; Zhou J, 1999, IN VITRO CELL DEV-AN, V35, P228	87	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160952	10.1371/journal.pone.0160952	http://dx.doi.org/10.1371/journal.pone.0160952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505250	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200084
J	Thiha, N; Chinnakali, P; Harries, AD; Shwe, M; Balathandan, TP; Tun, STT; Das, M; Tin, HH; Yi, Y; Babin, FX; Lwin, TT; Clevenbergh, PA				Thiha, Nay; Chinnakali, Palanivel; Harries, Anthony D.; Shwe, Myint; Balathandan, Thanumalaya Perumal; Tun, Sai Thein Than; Das, Mrinalini; Tin, Htay Htay; Yi, Yi; Babin, Francois Xavier; Lwin, Thi Thi; Clevenbergh, Philippe Albert			Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar	PLOS ONE			English	Article							ADULTS; ADOLESCENTS; RESISTANCE; ADHERENCE; DIAGNOSIS; OUTCOMES	Background WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced with tenofovir (TDF) for first-line treatment. In this context, the Integrated HIV Care Program, Myanmar, evaluated patients for ART failure using HIV RNA viral load (VL) before making the change. We aimed to determine prevalence and determinants of ART failure in those on first-line treatment. Methods Patients retained on stavudine-based or zidovudine-based ART for >12 months with no clinical/immunological evidence of failure were offered VL testing from August 2012. Plasma samples were tested using real time PCR. Those with detectable VL>250 copies/ml on the first test were provided with adherence counseling and three months later a second test was performed with > 1000 copies/ml indicating ART failure. We calculated the prevalence of ART failure and adjusted relative risks (aRR) to identify associated factors using log binomial regression. Results Of 4934 patients tested, 4324 (87%) had an undetectable VL at the first test while 610 patients had a VL>250 copies/ml. Of these, 502 had a second VL test, of whom 321 had undetectable VL and 181 had >1000 copies/ml signifying ART failure. There were 108 who failed to have the second test. Altogether, there were 94% with an undetectable VL, 4% with ART failure and 2% who did not follow the VL testing algorithm. Risk factors for ART failure were age 15-24 years (aRR 2.4, 95% CI: 1.5-3.8) compared to 25-44 years and previous ART in the private sector (aRR 1.6, 95% CI: 1.2-2.2) compared to the public sector. Conclusions This strategy of evaluating patients on first-line ART before changing to TDF was feasible and identified a small proportion with ART failure, and could be considered by HIV/AIDS programs in Myanmar and other countries.	[Thiha, Nay; Balathandan, Thanumalaya Perumal] Int Union TB & Lung Dis, Mandalay, Myanmar; [Chinnakali, Palanivel] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India; [Harries, Anthony D.] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England; [Shwe, Myint] Dept Hlth, Natl AIDS Program, Nay Pyi Taw, Myanmar; [Tun, Sai Thein Than] Burnett Inst, Yangon, Myanmar; [Das, Mrinalini] Doctors Borders OCB, Medecins Sans Frontieres, Bombay, Maharashtra, India; [Tin, Htay Htay; Lwin, Thi Thi] Dept Hlth, Natl Hlth Lab, Yangon, Myanmar; [Yi, Yi] Dept Hlth, Publ Hlth Lab, Mandalay, Myanmar; [Babin, Francois Xavier] Fdn Mereiux, Lyon, France; [Clevenbergh, Philippe Albert] Grp Hosp St Louis Lariboisiere, Hop Lariboisiere, Paris, France	Jawaharlal Institute of Postgraduate Medical Education & Research; University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Thiha, N (corresponding author), Int Union TB & Lung Dis, Mandalay, Myanmar.	naythiha.dr@gmail.com	Chinnakali, Palanivel/AAV-7708-2020	Chinnakali, Palanivel/0000-0001-8320-1016; Tun, Sai Thein Than/0000-0001-9733-8304				[Anonymous], 2014, GLOB UPD HLTH SECT R; Edginton M, 2012, PUBLIC HEALTH ACTION, V2, P21, DOI [10.5588/pha.12.0001, 10.5588/pha.12.0028]; Flynn PM, 2007, AIDS RES HUM RETROV, V23, P1208, DOI 10.1089/aid.2006.0290; Government of Myanmar, 2017, 2014 MYANM POP HOUS; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; Keebler D, 2014, LANCET GLOB HEALTH, V2, pE35, DOI 10.1016/S2214-109X(13)70048-2; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Madruga JVR, 2007, HIV CLIN TRIALS, V8, P381, DOI 10.1310/hct0806-381; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; National AIDS Programme, 2011, GUID CLIN MAN HIV IN; National AIDS Programme, 2012, HIV SENT SER SURV SU; National AIDS Programme, 2014, UNGASS COUNTR PROGR; Orrell C, 2007, ANTIVIR THER, V12, P83; Ryscavage PA, 2011, JAIDS-J ACQ IMM DEF, V58, P193, DOI [10.1097/QAI.0B013E31822D7564, 10.1097/QAI.0b013e31822d7564]; Segeral O, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/142076; Shet A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-277; Tang MW, 2013, J INFECT DIS, V207, pS70, DOI 10.1093/infdis/jit114; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; WHO, 2010, ANT THER HIV INF AD; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007; World Health Organization, 2013, CONGUID UANT DRU	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160616	10.1371/journal.pone.0160616	http://dx.doi.org/10.1371/journal.pone.0160616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505228	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000381374200047
J	Sun, FF; Cao, YC; Cai, CJ; Li, SX; Yu, C; Yao, JH				Sun, Feifei; Cao, Yangchun; Cai, Chuanjiang; Li, Shengxiang; Yu, Chao; Yao, Junhu			Regulation of Nutritional Metabolism in Transition Dairy Cows: Energy Homeostasis and Health in Response to Post-Ruminal Choline and Methionine	PLOS ONE			English	Article							RUMEN-PROTECTED CHOLINE; NONESTERIFIED FATTY-ACIDS; CARPIO VAR. JIAN; VITAMIN-E STATUS; MILK-PRODUCTION; EARLY LACTATION; OXIDATIVE STRESS; SMARTAMINE M; CHOLESTEROL DETERMINATION; REPRODUCTIVE-PERFORMANCE	This study investigated the effects of rumen-protected methionine (RPM) and rumen-protected choline (RPC) on energy balance, postpartum lactation performance, antioxidant capacity and immune response in transition dairy cows. Forty-eight multiparous transition cows were matched and divided into four groups: control, 15 g/d RPC, 15 g/d RPM or 15 g/d RPC + 15 g/d RPM. Diet samples were collected daily before feeding, and blood samples were collected weekly from the jugular vein before morning feeding from 21 days prepartum to 21 days postpartum. Postpartum dry matter intake (DMI) was increased by both additives (P < 0.05), and energy balance values in supplemented cows were improved after parturition (P < 0.05). Both RPC and RPM decreased the plasma concentrations of non-esterified fatty acids (NEFA), beta-hydroxybutyric acid (BHBA), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) (P < 0.05), but increased the plasma levels of glucose, very-low-density lipoprotein (VLDL) and apolipoprotein B100 (ApoB 100, P < 0.05). The supplements improved milk production (P < 0.05), and increased (P < 0.05) or tended to increase (0.05 < P < 0.10) the contents of milk fat and protein. The post-ruminal choline and methionine elevated the blood antioxidant status, as indicated by total antioxidant capacity (T-AOC), glutathione peroxidase (GSH-Px) activity and the vitamin E concentration (P < 0.05), and reduced the plasma malondialdehyde (MDA) level (P < 0.05). Furthermore, RPM and RPC elevated the plasma interleukin 2 (IL-2) concentration and the CD4(+)/CD8(+) T lymphocyte ratio in peripheral blood (P < 0.05). Alternatively, the levels of tumor necrosis factor-a (TNF-alpha) and IL-6 were decreased by RPM and RPC (P < 0.05). Overall, the regulatory responses of RPC and RPM were highly correlated with time and were more effective in the postpartum cows. The results demonstrated that dietary supplementation with RPC and RPM promoted energy balance by increasing postpartal DMI and regulating hepatic lipid metabolism, improved postpartum lactation performance and enhanced antioxidant capacity and immune function of transition dairy cows.	[Sun, Feifei; Cao, Yangchun; Cai, Chuanjiang; Li, Shengxiang; Yu, Chao; Yao, Junhu] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Yao, JH (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	yaojunhu2004@sohu.com		Cao, Yangchun/0000-0003-1033-2909	National Key Technologies R&D Program of China [2012BAD12B02]; National Natural Science Foundation of China [31472122]; Program of International S&T Cooperation, China [2010DFB34230]	National Key Technologies R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International S&T Cooperation, China	This research was supported by the National Key Technologies R&D Program of China (2012BAD12B02), National Natural Science Foundation of China (31472122) and the Program of International S&T Cooperation, China (2010DFB34230). All the fundings were received by Junhu Yao.; This research was supported by the National Key Technologies R&D Program of China (2012BAD12B02), National Natural Science Foundation of China (31472122) and the Program of International S&T Cooperation, China (2010DFB34230).	AOAC, 1990, OFFICIAL METHODS OF; Ardalan M, 2011, J AGR SCI-CAMBRIDGE, V149, P639, DOI 10.1017/S0021859610001292; ASSMANN G, 1984, CLIN CHIM ACTA, V140, P77, DOI 10.1016/0009-8981(84)90153-0; Banos G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065766; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Beitz DC, 2014, P 25 ANN FLOR RUM NU, P41; Benefield BC, 2009, J DAIRY SCI, V92, P4448, DOI 10.3168/jds.2008-1275; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BLOOM BR, 1992, IMMUNOL TODAY, V13, P131, DOI 10.1016/0167-5699(92)90110-S; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Bossaert P, 2012, VET J, V192, P222, DOI 10.1016/j.tvjl.2011.06.004; Cooke RF, 2007, J DAIRY SCI, V90, P2413, DOI 10.3168/jds.2006-028; Durand D., 1992, Journal of Dairy Science, V75, P279; Elek P, 2013, ACTA VET HUNG, V61, P59, DOI 10.1556/AVet.2012.053; Elek R, 2008, ANIMAL, V2, P1595, DOI 10.1017/S1751731108002917; Esposito G, 2014, ANIM REPROD SCI, V144, P60, DOI 10.1016/j.anireprosci.2013.11.007; Gao F, 2012, J DAIRY SCI, V95, P4510, DOI 10.3168/jds.2011-5087; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goselink RMA, 2013, J DAIRY SCI, V96, P1102, DOI 10.3168/jds.2012-5396; Gross JJ, 2013, J DAIRY SCI, V96, P5008, DOI 10.3168/jds.2012-6245; Grummer RR, 2008, VET J, V176, P10, DOI 10.1016/j.tvjl.2007.12.033; Guretzky NAJ, 2006, J DAIRY SCI, V89, P188, DOI 10.3168/jds.S0022-0302(06)72083-5; Han ZY, 2015, CELL STRESS CHAPERON, V20, P109, DOI 10.1007/s12192-014-0530-7; Itle AJ, 2015, J DAIRY SCI, V98, P128, DOI 10.3168/jds.2014-7932; Karimian M, 2015, J DAIRY SCI, V98, P330, DOI 10.3168/jds.2013-7577; Kohn RA, 2005, J ANIM SCI, V83, P879; Krempasky M, 2014, ACTA VET BRNO, V83, P411, DOI 10.2754/avb201483040411; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Lima FS, 2007, J DAIRY SCI, V90, P174; Lima FS, 2012, VET J, V193, P140, DOI 10.1016/j.tvjl.2011.09.019; Liu L, 2014, J DAIRY SCI, V97, P1328, DOI 10.3168/jds.2013-6654; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Nan XM, 2014, PHYSIOL GENOMICS, V46, P268, DOI 10.1152/physiolgenomics.00119.2013; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7437, DOI 10.3168/jds.2013-7679; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Ospina PA, 2010, J DAIRY SCI, V93, P1596, DOI 10.3168/jds.2009-2852; Patton RA, 2010, J DAIRY SCI, V93, P2105, DOI 10.3168/jds.2009-2693; Piepenbrink MS, 2003, J DAIRY SCI, V86, P1722, DOI 10.3168/jds.S0022-0302(03)73758-8; Pinotti L, 2008, ANIMAL, V2, P1019, DOI 10.1017/S1751731108002103; Pinotti L, 2003, J VET MED A, V50, P18, DOI 10.1046/j.1439-0442.2003.00502.x; Pires JAA, 2013, J DAIRY SCI, V96, P6423, DOI 10.3168/jds.2013-6801; Rahmani M, 2015, ANIM PROD SCI, V55, P752, DOI 10.1071/AN14429; Roche JR, 2013, ANIM PROD SCI, V53, P1000, DOI 10.1071/AN12293; Rossato M, 2014, ANDROLOGIA, V46, P322, DOI 10.1111/and.12076; Sejersen H, 2012, J DAIRY SCI, V95, P2409, DOI 10.3168/jds.2011-4604; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; Stadnik L, 2015, ANIM REPROD SCI, V155, P75, DOI 10.1016/j.anireprosci.2015.02.002; Tharwat M, 2012, RES VET SCI, V93, P1281, DOI 10.1016/j.rvsc.2012.03.011; Trevisi E, 2013, J DAIRY SCI, V96, P5712, DOI 10.3168/jds.2012-6375; Turk R, 2013, ANIM REPROD SCI, V141, P109, DOI 10.1016/j.anireprosci.2013.07.014; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Walsh RB, 2007, J DAIRY SCI, V90, P315, DOI 10.3168/jds.2007-0389; Wang H, 2016, BIOL TRACE ELEM RES, V172, P326, DOI 10.1007/s12011-015-0593-z; Waterman RC, 2012, AMINO ACIDS, V43, P2165, DOI 10.1007/s00726-012-1301-3; Weber C, 2013, J DAIRY SCI, V96, P165, DOI 10.3168/jds.2012-5574; Wu P, 2014, FISH SHELLFISH IMMUN, V38, P374, DOI 10.1016/j.fsi.2014.03.032; Wu P, 2013, FISH SHELLFISH IMMUN, V35, P697, DOI 10.1016/j.fsi.2013.05.030; Xu GZ, 2006, ASIAN AUSTRAL J ANIM, V19, P390, DOI 10.5713/ajas.2006.390; Zhang XD, 2008, AQUACULTURE, V280, P136, DOI 10.1016/j.aquaculture.2008.05.010; Zom RLG, 2011, J DAIRY SCI, V94, P4016, DOI 10.3168/jds.2011-4233	66	67	80	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160659	10.1371/journal.pone.0160659	http://dx.doi.org/10.1371/journal.pone.0160659			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501393	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500042
J	Yu, GJ; Wang, XL; Dou, YF; Wang, SH; Tian, MX; Qi, JJ; Li, T; Ding, C; Wu, YT; Yu, SQ				Yu, Guijing; Wang, Xiaolan; Dou, Yafeng; Wang, Shaohui; Tian, Mingxing; Qi, Jingjing; Li, Tao; Ding, Chan; Wu, Yantao; Yu, Shengqing			Riemerella anatipestifer M949_1360 Gene Functions on the Lipopolysaccharide Biosynthesis and Bacterial Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; IN-VITRO; DIVERSITY; ADHERENCE; INVASION; PROTEIN; SEROTYPES; CLUSTER; DUCKS; CORE	Riemerella anatipestifer causes septicemic and exudative diseases in poultry, resulting in major economic losses to the duck industry. Lipopolysaccharide (LPS), as an important virulence factor in Gram-negative bacteria, can be recognized by the immune system and plays a crucial role in many interactions between bacteria and animal hosts. In this study, we screened out one LPS defective mutant strain RA Delta 604 from a random transposon mutant library of R. anatipestifer serotype 1 strain CH3, which did not react with the anti-CH3 LPS monoclonal antibody 1C1 in an indirect enzyme-linked immunosorbent assay. Southern blot analysis confirmed that the genome of RA Delta 604 contained a single Tn4351 insert. Then, we found that the M949_1360 gene was inactivated by insertion of the transposon. Using silver staining and western blot analyses, we found that the LPS pattern of RA Delta 604 was defective, as compared with that of the wild-type (WT) strain CH3. The mutant strain RA Delta 604 showed no significant influence on bacterial growth, while bacterial counting and Live/dead BacLight Bacterial Viability staining revealed that bacterial viability was decreased, as compared with the WT strain CH3. In addition, the abilities of the mutant strain RA Delta 604 to adhere and invade Vero cells were significantly decreased. Animal studies revealed that the virulence of the mutant strain RA Delta 604 was decreased by more than 200-fold in a duck infection model, as compared with the WT strain CH3. Furthermore, immunization with live bacteria of the mutant strain RA Delta 604 protected 87.5% ducks from challenge with R. anatipestifer serotype 1 strain WJ4, indicating that the mutant strain RA Delta 604 could be used as a potential vaccine candidate in the future.	[Yu, Guijing; Wang, Xiaolan; Dou, Yafeng; Wang, Shaohui; Tian, Mingxing; Qi, Jingjing; Li, Tao; Ding, Chan; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China; [Yu, Guijing; Wu, Yantao] Yangzhou Univ, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Yangzhou University	Yu, SQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai 200241, Peoples R China.	yus@shvri.ac.cn	li, tao/W-7441-2019	Li, Tao/0000-0001-5080-3352	National Natural Science Foundation of China [31272591]; Shanghai Nature Science Fund [15ZR1449700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Fund	This work was supported by the National Natural Science Foundation of China (31272591, http://www.nsfc.gov.cn/) and Shanghai Nature Science Fund (15ZR1449700, http://www.stcsm.gov.cn/gk/gkml/xxgkbzsm/335201.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chang CF, 1998, AVIAN PATHOL, V27, P339, DOI 10.1080/03079459808419349; Crasta KC, 2002, J BACTERIOL, V184, P1932, DOI 10.1128/JB.184.7.1932-1939.2002; Driessen NN, 2009, INFECT IMMUN, V77, P4538, DOI 10.1128/IAI.01256-08; El Aamri F, 2012, J AQUAT ANIM HEALTH, V24, P165, DOI 10.1080/08997659.2012.675928; GALANOS C, 1972, EUR J BIOCHEM, V31, P230, DOI 10.1111/j.1432-1033.1972.tb02524.x; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GULUBOV S., 1967, C R ACAD BULG SCI, V20, P1189; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Hu QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039805; Hu QH, 2011, J MICROBIOL METH, V87, P64, DOI 10.1016/j.mimet.2011.07.007; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Hu QingHai, 2001, Chinese Journal of Veterinary Science and Technology, V31, P12; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; KLENA JD, 1993, J BACTERIOL, V175, P1524, DOI 10.1128/JB.175.5.1524-1527.1993; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lerner A, 2009, MICROBIOL-SGM, V155, P4058, DOI 10.1099/mic.0.031807-0; Liu HW, 2013, CLIN VACCINE IMMUNOL, V20, P691, DOI 10.1128/CVI.00768-12; MANNING PA, 1986, INFECT IMMUN, V53, P272, DOI 10.1128/IAI.53.2.272-277.1986; MANTEL N, 1967, BIOMETRICS, V23, P739, DOI 10.2307/2528425; MOHAN S, 1994, J BIOL CHEM, V269, P32896; PATHANASOPHON P, 1995, AVIAN PATHOL, V24, P195, DOI 10.1080/03079459508419059; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Pope CF, 2010, METHODS MOL BIOL, V642, P113, DOI 10.1007/978-1-60327-279-7_9; PRADEL E, 1992, J BACTERIOL, V174, P4736, DOI 10.1128/JB.174.14.4736-4745.1992; Pradhan B, 2016, GENE CHROMOSOME CANC, V55, P215, DOI 10.1002/gcc.22317; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768; Simpson BW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0029; Skorek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079525; Staroscik AM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-115; Steeghs L, 1997, GENE, V190, P263, DOI 10.1016/S0378-1119(97)00005-X; Tang YL, 2014, J VET MED SCI, V76, P1055, DOI 10.1292/jvms.13-0625; Trent MS, 2006, J ENDOTOXIN RES, V12, P205, DOI 10.1179/096805106X118825; Vilela CL, 2004, VET J, V167, P211, DOI 10.1016/S1090-0233(03)00085-6; Vinokurov MG, 2009, DOKL BIOCHEM BIOPHYS, V424, P35, DOI 10.1134/S1607672909010104; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109962; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Ye Q, 2015, DIS MARKERS, V2015, P1, DOI [10.1155/2015/192108, 10.1155/2015/387382]; YOUNG MRI, 1992, INVAS METAST, V12, P253; Yu CY, 2008, AVIAN PATHOL, V37, P273, DOI 10.1080/03079450802056546; Zhang G, 2013, CURR OPIN MICROBIOL, V16, P779, DOI 10.1016/j.mib.2013.09.007; Zheng FY, 2012, VET MICROBIOL, V156, P434, DOI 10.1016/j.vetmic.2011.11.002; Zou JC, 2015, APPL MICROBIOL BIOT, V99, P10107, DOI 10.1007/s00253-015-6848-y; Zou JC, 2015, VET MICROBIOL, V177, P193, DOI 10.1016/j.vetmic.2015.03.003	47	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160708	10.1371/journal.pone.0160708	http://dx.doi.org/10.1371/journal.pone.0160708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500736	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500047
J	Chen, R; Duan, J; Li, L; Ma, Q; Sun, Q; Ma, J; Li, C; Zhou, X; Chen, H; Jing, Y; Zhao, S; Wu, X; Zhang, H				Chen, R.; Duan, J.; Li, L.; Ma, Q.; Sun, Q.; Ma, J.; Li, C.; Zhou, X.; Chen, H.; Jing, Y.; Zhao, S.; Wu, X.; Zhang, H.			mTOR promotes pituitary tumor development through activation of PTTG1	ONCOGENE			English	Article							TUBEROUS SCLEROSIS COMPLEX; TRANSFORMING GENE PTTG; PROLACTIN-SECRETING CELLS; RECEPTOR-DEFICIENT MICE; LACTOTROPH HYPERPLASIA; MAMMALIAN TARGET; SUPPRESSOR GENE; TRANSGENIC MICE; MOUSE MODEL; ADENOMAS	As one of the most common intracranial tumors, pituitary tumor is associated with high morbidity. Effective therapy is currently not available for some pituitary tumors due to the largely undefined pathological processes of pituitary tumorigenesis. In this study, hyperactivation of mammalian/mechanistic target of rapamycin (mTOR) signaling was observed in estrogen-induced rat pituitary tumor and mTOR inhibitor rapamycin blocked the tumor development. Pituitary knockout of either mTOR signaling pathway negative regulator Tsc1 or Pten caused mouse pituitary prolactinoma, which was abolished by rapamycin treatment. Mechanistically, the expression of pituitary tumor transforming gene 1 (PTTG1) was upregulated in an mTOR complex 1-dependent manner. Overexpressed PTTG1 was crucial in hyperactive mTOR-mediated tumorigenesis. mTOR-PTTG1 signaling axis may be targeted for the treatment of tumors with mTOR hyperactivation.	[Chen, R.; Duan, J.; Li, L.; Ma, Q.; Sun, Q.; Ma, J.; Li, C.; Zhou, X.; Chen, H.; Jing, Y.; Zhao, S.; Zhang, H.] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch,State Key Lab Med Mol Biol, Sch Basic Med,Inst Basic Med Sci,Dept Physiol, Beijing, Peoples R China; [Wu, X.] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Internal Med, Div Endocrinol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Zhang, H (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol & Pathophysiol, Room 445,Old Res Bldg,5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	hbzhang@ibms.pumc.edu.cn			National Basic Research Program of China (973 Program) [2015CB553802]; National Natural Science Foundation of China [81372861, 30788004]; Ministry of Education of China (111 project) [B08007]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China (111 project)	We thank the staff of Animal Center, and Department of Pathology, Peking Union Medical College (Beijing, China) for help with in vivo studies and instructions on pathological analysis. This work was supported by the National Basic Research Program of China (973 Program) (2015CB553802), the National Natural Science Foundation of China (81372861, 30788004), and the Ministry of Education of China (111 project: B08007).	Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403; Asa SL, 1999, ENDOCRINOLOGY, V140, P5348, DOI 10.1210/en.140.11.5348; Asa SL, 2009, ANNU REV PATHOL-MECH, V4, P97, DOI 10.1146/annurev.pathol.4.110807.092259; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Cano DA, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00203; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Cruz-Soto ME, 2002, ENDOCRINOLOGY, V143, P4429, DOI 10.1210/en.2002-220173; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; Dworakowska D, 2009, ENDOCR-RELAT CANCER, V16, P1329, DOI 10.1677/ERC-09-0101; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fedele M, 2010, MOL CELL ENDOCRINOL, V326, P19, DOI 10.1016/j.mce.2010.03.019; Feng ZZ, 2012, MED ONCOL, V29, P304, DOI 10.1007/s12032-010-9775-x; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hikake T, 2009, J ENDOCRINOL, V203, P231, DOI 10.1677/JOE-09-0232; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lee M, 2015, CLIN CANCER RES, V21, P3204, DOI 10.1158/1078-0432.CCR-15-0288; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Liang M, 2015, TUMOR BIOL, V36, P7085, DOI 10.1007/s13277-015-3420-4; Lin SJ, 2015, ONCOTARGET, V6, P39329, DOI 10.18632/oncotarget.5744; Lin YH, 2015, TUMOUR BIOL; Lin Y, 2009, ENDOCR-RELAT CANCER, V16, P301, DOI 10.1677/ERC-08-0167; Lines KE, 2016, MOL CELL ENDOCRINOL, V421, P68, DOI 10.1016/j.mce.2015.08.024; Lu CX, 2008, ENDOCRINOLOGY, V149, P3339, DOI 10.1210/en.2007-1696; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Malhowski AJ, 2011, HUM MOL GENET, V20, P1290, DOI 10.1093/hmg/ddq570; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Marko NF, 2012, NAT REV ENDOCRINOL, V8, P572, DOI 10.1038/nrendo.2012.143; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Monsalves E, 2014, ENDOCR-RELAT CANCER, V21, pR331, DOI 10.1530/ERC-14-0188; Musat M, 2005, ENDOCR-RELAT CANCER, V12, P423, DOI 10.1677/erc.1.00949; Palumbo T, 2013, ONCOGENE, V32, P1651, DOI 10.1038/onc.2012.190; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pelletier G, 2003, NEUROENDOCRINOLOGY, V77, P324, DOI 10.1159/000070898; Peng H, 2013, ONCOGENE, V32, P4702, DOI 10.1038/onc.2012.481; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rubinfeld H, 2012, ENDOCRINE, V42, P285, DOI 10.1007/s12020-012-9682-3; Schuff KG, 2002, J CLIN INVEST, V110, P973, DOI 10.1172/JCI200215912; Squarize CH, 2008, CANCER RES, V68, P7066, DOI 10.1158/0008-5472.CAN-08-0922; Stefaneanu L, 1999, ENDOCRINOLOGY, V140, P3881, DOI 10.1210/en.140.9.3881; Thompson AD, 2005, FEBS LETT, V579, P3195, DOI 10.1016/j.febslet.2005.05.008; Vlotides G, 2006, MOL ENDOCRINOL, V20, P3321, DOI 10.1210/me.2006-0280; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Xie R, 2015, J NEURO-ONCOL, V125, P79, DOI 10.1007/s11060-015-1895-x; Yin Z, 2008, GENESIS, V46, P37, DOI 10.1002/dvg.20362; Yoon CH, 2012, J BIOL CHEM, V287, P19516, DOI 10.1074/jbc.M111.337428; Yu J, 2006, CANCER RES, V66, P9461, DOI 10.1158/0008-5472.CAN-06-1895; Yu R, 2010, PROG BRAIN RES, V182, P207, DOI 10.1016/S0079-6123(10)82009-6; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	62	25	26	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 16	2017	36	7					979	988		10.1038/onc.2016.264	http://dx.doi.org/10.1038/onc.2016.264			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8JG	27524416				2022-12-26	WOS:000394169100010
J	Frey, AG; Palenchar, DJ; Wildemann, JD; Philpott, CC				Frey, Avery G.; Palenchar, Daniel J.; Wildemann, Justin D.; Philpott, Caroline C.			A Glutaredoxin center dot BolA Complex Serves as an Iron-Sulfur Cluster Chaperone for the Cytosolic Cluster Assembly Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotin; iron; iron-sulfur protein; metal homeostasis; metal ion-protein interaction; metalloprotein; BolA2; Ciapin1; Glrx3; Ndor1	SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXIN; PROTEIN BIOGENESIS; REGULATORY PROTEINS; PHP4 FUNCTION; 3 PICOT; ANAMORSIN; GRX4; HOMEOSTASIS; MATURATION	Cells contain hundreds of proteins that require iron cofactors for activity. Iron cofactors are synthesized in the cell, but the pathways involved in distributing heme, iron-sulfur clusters, and ferrous/ferric ions to apoproteins remain incompletely defined. In particular, cytosolic monothiol glutaredoxins and BolA-like proteins have been identified as [2Fe-2S]-coordinating complexes in vitro and iron-regulatory proteins in fungi, but it is not clear how these proteins function in mammalian systems or how this complex might affect Fe-S proteins or the cytosolic Fe-S assembly machinery. To explore these questions, we use quantitative immunoprecipitation and live cell proximity-dependent biotinylation to monitor interactions between Glrx3, BolA2, and components of the cytosolic iron-sulfur cluster assembly system. We characterize cytosolic Glrx3<bold>BolA</bold>2 as a [2Fe-2S] chaperone complex in human cells. Unlike complexes formed by fungal orthologs, human Glrx3-BolA2 interaction required the coordination of Fe-S clusters, whereas Glrx3 homodimer formation did not. Cellular Glrx3<bold>BolA</bold>2 complexes increased 6-8-fold in response to increasing iron, forming a rapidly expandable pool of Fe-S clusters. Fe-S coordination by Glrx3<bold>BolA</bold>2 did not depend on Ciapin1 or Ciao1, proteins that bind Glrx3 and are involved in cytosolic Fe-S cluster assembly and distribution. Instead, Glrx3 and BolA2 bound and facilitated Fe-S incorporation into Ciapin1, a [2Fe-2S] protein functioning early in the cytosolic Fe-S assembly pathway. Thus, Glrx3<bold>BolA is a </bold>[2Fe-2S] chaperone complex capable of transferring [2Fe-2S] clusters to apoproteins in human cells.	[Frey, Avery G.; Philpott, Caroline C.] NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA; [Wildemann, Justin D.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University System of Ohio; Ohio State University	Philpott, CC (corresponding author), NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr,MSC 1800, Bethesda, MD 20892 USA.	Carolinep@mail.nih.gov			National Institutes of Health intramural research program of the NIDDK; Office of Dietary Supplements, Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510] Funding Source: NIH RePORTER	National Institutes of Health intramural research program of the NIDDK; Office of Dietary Supplements, Office of the Director, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health intramural research program of the NIDDK and the Office of Dietary Supplements, Office of the Director, National Institutes of Health. This work was authored, in whole or in part, by National Institutes of Health staff. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALDEA M, 1988, J BACTERIOL, V170, P5169, DOI 10.1128/jb.170.11.5169-5176.1988; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Banci L, 2015, J AM CHEM SOC, V137, P16133, DOI 10.1021/jacs.5b10592; Banci L, 2015, NAT CHEM BIOL, V11, P772, DOI [10.1038/NCHEMBIO.1892, 10.1038/nchembio.1892]; Banci L, 2013, J BIOL INORG CHEM, V18, P883, DOI 10.1007/s00775-013-1033-1; Banci L, 2013, P NATL ACAD SCI USA, V110, P7136, DOI 10.1073/pnas.1302378110; Belli G, 2004, J BIOL CHEM, V279, P12386, DOI 10.1074/jbc.M311879200; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Cheng NH, 2011, FEBS J, V278, P2525, DOI 10.1111/j.1742-4658.2011.08178.x; del Dedo JE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005106; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Hoffmann B, 2011, ANTIOXID REDOX SIGN, V15, P19, DOI 10.1089/ars.2010.3811; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Jacques JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098959; Jbel M, 2011, EUKARYOT CELL, V10, P629, DOI 10.1128/EC.00015-11; Jeong D, 2008, CIRC RES, V102, P711, DOI 10.1161/CIRCRESAHA.107.165985; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lipper CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139699; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mercier A, 2009, J BIOL CHEM, V284, P20249, DOI 10.1074/jbc.M109.009563; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Netz DJA, 2016, BIOCHEM J, V473, P2073, DOI 10.1042/BCJ20160416; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Oh JG, 2012, J MOL CELL CARDIOL, V53, P53, DOI 10.1016/j.yjmcc.2012.03.005; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Paul VD, 2015, ELIFE, V4, DOI 10.7554/eLife.08231; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Stehling O., 2007, METHOD MOL BIOL, P325; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; Vachon P, 2012, EUKARYOT CELL, V11, P806, DOI 10.1128/EC.00060-12; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08; Zhang Y, 2014, P NATL ACAD SCI USA, V111, pE1695, DOI 10.1073/pnas.1405204111; Zhang Y, 2011, J BIOL CHEM, V286, P41499, DOI 10.1074/jbc.M111.294074	56	51	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22344	22356		10.1074/jbc.M116.744946	http://dx.doi.org/10.1074/jbc.M116.744946			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27519415	Green Published, hybrid			2022-12-26	WOS:000386760600001
J	Saadane, A; Mast, N; Dao, T; Ahmad, B; Pikuleva, IA				Saadane, Aicha; Mast, Natalia; Dao, Tung; Ahmad, Baseer; Pikuleva, Irina A.			Retinal Hypercholesterolemia Triggers Cholesterol Accumulation and Esterification in Photoreceptor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); cholesterol; cholesterol metabolism; cytochrome P450; eye; gas chromatography-mass spectrometry (GC-MS); pathogenesis; retina; retinal degeneration; retinal metabolism	SUBRETINAL DRUSENOID DEPOSITS; LIPOPROTEIN-LIKE PARTICLES; RETICULAR MACULAR DISEASE; AGE-RELATED MACULOPATHY; HUMAN BRUCHS MEMBRANE; ACYL-COENZYME; GEOGRAPHIC ATROPHY; MOUSE RETINA; LIPID HISTOCHEMISTRY; ACYLTRANSFERASE ACAT	The process of vision is impossible without the photoreceptor cells, which have a unique structure and specific maintenance of cholesterol. Herein we report on the previously unrecognized cholesterol-related pathway in the retina discovered during follow-up characterizations of Cyp27a1(-/-)Cyp46a1(-/-) mice. These animals have retinal hypercholesterolemia and convert excess retinal cholesterol into cholesterol esters, normally present in the retina in very small amounts. We established that in the Cyp27a1(-/-)Cyp46a1(-/-) retina, cholesterol esters are generated by and accumulate in the photoreceptor outer segments (OS), which is the retinal layer with the lowest cholesterol content. Mouse OS were also found to express the cholesterol-esterifying enzyme acyl-coenzyme A:cholesterol acyltransferase (ACAT1), but not lecithin-cholesterol acyltransferase (LCAT), and to differ from humans in retinal expression of ACAT1. Nevertheless, cholesterol esters were discovered to be abundant in human OS. We suggest a mechanism for cholesterol ester accumulation in the OS and that activity impairment of ACAT1 in humans may underlie the development of subretinal drusenoid deposits, a hallmark of age-related macular degeneration, which is a common blinding disease. We generated Cyp27a1(-/-)Cyp46a1(-/-)Acat1(-/-) mice, characterized their retina by different imaging modalities, and confirmed that unesterified cholesterol does accumulate in their OS and that there is photoreceptor apoptosis and OS degeneration in this line. Our results provide insights into the retinal response to local hypercholesterolemia and the retinal significance of cholesterol esterification, which could be cell-specific and both beneficial and detrimental for retinal structure and function.	[Saadane, Aicha; Mast, Natalia; Dao, Tung; Ahmad, Baseer; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Rm 303a, Cleveland, OH 44106 USA; [Ahmad, Baseer] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 2085 Adelbert Rd,Rm 303a, Cleveland, OH 44106 USA.	iap8@case.edu		Saadane, Aicha/0000-0001-9985-2147; Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health [P30 EY11373]; NATIONAL EYE INSTITUTE [P30EY011373, R01EY018383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the former members of the Pikuleva laboratory, Dr. Saida Omarova and Dr. Casey Charvet, for isolating the OS from donors 3-6; Dr. Cristine Curcio (University of Alabama at Birmingham) for providing retinal sections for these donors; Dr. Krzysztof Palczewski (Case Western Reserve University) for providing the anti-rhodopsin antibodies B6-30; and the Visual Sciences Research Center Core Facility (supported by National Institutes of Health Grant P30 EY11373) for assistance with mouse breeding (Heather Butler and Kathryn Franke), animal genotyping (John Denker), tissue sectioning (Cathy Doller), and microscopy (Dr. Scott Howell). We are also grateful to Dr. Hisashi Fujioka of the Case EM core facility and Dr. Patrick Leahy of the Case LCM core facility.	Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Amaratunga A, 1996, J BIOL CHEM, V271, P5628, DOI 10.1074/jbc.271.10.5628; Anderson DH, 2001, AM J OPHTHALMOL, V131, P767, DOI 10.1016/S0002-9394(00)00961-2; Anderson RA, 1998, J BIOL CHEM, V273, P26747, DOI 10.1074/jbc.273.41.26747; BJORKHEM I, 1987, J LIPID RES, V28, P1137; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; BOESZEBATTAGLIA K, 1989, J BIOL CHEM, V264, P8151; BOESZEBATTAGLIA K, 1990, J BIOL CHEM, V265, P20727; Bok D., 1979, PHAGOCYTIC PROPERTIE; Bretillon L, 2008, EXP EYE RES, V87, P521, DOI 10.1016/j.exer.2008.08.010; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; CASTANHO MARB, 1992, J BIOL CHEM, V267, P204; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Charvet CD, 2013, J BIOL CHEM, V288, P29267, DOI 10.1074/jbc.M113.498832; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Curcio CA, 2005, EXP EYE RES, V81, P731, DOI 10.1016/j.exer.2005.04.012; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Elner Victor M, 2002, Trans Am Ophthalmol Soc, V100, P301; Farese RV, 2006, ARTERIOSCL THROM VAS, V26, P1684, DOI 10.1161/01.ATV.0000227511.35456.90; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Fliesler SJ, 2015, J LIPID RES, V56, P1, DOI 10.1194/jlr.C056358; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GUYTON JR, 1988, J HISTOCHEM CYTOCHEM, V36, P1319, DOI 10.1177/36.10.2458408; Hirsch-Reinshagen V, 2009, J LIPID RES, V50, P885, DOI 10.1194/jlr.M800584-JLR200; Huisingh C, 2016, INVEST OPHTH VIS SCI, V57, P739, DOI 10.1167/iovs.15-18316; Jayakody SA, 2015, PROG RETIN EYE RES, V46, P31, DOI 10.1016/j.preteyeres.2015.01.003; Khelef N, 1998, J BIOL CHEM, V273, P11218, DOI 10.1074/jbc.273.18.11218; Klein R, 2008, AM J OPHTHALMOL, V145, P317, DOI 10.1016/j.ajo.2007.09.008; Kuhrt H, 1997, J BRAIN RES, V38, P223; Lee JW, 2006, EXP EYE RES, V83, P465, DOI 10.1016/j.exer.2005.11.018; Lei XF, 2010, J ATHEROSCLER THROMB, V17, P740, DOI 10.5551/jat.4416; Li CM, 2005, INVEST OPHTH VIS SCI, V46, P2576, DOI 10.1167/iovs.05-0034; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Li L, 2000, ARTERIOSCL THROM VAS, V20, P2636, DOI 10.1161/01.ATV.20.12.2636; Liao WL, 2011, J PROTEOME RES, V10, P241, DOI 10.1021/pr1008898; Liao WL, 2010, ANAL CHEM, V82, P5760, DOI 10.1021/ac100811x; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Marsiglia M, 2013, INVEST OPHTH VIS SCI, V54, P7362, DOI 10.1167/iovs.12-11073; Mast N, 2011, INVEST OPHTH VIS SCI, V52, P594, DOI 10.1167/iovs.10-6021; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Mrejen S, 2014, OPHTHALMOLOGY, V121, P545, DOI 10.1016/j.ophtha.2013.09.026; Oak ASW, 2014, RETINA-J RET VIT DIS, V34, P825, DOI 10.1097/IAE.0000000000000121; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; Omarova S, 2012, J CLIN INVEST, V122, P3012, DOI 10.1172/JCI63816; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pikuleva IA, 2014, PROG RETIN EYE RES, V41, P64, DOI 10.1016/j.preteyeres.2014.03.002; Pumariega NM, 2011, OPHTHALMOLOGY, V118, P1619, DOI 10.1016/j.ophtha.2011.01.029; Querques G, 2014, RETINA-J RET VIT DIS, V34, P321, DOI 10.1097/IAE.0b013e3182993df1; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Saadane A, 2014, AM J PATHOL, V184, P2403, DOI 10.1016/j.ajpath.2014.05.024; Saade C, 2014, CLIN EXP OPHTHALMOL, V42, P865, DOI 10.1111/ceo.12353; Sakashita N, 2000, AM J PATHOL, V156, P227, DOI 10.1016/S0002-9440(10)64723-2; Sakashita N, 2010, J LIPID RES, V51, P1263, DOI [10.1194/jlr.M900288-JLR200, 10.1194/jlr.M900288]; Shanmugaratnam J, 1997, MOL BRAIN RES, V50, P113, DOI 10.1016/S0169-328X(97)00176-9; Steinberg JS, 2013, INVEST OPHTH VIS SCI, V54, P4054, DOI 10.1167/iovs.12-11538; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tserentsoodol N, 2006, MOL VIS, V12, P1319; UELMEN PJ, 1995, J BIOL CHEM, V270, P26192, DOI 10.1074/jbc.270.44.26192; Wang MY, 2012, ANAL CHEM, V84, P5186, DOI 10.1021/ac300587v; WOLTER JR, 1962, ARCH OPHTHALMOL-CHIC, V68, P219; Xu LN, 2013, RETINA-J RET VIT DIS, V33, P1850, DOI 10.1097/IAE.0b013e31828991b2; Yagyu H, 2000, J BIOL CHEM, V275, P21324, DOI 10.1074/jbc.M002541200; Zarubina AV, 2016, OPHTHALMOLOGY, V123, P1090, DOI 10.1016/j.ophtha.2015.12.034; Zheng WC, 2015, J LIPID RES, V56, P81, DOI 10.1194/jlr.M053439; Zheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037926; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P1775, DOI 10.1016/j.ophtha.2010.01.027; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	75	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20427	20439		10.1074/jbc.M116.744656	http://dx.doi.org/10.1074/jbc.M116.744656			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514747	Green Published, hybrid			2022-12-26	WOS:000384574800012
J	Abbas, AK				Abbas, Abdul-Karim			Protein Synthesis Inhibitors Did Not Interfere with Long-Term Depression Induced either Electrically in Juvenile Rats or Chemically in Middle-Aged Rats	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; METABOTROPIC GLUTAMATE RECEPTORS; HIPPOCAMPAL SYNAPTIC PLASTICITY; MENTAL-RETARDATION PROTEIN; MGLUR-DEPENDENT LTD; AMPA RECEPTOR; AREA CA1; MOUSE MODEL; IN-VITRO; RAPID REDISTRIBUTION	In testing the hypothesis that long-term potentiation (LTP) maintenance depends on triggered protein synthesis, we found no effect of protein synthesis inhibitors (PSIs) on LTP stabilization. Similarly, some studies reported a lack of effect of PSIs on long-term depression (LTD); the lack of effect on LTD has been suggested to be resulting from the short time recordings. If this proposal were true, LTD might exhibit sensitivity to PSIs when the recording intervals were enough long. We firstly induced LTD by a standard protocol involving low frequency stimulation, which is suitable for eliciting NMDAR-LTD in CA1 area of hippocampal slices obtained from juvenile Sprague-Dawley rats. This LTD was persistent for intervals in range of 8-10 h. Treating slices with anisomycin, however, did not interfere with the magnitude and persistence of this form of LTD. The failure of anisomycin to block synaptic-LTD might be relied on the age of animal, the type of protein synthesis inhibitors and/or the inducing protocol. To verify whether those variables altogether were determinant, NMDA or DHPG was used to chemically elicit LTD recorded up to 10 h on hippocampal slices obtained from middle-aged rats. In either form of LTD, cycloheximide did not interfere with LTD stabilization. Furthermore, DHPG application did show an increase in the global protein synthesis as assayed by radiolabeled methodology indicating that though triggered protein synthesis can occur but not necessarily required for LTD expression. The findings confirm that stabilized LTD in either juvenile, or middle-aged rats can be independent of triggered protein synthesis. Although the processes responsible for the independence of LTD stabilization on the triggered protein synthesis are not yet defined, these findings raise the possibility that de novo protein synthesis is not universally necessary.	[Abbas, Abdul-Karim] Univ Gothenburg, Inst Neurosci & Physiol, Box 432, SE-40530 Gothenburg, Sweden	University of Gothenburg	Abbas, AK (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Box 432, SE-40530 Gothenburg, Sweden.	abdul-karim.abbas@neuro.gu.se		Abbas, Abdul Karim/0000-0003-3867-4484	Stiftelserna Wilhelm och Martina Lundgrens [2015-0349]; Stiftelsen Handlanden Hjalmar Svenssons [HJSV2014045]; Gun och Bertil Stohnes [20140106]; Fredrik och Ingrid Thurings Stiftelse [20131211]; Sigurd och Elsa Goljes Minne [LA2013-0235]; Swedish Society of Medicine [SLS-348481]; Goteborgs Lakaresallskap [183/13]	Stiftelserna Wilhelm och Martina Lundgrens; Stiftelsen Handlanden Hjalmar Svenssons; Gun och Bertil Stohnes; Fredrik och Ingrid Thurings Stiftelse; Sigurd och Elsa Goljes Minne; Swedish Society of Medicine; Goteborgs Lakaresallskap	This work was supported by Stiftelserna Wilhelm och Martina Lundgrens (2015-0349), Stiftelsen Handlanden Hjalmar Svenssons (HJSV2014045), Gun och Bertil Stohnes (20140106), Fredrik och Ingrid Thurings Stiftelse (20131211), Sigurd och Elsa Goljes Minne (LA2013-0235), and Swedish Society of Medicine (SLS-348481), and Goteborgs Lakaresallskap (183/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NEUROSCIENCE, V246, P301, DOI 10.1016/j.neuroscience.2013.05.011; Abbas AK, 2011, BRAIN RES, V1426, P18, DOI 10.1016/j.brainres.2011.10.010; Abbas AK, 2009, NEUROSCI RES, V63, P59, DOI 10.1016/j.neures.2008.10.008; Abraham WC, 2001, NEURONAL MECHANISMS OF MEMORY FORMATION, P37; Amaral D. G., 1987, HDB PHYSL NERVOUS SY, P211; Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chamberlin T. C., 1897, J GEOL, V5, P837, DOI DOI 10.1086/607980; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Davidkova G, 2007, J NEUROSCI, V27, P13273, DOI 10.1523/JNEUROSCI.3334-07.2007; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Ghilan M, 2014, BRAIN RES, V1581, P117, DOI 10.1016/j.brainres.2014.06.011; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Goh JJ, 2015, BEHAV BRAIN RES, V285, P79, DOI 10.1016/j.bbr.2014.01.022; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; He KW, 2011, J NEUROPHYSIOL, V105, P1897, DOI 10.1152/jn.00913.2010; Henley JM, 2003, NEUROSCI RES, V45, P243, DOI 10.1016/S0168-0102(02)00229-8; Holahan MR, 2005, SYNAPTIC PLASTICITY AND TRANSSYNAPTIC SIGNALING, P419, DOI 10.1007/0-387-25443-9_24; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Izaki Y, 2000, NEUROSCI LETT, V294, P171, DOI 10.1016/S0304-3940(00)01570-6; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kamsler A, 2010, P NATL ACAD SCI USA, V107, P1618, DOI 10.1073/pnas.0912540107; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Kemp N, 1997, NEUROPHARMACOLOGY, V36, P397, DOI 10.1016/S0028-3908(96)90015-5; Kim HH, 2015, J NEUROSCI, V35, P6401, DOI 10.1523/JNEUROSCI.4208-14.2015; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Kuenzi FM, 2000, J NEUROSCI METH, V100, P117, DOI 10.1016/S0165-0270(00)00239-9; Kumar A, 2007, J NEUROPHYSIOL, V98, P2729, DOI 10.1152/jn.00514.2007; Kumar A, 2014, HIPPOCAMPUS, V24, P466, DOI 10.1002/hipo.22240; Kumar A, 2010, J NEUROPHYSIOL, V104, P607, DOI 10.1152/jn.00278.2010; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Lynch G, 2015, BRAIN RES, V1621, P62, DOI 10.1016/j.brainres.2014.11.060; Malleret G, 2010, J NEUROSCI, V30, P3813, DOI 10.1523/JNEUROSCI.1330-09.2010; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McEachern JC, 1996, BRAIN RES REV, V22, P51; Mockett BG, 2011, J NEUROSCI, V31, P7380, DOI 10.1523/JNEUROSCI.6656-10.2011; Moult PR, 2008, J PHYSIOL-LONDON, V586, P2499, DOI 10.1113/jphysiol.2008.153122; Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; NADEL L, 1968, PHYSIOL BEHAV, V3, P891, DOI 10.1016/0031-9384(68)90174-1; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Norris CM, 1996, J NEUROSCI, V16, P5382; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Pignatelli M, 2014, J NEUROSCI, V34, P4558, DOI 10.1523/JNEUROSCI.1846-13.2014; Ramachandran B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00023; Rothman S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-25; Sajikumar S, 2003, NEUROSCI LETT, V338, P147, DOI 10.1016/S0304-3940(02)01400-3; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shehata M, 2012, J NEUROSCI, V32, P10413, DOI 10.1523/JNEUROSCI.4533-11.2012; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Staubli U, 1997, J NEUROSCI, V17, P4820; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Trinh MA, 2014, LEARN MEMORY, V21, P298, DOI 10.1101/lm.032219.113; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Villers A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040823; Watabe AM, 2002, J NEUROPHYSIOL, V87, P1395, DOI 10.1152/jn.00723.2001; Weiler IJ, 1996, J NEUROCHEM, V66, P197; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; YAMAMOTO C, 1966, J NEUROCHEM, V13, P1333, DOI 10.1111/j.1471-4159.1966.tb04296.x; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X	96	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161270	10.1371/journal.pone.0161270	http://dx.doi.org/10.1371/journal.pone.0161270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517693	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100066
J	Toljamo, A; Blande, D; Karenlampi, S; Kokko, H				Toljamo, Anna; Blande, Daniel; Karenlampi, Sirpa; Kokko, Harri			Reprogramming of Strawberry (Fragaria vesca) Root Transcriptome in Response to Phytophthora cactorum	PLOS ONE			English	Article							LECTIN RECEPTOR KINASES; CELL-WALL DEVELOPMENT; SALICYLIC-ACID; X ANANASSA; CROWN ROT; PLANT DEFENSE; ISOCHORISMATE SYNTHASE; AUXIN BIOSYNTHESIS; GENETIC-VARIATION; BOTRYTIS-CINEREA	Crown rot (Phytophthora cactorum) causes significant economic losses in strawberry production. The best control strategy would be to use resistant cultivars, but polygenically inherited resistance makes the breeding of the garden strawberry (Fragaria x ananassa) challenging. The diploid wild strawberry Fragaria vesca Hawaii 4 genotype was shown previously to have resistance against crown rot. To explore the resistance mechanisms, we inoculated the roots of Hawaii 4 with P. cactorum in a novel in vitro hydroponic system to minimize interference caused by other microbes. Major reprogramming of the root transcriptome occurred, involving 30% of the genes. The surveillance system of the plant shifted from the development mode to the defense mode. Furthermore, the immune responses as well as many genes involved in the biosynthesis of the defense hormones jasmonic acid, ethylene and salicylic acid were up-regulated. Several major allergen-like genes encoding PR-10 proteins were highly expressed in the inoculated plants, suggesting that they also have a crucial role in the defense responses against P. cactorum. Additionally, flavonoids and terpenoids may be of vital importance, as several genes involved in their biosynthesis were up-regulated. The cell wall biosynthesis and developmental processes were downregulated, possibly as a result of the down-regulation of the key genes involved in the biosynthesis of growth-promoting hormones brassinosteroids and auxin. Of particular interest was the expression of potential resistance genes in the recently identified P. cactorum resistance locus RPc-1. These new findings help to target the breeding efforts aiming at more resistant strawberry cultivars.	[Toljamo, Anna; Blande, Daniel; Karenlampi, Sirpa; Kokko, Harri] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland	University of Eastern Finland	Toljamo, A; Kokko, H (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland.	anna.toljamo@uef.fi; harri.kokko@uef.fi			University of Eastern Finland	University of Eastern Finland	This research was supported by the strategic funding of the University of Eastern Finland (Innovative Research Initiatives). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2014, MOL BIOL REP, V41, P599, DOI 10.1007/s11033-013-2897-4; Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; Antolin-Llovera M, 2014, CURR BIOL, V24, P422, DOI 10.1016/j.cub.2013.12.053; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Bhat RG, 2006, PLANT DIS, V90, P161, DOI 10.1094/PD-90-0161; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourdais G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005373; Bouwmeester K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001327; Breitfellner F, 2002, EUR FOOD RES TECHNOL, V215, P28, DOI 10.1007/s00217-002-0536-8; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Casado-Diaz A, 2006, PHYSIOL PLANTARUM, V128, P633, DOI 10.1111/j.1399-3054.2006.00798.x; Casanal A, 2013, J BIOL CHEM, V288, P35322, DOI 10.1074/jbc.M113.501528; Chen XR, 2011, CURR GENET, V57, P297, DOI 10.1007/s00294-011-0348-0; Davik J, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0405-3; De Vleesschauwer D, 2012, PLANT PHYSIOL, V158, P1833, DOI 10.1104/pp.112.193672; Denance N, 2013, PLANT J, V73, P225, DOI 10.1111/tpj.12027; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eikemo H, 2004, MYCOL RES, V108, P317, DOI 10.1017/S0953756204009244; Eikemo H, 2003, PLANT DIS, V87, P345, DOI 10.1094/PDIS.2003.87.4.345; Eikemo H, 2003, ANN APPL BIOL, V142, P83, DOI 10.1111/j.1744-7348.2003.tb00232.x; Eikemo H, 2000, ANN APPL BIOL, V137, P237, DOI 10.1111/j.1744-7348.2000.tb00064.x; Eikemo H, 2010, HORTSCIENCE, V45, P193, DOI 10.21273/HORTSCI.45.2.193; Eshraghi L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-68; Fang XL, 2013, J PROTEOME RES, V12, P1772, DOI 10.1021/pr301117a; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gonzalez G, 2013, PHYSIOL MOL PLANT P, V82, P73, DOI 10.1016/j.pmpp.2013.02.001; Guidarelli M, 2011, PLANT PATHOL, V60, P685, DOI 10.1111/j.1365-3059.2010.02423.x; HAMM PB, 1991, PACIF FOR C, V331, P169; Hanhineva K, 2008, PHYTOCHEMISTRY, V69, P2463, DOI 10.1016/j.phytochem.2008.07.009; Hirai N, 2000, BIOSCI BIOTECH BIOCH, V64, P1707, DOI 10.1271/bbb.64.1707; Hok S, 2011, PLANT CELL ENVIRON, V34, P1944, DOI 10.1111/j.1365-3040.2011.02390.x; Hukkanen AT, 2007, J AGR FOOD CHEM, V55, P1862, DOI 10.1021/jf063452p; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Hussey SG, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-173; Jambagi S., 2015, TRANSCRIPTOMICS, V3, DOI [10.4172/2329-8936.1000106, DOI 10.4172/2329-8936.1000106]; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlund A, 2014, J AGR FOOD CHEM, V62, P4592, DOI 10.1021/jf405589f; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim YT, 2010, MOL BIOL REP, V37, P717, DOI 10.1007/s11033-009-9570-y; Kohorn Bruce D, 2015, Plant Signal Behav, V10, pe1035854, DOI 10.1080/15592324.2015.1035854; Koistinen KM, 2005, PHYTOCHEMISTRY, V66, P2524, DOI 10.1016/j.phytochem.2005.09.007; Koskinen P, 2015, BIOINFORMATICS, V31, P1544, DOI 10.1093/bioinformatics/btu851; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102245; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu H, 2014, J INTEGR PLANT BIOL, V56, P350, DOI 10.1111/jipb.12150; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lozano-Duran R, 2015, TRENDS PLANT SCI, V20, P12, DOI 10.1016/j.tplants.2014.09.003; Maas JL, 1998, COMPENDIUM OF STRAWB; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; MASHIGUCHI K, 2011, NATL ACAD SCI US, V108, P18512, DOI DOI 10.1073/PNAS.1108434108; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Mewalal R, 2014, PLANT CELL PHYSIOL, V55, P1031, DOI 10.1093/pcp/pcu050; Miedes E, 2015, FRONT PLANT SCI, P78; Munoz C, 2010, MOL PLANT, V3, P113, DOI 10.1093/mp/ssp087; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mutka AM, 2013, PLANT J, V74, P746, DOI 10.1111/tpj.12157; Nasrallah JB, 2014, BIOCHEM SOC T, V42, P313, DOI 10.1042/BST20130222; Nissen KS, 2016, TRENDS PLANT SCI; Nomura T, 2001, PHYTOCHEMISTRY, V57, P171, DOI 10.1016/S0031-9422(00)00440-4; Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x; Parikka P, 2003, ACTA HORTIC, P183, DOI 10.17660/ActaHortic.2003.626.24; Puhl I, 2008, J PLANT DIS PROTECT, V115, P247, DOI 10.1007/BF03356272; Ranocha P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3625; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rytkonen A, 2012, CAN J PLANT PATHOL, V34, P255, DOI 10.1080/07060661.2012.686455; Saubeau G, 2016, PLANT PATHOL, V65, P342, DOI 10.1111/ppa.12420; SHAH J, 2013, FRONT PLANT SCI, V4; Shaw DV, 2008, PLANT PATHOL, V57, P210, DOI 10.1111/j.1365-3059.2007.01773.x; Shaw DV, 2006, J AM SOC HORTIC SCI, V131, P687, DOI 10.21273/JASHS.131.5.687; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thimmappa R, 2014, ANNU REV PLANT BIOL, V65, P225, DOI 10.1146/annurev-arplant-050312-120229; Thompson JR, 2003, J VIROL METHODS, V111, P85, DOI 10.1016/S0166-0934(03)00164-2; VANDENHEUVEL JFJM, 1989, PHYTOPATHOLOGY, V79, P963, DOI 10.1094/Phyto-79-963; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Wang Y, 2015, J EXP BOT, V66, P6731, DOI 10.1093/jxb/erv379; Wang Y, 2014, MOL PLANT MICROBE IN, V27, P1390, DOI 10.1094/MPMI-06-14-0191-R; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wulf JS, 2008, J AGR FOOD CHEM, V56, P2875, DOI 10.1021/jf072495i; Yamamoto M, 2000, PHYTOPATHOLOGY, V90, P595, DOI 10.1094/PHYTO.2000.90.6.595; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yuan YA, 2009, P NATL ACAD SCI USA, V106, P22020, DOI 10.1073/pnas.0906869106; Zentmyer GA., 1969, CALIFORNIA AVOCADO S, P103; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	100	34	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161078	10.1371/journal.pone.0161078	http://dx.doi.org/10.1371/journal.pone.0161078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518577	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100044
J	Haseda, F; Imagawa, A; Nishikawa, H; Mitsui, S; Tsutsumi, C; Fujisawa, R; Sano, H; Murase-Mishiba, Y; Terasaki, J; Sakaguchi, S; Hanafusa, T				Haseda, Fumitaka; Imagawa, Akihisa; Nishikawa, Hiroyoshi; Mitsui, Shinobu; Tsutsumi, Chiharu; Fujisawa, Reiko; Sano, Hiroyuki; Murase-Mishiba, Yuko; Terasaki, Jungo; Sakaguchi, Shimon; Hanafusa, Toshiaki			Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes	PLOS ONE			English	Article							GALECTIN-3; PROTEIN; ONSET; MELLITUS; AUTOANTIBODIES; AUTOANTIGEN; MONOCYTES; RESPONSES; RECEPTOR; SUBTYPE	Aims/Hypothesis Fulminant type 1 diabetes (FT1D) is a distinct subtype of type 1 diabetes and is fatal without immediate diagnosis and treatment. At present, there are no biomarkers for early and predictive detection of FT1D. Methods First, we analyzed a total of 6 serum samples from 3 patients with FT1D (1 sample in the acute and 1 in the sub-acute phases from each patient) by seromic analysis. Second, titres of the antibody were measured by ELISA in sera from 30 patients with FT1D (both in the acute and sub-acute phases), 13 patients with FT1D in the chronic phase, 32 patients with autoimmune type 1 (type 1A) diabetes (T1AD), 30 patients with type 2 diabetes (T2D), 23 patients with autoimmune thyroid disease (AITD) and 31 healthy control subjects (HC). Results Seromic analysis revealed 9 antibodies which showed high signals from all 3 patients with FT1D in the acute phase. Among them, the titre of anti-CD300e antibody was significantly higher in FT1D patients in the acute phase than that in T1AD, T2D, AITD patients and HC, as determined by ELISA (P<0.01, respectively). The titre of anti-CD300e antibody was also higher in FT1D in the acute phase than that in the sub-acute phase (P = 0.0018, Wilcoxon signed-rank test). The titre of anti-LGALS3 antibody in FT1D patients in the acute phase did not differ from that in patients with FT1D in the sub-acute phase, T1AD, T2D, AITD and HC. Conclusion/Interpretation The titre of a novel antibody, anti-CD300e, was high in sera from patients with FT1D. This antibody might be a diagnostic marker and provide new insight into the pathogenesis of FT1D.	[Haseda, Fumitaka; Imagawa, Akihisa; Mitsui, Shinobu; Tsutsumi, Chiharu; Fujisawa, Reiko; Sano, Hiroyuki; Murase-Mishiba, Yuko; Terasaki, Jungo; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan; [Imagawa, Akihisa] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Nishikawa, Hiroyoshi; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Expt Immunol, Suita, Osaka, Japan; [Nishikawa, Hiroyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunol, Kashiwa, Chiba, Japan	Osaka Medical College; Osaka University; Osaka University; National Cancer Center - Japan	Hanafusa, T (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan.	hanafusa@osaka-med.ac.jp	Nishikawa, Hiroyoshi/AAI-7044-2020; Sakaguchi, Shimon/C-9535-2009		Novo Nordisk Pharma-Insulin Research Grant; Novo Nordisk Pharma Ltd; Japanese Society for the Promotion of Science (KAKENHI) [15K09402]; Grants-in-Aid for Scientific Research [15K09402] Funding Source: KAKEN	Novo Nordisk Pharma-Insulin Research Grant(Novo Nordisk); Novo Nordisk Pharma Ltd(Novo Nordisk); Japanese Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Novo Nordisk Pharma-Insulin Research Grant received by FH, a Junior Scientist Development Grant supported by Novo Nordisk Pharma Ltd received by FH, and a Grant-in-Aid from the Japanese Society for the Promotion of Science (KAKENHI 15K09402) received by TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; BOTTAZZO GF, 1974, LANCET, V2, P1279, DOI 10.1016/S0140-6736(74)90140-8; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Breuilh L, 2007, INFECT IMMUN, V75, P5148, DOI 10.1128/IAI.02006-06; Cho YM, 2007, DIABETOLOGIA, V50, P2276, DOI 10.1007/s00125-007-0812-z; Clark GJ, 2007, J IMMUNOTHER, V30, P303, DOI 10.1097/01.cji.0000211342.65964.9e; Gasiorowski RE, 2013, IMMUNOL LETT, V149, P93, DOI 10.1016/j.imlet.2012.10.005; Gnjatic S, 2010, P NATL ACAD SCI USA, V107, P5088, DOI 10.1073/pnas.0914213107; Gnjatic S, 2009, J IMMUNOL METHODS, V341, P50, DOI 10.1016/j.jim.2008.10.016; Haseda F, 2013, CLIN EXP IMMUNOL, V173, P207, DOI 10.1111/cei.12116; Imagawa A, 2003, DIABETES CARE, V26, P2345, DOI 10.2337/diacare.26.8.2345; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; Imagawa A, 2012, J DIABETES INVEST, V3, P536, DOI 10.1111/jdi.12024; Imagawa A, 2011, DIABETES-METAB RES, V27, P959, DOI 10.1002/dmrr.1236; Jeon SB, 2010, J IMMUNOL, V185, P7037, DOI 10.4049/jimmunol.1000154; Koo BK, 2014, DIABETES, V63, P3022, DOI 10.2337/db13-1566; Kotani R, 2004, DIABETOLOGIA, V47, P1285, DOI 10.1007/s00125-004-1441-4; Lockhart DC, 2001, SURGERY, V129, P749, DOI 10.1067/msy.2001.114554; Mensah-Brown EPK, 2009, CLIN IMMUNOL, V130, P83, DOI 10.1016/j.clim.2008.08.024; Moreau C, 2008, DIABETES METAB, V34, P529, DOI 10.1016/j.diabet.2008.05.003; Morishima A, 2014, JOINT BONE SPINE, V81, P546, DOI 10.1016/j.jbspin.2014.03.005; RABIN DU, 1994, J IMMUNOL, V152, P3183; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Shibasaki S, 2010, ENDOCR J, V57, P211, DOI 10.1507/endocrj.K09E-291; Tanaka S, 2000, NEW ENGL J MED, V342, P1835; Tanaka S, 2009, DIABETES, V58, P2285, DOI 10.2337/db09-0091; Wang T, 2008, CHINESE MED J-PEKING, V121, P181, DOI 10.1097/00029330-200801020-00018; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Zheng C, 2011, DIABETES-METAB RES, V27, P70, DOI 10.1002/dmrr.1148	31	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160576	10.1371/journal.pone.0160576	http://dx.doi.org/10.1371/journal.pone.0160576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513516	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100046
J	Klintstrom, E; Klintstrom, B; Moreno, R; Brismar, TB; Pahr, DH; Smedby, O				Klintstrom, Eva; Klintstrom, Benjamin; Moreno, Rodrigo; Brismar, Torkel B.; Pahr, Dieter H.; Smedby, Orjan			Predicting Trabecular Bone Stiffness from Clinical Cone-Beam CT and HR-pQCT Data; an In Vitro Study Using Finite Element Analysis	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; DISTAL RADIUS; OSTEODENT PROJECT; RISK-ASSESSMENT; FRACTURE RISK; OSTEOPOROSIS; MICROSTRUCTURE; WOMEN; MULTISLICE; CALCANEUS	Stiffness and shear moduli of human trabecular bone may be analyzed in vivo by finite element (FE) analysis from image data obtained by clinical imaging equipment such as high resolution peripheral quantitative computed tomography (HR-pQCT). In clinical practice today, this is done in the peripheral skeleton like the wrist and heel. In this cadaveric bone study, fourteen bone specimens from the wrist were imaged by two dental cone beam computed tomography (CBCT) devices and one HR-pQCT device as well as by dual energy X-ray absorptiometry (DXA). Histomorphometric measurements from micro-CT data were used as gold standard. The image processing was done with an in-house developed code based on the automated region growing (ARG) algorithm. Evaluation of how well stiffness (Young's modulus E3) and minimum shear modulus from the 12, 13, or 23 could be predicted from the CBCT and HR-pQCT imaging data was studied and compared to FE analysis from the micro-CT imaging data. Strong correlations were found between the clinical machines and micro-CT regarding trabecular bone structure parameters, such as bone volume over total volume, trabecular thickness, trabecular number and trabecular nodes (varying from 0.79 to 0.96). The two CBCT devices as well as the HR-pQCT showed the ability to predict stiffness and shear, with adjusted R-2-values between 0.78 and 0.92, based on data derived through our in-house developed code based on the ARG algorithm. These findings indicate that clinically used CBCT may be a feasible method for clinical studies of bone structure and mechanical properties in future osteoporosis research.	[Klintstrom, Eva; Smedby, Orjan] Linkoping Univ, Div Radiol, Dept Med & Hlth Sci, Linkoping, Sweden; [Klintstrom, Eva; Klintstrom, Benjamin] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden; [Moreno, Rodrigo; Smedby, Orjan] KTH Royal Inst Technol, Sch Technol & Hlth, Stockholm, Sweden; [Brismar, Torkel B.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Brismar, Torkel B.] Karolinska Univ Hosp, Dept Radiol, Stockholm, Sweden; [Pahr, Dieter H.] TU Wien, Inst Lightweight Design & Struct Biomech, Vienna, Austria	Linkoping University; Linkoping University; Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Technische Universitat Wien	Klintstrom, E (corresponding author), Linkoping Univ, Div Radiol, Dept Med & Hlth Sci, Linkoping, Sweden.; Klintstrom, E (corresponding author), Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden.	evaklintstrom@gmail.com	Brismar, Torkel B/H-2872-2019	Brismar, Torkel B/0000-0002-3409-1938; Smedby, Orjan/0000-0002-7750-1917; Pahr, Dieter/0000-0002-5822-2082				Arai Y, 1999, DENTOMAXILLOFAC RAD, V28, P245, DOI 10.1038/sj.dmfr.4600448; Bauer JS, 2007, CALCIFIED TISSUE INT, V80, P366, DOI 10.1007/s00223-007-9021-5; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Boutry N, 2003, RADIOLOGY, V227, P708, DOI 10.1148/radiol.2273020420; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burghardt AJ, 2013, J BONE MINER RES, V28, P524, DOI 10.1002/jbmr.1795; Burrows M, 2010, J CLIN DENSITOM, V13, P451, DOI 10.1016/j.jocd.2010.02.003; Chevalier Y, 2008, COMPUT METHOD BIOMEC, V11, P477, DOI 10.1080/10255840802078022; Christen D, 2013, J BONE MINER RES, V28, P2601, DOI 10.1002/jbmr.1996; CULLUM ID, 1989, BRIT J RADIOL, V62, P587, DOI 10.1259/0007-1285-62-739-587; De Cock J, 2012, SKELETAL RADIOL, V41, P93, DOI 10.1007/s00256-011-1198-z; Diederichs G, 2009, BONE, V44, P976, DOI 10.1016/j.bone.2009.01.372; GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0; Hassani-Nejad A, 2013, EUR J ORAL SCI, V121, P525, DOI 10.1111/eos.12087; Hsu JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050008; Ibrahim N, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20130206; Jarvinen TLN, 2015, J INTERN MED, V277, P662, DOI 10.1111/joim.12366; Jonasson G, 2013, CLIN ORAL INVEST, V17, P565, DOI 10.1007/s00784-012-0745-x; Jonasson G, 2013, OR SURG OR MED OR PA, V116, P362, DOI 10.1016/j.oooo.2013.06.009; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Karayianni K, 2007, BONE, V40, P223, DOI 10.1016/j.bone.2006.07.025; KLEEREKOPER M, 1985, CALCIFIED TISSUE INT, V37, P594, DOI 10.1007/BF02554913; Klintstrom E, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20140196; Klintstrom E, 2015, EUR C RAD ER VIENN A; Klintstrom E, 2014, SKELETAL RADIOL, V43, P197, DOI 10.1007/s00256-013-1766-5; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Laib A, 1999, BONE, V24, P35, DOI 10.1016/S8756-3282(98)00159-8; Lindh C, 2008, ORAL SURG ORAL MED O, V106, P285, DOI 10.1016/j.tripleo.2007.09.008; Liu XS, 2010, J BONE MINER RES, V25, P1496, DOI 10.1002/jbmr.50; Ludlow JB, 2008, ORAL SURG ORAL MED O, V106, P106, DOI 10.1016/j.tripleo.2008.03.018; MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017; Maquer G, 2015, J BONE MINER RES, V30, P1000, DOI 10.1002/jbmr.2437; Matsunaga S, 2013, DENT MATER J, V32, P425, DOI 10.4012/dmj.2012-281; Matsunaga S, 2010, INT J PROSTHODONT, V23, P333; Miller PD, 2002, J BONE MINER RES, V17, P2222, DOI 10.1359/jbmr.2002.17.12.2222; Miracle AC, 2009, AM J NEURORADIOL, V30, P1285, DOI 10.3174/ajnr.A1654; Moreno R, 2013, CORRELATIONS FABRIC; Moreno R, 2015, ANISOTROPY ESTIMATIO; Moreno R, 2012, SPIE MED IMAGING; Moreno R, 2016, BIOMECH MODEL MECHAN, V15, P831, DOI 10.1007/s10237-015-0726-5; Nackaerts O, 2011, CLIN ORAL IMPLAN RES, V22, P873, DOI 10.1111/j.1600-0501.2010.02076.x; Nemtoi A, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120443; Oliveira ML, 2013, OR SURG OR MED OR PA, V115, P558, DOI 10.1016/j.oooo.2013.01.021; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pein MK, 2014, RADIOLOGE, V54, P271, DOI 10.1007/s00117-013-2644-9; Peltonen LI, 2007, ACTA RADIOL, V48, P207, DOI 10.1080/02841850601080465; Petersson J, 2006, LECT NOTES COMPUT SC, V4191, P880; Phan CM, 2006, RADIOLOGY, V239, P488, DOI 10.1148/radiol.2392050574; Revol-Muller C, 2002, PATTERN RECOGN LETT, V23, P137, DOI 10.1016/S0167-8655(01)00116-7; Rudang R, 2013, J BONE MINER RES, V28, P2305, DOI 10.1002/jbmr.1974; Scarfe WC, 2006, J CAN DENT ASSOC, V72, P75; Sievanen H, 1998, J BONE MINER RES, V13, P871, DOI 10.1359/jbmr.1998.13.5.871; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; Van Dessel J, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20130145; van Rietbergen B, 2015, J BIOMECH, V48, P832, DOI 10.1016/j.jbiomech.2014.12.024; Wolfram U, 2012, J MECH BEHAV BIOMED, V15, P218, DOI 10.1016/j.jmbbm.2012.07.005; Wolfram U, 2010, J BIOMECH, V43, P1731, DOI 10.1016/j.jbiomech.2010.02.026; Xie WJ, 2003, PATTERN RECOGN, V36, P1529, DOI 10.1016/S0031-3203(02)00348-5; Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6	63	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161101	10.1371/journal.pone.0161101	http://dx.doi.org/10.1371/journal.pone.0161101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513664	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100120
J	Beaumont, J; Montgomery, J				Beaumont, Julia; Montgomery, Janet			The Great Irish Famine: Identifying Starvation in the Tissues of Victims Using Stable Isotope Analysis of Bone and Incremental Dentine Collagen	PLOS ONE			English	Article							ANOREXIA-NERVOSA; CHILDHOOD DIET; NITROGEN; CARBON; HAIR; STRESS; RATIOS; HISTORIES; SAMPLES; MARINE	The major components of human diet both past and present may be estimated by measuring the carbon and nitrogen isotope ratios (delta C-13 and delta N-15) of the collagenous proteins in bone and tooth dentine. However, the results from these two tissues differ substantially: bone collagen records a multi-year average whilst primary dentine records and retains time-bound isotope ratios deriving from the period of tooth development. Recent studies harnessing a sub-annual temporal sampling resolution have shed new light on the individual dietary histories of our ancestors by identifying unexpected radical short-term dietary changes, the duration of breastfeeding and migration where dietary change occurs, and by raising questions regarding factors other than diet that may impact on delta C-13 and delta N-15 values. Here we show that the dentine delta C-13 and delta N-15 profiles of workhouse inmates dating from the Great Irish Famine of the 19th century not only record the expected dietary change from C-3 potatoes to C-4 maize, but when used together they also document prolonged nutritional and other physiological stress resulting from insufficient sustenance. In the adults, the influence of the maize-based diet is seen in the delta C-13 difference between dentine (formed in childhood) and rib (representing an average from the last few years of life). The demonstrated effects of stress on the delta C-13 and delta N-15 values will have an impact on the interpretations of diet in past populations even in slow-turnover tissues such as compact bone. This technique also has applicability in the investigation of modern children subject to nutritional distress where hair and nails are unavailable or do not record an adequate period of time.	[Beaumont, Julia] Univ Bradford, Sch Archaeol Sci, Bradford, W Yorkshire, England; [Montgomery, Janet] Univ Durham, Dept Archaeol, Durham, England	University of Bradford; Durham University	Beaumont, J (corresponding author), Univ Bradford, Sch Archaeol Sci, Bradford, W Yorkshire, England.	j.beaumont6@bradford.ac.uk		Beaumont, Julia/0000-0002-7166-5857	Arts and Humanities Research Council under AHRC Studentship [AH/I503307/1]; AHRC [AH/I503307/1]	Arts and Humanities Research Council under AHRC Studentship(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	This study was supported by an Arts and Humanities Research Council grant funding to JB under AHRC Studentship AH/I503307/1.; The authors wish to thank Jonny Geber for his continuing support and the Irish Antiquities section of the Museum of Ireland for permission to sample the individuals from Kilkenny. They would like to acknowledge Andrew Gledhill for his support in the mass spectrometry laboratory at the University of Bradford when producing the isotope data. The manuscript has been greatly improved by the helpful comments and suggestions of editor and reviewers. This project was supported by AHRC grant funding to Julia Beaumont under AHRC Studentship AH/I503307/1.	Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Beaumont J., 2014, B INT ASS PALEODONT, V8, P212; Beaumont J, 2015, ANN HUM BIOL, V42, P407, DOI 10.3109/03014460.2015.1045027; Beaumont J, 2015, AM J PHYS ANTHROPOL, V157, P441, DOI 10.1002/ajpa.22736; Beaumont J, 2013, AM J PHYS ANTHROPOL, V150, P87, DOI 10.1002/ajpa.22179; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Casper RC, 1996, PSYCHIAT RES, V62, P85, DOI 10.1016/0165-1781(96)02984-8; Chamberlain A.T., 2006, DEMOGRAPHY ARCHAEOLO; Cherel Y, 2005, ECOLOGY, V86, P2881, DOI 10.1890/05-0562; Clarkson L. A., 2001, FEAST FAMINE FOOD NU; Crawford E. M., 1981, IRISH POPULATION EC, P113; DEAN MC, 1995, INT J OSTEOARCHAEOL, V5, P349, DOI 10.1002/oa.1390050405; DIRKS R, 1980, CURR ANTHROPOL, V21, P21, DOI 10.1086/202399; Dulloo AG, 1999, BRIT J NUTR, V82, P339, DOI 10.1017/S0007114599001580; Eerkens JW, 2011, J ARCHAEOL SCI, V38, P3101, DOI 10.1016/j.jas.2011.07.010; Fogel RW, 1992, NUTR POVERTY, P243; Fuller BT, 2003, J ARCHAEOL SCI, V30, P1673, DOI 10.1016/S0305-4403(03)00073-6; Geber J., 2012, ATLAS GREAT IRISH FA, P341; Geber J, 2014, AM J PHYS ANTHROPOL, V155, P149, DOI 10.1002/ajpa.22567; Hatch KA, 2006, RAPID COMMUN MASS SP, V20, P3367, DOI 10.1002/rcm.2740; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; Katzenberg MA, 1999, INT J OSTEOARCHAEOL, V9, P316, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<316::AID-OA500>3.0.CO;2-D; Lehn C, 2015, SCI JUSTICE, V55, P72, DOI 10.1016/j.scijus.2014.10.006; MacArthur WP, 1976, STUDIES IRISH HIST 1, p[1845, 263]; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; MOKYR J, 1980, J ECON HIST, V40, P159, DOI 10.1017/S0022050700104681; Mokyr J, 2002, EUR REV ECON HIST, V6, P339, DOI 10.1017/S1361491602000163; Montgomery J, 2013, ANTIQUITY, V87, P1060, DOI 10.1017/S0003598X00049863; Morgan J., 2013, ANTROCOM ONLINE J AN, V9, P115; Neuberger FM, 2013, FORENSIC SCI INT, V226, P22, DOI 10.1016/j.forsciint.2012.10.037; O'Neill T, 1976, STUDIES IRISH HIST 1, P1845; Orser Jr CE, 1997, ARCHAEOLOGY IRELAND, V11, P14; Peel M, 1997, BRIT MED J, V315, P829, DOI 10.1136/bmj.315.7112.829; RICHARDS MP, 2012, GLOBAL HIST PALEOPAT, P718; Roberts C., 2003, HLTH DIS BRITAIN PRE; SCHOENINGER MJ, 1983, SCIENCE, V220, P1381, DOI 10.1126/science.6344217; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Wright LE, 1999, J ARCHAEOL SCI, V26, P1159, DOI 10.1006/jasc.1998.0351	43	108	110	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160065	10.1371/journal.pone.0160065	http://dx.doi.org/10.1371/journal.pone.0160065			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DT3KR	27508412	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400021
J	Gomez-Acebo, I; Dierssen-Sotos, T; Palazuelos, C; Perez-Gomez, B; Lope, V; Tusquets, I; Alonso, MH; Moreno, V; Amiano, P; de la Torre, AJM; Barricarte, A; Tardon, A; Camacho, A; Peiro-Perez, R; Marcos-Gragera, R; Munoz, M; Michelena-Echeveste, MJ; Valin, LO; Guevara, M; Castano-Vinyals, G; Aragones, N; Kogevinas, M; Pollan, M; Llorca, J				Gomez-Acebo, Ines; Dierssen-Sotos, Trinidad; Palazuelos, Camilo; Perez-Gomez, Beatriz; Lope, Virginia; Tusquets, Ignasi; Henar Alonso, M.; Moreno, Victor; Amiano, Pilar; Jose Molina de la Torre, Antonio; Barricarte, Aurelio; Tardon, Adonina; Camacho, Antonio; Peiro-Perez, Rosana; Marcos-Gragera, Rafael; Munoz, Montse; Jesus Michelena-Echeveste, Maria; Ortega Valin, Luis; Guevara, Marcela; Castano-Vinyals, Gemma; Aragones, Nuria; Kogevinas, Manolis; Pollan, Marina; Llorca, Javier			The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; COHORT; WOMEN; APOPTOSIS; MORTALITY; CARCINOMA	Introduction The evidence on the relationship between breast cancer and different types of antihypertensive drugs taken for at least 5 years is limited and inconsistent. Furthermore, the debate has recently been fueled again with new data reporting an increased risk of breast cancer among women with a long history of use of antihypertensive drugs compared with nonusers. Methods In this case-control study, we report the antihypertensive drugs-breast cancer relationship in 1,736 breast cancer cases and 1,895 healthy controls; results are reported stratifying by the women's characteristics (i.e., menopausal status or body mass index category) tumor characteristics and length of use of antihypertensive drugs. Results The relationship among breast cancer and use of calcium channel blockers (CCB) for 5 or more years had odds ratio (OR) = 1.77 (95% CI, 0.99 to 3.17). Stratifying by BMI, the OR increased significantly in the group with BMI >= 25 (OR 2.54, 95% CI, 1.24 to 5.22). CCBs were even more strongly associated with more aggressive tumors, (OR for invasive tumors = 1.96, 95% CI = 1.09 to 3.53; OR for non ductal cancers = 3.97, 95% CI = 1.73 to 9.05; OR for Erbb2+cancer = 2.97, 95% CI: 1.20 to 7.32). On the other hand, premenopausal women were the only group in which angiotensin II receptor blockers may be associated with breast cancer (OR = 4.27, 95% CI = 1.32 to 13.84) but this could not be identified with any type or stage. Use of angiotensin-converting-enzyme inhibitors, beta blockers and diuretics were not associated with risk. Conclusions In this large population-based study we found that long term use of calcium channel blockers is associated with some subtypes of breast cancer (and with breast cancer in overweight women).	[Gomez-Acebo, Ines; Dierssen-Sotos, Trinidad; Perez-Gomez, Beatriz; Lope, Virginia; Henar Alonso, M.; Moreno, Victor; Amiano, Pilar; Tardon, Adonina; Peiro-Perez, Rosana; Guevara, Marcela; Castano-Vinyals, Gemma; Aragones, Nuria; Kogevinas, Manolis; Pollan, Marina; Llorca, Javier] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Gomez-Acebo, Ines; Dierssen-Sotos, Trinidad; Palazuelos, Camilo; Llorca, Javier] Univ Cantabria, IDIVAL, Santander, Spain; [Perez-Gomez, Beatriz; Lope, Virginia; Aragones, Nuria; Pollan, Marina] Carlos III Inst Hlth, Canc & Environm Epidemiol Unit, Natl Ctr Epidemiol, Madrid, Spain; [Perez-Gomez, Beatriz; Lope, Virginia; Aragones, Nuria; Pollan, Marina] IIS Puerta Hierro IDIPHIM, Canc Epidemiol Res Grp, Oncol & Hematol Area, Madrid, Spain; [Tusquets, Ignasi] Hosp Mar, Serv Oncol Med, Barcelona, Spain; [Tusquets, Ignasi] Hosp Mar Med Res Inst, Canc Res Program IMIM, Barcelona, Spain; [Tusquets, Ignasi] Univ Autonoma Barcelona, Barcelona, Spain; [Henar Alonso, M.; Moreno, Victor] Catalan Inst Oncol IDIBELL, Canc Prevent & Control Program, Barcelona, Spain; [Henar Alonso, M.; Moreno, Victor] Univ Barcelona, Barcelona, Spain; [Amiano, Pilar] Biodonostia Res Inst, Hlth Div Gipuzkoa, Guipuzkoa, Spain; [Jose Molina de la Torre, Antonio] Univ Leon, Dept Ciencias Biomed, Area Med Prevent & Salud Publ, Leon, Spain; [Jose Molina de la Torre, Antonio; Guevara, Marcela] Univ Leon, GIIGAS, Leon, Spain; [Barricarte, Aurelio] Navarra Publ Hlth Inst, Pamplona, Spain; [Barricarte, Aurelio] Navarra Inst Hlth Res IdiSNA Pamplona, Pamplona, Spain; [Tardon, Adonina] Univ Oviedo, IUOPA, Oviedo, Spain; [Camacho, Antonio] Hosp Juan Ramon Jimenez, Andalusian Hlth Serv, Huelva, Spain; [Camacho, Antonio] Univ Huelva, Res Ctr Hlth & Environm CYSMA, Huelva, Spain; [Peiro-Perez, Rosana] Fdn FISABIO Salud Publ, Area Canc & Salud Publ, Valencia, Spain; [Marcos-Gragera, Rafael] Autonomous Govt Catalonia, Epidemiol Unit, Girona, Spain; [Marcos-Gragera, Rafael] Autonomous Govt Catalonia, Girona Canc Registry, Oncol Coordinat Plan, Dept Hlth, Girona, Spain; [Marcos-Gragera, Rafael] Catalan Inst Oncol, Descript Epidemiol, Genet & Canc Prevent Grp, Girona Biomed Res Inst IdIBGi, Girona, Spain; [Munoz, Montse] Translat Genom & Targeted Therapeut Solid Tumors, Barcelona, Spain; [Jesus Michelena-Echeveste, Maria] Onkol Oncol Inst Gipuzkoa, Guipuzkoa, Spain; [Ortega Valin, Luis] Complex Assist Univ Leon, Serv Pharm, Leon, Spain; [Guevara, Marcela] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Castano-Vinyals, Gemma; Kogevinas, Manolis] Univ Pompeu Fabra UPF, Barcelona, Spain; [Castano-Vinyals, Gemma] Hosp Mar Med Res Inst, IMIM, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Cantabria; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Universidad de Leon; Universidad de Leon; Public Health Institute of Navarra; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Hospital Juan Ramon Jimenez; Universidad de Huelva; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Pompeu Fabra University; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Gomez-Acebo, I (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.; Gomez-Acebo, I (corresponding author), Univ Cantabria, IDIVAL, Santander, Spain.	gomezai@unican.es	Guevara, Marcela/B-4473-2015; Gomez-Acebo, Ines/C-9122-2018; Kogevinas, Manolis/C-3918-2017; Castaño-Vinyals, Gemma/H-7021-2017; Marcos-Gragera, Rafael/A-1437-2017; Castaño-Vinyals, Gemma/N-3885-2019; Pollan, Marina/M-3259-2014; Muñoz, Montserrat/AAO-9617-2020; Aragones, Nuria/O-5962-2015; Martínez, Tamara/AAL-1747-2020; Perez-Gomez, Beatriz/C-4715-2012; Alonso, Henar/ABH-3132-2020; Moreno, Victor/A-1697-2010; LOPE, VIRGINIA/S-4774-2016; TARDON, ADONINA/B-6563-2014; Llorca, Javier/F-7371-2011	Guevara, Marcela/0000-0001-9242-6364; Gomez-Acebo, Ines/0000-0001-8793-8314; Kogevinas, Manolis/0000-0002-9605-0461; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Marcos-Gragera, Rafael/0000-0001-9824-3657; Castaño-Vinyals, Gemma/0000-0003-4468-1816; Pollan, Marina/0000-0002-4328-1565; Muñoz, Montserrat/0000-0001-7772-1437; Aragones, Nuria/0000-0003-0983-2156; Perez-Gomez, Beatriz/0000-0002-4299-8214; Moreno, Victor/0000-0002-2818-5487; LOPE, VIRGINIA/0000-0002-6986-4021; TARDON, ADONINA/0000-0001-5150-1209; Llorca, Javier/0000-0001-8569-861X; Dierssen-Sotos, Trinidad/0000-0002-6127-0077; Peiro Perez, Rosana/0000-0003-1525-4030; ALONSO AGUADO, M. HENAR/0000-0003-0285-5451	"Accion Transversal del Cancer" project; Instituto de Salud Carlos III-FEDER [PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-Leon, PI09/01903-Valencia, PI09/02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219]; Fundacion Marques de Valdecilla [API 10/09]; ICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII)); ICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through Red Tematica de Investigacion del Cancer (RTICC) del ISCIII) [RD12/0036/0036]; Junta de Castilla y Leon [LE22A10-2]; Consejeria de Salud of the Junta de Andalucia [2009-S0143]; Conselleria de Sanitat of the Generalitat Valenciana [AP_061/10]; Recercaixa [2010ACUP 00310]; Regional Government of the Basque Country; European Commission [FOOD-CT-2006-036224-HIWATE]; Spanish Association Against Cancer (AECC) Scientific Foundation; Catalan Government DURSI grant [2009SGR1489]	"Accion Transversal del Cancer" project; Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos III); Fundacion Marques de Valdecilla(Instituto de Salud Carlos III); ICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII)); ICGC International Cancer Genome Consortium CLL (Spanish Ministerio de Economia y Competitividad (MINECO) through Red Tematica de Investigacion del Cancer (RTICC) del ISCIII); Junta de Castilla y Leon(Junta de Castilla y Leon); Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia); Conselleria de Sanitat of the Generalitat Valenciana; Recercaixa(La Caixa Foundation); Regional Government of the Basque Country; European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Association Against Cancer (AECC) Scientific Foundation; Catalan Government DURSI grant	The study was partially funded by the "Accion Transversal del Cancer" project, approved by the Spanish Council of Ministers on the 11th October 2007, by the Instituto de Salud Carlos III-FEDER (PI08/1770, PI08/0533, PI08/1359, PI09/00773-Cantabria, PI09/01286-Leon, PI09/01903-Valencia, PI09/02078-Huelva, PI09/01662-Granada, PI11/01403, PI11/01889-FEDER, PI11/00226, PI11/01810, PI11/02213, PI12/00488, PI12/00265, PI12/01270, PI12/00715, PI12/00150, PI14/01219), by the Fundacion Marques de Valdecilla (API 10/09), by the ICGC International Cancer Genome Consortium CLL (The ICGC CLL-Genome Project is funded by Spanish Ministerio de Economia y Competitividad (MINECO) through the Instituto de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII (RD12/0036/0036)), by the Junta de Castilla y Leon (LE22A10-2), by the Consejeria de Salud of the Junta de Andalucia (2009-S0143), by the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10), by the Recercaixa (2010ACUP 00310), by the Regional Government of the Basque Country, by the European Commission grants FOOD-CT-2006-036224-HIWATE, by the Spanish Association Against Cancer (AECC) Scientific Foundation and by the Catalan Government DURSI grant 2009SGR1489.	Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; Bhaskaran K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2697; Castano-Vinyals G, 2015, GAC SANIT, V29, P308, DOI 10.1016/j.gaceta.2014.12.003; Daling JR, 1996, AM J HYPERTENS, V9, P713; del Pozo JG, 2004, REV ESP CARDIOL, V57, P241; Devore EE, 2015, BREAST CANCER RES TR, V150, P219, DOI 10.1007/s10549-015-3311-9; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fitzpatrick AL, 1997, CANCER, V80, P1438, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6; Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x; Guo DL, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/420482; HEINONEN OP, 1974, LANCET, V2, P675; Hole DJ, 1998, J HYPERTENS, V16, P119, DOI 10.1097/00004872-199816010-00017; Hosmer DW, 2013, WILEY SER PROBAB ST, P269; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; Jick H, 1997, LANCET, V349, P1699, DOI 10.1016/S0140-6736(05)62672-4; Largent JA, 2010, CANCER CAUSE CONTROL, V21, P1615, DOI 10.1007/s10552-010-9590-x; Leung HWC, 2015, CARDIOL THER, V4, P65, DOI 10.1007/s40119-015-0035-1; Li CI, 2013, JAMA INTERN MED, V173, P1629, DOI 10.1001/jamainternmed.2013.9071; Li CI, 2003, CANCER, V98, P1504, DOI 10.1002/cncr.11663; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105801; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Meier CR, 2000, ARCH INTERN MED, V160, P349, DOI 10.1001/archinte.160.3.349; Michels KB, 1998, CANCER, V83, P2003, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2003::AID-CNCR17>3.3.CO;2-V; Michels KB, 1998, CIRCULATION, V97, P1540, DOI 10.1161/01.CIR.97.16.1540; Olsen JH, 1997, HYPERTENSION, V29, P1091, DOI 10.1161/01.HYP.29.5.1091; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Pahor M, 1996, AM J HYPERTENS, V9, P695, DOI 10.1016/0895-7061(96)00186-0; Rosenberg L, 1998, JAMA-J AM MED ASSOC, V279, P1000, DOI 10.1001/jama.279.13.1000; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; Sorensen HT, 2000, CANCER-AM CANCER SOC, V89, P165, DOI 10.1002/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200	34	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159672	10.1371/journal.pone.0159672	http://dx.doi.org/10.1371/journal.pone.0159672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508297	Green Published, gold			2022-12-26	WOS:000381380400010
J	Morelli, TL; Daly, C; Dobrowski, SZ; Dulen, DM; Ebersole, JL; Jackson, ST; Lundquist, JD; Millar, CI; Maher, SP; Monahan, WB; Nydick, KR; Redmond, KT; Sawyer, SC; Stock, S; Beissinger, SR				Morelli, Toni Lyn; Daly, Christopher; Dobrowski, Solomon Z.; Dulen, Deanna M.; Ebersole, Joseph L.; Jackson, Stephen T.; Lundquist, Jessica D.; Millar, Constance I.; Maher, Sean P.; Monahan, William B.; Nydick, Koren R.; Redmond, Kelly T.; Sawyer, Sarah C.; Stock, Sarah; Beissinger, Steven R.			Managing Climate Change Refugia for Climate Adaptation	PLOS ONE			English	Article							UNITED-STATES; RIVER RESTORATION; CHANGE IMPACTS; BIODIVERSITY; MICROREFUGIA; ECOSYSTEMS; MODELS; CONSERVATION; COMMUNITIES; RESPONSES	Refugia have long been studied from paleontological and biogeographical perspectives to understand how populations persisted during past periods of unfavorable climate. Recently, researchers have applied the idea to contemporary landscapes to identify climate change refugia, here defined as areas relatively buffered from contemporary climate change over time that enable persistence of valued physical, ecological, and socio-cultural resources. We differentiate historical and contemporary views, and characterize physical and ecological processes that create and maintain climate change refugia. We then delineate how refugia can fit into existing decision support frameworks for climate adaptation and describe seven steps for managing them. Finally, we identify challenges and opportunities for operationalizing the concept of climate change refugia. Managing climate change refugia can be an important option for conservation in the face of ongoing climate change.	[Morelli, Toni Lyn] US Geol Survey, DOI Northeast Climate Sci Ctr, Amherst, MA 01002 USA; [Morelli, Toni Lyn; Maher, Sean P.; Beissinger, Steven R.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Morelli, Toni Lyn; Maher, Sean P.; Beissinger, Steven R.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Daly, Christopher] Oregon State Univ, Coll Engn, Corvallis, OR 97331 USA; [Dobrowski, Solomon Z.] Univ Montana, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Dulen, Deanna M.] Natl Pk Serv, Devils Postpile Natl Monument, Mammoth Lakes, CA 93546 USA; [Ebersole, Joseph L.] US EPA, Western Ecol Div, Corvallis, OR 97333 USA; [Jackson, Stephen T.] US Geol Survey, DOI Southwest Climate Sci Ctr, Tucson, AZ 85721 USA; [Jackson, Stephen T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Jackson, Stephen T.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Lundquist, Jessica D.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98195 USA; [Millar, Constance I.] USDA Forest Serv, Pacific Southwest Res Stn, Albany, CA 94710 USA; [Maher, Sean P.] Missouri State Univ, Dept Biol, Springfield, MO 65897 USA; [Monahan, William B.] USDA Forest Serv, Forest Hlth Technol Enterprise Team, Ft Collins, CO 80526 USA; [Nydick, Koren R.] Natl Pk Serv, Sequoia & Kings Canyon Natl Pk, Three Rivers, CA USA; [Redmond, Kelly T.] Desert Res Inst, Western Reg Climate Ctr, Reno, NV 89506 USA; [Sawyer, Sarah C.] USDA Forest Serv, Pacific Southwest Reg, Vallejo, CA 94592 USA; [Stock, Sarah] Natl Pk Serv, Yosemite Natl Pk, El Portal, CA 95318 USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Oregon State University; University of Montana System; University of Montana; United States Department of the Interior; United States Environmental Protection Agency; United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); United States Forest Service; Missouri State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior	Morelli, TL (corresponding author), US Geol Survey, DOI Northeast Climate Sci Ctr, Amherst, MA 01002 USA.; Morelli, TL (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Morelli, TL (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	tmorelli@usgs.gov	Ebersole, Joseph/AAT-5862-2020; Dobrowski, Solomon Z/Q-7132-2019; Maher, Sean/V-7553-2017	Ebersole, Joseph/0000-0003-1050-1995; Dobrowski, Solomon Z/0000-0003-2561-3850; Jackson, Stephen/0000-0002-1487-4652; Morelli, Toni Lyn/0000-0001-5865-5294; Maher, Sean/0000-0002-3430-0410	California Landscape Conservation Cooperative; Department of Interior Northeast Climate Science Center	California Landscape Conservation Cooperative; Department of Interior Northeast Climate Science Center	This work was supported by funding from the California Landscape Conservation Cooperative (www.californialcc.org) and the Department of Interior Northeast Climate Science Center (necsc.umass.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LL, 2006, P NATL ACAD SCI USA, V103, P12447, DOI 10.1073/pnas.0605310103; [Anonymous], 2011, ECOLOGICAL NICHES GE; Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Beechie T, 2008, N AM J FISH MANAGE, V28, P891, DOI 10.1577/M06-174.1; Bogan MT, 2015, FRESHWATER BIOL, V60, P2547, DOI 10.1111/fwb.12522; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cain S.A., 1944, FDN PLANT GEOGRAPHY; Camp A, 1997, FOREST ECOL MANAG, V95, P63, DOI 10.1016/S0378-1127(97)00006-6; Chollett I, 2013, BIOL CONSERV, V167, P179, DOI 10.1016/j.biocon.2013.08.010; Coetzee BWT, 2009, GLOBAL ECOL BIOGEOGR, V18, P701, DOI 10.1111/j.1466-8238.2009.00485.x; Collen P, 2001, REV FISH BIOL FISHER, V10, P439; Curtis JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106984; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2010, INT J CLIMATOL, V30, P1857, DOI 10.1002/joc.2007; Davies PM, 2010, RESTOR ECOL, V18, P261, DOI 10.1111/j.1526-100X.2009.00648.x; Davis J, 2013, GLOBAL CHANGE BIOL, V19, P1970, DOI 10.1111/gcb.12203; Dobrowski SZ, 2013, GLOBAL CHANGE BIOL, V19, P241, DOI 10.1111/gcb.12026; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Ebersole JL, 2003, CAN J FISH AQUAT SCI, V60, P1266, DOI 10.1139/F03-107; Egloff B., 2015, HERITAGE RISK, P200; Eigenbrod F, 2015, GLOBAL CHANGE BIOL, V21, P275, DOI 10.1111/gcb.12669; Epps CW, 2006, MOL ECOL, V15, P4295, DOI 10.1111/j.1365-294X.2006.03103.x; Field C. B., 2014, CLIM CHANG 2014 I A; Gavin DG, 2014, NEW PHYTOL, V204, P37, DOI 10.1111/nph.12929; Greenwood O, 2016, J APPL ECOL, V53, P885, DOI 10.1111/1365-2664.12602; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hylander K, 2015, AMBIO, V44, pS60, DOI 10.1007/s13280-014-0599-3; Isaak DJ, 2015, GLOBAL CHANGE BIOL, V21, P2540, DOI 10.1111/gcb.12879; Isaak DJ, 2016, PROCEEDINGS OF THE N; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Keppel G, 2015, FRONT ECOL ENVIRON, V13, P106, DOI 10.1890/140055; Keppel G, 2012, GLOBAL CHANGE BIOL, V18, P2389, DOI 10.1111/j.1365-2486.2012.02729.x; Keppel G, 2012, GLOBAL ECOL BIOGEOGR, V21, P393, DOI 10.1111/j.1466-8238.2011.00686.x; Knapp RA, 2007, BIOL CONSERV, V135, P11, DOI 10.1016/j.biocon.2006.09.013; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Lundquist JD, 2006, J HYDROMETEOROL, V7, P1199, DOI 10.1175/JHM539.1; Lundquist JD, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009879; Mackey B, 2012, ECOL APPL, V22, P1852, DOI 10.1890/11-1479.1; Magris RA, 2014, BIOL CONSERV, V170, P207, DOI 10.1016/j.biocon.2013.12.032; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Millar CI, 2007, ECOL APPL, V17, P2145, DOI 10.1890/06-1715.1; Millar CI, 2014, ARCT ANTARCT ALP RES, V46, P483, DOI 10.1657/1938-4246-46.2.483; Millar CI, 2015, QUATERN INT, V387, P106, DOI 10.1016/j.quaint.2013.11.003; Monahan WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101302; Morelli TL, 2012, P ROY SOC B-BIOL SCI, V279, P4279, DOI 10.1098/rspb.2012.1301; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Ordonez A, 2014, NAT CLIM CHANGE, V4, P811, DOI [10.1038/nclimate2337, 10.1038/NCLIMATE2337]; Parra JL, 2008, GLOBAL CHANGE BIOL, V14, P2215, DOI 10.1111/j.1365-2486.2008.01649.x; Peterson DL, GTRPNW8552012 USDA F; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Sahlean TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091994; Saxon E, 2005, ECOL LETT, V8, P53, DOI 10.1111/j.1461-0248.2004.00694.x; Snyder CD, 2015, ECOL APPL, V25, P1397, DOI 10.1890/14-1354.1; Staudinger MD, 2013, FRONT ECOL ENVIRON, V11, P465, DOI 10.1890/120272; Stein B.A., 2014, CLIMATE SMART CONSER; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Tague C, 2007, HYDROL PROCESS, V21, P3288, DOI 10.1002/hyp.6538; Torgersen CE, 2012, 910C12001 EPA; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Turner W, 2015, BIOL CONSERV, V182, P173, DOI 10.1016/j.biocon.2014.11.048; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Vos CC, 2008, J APPL ECOL, V45, P1722, DOI 10.1111/j.1365-2664.2008.01569.x; Wallace KJ, 2012, ENVIRON SCI POLICY, V17, P1, DOI 10.1016/j.envsci.2011.12.001; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wilby RL, 2010, SCI TOTAL ENVIRON, V408, P4150, DOI 10.1016/j.scitotenv.2010.05.014; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams KB, 2014, APPL THRESHOLD CONCE, P45; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Wright JP, 2006, BIOSCIENCE, V56, P203, DOI 10.1641/0006-3568(2006)056[0203:TCOOAE]2.0.CO;2	76	226	233	11	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159909	10.1371/journal.pone.0159909	http://dx.doi.org/10.1371/journal.pone.0159909			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509088	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400017
J	Rachlis, B; Bakoyannis, G; Easterbrook, P; Genberg, B; Braithwaite, RS; Cohen, CR; Bukusi, EA; Kambugu, A; Bwana, MB; Somi, GR; Geng, EH; Musick, B; Yiannoutsos, CT; Wools-Kaloustian, K; Braitstein, P				Rachlis, Beth; Bakoyannis, Giorgos; Easterbrook, Philippa; Genberg, Becky; Braithwaite, Ronald Scott; Cohen, Craig R.; Bukusi, Elizabeth A.; Kambugu, Andrew; Bwana, Mwebesa Bosco; Somi, Geoffrey R.; Geng, Elvin H.; Musick, Beverly; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara; Braitstein, Paula			Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ANTIRETROVIRAL THERAPY; FOLLOW-UP; INFECTED PATIENTS; SOUTH-AFRICA; SERVICE DELIVERY; PATIENTS LOST; LINKAGE; ART; DECENTRALIZATION	Losses to follow-up (LTFU) remain an important programmatic challenge. While numerous patient-level factors have been associated with LTFU, less is known about facility-level factors. Data from the East African International epidemiologic Databases to Evaluate AIDS (EA-IeDEA) Consortium was used to identify facility-level factors associated with LTFU in Kenya, Tanzania and Uganda. Patients were defined as LTFU if they had no visit within 12 months of the study endpoint for pre-ART patients or 6 months for patients on ART. Adjusting for patient factors, shared frailty proportional hazard models were used to identify the facility-level factors associated with LTFU for the pre-and post-ART periods. Data from 77,362 patients and 29 facilities were analyzed. Median age at enrolment was 36.0 years (Interquartile Range: 30.1, 43.1), 63.9% were women and 58.3% initiated ART. Rates (95% Confidence Interval) of LTFU were 25.1 (24.7-25.6) and 16.7 (16.3-17.2) per 100 personyears in the pre-ART and post-ART periods, respectively. Facility-level factors associated with increased LTFU included secondary-level care, HIV RNA PCR turnaround time > 14 days, and no onsite availability of CD4 testing. Increased LTFU was also observed when no nutritional supplements were provided (pre-ART only), when TB patients were treated within the HIV program (pre-ART only), and when the facility was open <= 4 mornings per week (ART only). Our findings suggest that facility-based strategies such as point of care laboratory testing and separate clinic spaces for TB patients may improve retention.	[Rachlis, Beth] Ontario HIV Treatment Network, Toronto, ON, Canada; [Rachlis, Beth] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON, Canada; [Bakoyannis, Giorgos; Yiannoutsos, Constantin T.] Indiana Univ, Richard Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46204 USA; [Easterbrook, Philippa; Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Genberg, Becky] Brown Univ, Dept Hlth Serv, Providence, RI 02912 USA; [Braithwaite, Ronald Scott] NYU, Dept Populat Hlth, Sch Med, New York, NY 10003 USA; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bwana, Mwebesa Bosco] Mbarara Univ Sci & Technol, Dept Internal Med, Mbarara, Uganda; [Somi, Geoffrey R.] Natl AIDS Control Programme, Dar Es Salaam, Tanzania; [Geng, Elvin H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94110 USA; [Musick, Beverly] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Wools-Kaloustian, Kara] Indiana Univ Sch Med, Div Infect Dis, Dept Med, Indianapolis, IN 46202 USA; [Braitstein, Paula] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Braitstein, Paula] Moi Univ, Coll Hlth Sci, Sch Med, Dept Med, Eldoret, Kenya; [Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	University of Toronto; Indiana University System; Indiana University-Purdue University Indianapolis; Brown University; New York University; University of California System; University of California San Francisco; Kenya Medical Research Institute; Mbarara University of Science & Technology; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Moi University; University of Toronto	Braitstein, P (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Braitstein, P (corresponding author), Moi Univ, Coll Hlth Sci, Sch Med, Dept Med, Eldoret, Kenya.; Braitstein, P (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	paula.braitstein@utoronto.ca	Bakoyannis, Giorgos/AAW-8304-2020	Bakoyannis, Giorgos/0000-0002-2789-2497; Braithwaite, Ronald Scott/0000-0001-7067-3655; Easterbrook, Philippa/0000-0002-2603-5418; Genberg, Becky/0000-0002-9450-5311	National Institute of Allergy and Infectious Diseases of the National Institute of Health [U01AI069911]; Canadian Institutes of Health Research as a Research Chair of Applied Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099966, P30MH062246] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institute of Health; Canadian Institutes of Health Research as a Research Chair of Applied Public Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institute of Health under Award Number U01AI069911 East Africa IeDEA Consortium. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Paula Braitstein is supported by the Canadian Institutes of Health Research as a Research Chair of Applied Public Health.	Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; [Anonymous], WHO POL COLL TB HIV; Ansa GA, 2014, T ROY SOC TROP MED H, V108, P560, DOI 10.1093/trstmh/tru110; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Clouse K, 2013, TROP MED INT HEALTH, V18, P451, DOI 10.1111/tmi.12072; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Duda SN, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19045; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Joint United Nations Programme on HIV/AIDS, UNAIDS REP GLOB AIDS; Kaplan R, 2014, SAMJ S AFR MED J, V104, P204, DOI [10.7196/samj.7696, 10.7196/SAMJ.7696]; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Legido-Quigley H, 2013, TROP MED INT HEALTH, V18, P199, DOI 10.1111/tmi.12029; Molfino L, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23758; Mukora R, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-205; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Palchaudhuri S, 2014, MALAWI MED J, V26, P42; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Rebeiro P, 2013, JAIDS-J ACQ IMM DEF, V62, P356, DOI 10.1097/QAI.0b013e31827f578a; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Skiest DJ, 2007, J INFECT DIS, V195, P1426, DOI 10.1086/512681; Ulett KB, 2009, AIDS PATIENT CARE ST, V23, P41, DOI 10.1089/apc.2008.0132; Uyei J, 2014, INT J TUBERC LUNG D, V18, P315, DOI 10.5588/ijtld.13.0184; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; WHO, GUID START ANT THER; World Health Organization (WHO)/Joint United Nations Programme on HIV/AIDS (UNAIDS), GLOB HLTH SECT RESP; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	37	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159994	10.1371/journal.pone.0159994	http://dx.doi.org/10.1371/journal.pone.0159994			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509182	Green Published, gold			2022-12-26	WOS:000381380400018
J	Chen, KJ; Shanmugam, NKN; Pazos, MA; Hurley, BP; Cherayil, BJ				Chen, Kejie; Shanmugam, Nanda Kumar N.; Pazos, Michael A.; Hurley, Bryan P.; Cherayil, Bobby J.			Commensal Bacteria-Induced Inflammasome Activation in Mouse and Human Macrophages Is Dependent on Potassium Efflux but Does Not Require Phagocytosis or Bacterial Viability	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; INTESTINAL INFLAMMATION; IL-1-BETA PRODUCTION; CROHNS-DISEASE; RECEPTOR; AUTOPHAGY; PROTEIN; INFECTION; DECTIN-1; CELLS	Gut commensal bacteria contribute to the pathogenesis of inflammatory bowel disease, in part by activating the inflammasome and inducing secretion of interleukin-1 beta (IL-1 beta). Although much has been learned about inflammasome activation by bacterial pathogens, little is known about how commensals carry out this process. Accordingly, we investigated the mechanism of inflammasome activation by representative commensal bacteria, the Gram-positive Bifidobacterium longum subspecies infantis and the Gram-negative Bacteroides fragilis. B. infantis and B. fragilis induced IL-1 beta secretion by primary mouse bone marrow-derived macrophages after overnight incubation. IL-1 beta secretion also occurred in response to heat-killed bacteria and was only partly reduced when phagocytosis was inhibited with cytochalasin D. Similar results were obtained with a wild-type immortalized mouse macrophage cell line but neither B. infantis nor B. fragilis induced IL-1 beta secretion in a mouse macrophage line lacking the nucleotide-binding/leucine-rich repeat pyrin domain containing 3 (NLRP3) inflammasome. IL-1 beta secretion in response to B. infantis and B. fragilis was significantly reduced when the wild-type macrophage line was treated with inhibitors of potassium efflux, either increased extracellular potassium concentrations or the channel blocker ruthenium red. Both live and heat-killed B. infantis and B. fragilis also induced IL-1 beta secretion by human macrophages (differentiated THP-1 cells or primary monocyte-derived macrophages) after 4 hours of infection, and the secretion was inhibited by raised extracellular potassium and ruthenium red but not by cytochalasin D. Taken together, our findings indicate that the commensal bacteria B. infantis and B. fragilis activate the NLRP3 inflammasome in both mouse and human macrophages by a mechanism that involves potassium efflux and that does not require bacterial viability or phagocytosis.	[Chen, Kejie; Shanmugam, Nanda Kumar N.; Pazos, Michael A.; Hurley, Bryan P.; Cherayil, Bobby J.] Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Boston, MA 02114 USA; [Chen, Kejie; Shanmugam, Nanda Kumar N.; Pazos, Michael A.; Hurley, Bryan P.; Cherayil, Bobby J.] Harvard Med Sch, Boston, MA 02115 USA; [Chen, Kejie] Sichuan Agr Univ, Coll Vet Med, Yaan, Sichuan, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Sichuan Agricultural University	Cherayil, BJ (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Mucosal Immunol & Biol Res Ctr, Boston, MA 02114 USA.; Cherayil, BJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	cherayil@helix.mgh.harvard.edu		Navalpur Shanmugam, Nanda Kumar/0000-0003-2916-8563	National Institute of Allergy and Infectious Diseases [R01AI089700, R01AI095338]; China Scholarship Council; Cystic Fibrosis Foundation [PAZOS13F0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); China Scholarship Council(China Scholarship Council); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant numbers R01AI089700 and R01AI095338 from the National Institute of Allergy and Infectious Diseases to BJC and BPH, respectively. KC was supported by funding from the China Scholarship Council and MAP by fellowship number PAZOS13F0 from the Cystic Fibrosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Bauer C, 2012, DIGEST DIS, V30, P82, DOI 10.1159/000341681; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; de Luca A, 2014, P NATL ACAD SCI USA, V111, P3526, DOI 10.1073/pnas.1322831111; Eldridge MJG, 2015, CURR OPIN MICROBIOL, V23, P32, DOI 10.1016/j.mib.2014.10.008; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Ganesan S, 2014, J IMMUNOL, V193, P2519, DOI 10.4049/jimmunol.1400276; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Hari A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07281; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jun HK, 2012, IMMUNITY, V36, P755, DOI 10.1016/j.immuni.2012.05.002; Kalantari P, 2014, CELL REP, V6, P196, DOI 10.1016/j.celrep.2013.12.014; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Lahiri A, 2014, GASTROENTEROLOGY, V147, P835, DOI 10.1053/j.gastro.2014.06.024; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Liu ZP, 2012, J BIOL CHEM, V287, P16955, DOI 10.1074/jbc.M112.358705; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Mortimer L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004887; Opipari A, 2015, INFLAMM BOWEL DIS, V21, P173, DOI 10.1097/MIB.0000000000000230; Plantinga TS, 2011, GUT, V60, P1229, DOI 10.1136/gut.2010.228908; Rhee SJ, 2005, J IMMUNOL, V175, P1127, DOI 10.4049/jimmunol.175.2.1127; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schett G, 2016, NAT REV RHEUMATOL, V12, P14, DOI 10.1038/nrrheum.2016.166; Seo SU, 2015, IMMUNITY, V42, P744, DOI 10.1016/j.immuni.2015.03.004; Shanmugam NKN, 2015, J BIOL CHEM, V290, P30637, DOI 10.1074/jbc.M115.689190; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Storek KM, 2015, IMMUNOL REV, V265, P112, DOI 10.1111/imr.12289; Su CW, 2012, J IMMUNOL, V189, P1459, DOI 10.4049/jimmunol.1200484; Vanaja SK, 2015, TRENDS CELL BIOL, V25, P308, DOI 10.1016/j.tcb.2014.12.009; Vijayan D, 2012, METHODS MOL BIOL, V844, P183, DOI 10.1007/978-1-61779-527-5_13; Wang LJ, 2008, J IMMUNOL, V181, P2723, DOI 10.4049/jimmunol.181.4.2723; Wang LJ, 2011, J INNATE IMMUN, V3, P437, DOI 10.1159/000324833; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wlodarska M, 2015, CELL HOST MICROBE, V17, P577, DOI 10.1016/j.chom.2015.04.008; Yang JL, 2015, CURR OPIN IMMUNOL, V32, P78, DOI 10.1016/j.coi.2015.01.007; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	45	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160937	10.1371/journal.pone.0160937	http://dx.doi.org/10.1371/journal.pone.0160937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505062	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200082
J	Petrenyi, K; Molero, C; Konya, Z; Erdodi, F; Arino, J; Dombradi, V				Petrenyi, Katalin; Molero, Cristina; Konya, Zoltan; Erdodi, Ferenc; Arino, Joaquin; Dombradi, Viktor			Analysis of Two Putative Candida albicans Phosphopantothenoylcysteine Decarboxylase/Protein Phosphatase Z Regulatory Subunits Reveals an Unexpected Distribution of Functional Roles	PLOS ONE			English	Article							PPZ PROTEIN PHOSPHATASES; CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; SALT TOLERANCE; INHIBITORY SUBUNIT; GENE DELETION; YEAST PPZ1; HOMEOSTASIS; EXPRESSION; POTASSIUM	Protein phosphatase Z (Ppz) is a fungus specific enzyme that regulates cell wall integrity, cation homeostasis and oxidative stress response. Work on Saccharomyces cerevisiae has shown that the enzyme is inhibited by Hal3/ Vhs3 moonlighting proteins that together with Cab3 constitute the essential phosphopantothenoylcysteine decarboxylase (PPCDC) enzyme. In Candida albicans CaPpz1 is also involved in the morphological changes and infectiveness of this opportunistic human pathogen. To reveal the CaPpz1 regulatory context we searched the C. albicans database and identified two genes that, based on the structure of their S. cerevisiae counterparts, were termed CaHal3 and CaCab3. By pull down analysis and phosphatase assays we demonstrated that both of the bacterially expressed recombinant proteins were able to bind and inhibit CaPpz1 as well as its C-terminal catalytic domain (CaPpz1-Cter) with comparable efficiency. The binding and inhibition were always more pronounced with CaPpz1-Cter, indicating a protective effect against inhibition by the N-terminal domain in the full length protein. The functions of the C. albicans proteins were tested by their overexpression in S. cerevisiae. Contrary to expectations we found that only CaCab3 and not CaHal3 rescued the phenotypic traits that are related to phosphatase inhibition by ScHal3, such as tolerance to LiCl or hygromycin B, requirement for external K+ concentrations, or growth in a MAP kinase deficient slt2 background. On the other hand, both of the Candida proteins turned out to be essential PPCDC components and behaved as their S. cerevisiae counterparts: expression of CaCab3 and CaHal3 rescued the cab3 and hal3 vhs3 S. cerevisiae mutations, respectively. Thus, both CaHal3 and CaCab3 retained the PPCDC related functions and have the potential for CaPpz1 inhibition in vitro. The fact that only CaCab3 exhibits its phosphatase regulatory potential in vivo suggests that in C. albicans CaCab3, but not CaHal3, acts as a moonlighting protein.	[Petrenyi, Katalin; Konya, Zoltan; Erdodi, Ferenc; Dombradi, Viktor] Univ Debrecen, Dept Med Chem, Fac Med, H-4032 Debrecen, Hungary; [Molero, Cristina; Arino, Joaquin] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Molero, Cristina; Arino, Joaquin] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain	University of Debrecen; Autonomous University of Barcelona; Autonomous University of Barcelona	Dombradi, V (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, H-4032 Debrecen, Hungary.; Arino, J (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.; Arino, J (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain.	joaquin.arino@uab.es; dombradi@med.unideb.hu	Arino, Joaquin/D-3756-2011	Arino, Joaquin/0000-0002-6774-2987; Arino Carmona, Joaquin/0000-0002-0390-4270	Ministry of Science and Innovation, Spain [BFU2011-30197-C3-01, BFU2014-54591-C2-1-P]; Ministry of Economy and Competitivity, Spain [BFU2011-30197-C3-01, BFU2014-54591-C2-1-P]; FEDER [BFU2011-30197-C3-01, BFU2014-54591-C2-1-P]; Hungarian Science Reseach Found OTKA/NKHT [K108989, K109249]; Campus Hungary; National Excellence Program - European Union [TAMOP 4.2.4.A/2-11-1-2012-0001]; European Social Fund; Generalitat de Catalunya [Ajut 2014-SGR-4]	Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy and Competitivity, Spain(Spanish Government); FEDER(European Commission); Hungarian Science Reseach Found OTKA/NKHT(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Campus Hungary; National Excellence Program - European Union; European Social Fund(European Social Fund (ESF)); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants BFU2011-30197-C3-01 and BFU2014-54591-C2-1-P to J.A. (from the Ministry of Science and Innovation and Ministry of Economy and Competitivity, Spain and FEDER), as well as K108989 to V.D. and K109249 to F.E. (both from the Hungarian Science Reseach Found OTKA/NKHT). K.P. was the recipient of a traveling grant from the Campus Hungary, and was supported by the TAMOP 4.2.4.A/2-11-1-2012-0001 National Excellence Program that was subsidized by the European Union and co-financed by the European Social Fund. J.A. was recipient of an "Ajut 2014-SGR-4" (Generalitat de Catalunya) support.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; Adams A, 1997, METHODS YEAST GENETI; Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Abrie JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep15774; Abrie JA, 2012, BIOCHEM J, V442, P357, DOI 10.1042/BJ20111466; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clotet J, 1999, MOL CELL BIOL, V19, P2408; de Nadal E, 1998, P NATL ACAD SCI USA, V95, P7357, DOI 10.1073/pnas.95.13.7357; DICOMO CJ, 1995, GENETICS, V139, P95; ERDODI F, 1995, AM J PHYSIOL-CELL PH, V269, pC1176, DOI 10.1152/ajpcell.1995.269.5.C1176; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; GOMEZ MJ, 1994, FOLIA MICROBIOL, V39, P519, DOI 10.1007/BF02814083; Kupke T, 2001, J BIOL CHEM, V276, P19190, DOI 10.1074/jbc.M100776200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee S, 1988, FUNGAL GENET NEWSL, P3523; Manoj N, 2003, ACTA CRYSTALLOGR D, V59, P1762, DOI 10.1107/S0907444903016214; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Molero C, 2013, MOL MICROBIOL, V90, P367, DOI 10.1111/mmi.12370; Munoz I, 2004, J BIOL CHEM, V279, P42619, DOI 10.1074/jbc.M405656200; Navarrete C, 2010, FEMS YEAST RES, V10, P508, DOI 10.1111/j.1567-1364.2010.00630.x; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; POSAS F, 1995, J BIOL CHEM, V270, P13036, DOI 10.1074/jbc.270.22.13036; POSAS F, 1993, FEBS LETT, V318, P282, DOI 10.1016/0014-5793(93)80529-4; POSAS F, 1995, FEBS LETT, V368, P39, DOI 10.1016/0014-5793(95)00593-X; Ruiz A, 2004, J BIOL CHEM, V279, P34421, DOI 10.1074/jbc.M400572200; Ruiz A, 2003, EUKARYOT CELL, V2, P937, DOI 10.1128/EC.2.5.937-948.2003; Ruiz A, 2009, NAT CHEM BIOL, V5, P920, DOI 10.1038/nchembio.243; Ruiz A, 2007, EUKARYOT CELL, V6, P2175, DOI 10.1128/EC.00337-07; Sherman F, 1991, METHOD ENZYMOL, P1943; Song WJ, 1998, EMBO J, V17, P5757, DOI 10.1093/emboj/17.19.5757; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Vissi E, 2001, YEAST, V18, P115, DOI 10.1002/1097-0061(20010130)18:2<115::AID-YEA653>3.0.CO;2-G; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	36	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160965	10.1371/journal.pone.0160965	http://dx.doi.org/10.1371/journal.pone.0160965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504636	Green Published, gold			2022-12-26	WOS:000381374200086
J	Wang, YL; Wang, WY; Liu, J; Huang, X; Liu, RX; Xia, HK; Brecha, NC; Pu, ML; Gao, J				Wang, Yanling; Wang, Wenyao; Liu, Jessica; Huang, Xin; Liu, Ruixing; Xia, Huika; Brecha, Nicholas C.; Pu, Mingliang; Gao, Jie			Protective Effect of ALA in Crushed Optic Nerve Cat Retinal Ganglion Cells Using a New Marker RBPMS	PLOS ONE			English	Article							RNA-BINDING PROTEIN; LIPOIC ACID; QUANTITATIVE-ANALYSIS; ADULT-RATS; GLAUCOMA; PRESSURE; SURVIVAL; GENE; EXPRESSION; FIBERS	In this study we first sought to determine whether RNA-binding protein with multiple splicing (RBPMS) can serve as a specific marker for cat retina ganglion cells (RGCs) using retrograde labeling and immunohistochemistry staining. RBPM was then used as an RGC marker to study RGC survival after optic nerve crush (ONC) and alpha-lipoic acid (ALA) treatment in cats. ALA treatment yielded a peak density of RBPMS-alpha cells within the peak isodensity zone (>60/mm(2)) which did not differ from ONC retinas. The area within the zone was significantly enlarged (control: 2.3%, ONC: 0.06%, ONC+ALA: 0.1%). As for the 10-21/mm(2) zone, ALA treatment resulted in a significant increase in area (control: 34.5%, ONC: 12.1%, ONC+ALA: 35.9%). ALA can alleviate crush-induced RGC injury.	[Wang, Yanling; Wang, Wenyao; Huang, Xin; Liu, Ruixing; Xia, Huika; Pu, Mingliang; Gao, Jie] Peking Univ, Sch Basic Med Sci, Dept Anat, Beijing, Peoples R China; [Wang, Yanling; Wang, Wenyao; Huang, Xin; Liu, Ruixing; Xia, Huika; Pu, Mingliang; Gao, Jie] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing, Peoples R China; [Wang, Yanling; Wang, Wenyao; Huang, Xin; Liu, Ruixing; Xia, Huika; Pu, Mingliang; Gao, Jie] Peking Univ, Key Lab Visual Impairment & Restorat, Minist Educ, Beijing, Peoples R China; [Liu, Jessica; Brecha, Nicholas C.] Univ Calif Los Angeles, Dept Neurobiol & Mol Cellular & Integrat Physiol, Los Angeles, CA USA; [Liu, Jessica; Brecha, Nicholas C.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Liu, Jessica; Brecha, Nicholas C.] Univ Calif Los Angeles, Coll Life Sci, Los Angeles, CA USA	Peking University; Peking University; Peking University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gao, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Anat, Beijing, Peoples R China.; Gao, J (corresponding author), Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing, Peoples R China.; Gao, J (corresponding author), Peking Univ, Key Lab Visual Impairment & Restorat, Minist Educ, Beijing, Peoples R China.	gaojie@bjmu.edu.cn	Wang, Yanbo/HFZ-8018-2022; Wang, Yuan/HHC-1520-2022; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022		National Basic Research Program of China (973 Program) [2012CB825503]; National Science Foundation of China [31170986]; Beijing municipal Science and Technology Commission [Z151100000915070]; NIH [EY04067]; VA Merit Review; PKU-UCLA Joint Research Institute; NATIONAL EYE INSTITUTE [R01EY004067] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); PKU-UCLA Joint Research Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Basic Research Program of China (973 Program, 2012CB825503 to JGao), the National Science Foundation of China (31170986 to MPu), Beijing municipal Science and Technology Commission (Z151100000915070 to MPu), NIH EY04067 (NCB) and VA Merit Review (NCB). NCB is a VA Career Research Scientist. JL was supported by a summer fellowship from the PKU-UCLA Joint Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKE W, 1986, J PHYSIOL-LONDON, V376, P461, DOI 10.1113/jphysiol.1986.sp016164; Chidlow G, 2002, NEUROPHARMACOLOGY, V43, P1015, DOI 10.1016/S0028-3908(02)00129-6; Cottee LJ, 2003, EXP NEUROL, V184, P865, DOI 10.1016/S0014-4886(03)00310-8; COTTEE LJ, 1991, EUR J NEUROSCI, V3, P1245, DOI 10.1111/j.1460-9568.1991.tb00058.x; Gerber WV, 1999, MECH DEVELOP, V80, P77, DOI 10.1016/S0925-4773(98)00195-6; Goldblum D, 2002, VISION RES, V42, P471, DOI 10.1016/S0042-6989(01)00194-8; Grozdanic SD, 2010, INVEST OPHTH VIS SCI, V51, P255, DOI 10.1167/iovs.09-4081; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; HUGHES A, 1975, J COMP NEUROL, V163, P107, DOI 10.1002/cne.901630107; HUGHES A, 1981, J COMP NEUROL, V197, P303, DOI 10.1002/cne.901970209; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ji D, 2013, BIOL PHARM BULL, V36, P1060, DOI 10.1248/bpb.b12-00941; Koriyama Y, 2013, BRAIN RES, V1499, P145, DOI 10.1016/j.brainres.2012.12.041; Kwong JMK, 2013, EXP EYE RES, V112, P21, DOI 10.1016/j.exer.2013.04.008; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Mabuchi F, 2004, INVEST OPHTH VIS SCI, V45, P4352, DOI 10.1167/iovs.04-0355; Mackenzie P, 2008, SURV OPHTHALMOL, V53, pS39, DOI 10.1016/j.survophthal.2008.08.008; MISANTONE LJ, 1984, J NEUROCYTOL, V13, P449, DOI 10.1007/BF01148334; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P6095, DOI 10.1167/iovs.15-17195; Nadal-Nicolas FM, 2015, INVEST OPHTH VIS SCI, V56, P4309, DOI 10.1167/iovs.15-16963; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Osborne NN, 2013, CURR OPIN PHARMACOL, V13, P16, DOI 10.1016/j.coph.2012.09.002; Osborne NN, 2008, PROG BRAIN RES, V173, P339, DOI 10.1016/S0079-6123(08)01124-2; Piri N, 2006, MOL VIS, V12, P1660; Piri N, 2006, NEUROSCI LETT, V405, P40, DOI 10.1016/j.neulet.2006.06.049; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Santos JM, 2011, INVEST OPHTH VIS SCI, V52, P8791, DOI 10.1167/iovs.11-8203; Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076347; Shimamoto A, 1996, P NATL ACAD SCI USA, V93, P10913, DOI 10.1073/pnas.93.20.10913; SHOU TD, 1989, INVEST OPHTH VIS SCI, V30, P2093; STONE J, 1978, J COMP NEUROL, V180, P753, DOI 10.1002/cne.901800407; STONE J, 1965, J COMP NEUROL, V124, P337, DOI 10.1002/cne.901240305; Tatham AJ, 2013, AM J OPHTHALMOL, V156, P578, DOI 10.1016/j.ajo.2013.04.015; WASSLE H, 1975, J COMP NEUROL, V159, P419, DOI 10.1002/cne.901590308; Watanabe M, 2003, NEUROSCIENCE, V116, P733, DOI 10.1016/S0306-4522(02)00562-6; Weber AJ, 2008, INVEST OPHTH VIS SCI, V49, P2456, DOI 10.1167/iovs.07-1325; Weber AJ, 2013, INVEST OPHTH VIS SCI, V54, P6594, DOI 10.1167/iovs.13-12683; Weber AJ, 2010, INVEST OPHTH VIS SCI, V51, P327, DOI 10.1167/iovs.09-3740; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282	43	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160309	10.1371/journal.pone.0160309	http://dx.doi.org/10.1371/journal.pone.0160309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504635	gold, Green Submitted, Green Published			2022-12-26	WOS:000381374200032
J	Clewing, C; Albrecht, C; Wilke, T				Clewing, Catharina; Albrecht, Christian; Wilke, Thomas			A Complex System of Glacial Sub-Refugia Drives Endemic Freshwater Biodiversity on the Tibetan Plateau	PLOS ONE			English	Article							LAKE DONGGI CONA; POPULATION-STRUCTURE; MOLECULAR PHYLOGENY; GENETIC-STRUCTURE; NORTH-AMERICA; CYTOCHROME-B; EVOLUTION; MITOCHONDRIAL; AFLP; BIOGEOGRAPHY	Although only relatively few freshwater invertebrate families are reported from the Tibetan Plateau, the degree of endemism may be high. Many endemic lineages occur within permafrost areas, raising questions about the existence of isolated intra-plateau glacial refugia. Moreover, if such refugia existed, it might be instructive to learn whether they were associated with lakes or with more dynamic ecosystems such as ponds, wetlands, or springs. To study these hypotheses, we used pulmonate snails of the plateau-wide distributed genus Radix as model group and the Lake Donggi Cona drainage system, located in the northeastern part of the plateau, as model site. First, we performed plateau-wide phylogenetic analyses using mtDNA data to assess the overall relationships of Radix populations inhabiting the Lake Donggi Cona system for revealing refugial lineages. We then conducted regional phylogeographical analyses applying a combination of mtDNA and nuclear AFLP markers to infer the local structure and demographic history of the most abundant endemic Radix clade for identifying location and type of (sub-) refugia within the drainage system. Our phylogenetic analysis showed a high diversity of Radix lineages in the Lake Donggi Cona system. Subsequent phylogeographical analyses of the most abundant endemic clade indicated a habitat-related clustering of genotypes and several Late Pleistocene spatial/demographic expansion events. The most parsimonious explanation for these patterns would be a scenario of an intra-plateau glacial refugium in the Lake Donggi Cona drainage system, which might have consisted of isolated sub-refugia. Though the underlying processes remain unknown, an initial separation of lake and watershed populations could have been triggered by lake-level fluctuations before and during the Last Glacial Maximum. This study inferred the first intra-plateau refugium for freshwater animals on the Tibetan Plateau. It thus sheds new light on the evolutionary history of its endemic taxa and provides important insights into the complex refugial history of a high-altitude ecosystem.	[Clewing, Catharina; Albrecht, Christian; Wilke, Thomas] Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany	Justus Liebig University Giessen	Wilke, T (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany.	tom.wilke@allzool.bio.uni-giessen.de	Wilke, Thomas/G-1517-2012; Albrecht, Christian/AFV-5313-2022; Albrecht, Christian/AAJ-5484-2020	Wilke, Thomas/0000-0001-8263-7758; 	Deutsche Forschungsgemeinschaft [WI 1902/7]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/), project #WI 1902/7, within the priority programme 1372: "Tibetan Plateau: Formation - Climate - Ecosystems" (TiP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank P. V. von Oheimb, S. Mischke, U. Wiechert, M. Weynell, C. J. Zhang and R. Fan for the support during the field trip on the Tibetan Plateau. S. Nachtigall and A.-K. Hauswald are gratefully acknowledged for their assistance in the laboratory. All necessary permits for collecting Tibetan Plateau freshwater mollusks were issued by the Chinese Academy of Sciences (Beijing, China). This study was funded by the Deutsche Forschungsgemeinschaft (WI 1902/7) within the priority programme 1372: "Tibetan Plateau: Formation-Climate-Ecosystems" (TiP). Our special thanks go to F. Riedel, who introduced us to the Tibetan Plateau and initiated our joined research projects on the plateau. We also thank the editor and two anonymous referees for their comments, which helped improving the paper.	[Anonymous], 1997, INTRO SALINE LAKES Q; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Benke M, 2009, MOL ECOL, V18, P890, DOI 10.1111/j.1365-294X.2008.04073.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bousset L, 2014, BIOL INVASIONS, V16, P1769, DOI 10.1007/s10530-013-0626-5; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Campbell D, 2003, MOL ECOL, V12, P1979, DOI 10.1046/j.1365-294X.2003.01856.x; Clay J, 1939, REV MOD PHYS, V11, P129; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clewing C, 2016, CRUSTACEANA, V89, P239, DOI 10.1163/15685403-00003518; Clewing C, 2015, ECOL EVOL, V5, P2966, DOI 10.1002/ece3.1586; Clewing C, 2014, J MOLLUS STUD, V80, P452, DOI 10.1093/mollus/eyu016; Clewing C, 2013, MALACOLOGIA, V56, P231, DOI 10.4002/040.056.0213; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davison A, 2006, BIOESSAYS, V28, P642, DOI 10.1002/bies.20424; Dietze E, 2010, QUATERN INT, V218, P131, DOI 10.1016/j.quaint.2009.11.035; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drummond AJ, 2007, TRACER V 1 5; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu BH, 2007, J ASIAN EARTH SCI, V29, P253, DOI 10.1016/j.jseaes.2006.03.004; GBIF, 2013, GBIF BACKBONE TAXON; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; Hauswald AK, 2008, HYDROBIOLOGIA, V615, P169, DOI 10.1007/s10750-008-9556-0; Hauswald AK, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-206; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hofmann S, 2012, MOL PHYLOGENET EVOL, V63, P396, DOI 10.1016/j.ympev.2012.01.014; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kappes H, 2012, AQUAT SCI, V74, P1, DOI 10.1007/s00027-011-0187-6; Kelly DW, 2006, MOL ECOL, V15, P3641, DOI 10.1111/j.1365-294X.2006.03012.x; Marten A, 2006, MOL ECOL, V15, P2643, DOI 10.1111/j.1365-294X.2006.02940.x; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Mischke S, 2010, J PALEOLIMNOL, V43, P589, DOI 10.1007/s10933-009-9355-2; Opitz S, 2012, PALAEOGEOGR PALAEOCL, V337, P159, DOI 10.1016/j.palaeo.2012.04.013; Paun Ovidiu, 2012, Methods Mol Biol, V862, P75, DOI 10.1007/978-1-61779-609-8_7; Pfenninger M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-135; Pointing SB, 2014, P NATL ACAD SCI USA, V111, P5452, DOI 10.1073/pnas.1403594111; Pritchard JK, 2000, GENETICS, V155, P945; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Qi DL, 2015, ZOOL SCR, V44, P523, DOI 10.1111/zsc.12116; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneider S, 1999, GENETICS, V152, P1079; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shi Y, 2002, QUATERN INT, V97-8, P79, DOI 10.1016/S1040-6182(02)00053-8; Shimono A, 2010, HEREDITY, V104, P534, DOI 10.1038/hdy.2009.158; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Von Oheimb PV, 2013, BIOL J LINN SOC, V109, P526, DOI 10.1111/bij.12068; von Oheimb PV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026307; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Zhan XJ, 2011, MOL ECOL, V20, P3014, DOI 10.1111/j.1365-294X.2011.05144.x; Zhao K, 2011, MOL PHYLOGENET EVOL, V59, P303, DOI 10.1016/j.ympev.2011.02.001; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2; Zhou WW, 2013, MOL ECOL, V22, P130, DOI 10.1111/mec.12087	76	13	13	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160286	10.1371/journal.pone.0160286	http://dx.doi.org/10.1371/journal.pone.0160286			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500403	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500018
J	Madampage, CA; Wilson, D; Townsend, H; Crockford, G; Rawlyk, N; Dent, D; Evans, B; Van Donkersgoed, J; Dorin, C; Potter, A				Madampage, Claudia Avis; Wilson, Don; Townsend, Hugh; Crockford, Gordon; Rawlyk, Neil; Dent, Donna; Evans, Brock; Van Donkersgoed, Joyce; Dorin, Craig; Potter, Andrew			Cattle Immunized with a Recombinant Subunit Vaccine Formulation Exhibits a Trend towards Protection against Histophilus somni Bacterial Challenge	PLOS ONE			English	Article							BOVINE RESPIRATORY-DISEASE; FEEDLOT CATTLE; MANNHEIMIA-HAEMOLYTICA; REVERSE VACCINOLOGY; HAEMOPHILUS-SOMNUS; PREDICTION; CALVES; LIPOOLIGOSACCHARIDE; IDENTIFICATION; MYOCARDITIS	Histophilosis, a mucosal and septicemic infection of cattle is caused by the Gram negative pathogen Histophilus somni (H. somni). As existing vaccines against H. somni infection have shown to be of limited efficacy, we used a reverse vaccinology approach to identify new vaccine candidates. Three groups (B, C, D) of cattle were immunized with subunit vaccines and a control group (group A) was vaccinated with adjuvant alone. All four groups were challenged with H. somni. The results demonstrate that there was no significant difference in clinical signs, joint lesions, weight change or rectal temperature between any of the vaccinated groups (B, C, D) vs the control group A. However, the trend to protection was greatest for group C vaccinates. The group C vaccine was a pool of six recombinant proteins. Serum antibody responses determined using ELISA showed significantly higher titers for group C, with P values ranging from < 0.0148 to < 0.0002, than group A. Even though serum antibody titers in group B (5 out of 6 antigens) and group D were significantly higher compared to group A, they exerted less of a trend towards protection. In conclusion, the vaccine used in group C exhibits a trend towards protective immunity in cattle and would be a good candidate for further analysis to determine which proteins were responsible for the trend towards protection.	[Madampage, Claudia Avis; Wilson, Don; Townsend, Hugh; Crockford, Gordon; Rawlyk, Neil; Dent, Donna; Evans, Brock; Potter, Andrew] Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, 120 Vet Rd, Saskatoon, SK S7N 5E3, Canada; [Van Donkersgoed, Joyce] Alberta Beef Hlth Solut Inc, Box 307, Picture Butte, AB T0K 1V0, Canada; [Dorin, Craig] Vet Agri Hlth Serv, 201-151 East Lake Blvd, Airdrie, AB T4A 2G1, Canada	University of Saskatchewan	Madampage, CA (corresponding author), Univ Saskatchewan, Int Vaccine Ctr, Vaccine & Infect Dis Org, 120 Vet Rd, Saskatoon, SK S7N 5E3, Canada.	cam965@mail.usask.ca			Alberta Livestock and Meat Agency Ltd (ALMA); Alberta Cattle Feeders Association; Alberta Beef Health Solutions Inc.; Veterinary Agri-Health Solutions	Alberta Livestock and Meat Agency Ltd (ALMA); Alberta Cattle Feeders Association; Alberta Beef Health Solutions Inc.; Veterinary Agri-Health Solutions	The authors received funding for this study from Alberta Livestock and Meat Agency Ltd (ALMA) and Alberta Cattle Feeders Association. Co-author JVD received support in the form of salary from Alberta Beef Health Solutions Inc. Co-author CD received support in the form of salary from Veterinary Agri-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by Alberta Livestock and Meat Agency Ltd (ALMA) and Alberta Cattle Feeders Association.	[Anonymous], 2007, SOMNU STAR PH NEWBOR; Booker CW, 2008, CAN VET J, V49, P473; CORBEIL LB, 1986, CAN VET J, V27, P90; Corbeil Lynette B., 2007, Animal Health Research Reviews, V8, P151, DOI 10.1017/S1466252307001417; Doolan DL, 2014, INT J PARASITOL, V44, P901, DOI 10.1016/j.ijpara.2014.07.010; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Ellis JA, 2001, VET CLIN N AM-FOOD A, V17, P535, DOI 10.1016/S0749-0720(15)30005-0; Gagea MI, 2006, J VET DIAGN INVEST, V18, P18, DOI 10.1177/104063870601800104; Geertsema RS, 2011, VACCINE, V29, P4805, DOI 10.1016/j.vaccine.2011.04.075; Gomis SM, 1997, MICROB PATHOGENESIS, V22, P13, DOI 10.1006/mpat.1996.0086; GUICHON PT, 1988, CAN VET J, V29, P1012; Guzman-Brambila C, 2012, CLIN VACCINE IMMUNOL, V19, P1826, DOI 10.1128/CVI.00451-12; Headley SA, 2014, VET REC, V175, DOI 10.1136/vr.102562; Headley SA, 2014, J COMP PATHOL, V150, P101; Headley SA, 2013, TROP ANIM HEALTH PRO, V45, P1579, DOI 10.1007/s11250-013-0402-7; Hoshinoo K, 2009, MICROB PATHOGENESIS, V46, P273, DOI 10.1016/j.micpath.2009.02.003; INZANA TJ, 1992, INFECT IMMUN, V60, P2943, DOI 10.1128/IAI.60.7.2943-2951.1992; Jaiswal V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-211; Kindrachuk J, 2007, J BIOL CHEM, V282, P13944, DOI 10.1074/jbc.M608089200; Kumar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029435; Larson RL, 2012, VET CLIN N AM-FOOD A, V28, P97, DOI 10.1016/j.cvfa.2011.12.005; Lo KL, 2012, COMP IMMUNOL MICROB, V35, P453, DOI 10.1016/j.cimid.2012.04.002; Madampage CA, 2015, BIOLOGICALS, V43, P444, DOI 10.1016/j.biologicals.2015.09.001; Madampage CA, 2015, CAN J VET RES, V79, P190; Manns JG, 1998, US Patent, Patent No. [5,723,129, 5723129]; McQuiston JH, 2000, MICROB PATHOGENESIS, V28, P301, DOI 10.1006/mpat.1999.0351; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; O'Toole D, 2009, VET PATHOL, V46, P1015, DOI 10.1354/vp.08-VP-0332-O-DEX; Perez D. S., 2010, Anales de Veterinaria de Murcia, V26, P5; Potter AA, 2004, US Patent, Patent No. [6,797,272, 6797272]; Potter Andrew, 2008, Animal Health Research Reviews, V9, P187, DOI 10.1017/S1466252308001606; Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3; Rappuoli R, 2004, NAT MED, V10, P1177, DOI 10.1038/nm1129; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sandal I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-186; Sandal I, 2010, TRENDS MICROBIOL, V18, P90, DOI 10.1016/j.tim.2009.11.006; Sandal I, 2009, MICROBES INFECT, V11, P254, DOI 10.1016/j.micinf.2008.11.011; Seib KL, 2012, CLIN MICROBIOL INFEC, V18, P109, DOI 10.1111/j.1469-0691.2012.03939.x; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sharma A, 2014, VACCINE VACCINE TECH, P3; Slifka MK, 2014, VACCINE, V32, P2948, DOI 10.1016/j.vaccine.2014.03.078; Snowder GD, 2006, J ANIM SCI, V84, P1999, DOI 10.2527/jas.2006-046; Srikumaran Subramaniam, 2007, Animal Health Research Reviews, V8, P215, DOI 10.1017/S1466252307001326; STEPHENS LR, 1981, J AM VET MED ASSOC, V178, P378; THEISEN M, 1993, INFECT IMMUN, V61, P1793, DOI 10.1128/IAI.61.5.1793-1798.1993; Wildman BK, 2008, CAN VET J, V49, P463; Xiang ZS, 2009, PROCEDIA VACCINOL, V1, P23, DOI 10.1016/j.provac.2009.07.005; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	50	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0159070	10.1371/journal.pone.0159070	http://dx.doi.org/10.1371/journal.pone.0159070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501390	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500003
J	Das, A; Natarajan, M; Mandal, J				Das, Ankita; Natarajan, Mailan; Mandal, Jharna			The Emergence of Quinolone Resistant Shigella sonnei, Pondicherry, India	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA GYRASE; ERIC-PCR; PREVALENCE; MULTIPLEX; COUNTRIES; PROFILES; PATTERNS; DIARRHEA; KOLKATA	Ciprofloxacin resistant Shigella sonnei across the globe have been increasing alarmingly. In order to understand the emergence of S. sonnei with respect to ciprofloxacin resistance in our patient population, the following study was carried out. Of the 184 Shigella sp. Isolated from 2012 to 2015, 34 S. sonnei which were confirmed by standard methods and subjected to antimicrobial susceptibility testing were selected. The minimum inhibitory concentrations (MICs) of 16/34 quinolone resistant isolates tested ranged from 4micrograms/ml to 16micrograms/ml for ciprofloxacin, from 16 micrograms/ml to 64 micrograms/ml for ofloxacin and from 16micrograms/ml to 64micrograms/ml for levofloxacin. Sequence determination of the quinolone resistance determining regions of gyrA, gyrB, parC, and parE genes showed mutations in GyrA at Gln69/Trp, Phe71/Ser, Ser72/Pro, Met75/Leu, Ser90/Cys, Met94/Leu, His106/Pro, Asn161/His, Thr163/Ala and in ParC at Ala64/Asp. Among the plasmid-mediated quinolone resistance (PMQRs) targets investigated, qnrB was the most (93.7%) prevalent followed by qnrC (18.7%). None hadqnrA, qnrS and qepA. Two (0.1%) of the isolates harboured theaac(6')-lb gene. Drug accumulation assay detected the presence of efflux pump activity in 9/15 (60%) among ciprofloxacin resistant isolates. All isolates harboured the ipaH gene followed by ial (17.6%), sen (11.7%), set1A&set1B (5.8%) genes. None had stx1 element. PCR for Enterobacterial repetitive intergenic consensus (ERIC) sequences resulted in 4 unique clusters, of which Type III was the most (44%) dominant but there was no correlation between the ERIC types and the antibiotic resistance pattern or the virulence profile. A documented increase in S. sonnei harbouring the qnrgenes and some unusual genes like set1Aand indicate an ongoing process of horizontal gene transfer. The accumulation of novel mutations in GyrA and ParC in the presence of efflux pump and PMQR genes contributed to the raised MIC to quinolones. These findings are crucial in our understanding of quinolone resistance in these isolates.	[Das, Ankita; Natarajan, Mailan; Mandal, Jharna] Jawaharlal Inst Postgrad Med Educ & Res, Dept Microbiol, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research	Mandal, J (corresponding author), Jawaharlal Inst Postgrad Med Educ & Res, Dept Microbiol, Pondicherry, India.	drjharna@gmail.com	Mandal, Jharna/AAF-5908-2020					Bhattacharya D, 2014, EUR J CLIN MICROBIOL, V33, P157, DOI 10.1007/s10096-013-1937-2; Bonkoungou IJO, 2012, CLIN MICROBIOL INFEC, V18, P901, DOI 10.1111/j.1469-0691.2011.03675.x; Bopp CA, 2003, MANUAL CLIN MICROBIO, P654; Clinical Laboratory Standards Institute (CLSI), 2014, PERF STAND ANT SUSC; Dutta S, 2005, ANTIMICROB AGENTS CH, V49, P1660, DOI 10.1128/AAC.49.4.1660-1661.2005; Ha V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-204; Kim JS, 2015, EMERG INFECT DIS, V21, P1247, DOI 10.3201/eid2107.150363; Kosek M, 2012, AM J TROP MED HYG, V86, P1018, DOI 10.4269/ajtmh.2012.11-0671; Kumar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126560; Lamba K, 2016, EMERG INFECT DIS, V22, P679, DOI 10.3201/eid2204.151825; Liao CH, 2013, J ANTIMICROB CHEMOTH, V68, P2907, DOI 10.1093/jac/dkt295; LIU PYF, 1995, J CLIN MICROBIOL, V33, P1779, DOI 10.1128/JCM.33.7.1779-1783.1995; Lopez-Saucedo C, 2003, EMERG INFECT DIS, V9, P127, DOI 10.3201/eid0901.010507; Mandal J., 2015, New Microbes and New Infections, V7, P97, DOI 10.1016/j.nmni.2015.06.011; Mandal J, 2012, J CLIN DIAGN RES, V6, P1474, DOI 10.7860/JCDR/2012/4157.2536; Nandy S, 2011, EMERG INFECT DIS, V17, P2072, DOI 10.3201/eid1711.110403; Niyogi SK, 2005, J MICROBIOL, V43, P133; Poirel L, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00024; Ranjbar R, 2013, IRAN J PUBLIC HEALTH, V42, P1151; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Sangeetha AV, 2014, J HEALTH POPUL NUTR, V32, P580; Schuller S, 2011, TOXINS, V3, P626, DOI 10.3390/toxins3060626; Strockbine NA, 2001, BERGEYS MANUAL SYSTE, p[811, 2]; The HC, 2016, NAT REV MICROBIOL, V14, P235, DOI 10.1038/nrmicro.2016.10; Thong KL, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-8; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Veldman K, 2011, J ANTIMICROB CHEMOTH, V66, P1278, DOI 10.1093/jac/dkr084; VILA J, 1994, ANTIMICROB AGENTS CH, V38, P2477, DOI 10.1128/AAC.38.10.2477; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Weir E, 2002, CAN MED ASSOC J, V167, P281; Zaidi MB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00288	32	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160290	10.1371/journal.pone.0160290	http://dx.doi.org/10.1371/journal.pone.0160290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494616	Green Published, Green Submitted, gold			2022-12-26	WOS:000381369500029
J	Muszynski, A; Heiss, C; Hjuler, CT; Sullivan, JT; Kelly, SJ; Thygesen, MB; Stougaard, J; Azadi, P; Carlson, RW; Ronson, CW				Muszynski, Artur; Heiss, Christian; Hjuler, Christian T.; Sullivan, John T.; Kelly, Simon J.; Thygesen, Mikkel B.; Stougaard, Jens; Azadi, Parastoo; Carlson, Russell W.; Ronson, Clive W.			Structures of Exopolysaccharides Involved in Receptor-mediated Perception of Mesorhizobium loti by Lotus japonicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYMBIOTICALLY IMPORTANT EXOPOLYSACCHARIDE; MOLECULAR-WEIGHT SUCCINOGLYCAN; HOST-SYMBIONT INTERACTIONS; RHIZOBIUM-MELILOTI RM1021; SP STRAIN NGR234; SINORHIZOBIUM-MELILOTI; NODULE INVASION; MEDICAGO-SATIVA; GROUP MIGRATION; CAPILLARY GLC	In the symbiosis formed between Mesorhizobium loti strain R7A and Lotus japonicus Gifu, rhizobial exopolysaccharide (EPS) plays an important role in infection thread formation. Mutants of strain R7A affected in early exopolysaccharide biosynthetic steps form nitrogen-fixing nodules on L. japonicus Gifu after a delay, whereas mutants affected in mid or late biosynthetic steps induce uninfected nodule primordia. Recently, it was shown that a plant receptor-like kinase, EPR3, binds low molecular mass exopolysaccharide from strain R7A to regulate bacterial passage through the plant's epidermal cell layer (Kawaharada, Y., Kelly, S., Nielsen, M. W., Hjuler, C. T., Gysel, K., Muszyn ' ski, A., Carlson, R. W., Thygesen, M. B., Sandal, N., Asmussen, M. H., Vinther, M., Andersen, S. U., Krusell, L., Thirup, S., Jensen, K. J., et al. (2015) Nature 523, 308-312). In this work, we define the structure of both high and low molecular mass exopolysaccharide from R7A. The low molecular mass exopolysaccharide produced by R7A is a monomer unit of the acetylated octasaccharide with the structure (2,3/3-OAc)beta-D-RibfA-(1 -> 4)-alpha-D-GlcpA-(1 -> 4)-alpha-D-Glcp-(1 -> 6)-(3OAc)beta-D-Glcp-(1 -> 6)-*[(2OAc)beta-D-Glcp-(1 -> 4)-(2/3OAc)beta-D-Glcp(1 -> 4)-beta-D-Glcp-(1 -> 3)-beta-D-Galp]. We propose it is a biosynthetic constituent of high molecular mass EPS polymer. Every new repeating unit is attached via its reducing-end beta-D-Galp to C-4 of the fourth glucose (asterisked above) of the octasaccharide, forming a branch. TheO-acetylation occurs on the four glycosyl residues in a non-stoichiometric ratio, and each octasaccharide subunit is on average substituted with three O-acetyl groups. The availability of these structures will facilitate studies of EPR3 receptor binding of symbiotically compatible and incompatible EPS and the positive or negative consequences on infection by the M. loti exo mutants synthesizing such EPS variants.	[Muszynski, Artur; Heiss, Christian; Azadi, Parastoo; Carlson, Russell W.] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Sullivan, John T.; Kelly, Simon J.; Ronson, Clive W.] Univ Otago, Dept Microbiol & Immunol, 720 Cumberland St, Dunedin 9016, New Zealand; [Kelly, Simon J.; Stougaard, Jens] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Hjuler, Christian T.; Thygesen, Mikkel B.] Univ Copenhagen, Dept Chem, DK-1871 Frederiksberg C, Denmark	University System of Georgia; University of Georgia; University of Otago; Aarhus University; University of Copenhagen	Muszynski, A (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.; Ronson, CW (corresponding author), Univ Otago, Dept Microbiol & Immunol, 720 Cumberland St, Dunedin 9016, New Zealand.	muszynski@ccrc.uga.edu; Clive.Ronson@otago.ac.nz	Heiss, Christian/GPX-7678-2022; Thygesen, Mikkel B./F-4418-2014	Heiss, Christian/0000-0003-1118-8953; Thygesen, Mikkel B./0000-0002-0158-2802; Toftegaard Hjuler, Christian/0000-0001-6055-6391; Stougaard, Jens/0000-0002-9312-2685; Muszynski, Artur/0000-0003-3497-9977; Kelly, Simon/0000-0003-4243-300X; Azadi, Parastoo/0000-0002-6166-9432; Ronson, Clive/0000-0002-2217-9676	Chemical Sciences Geosciences and Biosciences Division, Office of Basic Energy Sciences, United States Department of Energy [DE-FG02-93ER20097]; Danish National Research Foundation [DNFR79]	Chemical Sciences Geosciences and Biosciences Division, Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by Chemical Sciences Geosciences and Biosciences Division, Office of Basic Energy Sciences, United States Department of Energy Grant DE-FG02-93ER20097 to the Department of Energy-Center for Plant and Microbial Complex Carbohydrates at the Complex Carbohydrate Research Center (to A. M., C. H., R. W. C., and P. A.), and the Danish National Research Foundation Grant DNFR79 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	AMAN P, 1981, CARBOHYD RES, V95, P263, DOI 10.1016/S0008-6215(00)85582-2; AMEMURA A, 1981, CARBOHYD RES, V91, P59, DOI 10.1016/S0008-6215(00)80991-X; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; BATTISTI L, 1992, P NATL ACAD SCI USA, V89, P5625, DOI 10.1073/pnas.89.12.5625; BENESI AJ, 1994, CARBOHYD RES, V258, P27, DOI 10.1016/0008-6215(94)84072-5; Brecker L, 2009, MAGN RESON CHEM, V47, P328, DOI 10.1002/mrc.2395; Broughton WJ, 2000, J BACTERIOL, V182, P5641, DOI 10.1128/JB.182.20.5641-5652.2000; Carlson RW, 2010, SUBCELL BIOCHEM, V53, P339, DOI 10.1007/978-90-481-9078-2_16; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Chouly C, 1995, INT J BIOL MACROMOL, V17, P357, DOI 10.1016/0141-8130(96)81846-0; Desbrosses GJ, 2011, CELL HOST MICROBE, V10, P348, DOI 10.1016/j.chom.2011.09.005; DJORDJEVIC SP, 1986, CARBOHYD RES, V148, P87, DOI 10.1016/0008-6215(86)80039-8; DJORDJEVIC SP, 1987, J BACTERIOL, V169, P53, DOI 10.1128/jb.169.1.53-60.1987; Fournier J, 2015, PLANT PHYSIOL, V167, P1233, DOI 10.1104/pp.114.253302; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; GERWIG GJ, 1978, CARBOHYD RES, V62, P349, DOI 10.1016/S0008-6215(00)80881-2; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GILSERRANO A, 1990, CARBOHYD RES, V204, P103, DOI 10.1016/0008-6215(90)84025-P; Gonzalez JE, 1998, P NATL ACAD SCI USA, V95, P13477, DOI 10.1073/pnas.95.23.13477; Gonzalez JE, 1996, P NATL ACAD SCI USA, V93, P8636, DOI 10.1073/pnas.93.16.8636; Hanniffy OM, 1999, CARBOHYD RES, V319, P124, DOI 10.1016/S0008-6215(99)00129-9; HER GR, 1990, CARBOHYD RES, V198, P305, DOI 10.1016/0008-6215(90)84300-J; Janczarek M, 2015, APPL SOIL ECOL, V85, P94, DOI 10.1016/j.apsoil.2014.08.010; JANSSON PE, 1987, J CHEM SOC PERK T 1, P377, DOI 10.1039/p19870000377; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Kelly SJ, 2013, MOL PLANT MICROBE IN, V26, P319, DOI 10.1094/MPMI-09-12-0227-R; Laus MC, 2005, MOL PLANT MICROBE IN, V18, P533, DOI 10.1094/MPMI-18-0533; Lehman AP, 2013, J BACTERIOL, V195, P5362, DOI 10.1128/JB.00681-13; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen LH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1009; Mendis HC, 2016, MBIO, V7, DOI 10.1128/mBio.00606-16; Mendis HC, 2013, MOL PLANT MICROBE IN, V26, P1089, DOI 10.1094/MPMI-03-13-0087-R; ONEILL MA, 1991, J BIOL CHEM, V266, P9549; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; PHILIPHOLLINGSWORTH S, 1989, J BIOL CHEM, V264, P5710; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; REINHOLD BB, 1994, J BACTERIOL, V176, P1997, DOI 10.1128/jb.176.7.1997-2002.1994; REUBER TL, 1993, CELL, V74, P269, DOI 10.1016/0092-8674(93)90418-P; REUBER TL, 1993, J BACTERIOL, V175, P3653, DOI 10.1128/jb.175.11.3653-3655.1993; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rodpothong P, 2009, MOL PLANT MICROBE IN, V22, P1546, DOI 10.1094/MPMI-22-12-1546; Rodriguez-Navarro DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115391; Roslund MU, 2008, J AM CHEM SOC, V130, P8769, DOI 10.1021/ja801177s; Skorupska A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-7; Staehelin C, 2006, J BACTERIOL, V188, P6168, DOI 10.1128/JB.00365-06; Sutherland IW, 2001, INT DAIRY J, V11, P663, DOI 10.1016/S0958-6946(01)00112-1; Tielen P, 2005, MICROBIOL RES, V160, P165, DOI 10.1016/j.micres.2004.11.003; URZAINQUI A, 1992, J BACTERIOL, V174, P3403, DOI 10.1128/jb.174.10.3403-3406.1992; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999; WU J, 1991, CARBOHYD RES, V210, P51, DOI 10.1016/0008-6215(91)80112-Z; Xie F, 2012, P NATL ACAD SCI USA, V109, P633, DOI 10.1073/pnas.1113992109; York GM, 1997, MOL MICROBIOL, V25, P117, DOI 10.1046/j.1365-2958.1997.4481804.x; York GM, 1998, J BACTERIOL, V180, P4184, DOI 10.1128/JB.180.16.4184-4191.1998; YORK WS, 1986, METHOD ENZYMOL, V118, P3; ZEVENHUIZEN LPTM, 1983, CARBOHYD RES, V118, P127, DOI 10.1016/0008-6215(83)88041-0	58	27	29	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20946	+		10.1074/jbc.M116.743856	http://dx.doi.org/10.1074/jbc.M116.743856			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27502279	Green Published, hybrid			2022-12-26	WOS:000385406200013
J	Lamothe, SM; Guo, J; Li, WT; Yang, TH; Zhang, ST				Lamothe, Shawn M.; Guo, Jun; Li, Wentao; Yang, Tonghua; Zhang, Shetuan			The Human Ether-a-go-go-related Gene (hERG) Potassium Channel Represents an Unusual Target for Protease-mediated Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface protein; electrophysiology; hERG; ion channel; patch clamp; potassium channel; protease	LONG QT SYNDROME; ISCHEMIA-REPERFUSION INJURY; HUMAN VENTRICULAR MYOCYTES; CORONARY-ARTERY-DISEASE; I-KR; CARDIAC-ARRHYTHMIA; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASE-2; INTERVAL PROLONGATION; SERINE PROTEASES	The human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel (I-Kr), which is important for cardiac repolarization. Dysfunction of hERG causes long QT syndrome and sudden death, which occur in patients with cardiac ischemia. Cardiac ischemia is also associated with activation, up-regulation, and secretion of various proteolytic enzymes. Here, using whole-cell patch clamp and Western blotting analysis, we demonstrate that the hERG/I-Kr channel was selectively cleaved by the serine protease, proteinase K (PK). Using molecular biology techniques including making a chimeric channel between protease-sensitive hERG and insensitive human ether-a-go-go (hEAG), as well as application of the scorpion toxin BeKm-1, we identified that the S5-pore linker of hERG is the target domain for proteinase K cleavage. To investigate the physiological relevance of the unique susceptibility of hERG to proteases, we show that cardiac ischemia in a rabbit model was associated with a reduction in mature ERG expression and an increase in the expression of several proteases, including calpain. Using cell biology approaches, we found that calpain-1 was actively released into the extracellular milieu and cleaved hERG at the S5-pore linker. Using protease cleavage-predicting software and site-directed mutagenesis, we identified that calpain-1 cleaves hERG at position Gly-603 in the S5-pore linker of hERG. Clarification of protease-mediated damage of hERG extends our understanding of hERG regulation. Damage of hERG mediated by proteases such as calpain may contribute to ischemia-associated QT prolongation and sudden cardiac death.	[Lamothe, Shawn M.; Guo, Jun; Li, Wentao; Yang, Tonghua; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Lamothe, Shawn/0000-0001-8722-2631; Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP 72911 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Chen J, 2015, J BIOL CHEM, V290, P21101, DOI 10.1074/jbc.M115.636324; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Chohan PK, 2006, CARDIOVASC RES, V69, P152, DOI 10.1016/j.cardiores.2005.07.016; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Gadaleta FL, 2003, AM J CARDIOL, V92, P203, DOI 10.1016/S0002-9149(03)00539-3; Gerlach AC, 2010, MOL PHARMACOL, V77, P58, DOI 10.1124/mol.109.059543; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Jin DN, 2004, J PHARMACOL EXP THER, V309, P490, DOI 10.1124/jpet.103.061465; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Kang YD, 2015, BIOCHEM J, V472, P71, DOI 10.1042/BJ20141282; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; KONARZEWSKA H, 1995, CIRCULATION, V92, P1179, DOI 10.1161/01.CIR.92.5.1179; Korolkova YV, 2002, J BIOL CHEM, V277, P43104, DOI 10.1074/jbc.M204083200; Lakhal S, 2011, J BIOL CHEM, V286, P4090, DOI 10.1074/jbc.M110.173096; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Letavernier E, 2012, CARDIOVASC RES, V96, P38, DOI 10.1093/cvr/cvs099; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Mehta D, 1997, CIRCULATION, V96, P3215, DOI 10.1161/01.CIR.96.9.3215; Muller AL, 2013, INT J CARDIOL, V164, P39, DOI 10.1016/j.ijcard.2012.01.103; Neuhof C, 2008, BIOL CHEM, V389, P1505, DOI 10.1515/BC.2008.172; PEETERS GA, 1995, AM J PHYSIOL-HEART C, V268, pH1757, DOI 10.1152/ajpheart.1995.268.4.H1757; Perez J, 2016, J IMMUNOL, V196, P168, DOI 10.4049/jimmunol.1500749; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Schaffer P, 1999, CARDIOVASC RES, V43, P332, DOI 10.1016/S0008-6363(99)00118-2; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; SHAWL FA, 1990, J AM COLL CARDIOL, V16, P325, DOI 10.1016/0735-1097(90)90581-9; SHEETS MF, 1983, CIRC RES, V53, P544, DOI 10.1161/01.RES.53.4.544; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Torres AM, 2003, J BIOL CHEM, V278, P42136, DOI 10.1074/jbc.M212824200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; VAHOUNY GV, 1970, SCIENCE, V167, P1616, DOI 10.1126/science.167.3925.1616; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Xu LJ, 2006, J BIOL CHEM, V281, P4457, DOI 10.1074/jbc.M510721200; Zhang M, 2003, BIOPHYS J, V84, P3022, DOI 10.1016/S0006-3495(03)70028-9; Zhao Y, 2016, HEART RHYTHM, V13, P2004, DOI 10.1016/j.hrthm.2016.06.019; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	57	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20387	20401		10.1074/jbc.M116.743138	http://dx.doi.org/10.1074/jbc.M116.743138			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27502273	Green Published, hybrid			2022-12-26	WOS:000384574800009
J	Cao, LL; Zhang, LJ; Zhao, X; Zhang, Y				Cao, Lili; Zhang, Lijun; Zhao, Xiang; Zhang, Ye			A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							CANCER-CELLS; TUBULIN POLYMERIZATION; BIOLOGICAL EVALUATION; MUTATIONAL LANDSCAPE; MOLECULAR THERAPIES; ANTITUBULIN AGENTS; NUCLEOLIN; KINASE; IDENTIFICATION; DERIVATIVES	Small molecule inhibitors that can simultaneously inhibit multiple oncogenic proteins in essential pathways are promising therapeutic chemicals for hepatocellular carcinoma (HCC). To combine the anticancer effects of combretastatins, chalcones and isatins, we synthesized a novel hybrid molecule 3', 4', 5'-trimethoxy-5-chloro-isatinylchalcone (3MCIC). 3MCIC inhibited proliferation of cultured HepG2 cells, causing rounding-up of the cells and massive vacuole accumulation in the cytoplasm. Paxillin and focal adhesion plaques were downregulated by 3MCIC. Surprisingly, unlike the microtubule (MT)-targeting agent CA-4 that inhibits tubulin polymerization, 3MCIC stabilized tubulin polymers both in living cells and in cell lysates. 3MCIC treatment reduced cyclin B1, CDK1, p-CDK1/2, and Rb, but increased p53 and p21. Moreover, 3MCIC caused GSK3 beta degradation by promoting GSK3 beta-Ser9 phosphorylation. Nevertheless, 3MCIC inhibited the Wnt/beta-catenin pathway by downregulating beta-catenin, c-Myc, cyclin D1 and E2F1. 3MCIC treatment not only activated the caspase-3-dependent apoptotic pathway, but also caused massive autophagy evidenced by rapid and drastic changes of LC3 and p62. 3MCIC also promoted cleavage and maturation of the lysosomal protease cathepsin D. Using ligand-affinity chromatography (LAC), target proteins captured onto the Sephacryl S1000-C-12-3MCIC resins were isolated and analyzed by mass spectrometry (MS). Some of the LAC-MS identified targets, i.e., septin-2, vimentin, pan-cytokeratin, nucleolin, EF1 alpha 1/2, EBP1 (PA2G4), cyclin B1 and GSK3 beta, were further detected by Western blotting. Moreover, both septin-2 and HIF-1 alpha decreased drastically in 3MCIC-treated HepG2 cells. Our data suggest that 3MCIC is a promising anticancer lead compound with novel targeting mechanisms, and also demonstrate the efficiency of LAC-MS based target identification in anticancer drug development.	[Cao, Lili; Zhao, Xiang; Zhang, Ye] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing, Peoples R China; [Zhang, Lijun] Peking Univ, Sch Life Sci, Beijing, Peoples R China	Peking University; Peking University	Zhang, Y (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing, Peoples R China.	zhangye@bjmu.edu.cn			National Natural Science Foundation of China [31171296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No. 31171296). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; Angelis D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096390; Bai Y, 2009, NEUROSCIENCE, V160, P371, DOI 10.1016/j.neuroscience.2009.01.076; Bai Y, 2009, NEUROREPORT, V20, P918, DOI 10.1097/WNR.0b013e32832c92d7; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bilsland AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006459; Bupathi M, 2014, ONCOTARGETS THER, V7, P1927, DOI 10.2147/OTT.S46457; Chen C, 2015, WORLD J HEPATOL, V7, P1964, DOI 10.4254/wjh.v7.i15.1964; Cheng DD, 2014, BIOCHEM BIOPH RES CO, V443, P598, DOI 10.1016/j.bbrc.2013.12.020; Cinghu S, 2014, P NATL ACAD SCI USA, V111, pE1581, DOI 10.1073/pnas.1318598111; Cleary SP, 2013, HEPATOLOGY, V58, P1693, DOI 10.1002/hep.26540; Delire B, 2015, EUR J CLIN INVEST, V45, P609, DOI 10.1111/eci.12441; Deng GL, 2015, WORLD J HEPATOL, V7, P787, DOI 10.4254/wjh.v7.i5.787; Dolat L, 2014, J CELL BIOL, V207, P225, DOI 10.1083/jcb.201405050; Dolat L, 2014, BIOL CHEM, V395, P123, DOI 10.1515/hsz-2013-0233; Galuppo R, 2014, DIGEST DIS SCI, V59, P1688, DOI 10.1007/s10620-014-3058-x; Gangjee A, 2014, ACS MED CHEM LETT, V5, P480, DOI 10.1021/ml4004793; Germano D, 2014, WORLD J GASTROENTERO, V20, P3087, DOI 10.3748/wjg.v20.i12.3087; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Guo XD, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0175-y; Kamal A, 2015, ORG BIOMOL CHEM, V13, P3963, DOI 10.1039/c4ob02606c; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kanda M, 2015, WORLD J GASTROENTERO, V21, P10584, DOI 10.3748/wjg.v21.i37.10584; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Karim MR, 2014, ANAL BIOCHEM, V465, P28, DOI 10.1016/j.ab.2014.07.007; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Krishnegowda G, 2011, BIOORGAN MED CHEM, V19, P6006, DOI 10.1016/j.bmc.2011.08.044; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Kuzuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138776; Lee WC, 2015, EJSO-EUR J SURG ONC, V41, P1144, DOI 10.1016/j.ejso.2015.05.024; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Liu M, 2010, MOL BIOL REP, V37, P3601, DOI 10.1007/s11033-010-0009-2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Mahapatra DM, 2015, EUR J MED CHEM, V98, P69, DOI 10.1016/j.ejmech.2015.05.004; Marks EI, 2016, CURR CANCER DRUG TAR, V16, P53, DOI 10.2174/1568009615666150916092903; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Mukhtar E, 2014, MOL CANCER THER, V13, P275, DOI 10.1158/1535-7163.MCT-13-0791; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Negi AS, 2015, BIOORGAN MED CHEM, V23, P373, DOI 10.1016/j.bmc.2014.12.027; Nepali K, 2014, EUR J MED CHEM, V77, P422, DOI 10.1016/j.ejmech.2014.03.018; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; Pakravan P, 2013, PHARMACOL REP, V65, P313, DOI 10.1016/S1734-1140(13)71007-7; Palmer DH, 2015, CANCER METAST REV, V34, P497, DOI 10.1007/s10555-015-9580-2; Palmieri D, 2015, P NATL ACAD SCI USA, V112, P9418, DOI 10.1073/pnas.1507087112; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patel A, 2014, CURR TREAT OPTION ON, V15, P380, DOI 10.1007/s11864-014-0291-7; Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112; Renz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148340; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sato S, 2010, CHEM BIOL, V17, P616, DOI 10.1016/j.chembiol.2010.05.015; Siemann DW, 2011, CANCER TREAT REV, V37, P63, DOI 10.1016/j.ctrv.2010.05.001; Singh P, 2014, EUR J MED CHEM, V85, P758, DOI 10.1016/j.ejmech.2014.08.033; Smith C, 2015, J MOL BIOL, V427, P3273, DOI 10.1016/j.jmb.2015.07.026; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Tsubota A, 2010, CARCINOGENESIS, V31, P504, DOI 10.1093/carcin/bgp313; Ursu A, 2015, BIOORG MED CHEM LETT, V25, P3079, DOI 10.1016/j.bmcl.2015.06.023; Vardi-Oknin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073179; Villanueva A, 2014, NAT REV CLIN ONCOL, V11, P73, DOI [10.1038/nrclinonc.2013.227, 10.1038/nrclinonc.2013.243]; Villanueva A, 2013, J HEPATOL, V59, P392, DOI 10.1016/j.jhep.2013.03.025; Vine KL, 2009, ANTI-CANCER AGENT ME, V9, P397; Wei H, 2016, RSC ADV, V6, P10846, DOI 10.1039/c5ra26294a; Yang F, 2011, ACS CHEM BIOL, V6, P252, DOI 10.1021/cb100287q; Yang J, 2010, J CELL SCI, V123, P861, DOI 10.1242/jcs.060475; Yang TT, 1996, ANAL BIOCHEM, V241, P103, DOI 10.1006/abio.1996.0383; Zhang L, 2000, J CELL BIOL, V151, P1; Zhang L, 2015, RSC ADV, V5, P97816, DOI 10.1039/c5ra21217k; Zhao P, 2014, EUR J MED CHEM, V86, P165, DOI 10.1016/j.ejmech.2014.08.049	76	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161025	10.1371/journal.pone.0161025	http://dx.doi.org/10.1371/journal.pone.0161025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525972	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100031
J	Nemska, S; Monassier, L; Gassmann, M; Frossard, N; Tavakoli, R				Nemska, Simona; Monassier, Laurent; Gassmann, Max; Frossard, Nelly; Tavakoli, Reza			Kinetic mRNA Profiling in a Rat Model of Left-Ventricular Hypertrophy Reveals Early Expression of Chemokines and Their Receptors	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CARDIAC-HYPERTROPHY; MYOCARDIAL FIBROSIS; DIASTOLIC DYSFUNCTION; INFLAMMATORY CELLS; OXIDATIVE STRESS; CXC CHEMOKINE; CC-CHEMOKINE; KAPPA-B; RECRUITMENT	Left-ventricular hypertrophy (LVH), a risk factor for heart failure and death, is characterized by cardiomyocyte hypertrophy, interstitial cell proliferation, and leukocyte infiltration. Chemokines interacting with G protein-coupled chemokine receptors may play a role in LVH development by promoting recruitment of activated leukocytes or modulating left-ventricular remodeling. Using a pressure overload-induced kinetic model of LVH in rats, we examined during 14 days the expression over time of chemokine and chemokine receptor mRNAs in left ventricles from aortic-banded vs sham-operated animals. Two phases were clearly distinguished: an inflammatory phase (D3-D5) with overexpression of inflammatory genes such as il-1 beta, tnfa, nlrp3, and the rela subunit of nf-kb, and a hypertrophic phase (D7-D14) where anp overexpression was accompanied by a heart weight/body weight ratio that increased by more than 20% at D14. No cardiac dysfunction was detectable by echocardiography at the latter time point. Of the 36 chemokines and 20 chemokine receptors analyzed by a Taqman Low Density Array panel, we identified at D3 (the early inflammatory phase) overexpression of mRNAs for the monocyte chemotactic proteins CCL2 (12-fold increase), CCL7 (7-fold increase), and CCL12 (3-fold increase), for the macrophage inflammatory proteins CCL3 (4-fold increase), CCL4 (2-fold increase), and CCL9 (2-fold increase), for their receptors CCR2 (4-fold increase), CCR1 (3-fold increase), and CCR5 (3-fold increase), and for CXCL1 (8-fold increase) and CXCL16 (2-fold increase). During the hypertrophic phase mRNA expression of chemokines and receptors returned to the baseline levels observed at D0. Hence, this first exhaustive study of chemokine and chemokine receptor mRNA expression kinetics reports early expression of monocyte/macrophage-related chemokines and their receptors during the development of LVH in rats, followed by regulation of inflammation as LVH progresses.	[Nemska, Simona; Gassmann, Max; Tavakoli, Reza] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Nemska, Simona; Gassmann, Max; Tavakoli, Reza] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Nemska, Simona; Frossard, Nelly] Univ Strasbourg, CNRS, Lab Innovat Therapeut, UMR7200, Strasbourg, France; [Monassier, Laurent] Univ Strasbourg, Federat Med Translat, Lab Neurobiol & Pharmacol Cardiovasc, EA7296, Strasbourg, France; [Tavakoli, Reza] Canton Hosp Lucerne, Dept Cardiac Surg, Luzern, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Lucerne Cantonal Hospital	Tavakoli, R (corresponding author), Univ Zurich, Inst Vet Physiol, Zurich, Switzerland.; Tavakoli, R (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.; Frossard, N (corresponding author), Univ Strasbourg, CNRS, Lab Innovat Therapeut, UMR7200, Strasbourg, France.; Tavakoli, R (corresponding author), Canton Hosp Lucerne, Dept Cardiac Surg, Luzern, Switzerland.	nelly.frossard@unistra.fr; reza.tavakoli@uzh.ch	Nemska, Simona/Y-1105-2019; Monassier, Laurent/AAE-4446-2022; /AAD-1664-2020; Frossard, Nelly/F-8301-2013	Nemska, Simona/0000-0002-6969-6494; Gassmann, Max/0000-0003-2750-8878	University of Zurich (Switzerland); St Jude Medical (Switzerland)	University of Zurich (Switzerland); St Jude Medical (Switzerland)(St. Jude Medical)	The study was funded by the University of Zurich and St Jude Medical (Switzerland) (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altara R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141394; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Bechara C, 2007, AM J PHYSIOL-HEART C, V293, pH3088, DOI 10.1152/ajpheart.00473.2007; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Bettink SI, 2010, BIOCHEM BIOPH RES CO, V397, P208, DOI 10.1016/j.bbrc.2010.05.086; Castellani C, 2010, HUM PATHOL, V41, P1566, DOI 10.1016/j.humpath.2009.12.017; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Dahl CP, 2009, CIRC-HEART FAIL, V2, P624, DOI 10.1161/CIRCHEARTFAILURE.108.821074; Daryadel A, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-81; Duerr GD, 2013, LIFE SCI, V92, P976, DOI 10.1016/j.lfs.2013.03.014; Fang L, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000270; Finsen AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112172; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Fujiu K, 2014, CARDIOVASC RES, V102, P232, DOI 10.1093/cvr/cvu059; Gupta S, 2002, J CELL BIOL, V159, P1019, DOI 10.1083/jcb.200207149; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Hayashidani S, 2003, CIRCULATION, V108, P2134, DOI 10.1161/01.CIR.0000092890.29552.22; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hill JA, 2012, J ELECTROCARDIOL, V45, P624, DOI 10.1016/j.jelectrocard.2012.08.003; HINGLAIS N, 1994, LAB INVEST, V70, P286; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Husberg C, 2008, J MOL CELL CARDIOL, V45, P261, DOI 10.1016/j.yjmcc.2008.05.009; Jia GQ, 1996, J EXP MED, V184, P1939, DOI 10.1084/jem.184.5.1939; Kai H, 2006, HYPERTENS RES, V29, P711, DOI 10.1291/hypres.29.711; Kang YJ, 2006, TOXICOL PATHOL, V34, P58, DOI 10.1080/01926230500419421; Kao J, 2003, CIRCULATION, V107, P1958, DOI 10.1161/01.CIR.0000069270.16498.75; Kolattukudy PE, 1998, AM J PATHOL, V152, P101; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Kuwahara F, 2003, HYPERTENSION, V41, P819, DOI 10.1161/01.HYP.0000056108.73219.0A; Ludwig A, 2008, J NEUROIMMUNOL, V198, P92, DOI 10.1016/j.jneuroim.2008.04.024; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Morimoto H, 2006, CIRC RES, V99, P891, DOI 10.1161/01.RES.0000246113.82111.2d; Nicoletti A, 1996, CARDIOVASC RES, V32, P1096, DOI 10.1016/S0008-6363(96)00158-7; Nicoletti A, 1999, CARDIOVASC RES, V41, P532, DOI 10.1016/S0008-6363(98)00305-8; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Opie LH, 2006, LANCET, V367, P356, DOI 10.1016/S0140-6736(06)68074-4; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Velazquez JR, 2011, CLIN REV ALLERG IMMU, V41, P76, DOI 10.1007/s12016-010-8202-6; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sarafi MN, 1997, J EXP MED, V185, P99, DOI 10.1084/jem.185.1.99; Sato E, 2001, ANTIMICROB AGENTS CH, V45, P401, DOI 10.1128/AAC.8.2.401-406.2001; Schultz MJ, 2000, J ANTIMICROB CHEMOTH, V46, P235, DOI 10.1093/jac/46.2.235; Shen JZ, 2014, ENDOCRINOLOGY, V155, P1057, DOI 10.1210/en.2013-1772; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Tarzami ST, 2002, J MOL CELL CARDIOL, V34, P209, DOI 10.1006/jmcc.2001.1503; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velten M, 2012, CARDIOVASC RES, V96, P422, DOI 10.1093/cvr/cvs280; Waehre A, 2012, J APPL PHYSIOL, V112, P1372, DOI 10.1152/japplphysiol.01350.2011; Wang X.D., 2014, J APPL MATH, V2014, P9; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Weisheit C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112710; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Xuan WL, 2011, CARDIOVASC RES, V92, P385, DOI 10.1093/cvr/cvr221; Younce CW, 2014, J MOL CELL CARDIOL, V76, P172, DOI 10.1016/j.yjmcc.2014.08.022; Zernecke A, 2010, CARDIOVASC RES, V86, P192, DOI 10.1093/cvr/cvp391	61	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161273	10.1371/journal.pone.0161273	http://dx.doi.org/10.1371/journal.pone.0161273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525724	Green Accepted, Green Published, gold			2022-12-26	WOS:000381471100051
J	Laranjeira, A; Schulz, J; Dotti, CG				Laranjeira, Antnio; Schulz, Joachim; Dotti, Carlos G.			Genes Related to Fatty Acid beta-Oxidation Play a Role in the Functional Decline of the Drosophila Brain with Age	PLOS ONE			English	Article							LIFE-SPAN; CARNITINE BIOSYNTHESIS; DIETARY RESTRICTION; ADULT DROSOPHILA; INSULIN-RECEPTOR; LIPID DROPLETS; NERVOUS-SYSTEM; AGING PROCESS; LONGEVITY; PROTEIN	In living organisms, ageing is widely considered to be the result of a multifaceted process consisting of the progressive accumulation of damage over time, having implications both in terms of function and survival. The study of ageing presents several challenges, from the different mechanisms implicated to the great diversity of systems affected over time. In the current study, we set out to identify genes involved in the functional decline of the brain with age and study its relevance in a tissue dependent manner using Drosophila melanogaster as a model system. Here we report the age-dependent upregulation of genes involved in the metabolic process of fatty acid -oxidation in the nervous tissue of female wild-type flies. Downregulation of CG10814, dHNF4 and lipid mobilizing genes bmm and dAkh rescues the functional decline of the brain with age, both at the cellular and behaviour level, while over-expression worsens performance. Our data proposes the occurrence of a metabolic alteration in the fly brain with age, whereby the process of beta-oxidation of fatty acids experiences a genetic gain-of-function. This event proved to be one of the main causes contributing to the functional decline of the brain with age.	[Laranjeira, Antnio; Schulz, Joachim] Univ Leuven, Ctr Human Genet, VIB Ctr Biol Dis, B-3000 Leuven, Belgium; [Dotti, Carlos G.] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus Univ Autonoma Madrid, Madrid 28049, Spain	Flanders Institute for Biotechnology (VIB); KU Leuven; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Dotti, CG (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	cdotti@cbm.csic.es			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER; NIH HHS [P40 OD018537] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5; BERNARDES DJB, 2012, EMBO MOL MED, V4, P691, DOI DOI 10.1002/EMMM.201200245; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bross TG, 2005, AGING CELL, V4, P309, DOI 10.1111/j.1474-9726.2005.00181.x; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Girardot F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-69; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houten S.M., 2015, ANN REV PHYSL; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KLASS MR, 1983, MECH AGEING DEV, V22, P279, DOI 10.1016/0047-6374(83)90082-9; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Mannaerts GP, 1996, ANN NY ACAD SCI, V804, P99, DOI 10.1111/j.1749-6632.1996.tb18611.x; Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Navarro A, 2008, AM J PHYSIOL-REG I, V294, pR501, DOI 10.1152/ajpregu.00492.2007; Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rigault C, 2013, BBA-MOL CELL BIOL L, V1831, P370, DOI 10.1016/j.bbalip.2012.10.007; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Sun XP, 2014, CELL REP, V8, P1781, DOI 10.1016/j.celrep.2014.08.022; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsai L, 1998, P NATL ACAD SCI USA, V95, P7975, DOI 10.1073/pnas.95.14.7975; Vaz FM, 2002, BIOCHEM J, V361, P417, DOI 10.1042/0264-6021:3610417; Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Wisely GB, 2002, STRUCTURE, V10, P1225, DOI 10.1016/S0969-2126(02)00829-8; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161143	10.1371/journal.pone.0161143	http://dx.doi.org/10.1371/journal.pone.0161143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518101	gold, Green Published, Green Submitted			2022-12-26	WOS:000381382100054
J	Bengtson, AM; Pence, BW; Crane, HM; Christopoulos, K; Fredericksen, RJ; Gaynes, BN; Heine, A; Mathews, WC; Moore, R; Napravnik, S; Safren, S; Mugavero, MJ				Bengtson, Angela M.; Pence, Brian W.; Crane, Heidi M.; Christopoulos, Katerina; Fredericksen, Rob J.; Gaynes, Bradley N.; Heine, Amy; Mathews, W. Christopher; Moore, Richard; Napravnik, Sonia; Safren, Steven; Mugavero, Michael J.			Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United States	PLOS ONE			English	Article							PATIENT HEALTH QUESTIONNAIRE-9; HUMAN-IMMUNODEFICIENCY-VIRUS; SCREENING-TEST ASSIST; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; PSYCHIATRIC-DISORDERS; ETHNIC-DIFFERENCES; MENTAL-DISORDERS; AFRICAN-AMERICAN; SUBSTANCE-ABUSE	Objective To describe disparities along the depression treatment cascade, from indication for antidepressant treatment to effective treatment, in HIV-infected individuals by gender and race/ethnicity. Methods The Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) cohort includes 31,000 HIV-infected adults in routine clinical care at 8 sites. Individuals were included in the analysis if they had a depressive symptoms measure within one month of establishing HIV care at a CNICS site. Depressive symptoms were measured using the validated Patient Health Questionnaire-9 (PHQ-9). Indication for antidepressant treatment was defined as PHQ-9 >= 10 or a current antidepressant prescription. Antidepressant treatment was defined as a current antidepressant prescription. Evidence-based antidepressant treatment was considered treatment changes based on a person's most recent PHQ-9, in accordance with clinical guidelines. We calculated the cumulative probability of moving through the depression treatment cascade within 24 months of entering CNICS HIV care. We used multivariable Cox proportional hazards models to estimate associations between gender, race/ethnicity, and a range of depression outcomes. Results In our cohort of HIV-infected adults in routine care, 47% had an indication for antidepressant treatment. Significant drop-offs along the depression treatment cascade were seen for the entire study sample. However, important disparities existed. Women were more likely to have an indication for antidepressant treatment (HR 1.54; 95% CI 1.34, 1.78), receive antidepressant treatment (HR 2.03; 95% CI 1.53, 2.69) and receive evidence-based antidepressant treatment (HR 1.67; 95% CI 1.03, 2.74), even after accounting for race/ethnicity. Black non-Hispanics (HR 0.47, 95% CI 0.35, 0.65), Hispanics (HR 0.63, 95% CI 0.44, 0.89) and other race/ethnicities (HR 0.35, 95% CI 0.17, 0.73) were less likely to initiate antidepressant treatment, compared to white non-Hispanics. Conclusions In our cohort of HIV-infected adults depressive symptoms were common. Important disparities in the prevalence of depressive symptoms and receipt of antidepressant treatment existed by gender and race/ethnicity.	[Bengtson, Angela M.; Pence, Brian W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Crane, Heidi M.; Fredericksen, Rob J.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Christopoulos, Katerina] Univ Calif San Francisco, Div HIV AIDS, San Francisco Gen Hosp, San Francisco, CA USA; [Gaynes, Bradley N.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Heine, Amy; Napravnik, Sonia] Univ N Carolina, Sch Med, Div Infect Dis, Dept Med, Chapel Hill, NC USA; [Mathews, W. Christopher] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Moore, Richard] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Safren, Steven] Univ Miami, Dept Psychol, Miami, FL USA; [Mugavero, Michael J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Mugavero, Michael J.] Univ Alabama Birmingham, UAB Ctr AIDS Res, Birmingham, AL USA	University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California San Diego; Johns Hopkins University; University of Miami; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bengtson, AM (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	abengtso@live.unc.edu		Bengtson, Angela/0000-0003-1305-8132	National Institutes of Mental Health [R01 MH100970]; National Institute of Allergy and Infectious Disease [R24 AI067039]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410, P30AI073961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100970] Funding Source: NIH RePORTER	National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Institutes of Mental Health (https://www.nimh.nih.gov/index.shtml, R01 MH100970; PI BWP) and by the National Institute of Allergy and Infectious Disease (https://www.niaid.nih.gov/Pages/default.aspx)-funded Center for AIDS Research Network of Integrated Clinical Systems (CNICS; (R24 AI067039; PI Mike Saag).	Agency for Health Care Policy and Research, 1993, DEPR PRIM CAR, V2; Ahaneku H, 2016, AIDS CARE, V28, P140, DOI 10.1080/09540121.2016.1146207; Alegria M, 2008, PSYCHIAT SERV, V59, P1264, DOI 10.1176/appi.ps.59.11.1264; Alegria M, 2014, MED CARE, V52, P989, DOI 10.1097/MLR.0000000000000232; American Psychiatric Association, 2010, PRACTICE GUIDELINE T, V3rd; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Asch SM, 2003, J GEN INTERN MED, V18, P450, DOI 10.1046/j.1525-1497.2003.20938.x; Ault-Brutus AA, 2012, PSYCHIAT SERV, V63, P531, DOI 10.1176/appi.ps.201000397; Bailey RK, 2009, J NATL MED ASSOC, V101, P1084, DOI 10.1016/S0027-9684(15)31102-0; Bengtson AM, 2015, AIDS CARE, V27, P47, DOI 10.1080/09540121.2014.946386; Bing EG, 2001, ARCH GEN PSYCHIAT, V58, P721, DOI 10.1001/archpsyc.58.8.721; Breslau J, 2006, PSYCHOL MED, V36, P57, DOI 10.1017/S0033291705006161; Breslau J, 2005, PSYCHOL MED, V35, P317, DOI 10.1017/S0033291704003514; Brown C, 2014, ARCH WOMEN MENT HLTH, V17, P549, DOI 10.1007/s00737-014-0444-5; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Ciesla JA, 2001, AM J PSYCHIAT, V158, P725, DOI 10.1176/appi.ajp.158.5.725; Dorstyn DS, 2013, J TELEMED TELECARE, V19, P338, DOI 10.1177/1357633X13501767; Dyer TP, 2015, ARCH SEX BEHAV, V44, P429, DOI 10.1007/s10508-014-0346-7; Fleury MJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-161; Gartlehner G, 2016, ANN INTERN MED, V164, P331, DOI 10.7326/M15-1813; Gazzard B, 2010, AIDS REV, V12, P67; Gonzalez HM, 2010, J PSYCHIATR RES, V44, P1043, DOI 10.1016/j.jpsychires.2010.03.017; Gonzalez HM, 2010, ARCH GEN PSYCHIAT, V67, P37, DOI 10.1001/archgenpsychiatry.2009.168; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Gordillo V, 1999, AIDS, V13, P1763, DOI 10.1097/00002030-199909100-00021; Harman JS, 2004, PSYCHIAT SERV, V55, P1379, DOI 10.1176/appi.ps.55.12.1379; Health Resources and Services Administration, R WHIT HIV AIDS PROG; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Howe CJ, 2016, EPIDEMIOLOGY, V27, P91, DOI 10.1097/EDE.0000000000000409; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kitahata MM, 2008, INT J EPIDEMIOL, V37, P948, DOI 10.1093/ije/dym231; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lagomasino IT, 2011, PSYCHIAT SERV, V62, P1019, DOI 10.1176/appi.ps.62.9.1019; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; Lewis-Fernandez R, 2005, J AM BOARD FAM PRACT, V18, P282, DOI 10.3122/jabfm.18.4.282; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Mack S, 2014, INT J METH PSYCH RES, V23, P289, DOI 10.1002/mpr.1438; Meyer OL, 2015, HEALTH SERV RES, V50, P750, DOI 10.1111/1475-6773.12261; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Mugavero M, 2006, AIDS PATIENT CARE ST, V20, P418, DOI 10.1089/apc.2006.20.418; Neighbors HW, 2007, ARCH GEN PSYCHIAT, V64, P485, DOI 10.1001/archpsyc.64.4.485; O'Cleirigh C, 2015, PSYCHOSOMATICS, V56, P470, DOI 10.1016/j.psym.2014.08.004; Pence BW, 2012, AIDS, V26, P656, DOI 10.1097/QAD.0b013e3283519aae; Prevention CfDCa, 2015, HIV AIDS US GEOGR DI; Quinones AR, 2014, PSYCHIAT SERV, V65, P193, DOI 10.1176/appi.ps.201300057; Reis RK, 2011, REV LAT-AM ENFERM, V19, P874, DOI 10.1590/S0104-11692011000400004; Riolo SA, 2005, AM J PUBLIC HEALTH, V95, P998, DOI 10.2105/AJPH.2004.047225; Sclar DA, 2012, CLIN DRUG INVEST, V32, P139, DOI 10.2165/11598950-000000000-00000; Secor AM, 2015, AIDS, V29, pS251, DOI 10.1097/QAD.0000000000000846; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Springer SA, 2012, AIDS BEHAV, V16, P2119, DOI 10.1007/s10461-012-0212-3; United States Census Burea, QUICKFACTS US 2015; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Vasiliadis HM, 2007, PSYCHIAT SERV, V58, P63, DOI 10.1176/appi.ps.58.1.63-a; Vasiliadis HM, 2013, INT PSYCHOGERIATR, V25, P374, DOI 10.1017/S1041610212001895; Williams DR, 2007, ARCH GEN PSYCHIAT, V64, P305, DOI 10.1001/archpsyc.64.3.305; Zimpel RR, 2014, PSYCHOL HEALTH MED, V19, P47, DOI 10.1080/13548506.2013.772302; 2002, ADDICTION, V97, P1183, DOI DOI 10.1111/J.1360-0443.2007.02114.X	62	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160738	10.1371/journal.pone.0160738	http://dx.doi.org/10.1371/journal.pone.0160738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513328	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100063
J	Das, A; Chatterjee, R; Karthick, M; Mahapatra, T; Chaudhuri, I				Das, Aritra; Chatterjee, Rahul; Karthick, Morchan; Mahapatra, Tanmay; Chaudhuri, Indrajit			The Influence of Seasonality and Community-Based Health Worker Provided Counselling on Exclusive Breastfeeding-Findings from a Cross-Sectional Survey in India	PLOS ONE			English	Article							INTERVENTIONS; CHILDREN; INFANT; NEWBORN; GROWTH	Background Exclusive breastfeeding (EBF) during the first six months of life is considered a high impact but low-cost measure for reducing the morbidity and mortality among children. The current study investigated the association of seasonality and frontline worker(FLW) provided counselling with practice of EBF in Bihar, India. Methods We used the 'Lot Quality Assurance Sampling' technique to conduct a multi-stage sampling survey in 8 districts of Bihar. Regarding EBF, mothers of 0-5 (completed) months old children were asked if they had given only breastmilk to their children during the previous day, while mothers of 6-8 (completed) months old children were inquired about the total duration of EBF. We tested for association between EBF during the previous day with season of interview and EBF for full 6 months with nursing season. We also assessed if receiving counselling on EBF and complementary feeding had any association with relevant EBF indicators. Results Among the under-6 month old children, 76% received EBF during the previous day, whereas 92% of 6-8 (completed) months old children reportedly received EBF for the recommended duration. Proportion of 0-5 (completed) month old children receiving only breastmilk (during last 24 hours) decreased significantly with increasing age and with change of season from colder to warmer months. Odds of receiving only breastmilk during the previous day was significantly higher during the winter months (Adjusted odds ratio (AOR) = 1.50; 95% CI = 1.37, 1.63) compared to summer. Also, the children nursed primarily during the winter season had higher odds of receiving EBF for 6 months (AOR = 1.90, 95% CI = 1.43, 2.52) than those with non-winter nursing. Receiving FLW-counselling was positively associated with breastfeeding exclusively, even after adjusting for seasonality and other covariates (AOR = 1.82; 95% CI = 1.67, 1.98). Conclusions Seasonality is a significant but non-modifiable risk factor for EBF. However, FLW-counselling was found to increase practice of EBF irrespective of season. Scale-up of FLW-counselling services, with emphasis on summer months and mothers of older infants, can potentially reduce the impact of seasonality on EBF.	[Das, Aritra; Chatterjee, Rahul; Karthick, Morchan; Chaudhuri, Indrajit] CARE India Solut Sustainable Dev, H 14, Patna, Bihar, India; [Mahapatra, Tanmay] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Mahapatra, T (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA.	drtanmaymahapatra@yahoo.com	; Das, Aritra/C-9076-2014	Chaudhuri, Indrajit/0000-0002-8248-4402; Das, Aritra/0000-0002-7033-1441	Bill and Melinda Gates Foundation [OPP1016872CARE]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was financially supported by a grant from the Bill and Melinda Gates Foundation (Grant ID# OPP1016872CARE) http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, J AM DIET ASSOC, V105, P810, DOI 10.1016/j.jada.2005.03.015; [Anonymous], 2001, Indian Pediatr, V38, P565; Bai Y, 2010, J HUM LACT, V26, P26, DOI 10.1177/0890334409350168; Behera D, 2015, RURAL REMOTE HEALTH, V15; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Dadhich JP, 2009, INDIAN PEDIATR, V46, P11; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Froozani MD, 1999, B WORLD HEALTH ORGAN, V77, P381; Godfrey JR, 2010, J WOMENS HEALTH, V19, P1597, DOI 10.1089/jwh.2010.2290; Gonzalez-Chica DA, 2012, INT J EPIDEMIOL, V41, P743, DOI 10.1093/ije/dys002; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; HUFFMAN SL, 1980, AM J CLIN NUTR, V33, P144, DOI 10.1093/ajcn/33.1.144; Integrated Family Health Initiative: Catalysing change for healthy communities, 2013, INT FAM HLTH IN CAT; JEESON U C, 1989, Indian Pediatrics, V26, P997; Jennifer HG, 2012, J CLIN DIAGN RES, V6, P1514, DOI 10.7860/JCDR/2012/4430.2546; Kanungo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125865; Kapil Umesh, 2002, Indian Journal of Pediatrics, V69, P597, DOI 10.1007/BF02722688; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kulkarni R, 2004, INDIAN J COMMUNITY M, V29, P3; Kumar Sanjiv, 2016, Indian J Community Med, V41, P1, DOI 10.4103/0970-0218.170955; LANATA C F, 1991, World Health Statistics Quarterly, V44, P133; LAWRENCE PB, 1994, PEDIATR CLIN N AM, V41, P925; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Patel A, 2010, FOOD NUTR BULL, V31, P314, DOI 10.1177/156482651003100221; Samuelsson U, 2001, J PEDIATR ENDOCR MET, V14, P43; Sapna PS, 2009, INT E J SCI MED ED, V3, P14; Sellen D W, 2001, J Hum Lact, V17, P233, DOI 10.1177/089033440101700307; Sethi Vani, 2003, Indian Journal of Pediatrics, V70, P463; Simondon KB, 1998, INT J EPIDEMIOL, V27, P490, DOI 10.1093/ije/27.3.490; Teka B, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0028-z; The United Nations Children's Fund (UNICEF), 2013, END PREV CHILD DEATH; Thulier D, 2009, JOGNN-J OBST GYN NEO, V38, P259, DOI 10.1111/j.1552-6909.2009.01021.x; UNICEF Uzbekistan, 2020, YOUTH UZB CHALL PROS; VALADEZ JJ, 1995, AM J PUBLIC HEALTH, V85, P1165, DOI 10.2105/AJPH.85.8_Pt_1.1165-a; Valadez JJ, 1996, INT J EPIDEMIOL, V25, P381, DOI 10.1093/ije/25.2.381; Valadez JJ, 2007, ASSESSING COMMUNITY; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wamani H, 2005, J TROP PEDIATRICS, V51, P356, DOI 10.1093/tropej/fmi048; WHO, GLOB STRAT INF YOUNG; WHO, 1996, WHOVRDTRAM9601	44	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161186	10.1371/journal.pone.0161186	http://dx.doi.org/10.1371/journal.pone.0161186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513642	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100129
J	Fernandez-Perez, MJ; Alarcon, JA; McNamara, JA; Velasco-Torres, M; Benavides, E; Galindo-Moreno, P; Catena, A				Jose Fernandez-Perez, Maria; Antonio Alarcon, Jose; McNamara, James A., Jr.; Velasco-Torres, Miguel; Benavides, Erika; Galindo-Moreno, Pablo; Catena, Andres			Spheno-Occipital Synchondrosis Fusion Correlates with Cervical Vertebrae Maturation	PLOS ONE			English	Article							SKELETAL-MATURATION; PUBERTAL GROWTH; BRIEF COMMUNICATION; MATURITY; WRIST; HAND; CLOSURE; TIME	The aim of this study was to determine the relationship between the closure stage of the spheno-occipital synchondrosis and the maturational stage of the cervical vertebrae (CVM) in growing and young adult subjects using cone beam computed tomography (CBCT). CBCT images with an extended field of view obtained from 315 participants (148 females and 167 males; mean age 15.6 +/- 7.3 years; range 6 to 23 years) were analyzed. The fusion status of the synchondrosis was determined using a five-stage scoring system; the vertebral maturational status was evaluated using a six-stage stratification (CVM method). Ordinal regression was used to study the ability of the synchondrosis stage to predict the vertebral maturation stage. Vertebrae and synchondrosis had a strong significant correlation (r = 0.89) that essential was similar for females (r = 0.88) and males (r = 0.89). CVM stage could be accurately predicted from synchondrosis stage by ordinal regression models. Prediction equations of the vertebral stage using synchondrosis stage, sex and biological age as predictors were developed. Thus this investigation demonstrated that the stage of sphenooccipital synchondrosis, as determined in CBCT images, is a reasonable indicator of growth maturation.	[Jose Fernandez-Perez, Maria; Antonio Alarcon, Jose] Univ Granada, Sch Dent, Dept Orthodont, Granada, Spain; [McNamara, James A., Jr.] Univ Michigan, Sch Dent, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [Velasco-Torres, Miguel; Galindo-Moreno, Pablo] Univ Granada, Sch Dent, Dept Oral Surg & Implant Dent, Granada, Spain; [Benavides, Erika] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Catena, Andres] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain	University of Granada; University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; University of Granada	Alarcon, JA (corresponding author), Univ Granada, Sch Dent, Dept Orthodont, Granada, Spain.	jalarcon@ugr.es	Catena, Andres/I-2159-2015; Galindo-Moreno, Pablo/F-5567-2015; ALARCON, JOSE ANTONIO/L-2079-2014	Catena, Andres/0000-0002-0775-5751; Galindo-Moreno, Pablo/0000-0002-6614-6470; ALARCON, JOSE ANTONIO/0000-0003-3977-476X				Abad V, 2002, ENDOCRINOLOGY, V143, P1851, DOI 10.1210/en.143.5.1851; Akhlaghi M, 2010, J FORENSIC LEG MED, V17, P304, DOI 10.1016/j.jflm.2010.04.009; Angelieri F, 2015, AM J ORTHOD DENTOFAC, V148, P1010, DOI 10.1016/j.ajodo.2015.06.016; Baccetti T., 2005, SEMIN ORTHOD, V11, P119, DOI DOI 10.1053/J.S0D0.2005.04.005; Bassed RB, 2010, FORENSIC SCI INT, V200, P161, DOI 10.1016/j.forsciint.2010.04.009; Byun BR, 2015, CLIN ORAL INVEST, V19, P2133, DOI 10.1007/s00784-015-1415-6; Byun BR, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/405912; Can IO, 2014, J CRANIOFAC SURG, V25, P1212, DOI 10.1097/SCS.0000000000000847; Coqueugniot H, 2007, AM J PHYS ANTHROPOL, V134, P424, DOI 10.1002/ajpa.20683; ElSheikh ME, 2006, FOR PHYS ANTHR P AM; Enlow D. H., 1990, FACIAL GROWTH; FISHMAN LS, 1982, ANGLE ORTHOD, V52, P88; Flores-Mir C, 2004, ANGLE ORTHOD, V74, P118; Franchi L, 2000, AM J ORTHOD DENTOFAC, V118, P335, DOI 10.1067/mod.2000.107009; Franchi L, 2004, AM J ORTHOD DENTOFAC, V126, P555, DOI 10.1016/j.ajodo.2003.10.036; Franklin D, 2014, AM J PHYS ANTHROPOL, V153, P132, DOI 10.1002/ajpa.22399; Gabriel DB, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2007.08.028; HAGG U, 1980, ACTA ODONTOL SCAND, V38, P187, DOI 10.3109/00016358009004719; INGERVALL B, 1972, ACTA ODONTOL SCAND, V30, P349, DOI 10.3109/00016357209004602; Joshi V, 2012, OR SURG OR MED OR PA, V113, P841, DOI 10.1016/j.oooo.2011.11.018; Kapila S, 2011, DENTOMAXILLOFAC RAD, V40, P24, DOI 10.1259/dmfr/12615645; Lamparski DG, 1972, THESIS; Lottering N, 2015, AM J PHYS ANTHROPOL, V157, P42, DOI 10.1002/ajpa.22687; Mann SS, 2000, NEUROIMAG CLIN N AM, V10, P1; Masoud M, 2008, AM J ORTHOD DENTOFAC, V134, P209, DOI 10.1016/j.ajodo.2006.09.063; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Nestman TS, 2011, AM J ORTHOD DENTOFAC, V140, P182, DOI 10.1016/j.ajodo.2011.04.013; OConnell A. A., 2006, LOGISTIC REGRESSION, DOI [10.4135/9781412984812, DOI 10.4135/9781412984812]; Okamoto K, 1996, AM J NEURORADIOL, V17, P117; Perinetti G, 2014, ORTHOD CRANIOFAC RES, V17, P270, DOI 10.1111/ocr.12052; Perinetti G, 2014, ANGLE ORTHOD, V84, P951, DOI 10.2319/120913-906.1; Perinetti G, 2012, ANGLE ORTHOD, V82, P1047, DOI 10.2319/123111-806.1; Sahni D, 1998, FORENSIC SCI INT, V98, P41, DOI 10.1016/S0379-0738(98)00135-2; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Shim JJ, 2012, INT ORTHOD, V10, P351, DOI 10.1016/j.ortho.2012.09.005; Shirley NR, 2011, J FORENSIC SCI, V56, P580, DOI 10.1111/j.1556-4029.2011.01705.x; Soegiharto BM, 2008, AM J ORTHOD DENTOFAC, V134, P227, DOI 10.1016/j.ajodo.2006.09.062; Viera AJ, 2005, FAM MED, V37, P360; WHEELER MD, 1991, ENDOCRIN METAB CLIN, V20, P1; Yang YM, 2014, ORTHOD CRANIOFAC RES, V17, P187, DOI 10.1111/ocr.12045	40	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161104	10.1371/journal.pone.0161104	http://dx.doi.org/10.1371/journal.pone.0161104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513752	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100121
J	Kriticos, DJ; Brunel, S				Kriticos, Darren J.; Brunel, Sarah			Assessing and Managing the Current and Future Pest Risk from Water Hyacinth, (Eichhornia crassipes), an Invasive Aquatic Plant Threatening the Environment and Water Security	PLOS ONE			English	Article							POTENTIAL GEOGRAPHICAL-DISTRIBUTION; CLIMATE-CHANGE; BIOLOGICAL-CONTROL; PISTIA-STRATIOTES; NUTRIENT STORAGE; SPECIES RANGE; FRUIT-FLY; UNCERTAINTIES; MANAGEMENT; GROWTH	Understanding and managing the biological invasion threats posed by aquatic plants under current and future climates is a growing challenge for biosecurity and land management agencies worldwide. Eichhornia crassipes is one of the world's worst aquatic weeds. Presently, it threatens aquatic ecosystems, and hinders the management and delivery of freshwater services in both developed and developing parts of the world. A niche model was fitted using CLIMEX, to estimate the potential distribution of E. crassipes under historical and future climate scenarios. Under two future greenhouse gas emission scenarios for 2080 simulated with three Global Climate Models, the area with a favourable temperature regime appears set to shift polewards. The greatest potential for future range expansion lies in Europe. Elsewhere in the northern hemisphere temperature gradients are too steep for significant geographical range expansion under the climate scenarios explored here. In the Southern Hemisphere, the southern range boundary for E. crassipes is set to expand southwards in Argentina, Australia and New Zealand; under current climate conditions it is already able to invade the southern limits of Africa. The opportunity exists to prevent its spread into the islands of Tasmania in Australia and the South Island of New Zealand, both of which depend upon hydroelectric facilities that would be threatened by the presence of E. crassipes. In Europe, efforts to slow or stop the spread of E. crassipes will face the challenge of limited internal biosecurity capacity. The modelling technique demonstrated here is the first application of niche modelling for an aquatic weed under historical and projected future climates. It provides biosecurity agencies with a spatial tool to foresee and manage the emerging invasion threats in a manner that can be included in the international standard for pest risk assessments. It should also support more detailed local and regional management.	[Kriticos, Darren J.] CSIRO, GPO Box 1700, Canberra, ACT, Australia; [Brunel, Sarah] European & Mediterranean Plant Protect Org, 21 Blvd Richard Lenoir, F-75011 Paris, France	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), CSIRO, GPO Box 1700, Canberra, ACT, Australia.	Darren.Kriticos@csiro.au	Kriticos, Darren J/A-4170-2008	Kriticos, Darren J/0000-0003-2599-8105	Cooperative Research Centre for National Plant Biosecurity [10071]	Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Cooperative Research Centre for National Plant Biosecurity project 10071 (www.crcplantbiosecurity.com.au).	Anonymous, 2008, Bulletin OEPP, V38, P441, DOI [10.1111/j.1365-2338.2008.01261.x, 10.1111/j.1365-2338.2009.02330.x]; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; BARRETT SCH, 1982, AQUAT BOT, V13, P299, DOI 10.1016/0304-3770(82)90065-1; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brundu G., 2012, Bulletin OEPP, V42, P568, DOI 10.1111/epp.12004; Brunel Sarah, 2009, V5, P319; Capdevila-Arguelles L, 2008, A PERSPECTIVE ON CLI; Center TD, 1999, ENVIRON MANAGE, V23, P241, DOI 10.1007/s002679900183; Chejara VK, 2010, WEED RES, V50, P174, DOI 10.1111/j.1365-3180.2010.00765.x; Cifuentes N, 2006, INTEGRAL CONTROL WAT, P266; Commission European, 2013, PROP REG EUR PARL CO; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Desprez-Loustau ML, 2007, CAN J PLANT PATHOL, V29, P101, DOI 10.1080/07060660709507447; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; EDWARDS D, 1975, Journal of the Limnological Society of Southern Africa, V1, P23; EPPO, 2011, PM 5 3 5 GUID PEST R, P1; EPPO, 2009, PEST RISK AN EICHH C; EPPO, 2013, INV AL PLANTS LIST M; FORNO IW, 1981, J AUST I AGR SCI, V47, P21; Gopal B., 1987, Water hyacinth.; HANSEN K L, 1971, Quarterly Journal of the Florida Academy of Sciences, V34, P107; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hennessy K. J., 2007, CLIMATE CHANGE AUSTR, P148; Hill G, 1999, P 1 IOBC GLOB WORK G, P39; Holm LG, 1997, WORLDS WORST WEEDS; IPPC, 2013, IPPC SECRETARIAT F; IPPC (International Plant Protection Convention), 2013, PEST RISK AN QUAR PE; Julien M., 2008, Bulletin OEPP, V38, P477, DOI 10.1111/j.1365-2338.2008.01267.x; JULIEN MH, 1995, J AQUAT PLANT MANAGE, V33, P55; Kasselmann C, 1995, AQUARIENPFLANZEN; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos D. J., 2014, NeoBiota, P81; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos D. J., 2015, CLIMEX VERSION 4 EXP; Kriticos DJ, 2003, J APPL ECOL, V40, P111, DOI 10.1046/j.1365-2664.2003.00777.x; LALLANA VH, 1987, J AQUAT PLANT MANAGE, V25, P48; Laranjeira C. M., 2008, Bulletin OEPP, V38, P487, DOI 10.1111/j.1365-2338.2008.01268.x; Lebreton A, 2007, SYMBIOSES NOUVELLE S, P60; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manning MR, 2010, NAT GEOSCI, V3, P376, DOI 10.1038/ngeo880; MCVEA C, 1975, J ENVIRON QUAL, V4, P375, DOI 10.2134/jeq1975.00472425000400030020x; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Mitchell TD, 2004, 55 TYND CTR, V55, P30; MURAMOTO S, 1991, J ENVIRON SCI HEAL A, V26, P205, DOI 10.1080/10934529109375628; Navarro LA., 2000, WATER HYACINTH AFRIC; O'HARA JAMES, 1967, QUART J FLA ACAD SCI, V30, P73; OWENS CS, 1995, J AQUAT PLANT MANAGE, V33, P63; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; PENFOUND WT, 1948, ECOL MONOGR, V18, P447, DOI 10.2307/1948585; Potter KJB, 2009, WEED RES, V49, P271, DOI 10.1111/j.1365-3180.2009.00697.x; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; REDDY KR, 1990, AQUAT BOT, V37, P355, DOI 10.1016/0304-3770(90)90021-C; REDDY KR, 1989, AQUAT BOT, V36, P33, DOI 10.1016/0304-3770(89)90089-2; Robertson MP, 2008, BIOL CONTROL, V46, P442, DOI 10.1016/j.biocontrol.2008.04.002; Ruiz Tellez T., 2008, Aquatic Invasions, V3, P42, DOI 10.3391/ai.2008.3.1.8; Scott John K., 2006, Plant Protection Quarterly, V21, P91; SHELFORD VE, 1963, ECOLOGY N AM; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst R. W., 2007, TERRESTRIAL ECOSYSTE, P211, DOI DOI 10.1007/978-3-540-32730-1_17; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Truscott AM, 2006, J ECOL, V94, P1080, DOI 10.1111/j.1365-2745.2006.01171.x; U.S. EPA, 2008, CLIM CHANG AQ INV SP; Ultsch G, 1973, ARCH HYDROBIOL; Uremis I., 2014, Bulletin OEPP, V44, P83, DOI 10.1111/epp.12096; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Watt MS, 2009, WEED RES, V49, P381, DOI 10.1111/j.1365-3180.2009.00704.x; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Watterson IG, 1996, INT J CLIMATOL, V16, P379, DOI 10.1002/(SICI)1097-0088(199604)16:4&lt;379::AID-JOC18&gt;3.0.CO;2-U; Wharton TN, 2004, DIVERS DISTRIB, V10, P253, DOI 10.1111/j.1366-9516.2004.00090.x; Whetton PH, 2005, 001 CSIRO; Wilson JR, 2002, MODELLING DYNAMICS C; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; Yonow T, 2013, CROP PROT, V44, P18, DOI 10.1016/j.cropro.2012.10.006	80	48	50	4	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0120054	10.1371/journal.pone.0120054	http://dx.doi.org/10.1371/journal.pone.0120054			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513336	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100001
J	Pinto, AT; Pinto, ML; Velho, S; Pinto, MT; Cardoso, AP; Figueira, R; Monteiro, A; Marques, M; Seruca, R; Barbosa, MA; Mareel, M; Oliveira, MJ; Rocha, S				Pinto, Ana T.; Pinto, Marta L.; Velho, Sergia; Pinto, Marta T.; Cardoso, Ana P.; Figueira, Rita; Monteiro, Armanda; Marques, Margarida; Seruca, Raquel; Barbosa, Mario A.; Mareel, Marc; Oliveira, Maria J.; Rocha, Sonia			Intricate Macrophage-Colorectal Cancer Cell Communication in Response to Radiation	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; IONIZING-RADIATION; BREAST-CANCER; ANTICANCER THERAPIES; AEROBIC GLYCOLYSIS; BCL-2 FAMILY; LUNG-CANCER; THP-1 CELLS; DNA-DAMAGE; LINES	Both cancer and tumour-associated host cells are exposed to ionizing radiation when a tumour is subjected to radiotherapy. Macrophages frequently constitute the most abundant tumour-associated immune population, playing a role in tumour progression and response to therapy. The present work aimed to evaluate the importance of macrophage-cancer cell communication in the cellular response to radiation. To address this question, we established monocultures and indirect co-cultures of human monocyte-derived macrophages with RKO or SW1463 colorectal cancer cells, which exhibit higher and lower radiation sensitivity, respectively. Mono-and co-cultures were then irradiated with 5 cumulative doses, in a similar fractionated scheme to that used during cancer patients' treatment (2 Gy/fraction/ day). Our results demonstrated that macrophages sensitize RKO to radiation-induced apoptosis, while protecting SW1463 cells. Additionally, the co-culture with macrophages increased the mRNA expression of metabolism-and survival-related genes more in SW1463 than in RKO. The presence of macrophages also upregulated glucose transporter 1 expression in irradiated SW1463, but not in RKO cells. In addition, the influence of cancer cells on the expression of pro-and anti-inflammatory macrophage markers, upon radiation exposure, was also evaluated. In the presence of RKO or SW1463, irradiated macrophages exhibit higher levels of pro-inflammatory TNF, IL6, CCL2 and CCR7, and of anti-inflammatory CCL18. However, RKO cells induce an increase of macrophage pro-inflammatory IL 1B, while SW1463 cells promote higher pro-inflammatory CXCL8 and CD80, and also anti-inflammatory VCAN and IL 10 levels. Thus, our data demonstrated that macrophages and cancer cells mutually influence their response to radiation. Notably, conditioned medium from irradiated co-cultures increased non-irradiated RKO cell migration and invasion and did not impact on angiogenesis in a chicken embryo chorioallantoic membrane assay. Overall, the establishment of primary human macrophage-cancer cell co-cultures revealed an intricate cell communication in response to ionizing radiation, which should be considered when developing therapies adjuvant to radiotherapy.	[Pinto, Ana T.; Pinto, Marta L.; Velho, Sergia; Pinto, Marta T.; Cardoso, Ana P.; Seruca, Raquel; Barbosa, Mario A.; Oliveira, Maria J.] Univ Porto, Inst Invest & Inovacao Saude i3s, Oporto, Portugal; [Pinto, Ana T.; Pinto, Marta L.; Cardoso, Ana P.; Barbosa, Mario A.; Oliveira, Maria J.] Univ Porto, INEB Inst Biomed Engn, Oporto, Portugal; [Pinto, Ana T.] Univ Porto, FEUP Fac Engn, Oporto, Portugal; [Pinto, Marta L.; Barbosa, Mario A.] Univ Porto, ICBAS Inst Biomed Sci Abel Salazar, Oporto, Portugal; [Velho, Sergia; Pinto, Marta T.; Seruca, Raquel] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Oporto, Portugal; [Figueira, Rita; Monteiro, Armanda; Marques, Margarida] Ctr Hosp S Joao, EPE, Radiotherapy Serv, Oporto, Portugal; [Seruca, Raquel; Oliveira, Maria J.] Univ Porto, Dept Pathol & Oncol, Fac Med, Oporto, Portugal; [Mareel, Marc] Ghent Univ Hosp, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium; [Rocha, Sonia] Univ Dundee, Ctr Gene Regulat & Express, Coll Life Sci, Dundee, Scotland	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade do Porto; Ghent University; Ghent University Hospital; University of Dundee	Oliveira, MJ (corresponding author), Univ Porto, Inst Invest & Inovacao Saude i3s, Oporto, Portugal.; Oliveira, MJ (corresponding author), Univ Porto, INEB Inst Biomed Engn, Oporto, Portugal.; Oliveira, MJ (corresponding author), Univ Porto, Dept Pathol & Oncol, Fac Med, Oporto, Portugal.	mariajo@ineb.up.pt	Pinto, Ana/AAZ-8360-2020; Marques, Margarida/HGE-4934-2022; Pinto, Marta T/J-2519-2013; Pinto, Marta/AAE-4575-2020; Velho, Sérgia/B-8501-2013; Barbosa, Mário A/F-5964-2011; Cardoso, Ana P/G-2150-2017; Oliveira, Maria Jose/K-3275-2013	Pinto, Ana/0000-0003-0974-2206; Pinto, Marta T/0000-0002-8521-2904; Pinto, Marta/0000-0002-5783-3965; Velho, Sérgia/0000-0002-7104-8234; Barbosa, Mário A/0000-0003-3568-7482; Cardoso, Ana P/0000-0003-1987-0316; Seruca, Raquel/0000-0002-8851-4166; Oliveira, Maria Jose/0000-0002-0724-0272	FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE - Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences" [POCI-01-0145-FEDER-007274]; FCT-Investigator Program; EACR travel Fellowship; ESTRO travel Fellowship; Cancer Research UK [C99667/A12918]; Wellcome Trust [097945/B/11/Z];  [SFRH/BD/74144/2010];  [SFRH/BD/81103/2011]; Cancer Research UK [12918] Funding Source: researchfish	FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE - Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal; Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences"; FCT-Investigator Program; EACR travel Fellowship; ESTRO travel Fellowship; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); ; ; Cancer Research UK(Cancer Research UK)	This work was financed by FEDER - Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 - Operacional Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT - Fundacao para a Ciencia e a Tecnologia/Ministerio da Ciencia, Tecnologia e Inovacao in the framework of the project "Institute for Research and Innovation in Health Sciences" (POCI-01-0145-FEDER-007274), FCT2012-Investigator Program (Maria Jose Oliveira) and PhD fellowships (SFRH/BD/74144/2010 and SFRH/BD/81103/2011, Ana Teresa Pinto and Marta Teixeira Pinto, respectively). Authors also thank EACR and ESTRO travel Fellowships, Cancer Research UK (C99667/A12918) and Wellcome Trust (097945/B/11/Z) for their grant support.	Aldridge DR, 1998, CANCER RES, V58, P2817; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Barcellos-Hoff MH, 2005, NAT REV CANCER, V5, P867, DOI 10.1038/nrc1735; Barker HE, 2015, NAT REV CANCER, V15, P409, DOI 10.1038/nrc3958; Baskar Rajamanickam, 2014, Front Mol Biosci, V1, P24, DOI 10.3389/fmolb.2014.00024; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Cardoso AP, 2014, ONCOGENE, V33, P2123, DOI 10.1038/onc.2013.154; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; De Ridder M, 2004, INT J RADIAT ONCOL, V60, P598, DOI 10.1016/j.ijrobp.2004.05.065; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Dokic I, 2015, INT J RADIAT BIOL, V91, P157, DOI 10.3109/09553002.2014.937511; Fujibayashi Y, 1997, RADIAT RES, V147, P729, DOI 10.2307/3579487; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gupta AK, 2001, METHOD ENZYMOL, V333, P284; Haabeth OAW, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1039763; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hellevik T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00001; Hollmen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09188; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kleiman LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082982; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Lee JU, 1999, EUR J CANCER, V35, P1374, DOI 10.1016/S0959-8049(99)00134-3; Li HH, 2015, INT J BIOL SCI, V11, P726, DOI 10.7150/ijbs.12009; Lynam-Lennon N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100738; Lynam-Lennon N, 2010, RADIAT RES, V174, P703, DOI 10.1667/RR2295.1; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Minjgee M, 2011, INT J RADIAT ONCOL, V81, P1506, DOI 10.1016/j.ijrobp.2011.05.057; Morel C, 2009, MOL CELL BIOL, V29, P3845, DOI 10.1128/MCB.00279-09; Mothersill C, 2003, ONCOGENE, V22, P7028, DOI 10.1038/sj.onc.1206882; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Pinto AT, 2016, SCI REP-UK, V6, DOI 10.1038/srep18765; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; REYNOLDS JE, 1994, CANCER RES, V54, P6348; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Servomaa K, 1996, CELL PROLIFERAT, V29, P219, DOI 10.1046/j.1365-2184.1996.01009.x; Shen ZL, 2012, CYTOKINE, V59, P352, DOI 10.1016/j.cyto.2012.04.033; Shimura T, 2014, RADIOTHER ONCOL, V112, P302, DOI 10.1016/j.radonc.2014.07.015; Song LX, 2005, CANCER BIOL THER, V4, P267, DOI 10.4161/cbt.4.3.1496; Stephenson-Famy A, 2012, MOL ENDOCRINOL, V26, P320, DOI 10.1210/me.2011-1282; Wang H, 2016, ONCOIMMUNOLOGY; Wang R, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-62; Williams JR, 2008, INT J RADIAT ONCOL, V72, P909, DOI 10.1016/j.ijrobp.2008.06.1928; Wu TH, 2014, CELL IMMUNOL, V290, P107, DOI 10.1016/j.cellimm.2014.05.015; Yang JS, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-117; Zannini L, 2014, J MOL CELL BIOL, V6, P442, DOI 10.1093/jmcb/mju045; Zhan QM, 1997, ONCOGENE, V14, P1031, DOI 10.1038/sj.onc.1200927; Zhang Y, 2013, EUR J CANCER, V49, P3320, DOI 10.1016/j.ejca.2013.06.005; Zhou N, 2015, INT J MOL SCI, V16, P11966, DOI 10.3390/ijms160611966	57	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160891	10.1371/journal.pone.0160891	http://dx.doi.org/10.1371/journal.pone.0160891			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513864	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100086
J	Wang, F; Gao, JW; Liu, Y; Tian, ZW; Muhammad, A; Zhang, YX; Jiang, D; Cao, WX; Dai, TB				Wang, Feng; Gao, Jingwen; Liu, Yang; Tian, Zhongwei; Muhammad, Abid; Zhang, Yixuan; Jiang, Dong; Cao, Weixing; Dai, Tingbo			Higher Ammonium Transamination Capacity Can Alleviate Glutamate Inhibition on Winter Wheat (Triticum aestivum L.) Root Growth under High Ammonium Stress	PLOS ONE			English	Article							NITROGEN ASSIMILATION; HIGHER-PLANTS; RICE ROOTS; LOW PH; TOXICITY; AUXIN; ARABIDOPSIS; SYNTHETASE; TOLERANCE; NUTRITION	Most of the studies about NH4+ stress mechanism simply address the effects of free NH4+, failing to recognize the changed nitrogen assimilation products. The objective of this study was to elucidate the effects of glutamate on root growth under high ammonium (NH4+) conditions in winter wheat (Triticum aestivum L.). Hydroponic experiments were conducted using two wheat cultivars, AK58 (NH4+-sensitive) and Xumai25 (NH4+-tolerant) with either 5 mM NH4+ nitrogen (AN) as stress treatment or 5 mM nitrate (NO3-) nitrogen as control. To evaluate the effects of NH4+- assimilation products on plant growth, 1 mu M L- methionine sulfoximine (MSO) (an inhibitor of glutamine synthetase (GS)) and 1 mM glutamates (a primary N assimilation product) were added to the solutions, respectively. The AN significantly reduced plant biomass, total root length, surface area and root volume in both cultivars, but less effect was observed in Xumai25. The inhibition effects were alleviated by the application of MSO but strengthened by the application of glutamate. The AN increased the activities of GS, glutamate dehydrogenase (GDH) in both cultivars, resulting in higher glutamate contents. However, its contents were decreased by the application of MSO. Compared to AK58, Xumai25 showed lower glutamate contents due to its higher activities of glutamicoxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT). With the indole-3-acetic acid (IAA) contents decreasing in roots, the ratio of shoot to root in IAA was increased, and further increased by the application of glutamate, and reduced by the application of MSO, but the ratio was lower in Xumai25. Meanwhile, the total soluble sugar contents and its root to shoot ratio also showed similar trends. These results indicate that the NH4+-tolerant cultivar has a greater transamination ability to prevent glutamate over-accumulation to maintain higher IAA transport ability, and consequently promoted soluble sugar transport to roots, further maintaining root growth.	[Wang, Feng; Gao, Jingwen; Liu, Yang; Tian, Zhongwei; Muhammad, Abid; Zhang, Yixuan; Jiang, Dong; Cao, Weixing; Dai, Tingbo] Nanjing Agr Univ, Key Lab Crop Physiol Ecol & Prod Management, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Dai, TB (corresponding author), Nanjing Agr Univ, Key Lab Crop Physiol Ecol & Prod Management, Nanjing 210095, Jiangsu, Peoples R China.	tingbod@njau.edu.cn		Wang, Feng/0000-0002-1788-8603; Gao, Jingwen/0000-0002-1711-5811	National Natural Science Foundation of China [31471443]; Natural Science Foundation of Jiangsu Province, China [BK20140705]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China (Grant No. 31471443), http://www.nsfc.gov.cn/, TD received the funding; and Natural Science Foundation of Jiangsu Province, China (Grant No. BK20140705), http://www.jstd.gov.cn/, TD received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloni R, 2006, ANN BOT-LONDON, V97, P883, DOI 10.1093/aob/mcl027; Ariz I, 2013, PHYSIOL PLANTARUM, V148, P522, DOI 10.1111/j.1399-3054.2012.01712.x; Ariz I, 2011, J PLANT PHYSIOL, V168, P1009, DOI 10.1016/j.jplph.2010.11.022; Ariz I, 2010, J PLANT PHYSIOL, V167, P1038, DOI 10.1016/j.jplph.2010.02.014; Berleth T, 2000, TRENDS PLANT SCI, V5, P387, DOI 10.1016/S1360-1385(00)01725-8; Bernard SM, 2008, PLANT MOL BIOL, V67, P89, DOI 10.1007/s11103-008-9303-y; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Britto DT, 2013, ANN BOT-LONDON, V112, P957, DOI 10.1093/aob/mct157; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; Cruz C, 2006, PLANTA, V223, P1068, DOI 10.1007/s00425-005-0155-2; El Omari R, 2010, FUNCT PLANT BIOL, V37, P55, DOI 10.1071/FP09162; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Gerendas J, 1997, Z PFLANZ BODENKUNDE, V160, P239, DOI 10.1002/jpln.19971600218; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo L, 2013, PLANT SOIL, V362, P1, DOI 10.1007/s11104-012-1455-5; Han HM, 2015, PLANT GROWTH REGUL, V77, P201, DOI 10.1007/s10725-015-0053-y; Hirano T, 2008, PHYSIOL PLANTARUM, V134, P183, DOI 10.1111/j.1399-3054.2008.01117.x; Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X; Jampeetong A, 2012, ECOTOX ENVIRON SAFE, V79, P69, DOI 10.1016/j.ecoenv.2011.12.003; Kronzucker HJ, 2001, TRENDS PLANT SCI, V6, P335, DOI 10.1016/S1360-1385(01)02022-2; Lea PJ, 2003, PLANT PHYSIOL BIOCH, V41, P555, DOI 10.1016/S0981-9428(03)00060-3; Li BH, 2014, TRENDS PLANT SCI, V19, P107, DOI 10.1016/j.tplants.2013.09.004; Li BH, 2011, ACTA PHYSIOL PLANT, V33, P325, DOI 10.1007/s11738-010-0551-5; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; NISHITANI K, 1981, PHYSIOL PLANTARUM, V52, P482, DOI 10.1111/j.1399-3054.1981.tb02720.x; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; PECKOL P, 1995, J EXP MAR BIOL ECOL, V190, P1, DOI 10.1016/0022-0981(95)00026-N; Schortemeyer M, 1997, ANN BOT-LONDON, V79, P25, DOI 10.1006/anbo.1996.0298; Sebastian A, 2014, ENVIRON SCI POLLUT R, V21, P986, DOI 10.1007/s11356-013-1948-7; Setien I, 2014, J PLANT PHYSIOL, V171, P49, DOI 10.1016/j.jplph.2013.10.021; Setien I, 2013, J PLANT PHYSIOL, V170, P758, DOI 10.1016/j.jplph.2012.12.015; Shi ZL, 2012, FIELD CROP RES, V127, P241, DOI 10.1016/j.fcr.2011.11.025; Taylor MW, 1999, MAR ECOL PROG SER, V184, P73, DOI 10.3354/meps184073; Tong DL, 2012, J ENVIRON SCI, V24, P682, DOI 10.1016/S1001-0742(11)60832-2; van den Berg LJL, 2005, NEW PHYTOL, V166, P551, DOI 10.1111/j.1469-8137.2005.01338.x; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Xu GH, 2012, ANNU REV PLANT BIOL, V63, P153, DOI 10.1146/annurev-arplant-042811-105532; Yousra M, 2013, PAK J AGR SCI, V50, P43; Zhou YB, 2014, MOL BREEDING, V34, P335, DOI 10.1007/s11032-014-0037-z; Zhu YY, 2009, PLANT CELL ENVIRON, V32, P1428, DOI 10.1111/j.1365-3040.2009.02009.x; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	43	12	18	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160997	10.1371/journal.pone.0160997	http://dx.doi.org/10.1371/journal.pone.0160997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512992	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100107
J	Zhang, YL; Rataj, K; Simpson, GG; Tong, L				Zhang, Yinglu; Rataj, Katarzyna; Simpson, Gordon G.; Tong, Liang			Crystal Structure of the SPOC Domain of the Arabidopsis Flowering Regulator FPA	PLOS ONE			English	Article							RNA-RECOGNITION MOTIFS; ANOMALOUS DIFFRACTION; MOLECULAR-MECHANISMS; POLYADENYLATION; PROTEINS; SHARP; TRANSFORMATION; TRANSCRIPTION; REPRESSION; INSIGHTS	The Arabidopsis protein FPA controls flowering time by regulating the alternative 3'-end processing of the FLOWERING LOCUS (FLC) antisense RNA. FPA belongs to the split ends (SPEN) family of proteins, which contain N-terminal RNA recognition motifs (RRMs) and a SPEN paralog and ortholog C-terminal (SPOC) domain. The SPOC domain is highly conserved among FPA homologs in plants, but the conservation with the domain in other SPEN proteins is much lower. We have determined the crystal structure of Arabidopsis thaliana FPA SPOC domain at 2.7 angstrom resolution. The overall structure is similar to that of the SPOC domain in human SMRT/HDAC1 Associated Repressor Protein (SHARP), although there are also substantial conformational differences between them. Structural and sequence analyses identify a surface patch that is conserved among plant FPA homologs. Mutations of two residues in this surface patch did not disrupt FPA functions, suggesting that either the SPOC domain is not required for the role of FPA in regulating RNA 3'-end formation or the functions of the FPA SPOC domain cannot be disrupted by the combination of mutations, in contrast to observations with the SHARP SPOC domain.	[Zhang, Yinglu; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Rataj, Katarzyna; Simpson, Gordon G.] Univ Dundee, Sch Life Sci, Div Plant Sci, Dundee DD1 5EH, Scotland; [Rataj, Katarzyna; Simpson, Gordon G.] Univ Dundee, Sch Life Sci, Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Simpson, Gordon G.] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland	Columbia University; University of Dundee; University of Dundee; James Hutton Institute	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Simpson, Gordon/0000-0001-6744-5889; Tong, Liang/0000-0002-0563-6468	NIH [R01GM077175, R35GM118093, S10OD012018]; BBSRC PhD studentship; BBSRC [BB/H002286/1, BB/M004155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM077175, R35GM118093] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012018] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/H002286/1, BB/M004155/1] Funding Source: researchfish; BBSRC [BB/M004155/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the NIH to LT (R01GM077175, R35GM118093 and S10OD012018). Katarzyna Rataj was supported by a BBSRC PhD studentship, and this research was supported by grants from BBSRC to GGS (BB/H002286/1 and BB/M004155).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arieti F, 2014, NUCLEIC ACIDS RES, V42, P6742, DOI 10.1093/nar/gku277; Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curinha A, 2014, NUCLEUS-PHILA, V5, P508, DOI 10.4161/nucl.36360; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Eletsky Alexander, 2011, Journal of Structural and Functional Genomics, V12, P159, DOI 10.1007/s10969-011-9115-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hornyik C, 2010, BIOCHEM SOC T, V38, P1077, DOI 10.1042/BST0381077; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Jurado AR, 2014, BIOCHEMISTRY-US, V53, P1882, DOI 10.1021/bi401715v; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lutz CS, 2011, WIRES RNA, V2, P22, DOI 10.1002/wrna.47; Mikami S, 2014, STRUCTURE, V22, P35, DOI 10.1016/j.str.2013.10.007; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanchez-Pulido L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-91; Schalch T, 2011, NAT STRUCT MOL BIOL, V18, P1351, DOI 10.1038/nsmb.2151; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Tian B, 2013, TRENDS BIOCHEM SCI, V38, P312, DOI 10.1016/j.tibs.2013.03.005; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Zhao X., 2015, CANC TRANSLATIONAL M, V1, P21, DOI [10.4103/2395-3977.151483, DOI 10.4103/2395-3977.151483]	35	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160694	10.1371/journal.pone.0160694	http://dx.doi.org/10.1371/journal.pone.0160694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513867	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100059
J	Miralles, L; Oremus, M; Silva, MA; Planes, S; Garcia-Vazquez, E				Miralles, Laura; Oremus, Marc; Silva, Monica A.; Planes, Serge; Garcia-Vazquez, Eva			Interspecific Hybridization in Pilot Whales and Asymmetric Genetic Introgression in Northern Globicephala melas under the Scenario of Global Warming	PLOS ONE			English	Article							POPULATION-STRUCTURE; PHYLOGENETIC-RELATIONSHIPS; NATURAL HYBRIDIZATION; CLIMATE-CHANGE; CYTOCHROME-B; SEA-SURFACE; ATLANTIC; DIVERSITY; EVOLUTION; SOFTWARE	Pilot whales are two cetacean species (Globicephala melas and G. macrorhynchus) whose distributions are correlated with water temperature and partially overlap in some areas like the North Atlantic Ocean. In the context of global warming, distribution range shifts are expected to occur in species affected by temperature. Consequently, a northward displacement of the tropical pilot whale G. macrorynchus is expected, eventually leading to increased secondary contact areas and opportunities for interspecific hybridization. Here, we describe genetic evidences of recurrent hybridization between pilot whales in northeast Atlantic Ocean. Based on mitochondrial DNA sequences and microsatellite loci, asymmetric introgression of G. macrorhynchus genes into G. melas was observed. For the latter species, a significant correlation was found between historical population growth rate estimates and paleotemperature oscillations. Introgressive hybridization, current temperature increases and lower genetic variation in G. melas suggest that this species could be at risk in its northern range. Under increasing environmental and human-mediated stressors in the North Atlantic Ocean, it seems recommendable to develop a conservation program for G. melas.	[Miralles, Laura; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, E-33006 Oviedo, Spain; [Oremus, Marc] 16 Rue Henri Niautou, Noumea 98800, New Caledonia; [Silva, Monica A.] Univ Azores, MARE Marine & Environm Sci Ctr, P-9901862 Horta, Portugal; [Silva, Monica A.] Univ Azores, Ctr IMAR, Inst Marine Res, P-9901862 Horta, Portugal; [Silva, Monica A.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Planes, Serge] Ctr Rech Insulaire & Observ Environm, Lab Excellence CORAIL, USR 3278, CNRS,EPHE,UPVD, BP 1013 Papetoai, F-98729 Moorea, France	University of Oviedo; Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Miralles, L (corresponding author), Univ Oviedo, Dept Funct Biol, E-33006 Oviedo, Spain.	lml.miralles@gmail.com	PLANES, Serge/ABF-1360-2021; Garcia-Vazquez, Eva/Y-7293-2019; Silva, Mónica/D-1893-2012	Silva, Mónica/0000-0002-2683-309X; Miralles, Laura/0000-0002-7146-9776; Garcia-Vazquez, Eva/0000-0002-8429-838X	Asturias Regional Government [BP 10-004]; FCT Investigator contract through POPH; Portuguese Ministry for Science and Education; Principality of Asturias [GRUPIN-2014-093]; FEDER [MAPCET-M2.1.2/F/012/2011]; QREN European Social Fund [MAPCET-M2.1.2/F/012/2011]; Proconvergencia Acores/EU Program [MAPCET-M2.1.2/F/012/2011]; Competitiveness Factors Operational (COMPETE) [MAPCET-M2.1.2/F/012/2011]	Asturias Regional Government(Principality of Asturias); FCT Investigator contract through POPH; Portuguese Ministry for Science and Education(Portuguese Foundation for Science and Technology); Principality of Asturias(Principality of Asturias); FEDER(European Commission); QREN European Social Fund; Proconvergencia Acores/EU Program; Competitiveness Factors Operational (COMPETE)	LM had a PCTI Grant from the Asturias Regional Government, referenced BP 10-004. MAS was supported by a 2013 FCT Investigator contract through POPH, QREN European Social Fund and the Portuguese Ministry for Science and Education. This study was also supported by a grant from the Principality of Asturias (reference: GRUPIN-2014-093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We want to thank B. Mikkelsen from the Feroese Museum of Natural History for the Feroese samples; S. Lens from IEO Vigo, A. Rodriguez-Folgar from GREMMAR and C. Fernandez Maldonado from Agencia de Medio Ambiente y Agua de la Junta de Andalucia for the Iberian Peninsula samples; M. Carrillo from Canarias Conservacion for the Canary Island samples, A. Benet, M. Poole and S. Baker for the Polynesian samples, and project MAPCET-M2.1.2/F/012/2011 [FEDER, the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, and Proconvergencia Acores/EU Program] for Azorean samples. This is a contribution of the Marine Observatory of Asturias (OMA). The authors declare that none of the authors have any competing interests.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander AM, 2006, THESIS; Alfonsi E, 2013, ZOOKEYS, P5, DOI 10.3897/zookeys.365.5873; Allentoft ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016670; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves F, 2013, AQUAT CONSERV, V23, P758, DOI 10.1002/aqc.2332; AMOS B, 1991, HEREDITY, V67, P49, DOI 10.1038/hdy.1991.64; Anderson EC, 2002, GENETICS, V160, P1217; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Belkhir K, 2001, GENETIX LOGICIEL SOU; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Bjorge A., 2002, MARINE MAMMALS BIOL, P63; BLOCH D, 1993, OPHELIA, V38, P55, DOI 10.1080/00785326.1993.10429924; Bloch D, 1995, DEV MAR BIO, V4, P499; Bloch D., 1998, SHETLAND SEA MAMMAL, P15; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Cornuet JM, 1996, GENETICS, V144, P2001; Desportes Genevieve, 1993, V14, P233; Dombrowski C., 2012, GLOBICEPHALA MACRORH; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frey A, 2005, 16 BIENN C BIOL MAR; Fullard KJ, 2000, MOL ECOL, V9, P949, DOI 10.1046/j.1365-294x.2000.00957.x; GISTEMP, 2015, NASA GODD I SPAC STU; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-25; Goudet J., 2002, FSTAT PROGRAM ESTIMA; GOWANS S, 1995, CAN J ZOOL, V73, P1599, DOI 10.1139/z95-190; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hatun H, 2009, PROG OCEANOGR, V80, P149, DOI 10.1016/j.pocean.2009.03.001; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Hoydal K, 1993, ANAL FAROESE CATCHES, V14, P391; KASUYA T, 1988, Scientific Reports of the Whales Research Institute Tokyo, P77; Kasuya T., 1975, PAST OCCURENCE GLOBI, V27, P95; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Lavery S, 1996, MOL BIOL EVOL, V13, P1106, DOI 10.1093/oxfordjournals.molbev.a025672; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Marchal O, 2002, QUATERNARY SCI REV, V21, P455, DOI 10.1016/S0277-3791(01)00105-6; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Martin AR, REPROD PARAMETERS FE; May-Collado L, 2006, MOL PHYLOGENET EVOL, V38, P344, DOI 10.1016/j.ympev.2005.09.019; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Miralles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069511; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Nishida S, 2007, ZOOL SCI, V24, P723, DOI 10.2108/zsj.24.723; NORES C, 1988, MAMMALIA, V52, P51, DOI 10.1515/mamm.1988.52.1.51; Odontocetes Culik B., 2010, THE TOOTHED WHALES; Oremus M, 2009, BIOL J LINN SOC, V98, P729, DOI 10.1111/j.1095-8312.2009.01325.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Payne P. Michael, 1993, Reports of the International Whaling Commission Special Issue, V14, P51; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sabatier E, 2015, MAMMALIA, V79, P111, DOI 10.1515/mammalia-2013-0155; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Sergeant DE, 1962, B FISH RES BD CANADA, V132, P1; Shane Susan H., 1994, Bulletin Southern California Academy of Sciences, V93, P13; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Steig EJ, 1999, SCIENCE, V286, P1485, DOI 10.1126/science.286.5444.1485; Taylor B. L., 2008, IUCN RED LIST THREAT; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Bree P. J. H., 1971, Beaufortia, V19, P79; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Whitehead H, 2005, MAR MAMMAL SCI, V21, P58, DOI 10.1111/j.1748-7692.2005.tb01208.x; Willis PM, 2004, CAN J ZOOL, V82, P828, DOI 10.1139/Z04-059; WRIGHT S, 1951, ANN EUGENIC, V15, P323	82	7	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160080	10.1371/journal.pone.0160080	http://dx.doi.org/10.1371/journal.pone.0160080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508496	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400022
J	Schabath, MB; Massion, PP; Thompson, ZJ; Eschrich, SA; Balagurunathan, Y; Goldof, D; Aberle, DR; Gillies, RJ				Schabath, Matthew B.; Massion, Pierre P.; Thompson, Zachary J.; Eschrich, Steven A.; Balagurunathan, Yoganand; Goldof, Dmitry; Aberle, Denise R.; Gillies, Robert J.			Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial	PLOS ONE			English	Article							BASE-LINE; STAGE-I	Lung cancer screening identifies cancers with heterogeneous behaviors. Some lung cancers will be identified among patients who had prior negative CT screens and upon follow-up scans develop a de novo nodule that was determined to be cancerous. Other lung cancers will be identified among patients who had one or more prior stable positive scans that were not determined to be lung cancer (indeterminate pulmonary nodules), but in follow-up scans was diagnosed with an incidence lung cancer. Using data from the CT arm of the National Lung Screening Trial, this analysis investigated differences in patient characteristics and survival endpoints between prevalence-, interval-, and screen-detected lung cancers, characterized based on sequence of screening results. Lung cancers immediately following a positive baseline (T0), and prior to the T1 screen, formed the prevalence cohort. Interval cancers were diagnosed following a negative screen at any time point prior to the next screening round. Two cohorts of screen-detected lung cancers (SDLC) were identified that had a baseline positive screen that was that was not determined to be lung cancer (i.e., an indeterminate pulmonary nodule), but in follow-up scans was diagnosed with an incidence lung cancer 12 (SDLC1) or 24 (SDLC2) months later. Two other incidence cohorts had screen-detected lung cancers that had baseline negative screen and upon follow-up scans developed a de novo nodule determined to be cancerous at 12 (SDLC3) or 24 (SDLC4) months later. Differences in patient characteristics, progression-free survival (PFS), and overall survival (OS) were assessed. The lung cancer-specific death rate was higher for SDLC3/SDLC4 compared to SDLC1/SDLC2 lung cancers (136.6/1,000 person-years vs. 71.3/1,000 person-years, P < 0.001). Moreover, PFS and OS were significantly lower for SDLC3/SDLC4 compared to SDLC1/SDLC2 (P < 0.004; P < 0.002, respectively). The findings were consistent when stratified by stage and histology. Multivariable Cox proportional models revealed that the SDLC3/SDLC4 case groups were associated with significantly poorer PFS (HR = 1.89; 95% CI 1.31-2.74) and OS (HR = 1.80; 95% CI 1.21-2.67) compared to SDLC1/SDLC2 lung cancers (HR = 1.00). Lung cancer patients who develop a de novo nodule that determined to be cancerous (i.e., at least one negative CT screen prior to cancer diagnosis) had poorer survival outcomes compared to patients who had at least one positive screen prior to cancer diagnosis. As such, the observation that de novo screen-detected are associated with poorer survival could be attributed to faster growing, more aggressive cancers that arose from a lung environment previously lacking focal abnormalities.	[Schabath, Matthew B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33607 USA; [Massion, Pierre P.] Vanderbilt Ingram Canc Ctr, Thorac Program, Nashville, TN 37232 USA; [Thompson, Zachary J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33607 USA; [Eschrich, Steven A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33607 USA; [Balagurunathan, Yoganand; Gillies, Robert J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Imaging, Tampa, FL 33607 USA; [Goldof, Dmitry] Univ S Florida, Dept Comp Sci & Engn, Tampa, FL 33620 USA; [Aberle, Denise R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA	H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schabath, MB (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33607 USA.	Matthew.Schabath@Moffitt.org	Eschrich, Steven/K-6848-2013; Balagurunathan, Yoganand/AAF-9163-2020; Schabath, Matthew B./J-3763-2016; Balagurunathan, Yoganand/AAH-9139-2021; Aberle, Denise R./D-5699-2014	Eschrich, Steven/0000-0002-9833-2788; Balagurunathan, Yoganand/0000-0002-5598-4727; Schabath, Matthew B./0000-0003-3241-3216; Aberle, Denise R./0000-0002-8858-3401; Gillies, Robert/0000-0002-8888-7747; Bruin, Joe/0000-0002-5601-9080	James & Esther King Biomedical Research Program-Team Science Project [2KT01]; National Cancer Institute (NCI) [U01-CA143062]; NCI Early Detection Research Network [U01-CA152662]; Cancer Center Support Grant (CCSG) at the H. Lee Moffitt Cancer Center and Research Institute; NCI designated Comprehensive Cancer Center [P30-CA76292]; NATIONAL CANCER INSTITUTE [U01CA143062, U01CA152662, U01CA186145, P30CA076292] Funding Source: NIH RePORTER	James & Esther King Biomedical Research Program-Team Science Project; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant (CCSG) at the H. Lee Moffitt Cancer Center and Research Institute; NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding support came from the James & Esther King Biomedical Research Program-Team Science Project (2KT01 to Dr. Gillies); the National Cancer Institute (NCI) (U01-CA143062 to Dr. Gillies) and the NCI Early Detection Research Network (U01-CA152662 to Dr. Massion). This work has also been supported in part by a Cancer Center Support Grant (CCSG) at the H. Lee Moffitt Cancer Center and Research Institute; an NCI designated Comprehensive Cancer Center (grant number P30-CA76292).	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aberle DR, 2010, JNCI-J NATL CANCER I, V102, P1771, DOI 10.1093/jnci/djq434; Carter D, 2007, LUNG CANCER, V56, P193, DOI 10.1016/j.lungcan.2006.12.001; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Hassanein M, 2012, CANCER PREV RES, V5, P992, DOI 10.1158/1940-6207.CAPR-11-0441; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Kondo R, 2011, LUNG CANCER, V74, P433, DOI 10.1016/j.lungcan.2011.05.007; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Manser R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001991.pub3; Padda SK, 2014, SEMIN ONCOL, V41, P40, DOI 10.1053/j.seminoncol.2013.12.011; Patz EF, 2016, LANCET ONCOL, V17, P590, DOI 10.1016/S1470-2045(15)00621-X; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Schabath MB, 2015, J THORAC ONCOL, V10, pS221; Veronesi G, 2013, LUNG CANCER, V82, P426, DOI 10.1016/j.lungcan.2013.08.026; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC	19	41	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159880	10.1371/journal.pone.0159880	http://dx.doi.org/10.1371/journal.pone.0159880			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509046	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400016
J	Trevisan, M; De Bortoli, SA; Vacari, AM; Laurentis, VL; Ramalho, DG				Trevisan, Maira; De Bortoli, Sergio A.; Vacari, Alessandra M.; Laurentis, Valeria L.; Ramalho, Dagmara G.			Quality of the Exotic Parasitoid Cotesia flavipes (Hymenoptera: Braconidae) Does Not Show Deleterious Effects after Inbreeding for 10 Generations	PLOS ONE			English	Article							COMPLEMENTARY SEX DETERMINATION; CAMERON HYMENOPTERA; MATING-BEHAVIOR; DIPLOID MALES; WASP; DEPRESSION; LEPIDOPTERA; POPULATION; GLOMERATA; GENETICS	Although the parasitoid Cotesia flavipes (Cameron) has proven effective in controlling sugarcane borer Diatraea saccharalis (Fabricius) for many years, concern has arisen over the quality of individuals produced at large scales. The parasitoid has been reared in laboratories in Brazil for more than 40 years, with no new introductions of new populations during that period. Since the quality of the parasitoids was not verified at the time of the species' introduction in Brazil, we do not know if there has been any reduction in quality so far. However, it is possible to determine whether the parasitoid could reduce in quality in future generations. Thus, the objective of this research was to assess the quality of these insects over 10 generations and look for evidence of any loss in quality. We used two populations: one from a biofactory that has been maintained in the laboratory for over 40 years, and an inbred laboratory population. Both were bred, and compared for 10 generations. We wanted to determine what happened to the quality of the parasitoid after 10 generations in an extreme inbreeding situation. To assure inbreeding, newly emerged females were forced to mate with a sibling. Individual females were then allowed to parasitize larvae of D. saccharalis. We performed evaluations for each generation until the tenth generation, and recorded the sex ratio, percentage emergence, number of offspring/females, and longevity of both males and females. Results of the measurements of biological characteristics demonstrated random significant differences between populations; best results were obtained intermittently for both the biofactory population and the inbred population. No significant differences across generations for the same population were observed. Thus, rearing of a C. flavipes population subjected to inbreeding for 10 generations was not sufficient to reveal any deleterious effects of inbreeding.	[Trevisan, Maira; De Bortoli, Sergio A.; Vacari, Alessandra M.; Laurentis, Valeria L.] Sao Paulo State Univ FCAV UNESP, LBIR, Dept Plant Protect, Sao Paulo, Brazil; [Ramalho, Dagmara G.] Univ Sao Paulo, Dept Biol, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo	Vacari, AM (corresponding author), Sao Paulo State Univ FCAV UNESP, LBIR, Dept Plant Protect, Sao Paulo, Brazil.	amvacari@gmail.com	Ramalho, Dagmara Gomes/L-2696-2015; De Bortoli, Sergio/E-9858-2012; Vacari, Alessandra Marieli/C-5453-2012; De Bortoli, Sergio Antonio/I-7783-2019	Ramalho, Dagmara Gomes/0000-0003-4756-1051; De Bortoli, Sergio/0000-0003-0957-6164; Vacari, Alessandra Marieli/0000-0001-7649-8288; De Bortoli, Sergio Antonio/0000-0003-0957-6164	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/25677-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, 2013/25677-3. MT was supported by a scholarship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SAS MIXED MODELS; Antolin MF, 1999, RES POPUL ECOL, V41, P29, DOI 10.1007/PL00011979; ANTOLIN MF, 1992, ECOL ENTOMOL, V17, P1, DOI 10.1111/j.1365-2311.1992.tb01032.x; ARAKAKI N, 1986, APPL ENTOMOL ZOOL, V21, P382, DOI 10.1303/aez.21.382; Bartlett A.C., 1984, ADV CHALLENGES INSEC, P2; Botelho P, 2002, CONTROLE BIOL BRASIL, P409; Botelho PSM, 1980, C INT SOC SUG CAN TE; BOTELHO PSM, 1992, PESQUI AGROPECU BRAS, V27, P255; Bueno V. H. P, 2009, CONTROLE BIOL PRAGAS, P371; BULL JJ, 1981, EVOLUTION, V35, P568, DOI 10.1111/j.1558-5646.1981.tb04918.x; Canova-Green MC, 2006, CAMBR COMPANION LIT, P1; Cassel A, 2001, CONSERV BIOL, V15, P1667, DOI 10.1046/j.1523-1739.2001.99557.x; CHARLESWORTH B, 1991, GENET RES, V57, P177, DOI 10.1017/S0016672300029256; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Conab-Companhia Nacional de Abastecimento, 2014, AC SAFR BRAS CAN DE; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Crozier R.H., 1985, P201; CROZIER RH, 1977, ANNU REV ENTOMOL, V22, P263, DOI 10.1146/annurev.en.22.010177.001403; CROZIER RH, 1971, AM NAT, V105, P399, DOI 10.1086/282733; de Boer JG, 2008, GENETICS, V180, P1525, DOI 10.1534/genetics.107.083907; de Boer JG, 2012, EVOL APPL, V5, P444, DOI 10.1111/j.1752-4571.2012.00270.x; Dinardo-Miranda LL, 2008, CANA DE ACUCAR, P349; ELAGOZE M, 1994, B ENTOMOL RES, V84, P213, DOI 10.1017/S0007485300039717; Elias J, 2010, MOL ECOL, V19, P2336, DOI 10.1111/j.1365-294X.2010.04645.x; Elias J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006024; Garcia JF, 2009, CONTROLE BIOL PRAGAS, P200; Godfray H.C.J., 1997, P211, DOI 10.1017/CBO9780511721946.013; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GRIFFITHS A. J. F., 2008, INTRO GENETICA; Gu HN, 2003, ANIM BEHAV, V66, P259, DOI 10.1006/anbe.2003.2185; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; Hernandez Dilcia, 2010, ENTOMOTROPICA, V25, P69; Joyce AL, 2010, ENTOMOL EXP APPL, V137, P153, DOI 10.1111/j.1570-7458.2010.01048.x; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAZMER DJ, 1995, ECOLOGY, V76, P412, DOI 10.2307/1941200; Lenteren van JC, 2009, CONTROLE BIOL PRAGAS, P339; Ma WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060459; MACBRIDE DH, 1946, GENETICS, V31, P224; MACKAUER M, 1972, Entomophaga, V17, P27, DOI 10.1007/BF02371071; Marconato JR, 1988, THESIS; Michel-Salzat A, 2004, SYST ENTOMOL, V29, P371, DOI 10.1111/j.0307-6970.2004.00246.x; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P705, DOI 10.1303/aez.2004.705; Niyibigira EI, 2004, APPL ENTOMOL ZOOL, V39, P717, DOI 10.1303/aez.2004.717; PETTERS RM, 1980, J HERED, V71, P353, DOI 10.1093/oxfordjournals.jhered.a109385; Pinto AS, 2006, CONTROLE BIOL PRAGAS, P65; Poirie Marylene, 1992, Seminars in Developmental Biology, V3, P357; Polanczyk RA, 2004, BIOTECHNOLOGIA CIENC, V33, P14; Polaszek A., 1991, Redia, V74, P335; Prezotti L, 2002, CONTROLE BIOL BRASIL, P295; RALLS K., 2007, ENCY BIODIVERSITY, P1; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; Riscado GM, 1982, THESIS; SMITH SG, 1971, CAN J GENET CYTOL, V13, P617, DOI 10.1139/g71-089; Snell GD, 1935, P NATL ACAD SCI USA, V21, P446, DOI 10.1073/pnas.21.7.446; STOUTHAMER R, 1992, ENVIRON ENTOMOL, V21, P427, DOI 10.1093/ee/21.3.427; TAGAWA J, 1981, APPL ENTOMOL ZOOL, V16, P345, DOI 10.1303/aez.16.345; Torvik MM, 1931, BIOL BULL-US, V61, P139, DOI 10.2307/1537009; Unica-Uniao da Agroindustria Canavieira de Sao Paulo, COL ENC SAFR 2014 20; Vacari AM, 2012, BIOL CONTROL, V63, P102, DOI 10.1016/j.biocontrol.2012.06.009; Volpe H. X. L., 2014, African Journal of Agricultural Research, V9, P436; Werren John H., 1993, P42; Whiting PW, 1943, GENETICS, V28, P365; WIEDENMANN RN, 1995, ENVIRON ENTOMOL, V24, P950, DOI 10.1093/ee/24.4.950; Zhou Y, 2007, BIOL CONTROL, V40, P273, DOI 10.1016/j.biocontrol.2006.11.002; Zhou Y, 2006, HEREDITY, V96, P487, DOI 10.1038/sj.hdy.6800829	65	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160898	10.1371/journal.pone.0160898	http://dx.doi.org/10.1371/journal.pone.0160898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509087	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400062
J	Wang, RJ; Ma, XJ; Li, YQ; He, YP; Huang, D; Cai, SJ; Peng, JJ				Wang, Renjie; Ma, Xiaoji; Li, Yaqi; He, Yiping; Huang, Dan; Cai, Sanjun; Peng, Junjie			The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma	PLOS ONE			English	Article							ADHESION MOLECULE UVOMORULIN; BETA-CATENIN; CANCER; COLON; RECTUM; SURVIVAL; INVASION	Purpose Signet ring cell carcinoma (SRCC) is rare. The aim of this study is to understand the clinicopathological features and identify the possible prognostic factors in colorectal SRCC. Methods Patients with SRCC who underwent primary lesion resection at Fudan University Shanghai Cancer Center from September 2008 to July 2014 were retrospectively analyzed. Patient's gender, age, tumor location, depth of invasion, lymph node metastasis, synchronous distant metastasis, perineural invasion, lymphovascular invasion, and E-cadherin expression were studied with prognosis, and the correlation between E-cadherin expression and clinicopathological features were analyzed. All clinicopathological and molecular factors were put into multivariate analysis using Cox proportional hazards model for detecting independent prognostic factors. Results 59 patients accounting for 0.89% of total colorectal cancer patients met the criteria and were enrolled in the study. The median survival time is 28.9 months, and the 3-year survival rate is 62.7%. SRCC were seen more common in young male patients. Advanced stage was more common in SRCC, 58 (98.3%) patients had T3/T4 lesions, 52 (88.1%) patients had lymph node metastasis, and 14 (23.7%) patients had distant metastasis. Distant metastases were seen more common in peritoneal cavity. Distant metastasis (HR = 4.194, 95% CI: 1.297-13.567), lymphovascular invasion (HR = 2.888, 95% CI: 1.115-7.483), and Ecadherin expression (HR = 0.272, 95% CI: 0.096-0.768) were independent predictors for survival. Conclusions SRCC is a rare subtype of colorectal cancer with poor prognosis. Distant metastasis, lymphovascular invasion, and E-cadherin expression can predict prognosis of colorectal SRCCs independently. More precise therapy and more close surveillance are needed for these patients.	[Wang, Renjie; Ma, Xiaoji; Li, Yaqi; Cai, Sanjun; Peng, Junjie] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China; [Wang, Renjie; Ma, Xiaoji; Li, Yaqi; He, Yiping; Huang, Dan; Cai, Sanjun; Peng, Junjie] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [He, Yiping] Fudan Univ, Shanghai Canc Ctr, Dept Endoscopy, Shanghai, Peoples R China; [Huang, Dan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Peng, JJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China.; Peng, JJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	junjiepeng67@163.com			National Natural Science Foundation of China [81101806]; Science and Technology Commission of Shanghai Municipality [134119a8602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by grants from the National Natural Science Foundation of China (No. 81101806) and Science and Technology Commission of Shanghai Municipality (No. 134119a8602).	ALMAGRO UA, 1983, CANCER, V52, P1453, DOI 10.1002/1097-0142(19831015)52:8<1453::AID-CNCR2820520819>3.0.CO;2-9; Anthony T, 1996, ANN SURG ONCOL, V3, P344, DOI 10.1007/BF02305663; Barker N, 2000, BIOESSAYS, V22, P961; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Belli S, 2014, INT SURG, V99, P691, DOI 10.9738/INTSURG-D-14-00067.1; Bittorf B, 2004, LANGENBECK ARCH SURG, V389, P178, DOI 10.1007/s00423-004-0474-y; Bosman F., 2010, WHO CLASSIFICATION T, V4th; de Leon MP, 2001, DIGEST LIVER DIS, V33, P372; Farmakovskaya M, 2016, CELL CYCLE, P0; GIACCHERO A, 1985, CANCER, V56, P2723, DOI 10.1002/1097-0142(19851201)56:11<2723::AID-CNCR2820561137>3.0.CO;2-N; Gopalan V, 2011, INT J COLORECTAL DIS, V26, P127, DOI 10.1007/s00384-010-1037-z; Hanby AM, 1996, AM J PATHOL, V148, P723; Hugen N, 2015, INT J CANCER, V136, P333, DOI 10.1002/ijc.28981; Inamura K, 2015, ANN SURG ONCOL, V22, P1226, DOI 10.1245/s10434-014-4159-7; Kang H, 2011, ANN SURG ONCOL, V18, P711, DOI 10.1245/s10434-010-1338-z; LAUFMAN H, 1951, AMA ARCH SURG, V62, P79, DOI 10.1001/archsurg.1951.01250030082009; Lee HS, 2015, INTEST RES, V13, P332, DOI 10.5217/ir.2015.13.4.332; Li C, 2007, ONCOLOGY-BASEL, V72, P64, DOI 10.1159/000111096; Li SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21713; Makino T, 2006, HEPATO-GASTROENTEROL, V53, P845; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; MESSERINI L, 1995, DIS COLON RECTUM, V38, P1189, DOI 10.1007/BF02048335; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ngan CY, 2007, J SURG ONCOL, V95, P652, DOI 10.1002/jso.20638; NIGAM AK, 1993, BRIT J CANCER, V68, P507, DOI 10.1038/bjc.1993.377; Nissan A, 1999, DIS COLON RECTUM, V42, P1176, DOI 10.1007/BF02238570; Nollet F, 1999, Mol Cell Biol Res Commun, V2, P77, DOI 10.1006/mcbr.1999.0155; Ooi BS, 2001, ANZ J SURG, V71, P703, DOI 10.1046/j.1445-1433.2001.02269.x; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pande R, 2008, DIS COLON RECTUM, V51, P50, DOI 10.1007/s10350-007-9073-7; Parnaby CN, 2015, BRIT J CANCER, V113, P212, DOI 10.1038/bjc.2015.211; Qin Y, 2016, ONCOTARGET, V7, P351, DOI 10.18632/oncotarget.5968; Roca F, 2006, J SURG ONCOL, V93, P151, DOI 10.1002/jso.20413; SECCO GB, 1994, ONCOLOGY, V51, P30; Seo KJ, 2015, INT J CLIN EXP PATHO, V8, P4148; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thota R, 2014, J GASTROINTEST ONCOL, V5, P18, DOI 10.3978/j.issn.2078-6891.2013.051; Tung SY, 1996, AM J GASTROENTEROL, V91, P2195; Zhang CD, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002190	40	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160527	10.1371/journal.pone.0160527	http://dx.doi.org/10.1371/journal.pone.0160527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509205	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400036
J	Canales-Aguirre, CB; Ferrada-Fuentes, S; Galleguillos, R; Hernandez, CE				Canales-Aguirre, Cristian B.; Ferrada-Fuentes, Sandra; Galleguillos, Ricardo; Hernandez, Cristian E.			Genetic Structure in a Small Pelagic Fish Coincides with a Marine Protected Area: Seascape Genetics in Patagonian Fjords	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; SPRAT SPRATTUS-FUEGENSIS; MULTILOCUS GENOTYPE DATA; HERRING CLUPEA-HARENGUS; BOCA DEL GUAFO; POPULATION-STRUCTURE; SOUTHERN CHILE; MAUROLICUS-MUELLERI; LANDSCAPE GENETICS; SIBSHIP INFERENCE	Marine environmental variables can play an important role in promoting population genetic differentiation in marine organisms. Although fjord ecosystems have attracted much attention due to the great oscillation of environmental variables that produce heterogeneous habitats, species inhabiting this kind of ecosystem have received less attention. In this study, we used Sprattus fuegensis, a small pelagic species that populates the inner waters of the continental shelf, channels and fjords of Chilean Patagonia and Argentina, as a model species to test whether environmental variables of fjords relate to population genetic structure. A total of 282 individuals were analyzed from Chilean Patagonia with eight microsatellite loci. Bayesian and non-Bayesian analyses were conducted to describe the genetic variability of S. fuegensis and whether it shows spatial genetic structure. Results showed two well-differentiated genetic clusters along the Chilean Patagonia distribution (i.e. inside the embayment area called TicToc, and the rest of the fjords), but no spatial isolation by distance (IBD) pattern was found with a Mantel test analysis. Temperature and nitrate were correlated to the expected heterozygosities and explained the allelic frequency variation of data in the redundancy analyses. These results suggest that the singular genetic differences found in S. fuegensis from inside TicToc Bay (East of the Corcovado Gulf) are the result of larvae retention bya combination of oceanographic mesoscale processes (i.e. the west wind drift current reaches the continental shelf exactly in this zone), and the local geographical configuration (i.e. embayment area, islands, archipelagos). We propose that these features generated an isolated area in the Patagonian fjords that promoted genetic differentiation by drift and a singular biodiversity, adding support to the existence of the largest marine protected area (MPA) of continental Chile, which is the Tic-Toc MPA.	[Canales-Aguirre, Cristian B.; Ferrada-Fuentes, Sandra; Galleguillos, Ricardo] Univ Concepcion, Fac CienciasNat & Oceanog, Lab Genet & Acuicultura, Dept Oceanog, Casilla 160-C, Concepcion, Chile; [Canales-Aguirre, Cristian B.; Ferrada-Fuentes, Sandra] Univ Concepcion, Fac CienciasNat & Oceanog, Lab Ecol Evolut & Filoinformat, Dept Zool, Casilla 160-C, Concepcion, Chile; [Canales-Aguirre, Cristian B.; Hernandez, Cristian E.] Univ Lagos, Ctr I Mar, Camino Chinquihue 6 Km, Puerto Montt, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad de Los Lagos	Canales-Aguirre, CB (corresponding author), Univ Concepcion, Fac CienciasNat & Oceanog, Lab Genet & Acuicultura, Dept Oceanog, Casilla 160-C, Concepcion, Chile.; Canales-Aguirre, CB (corresponding author), Univ Concepcion, Fac CienciasNat & Oceanog, Lab Ecol Evolut & Filoinformat, Dept Zool, Casilla 160-C, Concepcion, Chile.; Canales-Aguirre, CB (corresponding author), Univ Lagos, Ctr I Mar, Camino Chinquihue 6 Km, Puerto Montt, Chile.	cristian.canales@ulagos.cl	Hernández, Cristián E./AAS-1286-2020; Canales-Aguirre, Cristian B./G-8688-2013; Hernández, Cristián E./GLS-1111-2022; Canales-Aguirre, Cristian B./K-4034-2019	Hernández, Cristián E./0000-0002-9811-2881; Canales-Aguirre, Cristian B./0000-0002-8468-6139; Hernández, Cristián E./0000-0002-9811-2881; Canales-Aguirre, Cristian B./0000-0002-8468-6139	Doctoral Fellowships for the 'Programa de Doctorado en Sistematica y Biodiversidad', from the graduate school of the Universidad de Concepcion, Chile; CONICYT doctoral fellowship; FONDECYT [1140692, 1130807, 1130868]; Fondo de Investigacion Pesquera (FIP); Fondo Nacional de Desarrollo Cientifico y Tecnologico [3150456]	Doctoral Fellowships for the 'Programa de Doctorado en Sistematica y Biodiversidad', from the graduate school of the Universidad de Concepcion, Chile; CONICYT doctoral fellowship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Investigacion Pesquera (FIP); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	CCA and SFF were supported by Doctoral Fellowships for the 'Programa de Doctorado en Sistematica y Biodiversidad', from the graduate school of the Universidad de Concepcion, Chile. SFF was supported by a CONICYT doctoral fellowship. CEH was supported by FONDECYT #1140692, #1130807 and #1130868 (http://www.conicyt.cl/fondecyt/). This work was funded by Fondo de Investigacion Pesquera (FIP 2010-17; http://www.fip.cl/). CCA was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico, award number 3150456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful to Fernanda X. Oyarzun for comments and suggestions, which greatly improved the final version of the manuscript. We thank the editor and two anonymous reviewers for their constructive comments, which helped us to improve the manuscript. This manuscript was one the chapters of the PhD thesis of CCA. CCA and SFF were supported by Doctoral Fellowships for the 'Programa de Doctorado en Sistematica y Biodiversidad', from the graduate school of the Universidad de Concepcion, Chile. SFF was supported by a CONICYT doctoral fellowship. CEH was supported by FONDECYT. CCA, SFF, RG, CEH were supported by Fondo de Investigacion Pesquera (FIP 2010-17).	ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203; Alvarez R, 2010, CONSERVANDO MAR CHIL, P174; Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Aranis R Antonio, 2007, Gayana (Concepc.), V71, P102; Balbontin F, 2006, AVANCES CONOCIMIENTO, P115; Balbontin Fernando, 1999, Ciencia y Tecnologia del Mar, V20, P155; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Basedow SL, 2004, ESTUAR COAST SHELF S, V60, P113, DOI 10.1016/j.ecss.2003.12.004; Bernal Rolando, 2000, Ciencia y Tecnologia del Mar, V22, P143; Beuchel F, 2006, J MARINE SYST, V63, P35, DOI 10.1016/j.jmarsys.2006.05.002; Bradbury IR, 2009, J FISH BIOL, V75, P1393, DOI 10.1111/j.1095-8649.2009.02391.x; Bustos CA, 2008, REV CHIL HIST NAT, V81, P205; Bustos CA, 2007, FISH RES, V83, P23, DOI 10.1016/j.fishres.2006.08.010; Canales-Aguirre CB, 2010, FISH RES, V106, P102, DOI 10.1016/j.fishres.2010.06.010; Cardenas G, 2009, THESIS; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Castellani M, 2013, ECOL MODEL, V251, P54, DOI 10.1016/j.ecolmodel.2012.12.007; Cerna F, 2014, LAT AM J AQUAT RES, V42, P580, DOI 10.3856/vol42-issue3-fulltext-15; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coleman MA., 2013, LIMNOL OCEANOGR FLUI, V3, P295, DOI [10.1215/21573689-2409306, DOI 10.1215/21573689-2409306]; Corander J, 2003, GENETICS, V163, P367; Cousseau MB, 1982, REV INVEST DESARR PE, V3, P77; Davila PM, 2002, CONT SHELF RES, V22, P521, DOI 10.1016/S0278-4343(01)00072-3; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Ferrada Sandra, 2002, Gayana (Concepc.), V66, P243; Ferrada-Fuentes S, 2014, CONSERV GENET RESOUR; Fevolden SE, 2012, MAR ECOL PROG SER, V468, P267, DOI 10.3354/meps09990; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Galleguillos R, 1997, REV CHIL HIST NAT, V70, P351; Galleguillos R, 2012, 201017 FIP; Girard P, 2008, GENETICA, V134, P187, DOI 10.1007/s10709-007-9224-8; Glover KA, 2011, ICES J MAR SCI, V68, P2145, DOI 10.1093/icesjms/fsr153; Goodson MS, 1995, MAR BIOL, V124, P185, DOI 10.1007/BF00347122; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Guinand B, 2006, GENETICA, V127, P329, DOI 10.1007/s10709-005-5365-9; Guzman D., 2002, CIENC TECNOL MAR, V25, P45; Hansen JE, 1999, 27 INIDEP; Holtedahl H, 2006, GEOGR ANN A, V49, P188, DOI [10.1080/04353676.1967.11879749, DOI 10.1080/04353676.1967.11879749]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iriarte JL, 2007, ESTUAR COAST SHELF S, V74, P471, DOI 10.1016/j.ecss.2007.05.015; Johnson DW, 1915, SCIENCE, V41, P537, DOI 10.1126/science.41.1058.537; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jorgensen HBH, 2008, CAN J FISH AQUAT SCI, V65, P389, DOI 10.1139/F07-177; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kaartvedt S, 2009, MAR ECOL PROG SER, V390, P237, DOI 10.3354/meps08196; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kristoffersen JB, 1998, J FISH BIOL, V53, P1324, DOI 10.1111/j.1095-8649.1998.tb00252.x; Kristoffersen JB, 2009, MAR BIOL RES, V5, P596, DOI 10.1080/17451000903042479; Landaeta MF, 2012, ENVIRON BIOL FISH, V93, P73, DOI 10.1007/s10641-011-9891-2; Landaeta MF, 2011, LAT AM J AQUAT RES, V39, P236, DOI 10.3856/vol39-issue2-fulltext-5; Leal E, 2011, REV BIOL MAR OCEANOG, V46, P43, DOI 10.4067/S0718-19572011000100006; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Limborg MT, 2009, MAR ECOL PROG SER, V379, P213, DOI 10.3354/meps07889; Iriarte JL, 2010, AMBIO, V39, P463, DOI 10.1007/s13280-010-0049-9; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mariani S, 2005, MAR ECOL PROG SER, V303, P245, DOI 10.3354/meps303245; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Niklitschek E, 2009, 200705 FIP; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olsen RB, 2002, MAR ECOL PROG SER, V227, P97, DOI 10.3354/meps227097; Pantoja S, 2011, CONT SHELF RES, V31, P149, DOI 10.1016/j.csr.2010.10.013; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PEQUENO-R G, 1989, Revista de Biologia Marina, V24, P1; Pespeni MH, 2013, INTEGR COMP BIOL, V53, P857, DOI 10.1093/icb/ict094; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reusch TBH, 2014, EVOL APPL, V7, P104, DOI 10.1111/eva.12109; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rodriguez-Ramilo ST, 2012, MOL ECOL RESOUR, V12, P873, DOI 10.1111/j.1755-0998.2012.03156.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; SANCHEZ RP, 1995, FISH RES, V23, P47, DOI 10.1016/0165-7836(94)00339-X; Santure AW, 2009, GENETICS, V181, P259, DOI [10.1534/genetics.108.097998, 10.1534/genetics.108.100214]; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Semenova AV, 2014, RUSS J GENET+, V50, P175, DOI 10.1134/S1022795413120107; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Shirakova EN, 1978, BIOL SEA, V3, P78; SHIROKOVA E N, 1978, Soviet Journal of Marine Biology, V4, P697; Shulzitski K, 2016, P NATL ACAD SCI USA, V113, P6928, DOI 10.1073/pnas.1601606113; Sievers H.A., 2006, AVANCES CONOCIMIENTO, P53; Sievers H.A., 2002, REV CIENC TECNOL MAR, V25, P17; Sievers HA, 2006, PROGR OCEANOGRAPHIC, P31; Sievers HA, 2006, AVANCES CONOCIMIENTO, P31; Silva N, 2003, CIENC TECNOL MAR, V26, P5; Silva N., 1998, CIENCIA TECNOLOGIA M, V21, P17, DOI DOI 10.3856/VOL38-ISSUE1-FULLTEXT-1; SILVA N, 2008, CIENC TECNOL MAR, V31, P5; Silva N., 1997, CIENC TECNOL MAR, V20, P23; Silva N, 2010, CIENC TECNOL MAR, V33, P17; Silva N, 2006, PROGR OCEANOGRAPHIC, P37; Silva Nelson, 2006, Ciencia y Tecnologia del Mar, V29, P25; Silva S. Nelson, 2002, Ciencia y Tecnologia del Mar, V25, P23; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Storfer A, 2010, MOL ECOL, V19, P3496, DOI 10.1111/j.1365-294X.2010.04691.x; Sugaya T, 2008, FISHERIES SCI, V74, P579, DOI 10.1111/j.1444-2906.2008.01561.x; Syvitski J.P.M., 1995, DEV SEDIMENTOL, V53, P113, DOI DOI 10.1016/S0070-4571(05)80025-1; Syvitski JP, 1987, FJORDS THEIR STUDY F, P3; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; Valdenegro Alexander, 2003, Ciencia y Tecnologia del Mar, V26, P19; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Whitehead PJP, 1985, FAO SPECIES CATALOGU, V7; Wildes SL, 2010, FISH B, V109, P382; Willis K, 2006, J MARINE SYST, V61, P39, DOI 10.1016/j.jmarsys.2005.11.013; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67	118	10	10	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160670	10.1371/journal.pone.0160670	http://dx.doi.org/10.1371/journal.pone.0160670			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505009	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200054
J	Uchiyama, I; Albritton, J; Fukuyo, M; Kojima, KK; Yahara, K; Kobayashi, I				Uchiyama, Ikuo; Albritton, Jacob; Fukuyo, Masaki; Kojima, Kenji K.; Yahara, Koji; Kobayashi, Ichizo			A Novel Approach to Helicobacter pylori Pan-Genome Analysis for Identification of Genomic Islands	PLOS ONE			English	Article							BACTERIAL GENOMES; ESCHERICHIA-COLI; PLASTICITY ZONES; IN-SILICO; EVOLUTION; SEQUENCE; GENES; DNA; RESTRICTION; DIVERSITY	Genomes of a given bacterial species can show great variation in gene content and thus systematic analysis of the entire gene repertoire, termed the pan-genome, is important for understanding bacterial intra-species diversity, population genetics, and evolution. Here, we analyzed the pan-genome from 30 completely sequenced strains of the human gastric pathogen Helicobacter pylori belonging to various phylogeographic groups, focusing on 991 accessory (not fully conserved) orthologous groups (OGs). We developed a method to evaluate the mobility of genes within a genome, using the gene order in the syntenically conserved regions as a reference, and classified the 991 accessory OGs into five classes: Core, Stable, Intermediate, Mobile, and Unique. Phylogenetic networks based on the gene content of Core and Stable classes are highly congruent with that created from the concatenated alignment of fully conserved core genes, in contrast to those of Intermediate and Mobile classes, which show quite different topologies. By clustering the accessory OGs on the basis of phylogenetic pattern similarity and chromosomal proximity, we identified 60 co-occurring gene clusters (CGCs). In addition to known genomic islands, including cag pathogenicity island, bacteriophages, and integrating conjugative elements, we identified some novel ones. One island encodes TerY-phosphorylation triad, which includes the eukaryote-type protein kinase/phosphatase gene pair, and components of type VII secretion system. Another one contains a reverse-transcriptase homolog, which may be involved in the defense against phage infection through altruistic suicide. Many of the CGCs contained restriction-modification (RM) genes. Different RM systems sometimes occupied the same (orthologous) locus in the strains. We anticipate that our method will facilitate pangenome studies in general and help identify novel genomic islands in various bacterial species.	[Uchiyama, Ikuo] Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Aichi, Japan; [Albritton, Jacob; Fukuyo, Masaki; Kojima, Kenji K.; Yahara, Koji; Kobayashi, Ichizo] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo, Japan; [Fukuyo, Masaki; Kojima, Kenji K.; Yahara, Koji; Kobayashi, Ichizo] Univ Tokyo, Dept Computat Biol & Med Sci, Grad Sch Frontier Sci, Minato Ku, Tokyo, Japan; [Kojima, Kenji K.; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Kojima, Kenji K.] Genet Informat Res Inst, Los Altos, CA USA; [Yahara, Koji] Kurume Univ, Biostat Ctr, Kurume, Fukuoka, Japan; [Kobayashi, Ichizo] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Kobayashi, Ichizo] Kyorin Univ, Fac Med, Mitaka, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Tokyo; University of Tokyo; University of Tokyo; Kurume University; Tohoku University; Kyorin University	Uchiyama, I (corresponding author), Natl Inst Nat Sci, Natl Inst Basic Biol, Lab Genome Informat, Okazaki, Aichi, Japan.	uchiyama@nibb.ac.jp	Kobayashi, Ichizo/GVT-8377-2022; Kojima, Kenji/AAO-2213-2021	Uchiyama, Ikuo/0000-0002-9197-5000; Kobayashi, Ichizo/0000-0002-3854-1879	Cooperative Research Program of National Institute for Basic Biology [13-359]; National Bioscience Database Center, Japan Science Technology Agency; Japan Society for the Promotion of Science (JSPS) [25291080]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24113506, 26113704]; Global COE (Center of Excellence) Project of Genome Information Big Bang from MEXT; Bio-oriented Technology Research Advancement Institution [121205003001002100019]; Ministry of Agriculture, Forestry, and Fisheries [26025A]	Cooperative Research Program of National Institute for Basic Biology; National Bioscience Database Center, Japan Science Technology Agency; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE (Center of Excellence) Project of Genome Information Big Bang from MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bio-oriented Technology Research Advancement Institution; Ministry of Agriculture, Forestry, and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was carried out under the Cooperative Research Program of National Institute for Basic Biology [No. 13-359]. This work was supported by National Bioscience Database Center, Japan Science Technology Agency to IU, by KAKENHI from the Japan Society for the Promotion of Science (JSPS) (grant no. 25291080), by KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (grant nos. 24113506 and 26113704), by the Global COE (Center of Excellence) Project of Genome Information Big Bang from MEXT, by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry from the Bio-oriented Technology Research Advancement Institution (grant no. 121205003001002100019), and by Science and technology research promotion program for agriculture, forestry, fisheries and food industry from Ministry of Agriculture, Forestry, and Fisheries (grant no. 26025A) to IK. M.F. and K.Y. are JSPS Research Fellows. J.A. is a MIT-Japan program fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato O, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004408; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Chiapello H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-171; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Duncan SS, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00729-13; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fischer W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-310; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; Forde A, 1999, ANTON LEEUW INT J G, V76, P89, DOI 10.1023/A:1002027321171; Furuta Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004272; Furuta Y, 2011, P NATL ACAD SCI USA, V108, P1501, DOI 10.1073/pnas.1012579108; Ge RG, 2011, PROTEOMICS, V11, P1449, DOI 10.1002/pmic.201000649; Gordienko EN, 2013, J BACTERIOL, V195, P2786, DOI 10.1128/JB.02285-12; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Hudson CM, 2015, NUCLEIC ACIDS RES, V43, pD48, DOI 10.1093/nar/gku1072; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-104; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Laing C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-461; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; Langille MGI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-329; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lehours P, 2011, MBIO, V2, DOI 10.1128/mBio.00239-11; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lukjancenko O, 2010, MICROB ECOL, V60, P708, DOI 10.1007/s00248-010-9717-3; Luo CH, 2012, J VIROL, V86, P8781, DOI 10.1128/JVI.00446-12; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Nobusato A, 2000, GENE, V259, P89, DOI 10.1016/S0378-1119(00)00455-8; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Ou HY, 2007, NUCLEIC ACIDS RES, V35, pW97, DOI 10.1093/nar/gkm380; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Simon DM, 2008, NUCLEIC ACIDS RES, V36, P7219, DOI 10.1093/nar/gkn867; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Snipen L, 2010, STAND GENOMIC SCI, V2, P135, DOI 10.4056/sigs.38923; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Tekaia F, 1999, GENOME RES, V9, P550; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Uchiyama I, 2006, NUCLEIC ACIDS RES, V34, P647, DOI 10.1093/nar/gkj448; Uchiyama I, 2013, NUCLEIC ACIDS RES, V41, pD631, DOI 10.1093/nar/gks1006; Uchiyama I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-515; Uchiyama J, 2012, J VIROL, V86, P11400, DOI 10.1128/JVI.01767-12; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Wang C, 2011, NUCLEIC ACIDS RES, V39, P7620, DOI 10.1093/nar/gkr397; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Yahara K, 2013, MOL BIOL EVOL, V30, P1454, DOI 10.1093/molbev/mst055; Yahara K, 2012, GENOME BIOL EVOL, V4, P628, DOI 10.1093/gbe/evs043; Zhao YB, 2014, BIOINFORMATICS, V30, P1297, DOI 10.1093/bioinformatics/btu017; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	69	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159419	10.1371/journal.pone.0159419	http://dx.doi.org/10.1371/journal.pone.0159419			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504980	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200008
J	Wang, M; Liu, H; Zheng, J; Chen, BB; Zhou, M; Fan, WL; Wang, H; Liang, XY; Zhou, XL; Eriani, G; Jiang, PP; Guan, MX				Wang, Meng; Liu, Hao; Zheng, Jing; Chen, Bobei; Zhou, Mi; Fan, Wenlu; Wang, Hen; Liang, Xiaoyang; Zhou, Xiaolong; Eriani, Gilbert; Jiang, Pingping; Guan, Min-Xin			A Deafness- and Diabetes-associated tRNA Mutation Causes Deficient Pseudouridinylation at Position 55 in tRNA(Glu) and Mitochondrial Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WOBBLE MODIFICATION DEFICIENCY; PHENOTYPIC-EXPRESSION; NONSYNDROMIC DEAFNESS; CLINICAL-FEATURES; OXIDATIVE STRESS; LACTIC-ACIDOSIS; MESSENGER-RNA; DNA MUTATION; GENE; MTDNA	Several mitochondrial tRNA mutations have been associated with maternally inherited diabetes and deafness. However, the pathophysiology of these tRNA mutations remains poorly understood. In this report, we identified the novel homoplasmic 14692A -> G mutation in the mitochondrial tRNA(Glu) gene among three Han Chinese families with maternally inherited diabetes and deafness. The m.14692A -> G mutation affected a highly conserved uridine at position 55 of the T Psi C loop of tRNA(Glu). The uridine is modified to pseudouridine (Psi 55), which plays an important role in the structure and function of this tRNA. Using lymphoblastoid cell lines derived from a Chinese family, we demonstrated that the m.14692A -> G mutation caused loss of Psi 55 modification and increased angiogenin-mediated endonucleolytic cleavage in mutant tRNA(Glu). The destabilization of base-pairing (18A-Psi 55) caused by the m.14692A -> G mutation perturbed the conformation and stability of tRNA(Glu). An approximately 65% decrease in the steady-state level of tRNA(Glu) was observed in mutant cells compared with control cells. A failure in tRNA(Glu) metabolism impaired mitochondrial translation, especially for polypeptides with a high proportion of glutamic acid codons such as ND1, ND6, and CO2 in mutant cells. An impairment of mitochondrial translation caused defective respiratory capacity, especially reducing the activities of complexes I and IV. Furthermore, marked decreases in the levels of mitochondrial ATP and membrane potential were observed in mutant cells. These mitochondrial dysfunctions caused an increasing production of reactive oxygen species in the mutant cells. Our findings may provide new insights into the pathophysiology of maternally inherited diabetes and deafness, which is primarily manifested by the deficient nucleotide modification of mitochondrial tRNA(Glu).	[Wang, Meng; Zheng, Jing; Zhou, Mi; Liang, Xiaoyang; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Sch Med, Childrens Hosp, Div Clin Genet & Genom, Hangzhou 310001, Zhejiang, Peoples R China; [Wang, Meng; Liu, Hao; Zheng, Jing; Zhou, Mi; Liang, Xiaoyang; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310001, Zhejiang, Peoples R China; [Wang, Meng; Liu, Hao; Zheng, Jing; Zhou, Mi; Liang, Xiaoyang; Jiang, Pingping; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Joining Inst Genet & Genom Med Zhejiang Univ & Un, Hangzhou 310058, Zhejiang, Peoples R China; [Chen, Bobei] Wenzhou Med Univ, Affiliated Hosp 2, Dept Otolaryngol, Wenzhou 325035, Zhejiang, Peoples R China; [Chen, Bobei; Fan, Wenlu; Wang, Hen] Wenzhou Med Univ, Sch Life Sci, Attardi Inst Mitochondrial Biomed, Wenzhou 325035, Zhejiang, Peoples R China; [Zhou, Xiaolong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, 15 Rue Rene Descartes, F-67084 Strasbourg, France	Zhejiang University; Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Div Clin Genet & Genom, Hangzhou 310001, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Sch Med, Dept Genet, Hangzhou 310001, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Joining Inst Genet & Genom Med Zhejiang Univ & Un, Hangzhou 310058, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn		Guan, Min-Xin/0000-0001-5067-6736; Eriani, Gilbert/0000-0002-8518-4675	National Basic Research Priorities Program of China [2014CB541700]; Chinese National Natural Science Foundation [81330024, 81500611]; Fundamental Research Funds for the Central Universities [2016QNA7022]	National Basic Research Priorities Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Basic Research Priorities Program of China Grant 2014CB541700 and Chinese National Natural Science Foundation Grants 81330024 (to M. X. G.) and 81500611 (to M. W.), and Fundamental Research Funds for the Central Universities Grant 2016QNA7022 (to M. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Allner O, 2011, RNA, V17, P2177, DOI 10.1261/rna.029231.111; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; Becker HF, 1997, NUCLEIC ACIDS RES, V25, P4493, DOI 10.1093/nar/25.22.4493; Bykhovskaya Y, 1998, AM J MED GENET, V77, P421, DOI 10.1002/(SICI)1096-8628(19980605)77:5<421::AID-AJMG13>3.0.CO;2-K; Chen C, 2015, PROTEIN CELL, V6, P862, DOI 10.1007/s13238-015-0175-z; Chen DN, 2016, INT J BIOCHEM CELL B, V77, P1, DOI 10.1016/j.biocel.2016.05.012; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Craven L, 2011, HUM MOL GENET, V20, pR168, DOI 10.1093/hmg/ddr373; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Guan MX, 2004, ANN NY ACAD SCI, V1011, P259, DOI 10.1196/annals.1293.025; Guillausseau PJ, 2001, ANN INTERN MED, V134, P721, DOI 10.7326/0003-4819-134-9_Part_1-200105010-00008; Hao R, 2004, FEBS LETT, V578, P135, DOI 10.1016/j.febslet.2004.11.004; Hayashi G, 2015, FREE RADICAL BIO MED, V88, P10, DOI 10.1016/j.freeradbiomed.2015.05.039; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; James AM, 1999, EUR J BIOCHEM, V259, P462, DOI 10.1046/j.1432-1327.1999.00066.x; Jia ZD, 2013, HUM MOL GENET, V22, P4064, DOI 10.1093/hmg/ddt256; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; KING MP, 1993, J BIOL CHEM, V268, P10228; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Li RH, 2010, MOL CELL BIOL, V30, P2147, DOI 10.1128/MCB.01614-09; Li XM, 2004, NUCLEIC ACIDS RES, V32, P867, DOI 10.1093/nar/gkh226; Li YF, 2007, J BIOL CHEM, V282, P17557, DOI 10.1074/jbc.M701056200; Liu H, 2015, MITOCHONDRION, V21, P49, DOI 10.1016/j.mito.2015.01.004; Lu JX, 2006, BIOCHEM BIOPH RES CO, V348, P115, DOI 10.1016/j.bbrc.2006.07.010; Lu JX, 2010, MITOCHONDRION, V10, P69, DOI 10.1016/j.mito.2009.09.007; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Martinez-Zamora A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144273; MASUCCI JP, 1995, MOL CELL BIOL, V15, P2872; Mezghani N, 2010, J DIABETES COMPLICAT, V24, P270, DOI 10.1016/j.jdiacomp.2009.11.002; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Morton CC, 2002, HUM MOL GENET, V11, P1229, DOI 10.1093/hmg/11.10.1229; Murphy R, 2008, DIABETIC MED, V25, P383, DOI 10.1111/j.1464-5491.2008.02359.x; Negrier MLM, 1998, AM J HUM GENET, V63, P1227, DOI 10.1086/302045; ODAWARA M, 1995, J CLIN ENDOCR METAB, V80, P1290, DOI 10.1210/jc.80.4.1290; Ofengand J, 2001, METHODS, V25, P365, DOI 10.1006/meth.2001.1249; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Picard M, 2014, P NATL ACAD SCI USA, V111, pE4033, DOI 10.1073/pnas.1414028111; PUGLISI JD, 1989, METHOD ENZYMOL, V180, P304; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Roovers M, 2006, NUCLEIC ACIDS RES, V34, P4293, DOI 10.1093/nar/gkl530; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki Y, 1997, DIABETES CARE, V20, P1138, DOI 10.2337/diacare.20.7.1138; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Tang XW, 2015, MITOCHONDRION, V23, P17, DOI 10.1016/j.mito.2015.05.001; THOMAS F, 1994, DIABETES, V43, P63, DOI 10.2337/diabetes.43.1.63; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Wang XP, 2008, IEEE/SOLI'2008: PROCEEDINGS OF 2008 IEEE INTERNATIONAL CONFERENCE ON SERVICE OPERATIONS AND LOGISTICS, AND INFORMATICS, VOLS 1 AND 2, P1059, DOI 10.1109/SOLI.2008.4686555; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yan XK, 2011, J MED GENET, V48, P682, DOI 10.1136/jmedgenet-2011-100219; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Zhang JJ, 2014, MITOCHONDRION, V18, P18, DOI 10.1016/j.mito.2014.08.008; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133; Zheng J, 2012, MITOCHONDRION, V12, P406, DOI 10.1016/j.mito.2012.04.001	80	46	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21029	+		10.1074/jbc.M116.739482	http://dx.doi.org/10.1074/jbc.M116.739482			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27519417	Green Published, hybrid			2022-12-26	WOS:000385406200019
J	Chan, MC; Ilott, NE; Schodel, J; Sims, D; Tumber, A; Lippl, K; Mole, DR; Pugh, CW; Ratcliffe, PJ; Ponting, CP; Schofield, CJ				Chan, Mun Chiang; Ilott, Nicholas E.; Schoedel, Johannes; Sims, David; Tumber, Anthony; Lippl, Kerstin; Mole, David R.; Pugh, Christopher W.; Ratcliffe, Peter J.; Ponting, Chris P.; Schofield, Christopher J.			Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythropoiesis; hydroxylase; hypoxia; hypoxia-inducible factor (HIF); inhibitor; 2-oxoglutarate and ferrous iron dioxygenase; anaemia; metallo-enzyme inhibitor; oxygen sensing; transcriptional regulation	STRUCTURAL BASIS; HISTONE DEMETHYLASES; FACTOR (HIF)-1-ALPHA; FACTOR-ALPHA; TRANSACTIVATION DOMAIN; ROXADUSTAT FG-4592; GENE-EXPRESSION; OXYGEN SENSOR; BINDING SITES; TARGET GENES	The hypoxia-inducible factor (HIF) system orchestrates cellular responses to hypoxia in animals. HIF is an /-heterodimeric transcription factor that regulates the expression of hundreds of genes in a tissue context-dependent manner. The major hypoxia-sensing component of the HIF system involves oxygen-dependent catalysis by the HIF hydroxylases; in humans there are three HIF prolyl hydroxylases (PHD1-3) and an asparaginyl hydroxylase (factor-inhibiting HIF (FIH)). PHD catalysis regulates HIF levels, and FIH catalysis regulates HIF activity. How differences in HIF hydroxylation status relate to variations in the induction of specific HIF target gene transcription is unknown. We report studies using small molecule HIF hydroxylase inhibitors that investigate the extent to which HIF target gene expression is induced by PHD or FIH inhibition. The results reveal substantial differences in the role of prolyl and asparaginyl hydroxylation in regulating hypoxia-responsive genes in cells. PHD inhibitors with different structural scaffolds behave similarly. Under the tested conditions, a broad-spectrum 2-oxoglutarate dioxygenase inhibitor is a better mimic of the overall transcriptional response to hypoxia than the selective PHD inhibitors, consistent with an important role for FIH in the hypoxic transcriptional response. Indeed, combined application of selective PHD and FIH inhibitors resulted in the transcriptional induction of a subset of genes not fully responsive to PHD inhibition alone. Thus, for the therapeutic regulation of HIF target genes, it is important to consider both PHD and FIH activity, and in the case of some sets of target genes, simultaneous inhibition of the PHDs and FIH catalysis may be preferable.	[Chan, Mun Chiang; Lippl, Kerstin; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Chan, Mun Chiang; Schoedel, Johannes; Mole, David R.; Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX3 7BN, England; [Ilott, Nicholas E.; Sims, David; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Computat Genom Anal & Training Programme, South Parks Rd, Oxford OX1 3PT, England; [Tumber, Anthony] Univ Oxford, Target Discovery Inst, Oxford OX3 7FZ, England; [Ilott, Nicholas E.] Univ Oxford, Kennedy Inst Rheumatol, Roosevelt Dr, Headington OX3 7FY, England; [Schoedel, Johannes] Univ Erlangen Nurnberg, Dept Hypertens & Nephrol, Ulmenweg 18, D-91054 Erlangen, Germany; [Ponting, Chris P.] Univ Edinburgh, Western Gen Hosp, MRC Inst Genet & Mol Med, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Erlangen Nuremberg; University of Edinburgh	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	Ponting, Chris/AAV-2621-2021; Chan, Mun Chiang/T-4867-2019	Chan, Mun Chiang/0000-0002-3162-6036; Schofield, Christopher/0000-0002-0290-6565; Ilott, Nicholas/0000-0002-8432-8622; Ratcliffe, Peter/0000-0002-2853-806X; Pugh, Chris/0000-0002-5170-1662; Schodel, Johannes/0000-0002-3587-8839; Mole, David/0000-0002-0984-300X	Wellcome Trust [090532/Z/09/Z]; MRC Hub Grant [G0900747 91070]; BBSRC [BB/D011523/1, BB/J003018/1] Funding Source: UKRI; MRC [MC_EX_UU_G1000902, MC_UU_12021/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011523/1, BB/J003018/1] Funding Source: researchfish; British Heart Foundation [RG/11/1/28684, PG/12/33/29546] Funding Source: researchfish; Cancer Research UK [18245, 16466, 16016] Funding Source: researchfish; Medical Research Council [MC_UU_12021/1, MC_EX_UU_G1000902] Funding Source: researchfish; National Institute for Health Research [RP-2015-06-004] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Hub Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank the High-Throughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust Grant 090532/Z/09/Z and MRC Hub Grant G0900747 91070) for the generation of the Gene Expression and sequencing data.	Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bagnall J, 2014, J BIOL CHEM, V289, P5549, DOI 10.1074/jbc.M113.500405; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Besarab A, 2016, J AM SOC NEPHROL, V27, P1225, DOI 10.1681/ASN.2015030241; Besarab A, 2015, NEPHROL DIAL TRANSPL, V30, P1665, DOI 10.1093/ndt/gfv302; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Chan MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132004; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Holdstock L, 2016, J AM SOC NEPHROL, V27, P1234, DOI 10.1681/ASN.2014111139; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Ruas JL, 2010, J BIOL CHEM, V285, P2601, DOI 10.1074/jbc.M109.021824; Sanchez-Fernandez EM, 2013, BIOCHEM J, V449, P491, DOI 10.1042/BJ20121155; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sims D, 2014, BIOINFORMATICS, V30, P1290, DOI 10.1093/bioinformatics/btt756; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; Tegley CM, 2008, BIOORG MED CHEM LETT, V18, P3925, DOI 10.1016/j.bmcl.2008.06.031; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Williams ST, 2014, EPIGENETICS-US, V9, P1596, DOI 10.4161/15592294.2014.983381; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106	63	63	65	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20661	20673		10.1074/jbc.M116.749291	http://dx.doi.org/10.1074/jbc.M116.749291			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27502280	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000384574800029
J	Lee, JH; Han, JS; Kong, J; Ji, Y; Lv, XC; Lee, J; Li, P; Kim, JB				Lee, Jung Hyun; Han, Ji Seul; Kong, Jinuk; Ji, Yul; Lv, Xuchao; Lee, Junho; Li, Peng; Kim, Jae Bum			Protein Kinase A Subunit Balance Regulates Lipid Metabolism in Caenorhabditis elegans and Mammalian Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose triglyceride lipase (ATGL); lipid droplet; lipolysis; protein kinase A (PKA); stoichiometry	ADIPOSE TRIGLYCERIDE LIPASE; NF-KAPPA-B; RII-BETA-SUBUNIT; INSULIN-INDUCED PHOSPHORYLATION; CYCLIC ADENINE RIBONUCLEOTIDE; CHANARIN-DORFMAN-SYNDROME; FAT-SPECIFIC PROTEIN-27; CATALYTIC SUBUNIT; C. ELEGANS; 3T3-L1 ADIPOCYTES	Protein kinase A (PKA) is a cyclic AMP (cAMP)-dependent protein kinase composed of catalytic and regulatory subunits and involved in various physiological phenomena, including lipid metabolism. Here we demonstrated that the stoichiometric balance between catalytic and regulatory subunits is crucial for maintaining basal PKA activity and lipid homeostasis. To uncover the potential roles of each PKA subunit, Caenorhabditis elegans was used to investigate the effects of PKA subunit deficiency. In worms, suppression of PKA via RNAi resulted in severe phenotypes, including shortened life span, decreased egg laying, reduced locomotion, and altered lipid distribution. Similarly, in mammalian adipocytes, suppression of PKA regulatory subunits RI and RII via siRNAs potently stimulated PKA activity, leading to potentiated lipolysis without increasing cAMP levels. Nevertheless, insulin exerted anti-lipolytic effects and restored lipid droplet integrity by antagonizing PKA action. Together, these data implicate the importance of subunit stoichiometry as another regulatory mechanism of PKA activity and lipid metabolism.	[Lee, Jung Hyun; Han, Ji Seul; Kong, Jinuk; Ji, Yul; Lee, Junho; Kim, Jae Bum] Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, 1 Gwanak Ro, Seoul 08862, South Korea; [Lv, Xuchao; Li, Peng] Tsinghua Univ, MOE Key Lab Bioinformat, Sch Life Sci, Beijing 100084, Peoples R China; [Lv, Xuchao; Li, Peng] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Lee, Junho] Seoul Natl Univ, Dept Biophys & Chem Biol, Seoul 08862, South Korea	Seoul National University (SNU); Tsinghua University; Tsinghua University; Seoul National University (SNU)	Kim, JB (corresponding author), Seoul Natl Univ, Inst Mol Biol & Genet, Dept Biol Sci, 1 Gwanak Ro, Seoul 08862, South Korea.	jaebkim@snu.ac.kr	Lee, Junho/AAO-4706-2021; Song, Minsun/I-5701-2015	KIM, Jae Bum/0000-0003-2337-6935	National Research Foundation of Korea - South Korean government [MSIP 2011-0018312]	National Research Foundation of Korea - South Korean government	This work was supported by National Research Foundation of Korea Grant MSIP 2011-0018312 funded by the South Korean government. The authors declare that they have no conflicts of interest with the contents of this article.	Ackerman D, 2012, BIOESSAYS, V34, P466, DOI 10.1002/bies.201100189; Almahariq M, 2014, TRENDS ENDOCRIN MET, V25, P60, DOI 10.1016/j.tem.2013.10.004; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Asterholm Ingrid Wernstedt, 2007, Drug Discov Today Dis Models, V4, P17; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; BERTHET J, 1957, J BIOL CHEM, V229, P351; BROSTROM CO, 1971, P NATL ACAD SCI USA, V68, P2444, DOI 10.1073/pnas.68.10.2444; BUILDER SE, 1980, J BIOL CHEM, V255, P3514; C. elegans Deletion Mutant Consortium, 2012, LARG SCAL SCREEN TAR, VG3, P1415; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; CORBIN JD, 1978, J BIOL CHEM, V253, P3997; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; DiPilato LM, 2015, MOL CELL BIOL, V35, P2752, DOI 10.1128/MCB.00422-15; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Elle IC, 2010, FEBS LETT, V584, P2183, DOI 10.1016/j.febslet.2010.03.046; Faux MC, 1996, CELL, V85, P9, DOI 10.1016/S0092-8674(00)81075-2; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; Gao XJ, 2008, GENOMICS, V92, P457, DOI 10.1016/j.ygeno.2008.08.013; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GRANOT J, 1980, J BIOL CHEM, V255, P4569; GRANOT J, 1980, ARCH BIOCHEM BIOPHYS, V205, P1, DOI 10.1016/0003-9861(80)90078-8; GROSS RE, 1990, J BIOL CHEM, V265, P6896; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hegele RA, 2007, J LIPID RES, V48, P1433, DOI 10.1194/jlr.R700004-JLR200; HOFMANN F, 1980, J BIOL CHEM, V255, P1559; HOFMANN F, 1977, J BIOL CHEM, V252, P1441; JIANG H, 1992, BIOCHEM CELL BIOL, V70, P1283, DOI 10.1139/o92-175; Jo H, 2009, CELL METAB, V9, P440, DOI 10.1016/j.cmet.2009.04.004; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kim S, 2012, GENETICS, V192, P905, DOI 10.1534/genetics.112.143271; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; KREBS EG, 1959, J BIOL CHEM, V234, P2867; KUMON A, 1970, BIOCHEM BIOPH RES CO, V41, P1290, DOI 10.1016/0006-291X(70)90228-7; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee JH, 2014, MOL CELL BIOL, V34, P4165, DOI 10.1128/MCB.00722-14; LONDOS C, 1985, J BIOL CHEM, V260, P5139; LU XY, 1990, J BIOL CHEM, V265, P3293; Mantovani G, 2009, DIABETES, V58, P620, DOI 10.2337/db08-0585; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Nian ZQ, 2010, J BIOL CHEM, V285, P9604, DOI 10.1074/jbc.M109.043786; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Planas JV, 1999, J BIOL CHEM, V274, P36281, DOI 10.1074/jbc.274.51.36281; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; RALL TW, 1958, J BIOL CHEM, V232, P1065; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; REIMANN EM, 1971, BIOCHEM BIOPH RES CO, V42, P187, DOI 10.1016/0006-291X(71)90086-6; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Schreyer SA, 2001, DIABETES, V50, P2555, DOI 10.2337/diabetes.50.11.2555; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Soberg K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060935; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Steinbaugh MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07836; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TAO M, 1970, P NATL ACAD SCI USA, V67, P408, DOI 10.1073/pnas.67.1.408; Terauchi Y, 1999, NAT GENET, V21, P230, DOI 10.1038/6023; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vrablik TL, 2013, MOL REPROD DEV, V80, P244, DOI 10.1002/mrd.22167; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Yu JH, 1998, J BIOL CHEM, V273, P30199, DOI 10.1074/jbc.273.46.30199; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zmuda-Trzebiatowska E, 2006, CELL SIGNAL, V18, P382, DOI 10.1016/j.cellsig.2005.05.007; Zmuda-Trzebiatowska E, 2007, CELL SIGNAL, V19, P81, DOI 10.1016/j.cellsig.2006.05.024	91	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20315	20328		10.1074/jbc.M116.740464	http://dx.doi.org/10.1074/jbc.M116.740464			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496951	hybrid, Green Published			2022-12-26	WOS:000384574800004
J	McCormick, SM; Gowda, N; Fang, JX; Heller, NM				McCormick, Sarah M.; Gowda, Nagaraj; Fang, Jessie X.; Heller, Nicola M.			Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allergy; asthma; macrophage; monocyte; phosphotyrosine signaling; signal transduction; insulin receptor substrate 2; interleukin-4; suppressor of cytokine signaling 1; ubiquination	TARGET GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; SOCS BOX; ALVEOLAR MACROPHAGES; ADIPOSE-TISSUE; SH2 DOMAINS; IN-VITRO; ACTIVATION; INHIBITION; PROTEINS	Allergic asthma is a chronic lung disease initiated and driven by Th2 cytokines IL-4/-13. In macrophages, IL-4/-13 bind IL-4 receptors, which signal through insulin receptor substrate (IRS)-2, inducing M2 macrophage differentiation. M2 macrophages correlate with disease severity and poor lung function, although the mechanisms that regulate M2 polarization are not understood. Following IL-4 exposure, suppressor of cytokine signaling (SOCS)1 is highly induced in human monocytes. We found that siRNA knockdown of SOCS1 prolonged IRS-2 tyrosine phosphorylation and enhanced M2 differentiation, although siRNA knockdown of SOCS3 did not affect either. By co-immunoprecipitation, we found that SOCS1 complexes with IRS-2 at baseline, and this association increased after IL-4 stimulation. Because SOCS1 is an E3 ubiquitin ligase, we examined the effect of proteasome inhibitors on IL-4-induced IRS-2 phosphorylation. Proteasomal inhibition prolonged IRS-2 tyrosine phosphorylation, increased ubiquitination of IRS-2, and enhanced M2 gene expression. siRNA knockdown of SOCS1 inhibited ubiquitin accumulation on IRS-2, although siRNA knockdown of SOCS3 had no effect on ubiquitination of IRS-2. Monocytes from healthy and allergic individuals revealed that SOCS1 is induced by IL-4 in healthy monocytes but not allergic cells, whereas SOCS3 is highly induced in allergic monocytes. Healthy monocytes displayed greater ubiquitination of IRS-2 and lower M2 polarization than allergic monocytes in response to IL-4 stimulation. Here, we identify SOCS1 as a key negative regulator of IL-4-induced IRS-2 signaling and M2 differentiation. Our findings provide novel insight into how dysregulated expression of SOCS increases IL-4 responses in allergic monocytes, and this may represent a new therapeutic avenue for managing allergic disease.	[McCormick, Sarah M.; Gowda, Nagaraj; Fang, Jessie X.; Heller, Nicola M.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Ross 367,720 Rutland Ave, Baltimore, MD 21205 USA; [Heller, Nicola M.] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Heller, NM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Ross 367,720 Rutland Ave, Baltimore, MD 21205 USA.	nheller@jhmi.edu			National Institutes of Health [K99/R00 HL096897]; Canadian Institute of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL096897, K99HL096897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant K99/R00 HL096897. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a fellowship award from the Canadian Institute of Health Research.	Arnold CE, 2014, IMMUNOLOGY, V141, P96, DOI 10.1111/imm.12173; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Berard JL, 2010, GLIA, V58, P434, DOI 10.1002/glia.20935; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Bruun C, 2009, MOL CELL ENDOCRINOL, V311, P32, DOI 10.1016/j.mce.2009.07.019; Chung CS, 2007, APOPTOSIS, V12, P1143, DOI 10.1007/s10495-007-0059-7; Cuesta N, 2003, J IMMUNOL, V170, P5739, DOI 10.4049/jimmunol.170.11.5739; DAVID M, 1993, MOL CELL BIOL, V13, P7515, DOI 10.1128/MCB.13.12.7515; De Boever EH, 2014, J ALLERGY CLIN IMMUN, V133, P989, DOI 10.1016/j.jaci.2014.01.002; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Doran E, 2016, EUR RESPIR J, V48, P715, DOI 10.1183/13993003.00400-2015; Draijer C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/632049; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Fujimoto M, 2004, INT IMMUNOL, V16, P303, DOI 10.1093/intimm/dxh030; Fukushima T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7780; Fukuyama S, 2009, AM J RESP CRIT CARE, V179, P992, DOI 10.1164/rccm.200806-992OC; Gielen V, 2015, J ALLERGY CLIN IMMUN, V136, P177, DOI 10.1016/j.jaci.2014.11.039; Gordon P, 2016, J LEUKOCYTE BIOL, V100, P771, DOI 10.1189/jlb.3A1215-554RR; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Haffner MC, 2008, J BIOL CHEM, V283, P22089, DOI 10.1074/jbc.M801041200; Hambly N, 2014, CURR OPIN PULM MED, V20, P87, DOI 10.1097/MCP.0000000000000007; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Harada M, 2007, AM J RESP CELL MOL, V36, P491, DOI 10.1165/rcmb.2006-0090OC; Heller N, 2012, J IMMUNOL, V188; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Holgate ST, 2010, CLIN SCI, V118, P439, DOI 10.1042/CS20090474; Holt PG, 1999, NATURE, V402, pB12; Horiuchi Y, 2006, ARCH DERMATOL RES, V298, P163, DOI 10.1007/s00403-006-0674-0; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Jager LD, 2011, J NEUROIMMUNOL, V232, P108, DOI 10.1016/j.jneuroim.2010.10.018; Jiang YD, 2014, MOL VIS, V20, P1463; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Kau AL, 2014, CURR OPIN ALLERGY CL, V14, P570, DOI 10.1097/ACI.0000000000000108; Kelly EAB, 2003, J ALLERGY CLIN IMMUN, V111, P79, DOI 10.1067/mai.2003.28; Kelly-Welch AE, 2004, J IMMUNOL, V172, P4545, DOI 10.4049/jimmunol.172.7.4545; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kim TH, 2012, INT ARCH ALLERGY IMM, V158, P387, DOI 10.1159/000333103; Knosp CA, 2012, IMMUNOLOGY, V135, P101, DOI 10.1111/j.1365-2567.2011.03520.x; Kubo M, 2013, EUR J IMMUNOL, V43, P1702, DOI 10.1002/eji.201343748; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Leikfoss IS, 2013, GENES IMMUN, V14, P62, DOI 10.1038/gene.2012.52; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liang Y, 2014, EUR J IMMUNOL, V44, P1265, DOI 10.1002/eji.201344369; Linossi EM, 2013, CYTOKINE GROWTH F R, V24, P241, DOI 10.1016/j.cytogfr.2013.03.005; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu Y, 2008, J IMMUNOL, V180, P6270, DOI 10.4049/jimmunol.180.9.6270; Lopez E, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/917015; Madonna S, 2010, J IMMUNOL, V185, P2467, DOI 10.4049/jimmunol.1001426; McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Mostecki J, 2011, J IMMUNOL, V187, P2794, DOI 10.4049/jimmunol.0902569; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Prasse A, 2007, J ALLERGY CLIN IMMUN, V119, P464, DOI 10.1016/j.jaci.2006.09.030; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Recio C, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0458-1; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Sedeno-Monge V, 2014, J NEUROIMMUNOL, V273, P117, DOI 10.1016/j.jneuroim.2014.05.013; Seki Y, 2003, NAT MED, V9, P1047, DOI 10.1038/nm896; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Sheikh F, 2015, J INNATE IMMUN, V7, P494, DOI 10.1159/000376579; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; Stark JL, 2006, INT IMMUNOL, V18, P347, DOI 10.1093/intimm/dxh373; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Tamiya T, 2011, ARTERIOSCL THROM VAS, V31, P980, DOI 10.1161/ATVBAHA.110.207464; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Vandenbroeck K, 2012, GENES IMMUN, V13, P21, DOI 10.1038/gene.2011.44; Venieratos PD, 2010, CELL SIGNAL, V22, P791, DOI 10.1016/j.cellsig.2010.01.003; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Viksman MY, 2002, CLIN IMMUNOL, V104, P77, DOI 10.1006/clim.2002.5233; Wakioka T, 1999, LEUKEMIA, V13, P760, DOI 10.1038/sj.leu.2401397; Walsh GM, 2013, IMMUNOTHERAPY-UK, V5, P1255, DOI [10.2217/IMT.13.118, 10.2217/imt.13.118]; Watanabe H, 2006, J IMMUNOL, V177, P8650, DOI 10.4049/jimmunol.177.12.8650; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wilson HM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00357; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yokouchi M, 1997, ONCOGENE, V15, P7, DOI 10.1038/sj.onc.1201163; Zhang J., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1109/ICNP.2013.6733609; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303; Zhu JG, 2013, MOL CELL BIOCHEM, V381, P51, DOI 10.1007/s11010-013-1687-6	101	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20574	20587		10.1074/jbc.M116.746164	http://dx.doi.org/10.1074/jbc.M116.746164			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27507812	Green Published, hybrid			2022-12-26	WOS:000384574800023
J	Ng, TH; Tan, SK; Wong, WH; Meier, R; Chan, SY; Tan, HH; Yeo, DCJ				Ng, Ting Hui; Tan, Siong Kiat; Wong, Wing Hing; Meier, Rudolf; Chan, Sow-Yan; Tan, Heok Hui; Yeo, Darren C. J.			Molluscs for Sale: Assessment of Freshwater Gastropods and Bivalves in the Ornamental Pet Trade	PLOS ONE			English	Article							NONNATIVE APPLE SNAILS; MALILI LAKE SYSTEM; OXIDASE SUBUNIT-I; AQUARIUM TRADE; MUSSELS MOLLUSCA; GLOBAL DIVERSITY; DNA; FISH; TAXONOMY; CERITHIOIDEA	The ornamental pet trade is often considered a key culprit for conservation problems such as the introduction of invasive species (including infectious diseases) and overharvesting of rare species. Here, we present the first assessment of the biodiversity of freshwater molluscs in the ornamental pet trade in Singapore, one of the most important global hubs of the ornamental aquarium trade, and discuss associated conservation concerns. We recorded freshwater molluscs from ornamental pet shops and major exporters including non-ornamental species (e.g., hitchhikers, molluscs sold as fish feed). We recorded an unexpectedly high diversity-59 species-of freshwater bivalves and gastropods, with the majority (38 species or 64%) being from the Oriental region. In addition to morphological examination, we sequenced the DNA barcode region of mitochondrial CO1 and 16S genes to provide molecular data for the confirmation of the identification and for future re-identification. DNA barcodes were obtained for 50 species, and all but four were separated by > 3% uncorrected pairwise distances. The trade has been considered a main introduction pathway for non-native species to Singapore, and we found that out of 15 species in the trade as well as in the wild in Singapore, 12 are either introduced or of unknown origin, representing almost half of the known non-native freshwater molluscs in Singapore. Particularly prevalent are non-ornamental species: six hitchhikers on aquarium plants and six species sold as fish feed. We found that a quarter of the trade species have a history of introduction, which includes 11 known or potentially invasive species. We conclude that potential overharvesting is difficult to assess because only half of the trade species have been treated by IUCN. Of these, 21 species are of Least Concern and three are Data Deficient. Our checklist, with accompanying DNA barcodes, images, and museum vouchers, provides an important reference library for future monitoring, and constitutes a step toward creating a more sustainable ornamental pet trade.	[Ng, Ting Hui; Meier, Rudolf; Yeo, Darren C. J.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Tan, Siong Kiat; Meier, Rudolf; Tan, Heok Hui] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore; [Wong, Wing Hing] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Chan, Sow-Yan] VBox 888313, Singapore, Singapore	National University of Singapore; National University of Singapore; Washington University (WUSTL)	Ng, TH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	ng.tinghui@u.nus.edu	Ng, Ting Hui/E-8339-2011; Yeo, Darren CJ/H-9790-2012; Wong, Hing/J-2307-2019; Meier, Rudolf/A-7099-2011; Meier, Rudolf/AAB-3848-2021	Ng, Ting Hui/0000-0002-5123-0039; Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Wong, Wing Hing/0000-0003-2494-1721	Department of Biological Sciences of the National University of Singapore; Singapore National Research Foundation; Economic Development Board, SPORE [COY-15-EWI-RCFSA/N197-1]; Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore [R-154-000-617-720]	Department of Biological Sciences of the National University of Singapore(National University of Singapore); Singapore National Research Foundation(National Research Foundation, Singapore); Economic Development Board, SPORE(Singapore Economic Development Board); Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore(National University of Singapore)	The authors acknowledge financial support from the Department of Biological Sciences of the National University of Singapore, the Singapore National Research Foundation and the Economic Development Board, SPORE, COY-15-EWI-RCFSA/N197-1, http://www.nrf.gov.sg/, THN; and Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore grant number R-154-000-617-720, http://www.wrscf.org.sg/index.html, to DCJY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank colleagues and friends, particularly: Kelvin KP Lim for assistance in obtaining molluscs from the trade and providing important references; Swee Hee Tan for first suggesting the idea for an earlier version of this study; Thomas Eichhorst, Matthias Glaubrecht, Frank Kohler, and Thomas von Rintelen for help in species identifications; Kenneth Hayes and Ravindra C Joshi for photographs and information of Pomacea maculata; Wendy Y Wang, Darren Yeo and other members of the Evolutionary Biology Laboratory, members of the Freshwater and Invasion Biology Laboratory, and Amanda Windsor of the Smithsonian Institution, for assistance in various aspects of the molecular work and data collection process. We acknowledge financial support from the Department of Biological Sciences of the National University of Singapore, the Singapore National Research Foundation and the Economic Development Board, SPORE, COY-15-EWI-RCFSA/N197-1, and Wildlife Reserves Singapore Ah Meng Memorial Conservation Fund, National University of Singapore grant number R-154-000-617-720. Finally, we would like to thank three anonymous reviewers and the academic editor for their helpful recommendations that have greatly improved the manuscript.	Alacs E, 2008, AUST J FORENSIC SCI, V40, P147, DOI 10.1080/00450610802491382; Anderson R, 2008, ANNOTATED LIST NONMA; ANDREWS C, 1990, J FISH BIOL, V37, P53, DOI 10.1111/j.1095-8649.1990.tb05020.x; Appleton CC, 2015, AFR INVERTEBR, V56, P1, DOI 10.5733/afin.056.0102; Appleton C. C., 2003, African Journal of Aquatic Science, V28, P69, DOI 10.2989/16085914.2003.9626602; Areekijseree M, 2004, AQUACULTURE, V234, P575, DOI 10.1016/j.aquaculture.2003.12.008; Arias A, 2014, LIMNETICA, V33, P65; AVA (Agri-Food and Veterinary Authority of Singapore), 2011, ORN FISH NEWSL, V2, P1; Bastert J, 1998, DERMATOLOGY, V197, P84, DOI 10.1159/000017965; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Benson AJ, 2016, SINANODONTA WOODIANA; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bogan AE, 2008, HYDROBIOLOGIA, V595, P139, DOI 10.1007/s10750-007-9011-7; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; BRANDT R A M, 1974, Archiv fuer Molluskenkunde, V105, P1; BROWN DS, 1983, J MOLLUS STUD, V49, P77, DOI 10.1093/oxfordjournals.mollus.a065687; Brown DS, 1998, J AFRICAN ZOOLOGY, V112, P1; Bunje PMJ, 2004, THESIS; BUTOT L. J. M., 1954, BASTERIA, V18, P65; Chan SY, 2008, ELLIPSARIA, V10, P10; Charoenchai A, 1997, Southeast Asian J Trop Med Public Health, V28 Suppl 1, P209; Chee SY, 2016, MITOCHONDRIAL DNA A, V27, P2282, DOI 10.3109/19401736.2014.987237; Cianfanelli Simone, 2007, V2, P103, DOI 10.1007/978-1-4020-6029-8_5; Clausen JH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001945; Clements R, 2006, BIOL CONSERV, V128, P136, DOI 10.1016/j.biocon.2005.09.023; Cohen J, 2007, FRONT ECOL ENVIRON, V5, P528, DOI 10.1890/1540-9295(2007)5[528:TIATAP]2.0.CO;2; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Cowie Robert H., 2003, P93; Cowie RH, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P207; Cowie RH, 2009, AM MALACOL BULL, V27, P113, DOI 10.4003/006.027.0210; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; Deng ZH, 2011, SE ASIAN J TROP MED, V42, P1047; DJAJASASMITA M, 1982, VELIGER, V25, P175; Do VT, 2013, IUCN RED LIST THREAT; Douda K, 2012, BIOL INVASIONS, V14, P127, DOI 10.1007/s10530-011-9989-7; DUDGEON D, 1983, Malacological Review, V16, P93; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Eichhorst TE, 2016, NERITIDAE WORLD, V1; European Commission, 2012, OFFICIAL J EUROPEA L, V311, P14; Evans BB, 2001, BULL EUR ASSN FISH P, V21, P51; FAO (Food and Agriculture Organization of the United Nations), 2005, FISH AQ TOP ORN FISH; FAO (Food and Agricutural Organization of the United Nations), 2011, FAO YB FISH AQ STAT, P127; Filipova L, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011025; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Foster AM, 2015, CORBICULA FLUMINEA G; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Glaubrecht M, 2004, BIOL J LINN SOC, V82, P275, DOI 10.1111/j.1095-8312.2004.00361.x; Glaubrecht M, 2003, MALACOLOGIA, V45, P1; Glaubrecht Matthias, 2010, Zoosystematics and Evolution, V86, P185, DOI 10.1002/zoos.201000002; Gupta S., 2012, FISHING CHIMES, V32, P61; Habe T., 1964, Nat & Life in SW Asia, V3, P45; HALWART M, 1994, INT J PEST MANAGE, V40, P199, DOI 10.1080/09670879409371882; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Haynes A, 2001, FRESHWATER SNAILS TR; Hummel S, 2012, PRACTICAL FISHKEEPIN, V6, P30; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Ilarri MI, 2012, HANDBOOK OF GLOBAL FRESHWATER INVASIVE SPECIES, P173; International Enterprise Singapore, 2016, SING TRAD STAT SING; Ishibashi Ryo, 2003, Venus (Tokyo), V62, P65; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Joshi R. C., 2006, GLOBAL ADV; Jutting W. S. S. v. B., 1959, Beaufortia, V7, P41; Jutting W. S. S. v. B., 1956, Treubia, V23, P259; Jutting W. S. S.v. B., 1953, Treubia, V22, P19; Karatayev AY, 2009, HYDROBIOLOGIA, V619, P181, DOI 10.1007/s10750-008-9639-y; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keller RP, 2007, BIOSCIENCE, V57, P428, DOI 10.1641/B570509; Kim KC, 2006, ECOL RES, V21, P794, DOI 10.1007/s11284-006-0035-7; Kohler F, 2009, MOLLUSCAN RES, V29, P121; Kohler F, 2006, MALACOLOGIA, V48, P159; Kohler F, 2001, J MOLLUS STUD, V67, P281, DOI 10.1093/mollus/67.3.281; Kohler F, STATUS DISTRIBUTION, P67; KRISTENSEN TK, 1987, J MOLLUS STUD, V53, P245, DOI 10.1093/mollus/53.2.245; Kulsantiwong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079144; Lajtner J, 2011, AQUAT INVASIONS, V6, pS119, DOI 10.3391/ai.2011.6.S1.027; Layton KKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095003; Lee S., 2008, THESIS; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Liang Shih-Hisung, 2006, Taiwania, V51, P93; Ling K.H., 2005, SINGAPORE J PRI IND, V32, P59; Liu Y.Y., 1979, EC FAUNA CHINA FRESH; Lukhaup C., 2009, PRACTICAL FISHKEEPIN, V2009, P31; Lydeard C, 2004, BIOSCIENCE, V54, P321, DOI 10.1641/0006-3568(2004)054[0321:TGDONM]2.0.CO;2; Maceda-Veiga A, 2013, BIOL INVASIONS, V15, P2707, DOI 10.1007/s10530-013-0485-0; Mackie GL, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P135; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Maki K, 2004, BIOL CONSERV, V118, P389, DOI 10.1016/j.biocon.2003.09.015; Marwoto Ristiyanti M., 2011, Biotropia, V18, P123; McDowall RM, 2004, NEW ZEAL J MAR FRESH, V38, P503, DOI 10.1080/00288330.2004.9517256; MCMAHON RF, 1982, NAUTILUS, V96, P134; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Mienis HK, 1973, BASTERIA, V37, P1; Mitchell AJ, 2007, N AM J FISH MANAGE, V27, P1287, DOI 10.1577/M06-252.1; Naylor R, 1996, AMBIO, V25, P443; Ng HH, 2010, COSMOS, V6, P95, DOI [10.1142/S0219607710000504, DOI 10.1142/S0219607710000504]; Ng Peter K.L., 1997, Aquarium Sciences and Conservation, V1, P79, DOI 10.1023/A:1018335617835; NG PKL, 1993, BIOL CONSERV, V64, P19, DOI 10.1016/0006-3207(93)90379-F; Ng TH, 2015, BIOINVASIONS REC, V4, P189, DOI 10.3391/bir.2015.4.3.06; Ng Ting Hui, 2014, Nature in Singapore, V7, P31; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Palumbi S, 2002, THE SIMPLE FOOLS GUI; Pecnikar ZF, 2014, J APPL GENET, V55, P43, DOI 10.1007/s13353-013-0180-y; Petney T, 2012, PARASITOL INT, V61, P38, DOI 10.1016/j.parint.2011.07.019; Pigneur LM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-147; Pointier JP, 2001, MEM I OSWALDO CRUZ, V96, P67, DOI 10.1590/S0074-02762001000900009; Pointier JP, 1999, MALACOLOGIA, V41, P403; Posch H, 2013, J MOLLUS STUD, V79, P383, DOI 10.1093/mollus/eyt034; Poulin R, 2011, FRESHWATER BIOL, V56, P676, DOI 10.1111/j.1365-2427.2010.02425.x; Raghavan R, 2013, BIOL CONSERV, V164, P158, DOI 10.1016/j.biocon.2013.04.019; Raut SK, 1999, CURR SCI INDIA, V77, P1389; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; Rhyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008413; Rhyne AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035808; Robinson DG, 1999, MALACOLOGIA, V41, P413; Roll U, 2009, BIOL INVASIONS, V11, P1963, DOI 10.1007/s10530-008-9373-4; SALISBURY JR, 1976, AUST VET J, V52, P487, DOI 10.1111/j.1751-0813.1976.tb05413.x; Sarasin F, 1898, MAT NATURGESCHICHTE, P62; Sarasin P., 1897, ZOOL ANZ, V539, P308; Shea Michael, 1994, Molluscan Research, V15, P3; Shokralla S, 2014, MOL ECOL RESOUR, V14, P892, DOI 10.1111/1755-0998.12236; Simonis J, IUCN RED LIST THREAT; Singh K. Inder, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P303; Smith KF, 2008, CONSERV LETT, V1, P103, DOI 10.1111/j.1755-263X.2008.00014.x; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; SRI-AROON P., 2010, FRESHWATER SNAILS ME; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Strecker AL, 2011, FISHERIES, V36, P74, DOI 10.1577/03632415.2011.10389070; Strong EE, 2008, HYDROBIOLOGIA, V595, P149, DOI 10.1007/s10750-007-9012-6; Subba NV., 1989, ZOOLOGICAL SURVEY IN, P1; Tan SK, 2008, ZOOL STUD, V47, P481; Tan SK, 2012, GUID SNAILS OTHER NO; Teem John L, 2013, Hawaii J Med Public Health, V72, P11; Ng TH, 2014, MALACOLOGIA, V57, P401, DOI 10.4002/040.057.0211; Van Damme D., 2014, IUCN RED LIST THREAT; van Jutting WSS Benthem, 1946, J CONCHOL, V22, P221; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Vink CJ, 2012, BIOSCIENCE, V62, P451, DOI 10.1525/bio.2012.62.5.3; Von Rintelen T, 2003, J MOLLUS STUD, V69, P3; Von Rintelen T, 2008, ZOOTAXA, P37; von Rintelen T, 2007, HYDROBIOLOGIA, V592, P11, DOI 10.1007/s10750-007-0765-8; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Watters GT, 1997, VELIGER, V40, P152; Weese DA, 2009, ANIM CONSERV, V12, P13, DOI 10.1111/j.1469-1795.2008.00215.x; Welton LJ, 2013, BIOL CONSERV, V159, P7, DOI 10.1016/j.biocon.2012.10.013; Wethington AR, 2007, J MOLLUS STUD, V73, P241, DOI 10.1093/mollus/eym021; Whelan NV, 2011, MOL PHYLOGENET EVOL, V61, P504, DOI 10.1016/j.ympev.2011.07.016; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wong WH, 2014, MOL ECOL RESOUR, V14, P1271, DOI 10.1111/1755-0998.12275; Wong YT, 2011, BIOL INVASIONS, V13, P341, DOI 10.1007/s10530-010-9825-5; Wong YT, 2011, A GUIDE TO FRESHWATE, P11; Yang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04089; Yang SL, 1990, RAFFLES B ZOOL, V38, P1; YEO D. C. J., 2010, COSMOS, V6, P23, DOI DOI 10.1142/S0219607710000486; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zilch A., 1955, ARCH MOLLUSKENKD, V64, P1	164	56	61	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161130	10.1371/journal.pone.0161130	http://dx.doi.org/10.1371/journal.pone.0161130			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525660	gold, Green Published, Green Submitted			2022-12-26	WOS:000381471100036
J	Wang, LJ; Yang, KC; Lee, SY; Yang, CJ; Huang, TS; Lee, TL; Yuan, SS; Shyu, YC				Wang, Liang-Jen; Yang, Kang-Chung; Lee, Sheng-Yu; Yang, Chun-Ju; Huang, Ting-Shuo; Lee, Tung-Liang; Yuan, Shin-Sheng; Shyu, Yu-Chiau			Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; PHARMACOLOGICAL-TREATMENT; MEDICATION ADHERENCE; TREATMENT PATTERNS; SURVIVAL ANALYSIS; PUBLIC-ATTITUDES; DRUG-USE; CHILDREN; ADHD; ADOLESCENTS	Background Pharmacotherapy is an effective therapeutic option for attention deficit hyperactivity disorder (ADHD). Understanding the patterns of medication treatment is crucial for clinical practice. This study employed nationwide population-based data to elucidate the initiation and persistence of pharmacotherapy (immediate-release methylphenidate [IR-MPH], osmotic controlled-release formulations of methylphenidate [OROS-MPH] and atomoxetine [ATX]) for youths with ADHD in Taiwan. Methods Patients first receiving an ADHD diagnosis at age 18 or younger between January 2000 and December 2009 (n = 112,140; mean age at ADHD diagnosis: 7.7 years) were selected from Taiwan's National Health Insurance database. All patients were monitored through December 31, 2011, with an average follow-up time of 5.8 years. The initiation of ADHD drug therapy was defined as the first patient prescription, and discontinuation was defined as the cessation of ADHD medication for 180 days or longer. Results Within the first year after ADHD diagnosis, 47.3%, 14.4%, and 0.8% of the patients were prescribed IR-MPH, OROS-MPH, and ATX, respectively. Regarding the patients prescribed IR-MPH, OROS-MPH, and ATX, 17.8%, 12.6%, and 18.8%, respectively, received the prescription only once and never returned for a drug refill, and 51.0%, 38.9%, and 58.8%, respectively, discontinued drug therapy within 1 year after the first prescription. Male sex and neuropsychiatric comorbidities were associated with higher probabilities of being prescribed one of the medications. An older age at first prescription and a higher daily dose of prescription were significant predictors of early discontinuation of ADHD medication. Conclusions The current findings suggest that IR-MPH is the most frequently prescribed drug for ADHD treatment in Taiwan. Patients treated with OROS-MPH possessed the highest persistence rate, whereas those treated with ATX had the lowest persistence rate. The results provide insight into the delivery of pediatric mental health services and have crucial implications for ADHD medication treatment in real clinical settings.	[Wang, Liang-Jen] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Wang, Liang-Jen] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yang, Kang-Chung] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei, Taiwan; [Yang, Kang-Chung] Acad Sinica, Taipei, Taiwan; [Yang, Kang-Chung; Yuan, Shin-Sheng] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Lee, Sheng-Yu] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lee, Sheng-Yu] Natl Cheng Kung Univ, Coll Med & Hosp, Dept Psychiat, Tainan, Taiwan; [Yang, Chun-Ju] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Yang, Chun-Ju; Huang, Ting-Shuo; Shyu, Yu-Chiau] Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Huang, Ting-Shuo] Keelung Chang Gung Mem Hosp, Dept Gen Surg, Keelung, Taiwan; [Huang, Ting-Shuo] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan; [Lee, Tung-Liang] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Shyu, Yu-Chiau] Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Kaohsiung Veterans General Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan	Yuan, SS (corresponding author), Acad Sinica, Inst Stat Sci, Taipei, Taiwan.; Shyu, YC (corresponding author), Keelung Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.; Shyu, YC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	shinshengyuan@gmail.com; yuchiaushyu@gmail.com	Huang, Ting-Shuo/ABD-3205-2021; Wang, Liang-Jen/AAR-1089-2020; Yuan, Shinsheng/AAP-4855-2021	Huang, Ting-Shuo/0000-0002-2932-6878; Wang, Liang-Jen/0000-0002-5320-1151; Shyu, Yu-Chiau/0000-0003-1747-2226; Lee, Tung Liang/0000-0003-1913-1652	Chang Gung Memorial Hospital Research Projects [CMRPG8D0581, CLRPG2C0021, CLRPG2C0022, CMRPG2B0113]	Chang Gung Memorial Hospital Research Projects	This study was sponsored by the Chang Gung Memorial Hospital Research Projects (CMRPG8D0581, CLRPG2C0021, CLRPG2C0022 and CMRPG2B0113).	Ahmed R, 2013, EXPERT REV PHARM OUT, V13, P791, DOI 10.1586/14737167.2013.841544; Ahmed R, 2013, J CHILD ADOL PSYCHOP, V23, P163, DOI 10.1089/cap.2012.0087; ALLGULANDER C, 1986, ACTA PSYCHIAT SCAND, V74, P529, DOI 10.1111/j.1600-0447.1986.tb06279.x; American Psychiatric Association, 2000, DIAGNOSTIC AND STATI; Atzori P, 2009, J CHILD ADOL PSYCHOP, V19, P673, DOI 10.1089/cap.2008.0146; Ayaz M, 2014, J CHILD ADOL PSYCHOP, V24, P442, DOI 10.1089/cap.2014.0002; Charach A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0371-6; Chen CY, 2012, PSYCHIAT SERV, V63, P1011, DOI 10.1176/appi.ps.201100473; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Chien IC, 2012, SOC PSYCH PSYCH EPID, V47, P1885, DOI 10.1007/s00127-012-0501-1; Clavenna A, 2014, ARCH DIS CHILD, V99, P866, DOI 10.1136/archdischild-2013-304170; Didoni A, 2011, EUR J CLIN PHARMACOL, V67, P1061, DOI 10.1007/s00228-011-1050-3; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Findling RL, 2008, CLIN THER, V30, P942, DOI 10.1016/j.clinthera.2008.05.006; Gajria K, 2014, NEUROPSYCH DIS TREAT, V10, P1543, DOI 10.2147/NDT.S65721; Garbe E, 2012, J CHILD ADOL PSYCHOP, V22, P452, DOI 10.1089/cap.2012.0022; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; Gau SSF, 2008, J CLIN PSYCHIAT, V69, P131, DOI 10.4088/JCP.v69n0118; Hammerness P, 2009, NEUROPSYCH DIS TREAT, V5, P215; Hodgkins P, 2011, CLIN THER, V33, P188, DOI 10.1016/j.clinthera.2011.03.001; Hong JH, 2013, PATIENT PREFER ADHER, V7, P987, DOI 10.2147/PPA.S50628; Hong M, 2014, J CHILD ADOL PSYCHOP, V24, P341, DOI 10.1089/cap.2013.0090; Huang CLC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095014; Karam R. G., 2015, PSYCHOL MED, P1; Katzman M, 2014, CNS DRUGS, V28, P1005, DOI 10.1007/s40263-014-0175-1; Lambert MC, 2015, J CHILD ADOL PSYCHOP, V25, P475, DOI 10.1089/cap.2014.0151; Lang HC, 2010, HEALTH POLICY, V97, P71, DOI 10.1016/j.healthpol.2010.03.005; Lien YT, 2015, PSYCHIAT SERV, V66, P177, DOI 10.1176/appi.ps.201300501; Marcus SC, 2005, ARCH PEDIAT ADOL MED, V159, P572, DOI 10.1001/archpedi.159.6.572; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; McLeod JD, 2004, J HEALTH SOC BEHAV, V45, P53, DOI 10.1177/002214650404500104; Palli SR, 2012, J CHILD ADOL PSYCHOP, V22, P139, DOI 10.1089/cap.2011.0028; Partridge B, 2012, AUST NZ J PSYCHIAT, V46, P958, DOI 10.1177/0004867412450755; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Pottegard A, 2013, EUR J CLIN PHARMACOL, V69, P589, DOI 10.1007/s00228-012-1344-0; Rapoport JL, 2013, WORLD PSYCHIATRY, V12, P118, DOI 10.1002/wps.20028; Reddy DS, 2013, DRUG TODAY, V49, P647, DOI 10.1358/dot.2013.49.10.2008996; Spencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005; Treuer T, 2013, J CHILD ADOL PSYCHOP, V23, P179, DOI 10.1089/cap.2012.0093; van de Loo-Neus GHH, 2011, EUR NEUROPSYCHOPHARM, V21, P584, DOI 10.1016/j.euroneuro.2011.03.008; Vaughan BS, 2012, INT J NEUROPSYCHOPH, V15, P27, DOI 10.1017/S1461145711000095; Willoughby MT, 2003, J CHILD PSYCHOL PSYC, V44, P88, DOI 10.1111/1469-7610.t01-1-00104; Winterstein AG, 2008, ANN PHARMACOTHER, V42, P24, DOI 10.1345/aph.1K143; Wong ICK, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13490; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Zetterqvist J, 2013, ACTA PSYCHIAT SCAND, V128, P70, DOI 10.1111/acps.12004; Zoega H, 2011, ACTA PSYCHIAT SCAND, V123, P360, DOI 10.1111/j.1600-0447.2010.01607.x	48	27	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161061	10.1371/journal.pone.0161061	http://dx.doi.org/10.1371/journal.pone.0161061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518196	Green Published, gold, Green Submitted			2022-12-26	WOS:000381382100041
J	Xiao, L; Zhang, DL; Torrie, J; Auger, N; McHugh, NGL; Luo, ZC				Xiao, Lin; Zhang, Dan-Li; Torrie, Jill; Auger, Nathalie; McHugh, Nancy Gros-Louis; Luo, Zhong-Cheng			Macrosomia, Perinatal and Infant Mortality in Cree Communities in Quebec, 1996-2010	PLOS ONE			English	Article							JAMES BAY CREE; BIRTH-WEIGHT; INTERNATIONAL COMPARISONS; GESTATIONAL-AGE; NORTHERN QUEBEC; POPULATION; HEALTH; TRENDS; CANADA; PREVALENCE	Background Cree births in Quebec are characterized by the highest reported prevalence of macrosomia (similar to 35%) in the world. It is unclear whether Cree births are at greater elevated risk of perinatal and infant mortality than other First Nations relative to non-Aboriginal births in Quebec, and if macrosomia may be related. Methods This was a population-based retrospective birth cohort study using the linked birth-infant death database for singleton births to mothers from Cree (n = 5,340), other First Nations (n = 10,810) and non-Aboriginal (n = 229,960) communities in Quebec, 1996-2010. Community type was ascertained by residential postal code and municipality name. The primary outcomes were perinatal and infant mortality. Results Macrosomia (birth weight for gestational age > 90th percentile) was substantially more frequent in Cree (38.0%) and other First Nations (21.9%) vs non-Aboriginal (9.4%) communities. Comparing Cree and other First Nations vs non-Aboriginal communities, perinatal mortality rates were 1.52 (95% confidence intervals 1.17, 1.98) and 1.34 (1.10, 1.64) times higher, and infant mortality rates 2.27 (1.71, 3.02) and 1.49 (1.16, 1.91) times higher, respectively. The risk elevations in perinatal and infant death in Cree communities attenuated after adjusting for maternal characteristics (age, education, marital status, parity), but became greater after further adjustment for birth weight (small, appropriate, or large for gestational age). Conclusions Cree communities had greater risk elevations in perinatal and infant mortality than other First Nations relative to non-Aboriginal communities in Quebec. High prevalence of macrosomia did not explain the elevated risk of perinatal and infant mortality in Cree communities.	[Xiao, Lin; Torrie, Jill] Cree Board Hlth & Social Serv James Bay, Dept Publ Hlth, Mistissini, PQ G0W 1C0, Canada; [Xiao, Lin; Zhang, Dan-Li; Luo, Zhong-Cheng] Univ Montreal, St Justine Hosp, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada; [Zhang, Dan-Li; Luo, Zhong-Cheng] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth,Minist E, Shanghai 200092, Peoples R China; [Auger, Nathalie] Univ Montreal, Univ Montreal Hosp Res Ctr, Montreal, PQ H2X 0A9, Canada; [McHugh, Nancy Gros-Louis] First Nations Quebec & Labrador Hlth & Social Ser, Div Res, Wendake, PQ G0A 4V0, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Shanghai Jiao Tong University; Universite de Montreal	Torrie, J (corresponding author), Cree Board Hlth & Social Serv James Bay, Dept Publ Hlth, Mistissini, PQ G0W 1C0, Canada.; Luo, ZC (corresponding author), Univ Montreal, St Justine Hosp, Dept Obstet & Gynecol, Montreal, PQ H3T 1C5, Canada.; Luo, ZC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth,Minist E, Shanghai 200092, Peoples R China.	torrie.jill@ssss.gouv.qc.ca; zc_luo@yahoo.com	Auger, Nathalie/E-3736-2016; Luo, Zhong-Cheng/T-3882-2017	Auger, Nathalie/0000-0002-2412-0459; Luo, Zhong-Cheng/0000-0002-1794-1312	Canadian Institutes of Health Research (CIHR) [MOP 106521]; National Natural Science Foundation of China (NSFC) [81571451]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a research grant from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca, CIHR grant number MOP 106521). DL Zhang was partly supported by a research grant from the National Natural Science Foundation of China (www.nsfc.gov.cn, NSFC grant number 81571451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong IE, 1998, CAN J PUBLIC HEALTH, V89, P419, DOI 10.1007/BF03404087; Baldwin LM, 2002, AM J PUBLIC HEALTH, V92, P1491, DOI 10.2105/AJPH.92.9.1491; Castor ML, 2006, AM J PUBLIC HEALTH, V96, P1478, DOI 10.2105/AJPH.2004.053942; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138562; COLE S, 1989, ACTA OBSTET GYN SCAN, V68, P113, DOI 10.3109/00016348909009897; Collins SA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-190; Ehrenberg HM, 2004, AM J OBSTET GYNECOL, V191, P964, DOI 10.1016/j.ajog.2004.05.052; Fair M, 2000, Chronic Dis Can, V21, P8; Freemantle CJ, 2006, LANCET, V367, P1758, DOI 10.1016/S0140-6736(06)68771-0; Gilbert NL, 2015, HEALTH REP, V26, P3; Harris SB, 1997, DIABETES CARE, V20, P1422, DOI 10.2337/diacare.20.9.1422; Hauck FR, 2008, PEDIATRICS, V122, pS113, DOI 10.1542/peds.2008-1315o; Healey GK, 2007, INT J CIRCUMPOL HEAL, V66, P199, DOI 10.3402/ijch.v66i3.18256; Joseph KS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e746; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kirby R S, 1993, J Perinatol, V13, P433; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kyu HH, 2015, CAN J PUBLIC HEALTH, V106, pE22, DOI [10.17269/cjph.106.4663, 10.17269/CJPH.106.4663]; Luo ZC, 2004, INT J EPIDEMIOL, V33, P1252, DOI 10.1093/ije/dyh290; Luo ZC, 2004, PAEDIATR PERINAT EP, V18, P40, DOI 10.1111/j.1365-3016.2003.00529.x; Luo ZC, 2010, CAN MED ASSOC J, V182, P235, DOI 10.1503/cmaj.082042; NAKAMURA RM, 1991, JAMA-J AM MED ASSOC, V266, P2244, DOI 10.1001/jama.266.16.2244; Plessis V, 2001, RURAL SMALL TOWN CAN, V3; Quamrul HC., 2010, J BIOL SCI, V2, P132; Reading J, 1999, 1 NATIONS INUIT REGI, P87; Rodrigues S, 1999, CAN MED ASSOC J, V160, P1293; Rodrigues S, 2000, J NUTR, V130, P806, DOI 10.1093/jn/130.4.806; Smylie J, 2010, CAN J PUBLIC HEALTH, V101, P143, DOI 10.1007/BF03404361; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Tomashek KM, 2006, AM J PUBLIC HEALTH, V96, P2222, DOI 10.2105/AJPH.2004.053744; Wilkins R, 2012, PCCF VERSION 5F USER	32	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160766	10.1371/journal.pone.0160766	http://dx.doi.org/10.1371/journal.pone.0160766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27517613	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100023
J	Tirado, T; Saura, M; Rolan-Alvarez, E; Quesada, H				Tirado, Terencia; Saura, Maria; Rolan-Alvarez, Emilio; Quesada, Humberto			Historical Biogeography of the Marine Snail Littorina saxatilis Inferred from Haplotype and Shell Morphology Evolution in NW Spain	PLOS ONE			English	Article							ECOLOGICAL SPECIATION; POPULATION-GROWTH; LOCAL ADAPTATION; SEQUENCE; DIFFERENTIATION; PHYLOGEOGRAPHY; DIVERGENCE; ECOTYPES; REVEALS; GENOME	The marine snail Littorina saxatilis exhibits extreme morphological variation between and within geographical regions and represents an excellent model for assessing local adaptation. Previous studies support the hypothesis of parallel evolution in sympatry of two morphologically different ecotypes (named as RB and SU) that co-inhabit different habitats from Galician rocky shores (NW Spain), and which are interrupted by sheltered areas inhabited by a different morph never studied before (named as SRB). Here, we use morphological and mitochondrial DNA (mtDNA) sequence data to test hypotheses on the origin and diversification of SRB snails and to assess their evolutionary relationships with RB and SU ecotypes. Our results show that the SRB morph displays the largest size and shell elongation and the smallest relative shell aperture, representing an extreme type of the RB vs. SU polymorphism, which has been linked to adaptation to sheltered ecological factors. Phylogenetic analysis shows that the SRB morph shares ancestry with RB and SU ecotypes, rejecting the hypothesis that the SRB morph marks relict populations from which these ecotypes evolved in Galician coasts. Our data support that genetic differentiation among SRB, RB and SU morphs results from a general pattern of restricted gene flow and isolation by distance linked to the colonization of Galician coasts by two independent mtDNA lineages, rather than from a random fragmentation of the initial distributional range. Therefore, the confinement of distinct lineages to specific geographical areas denote evident limits to the distances these snails can disperse. Morphological analysis indicates no association between mtDNA lineage and a specific morphotype, and suggests the independent gain of convergent morphological patterns within each mtDNA lineage in populations occupying contrasting habitats following the colonization of Galician coasts.	[Tirado, Terencia; Saura, Maria; Rolan-Alvarez, Emilio; Quesada, Humberto] Univ Vigo, Fac Biol, Dept Bioquim Genet & Inmunol, Vigo, Spain; [Saura, Maria] INIA, Dept Mejora Genet Anim, Madrid, Spain	Universidade de Vigo	Quesada, H (corresponding author), Univ Vigo, Fac Biol, Dept Bioquim Genet & Inmunol, Vigo, Spain.	hquesada@uvigo.es	Saura, María/Q-1592-2018; Rolán-Alvarez, Emilio/F-3809-2016; Quesada, Humberto/Y-9619-2019	Rolán-Alvarez, Emilio/0000-0001-8396-278X; Quesada, Humberto/0000-0002-2927-0915; Saura, Maria/0000-0002-2744-2840	Ministerio de Economia y Competitividad [BFU2013-44635-P]; European Union's Seventh Framework Programme [KBBE.2013.1.2-10, 613611]; Xunta de Galicia [GPC2013-011]; Fondos Feder: "Unha maneira de facer Europa"	Ministerio de Economia y Competitividad(Spanish Government); European Union's Seventh Framework Programme(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondos Feder: "Unha maneira de facer Europa"	This work was funded by Ministerio de Economia y Competitividad (BFU2013-44635-P), European Union's Seventh Framework Programme (KBBE.2013.1.2-10) under grant agreement no 613611, Xunta de Galicia (GPC2013-011) and Fondos Feder: "Unha maneira de facer Europa." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bierne N, 2013, CURR ZOOL, V59, P72, DOI 10.1093/czoolo/59.1.72; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Butlin RK, 2014, EVOLUTION, V68, P935, DOI 10.1111/evo.12329; Cibois A, 2007, J BIOGEOGR, V34, P1150, DOI 10.1111/j.1365-2699.2007.01703.x; Conde-Padin P, 2009, EVOLUTION, V63, P1356, DOI 10.1111/j.1558-5646.2009.00636.x; Cuna V, 2011, MAR ECOL PROG SER, V427, P133, DOI 10.3354/meps09033; Dennenmoser S, 2015, J BIOGEOGR, V42, P1626, DOI 10.1111/jbi.12527; Doellman MM, 2011, P ROY SOC B-BIOL SCI, V278, P3175, DOI 10.1098/rspb.2011.0346; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Galindo J, 2013, J EVOLUTION BIOL, V26, P1472, DOI 10.1111/jeb.12152; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; Galindo J, 2014, BIOL J LINN SOC, V111, P391, DOI 10.1111/bij.12197; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johannesson K, 1997, BIOL J LINN SOC, V61, P267; JOHANNESSON K, 1993, EVOLUTION, V47, P1770, DOI 10.1111/j.1558-5646.1993.tb01268.x; Johannesson K, 2016, EVOL APPL, V9, P153, DOI 10.1111/eva.12277; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Panova M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017511; Peres-Neto PR, 2001, ANIM BEHAV, V61, P79, DOI 10.1006/anbe.2000.1576; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quesada H, 2007, EVOLUTION, V61, P1600, DOI 10.1111/j.1558-5646.2007.00135.x; Ravinet M, 2016, MOL ECOL, V25, P287, DOI 10.1111/mec.13332; Rohlf F.J., 2006, TPSDIG PROGRAM DIGIT; Rohlf F. J., 2005, TPSRELW RELATIVE WAR; Rolan-Alvarez E, 2004, MOL ECOL, V13, P3415, DOI 10.1111/j.1365-294X.2004.02330.x; Rolan-Alvarez E, 2015, OCEANOGR MAR BIOL, V53, P157; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Small MP, 2000, HEREDITY, V84, P692, DOI 10.1046/j.1365-2540.2000.00717.x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Westram AM, 2014, MOL ECOL, V23, P4603, DOI 10.1111/mec.12883; Wilding CS, 1999, J MOL EVOL, V48, P348, DOI 10.1007/PL00006479; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	50	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161287	10.1371/journal.pone.0161287	http://dx.doi.org/10.1371/journal.pone.0161287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513934	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100132
J	Zou, JY				Zou, Junyu			Sources and Dynamics of Inorganic Carbon within the Upper Reaches of the Xi River Basin, Southwest China	PLOS ONE			English	Article							CO2 PARTIAL-PRESSURE; WEATHERING PROCESSES; ISOTOPIC COMPOSITION; SEASONAL-VARIATION; XIJIANG RIVER; AMAZON RIVER; PEARL RIVER; DIOXIDE; ALKALINITY; FLUXES	The carbon isotopic composition (delta C-13) of dissolved and particulate inorganic carbon (DIC; PIC) was used to compare and analyze the origin, dynamics and evolution of inorganic carbon in two headwater tributaries of the Xi River, Southwest China. Carbonate dissolution and soil CO2 were regarded as the primary sources of DIC on the basis of delta C-13(DIC) values which varied along the Nanpan and Beipan Rivers, from -13.9 parts per thousand to 8.1 parts per thousand. Spatial trends in DIC differed between the two rivers (i.e., the tributaries), in part because factors controlling pCO(2), which strongly affected carbonate dissolution, differed between the two river basins. Transport of soil CO2 and organic carbon through hydrologic conduits predominately controlled the levels of pCO(2) in the Nanpan River. However, pCO2 along the upper reaches of the Nanpan River also was controlled by the extent of urbanization and industrialization relative to agriculture. DIC concentrations in the highly urbanized upper reaches of the Nanpan River were typical higher than in other carbonate-dominated areas of the upper Xi River. Within the Beipan River, the oxidation of organic carbon is the primary process that maintains pCO(2) levels. The pCO(2) within the Beipan River was more affected by sulfuric acid from coal industries, inputs from a scenic spot, and groundwater than along the Nanpan River. With regards to PIC, the contents and delta C-13 values in the Nanpan River were generally lower than those in the Beipan River, indicating that chemical and physical weathering contributes more marine carbonate detritus to the PIC along the Beipan River. The CO2 evasion flux from the Nanpan River was higher than that in the Beipan River, and generally higher than along the middle and lower reaches of the Xi River, demonstrating that the Nanpan River is an important net source of atmospheric CO2 in Southwest China.	[Zou, Junyu] China Univ Geosci Beijing, Sch Earth Sci & Resources, Beijing 100083, Peoples R China	China University of Geosciences	Zou, JY (corresponding author), China Univ Geosci Beijing, Sch Earth Sci & Resources, Beijing 100083, Peoples R China.	zoujy1117@163.com			National Natural Science Foundation of China [41325010]; National Key Basic Research Program of China [2013CB956703]; Fundamental Research Funds for the Central Universities [2652013055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 41325010), the National Key Basic Research Program of China (Grant No. 2013CB956703), and the Fundamental Research Funds for the Central Universities (Grant No. 2652013055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Abril G, 2015, BIOGEOSCIENCES, V12, P67, DOI 10.5194/bg-12-67-2015; Aitkenhead JA, 2000, GLOBAL BIOGEOCHEM CY, V14, P127, DOI 10.1029/1999GB900083; Amiotte-Suchet P, 1999, CHEM GEOL, V159, P129, DOI 10.1016/S0009-2541(99)00037-6; Aucour AM, 2003, CHEM GEOL, V197, P271, DOI 10.1016/S0009-2541(02)00398-4; Aucour AM, 1999, CHEM GEOL, V159, P87, DOI 10.1016/S0009-2541(99)00035-2; [李军 Li Jun], 2010, [地球化学, Geochimica], V39, P305; Baker A, 2008, AREA, V40, P117, DOI 10.1111/j.1475-4762.2007.00780.x; Barnes RT, 2009, CHEM GEOL, V266, P318, DOI 10.1016/j.chemgeo.2009.06.018; Barth JAC, 1999, CHEM GEOL, V159, P107, DOI 10.1016/S0009-2541(99)00036-4; Barth JAC, 2003, CHEM GEOL, V200, P203, DOI 10.1016/S0009-2541(03)00193-1; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Brunet F, 2005, HYDROL PROCESS, V19, P3321, DOI 10.1002/hyp.5973; Butman D, 2011, NAT GEOSCI, V4, P839, DOI [10.1038/ngeo1294, 10.1038/NGEO1294]; Calmels D, 2014, CHEM GEOL, V390, P74, DOI 10.1016/j.chemgeo.2014.10.010; CERLING TE, 1991, GEOCHIM COSMOCHIM AC, V55, P3403, DOI 10.1016/0016-7037(91)90498-T; Chen Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125265; Clark I., 1997, ENV ISOTOPES HYDROGE, P328; Cole JJ, 2001, MAR FRESHWATER RES, V52, P101, DOI 10.1071/MF00084; DEVOL AH, 1995, GLOBAL BIOGEOCHEM CY, V9, P307, DOI 10.1029/95GB01145; Dinsmore KJ, 2010, GLOBAL CHANGE BIOL, V16, P2750, DOI 10.1111/j.1365-2486.2009.02119.x; Doctor DH, 2008, HYDROL PROCESS, V22, P2410, DOI 10.1002/hyp.6833; Finlay JC, 2007, ECOL METHOD CONCEPT, P283, DOI 10.1002/9780470691854.ch10; Galy A, 1999, CHEM GEOL, V159, P31, DOI 10.1016/S0009-2541(99)00033-9; Han GL, 2010, ENVIRON EARTH SCI, V60, P893, DOI 10.1007/s12665-009-0226-y; Hope D, 2004, HYDROL PROCESS, V18, P3255, DOI 10.1002/hyp.5657; Hunt CW, 2011, BIOGEOSCIENCES, V8, P3069, DOI 10.5194/bg-8-3069-2011; Jing CY, 2002, YUNNAN ENV SCI, V21, P24; Johnson MS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034619; Jones JB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017056; Karim A, 2000, CHEM GEOL, V170, P153, DOI 10.1016/S0009-2541(99)00246-6; Kokic J, 2015, J GEOPHYS RES-BIOGEO, V120, P13, DOI 10.1002/2014JG002706; Lapierre JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3972; Li SL, 2008, EARTH PLANET SC LETT, V270, P189, DOI 10.1016/j.epsl.2008.02.039; Li SL, 2010, CHEM GEOL, V277, P301, DOI 10.1016/j.chemgeo.2010.08.013; Li SY, 2013, J HYDROL, V504, P40, DOI 10.1016/j.jhydrol.2013.09.024; Li SY, 2012, J HYDROL, V466, P141, DOI 10.1016/j.jhydrol.2012.08.011; Liu CQ, 2007, EARTH SURFACE BIOGEO; Liu ZH, 2015, SCI BULL, V60, P182, DOI 10.1007/s11434-014-0682-y; Liu ZH, 2011, APPL GEOCHEM, V26, pS292, DOI 10.1016/j.apgeochem.2011.03.085; Liu ZH, 2010, EARTH-SCI REV, V99, P162, DOI 10.1016/j.earscirev.2010.03.001; MCCONNAUGHEY TA, 1994, LIMNOL OCEANOGR, V39, P1319, DOI 10.4319/lo.1994.39.6.1319; MILLERO FJ, 1979, GEOCHIM COSMOCHIM AC, V43, P1651, DOI 10.1016/0016-7037(79)90184-4; Milliman J. D., 2011, RIVER DISCHARGE COAS, DOI 10.1017/CBO9780511781247; PINOL J, 1992, J HYDROL, V131, P205, DOI 10.1016/0022-1694(92)90218-K; PROBST JL, 1994, APPL GEOCHEM, V9, P1, DOI 10.1016/0883-2927(94)90047-7; Ran L, 2015, BIOGEOSCIENCES, V12, P921, DOI 10.5194/bg-12-921-2015; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Rive K, 2013, EARTH SURF PROC LAND, V38, P1020, DOI 10.1002/esp.3385; Shin WJ, 2011, HYDROL EARTH SYST SC, V15, P2551, DOI 10.5194/hess-15-2551-2011; Singh SK, 2005, GEOCHIM COSMOCHIM AC, V69, P3573, DOI 10.1016/j.gca.2005.02.033; Spence J, 2005, GEOCHIM COSMOCHIM AC, V69, P5441, DOI 10.1016/j.gca.2005.07.011; Striegl RG, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005201; Sun HG, 2008, QUATERN INT, V186, P65, DOI 10.1016/j.quaint.2007.11.009; Sun H.G., 2011, BIOGEOSCI DISCUSS, V8, P9471; Tamooh F, 2013, BIOGEOSCIENCES, V10, P6911, DOI 10.5194/bg-10-6911-2013; Tao WD, 1997, YUNNAN ENV SCI, V16, P36; Telmer K, 1999, CHEM GEOL, V159, P61, DOI 10.1016/S0009-2541(99)00034-0; Venkiteswaran JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101756; Wachniew P, 2006, CHEM GEOL, V233, P293, DOI 10.1016/j.chemgeo.2006.03.012; Wallin MB, 2013, GLOBAL CHANGE BIOL, V19, P785, DOI 10.1111/gcb.12083; Wallin MB, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003975; Wang FS, 2015, ATMOS ENVIRON, V103, P129, DOI 10.1016/j.atmosenv.2014.12.042; Wang FS, 2011, ATMOS ENVIRON, V45, P3827, DOI 10.1016/j.atmosenv.2011.04.014; Wang FS, 2007, GEOCHEM T, V8, DOI 10.1186/1467-4866-8-7; Wehrli B, 2013, NATURE, V503, P346, DOI 10.1038/503346a; Wu Y, 2009, J GUIZHOU U NATURAL, V26, P130; Xu ZF, 2007, CHEM GEOL, V239, P83, DOI 10.1016/j.chemgeo.2006.12.008; Xu ZF, 2010, APPL GEOCHEM, V25, P1603, DOI 10.1016/j.apgeochem.2010.08.012; Yang C, 1996, GEOCHIM COSMOCHIM AC, V60, P851, DOI 10.1016/0016-7037(95)00445-9; Yao GR, 2007, SCI TOTAL ENVIRON, V376, P255, DOI 10.1016/j.scitotenv.2007.01.080; YAWS CL, 2001, MATHESON GAS DATA BO; Zhang SR, 2009, SCI TOTAL ENVIRON, V407, P2796, DOI 10.1016/j.scitotenv.2008.12.036; Zhou YZ, 2015, RAPID COMMUN MASS SP, V29, P1827, DOI 10.1002/rcm.7280	74	7	9	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160964	10.1371/journal.pone.0160964	http://dx.doi.org/10.1371/journal.pone.0160964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513939	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100096
J	Matrone, C; Dzamko, N; Madsen, P; Nyegaard, M; Pohlmann, R; Sondergaard, RV; Lassen, LB; Andresen, TL; Halliday, GM; Jensen, PH; Nielsen, MS				Matrone, Carmela; Dzamko, Nicolas; Madsen, Peder; Nyegaard, Mette; Pohlmann, Regina; Sondergaard, Rikke V.; Lassen, Louise B.; Andresen, Thomas L.; Halliday, Glenda M.; Jensen, Poul Henning; Nielsen, Morten S.			Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN; CATHEPSIN-D; IN-VIVO; AMYLOIDOGENIC ROUTE; INTRACELLULAR PH; GOLGI RETRIEVAL; DISTINCT ROLES; PC12 CELLS; DEGRADATION	Increasing evidence points to defects in autophagy as a common denominator in most neurodegenerative conditions. Progressive functional decline in the autophagy-lysosomal pathway (ALP) occurs with age, and the consequent impairment in protein processing capacity has been associated with a higher risk of neurodegeneration. Defects in cathepsin D (CD) processing and alpha-synuclein degradation causing its accumulation in lysosomes are particularly relevant for the development of Parkinson's disease (PD). However, the mechanism by which alterations in CD maturation and alpha-synuclein degradation leads to autophagy defects in PD neurons is still uncertain. Here we demonstrate that MPR300 shuttling between endosomes and the trans Golgi network is altered in alpha-synuclein overexpressing neurons. Consequently, CD is not correctly trafficked to lysosomes and cannot be processed to generate its mature active form, leading to a reduced CD-mediated alpha-synuclein degradation and alpha-synuclein accumulation in neurons. MPR300 is downregulated in brain from alpha-synuclein overexpressing animal models and in PD patients with early diagnosis. These data indicate MPR300 as crucial player in the autophagy-lysosomal dysfunctions reported in PD and pinpoint MRP300 as a potential biomarker for PD.	[Matrone, Carmela; Madsen, Peder; Nyegaard, Mette; Lassen, Louise B.; Jensen, Poul Henning; Nielsen, Morten S.] Aarhus Univ, Fac Hlth, Dept Biomed, DK-8000 Aarhus C, Denmark; [Dzamko, Nicolas; Halliday, Glenda M.] Neurosci Res Australia, Sydney, NSW 2031, Australia; [Dzamko, Nicolas; Halliday, Glenda M.] Univ New South Wales, Fac Med, Sch Med Sci, Sydney, NSW 2052, Australia; [Madsen, Peder; Sondergaard, Rikke V.; Andresen, Thomas L.; Nielsen, Morten S.] Lundbeck Fdn, Res Initiat Blood Brain & Drug Delivery, DK-8000 Aarhus C, Denmark; [Pohlmann, Regina] Univ Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Sondergaard, Rikke V.; Andresen, Thomas L.] Tech Univ Denmark DTU Nanotech, DTU, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	Aarhus University; Neuroscience Research Australia; University of New South Wales Sydney; Lundbeckfonden; University of Munster; Technical University of Denmark	Nielsen, MS (corresponding author), Aarhus Univ, Fac Hlth, Dept Biomed, DK-8000 Aarhus C, Denmark.; Nielsen, MS (corresponding author), Lundbeck Fdn, Res Initiat Blood Brain & Drug Delivery, DK-8000 Aarhus C, Denmark.	matrone@biomed.au.dk	Matrone, Carmela/AAC-2966-2019; Halliday, Glenda M/E-8555-2011; Nyegaard, Mette/M-3379-2019; Matrone, Carmela/AAR-5405-2020; Dzamko, Nicolas/AAD-6922-2019; Nielsen, Morten Schallburg/G-9498-2016	Halliday, Glenda M/0000-0003-0422-8398; Nyegaard, Mette/0000-0003-4973-8543; Nielsen, Morten Schallburg/0000-0001-9863-9694; Jensen, Poul Henning/0000-0002-4439-9020; Madsen, Peder Sondergaard/0000-0002-8845-4802; Dzamko, Nicolas/0000-0002-9121-0294; Matrone, Carmela/0000-0002-6719-0107; Andresen, Thomas Lars/0000-0002-1048-127X	Danish Council [4004-00330B/FSS]; Lundbeck Foundation [R83-A6761, R151-2013 14806]; National Health and Medical Research Council of Australia (NHMRC) [1008307]; Lundbeck Foundation [R192-2015-895, R83-2011-6761] Funding Source: researchfish	Danish Council(Danish Medical Research Council); Lundbeck Foundation(Lundbeckfonden); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Lundbeck Foundation(Lundbeckfonden)	This study was funded by the Danish Council 2015 (4004-00330B/FSS to CM), by the Lundbeck Foundation (Grant no. R83-A6761 to MSN and Grant no. R151-2013 14806 to CM) and by the National Health and Medical Research Council of Australia (NHMRC project grant #1008307 to GMH). GMH is a NHMRC Senior Principal Research Fellow (#630434 & #1079679).	Benjaminsen RV, 2011, ACS NANO, V5, P5864, DOI 10.1021/nn201643f; Bobela W, 2015, BIOMOLECULES, V5, P2675, DOI 10.3390/biom5042675; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Burre J, 2015, J NEUROSCI, V35, P5221, DOI 10.1523/JNEUROSCI.4650-14.2015; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; CAPLAN MJ, 1987, NATURE, V329, P632, DOI 10.1038/329632a0; CAUSIN C, 1988, BIOCHEM J, V252, P795, DOI 10.1042/bj2520795; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Evdokimovskaya Y, 2010, CELL BIOL INT, V34, P985, DOI 10.1042/CBI20100147; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Forman MS, 2005, NEURON, V47, P479, DOI 10.1016/j.neuron.2005.07.021; Guo JL, 2014, NAT MED, V20, P130, DOI 10.1038/nm.3457; Hall H, 2014, BRAIN, V137, P2493, DOI 10.1093/brain/awu193; Hardy J, 2003, LANCET NEUROL, V2, P221, DOI 10.1016/S1474-4422(03)00350-8; Honing S, 1996, EMBO J, V15, P5230, DOI 10.1002/j.1460-2075.1996.tb00908.x; Jakobsen Lene Diness, 2003, Methods Mol Biol, V232, P57; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Jensen PH, 1999, EUR J NEUROSCI, V11, P3369, DOI 10.1046/j.1460-9568.1999.00754.x; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Kirik D, 2008, EXP NEUROL, V209, P3, DOI 10.1016/j.expneurol.2007.12.007; Klinger SC, 2011, J CELL SCI, V124, P1095, DOI 10.1242/jcs.072538; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; la Rosa LR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00109; Leksa V, 2011, CIRC RES, V108, P676, DOI 10.1161/CIRCRESAHA.110.234732; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lykkebo S, 2002, NEUROMOL MED, V2, P115, DOI 10.1385/NMM:2:2:115; MANTLE D, 1995, J NEUROL SCI, V131, P65, DOI 10.1016/0022-510X(95)00035-Z; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Matrone C, 2008, J ALZHEIMERS DIS, V13, P81; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Meyer C, 2001, J CELL SCI, V114, P4469; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Pepperkok R, 2005, METHOD ENZYMOL, V404, P8, DOI 10.1016/S0076-6879(05)04002-4; Petit GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060691; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sondergaard RV, 2014, NAT PROTOC, V9, P2841, DOI 10.1038/nprot.2014.196; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Struhal W, 2014, J NEURAL TRANSM, V121, P755, DOI 10.1007/s00702-014-1179-1; Sun HH, 2011, CHEM COMMUN, V47, P5268, DOI 10.1039/c1cc10439j; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Umeda A, 2003, J LIPID RES, V44, P1821, DOI 10.1194/jlr.M300153-JLR200; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vargas KJ, 2014, J NEUROSCI, V34, P9364, DOI 10.1523/JNEUROSCI.4787-13.2014; Westerlund M, 2008, MOL CELL NEUROSCI, V39, P586, DOI 10.1016/j.mcn.2008.08.001; Yelamanchili SV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-52; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	65	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160501	10.1371/journal.pone.0160501	http://dx.doi.org/10.1371/journal.pone.0160501			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509067	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400034
J	Xiong, HZ; Shi, AN; Mou, BQ; Qin, J; Motes, D; Lu, WG; Ma, JB; Weng, YJ; Yang, W; Wu, DX				Xiong, Haizheng; Shi, Ainong; Mou, Beiquan; Qin, Jun; Motes, Dennis; Lu, Weiguo; Ma, Jianbing; Weng, Yuejin; Yang, Wei; Wu, Dianxing			Genetic Diversity and Population Structure of Cowpea (Vigna unguiculata L. Walp)	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENUS VIGNA; GERMPLASM; SNP; SSR; WILD; DNA; ACCESSIONS; PROGRAMS; MARKERS	The genetic diversity of cowpea was analyzed, and the population structure was estimated in a diverse set of 768 cultivated cowpea genotypes from the USDA GRIN cowpea collection, originally collected from 56 countries. Genotyping by sequencing was used to discover single nucleotide polymorphism (SNP) in cowpea and the identified SNP alleles were used to estimate the level of genetic diversity, population structure, and phylogenetic relationships. The aim of this study was to detect the gene pool structure of cowpea and to determine its relationship between different regions and countries. Based on the model-based ancestry analysis, the phylogenetic tree, and the principal component analysis, three well-differentiated genetic populations were postulated from 768 worldwide cowpea genotypes. According to the phylogenetic analyses between each individual, region, and country, we may trace the accession from off-original, back to the two candidate original areas (West and East of Africa) to predict the migration and domestication history during the cowpea dispersal and development. To our knowledge, this is the first report of the analysis of the genetic variation and relationship between globally cultivated cowpea genotypes. The results will help curators, researchers, and breeders to understand, utilize, conserve, and manage the collection for more efficient contribution to international cowpea research.	[Xiong, Haizheng; Shi, Ainong; Qin, Jun; Lu, Weiguo; Ma, Jianbing; Weng, Yuejin; Yang, Wei] Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA; [Mou, Beiquan] ARS, USDA, Salinas, CA 93905 USA; [Motes, Dennis] Univ Arkansas, Vegetable Res Ctr, Alma, AR USA; [Xiong, Haizheng; Wu, Dianxing] Zhejiang Univ, State Key Lab Rice Biol, IAEA Collaborating Ctr, Hangzhou, Zhejiang, Peoples R China	University of Arkansas System; University of Arkansas Fayetteville; United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville; Zhejiang University	Shi, AN (corresponding author), Univ Arkansas, Dept Hort, Fayetteville, AR 72701 USA.; Mou, BQ (corresponding author), ARS, USDA, Salinas, CA 93905 USA.	ashi@uark.edu; Beiquan.Mou@ars.usda.gov	xiong, hai/GVT-7305-2022; Shi, Ainong/L-6384-2017; Lu, Wei/AAE-2921-2022	Shi, Ainong/0000-0002-1066-7920; Lu, Wei/0000-0002-4150-8674	USDA National Institute of Food and Agriculture Hatch project [1002423]; ARS [ARS-0424945] Funding Source: Federal RePORTER	USDA National Institute of Food and Agriculture Hatch project; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	USDA National Institute of Food and Agriculture Hatch project accession number 1002423.; Cowpea germplasm accessions were provided by USDA-ARS Station at GRIFFIN, GA. The cowpea_Genome_0.03.fa (6,750 scaffolds or contigs) (http://harvest-blast.org/) was kindly provided by Dr. Timothy J. Close, University of California, U.S.A. This work is supported, at least in part, by the USDA National Institute of Food and Agriculture Hatch project accession number 1002423.	Ajibade SR, 2000, EUPHYTICA, V111, P47, DOI 10.1023/A:1003763328768; Ali Z. B., 2015, African Journal of Plant Science, V9, P293; Asare AT, 2010, PLANT GENET RESOUR-C, V8, P142, DOI 10.1017/S1479262110000092; Ba FS, 2004, GENET RESOUR CROP EV, V51, P539, DOI 10.1023/B:GRES.0000024158.83190.4e; Baudoin J, 1985, COWPEA RES PRODUCTIO, P3; Behura R, 2015, METHODS MOL BIOL, V1223, P255, DOI 10.1007/978-1-4939-1695-5_20; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Coulibaly S, 2002, THEOR APPL GENET, V104, P358, DOI 10.1007/s001220100740; Deulvot C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-468; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egbadzor KF, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-541; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang JG, 2007, GENET RESOUR CROP EV, V54, P1197, DOI 10.1007/s10722-006-9101-9; FARIS DG, 1964, CAN J GENET CYTOL, V6, P255, DOI 10.1139/g64-033; FATOKUN CA, 1993, THEOR APPL GENET, V86, P97, DOI 10.1007/BF00223813; Gupta SK, 2010, GENOME, V53, P508, DOI [10.1139/G10-028, 10.1139/g10-028]; Huynh BL, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.03.0005; Iquira E, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0408-y; Kaga A, 1996, EUPHYTICA, V88, P17, DOI 10.1007/BF00029261; Kapoor-Vijay P., 1992, Conservation biology: a training manual for biological diversity and genetic resources., P13; Li, 2012, J LIFE SCI, V6; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Malviya N, 2012, PLANT SYST EVOL, V298, P523, DOI 10.1007/s00606-011-0545-9; Marechal R, 1978, ETUDE TAXONOMIQUE GR; Meglic V, 1996, THEOR APPL GENET, V92, P865, DOI 10.1007/BF00221899; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; Ng N, 1995, EVOLUTION CROP PLANT; Nimmakayala P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-767; Ogunkanmi LA, 2008, J FOOD AGRIC ENVIRON, V6, P263; Pant K. C., 1982, SABRAO Journal, V14, P103; Pritchard JK, 2000, GENETICS, V155, P945; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Simon MV, 2007, GENOME, V50, P538, DOI 10.1139/G07-029; Singh B. B., 1997, Advances in cowpea research, P30; Smartt J., 1986, EXPT AGR, V22, P431, DOI [10.1017/S001447970001468X, DOI 10.1017/S001447970001468X]; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Steele W., 1976, EVOLUTION CROP PLANT; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanhuanpaa P, 2012, HEREDITAS, V149, P114, DOI 10.1111/j.1601-5223.2012.02244.x; Varshney RK, 2007, PLANT SCI, V173, P638, DOI 10.1016/j.plantsci.2007.08.010; Xu P, 2012, HEREDITY, V109, P34, DOI 10.1038/hdy.2012.8; Zannouou A, 2008, AFRICAN J BIOTECHNOL, V7	47	68	72	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160941	10.1371/journal.pone.0160941	http://dx.doi.org/10.1371/journal.pone.0160941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509049	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400070
J	Yu, M; King, B; Ewert, E; Su, XY; Mardiyati, N; Zhao, ZH; Wang, WQ				Yu, Miao; King, Brenee; Ewert, Emily; Su, Xiaoyu; Mardiyati, Nur; Zhao, Zhihui; Wang, Weiqun			Exercise Activates p53 and Negatively Regulates IGF-1 Pathway in Epidermis within a Skin Cancer Model	PLOS ONE			English	Article							DIETARY CALORIE RESTRICTION; PHYSICAL-ACTIVITY; WEIGHT CONTROL; PROTEIN; PREVENTION; GROWTH; CARCINOGENESIS; MECHANISMS; INDUCTION; PI3K-AKT	Exercise has been previously reported to lower cancer risk through reducing circulating IGF-1 and IGF-1-dependent signaling in a mouse skin cancer model. This study aims to investigate the underlying mechanisms by which exercise may down-regulate the IGF-1 pathway via p53 and p53-related regulators in the skin epidermis. Female SENCAR mice were pair-fed an AIN-93 diet with or without 10-week treadmill exercise at 20 m/min, 60 min/day and 5 days/week. Animals were topically treated with TPA 2 hours before sacrifice and the target proteins in the epidermis were analyzed by both immunohistochemistry and Western blot. Under TPA or vehicle treatment, MDM2 expression was significantly reduced in exercised mice when compared with sedentary control. Meanwhile, p53 was significantly elevated. In addition, p53-transcriptioned proteins, i.e., p21, IGFBP-3, and PTEN, increased in response to exercise. There was a synergy effect between exercise and TPA on the decreased MDM2 and increased p53, but not p53-transcripted proteins. Taken together, exercise appeared to activate p53, resulting in enhanced expression of p21, IGFBP-3, and PTEN that might induce a negative regulation of IGF-1 pathway and thus contribute to the observed cancer prevention by exercise in this skin cancer model.	[Yu, Miao; King, Brenee; Ewert, Emily; Su, Xiaoyu; Mardiyati, Nur; Wang, Weiqun] Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA; [Zhao, Zhihui] Shanghai Acad Agr Sci, Inst Agri Food Stand & Testing Technol, Shanghai, Peoples R China	Kansas State University; Shanghai Academy of Agricultural Sciences	Wang, WQ (corresponding author), Kansas State Univ, Dept Food Nutr Dietet & Hlth, Manhattan, KS 66506 USA.	wwang@ksu.edu			NIH-National Cancer Institute [CA167678]	NIH-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant to WW from NIH-National Cancer Institute, CA167678. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken J, 2016, FASEB J, V30, P1120, DOI 10.1096/fj.15-276964; Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; ASHENDEL CL, 1985, BIOCHIM BIOPHYS ACTA, V822, P219, DOI 10.1016/0304-4157(85)90009-7; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; Corbit KC, 2000, MOL CELL BIOL, V20, P5392, DOI 10.1128/MCB.20.15.5392-5403.2000; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Grimberg A, 2000, MOL GENET METAB, V70, P85, DOI 10.1006/mgme.2000.3008; Higgins KA, 2014, CANCER-AM CANCER SOC, V120, P3302, DOI 10.1002/cncr.28878; Howard RA, 2009, CANCER CAUSE CONTROL, V20, P323, DOI 10.1007/s10552-008-9246-2; Jiang WD, 1999, ONCOGENE, V18, P4247, DOI 10.1038/sj.onc.1202789; Jiang Y., 2012, J NUTR FOOD SCI, VS2, P1, DOI [10.4172/2155-9600.S2-003, DOI 10.4172/2155-9600.S2-003]; Jiang Yu, 2008, Biophysical Reviews and Letters, V3, P421; King B, 2013, EXP BIOL MED, V238, P502, DOI 10.1177/1535370213480695; King BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116398; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kruk J, 2013, ASIAN PAC J CANCER P, V14, P3993, DOI 10.7314/APJCP.2013.14.7.3993; Leung PS, 2004, J APPL PHYSIOL, V96, P450, DOI 10.1152/japplphysiol.00871.2003; Lu S, 2006, INT J ONCOL, V28, P245; Lunz W, 2008, BRAZ J MED BIOL RES, V41, P1000, DOI 10.1590/S0100-879X2008001100009; Lynch BM, 2011, RECENT RESULTS CANC, V186, P13, DOI 10.1007/978-3-642-04231-7_2; Michna L, 2006, CARCINOGENESIS, V27, P2108, DOI 10.1093/carcin/bgl057; Moll UM, 2003, MOL CANCER RES, V1, P1001; Ouyang P, 2010, CANCER PREV RES, V3, P466, DOI 10.1158/1940-6207.CAPR-09-0021; Piguet AC, 2015, J HEPATOL, V62, P1296, DOI 10.1016/j.jhep.2015.01.017; Przybyszewski J, 2001, CARCINOGENESIS, V22, P1421, DOI 10.1093/carcin/22.9.1421; Roudier E, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.28; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Standard J, 2014, J NUTR BIOCHEM, V25, P1317, DOI 10.1016/j.jnutbio.2014.07.010; Tucci P, 2012, AGING-US, V4, P525, DOI 10.18632/aging.100481; WALDMAN T, 1995, CANCER RES, V55, P5187; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4; Xie LL, 2007, J BIOL CHEM, V282, P28025, DOI 10.1074/jbc.M604857200; Xie LL, 2013, EXP BIOL MED, V238, P127, DOI 10.1177/1535370213477602	37	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160939	10.1371/journal.pone.0160939	http://dx.doi.org/10.1371/journal.pone.0160939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509024	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400069
J	Chen, X; Zhong, SL; Lu, P; Wang, DD; Zhou, SY; Yang, SJ; Shen, HY; Zhang, L; Zhang, XH; Zhao, JH; Tang, JH				Chen, Xiu; Zhong, Shan-liang; Lu, Peng; Wang, Dan-dan; Zhou, Si-ying; Yang, Su-jin; Shen, Hong-yu; Zhang, Lei; Zhang, Xiao-hui; Zhao, Jian-hua; Tang, Jin-hai			miR-4443 Participates in the Malignancy of Breast Cancer	PLOS ONE			English	Article							MICRORNAS; EXPRESSION; MIR-B-10; TUMOR; PROGRESSION; METASTASIS; CELLS	Purpose Chemo-resistance is the leading cause of failure in cancer therapy, however, much remains to be understood about the intrinsic mechanisms. In the present study, we discovered the novel miR-4443 that regulated malignancy of breast cancer both in vitro and in vivo. Methods We examined the expression of miR-4443 in MDA-MB-231/S and MDA-MB-231 Epirubicin-resistant cell lines with 76 breast cancer formalin-fixed paraffin-embedded tissues by real-time PCR. Also, we investigated the loss- and gain-functions of miR-4443 by MTT assay and flow cytometry. Furthermore, we detected miR-4443 mediated tissue inhibitor of metalloproteinase 2 expression in cells by TargetScan, RT-qPCR and western blot. Results We identified the up-regulated expression of miR-4443 in Epi-resistant cell lines versus MDA-MB-231/S cell(Epi versus S) and in post-chemotherapy FFPE tissues, along with statistically differential expressions in PR(partial response) versus SD(stable disease)/PD(progressive disease) patients. Overexpression of miR-4443 increased the IC50 value of Epi for the target cells transfected, while inhibition of miR-4443 could restored sensitivity of the target cells to Epi. Besides, down-regulation of endogenous miR-4443 by miRNA-inhibitors significantly enhanced Epi-induced apoptosis while up-regulation of miR-4443 by miRNA-mimics lead to less Epi-induced apoptotic cells. Consequently, changes in TIMP2 mRNA and protein expression revealed that miR-4443 mimics suppressed expression of TIMP2 and induced migration in breast cancer cells. Furthermore, TIMP2 expression associated with better prognosis(HR = 0.721, 95% CI: 0.529-0.983). Conclusions We revealed that miR-4443 induced malignancy of breast cancer mainly in chemo-resistance aspect for the very first time, providing a novel biomarker in breast cancer diagnosis and therapy.	[Chen, Xiu] Nanjing Med Univ, Sch Clin 4, Nanjing, Jiangsu, Peoples R China; [Chen, Xiu; Wang, Dan-dan; Zhou, Si-ying; Yang, Su-jin; Shen, Hong-yu; Zhang, Lei; Tang, Jin-hai] Nanjing Med Univ, Jiangsu Canc Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Zhong, Shan-liang; Zhang, Xiao-hui; Zhao, Jian-hua] Nanjing Med Univ, Jiangsu Canc Hosp, Ctr Clin Lab Sci, Nanjing, Jiangsu, Peoples R China; [Lu, Peng] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Tang, Jin-hai] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Tang, JH (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.; Zhao, JH (corresponding author), Nanjing Med Univ, Jiangsu Canc Hosp, Ctr Clin Lab Sci, Nanjing, Jiangsu, Peoples R China.; Tang, JH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China.	jsccljhzhao@126.com; jschjhtang@163.com	yang, su/AGI-3961-2022		National Natural Science Foundation of China [81272470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81272470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2010, NATURE, V464, P1227, DOI 10.1038/4641227a; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen J, 2014, CLIN TRANSL ONCOL, V16, P225, DOI 10.1007/s12094-013-1132-z; Chen X, 2015, TUMOR BIOL, V36, P8259, DOI 10.1007/s13277-015-4027-5; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Flamini V, 2016, CRIT REV ONCOL HEMAT, V100, P177, DOI 10.1016/j.critrevonc.2016.02.010; Guestini F, 2016, EXPERT OPIN THER TAR, V20, P705, DOI 10.1517/14728222.2016.1125469; Jang K, 2014, TRANSL RES, V163, P242, DOI 10.1016/j.trsl.2013.11.005; Lei R, 2014, ONCOGENE, V33, P1287, DOI 10.1038/onc.2013.65; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Palumbo S, 2014, J CELL PHYSIOL, V229, P277, DOI 10.1002/jcp.24446; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Qin WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009429; Ren CL, 2016, INT J CANCER, V138, P1586, DOI 10.1002/ijc.29679; Sudarshan VK, 2016, COMPUT BIOL MED, V69, P97, DOI 10.1016/j.compbiomed.2015.12.006; Tang J, 2014, CURR PHARM DESIGN, V20, P5268, DOI 10.2174/1381612820666140128205239; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Vidula N, 2016, CLIN BREAST CANCER, V16, P8, DOI 10.1016/j.clbc.2015.07.005; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Xu J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-114; Xun M, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0288-2; Yigit MV, 2013, ONCOGENE, V32, P1530, DOI 10.1038/onc.2012.173; Zhong SL, 2016, ONCOTARGET, V7, P19601, DOI 10.18632/oncotarget.7481	24	27	30	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160780	10.1371/journal.pone.0160780	http://dx.doi.org/10.1371/journal.pone.0160780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504971	Green Submitted, gold, Green Published			2022-12-26	WOS:000381374200062
J	Cisler, JM; Sigel, BA; Kramer, TL; Smitherman, S; Vanderzee, K; Pemberton, J; Kilts, CD				Cisler, Josh M.; Sigel, Benjamin A.; Kramer, Teresa L.; Smitherman, Sonet; Vanderzee, Karin; Pemberton, Joy; Kilts, Clinton D.			Modes of Large-Scale Brain Network Organization during Threat Processing and Posttraumatic Stress Disorder Symptom Reduction during TF-CBT among Adolescent Girls	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; CHILDREN; CONNECTIVITY; DEPRESSION; MODULARITY	Posttraumatic stress disorder (PTSD) is often chronic and disabling across the lifespan. The gold standard treatment for adolescent PTSD is Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT), though treatment response is variable and mediating neural mechanisms are not well understood. Here, we test whether PTSD symptom reduction during TFCBT is associated with individual differences in large-scale brain network organization during emotion processing. Twenty adolescent girls, aged 11-16, with PTSD related to assaultive violence completed a 12-session protocol of TF-CBT. Participants completed an emotion processing task, in which neutral and fearful facial expressions were presented either overtly or covertly during 3T fMRI, before and after treatment. Analyses focused on characterizing network properties of modularity, assortativity, and global efficiency within an 824 region-of-interest brain parcellation separately during each of the task blocks using weighted functional connectivity matrices. We similarly analyzed an existing dataset of healthy adolescent girls undergoing an identical emotion processing task to characterize normative network organization. Pre-treatment individual differences in modularity, assortativity, and global efficiency during covert fear vs neutral blocks predicted PTSD symptom reduction. Patients who responded better to treatment had greater network modularity and assortativity but lesser efficiency, a pattern that closely resembled the control participants. At a group level, greater symptom reduction was associated with greater pre-to-post-treatment increases in network assortativity and modularity, but this was more pronounced among participants with less symptom improvement. The results support the hypothesis that modularized and resilient brain organization during emotion processing operate as mechanisms enabling symptom reduction during TF-CBT.	[Cisler, Josh M.; Sigel, Benjamin A.; Kramer, Teresa L.; Smitherman, Sonet; Vanderzee, Karin; Pemberton, Joy; Kilts, Clinton D.] Univ Arkansas Med Sci, Dept Psychiat, Brain Imaging Res Ctr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Cisler, JM (corresponding author), Univ Arkansas Med Sci, Dept Psychiat, Brain Imaging Res Ctr, Little Rock, AR 72205 USA.	jcisler@uams.edu	Cisler, Josh/L-8940-2016; Vanderzee, Karin/AAC-6683-2019	Vanderzee, Karin/0000-0001-9664-5652	NARSAD Young Investigator Award;  [1R21MH097784]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA022981] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Portions of this work were supported through grants 1R21MH097784 and a NARSAD Young Investigator Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of National Institute for Mental Health, National Institutes of Health, or Brain and Behavior Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admon R, 2013, TRENDS COGN SCI, V17, P337, DOI 10.1016/j.tics.2013.05.005; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Brownell R., 2001, RECEPTIVE ONE WORD P; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2010, BRAIN GRAPHS GRAPHIC, DOI [10.1146/annurev-clinpsy-040510-143934, DOI 10.1146/ANNUREV-CLINPSY-040510-143934]; Cary CE, 2012, CHILD YOUTH SERV REV, V34, P748, DOI 10.1016/j.childyouth.2012.01.003; Cisler JM, 2015, J PSYCHIATR RES, V71, P33, DOI 10.1016/j.jpsychires.2015.09.011; Cisler JM, 2014, NEUROIMAGE, V84, P1042, DOI 10.1016/j.neuroimage.2013.09.018; Cohen JA, 2010, PRACTICE PARAMETER A, P414; Cohen JA, 2004, MULTISITE RANDOMIZED, P393, DOI [10.1097/00004583-200404000-00005, DOI 10.1097/00004583-200404000-00005]; Cohen JA, 2011, ARCH PEDIAT ADOL MED, V165, P16, DOI 10.1001/archpediatrics.2010.247; Costafreda Sergi G, 2009, Front Neuroinform, V3, P33, DOI 10.3389/neuro.11.033.2009; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heller AS, 2013, JAMA PSYCHIAT, V70, P1181, DOI 10.1001/jamapsychiatry.2013.2430; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Kilpatrick DG, 2003, VIOLENCE RISK PTSD M, P692; Kilpatrick DG, 2000, RISK FACTORS ADOLESC, P19; Lei D, 2015, RADIOLOGY, V276, P818, DOI 10.1148/radiol.15141700; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Olatunji BO, 2007, CLIN PSYCHOL REV, V27, P572, DOI 10.1016/j.cpr.2007.01.015; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045103; Patel R, 2012, NEUROSCI BIOBEHAV R, V36, P2130, DOI 10.1016/j.neubiorev.2012.06.003; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Rissman J, 2004, MEASURING FUNCTIONAL, P752, DOI [10.1016/j.neuroimage, DOI 10.1016/J.NEUROIMAGE]; Rubinov M, 2010, COMPLEX NET IN PRESS, P1059, DOI [10.1016/j.neuroimage.2009.10.003, DOI 10.1016/J.NEUROIMAGE.2009.10.003]; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Servaas MN, 2015, NEUROPSYCHOPHARMACOL, V40, P296, DOI 10.1038/npp.2014.169; Shin DJ, 2014, BIOL PSYCHIAT, V75, P606, DOI 10.1016/j.biopsych.2013.09.002; Smith SM, 2012, FUTURE FMRI CONNECTI, P1257, DOI [10.1016/j.neuroimage.2012.01.022, DOI 10.1016/J.NEUROIMAGE.2012.01.022]; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Steinberg AM, 2004, U CALIFORNIA LOS ANG, V2004, P96; Suo XL, 2015, HUM BRAIN MAPP, V36, P3677, DOI 10.1002/hbm.22871; Variano EA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.188701; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Williams LM, 2006, HUM BRAIN MAPP, V27, P652, DOI 10.1002/hbm.20208	46	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159620	10.1371/journal.pone.0159620	http://dx.doi.org/10.1371/journal.pone.0159620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IK	27505076	Green Submitted, gold, Green Published			2022-12-26	WOS:000381374200010
J	Coelho, CRV; Pernollet, F; van der Werf, HMG				Coelho, Carla R. V.; Pernollet, Franck; van der Werf, Hayo M. G.			Environmental Life Cycle Assessment of Diets with Improved Omega-3 Fatty Acid Profiles	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; FATTY-ACIDS; HEALTHY; VEGETARIANS; SUSTAINABILITY	A high incidence of cardiovascular disease is observed worldwide, and dietary habits are one of the risk factors for these diseases. Omega-3 polyunsaturated fatty acids in the diet help to prevent cardiovascular disease. We used life cycle assessment to analyse the potential of two strategies to improve the nutritional and environmental characteristics of French diets: 1) modifying diets by changing the quantities and proportions of foods and 2) increasing the omega-3 contents in diets by replacing mainly animal foods with equivalent animal foods having higher omega-3 contents. We also investigated other possibilities for reducing environmental impacts. Our results showed that a diet compliant with nutritional recommendations for macronutrients had fewer environmental impacts than the current average French diet. Moving from an omnivorous to a vegetarian diet further reduced environmental impacts. Increasing the omega-3 contents in animal rations increased Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) in animal food products. Providing these enriched animal foods in human diets increased their EPA and DHA contents without affecting their environmental impacts. However, in diets that did not contain fish, EPA and DHA contents were well below the levels recommended by health authorities, despite the inclusion of animal products enriched in EPA and DHA. Reducing meat consumption and avoidable waste at home are two main avenues for reducing environmental impacts of diets.	[Coelho, Carla R. V.; Pernollet, Franck; van der Werf, Hayo M. G.] INRA, SAS, Agrocampus Ouest, Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	van der Werf, HMG (corresponding author), INRA, SAS, Agrocampus Ouest, Rennes, France.	hayo.van-der-werf@inra.fr	Coelho, Carla R. V./AAF-7760-2020; van der Werf, Hayo/L-7764-2013; SAS, ASAE UMR/M-4978-2013	Coelho, Carla R. V./0000-0001-9902-1095; van der Werf, Hayo/0000-0003-3561-3352; SAS, ASAE UMR/0000-0001-6346-7845; Pernollet, Franck/0000-0003-0503-320X	ANR, the French National Research Agency; AGRALID project [ANR-12-ALID-0003]	ANR, the French National Research Agency(French National Research Agency (ANR)); AGRALID project	This study was funded by ANR, the French National Research Agency (http://www.agence-nationale-recherche.fr/). It was part of the AGRALID project ANR-12-ALID-0003, a multidisciplinary project which proposes sustainable dietary menus as an alternative to current practices and nutritional recommendations by considering nutritional, environmental and socio-economic dimensions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarme-Vega TC, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-96; Agostoni C, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1461; ANSES, 2011, REPORT NO CONTRACT N; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Audsley E, 2009, HOW LOW CAN WE GO AN; Beretta C, 2013, WASTE MANAGE, V33, P764, DOI 10.1016/j.wasman.2012.11.007; Bourre JM, 2005, M S-MED SCI, V21, P773, DOI 10.1051/medsci/2005218-9773; Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119; Chilliard Y, 2009, J DAIRY SCI, V92, P5199, DOI 10.3168/jds.2009-2375; Clonan A, 2012, PUBLIC HEALTH NUTR, V15, P277, DOI 10.1017/S1368980011000930; CREDOC. Centre de recherche pour l'etude et l'observation des conditions de vie, 2015, RESEARCH CENTER FOR; Crowe FL, 2013, AM J CLIN NUTR, V97, P597, DOI 10.3945/ajcn.112.044073; FAOSTAT, 2012, THE STATE OF FISHERI; Fraser GE, 2009, AM J CLIN NUTR, V89, pS1607, DOI 10.3945/ajcn.2009.26736K; Green R, 2015, CLIMATIC CHANGE, V129, P253, DOI 10.1007/s10584-015-1329-y; Harris WS, 2014, AM J CLIN NUTR, V100, p449S, DOI 10.3945/ajcn.113.071324; Heijungs R, 1992, ENVIRONMENTAL LIFE C; Huang T, 2012, ANN NUTR METAB, V60, P233, DOI 10.1159/000337301; Huijbregts M.A.J., 2000, J IND ECOL, V4, P75, DOI [10.1162/108819800300106393, DOI 10.1162/108819800300106393]; ISSFAL, 2004, RECOMMENDATIONS FOR; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Langlois J, 2014, J CLEAN PROD, V73, P63, DOI 10.1016/j.jclepro.2014.01.087; Macdiarmid JI, 2013, P NUTR SOC, V72, P13, DOI 10.1017/S0029665112002893; Martin A, 2001, APPORTS NUTRITIONNEL; Meier T, 2013, ENVIRON SCI TECHNOL, V47, P877, DOI 10.1021/es302152v; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nguyen TLT, 2012, J CLEAN PROD, V28, P168, DOI 10.1016/j.jclepro.2011.08.018; Nichols M, 2014, COMPOSITION NUTRITIO, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Pernollet F, J CLEAN PROD; Quested T, 2013, HOUSEHOLD FOOD AND D; Roos E, 2015, ENVIRON SCI POLICY, V47, P157, DOI 10.1016/j.envsci.2014.12.001; Salou T, 2014, AGRIBALYSE METHODOLO; Saxe H, 2013, CLIMATIC CHANGE, V116, P249, DOI 10.1007/s10584-012-0495-4; Tillman A-M, 2004, AN ORIENTATION IN LI; UNEP, 2015, UNITED NATIONS ENVIR; van Dooren C, 2014, FOOD POLICY, V44, P36, DOI 10.1016/j.foodpol.2013.11.002; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	38	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160397	10.1371/journal.pone.0160397	http://dx.doi.org/10.1371/journal.pone.0160397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504959	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200035
J	DeLaughter, DM; Clark, CR; Christodoulou, DC; Seidman, CE; Baldwin, HS; Seidman, JG; Barnett, JV				DeLaughter, Daniel M.; Clark, Cynthia R.; Christodoulou, Danos C.; Seidman, Christine E.; Baldwin, H. Scott; Seidman, J. G.; Barnett, Joey V.			Transcriptional Profiling of Cultured, Embryonic Epicardial Cells Identifies Novel Genes and Signaling Pathways Regulated by TGF beta R3 In Vitro	PLOS ONE			English	Article							TGF-BETA RECEPTOR; CORONARY VESSEL DEVELOPMENT; NF-KAPPA-B; GROWTH-FACTOR; CHONDROITIN SULFATE; HEART DEVELOPMENT; HYALURONAN-BINDING; CYTOPLASMIC DOMAIN; ENDOTHELIAL-CELLS; III RECEPTOR	The epicardium plays an important role in coronary vessel formation and Tgfbr3(-/-) mice exhibit failed coronary vessel development associated with decreased epicardial cell invasion. Immortalized Tgfbr3(-/-) epicardial cells display the same defects. Tgfbr3(+/+) and Tgfbr3(-/-) cells incubated for 72 hours with VEH or ligands known to promote invasion via TGF beta R3 (TGF beta 1, TGF beta 2, BMP2), for 72 hours were harvested for RNA-seq analysis. We selected for genes >2-fold differentially expressed between Tgfbr3(+/+) and Tgfbr3(-/-) cells when incubated with VEH (604), TGF beta 1 (515), TGF beta 2 (553), or BMP2 (632). Gene Ontology (GO) analysis of these genes identified dysregulated biological processes consistent with the defects observed in Tgfbr3(-/-) cells, including those associated with extracellular matrix interaction. GO and Gene Regulatory Network (GRN) analysis identified distinct expression profiles between TGF beta 1-TGF beta 2 and VEH-BMP2 incubated cells, consistent with the differential response of epicardial cells to these ligands in vitro. Despite the differences observed between Tgfbr3(+/+) and Tgfbr3(-/-) cells after TGF beta and BMP ligand addition, GRNs constructed from these gene lists identified NF-kB as a key nodal point for all ligands examined. Tgfbr3(-/-) cells exhibited decreased expression of genes known to be activated by NF-kB signaling. NF-kB activity was stimulated in Tgfbr3(+/+) epicardial cells after TGF beta 2 or BMP2 incubation, while Tgfbr3(-/-) cells failed to activate NF-kB in response to these ligands. Tgfbr3(+/+) epicardial cells incubated with an inhibitor of NF-kB signaling no longer invaded into a collagen gel in response to TGF beta 2 or BMP2. These data suggest that NF-kB signaling is dysregulated in Tgfbr3(-/-) epicardial cells and that NF-kB signaling is required for epicardial cell invasion in vitro. Our approach successfully identified a signaling pathway important in epicardial cell behavior downstream of TGF beta R3. Overall, the genes and signaling pathways identified through our analysis yield the first comprehensive list of candidate genes whose expression is dependent on TGF beta R3 signaling.	[DeLaughter, Daniel M.; Baldwin, H. Scott] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Clark, Cynthia R.; Barnett, Joey V.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Christodoulou, Danos C.; Seidman, J. G.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Seidman, Christine E.] Harvard Med Sch, Boston, MA USA; [Baldwin, H. Scott] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vanderbilt University	Barnett, JV (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	joey.barnett@vanderbilt.edu			Roadmap for Medical Research/Common Fund, Systems-based Consortium for Organ Design and Engineering, NIH [U54 092551]; NHLBI Cardiac Development Consortium [1U01HL098166]; American Heart Association [13GRNT16690001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105334, UM1HL098166, R01HL075852] Funding Source: NIH RePORTER	Roadmap for Medical Research/Common Fund, Systems-based Consortium for Organ Design and Engineering, NIH; NHLBI Cardiac Development Consortium; American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Roadmap for Medical Research/Common Fund, Systems-based Consortium for Organ Design and Engineering, NIH U54 092551 (DMD, HSB, JGS, JVB), https://commonfund.nih.gov/; NHLBI Cardiac Development Consortium 1U01HL098166 (JGS), http://www.nhlbi.nih.gov/; and American Heart Association Grant-in-Aid 13GRNT16690001 (JVB), http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P, 2015, CELL SIGNAL, V27, P453, DOI 10.1016/j.cellsig.2014.11.037; Attar MA, 2012, EXP CELL RES, V318, P228, DOI 10.1016/j.yexcr.2011.10.018; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Blobe GC, 2001, J BIOL CHEM, V276, P24627, DOI 10.1074/jbc.M100188200; Blobe GC, 2001, J BIOL CHEM, V276, P39608, DOI 10.1074/jbc.M106831200; Bochmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011429; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Buermans HPJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015504; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Clark CR, 2016, CELL SIGNAL, V28, P688, DOI 10.1016/j.cellsig.2016.03.004; Cole WC, 2011, ARCH BIOCHEM BIOPHYS, V510, P160, DOI 10.1016/j.abb.2011.02.024; Compton LA, 2007, CIRC RES, V101, P784, DOI 10.1161/CIRCRESAHA.107.152082; Craig EA, 2010, EXP CELL RES, V316, P3397, DOI 10.1016/j.yexcr.2010.07.006; Craig EA, 2010, CELL SIGNAL, V22, P968, DOI 10.1016/j.cellsig.2010.02.004; Craig EA, 2009, GLYCOBIOLOGY, V19, P890, DOI 10.1093/glycob/cwp064; Criswell TL, 2008, CANCER RES, V68, P7304, DOI 10.1158/0008-5472.CAN-07-6777; Criswell TL, 2007, J BIOL CHEM, V282, P32491, DOI 10.1074/jbc.M704434200; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gittenberger-de Groot AC, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.002; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Guadix JA, 2006, DEV DYNAM, V235, P1014, DOI 10.1002/dvdy.20685; Hill CR, 2012, CELL SIGNAL, V24, P1012, DOI 10.1016/j.cellsig.2011.12.022; Ishii Y, 2010, DEV CELL, V19, P307, DOI 10.1016/j.devcel.2010.07.017; KALMAN F, 1995, ANAT EMBRYOL, V191, P451, DOI 10.1007/BF00304430; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Lie-Venema H, 2008, DIFFERENTIATION, V76, P809, DOI 10.1111/j.1432-0436.2007.00262.x; Lim SY, 2012, 2012 IEEE ANT PROP S, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0032705P0NE-D-11-19939; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; MANNER J, 1993, ANAT EMBRYOL, V187, P281; Masuda M, 2010, J BIOL CHEM, V285, P15511, DOI 10.1074/jbc.M109.076653; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; Moore AW, 1999, DEVELOPMENT, V126, P1845; Moore AW, 1998, MECH DEVELOP, V79, P169, DOI 10.1016/S0925-4773(98)00188-9; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Nesbitt TL, 2007, IN VITRO CELL DEV-AN, V43, P10, DOI 10.1007/s11626-006-9007-z; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Olivey HE, 2004, TRENDS CARDIOVAS MED, V14, P247, DOI 10.1016/j.tcm.2004.07.001; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perego C, 2002, J CELL SCI, V115, P3331; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Ricciardelli C, 2009, CANCER METAST REV, V28, P233, DOI 10.1007/s10555-009-9182-y; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Ruffell B, 2005, BIOCHEM BIOPH RES CO, V334, P306, DOI 10.1016/j.bbrc.2005.06.108; Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790; SAGGIN L, 1989, J BIOL CHEM, V264, P16299; SAGGIN L, 1988, J BIOL CHEM, V263, P18488; Sanchez NS, 2012, CELL SIGNAL, V24, P539, DOI 10.1016/j.cellsig.2011.10.006; Sanchez NS, 2011, DEV BIOL, V358, P331, DOI 10.1016/j.ydbio.2011.08.008; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Schlueter J, 2006, DEV BIOL, V295, P546, DOI 10.1016/j.ydbio.2006.03.036; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Sridurongrit S, 2008, DEV BIOL, V322, P208, DOI 10.1016/j.ydbio.2008.07.038; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; TIDBALL JG, 1992, J BIOL CHEM, V267, P21211; Tjew SL, 2005, GLYCOBIOLOGY, V15, p7C, DOI 10.1093/glycob/cwi050; Tomanek RJ, 2001, CIRC RES, V88, P1135, DOI 10.1161/hh1101.091191; Townsend TA, 2012, CELL SIGNAL, V24, P247, DOI 10.1016/j.cellsig.2011.09.006; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wang LY, 2007, AM J HUM GENET, V80, P650, DOI 10.1086/512981; Wang Q, 2001, ANAT RECORD, V263, P72, DOI 10.1002/ar.1078; Wiater E, 2006, J BIOL CHEM, V281, P17011, DOI 10.1074/jbc.M601459200; YANG JT, 1995, DEVELOPMENT, V121, P549; You HJ, 2009, CARCINOGENESIS, V30, P1281, DOI 10.1093/carcin/bgp071; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	91	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159710	10.1371/journal.pone.0159710	http://dx.doi.org/10.1371/journal.pone.0159710			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505173	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200011
J	Kazmierczak, RA; Gentry, B; Mumm, T; Schatten, H; Eisenstark, A				Kazmierczak, Robert A.; Gentry, Bettina; Mumm, Tyler; Schatten, Heide; Eisenstark, Abraham			Salmonella Bacterial Monotherapy Reduces Autochthonous Prostate Tumor Burden in the TRAMP Mouse Model	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ANDROGEN DEPRIVATION THERAPY; HUMAN PANCREATIC-CANCER; NEUROENDOCRINE DIFFERENTIATION; PATHOLOGY COMMITTEE; TRANSGENIC MOUSE; CONSENSUS REPORT; HUMAN BREAST; NUDE-MICE; STEM-LIKE	Attenuated Salmonella typhimurium injected in the circulatory system of mammals selectively targets tumors. Using weekly intraperitoneal injections of attenuated Salmonella strain CRC2631, we tested for regression and/or inhibition of tumor development in the TRAMP prostate tumor mouse model, which utilizes SV40 early region expression for autochthonous formation of prostate tumors that progress into metastatic, poorly differentiated prostatic carcinomas in an immunocompetent murine model. Thirteen weekly intraperitoneal administrations of 10(5)-10(7) CFU CRC2631 into 10 week old mice were well tolerated by the TRAMP model. Sacrifice and histological analysis of TRAMP prostates at 22 weeks indicated that Salmonella monotherapy at administrated levels decrease visible tumor size (>29%) but did not significantly inhibit previously described SV40 expression-driven TRAMP tumor progression to undifferentiated carcinomas when histologically examined. In conclusion, this work demonstrates baseline results for CRC2631 Salmonella monotherapy using the immunocompetent TRAMP prostate tumor model in preparation for study of combination therapies that resolve autochthonously generated TRAMP prostate tumors, further reduce tumor size, or inhibit prostate tumor progression.	[Kazmierczak, Robert A.; Mumm, Tyler; Eisenstark, Abraham] Canc Res Ctr, Columbia, MO 65201 USA; [Kazmierczak, Robert A.; Mumm, Tyler; Eisenstark, Abraham] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Gentry, Bettina; Schatten, Heide] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Kazmierczak, RA (corresponding author), Canc Res Ctr, Columbia, MO 65201 USA.; Kazmierczak, RA (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	KazmierczakR@missouri.edu			Cancer Research Center, Columbia, MO, USA	Cancer Research Center, Columbia, MO, USA	This work was funded internally by the Cancer Research Center, Columbia, MO, USA. http://cancerresearchcenter.org/.	Arrach N, 2010, CANCER RES, V70, P2165, DOI 10.1158/0008-5472.CAN-09-4005; Avogadri F, 2008, EUR J IMMUNOL, V38, P1937, DOI 10.1002/eji.200738035; Berger E, 2013, CANCER LETT, V331, P167, DOI 10.1016/j.canlet.2012.12.026; Bernardes N, 2013, APPL MICROBIOL BIOT, V97, P5189, DOI 10.1007/s00253-013-4926-6; Chakraborty S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002116; Chang SY, 2013, HUM VACC IMMUNOTHER, V9, P1654, DOI 10.4161/hv.24917; Chang WW, 2012, EXP BIOL MED, V237, P1189, DOI 10.1258/ebm.2012.012063; Chen G, 2012, APPL MICROBIOLOGY BI, DOI 10.1007/s00253-012-; Choe E, 2014, MBIO, V5, DOI 10.1128/mBio.01182-14; Coley W, 1929, AM J SURG, V1, P22; Eisenstark A, 2010, ANNU REV MICROBIOL, V64, P277, DOI 10.1146/annurev.micro.091208.073614; Eisenstark Abraham, 2007, V394, P323, DOI 10.1007/978-1-59745-512-1_16; Fensterle J, 2008, CANCER GENE THER, V15, P85, DOI 10.1038/sj.cgt.7701109; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Forbes NS, 2003, CANCER RES, V63, P5188; Frahm M, 2015, MBIO, V6, DOI 10.1128/mBio.00254-15; Friedlos F, 2008, CLIN CANCER RES, V14, P4259, DOI 10.1158/1078-0432.CCR-07-4800; Ganai S, 2011, CANCER GENE THER, V18, P457, DOI 10.1038/cgt.2011.10; Ganai S, 2009, BRIT J CANCER, V101, P1683, DOI 10.1038/sj.bjc.6605403; Grabowska MM, 2014, CANCER METAST REV, V33, P377, DOI 10.1007/s10555-013-9487-8; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Grille S, 2014, IMMUNOLOGY, V143, P428, DOI 10.1111/imm.12320; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hirano D, 2004, EUR UROL, V45, P586, DOI 10.1016/j.eururo.2003.11.032; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; Hoffman RM, 2015, METHODS MOL BIOL, V1317, P239, DOI 10.1007/978-1-4939-2727-2_14; Hoffman RM, 2009, AMINO ACIDS, V37, P509, DOI 10.1007/s00726-009-0261-8; Hong EH, 2013, VACCINE, V31, P1377, DOI 10.1016/j.vaccine.2013.01.006; Howlader N, 2015, SEER CANC STAT REV 1; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Kasinskas RW, 2006, BIOTECHNOL BIOENG, V94, P710, DOI 10.1002/bit.20883; Katzenwadel A, 2015, CANCER LETT, V367, P12, DOI 10.1016/j.canlet.2015.06.021; Kazmierczak R, 2015, METHODS MOL BIOL, V1225, P151, DOI 10.1007/978-1-4939-1625-2_11; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; Lee CH, 2011, APPL MICROBIOL BIOT, V92, P1251, DOI 10.1007/s00253-011-3386-0; Lee CH, 2011, APPL MICROBIOL BIOT, V90, P1381, DOI 10.1007/s00253-011-3180-z; Leschner S, 2010, J MOL MED, V88, P763, DOI 10.1007/s00109-010-0636-z; Leschner S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006692; Meng JZ, 2010, CLIN VACCINE IMMUNOL, V17, P889, DOI 10.1128/CVI.00044-10; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Panteli JT, 2015, INTEGR BIOL-UK, V7, P423, DOI 10.1039/c5ib00047e; Paterson Y, 2010, SEMIN IMMUNOL, V22, P183, DOI 10.1016/j.smim.2010.02.002; Pawelek JM, 2002, CANCER GENE THER, V9, P813, DOI 10.1038/sj.cgt.7700501; Pawelek JM, 1997, CANCER RES, V57, P4537; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Porwollik S, 2004, J BACTERIOL, V186, P1678, DOI 10.1128/JB.186.6.1678-1682.2004; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Quispe-Tintaya W, 2013, P NATL ACAD SCI USA, V110, P8668, DOI 10.1073/pnas.1211287110; Roberts N.J., 2014, SCI TRANSL MED, V6, P249, DOI DOI 10.1126/SCITRANSLMED.3008982; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Schatten H, 2000, BIOL CELL, V92, P331, DOI 10.1016/S0248-4900(00)01079-0; Shao C, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-160; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Slusarz A, 2012, ENDOCRINOLOGY, V153, P4160, DOI 10.1210/en.2012-1030; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Sun Y, 2009, AM J TRANSL RES, V1, P148; Sutton A, 2000, J BACTERIOL, V182, P4375, DOI 10.1128/JB.182.16.4375-4379.2000; Szeto J, 2009, INFECT IMMUN, V77, P996, DOI 10.1128/IAI.01275-08; Theys J, 2006, BRIT J CANCER, V95, P1212, DOI 10.1038/sj.bjc.6603367; Thornlow DN, 2015, BIOTECHNOL BIOENG, V112, P2397, DOI 10.1002/bit.25645; Toley BJ, 2012, INTEGR BIOL-UK, V4, P165, DOI 10.1039/c2ib00091a; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhong ZS, 2007, MICROSC MICROANAL, V13, P372, DOI [10.1017/S1431927607070833, 10.1017/SI431927607070833]; Zhu XY, 2010, CANCER SCI, V101, P2621, DOI 10.1111/j.1349-7006.2010.01722.x	68	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160926	10.1371/journal.pone.0160926	http://dx.doi.org/10.1371/journal.pone.0160926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504973	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200080
J	Franche, N; Tardif, C; Ravachol, J; Harchouni, S; Ferdinand, PH; Borne, R; Fierobe, HP; Perret, S				Franche, Nathalie; Tardif, Chantal; Ravachol, Julie; Harchouni, Seddik; Ferdinand, Pierre-Henri; Borne, Romain; Fierobe, Henri-Pierre; Perret, Stephanie			Cel5I, a SLH-Containing Glycoside Hydrolase: Characterization and Investigation on Its Role in Ruminiclostridium cellulolyticum	PLOS ONE			English	Article							CARBOHYDRATE-BINDING MODULES; CLOSTRIDIUM-CELLULOLYTICUM; NONCRYSTALLINE CELLULOSE; GENOME SEQUENCES; PROTEINS; HOMOLOGY; DATABASE; FAMILY; DECONSTRUCTION; IDENTIFICATION	Ruminiclostridium cellulolyticum (Clostridium cellulolyticum) is a mesophilic cellulolytic anaerobic bacterium that produces a multi-enzymatic system composed of cellulosomes and non-cellulosomal enzymes to degrade plant cell wall polysaccharides. We characterized one of the non-cellulosomal enzymes, Cel5I, composed of a Family-5 Glycoside Hydrolase catalytic module (GH5), a tandem of Family-17 and -28 Carbohydrate Binding Modules (CBM), and three S-layer homologous (SLH) modules, where the latter are expected to anchor the protein on the cell surface. Cel5I is the only putative endoglucanase targeting the cell surface as well as the only putative protein in R. cellulolyticum containing CBM17 and/or CBM28 modules. We characterized different recombinant structural variants from Cel5I. We showed that Cel5I has an affinity for insoluble cellulosic substrates through its CBMs, that it is the most active endoglucanase on crystalline cellulose of R. cellulolyticum characterized to date and mostly localized in the cell envelope of R. cellulolyticum. Its role in vivo was analyzed using a R. cellulolyticum cel5I mutant strain. Absence of Cel5I in the cell envelope did not lead to a significant variation of the phenotype compared to the wild type strain. Neither in terms of cell binding to cellulose, nor for its growth on crystalline cellulose, thus indicating that the protein has a rather subtle role in tested conditions. Cel5I might be more important in a natural environment, at low concentration of degradable glucose polymers, where its role might be to generate higher concentration of short cellodextrins close to the cell surface, facilitating their uptake or for signalization purpose.	[Franche, Nathalie; Tardif, Chantal; Ravachol, Julie; Harchouni, Seddik; Ferdinand, Pierre-Henri; Borne, Romain; Fierobe, Henri-Pierre; Perret, Stephanie] Aix Marseille Univ, CNRS, LCB, Marseille, France; [Harchouni, Seddik] Aix Marseille Univ, CNRS CEA, LGBP, Marseille, France; [Ferdinand, Pierre-Henri] Qiagen, Str 1, Hilden, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Aix-Marseille Universite; QIAGEN GmbH	Perret, S (corresponding author), Aix Marseille Univ, CNRS, LCB, Marseille, France.	perret@imm.cnrs.fr	FIEROBE, Henri-Pierre/P-4372-2019; Borne, Romain/AAC-6453-2019					Abbott DW, 2010, MOL MICROBIOL, V77, P183, DOI 10.1111/j.1365-2958.2010.07199.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araki Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1028, DOI 10.1271/bbb.80802; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; BAYER EA, 1983, J BACTERIOL, V156, P818, DOI 10.1128/JB.156.2.818-827.1983; Blouzard JC, 2010, APPL ENVIRON MICROB, V76, P4546, DOI 10.1128/AEM.02417-09; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, BIOCHEM J, V361, P35, DOI 10.1042/0264-6021:3610035; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Engelhardt H, 2007, J STRUCT BIOL, V160, P115, DOI 10.1016/j.jsb.2007.08.003; Fendri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0044708; Ferdinand PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069360; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Fierobe HP, 1999, BIOCHEMISTRY-US, V38, P12822, DOI 10.1021/bi9911740; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Franche N, 2015, LIGNOCELLULOSE DEGRA, P52; Fukuda M, 2010, J BACTERIOL, V192, P2210, DOI 10.1128/JB.01406-09; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; GELHAYE E, 1993, J BACTERIOL, V175, P3452, DOI 10.1128/jb.175.11.3452-3458.1993; GIALLO J, 1983, APPL ENVIRON MICROB, V45, P843, DOI 10.1128/AEM.45.3.843-849.1983; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Ichi-Ishi A, 1998, APPL ENVIRON MICROB, V64, P1086; Jamal S, 2004, J MOL BIOL, V339, P253, DOI 10.1016/j.jmb.2004.03.069; Jennert KCB, 2000, MICROBIOL-SGM, V146, P3071, DOI 10.1099/00221287-146-12-3071; Kosugi A, 2002, J BACTERIOL, V184, P884, DOI 10.1128/jb.184.4.884-888.2002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Mosbah A, 2002, J BIOMOL NMR, V23, P157, DOI 10.1023/A:1016354623398; Notenboom V, 2013, J MOL BIOL, V14, P797; Olabarria G, 1996, J BACTERIOL, V178, P4765, DOI 10.1128/jb.178.16.4765-4772.1996; Ozdemir I, 2012, APPL ENVIRON MICROB, V78, P768, DOI 10.1128/AEM.07031-11; PARK JT, 1949, J BIOL CHEM, V181, P149; Perret S, 2004, J BACTERIOL, V186, P6544, DOI 10.1128/JB.186.19.6544-6552.2004; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETITDEMANGE E, 1984, INT J SYST BACTERIOL, V34, P155, DOI 10.1099/00207713-34-2-155; Ravachol J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22770; Ravachol J, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0301-4; Ravachol J, 2014, J BIOL CHEM, V289, P7335, DOI 10.1074/jbc.M113.545046; SHIMA S, 1993, APPL MICROBIOL BIOT, V38, P750, DOI 10.1007/BF00167140; Sillitoe I, 2015, NUCLEIC ACIDS RES, V43, pD376, DOI 10.1093/nar/gku947; Tardif C, 2001, J IND MICROBIOL BIOT, V27, P271, DOI 10.1038/sj.jim.7000081; TARDIF C, 2006, CELLULOSOME, P221; Tsukimoto K, 2010, FEBS LETT, V584, P1205, DOI 10.1016/j.febslet.2010.02.027; WALSETH CS, 1952, TAPPI, V35, P228; Xu CG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-73; Yutin N, 2013, ENVIRON MICROBIOL, V15, P2631, DOI 10.1111/1462-2920.12173	54	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160812	10.1371/journal.pone.0160812	http://dx.doi.org/10.1371/journal.pone.0160812			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501457	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500056
J	Li, XH; Eiden, RD; Epstein, LH; Shenassa, ED; Xie, CB; Wen, XZ				Li, Xiuhong; Eiden, Rina D.; Epstein, Leonard H.; Shenassa, Edmond D.; Xie, Chuanbo; Wen, Xiaozhong			Etiological Subgroups of Small-for-Gestational-Age: Differential Neurodevelopmental Outcomes	PLOS ONE			English	Article							MATERNAL WEIGHT-GAIN; NORTH-AMERICAN WOMEN; MILD LANGUAGE DELAY; CIGARETTE-SMOKING; LOW-INCOME; NATURAL EXPERIMENT; BIRTH-WEIGHT; RISK-FACTORS; FOLLOW-UP; PREGNANCY	Objectives It remains unclear why substantial variations in neurodevelopmental outcomes exist within small-for-gestational-age (SGA) children. We prospectively compared 5-y neurodevelopmental outcomes across SGA etiological subgroups. Methods Children born SGA (N = 1050) from U.S. Early Childhood Longitudinal Study-Birth Cohort (2001-2007) was divided into etiological subgroups by each of 7 well-established prenatal risk factors. We fit linear regression models to compare 5-y reading, math, gross motor and fine motor scores across SGA subgroups, adjusting for socio-demographic confounders. Results Compared to singleton SGA subgroup, multiple-birth SGA subgroup had lower mean reading (adjusted mean difference, -4.08 [95% confidence interval, -6.10, -2.06]) and math (-2.22 [-3.61, -0.84]) scores. These disadvantages in reading and math existed only among multiple-birth SGA subgroup without ovulation stimulation (reading, -4.50 [-6.64, -2.36]; math, -2.91 [-4.37, -1.44]), but not among those with ovulation stimulation (reading, -2.33 [-6.24, 1.57]; math 0.63 [-1.86, 3.12]). Compared to singleton SGA subgroup without maternal smoking and inadequate gestational weight gain, singleton SGA subgroup with co-occurrence of maternal smoking and inadequate gestational weight gain (GWG) had lower mean reading (-4.81 [-8.50, -1.12]) and math (-2.95 [-5.51, -0.38]) scores. These differences were not mediated by Apgar score. Conclusions Multiple-birth SGA subgroups (vs. singleton SGA) or singleton SGA subgroup with co-occurrence of smoking and inadequate GWG (vs. singleton SGA subgroup without maternal smoking and inadequate gestational weight gain) have poorer cognitive development up to 5 y.	[Li, Xiuhong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Guangzhou 510080, Guangdong, Peoples R China; [Li, Xiuhong; Epstein, Leonard H.; Xie, Chuanbo; Wen, Xiaozhong] Univ Buffalo State Univ New York, Dept Pediat, Div Behav Med, Buffalo, NY 14214 USA; [Eiden, Rina D.] Univ Buffalo State Univ New York, Res Inst Addict, Buffalo, NY 14203 USA; [Shenassa, Edmond D.] Univ Maryland, Maternal & Child Hlth Program, Sch Publ Hlth, College Pk, MD 20742 USA; [Shenassa, Edmond D.] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA; [Shenassa, Edmond D.] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA; [Xie, Chuanbo] Sun Yat Sen Univ, Ctr Canc, Dept Canc Prevent Res, Guangzhou 510060, Guangdong, Peoples R China	Sun Yat Sen University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Brown University; Sun Yat Sen University	Wen, XZ (corresponding author), Univ Buffalo State Univ New York, Dept Pediat, Div Behav Med, Buffalo, NY 14214 USA.	xiaozhongwen@hotmail.com	Li, xiuhong/AHA-9848-2022; Epstein, Leonard/AAE-5619-2021	Li, xiuhong/0000-0001-8084-9706; Eiden, Rina/0000-0002-5303-3661	Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [R40 MC 26816]; China Medical Board (CMB) [13-133]; National Natural Science Foundation of China [81302437]	Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS); China Medical Board (CMB); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number R40 MC 26816 and title "Etiological subgroups of small-for-gestational-age: differential child outcomes" for grant amount $99,968.00 (0% financed with nongovernmental sources). Li's effort was also supported by the China Medical Board (CMB) under grant number 13-133 and the National Natural Science Foundation of China under grant number 81302437. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnert J, 2009, HUMAN DEVELOPMENT FROM EARLY CHILDHOOD TO EARLY ADULTHOOD: FINDINGS FROM A 20 YEAR LONGITUDINAL STUDY, P35; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berlin LJ, 1998, PREV MED, V27, P238, DOI 10.1006/pmed.1998.0282; Blickstein I, 2004, BEST PRACT RES CL OB, V18, P613, DOI 10.1016/j.bpobgyn.2004.04.008; Boutwell BB, 2010, INT J ENV RES PUB HE, V7, P146, DOI 10.3390/ijerph7010146; Bracken BA, 1998, BRACKEN BASIC CONCEP; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Cnattingius S, 1998, BRIT MED J, V316, P1483, DOI 10.1136/bmj.316.7143.1483; Collins John, 2007, Reprod Biomed Online, V15 Suppl 3, P45; D'Onofrio BM, 2010, CHILD DEV, V81, P80, DOI 10.1111/j.1467-8624.2009.01382.x; Davis RR, 2012, MATERN CHILD HLTH J, V16, P119, DOI 10.1007/s10995-010-0713-5; de Kieviet JF, 2012, DEV MED CHILD NEUROL, V54, P313, DOI 10.1111/j.1469-8749.2011.04216.x; Dearing E, 2009, CHILD DEV, V80, P1329, DOI 10.1111/j.1467-8624.2009.01336.x; Durazzo TC, 2010, INT J ENV RES PUB HE, V7, P3760, DOI 10.3390/ijerph7103760; Flidel-Rimon O, 2005, J PERINAT MED, V33, P379, DOI 10.1515/JPM.2005.069; Guerrini I, 2007, NEUROSCI BIOBEHAV R, V31, P212, DOI 10.1016/j.neubiorev.2006.06.022; Institute of Medicine and National Research Council, 2009, WEIGHT GAIN PREGNANC; Kramer MS, 2002, J PEDIATR-US, V141, P538, DOI 10.1067/mpd.2002.128029; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Levine MD, 2013, WOMEN HEALTH ISS, V23, pE389, DOI 10.1016/j.whi.2013.07.005; Lung FW, 2009, CHILD CARE HLTH DEV, V35, P409, DOI 10.1111/j.1365-2214.2009.00963.x; Marret S, 2005, J Gynecol Obstet Biol Reprod (Paris), V34 Spec No 1, p3S230; Meisels S. J., 1993, EARLY CHILDHOOD RES, V8, P327; Najarian M., 2010, 2010009 NCES US DEP; NELSON KB, 1981, PEDIATRICS, V68, P36; Nord C, 2004, 2004092 NCES; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; O'Keeffe MJ, 2003, PEDIATRICS, V112, P301, DOI 10.1542/peds.112.2.301; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Ota E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105155; Pickett KE, 2009, NICOTINE TOB RES, V11, P1166, DOI 10.1093/ntr/ntp117; PICONE TA, 1982, AM J CLIN NUTR, V36, P1205, DOI 10.1093/ajcn/36.6.1205; PICONE TA, 1982, AM J CLIN NUTR, V36, P1214, DOI 10.1093/ajcn/36.6.1214; Pinello L, 2013, J AAPOS, V17, P352, DOI 10.1016/j.jaapos.2013.03.026; Reichman NE, 2001, ANN EPIDEMIOL, V11, P186, DOI 10.1016/S1047-2797(00)00209-X; Reynolds AJ, 2001, JAMA-J AM MED ASSOC, V285, P2339, DOI 10.1001/jama.285.18.2339; Rivkin MJ, 2008, PEDIATRICS, V121, P741, DOI 10.1542/peds.2007-1399; Rohlman DS, 2008, NEUROTOXICOLOGY, V29, P556, DOI 10.1016/j.neuro.2008.04.003; Russell A, 2013, J OBSTET GYNAECOL CA, V35, P802, DOI 10.1016/S1701-2163(15)30836-7; Rutter M, 2003, J CHILD PSYCHOL PSYC, V44, P326, DOI 10.1111/1469-7610.00125; Snow K., 2009, EARLY CHILDHOOD LONG; Sommerfelt K, 2002, PEDIATR NEUROL, V26, P186, DOI 10.1016/S0887-8994(01)00381-2; Sutcliffe AG, 2006, EARLY HUM DEV, V82, P379, DOI 10.1016/j.earlhumdev.2006.03.007; Thorpe K, 2003, J CHILD PSYCHOL PSYC, V44, P342, DOI 10.1111/1469-7610.00126; Tourangeau K., 2001, ECLS K BASE YEAR PUB; Wen XZ, 2010, EPIDEMIOLOGY, V21, P786, DOI 10.1097/EDE.0b013e3181f20990	49	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160677	10.1371/journal.pone.0160677	http://dx.doi.org/10.1371/journal.pone.0160677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IE	27501456	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500043
J	Merino-Gracia, J; Zamora-Carreras, H; Bruix, M; Rodriguez-Crespo, I				Merino-Gracia, Javier; Zamora-Carreras, Hector; Bruix, Marta; Rodriguez-Crespo, Ignacio			Molecular Basis for the Protein Recognition Specificity of the Dynein Light Chain DYNLT1/Tctex1 CHARACTERIZATION OF THE INTERACTION WITH ACTIVIN RECEPTOR IIB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; MECHANISTIC INSIGHT; PEPSCAN TECHNIQUE; STRUCTURAL BASIS; TCTEX-1; SUBUNIT; COMPLEX; DOMAIN	It has been suggested that DYNLT1, a dynein light chain known to bind to various cellular and viral proteins, can function both as a molecular clamp and as a microtubule-cargo adapter. Recent data have shown that the DYNLT1 homodimer binds to two dynein intermediate chains to subsequently link cargo proteins such as the guanine nucleotide exchange factor Lfc or the small GTPases RagA and Rab3D. Although over 20 DYNLT1-interacting proteins have been reported, the exact sequence requirements that enable their association to the canonical binding groove or to the secondary site within the DYNLT1 surface are unknown. We describe herein the sequence recognition properties of the hydrophobic groove of DYNLT1 known to accommodate dynein intermediate chain. Using a pepscan approach, we have substituted each amino acid within the interacting peptide for all 20 natural amino acids and identified novel binding sequences. Our data led us to propose activin receptor IIB as a novel DYNLT1 ligand and suggest that DYNLT1 functions as a molecular dimerization engine bringing together two receptor monomers in the cytoplasmic side of the membrane. In addition, we provide evidence regarding a dual binding mode adopted by certain interacting partners such as Lfc or the parathyroid hormone receptor. Finally, we have used NMR spectroscopy to obtain the solution structure of human DYNLT1 forming a complex with dynein intermediate chain of similar to 74 kDa; it is the first mammalian structure available.	[Merino-Gracia, Javier; Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Fac Ciencias Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain; [Zamora-Carreras, Hector; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Serrano 119, E-28006 Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Rodriguez-Crespo, I (corresponding author), Univ Complutense, Fac Quim, Dept Bioquim & Biol Mol, E-28040 Madrid, Spain.	nacho@bbm1.ucm.es	Bruix, Marta/H-4161-2011; Zamora-Carreras, Héctor/AAC-2287-2020; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Bruix, Marta/0000-0002-0096-3558; Zamora-Carreras, Héctor/0000-0002-9141-2750; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Merino Gracia, Javier/0000-0003-3397-8171	Spanish Ministerio of Economia y Competitividad [BFU2012-37934, CTQ2014-252633-P]; Comunidad de Madrid [S2010/BMD-2305]; Ministerio de Ciencia e Innovacion; Ministerio de Economia y Competitividad	Spanish Ministerio of Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government)	This work was supported in part by Spanish Ministerio of Economia y Competitividad Grants BFU2012-37934 (to I. R.-C.) and CTQ2014-252633-P (to M. B.) as well as Comunidad de Madrid Grant S2010/BMD-2305 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Formacion de Personal Investigador (FPI) fellowship from the Ministerio de Ciencia e Innovacion.; Recipient of an FPI fellowship from the Ministerio de Economia y Competitividad.	Allan VJ, 2011, BIOCHEM SOC T, V39, P1169, DOI 10.1042/BST0391169; Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; Balan M., 2013, THESIS; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Bauch A, 1998, EUR J IMMUNOL, V28, P2167, DOI 10.1002/(SICI)1521-4141(199807)28:07<2167::AID-IMMU2167>3.0.CO;2-L; Cao JJ, 2015, J VIROL, V89, P2777, DOI 10.1128/JVI.03117-14; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Garcia-Mayoral MF, 2011, FEBS LETT, V585, P53, DOI 10.1016/j.febslet.2010.11.027; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Garcia-Mayoral MF, 2010, FEBS J, V277, P2340, DOI 10.1111/j.1742-4658.2010.07649.x; Goddard T. D., 2005, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Meiri D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5857; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Meng QJ, 2006, J BIOL CHEM, V281, P37069, DOI 10.1074/jbc.M608614200; Merino-Gracia J, 2016, J BIOL CHEM, V291, P11581, DOI 10.1074/jbc.M116.724427; Merino-Gracia J, 2015, FEBS J, V282, P3945, DOI 10.1111/febs.13388; Merino-Gracia J, 2011, FEBS J, V278, P2997, DOI 10.1111/j.1742-4658.2011.08252.x; Mital J, 2015, BIOCHEM BIOPH RES CO, V462, P165, DOI 10.1016/j.bbrc.2015.04.116; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Mueller S, 2002, J BIOL CHEM, V277, P7897, DOI 10.1074/jbc.M111937200; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Navarro-Lerida I, 2006, J CELL SCI, V119, P1558, DOI 10.1242/jcs.02878; Navarro-Lerida I, 2007, MOL BIOL CELL, V18, P2768, DOI 10.1091/mbc.E06-12-1102; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Pavlos NJ, 2011, MOL CELL BIOL, V31, P1551, DOI 10.1128/MCB.00834-10; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, MOL BIOL CELL, V7, P331, DOI 10.1091/mbc.7.2.331; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sanchez-Ruiloba L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095191; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Whitehead B, 1997, Methods Mol Biol, V60, P29; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Williams JC, 2012, DYNEINS: STRUCTURE, BIOLOGY AND DISEASE, P157, DOI 10.1016/B978-0-12-382004-4.10005-6; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu HW, 2000, NAT STRUCT BIOL, V7, P575; Wu HW, 2005, STRUCTURE, V13, P213, DOI 10.1016/j.str.2004.11.013; Yoshimura Y, 2011, BIOCHEM BIOPH RES CO, V408, P322, DOI 10.1016/j.bbrc.2011.04.032	53	8	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20962	20975		10.1074/jbc.M116.736884	http://dx.doi.org/10.1074/jbc.M116.736884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27502274	hybrid, Green Published			2022-12-26	WOS:000385406200014
J	Wadas, B; Piatkov, KI; Brower, CS; Varshavsky, A				Wadas, Brandon; Piatkov, Konstantin I.; Brower, Christopher S.; Varshavsky, Alexander			Analyzing N-terminal Arginylation through the Use of Peptide Arrays and Degradation Assays	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-RULE PATHWAY; UBIQUITIN FUSION TECHNIQUE; RNA-PROTEIN TRANSFERASE; MODIFIED HISTONE TAILS; IN-VIVO; CARDIOVASCULAR DEVELOPMENT; TRANSCRIPTIONAL REPRESSOR; BINDING-SPECIFICITY; PROTEOMICS ANALYSIS; CELLULAR-PROTEINS	N-alpha-terminal arginylation (Nt-arginylation) of proteins is mediated by the Ate1 arginyltransferase (R-transferase), a component of the Arg/N-end rule pathway. This proteolytic system recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome. The definitively identified ("canonical") residues that are Nt-arginylated by R-transferase are N-terminal Asp, Glu, and (oxidized) Cys. Over the last decade, several publications have suggested (i) that Ate1 can also arginylate non-canonical N-terminal residues; (ii) that Ate1 is capable of arginylating not only alpha-amino groups of N-terminal residues but also gamma-carboxyl groups of internal (non-N-terminal) Asp and Glu; and (iii) that some isoforms of Ate1 are specific for substrates bearing N-terminal Cys residues. In the present study, we employed arrays of immobilized 11-residue peptides and pulse-chase assays to examine the substrate specificity of mouse R-transferase. We show that amino acid sequences immediately downstream of a substrate's canonical (Nt-arginylatable) N-terminal residue, particularly a residue at position 2, can affect the rate of Nt-arginylation by R-transferase and thereby the rate of degradation of a substrate protein. We also show that the four major isoforms of mouse R-transferase have similar Nt-arginylation specificities in vitro, contrary to the claim about the specificity of some Ate1 isoforms for N-terminal Cys. In addition, we found no evidence for a significant activity of the Ate1 R-transferase toward previously invoked non-canonical N-terminal or internal amino acid residues. Together, our results raise technical concerns about earlier studies that invoked non-canonical arginylation specificities of Ate1.	[Wadas, Brandon; Varshavsky, Alexander] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Piatkov, Konstantin I.] Skolkovo Inst Sci & Technol, Ctr Biotechnol & Biomed, Moscow 143026, Russia; [Brower, Christopher S.] Texas Womans Univ, Dept Biol, Denton, TX 76204 USA	California Institute of Technology; Skolkovo Institute of Science & Technology; Texas Womans University	Varshavsky, A (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Wadas, Brandon/0000-0003-2796-2384	National Institutes of Health [R01-DK039520, R01-GM031530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health Grants R01-DK039520 and R01-GM031530 (to A. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; An JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037414; An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bock I, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-48; Bock I, 2011, EPIGENETICS-US, V6, P256, DOI 10.4161/epi.6.2.13837; Brower CS, 2014, P NATL ACAD SCI USA, V111, pE4936, DOI 10.1073/pnas.1419587111; Brower CS, 2013, MOL CELL, V50, P161, DOI 10.1016/j.molcel.2013.02.009; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Cha-Molstad H, 2015, NAT CELL BIOL, V17, P917, DOI 10.1038/ncb3177; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Comachione AS, 2014, CELL REP, V8, P469, DOI 10.1016/j.celrep.2014.06.019; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Dorfel MJ, 2015, GENE, V567, P103, DOI 10.1016/j.gene.2015.04.085; Dougan DA, 2012, BBA-MOL CELL RES, V1823, P83, DOI 10.1016/j.bbamcr.2011.07.002; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Ebhardt HA, 2014, RAPID COMMUN MASS SP, V28, P2735, DOI 10.1002/rcm.7069; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Eldeeb MA, 2014, ONCOTARGET, V5, P2714, DOI 10.18632/oncotarget.1931; Eriste E, 2005, J BIOL CHEM, V280, P35089, DOI 10.1074/jbc.M502567200; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; Gibbs DJ, 2014, MOL CELL, V53, P369, DOI 10.1016/j.molcel.2013.12.020; Graciet E, 2006, P NATL ACAD SCI USA, V103, P3078, DOI 10.1073/pnas.0511224103; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Hoernstein SNW, 2016, MOL CELL PROTEOMICS, V15, P1808, DOI 10.1074/mcp.M115.057190; Holman TJ, 2009, P NATL ACAD SCI USA, V106, P4549, DOI 10.1073/pnas.0810280106; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Hwang CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024925; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Khosrow-Khavar F, 2012, G3-GENES GENOM GENET, V2, P619, DOI 10.1534/g3.111.001933; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kim ST, 2013, AUTOPHAGY, V9, P1100, DOI 10.4161/auto.24643; Kitamura K, 2013, FEBS LETT, V587, P214, DOI 10.1016/j.febslet.2012.11.028; Kurosaka S, 2012, J MOL CELL CARDIOL, V53, P333, DOI 10.1016/j.yjmcc.2012.05.007; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Liu YJ, 2016, J BIOL CHEM, V291, P7426, DOI 10.1074/jbc.M116.714964; Majovsky P, 2014, J PROTEOME RES, V13, P4246, DOI 10.1021/pr500164j; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Piatkov KI, 2015, MICROB CELL, V2, P376, DOI 10.15698/mic2015.10.231; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, MOL CELL, V48, P926, DOI 10.1016/j.molcel.2012.10.012; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Rai R, 2008, DEVELOPMENT, V135, P3881, DOI 10.1242/dev.022723; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Rivera-Rivera I, 2014, P NATL ACAD SCI USA, V111, pE3853, DOI 10.1073/pnas.1414933111; Saha S, 2011, CHEM BIOL, V18, P1369, DOI 10.1016/j.chembiol.2011.08.019; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Sultana R, 2012, EXP CELL RES, V318, P53, DOI 10.1016/j.yexcr.2011.09.010; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2013, P NATL ACAD SCI USA, V110, P3800, DOI 10.1073/pnas.1217358110; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; van Dongen JT, 2015, ANNU REV PLANT BIOL, V66, P345, DOI 10.1146/annurev-arplant-043014-114813; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Varshavsky A, 2012, PROTEIN SCI, V21, P1634, DOI 10.1002/pro.2148; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wadas B, 2016, J BIOL CHEM, V291, P17178, DOI 10.1074/jbc.M116.734640; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Wang JL, 2014, CHEM BIOL, V21, P331, DOI 10.1016/j.chembiol.2013.12.017; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Weits DA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4425; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Wu CG, 2009, METHODS MOL BIOL, V570, P197, DOI 10.1007/978-1-60327-394-7_8; Xia ZX, 2008, J BIOL CHEM, V283, P28958, DOI 10.1074/jbc.M803980200; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xu T, 2009, NAT PROTOC, V4, P325, DOI 10.1038/nprot.2008.248; Xu ZZ, 2012, J BIOL CHEM, V287, P7495, DOI 10.1074/jbc.M111.301002; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yan OY, 2006, MUTAT RES-FUND MOL M, V596, P64, DOI 10.1016/j.mrfmmm.2005.12.016; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014017; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681; Zhang FL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8517; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhang GH, 2013, FASEB J, V27, P2893, DOI 10.1096/fj.12-222711; Zhang HT, 2015, PROTEOMICS, V15, P2447, DOI 10.1002/pmic.201400530; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	110	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20976	20992		10.1074/jbc.M116.747956	http://dx.doi.org/10.1074/jbc.M116.747956			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27510035	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000385406200015
J	Yu, J; Yun, H; Shin, B; Kim, Y; Park, ES; Choi, S; Yu, J; Amarasekara, DS; Kim, S; Inoue, J; Walsh, MC; Choi, Y; Takami, M; Rho, J				Yu, Jiyeon; Yun, Hyeongseok; Shin, Bongjin; Kim, Yongjin; Park, Eui-Soon; Choi, Seunga; Yu, Jungeun; Amarasekara, Dulshara Sachini; Kim, Sumi; Inoue, Jun-ichiro; Walsh, Matthew C.; Choi, Yongwon; Takami, Masamichi; Rho, Jaerang			Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor B (RANK) Signaling Complex Enhances Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); NFAT transcription factor; osteoclast; osteoporosis; signal transduction	NF-KAPPA-B; DEFECTIVE INTERLEUKIN-1; BONE MASS; TNF-ALPHA; OSTEOIMMUNOLOGY; OSTEOPETROSIS; PROTEINS; IMMUNE; MICE; AUTOUBIQUITINATION	The signaling pathway downstream of stimulation of receptor activator of nuclear factor B (RANK) by RANK ligand is crucial for osteoclastogenesis. RANK recruits TNF receptor-associated factor 6 (TRAF6) to TRAF6-binding sites (T6BSs) in the RANK cytoplasmic tail (RANK(cyto)) to trigger downstream osteoclastogenic signaling cascades. RANK(cyto) harbors an additional highly conserved domain (HCR) that also activates crucial signaling during RANK-mediated osteoclastogenesis. However, the functional cross-talk between T6BSs and the HCR in the RANK signaling complex remains unclear. To characterize the cross-talk between T6BSs and the HCR, we screened TRAF6-interacting proteins using a proteomics approach. We identified Vav3 as a novel TRAF6 binding partner and evaluated the functional importance of the TRAF6-Vav3 interaction in the RANK signaling complex. We demonstrated that the coiled-coil domain of TRAF6 interacts directly with the Dbl homology domain of Vav3 to form the RANK signaling complex independent of the TRAF6 ubiquitination pathway. TRAF6 is recruited to the RANK(cyto) mutant, which lacks T6BSs, via the Vav3 interaction; conversely, Vav3 is recruited to the RANK(cyto) mutant, which lacks the IVVY motif, via the TRAF6 interaction. Finally, we determined that the TRAF6-Vav3 interaction resulting from cross-talk between T6BSs and the IVVY motif in RANK(cyto) enhances downstream NF-B, MAPK, and NFATc1 activation by further strengthening TRAF6 signaling, thereby inducing RANK-mediated osteoclastogenesis. Thus, Vav3 is a novel TRAF6 interaction partner that functions in the activation of cooperative signaling between T6BSs and the IVVY motif in the RANK signaling complex.	[Yu, Jiyeon; Yun, Hyeongseok; Shin, Bongjin; Kim, Yongjin; Park, Eui-Soon; Choi, Seunga; Yu, Jungeun; Amarasekara, Dulshara Sachini; Kim, Sumi; Rho, Jaerang] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Daejeon 305764, South Korea; [Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Div Cellular & Mol Biol, Tokyo 1088639, Japan; [Walsh, Matthew C.; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Takami, Masamichi] Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan	Chungnam National University; University of Tokyo; University of Pennsylvania; Showa University	Rho, J (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Daejeon 305764, South Korea.	jrrho@cnu.ac.kr		Takami, Masamichi/0000-0002-4506-3975; Amarasekara, A D D Sachini/0000-0001-7085-0682; Rho, Jaerang/0000-0002-0019-4939	Basic Science Research Program through National Research Foundation of Korea; Ministry of Education [NRF-2014R1A1A2057884]; Chungnam National University; Ministry of National Defense Foundation [ADD14-01-06-06]; National Institutes of Health [AR069546, AR067726]; Grants-in-Aid for Scientific Research [26290036] Funding Source: KAKEN; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067726, R01AR069546] Funding Source: NIH RePORTER	Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education; Chungnam National University; Ministry of National Defense Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, by Ministry of Education Grant NRF-2014R1A1A2057884, by the research fund of Chungnam National University, by Ministry of National Defense Foundation Grant ADD14-01-06-06, and National Institutes of Health Grants AR069546 and AR067726 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amarasekara DS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/832127; Charvet C, 2005, J BIOL CHEM, V280, P15289, DOI 10.1074/jbc.M500275200; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Faccio R, 2005, NAT MED, V11, P284, DOI 10.1038/nm1194; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Gautheron J, 2010, HUM MOL GENET, V19, P3138, DOI 10.1093/hmg/ddq222; Gohda J, 2005, EMBO J, V24, P790, DOI 10.1038/sj.emboj.7600564; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Jules J, 2015, J BIOL CHEM, V290, P23738, DOI 10.1074/jbc.M115.667535; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kadono Y, 2005, EMBO REP, V6, P171, DOI 10.1038/sj.embor.7400345; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Park ES, 2015, J BIOL CHEM, V290, P9660, DOI 10.1074/jbc.M114.609685; Rauner M, 2007, INT ARCH ALLERGY IMM, V143, P31, DOI 10.1159/000098223; Rho J, 2004, MOL CELLS, V17, P1; Shin B, 2014, J BIOL CHEM, V289, P35868, DOI 10.1074/jbc.M114.589614; Taguchi Y, 2012, J BONE MINER METAB, V30, P543, DOI 10.1007/s00774-012-0353-5; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Wada T, 2005, NAT MED, V11, P394, DOI 10.1038/nm1203; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wong BR, 1998, J BIOL CHEM, V273, P28355, DOI 10.1074/jbc.273.43.28355; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yu Jing-Hua, 2012, Bulletin of Botanical Research, V32, P1	41	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20643	20660		10.1074/jbc.M116.728303	http://dx.doi.org/10.1074/jbc.M116.728303			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27507811	Green Published, hybrid			2022-12-26	WOS:000384574800028
J	Chen, HJ; Huang, N; Chen, LS; Chou, YJ; Li, CP; Wu, CY; Chang, YC				Chen, Huei-Ju; Huang, Nicole; Chen, Long-Sheng; Chou, Yiing-Jenq; Li, Chung-Pin; Wu, Chen-Yi; Chang, Yu-Chia			Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PROPENSITY SCORE; VIRAL-HEPATITIS; DIABETES CARE; HEALTH-CARE; MANAGEMENT; MORTALITY; DIAGNOSIS; UPDATE	Background Many people are concerned about that the quality of preventive care for patients with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is suboptimal. Taiwan, a hyperendemic area of chronic HBV and HCV infection, implemented a nationwide pay-for-performance (P4P) program in 2010, which aimed to improve the preventive care provided to HBV and HCV patients by increasing physicians' adherence to guidelines through financial incentives. The objective of this study was to evaluate the early effects of the P4P program on utilization of preventive services by HBV and HCV patients. Methods Using a quasi-experimental design with propensity score matching method, we matched the HBV and HCV patients enrolled in the P4P program with non-enrollees in 2010, resulting in 21,643 patients in each group. Generalized estimating equations was applied to examine the difference-in-difference effects of P4P program enrollment on the utilization of three guideline-recommended preventive services (regular outpatient follow-up visits, abdominal ultrasonography (US) examinations, and aspartate aminotransferase and alanine aminotransferase (AST/ALT) tests by HBV and HCV patients. Results The P4P program enrollees were significantly more likely to attend twice-annual follow-up visits, to receive recommended US examinations and AST/ALT tests, than non-enrollees. Conclusions The results of our preliminary assessment indicate that financial incentives offered by the P4P program was associated with a modest improvement in adherence to guidelines for better chronic HBV and HBC management.	[Chen, Huei-Ju; Huang, Nicole] Natl Yang Ming Univ, Inst Hosp Hlth Care Adm, Taipei, Taiwan; [Chen, Huei-Ju] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan; [Chen, Long-Sheng] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan; [Chou, Yiing-Jenq] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Li, Chung-Pin] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Li, Chung-Pin; Wu, Chen-Yi] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wu, Chen-Yi] Taipei Vet Gen Hosp, Dept Dermatol, Taipei, Taiwan; [Chang, Yu-Chia] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Chang, Yu-Chia] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, YC (corresponding author), Asia Univ, Dept Healthcare Adm, Taichung, Taiwan.; Chang, YC (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	ycchang@asia.edu.tw		Huang, Nicole/0000-0002-6629-1176	National Science Council, Executive Yuan, Taiwan, ROC [NSC 101-2314-B-010-038-MY3, NSC 100-2314-B-010-036]	National Science Council, Executive Yuan, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Executive Yuan, Taiwan, ROC (Grants number NSC 101-2314-B-010-038-MY3 and NSC 100-2314-B-010-036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the National Health Insurance Administration, Ministry of Health and Welfare, Taiwan, ROC for providing the database used in this study. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare.	Amarapurkar D, 2009, J GASTROEN HEPATOL, V24, P955, DOI 10.1111/j.1440-1746.2009.05805.x; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen DS, 2007, HEPATOL RES, V37, pS101, DOI 10.1111/j.1872-034X.2007.00170.x; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Cheng SH, 2012, MED CARE, V50, P109, DOI 10.1097/MLR.0b013e31822d5d36; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Cheng TM, 2010, SIX COUNTRIES SIX RE, P171; Chou YJ, 2006, BIRTH-ISS PERINAT C, V33, P195, DOI 10.1111/j.1523-536X.2006.00104.x; Christianson JB, 2008, MED CARE RES REV, V65, p5S, DOI 10.1177/1077558708324236; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Epstein AM, 2012, NEW ENGL J MED, V367, P1852, DOI 10.1056/NEJMe1212133; Fang Q, 2013, J HUAZHONG U SCI-MED, V33, P288, DOI 10.1007/s11596-013-1113-z; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Greene SE, 2009, AM J MED QUAL, V24, P140, DOI 10.1177/1062860608326517; Huang YT, 2011, J CLIN ONCOL, V29, P3643, DOI 10.1200/JCO.2011.36.2335; Kee KM, 2011, ONCOLOGY-BASEL, V81, P36, DOI 10.1159/000333257; Khalili M, 2011, DIGEST DIS SCI, V56, P1516, DOI 10.1007/s10620-010-1439-3; Kim DY, 2012, LIVER CANCER, V1, P2, DOI 10.1159/000339016; Kuo RN, AM J MANAG CARE, V17, pe203; Lai CL, 2013, J CHIN MED ASSOC, V76, P102, DOI 10.1016/j.jcma.2012.06.024; Lee Jin Yong, 2012, J Prev Med Public Health, V45, P137, DOI [10.3961/jpmph.2012.45.3.137, 10.3741/JKWRA.2012.45.2.137]; Lee TT, 2010, AM J MANAG CARE, V16, P65; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marrero CR, 2007, ARCH MED RES, V38, P612, DOI 10.1016/j.arcmed.2006.09.004; National Health Insurance Administration, 2013, INTRODUCTION OF NATI; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068315; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sargent S., 2009, LIVER DIS ESSENTIAL, P135; Selvapatt N, 2016, J CLIN GASTROENTEROL, V50, pE8, DOI 10.1097/MCG.0000000000000344; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Tan N. C., 2005, SMJ Singapore Medical Journal, V46, P333; Tan WS, 2014, AM J MANAG CARE, V20, pE388; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Tsai WC, 2010, J INFECTION, V61, P235, DOI 10.1016/j.jinf.2010.06.016; Van Herck P, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-247; Verslype C, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds225; Wai C. T., 2004, SMJ Singapore Medical Journal, V45, P423; Yeh YP, 2014, HEPATOLOGY, V59, P1840, DOI 10.1002/hep.26703; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	47	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161002	10.1371/journal.pone.0161002	http://dx.doi.org/10.1371/journal.pone.0161002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517172	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100035
J	Camarca, A; Gianfrani, C; Ariemma, F; Cimmino, I; Bruzzese, D; Scerbo, R; Picascia, S; D'Esposito, V; Beguinot, F; Formisano, P; Valentino, R				Camarca, Alessandra; Gianfrani, Carmen; Ariemma, Fabiana; Cimmino, Ilaria; Bruzzese, Dario; Scerbo, Roberta; Picascia, Stefania; D'Esposito, Vittoria; Beguinot, Francesco; Formisano, Pietro; Valentino, Rossella			Human Peripheral Blood Mononuclear Cell Function and Dendritic Cell Differentiation Are Affected by Bisphenol- A Exposure	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; REGULATORY T-CELLS; IN-VITRO; IMMUNE-RESPONSES; A BPA; MOLECULAR-MECHANISMS; CYTOKINE PRODUCTION; PRENATAL EXPOSURE; TYPE-2 IMMUNITY; MICE	Environmental pollutants, including endocrine disruptor chemicals (EDCs), interfere on human health, leading to hormonal, immune and metabolic perturbations. Bisphenol-A (BPA), a main component of polycarbonate plastics, has been receiving increased attention due to its worldwide distribution with a large exposure. In humans, BPA, for its estrogenic activity, may have a role in autoimmunity, inflammatory and allergic diseases. To this aim, we assessed the effect of low BPA doses on functionality of human peripheral blood mononuclear cells (PBMCs), and on in vitro differentiation of dendritic cells from monocytes (mDCs). Fresh peripheral blood samples were obtained from 12 healthy adult volunteers. PBMCs were left unstimulated or were activated with the mitogen phytohemagglutinin (PHA) or the anti-CD3 and anti-CD28 antibodies and incubated in presence or absence of BPA at 0.1 and 1nM concentrations. The immune-modulatory effect of BPA was assessed by evaluating the cell proliferation and the levels of interferon-. (IFN-gamma), interleukin-4 (IL-4), interleukin-10 (IL-10) and interleukin-13 (IL-13) secreted by PBMCs. mDCs were differentiated with IL-4 and GC-CSF with or without BPA and the expression of differentiation/maturation markers (CD11c, CD1a, CD86, HLA-DR) was evaluated by flow cytometry; furthermore, a panel of 27 different cytokines, growth factors and chemokines were assayed in the mDC culture supernatants. PBMCs proliferation significantly increased upon BPA exposure compared to BPA untreated cells. In addition, a significant decrease in IL-10 secretion was observed in PBMCs incubated with BPA, either in unstimulated or mitogenstimulated cells, and at both 0.1 and 1nM BPA concentrations. Similarly, IL-13 was reduced, mainly in cells activated by antiCD3/CD28. By contrast, no significant changes in IFN-gamma and IL-4 production were found in any condition assayed. Finally, BPA at 1nM increased the density of dendritic cells expressing CD1a and concomitantly decreased the expression of HLA-DR and CD86 activation markers. In conclusion, in humans the exposure to BPA causes on PBMCs a significant modulation of proliferative capacity and cytokine production, and on mDCs alteration in differentiation and phenotype. These immune cell alterations suggest that low dose chronic exposure to BPA could be involved in immune deregulation and possibly in the increased susceptibility to develop inflammatory and autoimmune diseases.	[Camarca, Alessandra; Scerbo, Roberta] CNR, Inst Food Sci ISA, Via Roma 64, I-83100 Avellino, Italy; [Gianfrani, Carmen; Picascia, Stefania] CNR, IBP, Via P Castellino 11, I-80131 Naples, Italy; [Ariemma, Fabiana; Cimmino, Ilaria; D'Esposito, Vittoria; Beguinot, Francesco; Formisano, Pietro; Valentino, Rossella] Univ Naples Federico II, Dept Translat Med Sci, Via S Pansini 5, I-80131 Naples, Italy; [Bruzzese, Dario] Univ Naples Federico II, Dept Publ Hlth, Via S Pansini 5, I-80131 Naples, Italy; [D'Esposito, Vittoria; Beguinot, Francesco; Formisano, Pietro; Valentino, Rossella] CNR, URT Genom Diabet, Inst Expt Endocrinol & Oncol IEOS, Via S Pansini 5, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Valentino, R (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Via S Pansini 5, I-80131 Naples, Italy.; Valentino, R (corresponding author), CNR, URT Genom Diabet, Inst Expt Endocrinol & Oncol IEOS, Via S Pansini 5, I-80131 Naples, Italy.	rossvalentino@yahoo.it	Formisano, Pietro/J-4237-2018; D'Esposito, Vittoria/K-7633-2016	D'Esposito, Vittoria/0000-0002-3675-8062; Formisano, Pietro/0000-0001-7020-6870; Bruzzese, Dario/0000-0001-9911-4646				Acconcia F, 2015, DOSE-RESPONSE, V13, DOI 10.1177/1559325815610582; Alizadeh M, 2006, J MED INVESTIG, V53, P70, DOI 10.2152/jmi.53.70; Alonso-Magdalena P, 2015, ENDOCRINOLOGY, V156, P1659, DOI 10.1210/en.2014-1952; Angle BM, 2013, REPROD TOXICOL, V42, P256, DOI 10.1016/j.reprotox.2013.07.017; Ariemma F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150762; Bao K, 2015, CYTOKINE, V75, P25, DOI 10.1016/j.cyto.2015.05.008; Boucher JG, 2014, OBESITY, V22, P2333, DOI 10.1002/oby.20848; Cernadas M, 2009, CLIN EXP IMMUNOL, V155, P523, DOI 10.1111/j.1365-2249.2008.03853.x; Couleau N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131428; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Forawi Hanan A, 2004, Rev Environ Health, V19, P1; Frawley R, 2011, ENVIRON HEALTH PERSP, V119, P371, DOI 10.1289/ehp.1002358; Gao XQ, 2014, INT J ENV RES PUB HE, V11, P8399, DOI 10.3390/ijerph110808399; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Gianfrani C, 2006, J IMMUNOL, V177, P4178, DOI 10.4049/jimmunol.177.6.4178; Gostner JM, 2015, IMMUNOL LETT, V168, P285, DOI 10.1016/j.imlet.2015.10.006; Goto M, 2004, BIOSCI BIOTECH BIOCH, V68, P263, DOI 10.1271/bbb.68.263; Guo HC, 2010, CELL MOL IMMUNOL, V7, P227, DOI 10.1038/cmi.2010.14; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; Jochmanova I, 2015, LUPUS, V24, P392, DOI 10.1177/0961203314560205; Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009; Khalil N, 2014, SCI TOTAL ENVIRON, V470, P726, DOI 10.1016/j.scitotenv.2013.09.088; Khan D, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00635; Kharrazian D, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/743616; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HR, 2013, J CELL MOL MED, V17, P1, DOI 10.1111/j.1582-4934.2012.01649.x; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Liu YZ, 2014, BIOCHEM BIOPH RES CO, V451, P592, DOI 10.1016/j.bbrc.2014.08.031; Lubrano C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/640673; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Matta R, 2012, AM J PHYSIOL-GASTR L, V302, pG1322, DOI 10.1152/ajpgi.00018.2012; May RD, 2015, CYTOKINE, V75, P89, DOI 10.1016/j.cyto.2015.05.018; Menard S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112752; Menard S, 2014, FASEB J, V28, P4893, DOI 10.1096/fj.14-255380; O'Brien E, 2014, J IMMUNOTOXICOL, V11, P205, DOI 10.3109/1547691X.2013.822036; Ohlstein JF, 2014, J MOL ENDOCRINOL, V53, P345, DOI 10.1530/JME-14-0052; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Olsen I, 2013, J IMMUNOL METHODS, V390, P106, DOI 10.1016/j.jim.2013.01.015; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Pelekanou V, 2016, J LEUKOCYTE BIOL, V99, P333, DOI 10.1189/jlb.3A0914-430RR; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Pisapia L, 2012, GEN COMP ENDOCR, V178, P54, DOI 10.1016/j.ygcen.2012.04.005; Rezg R, 2014, ENVIRON INT, V64, P83, DOI 10.1016/j.envint.2013.12.007; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Sajiki J, 1999, J CHROMATOGR B, V736, P255, DOI 10.1016/S0378-4347(99)00471-5; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Savastano S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0532-y; Sawai C, 2003, ENVIRON HEALTH PERSP, V111, P1883, DOI 10.1289/ehp.6359; Schonfelder G, ENV HLTH PERSPECT, V110, pA703; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Seshadri C, 2013, J IMMUNOL, V191, P1586, DOI 10.4049/jimmunol.1300575; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Snijder CA, 2013, ENVIRON HEALTH PERSP, V121, P393, DOI 10.1289/ehp.1205296; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407; Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Vaidya SV, 2012, J ASTHMA, V49, P800, DOI 10.3109/02770903.2012.721041; Valentino R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082099; van de Ven R, 2011, BLOOD, V118, P2502, DOI 10.1182/blood-2011-03-344838; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; vom Saal FS, 2014, MOL CELL ENDOCRINOL, V398, P101, DOI 10.1016/j.mce.2014.09.028; Watson CS, 2005, STEROIDS, V70, P364, DOI 10.1016/j.steroids.2005.03.002; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Yamashita Uki, 2003, Journal of UOEH, V25, P161; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014; Yin DQ, 2007, J ENVIRON SCI, V19, P232, DOI 10.1016/S1001-0742(07)60038-2; Yoshino S, 2004, IMMUNOLOGY, V112, P489, DOI 10.1111/j.1365-2567.2004.01900.x; Yoshino S, 2003, BRIT J PHARMACOL, V138, P1271, DOI 10.1038/sj.bjp.0705166; Youn JY, 2002, ARCH PHARM RES, V25, P946, DOI 10.1007/BF02977018	77	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0161122	10.1371/journal.pone.0161122	http://dx.doi.org/10.1371/journal.pone.0161122			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509021	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400078
J	Hao, LY; Zaini, PA; Hoch, HC; Burr, TJ; Mowery, P				Hao, Lingyun; Zaini, Paulo A.; Hoch, Harvey C.; Burr, Thomas J.; Mowery, Patricia			Grape Cultivar and Sap Culture Conditions Affect the Development of Xylella fastidiosa Phenotypes Associated with Pierce's Disease	PLOS ONE			English	Article							PLANT-PATHOGENIC BACTERIA; AFFECT TWITCHING MOTILITY; CYCLIC DI-GMP; BIOFILM FORMATION; IV PILI; PSEUDOMONAS-FLUORESCENS; INSECT TRANSMISSION; VIRULENCE; AGGREGATION; RESISTANCE	Xylella fastidiosa is a xylem-limited bacterium in plant hosts and causes Pierce's disease (PD) of grapevines, which differ in susceptibility according to the Vitis species (spp.). In this work we compared X. fastidiosa biofilm formation and population dynamics when cultured in xylem saps from PD-susceptible and -resistant Vitis spp. under different conditions. Behaviors in a closed-culture system were compared to those in different sap-renewal cultures that would more closely mimic the physicochemical environment encountered in planta. Significant differences in biofilm formation and growth in saps from PD-susceptible and- resistant spp. were only observed using sap renewal culture. Compared to saps from susceptible V. vinifera, those from PD-resistant V. aestivalis supported lower titers of X. fastidiosa and less biofilm and V. champinii suppressed both growth and biofilm formation, behaviors which are correlated with disease susceptibility. Furthermore, in microfluidic chambers X. fastidiosa formed thick mature biofilm with three-dimensional (3-D) structures, such as pillars and mounds, in saps from all susceptible spp. In contrast, only small aggregates of various shapes were formed in saps from four out of five of the resistant spp.; sap from the resistant spp. V. mustangensis was an exception in that it also supported thick lawns of biofilm but not the above described 3-D structures typically seen in a mature biofilm from the susceptible saps. Our findings provide not only critical technical information for future bioassays, but also suggest further understanding of PD susceptibility.	[Hao, Lingyun; Zaini, Paulo A.; Hoch, Harvey C.; Burr, Thomas J.] Cornell Univ, New York State Agr Expt Stn, Sect Plant Pathol & Plant Microbe Biol, SIPS, Geneva, NY 14456 USA; [Mowery, Patricia] Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA; [Zaini, Paulo A.] Univ Fed Uberlandia, Inst Genet & Biochem, Uberlandia, MG, Brazil	Cornell University; Universidade Federal de Uberlandia	Mowery, P (corresponding author), Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA.	mowery@hws.edu		Hao, Lingyun/0000-0003-4724-1875	University of California Pierce's Disease Research Grants Program [2010-287]; California Department of Agriculture - Pierce's Disease and Glassy-winged Sharpshooter Board [15-0138-SA]; United States Department of Agriculture - National Institute of Food Agriculture [2015-16-198]	University of California Pierce's Disease Research Grants Program; California Department of Agriculture - Pierce's Disease and Glassy-winged Sharpshooter Board; United States Department of Agriculture - National Institute of Food Agriculture	Support was provided by the University of California Pierce's Disease Research Grants Program #2010-287 to TJB, PM, and HCH [http://www.piercesdisease.org/grants/manage]; California Department of Agriculture - Pierce's Disease and Glassy-winged Sharpshooter Board #15-0138-SA to TJB, PM, and LH [http://www.piercesdisease.org/grants/manage]; and United States Department of Agriculture - National Institute of Food & Agriculture #2015-16-198 to TJB [https://nifa.usda.gov/program/capacity-grants]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PC, 2007, FEMS MICROBIOL LETT, V274, P210, DOI 10.1111/j.1574-6968.2007.00827.x; Baccari C, 2011, PHYTOPATHOLOGY, V101, P77, DOI 10.1094/PHYTO-04-10-0104; Basha SM, 2010, APPL BIOCHEM BIOTECH, V160, P932, DOI 10.1007/s12010-009-8620-1; Black M., 2009, TEX PD RES S DRIFTW; Boulanger A, 2014, MBIO, V5, DOI 10.1128/mBio.01527-14; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Chalabaev S, 2014, MBIO, V5, DOI 10.1128/mBio.01116-14; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105; Chatterjee S, 2010, MOL PLANT MICROBE IN, V23, P1356, DOI 10.1094/MPMI-03-10-0057; Cheng DW, 2009, EUR J PLANT PATHOL, V125, P213, DOI 10.1007/s10658-009-9473-8; Cursino L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121851; Cursino L, 2011, MOL PLANT MICROBE IN, V24, P1198, DOI 10.1094/MPMI-10-10-0252; Cursino L, 2009, FEMS MICROBIOL LETT, V299, P193, DOI 10.1111/j.1574-6968.2009.01747.x; Dalsing BL, 2015, MBIO, V6, DOI 10.1128/mBio.02471-14; Danhorn T, 2007, ANNU REV MICROBIOL, V61, P401, DOI 10.1146/annurev.micro.61.080706.093316; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Bernonville TD, 2014, FEMS MICROBIOL ECOL, V89, P527, DOI 10.1111/1574-6941.12345; De La Fuente L, 2008, APPL ENVIRON MICROB, V74, P5579, DOI 10.1128/AEM.00995-08; De La Fuente L, 2007, J BACTERIOL, V189, P7507, DOI 10.1128/JB.00934-07; de Souza AA, 2013, APPL ENVIRON MICROB, V79, P3444, DOI 10.1128/AEM.03834-12; Drake DR, 2002, POLYMICROBIAL DIS; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Fritschi FB, 2007, AM J ENOL VITICULT, V58, P326; FRY SM, 1990, PHYTOPATHOLOGY, V80, P66, DOI 10.1094/Phyto-80-66; Ham JH, 2013, MOL PLANT PATHOL, V14, P308, DOI 10.1111/mpp.12005; Hao LY, 2012, APPL ENVIRON MICROB, V78, P4561, DOI 10.1128/AEM.07867-11; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Karimi A, 2015, LAB CHIP, V15, P23, DOI 10.1039/c4lc01095g; Killiny N, 2013, MOL PLANT MICROBE IN, V26, P1044, DOI 10.1094/MPMI-09-12-0211-R; Kim J, 2012, MOLECULES, V17, P9818, DOI 10.3390/molecules17089818; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P44, DOI 10.1094/PHYTO-95-0044; Lee MW, 2014, PHYSIOL MOL PLANT P, V87, P59, DOI 10.1016/j.pmpp.2014.07.001; Li YX, 2007, MICROBIOL-SGM, V153, P719, DOI 10.1099/mic.0.2006/002311-0; LOOMIS N. H., 1958, PLANT DIS REPORTER, V42, P833; Lu J, 2008, ACTA HORTIC, P257; Matsumoto A, 2012, MICROBIOLOGYOPEN, V1, P33, DOI 10.1002/mbo3.6; McGaha LA, 2007, AM J ENOL VITICULT, V58, P398; Meng YZ, 2005, J BACTERIOL, V187, P5560, DOI 10.1128/JB.187.16.5560-5567.2005; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Nascimento R, 2016, SCI REP-UK, V6, DOI 10.1038/srep18598; Newman KL, 2003, APPL ENVIRON MICROB, V69, P7319, DOI 10.1128/AEM.69.12.7319-7327.2003; RAJU BC, 1981, AM J ENOL VITICULT, V32, P155; Ruel JJ, 2006, AM J ENOL VITICULT, V57, P158; Saponari M, 2013, J PLANT PATHOL, V95, P668; Shi XY, 2009, APPL ENVIRON MICROB, V75, P2275, DOI 10.1128/AEM.01964-08; Shi XY, 2013, EUR J PLANT PATHOL, V135, P127, DOI 10.1007/s10658-012-0071-9; Sillankorva S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-80; Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004; Stover L. H., 1960, Proceedings of the Florida State Horticultural Society held at Tampa, Florida, October 25-27, 1960., V73, P320; Sun Q, 2013, PLANT PHYSIOL, V161, P1529, DOI 10.1104/pp.112.208157; Zaini PA, 2009, FEMS MICROBIOL LETT, V295, P129, DOI 10.1111/j.1574-6968.2009.01597.x; Zhang SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133796	54	7	7	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160978	10.1371/journal.pone.0160978	http://dx.doi.org/10.1371/journal.pone.0160978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508296	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400073
J	Boncompte, G; Villena-Gonzalez, M; Cosmelli, D; Lopez, V				Boncompte, Gonzalo; Villena-Gonzalez, Mario; Cosmelli, Diego; Lopez, Vladimir			Spontaneous Alpha Power Lateralization Predicts Detection Performance in an Un-Cued Signal Detection Task	PLOS ONE			English	Article							VISUAL-ATTENTION; SPATIAL ATTENTION; BAND ACTIVITY; OSCILLATIONS; INCREASES; MECHANISM; REFLECT; MODEL	Focusing one's attention by external guiding stimuli towards a specific area of the visual field produces systematical neural signatures. One of the most robust is the change in topological distribution of oscillatory alpha band activity across parieto-occipital cortices. In particular, decreases in alpha activity over contralateral and/or increases over ipsilateral scalp sites, respect to the side of the visual field where attention was focused. This evidence comes mainly from experiments where an explicit cue informs subjects where to focus their attention, thus facilitating detection of an upcoming target stimulus. However, recent theoretical models of attention have highlighted a stochastic or non-deterministic component related to visuospatial attentional allocation. In an attempt to evidence this component, here we analyzed alpha activity in a signal detection paradigm in the lack of informative cues; in the absence of preceding information about the location (and time) of appearance of target stimuli. We believe that the unpredictability of this situation could be beneficial for unveiling this component. Interestingly, although total alpha power did not differ between Seen and Unseen conditions, we found a significant lateralization of alpha activity over parieto-occipital electrodes, which predicted behavioral performance. This effect had a smaller magnitude compared to paradigms in which attention is externally guided (cued). However we believe that further characterization of this spontaneous component of attention is of great importance in the study of visuospatial attentional dynamics. These results support the presence of a spontaneous component of visuospatial attentional allocation and they advance prestimulus alpha-band lateralization as one of its neural signatures.	[Boncompte, Gonzalo; Villena-Gonzalez, Mario; Cosmelli, Diego; Lopez, Vladimir] Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Boncompte, G (corresponding author), Pontificia Univ Catolica Chile, Escuela Psicol, Santiago, Chile.	gnboncompte@gmail.com	Lopez, Vladimir/N-7188-2017	Villena-Gonzalez, Mario/0000-0003-2080-8413; Boncompte, Gonzalo/0000-0003-4363-0670	National Corporation of Science and Technology of Chile (CONICYT) [FONDECYT 1150241, FONDECYT 1130758]	National Corporation of Science and Technology of Chile (CONICYT)	The present work was financially supported by the National Corporation of Science and Technology of Chile (CONICYT; http://www.conicyt.cl/, grants FONDECYT 1150241 to VL and FONDECYT 1130758 to DC). The funding source had no further role in the study design; collection, analysis or interpretation of data; the writing of the report; or the decision to submit the paper for publication.	Banerjee S, 2011, J NEUROSCI, V31, P9923, DOI 10.1523/JNEUROSCI.4660-10.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cosmelli D, 2011, PSYCHOPHYSIOLOGY, V48, P312, DOI 10.1111/j.1469-8986.2010.01066.x; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Hong XF, 2015, NEUROIMAGE, V106, P353, DOI 10.1016/j.neuroimage.2014.11.019; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kimura a., 2008, 2008 19 INT C PATT R, DOI [10.1109/ICPR.2008.4761025, DOI 10.1109/ICPR.2008.4761025]; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Koike T, 2006, NEUROCOMPUTING, V69, P2112, DOI 10.1016/j.neucom.2005.09.009; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Muller N, 2012, CEREB CORTEX, V22, P1604, DOI 10.1093/cercor/bhr232; Pang D, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P1073, DOI 10.1109/ICME.2008.4607624; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; Strauss A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00350; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Vollebregt MA, 2015, NEUROIMAGE, V123, P245, DOI 10.1016/j.neuroimage.2015.06.054; Vul E, 2009, J EXP PSYCHOL GEN, V138, P546, DOI 10.1037/a0017352; Worden MS, 2000, J NEUROSCI, V20	29	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160347	10.1371/journal.pone.0160347	http://dx.doi.org/10.1371/journal.pone.0160347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IK	27504824	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200033
J	Kwon, TS; Li, FQ; Kim, SS; Chun, JH; Park, YS				Kwon, Tae-Sung; Li, Fengqing; Kim, Sung-Soo; Chun, Jung Hwa; Park, Young-Seuk			Modelling Vulnerability and Range Shifts in Ant Communities Responding to Future Global Warming in Temperate Forests	PLOS ONE			English	Article							CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; RESPONSES; DIVERSITY; BIODIVERSITY; IMPACTS; PREDICTION; PATTERNS	Global warming is likely leading to species' distributional shifts, resulting in changes in local community compositions and diversity patterns. In this study, we applied species distribution models to evaluate the potential impacts of temperature increase on ant communities in Korean temperate forests, by testing hypotheses that 1) the risk of extinction of forest ant species would increase over time, and 2) the changes in species distribution ranges could drive upward movements of ant communities and further alter patterns of species richness. We sampled ant communities at 335 evenly distributed sites across South Korea and modelled the future distribution range for each species using generalized additive models. To account for spatial autocorrelation, autocovariate regressions were conducted prior to generalized additive models. Among 29 common ant species, 12 species were estimated to shrink their suitable geographic areas, whereas five species would benefit from future global warming. Species richness was highest at low altitudes in the current period, and it was projected to be highest at the mid-altitudes in the 2080s, resulting in an upward movement of 4.9 m yr(-1). This altered the altitudinal pattern of species richness from a monotonic-decrease curve (common in temperate regions) to a bell-shaped curve (common in tropical regions). Overall, ant communities in temperate forests are vulnerable to the on-going global warming and their altitudinal movements are similar to other faunal communities.	[Kwon, Tae-Sung] Natl Inst Forest Sci, Forest Insect Pests & Dis Div, Seoul 02455, South Korea; [Li, Fengqing; Park, Young-Seuk] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea; [Li, Fengqing; Park, Young-Seuk] Kyung Hee Univ, Dept Biol, Seoul 02447, South Korea; [Kim, Sung-Soo] Res Inst East Asian Environm & Biol, Arisuro 25 Nagil 24, Seoul 05207, South Korea; [Chun, Jung Hwa] Natl Inst Forest Sci, Div Forest Ecol, Seoul 02455, South Korea	Korea Forest Research Institute (KFRI); National Institute of Forest Science (NIFOS), Republic of South Korea; Kyung Hee University; Kyung Hee University; Korea Forest Research Institute (KFRI); National Institute of Forest Science (NIFOS), Republic of South Korea	Park, YS (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul 02447, South Korea.; Park, YS (corresponding author), Kyung Hee Univ, Dept Biol, Seoul 02447, South Korea.	parkys@khu.ac.kr			Korea Forest Research Institute [FE 0100-2009-01]	Korea Forest Research Institute	This study was conducted as part of a research project of the Korea Forest Research Institute (Project FE 0100-2009-01, Effect of climate change on forest ecosystem and adaptation of forest ecosystem).; This study was conducted as part of a research project of the Korea Forest Research Institute (Project FE 0100-2009-01, Effect of climate change on forest ecosystem and adaptation of forest ecosystem).	Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Choi SW, 2012, ENTOMOL SCI, V15, P1, DOI 10.1111/j.1479-8298.2011.00478.x; Choi SW, 2004, J BIOGEOGR, V31, P587, DOI 10.1046/j.1365-2699.2003.01007.x; Chung N, 2016, ANN LIMNOL-INT J LIM, V52, P171, DOI 10.1051/limn/2015024; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davis MB, 2005, ECOLOGY, V86, P1704, DOI 10.1890/03-0788; De Frenne P, 2013, P NATL ACAD SCI USA, V110, P18561, DOI 10.1073/pnas.1311190110; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dunn RR, 2009, ECOL LETT, V12, P324, DOI 10.1111/j.1461-0248.2009.01291.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher Brian L., 1996, Fieldiana Zoology, V85, P93; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; GUENARD B, 2012, ZOOTAXA 1121, P1; Hastie T., 2012, GEN ADDITIVE MODELS; Hof C, 2012, BIOL LETTERS, V8, P639, DOI 10.1098/rsbl.2012.0023; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Juggins S, 1992, USER GUIDE C2 SOFTWA; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Kwon T.-S., 2012, 459 KOR FOR RES I; Kwon Tae-Sung, 2014, Journal of Asia-Pacific Biodiversity, V7, pE179; Kwon Tae-Sung, 2014, Journal of Asia-Pacific Biodiversity, V7, pE133; Kwon TS, 2016, J ASIA-PAC ENTOMOL, V19, P95, DOI 10.1016/j.aspen.2015.12.006; Kwon Tae-Sung, 2014, Journal of Asia-Pacific Biodiversity, V7, pE19; Kwon TS, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0037-z; Lee CB, 2013, ECOL RES, V28, P67, DOI 10.1007/s11284-012-1001-1; Lee C, 2013, CHINESE SCI BULL, V58, P3747, DOI 10.1007/s11434-013-5957-1; Lehmann A, 2002, ECOL MODEL, V157, P189, DOI 10.1016/S0304-3800(02)00195-3; Li FQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11343; Li F, 2014, CONSERV BIOL, V28, P498, DOI 10.1111/cobi.12219; Li F, 2013, CLIMATIC CHANGE, V119, P421, DOI 10.1007/s10584-013-0720-9; Maslin M, 2012, NATURE, V486, P183, DOI 10.1038/486183a; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pelini SL, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00097.1; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Roura-Pascual N, 2004, P ROY SOC B-BIOL SCI, V271, P2527, DOI 10.1098/rspb.2004.2898; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Terayama Mamoru, 1998, Bulletin of the Biogeographical Society of Japan, V53, P43; TERBRAAK CJF, 1993, HYDROBIOLOGIA, V269, P485, DOI 10.1007/BF00028046; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Vaclavik T, 2012, J BIOGEOGR, V39, P42, DOI 10.1111/j.1365-2699.2011.02589.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ward PS, 2000, ANTS STANDARD METHOD, P1; Warren RJ, 2013, GLOBAL CHANGE BIOL, V19, P2082, DOI 10.1111/gcb.12169; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Yun JI, 2013, DEV DIGITAL CLIMATE, P125; Yun Jin, 2007, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V9, P1; Yun Jin, 2010, [Korean Journal of Agricultural and Forest Meteorology, 한국농림기상학회지], V12, P63	54	6	6	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159795	10.1371/journal.pone.0159795	http://dx.doi.org/10.1371/journal.pone.0159795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504632	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200014
J	Liu, XY; Meng, HY; Jiang, C; Yang, SB; Cui, FW; Yang, P				Liu, Xueyan; Meng, Heyu; Jiang, Chao; Yang, Sibao; Cui, Fengwen; Yang, Ping			Differential microRNA Expression and Regulation in the Rat Model of Post-Infarction Heart Failure	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; DILATED CARDIOMYOPATHY; MYOCARDIAL FIBROSIS; DOWN-REGULATION; IDENTIFICATION; GROWTH; TRANSCRIPTOME; CONTRIBUTES; INFARCTION; INHIBITION	Background Heart failure is a complex end stage of various cardiovascular diseases with a poor prognosis, and the mechanisms for development and progression of heart failure have always been a hot point. However, the molecular mechanisms underlying the post transcriptional regulation of heart failure have not been fully elucidated. Current data suggest that microRNAs (miRNAs) are involved in the pathogenesis of heart failure and could serve as a new biomarker, but the precise regulatory mechanisms are still unclear. Methods The differential miRNA profile in a rat model of post-infarction heart failure was determined using high throughout sequencing and analyzed through bioinformatics approaches. The results were validated using qRT-PCR for 8 selected miRNAs. Then the expression patterns of 4 miRNAs were analyzed in different periods after myocardial infarction. Finally, gain-and loss-of-function experiments of rno-miR-122-5p and rno-miR-184 were analyzed in H2O2 treated H9c2 cells. Results In the heart failure sample, 78 miRNAs were significantly upregulated and 28 were downregulated compared to the controls. GO and KEGG pathway analysis further indicated the likely roles of these miRNAs in heart failure. Time-course analysis revealed different expression patterns of 4 miRNAs: rno-miR-122-5p, rno-miR-199a-5p, rno-miR-184 and rno-miR-208a-3p. Additionally, rno-miR-122-5p and rno-miR-184 were proved to promote apoptosis in vitro. Conclusions Differential profile and expression patterns of miRNAs in the rats model of post-infarction heart failure were found, and the pro-apoptotic roles of rno-miR-122-5p and rno-miR-184 were revealed. These findings may provide a novel way that may assist in heart failure diagnosis and treatment.	[Liu, Xueyan; Yang, Sibao; Cui, Fengwen; Yang, Ping] Jilin Univ, China Japan Union Hosp, Dept Internal Med & Cardiol, Changchun, Peoples R China; [Meng, Heyu] Yanbian Univ, Med Clin, Yanji, Peoples R China; [Jiang, Chao] Jilin Univ, Dept Hepatobiliary Pancreat Surg, Hosp 1, Changchun, Peoples R China	Jilin University; Yanbian University; Jilin University	Yang, P (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Internal Med & Cardiol, Changchun, Peoples R China.	pyang@jlu.edu.cn	Meng, Heyu/GVU-2745-2022; Liu, Xueyan/GRS-2771-2022; Jiang, Chao/ACT-6505-2022	Liu, Xueyan/0000-0003-2736-6320; Jiang, Chao/0000-0001-6643-7991	National Natural Science Foundation of China [81570360]; Graduate Innovation Fund of Jilin University [2013112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Innovation Fund of Jilin University(Jilin University)	This work was supported by the National Natural Science Foundation of China (81570360 http://isisn.nsfc.gov.cn/egrantweb/) and Graduate Innovation Fund of Jilin University (2013112 http://gil.jlu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was supported by National Natural Science Foundation of China (81570360) and Graduate Innovation Fund of Jilin University.	An Z, 2013, CHINESE MED J-PEKING, V126, P2149, DOI 10.3760/cma.j.issn.0366-6999.20123223; Baumgarten A, 2013, INT J CARDIOL, V168, P1447, DOI 10.1016/j.ijcard.2012.12.094; Beaumont J, 2014, CLIN SCI, V126, P497, DOI 10.1042/CS20130538; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Brucculeri S, 2013, CLIN TER, V164, pE223, DOI 10.7417/CT.2013.1572; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; De Boer RA, 2003, MICROCIRCULATION, V10, P113, DOI 10.1038/sj.mn.7800188; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hilfiker-Kleiner D, 2005, TRENDS CARDIOVAS MED, V15, P152, DOI 10.1016/j.tcm.2005.05.002; Huang XY, 2012, J CELL MOL MED, V16, P2637, DOI 10.1111/j.1582-4934.2012.01577.x; Iemitsu M, 2001, AM J PHYSIOL-REG I, V281, pR2029, DOI 10.1152/ajpregu.2001.281.6.R2029; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Katsura A, 2016, GENES CELLS, V21, P99, DOI 10.1111/gtc.12323; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Levi F, 2002, HEART, V88, P119, DOI 10.1136/heart.88.2.119; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li XB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1764-1; Lian CJ, 2012, FEBS J, V279, P964, DOI 10.1111/j.1742-4658.2012.08480.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Okada K, 2015, CIRC-HEART FAIL, V8, P799, DOI 10.1161/CIRCHEARTFAILURE.114.001958; Prasad SVN, 2009, J BIOL CHEM, V284, P27487, DOI 10.1074/jbc.M109.036541; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shao M. J., 2012, EVID-BASED COMPL ALT, V2012, DOI [10.1155/2016.825056, DOI 10.1155/2016.825056]; Shyu KG, 2013, EUR J HEART FAIL, V15, P36, DOI 10.1093/eurjhf/hfs143; Takahashi Y, 2015, FEBS LETT, V589, P1143, DOI 10.1016/j.febslet.2015.03.010; Tao H, 2016, INT J BIOL MACROMOL, V88, P414, DOI 10.1016/j.ijbiomac.2016.04.010; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wang BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084188; Wang JX, 2015, MOL CELL, V59, P50, DOI 10.1016/j.molcel.2015.05.003; Yang C., 2014, J BOT, V2014, P9, DOI [10.1155/2014/181727, DOI 10.1155/2014/181727]; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Zhang LW, 2014, LIFE SCI, V94, P83, DOI 10.1016/j.lfs.2013.11.011; Zhu XM, 2013, J CELL MOL MED, V17, P1173, DOI 10.1111/jcmm.12096	46	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160920	10.1371/journal.pone.0160920	http://dx.doi.org/10.1371/journal.pone.0160920			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504893	gold, Green Submitted, Green Published			2022-12-26	WOS:000381374200079
J	Oygarden, H; Fromm, A; Sand, KM; Kvistad, CE; Eide, GE; Thomassen, L; Naess, H; Waje-Andreassen, U				Oygarden, Halvor; Fromm, Annette; Sand, Kristin Modalsli; Kvistad, Christopher Elnan; Eide, Geir Egil; Thomassen, Lars; Naess, Halvor; Waje-Andreassen, Ulrike			A Family History of Stroke Is Associated with Increased Intima-Media Thickness in Young Ischemic Stroke - The Norwegian Stroke in the Young Study (NOR-SYS)	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENOME-WIDE ASSOCIATION; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PARENTAL-HISTORY; GENETICS; ADULTS; ATHEROSCLEROSIS; DETERMINANTS; PROGRESSION	Background and Purpose Positive family history (FH+) of cardiovascular disease (CVD) is a risk factor for own CVD. We aimed to analyze the effect of different types of FH (stroke, coronary heart disease (CHD), peripheral artery disease (PAD) on carotid intima-media thickness (cIMT) in young and middle-aged ischemic stroke patients. Methods First-degree FH of CVD was assessed in ischemic stroke patients <= 60y using a standardized interview. Carotid ultrasound was performed and far wall cIMT in three carotid artery segments was registered, representing the common carotid (CCA-IMT), carotid bifurcation (BIF-IMT) and the internal carotid artery (ICA-IMT). Measurements were compared between FH+ and FH negative groups and stepwise backward regression analyses were performed to identify factors associated with increased cIMT. Results During the study period 382 patients were enrolled, of which 262 (68%) were males and 233 (61%) reported FH of CVD. Regression analyses adjusting for risk factors revealed age as the most important predictor of cIMT in all segments. The association between FH+ and cIMT was modified by age (p = 0.014) and was significant only regarding ICA-IMT. FH+ was associated with increased ICA-IMT in patients aged < 45y (p = 0.001), but not in patients >= 45y (p = 0.083). The association with ICA-IMT was present for a FH of stroke (p = 0.034), but not a FH+ of CHD or PAD. Conclusions FH of stroke is associated with higher ICA-IMT in young ischemic stroke patients. Subtyping of cardiovascular FH is important to investigate heredity in young ischemic stroke patients.	[Oygarden, Halvor; Fromm, Annette; Sand, Kristin Modalsli; Kvistad, Christopher Elnan; Thomassen, Lars; Naess, Halvor] Univ Bergen, Dept Clin Med, Bergen, Norway; [Fromm, Annette; Kvistad, Christopher Elnan; Thomassen, Lars; Naess, Halvor; Waje-Andreassen, Ulrike] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Eide, Geir Egil] Haukeland Hosp, Clin Res Ctr, Bergen, Norway; [Eide, Geir Egil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Lifestyle Epidemiol Res Grp, Bergen, Norway; [Waje-Andreassen, Ulrike] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Oygarden, H (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	hoygarden@gmail.com	Fromm, Annette/I-1575-2019	Fromm, Annette/0000-0003-0621-570X	University of Bergen	University of Bergen	University of Bergen funded the PhD scholarship of HO and KMS. Helse Vest provided the infrastructure needed to perform the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassarre D, 2013, ARTERIOSCL THROM VAS, V33, P2273, DOI 10.1161/ATVBAHA.113.301844; Banerjee A, 2012, INT J CLIN PRACT, V66, P536, DOI 10.1111/j.1742-1241.2012.02908.x; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chow CK, 2011, J AM COLL CARDIOL, V57, P619, DOI 10.1016/j.jacc.2010.07.054; Cuomo S, 2002, EUR HEART J, V23, P1345, DOI 10.1053/euhj.2001.3111; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Duggirala R, 1996, STROKE, V27, P833, DOI 10.1161/01.STR.27.5.833; Eikendal ALM, 2015, HYPERTENSION, V65, P707, DOI 10.1161/HYPERTENSIONAHA.114.04658; Fromm Annette, 2014, BMC Res Notes, V7, P176, DOI 10.1186/1756-0500-7-176; Fromm A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-89; Gaeta G, 2000, NEW ENGL J MED, V343, P840, DOI 10.1056/NEJM200009213431203; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Jerrard-Dunne P, 2003, STROKE, V34, P1364, DOI 10.1161/01.STR.0000069723.17984.FD; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1376, DOI 10.1161/01.ATV.0000222012.56447.00; Juonala M, 2010, CIRCULATION, V122, P2514, DOI 10.1161/CIRCULATIONAHA.110.966465; Kathiresan S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S17; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Majersik JJ, 2015, STROKE, V46, P279, DOI 10.1161/STROKEAHA.114.006839; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; McGill HC, 2008, CIRCULATION, V117, P1216, DOI 10.1161/CIRCULATIONAHA.107.717033; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Oygarden H, 2016, EUR J NEUROL, V23, P154, DOI 10.1111/ene.12824; Oygarden H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0276-6; Pandey AK, 2013, ATHEROSCLEROSIS, V228, P285, DOI 10.1016/j.atherosclerosis.2013.02.016; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Rundek T, 2013, STROKE, V44, P2101, DOI 10.1161/STROKEAHA.111.000745; Sacco RL, 2009, STROKE, V40, P2307, DOI 10.1161/STROKEAHA.109.554121; Thijs V, 2015, STROKE, V46, P1975, DOI 10.1161/STROKEAHA.115.009341; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Wang TJ, 2003, CIRCULATION, V108, P572, DOI 10.1161/01.CIR.0000081764.35431.DE; Zannad F, 1998, HUM GENET, V103, P183, DOI 10.1007/s004390050804; Ziegelbauer K, 2013, EUR J PREV CARDIOL, V20, P837, DOI 10.1177/2047487312449589	37	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159811	10.1371/journal.pone.0159811	http://dx.doi.org/10.1371/journal.pone.0159811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504830	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200015
J	Suckling, DM; Baker, G; Salehi, L; Woods, B				Suckling, David M.; Baker, Greg; Salehi, Latif; Woods, Bill			Is the Combination of Insecticide and Mating Disruption Synergistic or Additive in Lightbrown Apple Moth, Epiphyas postvittana?	PLOS ONE			English	Article							TERM PEST-MANAGEMENT; SEX-PHEROMONE; COMMUNICATION DISRUPTION; LEPIDOPTERA-TORTRICIDAE; SCALE TRIALS; CODLING MOTH; ERADICATION	Pest suppression from combinations of tactics is fundamental to pest management and eradication. Interactions may occur among tactical combinations and affect suppression. The best case is synergistic, where suppression from a combination is greater than the sum of effects from single tactics (AB >> A+B). We explored how mating disruption and insecticide interacted at field scale, additively or synergistically. Use of a pheromone delivery formulation (SPLAT (TM)) as either a mating disruption treatment (i.e. a two-component pheromone alone) or as a lure and kill treatment (i.e. the two-component pheromone plus a permethrin insecticide) was compared for efficacy against the lightbrown apple moth Epiphyas postvittana. Next, four point-source densities of the SPLAT (TM) formulations were compared for communication disruption. Finally, the mating disruption and lure and kill treatments were applied with a broadcast insecticide. Population assessment used virgin female traps and synthetic pheromone in replicated 9-ha vineyard plots compared with untreated controls and insecticide-treated plots, to investigate interactions. Lure and kill and mating disruption provided equivalent suppression; no additional benefit accrued from including permethrin with the pheromone suggesting lack of contact. The highest point-source density tested (625/ha) was most effective. The insect growth regulator methoxyfenoxide applied by broadcast application lowered pest prevalence by 70% for the first ten weeks compared to pre-trial. Pheromone addition suppressed the pest further by an estimated 92.5%, for overall suppression of 97.7% from the treatment combination of insecticide plus mating disruption. This was close to that expected for an additive model of interactivity between insecticide and mating disruption (AB = A+B) estimated from plots with single tactics as 98% suppression in a combination. The results indicate the need to examine other tactical combinations to achieve the potential cost-efficiencies of synergistic interactions.	[Suckling, David M.] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Suckling, David M.] Univ Auckland, Sch Biol Sci, Bldg 733,Tamaki Campus, Auckland, New Zealand; [Suckling, David M.; Baker, Greg; Salehi, Latif; Woods, Bill] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [Baker, Greg; Salehi, Latif] South Australian Res & Dev Inst, Entomol Unit, Adelaide, SA, Australia; [Woods, Bill] Dept Food & Agr, S Perth, WA, Australia; [Suckling, David M.] Better Border Biosecur, Christchurch, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; South Australian Research & Development Institute (SARDI)	Suckling, DM (corresponding author), New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand.; Suckling, DM (corresponding author), Univ Auckland, Sch Biol Sci, Bldg 733,Tamaki Campus, Auckland, New Zealand.; Suckling, DM (corresponding author), Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia.; Suckling, DM (corresponding author), Better Border Biosecur, Christchurch, New Zealand.	max.suckling@plantandfood.co.nz	Suckling, David M/F-7005-2010; Suckling, David Maxwell/M-7730-2019	Suckling, David M/0000-0001-7216-9348; Suckling, David Maxwell/0000-0001-7216-9348	Better Border Biosecurity; Plant Biosecurity Cooperative Research Centre [2034]	Better Border Biosecurity; Plant Biosecurity Cooperative Research Centre	This work was supported by: Better Border Biosecurity, www.b3nz.org (DMS); and by Plant Biosecurity Cooperative Research Centre (#2034), http://www.pbcrc.com.au/ (DMS GB BW LS).	BARCLAY HJ, 1984, PROT ECOL, V7, P281; BARCLAY HJ, 1992, RES POPUL ECOL, V34, P91, DOI 10.1007/BF02513524; Barclay HJ, 2011, INT J AGRON, V2011, DOI 10.1155/2011/409328; BELLAS TE, 1983, J CHEM ECOL, V9, P503, DOI 10.1007/BF00990222; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Blackwood JC, 2012, P ROY SOC B-BIOL SCI, V279, P2807, DOI 10.1098/rspb.2012.0255; Boukal DS, 2009, POPUL ECOL, V51, P445, DOI 10.1007/s10144-009-0154-4; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Brockerhoff EG, 2011, J ECON ENTOMOL, V104, P1514, DOI 10.1603/EC11160; Brockerhoff EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043767; Brockerhoff EG, 1999, J ECON ENTOMOL, V92, P853, DOI 10.1093/jee/92.4.853; Carpenter J., 2007, P351; Clare G., 2000, Proceedings of the New Zealand Plant Protection Conference, V53, P216; Duckworth JA, 2006, ECOL STU AN, V186, P421; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; El-Sayed AM, 2009, J ECON ENTOMOL, V102, P815, DOI 10.1603/029.102.0301; El-Sayed AM, 2011, J CHEM ECOL, V37, P640, DOI 10.1007/s10886-011-9964-x; Gamble JC, 2010, NEW ZEAL J CROP HORT, V38, P57, DOI 10.1080/01140671003767842; Gilligan TM, 2011, P ENTOMOL SOC WASH, V113, P426, DOI 10.4289/0013-8797.113.4.426; Liebhold AM, 2016, ANNU REV ENTOMOL, V61, P335, DOI 10.1146/annurev-ento-010715-023809; Lo P. L., 2013, New Zealand Plant Protection, V66, P264; Mafra-Neto A, 2014, MANIPULATION INSECT; Miller JR, 2015, ENVIRON ENTOMOL, V44, P427, DOI 10.1093/ee/nvv052; Mo JH, 2006, J ECON ENTOMOL, V99, P421, DOI 10.1603/0022-0493-99.2.421; Rodriguez-Saona Cesar R., 2009, P263, DOI 10.1007/978-1-4020-8992-3_11; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Soopaya R, 2015, J ECON ENTOMOL, V108, P1930, DOI 10.1093/jee/tov142; Suckling DM, 2014, BIOL INVASIONS, V16, P1851, DOI 10.1007/s10530-013-0631-8; Suckling DM, 2012, CROP PROT, V42, P327, DOI 10.1016/j.cropro.2012.07.009; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Suckling DM, 2007, PEST MANAG SCI, V63, P202, DOI 10.1002/ps.1312; Suckling DM, 2015, PEST MANAG SCI, V71, P1452, DOI 10.1002/ps.3950; Suckling DM, 2014, PEST MANAG SCI, V70, P179, DOI 10.1002/ps.3670; Suckling DM, 2012, J ECON ENTOMOL, V105, P1694, DOI 10.1603/EC12130; Suckling DM, 2012, J ECON ENTOMOL, V105, P1, DOI 10.1603/EC11293; SUCKLING DM, 1990, ENVIRON ENTOMOL, V19, P1702, DOI 10.1093/ee/19.6.1702; Suckling DM, 1999, J ECON ENTOMOL, V92, P367, DOI 10.1093/jee/92.2.367; SUCKLING DM, 1995, NEW ZEAL J CROP HORT, V23, P127, DOI 10.1080/01140671.1995.9513879; Suckling DM, 2015, FRONT ECOL EVOL, V3, P17, DOI DOI 10.3389/FEV0.2015.00017; Tobin PC, 2014, BIOL INVASIONS, V16, P401, DOI 10.1007/s10530-013-0529-5; Tobin PC, 2011, ECOL LETT, V14, P615, DOI 10.1111/j.1461-0248.2011.01614.x; Yamanaka T, 2007, POPUL ECOL, V49, P75, DOI 10.1007/s10144-006-0018-0	42	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160710	10.1371/journal.pone.0160710	http://dx.doi.org/10.1371/journal.pone.0160710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500834	Green Submitted, gold, Green Published			2022-12-26	WOS:000381373500048
J	Jiang, YX; Yang, SW; Li, PA; Luo, X; Li, ZY; Hao, YX; Yu, PW				Jiang, Y-X; Yang, S-W; Li, P-A; Luo, X.; Li, Z-Y; Hao, Y-X; Yu, P-W			The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-GROWTH; T-CELLS; ASSOCIATION; EXPRESSION; STAT3; CD26; HETEROGENEITY; INFLAMMATION; PREVENTION	Postoperative recurrence and metastasis have crucial roles in the poor prognosis of gastric cancer patients. Previous studies have indicated that gastric cancer originates from cancer stem cells (CSCs), and some investigators have found that a particular subset of CSCs possesses higher metastatic capacity. However, the specific mechanism remains uncertain. In the present study, we aimed to explore the biological functions of the inflammatory cytokine interleukin-17 (IL-17) in gastric cancer metastasis and the distinct IL-17-induced transformation of quiescent gastric CSCs. Our results showed that invasive gastric CSCs were CD26+ and CXCR4+ and were closely associated with increased metastatic ability. The quiescent gastric CSCs, which were CD26- and CXCR4-, were exposed to appropriate concentrations of IL-17; this resulted in the decreased expression of E-cadherin and the increased expression of vimentin and N-cadherin. In addition, the upregulation of IL-17 both in vitro and in vivo resulted in a significant induction of invasion, migration and tumor formation ability in gastric CSCs compared with the control group, which was not treated with IL-17. Further experiments indicated that the activation of the downstream phosphorylated signal transducer and activator of transcription 3 (STAT3) transcription factor pathway was facilitated by IL-17. On the contrary, the downregulation of STAT3 by the specific inhibitor Stattic significantly reversed the IL-17-induced epithelial-mesenchymal transition (EMT)-associated properties of quiescent gastric CSCs. Moreover, tumorigenesis and metastasis were suppressed. Taken together, we suggest that IL-17 is positively correlated with the transformation of quiescent gastric CSCs into invasive gastric CSCs and that targeting IL-17 may emerge as a possible novel therapeutic strategy for gastric cancer.	[Jiang, Y-X; Yang, S-W; Li, P-A; Luo, X.; Li, Z-Y; Hao, Y-X; Yu, P-W] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Dept Gen Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China	Army Medical University	Hao, YX; Yu, PW (corresponding author), Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, Dept Gen Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	haoyingxue@hotmail.com; yupeiwu01@sina.com			National Natural Science Foundation of China [81372559]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the National Natural Science Foundation of China (81372559).	Bleau AM, 2014, HISTOL HISTOPATHOL, V29, P1499, DOI 10.14670/HH-29.1499; Botelho FM, 2013, J IMMUNOL, V191, P1453, DOI 10.4049/jimmunol.1203318; Das UN, 2011, CANCER METAST REV, V30, P311, DOI 10.1007/s10555-011-9316-x; Davies S, 2015, BIOMED PHARMACOTHER, V71, P135, DOI 10.1016/j.biopha.2015.02.031; Fagoonee S, 2014, PANMINERVA MED, V56, P289; Guo D, 2012, ONCOL REP, V28, P241, DOI 10.3892/or.2012.1781; Guo HQ, 2003, WORLD J GASTROENTERO, V9, P432, DOI 10.3748/wjg.v9.i3.432; Hamada S, 2016, DIGEST DIS SCI, V61, P1561, DOI 10.1007/s10620-015-4001-5; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herrero R, 2014, JAMA-J AM MED ASSOC, V312, P1197, DOI 10.1001/jama.2014.10498; Huang XC, 2015, ONCOTARGETS THER, V8, P2989, DOI 10.2147/OTT.S91511; Iacopino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105166; Jinushi M, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28862; Jung A, 2007, ERNST SCHERING FOUND, V5, P109, DOI 10.1007/2789_2007_047; Lam CSC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098582; Liao WT, 2014, AM J STEM CELLS, V3, P46; Lin L, 2012, INT J CANCER, V130, P1459, DOI 10.1002/ijc.26152; Liu S, 2016, ONCOTARGET, V7, P13651, DOI 10.18632/oncotarget.7296; Liu XS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106834; Long ZW, 2015, WORLD J GASTROENTERO, V21, P5707, DOI 10.3748/wjg.v21.i18.5707; Lu Z, 2013, J RES MED SCI, V18, P647; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mannello F, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-169; Oliveras-Ferraros C, 2014, CELL CYCLE, V13, P1132, DOI 10.4161/cc.27982; Paganessi LA, 2011, EXP HEMATOL, V39, P384, DOI 10.1016/j.exphem.2010.12.003; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Prabhash K, 2010, ANN ONCOL, V21, P582, DOI 10.1093/annonc/mdp342; Qiao B, 2012, BIOL CELL, V104, P476, DOI 10.1111/boc.201100077; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207; Wang T, 2015, ONCOTARGET, V6, P30975, DOI 10.18632/oncotarget.5199; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wu X, 2015, TUMOR BIOL, V37, P5493; Yang L, 2011, CANCER LETT, V310, P46, DOI 10.1016/j.canlet.2011.06.003; Zhang X, 2016, ONCOTARGET, V7, P9851; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhu YT, 2014, STEM CELL RES, V13, P111, DOI 10.1016/j.scr.2014.04.006; Zhuang Y, 2012, GASTROENTEROLOGY, V143, P951, DOI 10.1053/j.gastro.2012.06.010	40	69	73	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1256	1264		10.1038/onc.2016.291	http://dx.doi.org/10.1038/onc.2016.291			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27524415	Green Published, hybrid			2022-12-26	WOS:000395861300009
J	Kesarwani, AK; Ramirez, O; Gupta, AK; Yang, X; Murthy, T; Minella, AC; Pillai, MM				Kesarwani, A. K.; Ramirez, O.; Gupta, A. K.; Yang, X.; Murthy, T.; Minella, A. C.; Pillai, M. M.			Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3 ' splice sites within RNA secondary structures	ONCOGENE			English	Article							EXPRESSION ANALYSIS; MUTATIONS; SELECTION; GENES; MYELODYSPLASIA; MITOFERRIN; UPSTREAM; BINDING; STEP	Recurrent mutations in core splicing factors have been reported in several clonal disorders, including cancers. Mutations in SF3B1, a component of the U2 splicing complex, are the most common. SF3B1 mutations are associated with aberrant pre-mRNA splicing using cryptic 3' splice sites (3' SSs), but the mechanism of their selection is not clear. To understand how cryptic 3' SSs are selected, we performed comprehensive analysis of transcriptome-wide changes to splicing and gene expression associated with SF3B1 mutations in patient samples as well as an experimental model of inducible expression. Hundreds of cryptic 3' SS were detectable across the genome in cells expressing mutant SF3B1. These 3' SS are typically sequestered within RNA secondary structures and poorly accessible compared with their corresponding canonical 3' SS. We hypothesized that these cryptic 3' SS are inaccessible during normal splicing catalysis and that this constraint is overcome in spliceosomes containing mutant SF3B1. This model of secondary structure-dependent selection of cryptic 3' SS was found across multiple clonal processes associated with SF3B1 mutations (myelodysplastic syndrome and chronic lymphocytic leukemia). We validated our model predictions in mini-gene splicing assays. Additionally, we found deregulated expression of proteins with relevant functions in splicing factor-related diseases both in association with aberrant splicing and without corresponding splicing changes. Our results show that SF3B1 mutations are associated with a distinct splicing program shared across multiple clonal processes and define a biochemical mechanism for altered 3' SS choice.	[Kesarwani, A. K.; Ramirez, O.; Gupta, A. K.; Yang, X.; Pillai, M. M.] Yale Canc Ctr, Sect Hematol, 300 George St, New Haven, CT 06511 USA; [Kesarwani, A. K.; Ramirez, O.; Gupta, A. K.; Yang, X.; Pillai, M. M.] Yale Univ, Sch Med, 300 George St, New Haven, CT 06511 USA; [Murthy, T.] Northwestern Univ, Feinberg Sch Med, Driskill Grad Program, Chicago, IL USA; [Minella, A. C.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA	Yale University; Yale University; Northwestern University; Feinberg School of Medicine; Versiti Blood Center of Wisconsin	Pillai, MM (corresponding author), Yale Canc Ctr, Sect Hematol, 300 George St, New Haven, CT 06511 USA.; Pillai, MM (corresponding author), Yale Univ, Sch Med, 300 George St, New Haven, CT 06511 USA.	Manoj.Pillai@Yale.edu	Gupta, Anjali/HCH-5986-2022	Minella, Alex/0000-0001-6693-3362	National Institutes of Health [R01 HL104070, R01 HL098608]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104070, R01HL098608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work was funded in part by the National Institutes of Health (R01 HL104070 to MMP and R01 HL098608 to ACM). We thank Barry Paw (Boston Children's Hospital, Boston, MA, USA) for anti-Mitoferrin antibody, Thomas A Cooper (Baylor College of Medicine, Houston, TX, USA) for the RG6 plasmid and Karla Neugebauer (Yale University) for helpful suggestions. We also thank The Yale Center for Genome Analysis (YCGA) for high-throughput sequencing and the Yale University Biomedical High Performance Computing Center for use of compute clusters to run bioinformatics analysis.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Alsafadi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10615; Balakrishnan I, 2014, STEM CELLS, V32, P662, DOI 10.1002/stem.1531; Bejar R, 2014, BLOOD, V124, P2793, DOI 10.1182/blood-2014-04-522136; Bevilacqua PC, 2008, ANNU REV PHYS CHEM, V59, P79, DOI 10.1146/annurev.physchem.59.032607.093743; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Cameron JM, 2011, AM J HUM GENET, V89, P486, DOI 10.1016/j.ajhg.2011.08.011; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Cordin O, 2013, RNA BIOL, V10, P83, DOI 10.4161/rna.22547; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; DeBoever C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004105; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI [10.1038/leu.2014.331, 10.1038/leu.2015.178]; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Gerstein MB, 2014, NATURE, V512, P445, DOI 10.1038/nature13424; Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Horowitz DS, 2012, WIRES RNA, V3, P331, DOI 10.1002/wrna.112; Ilagan JO, 2015, GENOME RES, V25, P14, DOI 10.1101/gr.181016.114; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kontos CK, 2012, GENE, V505, P153, DOI 10.1016/j.gene.2012.04.084; Lai Y, 2006, HUM GENE THER, V17, P1036, DOI 10.1089/hum.2006.17.1036; Mahen EM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000307; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mercer TR, 2015, GENOME RES, V25, P290, DOI 10.1101/gr.182899.114; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Meyer M, 2011, MOL CELL, V43, P1033, DOI 10.1016/j.molcel.2011.07.030; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Mupo A, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.140.140; Obeng EA, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.828.828; Okeyo-Owuor T, 2015, LEUKEMIA, V29, P909, DOI 10.1038/leu.2014.303; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Plass M, 2014, METHODS MOL BIOL, V1126, P341, DOI 10.1007/978-1-62703-980-2_25; Plass M, 2012, RNA, V18, P1103, DOI 10.1261/rna.030767.111; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Popp MWL, 2014, MOL CELLS, V37, P1, DOI 10.14348/molcells.2014.2193; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Yoshida K, 2014, WIRES RNA, V5, P445, DOI 10.1002/wrna.1222; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	58	44	45	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1123	1133		10.1038/onc.2016.279	http://dx.doi.org/10.1038/onc.2016.279			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27524419	Green Accepted			2022-12-26	WOS:000395371500010
J	Xu, Y; Qin, L; Sun, T; Wu, H; He, T; Yang, Z; Mo, Q; Liao, L; Xu, J				Xu, Y.; Qin, L.; Sun, T.; Wu, H.; He, T.; Yang, Z.; Mo, Q.; Liao, L.; Xu, J.			Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ESTROGEN-RECEPTOR-ALPHA; TUMOR-METASTASIS; LUMINAL SUBTYPE; ER-ALPHA; GENE; CELLS; TARGET; MICE; MORPHOGENESIS	The heterogeneous breast cancers can be classified into different subtypes according to their histopathological characteristics and molecular signatures. Foxa1 expression is linked with luminal breast cancer (LBC) with good prognosis, whereas Twist1 expression is associated with basal-like breast cancer (BLBC) with poor prognosis owing to its role in promoting epithelial-to-mesenchymal transition (EMT), invasiveness and metastasis. However, the regulatory and functional relationships between Twist1 and Foxa1 in breast cancer progression are unknown. In this study, we demonstrate that in the estrogen receptor (ERa)-positive LBC cells Twist1 silences Foxa1 expression, which has an essential role in relieving Foxa1-arrested migration, invasion and metastasis of breast cancer cells. Mechanistically, Twist1 binds to Foxa1 proximal promoter and recruits the NuRD transcriptional repressor complex to de-acetylate H3K9 and repress RNA polymerase II recruitment. Twist1 also silences Foxa1 promoter by inhibiting AP-1 recruitment. Twist1 expression in MCF7 cells silenced Foxa1 expression, which was concurrent with the induction of EMT, migration, invasion and metastasis of these cells. Importantly, restored Foxa1 expression in these cells largely inhibited Twist1-promoted migration, invasion and metastasis. Restored Foxa1 expression did not change the Twist1-induced mesenchymal cellular morphology and the expression of Twist1-regulated E-cadherin, beta-catenin, vimentin and Slug, but it partially rescued Twist1-silenced ERa and cytokeratin 8 expression and reduced Twist1-induced integrin alpha 5, integrin beta 1 and MMP9 expression. In a xenografted mouse model, restored Foxa1 also increased Twist1-repressed LBC markers and decreased Twist1-induced BLBC markers. Furthermore, Twist1 expression is negatively correlated with Foxa1 in the human breast tumors. The tumors with high Twist1 and low Foxa1 expressions are associated with poor distant metastasis-free survival. These results demonstrate that Twist1's silencing effect on Foxa1 expression is largely responsible for Twist1-induced migration, invasion and metastasis, but less responsible for Twist1-induced mesenchymal morphogenesis and expression of certain EMT markers.	[Xu, Y.; Qin, L.; Sun, T.; Wu, H.; Liao, L.; Xu, J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Xu, Y.; He, T.; Yang, Z.; Xu, J.] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [He, T.; Yang, Z.; Xu, J.] Southwest Med Univ, Inst Canc Med, Luzhou, Peoples R China; [Mo, Q.] Southwest Med Univ, Coll Basic Med Sci, Luzhou, Peoples R China; Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Med Hematol Oncol, Houston, TX USA	Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Southwest Medical University; Southwest Medical University; Baylor College of Medicine	Xu, J (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Mol & Cell Biol, Houston, TX 77030 USA.	jxu@bcm.edu	xu, yixiang/J-4297-2017	xu, yixiang/0000-0001-5793-7783; Qin, Li/0000-0003-0099-4992	National Institutes of Health (NIH) at Baylor College of Medicine [P30CA125123]; NIH [CA112403, CA193455]; Cancer Prevention and Research Institute of Texas [RP120732-P5, RP150197]; National Natural Science Foundation of China [81572619]; Sichuan Education Department research [15TD0020]; NATIONAL CANCER INSTITUTE [R01CA193455, P30CA125123, R01CA112403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health (NIH) at Baylor College of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Education Department research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Yuqing Xiong for assisting with manuscript preparation and the Genetically Engineered Mouse Core (GEMC) partially supported by the National Institutes of Health (NIH) grant P30CA125123 at Baylor College of Medicine for assisting with mouse models. This study is supported by NIH grants CA112403 and CA193455 and Cancer Prevention and Research Institute of Texas grants RP120732-P5 and RP150197. This study is also partially supported by National Natural Science Foundation of China grants 81572619 and Sichuan Education Department research grant 15TD0020.	Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Badve S, 2007, CLIN CANCER RES, V13, P4415, DOI 10.1158/1078-0432.CCR-07-0122; Banerjee S, 2006, J CLIN PATHOL, V59, P729, DOI 10.1136/jcp.2005.033043; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chen HF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5697; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fu JJ, 2012, INT J BIOL SCI, V8, P522, DOI 10.7150/ijbs.4164; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Gupta SK, 2013, ONCOGENE, V32, P141, DOI 10.1038/onc.2012.41; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lee DK, 2014, INT J BIOL SCI, V10, P1007, DOI 10.7150/ijbs.9997; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCune K, 2010, ONCOL REP, V24, P1233, DOI 10.3892/or_00000977; Mitra AK, 2011, ONCOGENE, V30, P1566, DOI 10.1038/onc.2010.532; Naderi A, 2012, NEOPLASIA, V14, P283, DOI 10.1593/neo.12294; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Qin L, 2014, CANCER RES, V74, P3477, DOI 10.1158/0008-5472.CAN-13-2639; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sawada K, 2008, CANCER RES, V68, P2329, DOI 10.1158/0008-5472.CAN-07-5167; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sottnik JL, 2013, CLIN EXP METASTAS, V30, P569, DOI 10.1007/s10585-012-9561-6; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thorat MA, 2008, J CLIN PATHOL, V61, P327, DOI 10.1136/jcp.2007.052431; Tien JCY, 2014, INT J BIOL SCI, V10, P1116, DOI 10.7150/ijbs.10236; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Wang S, 2009, P NATL ACAD SCI USA, V106, P151, DOI 10.1073/pnas.0808703105; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xu Y, 2013, AM J PATHOL, V183, P1281, DOI 10.1016/j.ajpath.2013.06.021; Xue GD, 2012, CANCER DISCOV, V2, P248, DOI 10.1158/2159-8290.CD-11-0270; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	55	95	100	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1157	1166		10.1038/onc.2016.286	http://dx.doi.org/10.1038/onc.2016.286			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27524420	Green Accepted			2022-12-26	WOS:000395371500013
J	Bach, LT; Taucher, J; Boxhammer, T; Ludwig, A; Achterberg, EP; Alguero-Muniz, M; Anderson, LG; Bellworthy, J; Budenbender, J; Czerny, J; Ericson, Y; Esposito, M; Fischer, M; Haunost, M; Hellemann, D; Horn, HG; Hornick, T; Meyer, J; Sswat, M; Zark, M; Riebesell, U				Bach, Lennart T.; Taucher, Jan; Boxhammer, Tim; Ludwig, Andrea; Achterberg, Eric P.; Alguero-Muniz, Maria; Anderson, Leif G.; Bellworthy, Jessica; Buedenbender, Jan; Czerny, Jan; Ericson, Ylva; Esposito, Mario; Fischer, Matthias; Haunost, Mathias; Hellemann, Dana; Horn, Henriette G.; Hornick, Thomas; Meyer, Jana; Sswat, Michael; Zark, Maren; Riebesell, Ulf		Kristineberg KOSMOS Consortium	Influence of Ocean Acidification on a Natural Winter-to-Summer Plankton Succession: First Insights from a Long-Term Mesocosm Study Draw Attention to Periods of Low Nutrient Concentrations	PLOS ONE			English	Article							TECHNICAL NOTE; MARINE-PHYTOPLANKTON; ION CONCENTRATION; GULLMAR-FJORD; CARBON; SEAWATER; WATER; CO2; DIVERSITY; VIRUSES	Every year, the oceans absorb about 30% of anthropogenic carbon dioxide (CO2) leading to a re-equilibration of the marine carbonate system and decreasing seawater pH. Today, there is increasing awareness that these changes-summarized by the term ocean acidification (OA)-could differentially affect the competitive ability of marine organisms, thereby provoking a restructuring of marine ecosystems and biogeochemical element cycles. In winter 2013, we deployed ten pelagic mesocosms in the Gullmar Fjord at the Swedish west coast in order to study the effect of OA on plankton ecology and biogeochemistry under close to natural conditions. Five of the ten mesocosms were left unperturbed and served as controls (similar to 380 mu atm pCO(2)), whereas the others were enriched with CO2-saturated water to simulate realistic end-of-the-century carbonate chemistry conditions (mu 760 mu atm pCO(2)). We ran the experiment for 113 days which allowed us to study the influence of high CO2 on an entire winter-to-summer plankton succession and to investigate the potential of some plankton organisms for evolutionary adaptation to OA in their natural environment. This paper is the first in a PLOS collection and provides a detailed overview on the experimental design, important events, and the key complexities of such a "long-term mesocosm" approach. Furthermore, we analyzed whether simulated end-of-the-century carbonate chemistry conditions could lead to a significant restructuring of the plankton community in the course of the succession. At the level of detail analyzed in this overview paper we found that CO2-induced differences in plankton community composition were non-detectable during most of the succession except for a period where a phytoplankton bloom was fueled by remineralized nutrients. These results indicate: (1) Long-term studies with pelagic ecosystems are necessary to uncover OA-sensitive stages of succession. (2) Plankton communities fueled by regenerated nutrients may be more responsive to changing carbonate chemistry than those having access to high inorganic nutrient concentrations and may deserve particular attention in future studies.	[Bach, Lennart T.; Taucher, Jan; Boxhammer, Tim; Ludwig, Andrea; Achterberg, Eric P.; Bellworthy, Jessica; Buedenbender, Jan; Czerny, Jan; Esposito, Mario; Fischer, Matthias; Haunost, Mathias; Hellemann, Dana; Meyer, Jana; Sswat, Michael; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Alguero-Muniz, Maria] Biol Anstalt Helgoland, Alfred Wegener Inst Helmholtz Zentrum Polar & Mee, Helgoland, Germany; [Anderson, Leif G.] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Bellworthy, Jessica; Esposito, Mario] Univ Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Ericson, Ylva] Univ Ctr Svalbard UNIS, Longyearbyen, Norway; [Hellemann, Dana] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Hornick, Thomas] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Expt Limnol, Stechlin, Germany; [Zark, Maren] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Res Grp Marine Geochem, ICBM MPI Bridging Grp, Oldenburg, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Gothenburg; University of Southampton; University Centre Svalbard (UNIS); University of Helsinki; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Carl von Ossietzky Universitat Oldenburg	Bach, LT (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	lbach@geomar.de	Boersma, Maarten/A-5475-2013; Jutfelt, Fredrik/B-6988-2014; Mark, Felix Christopher/P-4759-2016; Schulz, Kai/AEZ-9073-2022; Algueró-Muñiz, María/AAA-9748-2020; Sswat, Michael/B-7944-2019; Pansch, Christian/I-9170-2012; Schartau, Markus/A-5918-2017; Boxhammer, Tim/AAE-6416-2020; Boxhammer, Tim/GLN-6190-2022; Bellworthy, Jessica/ABG-6390-2020; Riebesell, Ulf/AAC-9717-2020; Achterberg, Eric P/C-5820-2009; Dittmar, Thorsten/L-7796-2013; Taucher, Jan/AAA-9195-2019; Thor, Peter/A-7522-2009; Hoffmann, Linn/J-3761-2019; Horn, Henriette G./R-7667-2016; Stiasny, Martina/O-4988-2018	Boersma, Maarten/0000-0003-1010-026X; Jutfelt, Fredrik/0000-0001-9838-3991; Mark, Felix Christopher/0000-0002-5586-6704; Schulz, Kai/0000-0002-8481-4639; Algueró-Muñiz, María/0000-0001-8064-6212; Sswat, Michael/0000-0002-5957-4792; Pansch, Christian/0000-0001-8442-4502; Schartau, Markus/0000-0003-1114-0415; Boxhammer, Tim/0000-0002-9632-5947; Boxhammer, Tim/0000-0002-9632-5947; Achterberg, Eric P/0000-0002-3061-2767; Dittmar, Thorsten/0000-0002-3462-0107; Thor, Peter/0000-0002-2603-2284; Hoffmann, Linn/0000-0003-0242-4686; Horn, Henriette G./0000-0002-4020-5559; Ericson, Ylva/0000-0002-5162-373X; Reusch, Thorsten B. H./0000-0002-8961-4337; Taucher, Jan/0000-0001-9944-0775; Storch, Daniela/0000-0003-3090-7554; Stiasny, Martina/0000-0001-6365-2610; Bach, Lennart/0000-0003-0202-3671; Hornick, Thomas/0000-0003-0280-9260; Riebesell, Ulf/0000-0002-9442-452X; Wohlrab, Sylke/0000-0003-3190-0880	German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project [FKZ 03F06550]; Leibniz Award, German Science Foundation (DFG); Hasselblad Foundation; association of European marine biological laboratories (ASSEMBLE) [227799]; UK Ocean Acidification research programme [NE/H017348/1]	German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project(Federal Ministry of Education & Research (BMBF)); Leibniz Award, German Science Foundation (DFG)(German Research Foundation (DFG)); Hasselblad Foundation; association of European marine biological laboratories (ASSEMBLE); UK Ocean Acidification research programme	Support was provided by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). U. Riebesell received funding from the Leibniz Award 2012 by the German Science Foundation (DFG). The carbonate chemistry measurements were supported by a grant from the Hasselblad Foundation. M. Zark and T. Hornick were supported by the association of European marine biological laboratories (ASSEMBLE, grant no. 227799). E. P. Achterberg received funding from the UK Ocean Acidification research programme (grant no. NE/H017348/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Sven Loven Centre for Marine Sciences, Kristineberg for giving us access to their facilities and the warm hospitality. We also gratefully acknowledge the captain and crew of RV ALKOR for their work transporting, deploying and recovering the mesocosms during cruises AL406 and AL420. This project was funded by the German Federal Ministry of Science and Education (BMBF) in the framework of the BIOACID II project (FKZ 03F06550). U. Riebesell received additional funding from the Leibniz Award 2012 by the German Science Foundation (DFG). The carbonate chemistry measurements were supported by a grant from the Hasselblad Foundation. M. Zark and T. Hornick were supported by the association of European marine biological laboratories (ASSEMBLE, grant no. 227799), M. Alguero-Muniz and H. G. Horn by the Swedish Academy of Sciences, and E. P. Achterberg received funding from the UK Ocean Acidification research programme (grant no. NE/H017348/1). This manuscript profited from the helpful comments of four anonymous reviewers.	Arneborg L, 2004, LIMNOL OCEANOGR, V49, P768, DOI 10.4319/lo.2004.49.3.0768; Arneborg L, 2004, CONT SHELF RES, V24, P443, DOI 10.1016/j.csr.2003.12.005; Arneborg L, 2001, J PHYS OCEANOGR, V31, P2549, DOI 10.1175/1520-0485(2001)031<2549:TISIGF>2.0.CO;2; Bach LT, 2015, BIOGEOSCIENCES, V12, P4939, DOI 10.5194/bg-12-4939-2015; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Boxhammer T, 2016, BIOGEOSCIENCES, V13, P2, DOI DOI 10.5194/BGD-12-18693-2015; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Calliari D, 2009, ESTUAR COAST SHELF S, V85, P107, DOI 10.1016/j.ecss.2009.06.016; Calosi P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0444; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; Collins S, 2014, EVOL APPL, V7, P140, DOI 10.1111/eva.12120; Czerny J, 2013, BIOGEOSCIENCES, V10, P1937, DOI 10.5194/bg-10-1937-2013; Czerny J, 2013, BIOGEOSCIENCES, V10, P1379, DOI 10.5194/bg-10-1379-2013; Dam HG, 2013, ANNU REV MAR SCI, V5, P349, DOI 10.1146/annurev-marine-121211-172229; Dorey N, 2013, GLOBAL CHANGE BIOL, V19, P3355, DOI 10.1111/gcb.12276; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hansen H.P., 2007, METHODS SEAWATER ANA, P159, DOI [10.1002/9783527613984.ch10, DOI 10.1002/9783527613984, DOI 10.1002/9783527613984.CH10]; Hansen H.P., 1983, METHODS SEAWATER ANA, V2nd ed., P347; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; JOHNSON KM, 1987, MAR CHEM, V21, P117, DOI 10.1016/0304-4203(87)90033-8; Jones D. L, 2015, FATHOM TOOLBOX MATLA; Kilnas M, 2006, SJOMATNING GULLMARSF, P1; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Larsen A, 2001, MAR ECOL PROG SER, V221, P47, DOI 10.3354/meps221047; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lindahl O, 1998, ICES J MAR SCI, V55, P723, DOI 10.1006/jmsc.1998.0379; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Marie D, 1999, CURR PROTOCOLS CYTOM, V11, P1, DOI [DOI 10.1002/0471142956.CY1111S10, 10.1002/0471142956.cy1111s10, 10.1002/0471142956.cy1112s11]; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Paul AJ, 2015, BIOGEOSCIENCES, V12, P6181, DOI 10.5194/bg-12-6181-2015; Pettit LR, 2013, MAR POLLUT BULL, V73, P452, DOI 10.1016/j.marpolbul.2013.02.011; Pierrot D, 2006, ORNLCDIAC105A US DOE; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U, 2015, NAT CLIM CHANGE, V5, P12; Sala MM, 2016, ICES J MAR SCI, V73, P670, DOI 10.1093/icesjms/fsv130; Schaum E, 2013, NAT CLIM CHANGE, V3, P298, DOI 10.1038/NCLIMATE1774; Scheinin M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0056; Schulz KG, 2013, MAR BIOL, V160, P1889, DOI 10.1007/s00227-012-1965-y; SHARP JH, 1974, LIMNOL OCEANOGR, V19, P984, DOI 10.4319/lo.1974.19.6.0984; Sswat M, 2015, VIDEO PLANKTON COMMU, DOI [10.3289/KOSMOS_PLANKTONBSWEDENB2013, DOI 10.3289/K0SM0S_PLANKT0NBSWEDENB]; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zark M, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500531; Ziveri P, 2014, BIOL BULL-US, V226, P282, DOI 10.1086/BBLv226n3p282	51	49	49	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159068	10.1371/journal.pone.0159068	http://dx.doi.org/10.1371/journal.pone.0159068			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525979	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000381471100003
J	Kromer, R; Buhmann, C; Hidding, U; Keseru, M; Keseru, D; Hassenstein, A; Stemplewitz, B				Kromer, Robert; Buhmann, Carsten; Hidding, Ute; Keserue, Matthias; Keserue, Diana; Hassenstein, Andrea; Stemplewitz, Birthe			Evaluation of Retinal Vessel Morphology in Patients with Parkinson's Disease Using Optical Coherence Tomography	PLOS ONE			English	Article							AUTOMATED LAYER SEGMENTATION; LEVODOPA USE; RISK-FACTOR; HOMOCYSTEINE; NERVE; POLYNEUROPATHY; PROGRESSION; NEUROPATHY; DIAGNOSIS; DETECT	Purpose The retina has been found affected in Parkinson's disease (PD). It is unclear if this is due to neurodegeneration of local dopamine-dependent retinal cells, a result of central nervous degeneration including the optic nerve or retinal small vessel disease. This study aimed to detect changes of the retinal vasculature in PD patients compared to controls. Methods We examined 49 PD patients and 49 age- and sex-matched healthy controls by spectral domain optical coherence tomography (SD-OCT) with a circular scan centred at the optic disc. Vessels within the retinal nerve fibre layer were identified by an automated algorithm and thereafter manually labelled as artery or vein. Layer segmentation, vessel lumen and direct surrounding tissue were marked automatically with a grey value and the contrast between both values in relation to the surrounding tissue was calculated. The differences in these grey value ratios among subjects were determined and used as an indicator for differences in vessel morphology. Furthermore, the diameters of the veins and arteries were measured and then compared between the groups. Results The contrast of retinal veins was significantly lower in PD patients compared to controls, which indicates changes in vessel morphology in PD. The contrast of arteries was not significantly different. Disease duration, disease stage according to Hoehn and Yahr or age did not influence the grey value ratios in PD patients. Vessel diameter in either veins or arteries did not differ between subject groups. The contrast of retinal veins contralateral to the clinically predominant and first affected side was significantly lower compared to the ipsilateral side. Conclusion Our data show a potential difference of the retinal vasculature in PD patients compared to controls. Vascular changes in the retina of PD patients might contribute to vision-related complaints in PD.	[Kromer, Robert; Keserue, Matthias; Keserue, Diana; Hassenstein, Andrea; Stemplewitz, Birthe] Hamburg Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany; [Buhmann, Carsten; Hidding, Ute] Hamburg Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany		Kromer, R (corresponding author), Hamburg Med Ctr Hamburg Eppendorf, Dept Ophthalmol, Hamburg, Germany.	rkromer@me.com	Keserü, Matthias/AAM-7020-2020; Kromer, Robert/G-4239-2017	Kromer, Robert/0000-0002-5986-5047				Aaker GD, 2010, CLIN OPHTHALMOL, V4, P1427, DOI 10.2147/OPTH.S15136; Ajith TA, 2015, CLIN CHIM ACTA, V450, P316, DOI 10.1016/j.cca.2015.09.007; Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891; Alten F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112311; Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068; Berganzo K, 2013, J NEUROL, V260, P1752, DOI 10.1007/s00415-013-6859-5; Bittersohl D, 2015, ACTA OPHTHALMOL, V93, pE578, DOI 10.1111/aos.12757; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Cense B, 2004, OPT EXPRESS, V12, P2435, DOI 10.1364/OPEX.12.002435; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Chung HS, 1999, BRIT J OPHTHALMOL, V83, P466, DOI 10.1136/bjo.83.4.466; de Jong FJ, 2011, NEUROLOGY, V76, P816, DOI 10.1212/WNL.0b013e31820e7baa; DeBuc D.C., 2011, IMAGE SEGMENTATION; Ding Y, 2014, J NEURAL TRANSM, V121, P1367, DOI 10.1007/s00702-014-1214-2; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Garcia-Martin E, 2012, OPHTHALMOLOGY, V119, P2161, DOI 10.1016/j.ophtha.2012.05.003; Gupta S, 2016, EXPERT REV NEUROTHER, V16, P765, DOI 10.1080/14737175.2016.1180978; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Hassan A, 2004, BRAIN, V127, P212, DOI 10.1093/brain/awh023; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Herzog A, 2004, LECT NOTES COMPUT SC, V3117, P395; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jaffe GJ, 2004, AM J OPHTHALMOL, V137, P156, DOI 10.1016/S0002-9394(03)00792-X; Jimenez B, 2014, MOVEMENT DISORD, V29, P68, DOI 10.1002/mds.25747; Kimber T, 2013, PARKINSONISM RELAT D, V19, P847, DOI 10.1016/j.parkreldis.2013.05.002; Kloppenborg RP, 2014, NEUROLOGY, V82, P777, DOI 10.1212/WNL.0000000000000168; Kolar P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/724780; Kwa VIH, 2002, NEUROLOGY, V59, P1536, DOI 10.1212/01.WNL.0000033093.16450.5C; La Morgia C, 2013, EUR J NEUROL, V20, P198, DOI 10.1111/j.1468-1331.2012.03701.x; Lee JY, 2014, J PARKINSON DIS, V4, P197, DOI 10.3233/JPD-130306; Lee P, 2010, APPL OPTICS, V49, P3538, DOI 10.1364/AO.49.003538; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Lu SJ, 2010, IEEE T BIO-MED ENG, V57, P2605, DOI 10.1109/TBME.2010.2055057; Maresca A, 2013, MOL CELL NEUROSCI, V55, P62, DOI 10.1016/j.mcn.2012.08.004; Marnane M, 2016, CURR ALZHEIMER RES, V13, P750, DOI 10.2174/1567205013666160222112634; Merola A, 2016, EUR J NEUROL, V23, P501, DOI 10.1111/ene.12846; Montastruc JL, 2010, MOVEMENT DISORD, V25, P660, DOI 10.1002/mds.22878; Motte J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102034; Muller T, 2002, J NEURAL TRANSM, V109, P175, DOI 10.1007/s007020200013; Nanhoe-Mahabier W, 2009, NAT REV NEUROL, V5, P533, DOI 10.1038/nrneurol.2009.136; Nolano M, 2011, ANN NEUROL, V69, P427, DOI 10.1002/ana.22330; Parkinson Study Group, 2000, JAMA, V284, P1931; Bambo MP, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/946540; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Rehak J, 2008, CURR EYE RES, V33, P111, DOI 10.1080/02713680701851902; Roth NM, 2014, MOVEMENT DISORD, V29, P1163, DOI 10.1002/mds.25896; Schneider M, 2014, J NEURAL TRANSM, V121, P41, DOI 10.1007/s00702-013-1072-3; Schwartz RS, 2012, MOVEMENT DISORD, V27, P1506, DOI 10.1002/mds.25112; Shahrizaila N, 2013, PARKINSONISM RELAT D, V19, P391, DOI 10.1016/j.parkreldis.2012.08.002; Staurenghi G, 2014, PROPOSED LEXICON ANA, P1572, DOI [10.1016/j.ophtha.2014.02.023, DOI 10.1016/J.OPHTHA.2014.02.023]; Stemplewitz B, 2015, ACTA OPHTHALMOL, V93, pE672, DOI 10.1111/aos.12764; Tatsch K, 1997, EUR J NUCL MED, V24, P415, DOI 10.1007/BF00881814; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; van der Holst HM, 2015, NEUROLOGY, V85, P1569, DOI 10.1212/WNL.0000000000002082; Wojtkowski M, 2003, OPT LETT, V28, P1745, DOI 10.1364/OL.28.001745; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Zucco GM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01020	61	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161136	10.1371/journal.pone.0161136	http://dx.doi.org/10.1371/journal.pone.0161136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525728	Green Submitted, gold, Green Published			2022-12-26	WOS:000381471100037
J	Harizanova, J; Fermin, Y; Malik-Sheriff, RS; Wieczorek, J; Ickstadt, K; Grecco, HE; Zamir, E				Harizanova, Jana; Fermin, Yessica; Malik-Sheriff, Rahuman S.; Wieczorek, Jakob; Ickstadt, Katja; Grecco, Hernan E.; Zamir, Eli			Highly Multiplexed Imaging Uncovers Changes in Compositional Noise within Assembling Focal Adhesions	PLOS ONE			English	Article							MATRIX ADHESIONS; CELLS; TOPONOMICS; PROTEOMICS; DYNAMICS; KINETICS; PAXILLIN	Integrin adhesome proteins bind each other in alternative manners, forming within the cell diverse cell-matrix adhesion sites with distinct properties. An intriguing question is how such modular assembly of adhesion sites is achieved correctly solely by self-organization of their components. Here we address this question using high-throughput multiplexed imaging of eight proteins and two phosphorylation sites in a large number of single focal adhesions. We found that during the assembly of focal adhesions the variances of protein densities decrease while the correlations between them increase, suggesting reduction in the noise levels within these structures. These changes correlate independently with the area and internal density of focal adhesions, but not with their age or shape. Artificial neural network analysis indicates that a joint consideration of multiple components improves the predictability of paxillin and zyxin levels in internally dense focal adhesions. This suggests that paxillin and zyxin densities in focal adhesions are fine-tuned by integrating the levels of multiple other components, thus averaging-out stochastic fluctuations. Based on these results we propose that increase in internal protein densities facilitates noise suppression in focal adhesions, while noise suppression enables their stable growth and further density increase-hence forming a feedback loop giving rise to a quality-controlled assembly.	[Harizanova, Jana; Malik-Sheriff, Rahuman S.; Grecco, Hernan E.; Zamir, Eli] Max Planck Inst Mol Physiol, Dept System Cell Biol, Dortmund, Germany; [Fermin, Yessica; Wieczorek, Jakob; Ickstadt, Katja] TU Dortmund Univ, Fac Stat, Dortmund, Germany; [Malik-Sheriff, Rahuman S.] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Malik-Sheriff, Rahuman S.] Imperial Coll London, MRC Clin Sci Ctr, London, England; [Grecco, Hernan E.] Univ Buenos Aires, FCEN, Dept Phys, Buenos Aires, DF, Argentina; [Grecco, Hernan E.] Consejo Nacl Invest Cient & Tecn, IFIBA, Buenos Aires, DF, Argentina	Max Planck Society; Dortmund University of Technology; European Molecular Biology Laboratory (EMBL); Imperial College London; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Grecco, HE; Zamir, E (corresponding author), Max Planck Inst Mol Physiol, Dept System Cell Biol, Dortmund, Germany.; Grecco, HE (corresponding author), Univ Buenos Aires, FCEN, Dept Phys, Buenos Aires, DF, Argentina.; Grecco, HE (corresponding author), Consejo Nacl Invest Cient & Tecn, IFIBA, Buenos Aires, DF, Argentina.	grecco@mpi-dortmund.mpg.de; eli.zamir@mpi-dortmund.mpg.de	Sheriff, Rahuman/ABB-9034-2020	Sheriff, Rahuman/0000-0003-0705-9809; Fermin Ruiz, Yessica Yulieth/0000-0002-6336-4042; Zamir, Eli/0000-0001-8226-5480	BMBF (Federal Ministry of Education and Research, Germany) [0315507]; German academic exchange service (DAAD) fellowship; BMBF [0315507]	BMBF (Federal Ministry of Education and Research, Germany)(Federal Ministry of Education & Research (BMBF)); German academic exchange service (DAAD) fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by BMBF (Federal Ministry of Education and Research, Germany) grant number 0315507. YF was supported by a German academic exchange service (DAAD) fellowship.; This work was supported by BMBF grant no. 0315507. YF was supported by a German academic exchange service (DAAD) fellowship. We thank Philippe Bastiaens for additional support.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Grecco HE, 2016, CYTOM PART A, V89A, P761, DOI 10.1002/cyto.a.22876; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Hirata Hiroaki, 2008, Commun Integr Biol, V1, P192; Hoffmann JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02257; Kam Z, 2001, TRENDS CELL BIOL, V11, P329, DOI 10.1016/S0962-8924(01)02067-0; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Lin JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9390; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; Rompp A, 2013, HISTOCHEM CELL BIOL, V139, P759, DOI 10.1007/s00418-013-1097-6; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Schubert W, 2006, CYTOM PART A, V69A, P109, DOI 10.1002/cyto.a.20234; Schubert W, 2003, ADV BIOCHEM ENG BIOT, V83, P189; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schubert W, 2015, CYTOM PART A, V87A, P696, DOI 10.1002/cyto.a.22671; Schubert W, 2014, J MOL RECOGNIT, V27, P3, DOI 10.1002/jmr.2326; Tukey JW, 1977, EXPLORATORY DATA ANA; Turner CE, 2000, J CELL SCI, V113, P4139; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 1999, J CELL SCI, V112, P1655; Zamir E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001901; Zrazhevskiy P, 2013, NAT PROTOC, V8, P1852, DOI 10.1038/nprot.2013.112	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160591	10.1371/journal.pone.0160591	http://dx.doi.org/10.1371/journal.pone.0160591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519053	gold, Green Published, Green Submitted			2022-12-26	WOS:000381382100020
J	Yang, XF; Zhu, YR; Hong, J; Yang, LX; Wu, YB; Tang, YY				Yang, Xiaofan; Zhu, Yuanrui; Hong, Jing; Yang, Lu-Xing; Wu, Yingbo; Tang, Yuan Yan			The Rationality of Four Metrics of Network Robustness: A Viewpoint of Robust Growth of Generalized Meshes	PLOS ONE			English	Article							ALGEBRAIC CONNECTIVITY; TOPOLOGICAL PROPERTIES; CENTRALITY; ALGORITHM	There are quite a number of different metrics of network robustness. This paper addresses the rationality of four metrics of network robustness (the algebraic connectivity, the effective resistance, the average edge betweenness, and the efficiency) by investigating the robust growth of generalized meshes (GMs). First, a heuristic growth algorithm (the Proximity-Growth algorithm) is proposed. The resulting proximity-optimal GMs are intuitively robust and hence are adopted as the benchmark. Then, a generalized mesh (GM) is grown up by stepwise optimizing a given measure of network robustness. The following findings are presented: (1) The algebraic connectivity-optimal GMs deviate quickly from the proximity-optimal GMs, yielding a number of less robust GMs. This hints that the rationality of the algebraic connectivity as a measure of network robustness is still in doubt. (2) The effective resistace-optimal GMs and the average edge betweenness-optimal GMs are in line with the proximity-optimal GMs. This partly justifies the two quantities as metrics of network robustness. (3) The efficiency-optimal GMs deviate gradually from the proximity-optimal GMs, yielding some less robust GMs. This suggests the limited utility of the efficiency as a measure of network robustness.	[Yang, Xiaofan; Zhu, Yuanrui; Yang, Lu-Xing; Wu, Yingbo] Chongqing Univ, Sch Software Engn, Chongqing 400044, Peoples R China; [Hong, Jing] Georgia Inst Technol, Dept Comp Sci, Atlanta, GA 30309 USA; [Yang, Lu-Xing] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2600 GA Delft, Netherlands; [Tang, Yuan Yan] Univ Macau, Dept Comp & Informat Sci, Ave Univ, Taipa, Macau, Peoples R China	Chongqing University; University System of Georgia; Georgia Institute of Technology; Delft University of Technology; University of Macau	Yang, LX (corresponding author), Chongqing Univ, Sch Software Engn, Chongqing 400044, Peoples R China.; Yang, LX (corresponding author), Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2600 GA Delft, Netherlands.	ylx910920@gmail.com		Yang, Lu-Xing/0000-0002-9229-5787	National Natural Science Foundation of China [61572006, 71301177]; National Sci-Tech Support Plan [2015BAF05B03]; Natural Science Foundation of Chongqing [cstc2013jcyjA40011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Sci-Tech Support Plan; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This work is supported by National Natural Science Foundation of China (Grant Nos. 61572006 [XY], 71301177 [YW]), National Sci-Tech Support Plan (Grant No. 2015BAF05B03 [YW]), and Natural Science Foundation of Chongqing (Grant No. cstc2013jcyjA40011 [YW]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W., 2012, 3 IFAC WORKSH DISTR, V45, P85, DOI DOI 10.3182/20120914-2-US-4030.00052; [Anonymous], THESIS; Cuzzocrea A, 2012, J NETW COMPUT APPL, V35, P1210, DOI 10.1016/j.jnca.2011.06.001; de Abreu NMM, 2007, LINEAR ALGEBRA APPL, V423, P53, DOI 10.1016/j.laa.2006.08.017; Decayeux C, 2005, IEEE T PARALL DISTR, V16, P875, DOI 10.1109/TPDS.2005.100; Domanski Z, 2005, SCI RES I MATH COMPU, V4, P34; Dong Q, 2008, INFORM SCIENCES, V178, P2396, DOI 10.1016/j.ins.2007.12.010; Dong Q, 2010, COMPUT ELECTR ENG, V36, P1021, DOI 10.1016/j.compeleceng.2010.03.003; Ellens W, 2011, LINEAR ALGEBRA APPL, V435, P2491, DOI 10.1016/j.laa.2011.02.024; Ellens W, 2013, ARXIV, V18, P359; FIEDLER M, 1973, CZECH MATH J, V23, P298; Ghosh A, 2006, IEEE DECIS CONTR P, P6605, DOI 10.1109/CDC.2006.377282; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grimmett G. R., 1999, PERCOLATION; Holub P, 2014, DISCRETE APPL MATH, V179, P139, DOI 10.1016/j.dam.2014.07.012; KLEIN DJ, 1993, J MATH CHEM, V12, P81, DOI 10.1007/BF01164627; Kresch E, 2015, PROCEEDINGS OF THE 2015 INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING & SIMULATION (HPCS 2015), P371, DOI 10.1109/HPCSim.2015.7237064; Lal AK, 2011, GRAPH COMBINATOR, V27, P215, DOI 10.1007/s00373-010-0975-0; Latora V, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/188; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.039901; Liu W, 2009, I C DES RELIABL COMM, P131, DOI 10.1109/DRCN.2009.5340016; Lu L, ENCY SYSTEMBIOL, P647; Martin-Hernandez J, 2014, PHYSICA A, V404, P92, DOI 10.1016/j.physa.2014.02.043; Mosk-Aoyama D, 2008, OPER RES LETT, V36, P677, DOI 10.1016/j.orl.2008.09.001; Nocetti FG, 2002, IEEE T PARALL DISTR, V13, P963, DOI 10.1109/TPDS.2002.1036069; Pradhan AK, 2014, J OPT-INDIA, V43, P330, DOI 10.1007/s12596-014-0211-z; Stojmenovic I, 1997, IEEE T PARALL DISTR, V8, P1036, DOI 10.1109/71.629486; [Tian Guixian 田贵贤], 2012, [数学进展, Advances in Mathematics], V41, P217; van de Bovenkamp R, 2014, 10TH INTERNATIONAL CONFERENCE ON SIGNAL-IMAGE TECHNOLOGY AND INTERNET-BASED SYSTEMS SITIS 2014, P347, DOI 10.1109/SITIS.2014.82; Wang H, 2008, ALGEBRAIC CONNECTIVI, P25; Wang XR, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50276-0; Xiang D, 2009, IEEE T COMPUT, V58, P620, DOI 10.1109/TC.2008.211; Xu DC, 2013, INFORM SCIENCES, V240, P184, DOI 10.1016/j.ins.2013.03.044; Xu JM, 2015, 1 COURSE GRAPH THEOR; Yang LX, 2016, PHYSICA A, V450, P403, DOI 10.1016/j.physa.2016.01.026; Yang LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134507; Yang LX, MATH METHODS APPL SC; Yang XF, 2008, INT J COMPUT MATH, V85, P201, DOI 10.1080/00207160701421144; Yang XF, 2006, APPL MATH COMPUT, V182, P1696, DOI 10.1016/j.amc.2006.06.009; Yang XF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155580; Yang XF, 2010, INFORM PROCESS LETT, V110, P559, DOI 10.1016/j.ipl.2010.04.007; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533	43	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161077	10.1371/journal.pone.0161077	http://dx.doi.org/10.1371/journal.pone.0161077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518448	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100043
J	DeWitt, WS; Lindau, P; Snyder, TM; Sherwood, AM; Vignali, M; Carlson, CS; Greenberg, PD; Duerkopp, N; Emerson, RO; Robins, HS				DeWitt, William S.; Lindau, Paul; Snyder, Thomas M.; Sherwood, Anna M.; Vignali, Marissa; Carlson, Christopher S.; Greenberg, Philip D.; Duerkopp, Natalie; Emerson, Ryan O.; Robins, Harlan S.			A Public Database of Memory and Naive B-Cell Receptor Sequences	PLOS ONE			English	Article							HUMAN-IMMUNOGLOBULIN HEAVY; INDUCED CYTIDINE DEAMINASE; ANTIBODY REPERTOIRE; SOMATIC HYPERMUTATION; AFFINITY MATURATION; GERMINAL-CENTERS; T-CELLS; REVEALS; VACCINATION; ACTIVATION	The vast diversity of B-cell receptors (BCR) and secreted antibodies enables the recognition of, and response to, a wide range of epitopes, but this diversity has also limited our understanding of humoral immunity. We present a public database of more than 37 million unique BCR sequences from three healthy adult donors that is many fold deeper than any existing resource, together with a set of online tools designed to facilitate the visualization and analysis of the annotated data. We estimate the clonal diversity of the naive and memory B-cell repertoires of healthy individuals, and provide a set of examples that illustrate the utility of the database, including several views of the basic properties of immunoglobulin heavy chain sequences, such as rearrangement length, subunit usage, and somatic hypermutation positions and dynamics.	[DeWitt, William S.; Snyder, Thomas M.; Sherwood, Anna M.; Vignali, Marissa; Emerson, Ryan O.; Robins, Harlan S.] Adapt Biotechnol, Seattle, WA 98102 USA; [Lindau, Paul; Carlson, Christopher S.; Greenberg, Philip D.; Duerkopp, Natalie; Robins, Harlan S.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lindau, Paul] Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Robins, HS (corresponding author), Adapt Biotechnol, Seattle, WA 98102 USA.; Robins, HS (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	hrobins@fredhutch.org		Snyder, Thomas/0000-0001-7256-7821; DeWitt, William/0000-0002-6802-9139	National Cancer Institute, National Institutes of Health [R01 CA175353]; W. M. Keck Foundation; Adaptive Biotechnologies, Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); W. M. Keck Foundation(W.M. Keck Foundation); Adaptive Biotechnologies, Corp.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant R01 CA175353 from the National Cancer Institute, National Institutes of Health to H.S.R., and by the W. M. Keck Foundation. Adaptive Biotechnologies, Corp. provided support in the form of salaries and stock options for authors W.S.D., T.M.S., A.M.S., M.V., and R.O.E., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Calis JJA, 2014, TRENDS IMMUNOL, V35, P581, DOI 10.1016/j.it.2014.09.004; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Chothia C, 1998, J MOL BIOL, V278, P457, DOI 10.1006/jmbi.1998.1653; Cortina-Ceballos B, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0239-y; DAVIS MM, 1980, NATURE, V283, P733, DOI 10.1038/283733a0; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; DeWitt WS, 2015, J VIROL, V89, P4517, DOI 10.1128/JVI.03474-14; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Elhanati Y, 2014, P NATL ACAD SCI USA, V111, P9875, DOI 10.1073/pnas.1409572111; Emerson RO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111943; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Galson JD, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0322-z; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Greene J, 2013, J THEOR BIOL, V326, P1, DOI 10.1016/j.jtbi.2013.02.009; HERZENBERG LA, 1980, J EXP MED, V151, P1071, DOI 10.1084/jem.151.5.1071; Hsu MS, 2016, CANCER IMMUNOL RES, V4, P412, DOI 10.1158/2326-6066.CIR-15-0240; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; Larimore K, 2012, J IMMUNOL, V189, P3221, DOI 10.4049/jimmunol.1201303; Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; Morris H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010760; Mroczek ES, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00096; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muraro PA, 2014, J CLIN INVEST, V124, P1168, DOI 10.1172/JCI71691; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Peron S, 2012, SCIENCE, V336, P931, DOI 10.1126/science.1218692; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Prabakaran P, 2012, IMMUNOGENETICS, V64, P337, DOI 10.1007/s00251-011-0595-8; Rempala GA, 2011, J THEOR BIOL, V269, P1, DOI 10.1016/j.jtbi.2010.10.001; Robins H, 2013, CURR OPIN IMMUNOL, V25, P646, DOI 10.1016/j.coi.2013.09.017; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rodrigues J, 2001, BIOMETRICAL J, V43, P737, DOI 10.1002/1521-4036(200110)43:6<737::AID-BIMJ737>3.0.CO;2-W; SANATHANAN L, 1977, J AM STAT ASSOC, V72, P669, DOI 10.2307/2286238; Schneider-Hohendorf T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11153; Sherwood AM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002536; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; Strauli NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0314-z; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681; Wu D, 2014, CLIN CANCER RES, V20, P4540, DOI 10.1158/1078-0432.CCR-13-3231; Wu D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003656; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Wu YCB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00081; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Zhang Y, 2013, J EXP MED, V210, P457, DOI 10.1084/jem.20120150	63	76	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160853	10.1371/journal.pone.0160853	http://dx.doi.org/10.1371/journal.pone.0160853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513338	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100081
J	Lan, CC; Peng, CK; Tang, SE; Wu, SY; Huang, KL; Wu, CP				Lan, Chou-Chin; Peng, Chung-Kan; Tang, Shih-En; Wu, Shu-Yu; Huang, Kun-Lun; Wu, Chin-Pyng			Anti-Vascular Endothelial Growth Factor Antibody Suppresses ERK and NF-.B Activation in Ischemia-Reperfusion Lung Injury	PLOS ONE			English	Article							INCREASED VASCULAR-PERMEABILITY; KAPPA-B; PULMONARY-EDEMA; VEGF; EXPRESSION; RECEPTORS; MECHANISMS; RESPONSES; MONOCYTE; SURVIVAL	Ischemia-reperfusion (IR)-induced acute lung injury (ALI) is implicated in several clinical conditions like lung transplantation, acute pulmonary embolism after thrombolytic therapy, re-expansion of collapsed lung from pneumothorax or pleural effusion, cardiopulmonary bypass and etc. Because mortality remains high despite advanced medical care, prevention and treatment are important clinical issues for IR-induced ALI. Vascular endothelial growth factor (VEGF) has a controversial role in ALI. We therefore conducted this study to determine the effects of anti-VEGF antibody in IR-induced ALI. In the current study, the IRinduced ALI was conducted in a rat model of isolated-perfused lung in situ in the chest. The animals were divided into the control, control + preconditioning anti-VEGF antibody (bevacizumab, 5mg/kg), IR, IR + preconditioning anti-VEGF antibody (1mg/kg), IR+ preconditioning anti-VEGF antibody (5mg/kg) and IR+ post-IR anti-VEGF antibody (5mg/kg) group. There were eight adult male Sprague-Dawley rats in each group. The IR caused significant pulmonary micro-vascular hyper-permeability, pulmonary edema, neutrophilic infiltration in lung tissues, increased tumor necrosis factor-a, and total protein concentrations in bronchoalveolar lavage fluid. VEGF and extracellular signal-regulated kinase (ERK) were increased in IR-induced ALI. Administration of preconditioning anti-VEGF antibody significantly suppressed the VEGF and ERK expressions and attenuated the IR-induced lung injury. This study demonstrates the important role of VEGF in early IR-induced ALI. The beneficial effects of preconditioning anti-VEGF antibody in IR-induced ALI include the attenuation of lung injury, pro-inflammatory cytokines, and neutrophilic infiltration into the lung tissues.	[Lan, Chou-Chin] Buddhist Tzu Chi Med Fdn, Buddhist Tzu Chi Gen Hosp, Div Pulm Med, Taipei, Taiwan; [Lan, Chou-Chin] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Peng, Chung-Kan; Tang, Shih-En; Huang, Kun-Lun] Triserv Gen Hosp, Div Pulm Med, Taipei, Taiwan; [Peng, Chung-Kan; Tang, Shih-En; Wu, Shu-Yu; Huang, Kun-Lun] Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan; [Wu, Chin-Pyng] Li Shin Hosp, Dept Crit Care Med, Ping Jen City, Tao Yuan County, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Tri-Service General Hospital; National Defense Medical Center	Huang, KL (corresponding author), Triserv Gen Hosp, Div Pulm Med, Taipei, Taiwan.; Huang, KL (corresponding author), Natl Def Med Ctr, Inst Undersea & Hyperbar Med, Taipei, Taiwan.; Wu, CP (corresponding author), Li Shin Hosp, Dept Crit Care Med, Ping Jen City, Tao Yuan County, Taiwan.	kun@ndmctsgh.edu.tw; chinpyng@mail.ndmctsgh.edu.tw	Wu, Chin-Pyng/W-8447-2019		Buddhist Tzu Chi General Hospital [TCRD-TPE-102-22, TCRD-TPE-103-38]; Li-Shin Hospital [LS2012-07, LS2013-02]	Buddhist Tzu Chi General Hospital; Li-Shin Hospital	This study was supported by grants from the Buddhist Tzu Chi General Hospital (TCRD-TPE-102-22 and TCRD-TPE-103-38), and the Li-Shin Hospital (LS2012-07 and LS2013-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Bradshaw M, 2013, CURR ONCOL REP, V15, P207, DOI 10.1007/s11912-013-0315-7; Breslin JW, 2003, AM J PHYSIOL-HEART C, V284, pH92, DOI 10.1152/ajpheart.00330.2002; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; den Hengst WA, 2010, AM J PHYSIOL-HEART C, V299, pH1283, DOI 10.1152/ajpheart.00251.2010; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Everhart MB, 2006, J IMMUNOL, V176, P4995, DOI 10.4049/jimmunol.176.8.4995; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Godzich M, 2006, FASEB J, V20, P1519, DOI 10.1096/fj.05-4708fje; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Kaner RJ, 2000, AM J RESP CELL MOL, V22, P657, DOI 10.1165/ajrcmb.22.6.3779; Karmpaliotis D, 2002, AM J PHYSIOL-LUNG C, V283, pL585, DOI 10.1152/ajplung.00048.2002; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kazi AA, 2000, AM J PHYSIOL-LUNG C, V279, pL460, DOI 10.1152/ajplung.2000.279.3.L460; Khimenko PL, 1998, J APPL PHYSIOL, V85, P2005, DOI 10.1152/jappl.1998.85.6.2005; Kiriakidis S, 2003, J CELL SCI, V116, P665, DOI 10.1242/jcs.00286; Koh H, 2008, RESPIROLOGY, V13, P281, DOI 10.1111/j.1440-1843.2007.01193.x; Kosmidou I, 2008, J THROMB THROMBOLYS, V25, P259, DOI 10.1007/s11239-007-0062-4; Krebs R, 2005, AM J RESP CRIT CARE, V171, P1421, DOI 10.1164/rccm.200408-1001OC; Lange M, 2012, BURNS, V38, P1072, DOI 10.1016/j.burns.2012.02.019; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lehmann S, 2012, ANN THORAC SURG, V93, P913, DOI 10.1016/j.athoracsur.2011.11.033; Liang GY, 2011, ACTA CARDIOL, V66, P323, DOI 10.1080/AC.66.3.2114132; Lucas R, 2009, BIOCHEM PHARMACOL, V77, P1763, DOI 10.1016/j.bcp.2009.01.014; Maddahi A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-14; Marti HH, 1998, P NATL ACAD SCI USA, V95, P15809, DOI 10.1073/pnas.95.26.15809; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Medford ARL, 2006, THORAX, V61, P621, DOI 10.1136/thx.2005.040204; Mura M, 2006, CRIT CARE, V10, DOI 10.1186/cc5042; Rottner M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-23; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Singer CA, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-14; Thickett DR, 2001, AM J RESP CRIT CARE, V164, P1601, DOI 10.1164/ajrccm.164.9.2011071; Thys F, 2001, RESUSCITATION, V49, P105, DOI 10.1016/S0300-9572(00)00339-7; Tsuang WM, 2013, ANN INTERN MED, V158, P650, DOI 10.7326/0003-4819-158-9-201305070-00004; Webb NJA, 1998, CYTOKINE, V10, P254, DOI 10.1006/cyto.1997.0297; Weyker PD, 2013, SEMIN CARDIOTHORAC V, V17, P28, DOI 10.1177/1089253212458329; Wu SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069530; Xu B, 2011, J SURG RES, V166, pE157, DOI 10.1016/j.jss.2010.11.902; Yang RH, 2012, EUR J PHARMACOL, V674, P391, DOI 10.1016/j.ejphar.2011.08.029; Yumoto Masato, 2005, J Anesth, V19, P287, DOI 10.1007/s00540-005-0338-9; Zhang XD, 2008, INHAL TOXICOL, V20, P805, DOI 10.1080/08958370802015091 ; Zittermann SI, 2006, J LEUKOCYTE BIOL, V80, P247, DOI 10.1189/jlb.1205718	48	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159922	10.1371/journal.pone.0159922	http://dx.doi.org/10.1371/journal.pone.0159922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513332	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100018
J	McKinney, BA; Lareau, C; Oberg, AL; Kennedy, RB; Ovsyannikova, IG; Poland, GA				McKinney, Brett A.; Lareau, Caleb; Oberg, Ann L.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Poland, Gregory A.			The Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; ASSOCIATION INTERACTION NETWORK; ANTIBODY-RESPONSE; FEATURE-SELECTION; EMERGING FIELD; GOLDEN-AGE; VITAMIN-A; CENTRALITY; EXPRESSION; APOPTOSIS	Although many diseases and traits show large heritability, few genetic variants have been found to strongly separate phenotype groups by genotype. Complex regulatory networks of variants and expression of multiple genes lead to small individual-variant effects and difficulty replicating the effect of any single variant in an affected pathway. Interaction network modeling of GWAS identifies effects ignored by univariate models, but population differences may still cause specific genes to not replicate. Integrative network models may help detect indirect effects of variants in the underlying biological pathway. In this study, we used gene-level functional interaction information from the Integrative Multi-species Prediction (IMP) tool to reveal important genes associated with a complex phenotype through evidence from epistasis networks and pathway enrichment. We test this method for augmenting variant-based network analyses with functional interactions by applying it to a smallpox vaccine immune response GWAS. The integrative analysis spotlights the role of genes related to retinoid X receptor alpha (RXRA), which has been implicated in a previous epistasis network analysis of smallpox vaccine.	[McKinney, Brett A.; Lareau, Caleb] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [McKinney, Brett A.; Lareau, Caleb] Univ Tulsa, Dept Math, Tulsa, OK 74104 USA; [Oberg, Ann L.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Kennedy, Richard B.; Ovsyannikova, Inna G.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55902 USA	University of Tulsa; University of Tulsa; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55902 USA.	poland.gregory@mayo.edu	Lareau, Caleb/ABF-9490-2020	Lareau, Caleb/0000-0003-4179-4807; Kennedy, Rick/0000-0001-6164-4967	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200400025C (N01AI40065)]	National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by federal funds from the National Institute of Allergies and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200400025C (N01AI40065). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; CHEN Z, 1994, P NATL ACAD SCI USA, V91, P1178, DOI 10.1073/pnas.91.3.1178; Chow YH, 1998, J IMMUNOL, V160, P1320; Davis NA, 2010, GENES IMMUN, V11, P630, DOI 10.1038/gene.2010.37; Davis NA, 2013, GENET EPIDEMIOL, V37, P614, DOI 10.1002/gepi.21739; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Greene CS, 2015, NAT GENET, V47, P569, DOI 10.1038/ng.3259; Grzegorzewska AE, 2014, EXPERT REV VACCINES, P1; Haralambieva IH, 2010, FUTURE MICROBIOL, V5, P1757, DOI [10.2217/fmb.10.146, 10.2217/FMB.10.146]; Huttenhower C, 2008, BIOINFORMATICS, V24, P1559, DOI 10.1093/bioinformatics/btn237; Kennedy R, 2009, CLIN VACCINE IMMUNOL, V16, P1105, DOI 10.1128/CVI.00109-09; Kennedy RB, 2012, HUM GENET, V131, P1433, DOI 10.1007/s00439-012-1179-x; Lareau CA, 2016, GENES IMMUN, V17, P244, DOI 10.1038/gene.2016.15; Lareau CA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00312; Lareau CA, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0040-x; Martin Perrine J, 2003, Nucl Recept, V1, P6, DOI 10.1186/1478-1336-1-6; McKinney BA, 2007, BIOINFORMATICS, V23, P2113, DOI 10.1093/bioinformatics/btm317; McKinney BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000432; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Ovsyannikova IG, 2012, VACCINE, V30, P4182, DOI 10.1016/j.vaccine.2012.04.055; Ovsyannikova IG, 2012, PHARMACOGENET GENOM, V22, P20, DOI 10.1097/FPC.0b013e32834df186; Ovsyannikova IG, 2011, AAPS J, V13, P438, DOI 10.1208/s12248-011-9281-x; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Pandey A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.80; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Poland GA, 2007, CLIN PHARMACOL THER, V82, P653, DOI 10.1038/sj.clpt.6100415; Poland GA, 2007, CLIN PHARMACOL THER, V82, P623, DOI 10.1038/sj.clpt.6100379; Poland GA, 2012, VACCINOMICS PERSONAL, P3; Poland GA, 2008, EXPERT OPIN BIOL TH, V8, P1659, DOI [10.1517/14712598.8.11.1659, 10.1517/14712598.8.11.1659 ]; Poland GA, 2013, SEMIN IMMUNOL, V25, P89, DOI 10.1016/j.smim.2013.04.007; Poland GA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002344; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Poland GA, 2010, VACCINE, V28, P3509, DOI 10.1016/j.vaccine.2010.03.031; Rahmani B, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00080; Rasooly R, 2005, J IMMUNOL, V175, P7916, DOI 10.4049/jimmunol.175.12.7916; Spilianakis CG, 2005, EUR J IMMUNOL, V35, P3400, DOI 10.1002/eji.200535588; Tagami T, 2009, J MOL ENDOCRINOL, V42, P415, DOI 10.1677/JME-08-0153; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang X, 2014, ANN HUM GENET, V78, P478, DOI 10.1111/ahg.12080; Wong AK, 2012, NUCLEIC ACIDS RES, V40, pW484, DOI 10.1093/nar/gks458; WONG JM, 1995, GENE DEV, V9, P2696, DOI 10.1101/gad.9.21.2696	42	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0158016	10.1371/journal.pone.0158016	http://dx.doi.org/10.1371/journal.pone.0158016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513748	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100005
J	Oriol, I; Llado, L; Vila, M; Baliellas, C; Tubau, F; Sabe, N; Fabregat, J; Carratala, J				Oriol, Isabel; Llado, Laura; Vila, Marina; Baliellas, Carme; Tubau, Fe; Sabe, Nuria; Fabregat, Joan; Carratala, Jordi			The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation	PLOS ONE			English	Article							POSITIVE CULTURES; INFECTIONS; BACTERIAL; RECIPIENT; CRITERIA	The role of contaminated preservation fluid in the development of infection after liver transplantation has not been fully elucidated. To assess the incidence and etiology of contaminated preservation fluid and determine its impact on the subsequent development of infection after liver transplantation, we prospectively studied 50 consecutive liver transplants, and cultured the following samples in each instance: preservation fluid (immediately before and at the end of the back-table procedure, and just before implantation), blood, and bile from the donor, and ascitic fluid from the recipient. When any culture was positive, blood cultures were obtained and targeted antimicrobial therapy was started. We found that the incidence of contaminated preservation fluid was 92% (46 of 50 cases of liver transplantation per year), but only 28% (14/50) were contaminated by recognized pathogens. Blood and bile cultures from the donor were positive in 28% and 6% respectively, whereas ascitic fluid was positive in 22%. The most frequently isolated microorganisms were coagulase-negative staphylococci. In nine cases, the microorganisms isolated from the preservation fluid concurred with those grown from the donor blood cultures, and in one case, the isolate matched with the one obtained from bile culture. No liver transplant recipient developed an infection due to the transmission of an organism isolated from the preservation fluid. Our findings indicate that contamination of the preservation fluid is frequent in liver transplantation, and it is mainly caused by saprophytic skin flora. Transmission of infection is low, particularly among those recipients given targeted antimicrobial treatment for organisms isolated in the preservation fluid.	[Oriol, Isabel; Sabe, Nuria; Carratala, Jordi] Univ Barcelona, Dept Infect Dis, Bellvitge Hosp, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Llado, Laura; Vila, Marina; Baliellas, Carme; Fabregat, Joan] Univ Barcelona, Liver Transplant Unit, Bellvitge Hosp, Inst Invest Biomed Bellvitge, Barcelona, Spain; [Tubau, Fe] Univ Barcelona, Dept Microbiol, Bellvitge Hosp, Inst Invest Biomed Bellvitge, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Oriol, I (corresponding author), Univ Barcelona, Dept Infect Dis, Bellvitge Hosp, Inst Invest Biomed Bellvitge, Barcelona, Spain.	isaoriolbermudez@gmail.com	Oriol, Isabel/AAI-9706-2021; Carratala, Jordi/AAC-2639-2020; Carratalà, Jordi/B-8410-2011	Oriol, Isabel/0000-0001-5542-7878; Carratala, Jordi/0000-0003-3209-2563; Carratalà, Jordi/0000-0003-3209-2563; Baliellas, Carme/0000-0002-3641-6484; Vila Tura, Marina/0000-0002-4985-9970; Sabe, Nuria/0000-0003-1697-4347	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS 14/00935]; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; FEDER funds/European Regional Development Fund (ERDF); University of Barcelona	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER funds/European Regional Development Fund (ERDF); University of Barcelona	This study was supported by research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS 14/00935] and Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III, cofunded by FEDER funds/European Regional Development Fund (ERDF)- a way to build Europe-//FONDOS FEDER "una manera de hacer Europa". Isabel Oriol is the recipient of a research grant from the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet M, 2011, TRANSPL INFECT DIS, V13, P84, DOI 10.1111/j.1399-3062.2010.00529.x; Avkan-Oguz V, 2013, TRANSPL P, V45, P993, DOI 10.1016/j.transproceed.2013.02.067; Cerutti E, 2006, LIVER TRANSPLANT, V12, P1253, DOI 10.1002/lt.20811; Chaim FHM, 2011, TRANSPL P, V43, P1313, DOI 10.1016/j.transproceed.2011.02.030; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Dorschner P, 2014, TRANSPL INFECT DIS, V16, P171, DOI 10.1111/tid.12203; Fishman JA, 2014, CLIN MICROBIOL INFEC, V20, P4, DOI 10.1111/1469-0691.12593; Gavalda J, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12658; Gavalda J, 2014, CLIN MICROBIOL INFEC, V20, P27, DOI 10.1111/1469-0691.12660; Grat M, 2012, ANN TRANSPL, V17, P20; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Janny S, 2011, TRANSPL INFECT DIS, V13, P9, DOI 10.1111/j.1399-3062.2010.00558.x; Khullar V, 2015, WORLD J HEPATOL, V7, P1843, DOI 10.4254/wjh.v7.i14.1843; Len O, 2008, AM J TRANSPLANT, V8, P2420, DOI 10.1111/j.1600-6143.2008.02397.x; Levesque E, 2014, TRANSPL INFECT DIS, V16, P827, DOI 10.1111/tid.12260; Liberal R, 2013, LIVER TRANSPLANT, V19, P1065, DOI 10.1002/lt.23704; Lucey MR, 2011, LIVER TRANSPLANT, V17, P751, DOI 10.1002/lt.22330; Lumbreras C, 2014, CLIN MICROBIOL INFEC, V20, P19, DOI 10.1111/1469-0691.12594; Mattana AMC, BRAZ J INFECT DIS JA, V15, P528; Ruiz P, TRANSPLANT P JAN, p[41, 2169]; Sauget M, 2011, TRANSPL INFECT DIS, V13, P331, DOI 10.1111/j.1399-3062.2010.00597.x; Tector AJ, 2006, ANN SURG, V244, P439, DOI 10.1097/01.sla.0000234896.18207.fa; Veroux M, 2010, TRANSPL P, V42, P1043, DOI 10.1016/j.transproceed.2010.03.041; Wayne P, 2012, PERFORMANCE STANDARD; Yansouni CP, 2012, INFECT CONT HOSP EP, V33, P672, DOI 10.1086/666344	25	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160701	10.1371/journal.pone.0160701	http://dx.doi.org/10.1371/journal.pone.0160701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513941	gold, Green Published			2022-12-26	WOS:000381381100060
J	Poder, TG; Dupras, J; Ndefo, FF; He, J				Poder, Thomas G.; Dupras, Jerome; Ndefo, Franck Fetue; He, Jie			The Economic Value of the Greater Montreal Blue Network (Quebec, Canada): A Contingent Choice Study Using Real Projects to Estimate Non-Market Aquatic Ecosystem Services Benefits	PLOS ONE			English	Article							QUALITY IMPROVEMENTS; VALUATION; HETEROGENEITY; AGRICULTURE; SCALE	This study used a contingent choice method to determine the economic value of improving various ecosystem services (ESs) of the Blue Network of Greater Montreal (Quebec, Canada). Three real projects were used and the evaluation focused on six ESs that are related to freshwater aquatic ecosystems: biodiversity, water quality, carbon sequestration, recreational activities, landscape aesthetics and education services. We also estimated the value associated with the superficies of restored sites. We calculated the monetary value that a household would be willing to pay for each additional qualitative or quantitative unit of different ESs, and these marginal values range from $0.11 to $15.39 per household per unit. Thus, under certain assumptions, we determined the monetary values that all Quebec households would allocate to improve each ES in Greater Montreal by one unit. The most valued ES was water quality ($13.5 million), followed by education services ($10.7 million), recreational activities ($8.9 million), landscape aesthetics ($4.1 million), biodiversity ($1.2 million), and carbon sequestration ($0.1 million). Our results ascribe monetary values to improved (or degraded) aquatic ecosystems in the Blue Network of Greater Montreal, but can also enhance economic analyses of various aquatic ecosystem restoration and management projects.	[Poder, Thomas G.] CIUSSS Estrie CHUS, CRCHUS, Sherbrooke, PQ, Canada; [Poder, Thomas G.; He, Jie] Univ Sherbrooke, GREDI, Sherbrooke, PQ, Canada; [Dupras, Jerome] Univ Quebec Outaouais, Dept Nat Sci, Ripon, PQ, Canada; [Dupras, Jerome] Univ Quebec Outaouais, Inst Sci Foret Temperee, Ripon, PQ, Canada; [Ndefo, Franck Fetue; He, Jie] Univ Sherbrooke, Dept Econ, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Quebec; University Quebec Outaouais; University of Quebec; University Quebec Outaouais; University of Sherbrooke	Poder, TG (corresponding author), CIUSSS Estrie CHUS, CRCHUS, Sherbrooke, PQ, Canada.; Poder, TG (corresponding author), Univ Sherbrooke, GREDI, Sherbrooke, PQ, Canada.	tpoder.chus@ssss.gouv.qc.ca		Poder, Thomas/0000-0001-7017-096X	David Suzuki Fundation; David Suzuki Foundation (DSF); FRQS	David Suzuki Fundation; David Suzuki Foundation (DSF); FRQS	The David Suzuki Fundation funded the study.; We acknowledge the financial contribution of the David Suzuki Foundation (DSF). We would also like to thank Karel Mayrand and Jean-Patrick Toussaint from the DSF, Pascal Bigras, Frederic Moreau, Emie Labrecque, Elise Belanger and Linda Fortin from Nature-Action Quebec and Alain Paquette from UQAM for their helpful contributions to the study design and their contribution to focus groups. We also thank Marc Girard from the Departement de geographie of the Universite de Montreal for his contribution to the cartography. TGP is member of the FRQS-funded Centre de recherche du CHUS (CRCHUS).	Bateman IJ, 2006, J ENVIRON MANAGE, V79, P221, DOI 10.1016/j.jenvman.2005.06.010; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Belanger L, 2002, LANDSCAPE ECOL, V17, P495, DOI 10.1023/A:1021443929548; Brouwer R, 2010, LAND ECON, V86, P552, DOI 10.3368/le.86.3.552; Communaute Metropolitaine de Montreal (CMM), 2010, PORTRAIT GRAND MONTR, V1; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; de Groot RS, 2002, ECOL ECON, V41, P393, DOI 10.1016/S0921-8009(02)00089-7; Doherty E, 2014, ECOSYST SERV, V7, P89, DOI 10.1016/j.ecoser.2013.09.003; Dube A, 2006, PENSER RENOUVELLEMEN, P50; Dupras J, 2014, AGR PAYSAGE RAPPORTS, P113; Dupras J, 2015, CAN GEOGR-GEOGR CAN, V59, P93, DOI 10.1111/cag.12138; Farber S, 2000, ECOL ECON, V34, P63, DOI 10.1016/S0921-8009(00)00153-1; Freeman III A M, 2003, MEASUREMENT ENV RESO; Hall C, 2004, J RURAL STUD, V20, P211, DOI 10.1016/j.jrurstud.2003.08.004; HANEMANN WM, 1984, AM J AGR ECON, V66, P332, DOI 10.2307/1240800; He J, 2013, OUTILS ANAL HYDROLOG; Institut de la statistique du Quebec (ISQ), 2013, COMPT TERR REG CHAUD; Jobin B, 2010, ENVIRON MONIT ASSESS, V164, P631, DOI 10.1007/s10661-009-0918-5; Kandulu J, 2014, J ENVIRON MANAGE, V125, P43; Knowler DJ, 2003, J ENVIRON MANAGE, V69, P261, DOI 10.1016/j.jenvman.2003.09.001; Kragt ME, 2013, ENVIRON RESOUR ECON, V54, P201, DOI 10.1007/s10640-012-9587-x; Kumar P., 2010, EC ECOSYSTEMS BIODIV; Lantz V, 2013, REG ENVIRON CHANGE, V13, P939, DOI 10.1007/s10113-012-0393-3; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Mitchell R.C., 1989, USING SURVEYS VALUE; Shrestha RK, 2004, ECOL ECON, V49, P349, DOI 10.1016/j.ecolecon.2004.01.015; Statistics Canada, 2014, NOMBR MEN PROJ SEL S; Statistics Canada, 2013, HUM ACT ENV MEAS EC; Tardif B., 2005, ATLAS BIODIVERSITE Q; Vergriete Y, 2007, ROLE ARBRES PLANTES	32	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0158901	10.1371/journal.pone.0158901	http://dx.doi.org/10.1371/journal.pone.0158901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513558	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100012
J	Henderson, MC; Hollingsworth, AB; Gordon, K; Silver, M; Mulpuri, R; Letsios, E; Reese, DE				Henderson, Meredith C.; Hollingsworth, Alan B.; Gordon, Kelly; Silver, Michael; Mulpuri, Rao; Letsios, Elias; Reese, David E.			Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer	PLOS ONE			English	Article							POSITIVE PREDICTIVE-VALUE; SCREENING MAMMOGRAPHY; GROWTH-FACTOR; WOMEN; BIOPSIES; STAGE	Despite significant advances in breast imaging, the ability to accurately detect Breast Cancer (BC) remains a challenge. With the discovery of key biomarkers and protein signatures for BC, proteomic technologies are currently poised to serve as an ideal diagnostic adjunct to imaging. Research studies have shown that breast tumors are associated with systemic changes in levels of both serum protein biomarkers (SPB) and tumor associated autoanti-bodies (TAAb). However, the independent contribution of SPB and TAAb expression data for identifying BC relative to a combinatorial SPB and TAAb approach has not been fully investigated. This study evaluates these contributions using a retrospective cohort of pre-biopsy serum samples with known clinical outcomes collected from a single site, thus minimizing potential site-to-site variation and enabling direct assessment of SPB and TAAb contributions to identify BC. All serum samples (n = 210) were collected prior to biopsy. These specimens were obtained from 18 participants with no evidence of breast disease (ND), 92 participants diagnosed with Benign Breast Disease (BBD) and 100 participants diagnosed with BC, including DCIS. All BBD and BC diagnoses were based on pathology results from biopsy. Statistical models were developed to differentiate BC from non-BC (i.e., BBD and ND) using expression data from SPB alone, TAAb alone, and a combination of SPB and TAAb. When SPB data was independently used for modeling, clinical sensitivity and specificity for detection of BC were 74.7% and 77.0%, respectively. When TAAb data was independently used, clinical sensitivity and specificity for detection of BC were 72.2% and 70.8%, respectively. When modeling integrated data from both SPB and TAAb, the clinical sensitivity and specificity for detection of BC improved to 81.0% and 78.8%, respectively. These data demonstrate the benefit of the integration of SPB and TAAb data and strongly support the further development of combinatorial proteomic approaches for detecting BC.	[Henderson, Meredith C.; Gordon, Kelly; Silver, Michael; Mulpuri, Rao; Letsios, Elias; Reese, David E.] Provista Diagnost Inc, 55 Broad St,18th Floor, New York, NY 10004 USA; [Hollingsworth, Alan B.] Mercy Womens Ctr Oklahoma City, 4300 McAuley Blvd, Oklahoma City, OK 73120 USA		Reese, DE (corresponding author), Provista Diagnost Inc, 55 Broad St,18th Floor, New York, NY 10004 USA.	ReeseD@ProvistaDx.com			Provista Diagnostics	Provista Diagnostics	This study was funded by Provista Diagnostics, a privately funded company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon LM, 2012, CANCER RES, V72, P1935, DOI 10.1158/0008-5472.CAN-11-3266; Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; [Anonymous], 2002, PIAA 2002 BREAST CAN; [Anonymous], 2011, BREAST CANC FACTS FI; Baum JK, 2011, RADIOLOGY, V260, P61, DOI 10.1148/radiol.11101285; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bond M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005855; Campbell JB, 2002, BREAST CANCER RES TR, V74, P187, DOI 10.1023/A:1016178415129; Cole K, 2011, CANCER BIOMARK, V9, P177, DOI 10.3233/CBM-2011-0187; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Elmore JG, 2014, JAMA-J AM MED ASSOC, V311, P1298, DOI 10.1001/jama.2014.2494; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Groessl M, 2014, J PROTEOME RES, V13, P4773, DOI 10.1021/pr500727h; Haas S, 2008, VIRCHOWS ARCH, V452, P277, DOI 10.1007/s00428-007-0563-8; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heer K, 2001, CLIN CANCER RES, V7, P3491; Howlader N, 2015, SEER CANC STAT REV 1; Kerlikowske K, 2013, JAMA INTERN MED, V173, P807, DOI 10.1001/jamainternmed.2013.307; Kovacs E, 2001, BIOMED PHARMACOTHER, V55, P391, DOI 10.1016/S0753-3322(01)00079-8; Kovacs E, 2001, BIOMED PHARMACOTHER, V55, P111, DOI 10.1016/S0753-3322(00)00023-8; Lacquement MA, 1999, J AM COLL SURGEONS, V189, P34, DOI 10.1016/S1072-7515(99)00080-0; Lai JTW, 2000, CAN ASSOC RADIOL J, V51, P232; Lu HL, 2012, CANCER PREV RES, V5, P1036, DOI 10.1158/1940-6207.CAPR-11-0558; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; Oeffinger KC, 2015, JAMA-J AM MED ASSOC, V314, P1599, DOI 10.1001/jama.2015.12783; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Pietrowska M, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-60; Sheen-Chen SM, 2005, CANCER EPIDEM BIOMAR, V14, P715, DOI 10.1158/1055-9965.EPI-04-0340; Sickles EA, 2013, ACR BI RADS ATLAS BR, V5th, P46; Sickles EA, 2013, ACR BI RADS ATLAS BR; Smallenburg VV, 2012, EUR J CANCER, V48, P2097, DOI 10.1016/j.ejca.2012.03.011; Venkatesan A, 2009, RADIOLOGY, V250, P648, DOI 10.1148/radiol.2503080541	35	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0157692	10.1371/journal.pone.0157692	http://dx.doi.org/10.1371/journal.pone.0157692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508384	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400002
J	Ni, X; Song, WT; Zhang, HC; Yang, XL; Wang, LG				Ni, Xue; Song, Weiting; Zhang, Huanchao; Yang, Xiulian; Wang, Lianggui			Effects of Mulching on Soil Properties and Growth of Tea Olive (Osmanthus fragrans)	PLOS ONE			English	Article							GRAVEL MULCH; SOLUBLE SUGARS; PLANTS; PROLINE; SURFACE; TREE	Different mulches have variable effects on soil physical properties and plant growth. This study aimed to compare the effects of mulching with inorganic (round gravel, RG), organic (wood chips, WC), and living (manila turf grass, MG) materials on soil properties at 0-5-cm and 5-10-cm depths, as well as on the growth and physiological features of Osmanthus fragrans L. 'Rixianggui' plants. Soil samples were collected at three different time points from field plots of O. fragrans plants treated with the different mulching treatments. Moisture at both soil depths was significantly higher after mulching with RG and WC than that in the unmulched control (CK) treatment. Mulching did not affect soil bulk density, pH, or total nitrogen content, but consistently improved soil organic matter. The available nitrogen in the soil increased after RG and WC treatments, but decreased after MG treatment during the experimental period. Mulching improved plant growth by increasing root activity, soluble sugar, and chlorophyll a content, as well as by providing suitable moisture conditions and nutrients in the root zone. Plant height and trunk diameter were remarkably increased after mulching, especially with RG and WC. However, while MG improved plant growth at the beginning of the treatment, the 'Rixianggui' plants later showed no improvement in growth. This was probably because MG competed with the plants for water and available nitrogen in the soil. Thus, our findings suggest that RG and WC, but not MG, improved the soil environment and the growth of 'Rixianggui' plants. Considering the effect of mulching on soil properties and plant growth and physiology, round gravel and wood chips appear to be a better choice than manila turf grass in 'Rixianggui' nurseries. Further studies are required to determine the effects of mulch quality and mulch-layer thickness on shoot and root growths.	[Ni, Xue; Yang, Xiulian; Wang, Lianggui] Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing 210037, Jiangsu, Peoples R China; [Ni, Xue] Anhui Univ Technol, Coll Civil Engn & Architecture, Maanshan 243000, Peoples R China; [Song, Weiting; Zhang, Huanchao] Nanjing Forestry Univ, Coll Forestry, Nanjing 210037, Jiangsu, Peoples R China	Nanjing Forestry University; Anhui University of Technology; Nanjing Forestry University	Wang, LG (corresponding author), Nanjing Forestry Univ, Coll Landscape Architecture, Nanjing 210037, Jiangsu, Peoples R China.	wlg@njfu.com.cn			Ministry of Science and Technology of the People's Republic of China	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was funded by the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Michael A., 2005, Journal of Arboriculture, V31, P163; ASHWORTH S, 1983, HORTSCIENCE, V18, P180; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BILLEAUD L A, 1989, Journal of Environmental Horticulture, V7, P155; Black RJ, 1994, MULCHES LANDSCAPE, P4; Brady N.C., 2008, NAT PROP SOILS, P311; Chalker-Scott Linda, 2007, Journal of Environmental Horticulture, V25, P239; Chen CL, 2003, PRINCIPLE TECHNOLOGY, P119; Cooper A., 1973, ROOT TEMPERATURE PLA; Duryea Mary L., 1999, Journal of Arboriculture, V25, P88; FAIRBOURN ML, 1973, AGRON J, V65, P925, DOI 10.2134/agronj1973.00021962006500060024x; Ferrini Francesco, 2008, Arboriculture & Urban Forestry, V34, P157; Gleason ML, 1998, AM NURSERYMAN, V187, P24; Goicoechea N, 2000, EUR J PLANT PATHOL, V106, P19, DOI 10.1023/A:1008724816041; Greenly Katrina M., 1995, Journal of Arboriculture, V21, P225; Griffin JJ, 2007, HORTSCIENCE, V42, P267, DOI 10.21273/HORTSCI.42.2.267; Hanada T., 1991, EFFECT MULCHING ROW; Hartman JR, 2000, PIRONES TREE MAINTEN; Hickman G. W., 1996, Journal of Arboriculture, V22, P279; Hogue EJ., 1987, HORTIC REV, V9, P377, DOI [10.1002/9781118060827.ch10, DOI 10.1002/9781118060827.CH10, DOI 10.1002/978118060827.CH10]; HOLLOWAY P S, 1992, Journal of Environmental Horticulture, V10, P23; HOOK PB, 1991, PLANT SOIL, V138, P247, DOI 10.1007/BF00012252; Iles Jeffery K., 1999, Journal of Arboriculture, V25, P163; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Koski Ronda, 2004, Journal of Arboriculture, V30, P165; Li XY, 2003, SOIL TILL RES, V70, P73, DOI 10.1016/S0167-1987(02)00137-X; LORENZEN CJ, 1967, LIMNOL OCEANOGR, V12, P343, DOI 10.4319/lo.1967.12.2.0343; Magdoff FR, 1996, SOIL SCI SOC AM J, V56, P11; Montague T, 2004, SCI HORTIC-AMSTERDAM, V100, P229, DOI 10.1016/j.scienta.2003.08.010; Nachtergaele J, 1998, SOIL TILL RES, V46, P51, DOI 10.1016/S0167-1987(97)00078-0; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; NELSON DW, 1980, J ASSOC OFF ANA CHEM, V63, P770; Omura H, 2000, J CHEM ECOL, V26, P655, DOI 10.1023/A:1005424121044; Page A.L., 1983, METHODS SOIL ANAL 2; Rathinasabapathi B, 2005, HORTSCIENCE, V40, P711, DOI 10.21273/HORTSCI.40.3.711; Saeed R., 2014, FUUAST J BIOL, V4, P221; Scharenbroch Bryant C., 2006, Arboriculture & Urban Forestry, V32, P180; Scharenbroch Bryant C., 2009, Arboriculture & Urban Forestry, V35, P221; SINGH B, 1988, Indian Forester, V114, P307; Sinkeviciene A., 2009, Agronomy Research, V7, P485; SKROCH WA, 1986, HORTSCIENCE, V21, P390; Tisdale S.L., 1993, SOIL FERTILITY FERTI, Vfifth, P634; Top GC, 2002, METHODS SOIL ANAL 4, P422; Wang HS, 2006, LWT-FOOD SCI TECHNOL, V39, P496, DOI 10.1016/j.lwt.2005.04.001; WATSON G W, 1988, Journal of Arboriculture, V14, P200; Yamanaka T, 2004, AGR WATER MANAGE, V67, P145, DOI 10.1016/j.agwat.2004.01.002; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; ZHU GR, 1990, PLANT PHYSL EXPT, P242	48	34	39	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0158228	10.1371/journal.pone.0158228	http://dx.doi.org/10.1371/journal.pone.0158228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508410	Green Published, gold			2022-12-26	WOS:000381380400003
J	Wang, WL; Duan, LM; Bai, Y; Wang, HY; Shao, H; Zhong, SY				Wang, Wuli; Duan, Liming; Bai, Yang; Wang, Haoyu; Shao, Hui; Zhong, Siyang			A Triangle Mesh Standardization Method Based on Particle Swarm Optimization	PLOS ONE			English	Article							HOLE-FILLING ALGORITHM; CONVERGENCE; REPAIR	To enhance the triangle quality of a reconstructed triangle mesh, a novel triangle mesh standardization method based on particle swarm optimization (PSO) is proposed. First, each vertex of the mesh and its first order vertices are fitted to a cubic curve surface by using least square method. Additionally, based on the condition that the local fitted surface is the searching region of PSO and the best average quality of the local triangles is the goal, the vertex position of the mesh is regulated. Finally, the threshold of the normal angle between the original vertex and regulated vertex is used to determine whether the vertex needs to be adjusted to preserve the detailed features of the mesh. Compared with existing methods, experimental results show that the proposed method can effectively improve the triangle quality of the mesh while preserving the geometric features and details of the original mesh.	[Wang, Wuli; Duan, Liming; Bai, Yang; Wang, Haoyu; Shao, Hui] Chongqing Univ, Coll Mech Engn, Chongqing, Peoples R China; [Wang, Wuli; Duan, Liming; Bai, Yang; Wang, Haoyu; Shao, Hui; Zhong, Siyang] Chongqing Univ, Engn Res Ctr Ind Comp Tomog Nondestruct Testing, Educ Minist China, Chongqing, Peoples R China; [Wang, Wuli] China Univ Petr, Coll Informat & Control Engn, Qingdao, Peoples R China	Chongqing University; Chongqing University; China University of Petroleum	Duan, LM (corresponding author), Chongqing Univ, Coll Mech Engn, Chongqing, Peoples R China.; Duan, LM (corresponding author), Chongqing Univ, Engn Res Ctr Ind Comp Tomog Nondestruct Testing, Educ Minist China, Chongqing, Peoples R China.	duanliming163@163.com			National Key Scientific Instrument and Equipment Development Projects, China [2013YQ030629]	National Key Scientific Instrument and Equipment Development Projects, China	This work is supported by National Key Scientific Instrument and Equipment Development Projects, China (grant number: 2013YQ030629; URL: http://www.most.gov.cn/index.htm).	Attene M, 2010, VISUAL COMPUT, V26, P1393, DOI 10.1007/s00371-010-0416-3; Bischoff S, 2005, ACM T GRAPHIC, V24, P1332, DOI 10.1145/1095878.1095883; Chen Zhong, 2013, Computer Integrated Manufacturing Systems, V19, P461; Clerc M, 2002, IEEE T EVOLUT COMPUT, V6, P58, DOI 10.1109/4235.985692; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; [段黎明 Duan Liminga], 2012, [重庆大学学报. 自然科学版, Journal of Chongqing University. Natural Science Edition], V35, P15; Duguet F, 2004, ROBUST HIGHER ORDER; Eberhart RC, 2000, IEEE C EVOL COMPUTAT, P84, DOI 10.1109/CEC.2000.870279; FIELD DA, 1988, COMMUN APPL NUMER M, V4, P709, DOI 10.1002/cnm.1630040603; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Gao ZH, 2013, GRAPH MODELS, V75, P23, DOI 10.1016/j.gmod.2012.10.007; Goldfeather J, 2004, ACM T GRAPHIC, V23, P45, DOI 10.1145/966131.966134; Hetroy F, 2011, COMPUT AIDED DESIGN, V43, P101, DOI 10.1016/j.cad.2010.09.012; Ji Zhong-ping, 2006, Journal of Zhejiang University, V40, P2083; Ju T, 2004, ACM T GRAPHIC, V23, P888, DOI 10.1145/1015706.1015815; Jun Y, 2005, COMPUT AIDED DESIGN, V37, P263, DOI 10.1016/j.cad.2004.06.012; Kennedy J, 2002, IEEE C EVOL COMPUTAT, P1671, DOI 10.1109/CEC.2002.1004493; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kennedy J, 2006, IEEE T SYST MAN CY C, V36, P515, DOI 10.1109/TSMCC.2006.875410; Li CH, 2012, IEEE T SYST MAN CY B, V42, P627, DOI 10.1109/TSMCB.2011.2171946; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097822; Mendes R, 2004, IEEE T EVOLUT COMPUT, V8, P204, DOI [10.1109/TEVC.2004.826074, 10.1109/tevc.2004.826074]; Nealen A., 2006, P 4 INT C COMP GRAPH, P381, DOI DOI 10.1145/1174429.1174494; Nickabadi A, 2011, APPL SOFT COMPUT, V11, P3658, DOI 10.1016/j.asoc.2011.01.037; Panchetti M, 2010, COMPUT AIDED DESIGN, V42, P693, DOI 10.1016/j.cad.2010.01.004; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Taubin G., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P351, DOI 10.1145/218380.218473; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Vollmer J, 1999, COMPUT GRAPH FORUM, V18, pC131, DOI 10.1111/1467-8659.00334; Wei MQ, 2013, OPT LASER ENG, V51, P1223, DOI 10.1016/j.optlaseng.2013.04.018; Zhan ZH, 2009, IEEE T SYST MAN CY B, V39, P1362, DOI 10.1109/TSMCB.2009.2015956; Zhang Xia, 2014, J INFORM COMPUTATION, V11, P3433; Zhao W, 2007, VISUAL COMPUT, V23, P987, DOI 10.1007/s00371-007-0167-y; Zheng YY, 2011, IEEE T VIS COMPUT GR, V17, P1521, DOI 10.1109/TVCG.2010.264; Zhu L, 2013, COMPUT GRAPH FORUM, V32, P371, DOI 10.1111/cgf.12245	36	1	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160657	10.1371/journal.pone.0160657	http://dx.doi.org/10.1371/journal.pone.0160657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509129	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400044
J	Chen, MJ; Zhao, JY; Xia, JJ; Liu, ZY; Jiang, H; Shen, G; Li, HB; Jiang, YZ; Zhang, J				Chen, Miaojuan; Zhao, Junyang; Xia, Jiejun; Liu, Zhenyin; Jiang, Hua; Shen, Gang; Li, Haibo; Jiang, Yizhou; Zhang, Jing			Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies	PLOS ONE			English	Article							REFRACTORY RETINOBLASTOMA; CHEMOREDUCTION; MANAGEMENT; LIFE; CATHETERIZATION; PRESERVATION; ENUCLEATION; MELPHALAN; EFFICACY; CHILDREN	Purpose Retinoblastoma is the most common primary malignant intra-ocular tumor in children. Although intra-arterial chemotherapy (IAC) by selectively infusing chemotherapy through the ophthalmic artery has become an essential technique in the treatment of advanced intra-ocular retinoblastoma in children, the outcome of IAC as primary therapy for infants less than 3 months of age remains unknown. In this retrospective study, we reviewed the outcome of IAC as primary therapy for retinoblastoma in infants less than 3 months of age. Methods We retrospectively reviewed ten retinoblastoma patients attending our center from January 2009 to September 2015 and beginning primary IAC before the age of 3 months. The patient characteristics, overall outcomes and therapy-related complications were assessed. Results The mean patient age at the first IAC treatment was 10.4 weeks (range 4.9-12.9 weeks). These eyes were classified according to the International Classification of Retinoblastoma (ICRB) as group A (n = 0), B (n = 2), C (n = 0), D (n = 9), or E (n = 2). A total of 28 catheterizations were performed, and the procedure was stopped in one patient because of internal carotid artery spasm. Each eye received a mean of 2.6 cycles of IAC (range 2-4 cycles). After IAC with a mean follow-up of 28.3 months (range 9-65 months), tumor regression was observed in 12 of 13 eyes. One eye was enucleated due to tumor progression. All patients are alive and no patient has developed metastatic disease or other malignancies. Conclusions Our experience suggests IAC as primary therapy is a feasible and promising treatment for retinoblastoma in infants less than 3 months of age.	[Chen, Miaojuan; Xia, Jiejun; Liu, Zhenyin; Jiang, Hua; Shen, Gang; Li, Haibo; Jiang, Yizhou; Zhang, Jing] Guangzhou Women & Childrens Med Ctr, Dept Intervent Radiol & Vasc Anomalies, Guangzhou 510623, Guangdong, Peoples R China; [Zhao, Junyang] Capital Med Univ, Beijing Childrens Hosp, Dept Ophthalmol, Beijing, Peoples R China	Capital Medical University	Zhang, J (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Intervent Radiol & Vasc Anomalies, Guangzhou 510623, Guangdong, Peoples R China.	fejr@foxmail.com			Natural Science Foundation of Guangdong Province [2015A030313878]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by Natural Science Foundation of Guangdong Province (grant no. 2015A030313878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 2005, INVEST OPHTH VIS SCI, V46, P2684, DOI 10.1167/iovs.04-1462; ABRAMSON DH, 1992, OPHTHALMIC PAED GEN, V13, P191, DOI 10.3109/13816819209105167; ABRAMSON DH, 1983, ARCH OPHTHALMOL-CHIC, V101, P1362; Benz MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P577; Chan MPY, 2009, BRIT J OPHTHALMOL, V93, P891, DOI 10.1136/bjo.2007.129981; Chawla B, 2013, INDIAN J OPHTHALMOL, V61, P479, DOI 10.4103/0301-4738.119424; Davidson AJ, 2015, LANCET; Dimaras H, 2008, HUM MOL GENET, V17, P1363, DOI 10.1093/hmg/ddn024; Dimaras H, 2012, LANCET, V379, P1436, DOI 10.1016/S0140-6736(11)61137-9; DuMond AA, 2012, PEDIATR CRIT CARE ME, V13, P39, DOI 10.1097/PCC.0b013e3182192c7b; Faranoush M, 2014, IRAN J PEDIATR, V24, P381; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Gobin YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044322; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2002, BRIT J OPHTHALMOL, V86, P80, DOI 10.1136/bjo.86.1.80; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; Hadjistilianou T, 2014, J PEDIAT OPHTH STRAB, V51, P32, DOI 10.3928/01913913-20131203-01; Huang DS, 2013, EUR J OPHTHALMOL, V23, P532, DOI 10.5301/ejo.5000245; Jabbour P, 2012, J NEUROSURG-PEDIATR, V10, P175, DOI 10.3171/2012.5.PEDS1277; Jehanne M, 2014, B CANCER, V101, P380, DOI 10.1684/bdc.2014.1931; Linn Murphree A, 2005, Ophthalmol Clin North Am, V18, P41; Liu Y, 2014, ASIAN PAC J CANCER P, V15, P7805, DOI 10.7314/APJCP.2014.15.18.7805; Magan T., 2016, RETIN CASES BRIEF RE; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Schiedler V, 2007, ARCH OPHTHALMOL-CHIC, V125, P680, DOI 10.1001/archopht.125.5.680; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; Shields JA, 2005, AM J OPHTHALMOL, V140, P505, DOI 10.1016/j.ajo.2005.04.047; Thampi S, 2013, CLIN OPHTHALMOL, V7, P981, DOI 10.2147/OPTH.S43398; Venkataraman ST, 1997, CLIN PEDIATR, V36, P311, DOI 10.1177/000992289703600601; Wang YZ, 2014, CHINESE MED J-PEKING, V127, P3581, DOI 10.3760/cma.j.issn.0366-6999.20140915; Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6	32	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160873	10.1371/journal.pone.0160873	http://dx.doi.org/10.1371/journal.pone.0160873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504917	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200070
J	Kliemann, DA; Tovo, CV; da Veiga, ABG; Machado, AL; West, J				Kliemann, Dimas Alexandre; Tovo, Cristiane Valle; Gorini da Veiga, Ana Beatriz; Machado, Andre Luiz; West, John			Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank	PLOS ONE			English	Article							DACLATASVIR PLUS SOFOSBUVIR; C VIRUS-REPLICATION; IN-VITRO RESISTANCE; HEPATITIS-C; DRUG-RESISTANCE; INHIBITOR; PROTEASE; INFECTION; THERAPY; PROFILE	Background & Aims Development of resistance results from mutations in the viral genome, and the presence of selective drug pressure leads to the emergence of a resistant virus population. The aim of this study was to analyze the impact of genetic variability on the genetic barrier to drug resistance to DAAs. Methods The genetic barrier was quantified based on the number and type of nucleotide mutations required to impart resistance, considering full-length HCV NS3, NS5A and NS5B regions segregated by genotype into subtypes 1a, 1b, 2a, 2b and 3a. This study analyzeds 789 NS3 sequences, 708 sequences and 536 NS5B sequences deposited in the European Hepatitis C Virus Database, in the following resistance-associated positions: NS3: F43/I/L/S/V, Q80K/R, R155K/G, A156G/S/T and D168A/C/E/G/H/N/T/V/Y; NS5A: L/M28A/T/V, Q30E/H/R, L31F/I/M/V, H58D or P58S and Y93C/F/H/N/S; NS5B: S282P/R/T, C316H/N/Y, S368T, Y448C/H, S556G/R, D559R. Results Variants that require only one transversion in NS3 were found in 4 positions and include F43S, R80K, R155K/G and A156T. The genetic barrier to resistance shows subtypic differences at position 155 of the NS3 gene where a single transition is necessary in subtype 1a. In the NS5A gene, 5 positions where only one nucleotide change can confer resistance were found, such as L31M which requires one transversion in all subtypes, except in 0.28% of 1b sequences; and R30H, generated by a single transition, which was found in 10.25% of the sequences of genotype 1b. Other subtypic differences were observed at position 58, where resistance is less likely in genotype 1a because a transversion is required to create the variant 58S. For the NS5B inhibitors, the genetic barrier at positions conferring resistance was nearly identical in subtypes 1a and 1b, and single transitions or transversions were necessary in 5 positions to generate a drug-resistant variant of HCV. The positions C316Y and S556D required only one transition in all genotypes, Y448H and S556 G/N/R positions required only one transition for up to 98.8% of the sequences analyzed. A single variant in position 448 in genotype 1a is less likely to become the resistance variant 448H because it requires two transversions. Also, in the position 559D a transversion and a transition were necessary to generate the resistance mutant D559H. Conclusion Results revealed that in 14 out of 16 positions, conversion to a drug-resistant variant of HCV required only one single nucleotide substitutions threatening direct acting antivirals from all three classes.	[Kliemann, Dimas Alexandre; Tovo, Cristiane Valle; Gorini da Veiga, Ana Beatriz; Machado, Andre Luiz] Univ Fed Ciencias Saude Porto Alegre, Grad Program Med, Hepatol, Porto Alegre, RS, Brazil; [Kliemann, Dimas Alexandre; Machado, Andre Luiz] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil; [Gorini da Veiga, Ana Beatriz] Univ Fed Ciencias Saude Porto Alegre, Grad Program Pathol, Dept Basic Hlth Sci, Mol Biol Lab, Porto Alegre, RS, Brazil; [West, John] Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Lincoln, NE USA	Universidade Federal de Ciencias da Saude de Porto Alegre; Universidade Federal de Ciencias da Saude de Porto Alegre; University of Nebraska System; University of Nebraska Lincoln	da Veiga, ABG (corresponding author), Univ Fed Ciencias Saude Porto Alegre, Grad Program Med, Hepatol, Porto Alegre, RS, Brazil.	anabgv@ufcspa.edu.br	Kliemann, Dimas A/J-9513-2017; da Veiga, Ana Beatriz Gorini/N-8581-2013	da Veiga, Ana Beatriz Gorini/0000-0003-1462-5506; Valle Tovo, Cristiane/0000-0002-7932-5937	CAPES (Ministry of Education, Brazil); CNPq (Ministry of Science and Technology, Brazil); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	CAPES (Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Ministry of Science and Technology, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D. A. Kliemann holds a fellowship from CAPES (Ministry of Education, Brazil); A. B. G. Veiga holds a research fellowship from CNPq (Ministry of Science and Technology, Brazil).	Ali S, 2008, ANTIMICROB AGENTS CH, V52, P4356, DOI 10.1128/AAC.00444-08; Aloia AL, 2012, ANTIVIR THER, V17, P1147, DOI 10.3851/IMP2426; Alves R, 2013, J VIRAL HEPATITIS, V20, P414, DOI 10.1111/jvh.12051; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Combet Christophe, 2004, Appl Bioinformatics, V3, P237, DOI 10.2165/00822942-200403040-00005; DeGoey DA, 2014, J MED CHEM, V57, P2047, DOI 10.1021/jm401398x; Di Maio VC, 2014, ANTIMICROB AGENTS CH, V58, P2781, DOI 10.1128/AAC.02386-13; Gotte M, 2012, CURR OPIN VIROL, V2, P644, DOI 10.1016/j.coviro.2012.08.004; Gray RR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002656; Halliday J, 2011, EXPERT REV VACCINES, V10, P659, DOI [10.1586/erv.11.55, 10.1586/ERV.11.55]; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hedskog C, 2015, J VIRAL HEPATITIS, V22, P871, DOI 10.1111/jvh.12405; Jensen DM, 2016, LIVER INT, V36, P505, DOI 10.1111/liv.12997; Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14; Kieffer TL, 2010, J ANTIMICROB CHEMOTH, V65, P202, DOI 10.1093/jac/dkp388; Lawitz E, 2015, ANN NY ACAD SCI, V1358, P56, DOI 10.1111/nyas.12832; Lenz O, 2013, J HEPATOL, V58, P445, DOI 10.1016/j.jhep.2012.10.028; Lenz O, 2010, ANTIMICROB AGENTS CH, V54, P1878, DOI 10.1128/AAC.01452-09; Maiga AI, 2009, ANTIVIR THER, V14, P123; McPhee F, 2013, HEPATOLOGY, V58, P902, DOI 10.1002/hep.26388; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P3670, DOI 10.1128/AAC.00308-12; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2007, GASTROENTEROLOGY, V132, P1979, DOI 10.1053/j.gastro.2007.03.116; Pilot-Matias T, 2015, ANTIMICROB AGENTS CH, V59, P988, DOI 10.1128/AAC.04227-14; Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poveda E, 2014, ANTIVIR RES, V108, P181, DOI 10.1016/j.antiviral.2014.05.015; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schneider MD, 2014, ANTIVIR RES, V105, P64, DOI 10.1016/j.antiviral.2014.02.011; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Svicher V, 2011, DIGEST LIVER DIS, V43, P975, DOI 10.1016/j.dld.2011.07.002; Szabo E, 2003, PATHOL ONCOL RES, V9, P215, DOI 10.1007/BF02893380; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Zaltron S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-S2-S2	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159924	10.1371/journal.pone.0159924	http://dx.doi.org/10.1371/journal.pone.0159924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504952	Green Published, gold			2022-12-26	WOS:000381374200016
J	Zhang, LR; Wang, DQ; Li, YM; Liu, YF; Xie, XD; Wu, YY; Zhou, YP; Ren, J; Zhang, JX; Zhu, HT; Su, ZL				Zhang, Lirong; Wang, Dongqing; Li, Yumei; Liu, Yanfang; Xie, Xiaodong; Wu, Yingying; Zhou, Yuepeng; Ren, Jing; Zhang, Jianxin; Zhu, Haitao; Su, Zhaoliang			CCL21/CCR7 Axis Contributed to CD133(+) Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-kappa B Pathway	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; EPITHELIAL-MESENCHYMAL TRANSITION; CHEMOKINE RECEPTORS; TUMOR-CELLS; CCR7; EXPRESSION; MICROENVIRONMENT; ASSOCIATION; ACTIVATION; MIGRATION	Background Tumor metastasis is driven by malignant cells and stromal cell components of the tumor microenvironment. Cancer stem cells (CSCs) are thought to be responsible for metastasis by altering the tumor microenvironment. Epithelial-mesenchymal transition (EMT) processes contribute to specific stages of the metastatic cascade, promoted by cytokines and chemokines secreted by stromal cell components in the tumor microenvironment. C-C chemokine receptor 7 (CCR7) interacts with its ligand, chemokine ligand 21(CCL21), to mediate metastasis in some cancer cells lines. This study investigated the role of CCL21/CCR7 in promoting EMT and metastasis of cluster of differentiation 133(+) (CD133(+)) pancreatic cancer stem-like cells. Methods Panc-1, AsPC-1, and MIA PaCa-2 pancreatic cancer cells were selected because of their aggressive invasive potentials. CCR7 expression levels were examined in total, CD133+ and CD133 -cell fractions by Immunofluorescence analysis and real time-quantitative polymerase chain reaction (RT-qPCR). The role of CCL21/CCR7 in mediating metastasis and survival of CD133(+) pancreatic cancer stem-like cells was detected by Transwell assays and flow cytometry, respectively. EMT and lymph node metastasis related markers (E-cadherin, N-cadherin, LYVE-1) were analyzed by western blot. CCR7 expression levels were analyzed by immunohistochemical staining and RT-qPCR in resected tumor tissues, metastatic lymph nodes, normal lymph nodes and adjacent normal tissues from patients with pancreatic carcinoma. Results CCR7 expression was significantly increased in CD133(+) pancreatic cancer stem-like cells, resected pancreatic cancer tissues, and metastatic lymph nodes, compared with CD133(+) cancer cells, adjacent normal tissues and normal lymph nodes, respectively. CCL21/CCR7 promoted metastasis and survival of CD133(+) pancreatic cancer stem-like cells and regulated CD133(+) pancreatic cancer stem-like cells metastasis by modulating EMT and Erk/NF-kappa B pathway. Conclusions These results indicate a specific role for CCL21/CCR7 in promoting EMT and metastasis in CD133(+) pancreatic cancer stem-like cells. Furthermore the data also indicated the potential importance of developing therapeutic strategies targeting cancer stem-like cells and CCL21/CCR7 for reducing metastasis.	[Zhang, Lirong; Wang, Dongqing; Li, Yumei; Xie, Xiaodong; Wu, Yingying; Zhou, Yuepeng; Ren, Jing; Zhang, Jianxin; Zhu, Haitao] Jiangsu Univ, Affiliated Hosp, Dept Radiol, Zhenjiang 212001, Peoples R China; [Su, Zhaoliang] Jiangsu Univ, Dept Immunol, Zhenjiang 212013, Peoples R China; [Liu, Yanfang] First Peoples Hosp Zhenjiang, Dept Cent Lab, Zhenjiang 212001, Peoples R China	Jiangsu University; Jiangsu University	Su, ZL (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Radiol, Zhenjiang 212001, Peoples R China.	wangdongqing71@163.com; zhht25@163.com; szl30@yeah.net	zhu, HAITAO/GVL-0589-2022; liu, yan/HCI-5542-2022; Zhang, Li/GWM-7501-2022; liu, yan/HGV-1365-2022; SU, Zhaoliang/ABD-9062-2021	SU, Zhaoliang/0000-0002-5998-5575	National Natural Science Foundation of China [81170573, 81502663, 81573053]; Natural Science Foundation of Jiangsu Province [BK2011487, BE2015668]; Social Development Foundation of Zhen jiang City [SH2013026, SH2014053, SH2015053]; Natural Science Foundation of Colleges and Universities in Jiangsu Province [14KJD310001]; Clinical Medicine Foundation of Jiangsu University [JDLCZX005]; Province in Jiangsu "six adults just" high peak [2013-WSN-002]; Key laboratory of Zhenjiang City [SS2013017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhen jiang City; Natural Science Foundation of Colleges and Universities in Jiangsu Province; Clinical Medicine Foundation of Jiangsu University; Province in Jiangsu "six adults just" high peak; Key laboratory of Zhenjiang City	This study was supported by grants from the National Natural Science Foundation of China (81170573, 81502663, 81573053), the Natural Science Foundation of Jiangsu Province (BK2011487, BE2015668), the Social Development Foundation of Zhen jiang City (SH2013026, SH2014053, SH2015053), Natural Science Foundation of Colleges and Universities in Jiangsu Province (14KJD310001), Clinical Medicine Foundation of Jiangsu University (JDLCZX005), Province in Jiangsu "six adults just" high peak (2013-WSN-002), and Key laboratory of Zhenjiang City (SS2013017).	Bonecchi R, 2009, FRONT BIOSCI-LANDMRK, V14, P540, DOI 10.2741/3261; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Fessler E, 2013, CANCER LETT, V341, P97, DOI 10.1016/j.canlet.2012.10.015; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Hafez H Z Abdel, 2008, Indian J Dermatol, V53, P206, DOI 10.4103/0019-5154.44806; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirao M, 2000, CANCER RES, V60, P2209; Hwang TL, 2012, WORLD J GASTROENTERO, V18, P1249, DOI 10.3748/wjg.v18.i11.1249; Irmisch A, 2013, EXP CELL RES, V319, P1604, DOI 10.1016/j.yexcr.2013.02.012; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Karamitopoulou E, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00209; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; Kodama J, 2007, ANN ONCOL, V18, P70, DOI 10.1093/annonc/mdl342; Lee HJ, 2011, J KOREAN SURG SOC, V81, P263, DOI 10.4174/jkss.2011.81.4.263; Lee SJ, 2010, PHYTOTHER RES, V24, P1870, DOI 10.1002/ptr.3214; Liu LF, 2012, J PINEAL RES, V53, P60, DOI 10.1111/j.1600-079X.2011.00971.x; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mashino K, 2002, CANCER RES, V62, P2937; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Prasad R, 2013, CANCER LETT, V334, P118, DOI 10.1016/j.canlet.2012.08.003; Ramani P, 2012, VIRCHOWS ARCH, V460, P183, DOI 10.1007/s00428-011-1190-y; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Shin SJ, 2005, JPN J CLIN ONCOL, V35, P342, DOI 10.1093/jjco/hyi094; Smith HA, 2013, J MOL MED, V91, P411, DOI 10.1007/s00109-013-1021-5; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu KM, 2011, J BIOL CHEM, V286, P2132, DOI 10.1074/jbc.M110.148395; Xu X, 2014, SCAND J IMMUNOL, V79, P386, DOI 10.1111/sji.12174; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu SY, 2008, CANCER BIOL THER, V7, P1037	38	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0158529	10.1371/journal.pone.0158529	http://dx.doi.org/10.1371/journal.pone.0158529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505247	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200002
J	Sato, W; Sawada, R; Kubota, Y; Toichi, M; Fushiki, T				Sato, Wataru; Sawada, Reiko; Kubota, Yasutaka; Toichi, Motomi; Fushiki, Tohru			Unconscious Affective Responses to Food	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTION; IMAGES; ACTIVATION; MOTIVATION; ATTENTION; AWARENESS; BEHAVIOR; MOOD; NEED	Affective or hedonic responses to food are crucial for humans, both advantageously (e.g., enhancing survival) and disadvantageously (e.g., promoting overeating and lifestyle-related disease). Although previous psychological studies have reported evidence of unconscious cognitive and behavioral processing related to food, it remains unknown whether affective reactions to food can be triggered unconsciously and its relationship with daily eating behaviors. We investigated these issues by using the subliminal affective priming paradigm. Photographs of food or corresponding mosaic images were presented in the peripheral visual field for 33 ms. Target photos of faces with emotionally neutral expressions were then presented, and participants rated their preferences for the faces. Eating behaviors were also assessed using questionnaires. The food images, relative to the mosaics, increased participants' preference for subsequent target faces. Furthermore, the difference in the preference induced by food versus mosaic images was positively correlated with the tendency to engage in external eating. These results suggest that unconscious affective reactions are elicited by the sight of food and that these responses contribute to daily eating behaviors related to overeating.	[Sato, Wataru; Sawada, Reiko] Kyoto Univ, Grad Sch Med, Dept Neurodev Psychiat Habilitat & Rehabil, Sakyo Ku, 53 Shogoin Kawaharacho, Kyoto 6068507, Japan; [Kubota, Yasutaka] Shiga Univ, Hlth & Med Serv Ctr, 1-1-1 Baba, Hikone, Shiga 5228522, Japan; [Toichi, Motomi] Kyoto Univ, Grad Sch Med, Fac Human Hlth Sci, Sakyo Ku, 53 Shogoin Kawaharacho, Kyoto 6068507, Japan; [Toichi, Motomi] Org Promoting Neurodev Disorder Res, Sakyo Ku, 40 Shogoin Sannocho, Kyoto 6068392, Japan; [Fushiki, Tohru] Ryukoku Univ, Fac Agr, 1-5 Seta Oe Cho Koya, Otsu, Shiga 5202194, Japan	Kyoto University; Shiga University; Kyoto University; Ryukoku University	Sato, W (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurodev Psychiat Habilitat & Rehabil, Sakyo Ku, 53 Shogoin Kawaharacho, Kyoto 6068507, Japan.	sato.wataru.4v@kyoto-u.ac.jp	Sato, Wataru/E-7503-2017	Sato, Wataru/0000-0002-5335-1272	Project of the NARO Bio-oriented Technology Research Advancement Institution (Integration research for agriculture and interdisciplinary fields, Japan)	Project of the NARO Bio-oriented Technology Research Advancement Institution (Integration research for agriculture and interdisciplinary fields, Japan)	This study was supported by grants from the Project of the NARO Bio-oriented Technology Research Advancement Institution (Integration research for agriculture and interdisciplinary fields, Japan). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Bornemann B, 2012, INT J PSYCHOPHYSIOL, V85, P116, DOI 10.1016/j.ijpsycho.2011.04.007; Brignell C, 2009, APPETITE, V52, P299, DOI 10.1016/j.appet.2008.10.007; Brooks SJ, 2012, CONSCIOUS COGN, V21, P751, DOI 10.1016/j.concog.2012.02.006; Burton P, 2007, APPETITE, V49, P191, DOI 10.1016/j.appet.2007.01.007; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Eastwood JD, 2005, CONSCIOUS COGN, V14, P565, DOI 10.1016/j.concog.2005.01.001; ERIKSEN CW, 1960, PSYCHOL REV, V67, P279, DOI 10.1037/h0041622; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Gearhardt AN, 2012, EAT BEHAV, V13, P371, DOI 10.1016/j.eatbeh.2012.07.004; Hepworth R, 2010, APPETITE, V54, P134, DOI 10.1016/j.appet.2009.09.019; Hou RH, 2011, APPETITE, V56, P424, DOI 10.1016/j.appet.2011.01.019; IMADA S, 1994, HIROSHIMA SYUDAI RON, V34, P281; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; Larsen JK, 2007, APPETITE, V49, P100, DOI 10.1016/j.appet.2006.12.005; Lundy RF, 2008, NEUROSCI BIOBEHAV R, V32, P1601, DOI 10.1016/j.neubiorev.2008.07.002; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Nummenmaa L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019215; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Passamonti L, 2009, J NEUROSCI, V29, P43, DOI 10.1523/JNEUROSCI.4966-08.2009; PERYAM DR, 1957, FOOD TECHNOL-CHICAGO, V11, P32; Rodriguez S, 2005, BIOL PSYCHOL, V70, P9, DOI 10.1016/j.biopsycho.2004.10.001; Sato W, 2006, BRAIN COGNITION, V62, P261, DOI 10.1016/j.bandc.2006.06.006; Schiff BB, 1995, BRAIN COGNITION, V29, P217, DOI 10.1006/brcg.1995.1279; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Sorensen LB, 2003, INT J OBESITY, V27, P1152, DOI 10.1038/sj.ijo.0802391; Suslow T, 2013, PSYCHIAT RES-NEUROIM, V211, P239, DOI 10.1016/j.pscychresns.2012.09.008; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Yeomans MR, 2004, BRIT J NUTR, V92, pS3, DOI 10.1079/BJN20041134; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zhong CB, 2010, PSYCHOL SCI, V21, P619, DOI 10.1177/0956797610366090; Ziauddeen H, 2012, INT J OBESITY, V36, P1245, DOI 10.1038/ijo.2011.239	36	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160956	10.1371/journal.pone.0160956	http://dx.doi.org/10.1371/journal.pone.0160956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IE	27501443	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500069
J	Simard, P; Wall, KR; Mann, DA; Wall, CC; Stallings, CD				Simard, Peter; Wall, Kara R.; Mann, David A.; Wall, Carrie C.; Stallings, Christopher D.			Quantification of Boat Visitation Rates at Artificial and Natural Reefs in the Eastern Gulf of Mexico Using Acoustic Recorders	PLOS ONE			English	Article							FLORIDA	Artificial reefs are commonly used as a management tool, in part to provide ecosystem services, including opportunities for recreational fishing and diving. Quantifying the use of artificial reefs by recreational boaters is essential for determining their value as ecosystem services. In this study, four artificial-natural reef pairs in the eastern Gulf of Mexico (off western Florida) were investigated for boat visitation rates using autonomous acoustic recorders. Digital SpectroGram (DSG) recorders were used to collect sound files from April 2013 to March 2015. An automatic detection algorithm was used to identify boat noise in individual files using the harmonic peaks generated by boat engines, and by comparing the sound amplitude of each file with surrounding files. In all four pairs, visitation rates were significantly higher at the artificial reef than the natural reef. This increase in boat visitation was likely due to actual or perceived increased quality of fishing and diving at the artificial reefs, or to lack of knowledge of the presence or locations of the natural reefs. Inshore reefs (< 15 m depth) had high variability in monthly visitation rates, which were generally highest in warmer months. However the seasonal signal was dampened on offshore reefs (> 25 m depth). This study appears to be the first to use acoustic data to measure participant use of boating destinations, and highlights the utility of acoustic monitoring for the valuation of this important ecosystem service provided by artificial reefs.	[Simard, Peter; Wall, Kara R.; Stallings, Christopher D.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Mann, David A.] Loggerhead Instruments, Sarasota, FL USA; [Wall, Carrie C.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Simard, Peter] Eckerd Coll, St Petersburg, FL 33733 USA	State University System of Florida; University of South Florida; University of Colorado System; University of Colorado Boulder	Simard, P (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.; Simard, P (corresponding author), Eckerd Coll, St Petersburg, FL 33733 USA.	simardpa@eckerd.edu		Stallings, Christopher/0000-0002-3410-4540	Florida Fish and Wildlife Conservation Commission, Artificial Reef Program [FWC 183, FWC-184 12164]	Florida Fish and Wildlife Conservation Commission, Artificial Reef Program	Funding was provided to authors CS and PS by the Florida Fish and Wildlife Conservation Commission, Artificial Reef Program using state saltwater fishing license revenues (FWC 183 Agreement No. FWC-184 12164). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. DM is president of Loggerhead Instruments, which manufactures for commercial sale the acoustic recorders used in this study. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. Loggerhead Instruments did not provide any funding for this work, and had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abileah R, 1996, OCEANS '96 MTS/IEEE, CONFERENCE PROCEEDINGS, VOLS 1-3 / SUPPLEMENTARY PROCEEDINGS, P378, DOI 10.1109/OCEANS.1996.572776; Au W. W., 1993, SONAR DOLPHINS; Barlett M.L., 2002, J ACOUST SOC AM, V112, P2221, DOI [10.1121/1.4778778, DOI 10.1121/1.4778778]; Bohnenstiehl DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143691; BOHNSACK JA, 1989, B MAR SCI, V44, P631; Bunin B, 2008, P SOC PHOTO-OPT INS, V6945, P94514, DOI 10.1117/12.779176; Ditton RB, 2002, ICES J MAR SCI, V59, pS186, DOI 10.1006/jmsc.2002.1188; Ferguson BG, 2001, J ACOUST SOC AM, V109, P3031, DOI 10.1121/1.1339823; Frankel AS, 2014, J ACOUST SOC AM, V135, P1624, DOI 10.1121/1.4863304; Grossman GD, 1997, FISHERIES, V22, P17, DOI 10.1577/1548-8446(1997)022<0017:DARIRF>2.0.CO;2; Huth B, 2015, MEASURING FLORIDA AR; Lammers MO, 2008, J ACOUST SOC AM, V123, P1720, DOI 10.1121/1.2836780; Leeworthy VR, 2006, B MAR SCI, V78, P29; Leeworthy VR, 2011, EC IMPACT USS VANDEN; Locascio JV, 2008, T AM FISH SOC, V137, P606, DOI 10.1577/T06-069.1; Lurton X., 2002, INTRO UNDERWATER ACO; Malme CI, 1989, 6945 US DEP INT MIN; Mathews HH, 2015, FWC13251; Ogden GL, 2011, J ACOUST SOC AM, V129, P3768, DOI 10.1121/1.3583500; Schuett MA, 2015, ATTITUDES BEHAV MANA, DOI DOI 10.13140/RG.2.1.2778.3208; Sidman C, 2004, TP130 FLOR SEA GRANT; Simard P, 2015, FWC12164; Simard P, 2015, AQUAT MAMM, V41, P167, DOI 10.1578/AM.41.2.2015.167; Simmonds M., 2004, OCEANS OF NOISE 2004; Sorensen EP, 2010, POSTCOLONIAL STUDIES AND THE LITERARY: THEORY, INTERPRETATION AND THE NOVEL, P1, DOI 10.1057/9780230277595; Stolk P, 2005, ANN LEIS RES, V8, P153, DOI 10.1080/11745398.2005.10600968; Swett RA, 2011, TP178 FLOR SEA GRANT; Tesei A, 2011, P SYMPOL KOCH IND NO; Wall CC, 2013, MAR ECOL PROG SER, V484, P173, DOI 10.3354/meps10268; WALL CC, 2012, THE EFFECTS OF NOISE, P403, DOI DOI 10.1007/978-1-4419-7311-5_92	30	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160695	10.1371/journal.pone.0160695	http://dx.doi.org/10.1371/journal.pone.0160695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500533	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500045
J	Park, SY; Lee, HR; Lee, WS; Shin, HK; Kim, HY; Hong, KW; Kim, CD				Park, So Youn; Lee, Hye Rin; Lee, Won Suk; Shin, Hwa Kyoung; Kim, Hye Young; Hong, Ki Whan; Kim, Chi Dae			Cilostazol Modulates Autophagic Degradation of beta-Amyloid Peptide via SIRT1-Coupled LKB1/AMPK alpha Signaling in Neuronal Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FOCAL CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; COGNITIVE DEFICITS; MAMMALIAN TARGET; MOUSE MODEL; SIRT1; NEUROPATHOLOGY; MTOR	A neuroprotective role of autophagy mediates the degradation of beta-amyloid peptide (A beta) in Alzheimer's disease (AD). The previous study showed cilostazol modulates autophagy by increasing beclin1, Atg5 and LC3-II expressions, and depletes intracellular A beta accumulation. This study elucidated the mechanisms through which cilostazolmodulates the autophagic degradation of A beta in neurons. In N2a cells, cilostazol (10-30 mu M), significantly increased the expression of P-AMPK alpha (Thr 172) and downstream P-ACC (acetyl-CoA carboxylase) (Ser 79) as did resveratrol (SIRT1 activator), or AICAR (AMPK activator), which were blocked by KT5720, compound C (AMPK inhibitor), or sirtinol. Furthermore, phosphorylated-mTOR (Ser 2448) and phosphorylated-P70S6K (Thr 389) expressions were suppressed, and LC3-II levels were elevated in association with decreased P62/Sqstm1 by cilostazol. Cilostazol increased cathepsin B activity and decreased p62/SQSTM 1, consequently decreased accumulation of A beta 1-42 in the activated N2aSwe cells, and these results were blocked by sirtinol, compound C and bafilomycin A1 (autophagosome blocker), suggesting enhanced autophagosome formation by cilostazol. In SIRT1 gene-silenced N2a cells, cilostazol failed to increase the expressions of P-LKB1 (Ser 428) and P-AMPKa, which contrasted with its effect in negative control cells transfected with scrambled siRNA duplex. Further, N2a cells transfected with expression vectors encoding pcDNA SIRT1 showed increased P-AMPKa expression, which mimicked the effect of cilostazol in N2a cells; suggesting cilostazol-stimulated expressions of P-LKB1 and P-AMPKa were SIRT1-dependent. Unlike their effects in N2a cells, in HeLa cells, which lack LKB1, cilostazol and resveratrol did not elevate SIRT1 or P-AMPKa expression, indicating cilostazol and resveratrol-stimulated expressions of SIRT1 and P-AMPKa are LKB1-dependent. In conclusion, cilostazol upregulates autophagy by activating SIRT1-coupled P-LKB1/P-AMPK alpha and inhibiting mTOR activation, thereby decreasing A beta accumulation.	[Park, So Youn; Lee, Won Suk; Kim, Chi Dae] Pusan Natl Univ, Sch Korean Med, Dept Pharmacol, Gyeongsangnam Do 50612, South Korea; [Park, So Youn; Lee, Hye Rin; Kim, Hye Young; Hong, Ki Whan; Kim, Chi Dae] Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongsangnam Do 50612, South Korea; [Shin, Hwa Kyoung] Pusan Natl Univ, Div Meridian & Struct Med, Gyeongsangnam Do 50612, South Korea	Pusan National University; Pusan National University; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Sch Korean Med, Dept Pharmacol, Gyeongsangnam Do 50612, South Korea.; Kim, CD (corresponding author), Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongsangnam Do 50612, South Korea.	chidkim@pusan.ac.kr			National Research Foundation of Korea [NRF-2013R1A1A2057741]; Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2015R1A5A2009656]	National Research Foundation of Korea(National Research Foundation of Korea); Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF-2013R1A1A2057741) and the Medical Research Center (MRC) Program through the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A5A2009656).	Anekonda TS, 2011, J ALZHEIMERS DIS, V23, P21, DOI 10.3233/JAD-2010-101287; Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hung SY, 2009, AUTOPHAGY, V5, P502, DOI 10.4161/auto.5.4.8096; Ihara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089516; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; KIMURA Y, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1144; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Lee H.H., 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0134486; Lee HR, 2014, J NEUROSCI RES, V92, P206, DOI 10.1002/jnr.23310; Lee JH, 2008, CNS NEUROSCI THER, V14, P143, DOI 10.1111/j.1527-3458.2008.00042.x; Lee JH, 2004, J PHARMACOL EXP THER, V308, P896, DOI 10.1124/jpet.103.061853; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Park SH, 2011, BIOCHEM BIOPH RES CO, V408, P602, DOI 10.1016/j.bbrc.2011.04.068; Patel NV, 2005, NEUROBIOL AGING, V26, P995, DOI 10.1016/j.neurobiolaging.2004.09.014; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Sakurai H, 2013, GERIATR GERONTOL INT, V13, P90, DOI 10.1111/j.1447-0594.2012.00866.x; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Taguchi A, 2013, PSYCHOGERIATRICS, V13, P164, DOI 10.1111/psyg.12021; Vingtdeux V, 2011, FASEB J, V25, P219, DOI 10.1096/fj.10-167361; Wang J, 2005, FASEB J, V19, P659, DOI 10.1096/fj.04-3182fje; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	38	42	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160620	10.1371/journal.pone.0160620	http://dx.doi.org/10.1371/journal.pone.0160620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494711	Green Published, gold, Green Submitted			2022-12-26	WOS:000381369500066
J	Qin, DZ; Wang, XH; Li, YT; Yang, LW; Wang, RT; Peng, JT; Essandoh, K; Mu, XJ; Peng, TQ; Han, QH; Yu, KJ; Fan, GC				Qin, Dongze; Wang, Xiaohong; Li, Yutian; Yang, Liwang; Wang, Ruitao; Peng, Jiangtong; Essandoh, Kobina; Mu, Xingjiang; Peng, Tianqing; Han, Qinghua; Yu, Kai-Jiang; Fan, Guo-Chang			MicroRNA-223-5p and-3p Cooperatively Suppress Necroptosis in Ischemic/Reperfused Hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammasome; ischemia; microRNA (miRNA); myocardial infarction; necrosis (necrotic death)	ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL ISCHEMIA/REPERFUSION INJURY; FACTOR-KAPPA-B; NLRP3 INFLAMMASOME; CELL-DEATH; IN-VIVO; NECROSIS; RECEPTOR; INHIBITION; PROTECTS	Recent studies have shown that myocardial ischemia/reperfusion (I/R)-induced necrosis can be controlled by multiple genes. In this study, we observed that both strands (5p and 3p) of miR-223 were remarkably dysregulated in mouse hearts upon I/R. Precursor miR-223 (pre-miR-223) transgenic mouse hearts exhibited better recovery of contractile performance over reperfusion period and lesser degree of myocardial necrosis than wild type hearts upon ex vivo and in vivo myocardial ischemia. Conversely, pre-miR-223 knock-out (KO) mouse hearts displayed opposite effects. Furthermore, we found that the RIP1/RIP3/MLKL necroptotic pathway and inflammatory response were suppressed in transgenic hearts, whereas they were activated in pre-miR-223 KO hearts upon I/R compared with wild type controls. Accordingly, treatment of pre-miR-223 KO mice with necrostatin-1s, a potent necroptosis inhibitor, significantly decreased I/R-triggered cardiac necroptosis, infarction size, and dysfunction. Mechanistically, we identified two critical cell death receptors, TNFR1 and DR6, as direct targets of miR-223-5p, whereas miR-223-3p directly suppressed the expression of NLRP3 and IB kinase , two important mediators known to be involved in I/R-induced inflammation and cell necroptosis. Our findings indicate that miR-223-5p/-3p duplex works together and cooperatively inhibits I/R-induced cardiac necroptosis at multiple layers. Thus, pre-miR-223 may constitute a new therapeutic agent for the treatment of ischemic heart disease.	[Qin, Dongze; Han, Qinghua] Shanxi Med Univ, Dept Cardiol, Hosp 1, Taiyuan 030001, Shanxi, Peoples R China; [Qin, Dongze; Wang, Xiaohong; Li, Yutian; Yang, Liwang; Peng, Jiangtong; Essandoh, Kobina; Mu, Xingjiang; Fan, Guo-Chang] Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA; [Wang, Ruitao; Yu, Kai-Jiang] Harbin Med Univ, Dept Intens Care Unit, Affiliated Hosp 3, Harbin 150081, Heilongjiang, Peoples R China; [Peng, Tianqing] Lawson Hlth Res Inst, Crit Illness Res, London, ON N6A 4G5, Canada	Shanxi Medical University; University System of Ohio; University of Cincinnati; Harbin Medical University; Western University (University of Western Ontario)	Fan, GC (corresponding author), Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	fangg@ucmail.uc.edu	Fan, Guo-Chang/E-1153-2012; Peng, Tianqing/G-3340-2011	Fan, Guo-Chang/0000-0002-0439-8277; Han, Qinghua/0000-0002-9099-2327; Li, Yutian/0000-0002-5118-0916	National Institutes of Health [HL-087861, GM-112930]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants HL-087861 and GM-112930 (to G.-C. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Benschop R, 2009, ADV EXP MED BIOL, V647, P186, DOI 10.1007/978-0-387-89520-8_13; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dmitriev YV, 2013, B EXP BIOL MED+, V155, P245; Essandoh K, 2016, SHOCK, V46, P122, DOI 10.1097/SHK.0000000000000604; Flaherty MP, 2008, J MOL CELL CARDIOL, V45, P735, DOI 10.1016/j.yjmcc.2008.08.014; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Gershlick AH, 2013, LANCET, V382, P624, DOI 10.1016/S0140-6736(13)61454-3; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hu R, 2014, FEBS LETT, V588, P401, DOI 10.1016/j.febslet.2013.12.010; Kang TB, 2014, METHOD ENZYMOL, V545, P67, DOI 10.1016/B978-0-12-801430-1.00003-2; Konstantinidis K, 2012, ARTERIOSCL THROM VAS, V32, P1552, DOI 10.1161/ATVBAHA.111.224915; Koshinuma S, 2014, J ANESTH, V28, P235, DOI 10.1007/s00540-013-1716-3; Koudstaal S, 2015, EUR J CLIN INVEST, V45, P150, DOI 10.1111/eci.12391; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Makarov Roman, 2013, Methods Mol Biol, V961, P201, DOI 10.1007/978-1-62703-227-8_12; Malik S, 2011, J CARDIOVASC PHARM, V58, P199, DOI 10.1097/FJC.0b013e31822002a6; Marchetti C, 2015, J CARDIOVASC PHARM, V66, P1, DOI 10.1097/FJC.0000000000000247; Oerlemans MIFJ, 2013, INT J CARDIOL, V165, P410, DOI 10.1016/j.ijcard.2012.03.055; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Taibi F, 2014, BBA-MOL BASIS DIS, V1842, P1001, DOI 10.1016/j.bbadis.2014.03.005; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Vilahur G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00496; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Wang JX, 2015, CIRC RES, V117, P352, DOI 10.1161/CIRCRESAHA.117.305781; Wang K, 2015, CELL DEATH DIFFER, V22, P743, DOI 10.1038/cdd.2014.165; Wang XH, 2014, BBA-MOL BASIS DIS, V1842, P701, DOI 10.1016/j.bbadis.2014.01.012; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Yang LW, 2016, J BIOL CHEM, V291, P15700, DOI 10.1074/jbc.M116.715805; Ye YM, 2010, CARDIOVASC RES, V87, P535, DOI 10.1093/cvr/cvq053; Zhang AB, 2014, TRANSPL INT, V27, P1077, DOI 10.1111/tri.12349; Zhang T, 2016, NAT MED, V22, P175, DOI 10.1038/nm.4017; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291; Zingarelli B, 2002, SHOCK, V17, P127, DOI 10.1097/00024382-200202000-00008	43	93	95	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20247	20259		10.1074/jbc.M116.732735	http://dx.doi.org/10.1074/jbc.M116.732735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502281	hybrid, Green Published			2022-12-26	WOS:000383243100043
J	Magini, D; Giovani, C; Mangiavacchi, S; Maccari, S; Cecchi, R; Ulmer, JB; De Gregorio, E; Geall, AJ; Brazzoli, M; Bertholet, S				Magini, Diletta; Giovani, Cinzia; Mangiavacchi, Simona; Maccari, Silvia; Cecchi, Raffaella; Ulmer, Jeffrey B.; De Gregorio, Ennio; Geall, Andrew J.; Brazzoli, Michela; Bertholet, Sylvie			Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge	PLOS ONE			English	Article							CD8(+) T-CELLS; A VIRUS; SEASONAL INFLUENZA; PANDEMIC INFLUENZA; NONVIRAL DELIVERY; ANTIBODY-RESPONSE; YOUNG-CHILDREN; M-GENE; MICE; DNA	Current hemagglutinin (HA)-based seasonal influenza vaccines induce vaccine strain-specific neutralizing antibodies that usually fail to provide protection against mismatched circulating viruses. Inclusion in the vaccine of highly conserved internal proteins such as the nucleoprotein (NP) and the matrix protein 1 (M1) was shown previously to increase vaccine efficacy by eliciting cross-reactive T-cells. However, appropriate delivery systems are required for efficient priming of T-cell responses. In this study, we demonstrated that administration of novel self-amplifying mRNA (SAM (R)) vectors expressing influenza NP (SAM (NP)), M1 (SAM(M1)), and NP and M1 (SAM(M1-NP)) delivered with lipid nanoparticles (LNP) induced robust polyfunctional CD4 T helper 1 cells, while NP-containing SAM also induced cytotoxic CD8 T cells. Robust expansions of central memory (T-CM) and effector memory (T-EM) CD4 and CD8 T cells were also measured. An enhanced recruitment of NP-specific cytotoxic CD8 T cells was observed in the lungs of SAM(NP)-immunized mice after influenza infection that paralleled with reduced lung viral titers and pathology, and increased survival after homologous and heterosubtypic influenza challenge. Finally, we demonstrated for the first time that the co-administration of RNA (SAM(M1-NP)) and protein (monovalent inactivated influenza vaccine (MIIV)) was feasible, induced simultaneously NP-, M1- and HA-specific T cells and HA-specific neutralizing antibodies, and enhanced MIIV efficacy against a heterologous challenge. In conclusion, systemic administration of SAM vectors expressing conserved internal influenza antigens induced protective immune responses in mice, supporting the SAM (R) platform as another promising strategy for the development of broad-spectrum universal influenza vaccines.	[Magini, Diletta; Giovani, Cinzia; Mangiavacchi, Simona; Maccari, Silvia; Cecchi, Raffaella; De Gregorio, Ennio; Brazzoli, Michela; Bertholet, Sylvie] Novartis Vaccines Srl, Siena, Italy; [Magini, Diletta] Univ Siena, Dipartimento Biotecnol Chim & Farm, Siena, Italy; [Ulmer, Jeffrey B.; Geall, Andrew J.] Novartis Vaccines Inc, Cambridge, MA USA; [Magini, Diletta] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Giovani, Cinzia; Mangiavacchi, Simona; Maccari, Silvia; Cecchi, Raffaella; De Gregorio, Ennio; Brazzoli, Michela; Bertholet, Sylvie] GSK Vaccines Srl, Siena, Italy; [Ulmer, Jeffrey B.] GSK Vaccines Inc, Cambridge, MA USA; [Geall, Andrew J.] Avid NanoMed LLC, San Diego, CA USA	Novartis; University of Siena; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; GlaxoSmithKline; GlaxoSmithKline	Brazzoli, M (corresponding author), Novartis Vaccines Srl, Siena, Italy.; Brazzoli, M (corresponding author), GSK Vaccines Srl, Siena, Italy.	michela.x.brazzoli@gsk.com		Magini, Diletta/0000-0002-2257-9979	Defense Advanced Research Project Agency [HR0011-12-3-0001]	Defense Advanced Research Project Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work is supported by the Defense Advanced Research Project Agency (HR0011-12-3-0001). AJG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the authors were employed or affiliated with Novartis Vaccines S.r.l. at the time of the study conduct.	Altenburg AF, 2014, VIRUSES-BASEL, V6, P2735, DOI 10.3390/v6072735; Altstein AD, 2006, ARCH VIROL, V151, P921, DOI 10.1007/s00705-005-0676-9; Ansaldi F, 2010, VACCINE, V28, P4123, DOI 10.1016/j.vaccine.2010.04.030; Antrobus RD, 2014, MOL THER, V22, P233, DOI 10.1038/mt.2013.162; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bogers WM, 2015, J INFECT DIS, V211, P947, DOI 10.1093/infdis/jiu522; Brazzoli M, 2016, J VIROL, V90, P332, DOI 10.1128/JVI.01786-15; Brito LA, 2014, MOL THER, V22, P2118, DOI 10.1038/mt.2014.133; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Chen QJ, 2009, VIRUS GENES, V38, P30, DOI 10.1007/s11262-008-0305-2; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cukalac T, 2014, J IMMUNOL, V192, P4061, DOI 10.4049/jimmunol.1301403; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308; Del Giudice G, 2013, EXPERT OPIN BIOL TH, V13, P121, DOI 10.1517/14712598.2013.748030; Donnelly JJ, 1997, VACCINE, V15, P865, DOI 10.1016/S0264-410X(96)00268-X; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Furuya Y, 2012, IMMUNOL CELL BIOL, V90, P571, DOI 10.1038/icb.2011.70; Geall AJ, 2012, P NATL ACAD SCI USA, V109, P14604, DOI 10.1073/pnas.1209367109; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hamm S, 2007, INT IMMUNOL, V19, P297, DOI 10.1093/intimm/dxl146; Hekele A, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.54; Hessel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088340; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Jameson J, 1998, J VIROL, V72, P8682, DOI 10.1128/JVI.72.11.8682-8689.1998; Jelinek I, 2011, J IMMUNOL, V186, P2422, DOI 10.4049/jimmunol.1002845; Jeon SH, 2002, VACCINE, V20, P2772, DOI 10.1016/S0264-410X(02)00187-1; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Jin HL, 2005, BIOCHEM BIOPH RES CO, V328, P979, DOI 10.1016/j.bbrc.2005.01.048; Johansson DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029732; Jungblut M, 2009, JOVE-J VIS EXP, DOI [10.3791/1266, DOI 10.3791/1266]; Kalams SA, 1998, J EXP MED, V188, P2199, DOI 10.1084/jem.188.12.2199; La Gruta NL, 2008, P NATL ACAD SCI USA, V105, P2034, DOI 10.1073/pnas.0711682102; Lambe T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01443; Lazzaro S, 2015, IMMUNOLOGY, V146, P312, DOI 10.1111/imm.12505; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; LIACOPOULOS P, 1975, PROG ALLERGY, V18, P97; Lillie PJ, 2012, CLIN INFECT DIS, V55, P19, DOI 10.1093/cid/cis327; Maisonneuve C, 2014, P NATL ACAD SCI USA, V111, P12294, DOI 10.1073/pnas.1400478111; Manoj S, 2003, VIROLOGY, V313, P296, DOI 10.1016/S0042-6822(03)00325-8; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; MORRISON J, 1992, EUR J IMMUNOL, V22, P903, DOI 10.1002/eji.1830220404; Mullarkey CE, 2013, EUR J IMMUNOL, V43, P1940, DOI 10.1002/eji.201242922; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Orsi A, 2013, HUM VACC IMMUNOTHER, V9, P582, DOI 10.4161/hv.23239; Perri S, 2003, J VIROL, V77, P10394, DOI 10.1128/JVI.77.19.10394-10403.2003; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soema PC, 2015, EUROPEAN J PHARM BIO; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Szewczyk B, 2014, ACTA BIOCHIM POL, V61, P397; Tamura S, 1996, J IMMUNOL, V156, P3892; Uematsu Y, 2012, CLIN VACCINE IMMUNOL, V19, P991, DOI 10.1128/CVI.00031-12; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Ulmer JB, 1998, J VIROL, V72, P5648, DOI 10.1128/JVI.72.7.5648-5653.1998; Wang WL, 2015, CLIN VACCINE IMMUNOL, V22, P618, DOI 10.1128/CVI.00091-15; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zaritskaya L, 2010, EXPERT REV VACCINES, V9, P601, DOI [10.1586/erv.10.49, 10.1586/ERV.10.49]; Zhirnov OP, 2007, INFLUENZA OTHER RESP, V1, P71, DOI 10.1111/j.1750-2659.2007.00010.x	67	70	104	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161193	10.1371/journal.pone.0161193	http://dx.doi.org/10.1371/journal.pone.0161193			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525409	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100042
J	Dilg, D; Saleh, RNM; Phelps, SEL; Rose, Y; Dupays, L; Murphy, C; Mohun, T; Anderson, RH; Scambler, PJ; Chapgier, ALA				Dilg, Daniel; Saleh, Rasha Noureldin M.; Phelps, Sarah Elizabeth Lee; Rose, Yoann; Dupays, Laurent; Murphy, Cian; Mohun, Timothy; Anderson, Robert H.; Scambler, Peter J.; Chapgier, Ariane L. A.			HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3	PLOS ONE			English	Article							SYNDROME CANDIDATE GENE; HISTONE CHAPERONE; CHROMATIN; H3.3; TRANSCRIPTION; SKELETAL; NKX2-5; SUPPRESSION; DEFECTS; COMPLEX	Chromatin remodelling is essential for cardiac development. Interestingly, the role of histone chaperones has not been investigated in this regard. HIRA is a member of the HUCA (HIRA/ UBN1/CABIN1/ASF1a) complex that deposits the variant histone H3.3 on chromatin independently of replication. Lack of HIRA has general effects on chromatin and gene expression dynamics in embryonic stem cells and mouse oocytes. Here we describe the conditional ablation of Hira in the cardiogenic mesoderm of mice. We observed surface oedema, ventricular and atrial septal defects and embryonic lethality. We identified dysregulation of a subset of cardiac genes, notably upregulation of troponins Tnni2 and Tnnt3, involved in cardiac contractility and decreased expression of Epha3, a gene necessary for the fusion of the muscular ventricular septum and the atrioventricular cushions. We found that HIRA binds GAGA rich DNA loci in the embryonic heart, and in particular a previously described enhancer of Tnni2/Tnnt3 (TTe) bound by the transcription factor NKX2.5. HIRA-dependent H3.3 enrichment was observed at the TTe in embryonic stem cells (ESC) differentiated toward cardiomyocytes in vitro. Thus, we show here that HIRA has locus-specific effects on gene expression and that histone chaperone activity is vital for normal heart development, impinging on pathways regulated by an established cardiac transcription factor.	[Dilg, Daniel; Saleh, Rasha Noureldin M.; Phelps, Sarah Elizabeth Lee; Rose, Yoann; Scambler, Peter J.; Chapgier, Ariane L. A.] UCL, Inst Child Hlth, Dev Biol Birth Defects Sect, 30 Guilford St, London WC1N 1EH, England; [Saleh, Rasha Noureldin M.; Mohun, Timothy] Univ Alexandria, Fac Med, El Gaish Rd, Alexandria, Egypt; [Dupays, Laurent] Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Murphy, Cian] UCL, UGI, Dept Genet Environm & Evolut, Gower St, London WC1E 6BT, England; [Anderson, Robert H.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Cent Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of London; University College London; Egyptian Knowledge Bank (EKB); Alexandria University; University of London; University College London; Newcastle University - UK	Scambler, PJ (corresponding author), UCL, Inst Child Hlth, Dev Biol Birth Defects Sect, 30 Guilford St, London WC1N 1EH, England.	p.scambler@ucl.ac.uk	Scambler, Peter/AAZ-6026-2020; Dupays, Laurent/HGU-2621-2022; Murphy, Cian/N-4343-2019	Scambler, Peter/0000-0002-1487-4628; Murphy, Cian/0000-0003-1356-959X; Chapgier, Ariane/0000-0002-1734-0744	British Heart Foundation [RG/15/14/31880, FS/11/83/29333, FS/10/031/28395]; Fondation Leducq (FR) [TNE 15CVD01]; National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; National Institute for Health Research Biomedical Research Centre at University College London; Biotechnology and Biological Sciences Research Council [BB/E009603/1] Funding Source: researchfish; British Heart Foundation [PG/15/6/31211, FS/10/31/28395] Funding Source: researchfish; The Francis Crick Institute [10117] Funding Source: researchfish; BBSRC [BB/E009603/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Fondation Leducq (FR)(Leducq Foundation); National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust; National Institute for Health Research Biomedical Research Centre at University College London; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); The Francis Crick Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by British Heart Foundation (grants RG/15/14/31880; FS/11/83/29333 (PJS); and FS/10/031/28395 (ALAC)), Fondation Leducq (FR) grant TNE 15CVD01 (PJS), and supported by the National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust and University College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins NL, 2006, BIOCHEM CELL BIOL, V84, P559, DOI 10.1139/O06-062; Ahmad A, 2003, BIOCHEM BIOPH RES CO, V312, P1266, DOI 10.1016/j.bbrc.2003.11.073; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Anderson RH, 2016, CLIN ANAT, V29, P290, DOI 10.1002/ca.22627; Banaszynski LA, 2013, CELL, V155, P107, DOI 10.1016/j.cell.2013.08.061; Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bible PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127285; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bouveret R, 2015, ELIFE, V4, DOI 10.7554/eLife.06942; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Dupays L, 2015, CELL REP, V13, P183, DOI 10.1016/j.celrep.2015.08.065; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; Farrell MJ, 1999, CIRC RES, V84, P127, DOI 10.1161/01.RES.84.2.127; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moorman A, 2003, HEART, V89, P806, DOI 10.1136/heart.89.7.806; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Nakayama T, 2012, DEVELOPMENT, V139, P4582, DOI 10.1242/dev.083246; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Ochala J, 2008, J MOL MED-JMM, V86, P1197, DOI 10.1007/s00109-008-0380-9; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Rai TS, 2014, GENE DEV, V28, P2712, DOI 10.1101/gad.247528.114; Ramsbottom SA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004871; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Stephen LJ, 2007, DEV BIOL, V302, P66, DOI 10.1016/j.ydbio.2006.08.058; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137797; Wang Xiang, 2008, J Vis Exp, DOI 10.3791/825; Wang Xiaohua, 2014, Zhonghua Yi Xue Za Zhi, V94, P1223; Watanabe Y, 2006, DEVELOPMENT, V133, P1625, DOI 10.1242/dev.02344; Wilming LG, 1997, HUM MOL GENET, V6, P247, DOI 10.1093/hmg/6.2.247; Zhang L, 2014, DEV BIOL, V390, P68, DOI 10.1016/j.ydbio.2014.02.023	45	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161096	10.1371/journal.pone.0161096	http://dx.doi.org/10.1371/journal.pone.0161096			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518902	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000381382100047
J	van Kuijk, SJA; Gieling, RG; Niemans, R; Lieuwes, NG; Biemans, R; Telfer, BA; Haenen, GRMM; Yaromina, A; Lambin, P; Dubois, LJ; Williams, KJ				van Kuijk, Simon J. A.; Gieling, Roben G.; Niemans, Raymon; Lieuwes, Natasja G.; Biemans, Rianne; Telfer, Brian A.; Haenen, Guido R. M. M.; Yaromina, Ala; Lambin, Philippe; Dubois, Ludwig J.; Williams, Kaye J.			The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; TUMOR HYPOXIA; FRACTIONATED-IRRADIATION; CHEMOTHERAPEUTIC-AGENTS; BREAST-CANCER; IN-VITRO; PH; EXPRESSION; MARKERS; MICROENVIRONMENT	Carbonic anhydrase IX (CAIX) is a tumor-specific protein that is upregulated during hypoxic conditions where it is involved in maintaining the pH balance. CAIX causes extracellular acidification, thereby limiting the uptake of weak basic chemotherapeutic agents, such as doxorubicin, and decreasing its efficacy. The aim of this study was to determine if doxorubicin efficacy can be increased when combined with the selective sulfamate CAIX inhibitor S4. The effect of S4 on doxorubicin efficacy was tested in vitro using cell viability assays with MDA-MB-231, FaDu, HT29 -CAIX high and HT29 -CAIX low cell lines. In addition, the efficacy of this combination therapy was investigated in tumor xenografts of the same cell lines. The addition of S4 in vitro increased the efficacy of doxorubicin in the MDA-MB-231 during hypoxic exposure (IC50 is 0.25 versus 0.14 mu M, p = 0.0003). Similar results were observed for HT29-CAIX high with S4 during normoxia (IC50 is 0.20 versus 0.08 mu M, p < 0.0001) and in the HT29 -CAIX low cells (IC50 is 0.09 mu M, p < 0.0001). In vivo doxorubicin treatment was only effective in the MDA-MB-231 xenografts, but the efficacy of doxorubicin was decreased when combined with S4. In conclusion, the efficacy of doxorubicin treatment can be increased when combined with the selective sulfamate CAIX inhibitor S4 in vitro in certain cell lines. Nevertheless, in xenografts S4 did not enhance doxorubicin efficacy in the FaDu and HT29 tumor models and decreased doxorubicin efficacy in the MDA-MB-231 tumor model. These results stress the importance of better understanding the role of CAIX inhibitors in intratumoral pH regulation before combining them with standard treatment modalities, such as doxorubicin.	[van Kuijk, Simon J. A.; Niemans, Raymon; Lieuwes, Natasja G.; Biemans, Rianne; Yaromina, Ala; Lambin, Philippe; Dubois, Ludwig J.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol MAASTRO Lab, Maastricht, Netherlands; [Gieling, Roben G.; Telfer, Brian A.; Williams, Kaye J.] Univ Manchester, Manchester Pharm Sch, Hypoxia & Therapeut Grp, Manchester, Lancs, England; [Haenen, Guido R. M. M.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Toxicol, Maastricht, Netherlands	Maastricht University; University of Manchester; Maastricht University; Maastricht University Medical Centre (MUMC)	van Kuijk, SJA (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Radiat Oncol MAASTRO Lab, Maastricht, Netherlands.; Gieling, RG (corresponding author), Univ Manchester, Manchester Pharm Sch, Hypoxia & Therapeut Grp, Manchester, Lancs, England.	s.vankuijk@maastrichtuniversity.nl; roben.gieling@manchester.ac.uk	Yaromina, Ala/AAN-9204-2021	van Kuijk, Sander/0000-0003-2796-729X; Telfer, Brian/0000-0003-1857-5120; Lambin, Philippe/0000-0001-7961-0191; Haenen, Guido/0000-0001-6986-290X	METOXIA (Metastatic Tumors Facilitated by Hypoxic Micro-Environment; EU 7th Research Framework Programme - Theme HEALTH) [222741]; NGI Pre-Seed grant [93612005]; Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Dutch Cancer Society [KWF UM 2011-5020, KWF UM 2009-4454, KWF MAC 2013-6425, KWF MAC 2013-6089, KWF UM 2015-7635]; EU [2008-222741]	METOXIA (Metastatic Tumors Facilitated by Hypoxic Micro-Environment; EU 7th Research Framework Programme - Theme HEALTH); NGI Pre-Seed grant; Kankeronderzoekfonds Limburg from the Health Foundation Limburg; Dutch Cancer Society(KWF Kankerbestrijding); EU(European Commission)	The authors acknowledge financial support from METOXIA (Metastatic Tumors Facilitated by Hypoxic Micro-Environment; EU 7th Research Framework Programme - Theme HEALTH; Grant no.: 222741), NGI Pre-Seed grant (no 93612005), Kankeronderzoekfonds Limburg from the Health Foundation Limburg and the Dutch Cancer Society (KWF UM 2011-5020, KWF UM 2009-4454, KWF MAC 2013-6425, KWF MAC 2013-6089, KWF UM 2015-7635).; Authors would like to thank Professor Silvia Pastorekova (Institute of Virology, Slovak Academy of Science, Slovak Republic) for providing us with the M75 antibody targeting CAIX. Authors would also like to thank Professor Claudiu Supuran (University of Florence, Italy) for providing us with S4. Pharmacokinetic studies were performed by Cyprotex Ltd. (Macclesfield, UK) as a part of the EU 7th framework program METOXIA (ref. 2008-222741) funded initiative.	Akurathi V, 2014, EUR J MED CHEM, V71, P374, DOI 10.1016/j.ejmech.2013.10.027; Akurathi V, 2010, NUCL MED BIOL, V37, P557, DOI 10.1016/j.nucmedbio.2010.02.006; Crown J, 2002, LANCET ONCOL, V3, P719, DOI 10.1016/S1470-2045(02)00927-0; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Dubois L, 2007, RADIOTHER ONCOL, V83, P367, DOI 10.1016/j.radonc.2007.04.018; Dubois L, 2013, RADIOTHER ONCOL, V108, P523, DOI 10.1016/j.radonc.2013.06.018; Dubois L, 2011, RADIOTHER ONCOL, V99, P424, DOI 10.1016/j.radonc.2011.05.045; Dubois L, 2009, RADIOTHER ONCOL, V92, P423, DOI 10.1016/j.radonc.2009.06.019; Dubois LJ, 2015, RADIOTHER ONCOL, V116, P352, DOI 10.1016/j.radonc.2015.08.022; Ebbesen P, 2009, J ENZYM INHIB MED CH, V24, P1, DOI 10.1080/14756360902784425; Eckman DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057554; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gieling RG, 2013, J ENZYM INHIB MED CH, V28, P360, DOI 10.3109/14756366.2012.736979; Gieling RG, 2012, J MED CHEM, V55, P5591, DOI 10.1021/jm300529u; Hartlieb KJ, 2015, ACS NANO, V9, P1461, DOI 10.1021/nn505895j; Hektoen HH, 2015, J ENZYM INHIB MED CH, P1; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; Meijer TWH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108068; Monti SM, 2013, EXPERT OPIN THER PAT, V23, P737, DOI 10.1517/13543776.2013.798648; Nagai K, 2014, PHARMAZIE, V69, P125, DOI 10.1691/ph.2014.3754; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Peeters SGJA, 2015, MOL IMAGING BIOL, V17, P615, DOI 10.1007/s11307-015-0831-y; Peeters SGJA, 2015, CLIN CANCER RES, V21, P2984, DOI 10.1158/1078-0432.CCR-15-0018; Rafajova M, 2004, INT J ONCOL, V24, P995; Raghunand N, 2003, BIOCHEM PHARMACOL, V66, P1219, DOI 10.1016/S0006-2952(03)00468-4; Rami M, 2013, J MED CHEM, V56, P8512, DOI 10.1021/jm4009532; Santiago A, 2010, RADIOTHER ONCOL, V97, P322, DOI 10.1016/j.radonc.2010.07.007; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2007, CANCER METAST REV, V26, P299, DOI 10.1007/s10555-007-9064-0; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; van Kuijk SJA, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00069; Walsh JC, 2014, ANTIOXID REDOX SIGN, V21, P1516, DOI 10.1089/ars.2013.5378; Ward C, 2015, ONCOTARGET; Winum JY, 2012, BIOORG MED CHEM LETT, V22, P4681, DOI 10.1016/j.bmcl.2012.05.083; Wojtkowiak JW, 2011, MOL PHARMACEUT, V8, P2032, DOI 10.1021/mp200292c; Yaromina A, 2006, RADIOTHER ONCOL, V81, P122, DOI 10.1016/j.radonc.2006.08.010; Yaromina A, 2009, INT J RADIAT BIOL, V85, P972, DOI 10.3109/09553000903232868	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161040	10.1371/journal.pone.0161040	http://dx.doi.org/10.1371/journal.pone.0161040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513947	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000381381100115
J	Nel, TH; Henshilwood, CS				Nel, Turid Hillestad; Henshilwood, Christopher Stuart			The Small Mammal Sequence from the c. 76-72 ka Still Bay Levels at Blombos Cave, South Africa - Taphonomic and Palaeoecological Implications for Human Behaviour	PLOS ONE			English	Article							MIDDLE STONE-AGE; 2 COEXISTING RODENTS; OWLS TYTO-ALBA; CAPE PROVINCE; PLEISTOCENE ENVIRONMENTS; RHABDOMYS-PUMILIO; ATAPUERCA BURGOS; OTOMYS-IRRORATUS; PINNACLE POINT; SHELL BEADS	The Still Bay, c. 76-72 ka, a prominent techno-tradition during the Middle Stone Age of southern Africa, has yielded innovative technologies, symbolic material culture, and shows evidence of expansion of hunting techniques and subsistence strategies. In this paper we present the results of the first systematic, taphonomic and palaeoenvironmental study of micromammals from the Still Bay levels at Blombos Cave. Our taphonomic analysis indicates that the micromammals were accumulated by avian predators occupying the cave. Post-depositional processes affecting the micromammal assemblage include organic waste decomposition and conditions associated with a limestone cave environment. The palaeoenvironmental reconstruction shows that Marine Isotope Stage (MIS) 5a at Blombos Cave had diverse micromammal communities occupying a variety of habitats and with rainfall pattern equal to present. The transition from MIS 5a to 4 is indicated by less diverse micromammal assemblages, increase in grassland and scrub vegetation, shifts in seasonal precipitation, and a decline in shrubs associated with fynbos. The onset of the glacial conditions associated with MIS 4 is visible in the micromammal assemblage. However humans occupying Blombos Cave during this c. 5 ka period showed an ability to cope with changing environmental conditions and were able to adapt and utilise a variety of available resources.	[Nel, Turid Hillestad; Henshilwood, Christopher Stuart] Univ Bergen, Dept Archaeol Hist Culture & Relig, Bergen, Norway; [Henshilwood, Christopher Stuart] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	University of Bergen; University of Witwatersrand	Nel, TH (corresponding author), Univ Bergen, Dept Archaeol Hist Culture & Relig, Bergen, Norway.	turhi@hotmail.com	Henshilwood, Christopher S/K-3806-2014	Henshilwood, Christopher S/0000-0002-2818-293X	National Research Foundation/Department of Science and Technology; University of Bergen, Norway	National Research Foundation/Department of Science and Technology(Department of Science & Technology (India)); University of Bergen, Norway	This study was funded by a National Research Foundation/Department of Science and Technology funded Chair awarded to CSH at the University of the Witwatersrand, South Africa, and by the University of Bergen, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by a National Research Foundation/Department of Science and Technology funded Chair awarded to CSH at the University of the Witwatersrand, South Africa, and by the University of Bergen, Norway. The assistance of Samantha Mienies during recording and analysis of the material is greatly appreciated. THN would like to thank staff at the Iziko South African Museum in particular Sarah Wurz, Petro Keene and Denise Hamerton for facilitating the study and enabling access to the faunal reference collections. Karen van Niekerk is thanked for enlightened discussions regarding the Blombos sequence and fauna. The comments of two anonymous reviewers and Margaret A very helped improve previous versions of this manuscript.	Andrews P, 2000, J ZOOL, V251, P205, DOI 10.1111/j.1469-7998.2000.tb00605.x; ANDREWS P, 1983, PALEOBIOLOGY, V9, P289, DOI 10.1017/S0094837300007703; Andrews P, 1990, OWLS CAVES FOSSILS; Antonanzas RL, 2002, PALAEOGEOGR PALAEOCL, V186, P311; Archer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132428; Avery D.M., 1999, Archaeozoologia, V10, P163; AVERY D M, 1982, Annals of the South African Museum, V85, P183; Avery D. M., 2007, Transactions of the Royal Society of South Africa, V62, P17, DOI 10.1080/00359190709519193; Avery D. M, 1979, THESIS; AVERY D. M., 1988, GEOARCHAEOLOGY, V3, P41, DOI DOI 10.1002/GEA.3340030103; AVERY DM, 1982, J ARCHAEOL SCI, V9, P187, DOI 10.1016/0305-4403(82)90049-8; Avery DM, 2005, J NAT HIST, V39, P2047, DOI 10.1080/00222930500044631; AVERY DM, 1992, PALAEOGEOGR PALAEOCL, V91, P71, DOI 10.1016/0031-0182(92)90033-2; AVERY DM, 1987, J ARCHAEOL SCI, V14, P405, DOI 10.1016/0305-4403(87)90028-8; Avery DM, 2003, PALAEOGEOGR PALAEOCL, V189, P55, DOI 10.1016/S0031-0182(02)00593-X; Avery DM, 2002, J ARCHAEOL SCI, V29, P537, DOI 10.1006/jasc.2001.0749; AVERY DM, 1992, ISRAEL J ZOOL, V38, P385; Avery DM, 2001, J HUM EVOL, V41, P113, DOI 10.1006/jhev.2001.0483; Backwell LR, 2014, QUATERNARY SCI REV, V99, P42, DOI 10.1016/j.quascirev.2014.06.017; Bar-Matthews M, 2010, QUATERNARY SCI REV, V29, P2131, DOI 10.1016/j.quascirev.2010.05.009; BEHRENSMEYER A K, 1975, Bulletin of the Museum of Comparative Zoology, V146, P473; Belmaker M, 2011, QUATERNARY SCI REV, V30, P3196, DOI 10.1016/j.quascirev.2011.08.001; Bergh NG, 2014, FYNBOS: ECOLOGY, EVOLUTION, AND CONSERVATION OF A MEGADIVERSE REGION, P1; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; BOND W, 1980, S AFR J ZOOL, V15, P34; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2015, QUATERNARY SCI REV, V107, P138, DOI 10.1016/j.quascirev.2014.10.011; Chase BM, 2010, J ARCHAEOL SCI, V37, P1359, DOI 10.1016/j.jas.2009.12.040; Clark JL, 2011, J ANTHROPOL ARCHAEOL, V30, P273, DOI 10.1016/j.jaa.2011.04.002; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; CRUZURIBE K, 1988, J ARCHAEOL SCI, V15, P179, DOI 10.1016/0305-4403(88)90006-4; Cuenca-Bescos G, 2009, J ARCHAEOL SCI, V36, P947, DOI 10.1016/j.jas.2008.09.025; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2015, ARCHAEOMETRY, V57, P51, DOI 10.1111/arcm.12072; D'Errico F, 2001, ANTIQUITY, V75, P309, DOI 10.1017/S0003598X00060968; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; Davis D. H. S., 1962, Annals of the Cape Provincial Museum, V2, P56; De Graaff G., 1981, RODENTS SO AFRICA; DELANY M J, 1972, Mammal Review, V2, P1, DOI 10.1111/j.1365-2907.1972.tb00155.x; Denys C, 2002, ARCHAEOMETRY, V44, P469, DOI 10.1111/1475-4754.00079; Denys C, 1997, B SOC GEOL FR, V168, P751; Discamps E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144866; du Toit N, 2012, MOL PHYLOGENET EVOL, V65, P75, DOI 10.1016/j.ympev.2012.05.036; Engelbrecht A, 2011, BIOL J LINN SOC, V104, P192, DOI 10.1111/j.1095-8312.2011.01696.x; Falk Carl R., 1998, Illinois State Museum Scientific Papers, V27, P285; Fernandez-Jalvo Y, 1998, J HUM EVOL, V34, P137, DOI 10.1006/jhev.1997.0188; FERNANDEZ-JALVO Y, 1992, J ARCHAEOL SCI, V19, P407, DOI 10.1016/0305-4403(92)90058-B; Fernandez-Jalvo Y, 1996, QUATERN INT, V33, P21, DOI 10.1016/1040-6182(95)00098-4; FERNANDEZ-JALVO Y, 1995, PALAEOGEOGR PALAEOCL, V114, P167, DOI 10.1016/0031-0182(94)00081-I; Fisher EC, 2010, QUATERNARY SCI REV, V29, P1382, DOI 10.1016/j.quascirev.2010.01.015; Fleming PA, 2002, OECOLOGIA, V132, P361, DOI 10.1007/s00442-002-0921-9; Friedmann Y, 2004, RED BOOK MAMMALS S A; Goodwin AJH., 1929, ANN SOUTH AFR MUS, V27, P1; Haaland M, 2012, THESIS; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Henshilwood C, 1997, CURR ANTHROPOL, V38, P890, DOI 10.1086/204678; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood C. S., 2008, S AFRICAN ARCHAEOLOG, V10, P35; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS., 2011, HOMOSYMBOLICUS DAWN, P49, DOI 10.1075/z.168; Hillestad-Nel TH, 2007, SO CAPE S AFRICA NYA, V68, P52; Hopley PJ, 2006, PALAEOGEOGR PALAEOCL, V233, P235, DOI 10.1016/j.palaeo.2005.09.011; Jacobs Z, 2006, RADIAT MEAS, V41, P264, DOI 10.1016/j.radmeas.2005.07.027; Jacobs Z, 2003, J HUM EVOL, V44, P599, DOI 10.1016/S0047-2484(03)00048-4; Jacobs Z, 2003, J HUM EVOL, V44, P613, DOI 10.1016/S0047-2484(03)00049-6; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Jacobs Z, 2009, S AFR J SCI, V105, P333; Kelly RL., 2007, FORAGING SPECTRUM DI, DOI 10.2307/j.ctv2sx9gc9; LEVINSON M, 1982, Annals of the Transvaal Museum, V33, P115; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Mackay A, 2014, J HUM EVOL, V72, P26, DOI 10.1016/j.jhevol.2014.03.003; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Matthews T, 2005, J HUM EVOL, V49, P432, DOI 10.1016/j.jhevol.2005.05.006; Matthews T., 2004, THESIS; Matthews T, 2011, PALAEOGEOGR PALAEOCL, V302, P213, DOI 10.1016/j.palaeo.2011.01.014; Matthews Thalassa, 2009, Palaeontologia Africana, V44, P112; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; Meester J. A., 1963, TRANSVAAL MUSEUM MEM, V13, P1; MEESTER JAJ, 1979, S AFR J SCI, V75, P183; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Mucina Ladislav, 2006, V19, P2; Nel T., 2013, THESIS; Nowell A, 2010, ANNU REV ANTHROPOL, V39, P437, DOI 10.1146/annurev.anthro.012809.105113; PERRIN M R, 1986, Cimbebasia Series A, V8, P63; PERRIN MR, 1980, ACTA OECOL-OEC GEN, V1, P383; PERRIN MR, 1981, S AFR J WILDL RES, V11, P21; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Quick LJ, 2015, QUAT INT IN PRESS; Rautenbach I. L, 1971, KOEDOE, V18, P195; Reed D. N, 2003, THESIS; Reynard Jerome P., 2014, Annals of the Ditsong National Museum of Natural History, V4, P9; Roberts A., 1951, MAMMALS S AFRICA; Roberts DL, 2008, PALAEOGEOGR PALAEOCL, V257, P261, DOI 10.1016/j.palaeo.2007.08.005; ROSENZWEIG ML, 1968, AM NAT, V102, P67, DOI 10.1086/282523; Schradin C, 2005, J MAMMAL, V86, P99, DOI 10.1644/1545-1542(2005)086<0099:IVITSA>2.0.CO;2; Shahack-Gross R, 2004, J ARCHAEOL SCI, V31, P1259, DOI 10.1016/j.jas.2004.02.004; Shortridge G. C., 1942, ANN S AFRICAN MUS, V36, P27; Shortridge G.C., 1934, MAMMALS S W AFRICA, V1; Shortridge GC, 1934, MAMMALS S W AFRICA, VII; Skinner J. D., 2005, MAMMALS SO AFRICAN S; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; South African National Biodiversity Institute, 2007, MUN BIOD SUMM PROJ B; Specht R. L, 1991, ECOSYSTEMS WORLD A, P81; Steyn P, 2009, DELIGHT OWLS AFRICAN; Stuart C., 2001, FIELD GUIDE MAMMALS; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Thompson J. C., 2008, THESIS; Thompson JC, 2014, J HUM EVOL, V67, P33, DOI 10.1016/j.jhevol.2013.09.010; Thompson JC, 2011, J HUM EVOL, V60, P746, DOI 10.1016/j.jhevol.2011.01.013; Tribolo C, 2006, ARCHAEOMETRY, V48, P341, DOI 10.1111/j.1475-4754.2006.00260.x; Tribolo C., 2003, THESIS; Urrego DH, 2015, CLIM PAST, V11, P1417, DOI 10.5194/cp-11-1417-2015; Van Niekerk K. L., 2011, THESIS; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Vargas J, 2002, J RAPTOR RES, V36, P146; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Voorhies M. R., 1969, Contr Geol Spec Pap Univ Wyoming, V1, P1; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V1; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	132	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159817	10.1371/journal.pone.0159817	http://dx.doi.org/10.1371/journal.pone.0159817			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KR	27509023	gold, Green Submitted, Green Published			2022-12-26	WOS:000381380400015
J	Yin, FG; Yu, H; Lepp, D; Shi, XJ; Yang, XJ; Hu, JL; Leeson, S; Yang, CB; Nie, SP; Hou, YQ; Gong, JS				Yin, Fugui; Yu, Hai; Lepp, Dion; Shi, Xuejiang; Yang, Xiaojian; Hu, Jielun; Leeson, Steve; Yang, Chengbo; Nie, Shaoping; Hou, Yongqing; Gong, Joshua			Transcriptome Analysis Reveals Regulation of Gene Expression for Lipid Catabolism in Young Broilers by Butyrate Glycerides	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; FAT DEPOSITION; ABDOMINAL FAT; DIFFERENTIAL EXPRESSION; PPAR-ALPHA; METABOLISM; ACID; RNA; CHICKENS; SEQUENCE	Background & Aims Butyrate has been shown to potently regulate energy expenditure and lipid metabolism in animals, yet the underlying mechanisms remain to be fully understood. The aim of this study was to investigate the molecular mechanisms of butyrate (in the form of butyrate glycerides, BG)-induced lipid metabolism at the level of gene expression in the jejunum and liver of broilers. Methodology/Principal Findings Two animal experiments were included in this study. In Experiment 1, two hundred and forty male broiler chickens were equally allocated into two groups: 1) basal diet (BD), 2) BG diets (BD + BG). Growth performance was compared between treatments for the 41-day trial. In Experiment 2, forty male broiler chickens were equally allocated into two groups. The general experimental design, group and management were the same as described in Experiment 1 except for reduced bird numbers and 21-day duration of the trial. Growth performance, abdominal fat deposition, serum lipid profiles as well as serum and tissue concentrations of key enzymes involved in lipid metabolism were compared between treatments. RNA-seq was employed to identify both differentially expressed genes (DEGs) and treatment specifically expressed genes (TSEGs). Functional clustering of DEGs and TSEGs and signaling pathways associated with lipid metabolism were identified using Ingenuity Pathways Analysis (IPA) and DAVID Bioinformatics Resources 6.7 (DAVID-BR). Quantitative PCR (qPCR) assays were subsequently conducted to further examine the expression of genes in the peroxisome proliferator-activated receptors (PPAR) signaling pathway identified by DAVID-BR. Dietary BG intervention significantly reduced abdominal fat ratio (abdominal fat weight/final body weight) in broilers. The decreased fat deposition in BG-fed chickens was in accordance with serum lipid profiles as well as the level of lipid metabolism-related enzymes in the serum, abdominal adipose, jejunum and liver. RNA-seq analysis indicated that dietary BG intervention induced 79 and 205 characterized DEGs in the jejunum and liver, respectively. In addition, 255 and 165 TSEGs were detected in the liver and jejunum of BG-fed group, while 162 and 211 TSEGs genes were observed in the liver and jejunum of BD-fed birds, respectively. Bioinformatic analysis with both IPA and DAVID-BR further revealed a significant enrichment of DEGs and TSEGs in the biological processes for reducing the synthesis, storage, transportation and secretion of lipids in the jejunum, while those in the liver were for enhancing the oxidation of ingested lipids and fatty acids. In particular, transcriptional regulators of THRSP and EGR-1 as well as several DEGs involved in the PPAR-alpha signaling pathway were significantly induced by dietary BG intervention for lipid catabolism. Conclusions Our results demonstrate that BG reduces body fat deposition via regulation of gene expression, which is involved in the biological events relating to the reduction of synthesis, storage, transportation and secretion, and improvement of oxidation of lipids and fatty acids.	[Yin, Fugui; Yu, Hai; Lepp, Dion; Yang, Xiaojian; Gong, Joshua] Agr & Agri Food Canada, Guelph Res & Dev Ctr, Guelph, ON, Canada; [Shi, Xuejiang] UHN MSH Gene Profiling Facil, Next Generat Sequencing Platforms, Clin Genom Ctr, Toronto, ON, Canada; [Hu, Jielun; Nie, Shaoping] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Leeson, Steve] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON, Canada; [Yang, Chengbo] Univ Manitoba, Dept Anim Sci, Winnipeg, MB, Canada; [Hou, Yongqing] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Wuhan, Hubei, Peoples R China	Agriculture & Agri Food Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Nanchang University; University of Guelph; University of Manitoba; Wuhan Polytechnic University	Gong, JS (corresponding author), Agr & Agri Food Canada, Guelph Res & Dev Ctr, Guelph, ON, Canada.	joshua.gong@agr.gc.ca	Nie, S/K-1124-2019	Nie, Shao-Ping/0000-0002-2412-4679	Agriculture and Agri-Food Canada's Poultry Cluster II [J-000264]; China Scholarship Council through the MOE-AAFC Ph.D. Research Program; Agriculture & Agri-Food Canada (AAFC); Canadian Poultry Research Council through AAFCAAFCip Council through the MOE-AAFC Ph.D. Research Program	Agriculture and Agri-Food Canada's Poultry Cluster II(Agriculture & Agri Food Canada); China Scholarship Council through the MOE-AAFC Ph.D. Research Program(China Scholarship Council); Agriculture & Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada); Canadian Poultry Research Council through AAFCAAFCip Council through the MOE-AAFC Ph.D. Research Program	This study was financially supported by Agriculture and Agri-Food Canada's Poultry Cluster II, Dr. Joshua Gong - Poultry Cluster Program (Project # J-000264). FY and XY were NSERC Visiting Fellows to the Canadian Federal Government Laboratories (NSERC-VF). JH was a visiting graduate student financially supported by the China Scholarship Council through the MOE-AAFC Ph.D. Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by Agriculture & Agri-Food Canada (AAFC) and Canadian Poultry Research Council through AAFCAAFCip Council through the MOE-AAFC Ph.D. Research Program. level of selected key enzymes cleavage enzyme system on the inner membrane oxint Laboratories (NSERC-VF). JH was a visiting graduate student financially supported by the China Scholarship Council through the MOE-AAFC Ph.D. Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Adamson ED, 2002, TUMOR BIOL, V23, P93, DOI 10.1159/000059711; Anders S., 2010, MOL BIOL+, V43, P1, DOI DOI 10.1186/GB-2010-11-10-R106; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORKHEM I, 1972, EUR J BIOCHEM, V30, P441, DOI 10.1111/j.1432-1033.1972.tb02116.x; Bourneuf E, 2006, GENE, V372, P162, DOI 10.1016/j.gene.2005.12.028; BUTTERWITH SC, 1989, BRIT POULTRY SCI, V30, P927, DOI 10.1080/00071668908417219; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; CLARKE SD, 1993, J ANIM SCI, V71, P1957, DOI 10.2527/1993.7171957x; Cogburn LA, 2004, COMP FUNCT GENOM, V5, P253, DOI 10.1002/cfg.402; Cohen LH, 2000, BIOPHARM DRUG DISPOS, V21, P353, DOI 10.1002/bdd.249; Colman H, 2013, J VIROL, V87, P6668, DOI 10.1128/JVI.00538-13; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Exeter HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041139; Fernandez-Rubio C, 2009, POULTRY SCI, V88, P943, DOI 10.3382/ps.2008-00484; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fruchart-Najib J, 2004, BIOCHEM BIOPH RES CO, V319, P397, DOI 10.1016/j.bbrc.2004.05.003; Fu RQ, 2014, GENE, V537, P120, DOI 10.1016/j.gene.2013.07.109; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gellert M. V, 2007, MOL GENETICS RECOMBI, P469; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; GREENBERG AS, 1993, P NATL ACAD SCI USA, V90, P12035, DOI 10.1073/pnas.90.24.12035; GRIFFIN HD, 1992, J NUTR, V122, P363, DOI 10.1093/jn/122.2.363; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hou YQ, 2014, BRIT J NUTR, V111, P1748, DOI 10.1017/S0007114514000038; Jones AC, 2012, PROSTATE, V72, P1159, DOI 10.1002/pros.22465; Kalavathy R, 2003, BRIT POULTRY SCI, V44, P139, DOI 10.1080/0007166031000085445; Kallen CB, 1998, J BIOL CHEM, V273, P26285, DOI 10.1074/jbc.273.41.26285; Lagarrigue S, 2006, GENET SEL EVOL, V38, P85, DOI 10.1051/gse:2005028; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkina TA, 2011, RUSS J GENET+, V47, P1012, DOI 10.1134/S1022795411080114; Leeson S, 2005, POULTRY SCI, V84, P1418, DOI 10.1093/ps/84.9.1418; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; LIU CY, 1994, DOMEST ANIM ENDOCRIN, V11, P125, DOI 10.1016/0739-7240(94)90040-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Meng H, 2005, DOMEST ANIM ENDOCRIN, V28, P105, DOI 10.1016/j.domaniend.2004.05.003; Mersmann HJ, 1998, J ANIM SCI, V76, P1396; Mignon GL, 2008, ANIM GENET, V40, P157; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Namkung H, 2011, POULTRY SCI, V90, P2217, DOI 10.3382/ps.2011-01498; Panda AK, 2009, ASIAN AUSTRAL J ANIM, V22, P1026, DOI 10.5713/ajas.2009.80298; PETERSON J, 1990, P NATL ACAD SCI USA, V87, P909, DOI 10.1073/pnas.87.3.909; Phan CT, 2001, FRONT BIOSCI-LANDMRK, V6, pD299, DOI 10.2741/Phan; Rajkumar AP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1767-y; Rendic S, 1999, J CHROMATOGR B, V735, P73, DOI 10.1016/S0378-4347(99)00400-4; Resnyk CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139549; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Richards MP, 2003, J NUTR, V133, P707, DOI 10.1093/jn/133.3.707; SAMPUGNA J, 1967, LIPIDS, V2, P397, DOI 10.1007/BF02531853; SERVETNICK DA, 1995, J BIOL CHEM, V270, P16970, DOI 10.1074/jbc.270.28.16970; Shi Y, 2014, GENE, V538, P313, DOI 10.1016/j.gene.2014.01.031; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Sunkara LT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049558; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TROTTER PJ, 1991, J LIPID RES, V32, P293; Vanhoutvin SALW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006759; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Woodhouse SD, 2010, HEPATOLOGY, V52, P443, DOI 10.1002/hep.23733; Yin FG, 2011, BRIT J NUTR, V106, P369, DOI 10.1017/S0007114511000213; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Yuan L, 2008, BRIT POULTRY SCI, V49, P487, DOI 10.1080/00071660802251731; Yue T, 2010, BMB REP, V43, P140, DOI 10.5483/BMBRep.2010.43.2.140; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6; Zhou Z, 2015, PLOS ONE, V10	83	23	26	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160751	10.1371/journal.pone.0160751	http://dx.doi.org/10.1371/journal.pone.0160751			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508934	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400050
J	Noronha, H; Araujo, D; Conde, C; Martins, AP; Soveral, G; Chaumont, F; Delrot, S; Geros, H				Noronha, Henrique; Araujo, Diogo; Conde, Carlos; Martins, Ana P.; Soveral, Graca; Chaumont, Francois; Delrot, Serge; Geros, Hernani			The Grapevine Uncharacterized Intrinsic Protein 1 (VvXIP1) Is Regulated by Drought Stress and Transports Glycerol, Hydrogen Peroxide, Heavy Metals but Not Water	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; PLASMA-MEMBRANE; HIGHLY DIVERGENT; AQUAPORINS; CHANNELS; PLANTS; YEAST; PERMEABILITY; ADJUSTMENTS; FACILITATE	A MIP (Major Intrinsic Protein) subfamily called Uncharacterized Intrinsic Proteins (XIP) was recently described in several fungi and eudicot plants. In this work, we cloned a XIP from grapevine, VvXIP1, and agrobacterium-mediated transformation studies in Nicotiana benthamiana revealed that the encoded aquaporin shows a preferential localization at the endoplasmic reticulum membrane. Stopped-flow spectrometry in vesicles from the aqy-null yeast strain YSH1172 overexpressing VvXIP1 showed that VvXIP1 is unable to transport water but is permeable to glycerol. Functional studies with the ROS sensitive probe CM-H(2)DCFDA in intact transformed yeasts showed that VvXIP1 is also able to permeate hydrogen peroxide (H2O2). Drop test growth assays showed that besides glycerol and H2O2, VvXIP1 also transports boric acid, copper, arsenic and nickel. Furthermore, we found that VvXIP1 transcripts were abundant in grapevine leaves from field grown plants and strongly repressed after the imposition of severe water-deficit conditions in potted vines. The observed downregulation of VvXIP1 expression in cultured grape cells in response to ABA and salt, together with the increased sensitivity to osmotic stress displayed by the aqy-null yeast overexpressing VvXIP1, corroborates the role of VvXIP1 in osmotic regulation besides its involvement in H2O2 transport and metal homeostasis.	[Noronha, Henrique; Araujo, Diogo; Geros, Hernani] CITAB, Vila Real, Portugal; [Noronha, Henrique; Geros, Hernani] Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal; [Conde, Carlos] Univ Porto, i3S, Porto, Portugal; [Conde, Carlos] Univ Porto, IBMC, Porto, Portugal; [Martins, Ana P.; Soveral, Graca] Univ Lisbon, Res Inst Med & Pharmaceut Sci iMed UL, Lisbon, Portugal; [Chaumont, Francois] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium; [Delrot, Serge] Univ Bordeaux, INRA, ISVV Ecophysiol & Genom Fonct Vigne, UMR 1287, Villenave Dornon, France	University of Tras-os-Montes & Alto Douro; Universidade do Minho; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade de Lisboa; Universite Catholique Louvain; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Geros, H (corresponding author), CITAB, Vila Real, Portugal.; Geros, H (corresponding author), Univ Minho, Dept Biol, Ctr Mol & Environm Biol CBMA, Braga, Portugal.	geros@bio.uminho.pt	Martins, Ana Paula/A-5657-2013; Gerós, Hernâni/A-8897-2010; Soveral, Graça/L-1550-2013; Conde, Carlos/I-8147-2013; Gerós, Hernâni/ABE-8410-2021; iMed.ULisboa, MetGen/B-5293-2014	Martins, Ana Paula/0000-0002-5064-6171; Gerós, Hernâni/0000-0002-3040-4095; Soveral, Graça/0000-0001-8487-110X; Conde, Carlos/0000-0002-4177-8519; Gerós, Hernâni/0000-0002-3040-4095; Noronha, Henrique/0000-0002-4809-6609	European Union Funds (FEDER/COMPETE Operational Competitiveness Programme); Portuguese national Funds (FCT-Portuguese Foundation for Science and Technology) [KBBE-2012-6-3117 "Inovinne", FCOMP-01-0124-FEDER-022692, PTDC/AGR-ALI/100636/2008]; FCT [SFRH/BD/74257/2010, SFRH/BD/65046/2009]; Interuniversity Attraction Poles Programme-Belgian Science Policy [IAP7/29]; Belgian French community [ARC11/16-036]	European Union Funds (FEDER/COMPETE Operational Competitiveness Programme); Portuguese national Funds (FCT-Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Interuniversity Attraction Poles Programme-Belgian Science Policy(Belgian Federal Science Policy Office); Belgian French community	This work was supported by European Union Funds (FEDER/COMPETE Operational Competitiveness Programme) and Portuguese national Funds (FCT-Portuguese Foundation for Science and Technology): KBBE-2012-6-3117 "Inovinne", FCOMP-01-0124-FEDER-022692 and PTDC/AGR-ALI/100636/2008. HN (SFRH/BD/74257/2010) and APM (SFRH/BD/65046/2009) were supported by PhD grants from FCT. The Interuniversity Attraction Poles Programme-Belgian Science Policy (IAP7/29) and the Belgian French community ARC11/16-036 project.	Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; Chevalier AS, 2014, PLANT PHYSIOL, V166, P125, DOI 10.1104/pp.114.240945; Conde A, 2015, J EXP BOT, V66, P889, DOI 10.1093/jxb/eru446; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Decendit A, 1996, BIOTECHNOL LETT, V18, P659, DOI 10.1007/BF00130761; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Gupta AB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-134; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Leitao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033219; Lopez D, 2012, J EXP BOT, V63, P2217, DOI 10.1093/jxb/err404; Lopez D, 2016, PLANT MOL BIOL, V91, P375, DOI 10.1007/s11103-016-0462-y; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Martins V, 2014, PLANT PHYSIOL BIOCH, V82, P270, DOI 10.1016/j.plaphy.2014.06.016; Martins V, 2014, PLANTA, V240, P91, DOI 10.1007/s00425-014-2067-5; Martins V, 2012, PLANT CELL PHYSIOL, V53, P1866, DOI 10.1093/pcp/pcs125; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Maurel C, 2009, CURR OPIN PLANT BIOL, V12, P690, DOI 10.1016/j.pbi.2009.09.002; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Noronha H, 2014, J EXP BOT, V65, P981, DOI 10.1093/jxb/ert448; Penarrubia L, 2010, J BIOL INORG CHEM, V15, P29, DOI 10.1007/s00775-009-0591-8; Rodrigues J, 2013, MICROBIOL-SGM, V159, P848, DOI 10.1099/mic.0.062570-0; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shelden MC, 2009, FUNCT PLANT BIOL, V36, P1065, DOI 10.1071/FP09117; Soveral G, 1997, J MEMBRANE BIOL, V158, P219; Soveral G, 2006, MICROBIOL-SGM, V152, P1515, DOI 10.1099/mic.0.28679-0; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tyerman SD, 2012, BIOCHEMISTRY OF THE GRAPE BERRY, P3; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Yool AJ, 1996, SCIENCE, V273, P1216, DOI 10.1126/science.273.5279.1216; Yool AJ, 2002, NEWS PHYSIOL SCI, V17, P68, DOI 10.1152/nips.01372.2001; Zeng L, 2011, J PLANT GROWTH REGUL, V30, P199, DOI 10.1007/s00344-010-9185-5	47	29	29	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160976	10.1371/journal.pone.0160976	http://dx.doi.org/10.1371/journal.pone.0160976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504956	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200088
J	O'Donnell, PE; Ye, XZ; DeChellis, MA; Davis, VM; Duan, SZ; Mortensen, RM; Milstone, DS				O'Donnell, Peter E.; Ye, Xiu Zhen; DeChellis, Melissa A.; Davis, Vannessa M.; Duan, Sheng Zhong; Mortensen, Richard M.; Milstone, David S.			Lipodystrophy, Diabetes and Normal Serum Insulin in PPAR gamma-Deficient Neonatal Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; BETA-CELLS; RESISTANCE; FAT; DISRUPTION; EXPRESSION; KNOCKOUT; MUSCLE	Peroxisome proliferator activated receptor gamma (PPAR gamma) is a pleiotropic ligand activated transcription factor that acts in several tissues to regulate adipocyte differentiation, lipid metabolism, insulin sensitivity and glucose homeostasis. PPAR gamma also regulates cardiomyocyte homeostasis and by virtue of its obligate role in placental development is required for embryonic survival. To determine the postnatal functions of PPAR gamma in vivo we studied globally deficient neonatal mice produced by epiblast-restricted elimination of PPAR gamma. PPAR gamma-rescued placentas support development of PPAR gamma-deficient embryos that are viable and born in near normal numbers. However, PPAR gamma-deficient neonatal mice show severe lipodystrophy, lipemia, hepatic steatosis with focal hepatitis, relative insulin deficiency and diabetes beginning soon after birth and culminating in failure to thrive and neonatal lethality between 4 and 10 days of age. These abnormalities are not observed with selective PPAR gamma 2 deficiency or with deficiency restricted to hepatocytes, skeletal muscle, adipocytes, cardiomyocytes, endothelium or pancreatic beta cells. These observations suggest important but previously unappreciated functions for PPAR gamma 1 in the neonatal period either alone or in combination with PPAR gamma 2 in lipid metabolism, glucose homeostasis and insulin sensitivity.	[O'Donnell, Peter E.; Ye, Xiu Zhen; DeChellis, Melissa A.; Davis, Vannessa M.; Milstone, David S.] Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA; [O'Donnell, Peter E.; Ye, Xiu Zhen; DeChellis, Melissa A.; Davis, Vannessa M.; Milstone, David S.] Harvard Med Sch, Boston, MA 02115 USA; [Duan, Sheng Zhong; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI USA; [O'Donnell, Peter E.] Novartis Inst Biomed Res, Cambridge, MA USA; [DeChellis, Melissa A.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Duan, Sheng Zhong] Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Novartis; Harvard University; Joslin Diabetes Center, Inc.; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Milstone, DS (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Vasc Res, Boston, MA 02115 USA.; Milstone, DS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	milstone@rics.bwh.harvard.edu			National Institute of Child Health and Human Development [R01HD40895]; National Heart, Lung and Blood Institute [P01HL36028]; pilot project and cores of the Michigan Diabetes Research and Training Center from the National Institute of Diabetes & Digestive & Kidney Diseases (RMM) [NIH5P60 DK20572]; Tissue Microarray and Imaging Core Facility of the Dana-Farber/Harvard Cancer Center [P30 CA06516]; Department of Pathology, Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); pilot project and cores of the Michigan Diabetes Research and Training Center from the National Institute of Diabetes & Digestive & Kidney Diseases (RMM); Tissue Microarray and Imaging Core Facility of the Dana-Farber/Harvard Cancer Center; Department of Pathology, Brigham and Women's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Child Health and Human Development R01HD40895 (DSM), the National Heart, Lung and Blood Institute P01HL36028 (DSM), a pilot project and cores of the Michigan Diabetes Research and Training Center (NIH5P60 DK20572) from the National Institute of Diabetes & Digestive & Kidney Diseases (RMM), the Tissue Microarray and Imaging Core Facility of the Dana-Farber/Harvard Cancer Center (P30 CA06516) and by the Department of Pathology, Brigham and Women's Hospital (DSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Duan SZ, 2010, DIABETOLOGIA, V53, P1493, DOI 10.1007/s00125-010-1748-2; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feldman D.B., 1988, NECROPSY GUIDE RODEN; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hayashi Shigemi, 2002, Gene Expression Patterns, V2, P93, DOI 10.1016/S0925-4773(02)00292-7; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Long J, 2014, HORM METAB RES, V46, P722, DOI 10.1055/s-0034-1382014; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Maxwell AE, 1971, METHUENS MONOGRAPHS; Milstone D S, 1999, Nucleic Acids Res, V27, pe10, DOI 10.1093/nar/27.15.e10; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Nicol CJ, 2005, AM J HYPERTENS, V18, P549, DOI 10.1016/j.amjhyper.2004.10.032; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; PINKUS GS, 1986, AM J CLIN PATHOL, V85, P269, DOI 10.1093/ajcp/85.3.269; Rosen ED, 2003, MOL CELL BIOL, V23, P7222, DOI 10.1128/MCB.23.20.7222-7229.2003; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosner B., 2011, FUNDAMENTALS BIOSTAT, V7th ed; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yang GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038117; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101	40	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160636	10.1371/journal.pone.0160636	http://dx.doi.org/10.1371/journal.pone.0160636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505464	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200049
J	Revilla, TA; Krivan, V				Revilla, Tomas A.; Krivan, Vlastimil			Pollinator Foraging Adaptation and Coexistence of Competing Plants	PLOS ONE			English	Article							IDEAL FREE DISTRIBUTION; STRATEGIES; VISITATION; NETWORKS	We use the optimal foraging theory to study coexistence between two plant species and a generalist pollinator. We compare conditions for plant coexistence for non-adaptive vs. adaptive pollinators that adjust their foraging strategy to maximize fitness. When pollinators have fixed preferences, we show that plant coexistence typically requires both weak competition between plants for resources (e.g., space or nutrients) and pollinator preferences that are not too biased in favour of either plant. We also show how plant coexistence is promoted by indirect facilitation via the pollinator. When pollinators are adaptive foragers, pollinator's diet maximizes pollinator's fitness measured as the per capita population growth rate. Simulations show that this has two conflicting consequences for plant coexistence. On the one hand, when competition between pollinators is weak, adaptation favours pollinator specialization on the more profitable plant which increases asymmetries in plant competition and makes their coexistence less likely. On the other hand, when competition between pollinators is strong, adaptation promotes generalism, which facilitates plant coexistence. In addition, adaptive foraging allows pollinators to survive sudden loss of the preferred plant host, thus preventing further collapse of the entire community.	[Revilla, Tomas A.; Krivan, Vlastimil] Czech Acad Sci, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic; [Krivan, Vlastimil] Univ South Bohemia, Dept Math & Biomath, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Revilla, TA (corresponding author), Czech Acad Sci, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic.	tomrevilla@gmail.com	Revilla, Tomás Augusto/K-6470-2015; Krivan, Vlastimil/J-7015-2019; Krivan, Vlastimil/F-1709-2010	Revilla, Tomás Augusto/0000-0001-6772-3412; Krivan, Vlastimil/0000-0003-0971-1231; Krivan, Vlastimil/0000-0003-0971-1231	Institute of Entomology [RVO:60077344]; European Union's Horizon RISE [690817]	Institute of Entomology(Czech Academy of Sciences); European Union's Horizon RISE	This work was supported by Institute of Entomology RVO:60077344 awarded to VK and European Union's Horizon 2020 RISE grant 690817 awarded to VK.	ARMSTRONG RA, 1976, J THEOR BIOL, V56, P499, DOI 10.1016/S0022-5193(76)80089-6; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Benadi G, 2013, AM NAT, V182, P131, DOI 10.1086/670942; Bewick S, 2013, OIKOS, V122, P1710, DOI 10.1111/j.1600-0706.2013.00016.x; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bronstein JL, 2015, MUTUALISM, P1, DOI 10.1093/acprof:oso/9780199675654.001.0001; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Grover JP, 1997, POPULATION COMMUNITY, V19; Gyllenberg M, 2006, PHYSICA D, V221, P135, DOI 10.1016/j.physd.2006.07.016; Hofbauer J, 1998, EVOLUTIONARY GAMES P; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P333; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Krivan V, 1997, AM NAT, V149, P164, DOI 10.1086/285984; Krivan V, 2008, THEOR POPUL BIOL, V73, P403, DOI 10.1016/j.tpb.2007.12.009; Krivan V, 2014, J THEOR BIOL, V343, P127, DOI 10.1016/j.jtbi.2013.11.020; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Morales CL, 2009, ECOL LETT, V12, P716, DOI 10.1111/j.1461-0248.2009.01319.x; LEVIN DA, 1970, AM NAT, V104, P455, DOI 10.1086/282680; MATLAB, 2010, VERSION 7 10 0; May, 1976, THEORETICAL ECOLOGY, P78; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Moeller DA, 2004, ECOLOGY, V85, P3289, DOI 10.1890/03-0810; Morales CL, 2008, CRIT REV PLANT SCI, V27, P221, DOI 10.1080/07352680802205631; Murcia C, 1996, ECOLOGY, V77, P550, DOI 10.2307/2265629; Okuyama T, 2008, ECOL LETT, V11, P208, DOI 10.1111/j.1461-0248.2007.01137.x; Rathcke B., 1983, P305; Revilla TA, 2015, J THEOR BIOL, V378, P39, DOI 10.1016/j.jtbi.2015.04.012; SCHOENER TW, 1976, THEOR POPUL BIOL, V10, P309, DOI 10.1016/0040-5809(76)90022-8; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Song ZY, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2437; THOMSON JD, 1982, OIKOS, V39, P241, DOI 10.2307/3544491; Valdovinos FS, 2013, OIKOS, V122, P907, DOI 10.1111/j.1600-0706.2012.20830.x; VANDERMEER JH, 1978, J THEOR BIOL, V74, P549, DOI 10.1016/0022-5193(78)90241-2	41	10	10	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160076	10.1371/journal.pone.0160076	http://dx.doi.org/10.1371/journal.pone.0160076			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505254	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200020
J	Atherton, LA; Burnell, ES; Mellor, JR				Atherton, Laura A.; Burnell, Erica S.; Mellor, Jack R.			Assessment of Methods for the Intracellular Blockade of GABA(A) Receptors	PLOS ONE			English	Article							RAT HIPPOCAMPAL SLICES; LONG-TERM POTENTIATION; WAVE-RIPPLE COMPLEXES; GAMMA-AMINOBUTYRIC-ACID; VASCULAR SMOOTH-MUSCLE; GATED CL-CONDUCTANCE; IN-VITRO; VISUAL-CORTEX; FEEDFORWARD INHIBITION; GABAERGIC INHIBITION	Selective blockade of inhibitory synaptic transmission onto specific neurons is a useful tool for dissecting the excitatory and inhibitory synaptic components of ongoing network activity. To achieve this, intracellular recording with a patch solution capable of blocking GABA(A) receptors has advantages over other manipulations, such as pharmacological application of GABAergic antagonists or optogenetic inhibition of populations of interneurones, in that the majority of inhibitory transmission is unaffected and hence the remaining network activity preserved. Here, we assess three previously described methods to block inhibition: intracellular application of the molecules picrotoxin, 4,4'-dinitro-stilbene-2,2'-disulphonic acid (DNDS) and 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid (DIDS). DNDS and picrotoxin were both found to be ineffective at blocking evoked, monosynaptic inhibitory postsynaptic currents (IPSCs) onto mouse CA1 pyramidal cells. An intracellular solution containing DIDS and caesium fluoride, but lacking nucleotides ATP and GTP, was effective at decreasing the amplitude of IPSCs. However, this effect was found to be independent of DIDS, and the absence of intracellular nucleotides, and was instead due to the presence of fluoride ions in this intracellular solution, which also blocked spontaneously occurring IPSCs during hippocampal sharp waves. Critically, intracellular fluoride ions also caused a decrease in both spontaneous and evoked excitatory synaptic currents and precluded the inclusion of nucleotides in the intracellular solution. Therefore, of the methods tested, only fluoride ions were effective for intracellular blockade of IPSCs but this approach has additional cellular effects reducing its selectivity and utility.	[Atherton, Laura A.; Burnell, Erica S.; Mellor, Jack R.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Bristol, Avon, England; [Atherton, Laura A.] Univ Bristol, Sch Engn Math, Bristol, Avon, England	University of Bristol; University of Bristol	Mellor, JR (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Ctr Synapt Plast, Bristol, Avon, England.	Jack.Mellor@bristol.ac.uk	MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Burnell, Erica/0000-0001-8257-3491	Engineering and Physical Sciences Research Council; Eli Lilly Company; Biotechnology and Biological Sciences Research Council UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/N013956/1, BB/K000454/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1280505] Funding Source: researchfish; Wellcome Trust [101029/Z/13/Z] Funding Source: researchfish; BBSRC [BB/K000454/1, BB/N013956/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Eli Lilly Company(Eli Lilly); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LAA supported by Engineering and Physical Sciences Research Council and Eli Lilly & Company, ESB supported by Biotechnology and Biological Sciences Research Council UK, and JRM supported by Wellcome Trust and Biotechnology and Biological Sciences Research Council UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEBE W, 1995, J CARDIOVASC PHARM, V26, P153, DOI 10.1097/00005344-199507000-00024; Adamek Ewa, 2005, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V51, P69; Aivar P, 2014, J NEUROSCI, V34, P2989, DOI 10.1523/JNEUROSCI.2826-13.2014; AKAIKE N, 1985, EXPERIENTIA, V41, P70; AKAIKE N, 1989, J NEUROPHYSIOL, V62, P1388, DOI 10.1152/jn.1989.62.6.1388; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; BEAR MF, 1992, J NEUROPHYSIOL, V67, P841, DOI 10.1152/jn.1992.67.4.841; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Blundon JA, 2011, J NEUROSCI, V31, P16012, DOI 10.1523/JNEUROSCI.3281-11.2011; Bolea S, 1999, J NEUROPHYSIOL, V81, P2095, DOI 10.1152/jn.1999.81.5.2095; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Born G, 2014, P NATL ACAD SCI USA, V111, pE1274, DOI 10.1073/pnas.1312112111; BOWERY NG, 1974, BRIT J PHARMACOL, V50, P205, DOI 10.1111/j.1476-5381.1974.tb08563.x; BRIDGES RJ, 1989, AM J PHYSIOL, V256, pC902, DOI 10.1152/ajpcell.1989.256.4.C902; CABANTCHIK ZI, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Covic EN, 2011, CEREB CORTEX, V21, P2425, DOI 10.1093/cercor/bhr029; Diaz-Quesada M, 2014, J NEUROSCI, V34, P515, DOI 10.1523/JNEUROSCI.2441-13.2014; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; English DF, 2014, J NEUROSCI, V34, P16509, DOI 10.1523/JNEUROSCI.2600-14.2014; FALKE JJ, 1986, BIOCHEMISTRY-US, V25, P7888, DOI 10.1021/bi00372a015; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P2139, DOI 10.1152/jn.1997.77.4.2139; Hajos N, 2013, J NEUROSCI, V33, P11677, DOI 10.1523/JNEUROSCI.5729-12.2013; Hajos N, 2009, EUR J NEUROSCI, V29, P319, DOI 10.1111/j.1460-9568.2008.06577.x; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hofer KT, 2015, HIPPOCAMPUS, V25, P169, DOI 10.1002/hipo.22361; Hollrigel GS, 1998, J NEUROPHYSIOL, V80, P2340, DOI 10.1152/jn.1998.80.5.2340; INOMATA N, 1988, NEUROSCI RES, V6, P72, DOI 10.1016/0168-0102(88)90007-7; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Khalilov I, 2014, BIOL MEMBRANY, V31, P25, DOI 10.7868/S023347551401006X; Khazipov R, 1997, J PHYSIOL-LONDON, V498, P763, DOI 10.1113/jphysiol.1997.sp021900; KOKUBUN S, 1991, PFLUG ARCH EUR J PHY, V418, P204, DOI 10.1007/BF00370515; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Lovett-Barron M, 2014, SCIENCE, V343, P857, DOI 10.1126/science.1247485; Luna VM, 2008, J NEUROSCI, V28, P8851, DOI 10.1523/JNEUROSCI.2385-08.2008; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Maier N, 2011, NEURON, V72, P137, DOI 10.1016/j.neuron.2011.08.016; Maier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006925; Mancilla JG, 2001, VISUAL NEUROSCI, V18, P9, DOI 10.1017/S0952523801181022; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P131, DOI 10.1113/jphysiol.1989.sp017831; METHERATE R, 1993, J NEUROSCI, V13, P5312, DOI 10.1523/JNEUROSCI.13-12-05312.1993; MILES R, 1983, NATURE, V306, P371, DOI 10.1038/306371a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NEWLAND CF, 1992, J PHYSIOL-LONDON, V447, P191, DOI 10.1113/jphysiol.1992.sp018998; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rademacher DJ, 2010, J NEUROSCI, V30, P4676, DOI 10.1523/JNEUROSCI.6165-09.2010; Rosenkranz JA, 2010, BIOL PSYCHIAT, V67, P1128, DOI 10.1016/j.biopsych.2010.02.008; Roux L, 2014, CURR OPIN NEUROBIOL, V26, P88, DOI 10.1016/j.conb.2013.12.013; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Schlingloff D, 2014, J NEUROSCI, V34, P11385, DOI 10.1523/JNEUROSCI.0867-14.2014; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHIRASAKI T, 1992, J PHYSIOL-LONDON, V449, P551, DOI 10.1113/jphysiol.1992.sp019101; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SIGEL E, 1988, J NEUROSCI, V8, P289; SINGH AK, 1991, AM J PHYSIOL, V261, pC51, DOI 10.1152/ajpcell.1991.261.1.C51; Smirnov S, 1999, J NEUROSCI, V19, P9252; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spruston N, 2008, NAT NEUROSCI, V11, P733, DOI 10.1038/nn0708-733; Stark E, 2014, NEURON, V83, P467, DOI 10.1016/j.neuron.2014.06.023; STELZER A, 1988, SCIENCE, V241, P339, DOI 10.1126/science.2455347; STEWARD O, 1990, BRAIN RES, V516, P292, DOI 10.1016/0006-8993(90)90930-A; Susa M, 1999, INT J MOL MED, V3, P115; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vida I, 2006, NEURON, V49, P107, DOI 10.1016/j.neuron.2005.11.036; Volgyi B, 2002, J PHYSIOL-LONDON, V539, P603, DOI 10.1013/jphysiol.2001.013133; Wang PY, 2001, AM J PHYSIOL-LUNG C, V281, pL1472, DOI 10.1152/ajplung.2001.281.6.L1472; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; YAKUSHIJI T, 1987, NEUROSCIENCE, V22, P1123, DOI 10.1016/0306-4522(87)92987-3; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Zemankovics R, 2013, J NEUROSCI, V33, P12337, DOI 10.1523/JNEUROSCI.3680-12.2013; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	95	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160900	10.1371/journal.pone.0160900	http://dx.doi.org/10.1371/journal.pone.0160900			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501143	Green Submitted, gold, Green Published			2022-12-26	WOS:000381373500065
J	Schmutz, S; Valente, M; Cumano, A; Novault, S				Schmutz, Sandrine; Valente, Mariana; Cumano, Ana; Novault, Sophie			Spectral Cytometry Has Unique Properties Allowing Multicolor Analysis of Cell Suspensions Isolated from Solid Tissues	PLOS ONE			English	Article							T-CELLS; PROGENITOR CELLS; FLOW-CYTOMETRY; CARDIOMYOCYTE; ORIGIN; MOUSE; HOST; FATE; STEM	Flow cytometry, initially developed to analyze surface protein expression in hematopoietic cells, has increased in analytical complexity and is now widely used to identify cells from different tissues and organisms. As a consequence, data analysis became increasingly difficult due the need of largemulti-parametric compensation matrices and to the eventual auto-fluorescence frequently found in cell suspensions obtained from solid organs. In contrast with conventional flow cytometry that detects the emission peak of fluorochromes, spectral flow cytometry distinguishes the shapes of emission spectra along a large range of continuous wave lengths. The data is analyzed with an algorithm that replaces compensation matrices and treats auto-fluorescence as an independent parameter. Thus, spectral flow cytometry should be capable to discriminate fluorochromes with similar emission peaks and providemulti-parametric analysis without compensation requirements. Here we show that spectral flow cytometry achieves a 21-parametric (19 fluorescent probes) characterization and deals with auto-fluorescent cells, providing high resolution of specifically fluorescence-labeled populations. Our results showed that spectral flow cytometry has advantages in the analysis of cell populations of tissues difficult to characterize in conventional flow cytometry, such as heart and intestine. Spectral flow cytometry thus combines themulti-parametric analytical capacity of the highest performing conventional flow cytometry without the requirement for compensation and enabling auto-fluorescence management.	[Schmutz, Sandrine; Novault, Sophie] Inst Pasteur, Flow Cytometry Core Facil, Paris, France; [Valente, Mariana; Cumano, Ana] Inst Pasteur, Dept Immunol, Lymphopoiesis Unit, Paris, France; [Valente, Mariana; Cumano, Ana] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Valente, Mariana; Cumano, Ana] INSERM, U1223, Paris, France; [Valente, Mariana] Inst Invest & Inovacao Saude i3s, Oporto, Portugal; [Valente, Mariana] INEB Inst Engn Biomed, Stem Cell Microenvironm Repair Regenerat Team, Microenvironm Newtherapies Grp, Oporto, Portugal; [Valente, Mariana] Univ Porto, ICBAS, Oporto, Portugal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Cumano, A (corresponding author), Inst Pasteur, Dept Immunol, Lymphopoiesis Unit, Paris, France.; Cumano, A (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France.; Cumano, A (corresponding author), INSERM, U1223, Paris, France.	ana.cumano@pasteur.fr	VOUGNY, Marie-Christine/K-8938-2017; Valente, Mariana/D-9692-2014	Valente, Mariana/0000-0002-0735-6814; novault, sophie/0000-0001-5708-3597	Pasteur Institute; Institut National de la Sante et de la Recherche Medicale (INSERM); Swiss National Science Foundation; Pasteur Bourse Roux; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/74218/2010]; Universite Paris Diderot; Agence Nationale de la Recherche (ANR)	Pasteur Institute; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Pasteur Bourse Roux; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Universite Paris Diderot; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Pasteur Institute, Institut National de la Sante et de la Recherche Medicale (INSERM), Swiss National Science Foundation (SS), Pasteur Bourse Roux (SS), Fundacao para a Ciencia e a Tecnologia - SFRH/BD/74218/2010 (MV), Universite Paris Diderot (AC), and the Agence Nationale de la Recherche (ANR) project Twothyme and the ANR Program REVIVE (Investment for the Future) (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Futamura K, 2015, CYTOM PART A, V87A, P830, DOI 10.1002/cyto.a.22725; Grigoriadou K, 2002, J IMMUNOL, V169, P3736, DOI 10.4049/jimmunol.169.7.3736; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Keith MCL, 2015, CIRC RES, V116, P1216, DOI 10.1161/CIRCRESAHA.116.305557; Lavoinne A, 2004, REV MED INTERNE, V25, P115, DOI 10.1016/S0248-8663(03)00218-2; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Ponten A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082403; Roederer Mario, 2002, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0508s49; Staudt DW, 2014, DEVELOPMENT, V141, P585, DOI 10.1242/dev.098632; Suetsugu A, 2012, ANTICANCER RES, V32, P31; Valente M, 2014, STEM CELLS DEV, V23, P2263, DOI 10.1089/scd.2014.0197; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387	19	29	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0159961	10.1371/journal.pone.0159961	http://dx.doi.org/10.1371/journal.pone.0159961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500930	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500010
J	Yamamoto, M; Zhao, M; Hiroshima, Y; Zhang, Y; Shurell, E; Eilber, FC; Bouvet, M; Noda, M; Hoffman, RM				Yamamoto, Mako; Zhao, Ming; Hiroshima, Yukihiko; Zhang, Yong; Shurell, Elizabeth; Eilber, Fritz C.; Bouvet, Michael; Noda, Makoto; Hoffman, Robert M.			Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; HUMAN PANCREATIC-CANCER; HUMAN OVARIAN-CANCER; TYPHIMURIUM A1-R; BREAST-CANCER; ATTENUATED SALMONELLA; METASTATIC MELANOMA; LUNG METASTASIS; ENGINEERED SALMONELLA; IMMUNOCOMPETENT MICE	Tumor-targeting Salmonella enterica serovar Typhimurium A1-R (Salmonella A1-R) had strong efficacy on a melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. GFP-expressing Salmonella A1-R highly and selectively colonized the PDOX melanoma and significantly suppressed tumor growth (p = 0.021). The combination of Salmonella A1-R and cisplatinum (CDDP), both at low-dose, also significantly suppressed the growth of the melanoma PDOX (P = 0.001). Salmonella A1-R has future clinical potential for combination chemotherapy with CDDP of melanoma, a highly-recalcitrant cancer.	[Yamamoto, Mako; Zhao, Ming; Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, Ostrow St, San Diego, CA 92111 USA; [Yamamoto, Mako; Hiroshima, Yukihiko; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, West Arbor Dr, San Diego, CA 92103 USA; [Noda, Makoto] Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan; [Shurell, Elizabeth; Eilber, Fritz C.] Univ Calif Los Angeles, Div Surg Oncol, Los Angeles, CA USA	Anti Cancer Inc; University of California System; University of California San Diego; Kyoto University; University of California System; University of California Los Angeles	Hoffman, RM (corresponding author), AntiCancer Inc, Ostrow St, San Diego, CA 92111 USA.; Hoffman, RM (corresponding author), Univ Calif San Diego, Dept Surg, West Arbor Dr, San Diego, CA 92103 USA.	all@anticancer.com			National Cancer Institute [CA183280]; AntiCancer Inc.	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AntiCancer Inc.(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This study was supported by National Cancer Institute grant number CA183280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AntiCancer Inc. provided support in the form of salary for authors [MZ and YZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Astoul P, 1996, ONCOL REP, V3, P483; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Forbes NS, 2010, NAT REV CANCER, V10, P784, DOI 10.1038/nrc2934; Forbes NS, 2003, CANCER RES, V63, P5188; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1993, ANTICANCER RES, V13, P283; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, CANCER RES, V53, P1204; Ganai S, 2011, CANCER GENE THER, V18, P457, DOI 10.1038/cgt.2011.10; Gandini S, 2016, CRIT REV ONCOL HEMAT, V100, P88, DOI 10.1016/j.critrevonc.2016.02.001; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134324; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120358; Hiroshima Y, 2015, ANTICANCER RES, V35, P697; Hiroshima Y, 2014, ONCOTARGET, V5, P12346, DOI 10.18632/oncotarget.2641; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; Hoffman RM, 2015, NAT REV CANCER, V15, P451, DOI 10.1038/nrc3972; Kasinskas RW, 2007, CANCER RES, V67, P3201, DOI 10.1158/0008-5472.CAN-06-2618; Kasinskas RW, 2006, BIOTECHNOL BIOENG, V94, P710, DOI 10.1002/bit.20883; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Kiyuna T, 2016, ONCOTARGET IN PRESS; Kufe DW, 2003, HOLLAND FREI CANC ME, V6th; Li YH, 2001, ACTA BIOCH BIOPH SIN, V33, P233; Li YH, 2001, INT J CANCER, V94, P438, DOI 10.1002/ijc.1489; Liu F, 2010, CELL CYCLE, V9, P4518, DOI 10.4161/cc.9.22.13744; Low KB, 1999, NAT BIOTECHNOL, V17, P37, DOI 10.1038/5205; Luo X, 2001, ONCOL RES, V12, P501, DOI 10.3727/096504001108747512; Matsumoto Y, 2015, ONCOTARGET, V6, P11369, DOI 10.18632/oncotarget.3607; Matsumoto Y, 2014, J CELL BIOCHEM, V115, P1996, DOI 10.1002/jcb.24871; Miwa S, 2014, ONCOTARGET, V5, P12849, DOI 10.18632/oncotarget.2561; Miwa S, 2014, J SURG RES, V192, P124, DOI 10.1016/j.jss.2014.05.049; Miwa S, 2014, ONCOTARGET, V5, P7119, DOI 10.18632/oncotarget.2226; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Murakami T, 2016, ONCOTARGET, V7, P12783, DOI 10.18632/oncotarget.7226; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Pawelek JM, 1997, CANCER RES, V57, P4537; Pawelek JM, 2003, LANCET ONCOL, V4, P548, DOI 10.1016/S1470-2045(03)01194-X; Platt J, 2000, EUR J CANCER, V36, P2397, DOI 10.1016/S0959-8049(00)00336-1; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Tang HD, 2016, CANCER CELL, V29, P285, DOI 10.1016/j.ccell.2016.02.004; Tome Y, 2013, ANTICANCER RES, V33, P97; Toso JF, 2002, J CLIN ONCOL, V20, P142, DOI 10.1200/JCO.20.1.142; Uchugonova A, 2012, ANTICANCER RES, V32, P4331; Uehara F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116865; WANG XO, 1992, INT J CANCER, V51, P992; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Zhang Y, 2015, ONCOTARGET, V6, P2615, DOI 10.18632/oncotarget.2811; Zhang Y, 2012, ANTICANCER RES, V32, P2501; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao M, 2012, CELL CYCLE, V11, P187, DOI 10.4161/cc.11.1.18667; Zheng LM, 2000, ONCOL RES, V12, P127, DOI 10.3727/096504001108747602	59	82	82	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160882	10.1371/journal.pone.0160882	http://dx.doi.org/10.1371/journal.pone.0160882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500926	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500062
J	Richard, J; Kim, ED; Nguyen, H; Kim, CD; Kim, S				Richard, Jessica; Kim, Elizabeth D.; Hoang Nguyen; Kim, Catherine D.; Kim, Sunyoung			Allostery Wiring Map for Kinesin Energy Transduction and Its Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DOUBLE-MUTANT CYCLES; PHYLOGENETIC TREES; NECK-LINKER; LONG-RANGE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; MOLECULAR MOTORS; ACTIVE-SITE; PROTEINS	How signals between the kinesin active and cytoskeletal binding sites are transmitted is an open question and an allosteric question. By extracting correlated evolutionary changes within 700+ sequences, we built a model of residues that are energetically coupled and that define molecular routes for signal transmission. Typically, these coupled residues are located at multiple distal sites and thus are predicted to form a complex, non-linear network that wires together different functional sites in the protein. Of note, our model connected the site for ATP hydrolysis with sites that ultimately utilize its free energy, such as the microtubule-binding site, drug-binding loop 5, and necklinker. To confirm the calculated energetic connectivity between non-adjacent residues, double-mutant cycle analysis was conducted with 22 kinesin mutants. There was a direct correlation between thermodynamic coupling in experiment and evolutionarily derived energetic coupling. We conclude that energy transduction is coordinated by multiple distal sites in the protein rather than only being relayed through adjacent residues. Moreover, this allosteric map forecasts how energetic orchestration gives rise to different nanomotor behaviors within the superfamily.	Louisiana State Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Kim, Sunyoung] Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA	Louisiana State University System	Kim, S (corresponding author), Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.; Kim, S (corresponding author), LSU Sch Med, 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu			National Institutes of Health [R01GM097350]; Louisiana Board of Regents; School of Graduate Studies at Louisiana State University Health Sciences Center in New Orleans; Louisiana State University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; School of Graduate Studies at Louisiana State University Health Sciences Center in New Orleans; Louisiana State University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM097350 (to S. K.) and by funds from the Louisiana Board of Regents (to S. K.), the School of Graduate Studies at Louisiana State University Health Sciences Center in New Orleans (to J. R.), and Louisiana State University School of Medicine (to H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2010, PROTEIN ENG DES SEL, V23, P321, DOI 10.1093/protein/gzp078; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Caraglio M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062712; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Friel CT, 2012, J MUSCLE RES CELL M, V33, P377, DOI 10.1007/s10974-012-9289-6; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; HOROVITZ A, 1994, J MOL BIOL, V238, P133, DOI 10.1006/jmbi.1994.1275; Howard J., 2011, POINC SEM 2009; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Istomin AY, 2008, PROTEINS, V70, P915, DOI 10.1002/prot.21620; Juanico B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238104; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0; Lawrence CJ, 2002, J MOL EVOL, V54, P42, DOI 10.1007/s00239-001-0016-y; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LEVY RM, 1982, P NATL ACAD SCI USA, V79, P1346, DOI 10.1073/pnas.79.4.1346; LICATA VJ, 1995, BIOCHEMISTRY-US, V34, P3133, DOI 10.1021/bi00010a001; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu LQ, 2014, J BIOL CHEM, V289, P16601, DOI 10.1074/jbc.M114.551408; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luccioli S, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/046008; Ma CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026453; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MILDVAN AS, 1992, ARCH BIOCHEM BIOPHYS, V294, P327, DOI 10.1016/0003-9861(92)90692-P; Miller M. A., 2010, P GAT COMP ENV WORKS, ps1; Nicolai A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18128; Oster G., 2002, MOL MOTORS; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pervez MT, 2014, EVOL BIOINFORM, V10, DOI 10.4137/EBO.S19199; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Prosdocimi F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-5; Reynolds KA, 2013, METHOD ENZYMOL, V523, P213, DOI 10.1016/B978-0-12-394292-0.00010-2; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Scarabelli G, 2014, BIOPHYS J, V107, P2204, DOI 10.1016/j.bpj.2014.09.019; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; van den Berg BHJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010642; Vologodskii A, 2006, PHYS LIFE REV, V3, P119, DOI 10.1016/j.plrev.2006.02.002; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-110; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023; Yu J., 2012, SATE	71	8	8	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					20932	20945		10.1074/jbc.M116.733675	http://dx.doi.org/10.1074/jbc.M116.733675			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27507814	hybrid, Green Published			2022-12-26	WOS:000385406200012
J	Suess, PM; Gomer, RH				Suess, Patrick M.; Gomer, Richard H.			Extracellular Polyphosphate Inhibits Proliferation in an Autocrine Negative Feedback Loop in Dictyostelium discoideum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell growth; cell proliferation; Dictyostelium; stress; inositol hexakisphosphate kinase; polyphosphate; polyphosphate kinase	REPRESSES CELL-PROLIFERATION; INORGANIC POLYPHOSPHATE; STATIONARY-PHASE; SACCHAROMYCES-CEREVISIAE; EPIDERMAL CHALONE; ESCHERICHIA-COLI; RECEPTOR-BINDING; GROWTH; MOLECULE; KINASE	Polyphosphate is a polymer of phosphate residues linked by high energy phosphoanhydride bonds. Despite being highly conserved throughout nature, its function is poorly understood. Here we show that Dictyostelium cells accumulate extracellular polyphosphate, and this acts to inhibit proliferation at high cell densities. In shaking culture, extracellular polyphosphate concentrations increase as cell density increases, and if the concentration of polyphosphate observed at the stationary phase is added to cells at mid-log, proliferation is halted. Adding an exopolyphosphatase to cell cultures or stationary phase conditioned medium decreases polyphosphate levels and abrogates the anti-proliferative effect. The cells show saturable binding of polyphosphate, suggesting the presence of a cell surface polyphosphate receptor. Extracellular polyphosphate accumulation is potentiated by decreased nutrient levels, potentially as a means to anticipate starvation. Loss of the Dictyostelium polyphosphate kinase DdPpk1 causes intracellular polyphosphate levels to become undetectable and negatively affects fitness, cytokinesis, and germination. However, cells lacking DdPpk1 accumulate approximate to 50% normal levels of extracellular polyphosphate, suggesting an additional means of synthesis. We found that cells lacking inositol hexakisphosphate kinase, which is responsible for the synthesis of the inositol pyrophosphates IP7 and IP8, reach abnormally high cell densities and show decreased extracellular polyphosphate levels. Two different enzymes thus appear to mediate the synthesis of Dictyostelium extracellular polyphosphate, which is used as a signal in an autocrine negative feedback loop to regulate cell proliferation.	[Suess, Patrick M.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, ILSB 301 Old Main Dr, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, ILSB 301 Old Main Dr, College Stn, TX 77843 USA.	rgomer@tamu.edu		Suess, Patrick/0000-0002-9805-9005; Gomer, Richard/0000-0003-2361-4307	National Institutes of Health [R01 GM102280]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102280] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health R01 GM102280. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achbergerova L, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-63; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; BOLDINGH WH, 1968, EUR J BIOCHEM, V5, P191; BRITIGAN BE, 1994, ADV EXP MED BIOL, V357, P143; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; BULLOUGH WS, 1965, CANCER RES, V25, P1683; BULLOUGH WS, 1964, EXP CELL RES, V36, P192, DOI 10.1016/0014-4827(64)90172-7; CATERINA MJ, 1995, J BIOL CHEM, V270, P4418, DOI 10.1074/jbc.270.9.4418; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Choi SH, 2010, BIOCHEMISTRY-US, V49, P9935, DOI 10.1021/bi1014437; Ghosh S, 2013, BLOOD, V122, P1478, DOI 10.1182/blood-2013-01-481549; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Kolozsvari B, 2014, BIOCHEM J, V460, P377, DOI 10.1042/BJ20140237; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Livermore TM, 2016, P NATL ACAD SCI USA, V113, P996, DOI 10.1073/pnas.1519440113; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; LOW JE, 1986, J PHARMACOL EXP THER, V238, P39; Luo HBR, 2003, CELL, V114, P559, DOI 10.1016/S0092-8674(03)00640-8; METCALF D, 1964, TRANSPLANTATION, V2, P387, DOI 10.1097/00007890-196405000-00008; Michalopoulos GK, 2005, ADV BIOCHEM ENG BIOT, V93, P101, DOI 10.1007/b99968; Morrissey JH, 2013, BLOOD, V122, P1331, DOI 10.1182/blood-2013-07-511006; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller A, 1996, J IMMUNOL, V156, P3418; Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001; Nikel PI, 2013, MICROB CELL FACT, V12, DOI [10.1186/s12934-014-0159-3, 10.1186/1475-2859-12-50]; PEERS FG, 1953, BIOCHEM J, V53, P102, DOI 10.1042/bj0530102; Phillips JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096633; Pisani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085533; Rao N N, 1999, Prog Mol Subcell Biol, V23, P183; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; SAETREN H, 1956, EXP CELL RES, V11, P229, DOI 10.1016/0014-4827(56)90212-9; Saiardi Adolfo, 2012, Advances in Biological Regulation, V52, P351, DOI 10.1016/j.jbior.2012.03.002; SASSIER P, 1977, CELL TISSUE KINET, V10, P223, DOI 10.1111/j.1365-2184.1977.tb00290.x; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; SODA R, 1984, BLOOD, V63, P270; SOLL DR, 1976, J CELL SCI, V20, P513; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; WURST H, 1994, J BIOL CHEM, V269, P10996; WURSTER B, 1980, EUR J BIOCHEM, V109, P613, DOI 10.1111/j.1432-1033.1980.tb04834.x; Yamanaka Y, 1999, ENDOCRINOLOGY, V140, P1319, DOI 10.1210/en.140.3.1319; YARGER J, 1974, J CELL SCI, V14, P681; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104; Zhang HY, 2005, P NATL ACAD SCI USA, V102, P2731, DOI 10.1073/pnas.0500023102	52	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20260	20269		10.1074/jbc.M116.737825	http://dx.doi.org/10.1074/jbc.M116.737825			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27519410	hybrid, Green Published			2022-12-26	WOS:000383243100044
J	Lange, N; Tontsa, AT; Wegscheid, C; Mkounga, P; Nkengfack, AE; Loscher, C; Sass, G; Tiegs, G				Lange, Nicole; Tontsa, Armelle Tsamo; Wegscheid, Claudia; Mkounga, Pierre; Nkengfack, Augustin Ephrem; Loscher, Christine; Sass, Gabriele; Tiegs, Gisa			The Limonoids TS3 and Rubescin E Induce Apoptosis in Human Hepatoma Cell Lines and Interfere with NF-kappa B Signaling	PLOS ONE			English	Article							CASPASE-DEPENDENT APOPTOSIS; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; CANCER; LIVER; EXPRESSION; NIMBOLIDE; GROWTH; PROTEINS; 5-FLUOROURACIL	Hepatocellular carcinoma (HCC) is extremely resistant towards pharmacological therapy. To date, the multi-kinase inhibitor Sorafenib is the only available therapeutic agent with the potential to prolong patient survival. Using the human hepatoma cell lines HepG2 and Huh7, we analyzed anti-cancer activities of 6 purified havanensin type limonoids isolated from the traditional African medicinal plant Trichilia rubescens Oliv. Our results show that two of the compounds, TR4 (TS3) and TR9 (Rubescin E) reduced hepatoma cell viability, but not primary hepatocyte viability, at TC50s of 5 to 10 mu M. These were significantly lower than the TC50s for Sorafenib, the histone deacetylase inhibitor SAHA or 5-Fluoruracil. In comparison, TR3 (Rubescin D), a limonoid isolated in parallel and structurally highly similar to TR4 and TR9, did not interfere with hepatoma cell viability. Both, TR4 and TR9, but not TR3, induced apoptosis in hepatoma cells and interfered with NF-kappa B activation. TR4 as well as TR9 significantly supported anti-cancer activities of Sorafenib. In summary, the limonoids TR4 and TR9 exhibit anti-cancer activities and support Sorafenib effects in vitro, having the potential to support future HCC therapy.	[Lange, Nicole; Wegscheid, Claudia; Loscher, Christine; Sass, Gabriele; Tiegs, Gisa] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany; [Tontsa, Armelle Tsamo; Mkounga, Pierre; Nkengfack, Augustin Ephrem] Univ Yaounde I, Dept Organ Chem, POB 812, Yaounde, Cameroon; [Sass, Gabriele] Calif Inst Med Res, San Jose, CA 95128 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Yaounde I	Tiegs, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany.	g.tiegs@uke.de		Armelle, Tsamo Tontsa/0000-0001-5672-046X	Else-Kroner-Fresenius-Stiftung, Bad Homburg, Germany [2013_A199]	Else-Kroner-Fresenius-Stiftung, Bad Homburg, Germany	This work was supported by Else-Kroner-Fresenius-Stiftung, Bad Homburg, Germany, Grant No 2013_A199 (www.ekfs.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Armelle TT PN, 2016, MED CHEM; Babykutty S, 2012, MOL CARCINOGEN, V51, P475, DOI 10.1002/mc.20812; Balsells J, 1996, BRIT J SURG, V83, P758, DOI 10.1002/bjs.1800830610; Busia K, 2005, PHYTOTHER RES, V19, P919, DOI 10.1002/ptr.1775; Cauchy F, 2012, LANGENBECK ARCH SURG, V397, P681, DOI 10.1007/s00423-012-0911-2; CHAMPAGNE DE, 1992, PHYTOCHEMISTRY, V31, P377, DOI 10.1016/0031-9422(92)90003-9; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; DARLINGTON GJ, 1980, J NATL CANCER I, V64, P809; deCarvalho ACV, 2002, MOL MED, V8, P75, DOI 10.1007/BF03402077; Elumalai P, 2012, TOXICOL LETT, V215, P131, DOI 10.1016/j.toxlet.2012.10.008; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Gonzalez-Vallinas M, 2013, NUTR REV, V71, P585, DOI 10.1111/nure.12051; Gouvea CF, 2008, ANN BOT-LONDON, V101, P39, DOI 10.1093/aob/mcm279; Gupta SC, 2011, J BIOL CHEM, V286, P1134, DOI 10.1074/jbc.M110.191379; Gupta SC, 2010, J BIOL CHEM, V285, P35406, DOI 10.1074/jbc.M110.161984; Hirchaud F, 2013, PLANTA MED, V79, P1628, DOI 10.1055/s-0033-1350956; Huang XH, 2014, ONCOTARGET, V5, P5570, DOI 10.18632/oncotarget.2141; Johnson PJ, 2002, GUT, V51, P459, DOI 10.1136/gut.51.4.459; Joshi P, 2014, STEROIDS, V79, P19, DOI 10.1016/j.steroids.2013.10.008; Karou Simplice D, 2011, Pak J Biol Sci, V14, P149, DOI 10.3923/pjbs.2011.149.169; Kavitha K, 2012, EUR J PHARMACOL, V681, P6, DOI 10.1016/j.ejphar.2012.01.024; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Li Y, 2013, TOXICOL APPL PHARM, V272, P37, DOI 10.1016/j.taap.2013.05.031; Liu ZL, 2014, J INTEGR MED-JIM, V12, P346, DOI 10.1016/S2095-4964(14)60034-0; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Louppe D., 2008, Bois d'oeuvre 1; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; Mehnert JM, 2007, CANCER J, V13, P23, DOI 10.1097/PPO.0b013e31803c72ba; Mulholland DA, 2000, CURR ORG CHEM, V4, P1011, DOI 10.2174/1385272003375941; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakatani M., 2004, LIMONOIDS MELIACEAE; Nishiumi Shin, 2011, Front Biosci (Schol Ed), V3, P1332; Nowak AK, 2004, EUR J CANCER, V40, P1474, DOI 10.1016/j.ejca.2004.02.027; Ocker M, 2005, J CANCER RES CLIN, V131, P385, DOI 10.1007/s00432-004-0664-6; Ozturk S, 2012, EXP CELL RES, V318, P1324, DOI 10.1016/j.yexcr.2012.01.019; Ortiz LMG, 2014, MOLECULES, V19, P12349, DOI 10.3390/molecules190812349; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pratheeshkumar P, 2012, INTEGR CANCER THER, V11, P48, DOI 10.1177/1534735411403307; Premratanachai Pongsathon, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P337, DOI 10.12980/APJTB.4.2014C1262; Sass G, 2007, J IMMUNOL, V179, P7042, DOI 10.4049/jimmunol.179.10.7042; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; Shirley S, 2013, CANCER LETT, V332, P141, DOI 10.1016/j.canlet.2010.10.009; Sieber S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029993; Tian QG, 2001, NUTR CANCER, V40, P180, DOI 10.1207/S15327914NC402_15; Tsai SC, 2012, INT J ONCOL, V41, P1431, DOI 10.3892/ijo.2012.1579; Tsamo TA MP, 2013, CHEM PHARM BULL, V61, P1; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159; Venturelli S, 2007, CANCER, V109, P2132, DOI 10.1002/cncr.22652; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Yamashita T, 2011, ONCOLOGY-BASEL, V81, P281, DOI 10.1159/000334439; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang HP, 2007, PHYTOTHER RES, V21, P731, DOI 10.1002/ptr.2148; Zhang LY, 2010, HEPATOLOGY, V51, P690, DOI 10.1002/hep.23384; Zhou J, 2014, J TRADIT CHIN MED, V34, P100, DOI 10.1016/S0254-6272(14)60062-5	60	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160843	10.1371/journal.pone.0160843	http://dx.doi.org/10.1371/journal.pone.0160843			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518192	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100027
J	Santos, FLN; Celedon, PAF; Zanchin, NIT; Brasil, TDC; Foti, L; de Souza, WV; Silva, ED; Gomes, YD; Krieger, MA				Neves Santos, Fred Luciano; Fiorani Celedon, Paola Alejandra; Tonin Zanchin, Nilson Ivo; Campos Brasil, Tatiana de Arruda; Foti, Leonardo; de Souza, Wayner Vieira; Silva, Edmilson Domingos; Gomes, Yara de Miranda; Krieger, Marco Aurelio			Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease	PLOS ONE			English	Article							SYNTHETIC PEPTIDE; SEROLOGICAL DIAGNOSIS; RECOMBINANT ANTIGENS; CLINICAL-DIAGNOSIS; PROTEIN; SERODIAGNOSIS; EPITOPE; ASSAY; DETERMINANTS; IMMUNOASSAY	The performance of serologic tests in chronic Chagas disease diagnosis largely depends on the type and quality of the antigen preparations that are used for detection of anti-Trypanosoma cruzi antibodies. Whole-cell T. cruzi extracts or recombinant proteins have shown variation in the performance and cross-reactivity. Synthetic chimeric proteins comprising fragments of repetitive amino acids of several different proteins have been shown to improve assay performances to detect Chagasic infections. Here, we describe the production of four chimeric T. cruzi proteins and the assessment of their performance for diagnostic purposes. Circular Dichroism spectra indicated the absence of well-defined secondary structures, while polydispersity evaluated by Dynamic Light Scattering revealed only minor aggregates in 50 mM carbonate-bicarbonate (pH 9.6), demonstrating that it is an appropriate buffering system for sensitizing microplates. Serum samples from T. cruzi-infected and non-infected individuals were used to assess the performance of these antigens for detecting antibodies against T. cruzi, using both enzyme-linked immunosorbent assay and a liquid bead array platform. Performance parameters (AUC, sensitivity, specificity, accuracy and J index) showed high diagnostic accuracy for all chimeric proteins for detection of specific anti-T. cruzi antibodies and differentiated seropositive individuals from those who were seronegative. Our data suggest that these four chimeric proteins are eligible for phase II studies.	[Neves Santos, Fred Luciano; de Souza, Wayner Vieira; Gomes, Yara de Miranda] FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil; [Fiorani Celedon, Paola Alejandra; Tonin Zanchin, Nilson Ivo; Foti, Leonardo; Krieger, Marco Aurelio] Mol Biol Inst Parana, Curitiba, PR, Brazil; [Tonin Zanchin, Nilson Ivo; Campos Brasil, Tatiana de Arruda; Foti, Leonardo; Krieger, Marco Aurelio] FIOCRUZ PR, Carlos Chagas Inst, Curitiba, PR, Brazil; [Silva, Edmilson Domingos] FIOCRUZ RJ, Biomanguinhos, Rio De Janeiro, RJ, Brazil; [Neves Santos, Fred Luciano] FIOCRUZ BA, Goncalo Moniz Res Ctr, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Santos, FLN (corresponding author), FIOCRUZ PE, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.; Santos, FLN (corresponding author), FIOCRUZ BA, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.	fred.santos@bahia.fiocruz.br	Foti, Leonardo/I-6677-2016; Souza, Wayner V/H-3798-2013; SANTOS, Fred/S-2954-2019; Foti, Leonardo/F-1763-2014; Zanchin, Nilson Ivo Tonin/AAB-4907-2019; Krieger, Marco/AAE-8611-2020	SANTOS, Fred/0000-0002-3944-0818; Foti, Leonardo/0000-0003-2948-9914; Zanchin, Nilson Ivo Tonin/0000-0002-1153-0694; Souza, Wayner/0000-0002-0939-9332; Krieger, Marco Aurelio/0000-0003-0030-3952; Celedon, Paola/0000-0002-1968-7039	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [404242/2012-0]; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE [APQ-1257-2.11/12]; RVE Finep [Convenio 01.13.0283.00-ref. 0473/12];  [304543/2012-8];  [306222/2013-2];  [590032/2011-9]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); RVE Finep; ; ; 	Funding support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (Proc. 404242/2012-0), Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco-FACEPE (Proc. APQ-1257-2.11/12) and RVE Finep (Convenio 01.13.0283.00-ref. 0473/12). Yara de Miranda Gomes, Wayner Vieira de Sousa, and Marco Aurelio Krieger are research fellows of CNPq Proc. No. 304543/2012-8, 306222/2013-2, and 590032/2011-9, respectively.	Ackermann AA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-736; Bottino CG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-568; Camussone C, 2009, CLIN VACCINE IMMUNOL, V16, P899, DOI 10.1128/CVI.00005-09; Thomas MC, 2012, CLIN VACCINE IMMUNOL, V19, P167, DOI 10.1128/CVI.05566-11; Chang CD, 2006, TRANSFUSION, V46, P1737, DOI 10.1111/j.1537-2995.2006.00965.x; Cheng KY, 2007, CLIN VACCINE IMMUNOL, V14, P355, DOI 10.1128/CVI.00401-06; D'Elia C, 2005, REV SOC BRAS MED TRO, V38, P7, DOI 10.1590/S0037-86822005000100002; da Silveira JF, 2001, TRENDS PARASITOL, V17, P286, DOI 10.1016/S1471-4922(01)01897-9; DaRocha W, 2002, PARASITOL RES, V88, P292, DOI 10.1007/s00436-001-0540-0; Ferreira AW, 2001, J CLIN MICROBIOL, V39, P4390, DOI 10.1128/JCM.39.12.4390-4395.2001; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Foti L, 2009, MEM I OSWALDO CRUZ, V104, P136, DOI 10.1590/S0074-02762009000900019; Gadelha AAM, 2003, VOX SANG, V85, P165, DOI 10.1046/j.1423-0410.2003.00340.x; Gomes YM, 2001, MEM I OSWALDO CRUZ, V96, P497, DOI 10.1590/S0074-02762001000400009; Gonzalez J, 2013, DIAGNOSIS TREATMENT, P105, DOI [10. 5772/ 55387, DOI 10.5772/55387]; Goto Y, 2008, INFECT IMMUN, V76, P3967, DOI 10.1128/IAI.00604-08; Hernandez P, 2010, CLIN VACCINE IMMUNOL, V17, P1598, DOI 10.1128/CVI.00489-08; HOFT DF, 1989, INFECT IMMUN, V57, P1959, DOI 10.1128/IAI.57.7.1959-1967.1989; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hotez PJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001498; Houghton RL, 2009, CLIN VACCINE IMMUNOL, V16, P515, DOI 10.1128/CVI.00383-08; Houghton RL, 1999, J INFECT DIS, V179, P1226, DOI 10.1086/314723; Houghton RL, 2000, J INFECT DIS, V181, P325, DOI 10.1086/315165; IBANEZ CF, 1988, MOL BIOCHEM PARASIT, V30, P27, DOI 10.1016/0166-6851(88)90129-6; Irwig L, 2002, BRIT MED J, V324, P669, DOI 10.1136/bmj.324.7338.669; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAFAILLE JJ, 1989, MOL BIOCHEM PARASIT, V35, P127, DOI 10.1016/0166-6851(89)90115-1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530; Machado CA, 2001, P NATL ACAD SCI USA, V98, P7396, DOI 10.1073/pnas.121187198; Manne-Goehler J, 2015, AM J TROP MED HYG, V93, P108, DOI 10.4269/ajtmh.14-0826; NETO VA, 2000, REV PATOL TROP, V29, P115; Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820; Ouchchane L, 2009, BIOSTATISTIQUE, P49; Pitcovsky TA, 2001, INFECT IMMUN, V69, P1869, DOI 10.1128/IAI.69.3.1869-1875.2001; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Reverberi Roberto, 2007, Blood Transfus, V5, P227, DOI 10.2450/2007.0047-07; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SCHOFIELD L, 1991, PARASITOL TODAY, V7, P99, DOI 10.1016/0169-4758(91)90166-L; Secretaria de Vigilancia em Saude (Ministerio da Saude do Brasil), 2015, B EPIDEMIOL, V46, P1; Teixeira-Carvalho A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122938; Umezawa ES, 2004, J CLIN MICROBIOL, V42, P449, DOI 10.1128/JCM.42.1.449-452.2004; Umezawa ES, 1999, MEM I OSWALDO CRUZ, V94, P285, DOI 10.1590/S0074-02761999000700051; Benedetti AFV, 2013, TROP MED INT HEALTH, V18, P1103, DOI 10.1111/tmi.12144; World Health Organization, 2007, WHO CONS INT BIOL RE	46	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161100	10.1371/journal.pone.0161100	http://dx.doi.org/10.1371/journal.pone.0161100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517281	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100049
J	Scholte, M; Neeleman-van der Steen, CWM; van der Wees, PJ; Nijhuis-van der Sanden, MWG; Braspenning, J				Scholte, Marijn; Neeleman-van der Steen, Catherina W. M.; van der Wees, Philip J.; Nijhuis-van der Sanden, Maria W. G.; Braspenning, Joze			The Reasons behind the (Non)Use of Feedback Reports for Quality Improvement in Physical Therapy: A Mixed-Method Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; INTRINSIC MOTIVATION; HEALTH-CARE; OF-CARE; IMPACT; CIRCLES	Objectives To explain the use of feedback reports for quality improvements by the reasons to participate in quality measuring projects and to identify barriers and facilitators. Design Mixed methods design. Methods In 2009-2011 a national audit and feedback system for physical therapy (Qualiphy) was initiated in the Netherlands. After each data collection round, an evaluation survey was held amongst its participants. The evaluation survey data was used to explain the use of feedback reports by studying the reasons to participate with Qualiphy with correlation measures and logistic regression. Semi-structured interviews with PTs served to seek confirmation and disentangle barriers and facilitators. Results Analysis of 257 surveys (response rate: 42.8%) showed that therapists with only financial reasons were less likely to use feedback reports (OR = 0.24; 95% CI = 0.11-0.52) compared to therapists with a mixture of reasons. PTs in 2009 and 2010 were more likely to use the feedback reports for quality improvement than PTs in 2011 (OR = 2.41; 95% CI = 1.25-4.64 respectively OR = 3.28; 95% CI = 1.51-7.10). Changing circumstances in 2011, i. e. using EHRs and financial incentives, had a negative effect on the use of feedback reports (OR = 0.40, 95% CI = 0.20-0.78). Interviews with 12 physical therapists showed that feedback reports could serve as a tool to support and structure quality improvement plans. Barriers were distrust and perceived self-reporting bias on indicator scores. Conclusions Implementing financial incentives that are not well-specified and well-targeted can have an adverse effect on using feedback reports to improve quality of care. Distrust is a major barrier to implementing quality systems.	[Scholte, Marijn; van der Wees, Philip J.; Nijhuis-van der Sanden, Maria W. G.; Braspenning, Joze] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Neeleman-van der Steen, Catherina W. M.] ROS Caransscoop, Beekbergen, Netherlands; [Scholte, Marijn] Radboud Univ Nijmegen, Dept Social Sci, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Scholte, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Inst Qual Healthcare, Nijmegen, Netherlands.; Scholte, M (corresponding author), Radboud Univ Nijmegen, Dept Social Sci, Nijmegen, Netherlands.	m.scholte@maw.ru.nl	van der Wees, Philip Jan/L-4748-2015; der Sanden, Maria WG Nijhuis-van/B-3463-2012; Braspenning, Jozé/AAG-7612-2021; Braspenning, Jozé CC/D-4268-2009	der Sanden, Maria WG Nijhuis-van/0000-0003-2637-6877; Braspenning, Jozé/0000-0003-0800-0630; Braspenning, Jozé CC/0000-0003-0800-0630				Beyer M, 2003, FAM PRACT, V20, P443, DOI 10.1093/fampra/cmg420; Bijlsma-Frankema K, 2005, INT SOCIOL, V20, P259, DOI 10.1177/0268580905055477; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Christianson JB, 2008, MED CARE RES REV, V65, p5S, DOI 10.1177/1077558708324236; Deci EL, 1985, INTRINSIC MOTIVATION; Dekker HC, 2004, ACCOUNT ORG SOC, V29, P27, DOI 10.1016/S0361-3682(02)00056-9; Friedberg MW, 2011, J GEN INTERN MED, V26, P498, DOI 10.1007/s11606-010-1597-1; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Geissler KH, 2013, MED CARE RES REV, V70, P621, DOI 10.1177/1077558713496319; Giuffrida A, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Gneezy U, 2011, J ECON PERSPECT, V25, P191, DOI 10.1257/jep.25.4.191; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2011, IMPROVING PATIENT CA; Grol R, 1995, BR J GEN PRACT, V5, P506; Ivers N, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub3; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Kirschner K, 2010, QUAL SAF HEALTH CARE, V19, P248, DOI 10.1136/qshc.2008.031526; Marshall MN, 2004, INT J QUAL HEALTH C, V16, pI57, DOI 10.1093/intqhc/mzh013; Neeleman-van der Steen CWM, 2009, PRESTATIE INDICATORE; Palinkas LA, 2011, ADM POLICY MENT HLTH, V38, P44, DOI 10.1007/s10488-010-0314-z; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Promberger M, 2013, HEALTH PSYCHOL, V32, P950, DOI 10.1037/a0032727; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schneider A, 2008, J EVAL CLIN PRACT, V14, P185, DOI 10.1111/j.1365-2753.2007.00827.x; Scholte M, 2014, INT J QUAL HEALTH C, V26, P261, DOI 10.1093/intqhc/mzu031; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; Smith MA, 2012, HEALTH AFFAIR, V31, P570, DOI 10.1377/hlthaff.2011.0853; Wensing M, 2004, J EVAL CLIN PRACT, V10, P457, DOI 10.1111/j.1365-2753.2004.00517.x; Wensing M, 2009, PHARMACOEPIDEM DR S, V18, P763, DOI 10.1002/pds.1778	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161056	10.1371/journal.pone.0161056	http://dx.doi.org/10.1371/journal.pone.0161056			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518113	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100040
J	Zahin, M; Joh, J; Khanal, S; Husk, A; Mason, H; Warzecha, H; Ghim, SJ; Miller, DM; Matoba, N; Jenson, AB				Zahin, Maryam; Joh, Joongho; Khanal, Sujita; Husk, Adam; Mason, Hugh; Warzecha, Heribert; Ghim, Shin-je; Miller, Donald M.; Matoba, Nobuyuki; Jenson, Alfred Bennett			Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; CAPSID PROTEIN; PAPILLOMAVIRUS; EXPRESSION; VACCINES; PLANTS; EPITOPES; BIOPHARMACEUTICALS; GENE; STEP	Cervical cancer is the most common malignancy among women particularly in developing countries, with human papillomavirus (HPV) 16 causing 50% of invasive cervical cancers. A plant-based HPV vaccine is an alternative to the currently available virus-like particle (VLP) vaccines, and would be much less expensive. We optimized methods to express HPV16 L1 protein and purify VLPs from tobacco (Nicotiana benthamiana) leaves transfected with the magnICON deconstructed viral vector expression system. L1 proteins were extracted from agro-infiltrated leaves using a series of pH and salt mediated buffers. Expression levels of L1 proteins and VLPs were verified by immunoblot and ELISA, which confirmed the presence of sequential and conformational epitopes, respectively. Among three constructs tested (16L1d22, TPL1d22, and TPL1F), TPL1F, containing a full-length L1 and chloroplast transit peptide, was best. Extraction of HPV16 L1 from leaf tissue was most efficient (> 2.5% of total soluble protein) with a low-salt phosphate buffer. VLPs were purified using both cesium chloride (CsCl) density gradient and size exclusion chromatography. Electron microscopy studies confirmed the presence of assembled forms of HPV16 L1 VLPs. Collectively; our results indicated that chloroplast-targeted transient expression in tobacco plants is promising for the production of a cheap, efficacious HPV16 L1 VLP vaccine. Studies are underway to develop plant VLPs for the production of a cervical cancer vaccine.	[Zahin, Maryam; Joh, Joongho; Khanal, Sujita; Husk, Adam; Ghim, Shin-je; Miller, Donald M.; Matoba, Nobuyuki; Jenson, Alfred Bennett] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Joh, Joongho; Miller, Donald M.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [Khanal, Sujita] Univ Louisville, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Husk, Adam; Matoba, Nobuyuki] Owensboro Canc Res Program, Owensboro, KY USA; [Mason, Hugh] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Mason, Hugh] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Warzecha, Heribert] Tech Univ Darmstadt, Plant Biotechnol & Metab Engn, Schnittspahnstr 3-5, D-64287 Darmstadt, Germany; [Matoba, Nobuyuki] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Technical University of Darmstadt; University of Louisville	Joh, J (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.; Joh, J (corresponding author), Univ Louisville, Dept Med, Louisville, KY 40292 USA.	j0joh001@louisville.edu		Matoba, Nobuyuki/0000-0001-7231-3004	Helmsley Trust Foundation; James Graham Brown Cancer Center, School of Medicine, University of Louisville	Helmsley Trust Foundation; James Graham Brown Cancer Center, School of Medicine, University of Louisville	This study was supported by Helmsley Trust Foundation and James Graham Brown Cancer Center, School of Medicine, University of Louisville to MZ, JJ and ABJ.; This study was supported by Helmsley Trust Foundation and James Graham Brown Cancer Center, School of Medicine, University of Louisville to MZ, JJ and ABJ. We thank M. Clarke Miller, University of North Georgia, Georgia for his help with the chromatographic purification of HPV16 VLPs from tobacco plants. We would also like to thank ICON genetics GmbH, Germany for providing us the (pICH26212) vector.	Ahmad I, 2008, DRUG FUTURE, V33, P329, DOI 10.1358/dof.2008.033.04.1186159; Baldauf KJ, 2015, TOXINS, V7, P974, DOI 10.3390/toxins7030974; Biemelt S, 2003, J VIROL, V77, P9211, DOI 10.1128/JVI.77.17.9211-9220.2003; Chebolu S, 2009, CURR TOP MICROBIOL, V332, P33, DOI 10.1007/978-3-540-70868-1_3; Chen Q, 2013, HUM VACC IMMUNOTHER, V9, P26, DOI 10.4161/hv.22218; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; CHRISTENSEN ND, 1994, VIROLOGY, V205, P329, DOI 10.1006/viro.1994.1649; GHIM SJ, 1992, VIROLOGY, V190, P548, DOI 10.1016/0042-6822(92)91251-O; Hefferon K, 2013, BIOTECHNOL J, V8, P1193, DOI 10.1002/biot.201300162; HINES JF, 1994, GYNECOL ONCOL, V55, P13, DOI 10.1006/gyno.1994.1239; Joh J, 2012, EXP MOL PATHOL, V93, P416, DOI 10.1016/j.yexmp.2012.07.001; Kessans SA, 2013, PLANT BIOTECHNOL J, V11, P681, DOI 10.1111/pbi.12058; Kim HJ, 2010, PROTEIN EXPRES PURIF, V70, P68, DOI 10.1016/j.pep.2009.08.005; Knappe M, 2007, J BIOL CHEM, V282, P27913, DOI 10.1074/jbc.M705127200; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; Lenzi P, 2008, TRANSGENIC RES, V17, P1091, DOI 10.1007/s11248-008-9186-3; Liu HL, 2005, ACTA BIOCH BIOPH SIN, V37, P153, DOI 10.1093/abbs/37.3.153; Lossl AG, 2011, PLANT BIOTECHNOL J, V9, P527, DOI 10.1111/j.1467-7652.2011.00615.x; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Maclean J, 2007, J GEN VIROL, V88, P1460, DOI 10.1099/vir.0.82718-0; Maliga P, 2002, CURR OPIN PLANT BIOL, V5, P164, DOI 10.1016/S1369-5266(02)00248-0; Mason HS, 1998, VACCINE, V16, P1336, DOI 10.1016/S0264-410X(98)80020-0; Millan AFS, 2008, PLANT BIOTECHNOL J, V6, P427, DOI 10.1111/j.1467-7652.2008.00338.x; Millan AFS, 2007, J BIOTECHNOL, V127, P593, DOI 10.1016/j.jbiotec.2006.08.010; Neeper MP, 1996, GENE, V180, P1, DOI 10.1016/S0378-1119(96)00388-5; Olcese VA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-29; Rybicki EP, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0205-0; Shen W. J., 1989, NUCLEIC ACIDS RES, V25, P83; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; Stanley M, 2008, BRIT MED BULL, V88, P59, DOI 10.1093/bmb/ldn037; Waheed MT, 2011, TRANSGENIC RES, V20, P271, DOI 10.1007/s11248-010-9415-4; Waheed MT, 2011, PLANT BIOTECHNOL J, V9, P651, DOI 10.1111/j.1467-7652.2011.00612.x; Warzecha H, 2003, J VIROL, V77, P8702, DOI 10.1128/JVI.77.16.8702-8711.2003; Wu Xiaocheng, 2012, Morbidity and Mortality Weekly Report, V61, P258	34	19	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160995	10.1371/journal.pone.0160995	http://dx.doi.org/10.1371/journal.pone.0160995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518899	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100033
J	Carpenter, JR; Merckelbach, L; Callies, U; Clark, S; Gaslikova, L; Baschek, B				Carpenter, Jeffrey R.; Merckelbach, Lucas; Callies, Ulrich; Clark, Suzanna; Gaslikova, Lidia; Baschek, Burkard			Potential Impacts of Offshore Wind Farms on North Sea Stratification	PLOS ONE			English	Article							COLLISION RISK; TURBULENCE; MODEL; TURBINES; CLIMATE; FLOWS; AREAS; WAVES; SHEAR	Advances in offshore wind farm (OWF) technology have recently led to their construction in coastal waters that are deep enough to be seasonally stratified. As tidal currents move past the OWF foundation structures they generate a turbulent wake that will contribute to a mixing of the stratified water column. In this study we show that the mixing generated in this way may have a significant impact on the large-scale stratification of the German Bight region of the North Sea. This region is chosen as the focus of this study since the planning of OWFs is particularly widespread. Using a combination of idealised modelling and in situ measurements, we provide order-of-magnitude estimates of two important time scales that are key to understanding the impacts of OWFs: (i) a mixing time scale, describing how long a complete mixing of the stratification takes, and (ii) an advective time scale, quantifying for how long a water parcel is expected to undergo enhanced wind farm mixing. The results are especially sensitive to both the drag coefficient and type of foundation structure, as well as the evolution of the pycnocline under enhanced mixing conditions-both of which are not well known. With these limitations in mind, the results show that OWFs could impact the large-scale stratification, but only when they occupy extensive shelf regions. They are expected to have very little impact on large-scale stratification at the current capacity in the North Sea, but the impact could be significant in future large-scale development scenarios.	[Carpenter, Jeffrey R.; Merckelbach, Lucas; Callies, Ulrich; Clark, Suzanna; Gaslikova, Lidia; Baschek, Burkard] Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany; [Clark, Suzanna] MIT, Joint Program Oceanog Appl Ocean Sci & Engn, Woods Hole Oceanog Inst, Woods Hole, MA USA	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Massachusetts Institute of Technology (MIT); Woods Hole Oceanographic Institution	Carpenter, JR (corresponding author), Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany.	jeff.carpenter@hzg.de			Helmholtz Foundation through the Polar Regions and Coasts in the Changing Earth System II (PACES II) program	Helmholtz Foundation through the Polar Regions and Coasts in the Changing Earth System II (PACES II) program	Funding was provided by the Helmholtz Foundation through the Polar Regions and Coasts in the Changing Earth System II (PACES II) program.	Ashley MC, 2014, MAR POLICY, V45, P301, DOI 10.1016/j.marpol.2013.09.002; BACKHAUS JO, 1989, DANA-J FISH MAR RES, V8, P69; Baeye M, 2015, GEO-MAR LETT, V35, P247, DOI 10.1007/s00367-015-0404-8; Brostrom G, 2008, J MARINE SYST, V74, P585, DOI 10.1016/j.jmarsys.2008.05.001; Burchard H, 2002, J SEA RES, V47, P223, DOI 10.1016/S1385-1101(02)00126-0; Burchard H, 2003, 20253 EUR EN EUR COM; Casulli V, 1998, J HYDRAUL ENG-ASCE, V124, P678, DOI 10.1061/(ASCE)0733-9429(1998)124:7(678); Dahne M, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025002; Davis RE, 2003, OCEAN SCI TECHNOL, V2, P37; Desholm M, 2005, BIOL LETTERS, V1, P296, DOI 10.1098/rsbl.2005.0336; Fischer HB., 1979, MIXING INLAND COASTA; Franks PJS, 2015, ICES J MAR SCI, V72, P1897, DOI 10.1093/icesjms/fsu175; GALPERIN B, 1988, J ATMOS SCI, V45, P55, DOI 10.1175/1520-0469(1988)045<0055:AQETEM>2.0.CO;2; Geyer B, 2014, EARTH SYST SCI DATA, V6, P147, DOI 10.5194/essd-6-147-2014; Hastie GD, 2015, J APPL ECOL, V52, P631, DOI 10.1111/1365-2664.12403; Inger R, 2009, J APPL ECOL, V46, P1145, DOI 10.1111/j.1365-2664.2009.01697.x; Ivey GN, 2008, ANNU REV FLUID MECH, V40, P169, DOI 10.1146/annurev.fluid.39.050905.110314; Jackson L, 2008, J PHYS OCEANOGR, V38, P1033, DOI 10.1175/2007JPO3779.1; Johnston A, 2014, J APPL ECOL, V51, P31, DOI 10.1111/1365-2664.12191; Kapitza H, 2008, LECT NOTES COMPUT SC, V5336, P63, DOI 10.1007/978-3-540-92859-1_8; Ludewig E, 2013, INFLUENCE OFFSHORE W; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Make M, 2015, RENEW ENERG, V83, P1326, DOI 10.1016/j.renene.2015.05.048; Mann K.H., 2013, DYNAMICS MARINE ECOS, DOI DOI 10.1007/BF00042919; Paskyabi MB, 2012, ENRGY PROCED, V24, P245, DOI 10.1016/j.egypro.2012.06.106; Petersen JK, 2006, AMBIO, V35, P75, DOI 10.1579/0044-7447(2006)35[75:OWFTTO]2.0.CO;2; Port A, 2011, OCEAN DYNAM, V61, P1567, DOI 10.1007/s10236-011-0412-9; Queste BY, 2013, BIOGEOCHEMISTRY, V113, P53, DOI 10.1007/s10533-012-9729-9; Rennau H, 2012, COAST ENG, V60, P53, DOI 10.1016/j.coastaleng.2011.08.002; Richardson K, 2000, J PLANKTON RES, V22, P1663, DOI 10.1093/plankt/22.9.1663; Roberson JA., 1997, ENG FLUID MECH, V6th; Rudnick DL, 2004, MAR TECHNOL SOC J, V38, P73, DOI 10.4031/002533204787522703; Simpson J., 2012, INTRO PHYS BIOL OCEA; Simpson JH, 1996, J PHYS OCEANOGR, V26, P1579, DOI 10.1175/1520-0485(1996)026<1579:TVSOTD>2.0.CO;2; Smyth WD, 2007, J PHYS OCEANOGR, V37, P1566, DOI 10.1175/JPO3037.1; Thomas H, 2004, SCIENCE, V304, P1005, DOI 10.1126/science.1095491; Thorpe S.A, 2007, INTRO OCEAN TURBULEN; Umlauf L, 2009, J PHYS OCEANOGR, V39, P3032, DOI 10.1175/2009JPO4006.1; van der Molen J, 2014, CONT SHELF RES, V85, P60, DOI 10.1016/j.csr.2014.05.018; van Haren H, 1998, J MAR RES, V56, P655, DOI 10.1357/002224098765213621; van Leeuwen S, 2015, J GEOPHYS RES-OCEANS, V120, P4670, DOI 10.1002/2014JC010485; Weisse R., 2015, EARTH PERSPECT, V2, P3, DOI DOI 10.1186/S40322-015-0029-0; Whitehead JA, 2008, ENVIRON FLUID MECH, V8, P551, DOI 10.1007/s10652-008-9076-5; Wilson JC, 2009, WIND ENERGY, V12, P203, DOI 10.1002/we.324; Zhang W, 2009, ADVANCES IN WATER RESOURCES AND HYDRAULIC ENGINEERING, VOLS 1-6, P1143, DOI 10.1007/978-3-540-89465-0_199	46	39	39	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160830	10.1371/journal.pone.0160830	http://dx.doi.org/10.1371/journal.pone.0160830			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513754	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100076
J	Rodpai, R; Intapan, PM; Thanchomnang, T; Sanpool, O; Sadaow, L; Laymanivong, S; Aung, WP; Phosuk, I; Laummaunwai, P; Maleewong, W				Rodpai, Rutchanee; Intapan, Pewpan M.; Thanchomnang, Tongjit; Sanpool, Oranuch; Sadaow, Lakkhana; Laymanivong, Sakhone; Aung, Win Papa; Phosuk, Issarapong; Laummaunwai, Porntip; Maleewong, Wanchai			Angiostrongylus cantonensis and A. malaysiensis Broadly Overlap in Thailand, Lao PDR, Cambodia and Myanmar: A Molecular Survey of Larvae in Land Snails	PLOS ONE			English	Article							EOSINOPHILIC MENINGITIS; RAT LUNGWORM; GENE	Angiostrongylus cantonensis is a zoonotic nematode parasite causing human eosinophilic meningitis (or meningoencephalitis) worldwide. A closely related species, Angiostrongylus malaysiensis, might also be a human pathogen. Larvae were obtained from land snails in Lao PDR, Cambodia, Myanmar and Thailand. We sequenced two nuclear gene regions (nuclear ribosomal ITS2 and SSU rRNA) and a portion of one mitochondrial gene (COI) from these larvae. Angiostrongylus cantonensis and A. malaysiensis were identified. This is the first report of the molecular identification of the two Angiostrongylus species in Lao PDR, Cambodia and Myanmar. The regional distributions of the two species broadly overlap. Phylogenetic relationships were inferred including data from Angiostrongylus species deposited in public databases. All the gene regions we sequenced have potential value in distinguishing between species of Angiostrongylus. The COI gene exhibited the greatest intraspecific variation in the study region (five haplotypes in A. cantonensis and four in A. malaysiensis) and might be suitable for more detailed phylogeographic studies.	[Rodpai, Rutchanee; Intapan, Pewpan M.; Sanpool, Oranuch; Sadaow, Lakkhana; Laymanivong, Sakhone; Aung, Win Papa; Phosuk, Issarapong; Laummaunwai, Porntip; Maleewong, Wanchai] Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen, Thailand; [Rodpai, Rutchanee; Intapan, Pewpan M.; Thanchomnang, Tongjit; Sanpool, Oranuch; Sadaow, Lakkhana; Laymanivong, Sakhone; Aung, Win Papa; Phosuk, Issarapong; Laummaunwai, Porntip; Maleewong, Wanchai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Fac Med, Khon Kaen, Thailand; [Thanchomnang, Tongjit] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand; [Laymanivong, Sakhone] Minist Hlth, Ctr Malariol Parasitol & Entomol, Lab Unit, Viangchan, Laos; [Aung, Win Papa] Univ Med 2, Dept Microbiol, Yangon, Myanmar	Khon Kaen University; Khon Kaen University; Mahasarakham University	Maleewong, W (corresponding author), Khon Kaen Univ, Dept Parasitol, Fac Med, Khon Kaen, Thailand.; Maleewong, W (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis, Fac Med, Khon Kaen, Thailand.	wanch_ma@kku.ac.th		Maleewong, Wanchai/0000-0002-6726-3759	Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS) [NRU592014]; Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0053/2556]; Postdoctoral Training Program Graduate School and Khon Kaen University [58101]; TRF Senior Research Scholar Grant; Thailand Research Fund [RTA5880001]	Higher Education Research Promotion; National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS); Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Postdoctoral Training Program Graduate School and Khon Kaen University; TRF Senior Research Scholar Grant; Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by: 1. The Higher Education Research Promotion and the National Research University Project of Thailand, Office of the Higher Education Commission, Thailand, through the Health Cluster (SHeP-GMS) Award Number: NRU592014, Recipient: Wanchai Maleewong, PhD. 2. The Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program Award Number: grant no. PHD/0053/2556, Recipient: Rutchanee Rodpai. 3. The Postdoctoral Training Program Graduate School and Khon Kaen University Award Number: grant no. 58101, Recipient: Oranuch Sanpool. 4. The TRF Senior Research Scholar Grant, Thailand Research Fund Award Number: grant number RTA5880001, Recipient: Wanchai Maleewong, PhD, and Pewpan M. Intapan. We certified that all the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the revised manuscript has not and will not be submitted for publication elsewhere, have reviewed and approved by all authors, and concurred in the revised submission by the corresponding author.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Eamsobhana Praphathip, 2013, Hawaii J Med Public Health, V72, P15; Eamsobhana P, 2010, ACTA TROP, V116, P152, DOI 10.1016/j.actatropica.2010.07.005; Fontanilla IKC, 2008, ACTA TROP, V105, P181, DOI 10.1016/j.actatropica.2007.10.007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Jefferies R, 2009, PARASITOLOGY, V136, P107, DOI 10.1017/S0031182008005258; Kramer MH, 1998, CLIN INFECT DIS, V26, P365, DOI 10.1086/516325; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Liu CY, 2011, J ANIM VET ADV, V10, P593, DOI 10.3923/javaa.2011.593.596; Monte TC, 2014, MEM I OSWALDO CRUZ, V109, P1057, DOI 10.1590/0074-0276130378; Monte TCC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-248; Nei M, 2000, MOL EVOLUTION PHYLOG, DOI DOI 10.1093/SYSBIO/SYS029; Newton LA, 1998, ACTA TROP, V69, P1, DOI 10.1016/S0001-706X(97)00105-8; De NV, 2015, KOREAN J PARASITOL, V53, P713, DOI 10.3347/kjp.2015.53.6.713; Prociv P, 2000, INT J PARASITOL, V30, P1295, DOI 10.1016/S0020-7519(00)00133-8; Robles MD, 2008, J PARASITOL, V94, P515, DOI 10.1645/GE-1340.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiengo Silvana Carvalho, 2013, Hawaii J Med Public Health, V72, P18; Tokiwa T, 2012, PARASITOL INT, V61, P431, DOI 10.1016/j.parint.2012.02.005; Tsai HC, 2001, AM J MED, V111, P109, DOI 10.1016/S0002-9343(01)00766-5; Tsai Hung-Chin, 2013, Hawaii J Med Public Health, V72, P26; Wan KS, 2004, ACTA TROP, V90, P51, DOI 10.1016/j.actatropica.2003.09.019; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Yong HS, 2015, ACTA TROP, V148, P66, DOI 10.1016/j.actatropica.2015.04.020	24	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161128	10.1371/journal.pone.0161128	http://dx.doi.org/10.1371/journal.pone.0161128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513930	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100123
J	Kitagaki, J; Miyauchi, S; Asano, Y; Imai, A; Kawai, S; Michikami, I; Yamashita, M; Yamada, S; Kitamura, M; Murakami, S				Kitagaki, Jirouta; Miyauchi, Shizuka; Asano, Yoshihiro; Imai, Atsuko; Kawai, Shinji; Michikami, Ikumi; Yamashita, Motozo; Yamada, Satoru; Kitamura, Masahiro; Murakami, Shinya			A Putative Association of a Single Nucleotide Polymorphism in GPR126 with Aggressive Periodontitis in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PROTEIN-COUPLED RECEPTOR; GENE POLYMORPHISMS; SCHWANN-CELLS; STEM-CELLS; LIGAMENT; DIFFERENTIATION; SUSCEPTIBILITY; MORPHOGENESIS; MYELINATION	Periodontitis is an inflammatory disease causing loss of tooth-supporting periodontal tissue. Disease susceptibility to the rapidly progressive form of periodontitis, aggressive periodontitis (AgP), appears to be influenced by genetic risk factors. To identify these in a Japanese population, we performed whole exome sequencing of 41 unrelated generalized or localized AgP patients. We found that AgP is putatively associated with single nucleotide polymorphism (SNP) rs536714306 in the G-protein coupled receptor 126 gene, GPR126 [c.3086 G>A (p.Arg1029Gln)]. Since GPR126 activates the cAMP/PKA signaling pathway, we performed cAMP ELISA analysis of cAMP concentrations, and found that rs536714306 impaired the signal transactivation of GPR126. Moreover, transfection of human periodontal ligament (HPDL) cells with wild-type or mutant GPR126 containing rs536714306 showed that wild-type GPR126 significantly increased the mRNA expression of bone sialoprotein, osteopontin, and Runx2 genes, while mutant GPR126 had no effect on the expression of these calcification-related genes. The increase in expression of these genes was through the GPR126-induced increase of bone morphogenic protein-2, inhibitor of DNA binding (ID) 2, and ID4 expression. These data indicate that GPR126 might be important in maintaining the homeostasis of periodontal ligament tissues through regulating the cytodifferentiation of HPDL cells. The GPR126 SNP rs536714306 negatively influences this homeostasis, leading to the development of AgP, suggesting that it is a candidate genetic risk factor for AgP in the Japanese population.	[Kitagaki, Jirouta; Miyauchi, Shizuka; Yamashita, Motozo; Yamada, Satoru; Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, Suita, Osaka, Japan; [Asano, Yoshihiro; Imai, Atsuko] Osaka Univ, Grad Sch Dent, Dept Cardiovasc Med, Suita, Osaka, Japan; [Kawai, Shinji; Michikami, Ikumi] Osaka Univ, Grad Sch Dent, Challenge Intractable Oral Dis, Ctr Frontier Oral Sci, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Kitagaki, J (corresponding author), Osaka Univ, Grad Sch Dent, Div Oral Biol & Dis Control, Dept Periodontol, Suita, Osaka, Japan.	k-jirou@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X	KAKENHI from the Japan Society for the Promotion of Science [15K11385, 15H025789]	KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Grants-in-Aid for Scientific Research (No. 15K11385 to Jirouta Kitagaki and 15H025789 to Shinya Murakami) from the Japan Society for the Promotion of Science.	Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Arai Y, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/819760; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Bochenek G, 2013, HUM MOL GENET, V22, P4516, DOI 10.1093/hmg/ddt299; BURNER WL, 1982, J PEDIATR ORTHOPED, V2, P383, DOI 10.1097/01241398-198210000-00006; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Diehl SR, 1999, J PERIODONTOL, V70, P418, DOI 10.1902/jop.1999.70.4.418; Divaris K, 2013, HUM MOL GENET, V22, P2312, DOI 10.1093/hmg/ddt065; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eberle MA, 2007, PLOS GENET, V3, P1827, DOI 10.1371/journal.pgen.0030170; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Geng FS, 2013, DEVELOPMENT, V140, P4362, DOI 10.1242/dev.098061; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Hong KW, 2015, J CLIN PERIODONTOL, V42, P703, DOI 10.1111/jcpe.12437; Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186; Hung VWY, 2005, J BONE JOINT SURG AM, V87A, P2709, DOI 10.2106/JBJS.D.02782; Itoh M, 2006, BIOTECHNIQUES, V41, P44, DOI 10.2144/000112209; Karner CM, 2015, HUM MOL GENET, V24, P4365, DOI 10.1093/hmg/ddv170; Kawahara T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125590; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kitagaki J, 2015, J PERIODONTAL RES, V50, P248, DOI 10.1111/jre.12202; Kobayashi M, 1999, J DENT RES, V78, P1624, DOI 10.1177/00220345990780100701; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Laine ML, 2012, PERIODONTOL 2000, V58, P37, DOI 10.1111/j.1600-0757.2011.00415.x; Lekic P, 1996, ANAT REC, V245, P327; Li XF, 2008, EUR SPINE J, V17, P1431, DOI 10.1007/s00586-008-0757-z; LOE H, 1991, J PERIODONTOL, V62, P608, DOI 10.1902/jop.1991.62.10.608; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MARAZITA ML, 1994, J PERIODONTOL, V65, P623, DOI 10.1902/jop.1994.65.6.623; Meng HX, 2007, PERIODONTOL 2000, V43, P133, DOI 10.1111/j.1600-0757.2006.00204.x; Meng HX, 2011, PERIODONTOL 2000, V56, P87, DOI 10.1111/j.1600-0757.2010.00367.x; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Narahara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100924; Nesse W, 2008, J CLIN PERIODONTOL, V35, P668, DOI 10.1111/j.1600-051X.2008.01249.x; Nibali L, 2013, J DENT RES, V92, P868, DOI 10.1177/0022034513501878; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Otsuki T, 2005, DNA RES, V12, P117, DOI 10.1093/dnares/12.2.117; Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rhodin K, 2014, J DENT RES, V93, P882, DOI 10.1177/0022034514544506; Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401; Schaefer AS, 2010, J DENT RES, V89, P384, DOI 10.1177/0022034509359575; Schaefer AS, 2010, GENES IMMUN, V11, P45, DOI 10.1038/gene.2009.75; Schaefer AS, 2013, J CLIN PERIODONTOL, V40, P563, DOI 10.1111/jcpe.12092; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Schaefer AS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000378; Schei O, 1959, J PERIODONTOLOGY, V30, P7, DOI DOI 10.1902/JOP.1959.30.1.7; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shaffer JR, 2014, G3-GENES GENOM GENET, V4, P307, DOI 10.1534/g3.113.008755; Shimizu S, 2015, J DENT RES, V94, P555, DOI 10.1177/0022034515570315; Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105; Takahashi M, 2011, OPEN DENT J, V5, P190, DOI 10.2174/1874210601105010190; Vaithilingam RD, 2014, J PERIODONTAL RES, V49, P683, DOI 10.1111/jre.12167; Wilkening S, 2009, GENOMICS, V93, P415, DOI 10.1016/j.ygeno.2008.12.011; Yamada S, 2001, GENE, V275, P279, DOI 10.1016/S0378-1119(01)00683-7; Yasuda K, 2003, GENES IMMUN, V4, P541, DOI 10.1038/sj.gene.6364021	66	14	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160765	10.1371/journal.pone.0160765	http://dx.doi.org/10.1371/journal.pone.0160765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509131	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400053
J	Nadal, J; Ponz, C; Margalida, A				Nadal, Jesus; Ponz, Carolina; Margalida, Antoni			Age and Sex Ratios in a High-Density Wild Red-Legged Partridge Population	PLOS ONE			English	Article							NORTHERN BOBWHITE; PERDIX-PERDIX; OFFSPRING SEX; EXTREME ENVIRONMENTS; ALPINE PTARMIGAN; ALECTORIS-RUFA; LIFE-HISTORY; SOUTH TEXAS; BIRDS; DEMOGRAPHY	The dynamics of a wild red-legged partridge population were examined over a 14-year period in Spain to identify patterns in age and sex ratios in relation to weather parameters, and to assess the importance of these parameters in population dynamics and management. The results gave age ratios of 1.07 (but 2.13 in July counts), juvenile sex ratios of 1.01 and adult sex ratios of 1.47. Overall, 12% more females were hatched and female juvenile mortality was 7.3% higher than in males. Sex differential mortality explains the 19.2% deficit in adult females, which are more heavily predated than males during the breeding period. Accordingly, age ratios are dependent on sex ratios and both are density dependent. Over time, ratios and density changes appear to be influenced by weather and management. When the habitat is well conserved, partridge population dynamics can be explained by a causal chain: weather operates on net primary production, thereby affecting partridge reproduction and predation and, as a result, age and sex ratios in the October population. A reduction in the impact of predation (i.e. the effects of ground predators on eggs, chicks and breeding females) is the key factor to improve the conservation of partridge populations and associated biological processes.	[Nadal, Jesus; Ponz, Carolina; Margalida, Antoni] Univ Lleida, Fac Life Sci & Engn, Div Wildlife, Dept Anim Sci, Lleida, Spain; [Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland	Universitat de Lleida; University of Bern	Nadal, J (corresponding author), Univ Lleida, Fac Life Sci & Engn, Div Wildlife, Dept Anim Sci, Lleida, Spain.	jnadal@prodan.udl.es	Margalida, Antoni/A-2723-2011; Nadal, Jesus/L-8658-2013; Nadal, Jesus/S-6008-2016; Margalida, Antoni/AAG-5337-2020; Nadal, Jesus/AAA-1102-2022; Nadal, Jesús/ABF-7958-2021; Margalida, Antoni/A-2723-2011	Margalida, Antoni/0000-0002-0576-3993; Nadal, Jesus/0000-0002-1875-7242; Nadal, Jesus/0000-0002-1875-7242; Nadal, Jesús/0000-0002-1875-7242; Margalida, Antoni/0000-0002-3904-6212; Margalida, Antoni/0000-0002-7383-671X	Ramon y Cajal research contract from the Ministry of Economy and Competitiveness [RYC-2012-11867]	Ramon y Cajal research contract from the Ministry of Economy and Competitiveness	AM was supported by a Ramon y Cajal research contract from the Ministry of Economy and Competitiveness (RYC-2012-11867).	Alkon PU, 2015, WILSON J ORNITHOL, V127, P181, DOI 10.1676/wils-127-02-181-199.1; Benito MM, 2013, J AVIAN BIOL, V44, P179, DOI 10.1111/j.1600-048X.2012.00024.x; Besnard A, 2010, WILDLIFE BIOL, V16, P135, DOI 10.2981/08-077; Bowers EK, 2015, J ANIM ECOL, V84, P473, DOI 10.1111/1365-2656.12294; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham Kenneth P., 2002, MODEL SELECTION MULT; Calderon J., 1988, B I ESTUD ALMER CIEN, V6, P249; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chiatante G, 2013, ITAL J ZOOL, V80, P402, DOI 10.1080/11250003.2013.806601; Correa SM, 2005, BIOL LETTERS, V1, P215, DOI 10.1098/rsbl.2004.0283; Demaso SJ, 2013, J WILDLIFE MANAGE, V77, P24, DOI 10.1002/jwmg.503; Dhondt AA, 2001, TRENDS ECOL EVOL, V16, P61, DOI 10.1016/S0169-5347(00)02069-3; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Duckworth RA, 2015, SCIENCE, V347, P875, DOI 10.1126/science.1260154; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Grubler MU, 2008, BIOL CONSERV, V141, P3040, DOI 10.1016/j.biocon.2008.09.008; Guthery FS, 2013, J WILDLIFE MANAGE, V77, P33, DOI 10.1002/jwmg.450; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; KARLIN S, 1986, SEX RATIO EVOLUTION; Kobriger G. D., 1992, Gibier Faune Sauvage, V9, P367; Korpimaki E, 2000, J AVIAN BIOL, V31, P128, DOI 10.1034/j.1600-048X.2000.310204.x; Kupper C, 2012, BIOL LETTERS, V8, P787, DOI 10.1098/rsbl.2012.0329; La perdiz Roja Calderon J., 1983, ALECTORIS RUFA L ASP; Lee SI, 2010, J AVIAN BIOL, V41, P139, DOI 10.1111/j.1600-048X.2009.04749.x; Lemons PR, 2012, J AVIAN BIOL, V43, P445, DOI 10.1111/j.1600-048X.2012.05715.x; Liker A, 2005, EVOLUTION, V59, P890, DOI 10.1554/04-560; Litun V. I., 1992, Gibier Faune Sauvage, V9, P371; Ludwig GX, 2006, P ROY SOC B-BIOL SCI, V273, P2009, DOI 10.1098/rspb.2006.3538; Magrath MJL, 2002, J AVIAN BIOL, V33, P260, DOI 10.1034/j.1600-048X.2002.330308.x; Manzer DL, 2008, WILDLIFE BIOL, V14, P16, DOI 10.2981/0909-6396(2008)14[16:SOSGTP]2.0.CO;2; Massa B, 2010, REV ECOL-TERRE VIE, V65, P73; Meriggi A, 2007, ITAL J ZOOL, V74, P215, DOI 10.1080/11250000701246484; Nadal J, 1996, REV ECOL-TERRE VIE, V51, P243; Nadal J., 2001, Game and Wildlife Science, V18, P483; Nadal J, 2000, HUNGARIAN SMALL GAME, V5, P139; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Oddie K, 1998, TRENDS ECOL EVOL, V13, P130, DOI 10.1016/S0169-5347(97)01320-7; Palmer WE, 2005, WILDLIFE SOC B, V33, P1398, DOI 10.2193/0091-7648(2005)33[1398:EOFBAN]2.0.CO;2; Panek M, 2005, EUR J WILDLIFE RES, V51, P14, DOI 10.1007/s10344-005-0079-y; PEPIN D, 1985, J WILDLIFE MANAGE, V49, P228, DOI 10.2307/3801876; PEPIN D, 1988, Gibier Faune Sauvage, V5, P213; Pepin P, 1981, B MENS OFF NATL CHAS, P77; Pike TW, 2005, BIOL LETTERS, V1, P204, DOI 10.1098/rsbl.2005.0295; Pipoly I, 2015, NATURE, V527, P91, DOI 10.1038/nature15380; Potter LM, 2011, J WILDLIFE MANAGE, V75, P46, DOI 10.1002/jwmg.18; Potts GR., 2012, PARTRIDGES; Prior GL, 2011, BIOL LETTERS, V7, P958, DOI 10.1098/rsbl.2011.0264; Rodrigues ASL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113934; Sandercock BK, 2005, OECOLOGIA, V146, P13, DOI 10.1007/s00442-005-0174-5; Sandercock BK, 2005, ECOLOGY, V86, P2176, DOI 10.1890/04-0563; SAS, 2015, FITT LIN MOD JMP 12; Schindler S, 2015, NATURE, V526, P249, DOI 10.1038/nature14968; Sheldon BC, 2002, TRENDS ECOL EVOL, V17, P247, DOI 10.1016/S0169-5347(02)02459-X; Shultz S, 2005, P ROY SOC B-BIOL SCI, V272, P2305, DOI 10.1098/rspb.2005.3250; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; SOUTHWOOD TR, 1969, J ANIM ECOL, V38, P497, DOI 10.2307/3030; Steifetten O, 2006, BIOL CONSERV, V132, P88, DOI 10.1016/j.biocon.2006.03.016; Taylor TD, 2008, J ZOOL, V276, P89, DOI 10.1111/j.1469-7998.2008.00476.x; Tirpak JM, 2006, BIOL CONSERV, V133, P364, DOI 10.1016/j.biocon.2006.06.014; Tri AN, 2013, J WILDLIFE MANAGE, V77, P579, DOI 10.1002/jwmg.490; Vidus-Rosin A, 2010, EUR J WILDLIFE RES, V56, P369, DOI 10.1007/s10344-009-0329-5; West SA, 2002, SCIENCE, V295, P1685, DOI 10.1126/science.1069043; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004; Wilson S, 2007, CONDOR, V109, P377, DOI 10.1650/0010-5422(2007)109[377:NSPIWP]2.0.CO;2; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	66	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159765	10.1371/journal.pone.0159765	http://dx.doi.org/10.1371/journal.pone.0159765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508503	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400013
J	Verma, A; Basile, AO; Bradford, Y; Kuivaniemi, H; Tromp, G; Carey, D; Gerhard, GS; Crowe, JE; Ritchie, MD; Pendergrass, SA				Verma, Anurag; Basile, Anna O.; Bradford, Yuki; Kuivaniemi, Helena; Tromp, Gerard; Carey, David; Gerhard, Glenn S.; Crowe, James E., Jr.; Ritchie, Marylyn D.; Pendergrass, Sarah A.			Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; RHEUMATOID-ARTHRITIS; VENOUS THROMBOEMBOLISM; RISK; POPULATION; INFLAMMATION; METAANALYSIS; SCAN; SNP; OSTEOARTHRITIS	We performed a Phenome-Wide Association Study (PheWAS) to identify interrelationships between the immune system genetic architecture and a wide array of phenotypes from two de-identified electronic health record (EHR) biorepositories. We selected variants within genes encoding critical factors in the immune system and variants with known associations with autoimmunity. To define case/control status for EHR diagnoses, we used International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes from 3,024 Geisinger Clinic MyCode (R) subjects (470 diagnoses) and 2,899 Vanderbilt University Medical Center BioVU biorepository subjects (380 diagnoses). A pooled-analysis was also carried out for the replicating results of the two data sets. We identified new associations with potential biological relevance including SNPs in tumor necrosis factor (TNF) and ankyrin-related genes associated with acute and chronic sinusitis and acute respiratory tract infection. The two most significant associations identified were for the C6orf10 SNP rs6910071 and "rheumatoid arthritis" (ICD-9 code category 714) (p(METAL) = 2.58 x 10(-9)) and the ATN1 SNP rs2239167 and "diabetes mellitus, type 2" (ICD-9 code category 250) (p(METAL) = 6.39 x 10(-9)). This study highlights the utility of using PheWAS in conjunction with EHRs to discover new genotypic-phenotypic associations for immune-system related genetic loci.	[Verma, Anurag; Bradford, Yuki; Ritchie, Marylyn D.; Pendergrass, Sarah A.] Geisinger Hlth Syst, Biomed & Translat Informat Program, Danville, PA 17822 USA; [Verma, Anurag; Basile, Anna O.; Ritchie, Marylyn D.] Penn State Univ, Huck Inst Life Sci, Dept Biochem & Mol Biol, Ctr Syst Genom, University Pk, PA 16802 USA; [Kuivaniemi, Helena; Tromp, Gerard; Carey, David] Geisinger Hlth Syst, Sigfried & Janet Weis Ctr Res, Danville, PA 17822 USA; [Kuivaniemi, Helena; Tromp, Gerard] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Biomed Sci, Div Mol Biol & Human Genet, Tygerberg, South Africa; [Gerhard, Glenn S.] Temple Univ, Sch Med, Dept Med Genet & Mol Biochem, Philadelphia, PA 19122 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Geisinger Health System; Stellenbosch University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Vanderbilt University	Pendergrass, SA (corresponding author), Geisinger Hlth Syst, Biomed & Translat Informat Program, Danville, PA 17822 USA.	spendergrass@geisinger.edu	Verma, Anurag/I-9795-2019; Tromp, Gerard/B-2677-2017; Crowe, James/B-5549-2009; Kuivaniemi, Helena/Q-8178-2019	Verma, Anurag/0000-0002-5063-9107; Tromp, Gerard/0000-0002-7761-0806; Crowe, James/0000-0002-0049-1079; Kuivaniemi, Helena/0000-0001-5753-8766; Pendergrass, Rion/0000-0002-0565-6522; Basile, Anna/0000-0001-5112-5880	Vanderbilt CTSA grant from NCATS/NIH [ULTR000445]; NIH grant from NIGMS/OD [RC2GM092618]; NIH grant from NHGRI/NIGMS [U01HG004603]; Pennsylvania Commonwealth Universal Research Enhancement Program; Ben Franklin Technology Development Fund of PA; NIH [P30DK072488, R01DK088231, R01DK091601]; Geisinger Clinical Research Fund; American Heart Association	Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH grant from NIGMS/OD; NIH grant from NHGRI/NIGMS; Pennsylvania Commonwealth Universal Research Enhancement Program; Ben Franklin Technology Development Fund of PA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Geisinger Clinical Research Fund; American Heart Association(American Heart Association)	The BioVU data used in the analyses described were obtained from Vanderbilt University Medical Centers BioVU which is supported by institutional funding and by the Vanderbilt CTSA grant ULTR000445 from NCATS/NIH. Genome-wide genotyping was funded by NIH grants RC2GM092618 from NIGMS/OD and U01HG004603 from NHGRI/NIGMS. The MyCode biobanking and genotyping at Geisinger Clinic was funded by Pennsylvania Commonwealth Universal Research Enhancement Program, the Ben Franklin Technology Development Fund of PA, Grants from the NIH (P30DK072488, R01DK088231 and R01DK091601), the Geisinger Clinical Research Fund, and a Grant-In-Aid from the American Heart Association.	Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Badeanlou L, 2011, NAT MED, V17, P1490, DOI 10.1038/nm.2461; Bush WS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P368; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dumitrescu L, 2010, GENET MED, V12, P648, DOI 10.1097/GIM.0b013e3181efe2df; Eicher JD, 2015, NUCLEIC ACIDS RES, V43, pD799, DOI 10.1093/nar/gku1202; Eleftherohorinou H, 2011, HUM MOL GENET, V20, P3494, DOI 10.1093/hmg/ddr248; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Germain M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038538; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Ghigliotti G, 2014, INFLAMMATION, V37, P1337, DOI 10.1007/s10753-014-9914-1; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hall MA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004678; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawasaki A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3134; Knight JC, 2013, TRENDS GENET, V29, P74, DOI 10.1016/j.tig.2012.10.006; Kujovich JL, 2011, GENET MED, V13, P1, DOI 10.1097/GIM.0b013e3181faa0f2; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lippi G, 2011, BLOOD COAGUL FIBRIN, V22, P160, DOI 10.1097/MBC.0b013e3283424883; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Moore CB, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu113; Oudot-Mellakh T, 2012, BRIT J HAEMATOL, V157, P230, DOI 10.1111/j.1365-2141.2011.09025.x; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Park JY, 2007, BULL HOSP JT DIS, V65, pS4; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pendergrass SA, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-25; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2012, R A LANGUAGE AND ENV; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sobota RS, 2015, ANN HUM GENET, V79, P136, DOI 10.1111/ahg.12095; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Steck AK, 2009, DIABETES, V58, P1028, DOI 10.2337/db08-1179; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Theoharides TC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-46; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; Verma SS, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00370, DOI 10.3389/FGENE.2014.00370]; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18	58	13	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160573	10.1371/journal.pone.0160573	http://dx.doi.org/10.1371/journal.pone.0160573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508393	gold, Green Published			2022-12-26	WOS:000381380400038
J	Yao, N; Lee, R; Semagn, K; Sow, M; Nwilene, F; Kolade, O; Bocco, R; Oyetunji, O; Mitchell-Olds, T; Ndjiondjop, MN				Yao, Nasser; Lee, Cheng-Ruei; Semagn, Kassa; Sow, Mounirou; Nwilene, Francis; Kolade, Olufisayo; Bocco, Roland; Oyetunji, Olumoye; Mitchell-Olds, Thomas; Ndjiondjop, Marie-Noelle			QTL Mapping in Three Rice Populations Uncovers Major Genomic Regions Associated with African Rice Gall Midge Resistance	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ORSEOLIA-ORYZIVORA DIPTERA; HEAD BLIGHT RESISTANCE; GENE; YIELD; WHEAT; CECIDOMYIIDAE; METAANALYSIS; PARASITOIDS; BIOMERCATOR	African rice gall midge (AfRGM) is one of the most destructive pests of irrigated and lowland African ecologies. This study aimed to identify the quantitative trait loci (QTL) associated with AfRGM pest incidence and resistance in three independent bi-parental rice populations (ITA306xBW348-1, ITA306xTOG7106 and ITA306xTOS14519), and to conduct meta QTL (mQTL) analysis to explore whether any genomic regions are conserved across different genetic backgrounds. Composite interval mapping (CIM) conducted on the three populations independently uncovered a total of 28 QTLs associated with pest incidence (12) and pest severity (16). The number of QTLs per population associated with AfRGM resistance varied from three in the ITA306xBW348-1 population to eight in the ITA306xTOG7106 population. Each QTL individually explained 1.3 to 34.1% of the phenotypic variance. The major genomic region for AfRGM resistance had a LOD score and R-2 of 60.0 and 34.1% respectively, and mapped at 111 cM on chromosome 4 (qAfrGM4) in the ITA306xTOS14519 population. The meta-analysis reduced the number of QTLs from 28 to 17 mQTLs, each explaining 1.3 to 24.5% of phenotypic variance, and narrowed the confidence intervals by 2.2 cM. There was only one minor effect mQTL on chromosome 1 that was common in the TOS14519 and TOG7106 genetic backgrounds; all other mQTLs were background specific. We are currently fine-mapping and validating the major effect genomic region on chromosome 4 (qAfRGM4). This is the first report in mapping the genomic regions associated with the AfRGM resistance, and will be highly useful for rice breeders.	[Yao, Nasser] BecA, Nairobi, Kenya; [Lee, Cheng-Ruei] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei, Taiwan; [Lee, Cheng-Ruei] Natl Taiwan Univ, Inst Plant Biol, Taipei, Taiwan; [Semagn, Kassa] Univ Alberta, Dept Agr Forestry & Nutr Sci, Agr Forestry Ctr 4 10, Edmonton, AB, Canada; [Sow, Mounirou; Kolade, Olufisayo; Bocco, Roland; Ndjiondjop, Marie-Noelle] AfricaRice, 01 BP 2031, Cotonou, Benin; [Nwilene, Francis; Oyetunji, Olumoye] AfricaRice, PMB 5320, Ibadan, Oyo State, Nigeria; [Mitchell-Olds, Thomas] Duke Univ, Inst Genome Sci & Policy, Dept Biol, Durham, NC USA	National Taiwan University; National Taiwan University; University of Alberta; CGIAR; Africa Rice Center; CGIAR; Africa Rice Center; Duke University	Ndjiondjop, MN (corresponding author), AfricaRice, 01 BP 2031, Cotonou, Benin.	m.ndjiondjop@cgiar.org	Semagn, Kassa/S-8858-2017; Mitchell-Olds, Thomas/K-8121-2012	Semagn, Kassa/0000-0001-6486-5685; Kolade, Olufisayo/0000-0003-1920-1972; Lee, Cheng-Ruei/0000-0002-1913-9964; Mitchell-Olds, Thomas/0000-0003-3439-9921	United States Agency for International Development (USAID); Global Rice Science Partnership (GRiSP); Ministry of Agriculture, Forestry and Fisheries (MAFF of Japan)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Global Rice Science Partnership (GRiSP); Ministry of Agriculture, Forestry and Fisheries (MAFF of Japan)(Ministry of Agriculture Forestry & Fisheries - Japan)	The work presented here was led by Marie Noelle Ndjiondjop and funded by United States Agency for International Development (USAID); Global Rice Science Partnership (GRiSP); Ministry of Agriculture, Forestry and Fisheries (MAFF of Japan).	Arcade A, 2004, BIOINFORMATICS, V20, P2324, DOI 10.1093/bioinformatics/bth230; Ba N. M., 2004, International Journal of Tropical Insect Science, V24, P177, DOI 10.1079/IJT200419; Bashir M., 2013, Journal of Plant Breeding and Crop Science, V5, P214; Buerstmayr H, 2002, THEOR APPL GENET, V104, P84, DOI 10.1007/s001220200009; Chee PW, 2001, CROP SCI, V41, P295, DOI 10.2135/cropsci2001.412295x; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Danan S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-16; Ethel D, 1993, APPLIED ENTOMOLOGY, V116, P391; Goffinet B, 2000, GENETICS, V155, P463; Gut IG, 2001, HUM MUTAT, V17, P475; Hao ZF, 2010, EUPHYTICA, V174, P165, DOI 10.1007/s10681-009-0091-5; Himabindu K, 2007, EUPHYTICA, V157, P267, DOI 10.1007/s10681-007-9419-1; Joyce RJV, 1954, FAO PLANT PROTECTION, V2; Katiyar SK, 2001, THEOR APPL GENET, V103, P953, DOI 10.1007/s001220100633; Khowaja FS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-276; Kumar A, 2005, CROP SCI, V45, P1631, DOI 10.2135/cropsci2004.0406; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; McCouch SR, 1997, RICE GENET NEWSLETT, V14, P11, DOI [DOI 10.1007/S10142-013-0328-1, DOI 10.1007/S10681-005-0449-2]; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nacro S, 1996, INT J PEST MANAGE, V42, P331, DOI 10.1080/09670879609372016; Nacro S, 1998, REUNION DE DISCUSSIO; Nwilene F.E, 2006, AFRICAN RICE GALL MI; Nwilene FE, 2002, INT J PEST MANAGE, V48, P195, DOI 10.1080/09670870110103890; Nwilene FE, 2013, REALIZING AFRICA'S RICE PROMISE, P229, DOI 10.1079/9781845938123.0229; Ogah E. O., 2012, African Crop Science Journal, V20, P137; Ogah E. O., 2009, International Journal of Tropical Insect Science, V29, P86, DOI 10.1017/S1742758409990154; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Sama VSAK, 2014, THEOR APPL GENET, V127, P113, DOI 10.1007/s00122-013-2205-7; Sama VSAK, 2012, EUPHYTICA, V187, P393, DOI 10.1007/s10681-012-0724-y; Sardesai N, 2002, THEOR APPL GENET, V105, P691, DOI 10.1007/s00122-002-1035-9; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Semagn K, 2007, CROP SCI, V47, P294, DOI 10.2135/cropsci2006.02.0095; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Semagn K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-313; Sere Y, 2013, REALIZING AFRICA'S RICE PROMISE, P213, DOI 10.1079/9781845938123.0213; Sobrino B, 2005, FORENSIC SCI INT, V154, P181, DOI 10.1016/j.forsciint.2004.10.020; Sosnowski O, 2012, BIOINFORMATICS, V28, P2082, DOI 10.1093/bioinformatics/bts313; Suvendhu DS, 2014, J EXP BIOL AGRIC SCI, V2; Trijatmiko KR, 2014, MOL BREEDING, V34, P283, DOI 10.1007/s11032-013-0012-0; Truntzler M, 2010, THEOR APPL GENET, V121, P1465, DOI 10.1007/s00122-010-1402-x; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Ukwungwu M, 1992, INT RICE RES NEWSL, V17, P17; Ukwungwu M. N., 1998, Insect Science and its Application, V18, P167; Umaru A. B., 2014, International Research Journal of Agricultural Science and Soil Science, V4, P101; Utz H, 2003, PLABQTL A COMPUTER P; Van Ooijen J. W, 2006, JOINMAP 4 SOFTWARE F; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Williams CT, 1999, B ENTOMOL RES, V89, P589, DOI 10.1017/S0007485399000747; WILLIAMS CT, 2002, AFRICAN RICE GALL MI; Yasala AK, 2012, PLANT OMICS, V5, P405	50	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160749	10.1371/journal.pone.0160749	http://dx.doi.org/10.1371/journal.pone.0160749			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508500	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400049
J	Garsen, M; Rops, AL; Li, JH; van Beneden, K; van den Branden, C; Berden, JHM; Rabelink, TJ; van der Vlag, J				Garsen, Marjolein; Rops, Angelique L.; Li, Jinhua; van Beneden, Katrien; van den Branden, Christiane; Berden, Jo H. M.; Rabelink, Ton J.; van der Vlag, Johan			Endothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria	PLOS ONE			English	Article							ATTENUATES PROTEINURIA; DIABETIC-NEPHROPATHY; VITAMIN-D; DEFICIENCY; EXPRESSION; INJURY	Endothelial nitric oxide synthase (eNOS) deficiency exacerbates proteinuria and renal injury in several glomerular diseases, but the underlying mechanism is not fully understood. We recently showed that heparanase is essential for the development of experimental diabetic nephropathy and glomerulonephritis, and hypothesize that heparanase expression is regulated by eNOS. Here, we demonstrate that induction of adriamycin nephropathy (AN) in C57BL/6 eNOS-deficient mice leads to an increased glomerular heparanase expression accompanied with overt proteinuria, which was not observed in the AN-resistant wild type counterpart. In vitro, the eNOS inhibitor asymmetric dimethylarginine (ADMA) induced heparanase expression in cultured mouse glomerular endothelial cells. Moreover, ADMA enhanced transendothelial albumin passage in a heparanase-dependent manner. We conclude that eNOS prevents heparanase induction and the development of proteinuria.	[Garsen, Marjolein; Rops, Angelique L.; Berden, Jo H. M.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands; [Li, Jinhua] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [van Beneden, Katrien; van den Branden, Christiane] Vrije Univ Brussel, Liver Cell Biol Lab, Dept Human Anat, Brussels, Belgium; [Rabelink, Ton J.] Leiden Univ, Med Ctr, Dept Nephrol, Einthoven Lab Vasc Med, Leiden, Netherlands	Radboud University Nijmegen; Monash University; Vrije Universiteit Brussel; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands.	Johan.vanderVlag@radboudumc.nl	Van der Vlag, Johan/E-4636-2010; Rabelink, Ton J./A-5316-2008; Stefanadis, Christodoulos/ABH-2232-2020	Van der Vlag, Johan/0000-0001-7843-5918; Rabelink, Ton J./0000-0001-6780-5186; Stefanadis, Christodoulos/0000-0001-5974-6454; Li, Jinhua/0000-0003-4039-5759	Dutch Kidney Foundation [C09.2296, 15OI36, KJBP09.010];  [CP09.03]	Dutch Kidney Foundation; 	This study was financially supported by the Dutch Kidney Foundation, by grants C09.2296, 15OI36, and KJBP09.010, and by the consortium grant CP09.03 (GLYCOREN) (www.nierstichting.nl).; This study was financially supported by the Dutch Kidney Foundation, by grants C09.2296, 15OI36, KJBP09.010, and the consortium grant CP09.03 (GLYCOREN).	Andrukhova O, 2014, MOL ENDOCRINOL, V28, P53, DOI 10.1210/me.2013-1252; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Garsen M., 2016, J AM SOC NEPHROL; Garsen M, 2016, AM J PATHOL, V186, P805, DOI 10.1016/j.ajpath.2015.12.008; Garsen M, 2015, J PATHOL, V237, P472, DOI 10.1002/path.4593; Gil N, 2012, DIABETES, V61, P208, DOI 10.2337/db11-1024; Heeringa P, 2000, AM J PATHOL, V156, P879, DOI 10.1016/S0002-9440(10)64957-7; Jeansson M, 2009, J AM SOC NEPHROL, V20, P114, DOI 10.1681/ASN.2007111205; Kanetsuna Y, 2007, AM J PATHOL, V170, P1473, DOI 10.2353/ajpath.2007.060481; Masola V, 2011, BBA-MOL CELL RES, V1813, P1475, DOI 10.1016/j.bbamcr.2011.05.004; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Nakayama T, 2009, AM J PHYSIOL-RENAL, V296, pF317, DOI 10.1152/ajprenal.90450.2008; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; Savard S, 2012, NEPHROL DIAL TRANSPL, V27, P2182, DOI 10.1093/ndt/gfr641; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Sun YBY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055027; Takahashi T, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/590541; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; van den Hoven MJ, 2009, NEPHROL DIAL TRANSPL, V24, P2637, DOI 10.1093/ndt/gfp182; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15	26	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160894	10.1371/journal.pone.0160894	http://dx.doi.org/10.1371/journal.pone.0160894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505185	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200074
J	Popper, AN; Gross, JA; Carlson, TJ; Skalski, J; Young, JV; Hawkins, AD; Zeddies, D				Popper, Arthur N.; Gross, Jackson A.; Carlson, Thomas J.; Skalski, John; Young, John V.; Hawkins, Anthony D.; Zeddies, David			Effects of Exposure to the Sound from Seismic Airguns on Pallid Sturgeon and Paddlefish	PLOS ONE			English	Article							PILE-DRIVING SOUNDS; AIR GUN; FISH DISTRIBUTION; PELAGIC FISH; CATCH RATES; WATER GUN; BAROTRAUMA; ABUNDANCE	This study examined the effects of exposure to a single acoustic pulse from a seismic airgun array on caged endangered pallid sturgeon (Scaphirhynchus albus) and on paddlefish (Polyodon spathula) in Lake Sakakawea (North Dakota, USA). The experiment was designed to detect the onset of physiological responses including minor to mortal injuries. Experimental fish were held in cages as close as 1 to 3 m from the guns where peak negative sound pressure levels (Peak-SPL) reached 231 dB re 1 mu Pa (205 dB re 1 mu Pa-2.s sound exposure level [SEL]). Additional cages were placed at greater distances in an attempt to develop a dose-response relationship. Treatment and control fish were then monitored for seven days, euthanized, and necropsied to determine injuries. Necropsy results indicated that the probability of delayed mortality associated with pulse pressure following the seven day monitoring period was the same for exposed and control fish of both species. Exposure to a single pulse from a small air gun array (10,160 cm(3)) was not lethal for pallid sturgeon and paddlefish. However, the risks from exposure to multiple sounds and to sound exposure levels that exceed those reported here remain to be examined.	[Popper, Arthur N.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Gross, Jackson A.] Smith Root Inc, Vancouver, WA USA; [Carlson, Thomas J.] ProBioSound LLC, Holmes Beach, FL USA; [Skalski, John] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Young, John V.] CSA Ocean Sci Inc, Stuart, FL USA; [Hawkins, Anthony D.] Loughine Ltd, Blairs, Aberdeen, Scotland; [Zeddies, David] JASCO Appl Sci Ltd, Washington, DC USA	University System of Maryland; University of Maryland College Park; University of Washington; University of Washington Seattle	Popper, AN (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	apopper@umd.edu	Popper, Arthur N/C-7428-2009	Zeddies, David/0000-0002-7478-0172	Hess Corporation; CSA	Hess Corporation; CSA	Funds were provided by the Hess Corporation. This was under a corporate contract to CSA Inc. which then organized the project [https://www.conshelf.com/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript or conclusions reached in the ms. Several Hess employees helped in various logistical aspects of the project but ONLY in a technical sense since the logistics of the project was highly complex and needed specialized assistance (e.g., managing the seismic air gun). No Hess employee was party to any aspect of the project from design to data analysis and reaching conclusions. The other organizations listed as providing funding only did this in the form of salaries for authors that was derived from subcontracts with CSA [JAG, TJC, JVY, ADH, DZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank and acknowledge Hess Corporation for providing the financial support to conduct this study. We thank Drew Popovich, Hess Seismic Operations Manager, for his assistance in providing field coordination during the study and. Surrender Sahai and Troy Brunsell of Hess Corporation for assistance in various aspects of the project. Portions of this paper appeared as a technical report written by the authors for CSA International on behalf of the Hess Corporation (http://ter.ps/9uw).	Carlson T. J., 2007, UPDATE RECOMMENDATIO; CARLSON TJ, 2012, THE EFFECTS OF NOISE, P229, DOI DOI 10.1007/978-1-4419-7311-5_51; Casper BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073844; Casper BM, 2013, COMP BIOCHEM PHYS A, V166, P352, DOI 10.1016/j.cbpa.2013.07.008; Casper BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039593; Casper BM, 2012, ADV EXP MED BIOL, V730, P93, DOI 10.1007/978-1-4419-7311-5_20; Cott PA, 2012, ADV EXP MED BIOL, V730, P367, DOI 10.1007/978-1-4419-7311-5_83; Engas A, 1996, CAN J FISH AQUAT SCI, V53, P2238, DOI 10.1139/cjfas-53-10-2238; Engas Arill, 2002, Bioacoustics, V12, P313; Finney D.J., 1971, PROBIT ANAL; Gross JA, 2013, T AM FISH SOC, V142, P1335, DOI 10.1080/00028487.2013.802252; Halvorsen M. B., 2011, HYDROACOUSTIC IMPACT, P363; Halvorsen M. B., 2011, PREDICTING MITIGATIN; HALVORSEN MB, 2012, THE EFFECTS OF NOISE, P235, DOI DOI 10.1007/978-1-4419-7311-5_52; Halvorsen MB, 2012, P ROY SOC B-BIOL SCI, V279, P4705, DOI 10.1098/rspb.2012.1544; Halvorsen MB, 2012, ADV EXP MED BIOL, V730, P235, DOI 10.1007/978-1-4419-7311-5_52; Hawkins A., 2014, ACOUST TODAY, V10, P30, DOI [10.1121/1.4870174, DOI 10.1121/1.4870174]; Hawkins AD, 2015, REV FISH BIOL FISHER, V25, P39, DOI 10.1007/s11160-014-9369-3; Hawkins AD, 2014, J ACOUST SOC AM, V135, P3101, DOI 10.1121/1.4870697; HUTCHINSON DR, 1984, MAR GEOPHYS RES, V6, P295, DOI 10.1007/BF00286531; Jorgenson JK, 2009, J ACOUST SOC AM, V126, P1598, DOI 10.1121/1.3177276; Ketten D., 2014, ACOUST TODAY, V10, P46; Lokkeborg S, 2012, CAN J FISH AQUAT SCI, V69, P1278, DOI 10.1139/F2012-059; McCullough P, 1989, GEN LINEAR MODELS; Pena H, 2013, ICES J MAR SCI, V70, P1174, DOI 10.1093/icesjms/fst079; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Popper AN, 2014, SPBR OCEANOGR, P33, DOI 10.1007/978-3-319-06659-2_7; Slotte A, 2004, FISH RES, V67, P143, DOI 10.1016/j.fishres.2003.09.046; Stephenson JR, 2010, FISH RES, V106, P271, DOI 10.1016/j.fishres.2010.08.006; YELVERTON JT, 1975, 3677T DNA	30	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159486	10.1371/journal.pone.0159486	http://dx.doi.org/10.1371/journal.pone.0159486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505029	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200009
J	Giacomelli, MG; Husvogt, L; Vardeh, H; Faulkner-Jones, BE; Hornegger, J; Connolly, JL; Fujimoto, JG				Giacomelli, Michael G.; Husvogt, Lennart; Vardeh, Hilde; Faulkner-Jones, Beverly E.; Hornegger, Joachim; Connolly, James L.; Fujimoto, James G.			Virtual Hematoxylin and Eosin Transillumination Microscopy Using Epi-Fluorescence Imaging	PLOS ONE			English	Article							INVASIVE BREAST-CANCER; CONSERVATIVE SURGERY; LOCAL RECURRENCE; IRRADIATION; PREDICTORS; MASTECTOMY; THERAPY; TRIAL	We derive a physically realistic model for the generation of virtual transillumination, white light microscopy images using epi-fluorescence measurements from thick, unsectioned tissue. We demonstrate this technique by generating virtual transillumination H&E images of unsectioned human breast tissue from epi-fluorescence multiphoton microscopy data. The virtual transillumination algorithm is shown to enable improved contrast and color accuracy compared with previous color mapping methods. Finally, we present an open source implementation of the algorithm in OpenGL, enabling real-time GPU-based generation of virtual transillumination microscopy images using conventional fluorescence microscopy systems.	[Giacomelli, Michael G.; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Giacomelli, Michael G.; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Husvogt, Lennart] Univ Erlangen Nurnberg, Pattern Recognit Lab, Erlangen, Germany; [Vardeh, Hilde; Faulkner-Jones, Beverly E.; Connolly, James L.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA; [Hornegger, Joachim] Univ Erlangen Nurnberg, Grad Sch Adv Opt Technol, Erlangen, Germany	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Erlangen Nuremberg; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Erlangen Nuremberg	Fujimoto, JG (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Fujimoto, JG (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	jgfuji@mit.edu	Hornegger, Joachim/H-2465-2017	Hornegger, Joachim/0000-0002-1834-8844	National Institutes of Health [R01-CA178636-02, R01-CA075289-18, F32-CA183400-02]; Air Force Office of Scientific Research AFOSR [FA9550-12-1-0551, FA9550-15-1-0473]; NATIONAL CANCER INSTITUTE [R01CA178636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work was provided by the National Institutes of Health under R01-CA178636-02, R01-CA075289-18 to JGF and F32-CA183400-02 to MGG (http://www.cancer.gov), as well as the Air Force Office of Scientific Research AFOSR under contracts FA9550-12-1-0551 and FA9550-15-1-0473 to JGF (http://www.wpafb.af.mil/afrl/afosr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bini J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3596742; Buchynska L., 2008, Experimental Oncology, V30, P327; Cefaro GA, 2006, BREAST CANCER RES TR, V98, P329, DOI 10.1007/s10549-006-9169-0; Connolly JL, 1998, MODERN PATHOL, V11, P134; Dobbs J, 2015, BREAST CANCER RES TR, V149, P303, DOI 10.1007/s10549-014-3182-5; Engel Jutta, 2004, Breast J, V10, P223, DOI 10.1111/j.1075-122X.2004.21323.x; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Freudiger CW, 2012, LAB INVEST, V92, P1492, DOI 10.1038/labinvest.2012.109; Gareau DS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3149853; Gareau DS, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981828; Kenny KB, 2014, SYSTEM METHODS GENER; Layfield DM, 2011, BRIT J SURG, V98, P4, DOI 10.1002/bjs.7229; Levenson R, 2008, ARCH PATHOL LAB MED, V132, P748, DOI 10.1043/1543-2165(2008)132[748:PTMBIM]2.0.CO;2; Mansfield JR, 2008, CURRENT PROTOCOLS MO; Olson TP, 2007, ANN SURG ONCOL, V14, P2953, DOI 10.1245/s10434-007-9437-1; Paylova I, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.036014; Stevens A, 2008, THEORY PRACTICE HIST, Vxiv; Tao YK, 2014, P NATL ACAD SCI USA, V111, P15304, DOI 10.1073/pnas.1416955111; van Dongen JA, 2000, JNCI-J NATL CANCER I, V92, P1143, DOI 10.1093/jnci/92.14.1143; Wang M, 2015, CANCER RES, V75, P4032, DOI 10.1158/0008-5472.CAN-14-3806; Weiser MR, 2000, ANN SURG ONCOL, V7, P651, DOI 10.1007/s10434-000-0651-3	21	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0159337	10.1371/journal.pone.0159337	http://dx.doi.org/10.1371/journal.pone.0159337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500636	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500007
J	van der Weide, RH; Simonis, M; Hermsen, R; Toonen, P; Cuppen, E; de Ligt, J				van der Weide, Robin H.; Simonis, Marieke; Hermsen, Roel; Toonen, Pim; Cuppen, Edwin; de Ligt, Joep			The Genomic Scrapheap Challenge; Extracting Relevant Data from Unmapped Whole Genome Sequencing Reads, Including Strain Specific Genomic Segments, in Rats	PLOS ONE			English	Article							INBRED STRAINS; LABORATORY RAT; GENERATION; EVOLUTION; SOFTWARE; PHYLOGENETICS; ALIGNMENTS; PHENOTYPES; DIVERSITY; RESOURCES	Unmapped next-generation sequencing reads are typically ignored while they contain biologically relevant information. We systematically analyzed unmapped reads from whole genome sequencing of 33 inbred rat strains. High quality reads were selected and enriched for biologically relevant sequences; similarity-based analysis revealed clustering similar to previously reported phylogenetic trees. Our results demonstrate that on average 20% of all unmapped reads harbor sequences that can be used to improve reference genomes and generate hypotheses on potential genotype-phenotype relationships. Analysis pipelines would benefit from incorporating the described methods and reference genomes would benefit from inclusion of the genomic segments obtained through these efforts.	[van der Weide, Robin H.; Simonis, Marieke; Hermsen, Roel; Toonen, Pim; Cuppen, Edwin; de Ligt, Joep] Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands; [van der Weide, Robin H.] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute	Cuppen, E (corresponding author), Univ Med Ctr Utrecht, Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, Utrecht, Netherlands.	ecuppen@umcutrecht.nl	Cuppen, Edwin/H-2389-2016; van der Weide, Robin H./GLV-1335-2022; van der Weide, Robin Harm/AAA-4474-2020; Cuppen, Edwin/F-5696-2011	Cuppen, Edwin/0000-0002-0400-9542; van der Weide, Robin Harm/0000-0002-6466-7280; Cuppen, Edwin/0000-0002-0400-9542; de Ligt, Joep/0000-0002-0348-419X	European Community [HEALTH-F4-2010-241504]	European Community(European Commission)	This work was financially supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F4-2010-241504 (EURATRANS) to EC.; The authors would like to thank Sander Boymans, Victor Guryev and Wim Spee for their scientific discussions. Furthermore, we thank Tadao Serikawa for making the F334/Stm unpublished data available to us. This work was financially supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No. HEALTH-F4-2010-241504 (EURATRANS) to EC.	ASHLEY T, 1984, HUM GENET, V67, P372, DOI 10.1007/BF00291394; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Bao SY, 2011, J HUM GENET, V56, P406, DOI 10.1038/jhg.2011.43; Bateman A, 2009, BIOINFORMATICS, V25, P429, DOI 10.1093/bioinformatics/btp037; Baud A, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.11; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Bradnam K, 2013, ASSEMBLATHON 2 EVALU; Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856; Chikhi R, 2013, INFORM AUTOMATED K M; Church DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0587-3; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Cullum R, 2011, RESPIROLOGY, V16, P210, DOI 10.1111/j.1440-1843.2010.01899.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dogan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085233; Faber-Hammond JJ, 2016, HUM GENET, V135, P727, DOI 10.1007/s00439-016-1667-5; Faber-Hammond JJ, 2016, ZEBRAFISH, V13, P95, DOI 10.1089/zeb.2015.1154; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gibbs R, 2005, UPGRADING DNA SEQUEN; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gouin A., 2013, JOURNEES OUVERTES BI; Guell O, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003637; Guo XS, 2013, GENETICS, V194, P1017, DOI 10.1534/genetics.113.153049; Hermsen R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1594-1; Illumina, 2012, UND ILL QUAL SCOR; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-685; Locke MEO, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1713-z; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Lusk RW, 2014, DIVERSE AND WIDESPRE; Ma MCJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-197; Marris E, 2005, NATURE, V435, P6, DOI 10.1038/435006a; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Petri A.W., 2006, VOGES MED PARASITOL; Rozen S, 2006, SEQUENCING ANNOTATIN, P1; Rozen S, SEQUENCING ANNOTATIN; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Shepherd AJ, 2003, BIOLOGICALS, V31, P251, DOI 10.1016/S1045-1056(03)00065-4; Shisa H, 1997, MAMM GENOME, V8, P324, DOI 10.1007/s003359900432; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simonis M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r31; Smit A., REPEATMASKER OPEN 3; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Thomas MA, 2003, MAMM GENOME, V14, P61, DOI 10.1007/s00335-002-2204-5; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; Wang WX, 2011, SCI REP-UK, V1, DOI 10.1038/srep00055; Wang YM, 2010, GENOME RES, V20, P19, DOI 10.1101/gr.100073.109; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Whitacre LK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2313-7; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	70	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160036	10.1371/journal.pone.0160036	http://dx.doi.org/10.1371/journal.pone.0160036			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501045	gold, Green Published			2022-12-26	WOS:000381373500012
J	Xu, NN; Mu, PQ; Yin, ZQ; Jia, Q; Yang, SM; Qian, YZ; Qiu, J				Xu, Nana; Mu, Pengqian; Yin, Zhiqiang; Jia, Qi; Yang, Shuming; Qian, Yongzhong; Qiu, Jing			Analysis of the Enantioselective Effects of PCB95 in Zebrafish (Danio rerio) Embryos through Targeted Metabolomics by UPLC-MS/MS	PLOS ONE			English	Article							MS-BASED METABOLOMICS; POLYCHLORINATED-BIPHENYLS; POTENTIAL BIOMARKERS; LYSINE DEFICIENCY; PIPECOLIC ACID; LIVER-FUNCTION; DISEASE; ATROPISOMERS; EXTRACTION; EXPOSURE	As persistent organic pollutants, polychlorinated biphenyls (PCBs) accumulate in the bodies of animals and humans, resulting in toxic effects on the reproductive, immune, nervous, and endocrine systems. The biological and toxicological characteristics of enantiomers of chiral PCBs may differ, but these enantioselective effects of PCBs have not been fully characterized. In this study, we performed metabolomics analysis, using ultra-high performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) to investigate the enantioselective toxic effects of PCB95 in zebrafish (Danio rerio) embryos after exposure to three dose levels of 0.1, 1, and 10 mu g/L for 72 h. Multivariate analysis directly reflected the metabolic perturbations caused by PCB95. The effects of (-)-PCB95 and (+)-PCB95 were more prominent than those of the racemate in zebrafish embryos. A total of 26 endogenous metabolites were selected as potential marker metabolites with variable importance at projection values larger than 1 and significant differences (p<0.05). These metabolites included amino acids, organic acids, nucleosides, betaine, and choline. The changes in these biomarkers were dependent on the enantiomer-specific structures of PCB95. Fifteen metabolic pathways were significantly affected, and several nervous and immune system-related metabolites were significantly validated after exposure. These metabolic changes indicated that the toxic effects of PCB95 may be associated with the interaction of PCB95 with the nervous and immune systems, thus resulting in disruption of energy metabolism and liver function.	[Xu, Nana; Mu, Pengqian; Yin, Zhiqiang; Jia, Qi; Yang, Shuming; Qian, Yongzhong; Qiu, Jing] Chinese Acad Agr Sci, Minist Agr, Key Lab Agroprod Qual & Safety, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs	Qiu, J (corresponding author), Chinese Acad Agr Sci, Minist Agr, Key Lab Agroprod Qual & Safety, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China.	qiujing@caas.cn			National Natural Science Foundation of China [21477161, 21177156]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (Nos. 21477161 and 21177156).	Aldterton WK, 2004, NEUROPSYCH DIS TREAT, V4, P567; Balaraman G, 2011, CELL STRESS CHAPERON, V16, P641; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Busquet F, 2014, REGUL TOXICOL PHARM, V69, P496, DOI 10.1016/j.yrtph.2014.05.018; Chen C, 2003, AVIAN DIS, V47, P1346, DOI 10.1637/7008; [陈蓉 Chen Rong], 2013, [环境化学, Environmental Chemistry], V32, P1226; Fujita T, 1999, CLIN CHIM ACTA, V287, P145, DOI 10.1016/S0009-8981(99)00129-1; Genilza SM, 2015, J THERM ANAL CALORIM, V122, P1395; Ghasemi M, 2010, BIOCHEM PHARMACOL, V79, P1791, DOI 10.1016/j.bcp.2010.02.007; Harrison PTC, 1997, SCI TOTAL ENVIRON, V205, P97, DOI 10.1016/S0048-9697(97)00212-X; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Izabela KK, 2011, ENVIRON SCI TECHNOL, V45, P9590, DOI [10.1021/es2014727, DOI 10.1021/ES2014727]; Kim HJ, 2015, METABOLOMICS, V11, P64, DOI 10.1007/s11306-014-0671-9; Kim PM, 2009, PNAS, V107, P3175; Kuratsune M, 1972, Environ Health Perspect, V1, P119, DOI 10.2307/3428163; Lai IK, 2012, TOXICOLOGY, V302, P25, DOI 10.1016/j.tox.2012.07.007; Li ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1516-2; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Ma MC, 2008, HYPERTENSION, V52, P938, DOI 10.1161/HYPERTENSIONAHA.108.114116; Madura JD, 1997, AMINO ACIDS, V13, P131, DOI 10.1007/BF01373211; Matsuda Y, 2000, HEPATOL RES, V18, P132, DOI 10.1016/S1386-6346(99)00097-2; MCENTEE WJ, 1993, PSYCHOPHARMACOLOGY, V111, P391, DOI 10.1007/BF02253527; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Niciu MJ, 2012, PHARMACOL BIOCHEM BE, V100, P656, DOI 10.1016/j.pbb.2011.08.008; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pavagadhi S, 2013, ENVIRON SCI TECHNOL, V47, P14376, DOI 10.1021/es4004125; PUTTMANN M, 1989, BIOCHEM PHARMACOL, V38, P1345, DOI 10.1016/0006-2952(89)90342-0; Reich S, 1999, ENVIRON SCI TECHNOL, V33, P1787, DOI 10.1021/es9807385; Slim R, 2000, TOXICOL APPL PHARM, V166, P36, DOI 10.1006/taap.2000.8944; Smriga M, 2002, J NUTR, V132, P3744, DOI 10.1093/jn/132.12.3744; Sun LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060598; Susan MH, 2005, J NUTR, V135, p1557s; Takarada T, 2008, J CELL PHYSIOL, V215, P320, DOI 10.1002/jcp.21310; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Umetrics, 2008, US GUID SIMCA P; Wang B, 2015, AMINO ACIDS, V47, P2143, DOI 10.1007/s00726-014-1773-4; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong CS, 2001, ENVIRON SCI TECHNOL, V35, P2448, DOI 10.1021/es0018872; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xu NN, 2015, CHINESE J ANAL CHEM, V43, P795; Yang J, 2006, J PROTEOME RES, V5, P554, DOI 10.1021/pr050364w; Yao WF, 2014, ANAL BIOANAL CHEM, V406, P7367, DOI 10.1007/s00216-014-8169-x; Yehezkel BA, 2002, NAT REV NEUROSCI, V3, P728; Zhang P, 2007, MAR POLLUT BULL, V54, P1105, DOI 10.1016/j.marpolbul.2007.05.005	44	13	14	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160584	10.1371/journal.pone.0160584	http://dx.doi.org/10.1371/journal.pone.0160584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500732	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500034
J	Garba, L; Ali, MSM; Oslan, SN; Rahman, RNZRA				Garba, Lawal; Ali, Mohd Shukuri Mohamad; Oslan, Siti Nurbaya; Rahman, Raja Noor Zaliha Raja Abd			Molecular Cloning and Functional Expression of a Delta 9-Fatty Acid Desaturase from an Antarctic Pseudomonas sp A3	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; ACYL-LIPID DESATURASE; FATTY-ACIDS; SUBSTRATE-SPECIFICITY; MEMBRANE TOPOLOGY; SIGNAL PEPTIDES; IDENTIFICATION; PREDICTION; ENZYME	Fatty acid desaturase enzymes play an essential role in the synthesis of unsaturated fatty acids. Pseudomonas sp. A3 was found to produce a large amount of palmitoleic and oleic acids after incubation at low temperatures. Using polymerase Chain Reaction (PCR), a novel Delta 9-fatty acid desaturase gene was isolated, cloned, and successfully expressed in Escherichia coli. The gene was designated as PA3FAD9 and has an open reading frame of 1,185 bp which codes for 394 amino acids with a predicted molecular weight of 45 kDa. The activity of the gene product was confirmed via GCMS, which showed a functional putative Delta 9-fatty acid desaturase capable of increasing the total amount of cellular unsaturated fatty acids of the E. coli cells expressing the gene. The results demonstrate that the cellular palmitoleic acids have increased two-fold upon expression at 15 degrees C using only 0.1 mM IPTG. Therefore, PA3FAD9 from Pseudomonas sp. A3 codes for a Delta 9-fatty acid desaturase-like protein which was actively expressed in E. coli.	[Garba, Lawal; Ali, Mohd Shukuri Mohamad; Oslan, Siti Nurbaya; Rahman, Raja Noor Zaliha Raja Abd] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Enzyme & Microbial Technol Res Ctr, Serdang 43400, Selangor Darul, Malaysia; [Garba, Lawal] Gombe State Univ, Fac Sci, Dept Microbiol, PMB 127, Tudun Wada Gombe, Gombe State, Nigeria	Universiti Putra Malaysia	Rahman, RNZRA (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Enzyme & Microbial Technol Res Ctr, Serdang 43400, Selangor Darul, Malaysia.	rnzaliha@upm.edu.my	Rahman, Raja Noor Zaliha Raja Abd/I-5556-2019; Oslan, Siti Nurbaya/U-5735-2019; Oslan, Siti Nurbaya/H-7262-2016; Ali, Mohd Shukuri Mohamad/AAG-5453-2021	Rahman, Raja Noor Zaliha Raja Abd/0000-0002-6316-6177; Oslan, Siti Nurbaya/0000-0003-0143-425X; Oslan, Siti Nurbaya/0000-0003-0143-425X; Ali, Mohd Shukuri Mohamad/0000-0003-2751-9649	Putra grant, University Putra Malaysia [GP-IPS/2016/9471000]	Putra grant, University Putra Malaysia	This work was supported by Putra grant, University Putra Malaysia (GP-IPS/2016/9471000).	Alonso DL, 2003, BIOCHEM SYST ECOL, V31, P1111, DOI 10.1016/S0305-1978(03)00041-3; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Chang BE, 2001, MOL REPROD DEV, V58, P245, DOI 10.1002/1098-2795(200103)58:3&lt;245::AID-MRD1&gt;3.0.CO;2-7; Chen HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058139; Chintalapati S, 2006, BIOCHEM J, V398, P207, DOI 10.1042/BJ20060039; Clustal X, 2007, BIOINFORMATICS, V23, P2947; Covington MB, 2004, OMEGA 3 FATTY ACIDS, V1; Diaz AR, 2002, J BIOL CHEM, V277, P48099, DOI 10.1074/jbc.M208960200; Garba L., 2016, RES J MICROBIOLOGY, V11, P146, DOI DOI 10.3923/JM.2016.146.152; Jadhav VV, 2010, ANN MICROBIOL, V60, P693, DOI 10.1007/s13213-010-0114-4; Khoddami A., 2009, World Applied Sciences Journal, V7, P127; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Li Y, 2008, LIPIDS, V43, P207, DOI 10.1007/s11745-007-3150-5; Li Y, 2009, J MOL CATAL B-ENZYM, V56, P96, DOI 10.1016/j.molcatb.2008.07.012; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Maali R, 2007, RUSS J GENET+, V43, P121, DOI 10.1134/S1022795407020044; MacKenzie DA, 2002, MICROBIOL-SGM, V148, P1725, DOI 10.1099/00221287-148-6-1725; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Mansilla Maria Cecilia, 2008, V49, P71, DOI 10.1007/978-1-4020-8831-5_3; Marillia EF, 2002, FEBS LETT, V526, P49, DOI 10.1016/S0014-5793(02)03112-5; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Mohamed HG, 2016, RES J MICROBIOLOGY, V11, P28, DOI DOI 10.3923/JM.2016.28.34; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Morita R.Y., 2001, ENCY BIODIVERSITY, V2, P298, DOI [10.1016/B978-0-12-384719-5.00176-3, DOI 10.1016/B978-0-12-384719-5.00176-3]; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Robert L, 1990, FOOD TECHNOLOGY, P99; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Sirot V, 2008, J FOOD COMPOS ANAL, V21, P8, DOI 10.1016/j.jfca.2007.05.006; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Subrahmanyam S, 1998, J BACTERIOL, V180, P4596, DOI 10.1128/JB.180.17.4596-4602.1998; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANBEILEN JB, 1992, J BIOL CHEM, V267, P9194; Wan X, 2013, MOL BIOL REP, V40, P4483, DOI 10.1007/s11033-013-2540-4; Warude D, 2006, CRIT REV BIOTECHNOL, V26, P83, DOI 10.1080/07388550600697479; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	38	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160681	10.1371/journal.pone.0160681	http://dx.doi.org/10.1371/journal.pone.0160681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494717	Green Submitted, Green Published, gold			2022-12-26	WOS:000381369500075
J	Konishi, A; Izumi, T; Shimizu, S				Konishi, Akimitsu; Izumi, Takashi; Shimizu, Shigeomi			TRF2 Protein Interacts with Core Histones to Stabilize Chromosome Ends	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromosomes; DNA damage response; histone; telomere; GAR domain; core histone	HUMAN TELOMERES; MAMMALIAN TELOMERES; EPIGENETIC REGULATION; CHROMATIN; COMPLEX; BINDING; LOOP; NUCLEOSOMES; RECRUITMENT; METHYLATION	Mammalian chromosome ends are protected by a specialized nucleoprotein complex called telomeres. Both shelterin, a telomere-specific multi-protein complex, and higher order telomeric chromatin structures combine to stabilize the chromosome ends. Here, we showed that TRF2, a component of shelterin, binds to core histones to protect chromosome ends from inappropriate DNA damage response and loss of telomeric DNA. The N-terminal Gly/Arg-rich domain (GAR domain) of TRF2 directly binds to the globular domain of core histones. The conserved arginine residues in the GAR domain of TRF2 are required for this interaction. A TRF2 mutant with these arginine residues substituted by alanine lost the ability to protect telomeres and induced rapid telomere shortening caused by the cleavage of a loop structure of the telomeric chromatin. These findings showed a previously unnoticed interaction between the shelterin complex and nucleosomal histones to stabilize the chromosome ends.	[Konishi, Akimitsu; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Konishi, Akimitsu] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Bunkyo Ku, Tokyo 1138510, Japan; [Konishi, Akimitsu; Izumi, Takashi] Gunma Univ, Dept Biochem, Grad Sch Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan; [Konishi, Akimitsu] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Gunma University; Rockefeller University	Konishi, A (corresponding author), Gunma Univ, Dept Biochem, Grad Sch Med, 3-39-22 Showa, Maebashi, Gunma 3718511, Japan.	akimitsukonishi@gunma-u.ac.jp	Konishi, Akimitsu/J-4024-2019	Konishi, Akimitsu/0000-0002-3291-0821	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF)	Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology (SCF) commissioned by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Benetti R, 2008, CELL CYCLE, V7, P3461, DOI 10.4161/cc.7.21.7013; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2010, COLD SH Q B, V75, P167, DOI 10.1101/sqb.2010.75.017; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; Galati A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034386; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Grigoriev M, 1998, MOL CELL, V2, P373, DOI 10.1016/S1097-2765(00)80281-6; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kim KY, 2013, J VIROL, V87, P6782, DOI 10.1128/JVI.00011-13; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Konishi A, 2012, J BIOL CHEM, V287, P13919, DOI 10.1074/jbc.M112.348375; LEJNINE S, 1995, P NATL ACAD SCI USA, V92, P2393, DOI 10.1073/pnas.92.6.2393; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Mitchell TRH, 2009, MOL CELL BIOL, V29, P4918, DOI 10.1128/MCB.00009-09; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nikitina T, 2004, J CELL BIOL, V166, P161, DOI 10.1083/jcb.200403118; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pisano S, 2007, J MOL BIOL, V369, P1153, DOI 10.1016/j.jmb.2007.04.027; Poulet A, 2009, EMBO J, V28, P641, DOI 10.1038/emboj.2009.11; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; Utley RT, 1996, METHOD ENZYMOL, V274, P276; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025	40	11	11	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20798	20810		10.1074/jbc.M116.719021	http://dx.doi.org/10.1074/jbc.M116.719021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514743	Green Published, hybrid			2022-12-26	WOS:000384574800040
J	Hartwich, H; Rosengauer, E; Ruttiger, L; Wilms, V; Waterholter, SK; Nothwang, HG				Hartwich, Heiner; Rosengauer, Elena; Ruettiger, Lukas; Wilms, Viviane; Waterholter, Sarah-Kristin; Nothwang, Hans Gerd			Functional Role of gamma-Crystallin N in the Auditory Hindbrain	PLOS ONE			English	Article							GLYCINE TRANSPORTER GLYT2; BRAIN-STEM; COCHLEAR NUCLEUS; MEDIAL NUCLEUS; EXPRESSION; GENE; EVOLUTION; PROTEINS; PATTERN; HEARING	gamma-crystallins are major components of the vertebrate lens but show expression in other tissues as well. Their extralenticular functions remain so far unclear. Here, we explored such roles in the rodent superior olivary complex in which previous analysis demonstrated developmentally regulated expression of Crygd, Cryge and Crygn. Immunohistochemistry with novel antibodies against Crygd/e and Crygn indicate that expression of Crygd/e was moderate and varied between the perinatal superior olivary complex of mice, rats, and gerbils. Crygn-immunoreactivity was more robust and consistently highest in the medial nucleus of the trapezoid body, but also present in other nuclei of the superior olivary complex. To analyze the function of Crygn in the auditory hindbrain, we used a Crygn allele with a floxed exon 2. Upon pairing with Egr2::Cre mice, exon 2, encoding the first two greek key motifs of Crygn, was deleted in the developing auditory hindbrain. Anatomical analysis of these mice revealed a 20% volume reduction in the medial nucleus of the trapezoid body and a 7% reduction in the lateral superior olive at postnatal day 25. This was due to cell loss between postnatal days 4 and 25, whereas cell size was unaffected. Auditory brainstem responses showed normal threshold but a significant increase in the amplitude of wave IV. Crygn is hence required for postmigratory survival and proper function of auditory hindbrain neurons. These results ascertain for the first time an essential extralenticular role for gamma-crystallins in vivo.	[Hartwich, Heiner; Rosengauer, Elena; Wilms, Viviane; Waterholter, Sarah-Kristin; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany; [Ruettiger, Lukas] Univ Tubingen, Dept Otolaryngol, THRC, Mol Physiol Hearing, Elfriede Aulhorn Str 5, D-72076 Tubingen, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, Neurogenet Grp, Ctr Excellence Hearing4All, D-26111 Oldenburg, Germany.; Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de	Waterholter, Sarah-Kristin/L-4650-2018	Nothwang, Hans Gerd/0000-0001-7695-6437	DFG [428/5-1]; DFG cluster of Excellence [EXC 1077/1]	DFG(German Research Foundation (DFG)); DFG cluster of Excellence(German Research Foundation (DFG))	This work was supported by the DFG grant No 428/5-1 and the DFG cluster of Excellence EXC 1077/1 "Hearing4all". The funding organization had no influence on the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Altieri SC, 2016, DEV NEUROBIOL, V76, P1266, DOI 10.1002/dneu.22388; Altieri SC, 2015, DEV BIOL, V408, P99, DOI 10.1016/j.ydbio.2015.10.008; BAGBY S, 1994, STRUCTURE, V2, P107, DOI 10.1016/S0969-2126(00)00013-7; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; CAIRD D, 1983, EXP BRAIN RES, V52, P385; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Dumoulin A, 1999, J CELL SCI, V112, P811; Ebbers L, 2015, J BIOL CHEM, V290, P23692, DOI 10.1074/jbc.M115.672675; Ehmann H, 2013, J BIOL CHEM, V288, P25865, DOI 10.1074/jbc.M113.490508; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Friauf E, 1999, J COMP NEUROL, V412, P17; FRIAUF E, 1994, J COMP NEUROL, V349, P193, DOI 10.1002/cne.903490204; Friauf E, 2004, SPR HDB AUD, V23, P49; Galbraith G, 2006, J NEUROSCI METH, V153, P214, DOI 10.1016/j.jneumeth.2005.10.017; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; HENRY KR, 1979, J AM AUDITORY SOC, V4, P173; Hirtz JJ, 2011, J NEUROSCI, V31, P8280, DOI 10.1523/JNEUROSCI.5098-10.2011; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Jalabi W, 2013, J NEUROSCI, V33, P15044, DOI 10.1523/JNEUROSCI.2604-13.2013; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kopp-Scheinpflug C, 2011, NEURON, V71, P911, DOI 10.1016/j.neuron.2011.06.028; Kulesza RJ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00035; KUWADA S, 1986, HEARING RES, V21, P179, DOI 10.1016/0378-5955(86)90038-9; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Lohmann C, 1998, J NEUROBIOL, V34, P97, DOI 10.1002/(SICI)1097-4695(19980205)34:2<97::AID-NEU1>3.0.CO;2-6; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Marrs GS, 2013, DEV NEUROBIOL, V73, P384, DOI 10.1002/dneu.22069; Mishra A, 2016, BBA-GEN SUBJECTS, V1860, P299, DOI 10.1016/j.bbagen.2015.06.012; Morner CT, 1893, Z PHYSL CHEM, V18, P61; Morrow JA, 1998, FEBS LETT, V439, P334, DOI 10.1016/S0014-5793(98)01390-8; Mostafapour SP, 2000, J COMP NEUROL, V426, P561, DOI 10.1002/1096-9861(20001030)426:4<561::AID-CNE5>3.0.CO;2-G; Nothwang HG, 2015, CELL TISSUE RES, V361, P33, DOI 10.1007/s00441-014-2110-7; Poyatos I, 1997, MOL BRAIN RES, V49, P63, DOI 10.1016/S0169-328X(97)00124-1; Rosengauer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049503; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Satheesh SV, 2012, HUM MOL GENET, V21, P3896, DOI 10.1093/hmg/dds217; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Schwartz I.R., 1992, Springer Handbook of Auditory Research, V1, P117; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Slingsby C, 2014, PROG BIOPHYS MOL BIO, V115, P52, DOI 10.1016/j.pbiomolbio.2014.02.006; Smith PH, 2005, J COMP NEUROL, V482, P349, DOI 10.1002/cne.20407; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Takeuchi T, 2009, GENES CELLS, V14, P941, DOI 10.1111/j.1365-2443.2009.01321.x; Templeton JP, 2013, EXP EYE RES, V116, P129, DOI 10.1016/j.exer.2013.08.001; Templeton JP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-90; Thanos S, 2014, PROG RETIN EYE RES, V42, P145, DOI 10.1016/j.preteyeres.2014.06.004; Toyoshima M, 2009, DEV BIOL, V336, P192, DOI 10.1016/j.ydbio.2009.09.043; Vendra VPR, 2016, BBA-GEN SUBJECTS, V1860, P333, DOI 10.1016/j.bbagen.2015.06.007; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wiechers B, 1999, J NEUROSCI, V19, P3033; Willaredt MA, 2015, CELLULAR MOLECULAR L; Wistow G, 2005, FEBS J, V272, P2276, DOI 10.1111/j.1742-4658.2005.04655.x; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208	64	4	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161140	10.1371/journal.pone.0161140	http://dx.doi.org/10.1371/journal.pone.0161140			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517863	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000381382100053
J	Waight, AB; Bargsten, K; Doronina, S; Steinmetz, MO; Sussman, D; Prota, AE				Waight, Andrew B.; Bargsten, Katja; Doronina, Svetlana; Steinmetz, Michel O.; Sussman, Django; Prota, Andrea E.			Structural Basis of Microtubule Destabilization by Potent Auristatin Anti-Mitotics	PLOS ONE			English	Article							VINCA-DOMAIN; DYNAMIC INSTABILITY; BETA-TUBULIN; BINDING; SITE; DOLASTATIN-10; COLCHICINE; INSIGHT; AGENTS; PHARMACOPHORE	The auristatin class of microtubule destabilizers are highly potent cytotoxic agents against several cancer cell types when delivered as antibody drug conjugates. Here we describe the high resolution structures of tubulin in complex with both monomethyl auristatin E and F and unambiguously define the trans-configuration of both ligands at the Val-Dil amide bond in their tubulin bound state. Moreover, we illustrate how peptidic vinca-site agents carrying terminal carboxylate residues may exploit an observed extended hydrogen bond network with the M-loop Arg278 to greatly improve the affinity of the corresponding analogs and to maintain the M-loop in an incompatible conformation for productive lateral tubulin-tubulin contacts in microtubules. Our results highlight a potential, previously undescribed molecular mechanism by which peptidic vinca-site agents maintain unparalleled potency as microtubule- destabilizing agents.	[Waight, Andrew B.; Doronina, Svetlana; Sussman, Django] Seattle Genet Inc, Dept Prot Sci, Bothell, WA 98021 USA; [Bargsten, Katja; Steinmetz, Michel O.; Prota, Andrea E.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland; [Bargsten, Katja] Univ Zurich, Dept Biochem, Zurich, Switzerland	Seattle Genetics; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich	Sussman, D (corresponding author), Seattle Genet Inc, Dept Prot Sci, Bothell, WA 98021 USA.; Prota, AE (corresponding author), Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, Villigen, Switzerland.	dsussman@seagen.com; andrea.prota@psi.ch	Steinmetz, Michel O/AAA-3349-2022; Prota, Andrea Enrico/R-9526-2019	Steinmetz, Michel O/0000-0001-6157-3687; Prota, Andrea Enrico/0000-0003-0875-5339	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; Swiss National Science Foundation [310030B_138659]; Seattle Genetics Inc.	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Seattle Genetics Inc.	The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. This work was supported by a grant from the Swiss National Science Foundation (310030B_138659 to MOS). Portions of this work were done under a Sponsored Research Agreement funded by Seattle Genetics Inc., which is developing antibody-drug conjugate technology including Monomethylauristatin E based ADCs like ADCETRIS1 (Brentuximab Vedotin). ABW, SD and DS are current full-time employees of Seattle Genetics and did play a role in our study design, data collection and analysis, decision to publish and preparation of the manuscript. All other authors of this manuscript declare no financial interest related to this work.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; BAI R, 1990, J BIOL CHEM, V265, P17141; BAI R, 1990, BIOCHEM PHARMACOL, V39, P1941, DOI 10.1016/0006-2952(90)90613-P; Cormier A, 2008, EMBO REP, V9, P1101, DOI 10.1038/embor.2008.171; CURMI PA, 1994, BIOCHEM J, V300, P331, DOI 10.1042/bj3000331; de Claro RA, 2012, CLIN CANCER RES, V18, P5845, DOI 10.1158/1078-0432.CCR-12-1803; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dorleans A, 2009, P NATL ACAD SCI USA, V106, P13775, DOI 10.1073/pnas.0904223106; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Francisco JA, 2003, BLOOD, V102, P1458, DOI 10.1182/blood-2003-01-0039; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; HAMEL E, 1992, PHARMACOL THERAPEUT, V55, P31, DOI 10.1016/0163-7258(92)90028-X; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; JOHNSON IS, 1963, CANCER RES, V23, P1390; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Komlodi-Pasztor E, 2011, NAT REV CLIN ONCOL, V8, DOI 10.1038/nrclinonc.2010.228-c2; Maderna A, 2014, J MED CHEM, V57, P10527, DOI 10.1021/jm501649k; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Pettit G R, 1997, Fortschr Chem Org Naturst, V70, P1; Pettit GR, 1998, ANTI-CANCER DRUG DES, V13, P243; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; Prota AE, 2014, P NATL ACAD SCI USA, V111, P13817, DOI 10.1073/pnas.1408124111; Prota AE, 2014, J MOL BIOL, V426, P1848, DOI 10.1016/j.jmb.2014.02.005; Prota AE, 2014, ANGEW CHEM INT EDIT, V53, P1621, DOI 10.1002/anie.201307749; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; PURICH DL, 1984, ADV PROTEIN CHEM, V36, P133, DOI 10.1016/S0065-3233(08)60297-1; Ranaivoson FM, 2012, ACTA CRYSTALLOGR D, V68, P927, DOI 10.1107/S0907444912017143; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Wang YX, 2016, MOL PHARMACOL, V89, P233, DOI 10.1124/mol.115.100149; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012	36	84	84	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160890	10.1371/journal.pone.0160890	http://dx.doi.org/10.1371/journal.pone.0160890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518442	Green Published, gold, Green Submitted			2022-12-26	WOS:000381382100029
J	Bai, JW; Di, CZ; Xiao, L; Evenson, KR; LaCroix, AZ; Crainiceanu, CM; Buchner, DM				Bai, Jiawei; Di, Chongzhi; Xiao, Luo; Evenson, Kelly R.; LaCroix, Andrea Z.; Crainiceanu, Ciprian M.; Buchner, David M.			An Activity Index for Raw Accelerometry Data and Its Comparison with Other Activity Metrics	PLOS ONE			English	Article							PHYSICAL-ACTIVITY MONITORS; ENERGY-EXPENDITURE; WRIST; CALIBRATION; ACTIGRAPH; AGE; PREDICTION; VALIDATION; FILTER; OUTPUT	Accelerometers have been widely deployed in public health studies in recent years. While they collect high-resolution acceleration signals (e.g., 10-100 Hz), research has mainly focused on summarized metrics provided by accelerometers manufactures, such as the activity count (AC) by ActiGraph or Actical. Such measures do not have a publicly available formula, lack a straightforward interpretation, and can vary by software implementation or hardware type. To address these problems, we propose the physical activity index (AI), a new metric for summarizing raw tri-axial accelerometry data. We compared this metric with the AC and another recently proposed metric for raw data, Euclidean Norm Minus One (ENMO), against energy expenditure. The comparison was conducted using data from the Objective Physical Activity and Cardiovascular Health Study, in which 194 women 60-91 years performed 9 lifestyle activities in the laboratory, wearing a tri-axial accelerometer (ActiGraph GT3X+) on the hip set to 30 Hz and an Oxycon portable calorimeter, to record both tri-axial acceleration time series (converted into AI, AC, and ENMO) and oxygen uptake during each activity (converted into metabolic equivalents (METs)) at the same time. Receiver operating characteristic analyses indicated that both AI and ENMO were more sensitive to moderate and vigorous physical activities than AC, while AI was more sensitive to sedentary and light activities than ENMO. AI had the highest coefficients of determination for METs (0.72) and was a better classifier of physical activity intensity than both AC (for all intensity levels) and ENMO (for sedentary and light intensity). The proposed AI provides a novel and transparent way to summarize densely sampled raw accelerometry data, and may serve as an alternative to AC. The AI's largely improved sensitivity on sedentary and light activities over AC and ENMO further demonstrate its advantage in studies with older adults.	[Bai, Jiawei; Crainiceanu, Ciprian M.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Di, Chongzhi] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Xiao, Luo] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Evenson, Kelly R.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [LaCroix, Andrea Z.] Univ Calif San Diego, Dept Family Med & Publ Hlth, Div Epidemiol, La Jolla, CA 92093 USA; [Buchner, David M.] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA	Johns Hopkins University; Fred Hutchinson Cancer Center; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of Illinois System; University of Illinois Urbana-Champaign	Bai, JW (corresponding author), Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA.	jbai@jhsph.edu	Bai, Jiawei/Q-7473-2017	Bai, Jiawei/0000-0003-4021-0101; Evenson, Kelly/0000-0002-3720-5830; Xiao, Luo/0000-0001-8707-0914; Di, Chongzhi/0000-0002-1371-581X	National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); US Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NHLBI/NIH [1 R01 HL105065]; NIH/NHLBI [1 R01 HL130483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130483, R01HL105065] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), US Department of Health and Human Services through contracts #HHSN268201100046C, #HHSN268201100001C, #HHSN268201100002C, #HHSN268201100003C, #HHSN268201100004C, and #HHSN271201100004C. The Objective Physical Activity and Cardiovascular Health (OPACH) study was funded by NHLBI/NIH #1 R01 HL105065. This work is partly supported by the NIH/NHLBI #1 R01 HL130483.	ActiGraph, 2011, WHAT AR COUNTS; ActiGraph, 2012, IDL SLEEP MOD EXPL; ActiGraph, 2012, LOW FREQ EXT EXPL; Bai JW, 2014, BIOSTATISTICS, V15, P102, DOI 10.1093/biostatistics/kxt029; Bai JW, 2012, ELECTRON J STAT, V6, P559, DOI 10.1214/12-EJS684; Bai Y, 2016, MED SCI SPORT EXER, V48, P151, DOI 10.1249/MSS.0000000000000727; Bankoski A, 2011, DIABETES CARE, V34, P497, DOI 10.2337/dc10-0987; Bao L, 2004, LECT NOTES COMPUT SC, V3001, P1, DOI 10.1007/978-3-540-24646-6_1; Borg G, 1967, ACTA MED SCAND S472, V181, P192; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Cain KL, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-51; Choi L, 2012, MED SCI SPORT EXER, V44, P2009, DOI 10.1249/MSS.0b013e318258cb36; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Colley R. C., 2011, HLTH REPORTS, V22, P15, DOI DOI 10.1016/j.yspm.2011.03.006; Crouter SE, 2015, MED SCI SPORT EXER, V47, P944, DOI 10.1249/MSS.0000000000000502; del Rosario MB, 2015, SENSORS-BASEL, V15, P18901, DOI 10.3390/s150818901; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Evenson Kelly R, 2015, Prev Med Rep, V2, P750; Feito Y, 2015, MED SCI SPORT EXER, V47, P211, DOI 10.1249/MSS.0000000000000395; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; He B, 2014, MED SCI SPORT EXER, V46, P1859, DOI 10.1249/MSS.0000000000000285; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Schrack JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093520; Schrack JA, 2014, J GERONTOL A-BIOL, V69, P973, DOI 10.1093/gerona/glt199; Staudenmayer J, 2015, J APPL PHYSIOL, V119, P396, DOI 10.1152/japplphysiol.00026.2015; Staudenmayer J, 2009, J APPL PHYSIOL, V107, P1300, DOI 10.1152/japplphysiol.00465.2009; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	37	54	54	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160644	10.1371/journal.pone.0160644	http://dx.doi.org/10.1371/journal.pone.0160644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513333	Green Published, gold			2022-12-26	WOS:000381381100054
J	Choi, S; Jang, WJ; Song, YB; Lima, JAC; Guallar, E; Choe, YH; Hwang, JK; Kim, EK; Yang, JH; Hahn, JY; Choi, SH; Lee, SC; Lee, SH; Gwon, HC				Choi, Soonuk; Jang, Woo Jin; Song, Young Bin; Lima, Joao A. C.; Guallar, Eliseo; Choe, Yeon Hyeon; Hwang, Jin Kyung; Kim, Eun Kyoung; Yang, Jeong Hoon; Hahn, Joo-Yong; Choi, Seung-Hyuk; Lee, Sang-Chol; Lee, Sang Hoon; Gwon, Hyeon-Cheol			D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study	PLOS ONE			English	Article							ACUTE PULMONARY-EMBOLISM; CORONARY ANGIOPLASTY; SIZE; RISK; REPERFUSION; AREA; CMR	Objectives Elevated D-dimer levels on admission predict prognosis in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), but the association of D-dimer levels with structural markers of myocardial injury in these patients is unknown. Methods We performed cardiac magnetic resonance (CMR) imaging in 208 patients treated with primary PCI for STEMI. CMR was performed a median of 3 days after the index procedure. Of the 208 patients studied, 75 patients had D-dimer levels above the normal range on admission (> 0.5 mu g/mL; high D-dimer group) while 133 had normal levels (<= 0.5 mu g/ mL; low D-dimer group). The primary outcome was myocardial infarct size assessed by CMR. Secondary outcomes included area at risk (AAR), microvascular obstruction (MVO) area, and myocardial salvage index (MSI). Results In CMR analysis, myocardial infarct size was larger in the high D-dimer group than in the low D-dimer group (22.3% [16.2-30.5] versus 18.8% [10.7-26.7]; p = 0.02). Compared to the low D-dimer group, the high D-dimer group also had a larger AAR (38.1% [31.7-46.9] versus 35.8% [24.2-45.3]; p = 0.04) and a smaller MSI (37.7 [28.2-46.9] versus 47.1 [33.2-57.0]; p = 0.01). In multivariate analysis, high D-dimer levels were significantly associated with larger myocardial infarct (OR 2.59; 95% CI 1.37-4.87; p < 0.01) and lower MSI (OR 2.62; 95% CI 1.44-4.78; p < 0.01). Conclusions In STEMI patients undergoing primary PCI, high D-dimer levels on admission were associated with a larger myocardial infarct size, a greater extent of AAR, and lower MSI, as assessed by CMR data. Elevated initial D-dimer level may be a marker of advanced myocardial injury in patients treated with primary PCI for STEMI.	[Choi, Soonuk; Song, Young Bin; Hwang, Jin Kyung; Kim, Eun Kyoung; Yang, Jeong Hoon; Hahn, Joo-Yong; Choi, Seung-Hyuk; Lee, Sang-Chol; Lee, Sang Hoon; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul, South Korea; [Jang, Woo Jin] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Cardiol,Dept Internal Med, Chang Won, South Korea; [Lima, Joao A. C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Guallar, Eliseo] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Choe, Yeon Hyeon] Sungkyunkwan Univ, Cardiovasc Imaging Ctr, Heart Vasc Stroke Inst, Dept Radiol,Samsung Med Ctr,Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Sungkyunkwan University (SKKU); Samsung Medical Center	Song, YB (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Med,Heart Vasc Stroke Inst, Seoul, South Korea.	youngbin.song@gmail.com	Choe, Yeon Hyeon/F-1422-2010; Hahn, Joo-Yong/AAU-7250-2020	Choe, Yeon Hyeon/0000-0002-9983-048X; Hahn, Joo-Yong/0000-0002-4412-377X				Akgul O, 2013, BLOOD COAGUL FIBRIN, V24, P704, DOI 10.1097/MBC.0b013e3283610396; Brener SJ, 2013, JACC-CARDIOVASC INTE, V6, P718, DOI 10.1016/j.jcin.2013.03.013; Chung S, 2014, INT J CARDIOVAS IMAG, V30, P129, DOI 10.1007/s10554-013-0303-x; Croisille P, 2012, RADIOLOGY, V265, P12, DOI 10.1148/radiol.12111769; Dall'Armellina E, 2010, NAT REV CARDIOL, V7, P624, DOI 10.1038/nrcardio.2010.140; Dunn KL, 2002, J AM COLL CARDIOL, V40, P1475, DOI 10.1016/S0735-1097(02)02172-1; Eitel I, 2014, J AM COLL CARDIOL, V64, P1217, DOI 10.1016/j.jacc.2014.06.1194; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019; Froehling DA, 2007, MAYO CLIN PROC, V82, P556, DOI 10.4065/82.5.556; Ganame J, 2009, EUR HEART J, V30, P1440, DOI 10.1093/eurheartj/ehp093; Hahn JY, 2008, AM J CARDIOL, V102, P1163, DOI 10.1016/j.amjcard.2008.06.042; Henriques JPS, 2003, CIRCULATION, V107, P2115, DOI 10.1161/01.CIR.0000065221.06430.ED; Kikkert WJ, 2014, J THROMB THROMBOLYS, V37, P155, DOI 10.1007/s11239-013-0953-5; Lonborg J, 2013, EUR HEART J-CARD IMG, V14, P387, DOI 10.1093/ehjci/jes271; Menown IBA, 2003, AM HEART J, V145, P986, DOI 10.1016/S0002-8703(03)00169-8; Oldgren J, 2001, ARTERIOSCL THROM VAS, V21, P1059, DOI 10.1161/01.ATV.21.6.1059; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; RIDKER PM, 1994, CIRCULATION, V90, P2236, DOI 10.1161/01.CIR.90.5.2236; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Song YB, 2012, AM HEART J, V163, P500, DOI 10.1016/j.ahj.2011.12.007; Stone GW, 2007, AM J CARDIOL, V100, P1370, DOI 10.1016/j.amjcard.2007.06.027; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065	23	26	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160955	10.1371/journal.pone.0160955	http://dx.doi.org/10.1371/journal.pone.0160955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513758	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100094
J	La Porta, J; Matus-Nicodemos, R; Valentin-Acevedo, A; Covey, LR				La Porta, James; Matus-Nicodemos, Rodrigo; Valentin-Acevedo, Anibal; Covey, Lori R.			The RNA-Binding Protein, Polypyrimidine Tract-Binding Protein 1 (PTBP1) Is a Key Regulator of CD4 T Cell Activation	PLOS ONE			English	Article							KINASE MESSENGER-RNA; GENE-EXPRESSION; CYCLIN D1; LIGAND EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; LYMPHOCYTE DEVELOPMENT; GLUCOSE-METABOLISM; DEPENDENT MANNER; IN-VIVO; B-CELLS	We have previously shown that the RNA binding protein, polypyrimidine tract-binding protein (PTBP1) plays a critical role in regulating the expression of CD40L in activated CD4 T cells. This is achieved mechanistically through message stabilization at late times of activation as well as by altered distribution of CD40L mRNA within distinct cellular compartments. PTBP1 has been implicated in many different processes, however whether PTBP1 plays a broader role in CD4 T cell activation is not known. To examine this question, experiments were designed to introduce shRNA into primary human CD4 T cells to achieve decreased, but not complete ablation of PTBP1 expression. Analyses of shPTB-expressing CD4 T cells revealed multiple processes including cell proliferation, activation-induced cell death and expression of activation markers and cytokines that were regulated in part by PTBP1 expression. Although there was an overall decrease in the steady-state level of several activation genes, only IL-2 and CD40L appeared to be regulated by PTBP1 at the level of RNA decay suggesting that PTBP1 is critical at different regulatory steps of expression that is gene-specific. Importantly, even though the IL-2 protein levels were reduced in cells with lowered PTBP1, the steady-state level of IL-2 mRNA was significantly higher in these cells suggesting a block at the translational level. Evaluation of T cell activation in shPTBexpressing T cells revealed that PTBP1 was linked primarily to the activation of the PLC.1/ ERK1/2 and the NF-.B pathways. Overall, our results reveal the importance of this critical RNA binding protein in multiple steps of T cell activation.	[La Porta, James; Matus-Nicodemos, Rodrigo; Valentin-Acevedo, Anibal; Covey, Lori R.] Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Matus-Nicodemos, Rodrigo] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD USA; [Valentin-Acevedo, Anibal] Univ Puerto Rico, Dept Nat Sci, Aguadilla, PR USA	Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Puerto Rico; University of Puerto Rico at Aguadilla	Covey, LR (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA.	covey@biology.rutgers.edu			National Institutes of Health/National Institute of Allergy and Infectious Disease [R03 AI107811-01, PO1 AI-57596]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI107811] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by R03 AI107811-01 and PO1 AI-57596 (project #2) (National Institutes of Health/National Institute of Allergy and Infectious Disease)(https://www.niaid.nih.gov) to LRC.	Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Barnhart B, 2000, IMMUNOLOGY, V99, P54, DOI 10.1046/j.1365-2567.2000.00943.x; Barnhart B, 2000, J IMMUNOL, V165, P4478, DOI 10.4049/jimmunol.165.8.4478; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Biswas R, 2003, J IMMUNOL, V170, P6202, DOI 10.4049/jimmunol.170.12.6202; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BUNNELL BA, 1990, P NATL ACAD SCI USA, V87, P7467, DOI 10.1073/pnas.87.19.7467; Campbell PM, 2014, METHODS MOL BIOL, V1170, P155, DOI 10.1007/978-1-4939-0888-2_9; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; CHATILA T, 1989, J IMMUNOL, V143, P1283; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen M, 2010, CANCER RES, V70, P8977, DOI 10.1158/0008-5472.CAN-10-2513; Chowdhury D, 2005, ADV IMMUNOL, V88, P267, DOI 10.1016/S0065-2776(05)88008-3; COVEY LR, 1994, MOL IMMUNOL, V31, P471, DOI 10.1016/0161-5890(94)90066-3; Crawford TQ, 2014, CYTOM PART A, V85, P268, DOI 10.1002/cyto.a.22444; Culjkovic B, 2005, J CELL BIOL, V169, P245, DOI 10.1083/jcb.200501019; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Engels B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033144; Ford GS, 1999, J IMMUNOL, V162, P4037; Fred RG, 2006, CURR DIABETES REV, V2, P363, DOI 10.2174/157339906777950570; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Hamilton BJ, 2003, MOL CELL BIOL, V23, P510, DOI 10.1128/MCB.23.2.510-525.2003; Hassan SB, 2014, IMMUNOPHARM IMMUNOT, V36, P96, DOI 10.3109/08923973.2014.890626; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; He X, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.47; Ivanov P, 2013, IMMUNOL REV, V253, P253, DOI 10.1111/imr.12051; Jiang SH, 2015, CURR OPIN IMMUNOL, V37, P21, DOI 10.1016/j.coi.2015.09.003; Jin W, 2000, CANCER RES, V60, P1221; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Lai HK, 2000, ONCOGENE, V19, P1623, DOI 10.1038/sj.onc.1203473; Laughlin J, 2008, IMMUNOLOGY, V124, P368, DOI 10.1111/j.1365-2567.2007.02783.x; Lee GH, 2014, CURR CANCER DRUG TAR, V14, P610, DOI 10.2174/1568009614666140828103253; Liu Z, 2014, J INFECTION, V68, P553, DOI 10.1016/j.jinf.2013.12.017; Lustig Y, 2014, DIABETES, V63, P433, DOI 10.2337/db13-1032; Maekawa M, 2002, J BIOL CHEM, V277, P37783, DOI 10.1074/jbc.M204506200; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Matus-Nicodemos R, 2011, J IMMUNOL, V186, P2164, DOI 10.4049/jimmunol.1003236; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Oh H, 2013, IMMUNOL REV, V252, P41, DOI 10.1111/imr.12033; Ohno S, 2011, CELL CYCLE, V10, P3706, DOI 10.4161/cc.10.21.17903; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Porter JF, 2008, J IMMUNOL, V181, P3336, DOI 10.4049/jimmunol.181.5.3336; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Rasola A, 2010, P NATL ACAD SCI USA, V107, P726, DOI 10.1073/pnas.0912742107; Riches JC, 2014, SEMIN HEMATOL, V51, P228, DOI 10.1053/j.seminhematol.2014.05.006; Romanelli MG, 2013, INT J MOL SCI, V14, P22906, DOI 10.3390/ijms141122906; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shibayama M, 2009, FEBS J, V276, P6658, DOI 10.1111/j.1742-4658.2009.07380.x; Soderberg M, 2007, MOL IMMUNOL, V44, P434, DOI 10.1016/j.molimm.2006.02.019; Spriggs KA, 2005, BIOCHEM SOC T, V33, P1483, DOI 10.1042/BST0331483; Sun B, 2014, ADV EXP MED BIOL, V841, P1, DOI 10.1007/978-94-017-9487-9_1; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Taniguchi K, 2015, CANCER LETT, V363, P17, DOI 10.1016/j.canlet.2015.03.026; Topisirovic I, 2002, MOL CELL BIOL, V22, P6183, DOI 10.1128/MCB.22.17.6183-6198.2002; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Turner M, 2012, ADV IMMUNOL, V115, P161, DOI 10.1016/B978-0-12-394299-9.00006-0; Turner M, 2012, CURR OPIN IMMUNOL, V24, P160, DOI 10.1016/j.coi.2012.01.011; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vavassori S, 2009, RNA BIOL, V6, P259, DOI 10.4161/rna.6.3.8581; Vazquez BN, 2009, J IMMUNOL, V183, P6513, DOI 10.4049/jimmunol.0900839; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Wang C, 2008, J BIOL CHEM, V283, P20277, DOI 10.1074/jbc.M803682200; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Yeh JH, 2001, MOL CELL BIOL, V21, P4515, DOI 10.1128/MCB.21.14.4515-4527.2001; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yin DL, 1999, J IMMUNOL, V163, P4328; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	76	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0158708	10.1371/journal.pone.0158708	http://dx.doi.org/10.1371/journal.pone.0158708			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513449	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100011
J	Assuncao, AR; Bottaro, M; Ferreira, JB; Izquierdo, M; Cadore, EL; Gentil, P				Assuncao, Ari R.; Bottaro, Martim; Ferreira-Junior, Joao B.; Izquierdo, Mikel; Cadore, Eduardo L.; Gentil, Paulo			The Chronic Effects of Low- and High-Intensity Resistance Training on Muscular Fitness in Adolescents	PLOS ONE			English	Article							ENDURANCE DEVELOPMENT; POSITION STATEMENT; STRENGTH GAINS; ADAPTATIONS; EXERCISE; PROTOCOLS; CHILDREN; PERFORMANCE; SIZE; HYPERTROPHY	To compare the effects of high-load, low-repetition maximum (LRM) and low-load, high-repetition maximum (HRM) resistance training regimens on muscular fitness in untrained adolescents. Forty-five untrained adolescents of both sexes (13.7 +/- 0.8 years; 161.3 +/- 7.5 cm, 56.8 +/- 13.4 kg) were randomly assigned into one of three groups: 1) LRM (n = 17): volunteers performed three sets of 4-6-repetition maximum (RM); 2) HRM (n = 16): volunteers performed three sets of 12-15 RM; and 3) control (CON, n = 12). Training was performed two times a week for 9 weeks. After training, there were significant increases in 1 RM chest press (LRM = 14.8% and HRM = 14.2%, p<0.05) and squat (LRM = 26.4% and HRM = 25.7%, p<0.05), with no differences between the LRM and HRM groups (p>0.05). Additionally, muscular endurance increased significantly for the chest press (LRM = 14.5% and HRM = 21.8%, p<0.05) and squat test (LRM = 31.4% and HRM = 32.4%, p<0.05) following resistance training, with no difference between the LRM and HRM groups (p>0.05). These results suggest that both high-load, low-repetition and moderate-load, high-repetition resistance training can be prescribed to improve muscular fitness in untrained adolescents.	[Assuncao, Ari R.; Bottaro, Martim] Univ Brasilia, Coll Phys Educ, Brasilia, DF, Brazil; [Ferreira-Junior, Joao B.] Fed Inst Sudeste Minas Gerais, Campus Rio Pomba, Rio Pomba, MG, Brazil; [Izquierdo, Mikel] Univ Publ Navarra, Dept Hlth Sci, Campus Tudela, Tudela, Navarre, Spain; [Cadore, Eduardo L.] Univ Fed Rio Grande do Sul, Sch Phys Educ, Pa, RS, Brazil; [Gentil, Paulo] Univ Fed Goias, Coll Phys Educ, Goiania, Go, Brazil	Universidade de Brasilia; Instituto Federal do Sudeste de Minas Gerais; Universidad Publica de Navarra; Universidade Federal do Rio Grande do Sul; Universidade Federal de Goias	Ferreira, JB (corresponding author), Fed Inst Sudeste Minas Gerais, Campus Rio Pomba, Rio Pomba, MG, Brazil.	jbfjunior@gmail.com	Cadore, Eduardo L./T-3016-2017; Gentil, Paulo/L-7968-2016; Izquierdo, Mikel/O-8049-2019; Bottaro, Martim/H-9593-2014; Bottaro, Martim/X-1433-2019; Izquierdo, Mikel/A-4894-2010	Cadore, Eduardo L./0000-0003-4397-9485; Gentil, Paulo/0000-0003-2459-4977; Bottaro, Martim/0000-0002-4315-3176; Izquierdo, Mikel/0000-0002-1506-4272				ANDERSON T, 1982, RES Q EXERCISE SPORT, V53, P1; Beck TW, 2013, J STRENGTH COND RES, V27, P2323, DOI 10.1519/JSC.0b013e318278eea0; Behm DG, 2008, APPL PHYSIOL NUTR ME, V33, P547, DOI 10.1139/H08-020; Behringer M, 2011, PEDIATR EXERC SCI, V23, P186, DOI 10.1123/pes.23.2.186; Behringer M, 2010, PEDIATRICS, V126, pE1199, DOI 10.1542/peds.2010-0445; BERGER RA, 1962, RES QUART, V33, P334, DOI 10.1080/10671188.1962.10616460; Campos GER, 2002, EUR J APPL PHYSIOL, V88, P50, DOI 10.1007/s00421-002-0681-6; Carpinelli RN, 2008, J EXERC SCI FIT, V6, P67; Carpinelli RF., 2004, J EXERC PHYSL, V2004, P1; Chen TC, 2014, EUR J APPL PHYSIOL, V114, P1183, DOI 10.1007/s00421-014-2848-3; Chestnut JL, 1999, J STRENGTH COND RES, V13, P353, DOI 10.1519/00124278-199911000-00009; DELORME TL, 1945, J BONE JOINT SURG, V27, P645; Drinkwater EJ, 2005, J STRENGTH COND RES, V19, P382; Faigenbaum AD, 2010, BRIT J SPORT MED, V44, P56, DOI 10.1136/bjsm.2009.068098; Faigenbaum AD, 2005, PEDIATR EXERC SCI, V17, P237, DOI 10.1123/pes.17.3.237; Faigenbaum AD, 2001, J STRENGTH COND RES, V15, P459; Faigenbaum AD, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e5; Faigenbaum AD, 2011, PEDIATR EXERC SCI, V23, P573, DOI 10.1123/pes.23.4.573; Faigenbaum AD, 2009, J STRENGTH COND RES, V23, pS60, DOI 10.1519/JSC.0b013e31819df407; Faigenbaum AD, 2008, PEDIATR EXERC SCI, V20, P457, DOI 10.1123/pes.20.4.457; Fleck SJ, 2011, REV KRONOS, V10, P15; Folland JP, 2002, BRIT J SPORT MED, V36, P370, DOI 10.1136/bjsm.36.5.370; Gentil Paulo, 2013, Asian J Sports Med, V4, P101; Gentil P, 2010, J STRENGTH COND RES, V24, P639, DOI 10.1519/JSC.0b013e3181ad3373; Holm L, 2008, J APPL PHYSIOL, V105, P1454, DOI 10.1152/japplphysiol.90538.2008; Izquierdo M, 2006, J APPL PHYSIOL, V100, P1647, DOI 10.1152/japplphysiol.01400.2005; Izquierdo-Gabarren M, 2010, MED SCI SPORT EXER, V42, P1191, DOI 10.1249/MSS.0b013e3181c67eec; Jungblut S, 2009, MED SPORT, V13, P203; Kraemer WJ, 2004, MED SCI SPORT EXER, V36, P674, DOI 10.1249/01.MSS.0000121945.36635.61; Lloyd RS, 2014, BRIT J SPORT MED, V48, P498, DOI 10.1136/bjsports-2013-092952; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; OSHEA P, 1966, RES QUART, V37, P95, DOI 10.1080/10671188.1966.10614741; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; ROONEY KJ, 1994, MED SCI SPORT EXER, V26, P1160; Sampson JA, 2015, SCAND J MED SCI SPOR; Schoenfeld BJ, 2015, J STRENGTH COND RES, V29, P2954, DOI 10.1519/JSC.0000000000000958; Schoenfeld BJ, 2014, J STRENGTH COND RES, V28, P2909, DOI 10.1519/JSC.0000000000000480; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P2857, DOI 10.1519/JSC.0b013e3181e840f3; Stone WJ, 1994, J STRENGTH COND RES, V8, P231; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; WITHERS RT, 1970, RES QUART, V41, P110, DOI 10.1080/10671188.1970.10614954	42	22	22	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160650	10.1371/journal.pone.0160650	http://dx.doi.org/10.1371/journal.pone.0160650			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509050	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400043
J	Hsieh, F; Hsueh, CH; Heitkamp, C; Matthews, M				Hsieh, Fushing; Hsueh, Chih-Hsin; Heitkamp, Constantin; Matthews, Mark			Integrative Inferences on Pattern Geometries of Grapes Grown under Water Stress and Their Resulting Wines	PLOS ONE			English	Article							LEAF	Multiple datasets of two consecutive vintages of replicated grape and wines from six different deficit irrigation regimes are characterized and compared. The process consists of four temporal-ordered signature phases: harvest field data, juice composition, wine composition before bottling and bottled wine. A new computing paradigm and an integrative inferential platform are developed for discovering phase-to-phase pattern geometries for such characterization and comparison purposes. Each phase is manifested by a distinct set of features, which are measurable upon phase-specific entities subject to the common set of irrigation regimes. Throughout the four phases, this compilation of data from irrigation regimes with subsamples is termed a space of media-nodes, on which measurements of phase-specific features were recoded. All of these collectively constitute a bipartite network of data, which is then normalized and binary coded. For these serial bipartite networks, we first quantify patterns that characterize individual phases by means of a new computing paradigm called "Data Mechanics". This computational technique extracts a coupling geometry which captures and reveals interacting dependence among and between media-nodes and featurenodes in forms of hierarchical block sub-matrices. As one of the principal discoveries, the holistic year-factor persistently surfaces as the most inferential factor in classifying all media-nodes throughout all phases. This could be deemed either surprising in its over-arching dominance or obvious based on popular belief. We formulate and test pattern-based hypotheses that confirm such fundamental patterns. We also attempt to elucidate the driving force underlying the phase-evolution in winemaking via a newly developed partial coupling geometry, which is designed to integrate two coupling geometries. Such partial coupling geometries are confirmed to bear causal and predictive implications. All pattern inferences are performed with respect to a profile of energy distributions sampled from network bootstrapping ensembles conforming to block-structures specified by corresponding hypotheses.	[Hsieh, Fushing; Hsueh, Chih-Hsin] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Heitkamp, Constantin; Matthews, Mark] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hsieh, F (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	fhsieh@ucdavis.edu			NSF (Cyber-enabled Discovery and Innovation [CDI] program) [DMS 1007219]	NSF (Cyber-enabled Discovery and Innovation [CDI] program)	This research is supported by the NSF under Grants No: DMS 1007219 (cofunded by Cyber-enabled Discovery and Innovation [CDI] program) (FH).	Barvinok A, 2010, COMB PROBAB COMPUT, V19, P517, DOI 10.1017/S0963548310000039; Bayati M, 2010, ALGORITHMICA, V58, P860, DOI 10.1007/s00453-009-9340-1; Berkowitz M., 1996, ARCHAEOLOGY, V49; Bowen P, 2011, AM J ENOL VITICULT, V62, P9, DOI 10.5344/ajev.2010.10046; Castellarin SD, 2007, PLANTA, V227, P101, DOI 10.1007/s00425-007-0598-8; Chen C-H, 2014, PLOS ONE; Chen C, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041120; Chen YG, 2005, J AM STAT ASSOC, V100, P109, DOI 10.1198/016214504000001303; COOMBE BG, 1976, ANNU REV PLANT PHYS, V27, P207, DOI 10.1146/annurev.pp.27.060176.001231; Fushing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114177; Fushing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106154; Fushing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056259; Fushing H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.061110; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; Heitkamp C., 2015, THESIS; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hsieh FS, 2014, J STAT PHYS, V156, P823, DOI 10.1007/s10955-014-1043-6; Kennedy JA, 2002, AM J ENOL VITICULT, V53, P268; MATTHEWS MA, 1987, J AM SOC HORTIC SCI, V112, P314; MATTHEWS MA, 1989, AM J ENOL VITICULT, V40, P52; MATTHEWS MA, 1990, J SCI FOOD AGR, V51, P321, DOI 10.1002/jsfa.2740510305; Phillips R., 2000, SHORT HIST WINE; Shev A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115367; WANG H, 2012, PLOS ONE, V0007; Williams LE, 2002, J AM SOC HORTIC SCI, V127, P448, DOI 10.21273/JASHS.127.3.448	25	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160621	10.1371/journal.pone.0160621	http://dx.doi.org/10.1371/journal.pone.0160621			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508416	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400039
J	Humbert, MV; Hung, MC; Phillips, R; Akoto, C; Hill, A; Tan, WM; Heckels, JE; Christodoulides, M				Humbert, Maria Victoria; Hung, Miao-Chiu; Phillips, Renee; Akoto, Charlene; Hill, Alison; Tan, Wei-Ming; Heckels, John Edward; Christodoulides, Myron			Vaccine Potential and Diversity of the Putative Cell Binding Factor (CBF, NMB0345/NEIS1825) Protein of Neisseria meningitidis	PLOS ONE			English	Article							SEROGROUP-B MENINGOCOCCUS; OUTER-MEMBRANE; DISEASE; IMMUNIZATION; PROTECTION; CANDIDATE; VESICLES; COVERAGE; MUTANT; 4CMENB	The cbf gene from Neisseria meningitidis strain MC58 encoding the putative Cell Binding Factor (CBF, NMB0345/NEIS1825) protein was cloned into the pRSETA system and a similar to 36-kDa recombinant (r)CBF protein expressed in Escherichia coli and purified by metal affinity chromatography. High titres of rCBF antibodies were induced in mice following immunization with rCBF-saline, rCBF-Al(OH)(3), rCBF-Liposomes or rCBF-Zwittergent (Zw) 3-14 micelles, both with and without incorporated monophosphoryl lipid A (MPLA) adjuvant. Anti-rCBF sera reacted in western blots of meningococcal lysates with a single protein band of molecular mass similar to 29.5 kDa, indicative of mature CBF protein, but did not react with a lysate of a Delta nmb0345 mutant (CBF-), demonstrating specificity of the murine immune responses. CBF protein was produced by all strains of meningococci studied thus far and the protein was present on the surface of MC58 (CBF+) bacteria, but absent on Delta nmb0345 mutant (CBF-) bacteria, as judged by FACS reactivity of anti-rCBF sera. Analysis of the NEIS1825 amino acid sequences from 6644 N. meningitidis isolates with defined Alleles in the pubmlst. org/Neisseria database showed that there were 141 ST types represented and there were 136 different allelic loci encoding 49 non-redundant protein sequences. Only 6/6644 (< 0.1%) of N. meningitidis isolates lacked the nmb0345 gene. Amongst serogroup B isolates worldwide, similar to 68% and similar to 20% expressed CBF encoded by Allele 1 and 18 respectively, with the proteins sharing >99% amino acid identity. Murine antisera to rCBF in Zw 3-14 micelles + MPLA induced significant serum bactericidal activity (SBA) against homologous Allele 1 and heterologous Allele 18 strains, using both baby rabbit serum complement and human serum complement (h) SBA assays, but did not kill strains expressing heterologous protein encoded by Alelle 2 or 3. Furthermore, variable bactericidal activity was induced by murine antisera against different meningococcal strains in the hSBA assay, which may correlate with variable surface exposure of CBF. Regardless, the attributes of amino acid sequence conservation and protein expression amongst different strains and the ability to induce cross-strain bactericidal antibodies indicates that rCBF could be a potential meningococcal vaccine antigen and merits further testing.	[Humbert, Maria Victoria; Hung, Miao-Chiu; Phillips, Renee; Akoto, Charlene; Hill, Alison; Tan, Wei-Ming; Heckels, John Edward; Christodoulides, Myron] Univ Southampton, Fac Med, Sir Henry Wellcome Labs, Neisseria Res,Mol Microbiol,Acad Unit Clin & Expt, Southampton, Hants, England; [Phillips, Renee] Univ Adelaide, Sch Dent, Craniofacial Biol Res Grp, Adelaide, SA, Australia	University of Southampton; University of Adelaide	Christodoulides, M (corresponding author), Univ Southampton, Fac Med, Sir Henry Wellcome Labs, Neisseria Res,Mol Microbiol,Acad Unit Clin & Expt, Southampton, Hants, England.	mc4@soton.ac.uk	Christodoulides, Myron/C-6699-2011	Christodoulides, Myron/0000-0002-9663-4731; Phillips, Renee/0000-0001-8340-9319; WEI MING, TAN/0000-0001-8720-3131; Hill, Alison/0000-0001-5397-873X; Akoto, Charlene/0000-0003-3355-1688	Meningitis UK [6015]; Medical Research Council, UK [MR/K027131/1]; Wellcome Trust; European Union; Medical Research Council [MR/K027131/1] Funding Source: researchfish; MRC [MR/K027131/1] Funding Source: UKRI	Meningitis UK; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Meningitis UK (grant 6015) [https://www.meningitisnow.org/]. Maria V. Humbert is a postdoctoral research fellow supported by the Medical Research Council, UK (grant MR/K027131/1) [http://www.mrc.ac.uk/].; We are grateful to Karl Wooldridge, University of Nottingham for providing the MC58 Delta nmb0345 mutant strain. We thank Jay Lucidarme and Ray Borrow, Public Health England Meningococcal Reference Unit, Manchester for provision of meningococcal strains. This publication made use of the Neisseria Multi Locus Sequence Typing website (http://pubmlst.org/neisseria/) developed by Keith Jolley and sited at the University of Oxford. The development of this site has been funded by the Wellcome Trust and European Union. We are especially grateful to Karl Staples, University of Southampton for phlebotomy service.	Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Bakshi S., 2004, ROLE NMB0342 NMB0348; Bernfield L, 2002, 13 INT PATH NEISS C; Bettinger JA, 2013, VACCINE, V32, P124, DOI 10.1016/j.vaccine.2013.03.063; Christodoulides M, 1998, MICROBIOL-SGM, V144, P3027, DOI 10.1099/00221287-144-11-3027; Christodoulides M, 2014, EXPERT REV PROTEOMIC, V11, P573, DOI 10.1586/14789450.2014.938640; Dull PM, 2012, VACCINE, V30, pB18, DOI 10.1016/j.vaccine.2012.01.062; Ferrari G, 2006, PROTEOMICS, V6, P1856, DOI 10.1002/pmic.200500164; Findlow H, 2013, ADV THER, V30, P431, DOI 10.1007/s12325-013-0032-5; FINNE J, 1983, LANCET, V2, P355; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; HECKELS JE, 1977, J GEN MICROBIOL, V99, P333, DOI 10.1099/00221287-99-2-333; Hey A, 2013, INFECT IMMUN, V81, P4149, DOI 10.1128/IAI.00397-13; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Humbert MV, 2015, EXPERT REV VACCINES, V14, P1633, DOI 10.1586/14760584.2015.1095638; Hung MC, 2015, VACCINE, V33, P4486, DOI 10.1016/j.vaccine.2015.07.032; Hung MC, 2013, MBIO, V4, DOI 10.1128/mBio.00041-13; Hung MC, 2011, INFECT IMMUN, V79, P3784, DOI 10.1128/IAI.05019-11; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jordan PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005198; McNeil LK, 2013, MICROBIOL MOL BIOL R, V77, P234, DOI 10.1128/MMBR.00056-12; Medini D, 2015, VACCINE, V33, P2629, DOI 10.1016/j.vaccine.2015.04.015; Nissen MD, 2012, PEDIATRINFECT DIS J; Perez-Trallero E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116024; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Pollard AJ, 2014, LANCET, V383, P1103, DOI 10.1016/S0140-6736(14)60226-9; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Ray TD, 2011, J IMMUNOL, V186, P4881, DOI 10.4049/jimmunol.1003623; Shirley M, 2015, BIODRUGS, V29, P353, DOI 10.1007/s40259-015-0139-0; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; Vermont C, 2002, FEMS IMMUNOL MED MIC, V34, P89, DOI 10.1111/j.1574-695X.2002.tb00608.x; Vesikari T, 2016, J PEDIAT INF DIS SOC, V5, P152, DOI 10.1093/jpids/piv039; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Williams JN, 2007, INFECT IMMUN, V75, P1364, DOI 10.1128/IAI.01424-06; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09	35	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160403	10.1371/journal.pone.0160403	http://dx.doi.org/10.1371/journal.pone.0160403			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505005	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200036
J	Tkacz, MA; Chrominski, K; Idziak-Helmcke, D; Robaszkiewicz, E; Hasterok, R				Tkacz, Magdalena A.; Chrominski, Kornel; Idziak-Helmcke, Dominika; Robaszkiewicz, Ewa; Hasterok, Robert			Chromosome Territory Modeller and Viewer	PLOS ONE			English	Article							ORDER CHROMATIN ARRANGEMENTS; NUCLEAR ARCHITECTURE; SPATIAL-ORGANIZATION; ARABIDOPSIS-THALIANA; INTERPHASE NUCLEI; GENE-REGULATION; CELL-NUCLEI; GENOME; TRANSLOCATIONS; LIBRARIES	This paper presents ChroTeMo, a tool for chromosome territory modelling, accompanied by ChroTeVi-a chromosome territory visualisation software that uses the data obtained by ChroTeMo. These tools have been developed in order to complement the molecular cytogenetic research of interphase nucleus structure in a model grass Brachypodium distachyon. Although the modelling tool has been initially created for one particular species, it has universal application. The proposed version of ChroTeMo allows for generating a model of chromosome territory distribution in any given plant or animal species after setting the initial, species-specific parameters. ChroTeMo has been developed as a fully probabilistic modeller. Due to this feature, the comparison between the experimental data on the structure of a nucleus and the results obtained from ChroTeMo can indicate whether the distribution of chromosomes inside a nucleus is also fully probabilistic or is subjected to certain non-random patterns. The presented tools have been written in Python, so they are multiplatform, portable and easy to read. Moreover, if necessary they can be further developed by users writing their portions of code. The source code, documentation, and wiki, as well as the issue tracker and the list of related articles that use ChroTeMo and ChroTeVi, are accessible in a public repository at Github under GPL 3.0 license.	[Tkacz, Magdalena A.] Univ Silesia Katowice, Fac Mat & Comp Sci, Inst Comp Sci, Sosnowiec, Poland; [Chrominski, Kornel] Univ Silesia Katowice, Fac Mat & Comp Sci, Inst Technol & Mechatron, Sosnowiec, Poland; [Idziak-Helmcke, Dominika; Robaszkiewicz, Ewa; Hasterok, Robert] Univ Silesia Katowice, Fac Biol & Environm Protect, Dept Plant Anat & Cytol, Katowice, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Tkacz, MA (corresponding author), Univ Silesia Katowice, Fac Mat & Comp Sci, Inst Comp Sci, Sosnowiec, Poland.	magdalena.tkacz@us.edu.pl	Tkacz, Magdalena A./AAC-8124-2020; Hasterok, Robert/A-1629-2008	Tkacz, Magdalena A./0000-0002-3931-0474; Idziak-Helmcke, Dominika/0000-0002-0713-2466; Robaszkiewicz, Ewa/0000-0001-8615-004X; Hasterok, Robert/0000-0001-6667-2721; Chrominski, Kornel/0000-0001-9875-5812	National Science Centre, Poland [DEC-2012/04/A/NZ3/00572]	National Science Centre, Poland(National Science Centre, Poland)	DIH, ER and RH acknowledge financial support from the National Science Centre, Poland (grant no. DEC-2012/04/A/NZ3/00572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; Berr A, 2006, PLANT J, V48, P771, DOI 10.1111/j.1365-313X.2006.02912.x; Betekhtin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115108; Boveri T., 1909, ARCH ZELLFORSCH, V3, P181; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Caddle LB, 2007, CHROMOSOME RES, V15, P1061, DOI 10.1007/s10577-007-1181-7; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Farrar K, 2007, NAT PROTOC, V2, P1661, DOI 10.1038/nprot.2007.204; Febrer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013461; Federico C, 2006, CHROMOSOMA, V115, P123, DOI 10.1007/s00412-005-0039-z; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Heride C, 2010, J CELL SCI, V123, P4063, DOI 10.1242/jcs.066498; Idziak D, 2011, CHROMOSOMA, V120, P469, DOI 10.1007/s00412-011-0326-9; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Pecinka A, 2004, CHROMOSOMA, V113, P258, DOI 10.1007/s00412-004-0316-2; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Visser AE, 1999, J CELL SCI, V112, P3353; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	25	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160303	10.1371/journal.pone.0160303	http://dx.doi.org/10.1371/journal.pone.0160303			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505434	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200031
J	Zybura-Broda, K; Amborska, R; Ambrozek-Latecka, M; Wilemska, J; Bogusz, A; Bucko, J; Konopka, A; Grajkowska, W; Roszkowski, M; Marchel, A; Rysz, A; Koperski, L; Wilczynski, GM; Kaczmarek, L; Rylski, M				Zybura-Broda, Katarzyna; Amborska, Renata; Ambrozek-Latecka, Magdalena; Wilemska, Joanna; Bogusz, Agnieszka; Bucko, Joanna; Konopka, Anna; Grajkowska, Wieslawa; Roszkowski, Marcin; Marchel, Andrzej; Rysz, Andrzej; Koperski, Lukasz; Wilczynski, Grzegorz M.; Kaczmarek, Leszek; Rylski, Marcin			Epigenetics of Epileptogenesis-Evoked Upregulation of Matrix Metalloproteinase-9 in Hippocampus	PLOS ONE			English	Article								Enhanced levels of Matrix Metalloproteinase-9 (MMP-9) have been implicated in the pathogenesis of epilepsy in humans and rodents. Lack of Mmp-9 impoverishes, whereas excess of Mmp-9 facilitates epileptogenesis. Epigenetic mechanisms driving the epileptogenesis-related upregulation of MMP-9 expression are virtually unknown. The aim of this study was to reveal these mechanisms. We analyzed hippocampi extracted from adult and pediatric patients with temporal lobe epilepsy as well as from partially and fully pentylenetetrazole kindled rats. We used a unique approach to the analysis of the kindling model results (inclusion in the analysis of rats being during kindling, and not only a group of fully kindled animals), which allowed us to separate the molecular effects exerted by the epileptogenesis from those related to epilepsy and epileptic activity. Consequently, it allowed for a disclosure of molecular mechanisms underlying causes, and not consequences, of epilepsy. Our data show that the epileptogenesis-evoked upregulation of Mmp-9 expression is regulated by removal from Mmp-9 gene proximal promoter of the two, interweaved potent silencing mechanisms-DNA methylation and Polycomb Repressive Complex 2 (PRC2)-related repression. Demethylation depends on a gradual dissociation of the DNA methyltransferases, Dnmt3a and Dnmt3b, and on progressive association of the DNA demethylation promoting protein Gadd45 beta to Mmp-9 proximal gene promoter in vivo. The PRC2-related mechanism relies on dissociation of the repressive transcription factor YY1 and the dissipation of the PRC2-evoked trimethylation on Lys27 of the histone H3 from the proximal Mmp-9 promoter chromatin in vivo. Moreover, we show that the DNA hydroxymethylation, a new epigenetic DNA modification, which is localized predominantly in the gene promoters and is particularly abundant in the brain, is not involved in a regulation of MMP-9 expression during the epileptogenesis in the rat hippocampus as well as in the hippocampi of pediatric and adult epileptic patients. Additionally, we have also found that despite of its transient nature, the histone modification H3S10ph is strongly and gradually accumulated during epileptogenesis in the cell nuclei and in the proximal Mmp-9 gene promoter in the hippocampus, which suggests that H3S10ph can be involved in DNA demethylation in mammals, and not only in Neurospora. The study identifies MMP-9 as the first protein coding gene which expression is regulated by DNA methylation in human epilepsy. We present a detailed epigenetic model of the epileptogenesis-evoked upregulation of MMP-9 expression in the hippocampus. To our knowledge, it is the most complex and most detailed mechanism of epigenetic regulation of gene expression ever revealed for a particular gene in epileptogenesis. Our results also suggest for the first time that dysregulation of DNA methylation found in epilepsy is a cause rather than a consequence of this condition.	[Zybura-Broda, Katarzyna; Ambrozek-Latecka, Magdalena; Wilemska, Joanna; Bogusz, Agnieszka; Bucko, Joanna; Rylski, Marcin] Med Ctr Postgrad Educ, Dept Clin Cytol, Warsaw, Poland; [Amborska, Renata; Kaczmarek, Leszek] Nencki Inst Expt Biol PAS, Neurobiol Lab, Warsaw, Poland; [Konopka, Anna; Wilczynski, Grzegorz M.] Nencki Inst Expt Biol PAS, Lab Mol & System Neuromorphol, Warsaw, Poland; [Grajkowska, Wieslawa] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Roszkowski, Marcin] Childrens Mem Hlth Inst, Dept Neurosurg, Warsaw, Poland; [Marchel, Andrzej; Rysz, Andrzej] Med Univ Warsaw, Dept Neurosurg, Warsaw, Poland; [Koperski, Lukasz] Med Univ Warsaw, Dept Pathol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Children's Memorial Health Institute; Children's Memorial Health Institute; Medical University of Warsaw; Medical University of Warsaw	Rylski, M (corresponding author), Med Ctr Postgrad Educ, Dept Clin Cytol, Warsaw, Poland.	mrylski@gmail.com	Kaczmarek, Leszek/B-6171-2008; Rylski, Marcin/AAB-9277-2021; Ambrożek-Latecka, Magdalena/AAD-8170-2022; Koperski, Lukasz/U-4594-2018; Rysz, Andrzej/M-8630-2018; Kaczmarek, Leszek/AHA-0076-2022	Kaczmarek, Leszek/0000-0002-7207-3490; Ambrożek-Latecka, Magdalena/0000-0003-1025-6280; Koperski, Lukasz/0000-0001-8163-1813; Rysz, Andrzej/0000-0002-8272-7275; Kaczmarek, Leszek/0000-0002-7207-3490; Rylski, Marcin/0000-0002-9892-8979; Wilczynski, Grzegorz/0000-0001-6667-0291; Roszkowski, Marcin/0000-0002-8735-8296; Grajkowska, Wieslawa/0000-0001-8318-5781; Zybura-Broda, Katarzyna/0000-0002-4117-2613; Konopka, Anna/0000-0002-5487-6003	Polish National Science Centre [2011/01/B/NZ2/05281]	Polish National Science Centre	This work was supported by the Polish National Science Centre grant no. 2011/01/B/NZ2/05281 (M Rylski). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, JIANGXI FORESTRY SCI, DOI DOI 10.1100/2012/913693; Blumcke I, 2012, EPILEPSIA S9, V53; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; CHENG X, 2015, ONCOGENE, V34; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Foret MR, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00252; Ghasemi M, 2011, EPILEPSY BEHAV, V22, P617, DOI 10.1016/j.yebeh.2011.07.024; Guo JU, 2011, NAT NEUROSCI, V14; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hevroni D, 1998, J MOL NEUROSCI, V10, P75, DOI 10.1007/BF02737120; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Johnson AA, 2012, REJUVENATION RES, V15; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Kobow K, 2013, ACTA NEUROPATHOL, V126, P741, DOI 10.1007/s00401-013-1168-8; Konopka A, 2013, EPILEPSY RES, V104, P45, DOI 10.1016/j.eplepsyres.2012.09.018; Kurada L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088109; Leach PT, 2012, LEARN MEM, V19; Lemberger T, 2008, FASEB J, V22, P2872, DOI 10.1096/fj.08-107888; Liu G, 2014, EPILEPSIA, V55; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin FD, 2007, J NEUROCHEM, V103, P1381, DOI 10.1111/j.1471-4159.2007.04863.x; Ma DK, 2009, CELL CYCLE, V8; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Matsunaga E, 2015, NEUROSCIENCE, V284, P566, DOI 10.1016/j.neuroscience.2014.10.032; Meighan SE, 2006, J NEUROCHEM, V96, P1227, DOI 10.1111/j.1471-4159.2005.03565.x; Miller-Delaney SF, 2015, BRAIN 3, V138; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rush M, 2009, EPIGENETICS, V4; Rylski M, 2009, MOL CELL NEUROSCI, V40, P98, DOI 10.1016/j.mcn.2008.09.005; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Sabbattini P, 2007, EMBO J, V26, P4657, DOI 10.1038/sj.emboj.7601875; Selker EU, 2008, GENES DEV, V22; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stephenson JB, 2005, BRAIN DEV, V27; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Sultan FA, 2012, J NEUROSCI, V32, P17059, DOI 10.1523/JNEUROSCI.1747-12.2012; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Thu KL, 2009, J VIS EXP, P23; Tian L, 2007, J CELL BIOL, V178; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weaver IC, 2004, NAT NEUROSCI, V7; Wen B, 2009, NAT GENET, V41; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Williams-Karnesky RL, 2013, J CLIN INVEST, V123; Zhang Y, 2011, GENES DEV, V25; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	53	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159745	10.1371/journal.pone.0159745	http://dx.doi.org/10.1371/journal.pone.0159745			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505431	Green Submitted, gold, Green Published			2022-12-26	WOS:000381374200013
J	Gakh, O; Ranatunga, W; Smith, DY; Ahlgren, EC; Al-Karadaghi, S; Thompson, JR; Isaya, G				Gakh, Oleksandr; Ranatunga, Wasantha; Smith, Douglas Y.; Ahlgren, Eva-Christina; Al-Karadaghi, Salam; Thompson, James R.; Isaya, Grazia			Architecture of the Human Mitochondrial Iron-Sulfur Cluster Assembly Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL CROSS-LINKING; N-HYDROXYSUCCINIMIDE ESTERS; X-RAY CRYSTALLOGRAPHY; YEAST FRATAXIN; FRIEDREICH ATAXIA; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; BINDING-SITES; CYSTEINE DESULFURASE; ELECTRON-MICROSCOPY	Fe-S clusters, essential cofactors needed for the activity of many different enzymes, are assembled by conserved protein machineries inside bacteria and mitochondria. As the architecture of the human machinery remains undefined, we co-expressed in Escherichia coli the following four proteins involved in the initial step of Fe-S cluster synthesis: FXN42-210 (iron donor); [NFS1]center dot[ISD11] (sulfur donor); and ISCU (scaffold upon which new clusters are assembled). We purified a stable, active complex consisting of all four proteins with 1:1:1:1 stoichiometry. Using negative staining transmission EM and single particle analysis, we obtained a three-dimensional model of the complex with similar to 14 angstrom resolution. Molecular dynamics flexible fitting of protein structures docked into the EM map of the model revealed a [FXN42-210](24)center dot[NFS1](24)center dot[ISD11](24)center dot[ISCU](24) complex, consistent with the measured 1:1:1:1 stoichiometry of its four components. The complex structure fulfills distance constraints obtained from chemical cross-linking of the complex at multiple recurring interfaces, involving hydrogen bonds, salt bridges, or hydrophobic interactions between conserved residues. The complex consists of a central roughly cubic [FXN42-210](24)center dot[ISCU](24) sub-complex with one symmetric ISCU trimer bound on top of one symmetric FXN42-210 trimer at each of its eight vertices. Binding of 12 [NFS1](2)center dot[ISD11](2) sub-complexes to the surface results in a globular macromolecule with a diameter of similar to 15 nm and creates 24 Fe-S cluster assembly centers. The organization of each center recapitulates a previously proposed conserved mechanism for sulfur donation from NFS1 to ISCU and reveals, for the first time, a path for iron donation from FXN42-210 to ISCU.	[Gakh, Oleksandr; Ranatunga, Wasantha; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Childrens Res Ctr, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Gakh, Oleksandr; Ranatunga, Wasantha; Smith, Douglas Y.; Isaya, Grazia] Mayo Clin, Childrens Res Ctr, Dept Biochem Mol Biol, Rochester, MN 55905 USA; [Thompson, James R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; [Ahlgren, Eva-Christina; Al-Karadaghi, Salam] Lund Univ, Inst Chem & Chem Engn, Ctr Mol Prot Sci, POB 124, SE-22100 Lund, Sweden	Mayo Clinic; Mayo Clinic; Mayo Clinic; Lund University	Isaya, G (corresponding author), Mayo Clin, 200 First St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health from NIA [AG15709-19]; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health from NIA; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant AG15709-19 from NIA (to G.I. and J.T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Amela I, 2013, PROTEIN J, V32, P183, DOI 10.1007/s10930-013-9475-4; ANDREWS P, 1965, BIOCHEM J, V96, P595, DOI 10.1042/bj0960595; Bedekovics T, 2007, FEMS YEAST RES, V7, P1276, DOI 10.1111/j.1567-1364.2007.00296.x; Blanc B, 2015, BBA-MOL CELL RES, V1853, P1436, DOI 10.1016/j.bbamcr.2014.12.009; Blow DM, 2002, ACTA CRYSTALLOGR D, V58, P792, DOI 10.1107/S0907444902003931; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chan KY, 2011, STRUCTURE, V19, P1211, DOI 10.1016/j.str.2011.07.017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colin F, 2013, J AM CHEM SOC, V135, P733, DOI 10.1021/ja308736e; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox NG, 2015, BIOCHEMISTRY-US, V54, P3880, DOI 10.1021/bi5014497; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hagel L, 1996, J CHROMATOGR A, V743, P33, DOI 10.1016/0021-9673(96)00130-6; HEMPSTEAD PD, 1994, FEBS LETT, V350, P258, DOI 10.1016/0014-5793(94)00781-0; Jobling RK, 2015, BRAIN, V138, P1505, DOI 10.1093/brain/awv057; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kim JH, 2015, BBA-MOL CELL RES, V1853, P1416, DOI 10.1016/j.bbamcr.2014.11.020; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Li HQ, 2013, J BIOL CHEM, V288, P4116, DOI 10.1074/jbc.M112.435263; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Madler S, 2010, ANAL BIOCHEM, V398, P123, DOI 10.1016/j.ab.2009.11.020; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Manicki M, 2014, J BIOL CHEM, V289, P30268, DOI 10.1074/jbc.M114.596726; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; MOORE S, 1963, J BIOL CHEM, V238, P235; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Neupane GP, 2009, TRANSFUSION, V49, P1762, DOI 10.1111/j.1537-2995.2009.02186.x; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Pandey A, 2013, J BIOL CHEM, V288, P36773, DOI 10.1074/jbc.M113.525857; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Park S, 2003, J BIOL CHEM, V278, P31340, DOI 10.1074/jbc.M303158200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Ramelot TA, 2004, J MOL BIOL, V344, P567, DOI 10.1016/j.jmb.2004.08.038; Ranatunga W, 2016, J BIOL CHEM, V291, P10378, DOI 10.1074/jbc.M115.712414; Saha PP, 2015, J BIOL CHEM, V290, P25876, DOI 10.1074/jbc.M115.678508; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Schagerlof U, 2008, BIOCHEMISTRY-US, V47, P4948, DOI 10.1021/bi800052m; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Seguin A, 2010, BBA-MOL BASIS DIS, V1802, P531, DOI 10.1016/j.bbadis.2010.03.008; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Soderberg CAG, 2013, J BIOL CHEM, V288, P8156, DOI 10.1074/jbc.M112.442285; Soderberg CAG, 2011, J MOL BIOL, V414, P783, DOI 10.1016/j.jmb.2011.10.034; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Tsai CL, 2011, BIOCHEMISTRY-US, V50, P6478, DOI 10.1021/bi200666h; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Vaubel RA, 2013, MOL CELL NEUROSCI, V55, P50, DOI 10.1016/j.mcn.2012.08.003; Webert H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6013; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	75	21	21	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21296	+		10.1074/jbc.M116.738542	http://dx.doi.org/10.1074/jbc.M116.738542			69	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27519411	Green Published, hybrid			2022-12-26	WOS:000385406200041
J	Nadtochiy, SM; Schafer, X; Fu, D; Nehrke, K; Munger, J; Brookes, PS				Nadtochiy, Sergiy M.; Schafer, Xenia; Fu, Dragony; Nehrke, Keith; Munger, Joshua; Brookes, Paul S.			Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acidosis; cancer; epigenetics; hypoxia; metabolism; 2-hydroxyglutarate	L-2-HYDROXYGLUTARIC ACIDURIA; ALPHA-KETOGLUTARATE; CANCER; DEHYDROGENASE; CELLS; ACIDIFICATION; ACTIVATION; SIGNATURE; ACIDOSIS; ANOXIA	2-Hydroxyglutarate (2-HG) is an important epigenetic regulator, with potential roles in cancer and stem cell biology. The d-(R)-enantiomer (d-2-HG) is an oncometabolite generated from -ketoglutarate (-KG) by mutant isocitrate dehydrogenase, whereas l-(S)-2-HG is generated by lactate dehydrogenase and malate dehydrogenase in response to hypoxia. Because acidic pH is a common feature of hypoxia, as well as tumor and stem cell microenvironments, we hypothesized that pH may regulate cellular 2-HG levels. Herein we report that cytosolic acidification under normoxia moderately elevated 2-HG in cells, and boosting endogenous substrate -KG levels further stimulated this elevation. Studies with isolated lactate dehydrogenase-1 and malate dehydrogenase-2 revealed that generation of 2-HG by both enzymes was stimulated severalfold at acidic pH, relative to normal physiologic pH. In addition, acidic pH was found to inhibit the activity of the mitochondrial l-2-HG removal enzyme l-2-HG dehydrogenase and to stimulate the reverse reaction of isocitrate dehydrogenase (carboxylation of -KG to isocitrate). Furthermore, because acidic pH is known to stabilize hypoxia-inducible factor (HIF) and 2-HG is a known inhibitor of HIF prolyl hydroxylases, we hypothesized that 2-HG may be required for acid-induced HIF stabilization. Accordingly, cells stably overexpressing l-2-HG dehydrogenase exhibited a blunted HIF response to acid. Together, these results suggest that acidosis is an important and previously overlooked regulator of 2-HG accumulation and other oncometabolic events, with implications for HIF signaling.	[Nadtochiy, Sergiy M.; Brookes, Paul S.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14642 USA; [Schafer, Xenia; Munger, Joshua] Univ Rochester, Dept Biochem, Rochester, NY 14642 USA; [Fu, Dragony] Univ Rochester, Dept Biol, Rochester, NY 14642 USA; [Nehrke, Keith] Univ Rochester, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Brookes, PS (corresponding author), Univ Rochester, Dept Anesthesiol, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu	Munger, Joshua/ABA-6395-2020	Munger, Joshua/0000-0001-5379-9440; Brookes, Paul/0000-0002-8639-8413; Fu, Dragony/0000-0002-8725-8658; Nehrke, Keith/0000-0001-9697-726X	National Institutes of Health [RO1 HL-071158, R01 AI-081773, R01-HL127891]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127891, R01HL071158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI127370, R01AI081773, R56AI081773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants RO1 HL-071158 (to P. S. B.), R01 AI-081773 (to J. M.), and R01-HL127891 (to P. S. B. and K. W. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barth PG, 1998, J INHERIT METAB DIS, V21, P251, DOI 10.1023/A:1005316121584; Butler JA, 2013, AGING CELL, V12, P130, DOI 10.1111/acel.12029; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; De Los Angeles A, 2015, NATURE, V525, pE6, DOI 10.1038/nature15513; GASBARRINI A, 1992, J BIOL CHEM, V267, P6654; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Jin YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131998; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Ladilov YV, 1998, CIRC RES, V82, P451, DOI 10.1161/01.RES.82.4.451; Legault JT, 2015, CELL REP, V13, P981, DOI 10.1016/j.celrep.2015.09.054; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Nadtochiy SM, 2015, J MOL CELL CARDIOL, V88, P64, DOI 10.1016/j.yjmcc.2015.09.008; Nadtochiy SM, 2014, BRIT J PHARMACOL, V171, P2091, DOI 10.1111/bph.12405; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; ROSE UM, 1995, PFLUG ARCH EUR J PHY, V429, P722, DOI 10.1007/BF00373995; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Rzem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119540; SANDVIG K, 1987, J CELL BIOL, V105, P679, DOI 10.1083/jcb.105.2.679; Stacpoole PW, 2003, J CLIN PHARMACOL, V43, P683, DOI 10.1177/0091270003254637; Struys EA, 2006, J INHERIT METAB DIS, V29, P21, DOI 10.1007/s10545-006-0317-9; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Teng X, 2016, ACS CHEM BIOL, V11, P2420, DOI 10.1021/acschembio.6b00290; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Venneti S, 2013, BRAIN PATHOL, V23, P217, DOI 10.1111/bpa.12022; Wang P, 2015, CELL REP, V13, P2353, DOI 10.1016/j.celrep.2015.11.029; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	37	93	93	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20188	20197		10.1074/jbc.M116.738799	http://dx.doi.org/10.1074/jbc.M116.738799			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27510037	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000383243100038
J	Trickey, A; May, MT; Vehreschild, J; Obel, N; Gill, MJ; Crane, H; Boesecke, C; Samji, H; Grabar, S; Cazanave, C; Cavassini, M; Shepherd, L; Monforte, AD; Smit, C; Saag, M; Lampe, F; Hernando, V; Montero, M; Zangerle, R; Justice, AC; Sterling, T; Miro, J; Ingle, S; Sterne, JAC				Trickey, Adam; May, Margaret T.; Vehreschild, Janne; Obel, Niels; Gill, Michael John; Crane, Heidi; Boesecke, Christoph; Samji, Hasina; Grabar, Sophie; Cazanave, Charles; Cavassini, Matthias; Shepherd, Leah; Monforte, Antonella d'Arminio; Smit, Colette; Saag, Michael; Lampe, Fiona; Hernando, Vicky; Montero, Marta; Zangerle, Robert; Justice, Amy C.; Sterling, Timothy; Miro, Jose; Ingle, Suzanne; Sterne, Jonathan A. C.		Antiretroviral Therapy Cohort Coll	Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy	PLOS ONE			English	Article							CD4 CELL COUNT; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; INFECTED INDIVIDUALS; PROPORTIONAL-HAZARDS; CLINICAL-PRACTICE; RISK-FACTORS; DRUG-USE; DEATH; COHORT	Objectives To estimate mortality rates and prognostic factors in HIV-positive patients who started combination antiretroviral therapy between 1996-1999 and survived for more than ten years. Methods We used data from 18 European and North American HIV cohort studies contributing to the Antiretroviral Therapy Cohort Collaboration. We followed up patients from ten years after start of combination antiretroviral therapy. We estimated overall and cause-specific mortality rate ratios for age, sex, transmission through injection drug use, AIDS, CD4 count and HIV-1 RNA. Results During 50,593 person years 656/13,011 (5%) patients died. Older age, male sex, injecting drug use transmission, AIDS, and low CD4 count and detectable viral replication ten years after starting combination antiretroviral therapy were associated with higher subsequent mortality. CD4 count at ART start did not predict mortality in models adjusted for patient characteristics ten years after start of antiretroviral therapy. The most frequent causes of death (among 340 classified) were non-AIDS cancer, AIDS, cardiovascular, and liver-related disease. Older age was strongly associated with cardiovascular mortality, injecting drug use transmission with non-AIDS infection and liver-related mortality, and low CD4 and detectable viral replication ten years after starting antiretroviral therapy with AIDS mortality. Five-year mortality risk was <5% in 60% of all patients, and in 30% of those aged over 60 years. Conclusions Viral replication, lower CD4 count, prior AIDS, and transmission via injecting drug use continue to predict higher all-cause and AIDS-related mortality in patients treated with combination antiretroviral therapy for over a decade. Deaths from AIDS and non-AIDS infection are less frequent than deaths from other non-AIDS causes.	[Trickey, Adam; May, Margaret T.; Ingle, Suzanne; Sterne, Jonathan A. C.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Vehreschild, Janne] German Ctr Infect Res, Partner Site Bonn Cologne, Cologne, Germany; [Vehreschild, Janne] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Obel, Niels] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Gill, Michael John] Univ Calgary, Div Infect Dis, Calgary, AB, Canada; [Crane, Heidi] Univ Washington, Ctr AIDS Res, Seattle, WA 98195 USA; [Boesecke, Christoph] Univ Bonn, Dept Internal Med, Bonn, Germany; [Samji, Hasina] British Columbia Ctr Excellence HIV AIDS, Epidemiol & Populat Hlth Program, Vancouver, BC, Canada; [Samji, Hasina] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada; [Grabar, Sophie] Univ Paris 06, Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, F-75013 Paris, France; [Grabar, Sophie] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMR S 1136, F-75013 Paris, France; [Grabar, Sophie] Univ Paris 05, Paris, France; [Grabar, Sophie] Grp Hosp Cochin Hotel Dieu, AP HP, Paris, France; [Cazanave, Charles] Ctr Hosp Univ Bordeaux, Hop Pellegrin, F-33000 Bordeaux, France; [Cavassini, Matthias] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Cavassini, Matthias] Univ Lausanne, Lausanne, Switzerland; [Shepherd, Leah; Lampe, Fiona] UCL Med Sch, Res Dept Infect & Populat Hlth, London, England; [Monforte, Antonella d'Arminio] Univ Milan, Clin Infect Dis & Trop Med, San Paolo Hosp, Milan, Italy; [Smit, Colette] Stichting HIV Monitoring, Amsterdam, Netherlands; [Saag, Michael] Univ Alabama Birmingham, Dept Med, Div Infect Dis, Birmingham, AL 35294 USA; [Hernando, Vicky] Inst Salud Carlos III, Ctr Nacl Epidemiol, Red Invest Sida, Avda Monforte de Lemos 5, Madrid 28029, Spain; [Montero, Marta] Hosp La Fe, Valencia, Spain; [Zangerle, Robert] Med Univ Innsbruck, Innsbruck, Austria; [Justice, Amy C.] Yale Univ, Sch Med, New Haven, CT USA; [Justice, Amy C.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Sterling, Timothy] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Miro, Jose] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain	University of Bristol; German Center for Infection Research; University of Cologne; University of Cologne; University of Copenhagen; University of Calgary; University of Washington; University of Washington Seattle; University of Bonn; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of London; University College London; San Paolo-Polo Universitaria Hospital; University of Milan; University of Alabama System; University of Alabama Birmingham; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE); Hospital Universitari i Politecnic La Fe; Medical University of Innsbruck; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Vanderbilt University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Trickey, A (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	adam.trickey@bristol.ac.uk; Niels.Obel@regionh.dk; Matthias.Cavassini@chuv.ch; leah.shepherd@ucl.ac.uk; antonella.darminio@unimi.it; c.smith@ucl.ac.uk; robert.zangerle@uki.at; amy.justice2@va.gov; timothy.sterling@vanderbilt.edu; miro97@fundsoriano.es	Montero, Marta/H-7555-2017; Cazanave, Charles/AHE-5492-2022; Hernando, Victoria/E-1740-2015; Lampe, Fiona/I-5826-2019; Sterne, Jonathan/Z-3106-2019; Dodsley, Maria/G-7083-2016; Grabar, Sophie/AAM-9857-2020; cavassini, matthias/F-8987-2017; Gill, Michael John/G-7083-2016; Boulle, Andrew/C-1413-2008; Vehreschild, Jorg Janne/G-6764-2013	Montero, Marta/0000-0002-3432-5394; Hernando, Victoria/0000-0003-2762-4924; Lampe, Fiona/0000-0001-6851-5471; Sterne, Jonathan/0000-0001-8496-6053; Dodsley, Maria/0000-0001-7587-558X; cavassini, matthias/0000-0003-0933-7833; Trickey, Adam/0000-0003-3462-2898; Obel, Niels/0000-0002-5031-0045; Gill, Michael John/0000-0002-8546-8790; Boulle, Andrew/0000-0002-7713-8062; Vehreschild, Jorg Janne/0000-0002-5446-7170; Samji, Hasina/0000-0002-4555-7609	UK Medical Research Council (MRC) [MR/J002380/1]; UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; European Union; National Institute for Health Research [NF-SI-0611-10168]; Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministry of Health; Italian Ministry of Health; Spanish Ministry of Health; Swiss National Science Foundation [33CS30_134277]; Ministry of Science and Innovation; Spanish Network for AIDS Research (RIS) [ISCIII-RETIC RD06/006]; Stichting HIV Monitoring; European Commission (EuroCoord grant) [260694]; British Columbia Government; Alberta Government; National Institutes of Health (NIH) [UW Center for AIDS Research (CFAR) (NIH)] [P30 AI027757]; National Institutes of Health (NIH) [UAB CFAR (NIH)] [P30 AI027767]; National Institutes of Health (NIH) [Vanderbilt-Meharry CFAR (NIH grant)] [P30 AI54999]; National Institute on Alcohol Abuse and Alcoholism [U10-AA13566, U24-AA020794]; US Department of Veterans Affairs; Michael Smith Foundation for Health Research; Canadian Institutes of Health Research; VHA Office of Research and Development; Abbott; Gilead; Tibotec-Upjohn; ViiV Healthcare; MSD; GlaxoSmithKline; Pfizer; Bristol Myers Squibb; Roche; Boehringer-Ingelheim; European Union Seventh Framework Programme (FP7) under EuroCoord grant [260694]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U01AA020790] Funding Source: NIH RePORTER; Medical Research Council [G0100221, MR/J002380/1, G0700820] Funding Source: researchfish; MRC [MR/J002380/1, G0100221, G0700820] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministry of Health; Italian Ministry of Health(Ministry of Health, Italy); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Network for AIDS Research (RIS); Stichting HIV Monitoring; European Commission (EuroCoord grant)(European Commission); British Columbia Government; Alberta Government; National Institutes of Health (NIH) [UW Center for AIDS Research (CFAR) (NIH)]; National Institutes of Health (NIH) [UAB CFAR (NIH)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) [Vanderbilt-Meharry CFAR (NIH grant)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US Department of Veterans Affairs(US Department of Veterans Affairs); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); VHA Office of Research and Development; Abbott(Abbott Laboratories); Gilead(Gilead Sciences); Tibotec-Upjohn; ViiV Healthcare; MSD; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Bristol Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Boehringer-Ingelheim(Boehringer Ingelheim); European Union Seventh Framework Programme (FP7) under EuroCoord grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council (MRC) MR/J002380/1-http://www.mrc.ac.uk/-and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. Jonathan Sterne is funded by National Institute for Health Research Senior Investigator award NF-SI-0611-10168. Sources of funding of individual cohorts include the Agence Nationale de Recherche sur le SIDA et les hepatites virales (ANRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), the French, Italian and Spanish Ministries of Health, the Swiss National Science Foundation (grant 33CS30_134277), the Ministry of Science and Innovation and the "Spanish Network for AIDS Research (RIS; ISCIII-RETIC RD06/006), the Stichting HIV Monitoring, the European Commission (EuroCoord grant 260694), the British Columbia and Alberta Governments, the National Institutes of Health (NIH) [UW Center for AIDS Research (CFAR) (NIH grant P30 AI027757), UAB CFAR (NIH grant P30 AI027767), The Vanderbilt-Meharry CFAR (NIH grant P30 AI54999), National Institute on Alcohol Abuse and Alcoholism (U10-AA13566, U24-AA020794), the US Department of Veterans Affairs, the Michael Smith Foundation for Health Research, the Canadian Institutes of Health Research, the VHA Office of Research and Development and unrestricted grants from Abbott, Gilead, Tibotec-Upjohn, ViiV Healthcare, MSD, GlaxoSmithKline, Pfizer, Bristol Myers Squibb, Roche and Boehringer-Ingelheim. The Danish HIV Cohort Study is founded by Preben and Anne Simonsens Foundation. Data from 11 European cohorts were pooled in June 2014 within COHERE in EuroCoord (www.cohere.org and www.EuroCoord.net). COHERE receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) under EuroCoord grant agreement no 260694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti N, 2014, INFECT DIS THER, V3, P1, DOI 10.1007/s40121-014-0024-z; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ehren K, 2014, INFECTION, V42, P135, DOI 10.1007/s15010-013-0535-7; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; Kim HY, 2001, RADIOGRAPHICS, V21, P839, DOI 10.1148/radiographics.21.4.g01jl06839; Kowalska JD, 2010, HIV MED, V11, P200, DOI 10.1111/j.1468-1293.2009.00763.x; Kowalska JD, 2012, AIDS, V26, P315, DOI 10.1097/QAD.0b013e32834e8805; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kowalska JD, 2011, HIV CLIN TRIALS, V12, P109, DOI 10.1310/hct1202-109; Lanoy E, 2009, AIDS, V23, P2199, DOI 10.1097/QAD.0b013e3283305a00; Laut KG, 2014, J INT AIDS SOC, V17, P11, DOI 10.7448/IAS.17.4.19504; Legarth RA, 2016, JAIDS-J ACQ IMM DEF, V71, P213, DOI 10.1097/QAI.0000000000000825; Leone S, 2011, INFECTION, V39, P13, DOI 10.1007/s15010-010-0079-z; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Lima VD, 2015, LANCET HIV, V2, pE92, DOI 10.1016/S2352-3018(15)00017-X; Blanco JL, 2015, EXPERT OPIN PHARMACO, V16, P1313, DOI 10.1517/14656566.2015.1044436; May M, 2005, J CLIN EPIDEMIOL, V58, P1033, DOI 10.1016/j.jclinepi.2005.02.015; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; May MT, 2015, JAIDS-J ACQ IMM DEF, V69, P348, DOI 10.1097/QAI.0000000000000603; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; May MT, 2012, INT J EPIDEMIOL, V41, P1807, DOI 10.1093/ije/dys164; May MT, 2013, IJE, V12; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mocroft A, 2014, INFECTION, V42, P757, DOI 10.1007/s15010-014-0630-4; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Phillips AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055312; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sigel Keith, 2011, Curr HIV/AIDS Rep, V8, P142, DOI 10.1007/s11904-011-0085-5; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Swain SD, 2007, AM J PATHOL, V171, P790, DOI 10.2353/ajpath.2007.070178; Tate JP, 2013, AIDS, V27, P563, DOI 10.1097/QAD.0b013e32835b8c7f; Thorsteinsson K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-256; Weber R, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12184; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Wells JS, 2014, AIDS PATIENT CARE ST, V28, P350, DOI 10.1089/apc.2013.0358; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	46	58	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160460	10.1371/journal.pone.0160460	http://dx.doi.org/10.1371/journal.pone.0160460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525413	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100014
J	Yang, PY; Miao, NF; Lin, CW; Chou, YE; Yang, SF; Huang, HC; Chang, HJ; Tsai, HT				Yang, Po-Yu; Miao, Nae-Fang; Lin, Chiao-Wen; Chou, Ying-Erh; Yang, Shun-Fa; Huang, Hui-Chuan; Chang, Hsiu-Ju; Tsai, Hsiu-Ting			Impact of Maspin Polymorphism rs2289520 G/C and Its Interaction with Gene to Gene, Alcohol Consumption Increase Susceptibility to Oral Cancer Occurrence	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EXTRACELLULAR-MATRIX; IN-VITRO; SUPPRESSOR; EXPRESSION; PROGRESSION; METASTASIS; ADHESION; MUCOSA; TONGUE	Background The purpose of this study was to identify gene polymorphisms of mammary serine protease inhibitor (Maspin) specific to patients with oral cancer susceptibility and clinicopathological status. Methodology/Principal Findings Three single-nucleotide polymorphisms (SNPs) of the Maspin gene from 741 patients with oral cancer and 601 non-cancer controls were analyzed by real-time PCR. The participants with G/G homozygotes or with G/C heterozygotes of Maspin rs2289520 polymorphism had a 2.07-fold (p = 0.01) and a 2.01-fold (p = 0.02) risk of developing oral cancer compared to those with C/C homozygotes. Moreover, gene-gene interaction increased the risk of oral cancer susceptibility among subjects expose to oral cancer related risk factors, including areca, alcohol, and tobacco consumption. Conclusion G allele of Maspin rs2289520 polymorphism may be a factor that increases the susceptibility to oral cancer. The interactions of gene to oral cancer-related environmental risk factors have a synergetic effect that can further enhance oral cancer development.	[Yang, Po-Yu] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan; [Yang, Po-Yu; Lin, Chiao-Wen] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan; [Miao, Nae-Fang; Huang, Hui-Chuan; Tsai, Hsiu-Ting] Taipei Med Univ, Coll Nursing, Accelerated Bachelor Sci Nursing, Taipei, Taiwan; [Lin, Chiao-Wen] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan; [Chou, Ying-Erh] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chou, Ying-Erh; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Chang, Hsiu-Ju; Tsai, Hsiu-Ting] Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan; [Tsai, Hsiu-Ting] Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Tsai, HT (corresponding author), Taipei Med Univ, Coll Nursing, Accelerated Bachelor Sci Nursing, Taipei, Taiwan.; Tsai, HT (corresponding author), Taipei Med Univ, Sch Nursing, Coll Nursing, Taipei, Taiwan.; Tsai, HT (corresponding author), Taipei Med Univ Hosp, Dept Nursing, Taipei, Taiwan.	tsaihsiuting@yahoo.com.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Tsai, Hsiu Ting/0000-0003-1137-9274; Chang, Hsiu-Ju/0000-0002-8544-0712	Ministry of Science and Technology, Taiwan [MOST 102-2314-B-040-002, MOST 103-2314-B-040-005-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was financially supported by grants from Ministry of Science and Technology, Taiwan (MOST 102-2314-B-040-002) & (MOST 103-2314-B-040-005-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Al-Mamun MA, 2016, J THEOR BIOL, V388, P37, DOI 10.1016/j.jtbi.2015.10.007; Lopes CFB, 2012, ARCH ORAL BIOL, V57, P1026, DOI 10.1016/j.archoralbio.2012.05.006; Chen MK, 2009, ORAL ONCOL, V45, pE222, DOI 10.1016/j.oraloncology.2009.07.015; Department of Health, 2012, REP CHIN HLTH STAT 2; Gupta B, 2013, INT DENT J, V63, P12, DOI 10.1111/j.1875-595x.2012.00131.x; HARVEY W, 1986, ARCH ORAL BIOL, V31, P45, DOI 10.1016/0003-9969(86)90112-3; Jang HL, 2008, INT J MOL MED, V22, P333, DOI 10.3892/ijmm_00000027; Kim M, 2012, CARCINOGENESIS, V33, P2344, DOI 10.1093/carcin/bgs280; Loyha K, 2012, ASIAN PAC J CANCER P, V13, P5087, DOI 10.7314/APJCP.2012.13.10.5087; Meng H, 2015, TUMOR BIOL, V36, P6231, DOI 10.1007/s13277-015-3308-3; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ramot Y, 2012, TOXICOL PATHOL, V40, P40, DOI 10.1177/0192623311424169; Ray Jay Gopal, 2013, J Oral Maxillofac Pathol, V17, P45, DOI 10.4103/0973-029X.110720; Schwartz J, 2012, J ORAL MAXIL SURG, V70, P1867, DOI 10.1016/j.joms.2011.08.005; Semenzati GD, 2012, INHAL TOXICOL, V24, P723, DOI 10.3109/08958378.2012.715317; Shpitzer T, 2009, BRIT J CANCER, V101, P1194, DOI 10.1038/sj.bjc.6605290; Smith SL, 2003, ONCOGENE, V22, P8677, DOI 10.1038/sj.onc.1207127; Teng YH, 2009, HEAD NECK-J SCI SPEC, V31, P1282, DOI 10.1002/hed.21094; Tsai HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083572; Umekita Y, 1997, CANCER LETT, V113, P87, DOI 10.1016/S0304-3835(97)04600-4; Wang CC, 2011, J ORAL PATHOL MED, V40, P769, DOI 10.1111/j.1600-0714.2011.01043.x; Xia WY, 2000, ONCOGENE, V19, P2398, DOI 10.1038/sj.onc.1203535; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yasumatsu R, 2001, HEAD NECK-J SCI SPEC, V23, P962, DOI 10.1002/hed.1139; Yoshizawa K, 2009, J ORAL PATHOL MED, V38, P535, DOI 10.1111/j.1600-0714.2009.00762.x	27	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160841	10.1371/journal.pone.0160841	http://dx.doi.org/10.1371/journal.pone.0160841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525723	gold, Green Submitted, Green Published			2022-12-26	WOS:000381471100023
J	Lee, HS; Cui, L; Li, Y; Choi, JS; Choi, JH; Li, Z; Kim, GE; Choi, W; Yoon, KC				Lee, Hyo Seok; Cui, Lian; Li, Ying; Choi, Ji Suk; Choi, Joo-Hee; Li, Zhengri; Kim, Ga Eon; Choi, Won; Yoon, Kyung Chul			Influence of Light Emitting Diode-Derived Blue Light Overexposure on Mouse Ocular Surface	PLOS ONE			English	Article							CORNEAL EPITHELIAL-CELLS; SJOGREN SYNDROME PATIENTS; EXPERIMENTAL DRY EYE; VERSUS-HOST-DISEASE; OXIDATIVE STRESS; IN-VITRO; ULTRAVIOLET-RADIATION; MACULAR DEGENERATION; DESICCATING STRESS; DNA-DAMAGE	Purpose To investigate the influence of overexposure to light emitting diode (LED)-derived light with various wavelengths on mouse ocular surface. Methods LEDs with various wavelengths were used to irradiate C57BL/6 mice at an energy dose of 50 J/cm(2), twice a day, for 10 consecutive days. The red, green, and blue groups represented wavelengths of 630 nm, 525 nm, and 410 nm, respectively. The untouched group (UT) was not exposed to LED light and served as the untreated control. Tear volume, tear film break-up time (TBUT), and corneal fluorescein staining scores were measured on days 1, 3, 5, 7, and 10. Levels of interferon (IFN)-gamma, interleukin (IL)-1 beta, IL-6, and tumor necrosis factor (TNF)-alpha were measured in the cornea and conjunctiva using a multiplex immunobead assay at day 10. Levels of malondialdehyde (MDA) were measured with an enzyme-linked immunosorbent assay. Flow cytometry, 2' 7'-dichlorofluorescein diacetate (DCF-DA) assay, histologic analysis, immunohistochemistry with 4-hydroxynonenal, and terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling (TUNEL) staining were also performed. Results TBUT of the blue group showed significant decreases at days 7 and 10, compared with the UT and red groups. Corneal fluorescein staining scores significantly increased in the blue group when compared with UT, red, and green groups at days 5, 7, and 10. A significant increase in the corneal levels of IL-1 beta and IL-6 was observed in the blue group, compared with the other groups. The blue group showed significantly increased reactive oxygen species production in the DCF-DA assay and increased inflammatory T cells in the flow cytometry. A significantly increased TUNEL positive cells was identified in the blue group. Conclusions Overexposure to blue light with short wavelengths can induce oxidative damage and apoptosis to the cornea, which may manifest as increased ocular surface inflammation and resultant dry eye.	[Lee, Hyo Seok; Cui, Lian; Li, Ying; Choi, Ji Suk; Li, Zhengri; Choi, Won; Yoon, Kyung Chul] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea; [Cui, Lian; Li, Ying] Chonnam Natl Univ, Dept Biomed Sci, Gwangju, South Korea; [Cui, Lian; Li, Ying] Chonnam Natl Univ, Ctr Creat Biomed Sci, Gwangju, South Korea; [Choi, Joo-Hee] Chonnam Natl Univ, Coll Vet Med, Gwangju, South Korea; [Choi, Joo-Hee] Chonnam Natl Univ, BK PLUS Project Team 21, Gwangju, South Korea; [Li, Zhengri] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Kim, Ga Eon] Chonnam Natl Univ, Med Sch & Hosp, Dept Pathol, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Xiamen University; Chonnam National University	Yoon, KC (corresponding author), Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Gwangju, South Korea.	kcyoon@jnu.ac.kr		Kim, Ga-Eon/0000-0001-8539-6654	Forest Science & Technology Projects of the Korea Forest Service [S121313L50100]; Chonnam National University Hospital Biomedical Research Institute [CRI13906-22]	Forest Science & Technology Projects of the Korea Forest Service; Chonnam National University Hospital Biomedical Research Institute	The study was partially supported by the Forest Science & Technology Projects (project no. S121313L50100) of the Korea Forest Service (http://www.forest.go.kr/newkfsweb/kfs/idx/Index.do?mn=KFS_01). In addition, the study was partially supported by the Chonnam National University Hospital Biomedical Research Institute (http://www.cnuhcrin.com/) (CRI13906-22). The funders had no role in study design, data collection or analysis, in the decision to publish, or in manuscript preparation. The authors have no proprietary or commercial interest in any material described in this article.	ABEDINIA M, 1990, EXP EYE RES, V51, P419, DOI 10.1016/0014-4835(90)90154-M; Behar-Cohen F, 2011, PROG RETIN EYE RES, V30, P239, DOI 10.1016/j.preteyeres.2011.04.002; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Cejkova J, 2015, HISTOL HISTOPATHOL, V30, P893, DOI 10.14670/HH-11-611; Choi W, 2012, CURR EYE RES, V37, P12, DOI 10.3109/02713683.2011.622852; Choy CKM, 2011, OPTOMETRY VISION SCI, V88, P507, DOI 10.1097/OPX.0b013e31820e9fe2; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Cocho L, 2015, INVEST OPHTH VIS SCI, V56, P4570, DOI 10.1167/iovs.15-16736; CRUICKSHANKS KJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P514, DOI 10.1001/archopht.1993.01090040106042; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; Dedon PC, 1998, P NATL ACAD SCI USA, V95, P11113, DOI 10.1073/pnas.95.19.11113; Di Girolamo N, 2005, AM J PATHOL, V167, P489, DOI 10.1016/S0002-9440(10)62992-6; Di Girolamo N, 2000, INVEST OPHTH VIS SCI, V41, P671; Estil S, 1997, ACTA OPHTHALMOL SCAN, V75, P120; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Grimm C, 2001, INVEST OPHTH VIS SCI, V42, P497; Grimm Christian, 2013, Methods Mol Biol, V935, P87, DOI 10.1007/978-1-62703-080-9_6; Hall LR, 2001, J IMMUNOL, V166, P4035, DOI 10.4049/jimmunol.166.6.4035; Huang DP, 2014, INVEST OPHTH VIS SCI, V55, P4935, DOI 10.1167/iovs.13-13704; Ibrahim OMA, 2012, INVEST OPHTH VIS SCI, V53, P2403, DOI 10.1167/iovs.11-6863; Jaadane I, 2015, FREE RADICAL BIO MED, V84, P373, DOI 10.1016/j.freeradbiomed.2015.03.034; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kennedy M, 1997, INVEST OPHTH VIS SCI, V38, P2483; Khan S, 2007, J LEUKOCYTE BIOL, V81, P315, DOI 10.1189/jlb.0506344; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Kuse Y, 2014, SCI REP, P4; Lee JB, 2014, INVEST OPHTH VIS SCI, V55, P4119, DOI 10.1167/iovs.13-13441; Li B, 2014, SCI REP-UK, V4, DOI 10.1038/srep05772; Macri A, 2015, GRAEF ARCH CLIN EXP, V253, P425, DOI 10.1007/s00417-014-2853-6; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; MORAN DJ, 1984, BRIT J OPHTHALMOL, V68, P343, DOI 10.1136/bjo.68.5.343; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Niwano Y, 2014, BRIT J OPHTHALMOL, V98, P990, DOI 10.1136/bjophthalmol-2014-305205; Noell W K, 1966, Invest Ophthalmol, V5, P450; Ogawa K, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-120; Oh HJ, 2014, J OCUL PHARMACOL TH, V30, P533, DOI 10.1089/jop.2013.0050; Organisciak DT, 1999, CURR EYE RES, V19, P188, DOI 10.1076/ceyr.19.2.188.5333; Organisciak DT, 1999, PHOTOCHEM PHOTOBIOL, V70, P261, DOI 10.1562/0031-8655(1999)070<0261:LIDITR>2.3.CO;2; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113798; Park JW, 2012, CORNEA, V31, P1246, DOI [10.1097/ICO.0b013e31823f8eb0, 10.1097/ICO.0b013e31826a80ea]; Roehlecke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071570; Roehlecke C, 2011, MOL VIS, V17, P876; Roehlecke C, 2009, MOL VIS, V15, P1929; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; Sahli E, 2010, CORNEA, V29, P1412, DOI 10.1097/ICO.0b013e3181e7845b; Sanz-Marco E, 2013, J OCUL PHARMACOL TH, V29, P776, DOI 10.1089/jop.2012.0265; SCHMITZ GG, 1991, ANAL BIOCHEM, V192, P222, DOI 10.1016/0003-2697(91)90212-C; Sliney D H, 2006, Med Lav, V97, P215; Stamatacos Catherine, 2013, J Tenn Dent Assoc, V93, P25; Sung MS, 2015, INVEST OPHTH VIS SCI, V56, P3149, DOI 10.1167/iovs.14-16153; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P3859, DOI 10.1167/iovs.05-0672; TAYLOR HR, 1989, ARCH OPHTHALMOL-CHIC, V107, P1481, DOI 10.1001/archopht.1989.01070020555039; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Uchino Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045805; Uchino Yuichi, 2012, Cornea, V31 Suppl 1, pS63, DOI 10.1097/ICO.0b013e31826a5de1; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; Wakamatsu TH, 2013, INVEST OPHTH VIS SCI, V54, P201, DOI 10.1167/iovs.12-10325; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285; Yoon KC, 2008, J AUTOIMMUN, V30, P212, DOI 10.1016/j.jaut.2007.09.003; Yoon KC, 2007, INVEST OPHTH VIS SCI, V48, P2561, DOI 10.1167/iovs.07-0002; Yoon KC, 2011, INVEST OPHTH VIS SCI, V52, P7267, DOI 10.1167/iovs.11-7231; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Zhang Z, 2014, INVEST OPHTH VIS SCI, V55, P2963, DOI 10.1167/iovs.13-13577	63	30	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161041	10.1371/journal.pone.0161041	http://dx.doi.org/10.1371/journal.pone.0161041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517861	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100039
J	Mortensen, AN; Ellis, JD				Mortensen, Ashley N.; Ellis, James D.			Managed European-Derived Honey Bee, Apis mellifera sspp, Colonies Reduce African-Matriline Honey Bee, A-m. scutellata, Drones at Regional Mating Congregations	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GENETIC-STRUCTURE; HYMENOPTERA; SPREAD; POPULATIONS; HISTORY; QUEEN; RACES	African honey bees (Apis mellifera scutellata) dramatically changed the South American beekeeping industry as they rapidly spread through the Americas following their introduction into Brazil. In the present study, we aimed to determine if the management of European- derived honey bees (A. mellifera sspp.) could reduce the relative abundance of African-matriline drones at regional mating sites known as drone congregation areas (DCAs). We collected 2,400 drones at six DCAs either 0.25 km or >2.8 km from managed European-derived honey bee apiaries. The maternal ancestry of each drone was determined by Bgl II enzyme digestion of an amplified portion of the mitochondrial Cytochrome b gene. Furthermore, sibship reconstruction via nuclear microsatellites was conducted for a subset of 1,200 drones to estimate the number of colonies contributing drones to each DCA. Results indicate that DCAs distant to managed European apiaries (>2.8 km) had significantly more African-matriline drones (34.33% of the collected drones had African mitochondrial DNA) than did DCAs close (0.25 km) to managed European apiaries (1.83% of the collected drones had African mitochondrial DNA). Furthermore, nuclear sibship reconstruction demonstrated that the reduction in the proportion of African matriline drones at DCAs near apiaries was not simply an increase in the number of European matriline drones at the DCAs but also the result of fewer African matriline colonies contributing drones to the DCAs. Our data demonstrate that the management of European honey bee colonies can dramatically influence the proportion of drones with African matrilines at nearby drone congregation areas, and would likely decreasing the probability that virgin European queens will mate with African drones at those drone congregation areas.	[Mortensen, Ashley N.; Ellis, James D.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Mortensen, AN; Ellis, JD (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.	mortensena@ufl.edu; jdellis@ufl.edu	Mortensen, Ashley/B-8058-2018; Ellis, James/L-7985-2013	Mortensen, Ashley/0000-0002-4560-0574; Ellis, James/0000-0003-0318-8646	Florida Department of Agricultural and Consumer Services under the advisement of the Honey Bee Technical Counsel [00113280]	Florida Department of Agricultural and Consumer Services under the advisement of the Honey Bee Technical Counsel	Funding for this research was awarded to JDE and ANM (project number: 00113280) by the Florida Department of Agricultural and Consumer Services under the advisement of the Honey Bee Technical Counsel [http://www.freshfromflorida.com]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascunce MS, 2009, MOL ECOL RESOUR, V9, P1476, DOI 10.1111/j.1755-0998.2009.02688.x; CROZIER YC, 1991, EXPERIENTIA, V47, P968, DOI 10.1007/BF01929894; Diniz NM, 2003, GENET MOL BIOL, V26, P47, DOI 10.1590/S1415-47572003000100008; ESTOUP A, 1995, GENETICS, V140, P679; GARY NE, 1962, SCIENCE, V136, P773, DOI 10.1126/science.136.3518.773; Gries M, 1996, J COMP PHYSIOL A, V179, P539, DOI 10.1007/BF00192319; HALL HG, 1989, NATURE, V339, P211, DOI 10.1038/339211a0; HALL HG, 1992, FLA ENTOMOL, V75, P51, DOI 10.2307/3495480; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Jean-Prost P., 1985, 17 INT BEEK C, P404; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kerr W.E., 1957, BRASIL APICOLA, V3, P211; Kerr W.E., 1967, S AFR BEE J, V39, P3; KERR WE, 1970, EVOLUTION, V24, P145, DOI 10.1111/j.1558-5646.1970.tb01747.x; Kraus FB, 2005, APIDOLOGIE, V36, P223, DOI 10.1051/apido:2005010; LOPER GM, 1991, J APICULT RES, V30, P119, DOI 10.1080/00218839.1991.11101245; MICHENER CD, 1975, ANNU REV ENTOMOL, V20, P399, DOI 10.1146/annurev.en.20.010175.002151; Michener CD, 1972, FINAL REPORT COMMITT; Mortensen AN, 2014, J APICULT RES, V53, P424, DOI 10.3896/IBRA.1.53.4.12; Pinto MA, 2005, GENETICS, V170, P1653, DOI 10.1534/genetics.104.035030; Pinto MA, 2003, ANN ENTOMOL SOC AM, V96, P679, DOI 10.1603/0013-8746(2003)096[0679:IOAHBH]2.0.CO;2; Quezada-Euan JJG, 2001, ANN ENTOMOL SOC AM, V94, P540, DOI 10.1603/0013-8746(2001)094[0540:PSIOAA]2.0.CO;2; Ratnieks F.L.W., 1991, P119; ROWELL GA, 1992, J KANSAS ENTOMOL SOC, V65, P218; RUTTNER F, 1985, FORTS ZOOL, V31, P225; Scheiner R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.04; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Shaibi T, 2008, MOL ECOL RESOUR, V8, P1034, DOI 10.1111/j.1755-0998.2008.02146.x; SHEPPARD WS, 1989, AM BEE J, V129, P664; SHEPPARD WS, 1989, AM BEE J, V129, P617; TAYLOR O R JR, 1985, Bulletin of the Entomological Society of America, V31, P15; TAYLOR OR, 1984, BEE WORLD, V65, P38, DOI 10.1080/0005772X.1984.11098769; TAYLOR OR, 1977, BEE WORLD, V58, P19, DOI 10.1080/0005772X.1977.11097632; Tribe G. D., 1982, South African Bee Journal, V54, P99; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; WILLIAMS JL, 1987, J ECON ENTOMOL, V80, P532, DOI 10.1093/jee/80.2.532	38	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161331	10.1371/journal.pone.0161331	http://dx.doi.org/10.1371/journal.pone.0161331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518068	gold, Green Submitted, Green Published			2022-12-26	WOS:000381382100068
J	Thormann, I; Reeves, P; Reilley, A; Engels, JMM; Lohwasser, U; Borner, A; Pillen, K; Richards, CM				Thormann, Imke; Reeves, Patrick; Reilley, Ann; Engels, Johannes M. M.; Lohwasser, Ulrike; Boerner, Andreas; Pillen, Klaus; Richards, Christopher M.			Geography of Genetic Structure in Barley Wild Relative Hordeum vulgare subsp spontaneum in Jordan	PLOS ONE			English	Article							AB-QTL ANALYSIS; SSP SPONTANEUM; RESISTANCE GENES; POWDERY MILDEW; SPRING BARLEY; EX-SITU; ENVIRONMENTAL ASSOCIATIONS; POPULATION-STRUCTURE; EXOTIC ALLELES; LEAF RUST	Informed collecting, conservation, monitoring and utilization of genetic diversity requires knowledge of the distribution and structure of the variation occurring in a species. Hordeum vulgare subsp. spontaneum (K. Koch) Thell., a primary wild relative of barley, is an important source of genetic diversity for barley improvement and co-occurs with the domesticate within the center of origin. We studied the current distribution of genetic diversity and population structure in H. vulgare subsp. spontaneum in Jordan and investigated whether it is correlated with either spatial or climatic variation inferred from publically available climate layers commonly used in conservation and ecogeographical studies. The genetic structure of 32 populations collected in 2012 was analyzed with 37 SSRs. Three distinct genetic clusters were identified. Populations were characterized by admixture and high allelic richness, and genetic diversity was concentrated in the northern part of the study area. Genetic structure, spatial location and climate were not correlated. This may point out a limitation in using large scale climatic data layers to predict genetic diversity, especially as it is applied to regional genetic resources collections in H. vulgare subsp. spontaneum.	[Thormann, Imke; Engels, Johannes M. M.] Biovers Int, Rome, Italy; [Reeves, Patrick; Reilley, Ann; Richards, Christopher M.] USDA ARS, Natl Ctr Genet Resources Preservat, Ft Collins, CO 80522 USA; [Lohwasser, Ulrike; Boerner, Andreas] Leibniz Inst Plant Genet & Crop Plant Res, Genebank Dept, Gatersleben, Germany; [Pillen, Klaus] Univ Halle Wittenberg, Plant Breeding, Inst Agr & Nutr Sci, Halle, Germany	Alliance; Bioversity International; United States Department of Agriculture (USDA); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Martin Luther University Halle Wittenberg	Thormann, I (corresponding author), Biovers Int, Rome, Italy.	i.thormann@cgiar.org	Pillen, Klaus/I-6511-2012; Lohwasser, Ulrike/AAI-9445-2020; Lohwasser, Ulrike/AGV-5737-2022; Richards, Christopher/A-8328-2013	Pillen, Klaus/0000-0003-4646-6351; Lohwasser, Ulrike/0000-0002-3788-5258; Lohwasser, Ulrike/0000-0002-3788-5258; Richards, Christopher/0000-0002-9978-6079; Reeves, Patrick/0000-0001-9991-1397; Thormann, Imke/0000-0003-2703-9805; Borner, Andreas/0000-0003-3301-9026				Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Al-Eisawi Dawud, 1996, VEGETATION OF JORDAN; Al-Saghir M. G., 2009, Middle East Journal of Scientific Research, V4, P24; Andersen MS, 2010, GENE FLOW CROPS THEI; Backes G, 2003, THEOR APPL GENET, V106, P353, DOI 10.1007/s00122-002-1148-1; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baek HJ, 2003, THEOR APPL GENET, V106, P397, DOI 10.1007/s00122-002-1029-7; Batchu AK, 2006, GENETICA, V127, P87, DOI 10.1007/s10709-005-2484-2; Baum BR, 1997, GENET RESOUR CROP EV, V44, P147, DOI 10.1023/A:1008655023906; Castaneda-Alvarez NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122599; Chen G, 2008, SCI COLD ARID REGION, V1; Chen GX, 2004, SEED SCI RES, V14, P137, DOI 10.1079/SSR2004163; Cronin JK, 2007, P NATL ACAD SCI USA, V104, P2773, DOI 10.1073/pnas.0611226104; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dreiseitl A, 2003, GENET RESOUR CROP EV, V50, P345, DOI 10.1023/A:1023953819787; Dulloo ME, 2008, CONSERVING PLANT GENETIC DIVERSITY IN PROTECTED AREAS: POPULATION MANAGEMENT OF CROP WILD RELATIVES, P23, DOI 10.1079/9781845932824.0023; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 2003, CULTIVATED PLANTS MA; Erkkila MJ, 1998, PLANT PHYSIOL, V117, P679, DOI 10.1104/pp.117.2.679; ERSTS PJ, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2013, 14 REG SESS COMM GEN; FISCHBECK G, 1976, Z PFLANZENZUCHT, V76, P163; Fu YB, 2010, MOL ECOL RESOUR, V10, P389, DOI 10.1111/j.1755-0998.2009.02752.x; Fu YongBi, 2012, Diversity, V4, P239, DOI 10.3390/d4020239; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Genger RK, 2003, AUST J AGR RES, V54, P1335, DOI 10.1071/AR02230; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gupta PK, 2002, THEOR APPL GENET, V104, P473, DOI 10.1007/s001220100690; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoban S, 2015, BIOL CONSERV, V187, P182, DOI 10.1016/j.biocon.2015.04.023; Hoban S, 2014, EVOL APPL, V7, P984, DOI 10.1111/eva.12197; HOLM S, 1979, SCAND J STAT, V6, P65; Huber S, 2009, MOL ECOL, V18, P1523, DOI 10.1111/j.1365-294X.2009.04106.x; Hubner S, 2012, MOL ECOL, V21, P1115, DOI 10.1111/j.1365-294X.2011.05434.x; Ivandic V, 1998, THEOR APPL GENET, V97, P1235, DOI 10.1007/s001220051015; Ivandic V, 2002, PLANT MOL BIOL, V48, P511, DOI 10.1023/A:1014875800036; Jain S. K., 1975, Crop genetic resources for today and tomorrow. Conservation and storage., P379; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JARADAT AA, 1989, THEOR APPL GENET, V78, P857, DOI 10.1007/BF00266671; JARADAT AA, 1992, THEOR APPL GENET, V84, P725, DOI 10.1007/BF00224176; JARADAT AA, 1989, THEOR APPL GENET, V78, P653, DOI 10.1007/BF00262560; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jarvis S, 2015, BIOL CONSERV, V191, P444, DOI 10.1016/j.biocon.2015.07.039; Kantar MB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00841; Khazaei H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063107; Khoury CK, 2015, BIOL CONSERV, V184, P259, DOI 10.1016/j.biocon.2015.01.032; Lakew B, 2013, EUPHYTICA, V191, P231, DOI 10.1007/s10681-012-0795-9; Lewis PO, 2001, GENETIC DATA ANAL GD; Lin JZ, 2001, P NATL ACAD SCI USA, V98, P531, DOI 10.1073/pnas.011537898; Liviero L, 2002, GENET RESOUR CROP EV, V49, P133, DOI 10.1023/A:1014792509087; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Maxted N., 1995, P255; Maxted N, 2009, 39 FAO UN COMM GEN R; Maxted N, 2013, RESOURCE BOOK PREPAR; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Molina-Cano JL, 2005, THEOR APPL GENET, V110, P613, DOI 10.1007/s00122-004-1878-3; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Nagy S, 2012, BIOCHEM GENET, V50, P670, DOI 10.1007/s10528-012-9509-1; Nevo E., 1992, Barley: genetics, biochemistry, molecular biology and biotechnology., P19; NEVO E, 1979, EVOLUTION, V33, P815, DOI 10.2307/2407648; Nevo E, 1998, GENET RESOUR CROP EV, V45, P355, DOI 10.1023/A:1008689304103; NEVO E, 1986, GENETICA, V68, P203, DOI 10.1007/BF02424444; NEVO E, 1984, EUPHYTICA, V33, P737, DOI 10.1007/BF00021901; Nevo E, 2015, ISR J PLANT SCI, V62, P22, DOI 10.1080/07929978.2014.940783; Newman CE, 2011, MOL ECOL, V20, P5295, DOI 10.1111/j.1365-294X.2011.05353.x; Orabi J, 2007, THEOR APPL GENET, V114, P1117, DOI 10.1007/s00122-007-0505-5; Ozkan H, 2005, THEOR APPL GENET, V112, P12, DOI 10.1007/s00122-005-0067-3; Pakniyat H, 1997, GENOME, V40, P332, DOI 10.1139/g97-046; Parra-Quijano M., 2012, Genetic Resources and Crop Evolution, V59, P205, DOI 10.1007/s10722-011-9676-7; Parra-Quijano M, 2012, AGROBIODIVERSITY CONSERVATION: SECURING THE DIVERSITY OF CROP WILD RELATIVES AND LANDRACES, P20, DOI 10.1079/9781845938512.0020; Parra-Quijano M, 2012, SPAN J AGRIC RES, V10, P419, DOI [10.5424/sjar/2011102-303-11, 10.5424/sjar/2012102-303-11]; Parra-Quijano M, 2012, BIODIVERS CONSERV, V21, P79, DOI 10.1007/s10531-011-0167-0; Parra-Quijano M., 2008, P249, DOI 10.1079/9781845930998.0249; Parra-Quijano M, 2014, CAPFITOGEN TOOLS USE; Parra-Quijano M, 2011, CROP SCI, V51, P656, DOI 10.2135/cropsci2010.04.0191; Perrier X., 2006, DARWIN SOFTWARE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Villegas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013497; Repkova J, 2006, EUPHYTICA, V151, P23, DOI 10.1007/s10681-006-9109-4; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Russell J, 2011, NEW PHYTOL, V191, P564, DOI 10.1111/j.1469-8137.2011.03704.x; SCHOEN DJ, 1991, P NATL ACAD SCI USA, V88, P4494, DOI 10.1073/pnas.88.10.4494; Shakhatreh Y, 2010, GENET RESOUR CROP EV, V57, P131, DOI 10.1007/s10722-009-9457-8; Sharma S, 2004, PLANT SCI, V166, P467, DOI 10.1016/j.plantsci.2003.10.013; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Steiner J. J., 1999, Linking genetic resources and geography: emerging strategies for conserving and using crop biodiversity. Proceedings of a symposium, Anaheim, California, USA, 29 October, 1997., P39; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thormann I, 2014, GENET RESOUR CROP EV; Turpeinen T, 2001, MOL ECOL, V10, P1577, DOI 10.1046/j.1365-294X.2001.01281.x; Turpeinen T, 2003, THEOR APPL GENET, V106, P1333, DOI 10.1007/s00122-002-1151-6; van Hintum T, 2003, DEV PL GEN, V7, P247, DOI 10.1016/S0168-7972(03)80014-2; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Vincent H, 2012, PLANT GENET RESOUR-C, V10, P242, DOI 10.1017/S1479262112000317; Volis S, 2002, OECOLOGIA, V133, P131, DOI 10.1007/s00442-002-0999-0; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; von Korff M, 2005, THEOR APPL GENET, V111, P583, DOI 10.1007/s00122-005-2049-x; von Korff M, 2008, MOL BREEDING, V21, P81, DOI 10.1007/s11032-007-9110-1; VONBOTHMER R, 1995, SYSTEMATIC ECOGEOGRA, V7; Wang AH, 2009, CR BIOL, V332, P393, DOI 10.1016/j.crvi.2008.11.007; Witcombe J. R., 1982, Plant Genetic Resources Newsletter, P2; Yang ZJ, 2009, MOL ECOL, V18, P2063, DOI 10.1111/j.1365-294X.2009.04140.x; Zohary D., 1993, DOMESTICATION PLANTS	110	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160745	10.1371/journal.pone.0160745	http://dx.doi.org/10.1371/journal.pone.0160745			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513459	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100064
J	Lan, XW; Zou, XB; Xiao, Y; Tang, J; OuYang, PY; Su, Z; Xie, FY				Lan, Xiao-Wen; Zou, Xue-Bin; Xiao, Yao; Tang, Jie; OuYang, Pu-Yun; Su, Zhen; Xie, Fang-Yun			Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; CONCURRENT CISPLATIN-RADIOTHERAPY; RANDOMIZED PHASE-II; ADJUVANT CHEMOTHERAPY; TRIAL; CHEMORADIOTHERAPY; CHEMORADIATION; BIOMARKER; CANCER; PLANS	Purpose The value of adding induction chemotherapy to chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LA-NPC) remains controversial, yet high-risk patients with LA-NPC have poor outcomes after chemoradiotherapy. We aimed to assess the survival benefits of induction chemotherapy in stage IVa-b NPC. Patients and Methods A total of 602 patients with stage IVa-b NPC treated with intensity-modulated radiation therapy (IMRT) and concurrent chemotherapy with or without induction chemotherapy were retrospectively analyzed. Overall survival (OS), locoregional relapse-free survival (LRFS), distant metastasis-free survival (DMFS) and progression-free survival (PFS) were evaluated using the Kaplan-Meier method, log-rank test and Cox regression analysis. Results In univariate analysis, 5-year OS was 83.2% for induction chemotherapy plus concurrent chemotherapy and 74.8% for concurrent chemotherapy alone, corresponding to an absolute risk reduction of 8.4% (P = 0.022). Compared to concurrent chemotherapy alone, addition of induction chemotherapy improved 5-year DMFS (83.2% vs. 74.4%, P = 0.018) but not 5-year LRFS (83.7% vs. 83.0%, P = 0.848) or PFS (71.9% vs. 66.0%, P = 0.12). Age, T category, N category, chemotherapy strategy and clinical stage were associated with 5year OS (P = 0.017, P = 0.031, P = 0.007, P = 0.022, P = 0.001, respectively). In multivariate analysis, induction chemotherapy plus concurrent chemotherapy was an independent favorable prognostic factor for OS (HR, 0.62; 95% CI, 0.43-0.90, P = 0.012) and DMFS (HR, 0.57; 95% CI, 0.38-0.83, P = 0.004). In subgroup analysis, induction chemotherapy significantly improved 5-year DMFS in stage IVa (86.8% vs. 77.3%, P = 0.008), but provided no significant benefit in stage IVb. Conclusions In patients with stage IVa-b NPC treated with IMRT, addition of induction chemotherapy to concurrent chemotherapy significantly improved 5-year OS and 5-year DMFS. This study provides a basis for selection of high risk patients in future clinical therapeutic trials.	[Lan, Xiao-Wen; Xiao, Yao; Tang, Jie; OuYang, Pu-Yun; Su, Zhen; Xie, Fang-Yun] Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Zou, Xue-Bin] Sun Yat Sen Univ, Dept Ultrasound, Ctr Canc, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xie, FY (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	xiefysysucc@163.com						BYERS RM, 1978, INT J RADIAT ONCOL, V4, P215, DOI 10.1016/0360-3016(78)90140-2; Cao SM, 2011, PREVALENCE PREVENTIO, P114; Chan ATC, 2005, J NATL CANCER I, V97, P536, DOI 10.1093/jnci/dji084; Chen L, 2012, INT J RADIAT ONCOL, V84, P196, DOI 10.1016/j.ijrobp.2011.11.021; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P2230, DOI 10.1002/cncr.28049; Chua M, 2014, INT J RADIAT ONCOL, V90, pS120, DOI 10.1016/j.ijrobp.2014.05.555; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fountzilas G, 2012, ANN ONCOL, V23, P427, DOI 10.1093/annonc/mdr116; Hui EP, 2009, J CLIN ONCOL, V27, P242, DOI 10.1200/JCO.2008.18.1545; Kam MKM, 2003, INT J RADIAT ONCOL, V56, P145, DOI 10.1016/S0360-3016(03)00075-0; Kwong DLW, 2004, J CLIN ONCOL, V22, P2643, DOI 10.1200/JCO.2004.05.173; Lee AWM, 2008, RADIOTHER ONCOL, V87, P204, DOI 10.1016/j.radonc.2008.02.003; Lee AWM, 2015, CANCER-AM CANCER SOC, V121, P1328, DOI 10.1002/cncr.29208; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Lin JC, 2003, J CLIN ONCOL, V21, P631, DOI 10.1200/JCO.2003.06.158; Lin JC, 2004, ANOTHER WAY ESTIMATE, P156; Liu Q, 2013, CHIN J CANCER, V32, P325, DOI 10.5732/cjc.012.10189; Nutting C, 2000, BRIT J RADIOL, V73, P459, DOI 10.1259/bjr.73.869.10884741; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Tan T, 2015, INT J RADIAT ONCOL, V91, P952, DOI 10.1016/j.ijrobp.2015.01.002; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wu X, 2013, ANN ONCOL, V24, P2131, DOI 10.1093/annonc/mdt163; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X; Zhao Chong, 2004, Ai Zheng, V23, P1532; Zhou GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067488	25	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160758	10.1371/journal.pone.0160758	http://dx.doi.org/10.1371/journal.pone.0160758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509025	gold, Green Submitted, Green Published			2022-12-26	WOS:000381380400051
J	Poulsen, JY; Sado, T; Hahn, C; Byrkjedal, I; Moku, M; Miya, M				Poulsen, Jan Yde; Sado, Tetsuya; Hahn, Christoph; Byrkjedal, Ingvar; Moku, Masatoshi; Miya, Masaki			Preservation Obscures Pelagic Deep-Sea Fish Diversity: Doubling the Number of Sole-Bearing Opisthoproctids and Resurrection of the Genus Monacoa (Opisthoproctidae, Argentiniformes)	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; TUBULAR EYES; OPEN-OCEAN; SEQUENCES; REARRANGEMENTS; SPECIATION; READS; RIDGE	The family Opisthoproctidae (barreleyes) constitutes one of the most peculiar looking and unknown deep-sea fish groups in terms of taxonomy and specialized adaptations. All the species in the family are united by the possession of tubular eyes, with one distinct lineage exhibiting also drastic shortening of the body. Two new species of the mesopelagic opisthoproctid mirrorbelly genus Monacoa are described based on pigmentation patterns of the "sole"-a unique vertebrate structure used in the reflection and control of bioluminescence in most short-bodied forms. Different pigmentation patterns of the soles, previously noted as intraspecific variations based on preserved specimens, are here shown species-specific and likely used for communication in addition to counter-illumination of down-welling sunlight. The genus Monacoa is resurrected from Opisthoproctus based on extensive morphological synaphomorphies pertaining to the anal fin and snout. Doubling the species diversity within sole-bearing opisthoproctids, including recognition of two genera, is unambiguously supported by mitogenomic DNA sequence data. Regular fixation with formalin and alcohol preservation is shown problematic concerning the retention of species-specific pigmentation patterns. Examination or photos of fresh material before formalin fixation is shown paramount for correct species recognition of sole-bearing opisthoproctids-a relatively unknown issue concerning species diversity in the deep-sea pelagic realm.	[Poulsen, Jan Yde] Australian Museum, Fish Sect, Sydney, NSW, Australia; [Poulsen, Jan Yde] Greenland Inst Nat Resources, Dept Fish & Shellfish, Nuuk, Greenland; [Sado, Tetsuya; Miya, Masaki] Nat Hist Museum & Inst, Chuo Ku, 955-2 Aoba Cho, Chiba, Japan; [Hahn, Christoph] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull, N Humberside, England; [Byrkjedal, Ingvar] Univ Bergen, Bergen Museum, Nat Hist Collect, Bergen, Norway; [Moku, Masatoshi] Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwano Ha, Kashiwa, Chiba, Japan	Australian Museum; Greenland Institute of Natural Resources; University of Hull; University of Bergen; University of Tokyo	Poulsen, JY (corresponding author), Australian Museum, Fish Sect, Sydney, NSW, Australia.; Poulsen, JY (corresponding author), Greenland Inst Nat Resources, Dept Fish & Shellfish, Nuuk, Greenland.	JaPo@natur.gl	Miya, Masaki/O-2664-2019	Hahn, Christoph/0000-0003-4265-4793; Poulsen, Jan Yde/0000-0003-2137-0759	MEXT/JSPS KAKENHI [26291083]; JST (CREST); CANON Foundation; Grants-in-Aid for Scientific Research [26291083] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); CANON Foundation(Canon Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by MEXT/JSPS KAKENHI grant number 26291083, JST (CREST) and the CANON Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom EH, 1984, ONTOGENY SYSTEMATICS, P155; BEKKER V E, 1968, Voprosy Ikhtiologii, V8, P241; Belloc G., 1949, Bulletin de l'Institut Oceanographique Monaco, VNo. 958, P1; Belyanina T.N., 1982, Trudy Instituta Okeanologii Akademii Nauk SSSR, V118, P5; Bergstad OA, 2008, DEEP-SEA RES PT II, V55, P1, DOI 10.1016/j.dsr2.2007.10.001; Bertelsen E., 1965, Videnskabelige Meddelelser Dansk naturh Foren, V128, P357; BERTELSEN E, 1958, NATURE, V181, P862, DOI 10.1038/181862b0; BERTELSEN E., 1964, DANA REP CARLSBERG FOUND, V62, P1; Betancur-R R., 2014, PHYLOGENETIC CLASSIF; Brady PC, 2015, SCIENCE, V350, P965, DOI 10.1126/science.aad5284; Byrkjedal I, 2011, ZOOTAXA, P49; Campbell MA, 2013, GENE, V530, P57, DOI 10.1016/j.gene.2013.07.068; Chakrabarty P, 2013, ZOOKEYS, P29, DOI 10.3897/zookeys.346.5753; CHAPMAN WILBERT McLEOD, 1939, PROC U S NATION MUS, V86, P501; Chapman WM, 1942, ANN MAG NAT HIST, V8, P272; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; CLARKE TA, 1976, FISH B-NOAA, V74, P635; Cohen D.M., 1964, MEM SEARS F MAR RES, V1, P1; COHEN DANIEL M., 1960, REPT SCI RESULTS MICHAEL SARS" NORTH ATLANTIC DEEP SEA EXPED 1910, V4, P1; Cohen DM, 1986, FISHES NE ATLANTIC M, P395; Collin SP, 1997, BRAIN BEHAV EVOLUT, V50, P335, DOI 10.1159/000113345; Davis MP, 2014, MAR BIOL, V161, P1139, DOI 10.1007/s00227-014-2406-x; Evseenko S.A., 2009, J ICHTHYOLOGY, V49, P839, DOI [10.1134/S0032945209100014, DOI 10.1134/S0032945209100014]; Evseenko SA, 1995, J ICHTHYOL, V35, P111; Froese R., 2012, FISHBASE; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; HAYGOOD MG, 1992, J MAR BIOL ASSOC UK, V72, P149, DOI 10.1017/S0025315400048852; Herring P., 2000, J OPT A-PURE APPL OP, V2, P29; Herring PJ, 2002, BIOL DEEP OCEAN; Herring PJ, 1975, P 9 EUR MAR BIOL S A, P563; Ishiguro NB, 2003, MOL PHYLOGENET EVOL, V27, P476, DOI 10.1016/S1055-7903(02)00418-9; Johnson G. David, 1996, P251; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Loytynoja A, 2003, BIOINFORMATICS, V19, P1505, DOI 10.1093/bioinformatics/btg193; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Miya M, 1997, NATURE, V389, P803, DOI 10.1038/39774; Mundy Bruce C., 2005, Bishop Museum Bulletins in Zoology, V6, P1; Munk O., 1966, Dana Reports, VNo. 70, P1; Parr A.E., 1937, B BINGHAM OCEANOGR C, V3, P1; Partidge J. C., 2014, P R SOC B, V281, P1; Paxton JR, 1999, FAO SPECIES IDENTIFI, V3, P1887; Poulsen JY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-111; Poulsen JY, 2015, ZOOTAXA, V4020, P517, DOI 10.11646/zootaxa.4020.3.6; Robison BH, 2008, COPEIA, P780, DOI 10.1643/CG-07-082; Roule L., 1915, B MUSEUM NATL HIST 1, V21, P175; RUBY EG, 1978, DEEP-SEA RES, V25, P161, DOI 10.1016/0146-6291(78)90003-6; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schmidt J., 1918, BIOLOGY A, VA5, P1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suntsov AV, 2008, BIOLUMINESCENCE, P51; Uiblein Franz, 1994, Cybium, V18, P15; Vaillant LL, 1888, EXPEDITIONS SCI TRAV, P1; Wagner HJ, 2009, CURR BIOL, V19, P108, DOI 10.1016/j.cub.2008.11.061; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Whitley Gilbert P., 1943, AUSTRALIAN ZOOL, V10, P167; Zugmayer E., 1911, Bul Inst Ocean Monaco, V193	58	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159762	10.1371/journal.pone.0159762	http://dx.doi.org/10.1371/journal.pone.0159762			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508419	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400012
J	Pumarega, J; Gasull, M; Lee, DH; Lopez, T; Porta, M				Pumarega, Jose; Gasull, Magda; Lee, Duk-Hee; Lopez, Tomas; Porta, Miquel			Number of Persistent Organic Pollutants Detected at High Concentrations in Blood Samples of the United States Population	PLOS ONE			English	Article							OCCUPATIONAL SOCIAL-CLASS; ORGANOCHLORINE PESTICIDES; GENERAL-POPULATION; BIOMONITORING DATA; REPRESENTATIVE SAMPLE; SYSTEMATIC EVALUATION; ENVIRONMENTAL-HEALTH; WIDE ASSOCIATION; US POPULATION; EXPOSURE	Human exposure to environmental chemicals as persistent organic pollutants (POPs) is usually assessed considering each pollutant individually, with little attention to concentrations of mixtures in individuals or social groups. Yet, it may be relatively common for humans to have low and high concentrations of numerous POPs. The study objectives were to analyze the number of POPs detected per person at high concentrations in the U.S. population, and the associations between such type of indicators and socioeconomic factors as gender, race/ethnicity, education, and poverty level. From 91 POPs analyzed in serum samples of 4,739 individuals in three subsamples of the National Health and Nutrition Examination Survey (NHANES) 2003-2004 (the last period with valid updated individual data for the compounds considered in the present study), we computed the number of POPs whose serum concentrations were above selected cutoff points. POPs included were 13 organochlorine compounds (OCs), 10 polybrominated diphenyl ethers (PBDEs), the polybrominated biphenyl (PBB) 153, 38 polychlorinated biphenyls (PCBs), 17 polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs/Fs), and 12 perfluorinated compounds (PFCs). Over 13% of participants had >= 10 of the 37 most detected POPs each at a concentration in the top decile (P90). Over 30% of subjects with total toxic equivalency (TEQ) >= P75, had >= 10 of 24 POPs not included in TEQ calculations at concentrations >= P90. Compared to non-Hispanic whites, the adjusted odds ratio of having >= 10 of the 37 POPs at P90 was 9.2 for non-Hispanic blacks and 0.18 for Mexican Americans. Poverty, body mass index, age, and gender were also independently associated with having >= 10 POPs in the top decile. More than one tenth of the US population may have >= 10 POPs each at concentrations in the top decile. Such pattern is nine times more frequent in Non-Hispanic blacks and four times less frequent in Mexican Americans than in non-Hispanic whites.	[Pumarega, Jose; Gasull, Magda; Lopez, Tomas; Porta, Miquel] Hosp Mar Med Res Inst IMIM, Barcelona, Spain; [Pumarega, Jose; Gasull, Magda; Lopez, Tomas; Porta, Miquel] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Gasull, Magda; Lopez, Tomas; Porta, Miquel] Univ Autonoma Barcelona, Sch Med, Catalonia, Spain; [Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Prevent Med, Daegu, South Korea	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; Kyungpook National University	Porta, M (corresponding author), Hosp Mar Med Res Inst IMIM, Barcelona, Spain.; Porta, M (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.; Porta, M (corresponding author), Univ Autonoma Barcelona, Sch Med, Catalonia, Spain.	mporta@imim.es	Porta, Miquel/AAD-5371-2020; Porta, Miquel/B-5787-2008	Porta, Miquel/0000-0003-1684-7428; Porta, Miquel/0000-0003-1684-7428; Gasull, Magda/0000-0003-4546-3650; Lopez-Jimenez, Tomas/0000-0001-8255-4936	Instituto de Salud Carlos III - FEDER, Government of Spain [FIS PI13/00020]; Instituto de Salud Carlos III - FEDER (CIBER de Epidemiologia y Salud Publica - CIBERESP), Government of Spain; Government of Catalonia [2014 SGR 1012]	Instituto de Salud Carlos III - FEDER, Government of Spain; Instituto de Salud Carlos III - FEDER (CIBER de Epidemiologia y Salud Publica - CIBERESP), Government of Spain; Government of Catalonia(Generalitat de Catalunya)	The work was supported in part by research grants from Instituto de Salud Carlos III - FEDER (FIS PI13/00020 and CIBER de Epidemiologia y Salud Publica - CIBERESP), Government of Spain; Fundacio La Marato de TV3 (20132910); and Government of Catalonia (2014 SGR 1012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkiewicz G, 2014, AM J PUBLIC HEALTH, V104, P1650, DOI 10.2105/AJPH.2013.301253; AMAP, 1998, AMAP ASS REP ARCT PO; Angerer J, 2011, INT J HYG ENVIR HEAL, V214, P348, DOI 10.1016/j.ijheh.2011.06.002; Armitage P., 2002, STAT METHODS MED RES; Aylward LL, 2014, ENVIRON INT, V68, P127, DOI 10.1016/j.envint.2014.03.026; Aylward LL, 2013, ENVIRON HEALTH PERSP, V121, P287, DOI 10.1289/ehp.1205740; Barouki Robert, 2012, Environ Health, V11, P42, DOI 10.1186/1476-069X-11-42; Belova A, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-114; Burger J, 2011, AM J PUBLIC HEALTH, V101, pS64, DOI 10.2105/AJPH.2010.300077; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Centers for Disease Control and Prevention, 2009, 4 CDCP; Centers for Disease Control and Prevention (CDC), 2015, 4 CDCP; Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2003, NAT HLTH NUTR EX SUR; De Roos AJ, 2005, CANCER RES, V65, P11214, DOI 10.1158/0008-5472.CAN-05-1755; Den Hond E, 2015, ENVIRON HEALTH PERSP, V123, P255, DOI 10.1289/ehp.1408616; Engel SM, 2013, ANNU REV PUBL HEALTH, V34, P139, DOI 10.1146/annurev-publhealth-031811-124556; Freeman Michael D, 2012, J Environ Public Health, V2012, P258981, DOI 10.1155/2012/258981; Freire C, 2011, CHEMOSPHERE, V83, P831, DOI 10.1016/j.chemosphere.2011.02.076; Gascon M, 2012, EUR RESPIR J, V39, P1188, DOI 10.1183/09031936.00011711; Gasull M, 2013, ENVIRON INT, V60, P190, DOI 10.1016/j.envint.2013.08.001; Glynn AW, 2003, ENVIRON HEALTH PERSP, V111, P349, DOI 10.1289/ehp.5456; Grandjean P, 2011, EPIDEMIOLOGY, V22, P410, DOI 10.1097/EDE.0b013e318212fab9; Health Canada, 2010, REP HUM BIOM ENV CHE; Heindel J., 2013, STATE SCI ENDOCRINE, DOI DOI 10.1590/S1414-462X2013000100003; Henkler F, 2011, J EPIDEMIOL COMMUN H, V65, P1, DOI 10.1136/jech.2008.083881; Hernandez LG, 2009, MUTAT RES-REV MUTAT, V682, P94, DOI 10.1016/j.mrrev.2009.07.002; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Human Biomonitoring Commission. German Federal Environment Agency, HUM BIOM HBM VAL BLO; Jacobs DE, 2011, AM J PUBLIC HEALTH, V101, pS115, DOI 10.2105/AJPH.2010.300058; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Kolossa-Gehring Marike, 2012, Int J Hyg Environ Health, V215, P247, DOI 10.1016/j.ijheh.2011.10.019; Lakind JS, 2009, J EXPO SCI ENV EPID, V19, P435, DOI 10.1038/jes.2008.63; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee DH, 2014, ENDOCR REV, V35, P557, DOI 10.1210/er.2013-1084; Lee DH, 2011, DIABETES CARE, V34, P1778, DOI 10.2337/dc10-2116; Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480; Lind PM, 2013, CHEMOSPHERE, V90, P998, DOI 10.1016/j.chemosphere.2012.07.051; Lind PM, 2013, ENVIRON INT, V55, P1, DOI 10.1016/j.envint.2013.01.017; Little R. J. A., 2002, STAT ANAL MISSING DA; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McGlynn KA, 2008, JNCI-J NATL CANCER I, V100, P663, DOI 10.1093/jnci/djn101; Morrens B, 2012, INT J HYG ENVIR HEAL, V215, P474, DOI 10.1016/j.ijheh.2011.10.008; National Research Council, 2006, COMM HUM BIOM ENV TO; National Research Council, 2008, COMM HLTH RISKS PHTH; Park SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098632; Patel CJ, 2013, INT J EPIDEMIOL, V42, P1795, DOI 10.1093/ije/dyt208; Patel CJ, 2012, INT J EPIDEMIOL, V41, P828, DOI 10.1093/ije/dys003; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Patterson DG, 2008, CHEMOSPHERE, V73, pS261, DOI 10.1016/j.chemosphere.2007.08.074; Patterson DG, 2009, ENVIRON SCI TECHNOL, V43, P1211, DOI 10.1021/es801966w; Paul DS, 2014, TRENDS MOL MED, V20, P541, DOI 10.1016/j.molmed.2014.07.002; Porta M, 2012, PREV MED, V55, P560, DOI 10.1016/j.ypmed.2012.09.020; Porta M, 2010, ENVIRON INT, V36, P655, DOI 10.1016/j.envint.2010.04.013; Porta M, 2008, ENVIRON INT, V34, P546, DOI 10.1016/j.envint.2007.10.004; Porta M, 2012, ENVIRON INT, V44, P106, DOI 10.1016/j.envint.2012.02.005; PRUSS-USTUN A., 2016, PREVENTING DIS HLTH; Quinn CL, 2012, ENVIRON HEALTH PERSP, V120, P554, DOI 10.1289/ehp.1104236; Rosner B., 2010, FUNDAMENTALS BIOSTAT; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schettgen T, 2015, INT J HYG ENVIR HEAL, V218, P380, DOI 10.1016/j.ijheh.2015.02.006; Schulz C, 2012, INT J HYG ENVIR HEAL, V215, P150, DOI 10.1016/j.ijheh.2012.01.003; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Stein RA, 2012, J EPIDEMIOL COMMUN H, V66, P8, DOI 10.1136/jech.2010.130690; Taylor KW, 2013, ENVIRON HEALTH PERSP, V121, P774, DOI 10.1289/ehp.1205502; Thornton JW, 2002, PUBLIC HEALTH REP, V117, P315, DOI 10.1016/S0033-3549(04)50167-X; Trasande L, 2016, ANDROLOGY-US, V4, P565, DOI 10.1111/andr.12178; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vrijheid M, 2012, J EPIDEMIOL COMMUN H, V66, P106, DOI 10.1136/jech.2010.117408; Wolff MS, 2007, CANCER EPIDEM BIOMAR, V16, P1925, DOI 10.1158/1055-9965.EPI-07-0394; Wolff MS, 2005, ENVIRON RES, V97, P170, DOI 10.1016/j.envres.2004.07.014; Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727	72	31	31	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160432	10.1371/journal.pone.0160432	http://dx.doi.org/10.1371/journal.pone.0160432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KR	27508420	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400030
J	Micheletti, VCD; Kritski, AL; Braga, JU				Dezoti Micheletti, Vania Celina; Kritski, Afranio Lineu; Braga, Jose Ueleres			Clinical Features and Treatment Outcomes of Patients with Drug-Resistant and Drug-Sensitive Tuberculosis: A Historical Cohort Study in Porto Alegre, Brazil	PLOS ONE			English	Article							CULTURE CONVERSION; HIV-INFECTION; PREDICTORS	Purpose To evaluate the clinical features and treatment outcomes of patients with pulmonary tuberculosis, stratified by level of drug resistance. Methods This was a historical cohort study based on data from the II National Anti-Tuberculosis Drug Resistance Survey (2006-2007) collected at eight participating health care facilities in Porto Alegre, southern Brazil. The cohort was followed for 3 years after the start of treatment. Results Of 299 cases of smear-positive pulmonary tuberculosis included in the study, 216 (72.2%) were diagnosed at five public primary health care units and 83 (27.8%) at three public hospitals. Among these cases, the prevalence of drug-resistant tuberculosis was 14.4%, and that of multidrug-resistant tuberculosis was 4.7%. Overall, 32.0% of drug-resistant and 2.0% of multidrug-resistant cases occurred in previously treated patients. The most common comorbidity in the sample was HIV infection (26.2%). There was no association between drug-resistant or multidrug-resistant tuberculosis and sociodemographic variables. Cure was achieved in 66.7% of patients, and the default rate was 21.2%. The 2-month sputum conversion rate was 34.2%, and the relapse rate was 16.9%. Patients with drug-resistant tuberculosis had lower rates of cure (45.2%) and 2-month sputum conversion (25%), as well as a higher relapse rate (30.7%). Conclusion These results highlight the urgent need for a more effective TB control program in this geographical setting, with a major emphasis on treatment of drug-resistant and multidrug-resistant tuberculosis.	[Dezoti Micheletti, Vania Celina] Univ Fed Rio Grande do Sul, Postgrad Sch Pulmonol, Porto Alegre, RS, Brazil; [Kritski, Afranio Lineu] Univ Fed Rio de Janeiro, Sch Med, Rio De Janeiro, RJ, Brazil; [Braga, Jose Ueleres] Univ Estado Rio De Janeiro, Dept Collect Hlth, Rio De Janeiro, RJ, Brazil; [Braga, Jose Ueleres] Fundacao Oswaldo Cruz, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz	Micheletti, VCD (corresponding author), Univ Fed Rio Grande do Sul, Postgrad Sch Pulmonol, Porto Alegre, RS, Brazil.	vaniadezoti@uol.com.br	Braga, Jose Ueleres/AAB-1326-2021; Kritski, Afranio/I-6760-2016	Braga, Jose Ueleres/0000-0001-5247-007X; kritski, afranio/0000-0002-5900-6007				Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Drummond AMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145553; Brazil. Ministry of Health, 2012, TUB BRAS MUND; Brazil. Ministry of Health, 1994, MAN BACT TUB; Brazil. Ministry of Health, 2005, 2 INQ NAC RES DROG T; Brito RC, 2010, INT J TUBERC LUNG D, V14, P24; Brust JCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073975; Calixto M, 2010, UMA ANALISE HISTORIC; Castelo Filho Adauto, 2004, J. bras. pneumol., V30, pS57, DOI 10.1590/S1806-37132004000700002; da Silva MV, 2006, B PNEUMOL SANIT, V14, P145; de Oliveira H B, 2000, Rev Panam Salud Publica, V7, P232; Micheletti VCD, 2014, J BRAS PNEUMOL, V40, P155, DOI 10.1590/S1806-37132014000200009; Ferreira MMC, 1996, J ACQ IMMUN DEF SYND, V13, P177, DOI 10.1097/00042560-199610010-00009; Haar CH, 2007, EMERG INFECT DIS, V13, P776, DOI 10.3201/eid1305.060334; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; [Ministry of Health Health Surveillance Department Department of Epidemiological Surveillance Brazil], 2011, PROGR NAC CONTR TUB; [Municipal Administration of Porto Alegre Brazil. National Cancer Institute], 2011, REL GEST 2010; [National Secretariat for Drug Policy Brazil. Presidency of the Republic], 2009, RELATORIO BRASILEIRO; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Ruffino-Netto Antonio, 2007, J. bras. pneumol., V33, pxxvii, DOI 10.1590/S1806-37132007000500001; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Vieira R, 2007, REV BRAS EPIDEMIOL, V10, P10; WHO, 1998, LAB SERV TUB CONTR 2; Word Health Organization, 1997, ANT DRUG RES WORLD; World Health Organization, 2003, GLOB TUB CONTR SURV; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2009, WHOHTMTB2008402	33	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160109	10.1371/journal.pone.0160109	http://dx.doi.org/10.1371/journal.pone.0160109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505633	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200022
J	Huque, R; Shah, S; Mushtaq, N; Siddiqi, K				Huque, Rumana; Shah, Sarwat; Mushtaq, Nasir; Siddiqi, Kamran			Determinants of Salivary Cotinine among Smokeless Tobacco Users: A Cross-Sectional Survey in Bangladesh	PLOS ONE			English	Article							NICOTINE DEPENDENCE; HEALTH; INDIA; COUNTRIES; EXPOSURE; COHORT; MUMBAI; WOMEN; RISK	Introduction More than 80% of all smokeless tobacco (ST) products in the world are consumed in South Asia; yet little is known about their consumption behaviour, addictiveness, and toxic properties. This paper, for the first time, describes associations between salivary cotinine concentrations among ST users in Bangladesh and their socio-demographic characteristics and tobacco use behaviours. Methods In a survey of ST users in Dhaka, Bangladesh, we purposively recruited 200 adults who were non-smokers but consumed ST on a regular basis. In-person interviews were conducted to obtain information about socio-demographic and ST use behaviours, and saliva samples were collected to measure cotinine concentration. Simple and multiple linear regression analyses were conducted to test associations between the log transformed salivary cotinine concentration and other study variables. Results The geometric mean of cotinine concentration among ST users was 380ng/ml (GSD: 2). Total duration of daily ST use in months had a statistically significant association with cotinine concentration. Other ST use characteristics including type and quantity of ST use, swallowing of tobacco juice, urges and strength of urges and attempts to cut down on tobacco use were not found to be associated with cotinine concentration in a multivariable model. Conclusion This is the first report from Bangladesh studying cotinine concentration among ST users and it points towards high levels of addiction. This warrants effective tobacco control policies to help ST cessation and prevention.	[Huque, Rumana] Univ Dhaka, Dept Econ, Dhaka, Bangladesh; [Shah, Sarwat; Siddiqi, Kamran] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Mushtaq, Nasir] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Tulsa, OK USA	University of Dhaka; University of York - UK; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Tulsa	Huque, R (corresponding author), Univ Dhaka, Dept Econ, Dhaka, Bangladesh.	rumanah14@yahoo.com	Siddiqi, Kamran/AAD-8801-2021; Mushtaq, Nasir/W-2692-2018	Siddiqi, Kamran/0000-0003-1529-7778; Mushtaq, Nasir/0000-0002-2686-7601	Leeds City Council, Leeds, UK; MRC [MC_PC_13081] Funding Source: UKRI; Medical Research Council [MC_PC_13081] Funding Source: researchfish	Leeds City Council, Leeds, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Leeds City Council, Leeds, UK funded the study.	Craney T. A., 2002, Quality Engineering, V14, P391, DOI 10.1081/QEN-120001878; Ebbert JO, 2004, ADDICT BEHAV, V29, P349, DOI 10.1016/j.addbeh.2003.08.046; Ebbert JO, 2006, ADDICT BEHAV, V31, P1716, DOI 10.1016/j.addbeh.2005.12.015; England LJ, 2012, ACTA OBSTET GYN SCAN, V91, P93, DOI 10.1111/j.1600-0412.2011.01273.x; FDA Food and Drug Administration, 2001, GUIDANCE FOR INDUSTR; Ferketich AK, 2007, ADDICT BEHAV, V32, P1970, DOI 10.1016/j.addbeh.2007.01.005; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Global Adult Tobacco Survey, 2009, GLOB AD TOB SURV BAN; Gupta PC, 2006, EPIDEMIOLOGY, V17, P47, DOI 10.1097/01.ede.0000190545.19168.c4; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; HATSUKAMI DK, 1988, PSYCHOPHARMACOLOGY, V96, P428, DOI 10.1007/BF00216076; Imam SZ, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-231; Jarvis MJ, 2003, NICOTINE TOB RES, V5, P349, DOI 10.1080/1462220031000094213; Mushtaq N, 2014, P 20 ANN M SOC RES N; Mushtaq N, 2012, NICOTINE TOB RES, V14, P1229, DOI 10.1093/ntr/ntr279; Rostron BL, 2015, CANCER EPIDEM BIOMAR, V24, P1829, DOI 10.1158/1055-9965.EPI-15-0376; Siddiqi K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0424-2; Sousa VD, 2011, J EVAL CLIN PRACT, V17, P268, DOI 10.1111/j.1365-2753.2010.01434.x; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stanfill SB, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.037465; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; World Health Organization, 2004, OR TOB US ITS IMPL S	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160211	10.1371/journal.pone.0160211	http://dx.doi.org/10.1371/journal.pone.0160211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IK	27504912	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000381374200025
J	Michna, A; Braselmann, H; Selmansberger, M; Dietz, A; Hess, J; Gomolka, M; Hornhardt, S; Bluthgen, N; Zitzelsberger, H; Unger, K				Michna, Agata; Braselmann, Herbert; Selmansberger, Martin; Dietz, Anne; Hess, Julia; Gomolka, Maria; Hornhardt, Sabine; Bluethgen, Nils; Zitzelsberger, Horst; Unger, Kristian			Natural Cubic Spline Regression Modeling Followed by Dynamic Network Reconstruction for the Identification of Radiation-Sensitivity Gene Association Networks from Time-Course Transcriptome Data	PLOS ONE			English	Article							CELLULAR SENESCENCE; BAYESIAN-ESTIMATION; EXPRESSION; RADIOTHERAPY; CELLS; CLASSIFICATION; ALGORITHM; TOOL	Gene expression time-course experiments allow to study the dynamics of transcriptomic changes in cells exposed to different stimuli. However, most approaches for the reconstruction of gene association networks (GANs) do not propose prior-selection approaches tailored to time-course transcriptome data. Here, we present a workflow for the identification of GANs from time-course data using prior selection of genes differentially expressed over time identified by natural cubic spline regression modeling (NCSRM). The workflow comprises three major steps: 1) the identification of differentially expressed genes from time-course expression data by employing NCSRM, 2) the use of regularized dynamic partial correlation as implemented in GeneNet to infer GANs from differentially expressed genes and 3) the identification and functional characterization of the key nodes in the reconstructed networks. The approach was applied on a time-resolved transcriptome data set of radiation-perturbed cell culture models of non-tumor cells with normal and increased radiation sensitivity. NCSRM detected significantly more genes than another commonly used method for time-course transcriptome analysis (BETR). While most genes detected with BETR were also detected with NCSRM the false-detection rate of NCSRM was low (3%). The GANs reconstructed from genes detected with NCSRM showed a better overlap with the interactome network Reactome compared to GANs derived from BETR detected genes. After exposure to 1 Gy the normal sensitive cells showed only sparse response compared to cells with increased sensitivity, which exhibited a strong response mainly of genes related to the senescence pathway. After exposure to 10 Gy the response of the normal sensitive cells was mainly associated with senescence and that of cells with increased sensitivity with apoptosis. We discuss these results in a clinical context and underline the impact of senescence-associated pathways in acute radiation response of normal cells. The workflow of this novel approach is implemented in the open-source Bioconductor R-package splineTimeR.	[Michna, Agata; Braselmann, Herbert; Selmansberger, Martin; Hess, Julia; Zitzelsberger, Horst; Unger, Kristian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Radiat Cytogenet, Neuherberg, Germany; [Braselmann, Herbert; Hess, Julia; Zitzelsberger, Horst; Unger, Kristian] Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany; [Dietz, Anne; Gomolka, Maria; Hornhardt, Sabine] Fed Off Radiat Protect, Dept Radiat Protect & Hlth, Neuherberg, Germany; [Bluethgen, Nils] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Unger, K (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Radiat Cytogenet, Neuherberg, Germany.; Unger, K (corresponding author), Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany.	unger@helmholtz-muenchen.de	Unger, Kristian/F-3730-2018; Bluthgen, Nils/A-1711-2011	Unger, Kristian/0000-0002-0374-2320; Bluthgen, Nils/0000-0002-0171-7447; Hess, Julia/0000-0001-9860-1426	ZiSS project, Federal Ministry of Education and Research [02NUK024B]; Federal Ministry of Education and Research, ZiSS project [02NUK024B]	ZiSS project, Federal Ministry of Education and Research; Federal Ministry of Education and Research, ZiSS project	ZiSS project, 02NUK024B, https://www.bmbf.de/en/index.html, Federal Ministry of Education and Research, KU JH HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Aaron Selmaier from the Research Unit Radiation Cytogenetics for technical support. This study was supported by the Federal Ministry of Education and Research, ZiSS project, 02NUK024B.	ABBASI A, 2013, COMPLEX NETWORKS, V424, P1, DOI DOI 10.1007/978-3-642-30287-9; Alsner J, 2008, SEMIN RADIAT ONCOL, V18, P126, DOI 10.1016/j.semradonc.2007.10.004; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Andreassen CN, 2005, ACTA ONCOL, V44, P801, DOI 10.1080/02841860500374513; Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Badie C, 2008, BRIT J CANCER, V98, P1845, DOI 10.1038/sj.bjc.6604381; Bandyopadhyay S, 2011, IEEE ACM T COMPUT BI, V8, P929, DOI 10.1109/TCBB.2010.106; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Costa IG, 2009, BIOINFORMATICS, V25, pI6, DOI 10.1093/bioinformatics/btp222; di Masi A, 2008, CELL CYCLE, V7, P2030, DOI 10.4161/cc.7.13.6149; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gurtler A, 2014, ARCH PHYSIOL BIOCHEM, V120, P198, DOI 10.3109/13813455.2014.953548; Guertler A, 2011, RADIAT PROT DOSIM, V143, P487, DOI 10.1093/rpd/ncq515; Hafemeister C, 2011, BIOINFORMATICS, V27, P946, DOI 10.1093/bioinformatics/btr037; Jung, 1996, Semin Radiat Oncol, V6, P268, DOI 10.1016/S1053-4296(96)80022-1; Koschutzki D, 2007, ANAL BIOL NETWORKS, P65; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Lee M, 2012, RADIAT RES, V177, P152, DOI 10.1667/RR2812.1; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Li L, 2001, INT J RADIAT ONCOL, V49, P1157, DOI 10.1016/S0360-3016(00)01524-8; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Lienau J, 2010, TISSUE ENG PT A, V16, P191, DOI [10.1089/ten.tea.2009.0187, 10.1089/ten.TEA.2009.0187]; Lin TH, 2008, BIOINFORMATICS, V24, pI147, DOI 10.1093/bioinformatics/btn152; Liu HS, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00026; Lopez-Romero P, AGI4X44PREPROCESS PR; Magni P, 2008, BIOINFORMATICS, V24, P430, DOI 10.1093/bioinformatics/btm605; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Meng YR, 2012, MOL THER, V20, P1046, DOI 10.1038/mt.2012.19; Nelson G, 2012, AGING CELL, V11, P345, DOI 10.1111/j.1474-9726.2012.00795.x; Opgen-Rhein R, 2006, 4 INT WORKSH COMP SY; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; R Core Team, R LANG ENV STAT COMP; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Rosenberger A, 2011, DNA REPAIR, V10, P322, DOI 10.1016/j.dnarep.2010.12.003; Sabin Rebecca J, 2011, Genome Integr, V2, P7, DOI 10.1186/2041-9414-2-7; Schell H, 2008, J BIOMECH, V41, P3066, DOI 10.1016/j.jbiomech.2008.06.038; Schliep A, 2004, BIOINFORMATICS, V20, P283, DOI 10.1093/bioinformatics/bth937; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Sinha A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-13; Sivriver J, 2011, BIOINFORMATICS, V27, pI392, DOI 10.1093/bioinformatics/btr250; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderlund K, 2007, INT J RADIAT ONCOL, V68, P50, DOI 10.1016/j.ijrobp.2006.12.005; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Tsai KKC, 2009, RADIAT RES, V172, P306, DOI 10.1667/RR1764.1; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wu P. C., 2012, Experimental Oncology, V34, P298; Xu M, 2004, INT J HYPERTHERMIA, V20; Xu M, 2003, INT J RADIAT ONCOL, V57, P144; Yuan M, 2006, J AM STAT ASSOC, V101, P1323, DOI 10.1198/016214505000000394	56	21	21	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160791	10.1371/journal.pone.0160791	http://dx.doi.org/10.1371/journal.pone.0160791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505168	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200065
J	Tsai, MH; Lee, IT; Chu, SM; Lien, R; Huang, HR; Chiang, MC; Fu, RH; Hsu, JF; Huang, YC				Tsai, Ming-Horng; Lee, I-Ta; Chu, Shih-Ming; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Hsu, Jen-Fu; Huang, Yhu-Chering			Clinical and Molecular Characteristics of Neonatal Extended-Spectrum beta-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC USE; INFECTIONS; ENTEROBACTERIACEAE; OUTBREAK; EPIDEMIOLOGY	Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteremia (GNB) in the neonatal intensive care unit was characterized by comparison with two control groups: a susceptible control group and a general base population group over 2001 to 2012. The influence of ESBL production on mortality was studied in all study subjects and ESBL-GNB isolates were microbiologically characterized. We identified 77 episodes of ESBL-GNB (14.2% of all neonatal late-onset GNB), which were caused by Klebsiella spp. (62.3%), E. coli (20.8%) and Enterobacter spp. (16.9%). Most ESBL-GNB strains were genetically unrelated and the SHV-type ESBLs were the most prevalent (67% of isolates). Comparison with both control groups disclosed previous usage of 3rd generation cephalosporin (odds ratio [OR], 4.72; 95% confidence interval [CI], 2.03-10.97; P < 0.001), and underlying renal disease (OR, 4.07; 95% CI, 1.10-15.08; P = 0.035) as independent risk factors for ESBL-GNB. Inadequate empiric antibiotics, a higher illness severity, higher rates of infectious complications and sepsis-attributable mortality were more frequently seen in neonates with ESBL-GNB than those with non-ESBL GNB (20.8% and 15.6% vs. 9.2% and 7.9%, respectively; P = 0.008 and 0.049, respectively). Neonates with underlying secondary hypertension (OR, 7.22; 95% CI, 2.17-24.06) and infectious complications after bacteremia (OR, 6.66; 95% CI, 1.81-19.31) were identified as independent risk factor for in-hospital mortality. ESBL-GNB accounted for one-seventh of all neonatal gram-negative bacteremia, especially in neonates exposed to broad-spectrum cephalosporins. Neonates with ESBL-GNB bacteremia more frequently received inadequate empirical antibiotic therapy, which were associated with a higher rate of infectious complications and an adverse outcome.	[Tsai, Ming-Horng] Chang Gung Mem Hosp, Linkou, Yunlin, Taiwan; [Tsai, Ming-Horng; Chu, Shih-Ming; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Hsu, Jen-Fu] Chang Gung Mem Hosp, Div Pediat Neonatol, Taoyuan, Taiwan; [Tsai, Ming-Horng] Chang Gung Univ Sci & Technol, Chiayi, Taiwan; [Lee, I-Ta] China Med Univ, Dept Anat, Coll Med, Taichung, Taiwan; [Chu, Shih-Ming; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Hsu, Jen-Fu; Huang, Yhu-Chering] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan; [Chu, Shih-Ming; Lien, Reyin; Huang, Hsuan-Rong; Chiang, Ming-Chou; Fu, Ren-Huei; Hsu, Jen-Fu; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp, Div Pediat Infect Dis, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Hsu, JF; Huang, YC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.; Hsu, JF; Huang, YC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Huang, YC (corresponding author), Chang Gung Mem Hosp, Div Pediat Infect Dis, Taoyuan, Taiwan.	jeff0724@gmail.com; ychuang@adm.cgmh.org.tw						Badal RE, 2013, PEDIATR INFECT DIS J, V32, P636, DOI 10.1097/INF.0b013e3182886377; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Cantey JB, 2013, J PEDIATR-US, V163, P672, DOI 10.1016/j.jpeds.2013.03.001; Chia JH, 2005, J CLIN MICROBIOL, V43, P4486, DOI 10.1128/JCM.43.9.4486-4491.2005; Clark RH, 2006, PEDIATRICS, V117, P67, DOI 10.1542/peds.2005-0179; Clinical and Laboratory Standards Institute, 2009, M02A10 CLSI; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Crivaro V, 2007, J HOSP INFECT, V67, P135, DOI 10.1016/j.jhin.2007.07.026; D'Agata EMC, 2005, INFECT CONT HOSP EP, V26, P338, DOI 10.1086/502548; Gibold L, 2014, CLIN MICROBIOL INFEC, V20, pO20, DOI 10.1111/1469-0691.12321; Giuffre M, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-8; Gleason CA, 2011, AVERYS DIS NEWBORN; GRAY JE, 1992, PEDIATRICS, V90, P561; Harris AD, 2001, CLIN INFECT DIS, V32, P1055, DOI 10.1086/319600; Helldal L, 2013, CLIN MICROBIOL INFEC, V19, pE87, DOI 10.1111/1469-0691.12086; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang Y, 2007, INFECTION, V35, P339, DOI 10.1007/s15010-007-6356-9; Huang YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023001; Kaier K, 2009, J ANTIMICROB CHEMOTH, V63, P609, DOI 10.1093/jac/dkn534; Katsuta T, 2013, PEDIATR INFECT DIS J, V32, P417, DOI 10.1097/INF.0b013e318284b1e8; Kaye KS, 2005, INFECT CONT HOSP EP, V26, P346, DOI 10.1086/502550; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; Khanna N, 2012, J ANTIMICROB CHEMOTH, V67, P573, DOI 10.1093/jac/dkr523; Kritsotakis EI, 2011, J ANTIMICROB CHEMOTH, V66, P1383, DOI 10.1093/jac/dkr116; Le J, 2008, PEDIATR INFECT DIS J, V27, P314, DOI 10.1097/INF.0b013e3181606850; Linkin DR, 2004, INFECT CONT HOSP EP, V25, P781, DOI 10.1086/502477; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Oteo J, 2012, ANTIMICROB AGENTS CH, V56, P54, DOI 10.1128/AAC.05103-11; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Qureshi ZA, 2012, CLIN MICROBIOL INFEC, V18, P887, DOI 10.1111/j.1469-0691.2011.03658.x; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P180, DOI 10.1111/j.1469-0691.2007.01884.x; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Shakil S, 2010, J MED MICROBIOL, V59, P948, DOI 10.1099/jmm.0.020214-0; Shorr AF, 2009, CRIT CARE MED, V37, P1463, DOI 10.1097/CCM.0b013e31819ced02; Shu JC, 2010, EPIDEMIOL INFECT, V138, P253, DOI 10.1017/S0950268809990409; Singh N, 2002, PEDIATR INFECT DIS J, V21, P1029, DOI 10.1097/00006454-200211000-00010; Somily AM, 2014, AM J INFECT CONTROL, V42, P277, DOI 10.1016/j.ajic.2013.09.028; Thatrimontrichai A, 2013, PEDIATR INFECT DIS J, V32, P140, DOI 10.1097/INF.0b013e318270b108; Tsai MH, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.06.024; Tsai MH, 2014, CLIN MICROBIOL INFEC, V20, pO928, DOI 10.1111/1469-0691.12661; Tsai MH, 2014, PEDIATRICS, V133, pE322, DOI 10.1542/peds.2013-1248; Tsai MH, 2014, PEDIATR INFECT DIS J, V33, pE7, DOI 10.1097/INF.0b013e3182a72ee0; Wojkowska-Mach J, 2013, PEDIATR INFECT DIS J, V32, P594, DOI 10.1097/INF.0b013e318287fe2a	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159744	10.1371/journal.pone.0159744	http://dx.doi.org/10.1371/journal.pone.0159744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505270	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200012
J	Zhang, S; Chen, WL; Tang, H; Han, Q; Yan, SQ; Zhang, XC; Chen, QM; Parsons, M; Wang, SS; Lou, M				Zhang, Sheng; Chen, Weili; Tang, Huan; Han, Quan; Yan, Shenqiang; Zhang, Xiaocheng; Chen, Qingmeng; Parsons, Mark; Wang, Shaoshi; Lou, Min			The Prognostic Value of a Four-Dimensional CT Angiography-Based Collateral Grading Scale for Reperfusion Therapy in Acute Ischemic Stroke Patients	PLOS ONE			English	Article							LARGE-VESSEL OCCLUSION; ENDOVASCULAR TREATMENT; FLOW; THROMBOLYSIS; ALTEPLASE; TRIAL; TIME	Objective Leptomeningeal collaterals, which affects tissue fate, are still challenging to assess. Four-dimensional CT angiography (4D CTA) originated from CT perfusion (CTP) provides the possibility of non-invasive and time-resolved assessment of leptomeningeal collateral flow. We sought to develop a comprehensive rating system to integrate the speed and extent of collateral flow on 4D CTA, and investigate its prognostic value for reperfusion therapy in acute ischemic stroke (AIS) patients. Methods We retrospectively studied 80 patients with M1 +/- internal carotid artery (ICA) occlusion who had baseline CTP before intravenous thrombolysis. The velocity and extent of collaterals were evaluated by regional leptomeningeal collateral score on peak phase (rLMC-P) and temporally fused intensity projections (tMIP) (rLMC-M) on 4D CTA, respectively. The cutoffs of rLMC-P and rLMC-M score for predicting good outcome (mRS score <= 2) were integrated to develop the collateral grading scale (CGS) (rating from 0-2). Results The CGS score was correlated with 3-months mRS score (non-recanalizers: rho = -0.495, p = 0.01; recanalizers: rho = -0.671, p < 0.001). Patients with intermediate or good collaterals (CGS score of 1 and 2) who recanalized were more likely to have good outcome than those without recanalization (p = 0.038, p = 0.018), while there was no significant difference in outcome in patients with poor collaterals (CGS score of 0) stratified by recanalization (p = 0.227). Conclusions Identification of collaterals based on CGS may help to select good responders to reperfusion therapy in patients with large artery occlusion.	[Zhang, Sheng; Chen, Weili; Tang, Huan; Han, Quan; Yan, Shenqiang; Zhang, Xiaocheng; Chen, Qingmeng; Parsons, Mark; Wang, Shaoshi; Lou, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Lou, M (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.	loumingxc@vip.sina.com		Wang, Shaoshi/0000-0003-2547-0247; Yan, Shenqiang/0000-0001-6425-0672	Science Technology Department of Zhejiang Province [2013C13G2010032]; National Natural Science Foundation of China [81171095, 81471170]; 2nd affiliated hospital of Zhejiang University, School of Medicine	Science Technology Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2nd affiliated hospital of Zhejiang University, School of Medicine	Support was provided by the Science Technology Department of Zhejiang Province (2013C13G2010032), the 2nd affiliated hospital of Zhejiang University, School of Medicine, to ML and the National Natural Science Foundation of China (81171095, 81471170), the 2nd affiliated hospital of Zhejiang University, School of Medicine to ML.	Bai J, 2015, INT J STROKE, V10, P143, DOI 10.1111/ijs.12434; Bang OY, 2011, STROKE, V42, P2235, DOI 10.1161/STROKEAHA.110.604603; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Berkhemer OA, 2016, STROKE, V47, P768, DOI 10.1161/STROKEAHA.115.011788; Campbell BCV, 2014, INT J STROKE, V9, P126, DOI 10.1111/ijs.12206; Campbell BCV, 2011, STROKE, V42, P3435, DOI 10.1161/STROKEAHA.111.618355; Frolich AMJ, 2014, EUR RADIOL, V24, P390, DOI 10.1007/s00330-013-3024-6; Frolich AMJ, 2012, STROKE, V43, P97, DOI 10.1161/STROKEAHA.111.630954; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Khatri P, 2005, STROKE, V36, P2400, DOI 10.1161/01.STR.0000185698.45720.58; Kidwell CS, 2013, NEW ENGL J MED, V368, P914, DOI 10.1056/NEJMoa1212793; Lin LT, 2014, STROKE, V45, P1727, DOI 10.1161/STROKEAHA.114.005419; Maas MB, 2009, STROKE, V40, P3001, DOI 10.1161/STROKEAHA.109.552513; Menon BK, 2011, AM J NEURORADIOL, V32, P1640, DOI 10.3174/ajnr.A2564; Miteff F, 2009, BRAIN, V132, P2231, DOI 10.1093/brain/awp155; Parsons M, 2012, NEW ENGL J MED, V366, P1099, DOI 10.1056/NEJMoa1109842; Pranevicius O, 2012, STROKE, V43, P575, DOI 10.1161/STROKEAHA.111.635037; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8	19	23	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160502	10.1371/journal.pone.0160502	http://dx.doi.org/10.1371/journal.pone.0160502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505435	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200039
J	Dakal, TC; Giudici, P; Solieri, L				Dakal, Tikam Chand; Giudici, Paolo; Solieri, Lisa			Contrasting Patterns of rDNA Homogenization within the Zygosaccharomyces rouxii Species Complex	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL DNA REPEATS; LARGE-SUBUNIT RDNA; SACCHAROMYCES-CEREVISIAE; NATURAL HYBRIDS; INTRAGENOMIC VARIATION; CONCERTED EVOLUTION; SEQUENCE VARIATION; MOLECULAR DRIVE; D1/D2 DOMAIN	Arrays of repetitive ribosomal DNA (rDNA) sequences are generally expected to evolve as a coherent family, where repeats within such a family are more similar to each other than to orthologs in related species. The continuous homogenization of repeats within individual genomes is a recombination process termed concerted evolution. Here, we investigated the extent and the direction of concerted evolution in 43 yeast strains of the Zygosaccharomyces rouxii species complex (Z. rouxii, Z. sapae, Z. mellis), by analyzing two portions of the 35S rDNA cistron, namely the D1/D2 domains at the 5' end of the 26S rRNA gene and the segment including the internal transcribed spacers (ITS) 1 and 2 (ITS regions). We demonstrate that intra-genomic rDNA sequence variation is unusually frequent in this clade and that rDNA arrays in single genomes consist of an intermixing of Z. rouxii, Z. sapae and Z. mellis-like sequences, putatively evolved by reticulate evolutionary events that involved repeated hybridization between lineages. The levels and distribution of sequence polymorphisms vary across rDNA repeats in different individuals, reflecting four patterns of rDNA evolution: I) rDNA repeats that are homogeneous within a genome but are chimeras derived from two parental lineages via recombination: Z. rouxii in the ITS region and Z. sapae in the D1/D2 region; II) intra-genomic rDNA repeats that retain polymorphisms only in ITS regions; III) rDNA repeats that vary only in their D1/D2 domains; IV) heterogeneous rDNA arrays that have both polymorphic ITS and D1/D2 regions. We argue that an ongoing process of homogenization following allodiplodization or incomplete lineage sorting gave rise to divergent evolutionary trajectories in different strains, depending upon temporal, structural and functional constraints. We discuss the consequences of these findings for Zygosaccharomyces species delineation and, more in general, for yeast barcoding.	[Dakal, Tikam Chand; Giudici, Paolo; Solieri, Lisa] Univ Modena & Reggio Emilia, Dept Life Sci, Via Amendola 2, I-42122 Reggio Emilia, Italy	Universita di Modena e Reggio Emilia	Solieri, L (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via Amendola 2, I-42122 Reggio Emilia, Italy.	lisa.solieri@unimore.it	Solieri, Lisa/I-4352-2012	Solieri, Lisa/0000-0003-3546-6903	AEB spa (Brescia Italy)	AEB spa (Brescia Italy)	The present work has been partially supported with a grant funded by AEB spa (Brescia Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present work has been partially supported with a grant funded by AEB spa (Brescia Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Luciana De Vero PhD, for maintenance of yeast strains in the Unimore Microbial Culture Collection (UMCC; www.umcc.unimore.it).	Alper I, 2011, FUNGAL BIOL-UK, V115, P1259, DOI 10.1016/j.funbio.2011.09.002; Antunovics Z, 2005, FEMS YEAST RES, V5, P1141, DOI 10.1016/j.femsyr.2005.04.008; Bik HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078230; Bizzarri M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152558; BROWN DD, 1972, J MOL BIOL, V63, P57, DOI 10.1016/0022-2836(72)90521-9; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Fell JW, 2000, INT J SYST EVOL MICR, V50, P1351, DOI 10.1099/00207713-50-3-1351; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Gordon JL, 2008, YEAST, V25, P449, DOI 10.1002/yea.1598; Gribble KE, 2007, PHYCOLOGIA, V46, P315, DOI 10.2216/06-68.1; Harris DJ, 2000, MOL BIOL EVOL, V17, P284, DOI 10.1093/oxfordjournals.molbev.a026308; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; James SA, 1996, INT J SYST BACTERIOL, V46, P189, DOI 10.1099/00207713-46-1-189; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Keller I, 2006, GENETICS, V174, P863, DOI 10.1534/genetics.106.061341; Kobayashi T, 1998, GENE DEV, V12, P3821, DOI 10.1101/gad.12.24.3821; Kobayashi T, 2011, CELL MOL LIFE SCI, V68, P1395, DOI 10.1007/s00018-010-0613-2; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lachance MA, 2003, FEMS YEAST RES, V4, P253, DOI 10.1016/S1567-1356(03)00113-2; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Jeune C, 2007, FEMS YEAST RES, V7, P540, DOI 10.1111/j.1567-1364.2007.00207.x; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Louis VL, 2012, G3-GENES GENOM GENET, V2, P299, DOI 10.1534/g3.111.000745; Mallet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035842; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Morales L, 2012, MICROBIOL MOL BIOL R, V76, P721, DOI 10.1128/MMBR.00022-12; Naidoo K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059355; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Norskov-Lauritsen N, 2011, MICROBIOL-SGM, V157, P1050, DOI 10.1099/mic.0.047233-0; ODONNELL K, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P225; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Pawlowska TE, 2004, NATURE, V427, P733, DOI 10.1038/nature02290; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Prista C, 2005, FEMS YEAST RES, V5, P693, DOI 10.1016/j.femsyr.2004.12.009; Proux-Wera E, 2013, GENOME BIOL EVOL, V5, P525, DOI 10.1093/gbe/evt022; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saksinchai S, 2012, FUNGAL DIVERS, V52, P123, DOI 10.1007/s13225-011-0115-z; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Sipiczki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067384; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; Solieri L, 2015, J APPL MICROBIOL, V119, P149, DOI 10.1111/jam.12827; Solieri L, 2007, YEAST, V24, P403, DOI 10.1002/yea.1471; Solieri L, 2014, FEMS YEAST RES, V14, P586, DOI 10.1111/1567-1364.12146; Solieri L, 2013, FEMS YEAST RES, V13, P245, DOI 10.1111/1567-1364.12027; Solieri L, 2013, INT J SYST EVOL MICR, V63, P364, DOI 10.1099/ijs.0.043323-0; Solieri L, 2008, FUNGAL GENET BIOL, V45, P1582, DOI 10.1016/j.fgb.2008.10.001; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; STRACHAN T, 1985, EMBO J, V4, P1701, DOI 10.1002/j.1460-2075.1985.tb03839.x; Suezawa Y, 2008, BIOSCI BIOTECH BIOCH, V72, P2452, DOI 10.1271/bbb.80211; SZOSTAK JW, 1980, NATURE, V284, P426, DOI 10.1038/284426a0; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; VELDMAN GM, 1981, NUCLEIC ACIDS RES, V9, P6935, DOI 10.1093/nar/9.24.6935; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weiss S, 2013, FEMS YEAST RES, V13, P117, DOI 10.1111/1567-1364.12017; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158	83	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160744	10.1371/journal.pone.0160744	http://dx.doi.org/10.1371/journal.pone.0160744			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501051	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500051
J	Yeatman, GJ; Wayne, AF; Mills, HR; Prince, J				Yeatman, Georgina J.; Wayne, Adrian F.; Mills, Harriet R.; Prince, Jane			Temporal Patterns in the Abundance of a Critically Endangered Marsupial Relates to Disturbance by Roads and Agriculture	PLOS ONE			English	Article							BRUSH-TAILED BETTONG; EUCALYPTUS-MARGINATA FOREST; SOUTH-EASTERN AUSTRALIA; HABITAT FRAGMENTATION; ARBOREAL MARSUPIALS; PENICILLATA-OGILBYI; POPULATION DECLINE; SMALL MAMMALS; WILDLIFE; WOYLIE	The aim of this study was to investigate how landscape disturbance associated with roads, agriculture and forestry influenced temporal patterns in woylie (Bettongia penicillata) abundance before, during and after periods of rapid population change. Data were collected from an area of approximately 140,000 ha of forest within the Upper Warren region in south-western Australia. Woylie abundance was measured using cage trapping at 22 grid and five transect locations with varying degrees of landscape disturbance between 1994 and 2012. We found evidence that the distribution and abundance of woylies over time appears to be related to the degree of fragmentation by roads and proximity to agriculture. Sites furthest from agriculture supported a greater abundance of woylies and had slower rates of population decline. Sites with fewer roads had a greater abundance of woylies generally and a greater rate of increase in abundance after the implementation of invasive predator control. The results of this study suggest that landscape disturbance is less important at peak population densities, but during times of environmental and population change, sites less dissected by roads and agriculture better support woylie populations. This may be due to the role these factors play in increasing the vulnerability of woylies to introduced predators, population fragmentation, weed species invasion, mortality from road collisions or a reduction in available habitat. Strategies that reduce the impact of disturbance on woylie populations could include the rationalisation of forest tracks and consolidation of contiguous habitat through the acquisition of private property. Reducing the impact of disturbance in the Upper Warren region could improve the resilience of this critically important woylie population during future environmental change.	[Yeatman, Georgina J.; Mills, Harriet R.; Prince, Jane] Univ Western Australia, Fac Sci, Sch Anim Biol, Crawley, WA, Australia; [Wayne, Adrian F.] Dept Pk & Wildlife, Manjimup, WA, Australia	University of Western Australia	Yeatman, GJ (corresponding author), Univ Western Australia, Fac Sci, Sch Anim Biol, Crawley, WA, Australia.	georgina.yeatman@graduate.uwa.edu.au		Mills, Harriet/0000-0003-4590-3097	University of Western Australia; Western Australian Department of Parks and Wildlife	University of Western Australia; Western Australian Department of Parks and Wildlife	The authors received no specific funding for this work but the research was conducted as part of a PhD project supported by the University of Western Australia and the Western Australian Department of Parks and Wildlife.	AbenspergTraun M, 1996, J APPL ECOL, V33, P1281, DOI 10.2307/2404770; Alexander J.S.A., 2002, Australian Forestry, V65, P182; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arneberg P, 1998, P ROY SOC B-BIOL SCI, V265, P1283, DOI 10.1098/rspb.1998.0431; Bayne EM, 1998, CAN J ZOOL, V76, P62, DOI 10.1139/cjz-76-1-62; BENNETT AF, 1991, NAT CONSERV SER, P99; Bennett MD, 2010, J VIROL, V84, P5448, DOI 10.1128/JVI.02635-09; BESCHTA RL, 1978, WATER RESOUR RES, V14, P1011, DOI 10.1029/WR014i006p01011; Botero Adriana, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P77, DOI 10.1016/j.ijppaw.2013.03.001; BURNS JW, 1972, T AM FISH SOC, V101, P1, DOI 10.1577/1548-8659(1972)101<1:SEOLAA>2.0.CO;2; Caley P, 2001, J APPL ECOL, V38, P1362, DOI 10.1046/j.0021-8901.2001.00676.x; CATLING PC, 1995, WILDLIFE RES, V22, P535, DOI 10.1071/WR9950535; Christensen PE, 1977, THESIS; Corbacho C, 2003, AGR ECOSYST ENVIRON, V95, P495, DOI 10.1016/S0167-8809(02)00218-9; Czech B, 2000, BIOSCIENCE, V50, P593, DOI 10.1641/0006-3568(2000)050[0593:EAACOS]2.0.CO;2; Death RG, 1996, OECOLOGIA, V108, P567, DOI 10.1007/BF00333735; Department of Environment and Conservation, 2012, PER MAN PLAN; Department of Environment and Conservation, 2008, DIAGN REC WOYL BETT; Dickman CR, 2008, ANIM CONSERV, V11, P11, DOI 10.1111/j.1469-1795.2008.00159.x; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; ESRI, 2013, ARCGIS DESKT REL 10; FREEMARK K, 1995, AGR ECOSYST ENVIRON, V52, P67, DOI 10.1016/0167-8809(94)00534-L; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Graham CA, 2012, WILDLIFE RES, V39, P661, DOI 10.1071/WR12008; Groom C, 2010, WILDLIFE RES, V37, P183, DOI 10.1071/WR09129; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Jones JA, 2000, CONSERV BIOL, V14, P76, DOI 10.1046/j.1523-1739.2000.99083.x; Kallimanis AS, 2005, CONSERV BIOL, V19, P534, DOI 10.1111/j.1523-1739.2005.00418.x; Kinnear JE, 2002, BIOL CONSERV, V108, P335, DOI 10.1016/S0006-3207(02)00116-7; Lada H, 2008, J APPL ECOL, V45, P1732, DOI 10.1111/j.1365-2664.2008.01563.x; Lancaster ML, 2011, MOL ECOL, V20, P2258, DOI 10.1111/j.1365-294X.2011.05072.x; Laurance WF, 1996, BIOTROPICA, V28, P310, DOI 10.2307/2389195; Li Y, 2015, CONSERV GENET, V16, P331, DOI 10.1007/s10592-014-0661-5; Lindenmayer D. B., 2002, Pacific Conservation Biology, V8, P121; LINDENMAYER DB, 1995, BIOL CONSERV, V73, P239, DOI 10.1016/0006-3207(94)00121-6; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; Marlow NJ, 2015, AUST J ZOOL, V63, P18, DOI 10.1071/ZO14024; May SA, 1996, WILDLIFE RES, V23, P387, DOI 10.1071/WR9960387; Mccaw WL, 2011, AUST FORESTRY, V74, P240, DOI 10.1080/00049158.2011.10676369; Meek PD, 2000, WILDLIFE RES, V27, P663, DOI 10.1071/WR98030; Pacioni C, 2011, J ZOOL, V283, P98, DOI 10.1111/j.1469-7998.2010.00750.x; Pacioni C, 2015, ECOL MANAG RESTOR, V16, P142, DOI 10.1111/emr.12155; Paparini A, 2012, EXP PARASITOL, V131, P25, DOI 10.1016/j.exppara.2012.02.021; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Rogers P., 1996, DISTURBANCE ECOLOGY; Smith A, 2008, PARASITOLOGY, V135, P1329, DOI 10.1017/S0031182008004824; Sullivan TP, 2001, J APPL ECOL, V38, P1234, DOI 10.1046/j.0021-8901.2001.00674.x; Thompson CK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-169; Thompson CK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-121; Vos CC, 1998, J APPL ECOL, V35, P44, DOI 10.1046/j.1365-2664.1998.00284.x; Wayne AF, 2013, WILDLIFE RES, V40, P169, DOI 10.1071/WR12115; Wayne AF, 2016, FOREST ECOL MANAG, V363, P190, DOI 10.1016/j.foreco.2015.12.019; Wayne AF, 2011, AUST FORESTRY, V74, P336, DOI 10.1080/00049158.2011.10676377; Wayne AF, 2013, WOYLIE CONSERVATION; Wayne AF, 2015, ORYX, P1; Yeatman G. J., 2012, 51 DEP ENV CONS; Zosky K., 2011, THESIS	57	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160790	10.1371/journal.pone.0160790	http://dx.doi.org/10.1371/journal.pone.0160790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501320	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500054
J	van Galen, LS; Dijkstra, CC; Ludikhuize, J; Kramer, MHH; Nanayakkara, PWB				van Galen, Louise S.; Dijkstra, Casper C.; Ludikhuize, Jeroen; Kramer, Mark H. H.; Nanayakkara, Prabath W. B.			A Protocolised Once a Day Modified Early Warning Score (MEWS) Measurement Is an Appropriate Screening Tool for Major Adverse Events in a General Hospital Population	PLOS ONE			English	Article							RAPID RESPONSE SYSTEM; PHYSIOLOGICAL TRACK; RISK PATIENTS; WARD; OUTCOMES	Background The Modified Early Warning Score (MEWS) was developed to timely recognise clinically deteriorating hospitalised patients. However, the ability of the MEWS in predicting serious adverse events (SAEs) in a general hospital population has not been examined prospectively. The aims were to (1) analyse protocol adherence to a MEWS protocol in a real-life setting and (2) to determine the predictive value of protocolised daily MEWS measurement on SAEs: death, cardiac arrests, ICU-admissions and readmissions. Methods All adult patients admitted to 6 hospital wards in October and November 2015 were included. MEWS were checked each morning by the research team. For each critical score (MEWS >= 3), the clinical staff was inquired about the actions performed. 30-day follow-up for SAEs was performed to compare between patients with and without a critical score. Results 1053 patients with 3673 vital parameter measurements were included, 200 (19.0%) had a critical score. The protocol adherence was 89.0%. 18.2% of MEWS were calculated wrongly. Patients with critical scores had significant higher rates of unplanned ICU admissions [7.0% vs 1.3%, p < 0.001], in-hospital mortality [6.0% vs 0.8%, p < 0.001], 30-day readmission rates [18.6% vs 10.8%, p < 0.05], and a longer length of stay [15.65 (SD: 15.7 days) vs 6.09 (SD: 6.9), p < 0.001]. Specificity of MEWS related to composite adverse events was 83% with a negative predicting value of 98.1%. Conclusions Protocol adherence was high, even though one-third of the critical scores were calculated wrongly. Patients with a MEWS >= 3 experienced significantly more adverse events. The negative predictive value of early morning MEWS < 3 was 98.1%, indicating the reliability of this score as a screening tool.	[van Galen, Louise S.; Dijkstra, Casper C.; Kramer, Mark H. H.; Nanayakkara, Prabath W. B.] Vrije Univ Amsterdam Med Ctr, Sect Acute Med, Dept Internal Med, Amsterdam, Netherlands; [Ludikhuize, Jeroen] Acad Med Ctr, Dept Anaesthesiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Nanayakkara, PWB (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Acute Med, Dept Internal Med, Amsterdam, Netherlands.	p.nanayakkara@vumc.nl	Kramer, Mark/GWQ-3502-2022	Nanayakkara, Prabath WB/0000-0002-1555-3682				Alam N, 2014, RESUSCITATION, V85, P587, DOI 10.1016/j.resuscitation.2014.01.013; Armagan E, 2008, EUR J EMERG MED, V15, P338, DOI 10.1097/MEJ.0b013e3283034222; Balla U, 2008, MEDICINE, V87, P294, DOI 10.1097/MD.0b013e3181886f93; Davies O, 2014, RESUSCITATION, V85, P1557, DOI 10.1016/j.resuscitation.2014.07.013; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Gao HY, 2007, INTENS CARE MED, V33, P667, DOI 10.1007/s00134-007-0532-3; Greysen SR, 2015, JAMA INTERN MED, V175, P559, DOI 10.1001/jamainternmed.2014.7756; Hillman K, 2001, RESUSCITATION, V48, P105, DOI 10.1016/S0300-9572(00)00334-8; Ho LO, 2013, WORLD J EMERG MED, V4, P273, DOI [10.5847/wjem.j.issn.1920-8642.2013.04.005, 10.5847/wjem.j.1920-8642.2013.04.005]; Jones S, 2011, CRIT CARE RESUSC, V13, P83; Kim WY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130523; Kolic I, 2015, RESUSCITATION, V90, P85, DOI 10.1016/j.resuscitation.2015.02.009; Kruisselbrink R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151408; Kyriacos U, 2011, J NURS MANAGE, V19, P311, DOI 10.1111/j.1365-2834.2011.01246.x; Ludikhuize J, 2014, RESUSCITATION, V85, P676, DOI 10.1016/j.resuscitation.2014.02.009; Ludikhuize J, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.003; Ludikhuize J, 2011, JT COMM J QUAL PATIE, V37, P138, DOI 10.1016/S1553-7250(11)37017-1; Mathukia C, 2015, J COMMUNITY HOSP INT, V5, DOI 10.3402/jchimp.v5.26716; Moon A, 2011, RESUSCITATION, V82, P150, DOI 10.1016/j.resuscitation.2010.09.480; Morgan R., 1997, CLIN INTENSIVE CARE, V8, P100, DOI DOI 10.3109/TCIC.8.2.93.110; Shearer B, 2012, BMJ QUAL SAF, V21, P569, DOI 10.1136/bmjqs-2011-000692; Smith GB, 2008, RESUSCITATION, V77, P170, DOI 10.1016/j.resuscitation.2007.12.004; Smith T, 2012, BRIT J SURG, V99, P192, DOI 10.1002/bjs.7777; Subbe CP, 2007, INTENS CARE MED, V33, P619, DOI 10.1007/s00134-006-0516-8; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; van Rooijen CR, 2013, NETH J MED, V71, P38; Zanocchi M, 2006, AGING CLIN EXP RES, V18, P63	27	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160811	10.1371/journal.pone.0160811	http://dx.doi.org/10.1371/journal.pone.0160811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494719	gold, Green Published, Green Submitted			2022-12-26	WOS:000381369500084
J	Hwang, MH; Cho, KH; Jeong, KJ; Park, YY; Kim, JM; Yu, SL; Park, CG; Mills, GB; Lee, HY				Hwang, M. H.; Cho, K. H.; Jeong, K. J.; Park, Y-Y; Kim, J. M.; Yu, S-L; Park, C. G.; Mills, G. B.; Lee, H. Y.			RCP induces Slug expression and cancer cell invasion by stabilizing beta 1 integrin	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTEGRIN BETA-1; HUMAN BREAST; OVARIAN; SNAIL; OVEREXPRESSION; METASTASIS; MIGRATION; ADHESION; LEADS	Rab coupling protein (RCP)-induced tumor cell migration has been implicated in tumor pathophysiology and patient outcomes. In the present study, we demonstrate that RCP stabilizes beta 1 integrin leading to increased beta 1 integrin levels and activation of a signaling cascade culminating in Slug induction, epithelial-to-mesenchymal transition and increased invasion. Ectopic expression of RCP induced Slug expression. Silencing beta 1 integrin efficiently inhibited RCP-induced Slug expression and subsequent cancer cell invasion. Conversely, ectopic expression of beta 1 integrin was sufficient to induce Slug expression. Pharmacological inhibition of integrin linked kinase ( ILK), EGFR and NF-kappa B, as well as transfection of a dominant-negative mutant of Ras (RasN17), significantly inhibited RCP-induced Slug expression and cancer cell invasion. Strikingly, ectopic expression of RCP was sufficient to enhance metastasis of ovarian cancer cells to the lung. Collectively, we demonstrate a mechanism by which RCP promotes cancer cell aggressiveness through sequential beta 1 integrin stabilization, activation of an ILK/EGFR/Ras/NF-kappa B signaling cascade and subsequent Slug expression.	[Hwang, M. H.; Cho, K. H.; Yu, S-L; Park, C. G.; Lee, H. Y.] Konyang Univ, Coll Med, Dept Pharmacol, 821 Myunggok Med Bldg,158 Gwanjeodong Ro, Daejeon 35365, South Korea; [Hwang, M. H.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX USA; [Jeong, K. J.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX USA; [Park, Y-Y] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci,Dept Convergence Med, Seoul, South Korea; [Kim, J. M.] Chungnam Natl Univ, Reg Canc Ctr, Canc Res Inst, Sch Med, Daejeon, South Korea; [Kim, J. M.] Chungnam Natl Univ, Infect Signaling Network Res Ctr, Sch Med, Daejeon, South Korea	Konyang University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Ulsan; Asan Medical Center; Chungnam National University; Chungnam National University	Lee, HY (corresponding author), Konyang Univ, Coll Med, Dept Pharmacol, 821 Myunggok Med Bldg,158 Gwanjeodong Ro, Daejeon 35365, South Korea.	hoi@konyang.ac.kr	Jeong, Kangjin/HGT-9268-2022	Mills, Gordon/0000-0002-0144-9614; KIM, JIN MAN/0000-0003-0905-9730	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2014R1A2A1A11051091]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by a grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2014R1A2A1A11051091).	Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Arboleda MJ, 2003, CANCER RES, V63, P196; Azimifar SB, 2012, J CELL SCI, V125, P435, DOI 10.1242/jcs.091652; Braune S, 2015, CLIN HEMORHEOL MICRO, V61, P225, DOI 10.3233/CH-151995; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Choi MJ, 2015, ONCOGENE, V34, P3402, DOI 10.1038/onc.2014.270; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Jacquemet G, 2013, J CELL BIOL, V202, P917, DOI 10.1083/jcb.201302041; Jeong KJ, 2012, ONCOGENE, V31, P4279, DOI 10.1038/onc.2011.595; Ju LX, 2013, CANCER BIOMARK, V13, P329, DOI 10.3233/CBM-130362; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Krishnan M, 2013, MOL BIOL CELL, V24, P818, DOI 10.1091/mbc.E12-10-0745; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Lee M, 2010, INT J RADIAT ONCOL, V76, P1528, DOI 10.1016/j.ijrobp.2009.11.022; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mills GB, 2009, J CLIN INVEST, V119, P2123, DOI 10.1172/JCI40256; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Rhee CM, 2016, NEPHROL DIAL TRANSPL, V31, P992, DOI 10.1093/ndt/gfv341; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Toguri JT, 2015, CLIN HEMORHEOL MICRO, V61, P237, DOI 10.3233/CH-151996; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Zhang C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000106; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	34	32	32	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1102	1111		10.1038/onc.2016.277	http://dx.doi.org/10.1038/onc.2016.277			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27524413				2022-12-26	WOS:000395371500008
J	Kao, YC; Jheng, JR; Pan, HJ; Liao, WY; Lee, CH; Kuo, PL				Kao, Y-C; Jheng, J-R; Pan, H-J; Liao, W-Y; Lee, C-H; Kuo, P-L			Elevated hydrostatic pressure enhances the motility and enlarges the size of the lung cancer cells through aquaporin upregulation mediated by caveolin-1 and ERK1/2 signaling	ONCOGENE			English	Article							INTERSTITIAL FLUID PRESSURE; PROGNOSTIC-FACTORS; CERVIX CANCER; METASTASIS; TUMOR; MIGRATION; ACTIVATION; MELANOMA; INVASION; PATHWAYS	The mechanical characteristics presented in cancer microenvironment are known to have pivotal roles in cancer metastasis, which accounts for the leading cause of death from malignant tumors. However, while a uniformly distributed high interstitial fluid pressure (IFP) is a common feature in solid tumors, the effects of high IFP on the motility and invasiveness of cancer cells remain obscure. Using cell-culture devices that simulated increased IFP conditions by applying hydrostatic pressure (HP) ranging from 0 to 20 mm Hg to the cells, we found that the elevated HPs increased the migration speeds, invasiveness, cell volume, filopodial number and aquaporin-1 (AQP1), Snail and vinculin expression levels, as well as phosphorylation of caveolin-1 and extracellular signalregulated kinase1/2 (ERK1/2), in the lung cancer cells CL1-5 and A549. The increases of migration speed and cell volume correlated temporally with the increase of AQP1 expression. The elevated HP-induced migration acceleration was hindered by AQP1 knockdown using small interfering RNA (siRNA) transfection. Inhibition of ERK1/2 phosphorylation using the mitogen-activated protein kinase kinase inhibitor PD98059 abrogated the elevated HP-induced AQP1 upregulation and migration acceleration in the cancer cells. Caveolin-1 knockdown by siRNA transfection attenuated the HP-induced, ERK1/2-depedent AQP1 upregulation and migration acceleration. Further biochemical studies revealed that the caveolin-1 activation-driven ERK1/2 signaling is mediated by Akt1/2 phosphorylation. By contrast, the elevated HPs had negligible effects on the migration speed and volume of normal bronchial epithelial cells. These results disclose a novel mechanism relating high IFP to the invasiveness of cancer cells and highlight potential targets to impede cancer spreading.	[Kao, Y-C; Jheng, J-R; Kuo, P-L] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan; [Kao, Y-C; Pan, H-J; Lee, C-H] Acad Sinica, Res Ctr Appl Sci, 128,Sec 2,Acad Rd, Taipei 11529, Taiwan; [Liao, W-Y] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Liao, W-Y] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Lee, C-H] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Lee, C-H] Natl Taiwan Univ, Dept Phys, Taipei, Taiwan; [Kuo, P-L] Natl Taiwan Univ, Dept Elect Engn, Taipei, Taiwan; [Kuo, P-L] Natl Taiwan Univ Hosp, Dept Rehabil, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Kuo, PL (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.; Lee, CH (corresponding author), Acad Sinica, Res Ctr Appl Sci, 128,Sec 2,Acad Rd, Taipei 11529, Taiwan.	clee@gate.sinica.edu.tw; poling@ntu.edu.tw	Lee, Chau-Hwang/B-2204-2008; Liao, Wei-Yu/HGE-3881-2022	Lee, Chau-Hwang/0000-0001-5013-7062; LIAO, WEI-YU/0000-0001-6383-3470	Taiwan Ministry of Science of Technology [MOST 102-2221-E-002-066, 103-2320-B-002-004-MY3, 103-2112-M-001-019-MY3]	Taiwan Ministry of Science of Technology	This work was supported by the grants from the Taiwan Ministry of Science of Technology (Grant Nos. MOST 102-2221-E-002-066, 103-2320-B-002-004-MY3 and 103-2112-M-001-019-MY3).	Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Arciszewski MB, 2011, ANN ANAT, V193, P81, DOI 10.1016/j.aanat.2010.11.003; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bekaii-Saab T, 2011, J CLIN ONCOL, V29, P2357, DOI 10.1200/JCO.2010.33.9473; BOUCHER Y, 1990, CANCER RES, V50, P4478; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; CURTI BD, 1993, CANCER RES, V53, P2204; Deschenes-Simard X, 2014, CANCER RES, V74, P412, DOI 10.1158/0008-5472.CAN-13-2381; Dubroca C, 2007, CARDIOVASC RES, V73, P190, DOI 10.1016/j.cardiores.2006.10.020; Eikenes L, 2004, CANCER RES, V64, P4768, DOI 10.1158/0008-5472.CAN-03-1472; Fyles A, 2006, RADIOTHER ONCOL, V80, P132, DOI 10.1016/j.radonc.2006.07.014; Gomes LR, 2015, ONCOGENE, V34, P5329, DOI 10.1038/onc.2014.461; Gortazar AR, 2013, J BIOL CHEM, V288, P8168, DOI 10.1074/jbc.M112.437921; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; JAIN RK, 1994, SCI AM, V271, P58, DOI 10.1038/scientificamerican0794-58; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Liao WY, 2015, J PATHOL, V235, P50, DOI 10.1002/path.4421; Liou YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089767; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Luo DX, 2010, BIOCHEM BIOPH RES CO, V391, P1693, DOI 10.1016/j.bbrc.2009.12.132; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Merikallio H, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-104; Milosevic M, 2001, CANCER RES, V61, P6400; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nicchia GP, 2013, J MOL MED, V91, P613, DOI 10.1007/s00109-012-0977-x; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Ribatti D, 2014, BBA-GEN SUBJECTS, V1840, P1550, DOI 10.1016/j.bbagen.2013.09.025; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; Rofstad EK, 2002, CANCER RES, V62, P661; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Rubin K, 2000, INT J CANCER, V86, P636, DOI 10.1002/(SICI)1097-0215(20000601)86:5<636::AID-IJC6>3.0.CO;2-R; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wang CC, 2011, LAB CHIP, V11, P695, DOI 10.1039/c0lc00155d; Wang CC, 2009, OPT LETT, V34, P3538, DOI 10.1364/OL.34.003538; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	52	21	21	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					863	874		10.1038/onc.2016.255	http://dx.doi.org/10.1038/onc.2016.255			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27499095				2022-12-26	WOS:000394168200013
J	Sahu, U; Rangarajan, PN				Sahu, Umakant; Rangarajan, Pundi N.			Methanol Expression Regulator 1 (Mxr1p) Is Essential for the Utilization of Amino Acids as the Sole Source of Carbon by the Methylotrophic Yeast, Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; glutamate dehydrogenase; transcription factor; transcription regulation; yeast; methanol expression regulator 1; Pichia pastoris; amino acids; aspartate aminotransferase; malate dehydrogenase	SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; PHOSPHOENOLPYRUVATE CARBOXYKINASE; UTILIZATION PATHWAY; AOX1 PROMOTER; METABOLISM; PROTEIN; IDENTIFICATION; BINDING; SUPPLEMENTATION	Unlike Saccharomyces cerevisiae, the methylotrophic yeast Pichia pastoris can assimilate amino acids as the sole source of carbon and nitrogen. It can grow in media containing yeast extract and peptone (YP), yeast nitrogen base (YNB) + glutamate (YNB + Glu), or YNB + aspartate (YNB + Asp). Methanol expression regulator 1 (Mxr1p), a zinc finger transcription factor, is essential for growth in these media. Mxr1p regulates the expression of several genes involved in the utilization of amino acids as the sole source of carbon and nitrogen. These include the following: (i) GDH2 encoding NAD-dependent glutamate dehydrogenase; (ii) AAT1 and AAT2 encoding mitochondrial and cytosolic aspartate aminotransferases, respectively; (iii) MDH1 and MDH2 encoding mitochondrial and cytosolic malate dehydrogenases, respectively; and (iv) GLN1 encoding glutamine synthetase. Synthesis of all these enzymes is regulated by Mxr1p at the level of transcription except GDH2, whose synthesis is regulated at the level of translation. Mxr1p activates the transcription of AAT1, AAT2, and GLN1 in cells cultured in YP as well as in YNB + Glu media, whereas transcription of MDH1 and MDH2 is activated in cells cultured in YNB + Glu but not in YP. A truncated Mxr1p composed of 400 N-terminal amino acids activates transcription of target genes in cells cultured in YP but not in YNB + Glu. Mxr1p binds to Mxr1p response elements present in the promoters of AAT2, MDH2, and GLN1. We conclude that Mxr1p is essential for utilization of amino acids as the sole source of carbon and nitrogen, and it is a global regulator of multiple metabolic pathways in P. pastoris.	[Sahu, Umakant; Rangarajan, Pundi N.] Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Rangarajan, PN (corresponding author), Indian Inst Sci, Dept Biochem, FE15,Biol Bldg, Bangalore 560012, Karnataka, India.	pnr@biochem.iisc.ernet.in	Rangarajan, Pundi/A-7365-2009	Rangarajan, Pundi/0000-0002-6536-9891	Department of Biotechnology, New Delhi [BT/PR3889/BRB/10/996/2011]; J. C. Bose Fellowship by Science and Engineering Research Board, New Delhi, India [SB/S2/JCB-02/2015]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); J. C. Bose Fellowship by Science and Engineering Research Board, New Delhi, India	This work was supported by Research Grant BT/PR3889/BRB/10/996/2011 from the Department of Biotechnology, New Delhi, and J. C. Bose Fellowship Grant SB/S2/JCB-02/2015 by the Science and Engineering Research Board, New Delhi, India (to P. N. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Freese S, 2011, YEAST, V28, P375, DOI 10.1002/yea.1845; Gorgens JF, 2005, APPL MICROBIOL BIOT, V67, P684, DOI 10.1007/s00253-004-1803-3; Gorgens JF, 2005, FEMS YEAST RES, V5, P677, DOI 10.1016/j.femsyr.2004.12.003; Heyland J, 2011, BIOTECHNOL BIOENG, V108, P1942, DOI 10.1002/bit.23114; Jorda J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-57; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; Kranthi BV, 2010, YEAST, V27, P705, DOI 10.1002/yea.1766; Kranthi BV, 2009, BBA-GENE REGUL MECH, V1789, P460, DOI 10.1016/j.bbagrm.2009.05.004; Kumar NV, 2012, J BIOL CHEM, V287, P34465, DOI 10.1074/jbc.M112.365304; Kumar NV, 2011, MICROBIOL-SGM, V157, P3361, DOI 10.1099/mic.0.053488-0; Lin-Cereghino GP, 2006, MOL CELL BIOL, V26, P883, DOI 10.1128/MCB.26.3.883-897.2006; Magasanik B, 2003, EUKARYOT CELL, V2, P827, DOI 10.1128/EC.2.5.827-829.2003; MascorroGallardo JO, 1996, GENE, V172, P169, DOI 10.1016/0378-1119(96)00059-5; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Parua PK, 2012, MOL MICROBIOL, V85, P282, DOI 10.1111/j.1365-2958.2012.08112.x; Sahu U, 2016, J BIOL CHEM, V291, P3648, DOI 10.1074/jbc.M115.673640; Sahu U, 2014, BIOCHEM BIOPH RES CO, V451, P158, DOI 10.1016/j.bbrc.2014.07.094; Wang XL, 2016, J BIOL CHEM, V291, P6245, DOI 10.1074/jbc.M115.692053; Wang XL, 2016, BIOTECHNOL LETT, V38, P291, DOI 10.1007/s10529-015-1972-4	23	10	10	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20588	20601		10.1074/jbc.M116.740191	http://dx.doi.org/10.1074/jbc.M116.740191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27519409	hybrid, Green Published			2022-12-26	WOS:000384574800024
J	Onorato, I; D'Alessandro, G; Di Castro, MA; Renzi, M; Dobrowolny, G; Musaro, A; Salvetti, M; Limatola, C; Crisanti, A; Grassi, F				Onorato, Irene; D'Alessandro, Giuseppina; Di Castro, Maria Amalia; Renzi, Massimiliano; Dobrowolny, Gabriella; Musaro, Antonio; Salvetti, Marco; Limatola, Cristina; Crisanti, Andrea; Grassi, Francesca			Noise Enhances Action Potential Generation in Mouse Sensory Neurons via Stochastic Resonance	PLOS ONE			English	Article							ROOT GANGLION NEURONS; SUBTHRESHOLD OSCILLATIONS; ION CHANNELS; MEMBRANE; MECHANORECEPTORS; CONDUCTION; CURRENTS; SYSTEMS	Noise can enhance perception of tactile and proprioceptive stimuli by stochastic resonance processes. However, the mechanisms underlying this general phenomenon remain to be characterized. Here we studied how externally applied noise influences action potential firing in mouse primary sensory neurons of dorsal root ganglia, modelling a basic process in sensory perception. Since noisy mechanical stimuli may cause stochastic fluctuations in receptor potential, we examined the effects of sub-threshold depolarizing current steps with superimposed random fluctuations. We performed whole cell patch clamp recordings in cultured neurons of mouse dorsal root ganglia. Noise was added either before and during the step, or during the depolarizing step only, to focus onto the specific effects of external noise on action potential generation. In both cases, step + noise stimuli triggered significantly more action potentials than steps alone. The normalized power norm had a clear peak at intermediate noise levels, demonstrating that the phenomenon is driven by stochastic resonance. Spikes evoked in step + noise trials occur earlier and show faster rise time as compared to the occasional ones elicited by steps alone. These data suggest that external noise enhances, via stochastic resonance, the recruitment of transient voltage-gated Na channels, responsible for action potential firing in response to rapid step-wise depolarizing currents.	[Onorato, Irene; D'Alessandro, Giuseppina; Di Castro, Maria Amalia; Renzi, Massimiliano; Limatola, Cristina; Grassi, Francesca] Sapienza Univ, Inst Pasteur, Dept Physiol & Pharmacol, Cenci Bolognetti Fdn, Rome, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Sapienza Univ Rome, Inst Pasteur, DAHFMO Unit Histol & Med Embryol, IIM,Cenci Bolognetti Fdn, Rome, Italy; [Dobrowolny, Gabriella; Musaro, Antonio] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Salvetti, Marco] Sapienza Univ, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy; [Limatola, Cristina] NeuroMed, Pozzilli, IS, Italy; [Crisanti, Andrea] Sapienza Univ, Dept Phys, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; IRCCS Neuromed; Sapienza University Rome	Grassi, F (corresponding author), Sapienza Univ, Inst Pasteur, Dept Physiol & Pharmacol, Cenci Bolognetti Fdn, Rome, Italy.	francesca.grassi@uniroma1.it	D'ALESSANDRO, GIUSEPPINA/L-6726-2019; Crisanti, Andrea/C-1705-2016; Musarò, Antonio/K-9598-2016; Di Castro, Maria Amalia/AGY-9938-2022; Grassi, Francesca/D-3963-2009; D'Alessandro, Giuseppina/K-7825-2016; Musaro, Antonio/P-2953-2019; Salvetti, Marco/K-3836-2016	D'ALESSANDRO, GIUSEPPINA/0000-0001-7220-6065; Crisanti, Andrea/0000-0002-9869-4420; Musarò, Antonio/0000-0002-2944-9739; Di Castro, Maria Amalia/0000-0001-7480-1087; Grassi, Francesca/0000-0002-0169-8397; D'Alessandro, Giuseppina/0000-0001-7220-6065; Musaro, Antonio/0000-0002-2944-9739; RENZI, MASSIMILIANO/0000-0001-6973-3569; Crisanti, Andrea/0000-0002-2406-4426; Dobrowolny, Gabriella/0000-0001-8693-0724; limatola, cristina/0000-0001-7504-8197	Ministero Istruzione Universita Ricerca grant [2010R8JK2X_003]; Telethon grant [GGP14066]; Fondazione Roma grant; ASI grant; NeuroMed (Pozzilli, Italy)	Ministero Istruzione Universita Ricerca grant(Ministry of Education, Universities and Research (MIUR)); Telethon grant(Fondazione Telethon); Fondazione Roma grant(Fondazione Roma); ASI grant; NeuroMed (Pozzilli, Italy)	This work was supported by Ministero Istruzione Universita Ricerca grant n. 2010R8JK2X_003 (www.miur.it) to FG; ASI, Telethon (GGP14066), and Fondazione Roma grants to AM. NeuroMed (Pozzilli, Italy) provided support in the form of ancillary salary for CL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Amir R, 2003, BIOPHYS J, V84, P2181, DOI 10.1016/S0006-3495(03)75024-3; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BENZI R, 1982, TELLUS, V34, P10, DOI 10.1111/j.2153-3490.1982.tb01787.x; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Breen PP, 2014, MED ENG PHYS, V36, P1088, DOI 10.1016/j.medengphy.2014.04.010; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642, DOI 10.1152/jn.1996.76.1.642; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Dong H, 2008, PHYSIOL RES, V57, P639, DOI 10.33549/physiolres.931164; Dorval AD, 2005, J NEUROSCI, V25, P10025, DOI 10.1523/JNEUROSCI.3557-05.2005; England S, 1996, J PHYSIOL-LONDON, V495, P429, DOI 10.1113/jphysiol.1996.sp021604; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000348; Momin A, 2008, J PHYSIOL-LONDON, V586, P5911, DOI 10.1113/jphysiol.2008.163154; Motomura H, 1995, PFLUG ARCH EUR J PHY, V431, P221, DOI 10.1007/BF00410194; NICOLIS C, 1981, TELLUS, V33, P225, DOI 10.1111/j.2153-3490.1981.tb01746.x; Reinker S, 2004, J COMPUT NEUROSCI, V16, P15, DOI 10.1023/B:JCNS.0000004838.67584.77; Richardson KA, 1998, CHAOS, V8, P599, DOI 10.1063/1.166341; RITCHIE JM, 1977, P NATL ACAD SCI USA, V74, P211, DOI 10.1073/pnas.74.1.211; Schmid G, 2001, EUROPHYS LETT, V56, P22, DOI 10.1209/epl/i2001-00482-6; Sejdic E, 2013, COMPUT METH PROG BIO, V111, P459, DOI 10.1016/j.cmpb.2013.03.014; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; WADDELL PJ, 1990, NEUROSCIENCE, V36, P811, DOI 10.1016/0306-4522(90)90024-X; WALL PD, 1983, PAIN, V17, P321, DOI 10.1016/0304-3959(83)90164-1; Wang YY, 2011, NEUROSIGNALS, V19, P54, DOI 10.1159/000324519; White JA, 1998, J NEUROPHYSIOL, V80, P262, DOI 10.1152/jn.1998.80.1.262; Xing JL, 2001, BRAIN RES, V901, P128, DOI 10.1016/S0006-8993(01)02329-0	36	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160950	10.1371/journal.pone.0160950	http://dx.doi.org/10.1371/journal.pone.0160950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525414	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100028
J	Li, D; Fang, Q; Yu, HB				Li, Dake; Fang, Qi; Yu, Hongbo			The Shift of ERG B-Wave Induced by Hours' Dark Exposure in Rodents	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; DEPRIVED CATS; INNER RETINA; ELECTRORETINOGRAM; ADAPTATION; MOUSE; RAT; DEPRIVATION; LIGHT	Purpose Dark adaptation can induce a rapid functional shift in the retina, and after that, the retinal function is believed to remain stable during the continuous dark exposure. However, we found that electroretinograms (ERG) b-waves gradually shifted during 24 hours' dark exposure in rodents. Detailed experiments were designed to explore this non-classical dark adaptation. Methods In vivo ERG recording in adult and developing rodents after light manipulations. Results We revealed a five-fold decrease in ERG b-waves in adult rats that were dark exposed for 24 hours. The ERG b-waves significantly increased within the first hour's dark exposure, but after that decreased continuously and finally attained steady state after 1 day's dark exposure. After 3 repetitive, 10 minutes' light exposure, the dark exposed rats fully recovered. This recovery effect was eye-specific, and light exposure to one eye could not restore the ERGs in the non-exposed eye. The prolonged dark exposure-induced functional shift was also reflected in the down-regulation on the amplitude of intensity-ERG response curve, but the dynamic range of the responsive light intensity remained largely stable. Furthermore, the ERG b-wave shifts occurred in and beyond classical critical period, and in both rats and mice. Importantly, when ERG b-wave greatly shifted, the amplitude of ERG awave did not change significantly after the prolonged dark exposure. Conclusions This rapid age-independent ERG change demonstrates a generally existing functional shift in the retina, which is at the entry level of visual system.	[Li, Dake; Fang, Qi; Yu, Hongbo] Fudan Univ, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Sch Life Sci,Vis Res Lab, Shanghai, Peoples R China	Fudan University	Yu, HB (corresponding author), Fudan Univ, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Sch Life Sci,Vis Res Lab, Shanghai, Peoples R China.	hongboyu@fudan.edu.cn	Fang, Qi/J-3618-2019	Fang, Qi/0000-0002-7148-6269	863 Program of the Ministry of Science and Technology of China [2015AA020508]; National Natural Science Foundation of China [31571076]; Shanghai Key Discipline Foundation [B111]	863 Program of the Ministry of Science and Technology of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Discipline Foundation	This study was supported by grants from 863 Program of the Ministry of Science and Technology of China (No. 2015AA020508, URLs: http://www.most.gov.cn/eng/programmes1/), the National Natural Science Foundation of China (No. 31571076, URLs: http://www.nsfc.gov.cn/), and the Shanghai Key Discipline Foundation (No. B111, URLs: http://www.shmec.gov.cn/) to HY.	BABKOFF H, 1975, Annals of Ophthalmology, V7, P1335; BARO JA, 1990, INVEST OPHTH VIS SCI, V31, P1405; BIRCH DG, 1979, INVEST OPHTH VIS SCI, V18, P752; BIRCH DG, 1986, INVEST OPHTH VIS SCI, V27, P268; Cameron AM, 2006, J PHYSIOL-LONDON, V575, P507, DOI 10.1113/jphysiol.2006.108027; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; CONE RA, 1964, J GEN PHYSIOL, V47, P1089, DOI 10.1085/jgp.47.6.1089; DAW N, 1995, VISUAL DEV; DOWLING JE, 1963, NATURE, V199, P972, DOI 10.1038/199972a0; DOWLING JE, 1963, J GEN PHYSIOL, V46, P1287, DOI 10.1085/jgp.46.6.1287; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; FOWLKES DH, 1984, INVEST OPHTH VIS SCI, V25, P121; Francis G, 1903, J PHYSL, V29, P388; He QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079625; HENDRICKSON A, 1976, VISION RES, V16, P517, DOI 10.1016/0042-6989(76)90033-X; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Levine M. W., 1991, FUNDAMENTALS SENSATI; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; RAYNAULD JP, 1979, SCIENCE, V204, P1436, DOI 10.1126/science.451577; Ren JQ, 2004, VISION RES, V44, P2147, DOI 10.1016/j.visres.2004.03.022; REUTER JH, 1976, PFLUG ARCH EUR J PHY, V363, P7, DOI 10.1007/BF00587395; Robson JG, 2004, VISION RES, V44, P3253, DOI 10.1016/j.visres.2004.09.002; Robson JG, 1998, DOC OPHTHALMOL, V95, P187, DOI 10.1023/A:1001891904176; Rodieck RW, 1998, OPTOMETRY VISION SCI, V75, P203; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; SHERMAN SM, 1973, BRAIN RES, V60, P224, DOI 10.1016/0006-8993(73)90861-5; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tian N, 2001, NEURON, V32, P439, DOI 10.1016/S0896-6273(01)00470-6; Vistamehr S, 2004, VISUAL NEUROSCI, V21, P23, DOI 10.1017/S0952523804041033	32	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161010	10.1371/journal.pone.0161010	http://dx.doi.org/10.1371/journal.pone.0161010			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517462	Green Published, gold, Green Submitted			2022-12-26	WOS:000381382100036
J	Gallini, R; Huusko, J; Yla-Herttuala, S; Betsholtz, C; Andrae, J				Gallini, Radiosa; Huusko, Jenni; Yla-Herttuala, Seppo; Betsholtz, Christer; Andrae, Johanna			Isoform-Specific Modulation of Inflammation Induced by Adenoviral Mediated Delivery of Platelet-Derived Growth Factors in the Adult Mouse Heart	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR A-CHAIN; PDGFR-BETA; CARDIAC FIBROSIS; RECEPTOR; MECHANISMS; FIBROBLASTS; GENE; RECRUITMENT; EXPRESSION	Platelet-derived growth factors (PDGFs) are key regulators of mesenchymal cells in vertebrate development. To what extent PDGFs also exert beneficial homeostatic or reparative roles in adult organs, as opposed to adverse fibrogenic responses in pathology, are unclear. PDGF signaling plays critical roles during heart development, during which forced overexpression of PDGFs induces detrimental cardiac fibrosis; other studies have implicated PDGF signaling in post-infarct myocardial repair. Different PDGFs may exert different effects mediated through the two PDGF receptors (PDGFR alpha and PDGFR beta) in different cell types. Here, we assessed responses induced by five known PDGF isoforms in the adult mouse heart in the context of adenovirus vector-mediated inflammation. Our results show that different PDGFs have different, in some cases even opposing, effects. Strikingly, whereas the major PDGFRa agonists (PDGF-A and -C) decreased the amount of scar tissue and increased the numbers of PDGFR alpha-positive fibroblasts, PDGFR beta agonists either induced large scars with extensive inflammation (PDGF-B) or dampened the adenovirusinduced inflammation and produced a small and dense scar (PDGF-D). These results provide evidence for PDGF isoform-specific inflammation-modulating functions that may have therapeutic implications. They also illustrate a surprising complexity in the PDGF-mediated pathophysiological responses.	[Gallini, Radiosa; Betsholtz, Christer; Andrae, Johanna] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Gallini, Radiosa; Betsholtz, Christer] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Huusko, Jenni; Yla-Herttuala, Seppo] Univ Kuopio, Dept Biotechnol & Mol Med, Al Virtanen Inst Mol Sci, Kuopio, Finland	Uppsala University; Karolinska Institutet; University of Eastern Finland	Andrae, J (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Johanna.Andrae@igp.uu.se	Andrae, Johanna/L-3875-2014	Gallini, Radiosa/0000-0002-2709-3337; Yla-Herttuala, Seppo/0000-0001-7593-2708	Swedish Cancer Foundation; Swedish Science Council; Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderberg Foundation; Karolinska Institutet; Uppsala University	Swedish Cancer Foundation; Swedish Science Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderberg Foundation; Karolinska Institutet(Karolinska Institutet); Uppsala University	This work was supported by the Swedish Cancer Foundation (https://www.cancerfonden.se), Swedish Science Council (http://www.vr.se), Knut and Alice Wallenberg (https://www.wallenberg.com/kaw/), Torsten and Ragnar Soderberg Foundations (http://www.torstensoderbergsstiftelse.se) Karolinska Institutet (http://ki.se), and Uppsala University (http://www.uu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2002, MECH DEVELOP, V110, P187, DOI 10.1016/S0925-4773(01)00560-3; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Andrae J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105477; Bax NAM, 2009, DEV DYNAM, V238, P2658, DOI 10.1002/dvdy.22073; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Betsholtz C, 2005, EXP SUPPL, V94, P115; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; Fan B, 2013, INT J CLIN EXP PATHO, V6, P2468; Hamilton TG, 2003, MOL CELL BIOL, V23, P4013, DOI 10.1128/MCB.23.11.4013-4025.2003; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; He CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8770; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Huusko J, 2010, CARDIOVASC RES, V86, P122, DOI 10.1093/cvr/cvp382; Kern S, 2014, FEBS OPEN BIO, V4, P11, DOI 10.1016/j.fob.2013.11.002; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Korpisalo P, 2008, CIRC RES, V103, P1092, DOI 10.1161/CIRCRESAHA.108.182287; Merentie M, 2016, GENE THER, V23, P296, DOI 10.1038/gt.2015.114; Olson LE, 2011, DEV CELL, V20, P815, DOI 10.1016/j.devcel.2011.04.019; Ponten A, 2005, CIRC RES, V97, P1036, DOI 10.1161/01.RES.0000190590.31545.d4; Ponten A, 2003, AM J PATHOL, V163, P673, DOI 10.1016/S0002-9440(10)63694-2; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Suurmeijer AJH, 2003, J PATHOL, V199, P387, DOI 10.1002/path.1311; Tuuminen R, 2006, TRANSPLANT P, V38, P3271, DOI 10.1016/j.transproceed.2006.10.056; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; Van den Arker NMS, 2005, DEV DYNAM, V233, P1579, DOI 10.1002/dvdy.20476; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhao TQ, 2013, AM J PHYSIOL-HEART C, V304, pH1719, DOI 10.1152/ajpheart.00130.2013; Zymek P, 2006, J AM COLL CARDIOL, V48, P2315, DOI 10.1016/j.jacc.2006.07.060	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160930	10.1371/journal.pone.0160930	http://dx.doi.org/10.1371/journal.pone.0160930			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513343	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100090
J	Lee, JC; Hung, YP; Lin, HJ; Tsai, PJ; Ko, WC				Lee, Jen-Chieh; Hung, Yuan-Pin; Lin, Hsiao-Ju; Tsai, Pei-Jane; Ko, Wen-Chien			Clostridium difficile Infections in Medical Intensive Care Units of a Medical Center in Southern Taiwan: Variable Seasonality and Disease Severity	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; RISK-FACTORS; HOSPITALIZED-PATIENTS; PRACTICE GUIDELINES; CLINICAL-FEATURES; ANTIBIOTIC USE; DIARRHEA; EPIDEMIOLOGY; UPDATE; ACQUISITION	Critical patients are susceptible to Clostridium difficile infections (CDIs), which cause significant morbidity and mortality in the hospital. In Taiwan, the epidemiology of CDI in intensive care units (ICUs) is not well understood. This study was aimed to describe the incidence and the characteristics of CDI in the ICUs of a medical center in southern Taiwan. Adult patients with diarrhea but without colostomy/colectomy or laxative use were enrolled. Stool samples were collected with or without 5 ml alcohol and were plated on cycloserine-cefoxitin-fructose agar. C. difficile identification was confirmed by polymerase chain reaction. There were 1,551 patients admitted to ICUs, 1,488 screened, and 145 with diarrhea. A total of 75 patients were excluded due either to laxative use, a lack of stool samples, or refusal. Overall, 70 patients were included, and 14 (20%) were diagnosed with CDI, with an incidence of 8.8 cases per 10,000 patient-days. The incidence of CDI was found to be highest in March 2013 and lowest in the last quarter of 2013. The cases were categorized as the following: 5 severe, complicated, 5 severe, and 4 mild or moderate diseases. Among the 14 cases of CDI, the median patient age was 74 (range: 47-94) years, and the median time from admission to diarrhea onset was 16.5 (4-53) days. Eight cases received antimicrobial treatment (primarily metronidazole), and the time to diarrheal resolution was 11.5 days. Though 6 cases were left untreated, no patients died of CDI. The in-hospital mortality of CDI cases was 50%, similar to that of patients without CDI (46.4%; P = 1.0). We concluded that the overall incidence of CDI in our medical ICUs was low and there were variable seasonal incidences and disease severities of CDI.	[Lee, Jen-Chieh; Ko, Wen-Chien] Natl Cheng Kung Univ, Dept Internal Med, Natl Cheng Kung Univ Hosp, Coll Med, Tainan, Taiwan; [Hung, Yuan-Pin; Lin, Hsiao-Ju] Minist Hlth & Welf, Dept Internal Med, Tainan, Taiwan; [Lin, Hsiao-Ju] Natl Hlth Res Inst, Grad Inst Clin Med, Tainan, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Ko, Wen-Chien] Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Ko, WC (corresponding author), Natl Cheng Kung Univ, Dept Internal Med, Natl Cheng Kung Univ Hosp, Coll Med, Tainan, Taiwan.; Tsai, PJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.; Ko, WC (corresponding author), Natl Cheng Kung Univ Hosp, Ctr Infect Control, Tainan, Taiwan.	peijtsai@mail.ncku.edu.com; winston3415@gmail.com	Ko, Wen-Chien/ABG-4316-2020; hong, hesse/EUM-0179-2022; Tsai, Pei-Jane/G-3563-2011	Ko, Wen-Chien/0000-0001-7497-149X; hong, hesse/0000-0003-1006-705X; 	Ministry of Science and Technology [MOST 105-2321-B-006-012, 102-2628-B-006-015-MY3]; Ministry of Health and Welfare, Taiwan [MOHW 104-CDC-C-114-112403, 105-TDU-B-211-133016]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare, Taiwan	This study was supported by the grants from the Ministry of Science and Technology (MOST 105-2321-B-006-012 and 102-2628-B-006-015-MY3) and the Ministry of Health and Welfare, Taiwan (MOHW 104-CDC-C-114-112403 and 105-TDU-B-211-133016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the grants from the Ministry of Science and Technology (MOST 105-2321-B-006-012 and 102-2628-B-006-015-MY3) and the Ministry of Health and Welfare, Taiwan (MOHW 104-CDC-C-114-112403 and 105-TDU-B-211-133016).	Aldeyab MA, 2009, ANTIMICROB AGENTS CH, V53, P2082, DOI 10.1128/AAC.01214-08; Aldrete SD, 2015, AM J CLIN PATHOL, V143, P895, DOI 10.1309/AJCP9EWI6QPVTPQY; Ang CW, 2008, J INFECTION, V57, P435, DOI 10.1016/j.jinf.2008.10.002; Argamany JR, 2015, AM J INFECT CONTROL, V43, P435, DOI 10.1016/j.ajic.2014.11.018; Blaser AR, 2015, CURR OPIN CRIT CARE, V21, P142, DOI 10.1097/MCC.0000000000000188; Bliss DZ, 1998, ANN INTERN MED, V129, P1012, DOI 10.7326/0003-4819-129-12-199812150-00004; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Bouza E, 2015, J CRIT CARE, V30, P543, DOI 10.1016/j.jcrc.2015.02.011; Brown KA, 2013, AM J EPIDEMIOL, V178, P118, DOI 10.1093/aje/kws463; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung CH, 2010, J MICROBIOL IMMUNOL, V43, P119, DOI 10.1016/S1684-1182(10)60019-9; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crabtree SJ, 2011, BURNS, V37, P42, DOI 10.1016/j.burns.2010.06.008; Dodek PM, 2013, J CRIT CARE, V28, P335, DOI 10.1016/j.jcrc.2012.11.008; Dubberke ER, 2007, CLIN INFECT DIS, V45, P1543, DOI 10.1086/523582; Fujitani S, 2011, AM J INFECT CONTROL, V39, P188, DOI 10.1016/j.ajic.2010.10.024; Furuya-Kanamori L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120730; Furuya-Kanamori L, 2014, J INFECTION, V69, P447, DOI 10.1016/j.jinf.2014.06.014; Gilca R, 2012, ANTIMICROB AGENTS CH, V56, P639, DOI 10.1128/AAC.05411-11; Hsu Meng-Shiuan, 2006, Journal of Microbiology Immunology and Infection, V39, P242; Hung YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069577; Jury LA, 2013, INFECT CONT HOSP EP, V34, P1222, DOI 10.1086/673459; Karanika S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv186; Keddis MT, 2012, MAYO CLIN PROC, V87, P1046, DOI 10.1016/j.mayocp.2012.05.025; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lawrence SJ, 2007, INFECT CONT HOSP EP, V28, P123, DOI 10.1086/511793; Lin HJ, 2015, J MICROBIOL IMMUNOL, V48, P183, DOI 10.1016/j.jmii.2013.08.003; Lo Vecchio A, 2012, CURR OPIN GASTROEN, V28, P1, DOI 10.1097/MOG.0b013e32834bc9a9; Micek ST, 2013, CRIT CARE MED, V41, P1968, DOI 10.1097/CCM.0b013e31828a40d5; Monaghan TM, 2015, INFECT DIS CLIN N AM, V29, P1, DOI 10.1016/j.idc.2014.11.007; Musa SA, 2010, NEUROCRIT CARE, V13, P87, DOI 10.1007/s12028-010-9374-x; Musa SA, 2011, J CARDIOTHOR VASC AN, V25, P263, DOI 10.1053/j.jvca.2010.05.004; Polage CR, 2012, CLIN INFECT DIS, V55, P982, DOI 10.1093/cid/cis551; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P382, DOI 10.1086/651095; Qu HQ, 2014, DIABETES RES CLIN PR, V105, P285, DOI 10.1016/j.diabres.2014.06.002; Garzotto AR, 2015, SUPPORT CARE CANCER, V23, P1569, DOI 10.1007/s00520-014-2506-7; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Tripathy S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00082; Wang XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111735; Zahar JR, 2012, CRIT CARE, V16, DOI 10.1186/cc11852	40	6	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160760	10.1371/journal.pone.0160760	http://dx.doi.org/10.1371/journal.pone.0160760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509051	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400052
J	Masse-Alarie, H; Cancino, EE; Schneider, C; Hodges, P				Masse-Alarie, Hugo; Cancino, Edith Elgueta; Schneider, Cyril; Hodges, Paul			Paired-Pulse TMS and Fine-Wire Recordings Reveal Short-Interval Intracortical Inhibition and Facilitation of Deep Multifidus Muscle Fascicles	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; TRANSCRANIAL MAGNETIC STIMULATION; SHORT-LATENCY FACILITATION; POSTURAL CONTROL; 2 PHASES; EXCITABILITY; MECHANISMS; CONTRACTION; MODULATION; BRAIN	Objective Paired-pulse transcranial magnetic stimulation (ppTMS) is used to probe inhibitory and excitatory networks within the primary motor cortex (M1). These mechanisms are identified for limb muscles but it is unclear whether they share properties with trunk muscles. The aim was to determine whether it was possible to test the intracortical inhibition and facilitation of the deep multifidus muscle fascicles (DM) and at which inter-stimulus intervals (ISI). Methods In ten pain-free individuals, TMS was applied over M1 and motor evoked potentials ( MEP) were recorded using fine-wire electrodes in DM. MEPs were conditioned with subthreshold stimuli at ISIs of 1 to 12 ms to test short-interval intracortical inhibition (SICI) and at 15 ms for long-interval intracortical facilitation. Short-interval facilitation (SICF) was tested using 1-ms ISI. Results SICI of DM was consistently obtained with ISI of 1-, 3-, 4- and 12-ms. Facilitation of DM MEP was only identified using SICF paradigm. Conclusions A similar pattern of MEP modulation with ISI changes for deep trunk and limb muscles implies that M1 networks share some functional properties. Significance The ppTMS paradigm presents a potential to determine how M1 inhibitory and excitatory mechanisms participate in brain re-organization in back pain that affects control of trunk muscles.	[Masse-Alarie, Hugo; Schneider, Cyril] Univ Laval, CHU Quebec Res Ctr, Neurosci Unit CHUL, Lab Clin Neurosci & neuroStimulat,Dept Rehabil, Quebec City, PQ, Canada; [Cancino, Edith Elgueta; Hodges, Paul] Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Laval University; University of Queensland	Hodges, P (corresponding author), Univ Queensland, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Hodges, Paul W/B-6578-2008	Hodges, Paul W/0000-0002-1206-9107; Schneider, Cyril/0000-0002-2179-0481; Masse-Alarie, Hugo/0000-0003-4472-9656	Fonds de Recherche du Quebec - Sante; Universite Laval; Canadian Institutes for Health Research; National Health and Medical Research Council of Australia [ID1102905]	Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Universite Laval; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	HMA is supported by the Fonds de Recherche du Quebec - Sante, Universite Laval and the Canadian Institutes for Health Research (studentship & travel grant). PH is supported by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia (ID1102905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Richard Preuss for his comments on the first draft. HMA is supported by the Fonds de Recherche du Quebec-Sante, Universite Laval and the Canadian Institutes for Health Research (studentship & travel grant). P.H. is supported by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia (ID1102905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buccolieri A, 2004, J PHYSIOL-LONDON, V558, P685, DOI 10.1113/jphysiol.2004.064774; Byblow WD, 2006, EXP BRAIN RES, V168, P287, DOI 10.1007/s00221-005-0205-9; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cohen J.E., 1988, STAT POWER ANAL BEHA; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Di Lazzaro V, 1999, EXP BRAIN RES, V129, P494, DOI 10.1007/s002210050919; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; FERBERT A, 1992, ELECTROEN CLIN NEURO, V85, P382, DOI 10.1016/0168-5597(92)90051-C; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; Gagne M, 2008, BRAIN RES, V1195, P77, DOI 10.1016/j.brainres.2007.12.021; Goss DA, 2011, J NEUROSCI METH, V194, P329, DOI 10.1016/j.jneumeth.2010.10.012; Hanajima R, 2002, J PHYSIOL-LONDON, V538, P253, DOI 10.1113/jphysiol.2001.013094; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Hanajima R, 2003, EXP BRAIN RES, V151, P427, DOI 10.1007/s00221-003-1455-z; Hanajima R, 1998, NEUROLOGY, V51, P1771, DOI 10.1212/WNL.51.6.1771; Hodges PW, 2013, EUR J PAIN, V17, P1138, DOI 10.1002/j.1532-2149.2013.00286.x; Hodges PW, 1996, SPINE, P21, DOI [10.1007/s00221-012-3008-9, DOI 10.1007/S00221-012-3008-9]; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; MacDonald D, 2009, PAIN, V142, P183, DOI 10.1016/j.pain.2008.12.002; Masse-Alarie H, 2016, SCAND J PAIN, V12, P74, DOI 10.1016/j.sjpain.2016.03.005; Masse-Alarie H, 2016, EXP BRAIN RES, V234, P1033, DOI 10.1007/s00221-015-4528-x; Masse-Alarie H, 2012, EXP BRAIN RES, V218, P99, DOI 10.1007/s00221-012-3008-9; Nathan PW, 1996, BRAIN, V119, P1809, DOI 10.1093/brain/119.6.1809; Novak K, 2004, CLIN NEUROPHYSIOL, V115, P1931, DOI 10.1016/j.clinph.2004.03.016; Ortu E, 2008, J PHYSIOL-LONDON, V586, P5147, DOI 10.1113/jphysiol.2008.158956; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reynolds C, 1999, NEUROLOGY, V53, P730, DOI 10.1212/WNL.53.4.730; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Strutton PH, 2005, J SPINAL DISORD TECH, V18, P420, DOI 10.1097/01.bsd.0000169063.84628.fe; Strutton PH, 2004, EXP BRAIN RES, V158, P474, DOI 10.1007/s00221-004-1939-5; Tokimura H, 1996, ELECTROMYOGR MOTOR C, V101, P263, DOI 10.1016/0924-980X(96)95664-7; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; Tsao H, 2008, J NEUROSCI METH, V171, P132, DOI 10.1016/j.jneumeth.2008.02.005; Tsao H, 2011, SPINE, V36, P1721, DOI 10.1097/BRS.0b013e31821c4267; Tsao H, 2011, CLIN NEUROPHYSIOL, V122, P1580, DOI 10.1016/j.clinph.2011.01.048; Tsao H, 2010, J PAIN, V11, P1120, DOI 10.1016/j.jpain.2010.02.004; Tsao H, 2010, EUR J PAIN, V14, P832, DOI 10.1016/j.ejpain.2010.01.001; Volz LJ, 2015, CEREB CORTEX, V25, P2346, DOI 10.1093/cercor/bhu032; WILKE HJ, 1995, SPINE, V20, P192, DOI 10.1097/00007632-199501150-00011; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Ziemann Ulf, 2013, Handb Clin Neurol, V116, P387, DOI 10.1016/B978-0-444-53497-2.00032-2; Zoghi M, 2003, J PHYSIOL-LONDON, V550, P933, DOI 10.1113/jphysiol.2003.042606	49	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159391	10.1371/journal.pone.0159391	http://dx.doi.org/10.1371/journal.pone.0159391			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509086	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400008
J	Wang, Z; Tran, MC; Bhatia, NJ; Hsing, AW; Chen, C; LaRussa, MF; Fattakhov, E; Rashidi, V; Jang, KY; Choo, KJ; Nie, XJ; Mathy, JA; Longaker, MT; Dauskardt, RH; Helms, JA; Yang, GP				Wang, Zhen; Tran, Misha C.; Bhatia, Namrata J.; Hsing, Alexander W.; Chen, Carol; LaRussa, Marie F.; Fattakhov, Ernst; Rashidi, Vania; Jang, Kyu Yun; Choo, Kevin J.; Nie, Xingju; Mathy, Jonathan A.; Longaker, Michael T.; Dauskardt, Reinhold H.; Helms, Jill A.; Yang, George P.			Del1 Knockout Mice Developed More Severe Osteoarthritis Associated with Increased Susceptibility of Chondrocytes to Apoptosis	PLOS ONE			English	Article							PROGRESSIVE PSEUDORHEUMATOID DYSPLASIA; DEVELOPMENTAL ENDOTHELIAL LOCUS-1; KNEE OSTEOARTHRITIS; CARTILAGE; CELLS; MOUSE; GENE; ANGIOGENESIS; PROTEIN; MODEL	Objective We identified significant expression of the matricellular protein, DEL1, in hypertrophic and mature cartilage during development. We hypothesized that this tissue-specific expression indicated a biological role for DEL1 in cartilage biology. Methods Del1 KO and WT mice had cartilage thickness evaluated by histomorphometry. Additional mice underwent medial meniscectomy to induce osteoarthritis, and were assayed at 1 week for apoptosis by TUNEL staining and at 8 weeks for histology and OA scoring. In vitro proliferation and apoptosis assays were performed on primary chondrocytes. Results Deletion of the Del1 gene led to decreased amounts of cartilage in the ears and knee joints in mice with otherwise normal skeletal morphology. Destabilization of the knee led to more severe OA compared to controls. In vitro, DEL1 blocked apoptosis in chondrocytes. Conclusion Osteoarthritis is among the most prevalent diseases worldwide and increasing in incidence as our population ages. Initiation begins with an injury resulting in the release of inflammatory mediators. Excessive production of inflammatory mediators results in apoptosis of chondrocytes. Because of the limited ability of chondrocytes to regenerate, articular cartilage deteriorates leading to the clinical symptoms including severe pain and decreased mobility. No treatments effectively block the progression of OA. We propose that direct modulation of chondrocyte apoptosis is a key variable in the etiology of OA, and therapies aimed at preventing this important step represent a new class of regenerative medicine targets.	[Wang, Zhen; Tran, Misha C.; Bhatia, Namrata J.; Chen, Carol; LaRussa, Marie F.; Fattakhov, Ernst; Rashidi, Vania; Jang, Kyu Yun; Choo, Kevin J.; Nie, Xingju; Mathy, Jonathan A.; Longaker, Michael T.; Helms, Jill A.; Yang, George P.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Hsing, Alexander W.; Dauskardt, Reinhold H.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Jang, Kyu Yun] Chonbuk Natl Univ, Sch Med, Dept Pathol, Jeonju, South Korea; [Yang, George P.] Palo Alto VA Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Jeonbuk National University	Yang, GP (corresponding author), Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA.; Yang, GP (corresponding author), Palo Alto VA Hlth Care Syst, Palo Alto, CA USA.	gpyang@stanford.edu	Choo, Kevin/AAB-7838-2019; nie, xingju/AFR-3358-2022	nie, xingju/0000-0003-4247-8945; Helms, Jill/0000-0002-0463-396X	US Department of Veterans Affairs; American Heart Association; Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Eilenberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003754] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; Eilenberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by the US Department of Veterans Affairs, American Heart Association, Oak Foundation, Hagey Laboratory for Pediatric Regenerative Medicine, and the Eilenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye LG, 2006, CURR OPIN RHEUMATOL, V18, P537, DOI 10.1097/01.bor.0000240369.39713.af; Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359; Chambers MG, 2001, ARTHRITIS RHEUM-US, V44, P1455, DOI 10.1002/1529-0131(200106)44:6<1455::AID-ART241>3.0.CO;2-J; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Fernandes JC, 2002, BIORHEOLOGY, V39, P237; Gabay O, 2013, ARTHRITIS RHEUM-US, V65, P159, DOI 10.1002/art.37750; Gigout A, 2008, J BIOL CHEM, V283, P31522, DOI 10.1074/jbc.M804234200; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, J IMMUNOL, V172, P3876, DOI 10.4049/jimmunol.172.6.3876; Hidai C, 1998, GENE DEV, V12, P21, DOI 10.1101/gad.12.1.21; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Hurvitz JR, 1999, NAT GENET, V23, P94, DOI 10.1038/12699; Isozaki T, 2013, ARTHRITIS RHEUM-US, V65, P98, DOI 10.1002/art.37755; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Kumar S, 2011, MOL CELL BIOL, V31, P4036, DOI 10.1128/MCB.01342-10; Kutz WE, 2005, MOL CELL BIOL, V25, P414, DOI 10.1128/MCB.25.1.414-421.2005; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Little CB, 2013, NAT REV RHEUMATOL, V9, P485, DOI 10.1038/nrrheum.2013.72; Mason RM, 2001, OSTEOARTHR CARTILAGE, V9, P85, DOI 10.1053/joca.2000.0363; Meulenbelt I, 1997, J MED GENET, V34, P1024, DOI 10.1136/jmg.34.12.1024; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Mosher DF, 2012, MATRIX BIOL, V31, P155, DOI 10.1016/j.matbio.2012.01.003; Penta K, 1999, J BIOL CHEM, V274, P11101, DOI 10.1074/jbc.274.16.11101; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Sarzi-Puttini P, 2005, SEMIN ARTHRITIS RHEU, V35, P1, DOI 10.1016/j.semarthrit.2005.01.013; Uehara Y, 2014, OSTEOARTHR CARTILAGE, V22, P1007, DOI 10.1016/j.joca.2014.04.025; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; Wang Z, 2012, SURGERY, V151, P296, DOI 10.1016/j.surg.2011.07.013; Weng LH, 2012, ARTHRITIS RHEUM-US, V64, P3267, DOI 10.1002/art.34602; Weng LH, 2010, ARTHRITIS RHEUM-US, V62, P1393, DOI 10.1002/art.27357; WILLIAMS CJ, 1995, J RHEUMATOL, V22, P28; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Zhen GH, 2013, NAT MED, V19, P704, DOI 10.1038/nm.3143	39	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160684	10.1371/journal.pone.0160684	http://dx.doi.org/10.1371/journal.pone.0160684			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505251	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200057
J	Zach, B; Hofer, E; Asslaber, M; Ahammer, H				Zach, Bernhard; Hofer, Ernst; Asslaber, Martin; Ahammer, Helmut			Automated Texture Analysis and Determination of Fibre Orientation of Heart Tissue: A Morphometric Study	PLOS ONE			English	Article							COLLAGEN ORIENTATION; IMAGE-ANALYSIS; MICROSCOPY	The human heart has a heterogeneous structure, which is characterized by different cell types and their spatial configurations. The physical structure, especially the fibre orientation and the interstitial fibrosis, determines the electrical excitation and in further consequence the contractility in macroscopic as well as in microscopic areas. Modern image processing methods and parameters could be used to describe the image content and image texture. In most cases the description of the texture is not satisfying because the fibre orientation, detected with common algorithms, is biased by elements such as fibrocytes or endothelial nuclei. The goal of this work is to figure out if cardiac tissue can be analysed and classified on a microscopic level by automated image processing methods with a focus on an accurate detection of the fibre orientation. Quantitative parameters for identification of textures of different complexity or pathological attributes inside the heart were determined. The focus was set on the detection of the fibre orientation, which was calculated on the basis of the cardiomyocytes' nuclei. It turned out that the orientation of these nuclei corresponded with a high precision to the fibre orientation in the image plane. Additionally, these nuclei also indicated very well the inclination of the fibre.	[Zach, Bernhard; Hofer, Ernst; Ahammer, Helmut] Med Univ Graz, Ctr Physiol Med, Inst Biophys, Harrachgasse 21, A-8010 Graz, Austria; [Asslaber, Martin] Med Univ Graz, Inst Pathol, Auenbruggerpl 25, A-8036 Graz, Austria	Medical University of Graz; Medical University of Graz	Ahammer, H (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Biophys, Harrachgasse 21, A-8010 Graz, Austria.	helmut.ahammer@medunigraz.at	Hofer, Ernst/AAO-7747-2020	Ahammer, Helmut/0000-0001-5400-294X				BAY RS, 1992, POLYM ENG SCI, V32, P240, DOI 10.1002/pen.760320404; Campos FO, 2013, IEEE T BIO-MED ENG, V60, P2339, DOI 10.1109/TBME.2013.2256359; Daniels F, 2007, IFMBE PROC, V15, P282; Elbischger PJ, 2005, ST HEAL T, V113, P97; Enomae T, 2006, NORD PULP PAP RES J, V21, P253, DOI 10.3183/npprj-2006-21-02-p253-259; Garcia-Canadilla P, 2014, J BIOMEDICAL OPTICS, P19; Hu WY, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.026007; Ilea DE, VISAPP 2008 3 INT C; Karathanassi V, 2004, P SPIE, V5574; Khorasani H, 2011, AM J PATHOL, V178, P621, DOI 10.1016/j.ajpath.2010.10.019; KORECKY B, 1979, CAN J PHYSIOL PHARM, V57, P1122, DOI 10.1139/y79-167; MATTFELDT T, 1994, J MICROSC-OXFORD, V173, P87, DOI 10.1111/j.1365-2818.1994.tb03432.x; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Severs NJ, 1989, ISOLATED ADULT CARDI, V1, P3; Stoeck C, 2012, P INT SOC MAG RESON, V20; Toussaint N, 2012, ISMRM 2012; Tracy RE, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/658958; van Zuijlen PPM, 2002, J PATHOL, V198, P284, DOI 10.1002/path.1219; Velez-Garcia GM, 2012, J MICROSC-OXFORD, V248, P23, DOI 10.1111/j.1365-2818.2012.03646.x	20	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160735	10.1371/journal.pone.0160735	http://dx.doi.org/10.1371/journal.pone.0160735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505420	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200058
J	Do, LAH; Bryant, JE; Tran, AT; Nguyen, BH; Tran, TTL; Tran, QH; Vo, QB; Dac, NAT; Trinh, HN; Nguyen, TTH; Binh, BTL; Le, K; Nguyen, MT; Thai, QT; Vo, TV; Ngo, NQM; Dang, TKH; Cao, NH; Tran, TV; Ho, LV; Farrar, J; Jong, MD; Doorn, HRV				Lien Anh Ha Do; Juliet E. Bryant; Anh Tuan Tran; Bach Hue Nguyen; Thi Thu Loan Tran; Quynh Huong Tran; Quoc Bao Vo; Nguyen Anh Tran Dac; Hong Nhien Trinh; Thi Thanh Hai Nguyen; Bao Tinh Le Binh; Khanh Le; Minh Tien Nguyen; Quang Tung Thai; Thanh Vu Vo; Ngoc Quang Minh Ngo; Thi Kim Huyen Dang; Ngoc Huong Cao; Thu Van Tran; Lu Viet Ho; Farrar, Jeremy; Menno de Jong; Rogier van Doorn, H.			Respiratory Syncytial Virus and Other Viral Infections among Children under Two Years Old in Southern Vietnam 2009-2010: Clinical Characteristics and Disease Severity	PLOS ONE			English	Article							TRACT INFECTIONS; ACUTE BRONCHIOLITIS; HOSPITALIZED INFANTS; PCR ASSAY; LOAD; RHINOVIRUS; COMMUNITY; COINFECTION; EPIDEMIOLOGY; ASSOCIATION	Background Despite a high burden of respiratory syncytial virus (RSV) infections among children, data on demographic and clinical characteristics of RSV are scarce in low and middle income countries. This study aims to describe the viral etiologies, the demographic, epidemiological, and clinical characteristics of children under two years of age who were hospitalized with a lower respiratory tract infections (LRTI), focusing on RSV (prevalence, seasonality, subgroups, viral load) and its association with disease severity. Methods A prospective study among children under two years of age, hospitalized with LRTI was conducted in two referral pediatric hospitals in Ho Chi Minh City, Vietnam, from May 2009 to December 2010. Socio-demographic, clinical data and nasopharyngeal swabs were collected on enrolment and discharge. Multiplex real-time RT-PCR (13 viruses) and quantitative RSV RT-PCR were used to identify viral pathogens, RSV load and subgroups. Results Among 632 cases, 48% were RSV positive. RSV infections occurred at younger age than three other leading viral infections i.e rhinovirus (RV), metapneumovirus (MPV), parainfluenza virus (PIV-3) and were significantly more frequent in the first 6 months of life. Clinical severity score of RSV infection was significantly higher than PIV-3 but not for RV or MPV. In multivariate analysis, RV infection was significantly associated with severity while RSV infection was not. Among RSV infections, neither viral load nor viral co-infections were significantly associated with severity. Young age and having fever at admission were significantly associated with both RSV and LRTI severity. A shift in RSV subgroup predominance was observed during two consecutive rainy seasons but was not associated with severity. Conclusion We report etiologies, the epidemiological and clinical characteristics of LRTI among hospitalized children under two years of age and risk factors of RSV and LRTI severity.	[Lien Anh Ha Do; Juliet E. Bryant; Farrar, Jeremy; Menno de Jong; Rogier van Doorn, H.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Program, Ho Chi Minh City, Vietnam; [Lien Anh Ha Do] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Juliet E. Bryant; Menno de Jong; Rogier van Doorn, H.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Anh Tuan Tran; Bach Hue Nguyen; Hong Nhien Trinh; Thi Thanh Hai Nguyen; Bao Tinh Le Binh; Khanh Le; Minh Tien Nguyen; Quang Tung Thai; Thanh Vu Vo; Ngoc Quang Minh Ngo] Children Hosp 1, 341 Su Van Hanh,Ward 10,Dist 10, Ho Chi Minh City, Vietnam; [Thi Thu Loan Tran; Quynh Huong Tran; Quoc Bao Vo; Nguyen Anh Tran Dac; Thi Kim Huyen Dang; Ngoc Huong Cao; Thu Van Tran; Lu Viet Ho] Children Hosp 2, 14 Ly Tu Trong,Dist 1, Ho Chi Minh City, Vietnam; [Menno de Jong] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands	University of Oxford; Murdoch Children's Research Institute; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam	Do, LAH (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Program, Ho Chi Minh City, Vietnam.; Do, LAH (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.	dr.anhha@gmail.com	Tran, Anh Tuan/GZB-0391-2022; Farrar, Jeremy J./HGA-7610-2022; van Doorn, H. Rogier/H-3080-2019	van Doorn, H. Rogier/0000-0002-9807-1821; Do, Lien Anh Ha/0000-0002-2401-8980; Bryant, Juliet/0000-0001-9535-4925	Wellcome Trust of Great Britain [077078/Z/05/Z]	Wellcome Trust of Great Britain(Wellcome Trust)	The study was funded by Wellcome Trust of Great Britain Grant, Ref: 077078/Z/05/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Wellcome Trust of Great Britain (077078/Z/05/Z). The funder had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript.	Anh HLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018176; Aramburo A, 2011, PEDIATR CRIT CARE ME, V12, pE160, DOI 10.1097/PCC.0b013e3181f36e86; Bera MM, 2011, J IMMUNOL, V187, P4245, DOI 10.4049/jimmunol.1101789; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Brand H. K., 2011, PEDIAT PULMONOL; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Calvo C, 2007, PEDIATR INFECT DIS J, V26, P904, DOI 10.1097/INF.0b013e31812e52e6; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Carnpanini G, 2007, J CLIN VIROL, V39, P119, DOI 10.1016/j.jcv.2007.03.009; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; Cui BL, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0863-6; DeVincenzo JP, 2004, PEDIATR RES, V56, P914, DOI 10.1203/01.PDR.0000145255.86117.6A; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Do LA, 2015, J GEN VIROL; EVERARD ML, 1994, ARCH DIS CHILD, V71, P428, DOI 10.1136/adc.71.5.428; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Fuller DG, 2005, PEDIATR INFECT DIS J, V24, P195, DOI 10.1097/01.inf.0000154367.02996.b1; Gern JE, 2002, PEDIAT ALLERG IMM-UK, V13, P386, DOI 10.1034/j.1399-3038.2002.01093.x; Gerna G, 2008, J CLIN VIROL, V41, P49, DOI 10.1016/j.jcv.2007.10.018; Gerna G, 2009, J MED VIROL, V81, P1498, DOI 10.1002/jmv.21548; HALL CB, 1976, J PEDIATR-US, V89, P11, DOI 10.1016/S0022-3476(76)80918-3; Healing T., 2006, COLL PRES SHIPP SPEC; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; Jansen RR, 2011, J CLIN VIROL, V51, P179, DOI 10.1016/j.jcv.2011.04.010; Kuypers J, 2004, J CLIN VIROL, V31, P123, DOI 10.1016/j.jcv.2004.03.018; Lee Jian-Te, 2007, Journal of Microbiology Immunology and Infection, V40, P293; Lien AHD, 2012, J VIROL METHODS, V179, P250, DOI 10.1016/j.jviromet.2011.11.012; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Mejias A, 2005, PEDIATR INFECT DIS J, V24, pS96; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Molenkamp R, 2007, J VIROL METHODS, V141, P205, DOI 10.1016/j.jviromet.2006.12.007; Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; O'Donnell DR, 2002, PEDIATR PULM, V34, P128, DOI 10.1002/ppul.10140; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Papoff P, 2011, ACTA PAEDIATR, V100, pe17, DOI 10.1111/j.1651-2227.2011.02181.x; Perkins SM, 2005, J CLIN MICROBIOL, V43, P2356, DOI 10.1128/JCM.43.5.2356-2362.2005; Peter F, 2000, GENERIC EXAMINE INCI; Rodriguez WJ, 1997, PEDIATRICS, V100, P937, DOI 10.1542/peds.100.6.937; Sanghavi SK, 2012, J MED VIROL, V84, P162, DOI 10.1002/jmv.22186; Simoes EAF, 2011, PEDIATR INFECT DIS J, V30, P778, DOI 10.1097/INF.0b013e318218ab9e; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Tuan TA, 2015, INFLUENZA OTHER RESP, V9, P110, DOI 10.1111/irv.12307; Van Leeuwen JC, 2011, PEDIAT INFECT DIS J; Wainwright C, 2003, NEW ENGL J MED, V349, P27, DOI 10.1056/NEJMoa022226; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Welliver Robert, 2009, Paediatr Respir Rev, V10 Suppl 1, P6, DOI 10.1016/S1526-0542(09)70004-1; Yoshida LM, 2010, PEDIATR INFECT DIS J, V29, P75, DOI 10.1097/INF.0b013e3181af61e9	52	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160606	10.1371/journal.pone.0160606	http://dx.doi.org/10.1371/journal.pone.0160606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500954	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500037
J	Marcus, DJ; Zee, ML; Davis, BJ; Haskins, CP; Andrews, MJ; Amin, R; Henderson-Redmond, AN; Mackie, K; Czyzyk, TA; Morgan, DJ				Marcus, David J.; Zee, Michael L.; Davis, Brian J.; Haskins, Chris P.; Andrews, Mary-Jeanette; Amin, Randa; Henderson-Redmond, Angela N.; Mackie, Ken; Czyzyk, Traci A.; Morgan, Daniel J.			Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic	PLOS ONE			English	Article							STIMULATES FOOD-INTAKE; BODY-WEIGHT; ENDOCANNABINOID SYSTEM; ENERGY-EXPENDITURE; RIMONABANT; DESENSITIZATION; DELTA(9)-THC; RATS; ANTAGONIST; BLOCKADE	Multiple lines of evidence implicate the endocannabinoid signaling system in the modulation of metabolic disease. Genetic or pharmacological inactivation of CB1 in rodents leads to reduced body weight, resistance to diet-induced obesity, decreased intake of highly palatable food, and increased energy expenditure. Cannabinoid agonists stimulate feeding in rodents and increased levels of endocannabinoids can disrupt lipid metabolism. Therefore, the hypothesis that sustained endocannabinoid signaling can lead to obesity and diabetes was examined in this study using S426A/S430A mutant mice expressing a desensitization-resistant CB1 receptor. These mice display exaggerated and prolonged responses to acute administration of phytocannabinoids, synthetic cannabinoids, and endocannabinoids. As a consequence these mice represent a novel model for determining the effect of enhanced endocannabinoid signaling on metabolic disease. S426A/S430A mutants consumed equivalent amounts of both high fat (45%) and low fat (10%) chow control diet compared to wildtype littermate controls. S426A/S430A mutants and wild-type mice fed either high or low fat control diet displayed similar fasting blood glucose levels and normal glucose clearance following a 2 g/kg glucose challenge. Furthermore, S426A/S430A mutants and wild-type mice consumed similar amounts of chow following an overnight fast. While both THC and JZL195 significantly increased food intake two hours after injection, this increase was similar between the S426A/S430A mutant and wildtype control mice Our results indicate that S426A/S430A mutant mice expressing the desensitization-resistant form of CB1 do not exhibit differences in body weight, food intake, glucose homeostasis, or re-feeding following a fast.	[Marcus, David J.; Davis, Brian J.; Haskins, Chris P.; Andrews, Mary-Jeanette; Amin, Randa; Mackie, Ken; Morgan, Daniel J.] Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA; [Marcus, David J.; Davis, Brian J.; Haskins, Chris P.; Andrews, Mary-Jeanette; Amin, Randa; Mackie, Ken; Morgan, Daniel J.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [Marcus, David J.; Zee, Michael L.; Haskins, Chris P.; Henderson-Redmond, Angela N.; Czyzyk, Traci A.; Morgan, Daniel J.] Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA; [Andrews, Mary-Jeanette; Amin, Randa; Mackie, Ken; Morgan, Daniel J.] Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Indiana University System; Indiana University Bloomington	Morgan, DJ (corresponding author), Indiana Univ, Gill Ctr Biomol Sci, Bloomington, IN 47405 USA.; Morgan, DJ (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.; Czyzyk, TA; Morgan, DJ (corresponding author), Penn State Coll Med, Dept Anesthesiol, Hershey, PA 17033 USA.; Morgan, DJ (corresponding author), Indiana Univ, Ctr Integrat Study Anim Behav, Bloomington, IN 47405 USA.	tczyzyk@hmc.psu.edu; djm68@psu.edu	Mackie, Ken/E-3715-2013	Mackie, Ken/0000-0001-8501-6199; Czyzyk, Traci/0000-0002-3888-8338; Morgan, Daniel/0000-0002-9467-4019	National Institutes of Health [DA011322, DA021696, DA036385]; Pennsylvania Department of Health using Tobacco CURE Funds; Indiana Academy of Sciences; Indiana University METACyt Initiative (Lilly Foundation); Linda and Jack Gill Center for Biomolecular Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health using Tobacco CURE Funds; Indiana Academy of Sciences; Indiana University METACyt Initiative (Lilly Foundation); Linda and Jack Gill Center for Biomolecular Science	This work was funded by National Institutes of Health grants DA011322 (KM), DA021696 (KM), and DA036385 (DJM). This project is funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco CURE Funds. Additional support was provided by the Indiana Academy of Sciences, the Indiana University METACyt Initiative (funded in part by a grant from the Lilly Foundation), and the Linda and Jack Gill Center for Biomolecular Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bermudez-Siva FJ, 2006, EUR J PHARMACOL, V531, P282, DOI 10.1016/j.ejphar.2005.12.016; Bisogno T, 2013, BRIT J PHARMACOL, V169, P784, DOI 10.1111/bph.12013; Burston JJ, 2010, BRIT J PHARMACOL, V161, P103, DOI 10.1111/j.1476-5381.2010.00870.x; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; Cristino L, 2013, P NATL ACAD SCI USA, V110, pE2229, DOI 10.1073/pnas.1219485110; Daigle TL, 2008, J NEUROCHEM, V106, P70, DOI 10.1111/j.1471-4159.2008.05336.x; Daigle TL, 2008, NEUROPHARMACOLOGY, V54, P36, DOI 10.1016/j.neuropharm.2007.06.005; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Gorter R, 1991, Oncology (Williston Park), V5, P13; GORTER R, 1992, AIDS, V6, P127, DOI 10.1097/00002030-199201000-00018; Hao SZ, 2000, EUR J PHARMACOL, V392, P147, DOI 10.1016/S0014-2999(00)00059-5; Herling AW, 2008, ENDOCRINOLOGY, V149, P2557, DOI 10.1210/en.2007-1515; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hsieh C, 1999, J NEUROCHEM, V73, P493, DOI 10.1046/j.1471-4159.1999.0730493.x; Jin WZ, 1999, J NEUROSCI, V19, P3773; Jourdan T, 2016, DIABETES OBES METAB, V18, P549, DOI 10.1111/dom.12646; Kirkham TC, 2001, NUTR RES REV, V14, P65, DOI 10.1079/NRR200118; Kirkham Tim C, 2004, Treat Endocrinol, V3, P345, DOI 10.2165/00024677-200403060-00003; Koch JE, 2001, PHARMACOL BIOCHEM BE, V68, P539, DOI 10.1016/S0091-3057(01)00467-1; Kunz I, 2008, INT J OBESITY, V32, P863, DOI 10.1038/ijo.2008.3; Lazenka MF, 2014, NEUROPHARMACOLOGY, V77, P224, DOI 10.1016/j.neuropharm.2013.09.019; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; LoVerme J, 2009, BIOORG MED CHEM LETT, V19, P639, DOI 10.1016/j.bmcl.2008.12.059; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; May AL, 2013, MMWR-MORBID MORTAL W, V62, P120; McKinney DL, 2008, J PHARMACOL EXP THER, V324, P664, DOI 10.1124/jpet.107.130328; Morgan DJ, 2014, J NEUROSCI, V34, P5152, DOI 10.1523/JNEUROSCI.3445-12.2014; Nam DH, 2012, ENDOCRINOLOGY, V153, P1387, DOI 10.1210/en.2011-1423; Nguyen PT, 2012, BIOL PSYCHIAT, V71, P714, DOI 10.1016/j.biopsych.2011.11.027; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; SALLAN SE, 1975, NEW ENGL J MED, V293, P795, DOI 10.1056/NEJM197510162931603; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Soria-Gomez E, 2007, BRIT J PHARMACOL, V151, P1109, DOI 10.1038/sj.bjp.0707313; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Thornton-Jones ZD, 2006, PHARMACOL BIOCHEM BE, V84, P353, DOI 10.1016/j.pbb.2006.06.001; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Trillou CR, 2004, INT J OBESITY, V28, P640, DOI 10.1038/sj.ijo.0802583; Wiley JL, 2005, BRIT J PHARMACOL, V145, P293, DOI 10.1038/sj.bjp.0706157; Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953; Williams CM, 1998, PHYSIOL BEHAV, V65, P343, DOI 10.1016/S0031-9384(98)00170-X; Williams CM, 2002, PHARMACOL BIOCHEM BE, V71, P333, DOI 10.1016/S0091-3057(01)00694-3; Zhuang SY, 1998, MOL BRAIN RES, V62, P141, DOI 10.1016/S0169-328X(98)00232-0	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160462	10.1371/journal.pone.0160462	http://dx.doi.org/10.1371/journal.pone.0160462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501235	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500027
J	Sawant, S; Dongre, H; Singh, AK; Joshi, S; Costea, DE; Mahadik, S; Ahire, C; Makani, V; Dange, P; Sharma, S; Chaukar, D; Vaidya, M				Sawant, Sharada; Dongre, Harsh; Singh, Archana Kumari; Joshi, Shriya; Costea, Daniela Elena; Mahadik, Snehal; Ahire, Chetan; Makani, Vidhi; Dange, Prerana; Sharma, Shilpi; Chaukar, Devendra; Vaidya, Milind			Establishment of 3D Co-Culture Models from Different Stages of Human Tongue Tumorigenesis: Utility in Understanding Neoplastic Progression	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DELTA T-CELLS; EPITHELIAL-CELLS; ORAL-MUCOSA; IN-VITRO; TUMOR MICROENVIRONMENT; ORGANOTYPIC MODEL; HUMAN SKIN; FIBROBLASTS; CANCER	To study multistep tumorigenesis process, there is a need of in-vitro 3D model simulating in-vivo tissue. Present study aimed to reconstitute in-vitro tissue models comprising various stages of neoplastic progression of tongue tumorigenesis and to evaluate the utility of these models to investigate the role of stromal fibroblasts in maintenance of desmosomal anchoring junctions using transmission electronmicroscopy. We reconstituted in-vitro models representing normal, dysplastic, and malignant tissues by seeding primary keratinocytes on either fibroblast embedded in collagen matrix or plain collagen matrix in growth factor-free medium. The findings of histomorphometry, immunohistochemistry, and electron microscopy analyses of the three types of 3D cultures showed that the stratified growth, cell proliferation, and differentiation were comparable between co-cultures and their respective native tissues; however, they largely differed in cultures grown without fibroblasts. The immunostaining intensity of proteins, viz., desmoplakin, desmoglein, and plakoglobin, was reduced as the disease stage increased in all co-cultures as observed in respective native tissues. Desmosome-like structures were identified using immunogold labeling in these cultures. Moreover, electron microscopic observations revealed that the desmosome number and their length were significantly reduced and intercellular spaces were increased in cultures grown without fibroblasts when compared with their co-culture counterparts. Our results showed that the major steps of tongue tumorigenesis can be reproduced in-vitro. Stromal fibroblasts play a role in regulation of epithelial thickness, cell proliferation, differentiation, and maintenance of desmosomalanchoring junctions in in-vitro grown tissues. The reconstituted co-culture models could help to answer various biological questions especially related to tongue tumorigenesis.	[Sawant, Sharada; Dongre, Harsh; Singh, Archana Kumari; Joshi, Shriya; Mahadik, Snehal; Ahire, Chetan; Dange, Prerana; Vaidya, Milind] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Vaidya Lab, Navi Mumbai, Maharashtra, India; [Costea, Daniela Elena] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Costea, Daniela Elena] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Costea, Daniela Elena] Haukeland Hosp, Dept Pathol, Bergen, Norway; [Makani, Vidhi] Indian Inst Sci Educ & Res, Nups & Sumo Biol Grp, Dept Biol Sci, Bhopal, Madhya Pradesh, India; [Sharma, Shilpi; Chaukar, Devendra] Tata Mem Hosp, Oral Surg Head & Neck Unit, Bombay, Maharashtra, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Indian Institute of Science Education & Research (IISER) - Bhopal; Tata Memorial Centre (TMC); Tata Memorial Hospital	Sawant, S (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Vaidya Lab, Navi Mumbai, Maharashtra, India.	sssawant@actrec.gov.in	Costea, Daniela Elena/AAB-9705-2020; Dongre, Harsh/O-2246-2019	Dongre, Harsh/0000-0003-4378-2869; Costea, Daniela-Elena/0000-0001-7673-0358; Sharma, Shilpi/0000-0002-6601-8559; Ahire, Chetan/0000-0003-1034-2031	Lady Tata Memorial Trust (IN) [2864]	Lady Tata Memorial Trust (IN)	S. Sawant received support from Lady Tata Memorial Trust (IN [http://www.ladytatatrust.org/StaticPageIndia/Home/0] grant no. 2864.	Atula S, 1997, EXP CELL RES, V235, P180, DOI 10.1006/excr.1997.3676; Bao K, 2014, CELLS TISSUES ORGANS, V199, P228, DOI 10.1159/000363694; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; BERGSTRAESSER LM, 1993, CANCER RES, V53, P2644; Berndt A, 1997, INVAS METAST, V17, P251; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Colley HE, 2011, BRIT J CANCER, V105, P1582, DOI 10.1038/bjc.2011.403; Costea DE, 2006, AM J PATHOL, V168, P1889, DOI 10.2353/ajpath.2006.050843; Costea DE, 2013, CANCER RES, V73, P3888, DOI 10.1158/0008-5472.CAN-12-4150; Costea DE, 2005, DIFFERENTIATION, V73, P134, DOI 10.1111/j.1432-0436.2005.00017.x; Costea DE, 2003, J INVEST DERMATOL, V121, P1479, DOI 10.1111/j.1523-1747.2003.12616.x; CUNHA GR, 1983, RECENT PROG HORM RES, V39, P559; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; DELUCA M, 1990, P NATL ACAD SCI USA, V87, P6888, DOI 10.1073/pnas.87.17.6888; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Gaballah K, 2008, J PATHOL, V215, P280, DOI 10.1002/path.2360; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gibbs S, 2000, ARCH ORAL BIOL, V45, P149, DOI 10.1016/S0003-9969(99)00116-8; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844; Kinikoglu B, 2011, BIOMATERIALS, V32, P5756, DOI 10.1016/j.biomaterials.2011.04.054; Klausner M, 2007, TOXICOL IN VITRO, V21, P938, DOI 10.1016/j.tiv.2007.01.024; KOVACS EJ, 1994, FASEB J, V8, P854, DOI 10.1096/fasebj.8.11.7520879; Kunz-Schughart LA, 2001, EXP CELL RES, V266, P74, DOI 10.1006/excr.2001.5210; MACKENZIE IC, 1984, CELL TISSUE RES, V235, P551; Merne M, 2003, ARCH DERMATOL RES, V295, P190, DOI 10.1007/s00403-003-0419-2; Misra Vatsala, 2009, Indian J Community Med, V34, P321, DOI 10.4103/0970-0218.58391; Mostefaoui Y, 2004, CELL MICROBIOL, V6, P1085, DOI 10.1111/j.1462-5822.2004.00420.x; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Mueller MM, 2002, DIFFERENTIATION, V70, P486, DOI 10.1046/j.1432-0436.2002.700903.x; Nurmenniemi S, 2009, AM J PATHOL, V175, P1281, DOI 10.2353/ajpath.2009.081110; Okazaki M, 2003, PLAST RECONSTR SURG, V112, P784, DOI 10.1097/01.PRS.0000069710.48139.4E; PAN YM, 1995, J PERIODONTAL RES, V30, P97, DOI 10.1111/j.1600-0765.1995.tb01258.x; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Sawant SS, 2014, ORAL DIS, V20, P453, DOI 10.1111/odi.12151; Sawant S, 2016, CLIN ORAL INVEST, V20, P43, DOI 10.1007/s00784-015-1476-6; SHARPE PM, 1988, J CELL SCI, P195; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Stark HJ, 1999, J INVEST DERMATOL, V112, P681, DOI 10.1046/j.1523-1747.1999.00573.x; Teppo S, 2013, EXP CELL RES, V319, P376, DOI 10.1016/j.yexcr.2012.12.010; Yamashita S, 2014, J HISTOCHEM CYTOCHEM, V62, P584, DOI 10.1369/0022155414537899	47	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160615	10.1371/journal.pone.0160615	http://dx.doi.org/10.1371/journal.pone.0160615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501241	gold, Green Submitted, Green Published			2022-12-26	WOS:000381373500040
J	Garcia-Benitez, C; Melgarejo, P; De Cal, A; Fontaniella, B				Garcia-Benitez, Carlos; Melgarejo, Paloma; De Cal, Antonieta; Fontaniella, Blanca			Microscopic Analyses of Latent and Visible Monilinia fructicola Infections in Nectarines	PLOS ONE			English	Article							F-SP-TRITICI; BROWN-ROT; COLLETOTRICHUM-GLOEOSPORIOIDES; PEACH FRUIT; IN-VITRO; CONIDIAL GERMINATION; FUSARIUM-MONILIFORME; DISEASE EXPRESSION; AIRBORNE CONIDIA; PLUM FRUIT	Little is known about the histologic features of a latent Monilinia fructicola infection and brown rot in infected fruit. This report informs on the results of an investigation whose aim was to analyze the microanatomy of nectarines with a latent and visible M. fructicola infection. Mature nectarines were inoculated with an M. fructicola isolate and incubated at 25 degrees C for 0, 24, 48, 72, or 96 hours in the dark. For investigating the latent infection process, the inoculated nectarines were first incubated at 25 degrees C for 24 hours in the dark and then incubated at 4 degrees C for 72, 144, 216, and 288 hours in the dark. At the end of the incubation, samples of nectarine tissue were excised from the inoculation points and prepared for light and transmission electron microscopic examinations. No signs of disease were seen on the surface of nectarines with a latent infection over the 288-hour incubation period. When the tissue samples were microscopically examined, M. fructicola colonized the stomata and this stomatal colonization progressively increased over time and was associated with gradual collapse of the epidermal cells and colonization of the subepidermis. In nectarines with visible brown rot, the disease usually appeared after 24 hours on the surface and in the uppermost layers of epidermal cells, which began to collapse after 48 hours. Subsequently, the diseased tissues of the nectarines displayed (a) colonization of the epidermis and mesocarp by M. fructicola with thin and thick hyphae, (b) collapse and disruption of epidermal and mesocarpic cells, (c) lysogenic cavities in the subepidermis and mesocarp, (d) degradation of the cuticle and epidermis, and (e) M. fructicola sporulation. M. fructicola is active during latent infections because slow and progressive colonization of nectarine subcuticular cells by the fungus occurs.	[Garcia-Benitez, Carlos; Melgarejo, Paloma; De Cal, Antonieta] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Madrid, Spain; [Fontaniella, Blanca] Univ Complutense Madrid, Fac Biol, Dept Vegetal Biol 1, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Complutense University of Madrid	De Cal, A (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Plant Protect, Madrid, Spain.	cal@inia.es	De Cal, Antonieta/ABB-6197-2020; De Cal, Antonieta/E-5260-2010	De Cal, Antonieta/0000-0002-7725-7782; De Cal, Antonieta/0000-0002-7725-7782; Fontaniella, Blanca/0000-0001-9396-7816	Ministry of Science and Innovation (Spain) [AGL2011-30472-CO2-02, AGL2014-55287-CO2-01, BES-2012-053796]; ICTS Centro Microscopia Electronica from the Complutense University of Madrid (Spain)	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICTS Centro Microscopia Electronica from the Complutense University of Madrid (Spain)	This study was supported by grants AGL2011-30472-CO2-02 and AGL2014-55287-CO2-01 from the Ministry of Science and Innovation (Spain). C. Garcia-Benitez received a scholarship BES-2012-053796 from the Ministry of Science and Innovation (Spain).; This study was supported by grants AGL2011-30472-CO2-02 and AGL2014-55287-CO2-01 from the Ministry of Science and Innovation (Spain). C. Garcia-Benitez received a scholarship BES-2012-053796 from the Ministry of Science and Innovation (Spain). We thank R. Castillo for their technical collaboration. We also thank the ICTS Centro Microscopia Electronica from the Complutense University of Madrid (Spain) for their support and technical expertise for the transmission electron microscopic analysis. The authors would like to acknowledge Dr. Arieh Bomzon, ConsulWrite (www.consulwrite.com) for his editorial assistance in preparing this manuscript.	Ahimera N, 2003, PLANT DIS, V87, P846, DOI 10.1094/PDIS.2003.87.7.846; Bacon CW, 1996, CAN J BOT, V74, P1195, DOI 10.1139/b96-144; BIGGS AR, 1988, PLANT DIS, V72, P1070, DOI 10.1094/PD-72-1070; BINYAMINI N, 1972, MYCOLOGIA, V64, P916, DOI 10.2307/3757948; BROWN GE, 1975, PHYTOPATHOLOGY, V65, P404, DOI 10.1094/Phyto-65-404; BROWN GE, 1977, PHYTOPATHOLOGY, V67, P315, DOI 10.1094/Phyto-67-315; Byrde R.J.W., 1977, BROWN ROT FUNGI FRUI; Curtis KM, 1928, ANN BOT-LONDON, V42, P39, DOI 10.1093/oxfordjournals.aob.a090116; DAYKIN ME, 1984, PLANT DIS, V68, P948, DOI 10.1094/PD-69-948; De Cal A, 1999, PLANT DIS, V83, P62, DOI 10.1094/PDIS.1999.83.1.62; De Cal A, 2013, POSTHARVEST BIOL TEC, V86, P418, DOI 10.1016/j.postharvbio.2013.07.012; Emery KM, 2000, PLANT DIS, V84, P853, DOI 10.1094/PDIS.2000.84.8.853; FOURIE JF, 1995, PHYTOPATHOLOGY, V85, P82, DOI 10.1094/Phyto-85-82; Fourie PH, 2003, AUSTRALAS PLANT PATH, V32, P9, DOI 10.1071/AP02063; Fourie PH, 2003, AUSTRALAS PLANT PATH, V32, P19, DOI 10.1071/AP02066; Gell I, 2008, EUR J PLANT PATHOL, V121, P487, DOI 10.1007/s10658-008-9268-3; GRAMBOW HJ, 1978, Z PFLANZENPHYSIOL, V90, P1; GRAMBOW HJ, 1977, PHYSIOL PLANT PATHOL, V11, P213, DOI 10.1016/0048-4059(77)90060-1; Holliday P, 2001, DICT PLANT PATHOLOGY; Horowitz S, 2002, PHYTOPATHOLOGY, V92, P743, DOI 10.1094/PHYTO.2002.92.7.743; Impullitti AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098311; Janisiewicz WJ, 2011, ACTA HORTIC, V905, P241, DOI 10.17660/ActaHortic.2011.905.26; Lalancette N, 2015, ACTA HORTIC, V1084, P563, DOI 10.17660/ActaHortic.2015.1084.76; Lee MH, 2007, PHYTOPATHOLOGY, V97, P269, DOI 10.1094/PHYTO-97-3-0269; Lee MH, 2006, PHYTOPATHOLOGY, V96, P1072, DOI 10.1094/PHYTO-96-1072; Lee MH, 2010, MOL PLANT MICROBE IN, V23, P176, DOI 10.1094/MPMI-23-2-0176; Luo Y, 2001, PLANT DIS, V85, P999, DOI 10.1094/PDIS.2001.85.9.999; Luo Y, 2001, PHYTOPATHOLOGY, V91, P864, DOI 10.1094/PHYTO.2001.91.8.759; MAGAN N, 1988, INT J FOOD MICROBIOL, V7, P245, DOI [10.1016/0168-1605(88)90043-8, 10.1016/S0168-1605(97)00067-6]; MUIRHEAD IF, 1981, PHYSIOL PLANT PATHOL, V19, P77; NORTHOVER J, 1994, CAN J PLANT PATHOL, V16, P30, DOI 10.1080/07060669409500785; Oren L, 2003, APPL ENVIRON MICROB, V69, P1695, DOI 10.1128/AEM.69.3.1695-1701.2003; PETERSON GW, 1969, PHYTOPATHOLOGY, V59, P1044; PHILLIPS DJ, 1984, PLANT DIS, V68, P610, DOI 10.1094/PD-69-610; PRUSKY D, 1983, PLANT DIS, V67, P816, DOI 10.1094/PD-67-816; Prusky D, 1996, ANNU REV PHYTOPATHOL, V34, P413, DOI 10.1146/annurev.phyto.34.1.413; Prusky D, 2003, ACTA HORTIC, V645, P605; Prusky D, 2013, ANNU REV PHYTOPATHOL, V51, P155, DOI 10.1146/annurev-phyto-082712-102349; Rungjindamai N, 2014, EUR J PLANT PATHOL, V140, P1, DOI 10.1007/s10658-014-0452-3; Smith MA, 1936, PHYTOPATHOLOGY, V26, P1056; STANGHEL.ME, 1966, PHYTOPATHOLOGY, V56, P444; TAMM L, 1993, PHYTOPATHOLOGY, V83, P1321, DOI 10.1094/Phyto-83-1321; TAMM L, 1995, PHYTOPATHOLOGY, V85, P401; VERHOEFF K, 1974, ANNU REV PHYTOPATHOL, V12, P99, DOI 10.1146/annurev.py.12.090174.000531; Villarino M, 2016, INT J FOOD MICROBIOL, V224, P22, DOI 10.1016/j.ijfoodmicro.2016.02.011; Villarino M, 2011, J AGR FOOD CHEM, V59, P3205, DOI 10.1021/jf104251z; WADE GC, 1992, J PHYTOPATHOL, V136, P95, DOI 10.1111/j.1439-0434.1992.tb01287.x; Wang GY, 2000, ARCH BIOCHEM BIOPHYS, V382, P31, DOI 10.1006/abbi.2000.1995; Xu XM, 2007, PLANT PATHOL, V56, P114, DOI 10.1111/j.1365-3059.2006.01502.x; Xu XM, 2001, PLANT PATHOL, V50, P561, DOI 10.1046/j.1365-3059.2001.00606.x; Yates IE, 1997, PLANT DIS, V81, P723, DOI 10.1094/PDIS.1997.81.7.723	51	17	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160675	10.1371/journal.pone.0160675	http://dx.doi.org/10.1371/journal.pone.0160675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494620	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000381369500074
J	Ball, J; Salvi, F; Gadda, G				Ball, Jacob; Salvi, Francesca; Gadda, Giovanni			Functional Annotation of a Presumed Nitronate Monoxygenase Reveals a New Class of NADH:Quinone Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLD YELLOW ENZYME; FATTY-ACID OXIDATION; QUINONE REDUCTASE; DT-DIAPHORASE; 2-NITROPROPANE DIOXYGENASE; 2-ELECTRON REDUCTION; CRYSTAL-STRUCTURE; 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE CB-1954; NAD(P)H-QUINONE REDUCTASE; SACCHAROMYCES-CEREVISIAE	The protein PA1024 from Pseudomonas aeruginosa PAO1 is currently classified as 2-nitropropane dioxygenase, the previous name for nitronate monooxygenase in the GenBank (TM) and PDB databases, but the enzyme was not kinetically characterized. In this study, PA1024 was purified to high levels, and the enzymatic activity was investigated by spectroscopic and polarographic techniques. Purified PA1024 did not exhibit nitronate monooxygenase activity; however, it displayed NADH: quinone reductase and a small NADH: oxidase activity. The enzyme preferred NADH to NADPH as a reducing substrate. PA1024 could reduce a broad spectrum of quinone substrates via a Ping Pong Bi Bi steady-state kinetic mechanism, generating the corresponding hydroquinones. The reductive half-reaction with NADH showed a k(red) value of 24 s(-1) and an apparent K-d value estimated in the low micromolar range. The enzyme was not able to reduce the azo dye methyl red, routinely used in the kinetic characterization of azoreductases. Finally, we revisited and modified the existing six conserved motifs of PA1024, which define a new class of NADH:quinone reductases and are present in more than	[Ball, Jacob; Salvi, Francesca; Gadda, Giovanni] Georgia State Univ, Dept Chem, POB 3965, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Biotechnol & Drug Design, Atlanta, GA 30302 USA; [Gadda, Giovanni] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Gadda, G (corresponding author), Georgia State Univ, Dept Chem, POB 3965, Atlanta, GA 30302 USA.	ggadda@gsu.edu	Gadda, Giovanni/M-2354-2016	Gadda, Giovanni/0000-0002-7508-4195; Ball, Jacob/0000-0002-5176-0048; Salvi, Francesca/0000-0001-5294-1310	National Science Foundation [CHE-1506518]; Georgia State University	National Science Foundation(National Science Foundation (NSF)); Georgia State University	This work was supported in part by National Science Foundation Grant CHE-1506518 (to G. G.), and a Molecular Basis of Disease Fellowship from Georgia State University (to F. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anton BP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001638; Anusevicius Z, 2005, ARCH BIOCHEM BIOPHYS, V437, P144, DOI 10.1016/j.abb.2005.03.015; Bin Y, 2004, FEMS MICROBIOL LETT, V236, P129, DOI 10.1016/j.femsle.2004.05.034; Bogachev AV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P143, DOI 10.1007/s10541-005-0093-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen HZ, 2004, PROTEIN EXPRES PURIF, V34, P302, DOI 10.1016/j.pep.2003.12.016; CHESIS PL, 1984, P NATL ACAD SCI-BIOL, V81, P1696, DOI 10.1073/pnas.81.6.1696; Deller S, 2008, CELL MOL LIFE SCI, V65, P141, DOI 10.1007/s00018-007-7300-y; Foster CE, 1999, BIOCHEMISTRY-US, V38, P9881, DOI 10.1021/bi990799v; Francis K, 2005, J BIOL CHEM, V280, P5195, DOI 10.1074/jbc.M411249200; Francis K, 2013, IUBMB LIFE, V65, P759, DOI 10.1002/iub.1195; Francis K, 2009, BIOORG CHEM, V37, P167, DOI 10.1016/j.bioorg.2009.07.005; Gadda G, 2012, BIOCHEMISTRY-US, V51, P2662, DOI 10.1021/bi300227d; Gonzalez CF, 2005, J BIOL CHEM, V280, P22590, DOI 10.1074/jbc.M501654200; Green LK, 2014, J MICROBIOL, V52, P771, DOI 10.1007/s12275-014-4208-8; Ha JY, 2006, J BIOL CHEM, V281, P18660, DOI 10.1074/jbc.M601658200; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; IYANAGI T, 1990, FREE RADICAL RES COM, V8, P259, DOI 10.3109/10715769009053359; Jadhav SB, 2013, ENVIRON SCI POLLUT R, V20, P2854, DOI 10.1007/s11356-012-1155-y; Jordan BJ, 2007, CHEM COMMUN, P1248, DOI 10.1039/b616159f; Kabra AN, 2013, WATER RES, V47, P1035, DOI 10.1016/j.watres.2012.11.007; Karplus PA, 1995, FASEB J, V9, P1518, DOI 10.1096/fasebj.9.15.8529830; KIMURA RE, 1988, PEDIATR RES, V23, P262, DOI 10.1203/00006450-198803000-00006; Knox RJ, 2000, CANCER RES, V60, P4179; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4661, DOI 10.1016/0006-2952(88)90335-8; KNOX RJ, 1988, BIOCHEM PHARMACOL, V37, P4671, DOI 10.1016/0006-2952(88)90336-X; Laskowski MJ, 2002, PLANT PHYSIOL, V128, P578, DOI 10.1104/pp.010581; LEQUOC D, 1989, ARCH BIOCHEM BIOPHYS, V273, P466, DOI 10.1016/0003-9861(89)90506-7; Leskovac V, 2005, INT J BIOCHEM CELL B, V37, P731, DOI 10.1016/j.biocel.2004.10.014; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; MATTHEWS RG, 1986, METHOD ENZYMOL, V122, P372; MCCOMB RB, 1976, CLIN CHEM, V22, P141; Mijatovic S, 2008, ARCH BIOCHEM BIOPHYS, V473, P61, DOI 10.1016/j.abb.2008.02.029; Muller N, 2009, J BACTERIOL, V191, P6167, DOI 10.1128/JB.01605-08; Munday R, 2000, FREE RADICAL RES, V32, P245, DOI 10.1080/10715760000300251; Nakanishi M, 2001, J BIOL CHEM, V276, P46394, DOI 10.1074/jbc.M104483200; Nam S, 2000, CHEMOSPHERE, V40, P351, DOI 10.1016/S0045-6535(99)00226-X; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; NISHIMOTO K, 1978, BIOCHIM BIOPHYS ACTA, V526, P34, DOI 10.1016/0005-2744(78)90287-5; Nivinskas H, 2002, ARCH BIOCHEM BIOPHYS, V403, P249, DOI 10.1016/S0003-9861(02)00228-X; Opperman DJ, 2008, J BACTERIOL, V190, P3076, DOI 10.1128/JB.01766-07; Patridge EV, 2006, J BACTERIOL, V188, P3498, DOI 10.1128/JB.188.10.3498-3506.2006; Pintea AM, 2008, CHEM FUNCT PROP FOOD, P101; Punj S, 2009, CURR ISSUES MOL BIOL, V11, P59; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; Ryan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098551; Ryan A, 2010, PROTEIN CELL, V1, P780, DOI 10.1007/s13238-010-0090-2; Salvi F, 2014, J BIOL CHEM, V289, P23764, DOI 10.1074/jbc.M114.577791; Sedlacek V, 2009, ARCH BIOCHEM BIOPHYS, V483, P29, DOI 10.1016/j.abb.2008.12.016; Siegel David, 2008, P169, DOI 10.1007/978-0-387-77300-1_7; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Skelly JV, 1999, J MED CHEM, V42, P4325, DOI 10.1021/jm991060m; Smitherman C, 2013, BIOCHEMISTRY-US, V52, P2694, DOI 10.1021/bi400030d; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sparla F, 1999, FEBS LETT, V463, P382, DOI 10.1016/S0014-5793(99)01625-7; Suzuki Y, 2001, J BIOL CHEM, V276, P9059, DOI 10.1074/jbc.M008083200; TEDESCHI G, 1995, J BIOL CHEM, V270, P1198, DOI 10.1074/jbc.270.3.1198; THOMSON RH, 1991, PHARM WEEKBLAD, V13, P70, DOI 10.1007/BF01974983; Ullmann E, 2014, BIOSCIENCE REP, V34, P893, DOI 10.1042/BSR20140143; WAKIL SJ, 1954, J BIOL CHEM, V207, P631; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhao M, 2014, ENVIRON SCI POLLUT R, V21, P6136, DOI 10.1007/s11356-014-2579-3	67	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21160	+		10.1074/jbc.M116.739151	http://dx.doi.org/10.1074/jbc.M116.739151			32	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27502282	hybrid, Green Published			2022-12-26	WOS:000385406200030
J	Bednarski, C; Tomczak, K; vom Hoevel, B; Weber, WM; Cathomen, T				Bednarski, Christien; Tomczak, Katja; vom Hoevel, Beate; Weber, Wolf-Michael; Cathomen, Toni			Targeted Integration of a Super-Exon into the CFTR Locus Leads to Functional Correction of a Cystic Fibrosis Cell Line Model	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; CONDUCTANCE REGULATOR GENE; EXPRESSION; IDENTIFICATION; COMBINATION; GENERATION; DELTA-F508; MUTATIONS; TRANSPORT; DISEASE	In vitro disease models have enabled insights into the pathophysiology of human disease as well as the functional evaluation of new therapies, such as novel genome engineering strategies. In the context of cystic fibrosis (CF), various cellular disease models have been established in recent years, including organoids based on induced pluripotent stem cell technology that allowed for functional readouts of CFTR activity. Yet, many of these in vitro CF models require complex and expensive culturing protocols that are difficult to implement and may not be amenable for high throughput screens. Here, we show that a simple cellular CF disease model based on the bronchial epithelial Delta F508 cell line CFBE41o-can be used to validate functional CFTR correction. We used an engineered nuclease to target the integration of a super-exon, encompassing the sequences of CFTR exons 11 to 27, into exon 11 and re-activated endogenous CFTR expression by treating CFBE41o-cells with a demethylating agent. We demonstrate that the integration of this super-exon resulted in expression of a corrected mRNA from the endogenous CFTR promoter and used short-circuit current measurements in Ussing chambers to corroborate restored ion transport of the repaired CFTR channels. In conclusion, this study proves that the targeted integration of a large super-exon in CFTR exon 11 leads to functional correction of CFTR, suggesting that this strategy can be used to functionally correct all CFTR mutations located downstream of the 5' end of exon 11.	[Bednarski, Christien; vom Hoevel, Beate; Cathomen, Toni] Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany; [Bednarski, Christien; vom Hoevel, Beate; Cathomen, Toni] Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Tomczak, Katja; Weber, Wolf-Michael] Univ Munster, Inst Anim Physiol, Munster, Germany; [Cathomen, Toni] Univ Freiburg, Fac Med, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Munster; University of Freiburg	Cathomen, T (corresponding author), Univ Freiburg, Med Ctr, Inst Cell & Gene Therapy, Freiburg, Germany.; Cathomen, T (corresponding author), Univ Freiburg, Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.; Cathomen, T (corresponding author), Univ Freiburg, Fac Med, Freiburg, Germany.	toni.cathomen@uniklinik-freiburg.de	Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630	Bundesministerium fur Bildung und Forschung [BMBF-01EO0803, GALENUS-01GM1106F]; Mukoviszidose Institut GmbH [S03/11]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Mukoviszidose Institut GmbH	This study was supported by Bundesministerium fur Bildung und Forschung, (BMBF-01EO0803 and GALENUS-01GM1106F to TC), http://www.bmbf.de/; and Mukoviszidose Institut GmbH (S03/11 to TC), https://muko.info/mukoviszidose-institut/mukoviszidose-institut.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Alton EWFW, 2013, THORAX; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Botelho HM, 2015, SCI REP-UK, V5, DOI 10.1038/srep09038; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Cormet-Boyaka E, 2009, FASEB J, V23, P3743, DOI 10.1096/fj.08-127878; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; Dreyer AK, 2015, BIOMATERIALS, V69, P191, DOI 10.1016/j.biomaterials.2015.07.057; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Gellhaus K, 2010, HUM GENE THER, V21, P543, DOI 10.1089/hum.2009.167; Gosalia N, 2015, GENES-BASEL, V6, P543, DOI 10.3390/genes6030543; Gruenert D C, 2004, J Cyst Fibros, V3 Suppl 2, P191, DOI 10.1016/j.jcf.2004.05.040; Heda GD, 2000, BIOCHEM BIOPH RES CO, V271, P659, DOI 10.1006/bbrc.2000.2684; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Iiizumi S, 2008, NUCLEIC ACIDS RES, V36, P6333, DOI 10.1093/nar/gkn649; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maier DA, 2013, HUM GENE THER, V24, P245, DOI 10.1089/hum.2012.172; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Muller M, 2016, MOL THER, V24, P636, DOI 10.1038/mt.2015.218; Mussolino C, 2014, NUCL ACIDS RES; Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Ott CJ, 2009, P NATL ACAD SCI USA, V106, P19934, DOI 10.1073/pnas.0900946106; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Rahman SH, 2013, HUM GENE THER, V24, P67, DOI 10.1089/hum.2012.168; Ramalingam S, 2013, STEM CELLS DEV, V22, P595, DOI 10.1089/scd.2012.0245; Randell SH, 2011, METHODS MOL BIOL, V742, P285, DOI 10.1007/978-1-61779-120-8_18; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Riordan JR, 1989, SCIENCE, P245; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Suzuki S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.43; Swiatecka-Urban A, 2005, J BIOL CHEM, V280, P36762, DOI 10.1074/jbc.M508944200; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358; Yigit E, 2013, NUCLEIC ACIDS RES, V41, P2857, DOI 10.1093/nar/gks1462; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K	58	31	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161072	10.1371/journal.pone.0161072	http://dx.doi.org/10.1371/journal.pone.0161072			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526025	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100032
J	Choi, JP; Foley, M; Zhou, ZN; Wong, WY; Gokoolparsadh, N; Arthur, JSC; Li, DY; Zheng, XJ				Choi, Jaesung P.; Foley, Matthew; Zhou, Zinan; Wong, Weng-Yew; Gokoolparsadh, Naveena; Arthur, J. Simon C.; Li, Dean Y.; Zheng, Xiangjian			Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice	PLOS ONE			English	Article							VASCULAR INTEGRITY; OSMIUM-TETROXIDE; ENCODING KRIT1; MUTATIONS; PATHWAY; PROTEIN; CCM1; DISEASE; GROWTH; HEART	Mutations in CCM1 (aka KRIT1), CCM2, or CCM3 (aka PDCD10) gene cause cerebral cavernous malformation in humans. Mouse models of CCM disease have been established by deleting Ccm genes in postnatal animals. These mouse models provide invaluable tools to investigate molecular mechanism and therapeutic approaches for CCM disease. However, the full value of these animal models is limited by the lack of an accurate and quantitative method to assess lesion burden and progression. In the present study we have established a refined and detailed contrast enhanced X-ray micro-CT method to measure CCM lesion burden in mouse brains. As this study utilized a voxel dimension of 9.5 mu m (leading to a minimum feature size of approximately 25 mu m), it is therefore sufficient to measure CCM lesion volume and number globally and accurately, and provide high-resolution 3-D mapping of CCM lesions in mouse brains. Using this method, we found loss of Ccm1 or Ccm2 in neonatal endothelium confers CCM lesions in the mouse hindbrain with similar total volume and number. This quantitative approach also demonstrated a rescue of CCM lesions with simultaneous deletion of one allele of Mekk3. This method would enhance the value of the established mouse models to study the molecular basis and potential therapies for CCM and other cerebrovascular diseases.	[Choi, Jaesung P.; Wong, Weng-Yew; Zheng, Xiangjian] Centenary Inst, Lab Cardiovasc Signaling, Sydney, NSW 2050, Australia; [Choi, Jaesung P.; Zheng, Xiangjian] Univ Sydney, Sydney Med Sch, Fac Med, Sydney, NSW 2050, Australia; [Foley, Matthew; Gokoolparsadh, Naveena] Univ Sydney, Australian Ctr Microscopy & Microanal, Sydney, NSW 2006, Australia; [Zhou, Zinan] Univ Penn, Dept Pharmacol, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Zhou, Zinan] Univ Penn, Cardiovasc Inst, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Arthur, J. Simon C.] Univ Dundee, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland; [Li, Dean Y.] Univ Utah, Div Cardiovasc Med, Salt Lake City, UT 84112 USA; [Li, Dean Y.] Univ Utah, Program Mol Med, Salt Lake City, UT 84112 USA	University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Pennsylvania; University of Pennsylvania; University of Dundee; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Zheng, XJ (corresponding author), Centenary Inst, Lab Cardiovasc Signaling, Sydney, NSW 2050, Australia.; Zheng, XJ (corresponding author), Univ Sydney, Sydney Med Sch, Fac Med, Sydney, NSW 2050, Australia.	x.zheng@centenary.org.au		Arthur, Simon/0000-0002-8135-1958; Choi, Jaesung Peter/0000-0002-0135-8632; Zheng, Xiangjian/0000-0001-6277-5168; Foley, Matthew/0000-0003-4077-445X	Australian National Health and Medical Research Council NHMRC [161558]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080893] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by Australian National Health and Medical Research Council NHMRC 161558 to XZ.	ANGERMULLER S, 1982, HISTOCHEM J, V14, P823, DOI 10.1007/BF01033631; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Ghanavati S, 2014, NEUROIMAGE, V95, P117, DOI 10.1016/j.neuroimage.2014.03.044; Gibson CC, 2015, CIRCULATION, V131, P289, DOI 10.1161/CIRCULATIONAHA.114.010403; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Johnson JT, 2006, PLOS GENET, V2, P471, DOI 10.1371/journal.pgen.0020061; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Mably JD, 2006, DEVELOPMENT, V133, P3139, DOI 10.1242/dev.02469; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; McDonald DA, 2012, STROKE, V43, P571, DOI 10.1161/STROKEAHA.111.625467; McDonald DA, 2011, HUM MOL GENET, V20, P211, DOI 10.1093/hmg/ddq433; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Schulz GB, 2015, STROKE, V46, P1337, DOI 10.1161/STROKEAHA.114.007512; Shannon CE, 1998, P IEEE, V86, P447, DOI 10.1109/JPROC.1998.659497; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Walker EJ, 2011, JOVE-J VIS EXP, P1742; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; WHITE DL, 1976, BIOCHIM BIOPHYS ACTA, V436, P577, DOI 10.1016/0005-2736(76)90442-9; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Zheng XJ, 2014, STROKE, V45, P1505, DOI 10.1161/STROKEAHA.114.004809; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhou Z, 2016, NATURE; Zhou ZN, 2015, DEV CELL, V32, P168, DOI 10.1016/j.devcel.2014.12.009	35	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160833	10.1371/journal.pone.0160833	http://dx.doi.org/10.1371/journal.pone.0160833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513872	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100077
J	Koch, F; Lamp, O; Eslamizad, M; Weitzel, J; Kuhla, B				Koch, Franziska; Lamp, Ole; Eslamizad, Mehdi; Weitzel, Joachim; Kuhla, Bjoern			Metabolic Response to Heat Stress in Late-Pregnant and Early Lactation Dairy Cows: Implications to Liver-Muscle Crosstalk	PLOS ONE			English	Article							SKELETAL-MUSCLE; GENE-EXPRESSION; PROTEIN-DEGRADATION; HOLSTEIN COWS; CATTLE; FAT; TRANSITION; NUTRITION; MOBILIZATION; RESTRICTION	Climate changes lead to rising temperatures during summer periods and dramatic economic losses in dairy production. Modern high-yielding dairy cows experience severe metabolic stress during the transition period between late gestation and early lactation to meet the high energy and nutrient requirements of the fetus or the mammary gland, and additional thermal stress during this time has adverse implications on metabolism and welfare. The mechanisms enabling metabolic adaptation to heat apart from the decline in feed intake and milk yield are not fully elucidated yet. To distinguish between feed intake and heat stress related effects, German Holstein dairy cows were first kept at thermoneutral conditions at 15 degrees C followed by exposure to heat-stressed (HS) at 28 degrees C or pair-feeding (PF) at 15 degrees C for 6 days; in late-pregnancy and again in early lactation. Liver and muscle biopsies and plasma samples were taken to assess major metabolic pathway regulation using real-time PCR and Western Blot. The results indicate that during heat stress, late pregnant cows activate Cahill but reduce Cori cycling, prevent increase in skeletal muscle fatty acid oxidation, and utilize increased amounts of pyruvate for gluconeogenesis, without altering urea-genesis despite reduced plane of nutrition. These homeorhetic adaptations are employed to reduce endogenous heat production while diverting amino acids to the growing fetus. Metabolic adaptation to heat stress in early lactation involves increased long-chain fatty acid degradation in muscle peroxisomes, allowance for muscle glucose utilization but diminished hepatic use of amino acid-derived pyruvate for gluconeogenesis and reduced peroxisomal fatty acid oxidation and ATP production in liver of HS compared to PF cows in early lactation. Consequently, metabolic adaptation to heat stress and reduced feed intake differ between late pregnancy and early lactation of dairy cows to maintain energy supply for fetus development or milk production simultaneously reducing endogenous heat production.	[Koch, Franziska; Lamp, Ole; Eslamizad, Mehdi; Kuhla, Bjoern] Leibnitz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Lamp, Ole] Schleswig Holstein Chamber Agr, Dept Anim Prod, Futterkamp, Blekendorf, Germany; [Eslamizad, Mehdi] Univ Tehran, Dept Anim Sci, Campus Agr & Nat Resources, Tehran, Iran; [Weitzel, Joachim] Leibnitz Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); University of Tehran; Forschungsinstitut fur Nutztierbiologie (FBN)	Kuhla, B (corresponding author), Leibnitz Inst Farm Anim Biol FBN, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany.	b.kuhla@fbn-dummerstorf.de	Koch, Franziska/AAF-2159-2021	Weitzel, Joachim/0000-0002-4073-6691; Koch, Franziska/0000-0002-1798-5374	Leibniz Institute for Farm Animal Biology (FBN), Germany; Open Access fund of the Leibniz Association; Leibniz Institute for Farm Animals (FBN)	Leibniz Institute for Farm Animal Biology (FBN), Germany; Open Access fund of the Leibniz Association; Leibniz Institute for Farm Animals (FBN)	This study was supported by the core budget of the Leibniz Institute for Farm Animal Biology (FBN), Germany. The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S. Wiese, C. Arlt, U. Wiedemuth for technical support and the staff at the FBN 'Tiertechnikum' for assistance with the animal care and sample collection to perform biochemical analyses and protein/ gene expression studies. This study was supported by the core budget of the Leibniz Institute for Farm Animals (FBN). The publication of this article was funded by the Open Access fund of the Leibniz Association. The authors declare no competing interests exist.	Basirico L, 2011, CELL STRESS CHAPERON, V16, P441, DOI 10.1007/s12192-011-0257-7; Baumgard LH, 2012, J ANIM SCI, V90, P1855, DOI 10.2527/jas.2011-4675; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Borner S, 2013, J ENDOCRINOL, V216, P217, DOI 10.1530/JOE-12-0384; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chibisa GE, 2008, J DAIRY SCI, V91, P3512, DOI 10.3168/jds.2007-0920; COPPOCK CE, 1985, J DAIRY SCI, V68, P3403, DOI 10.3168/jds.S0022-0302(85)81253-4; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Gauly M, 2013, ANIMAL, V7, P843, DOI 10.1017/S1751731112002352; Graber M, 2010, J DAIRY SCI, V93, P5200, DOI 10.3168/jds.2010-3265; Greenfield RB, 2000, J DAIRY SCI, V83, P1228, DOI 10.3168/jds.S0022-0302(00)74989-7; Hahn GL, 1999, J ANIM SCI, V77, P10; HALL GM, 1980, BRIT J ANAESTH, V52, P11, DOI 10.1093/bja/52.1.11; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jeong JY, 2012, DIABETES METAB J, V36, P328, DOI 10.4093/dmj.2012.36.5.328; Kuhla B, 2011, J PROTEOME RES, V10, P4252, DOI 10.1021/pr200425h; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Lamp O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125264; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Mayer DG, 1999, AUST VET J, V77, P804, DOI 10.1111/j.1751-0813.1999.tb12950.x; Pires JAA, 2013, J DAIRY SCI, V96, P6423, DOI 10.3168/jds.2013-6801; Rhoads ML, 2009, J DAIRY SCI, V92, P1986, DOI 10.3168/jds.2008-1641; Rhoads RP, 2013, J ANIM SCI, V91, P2492, DOI 10.2527/jas.2012-6120; Rhoads RP, 2011, J DAIRY SCI, V94, P1917, DOI 10.3168/jds.2010-3722; ROUSH W, 1994, SCIENCE, V265, P1164, DOI 10.1126/science.8066455; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Shahzad K, 2015, J DAIRY SCI, V98, P5401, DOI 10.3168/jds.2015-9409; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sugden MC, 2000, BIOCHEM J, V346, P651, DOI 10.1042/0264-6021:3460651; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Temim S, 2000, J NUTR, V130, P813, DOI 10.1093/jn/130.4.813; Tian H, 2015, J PROTEOMICS, V125, P17, DOI 10.1016/j.jprot.2015.04.014; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Drift SGA, 2012, J DAIRY SCI, V95, P4911, DOI 10.3168/jds.2011-4771; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Velez JC, 2005, J DAIRY SCI, V88, P2938, DOI 10.3168/jds.S0022-0302(05)72974-X; Walter K, 2010, LANDBAUFORSCHUNG-GER, V60, P17; Walters AH, 2004, J ANDROL, V25, P554; West JW, 2003, J DAIRY SCI, V86, P2131, DOI 10.3168/jds.S0022-0302(03)73803-X; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Wood KM, 2013, J ANIM SCI, V91, P4245, DOI 10.2527/jas.2013-6421; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshihara T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12597; YOUNG JW, 1977, J DAIRY SCI, V60, P1, DOI 10.3168/jds.S0022-0302(77)83821-6; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	48	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160912	10.1371/journal.pone.0160912	http://dx.doi.org/10.1371/journal.pone.0160912			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513961	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100088
J	Le Goff, C; Ganot, P; Zoccola, D; Caminiti-Segonds, N; Allemand, D; Tambutte, S				Le Goff, Carine; Ganot, Philippe; Zoccola, Didier; Caminiti-Segonds, Natacha; Allemand, Denis; Tambutte, Sylvie			Carbonic Anhydrases in Cnidarians: Novel Perspectives from the Octocorallian Corallium rubrum	PLOS ONE			English	Article							MEDITERRANEAN RED CORAL; SPICULE FORMATION; ORGANIC MATRIX; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORAL; MOLECULAR EVOLUTION; PROTEINS VIII; ALPHA; CALCIFICATION; EXPRESSION	Although the ability to elaborate calcium carbonate biominerals was apparently gained independently during animal evolution, members of the alpha carbonic anhydrases (alpha-CAs) family, which catalyze the interconversion of CO2 into HCO3-, are involved in the biomineralization process across metazoans. In the Mediterranean red coral Corallium rubrum, inhibition studies suggest an essential role of CAs in the synthesis of two biominerals produced in this octocoral, the axial skeleton and the sclerites. Hitherto no molecular characterization of these enzymes was available. In the present study we determined the complete set of aCAs in C. rubrum by data mining the genome and transcriptome, and measured their differential gene expression between calcifying and non-calcifying tissues. We identified six isozymes (CruCA1- 6), one cytosolic and five secreted/membrane- bound among which one lacked two of the three zinc-binding histidines and was so referred to as a carbonic anhydrase related protein (CARP). One secreted isozyme (CruCA4) showed specific expression both by qPCR and western-blot in the calcifying tissues, suggesting its involvement in biomineralization. Moreover, phylogenetic analyses of a-CAs, identified in six representative cnidarians with complete genome, support an independent recruitment of a-CAs for biomineralization within anthozoans. Finally, characterization of cnidarian CARPs highlighted two families: the monophyletic cytosolic CARPs, and the polyphyletic secreted CARPs harboring a cnidarian specific cysteine disulfide bridge. Alignment of the cytosolic CARPs revealed an evolutionary conserved R-H-Q motif in place of the characteristic zincbinding H-H-H necessary for the catalytic function of a-CAs.	[Le Goff, Carine; Ganot, Philippe; Zoccola, Didier; Caminiti-Segonds, Natacha; Allemand, Denis; Tambutte, Sylvie] Ctr Sci Monaco, Monaco, Monaco		Tambutte, S (corresponding author), Ctr Sci Monaco, Monaco, Monaco.	stambutte@centrescientifique.mc	Zoccola, Didier/A-5997-2009	Zoccola, Didier/0000-0002-1524-8098	Government of the Principality of Monaco - Fondation Paul Hamel	Government of the Principality of Monaco - Fondation Paul Hamel	Government of the Principality of Monaco - Fondation Paul Hamel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allemand D., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P129; Allemand D, 1996, J EXP ZOOL, V276, P270, DOI 10.1002/(SICI)1097-010X(19961101)276:4<270::AID-JEZ4>3.0.CO;2-L; ALLEMAND D, 1992, J EXP ZOOL, V262, P237, DOI 10.1002/jez.1402620302; Allemand Denis, 1993, Precious Corals & Octocoral Research, V2, P19; Aspatwar A, 2013, J ENZYM INHIB MED CH, V28, P1129, DOI 10.3109/14756366.2012.727813; Aspatwar A, 2013, HUM MOL GENET, V22, P417, DOI 10.1093/hmg/dds438; Aspatwar A, 2010, CURR PHARM DESIGN, V16, P3264, DOI 10.2174/138161210793429823; Aspatwar A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-25; Baumgarten S, 2015, P NATL ACAD SCI USA, V112, P11893, DOI 10.1073/pnas.1513318112; Bertucci A, 2013, BIOORGAN MED CHEM, V21, P1437, DOI 10.1016/j.bmc.2012.10.024; Bertucci A, 2011, MAR BIOTECHNOL, V13, P992, DOI 10.1007/s10126-011-9363-x; Borelli G, 2003, CALCIFIED TISSUE INT, V72, P717, DOI 10.1007/s00223-001-2115-6; BROWN D, 1992, J AM SOC NEPHROL, V3, P895; Christianson DW, 1996, ACCOUNTS CHEM RES, V29, P331, DOI 10.1021/ar9501232; Culver Billy W., 2015, International Journal of Evolutionary Biology, P538918, DOI 10.1155/2015/538918; Debreuil J, 2011, MAR BIOL, V158, P2765, DOI 10.1007/s00227-011-1775-7; Debreuil J, 2011, COMP BIOCHEM PHYS B, V159, P40, DOI 10.1016/j.cbpb.2011.01.007; Debreuil J, 2012, J BIOL CHEM, V287, P19367, DOI 10.1074/jbc.M112.352005; Del Prete S, 2014, BIOORG MED CHEM LETT, V24, P4389, DOI 10.1016/j.bmcl.2014.08.015; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; DUNKELBERGER DG, 1974, TISSUE CELL, V6, P573, DOI 10.1016/0040-8166(74)90001-9; Elleuche S, 2009, CURR GENET, V55, P211, DOI 10.1007/s00294-009-0238-x; Emameh RZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-38; Fasseas MK, 2010, MOL BIOL REP, V37, P2941, DOI 10.1007/s11033-009-9857-z; Ganot P, 2015, MOL BIOL EVOL, V32, P44, DOI 10.1093/molbev/msu265; GOLDBERG WM, 1987, B MAR SCI, V40, P287; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; GRILLO MC, 1993, MAR BIOL, V117, P119, DOI 10.1007/BF00346433; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Isa Y., 1984, Galaxea, V3, P25; Jackson DJ, 2007, SCIENCE, V316, P1893, DOI 10.1126/science.1141560; Jeng MS, 2011, CORAL REEFS, V30, P925, DOI 10.1007/s00338-011-0765-z; KATO K, 1990, FEBS LETT, V271, P137, DOI 10.1016/0014-5793(90)80390-5; Kelava I, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0065; KINGSLEY RJ, 1982, CELL TISSUE RES, V223, P325, DOI 10.1007/BF01258493; KINGSLEY RJ, 1984, AM ZOOL, V24, P883; Kingsley RJ, 1987, VITR CELL DEV BIOL, V23, P3; Le Roy N., 2016, KEY ENG MAT, V672, P151, DOI 10.4028/www.scientific.net/kem.672.151; Le Roy N, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0075-8; Liew YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091101; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Lovejoy DA, 1998, GENOMICS, V54, P484, DOI 10.1006/geno.1998.5585; Mann K, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-22; Massa T, 2014, P NATL ACAD SCI USA, V111, P12728, DOI 10.1073/pnas.1408621111; McDevitt ME, 2011, BBA-PROTEINS PROTEOM, V1814, P1854, DOI 10.1016/j.bbapap.2011.07.007; Medakovic D, 2000, HELGOLAND MAR RES, V54, P1, DOI 10.1007/s101520050030; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Moya A, 2008, MAR BIOTECHNOL, V10, P653, DOI 10.1007/s10126-008-9101-1; Moya A, 2008, J BIOL CHEM, V283, P25475, DOI 10.1074/jbc.M804726200; Moya A, 2006, J EXP BIOL, V209, P3413, DOI 10.1242/jeb.02382; Nicholas K.B., 1997, EMBNET NEWS, V4, P4; Nishimori I, 2013, BIOORG MED CHEM LETT, V23, P256, DOI 10.1016/j.bmcl.2012.10.103; Ohradanova A, 2012, BIOORGAN MED CHEM, V20, P1403, DOI 10.1016/j.bmc.2012.01.007; Picaud SS, 2009, PROTEINS, V76, P507, DOI 10.1002/prot.22411; Rahman MA, 2008, MAR BIOTECHNOL, V10, P31, DOI 10.1007/s10126-007-9030-4; Rahman MA, 2006, MAR BIOTECHNOL, V8, P415, DOI 10.1007/s10126-005-6150-6; Rahman MA, 2005, J EXP MAR BIOL ECOL, V321, P71, DOI 10.1016/j.jembe.2005.01.012; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; Sterling D, 2001, JOP, V2, P165; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Syrjanen L, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-28; Tambutte S, 2007, MAR BIOL, V151, P71, DOI 10.1007/s00227-006-0452-8; Tashian RE, 2000, EXS, V90, P105; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; Vidal-Dupiol J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058652; Vidal-Dupiol J, 2011, J BIOL CHEM, V286, P22688, DOI 10.1074/jbc.M110.216358; Vielzeuf D, 2008, AM MINERAL, V93, P1799, DOI 10.2138/am.2008.2923; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Voigt O, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0230-z; Wirshing HH, 2014, MOL PHYLOGENET EVOL, V77, P281, DOI 10.1016/j.ympev.2014.04.015	74	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160368	10.1371/journal.pone.0160368	http://dx.doi.org/10.1371/journal.pone.0160368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513959	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100034
J	Rajabi, H; Ghoroubi, N; Malaki, M; Darvizeh, A; Gorb, SN				Rajabi, H.; Ghoroubi, N.; Malaki, M.; Darvizeh, A.; Gorb, S. N.			Basal Complex and Basal Venation of Odonata Wings: Structural Diversity and Potential Role in the Wing Deformation	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; AERODYNAMIC CHARACTERISTICS; MECHANICAL-PROPERTIES; INSECT WINGS; DESIGN; PERFORMANCE	Dragonflies and damselflies, belonging to the order Odonata, are known to be excellent fliers with versatile flight capabilities. The ability to fly over a wide range of speeds, high manoeuvrability and great agility are a few characteristics of their flight. The architecture of the wings and their structural elements have been found to play a major role in this regard. However, the precise influence of individual wing components on the flight performance of these insects remains unknown. The design of the wing basis (so called basal complex) and the venation of this part are responsible for particular deformability and specific shape of the wing blade. However, the wing bases are rather different in representatives of different odonate groups. This presumably reflects the dimensions of the wings on one hand, and different flight characteristics on the other hand. In this article, we develop the first three-dimensional (3D) finite element (FE) models of the proximal part of the wings of typical representatives of five dragonflies and damselflies families. Using a combination of the basic material properties of insect cuticle, a linear elastic material model and a nonlinear geometric analysis, we simulate the mechanical behaviour of the wing bases. The results reveal that although both the basal venation and the basal complex influence the structural stiffness of the wings, it is only the latter which significantly affects their deformation patterns. The use of numerical simulations enabled us to address the role of various wing components such as the arculus, discoidal cell and triangle on the camber formation in flight. Our study further provides a detailed representation of the stress concentration in the models. The numerical analysis presented in this study is not only of importance for understanding structure-function relationship of insect wings, but also might help to improve the design of the wings for biomimetic micro-air vehicles (MAVs).	[Rajabi, H.; Gorb, S. N.] Univ Kiel, Inst Zool Funct Morphol & Biomech, Kiel, Germany; [Ghoroubi, N.] Islamic Azad Univ, Rasht Branch, Young Researchers Club, Rasht, Iran; [Malaki, M.] Univ Guilan, Dept Mech Engn, Rasht, Iran; [Darvizeh, A.] Islamic Azad Univ, Anzali Branch, Dept Mech Engn, Bandar Anzali, Iran	University of Kiel; Islamic Azad University; University of Guilan; Islamic Azad University	Rajabi, H (corresponding author), Univ Kiel, Inst Zool Funct Morphol & Biomech, Kiel, Germany.	hrajabi@zoologie.uni-kiel.de	darvizeh, Abolfazl/AAC-4155-2019; Rajabi, Hamed/B-7359-2009	Rajabi, Hamed/0000-0002-1792-3325	Federal State Funding at Kiel University; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	Federal State Funding at Kiel University; Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds	This study was financially supported by "Federal State Funding at Kiel University" to HR. The authors also acknowledge financial support by Land Schleswig-Holstein within the funding programme Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott J.C., 2011, DAMSELFLIES TEXAS FI; [Anonymous], 2007, ABAQUS V6 7 AN US MA; Appel E., 2014, COMP FUNCTIONAL MORP; Appel E, 2015, J ANAT, V227, P561, DOI 10.1111/joa.12362; Appel E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046006; AZUMA A, 1985, J EXP BIOL, V116, P79; Busse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055787; Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524; Corbet P. S., 1962, BIOL DRAGONFLIES; Darvizeh A., 2015, MODARES J MECH ENG, V14, P235; Darvizeh M, 2009, INT J MULTIPHYSICS, V3, P101, DOI 10.1260/175095409787924454; Dirks JH, 2013, J EXP BIOL, V216, P1924, DOI 10.1242/jeb.083824; Dirks JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043411; Dirks JH, 2012, J EXP BIOL, V215, P1502, DOI 10.1242/jeb.068221; Donoughe S, 2011, J MORPHOL, V272, P1409, DOI 10.1002/jmor.10992; ENNOS AR, 1988, J EXP BIOL, V140, P137; ENNOS AR, 1989, ZOOL J LINN SOC-LOND, V96, P27, DOI 10.1111/j.1096-3642.1989.tb01820.x; Fauziyah S, 2014, ARTHROPOD STRUCT DEV, V43, P415, DOI 10.1016/j.asd.2014.06.004; Gorb SN, 1999, NATURWISSENSCHAFTEN, V86, P552, DOI 10.1007/s001140050674; Gorb SN, 2000, ARTHROPOD STRUCT DEV, V29, P129, DOI 10.1016/S1467-8039(00)00020-7; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; Kesel AB, 2000, J EXP BIOL, V203, P3125; Kesel AB, 1998, COMPUT BIOL MED, V28, P423, DOI 10.1016/S0010-4825(98)00018-3; Kim WK, 2009, J THEOR BIOL, V260, P523, DOI 10.1016/j.jtbi.2009.07.015; Koehler C, 2012, J EXP BIOL, V215, P3018, DOI 10.1242/jeb.069005; Kreuz P, 2001, ANN BIOMED ENG, V29, P1054, DOI 10.1114/1.1424921; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Mountcastle AM, 2009, EXP FLUIDS, V46, P873, DOI 10.1007/s00348-008-0607-0; Nakata T, 2012, P ROY SOC B-BIOL SCI, V279, P722, DOI 10.1098/rspb.2011.1023; Newman DJS., 1982, FUNCTIONAL WING MORP; Noda R, 2014, ACTA MECH SINICA-PRC, V30, P819, DOI 10.1007/s10409-014-0095-9; NORBERG RA, 1972, J COMP PHYSIOL, V81, P9; Okamoto M, 1996, J EXP BIOL, V199, P281; Rajabi H, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150610; Rajabi H, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160006; Rajabi H, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/5/056003; Rajabi H, 2015, J BIOMECH, V48, P89, DOI 10.1016/j.jbiomech.2014.10.037; Rajabi H, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/8/088702; Rajabi H, 2011, J BIONIC ENG, V8, P165, DOI 10.1016/S1672-6529(11)60014-0; Rajabi H, 2016, APPL PHYS A, V122, P1; RUPPELL G, 1989, J EXP BIOL, V144, P13; Russell RW, 1998, AM MIDL NAT, V140, P325, DOI 10.1674/0003-0031(1998)140[0325:MSMODO]2.0.CO;2; Smith CW, 2000, J EXP BIOL, V203, P2933; STEPPAN SJ, 2000, J RES LEPIDOPTERA, V35, P61; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; VOGEL S, 1967, J EXP BIOL, V46, P431; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Wootton R.J., 1991, Advances in Odonatology, V5, P153; Wootton RJ, 2000, J EXP BIOL, V203, P2921; Wootton RJ, 2003, PHILOS T R SOC B, V358, P1577, DOI 10.1098/rstb.2003.1351; WOOTTON RJ, 1993, J EXP BIOL, V180, P105; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; WOOTTON RJ, 1981, J ZOOL, V193, P447; Wootton RJ, 1998, SCIENCE, V282, P749, DOI 10.1126/science.282.5389.749; WOOTTON RJ, 1989, SYST ENTOMOL, V14, P507, DOI 10.1111/j.1365-3113.1989.tb00300.x; WOOTTON RJ, 1990, SCI AM, V263, P114, DOI 10.1038/scientificamerican1190-114; Wootton RJ, 2008, MODEL ORGANISMS ECOL; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928	58	16	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160610	10.1371/journal.pone.0160610	http://dx.doi.org/10.1371/journal.pone.0160610			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513753	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000381381100049
J	Kang, MR; Park, KH; Yang, JO; Lee, CW; Oh, SJ; Yun, J; Lee, MY; Han, SB; Kang, JS				Kang, Moo Rim; Park, Ki Hwan; Yang, Jeong-Ook; Lee, Chang Woo; Oh, Soo Jin; Yun, Jieun; Lee, Myeong Youl; Han, Sang-Bae; Kang, Jong Soon			miR-6734 Up-Regulates p21 Gene Expression and Induces Cell Cycle Arrest and Apoptosis in Colon Cancer Cells	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; RNA; P21(WAF1/CIP1); MICRORNA; DSRNAS; MIRNA	Recently, microRNAs have been implicated in the regulation of gene expression in terms of both gene silencing and gene activation. Here, we investigated the effects of miR-6734, which has a sequence homology with a specific region of p21(WAF1/CIP1) (p21) promoter, on cancer cell growth and the mechanisms involved in this effect. miR-6734 up-regulated p21 expression at both mRNA and protein levels and chromatin immunoprecipitation analysis using biotin-labeled miR-6734 confirmed the association of miR-6734 with p21 promoter. Moreover, miR-6734 inhibited cancer cell growth and induced cell cycle arrest and apoptosis in HCT-116 cells, which was abolished by knockdown of p21. The phosphorylation of Rb and the cleavage of caspase 3 and PARP were suppressed by miR-6734 transfection in HCT-116 cells and these effects were also reversed by p21 knockdown. In addition, miR6734 transfection caused prolonged induction of p21 gene and modification of histones in p21 promoter, which are typical aspects of a phenomenon referred to as RNA activation (RNAa). Collectively, our results demonstrated that miR-6734 inhibits the growth of colon cancer cells by up-regulating p21 gene expression and subsequent induction of cell cycle arrest and apoptosis, suggesting its role as an important endogenous regulator of cancer cell proliferation and survival.	[Kang, Moo Rim; Park, Ki Hwan; Yang, Jeong-Ook; Lee, Chang Woo; Oh, Soo Jin; Yun, Jieun; Lee, Myeong Youl; Kang, Jong Soon] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju, South Korea; [Han, Sang-Bae] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University	Kang, JS (corresponding author), Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, Cheongju, South Korea.	kanjon@kribb.re.kr		Kang, Jong Soon/0000-0001-7698-0162	KRIBB Research Initiative Program [KGS5331612]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A101836]	KRIBB Research Initiative Program; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by a grant (No. KGS5331612) from the KRIBB Research Initiative Program and a grant (No. A101836) of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Chen Z, 2008, MOL CANCER THER, V7, P698, DOI 10.1158/1535-7163.MCT-07-2312; Gartel AL, 2005, LEUK RES, V29; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Huang V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003821; Huang V, 2012, NUCLEIC ACIDS RES, V40, P1695, DOI 10.1093/nar/gkr934; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Jiao AL, 2014, EPIGENETICS-US, V9, P27, DOI 10.4161/epi.26942; Kang MR, 2012, CANCER RES, V72, P5069, DOI 10.1158/0008-5472.CAN-12-1871; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kosaka M, 2012, NUCLEIC ACID THER, V22, P335, DOI 10.1089/nat.2012.0354; Kurokawa R, 2011, PROG MOL SUBCELL BIO, V51, P29, DOI 10.1007/978-3-642-16502-3_2; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Majid S, 2010, CANCER-AM CANCER SOC, V116, P5637, DOI 10.1002/cncr.25488; Matsui M, 2013, NUCLEIC ACIDS RES, V41, P10086, DOI 10.1093/nar/gkt777; Omer AD, 2009, MOL CELL, V35, P739, DOI 10.1016/j.molcel.2009.09.003; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Place RF, 2010, CURR PHARM BIOTECHNO, V11, P518; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Wang CH, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.08.014; Wang CH, 2014, FEBS LETT, V588, P4654, DOI 10.1016/j.febslet.2014.10.037; Wu ZM, 2011, ACTA PHARMACOL SIN, V32, P939, DOI 10.1038/aps.2011.28; Yang K, 2013, INT J BIOCHEM CELL B, V45, P1338, DOI 10.1016/j.biocel.2013.03.022; Younger ST, 2009, BIOORG MED CHEM LETT, V19, P3791, DOI 10.1016/j.bmcl.2009.04.032; Zhu WG, 2005, ADV EXP MED BIOL, V570, P249, DOI 10.1007/1-4020-3764-3_9	26	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160961	10.1371/journal.pone.0160961	http://dx.doi.org/10.1371/journal.pone.0160961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509128	gold, Green Submitted, Green Published			2022-12-26	WOS:000381380400071
J	Nateghi, R; Bricker, JD; Guikema, SD; Bessho, A				Nateghi, Roshanak; Bricker, Jeremy D.; Guikema, Seth D.; Bessho, Akane			Statistical Analysis of the Effectiveness of Seawalls and Coastal Forests in Mitigating Tsunami Impacts in Iwate and Miyagi Prefectures	PLOS ONE			English	Article								The Pacific coast of the Tohoku region of Japan experiences repeated tsunamis, with the most recent events having occurred in 1896, 1933, 1960, and 2011. These events have caused large loss of life and damage throughout the coastal region. There is uncertainty about the degree to which seawalls reduce deaths and building damage during tsunamis in Japan. On the one hand they provide physical protection against tsunamis as long as they are not overtopped and do not fail. On the other hand, the presence of a seawall may induce a false sense of security, encouraging additional development behind the seawall and reducing evacuation rates during an event. We analyze municipality-level and sub-municipality-level data on the impacts of the 1896, 1933, 1960, and 2011 tsunamis, finding that seawalls larger than 5 m in height generally have served a protective role in these past events, reducing both death rates and the damage rates of residential buildings. However, seawalls smaller than 5 m in height appear to have encouraged development in vulnerable areas and exacerbated damage. We also find that the extent of flooding is a critical factor in estimating both death rates and building damage rates, suggesting that additional measures, such as multiple lines of defense and elevating topography, may have significant benefits in reducing the impacts of tsunamis. Moreover, the area of coastal forests was found to be inversely related to death and destruction rates, indicating that forests either mitigated the impacts of these tsunamis, or displaced development that would otherwise have been damaged.	[Nateghi, Roshanak] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Nateghi, Roshanak] Purdue Univ, Div Environm & Ecol Engn, W Lafayette, IN 47907 USA; [Bricker, Jeremy D.] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi, Japan; [Guikema, Seth D.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Bessho, Akane] Maryland Inst Coll Art, Undergrad Program Architectural Design, Baltimore, MD 21217 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tohoku University; University of Michigan System; University of Michigan	Nateghi, R (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.; Nateghi, R (corresponding author), Purdue Univ, Div Environm & Ecol Engn, W Lafayette, IN 47907 USA.	rnateghi@purdue.edu	Nateghi, Roshanak/AAQ-2425-2020	Bessho, Akihiro/0000-0002-0394-7377	National Science Foundation [1331399, 1215872]; NSF SEES [1215872]; NSF Hazard-SEES Type 2 grant [1331399]; Japan Society for the Promotion of Science, JSPS-NSF Cooperative Program for Interdisciplinary Joint Research Projects in Hazards and Disasters, project entitled "Evolution of Urban Regions in Response to Recurring Disasters"; Directorate For Engineering [1555582] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF SEES(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF Hazard-SEES Type 2 grant; Japan Society for the Promotion of Science, JSPS-NSF Cooperative Program for Interdisciplinary Joint Research Projects in Hazards and Disasters, project entitled "Evolution of Urban Regions in Response to Recurring Disasters"; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1331399) Award Number 1331399 to SDG; National Science Foundation (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1215872) Award Number 1215872 to RN; and Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-bottom/04_d_progress.html), JSPS-NSF Cooperative Program for Interdisciplinary Joint research projects in Hazards and Disasters, project entitled 'Evolution of Urban Regions in Response to Recurring Disasters', to JDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Tom Logan, Nobuo Shuto, Anawat Suppasri, Carine Yi, and Midori (Katie) Saito for advice and assistance in data collection. Funding for this project was provided by the NSF SEES # 1215872, entitled "Sustainable Infrastructure Planning", the NSF Hazard-SEES Type 2 grant # 1331399, entitled "Modeling to Promote Regional Resilience to Repeated Heat Waves and Hurricanes", and the Japan Society for the Promotion of Science, JSPS-NSF Cooperative Program for Interdisciplinary Joint Research Projects in Hazards and Disasters, project entitled "Evolution of Urban Regions in Response to Recurring Disasters".	Aldrich DP, 2015, SOC SCI MED, V124, P66, DOI 10.1016/j.socscimed.2014.11.025; [Anonymous], 2015, DAMAGE MAP; [Anonymous], 1961, CHIL EARTHQ TSUN DAM; [Anonymous], 2015, BEARING COSTS RECONS; [Anonymous], 2011, 3 M TAR REC PLANN CO; [Anonymous], 2016, JAPAN TIMES; [Anonymous], 2014, DAMAGE RECORD; [Anonymous], 2014, ECONOMIST; [Anonymous], 2014, STAT DAM DUE GREAT E; [Anonymous], 1903, SURV MIYAG PREF KAIS; [Anonymous], 2011, NY TIMES; [Anonymous], 2011, POPULATION NUMBER BU; [Anonymous], 2011, HUFFINGTON POST; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bricker JD, 2014, J HYDRAUL ENG, V140, DOI 10.1061/(ASCE)HY.1943-7900.0000855; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Cyranoski D, 2012, NATURE, V483, P141, DOI 10.1038/483141a; Drucker H, 1997, ADV NEUR IN, V9, P155; E-Stat, 2009, DWELL OCC STAT; FDMA, 2013, EXT IN FLOOD AR EACH; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, P1; Fritz HM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029404; Fritz HM, 2009, NAT GEOSCI, V2, P448, DOI 10.1038/ngeo558; GSI, 2012, COUNTR TABL MUN LAND; Harada K, 2005, ADV NAT TECH HAZ RES, V23, P279; Hasti T, 2001, ELEMENTS STAT LEARNI, p[283, 267]; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Hayashi N., 2012, THESIS; Hill EM, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009159; Ishinomaki City, 2015, CASUALTIES POPULATIO; Iwate Prefecture, 2004, IW PREF EXP TSUN IN; Iwate Prefecture, 2015, REC MAINT TSUN DIS P; Iwate Prefecture, 2015, IW PREF POP MOV ANN; Iwate Prefecture, 2011, GREAT E JAP EARTHQ T; Iwate Prefecture, 1936, REP DAM CIV WORKS DU; Iwate Prefecture, 1969, REP REC CHIL EARTHQ; Iwate Prefecture, 2013, REC GREAT E JAP EART; Iwate Prefecture, 1896, SURV COND IW PREF KA; JMA, 2012, IMPR TSUN WARN SYST; Jonkman SN, 2008, NAT HAZARDS, V46, P353, DOI 10.1007/s11069-008-9227-5; JSCE, 2011, SUMM DAM AR SURV; Kamaishi City, 2011, STATUS DAMAGE DUE GR; Kesennuma City, 2011, DAMAGE STATUS; Kesennuma Survey Group, 1961, 1960 CHIL EARTHQ SAN; Koshimura S, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0373; Liu HJ, 2013, PURE APPL GEOPHYS, V170, P1033, DOI 10.1007/s00024-012-0496-2; MAFF, 2013, DAT TOWN IW; Miyagi Prefecture, 2011, EARTHQ DIS REC PLAN; MLITT, 2015, POL MAP BOUND DAT; MLITT, 2013, DAM SEAW DUE EARTHQ; MLITT, 2013, SPEC HEIGHTS COAST L; Mori N, 2013, EARTHQ SPECTRA, V29, pS127, DOI 10.1193/1.4000118; Mori N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049210; Muhari A., 2012, J NAT DISASTER SCI, V34, P91; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; PWRI, 2011, 4202 PWRI NAT I LAND; Reconstruction Agency, 2011, REC PLAN EACH MUN; Reconstruction Agency, 2013, PLAN REC COAST PROT; Rikuzentakada City, 2015, DAMAGE STATUS; Sasaki Yoshihiro, 2000, DOBOKU GAKKAI RONBUN, V639, P1; Sendai City, 2011, DAMAGE REPORT; Shimozono T, 2014, PURE APPL GEOPHYS, V171, P3217, DOI 10.1007/s00024-014-0803-1; Shuto N, 2009, P JPN ACAD B-PHYS, V85, P267, DOI 10.2183/pjab.85.267; Statistics Japan, 2015, HIST JAP CENS DAT 19; Takahashi M, 2015, J GEOGR-TOKYO, V124, P193, DOI 10.5026/jgeography.124.193; Tani K., 2012, CASUALTY RAT PER NEI; Tani K., 2015, PRESENT MAP COMP WEB; Tohoku University, 2015, JAP TSUN TRAC DAT; Tomita T, 2012, J JAPAN SOC CIVIL B2, V68; Vapnik V, 1996, ADV NEURAL INFORM PR, P9; Watanabe H., 1998, COMPLIHENSIVE LIST T, Vsecond, P238; Yun NY, 2014, EARTHQ SPECTRA, V10, P1193	73	31	31	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0158375	10.1371/journal.pone.0158375	http://dx.doi.org/10.1371/journal.pone.0158375			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508461	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400004
J	Oliveira, MP; Matos, MAD; Silva, AMC; Lopes, CLR; Teles, SA; Matos, MA; Spitz, N; Araujo, NM; Mota, RMS; Kerr, LRFS; Martins, RMB				Oliveira, Marina P.; Matos, Marcia A. D.; Silva, Agabo M. C.; Lopes, Carmen L. R.; Teles, Sheila A.; Matos, Marcos A.; Spitz, Natalia; Araujo, Natalia M.; Mota, Rosa M. S.; Kerr, Ligia R. F. S.; Martins, Regina M. B.			Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling Survey	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; C VIRUS; GENOTYPES; ASSOCIATION; MUTATION; WORKERS; MSM; HIV	Background Men who have sex with men (MSM) are at increased risk of exposure to hepatitis B virus (HBV) compared with the general population. This study aims to assess the epidemiological and virological characteristics of HBV infection in a sample of MSM in Brazil, where data are scarce. Methods A cross-sectional study was conducted among MSM in the City of Goiania, Central Brazil, from March to November 2014, using Respondent-Driven Sampling (RDS). After signing the consent form, participants were interviewed and a blood sample collected. All samples were tested for HBV serological markers and HBV DNA. HBV nucleotide sequence analysis was also performed. Results A total of 522 MSM were recruited in the study. The prevalence of HBV infection (current or past [presence of anti-HBc marker]) was 15.4%(95% CI: 8.7-25.8) and the rate of HBsAg carriers was 0.6% (95% CI: 0.2-1.6). About 40% (95% CI: 32.3-48.8) of the participants had serological evidence of previous HBV vaccination (reactive for isolated anti-HBs). In addition, 44.3%(95% CI: 36.1-52.9) were seronegative for all HBV markers. Age over 25 years old, receptive anal intercourse, previous sex with women, and history of sexually transmitted infections (STIs) were factors associated with HBV infection. HBV DNA was detected only in HBsAg-positive individuals. HBV isolates were classified into genotype A (subgenotypes A1 and A2), and some mutations were identified throughout the genome. Therefore, occult HBV infection was not observed in the study population. Conclusions Public health strategies should be improved for the MSM population in order to prevent HBV and other STIs, as well as to provide appropriate management of patients with active infections.	[Oliveira, Marina P.; Matos, Marcia A. D.; Silva, Agabo M. C.; Martins, Regina M. B.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Lopes, Carmen L. R.; Teles, Sheila A.; Matos, Marcos A.] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil; [Spitz, Natalia; Araujo, Natalia M.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Mota, Rosa M. S.; Kerr, Ligia R. F. S.] Univ Fed Ceara, Dept Community Hlth, Fortaleza, Ceara, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Fundacao Oswaldo Cruz; Universidade Federal do Ceara	Martins, RMB (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	rbringel.iptsp.ufg@gmail.com	Matos, Marcos/AAN-5631-2021; KERR, LIGIA REGINA FRANCO SANSIGOLO/F-9250-2012; TELES, SHEILA/X-7998-2019; Teles, Sheila Araujo/D-8837-2015; Araujo, Natalia M/B-6596-2013	KERR, LIGIA REGINA FRANCO SANSIGOLO/0000-0003-4941-408X; TELES, SHEILA/0000-0002-7059-4241; Teles, Sheila Araujo/0000-0003-4030-6947; Spitz Toledo Dias, Natalia/0000-0003-4776-1758	Brazilian Ministry of Health/Secretariat of Health Surveillance/Department of STD, Aids and Viral Hepatitis [BRAK57]	Brazilian Ministry of Health/Secretariat of Health Surveillance/Department of STD, Aids and Viral Hepatitis	Funding was provided by the Brazilian Ministry of Health/Secretariat of Health Surveillance/Department of STD, Aids and Viral Hepatitis through the Project of International Technical Cooperation BRAK57 between the Brazilian Government and the United Nations Office on Drugs and Crime-UNODC.	Bowring A, 2019, 10 IAS C HIV SCI; Brasil. Secretaria de Assuntos Estrategicos da Presidencia da Republica do Brasil, 2014, ASS ESTR SOC REND A; Centers for Disease Control and Prevention (CDC), 2013, VIR HEP INF GAY BIS; Chandra PK, 2007, INTERVIROLOGY, V50, P173, DOI 10.1159/000098960; Chow EP, 2014, PLOS ONE, V9, P1; de Vries HJC, 2014, CLIN DERMATOL, V32, P181, DOI 10.1016/j.clindermatol.2013.08.001; Souto FJD, 2016, REV SOC BRAS MED TRO, V49, P11, DOI 10.1590/0037-8682-0176-2015; Gamagedara N, 2014, SEX TRANSM INFECT, V90, P41, DOI 10.1136/sextrans-2013-051131; Gao S, 2015, WORLD J HEPATOL, V7, P1086, DOI 10.4254/wjh.v7.i8.1086; GUNTHER S, 1995, J VIROL, V69, P5437; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Jansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142515; Johnston LG, 2016, AIDS BEHAV, V20, P1754, DOI 10.1007/s10461-016-1346-5; Kassak K, 2011, SEX HEALTH, V8, P229, DOI 10.1071/SH10080; Kendall C, 2008, AIDS BEHAV, V12, pS97, DOI 10.1007/s10461-008-9390-4; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Kimbi GC, 2012, VIRUS RES, V163, P334, DOI 10.1016/j.virusres.2011.10.024; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kwak MS, 2014, WORLD J HEPATOL, V6, P860, DOI 10.4254/wjh.v6.i12.860; Lago BV, 2014, PLOS ONE, V9, P1; Lama JR, 2010, AM J TROP MED HYG, V83, P194, DOI 10.4269/ajtmh.2010.10-0003; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Linkins RW, 2013, J MED VIROL, V85, P1499, DOI 10.1002/jmv.23637; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; NIEL C, 1994, J MED VIROL, V44, P180, DOI 10.1002/jmv.1890440212; Nyamathi A, 2013, AM J MENS HEALTH, V7, P18, DOI 10.1177/1557988312456068; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240; Pitasi MA, 2014, AIDS BEHAV, V18, pS248, DOI 10.1007/s10461-013-0670-2; Ponde RAA, 2015, EUR J CLIN MICROBIOL, V34, P1709, DOI 10.1007/s10096-015-2422-x; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Russi JC, 2003, AM J TROP MED HYG, V68, P716, DOI 10.4269/ajtmh.2003.68.716; Sabido M, 2015, AIDS BEHAV, V19, P1630, DOI 10.1007/s10461-015-1016-z; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Shiffman ML, 2010, CLIN LIVER DIS, V4, P75; Soares CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102676; Sutmoller F, 1997, MEM I OSWALDO CRUZ, V92, P39, DOI 10.1590/S0074-02761997000100009; Sutmoller Frits, 2002, International Journal of Infectious Diseases, V6, P259, DOI 10.1016/S1201-9712(02)90158-X; Svicher V, 2011, DIGEST LIVER DIS, V43, P975, DOI 10.1016/j.dld.2011.07.002; Tseng YT, 2012, J FORMOS MED ASSOC, V111, P431, DOI 10.1016/j.jfma.2011.06.022; Urbanus A T, 2009, Euro Surveill, V14; van Houdt R, 2012, J HEPATOL, V57, P529, DOI 10.1016/j.jhep.2012.04.030; White RG, 2012, SEX TRANSM INFECT, V88, P397, DOI 10.1136/sextrans-2012-050703; WHO, 2015, HEP B	46	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160916	10.1371/journal.pone.0160916	http://dx.doi.org/10.1371/journal.pone.0160916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508385	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400065
J	Gobl, CS; Ott, J; Bozkurt, L; Feichtinger, M; Rehmann, V; Cserjan, A; Heinisch, M; Steinbrecher, H; JustKukurova, I; Tuskova, R; Leutner, M; Vytiska-Binstorfer, E; Kurz, C; Weghofer, A; Tura, A; Egarter, C; Kautzky-Willer, A				Goebl, Christian S.; Ott, Johannes; Bozkurt, Latife; Feichtinger, Michael; Rehmann, Victoria; Cserjan, Anna; Heinisch, Maike; Steinbrecher, Helmut; JustKukurova, Ivica; Tuskova, Radka; Leutner, Michael; Vytiska-Binstorfer, Elisabeth; Kurz, Christine; Weghofer, Andrea; Tura, Andrea; Egarter, Christian; Kautzky-Willer, Alexandra			To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; BETA-CELL FUNCTION; GESTATIONAL DIABETES-MELLITUS; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; TOLERANCE; OBESITY; RISK; SENSITIVITY	Aims There are emerging data indicating an association between PCOS (polycystic ovary syndrome) and metabolic derangements with potential impact on its clinical presentation. This study aims to evaluate the pathophysiological processes beyond PCOS with particular focus on carbohydrate metabolism, ectopic lipids and their possible interaction. Differences between the two established classifications of the disease should be additionally evaluated. Methods A metabolic characterization was performed in 53 untreated PCOS patients as well as 20 controls including an extended oral glucose tolerance test (OGTT, to assess insulin sensitivity, secretion and beta-cell function) in addition to a detailed examination of ectopic lipid content in muscle and liver by nuclear magnetic resonance spectroscopy. Results Women with PCOS classified by the original NIH 1990 definition showed a more adverse metabolic risk profile compared to women characterized by the additional Rotterdam 2003 phenotypes. Subtle metabolic derangements were observed in both subgroups, including altered shapes of OGTT curves, impaired insulin action and hyperinsulinemia due to increased secretion and attenuated hepatic extraction. No differences were observed for ectopic lipids between the groups. However, particularly hepatocellular lipid content was significantly related to clinical parameters of PCOS like whole body insulin sensitivity, dyslipidemia and free androgen index. Conclusions Subtle alterations in carbohydrate metabolism are present in both PCOS classifications, but more profound in subjects meeting the NIH 1990 criteria. Females with PCOS and controls did not differ in ectopic lipids, however, liver fat was tightly related to hyperandrogenism and an adverse metabolic risk profile.	[Goebl, Christian S.; Ott, Johannes; Feichtinger, Michael; Rehmann, Victoria; Cserjan, Anna; Heinisch, Maike; Steinbrecher, Helmut; Vytiska-Binstorfer, Elisabeth; Kurz, Christine; Weghofer, Andrea; Egarter, Christian] Med Univ Vienna, Div Gynecol Endocrinol & Reprod Med, Dept Obstet & Gynecol, Vienna, Austria; [Bozkurt, Latife; Leutner, Michael; Kautzky-Willer, Alexandra] Med Univ Vienna, Unit Gender Med, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [JustKukurova, Ivica; Tuskova, Radka] Med Univ Vienna, High Field Magnet Resonance Ctr Excellence, Vienna, Austria; [Tura, Andrea] CNR, Inst Neurosci, Metab Unit, Padua, Italy	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Consiglio Nazionale delle Ricerche (CNR)	Kautzky-Willer, A (corresponding author), Med Univ Vienna, Unit Gender Med, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria.	alexandra.kautzky-willer@meduniwien.ac.at	Ott, Johannes/AAD-1700-2019; Feichtinger, Michael/ABD-1214-2020	Feichtinger, Michael/0000-0001-6453-9281; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Ott, Johannes/0000-0002-2761-5262	Medical Scientific Fund of the Mayor of Vienna [13072]	Medical Scientific Fund of the Mayor of Vienna	This work was supported by the Medical Scientific Fund of the Mayor of Vienna (Pr.Nr.: 13072).	Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Arslanian SA, 2001, J CLIN ENDOCRINOL S6, V13, P1385; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Brzozowska MM, 2009, J GASTROEN HEPATOL, V24, P243, DOI 10.1111/j.1440-1746.2008.05740.x; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Daskalopoulos GN, 2011, ANGIOLOGY, V62, P285, DOI 10.1177/0003319711399571; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; DUNAIF A, 1989, DIABETES, V38, P1165, DOI 10.2337/diabetes.38.9.1165; Dunaif A, 1996, J CLIN ENDOCR METAB, V81, P942, DOI 10.1210/jc.81.3.942; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Gobl CS, 2015, AM J PHYSIOL-REG I, V309, pR13, DOI 10.1152/ajpregu.00059.2015; Gobl CS, 2013, AM J PHYSIOL-ENDOC M, V304, pE524, DOI 10.1152/ajpendo.00461.2012; Hahn S, 2007, CLIN CHEM LAB MED, V45, P202, DOI 10.1515/CCLM.2007.031; Jones H, 2012, J CLIN ENDOCR METAB, V97, P3709, DOI 10.1210/jc.2012-1382; Konietschke F, 2015, J STAT SOFTW, V64; Lim SS, 2013, OBES REV, V14, P95, DOI 10.1111/j.1467-789X.2012.01053.x; Lorenzo C, 2012, DIABETIC MED, V29, pE151, DOI 10.1111/j.1464-5491.2012.03660.x; Luque-Ramirez M, 2010, FERTIL STERIL, V94, P2214, DOI 10.1016/j.fertnstert.2009.11.049; Manco M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092995; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Moran LJ, 2015, TRENDS ENDOCRIN MET, V26, P136, DOI 10.1016/j.tem.2014.12.003; Morbiducci U, 2014, ANN BIOMED ENG, V42, P1112, DOI 10.1007/s10439-014-0979-7; Nestler JE, 2008, NEW ENGL J MED, V358, P47, DOI 10.1056/NEJMct0707092; Pacini G, 2006, NUTR METAB CARDIOVAS, V16, pS22, DOI 10.1016/j.numecd.2005.10.014; Perseghin G, 2011, DIABETES CARE, V34, pS367, DOI 10.2337/dc11-s249; R Core Team, 2013, R LANG ENV STAT COMP; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Stadler M, 2006, DIABETES CARE, V29, P1031, DOI 10.2337/dc05-1247; Stepto NK, 2013, HUM REPROD, V28, P777, DOI 10.1093/humrep/des463; Szendroedi J, 2009, CURR OPIN LIPIDOL, V20, P50, DOI 10.1097/MOL.0b013e328321b3a8; Teede HJ, 2013, HUM REPROD, V28, P2024, DOI 10.1093/humrep/det227; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Vassilatou E, 2014, WORLD J GASTROENTERO, V20, P8351, DOI 10.3748/wjg.v20.i26.8351; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160571	10.1371/journal.pone.0160571	http://dx.doi.org/10.1371/journal.pone.0160571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505055	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200045
J	Fecher, D; Hofmann, E; Buck, A; Bundschuh, R; Nietzer, S; Dandekar, G; Walles, T; Walles, H; Luckerath, K; Steinke, M				Fecher, David; Hofmann, Elisabeth; Buck, Andreas; Bundschuh, Ralph; Nietzer, Sarah; Dandekar, Gudrun; Walles, Thorsten; Walles, Heike; Luckerath, Katharina; Steinke, Maria			Human Organotypic Lung Tumor Models: Suitable For Preclinical F-18-FDG PET-Imaging	PLOS ONE			English	Article							ANTICANCER DRUG DEVELOPMENT; CANCER-RESEARCH; PHASE-II; IN-VITRO; TISSUE; MATRIX; TRANSPLANTATION; RESISTANCE; CELLS; DECELLULARIZATION	Development of predictable in vitro tumor models is a challenging task due to the enormous complexity of tumors in vivo. The closer the resemblance of these models to human tumor characteristics, the more suitable they are for drug-development and-testing. In the present study, we generated a complex 3D lung tumor test system based on acellular rat lungs. A decellularization protocol was established preserving the architecture, important ECM components and the basement membrane of the lung. Human lung tumor cells cultured on the scaffold formed cluster and exhibited an up-regulation of the carcinoma-associated marker mucin1 as well as a reduced proliferation rate compared to respective 2D culture. Additionally, employing functional imaging with 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography (FDG-PET) these tumor cell cluster could be detected and tracked over time. This approach allowed monitoring of a targeted tyrosine kinase inhibitor treatment in the in vitro lung tumor model non-destructively. Surprisingly, FDG-PET assessment of single tumor cell cluster on the same scaffold exhibited differences in their response to therapy, indicating heterogeneity in the lung tumor model. In conclusion, our complex lung tumor test system features important characteristics of tumors and its microenvironment and allows monitoring of tumor growth and -metabolism in combination with functional imaging. In longitudinal studies, new therapeutic approaches and their long-term effects can be evaluated to adapt treatment regimes in future.	[Fecher, David; Hofmann, Elisabeth; Nietzer, Sarah; Dandekar, Gudrun; Walles, Heike; Steinke, Maria] Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med, Wurzburg, Germany; [Dandekar, Gudrun; Walles, Heike; Steinke, Maria] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, Translat Ctr Regenerat Therapies Oncol & Musculos, Wurzburg, Germany; [Buck, Andreas; Luckerath, Katharina] Univ Hosp Wuerzburg, Dept Nucl Med, Wurzburg, Germany; [Walles, Thorsten] Univ Hosp Wuerzburg, Dept Cardiothorac Surg, Wurzburg, Germany; [Bundschuh, Ralph] Univ Hosp Bonn, Dept Nucl Med, Bonn, Germany	University of Wurzburg; Fraunhofer Gesellschaft; University of Wurzburg; University of Wurzburg; University of Bonn	Fecher, D (corresponding author), Univ Hosp Wuerzburg, Dept Tissue Engn & Regenerat Med, Wurzburg, Germany.	david.fecher@uni-wuerzburg.de	Lueckerath, Katharina/AAF-8598-2019; Lueckerath, Katharina/S-5882-2018	Lueckerath, Katharina/0000-0001-6109-2066; Lueckerath, Katharina/0000-0001-6109-2066; Walles, Heike/0000-0002-1512-7448; Buck, Andreas/0000-0002-6447-0613	Bavarian Ministry of Economic Affairs and Media, Energy and Technology [B7-RI/691042-011]	Bavarian Ministry of Economic Affairs and Media, Energy and Technology	This work was supported by the Bavarian Ministry of Economic Affairs and Media, Energy and Technology (http://www.stmwi.bayern.de/), grant number B7-RI/691042-011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2012, TRENDS PHARMACOL SCI, V33, P173, DOI 10.1016/j.tips.2012.02.001; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Cree IA, 2010, CURR OPIN PHARMACOL, V10, P375, DOI 10.1016/j.coph.2010.05.001; Cullen PJ, 2007, CRIT REV EUKAR GENE, V17, P241, DOI 10.1615/CritRevEukarGeneExpr.v17.i3.50; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dickson Michael, 2004, Discov Med, V4, P172; DiMasi JA, 2013, CLIN PHARMACOL THER, V94, P329, DOI 10.1038/clpt.2013.117; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Dohadwala M, 2001, J BIOL CHEM, V276, P20809, DOI 10.1074/jbc.C100140200; Einhorn Lawrence H, 2008, J Thorac Oncol, V3, P545, DOI 10.1097/JTO.0b013e318170627f; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P292, DOI 10.6004/jnccn.2012.0029; Ghaedi M, 2013, J CLIN INVEST, V123, P4950, DOI 10.1172/JCI68793; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Guyette JP, 2014, NAT PROTOC, V9, P1451, DOI 10.1038/nprot.2014.097; Haga Y, 2003, ANN THORAC SURG, V75, P1727, DOI 10.1016/S0003-4975(03)00119-X; Hait WN, 2010, NAT REV DRUG DISCOV, V9, P253, DOI 10.1038/nrd3144; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Kumar Vinay A AK, 2007, ROBBINS BASIC PATHOL; Lodillinsky C, 2016, ONCOGENE, V35, P344, DOI 10.1038/onc.2015.87; Luckerath K, 2015, ONCOTARGET, V6, P8418; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Menon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017277; Mertsching H, 2009, TRANSPLANTATION, V88, P203, DOI 10.1097/TP.0b013e3181ac15e1; Mishra DK, 2014, INT J CANCER, V134, P789, DOI 10.1002/ijc.28428; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Regales L, 2009, J CLIN INVEST, V119, P3000, DOI 10.1172/JCI38746; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Skardal A, 2012, BIOMATERIALS, V33, P4565, DOI 10.1016/j.biomaterials.2012.03.034; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Soto-Gutierrez A, 2012, J CLIN INVEST, V122, P3817, DOI 10.1172/JCI61974; Steinke M, 2015, TISSUE ENG PT A, V21, P573, DOI [10.1089/ten.TEA.2014.0200, 10.1089/ten.tea.2014.0200]; Stratmann AT, 2014, MOL ONCOL, V8, P351, DOI 10.1016/j.molonc.2013.11.009; Takimoto CH, 2001, CLIN CANCER RES, V7, P229; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; Tsvetkova E, 2012, CURR ONCOL, V19, pS45, DOI 10.3747/co.19.1113; van Gool MH, 2014, WORLD J RADIOL, V6, P392, DOI 10.4329/wjr.v6.i7.392; VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q; Walles T, 2004, J THORAC CARDIOV SUR, V128, P900, DOI 10.1016/j.jtcvs.2004.07.036; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005; Ziko L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/430569	68	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160282	10.1371/journal.pone.0160282	http://dx.doi.org/10.1371/journal.pone.0160282			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501455	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500017
J	Horseman, SV; Buller, H; Mullan, S; Whay, HR				Horseman, Susan V.; Buller, Henry; Mullan, Siobhan; Whay, Helen R.			Current Welfare Problems Facing Horses in Great Britain as Identified by Equine Stakeholders	PLOS ONE			English	Article							FREE-RANGING HORSES; UK LEISURE HORSES; RISK-FACTORS; MANAGEMENT-PRACTICES; BEHAVIOR PROBLEMS; GERIATRIC HORSES; ANIMAL-WELFARE; SOUTH WALES; HEALTH-CARE; PART 1	Despite growing concerns about the welfare of horses in Great Britain (GB) there has been little surveillance of the welfare status of the horse population. Consequently we have limited knowledge of the range of welfare problems experienced by horses in GB and the situations in which poor welfare occurs. Thirty-one in-depth interviews were conducted with a cross-section of equine stakeholders, in order to explore their perceptions of the welfare problems faced by horses in GB. Welfare problems relating to health, management and riding and training were identified, including horses being under or over weight, stabling 24 hours a day and the inappropriate use of training aids. The interviewees also discussed broader contexts in which they perceived that welfare was compromised. The most commonly discussed context was where horses are kept in unsuitable environments, for example environments with poor grazing. The racing industry and travellers horses were identified as areas of the industry where horse welfare was particularly vulnerable to compromise. Lack of knowledge and financial constraints were perceived to be the root cause of poor welfare by many interviewees. The findings give insight into the range of welfare problems that may be faced by horses in GB, the contexts in which these may occur and their possible causes. Many of the problems identified by the interviewees have undergone limited scientific investigation pointing to areas where further research is likely to be necessary for welfare improvement. The large number of issues identified suggests that some form of prioritisation may be necessary to target research and resources effectively.	[Horseman, Susan V.; Mullan, Siobhan; Whay, Helen R.] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Buller, Henry] Univ Exeter, Dept Geog, Exeter, Devon, England	University of Bristol; University of Exeter	Horseman, SV (corresponding author), Univ Bristol, Sch Vet Sci, Bristol, Avon, England.	Sue.Horseman@bristol.ac.uk		Mullan, Siobhan/0000-0002-3166-6396	World Horse Welfare [DFAS SJ1045]	World Horse Welfare	The research was funded by World Horse Welfare: http://www.worldhorsewelfare.org/Home Grant code: DFAS SJ1045. The funders had minor involvement in determining the sampling criteria for this research, i.e., they helped identify the main activities that horses are engaged in and the roles that industry stakeholders have. The funders saw a draft of the manuscript before the decision to publish was made.	Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Blue Cross, 2014, NAT EQ HLTH SURV; Boden LA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-188; Boden LA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-43; Buckland EL, 2013, ANIM WELFARE, V22, P239, DOI 10.7120/09627286.22.2.239; Christensen JW, 2014, PHYSIOL BEHAV, V128, P39, DOI 10.1016/j.physbeh.2014.01.024; Christensen JW, 2011, APPL ANIM BEHAV SCI, V133, P199, DOI 10.1016/j.applanim.2011.05.013; Christensen JW, 2002, APPL ANIM BEHAV SCI, V75, P233, DOI 10.1016/S0168-1591(01)00196-4; Clayton HM, 2010, EQUINE VET J, V42, P688, DOI 10.1111/j.2042-3306.2010.00196.x; Collins JA, 2012, VET REC, V170, P442, DOI 10.1136/vr.100281; Collins JA, 2010, EQUINE VET J, V42, P105, DOI 10.2746/042516409X471458; Collins J, 2009, VET J, V181, P63, DOI 10.1016/j.tvjl.2009.03.012; Cook WR, 2003, PFERDEHEILKUNDE, V19, P75, DOI 10.21836/PEM20030111; Fraser D, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-S1-S1; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Gomez Alvarez CB, 2006, EQUINE VET J S, V36, P445; Greening L, 2009, P BRIT SOC AN SCI 20, P7; Hancock E, 2014, CONFERENCE PROCEEDIN, P76; Hausberger M., 2009, PLOS ONE, V4; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; Hemsworth LM, 2015, APPL ANIM BEHAV SCI, V165, P1, DOI 10.1016/j.applanim.2014.11.019; Hockenhull J, 2014, EQUINE VET EDUC, V26, P159, DOI 10.1111/eve.12129; Hockenhull J, 2013, EQUINE VET J, V45, P15, DOI 10.1111/j.2042-3306.2012.00567.x; Hockenhull J, 2014, APPL ANIM BEHAV SCI, V155, P49, DOI 10.1016/j.applanim.2014.02.014; Hood DM, 1999, VET CLIN N AM-EQUINE, V15, P287, DOI 10.1016/S0749-0739(17)30145-1; Horseman SV, 2014, ANIM WELFARE, V23, P157, DOI 10.7120/09627286.23.2.157; Horseman SV, 2017, J APPL ANIM WELF SCI, V20, P9, DOI 10.1080/10888705.2016.1197776; Hotchkiss JW, 2007, EQUINE VET J, V39, P294, DOI 10.2746/042516407X177538; Ireland JL, 2013, RES VET SCI, V95, P418, DOI 10.1016/j.rvsc.2013.05.007; Ireland JL, 2011, EQUINE VET J, V43, P37, DOI 10.1111/j.2042-3306.2010.00142.x; Ireland JL, 2011, EQUINE VET J, V43, P30, DOI 10.1111/j.2042-3306.2010.00145.x; Kauppinen T, 2010, ANIM WELFARE, V19, P523; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Lesimple C, 2011, 62 ANN M EUR FED AN, DOI 10.1017/S1751731109004820; Lesimple C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00021; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Lindberg A. C., 2004, Animal Welfare, V13, pS247; Mejdell CM, 2014, C P 10 INT EQ SCI C, P33; Mullan S, 2014, ANIM WELFARE, V23, P25, DOI 10.7120/09627286.23.1.025; Murray RC, 2010, VET J, V184, P27, DOI 10.1016/j.tvjl.2009.03.020; Padalino B, 2015, ANIMALS, V5, P1296, DOI 10.3390/ani5040412; Samuel EK, 2012, ANIM WELFARE, V21, P593, DOI 10.7120/09627286.21.4.593; Scantlebury CE, 2015, EQUINE VET J, V47, P202, DOI 10.1111/evj.12276; Schmidt A, 2010, HORM BEHAV, V57, P209, DOI 10.1016/j.yhbeh.2009.11.003; Silverman D., 1993, INTERPRETING QUALITA; Slater J., 2014, REPORT NATL EQUINE H; The Association For Qualitative Research, 2015, SNOWB; The Royal Society for the Prevention of Cruelty to Animals Redwings Blue Cross World Horse Welfare Horse World and British Horse Society, 2012, LEFT VERG APPR EQ CR; The Royal Society for the Prevention of Cruelty to Animals Redwings Blue Cross World Horse Welfare Horse World and British Horse Society, 2013, LEFT VERG GRIP HORS; Thorne JB, 2005, APPL ANIM BEHAV SCI, V94, P149, DOI 10.1016/j.applanim.2005.02.002; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Visser EK, 2012, J VET BEHAV, V7, P295, DOI 10.1016/j.jveb.2011.10.007; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Waran NK, 2008, APPL ANIM BEHAV SCI, V110, P42, DOI 10.1016/j.applanim.2007.03.024; Ward S, 2015, EQUINE VET EDUC, V27, P655, DOI 10.1111/eve.12491; Waters AJ, 2002, EQUINE VET J, V34, P572, DOI 10.2746/042516402776180241; Whay H. R., 2001, Research in Veterinary Science, V70, P34; Wylie CE, 2013, RES VET SCI, V95, P410, DOI 10.1016/j.rvsc.2013.05.004; Wylie CE, 2013, VET J, V198, P57, DOI 10.1016/j.tvjl.2013.08.028; Zenisch A, 2014, J ANIMAL PHYSL ANIMA, V98, P901, DOI [10.1111/jpn.12155, DOI 10.1111/JPN.12155]	60	28	29	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160269	10.1371/journal.pone.0160269	http://dx.doi.org/10.1371/journal.pone.0160269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501387	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500016
J	Thomas, B; Jurdak, R; Zhao, K; Atkinson, I				Thomas, Bryce; Jurdak, Raja; Zhao, Kun; Atkinson, Ian			Diffusion in Colocation Contact Networks: The Impact of Nodal Spatiotemporal Dynamics	PLOS ONE			English	Article							PATTERNS	Temporal contact networks are studied to understand dynamic spreading phenomena such as communicable diseases or information dissemination. To establish how spatiotemporal dynamics of nodes impact spreading potential in colocation contact networks, we propose "inducement-shuffling" null models which break one or more correlations between times, locations and nodes. By reconfiguring the time and/or location of each node's presence in the network, these models induce alternative sets of colocation events giving rise to contact networks with varying spreading potential. This enables second-order causal reasoning about how correlations in nodes' spatiotemporal preferences not only lead to a given contact network but ultimately influence the network's spreading potential. We find the correlation between nodes and times to be the greatest impediment to spreading, while the correlation between times and locations slightly catalyzes spreading. Under each of the presented null models we measure both the number of contacts and infection prevalence as a function of time, with the surprising finding that the two have no direct causality.	[Thomas, Bryce] James Cook Univ, Dept Informat Technol, Townsville, Qld, Australia; [Jurdak, Raja; Zhao, Kun] CSIRO, Autonomous Syst, Brisbane, Qld, Australia; [Atkinson, Ian] James Cook Univ, eRes, Townsville, Qld, Australia	James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Thomas, B (corresponding author), James Cook Univ, Dept Informat Technol, Townsville, Qld, Australia.	bryce.m.thomas@gmail.com	atkinson, ian m/H-1806-2011; Jurdak, Raja/B-7637-2011	Jurdak, Raja/0000-0001-7517-0782; Atkinson, Ian/0000-0002-2295-6818	Australian Postgraduate Award (APA) scholarship; Commonwealth Scientific Industrial and Research Organisation (CSIRO) Office of the Chief Executive (OCE) "top up" scholarship, Australia; CSIRO, Australia; James Cook University (JCU), Australia	Australian Postgraduate Award (APA) scholarship(Australian Government); Commonwealth Scientific Industrial and Research Organisation (CSIRO) Office of the Chief Executive (OCE) "top up" scholarship, Australia; CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); James Cook University (JCU), Australia	The work of BT is partially funded by an Australian Postgraduate Award (APA) scholarship and Commonwealth Scientific Industrial and Research Organisation (CSIRO) Office of the Chief Executive (OCE) "top up" scholarship, Australia. The work of RJ and KZ is funded by the CSIRO, Australia. The work of IA is funded by James Cook University (JCU), Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ANDERSON R M, 1991; Aschenbruck N, 2011, COMPUT COMMUN, V34, P704, DOI 10.1016/j.comcom.2010.11.002; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Fall K, 2003, ACM SIGCOMM COMP COM, V33, P27; Gauvin L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03099; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Holme P, 2012, PHYS REP, V519, P97, DOI 10.1016/j.physrep.2012.03.001; Hsu WJ, 2010, IEEE T MOBILE COMPUT, V9, P1563, DOI 10.1109/TMC.2010.123; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Johnson D.B., 1994, P 1994 1 WORKSHOP MO, P158; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Liu SY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032805; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Su J, 2004, SIXTH IEEE WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS, PROCEEDINGS, P41, DOI 10.1109/mcsa.2004.29; Thomas B, 2014, INT WIREL COMMUN, P959, DOI 10.1109/IWCMC.2014.6906485; Zhao K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056109	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0152624	10.1371/journal.pone.0152624	http://dx.doi.org/10.1371/journal.pone.0152624			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501240	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000381373500001
J	Wieczorek, E; Kedracka-Krok, S; Soltys, K; Jankowska, U; Holubowicz, R; Seliga, J; Ozyhar, A				Wieczorek, Elzbieta; Kedracka-Krok, Sylwia; Soltys, Katarzyna; Jankowska, Urszula; Holubowicz, Rafal; Seliga, Justyna; Ozyhar, Andrzej			Is Transthyretin a Regulator of Ubc9 SUMOylation?	PLOS ONE			English	Article							FUSION-DIRECTED SUMOYLATION; ALPHA-SYNUCLEIN; X-RAY; CONJUGATING ENZYME; SUMO MODIFICATION; CHOROID-PLEXUS; PROTEIN; BINDING; ACETYLATION; NETWORK	Ageing and mutations of transthyretin (TTR), the thyroid hormones and retinol transporting protein lead to amyloidosis by destabilizing the structure of TTR. Because protein structure is regulated through posttranslational modifications, we investigated the Small Ubiquitinlike Modifier (SUMO)ylation of TTR. We chose the widely used Ubc9 fusion-directed SUMOylation system, which is based on a fusion of the SUMOylation substrate of interest with Ubc9, a sole SUMO conjugating enzyme. Surprisingly, despite our presumptions, we found that Ubc9 fused to TTR was SUMOylated at a unique set of lysine residues. Three unknown SUMOylation sites of Ubc9-K154, K18 and K65-were revealed by mass spectrometry (MS). The previously reported SUMOylation at K49 of Ubc9 was also observed. SUMOylation of the lysine residues of TTR fused to Ubc9 was hardly detectable. However, non-fused TTR was SUMOylated via trans-SUMOylation by Ubc9 fused to TTR. Interestingly, mutating the catalytic residue of Ubc9 fused to TTR did not result in complete loss of the SUMOylation signal, suggesting that Ubc9 linked to TTR is directly cross-SUMOylated by the SUMO-activating enzyme E1. Ubc9, TTR or fusion proteins composed of TTR and Ubc9 specifically affected the global SUMOylation of cellular proteins. TTR or Ubc9 alone increased global SUMOylation, whereas concomitant presence of TTR and Ubc9 did not further increase the amount of high-molecular weight (HMW) SUMO conjugates. Our data suggest that TTR may influence the SUMOylation of Ubc9, thereby altering signalling pathways in the cell.	[Wieczorek, Elzbieta; Soltys, Katarzyna; Holubowicz, Rafal; Seliga, Justyna; Ozyhar, Andrzej] Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, Wroclaw, Poland; [Kedracka-Krok, Sylwia] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Jankowska, Urszula] Jagiellonian Univ, Malopolska Ctr Biotechnol, Dept Biol Struct, Krakow, Poland	Wroclaw University of Science & Technology; Jagiellonian University; Jagiellonian University	Wieczorek, E (corresponding author), Wroclaw Univ Sci & Technol, Dept Biochem, Fac Chem, Wybrzeze Wyspianskiego 27, Wroclaw, Poland.	elzbieta.wieczorek@pwr.edu.pl	Jankowska, Urszula/C-4898-2015; Wieczorek, Elżbieta/GXZ-9842-2022; Holubowicz, Rafal/AAB-7552-2020; Sołtys, Katarzyna/GVT-6447-2022	Jankowska, Urszula/0000-0002-7165-8964; Holubowicz, Rafal/0000-0002-2555-2069; Sołtys, Katarzyna/0000-0003-0521-2099; OZYHAR, Andrzej/0000-0002-5874-784X				Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; ALESHIRE SL, 1983, J HISTOCHEM CYTOCHEM, V31, P608, DOI 10.1177/31.5.6341455; Alontaga AY, 2015, J BIOL CHEM, V290, P16550, DOI 10.1074/jbc.M115.644047; ANDERSEN MM, 1982, SCAND J IMMUNOL, V15, P399, DOI 10.1111/j.1365-3083.1982.tb00664.x; Andreou Artemisia M., 2009, Biotechnology Journal, V4, P1740, DOI 10.1002/biot.200900219; Bielska K, 2012, J STEROID BIOCHEM, V132, P227, DOI 10.1016/j.jsbmb.2012.05.011; Blake CCF, 1978, BIOCHEM SOC T, V6, P1114, DOI 10.1042/bst0061114; BLAKE CCF, 1971, J MOL BIOL, V61, P217, DOI 10.1016/0022-2836(71)90218-X; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; CAVALLARO T, 1990, INVEST OPHTH VIS SCI, V31, P497; Choi HS, 2012, BIOCHEM BIOPH RES CO, V424, P597, DOI 10.1016/j.bbrc.2012.06.159; Ciarrocchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004404; Costa MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024812; da Costa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024850; del Monte F, 2014, PROTEOM CLIN APPL, V8, P534, DOI 10.1002/prca.201400037; Dorval V, 2006, J BIOL CHEM, V281, P9919, DOI 10.1074/jbc.M510127200; DWORK AJ, 1990, INVEST OPHTH VIS SCI, V31, P489; Fleming CE, 2007, J NEUROCHEM, V103, P831, DOI 10.1111/j.1471-4159.2007.04828.x; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Getz RK, 1999, EXP EYE RES, V68, P629, DOI 10.1006/exer.1998.0646; Groenning M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11443; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Hamilton JA, 2001, CELL MOL LIFE SCI, V58, P1491, DOI 10.1007/PL00000791; HAMILTON JA, 1993, J BIOL CHEM, V268, P2416; Heegaard NHH, 2006, J SEP SCI, V29, P371, DOI 10.1002/jssc.200500377; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Hsieh YL, 2013, EMBO J, V32, P791, DOI 10.1038/emboj.2013.5; Hyung SJ, 2010, ACS CHEM BIOL, V5, P1137, DOI 10.1021/cb100144v; Ihara M, 2008, BIOL REPROD, V79, P906, DOI 10.1095/biolreprod.108.070474; JACOBSSON B, 1989, J HISTOCHEM CYTOCHEM, V37, P31, DOI 10.1177/37.1.2642294; Jakobs A, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm617; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Kim ET, 2009, BIOCHEM BIOPH RES CO, V388, P41, DOI 10.1016/j.bbrc.2009.07.103; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; KOZIK A, 2015, BMC MICROBIOL, V15; Krumova P, 2011, J CELL BIOL, V194, P49, DOI 10.1083/jcb.201010117; Kuchler-Bopp S, 1998, BRAIN RES, V793, P219, DOI 10.1016/S0006-8993(98)00154-1; Kuwata T, 2008, GENES CELLS, V13, P931, DOI 10.1111/j.1365-2443.2008.01216.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Liz MA, 2009, BIOCHEM J, V419, P467, DOI 10.1042/BJ20082090; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Nguyen L, 2010, TRENDS MOL MED, V16, P1, DOI 10.1016/j.molmed.2009.11.002; Nunes AF, 2005, FASEB J, V19, P166, DOI 10.1096/fj.05-4106fje; Nuvolone M, 2012, US NEUROL, V8, P24; PETTERSSON T, 1987, BIOCHEMISTRY-US, V26, P4572, DOI 10.1021/bi00388a061; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Refai E, 2005, P NATL ACAD SCI USA, V102, P17020, DOI 10.1073/pnas.0503219102; Richardson SJ, 2009, FEBS J, V276, P5342, DOI 10.1111/j.1742-4658.2009.07244.x; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Shrivastava V, 2010, REPRODUCTION, V139, P999, DOI 10.1530/REP-09-0492; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; Sousa JC, 2007, NEUROBIOL LEARN MEM, V88, P381, DOI 10.1016/j.nlm.2007.07.006; Sousa MM, 2001, AM J PATHOL, V159, P1993; Srivastav RK, 2011, BIOCHEM J, V438, P495, DOI 10.1042/BJ20110035; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su Y, 2012, FEBS LETT, V586, P4215, DOI 10.1016/j.febslet.2012.10.025; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Truong K., 2012, J BIOL CHEM; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Vieira M, 2013, FEBS LETT, V587, P1482, DOI 10.1016/j.febslet.2013.03.011; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang JG, 2010, 2010 INTERNATIONAL CONFERENCE ON INFORMATION, ELECTRONIC AND COMPUTER SCIENCE, VOLS 1-3, P5; Wang X, 2014, J NEUROSCI, V34, P7253, DOI 10.1523/JNEUROSCI.4936-13.2014; Watts FZ, 2013, CHROMOSOMA, V122, P451, DOI 10.1007/s00412-013-0422-0; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002; Zhang YQ, 2008, BIOCHEM BIOPH RES CO, V374, P673, DOI 10.1016/j.bbrc.2008.07.109; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	84	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160536	10.1371/journal.pone.0160536	http://dx.doi.org/10.1371/journal.pone.0160536			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501389	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500029
J	Wang, YF; Rahman, D; Mistry, M; Lehner, T				Wang, Yufei; Rahman, Durdana; Mistry, Mukesh; Lehner, Thomas			The Effect of Cellular Stress on T and B Cell Memory Pathways in Immunized and Unimmunized BALB/c Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellular immune response; heat shock protein (HSP); inflammasome; interleukin 1 (IL-1); oxidative stress; stress response; AID; IL-15; T and B memory cells	CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; ACTIVATION; EXPRESSION; PHENOTYPE; RECEPTOR; BIOLOGY; NAIVE; AID	Immunological memory is a fundamental function of vaccination. The antigenic breakdown products of the vaccine may not persist, and undefined tonic stimulation has been proposed to maintain the specific memory. We have suggested that cellular stress agents to which the immune cells are constantly exposed may be responsible for tonic stimulation. Here we have studied four stress agents: sodium arsenite, an oxidative agent; Gramicidin, eliciting K+ efflux and calcium influx; dithiocarbamate, a metal ionophore; and aluminum hydroxide (alum), an immunological adjuvant. The aims of this study are to extend these investigations to T and B cell responses of unimmunized and ovalbumin (OVA)-immunized BALB/c mice, and furthermore, to ascertain whether stress is involved in optimal expression of memory B cells, as demonstrated in CD4(+) T cells. Examination of the homeostatic pathway defined by IL-15/IL-15R (IL-15 receptor) interaction and the inflammasome pathway defined by the IL-1-IL-1R interaction between dendritic cells (DC) and CD4(+) T cells suggests that both pathways are involved in the development of optimal expression of CD4(+)CD45RO(+) memory T cells in unimmunized and OVA-immunized BALB/c mice. Furthermore, significant direct correlation was found between CD4(+)CD44(+) memory T cells and both IL-15 of the homeostatic and IL-1 of the inflammasome pathways. However, CD19(+)CD27(+) memory B cells in vivo seem to utilize only the IL-15/IL-15R homeostatic pathway, although the proliferative responses are enhanced by the stress agents. Altogether, stress agents may up-regulate unimmunized and OVA-immunized CD4(+)CD44(+) memory T cells by the homeostatic and inflammasome pathways. However, the CD19(+)CD27(+) memory B cells utilize only the homeostatic pathway.	[Wang, Yufei; Rahman, Durdana; Mistry, Mukesh; Lehner, Thomas] Kings Coll London, Guys Hosp, Mucosal Immunol Unit, London SE1 1UT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Lehner, T (corresponding author), Kings Coll London, Guys Hosp, Mucosal Immunol Unit, London SE1 1UT, England.	Thomas.lehner@kcl.ac.uk			European Union [280873]; King's Health Partner's Research and Challenge Fund; King's College London	European Union(European Commission); King's Health Partner's Research and Challenge Fund; King's College London	This work was supported by the European Union 'Advanced Immunization Technology Grant 280873' and the King's Health Partner's Research and Challenge Fund. Open access for this article was funded by King's College London. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; BOURINBAIAR AS, 1994, LIFE SCI, V54, pPL5, DOI 10.1016/0024-3205(94)00579-6; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Geginat J, 2001, J EXP MED, V194, P1711, DOI 10.1084/jem.194.12.1711; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Intlekofer AM, 2006, IMMUNOL REV, V211, P203, DOI 10.1111/j.0105-2896.2006.00396.x; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tomlin C., 1994, PESTICIDE MANUAL WOR, V10th ed.; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang YF, 2015, J BIOL CHEM, V290, P15595, DOI 10.1074/jbc.M115.645754; Wang YF, 2012, J BIOL CHEM, V287, P17152, DOI 10.1074/jbc.M112.347179; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	25	1	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20707	20717		10.1074/jbc.M116.746057	http://dx.doi.org/10.1074/jbc.M116.746057			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27502276	Green Published, hybrid			2022-12-26	WOS:000384574800032
J	Li, YH; Xu, JY; Tao, L; Li, XF; Li, S; Zeng, X; Chen, SY; Zhang, P; Qin, C; Zhang, C; Chen, Z; Zhu, F; Chen, YZ				Li, Ying Hong; Xu, Jing Yu; Tao, Lin; Li, Xiao Feng; Li, Shuang; Zeng, Xian; Chen, Shang Ying; Zhang, Peng; Qin, Chu; Zhang, Cheng; Chen, Zhe; Zhu, Feng; Chen, Yu Zong			SVM-Prot 2016: A Web-Server for Machine Learning Prediction of Protein Functional Families from Sequence Irrespective of Similarity	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINE; DNA-BINDING PROTEINS; SECONDARY STRUCTURE; PHYSICOCHEMICAL FEATURES; CLASSIFICATION; IDENTIFICATION; UPDATE; RESOURCE; DATABASE	Knowledge of protein function is important for biological, medical and therapeutic studies, but many proteins are still unknown in function. There is a need for more improved functional prediction methods. Our SVM-Prot web-server employed a machine learning method for predicting protein functional families from protein sequences irrespective of similarity, which complemented those similarity-based and other methods in predicting diverse classes of proteins including the distantly-related proteins and homologous proteins of different functions. Since its publication in 2003, we made major improvements to SVM-Prot with (1) expanded coverage from 54 to 192 functional families, (2) more diverse protein descriptors protein representation, (3) improved predictive performances due to the use of more enriched training datasets and more variety of protein descriptors, (4) newly integrated BLAST analysis option for assessing proteins in the SVM-Prot predicted functional families that were similar in sequence to a query protein, and (5) newly added batch submission option for supporting the classification of multiple proteins. Moreover, 2 more machine learning approaches, K nearest neighbor and probabilistic neural networks, were added for facilitating collective assessment of protein functions by multiple methods. SVM-Prot can be accessed at http://bidd2.nus.edu.sg/cgi-bin/svmprot/svmprot.cgi.	[Li, Ying Hong; Xu, Jing Yu; Tao, Lin; Li, Xiao Feng; Li, Shuang; Zhu, Feng] Chongqing Univ, Innovat Drug Res & Bioinformat Grp, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China; [Li, Ying Hong; Xu, Jing Yu; Tao, Lin; Li, Xiao Feng; Li, Shuang; Zhu, Feng] Chongqing Univ, Sch Pharmaceut Sci, Chongqing 401331, Peoples R China; [Tao, Lin; Zeng, Xian; Chen, Shang Ying; Zhang, Peng; Qin, Chu; Zhang, Cheng; Chen, Yu Zong] Natl Univ Singapore, Dept Pharm, Bioinformat & Drug Discovery Grp, Singapore 117543, Singapore; [Chen, Zhe] Zhejiang Chinese Med Univ, Zhejiang Hosp Tradit Chinese Med, Zhejiang Key Lab Gastrointestinal Pathophysiol, Hangzhou, Zhejiang, Peoples R China; [Xu, Jing Yu] Beijing Inst Technol, Sch Math & Stat, Beijing, Peoples R China	Chongqing University; Chongqing University; National University of Singapore; Zhejiang Chinese Medical University; Beijing Institute of Technology	Zhu, F (corresponding author), Chongqing Univ, Innovat Drug Res & Bioinformat Grp, Innovat Drug Res Ctr, Chongqing 401331, Peoples R China.; Zhu, F (corresponding author), Chongqing Univ, Sch Pharmaceut Sci, Chongqing 401331, Peoples R China.	zhufeng@cqu.edu.cn	Zeng, Xian/AAL-8713-2020; ZHU, Feng/ABF-5843-2021; Zhang, Peng/I-4665-2019; Li, Ying Hong/U-4004-2017; ZHU, Feng/X-2659-2018; Zeng, Xian/O-8750-2018	Zeng, Xian/0000-0002-1397-554X; ZHU, Feng/0000-0001-8069-0053; Zhang, Peng/0000-0002-6129-567X; Li, Ying Hong/0000-0003-3629-519X; ZHU, Feng/0000-0001-8069-0053; Zeng, Xian/0000-0002-1397-554X; Zhang, Cheng/0000-0003-3843-1562; Chen, Yu Zong/0000-0002-5473-8022; Tao, Lin/0000-0001-7494-4758; Zhu, Feng/0000-0001-6661-0002	Fundamental Research Funds for the Central Universities [CDJZR14468801, CDJKXB14011, 2015CDJXY]; Ministry of Science and Technology, 863 Hi-Tech Program [2007AA02Z160]; Key Special Project China [2009ZX09501-004]; Singapore Academic Research Fund [R-148-000-208-112]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology, 863 Hi-Tech Program; Key Special Project China; Singapore Academic Research Fund(Ministry of Education, Singapore)	FZ is supported by grants from the Fundamental Research Funds for the Central Universities (CDJZR14468801, CDJKXB14011, 2015CDJXY); Ministry of Science and Technology, 863 Hi-Tech Program (2007AA02Z160); Key Special Project Grant 2009ZX09501-004 China; and Singapore Academic Research Fund grant R-148-000-208-112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the Fundamental Research Funds for the Central Universities (CDJZR14468801, CDJKXB14011, 2015CDJXY); Ministry of Science and Technology, 863 Hi-Tech Program (2007AA02Z160); Key Special Project Grant 2009ZX09501-004 China; and Singapore Academic Research Fund grant R-148-000-208-112.	Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bernardes Juliana S, 2013, Recent Pat Biotechnol, V7, P122; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; BROTO P, 1984, EUR J MED CHEM, V19, P79; Cai CZ, 2004, PROTEINS, V55, P66, DOI 10.1002/prot.20045; Cai CZ, 2003, NUCLEIC ACIDS RES, V31, P3692, DOI 10.1093/nar/gkg600; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao P, 2013, IEEE ENG MED BIO, P3981, DOI 10.1109/EMBC.2013.6610417; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Cui J, 2007, MOL IMMUNOL, V44, P514, DOI 10.1016/j.molimm.2006.02.010; Dai HL, 2015, IEEE T NANOBIOSCI, V14, P350, DOI 10.1109/TNB.2015.2431292; Date SV, 2005, BIOINFORMATICS, V21, P2558, DOI 10.1093/bioinformatics/bti313; Dobson PD, 2005, J MOL BIOL, V345, P187, DOI 10.1016/j.jmb.2004.10.024; DUBCHAK I, 1995, P NATL ACAD SCI USA, V92, P8700, DOI 10.1073/pnas.92.19.8700; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Garg Aarti, 2008, In Silico Biology, V8, P129; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Grassmann J, 1999, Proc Int Conf Intell Syst Mol Biol, P106; Guan YF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s3; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Han LY, 2004, NUCLEIC ACIDS RES, V32, P6437, DOI 10.1093/nar/gkh984; Han LY, 2004, RNA, V10, P355, DOI 10.1261/rna.5890304; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; Hodges J. L., 1951, DISCRIMINATORY ANAL, P261; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Khan ZU, 2015, J THEOR BIOL, V365, P197, DOI 10.1016/j.jtbi.2014.10.014; Kotlyar M, 2015, NAT METHODS, V12, P79, DOI [10.1038/NMETH.3178, 10.1038/nmeth.3178]; Le Novere N, 2001, NUCLEIC ACIDS RES, V29, P294, DOI 10.1093/nar/29.1.294; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin HT, 2007, MACH LEARN, V68, P267, DOI 10.1007/s10994-007-5018-6; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15479; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; Lyons J, 2014, J COMPUT CHEM, V35, P2040, DOI 10.1002/jcc.23718; Majid A, 2014, COMPUT METH PROG BIO, V113, P792, DOI 10.1016/j.cmpb.2014.01.001; Minneci F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063754; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nath N, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-60; Naveed M, 2012, AMINO ACIDS, V42, P1809, DOI 10.1007/s00726-011-0902-6; Needham CJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-405; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Ong SAK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-300; Piovesan D, 2015, NUCLEIC ACIDS RES, V43, pW134, DOI 10.1093/nar/gkv523; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rentzsch R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S5; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Sahraeian SM, 2015, NUCLEIC ACIDS RES, V43, pW141, DOI 10.1093/nar/gkv461; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; Spencer M, 2015, IEEE ACM T COMPUT BI, V12, P103, DOI 10.1109/TCBB.2014.2343960; Tang H, 2016, MOL BIOSYST, V12, P1269, DOI 10.1039/c5mb00883b; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Wang P, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/767136; Wass MN, 2012, NUCLEIC ACIDS RES, V40, pW466, DOI 10.1093/nar/gks489; Wei LY, 2016, COMB CHEM HIGH T SCR, V19, P144, DOI 10.2174/1386207319666151110122621; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P339, DOI 10.1109/TNB.2014.2352454; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Xu RF, 2015, BMC SYST BIOL, V9, DOI 10.1186/1752-0509-9-S1-S10; Xue WW, 2016, PHYS CHEM CHEM PHYS, V18, P3260, DOI 10.1039/c5cp05771j; Yang H, 2016, NUCLEIC ACIDS RES, V44, pD1069, DOI 10.1093/nar/gkv1230; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]	80	132	136	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0155290	10.1371/journal.pone.0155290	http://dx.doi.org/10.1371/journal.pone.0155290			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525735	gold, Green Submitted, Green Published			2022-12-26	WOS:000381471100002
J	Baack, ML; Forred, BJ; Larsen, TD; Jensen, DN; Wachal, AL; Khan, MA; Vitiello, PF				Baack, Michelle L.; Forred, Benjamin J.; Larsen, Tricia D.; Jensen, Danielle N.; Wachal, Angela L.; Khan, Muhammad Ali; Vitiello, Peter F.			Consequences of a Maternal High-Fat Diet and Late Gestation Diabetes on the Developing Rat Lung	PLOS ONE			English	Article							FETAL LUNG; PULMONARY-HYPERTENSION; MOLECULAR-MECHANISMS; VASCULAR INJURY; PREGNANCY; OBESITY; MATURATION; MELLITUS; INFANTS; GROWTH	Rationale Infants born to diabetic or obese mothers are at risk of respiratory distress and persistent pulmonary hypertension of the newborn (PPHN), conceivably through fuel-mediated pathogenic mechanisms. Prior research and preventative measures focus on controlling maternal hyperglycemia, but growing evidence suggests a role for additional circulating fuels including lipids. Little is known about the individual or additive effects of a maternal high-fat diet on fetal lung development. Objective The objective of this study was to determine the effects of a maternal high-fat diet, alone and alongside late-gestation diabetes, on lung alveologenesis and vasculogenesis, as well as to ascertain if consequences persist beyond the perinatal period. Methods A rat model was used to study lung development in offspring from control, diabetes-exposed, high-fat diet-exposed and combination-exposed pregnancies via morphometric, histologic (alveolarization and vasculogenesis) and physiologic (echocardiography, pulmonary function) analyses at birth and 3 weeks of age. Outcomes were interrogated for diet, diabetes and interaction effect using ANOVA with significance set at p <= 0.05. Findings prompted additional mechanistic inquiry of key molecular pathways. Results Offspring exposed to maternal diabetes or high-fat diet, alone and in combination, had smaller lungs and larger hearts at birth. High-fat diet-exposed, but not diabetes-exposed offspring, had a higher perinatal death rate and echocardiographic evidence of PPHN at birth. Alveolar mean linear intercept, septal thickness, and airspace area (D-2) were not significantly different between the groups; however, markers of lung maturity were. Both diabetes-exposed and diet-exposed offspring expressed more T1 alpha protein, a marker of type I cells. Diet-exposed newborn pups expressed less surfactant protein B and had fewer pulmonary vessels enumerated. Mechanistic inquiry revealed alterations in AKT activation, higher endothelin-1 expression, and an impaired Txnip/VEGF pathway that are important for vessel growth and migration. After 3 weeks, mortality remained highest and static lung compliance and hysteresis were lowest in combination-exposed offspring. Conclusion This study emphasizes the effects of a maternal high-fat diet, especially alongside late-gestation diabetes, on pulmonary vasculogenesis, demonstrates adverse consequences beyond the perinatal period and directs attention to mechanistic pathways of interest. Findings provide a foundation for additional investigation of preventative and therapeutic strategies aimed at decreasing pulmonary morbidity in at-risk infants.	[Baack, Michelle L.; Forred, Benjamin J.; Larsen, Tricia D.; Jensen, Danielle N.; Wachal, Angela L.; Vitiello, Peter F.] Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Baack, Michelle L.; Khan, Muhammad Ali] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD 57105 USA; [Baack, Michelle L.; Vitiello, Peter F.] Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA; [Baack, Michelle L.] Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD 57117 USA	Sanford Health; University of South Dakota; University of South Dakota; Sanford Health	Baack, ML (corresponding author), Sanford Res, Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA.; Baack, ML (corresponding author), Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD 57105 USA.; Baack, ML (corresponding author), Univ South Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA.; Baack, ML (corresponding author), Sanford Childrens Hosp, Childrens Hlth Specialty Clin, Sioux Falls, SD 57117 USA.	michelle.baack@sanfordhealth.org	Baack, Michelle/T-4645-2019	Baack, Michelle/0000-0001-5966-669X; Forred, Benjamin/0000-0002-5340-6886	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K08D078504, R25HD072596]; National Institutes of Health General Medical Sciences [P20GM103620, P20GM103548]; National Science Foundation-Research Experiences for Undergraduates [DBI-1262744]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD078504, R25HD072596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103620] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation-Research Experiences for Undergraduates(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, K08D078504 MLB; https://www.nichd.nih.gov/Pages/index.aspx; National Institutes of Health General Medical Sciences, P20GM103620 COBRE PFV BJF, https://www.nigms.nih.gov/Pages/default.aspx; National Institutes of Health General Medical Sciences, P20GM103548 COBRE the Sanford Research Molecular Pathology Core, https://www.nigms.nih.gov/Pages/default.aspx; National Science Foundation-Research Experiences for Undergraduates, DBI-1262744 funds Sanford Program for Undergraduate Research (SPUR) DNJ, http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5517& and Eunice Kennedy Shriver National Institute of Child Health and Human Development, R25HD072596 funds Sanford Science Educator Research Fellowship (SERF) ALW, https://www.nichd.nih.gov/Pages/index.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Blagosklonny MV, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.506; Boucherat O, 2014, DEVELOPMENT, V141, P3197, DOI 10.1242/dev.110254; BOURBON JR, 1985, PEDIATR RES, V19, P253, DOI 10.1203/00006450-198503000-00001; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; COLPAERT C, 1995, PEDIATR PATHOL LAB M, V15, P689, DOI 10.3109/15513819509027006; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; DABESTANI A, 1987, AM J CARDIOL, V59, P662, DOI 10.1016/0002-9149(87)91189-1; Deng FT, 2015, J HUAZHONG U SCI-MED, V35, P122, DOI 10.1007/s11596-015-1400-y; Dennedy M C, 2012, Ir Med J, V105, P23; Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018; Fan L, 2013, INT J OBESITY, V37, P254, DOI 10.1038/ijo.2012.42; Feng XS, 2010, DEVELOPMENT, V137, P4191, DOI 10.1242/dev.052043; Floen MJ, 2014, FREE RADICAL BIO MED, V75, P167, DOI 10.1016/j.freeradbiomed.2014.07.023; Fung GPG, 2014, EARLY HUM DEV, V90, P527, DOI 10.1016/j.earlhumdev.2014.04.006; Gewolb IH, 1996, EXP LUNG RES, V22, P201, DOI 10.3109/01902149609050847; Grover TR, 2005, AM J PHYSIOL-LUNG C, V288, pL648, DOI 10.1152/ajplung.00288.2004; Haberg SE, 2009, PAEDIATR PERINAT EP, V23, P352, DOI 10.1111/j.1365-3016.2009.01034.x; Hernandez-Diaz S, 2007, PEDIATRICS, V120, pE272, DOI 10.1542/peds.2006-3037; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Huang LT, 2016, PEDIATR NEONATOL, V57, P508, DOI 10.1016/j.pedneo.2016.03.003; Ikeda H, 2011, MOL CELL BIOL, V31, P1054, DOI 10.1128/MCB.00732-10; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; KITABATAKE A, 1983, CIRCULATION, V68, P302, DOI 10.1161/01.CIR.68.2.302; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Koskinen A, 2012, PEDIATR PULM, V47, P275, DOI 10.1002/ppul.21541; Langer O, 2015, J MATERN-FETAL NEO M, P1, DOI DOI 10.3109/14767058; Lock M, 2013, CLIN EXP PHARMACOL P, V40, P803, DOI 10.1111/1440-1681.12166; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Madonna R, 2011, VASC PHARMACOL, V54, P75, DOI 10.1016/j.vph.2011.03.007; Mayor RS, 2015, AM J PHYSIOL-LUNG C, V309, pL360, DOI 10.1152/ajplung.00105.2015; Mdaki KS, 2016, AM J PHYSIOL-HEART C, V310, pH681, DOI 10.1152/ajpheart.00795.2015; Mitzner W, 2008, J APPL PHYSIOL, V105, P1980, DOI 10.1152/japplphysiol.90968.2008; Park SY, 2013, ARTERIOSCL THROM VAS, V33, P737, DOI 10.1161/ATVBAHA.112.300386; Perez MK, 2014, IMMUNOL ALLERGY CLIN, V34, P777, DOI 10.1016/j.iac.2014.07.002; Piazze JJ, 1999, EUR J OBSTET GYN R B, V83, P145, DOI 10.1016/S0301-2115(98)90333-5; PIPER JM, 1993, AM J OBSTET GYNECOL, V168, P783, DOI 10.1016/S0002-9378(12)90819-4; Rayani HH, 1999, EXP LUNG RES, V25, P69, DOI 10.1080/019021499270439; Satwiko MG, 2015, BIOCHEM BIOPH RES CO, V465, P356, DOI 10.1016/j.bbrc.2015.08.002; SOSENKO IRS, 1980, AM REV RESPIR DIS, V122, P687, DOI 10.1164/arrd.1980.122.5.687; Sutton L, 2001, ACTA OBSTET GYN SCAN, V80, P917, DOI 10.1080/791200707; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Trevino-Alanis M, 2009, ANAT HISTOL EMBRYOL, V38, P169, DOI 10.1111/j.1439-0264.2008.00902.x; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Vela-Huerta M, 2007, ACTA PAEDIATR, V96, P1303, DOI 10.1111/j.1651-2227.2007.00414.x; Wieck MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148323; World C, 2011, ARTERIOSCL THROM VAS, V31, P1890, DOI 10.1161/ATVBAHA.111.226340; Yared K, 2011, J AM SOC ECHOCARDIOG, V24, P687, DOI 10.1016/j.echo.2011.03.008	51	23	24	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160818	10.1371/journal.pone.0160818	http://dx.doi.org/10.1371/journal.pone.0160818			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518105	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100026
J	Ben Amor, A; Beauchemin, K; Faucher, MC; Hamzaoui, A; Hamzaoui, K; Roger, M				Ben Amor, Amira; Beauchemin, Karine; Faucher, Marie-Claude; Hamzaoui, Agnes; Hamzaoui, Kamel; Roger, Michel			Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage	PLOS ONE			English	Article							CLASS-I MOLECULES; SOLUBLE HLA-G; CARCINOMA	Human leukocyte antigen (HLA)-G acts as negative regulator of the immune responses and its expression may enable tumor cells to escape immunosurveillance. The purpose of this study was to investigate the influence of HLA-G allelic variants and serum soluble HLA-G (sHLA-G) levels on risk of non-small-cell lung cancer (NSCLC). We analyzed 191 Caucasian adults with NSCLC and 191 healthy subjects recruited between January 2009 and March 2014 in Ariana (Tunisia). Serum sHLA-G levels were measured by immunoassay and HLA-G alleles were determined using a direct DNA sequencing procedures. The heterozygous genotypes of HLA-G 010101 and -G 010401 were associated with increased risks of both NSCLC and advanced disease stages. In contrast, the heterozygous genotypes of HLA-G 0105N and -G 0106 were associated with decreased risks of NSCC and clinical disease stage IV, respectively. Serum sHLA-G levels were significantly higher in patients with NSCLC and particularly in those with advanced disease stages compared to healthy subjects. The area under the receiver-operating characteristic (ROC) curves was 0.82 for controls vs patients. Given 100% specificity, the highest sensitivity achieved to detect NSCLC was 52.8% at a cutoff value of 24.9 U/ml. Patients with the sHLA-G above median level (similar to 50 U/ml) had a significantly shorter survival time. This study demonstrates that HLA-G allelic variants are independent risk factors for NSCLC. Serum sHLA-G levels in NSCLC patients could be useful biomarkers for the diagnostic and prognosis of NSCLC.	[Ben Amor, Amira; Hamzaoui, Agnes; Hamzaoui, Kamel] Tunis El Manar Univ, Med Fac Tunis, Dept Immunol & Histol, Tunis, Tunisia; [Beauchemin, Karine; Faucher, Marie-Claude; Roger, Michel] CRCHUM, Lab Immunogenet, Montreal, PQ, Canada; [Hamzaoui, Agnes; Hamzaoui, Kamel] Abderrahmen Mami Hosp, Unit Res UR Homeostasis & cell Immune Dysfunct 12, Ariana, Tunisia; [Roger, Michel] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada	Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Universite de Montreal; Universite de Tunis-El-Manar; Hopital Abderrahmene Mami; Universite de Montreal	Roger, M (corresponding author), CRCHUM, Lab Immunogenet, Montreal, PQ, Canada.; Roger, M (corresponding author), Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada.	michel.roger@ssss.gouv.qc.ca	Hamzaoui, kamel/AAH-2814-2019					Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Castelli EC, 2008, TISSUE ANTIGENS, V72, P149, DOI 10.1111/j.1399-0039.2008.01091.x; Chen Y, 2012, BIOMARKERS, V17, P9, DOI 10.3109/1354750X.2011.633242; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Fainardi E, 2011, CELL MOL LIFE SCI, V68, P433, DOI 10.1007/s00018-010-0584-3; Ferguson R, 2012, INT J CANCER, V131, pE312, DOI 10.1002/ijc.27356; Ferguson R, 2011, HUM IMMUNOL, V72, P337, DOI 10.1016/j.humimm.2011.01.010; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FERRONE S, 1995, IMMUNOL TODAY, V16, P487, DOI 10.1016/0167-5699(95)80033-6; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Ghandri N, 2011, HUM IMMUNOL, V72, P150, DOI 10.1016/j.humimm.2010.10.006; Howlader N, 2011, SEER CANC STAT REV 1; Jeong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098284; Kowal A, 2015, THORAC CANCER, V6, P613, DOI 10.1111/1759-7714.12232; LeMaoult J, 2007, BLOOD, V109, P2040, DOI 10.1182/blood-2006-05-024547; Lin A, 2010, J CELL MOL MED, V14, P2318, DOI 10.1111/j.1582-4934.2009.00858.x; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schutt P, 2010, HUM IMMUNOL, V71, P489, DOI 10.1016/j.humimm.2010.02.015; Sheu J, 2010, J FORMOS MED ASSOC, V109, P248, DOI 10.1016/S0929-6646(10)60050-2; Urosevic M, 2001, AM J PATHOL, V159, P817, DOI 10.1016/S0002-9440(10)61756-7; Wisniewski A, 2015, TISSUE ANTIGENS, V85, P466, DOI 10.1111/tan.12561; Yan WH, 2015, J CELL MOL MED, V19, P778, DOI 10.1111/jcmm.12400; Yie SM, 2007, LUNG CANCER, V58, P267, DOI 10.1016/j.lungcan.2007.06.011	25	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161210	10.1371/journal.pone.0161210	http://dx.doi.org/10.1371/journal.pone.0161210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517300	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100063
J	Gaddam, RR; Fraser, R; Badiei, A; Chambers, S; Cogger, VC; Le Couteur, DG; Ishii, I; Bhatia, M				Gaddam, Ravinder Reddy; Fraser, Robin; Badiei, Alireza; Chambers, Stephen; Cogger, Victoria C.; Le Couteur, David G.; Ishii, Isao; Bhatia, Madhav			Cystathionine-Gamma-Lyase Gene Deletion Protects Mice against Inflammation and Liver Sieve Injury following Polymicrobial Sepsis	PLOS ONE			English	Article							SINUSOIDAL ENDOTHELIAL-CELLS; PUNCTURE-INDUCED SEPSIS; HYDROGEN-SULFIDE; CECAL LIGATION; KUPFFER CELLS; LUNG INJURY; RAT-LIVER; PROPARGYLGLYCINE; INACTIVATION; PATHOGENESIS	Background Hydrogen sulfide (H2S), produced by the activity of cystathionine-gamma-lyase (CSE), is a key mediator of inflammation in sepsis. The liver sinusoidal endothelial cells (LSECs) are important target and mediator of sepsis. The aim of this study was to investigate the role of CSE-derived H2S on inflammation and LSECs fenestrae in caecal-ligation and puncture (CLP)-induced sepsis using CSE KO mice. Methods Sepsis was induced by CLP, and mice (C57BL/6J, male) were sacrificed after 8 hours. Liver, lung, and blood were collected and processed to measure CSE expression, H2S synthesis, MPO activity, NF-.B p65, ERK1/2, and cytokines/chemokines levels. Diameter, frequency, porosity and gap area of the liver sieve were calculated from scanning electron micrographs of the LSECs. Results An increased CSE expression and H2S synthesizing activity in the liver and lung of wildtype mice following CLP-induced sepsis. This was associated with an increased liver and lung MPO activity, and increased liver and lung and plasma levels of the pro-inflammatory cytokines TNF-alpha, IL-6, and IL-1 beta, and the chemokines MCP-1 and MIP-2 alpha. Conversely, CSE KO mice had less liver and lung injury and reduced inflammation following CLPinduced sepsis as evidenced by decreased levels of H2S synthesizing activity, MPO activity, and pro-inflammatory cytokines/chemokines production. Extracellular-regulated kinase (ERK1/2) and nuclear factor-kappa B p65 (NF-kappa B) became significantly activated after the CLP in WT mice but not in CSE KO mice. In addition, CLP-induced damage to the LSECs, as indicated by increased defenestration and gaps formation in the LSECs compared toWT sham control. CSE KO mice showed decreased defenestration and gaps formation following sepsis. Conclusions Mice with CSE (an H2S synthesising enzyme) gene deletion are less susceptible to CLPinduced sepsis and associated inflammatory response through ERK1/ 2-NF-kappa B p65 pathway as evidenced by reduced inflammation, tissue damage, and LSECs defenestration and gaps formation.	[Gaddam, Ravinder Reddy; Fraser, Robin; Badiei, Alireza; Chambers, Stephen; Bhatia, Madhav] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Cogger, Victoria C.; Le Couteur, David G.] Univ Sydney, Alzheimers & Ageing Inst, ANZAC Res Inst, Ctr Educ & Res Ageing,Biogerentol, Sydney, NSW, Australia; [Cogger, Victoria C.; Le Couteur, David G.] Concord Hosp, Sydney, NSW, Australia; [Ishii, Isao] Keio Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Tokyo, Japan	University of Otago; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Keio University	Bhatia, M (corresponding author), Univ Otago, Dept Pathol, Christchurch, New Zealand.	madhav.bhatia@otago.ac.nz	Ekanayake, Kanchana/P-8817-2016; Gaddam, Ravinder Reddy/I-5703-2019; Research Institute, ANZAC/CAE-9030-2022	Gaddam, Ravinder Reddy/0000-0003-1062-5082; Le Couteur, David/0000-0002-4227-5817; Ishii, Isao/0000-0002-5367-205X; Chambers, Stephen/0000-0002-0698-3285	University of Otago; Canterbury Medical Research Foundation (CMRF, New Zealand); Aging and Alzheimers Institute (Australia)	University of Otago; Canterbury Medical Research Foundation (CMRF, New Zealand); Aging and Alzheimers Institute (Australia)	Support was provided by the University of Otago, Canterbury Medical Research Foundation (CMRF, New Zealand), and the Aging and Alzheimers Institute (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the University of Otago, and Canterbury Medical Research Foundation (CMRF), New Zealand and the Aging and Alzheimers Institute, Australia. We thank Katie Saunders, Aaron Dyer, and Abel Ang for their technical assistance. We would like to thank Dr. John Pearson, Department of Population Health, University of Otago, Christchurch for advice with statistics.	Ang SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024535; Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Brown AP, 1997, SHOCK, V7, P186, DOI 10.1097/00024382-199703000-00006; Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136; BURNETT G, 1980, J BIOL CHEM, V255, P3487; Cheluvappa R, 2010, INT J INFECT DIS, V14, pE857, DOI 10.1016/j.ijid.2010.02.2263; Cogger VC, 2004, J HEPATOL, V41, P370, DOI 10.1016/j.jhep.2004.04.034; Cogger VC, 2015, JOVE-J VIS EXP, DOI 10.3791/52698; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Dal-Secco D, 2008, J IMMUNOL, V181, P4287, DOI 10.4049/jimmunol.181.6.4287; DOBBS BR, 1994, LIVER, V14, P230; Francescato HD, 2011, NEPHROL DIAL TRANSPL, V26, P479, DOI 10.1093/ndt/gfq447; Fry DE, 2012, AM SURGEON, V78, P1; Huang CW, 2015, HANDB EXP PHARMACOL, V230, P3, DOI 10.1007/978-3-319-18144-8_1; Ishii I, 2010, J BIOL CHEM, V285, P26358, DOI 10.1074/jbc.M110.147439; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Knolle PA, 1997, CLIN EXP IMMUNOL, V107, P555, DOI 10.1046/j.1365-2249.1997.d01-959.x; Kolios G, 2008, MOL CELL BIOCHEM, V319, P91, DOI 10.1007/s11010-008-9881-7; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; MARCOTTE P, 1976, BIOCHEMISTRY-US, V15, P3070, DOI 10.1021/bi00659a021; Marshall JC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001341; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Niwano M, 1997, J SURG RES, V72, P36, DOI 10.1006/jsre.1997.5162; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Sarphie TG, 1996, HEPATOLOGY, V23, P788, DOI 10.1053/jhep.1996.v23.pm0008666333; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Sidhapuriwala JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032574; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; Streetz KL, 2001, CELL MOL BIOL, V47, P661; Wang G, 2013, APOPTOSIS, V18, P28, DOI 10.1007/s10495-012-0770-x; Warren A, 2010, MICROCIRCULATION, V17, P32, DOI 10.1111/j.1549-8719.2009.00004.x; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Whiteman M, 2010, ANN NY ACAD SCI, V1203, P146, DOI 10.1111/j.1749-6632.2010.05556.x; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang CY, 2003, BIOCHEM BIOPH RES CO, V302, P810, DOI 10.1016/S0006-291X(03)00256-0; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang HL, 2008, J IMMUNOL, V181, P4320, DOI 10.4049/jimmunol.181.6.4320; Zhang HL, 2007, J LEUKOCYTE BIOL, V82, P894, DOI 10.1189/jlb.0407237; Zhang HL, 2007, J IMMUNOL, V179, P4153, DOI 10.4049/jimmunol.179.6.4153; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599; Zhou HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154483	45	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160521	10.1371/journal.pone.0160521	http://dx.doi.org/10.1371/journal.pone.0160521			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518439	Green Published, gold, Green Submitted			2022-12-26	WOS:000381382100015
J	Wang, YQ; Wang, YD; Wang, ZY; Bravo, A; Soberon, M; He, KL				Wang, Yueqin; Wang, Yidong; Wang, Zhenying; Bravo, Alejandra; Soberon, Mario; He, Kanglai			Genetic Basis of Cry1F-Resistance in a Laboratory Selected Asian Corn Borer Strain and Its Cross-Resistance to Other Bacillus thuringiensis Toxins	PLOS ONE			English	Article							FRUGIPERDA LEPIDOPTERA-NOCTUIDAE; OSTRINIA-NUBILALIS LEPIDOPTERA; HELICOVERPA-ARMIGERA HUBNER; BORDER MEMBRANE-VESICLES; FIELD-EVOLVED RESISTANCE; SPODOPTERA-FRUGIPERDA; DIAMONDBACK MOTH; INSECT RESISTANCE; CRY1F RESISTANCE; DELTA-ENDOTOXINS	The Asian corn borer (ACB), Ostrinia furnacalis (Guenee) (Lepidoptera: Crambidae), is the most destructive insect pest of corn in China. Susceptibility to the Cry1F toxin derived from Bacillus thuringiensis has been demonstrated for ACB, suggesting the potential for Cry1F inclusion as part of an insect pest management program. Insects can develop resistance to Cry toxins, which threatens the development and use of Bt formulations and Bt crops in the field. To determine possible resistance mechanisms to Cry1F, a Cry1F-resistant colony of ACB (ACB-FR) that exhibited more than 1700-fold resistance was established through selection experiments after 49 generations of selection under laboratory conditions. The ACB-FR strain showed moderate cross-resistance to Cry1Ab and Cry1Ac of 22.8-and 26.9-fold, respectively, marginally cross-resistance to Cry1Ah (3.7-fold), and no cross-resistance to Cry1Ie (0.6-fold). The bioassay responses of progeny from reciprocal F-1 crosses to different Cry1 toxin concentrations indicated that the resistance trait to Cry1Ab, Cry1Ac and Cry1F has autosomal inheritance with no maternal effect or sex linked. The effective dominance (h) of F-1 offspring was calculated at different concentrations of Cry1F, showing that h decreased as concentration of Cry1F increased. Finally, the analysis of actual and expected mortality of the progeny from a backcross (F-1 x resistant strain) indicated that the inheritance of the resistance to Cry1F in ACB-FR was due to more than one locus. The present study provides an understanding of the genetic basis of Cry1F resistance in ACB-FR and also shows that pyramiding Cry1F with Cry1Ah or Cry1Ie could be used as a strategy to delay the development of ACB resistance to Bt proteins.	[Wang, Yueqin; Wang, Yidong; Wang, Zhenying; He, Kanglai] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Bravo, Alejandra; Soberon, Mario] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo Postal 510-3, Cuernavaca 62250, Morelos, Mexico	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Universidad Nacional Autonoma de Mexico	He, KL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	klhe@ippcaas.cn	de la Parra, Maria Alejandra Bravo/R-6740-2017	Bravo, Alejandra/0000-0002-7573-7475; Wang, Yidong/0000-0001-6939-1490	Genetically Modified Organisms Breeding Major Project [2014ZX08011-003]; National Science and Technology Major Project of China	Genetically Modified Organisms Breeding Major Project; National Science and Technology Major Project of China	This work was funded by Genetically Modified Organisms Breeding Major Project (2014ZX08011-003), National Science and Technology Major Project of China. Dow AgroSciences provided Cry1F protein.	Alves AP, 2006, J ECON ENTOMOL, V99, P494, DOI 10.1603/0022-0493-99.2.494; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; CHAMBERS JA, 1991, J BACTERIOL, V173, P3966, DOI 10.1128/jb.173.13.3966-3976.1991; Crespo ALB, 2009, PEST MANAG SCI, V65, P1071, DOI 10.1002/ps.1793; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Farias JR, 2016, PEST MANAG SCI, V72, P974, DOI 10.1002/ps.4077; Farias JR, 2014, CROP PROT, V64, P150, DOI 10.1016/j.cropro.2014.06.019; Gahan LJ, 2005, J ECON ENTOMOL, V98, P1357, DOI 10.1603/0022-0493-98.4.1357; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gonzalez-Cabrera J, 2001, APPL ENVIRON MICROB, V67, P5043, DOI 10.1128/AEM.67.11.5043-5048.2001; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; GOULD F, 1994, BIOCONTROL SCI TECHN, V4, P451, DOI 10.1080/09583159409355357; He K, 2005, J APPL ENTOMOL, V129, P407, DOI 10.1111/j.1439-0418.2005.00989.x; He KL, 2003, J ECON ENTOMOL, V96, P935, DOI 10.1603/0022-0493-96.3.935; Hernandez CS, 2005, APPL ENVIRON MICROB, V71, P5627, DOI 10.1128/AEM.71.9.5627-5629.2005; Hua G, 2001, APPL ENVIRON MICROB, V67, P872, DOI 10.1128/AEM.67.2.872-879.2001; Huang F, 1999, SCIENCE, V284, P965, DOI 10.1126/science.284.5416.965; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; JAMES C, 2003, GLOBAL REV COMMERCIA; Janmaat AF, 2004, APPL ENVIRON MICROB, V70, P5859, DOI 10.1128/AEM.70.10.5859-5867.2004; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; Kranthi KR, 2006, CROP PROT, V25, P119, DOI 10.1016/j.cropro.2005.03.011; Krishna VV, 2012, AGR SYST, V107, P47, DOI 10.1016/j.agsy.2011.11.005; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liu YB, 1997, APPL ENVIRON MICROB, V63, P2218, DOI 10.1128/AEM.63.6.2218-2223.1997; Luo K, 1999, APPL ENVIRON MICROB, V65, P457; Mahon RJ, 2007, J ECON ENTOMOL, V100, P894, DOI 10.1603/0022-0493(2007)100[894:RTBTTC]2.0.CO;2; MCGAUGHEY WH, 1985, SCIENCE, V229, P193, DOI 10.1126/science.229.4709.193; Monnerat R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119544; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Pereira EJG, 2008, ENTOMOL EXP APPL, V126, P115, DOI 10.1111/j.1570-7458.2007.00642.x; ROUSH RT, 1989, PESTIC SCI, V26, P423, DOI 10.1002/ps.2780260409; Roush RT, 1998, PHILOS T R SOC B, V353, P1777, DOI 10.1098/rstb.1998.0330; Santos-Amaya OF, 2016, CROP PROT, V81, P154, DOI 10.1016/j.cropro.2015.12.014; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; Sayyed AH, 2000, PEST MANAG SCI, V56, P743, DOI 10.1002/1526-4998(200009)56:9<743::AID-PS195>3.0.CO;2-8; SIMS SR, 1991, J INVERTEBR PATHOL, V57, P206, DOI 10.1016/0022-2011(91)90118-A; Siqueira HAA, 2004, J ECON ENTOMOL, V97, P1049, DOI 10.1603/0022-0493(2004)097[1049:COCONL]2.0.CO;2; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Tabashnik BE, 2003, J ECON ENTOMOL, V96, P1031, DOI 10.1603/0022-0493-96.4.1031; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TABASHNIK BE, 1989, J ECON ENTOMOL, V82, P1263, DOI 10.1093/jee/82.5.1263; Tabashnik BE, 1997, P NATL ACAD SCI USA, V94, P1640, DOI 10.1073/pnas.94.5.1640; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; Tan SY, 2013, J INVERTEBR PATHOL, V114, P234, DOI 10.1016/j.jip.2013.08.007; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wirth MC, 2012, J MED ENTOMOL, V49, P886, DOI 10.1603/ME11192; Xu L, 2010, J APPL ENTOMOL, V134, P429, DOI 10.1111/j.1439-0418.2010.01517.x; Xue J, 2008, FEMS MICROBIOL LETT, V280, P95, DOI 10.1111/j.1574-6968.2007.01053.x; Zhang TT, 2014, TOXINS, V6, P2694, DOI 10.3390/toxins6092694; Zhou DR, 1992, ADV INSECT REARING R, P230; Zhou DR, 1995, ASIAN CORN BORER ITS	55	18	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161189	10.1371/journal.pone.0161189	http://dx.doi.org/10.1371/journal.pone.0161189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518813	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100060
J	Wiloch, MZ; Wawrzyniak, UE; Ufnalska, I; Piotrowski, G; Bonna, A; Wroblewski, W				Wiloch, Magdalena Zofia; Wawrzyniak, Urszula Elzbieta; Ufnalska, Iwona; Piotrowski, Grzegorz; Bonna, Arkadiusz; Wroblewski, Wojciech			Redox Activity of Copper(II) Complexes with NSFRY Pentapeptide and Its Analogues	PLOS ONE			English	Article							CATION-PI INTERACTIONS; VIBRATIONAL SPECTROSCOPY; X-RAY; STABILITY; PROTEIN; CU(II); ION; BIOLOGY; LIGAND; PH	The influence of cation-pi interactions on the electrochemical properties of copper(II) complexes with synthesized pentapeptide C-terminal fragment of Atrial Natriuretic Factor (ANF) hormone was studied in this work. Molecular modeling performed for Cu(II)-NSFRY-NH2 complex indicated that the cation-pi interactions between Tyr and Cu(II), and also between Phe-Arg led to specific conformation defined as peptide box, in which the metal cation is isolated from the solvent by peptide ligand. Voltammetry experiments enabled to compare the redox properties and stability of copper(II) complexes with NSFRY-NH2 and its analogues (namely: NSFRA-NH2, NSFRF-NH2, NSAAY-NH2, NSAAA-NH2, AAAAA-NH2) as well as to evaluate the contribution of individual amino acid residues to these properties. The obtained results led to the conclusion, that cation-p interactions play a crucial role in the effective stabilization of copper(II) complexes with the fragments of ANF peptide hormone and therefore could control the redox processes in other metalloproteins.	[Wiloch, Magdalena Zofia; Wawrzyniak, Urszula Elzbieta; Ufnalska, Iwona; Wroblewski, Wojciech] Warsaw Univ Technol, Dept Microbioanalyt, Fac Chem, Noakowskiego 3, PL-00664 Warsaw, Poland; [Piotrowski, Grzegorz] Univ Gdansk, Fac Chem, Wita Stwosza 63, PL-80308 Gdansk, Poland; [Bonna, Arkadiusz] Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Pawinskiego 5a, PL-02106 Warsaw, Poland; [Bonna, Arkadiusz] Univ Cambridge, Dept Biochem, Tennis Court Rd,Downing Site, Cambridge CB2 1QW, England	Warsaw University of Technology; Fahrenheit Universities; University of Gdansk; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Cambridge	Wawrzyniak, UE (corresponding author), Warsaw Univ Technol, Dept Microbioanalyt, Fac Chem, Noakowskiego 3, PL-00664 Warsaw, Poland.; Bonna, A (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Dept Biophys, Pawinskiego 5a, PL-02106 Warsaw, Poland.; Bonna, A (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd,Downing Site, Cambridge CB2 1QW, England.	uwawrzyniak@ch.pw.edu.pl; abonna@peptidebiochem.eu	Bonna, Arkadiusz/T-3927-2019; Wiloch, Magdalena/B-2788-2019	Bonna, Arkadiusz/0000-0002-3957-7849; Wawrzyniak, Urszula/0000-0001-5011-7002; Wiloch, Magdalena/0000-0001-8331-8572; Wroblewski, Wojciech/0000-0002-2806-4220	National Science Centre [2012/07/D/ST4/02187]	National Science Centre(National Science Centre, Poland)	This work has been financially supported by the National Science Centre (project Sonata nr 2012/07/D/ST4/02187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been financially supported by the National Science Centre (project Sonata nr 2012/07/D/ST4/02187). The authors gratefully thank Agata Prokopczyk for technical assistance in voltammetric measurements.	Bal W, 1998, INORG CHIM ACTA, V283, P1, DOI 10.1016/S0020-1693(98)00084-X; BAL W, 1993, J INORG BIOCHEM, V52, P79, DOI 10.1016/0162-0134(93)85024-3; BHATHENA S J, 1988, Journal of Trace Elements in Experimental Medicine, V1, P199; Bonna A., 2009, THESIS; Chan WC, 2000, FMOC SOLID PHASE PEP; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Durand J, 2010, METALLOMICS, V2, P741, DOI 10.1039/c0mt00027b; Enache TA, 2011, J ELECTROANAL CHEM, V655, P9, DOI 10.1016/j.jelechem.2011.02.022; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Giri SD, 2016, J ELECTROCHEM SOC, V163, pI1252, DOI 10.1149/2.0071605jes; Grujicic D, 2002, ELECTROCHIM ACTA, V47, P2901, DOI 10.1016/S0013-4686(02)00161-5; Helios K, 2009, J PHYS CHEM B, V113, P8158, DOI 10.1021/jp901912v; Hureau C, 2008, J BIOL INORG CHEM, V13, P1055, DOI 10.1007/s00775-008-0389-0; Hureau C, 2006, J BIOL INORG CHEM, V11, P735, DOI 10.1007/s00775-006-0118-5; Hureau C, 2011, CHEM-EUR J, V17, P10151, DOI 10.1002/chem.201100751; Janicka-Klos A, 2013, DALTON T, V42, P448, DOI 10.1039/c2dt31959d; Lim YB, 2007, ANGEW CHEM INT EDIT, V46, P3475, DOI 10.1002/anie.200604576; Lu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039252; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; MARGERUM DW, 1975, J AM CHEM SOC, V97, P6894, DOI 10.1021/ja00856a065; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Michalska D, 2007, POLYHEDRON, V26, P4303, DOI 10.1016/j.poly.2007.05.052; Prajapati RS, 2006, BIOCHEMISTRY-US, V45, P15000, DOI 10.1021/bi061275f; Rorabacher DB, 2004, CHEM REV, V104, P651, DOI 10.1021/cr020630e; SINGH J, 1990, J MOL BIOL, V211, P595, DOI 10.1016/0022-2836(90)90268-Q; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; Zacharias N, 2002, TRENDS PHARMACOL SCI, V23, P281, DOI 10.1016/S0165-6147(02)02027-8	28	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160256	10.1371/journal.pone.0160256	http://dx.doi.org/10.1371/journal.pone.0160256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517864	gold, Green Published, Green Submitted			2022-12-26	WOS:000381382100011
J	Bayer, CN; Luberda, M				Bayer, Chris N.; Luberda, Michael			Measure, Then Show: Grasping Human Evolution Through an Inquiry-Based, Datadriven Hominin Skulls Lab	PLOS ONE			English	Article							KNOWLEDGE; CREATIONISM; BIOLOGY	Incomprehension and denial of the theory of evolution among high school students has been observed to also occur when teachers are not equipped to deliver a compelling case also for human evolution based on fossil evidence. This paper assesses the outcomes of a novel inquiry-based paleoanthropology lab teaching human evolution to high-school students. The inquiry- based Be a Paleoanthropologist for a Day lab placed a dozen hominin skulls into the hands of high-school students. Upon measuring three variables of human evolution, students explain what they have observed and discuss findings. In the 2013/14 school year, 11 biology classes in 7 schools in the Greater New Orleans area participated in this lab. The interviewed teacher cohort unanimously agreed that the lab featuring hominin skull replicas and stimulating student inquiry was a pedagogically excellent method of delivering the subject of human evolution. First, the lab's learning path of transforming facts to data, information to knowledge, and knowledge to acceptance empowered students to themselves execute part of the science that underpins our understanding of deep time hominin evolution. Second, although challenging, the hands-on format of the lab was accessible to high-school students, most of whom were readily able to engage the lab's scientific process. Third, the lab's exciting and compelling pedagogy unlocked higher order thinking skills, effectively activating the cognitive, psychomotor and affected learning domains as defined in Bloom's taxonomy. Lastly, the lab afforded students a formative experience with a high degree of retention and epistemic depth. Further study is warranted to gauge the degree of these effects.	[Bayer, Chris N.; Luberda, Michael] AncientAncestors, New Orleans, LA USA		Bayer, CN (corresponding author), AncientAncestors, New Orleans, LA USA.	cbayer@tulane.edu						Ackoff R.L., 1989, J APPL SYSTEMS ANAL, V16, P3, DOI DOI 10.1002/9781444303179.CH3; Anderson L. W., 1994, 93 YB NATL SOC STU 2; Anisman M.S., 1995, ED388574 PHYS ANTHR; [Anonymous], 1996, NAT SCI ED STAND; Bakalar N., 2011, NY TIMES; Banchi H., 2008, SCI CHILDREN, V46, P26; Berkman MB, 2011, SCIENCE, V331, P404, DOI 10.1126/science.1198902; Blackler F, 1995, ORGAN STUD, V16, P1021, DOI 10.1177/017084069501600605; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; ExploreLearning, 2014, HUM EV SKULL AN GIZM; Fricke M, 2009, J INF SCI, V35, P131, DOI 10.1177/0165551508094050; Gackowski Z., 2012, INFORM SCI INT J EME, V15; HENRY NL, 1974, PUBLIC ADMIN REV, V34, P189, DOI 10.2307/974902; Jaksetic J, 2012, THESIS; Moore R, 2005, AM BIOL TEACH, V67, P457, DOI 10.1662/0002-7685(2005)067[0457:TTOECI]2.0.CO;2; Moore R, 2004, BIOSCIENCE, V54, P860; Nadelson LS, 2010, J EXP EDUC, V78, P151, DOI 10.1080/00220970903292983; National Research Council, 2009, NEW BIOL 21 CENT ENS, P17; National Research Council (NRC), 1996, NAT SCI ED STAND; Nickels M., 1999, HOMINID CRANIUM COMP, Vhttp://www.indiana.edu/~ensiweb/lessons/hom.cran.html; Palincsar AS, 1998, ANNU REV PSYCHOL, V49, P345, DOI 10.1146/annurev.psych.49.1.345; Price RM, 2012, SCIENCE, V338, P1554, DOI 10.1126/science.1215221; Roberson JC, 2007, DIGITAL IMAGING CRAN, P37, DOI [10.1662/0002-7685, DOI 10.1662/0002-7685]; Ruff C, 1997, NATURE, V387; Russo GA, 2013, J HUM EVOL, V65, P656, DOI 10.1016/j.jhevol.2013.07.007; Schrein C.M., 2014, THESIS, P425; Schwartz MS, 2009, SCI EDUC, V93, P798, DOI 10.1002/sce.20328; Sinatra G.M., 2003, INTENTIONAL CONCEPTU; Singer J, 2000, EDUC PSYCHOL-US, V35, P165, DOI 10.1207/S15326985EP3503_3; van der Merwe N.J., 2008, S AFRICAN J SCI, V104; Wallace D. P., 2007, KNOWLEDGE MANAGEMENT, P1; Yerky M.D., AM BIOL TEACHER, V76, P109; Zeleny M., 1980, MANAGEMENT, V1, P7	33	3	3	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160054	10.1371/journal.pone.0160054	http://dx.doi.org/10.1371/journal.pone.0160054			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513927	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100024
J	Krasnov, H; Kloog, I; Friger, M; Katra, I				Krasnov, Helena; Kloog, Itai; Friger, Michael; Katra, Itzhak			The Spatio-Temporal Distribution of Particulate Matter during Natural Dust Episodes at an Urban Scale	PLOS ONE			English	Article							AIR-POLLUTION; SAHARAN DUST; SOURCE APPORTIONMENT; EXPOSURE ASSESSMENT; NITROGEN-DIOXIDE; AMBIENT AIR; PM10; PM2.5; QUALITY; AEROSOL	Dust storms are a common phenomenon in arid and semi-arid areas, and their impacts on both physical and human environments are of great interest. Number of studies have associated atmospheric PM pollution in urban environments with origin in natural soil/dust, but less evaluated the dust spatial patterns over a city. We aimed to analyze the spatial-temporal behavior of PM concentrations over the city of Beer Sheva, in southern Israel, where dust storms are quite frequent. PM data were recorded during the peak of each dust episode simultaneously in 23 predetermined fixed points around the city. Data were analyzed for both dust days and non-dust days (background). The database was constructed using Geographic Information System and includes distributions of PM that were derived using inverse distance weighted (IDW) interpolation. The results show that the daily averages of atmospheric PM10 concentrations during the background period are within a narrow range of 31 to 48 mu g m(-3) with low variations. During dust days however, the temporal variations are significant and can range from an hourly PM10 concentration of 100 mu g m(-3) to more than 1280 mu g m(-3) during strong storms. IDW analysis demonstrates that during the peak time of the storm the spatial variations in PM between locations in the city can reach 400 mu g m(-3). An analysis of site and storm contribution to total PM concentration revealed that higher concentrations are found in parts of the city that are proximal to dust sources. The results improve the understanding of the dynamics of natural PM and the dependence on wind direction. This may have implications for environmental and health outcomes.	[Krasnov, Helena; Kloog, Itai; Katra, Itzhak] Ben Gurion Univ Negev, Dept Geog & Environm Dev, Beer Sheva, Israel; [Friger, Michael] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Publ Hlth, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Krasnov, H (corresponding author), Ben Gurion Univ Negev, Dept Geog & Environm Dev, Beer Sheva, Israel.	krasnovh@post.bgu.ac.il			Environment and Health Fund [RGA1004]	Environment and Health Fund	The research was supported by a grant from the Environment and Health Fund (No. RGA1004).; We thank Yuval Helberg from the GIS unit of Beer Sheva municipality for providing geographic data of the city. The research was supported by a grant from the Environment and Health Fund (No. RGA1004).	Arku RE, 2008, SCI TOTAL ENVIRON, V402, P217, DOI 10.1016/j.scitotenv.2008.04.042; Artinano B, 2004, SCI TOTAL ENVIRON, V334, P111, DOI 10.1016/j.scitotenv.2004.04.032; Bitan A., 1991, CLIMATIC ATLAS ISRAE; Blumberg DG, 2001, J ENVIRON MANAGE, V63, P103, DOI 10.1006/jema.2001.0472; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Branis M, 2010, AEROSOL AIR QUAL RES, V10, P102, DOI 10.4209/aaqr.2009.09.0055; Brauer M, 2012, ENVIRON SCI TECHNOL, V46, P652, DOI 10.1021/es2025752; Brook JR, 1997, J AIR WASTE MANAGE, V47, P2, DOI 10.1080/10473289.1997.10464407; Bukowiecki N, 2002, ATMOS ENVIRON, V36, P5569, DOI 10.1016/S1352-2310(02)00694-5; Burton RM, 1996, ENVIRON SCI TECHNOL, V30, P400, DOI 10.1021/es950030f; Chen YS, 2004, ENVIRON RES, V95, P151, DOI 10.1016/j.envres.2003.08.008; CHOW JC, 1994, ATMOS ENVIRON, V28, P2061, DOI 10.1016/1352-2310(94)90474-X; Chung A, 2001, J AIR WASTE MANAGE, V51, P109, DOI 10.1080/10473289.2001.10464254; DAYAN U, 1991, J APPL METEOROL, V30, P1185, DOI [10.1175/1520-0450(1991)030<1185:DIEITM>2.0.CO;2, 10.1175/1520-0450(1991)030&lt;1185:DIEITM&gt;2.0.CO;2]; Dionisio KL, 2010, ENVIRON SCI TECHNOL, V44, P2270, DOI 10.1021/es903276s; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Engelbrecht JP, 2001, ENVIRON MONIT ASSESS, V69, P1, DOI 10.1023/A:1010786615180; Escudero M, 2007, ATMOS ENVIRON, V41, P5516, DOI 10.1016/j.atmosenv.2007.04.047; Etyemezian V, 2005, ATMOS ENVIRON, V39, P7849, DOI 10.1016/j.atmosenv.2005.08.033; Ganor E, 2010, J GEOPHYS RES ATMOSP, V115; GERTLER AW, 1995, J AIR WASTE MANAGE, V45, P75, DOI 10.1080/10473289.1995.10467349; Gulliver J, 2005, ENVIRON RES, V97, P10, DOI 10.1016/j.envres.2004.05.002; Gyan K, 2005, INT J BIOMETEOROL, V49, P371, DOI 10.1007/s00484-005-0257-3; Heal MR, 2000, J ENVIRON MONITOR, V2, P455, DOI 10.1039/b002741n; Isaaks EH, 1989, APPL GEOSTATISTICS; Janssen LHJM, 1999, ATMOS ENVIRON, V33, P3325, DOI 10.1016/S1352-2310(98)00435-X; Jayaratne E. R., 2011, ATMOS ENVIRON, V45, P3996, DOI DOI 10.1016/J.ATM0SENV:2011.04.059; Johnson M, 2010, ATMOS ENVIRON, V44, P3660, DOI 10.1016/j.atmosenv.2010.06.041; Kallos G, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006207; Kassomenos PA, 2014, ATMOS ENVIRON, V87, P153, DOI 10.1016/j.atmosenv.2014.01.004; Kassomenos PA, 2011, ATMOS ENVIRON, V45, P7293, DOI 10.1016/j.atmosenv.2011.08.034; Katra I, 2014, SCI REPORTS, P4; Kim JY, 2004, J OCCUP ENVIRON HYG, V1, P707, DOI 10.1080/15459620490515833; Kloog I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088578; Kocak M, 2007, ATMOS ENVIRON, V41, P3806, DOI 10.1016/j.atmosenv.2007.01.009; Krasnov H, 2014, J AIR WASTE MANAGE, V64, P89, DOI 10.1080/10962247.2013.841599; Kuo HW, 2010, BUILD ENVIRON, V45, P610, DOI 10.1016/j.buildenv.2009.07.017; Levy I, 2014, ENVIRON HEALTH PERSP, V122, P65, DOI 10.1289/ehp.1306518; Liu JF, 2009, ATMOS ENVIRON, V43, P4327, DOI 10.1016/j.atmosenv.2009.03.054; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; Merbitz H, 2012, APPL GEOGR, V33, P94, DOI 10.1016/j.apgeog.2011.06.008; Mitsakou C, 2008, ATMOS CHEM PHYS, V8, P7181, DOI 10.5194/acp-8-7181-2008; Monn C, 2001, ATMOS ENVIRON, V35, P1, DOI 10.1016/S1352-2310(00)00330-7; Moore DK, 2007, J ENVIRON MONITOR, V9, P246, DOI 10.1039/b615795e; Padhi BK, 2008, INHAL TOXICOL, V20, P973, DOI 10.1080/08958370701866420 ; Park JW, 2005, RESPIROLOGY, V10, P470, DOI 10.1111/j.1440-1843.2005.00728.x; Peled R, 2005, PUBLIC HEALTH, V119, P418, DOI 10.1016/j.puhe.2004.05.023; Perez L, 2008, EPIDEMIOLOGY, V19, P800, DOI 10.1097/EDE.0b013e31818131cf; Querol X, 2001, ATMOS ENVIRON, V35, P6407, DOI 10.1016/S1352-2310(01)00361-2; Querol X, 2004, ATMOS ENVIRON, V38, P6547, DOI 10.1016/j.atmosenv.2004.08.037; Rodriguez S, 2001, ATMOS ENVIRON, V35, P2433, DOI 10.1016/S1352-2310(00)00496-9; Saksena S, 2003, J EXPO ANAL ENV EPID, V13, P219, DOI 10.1038/sj.jea.7500273; Ta WQ, 2004, SCI TOTAL ENVIRON, V320, P163, DOI 10.1016/j.scitotenv.2003.08.026; van Vliet EDS, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045028; Vodonos A, 2014, AIR QUAL ATMOS HLTH, V7, P433, DOI 10.1007/s11869-014-0253-z; Wang HB, 2014, CATENA, V119, P104, DOI 10.1016/j.catena.2014.03.015; Weimer S, 2009, ATMOS ENVIRON, V43, P624, DOI 10.1016/j.atmosenv.2008.10.034; Yu HD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002669; Yu HL, 2010, ATMOS ENVIRON, V44, P3053, DOI 10.1016/j.atmosenv.2010.04.030; Yuval, 2006, ATMOS ENVIRON, V40, P3653, DOI 10.1016/j.atmosenv.2006.03.037; Zheng M, 2005, ATMOS ENVIRON, V39, P3967, DOI 10.1016/j.atmosenv.2005.03.036	61	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160800	10.1371/journal.pone.0160800	http://dx.doi.org/10.1371/journal.pone.0160800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513479	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100073
J	Kudo, T; Uda, S; Tsuchiya, T; Wada, T; Karasawa, Y; Fujii, M; Saito, TH; Kuroda, S				Kudo, Takamasa; Uda, Shinsuke; Tsuchiya, Takaho; Wada, Takumi; Karasawa, Yasuaki; Fujii, Masashi; Saito, Takeshi H.; Kuroda, Shinya			Laguerre Filter Analysis with Partial Least Square Regression Reveals a Priming Effect of ERK and CREB on c-FOS Induction	PLOS ONE			English	Article							TRANSFORMING ACTIVITY; DYNAMICS; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; PATHWAYS; SYSTEMS; MODEL; CELL	Signaling networks are made up of limited numbers of molecules and yet can code information that controls different cellular states through temporal patterns and a combination of signaling molecules. In this study, we used a data-driven modeling approach, the Laguerre filter with partial least square regression, to describe how temporal and combinatorial patterns of signaling molecules are decoded by their downstream targets. The Laguerre filter is a time series model used to represent a nonlinear system based on Volterra series expansion. Furthermore, with this approach, each component of the Volterra series expansion is expanded by Laguerre basis functions. We combined two approaches, application of a Laguerre filter and partial least squares (PLS) regression, and applied the combined approach to analysis of a signal transduction network. We applied the Laguerre filter with PLS regression to identify input and output (IO) relationships between MAP kinases and the products of immediate early genes (IEGs). We found that Laguerre filter with PLS regression performs better than Laguerre filter with ordinary regression for the reproduction of a time series of IEGs. Analysis of the nonlinear characteristics extracted using the Laguerre filter revealed a priming effect of ERK and CREB on c-FOS induction. Specifically, we found that the effects of a first pulse of ERK enhance the subsequent effects on c-FOS induction of treatment with a second pulse of ERK, a finding consistent with prior molecular biological knowledge. The variable importance of projections and output loadings in PLS regression predicted the upstream dependency of each IEG. Thus, a Laguerre filter with partial least square regression approach appears to be a powerful method to find the processing mechanism of temporal patterns and combination of signaling molecules by their downstream gene expression.	[Kudo, Takamasa; Tsuchiya, Takaho; Wada, Takumi; Fujii, Masashi; Saito, Takeshi H.; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Kuroda, Shinya] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Karasawa, Yasuaki] Univ Tokyo, Dept Neurosurg, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan; [Kuroda, Shinya] Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan; [Uda, Shinsuke] Kyushu Univ, Med Inst Bioregulat, Res Ctr Trans Med, Div Integrated Omics,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan; [Kudo, Takamasa] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Saito, Takeshi H.] Astellas Pharma Inc, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); Kyushu University; Stanford University; Astellas Pharmaceuticals	Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.; Kuroda, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.; Kuroda, S (corresponding author), Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan.; Uda, S (corresponding author), Kyushu Univ, Med Inst Bioregulat, Res Ctr Trans Med, Div Integrated Omics,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	uda@bioreg.kyushu-u.ac.jp; skuroda@bs.s.u-tokyo.ac.jp	Fujii, Masashi/S-1516-2019	Fujii, Masashi/0000-0002-1586-6435; Wada, Takumi/0000-0002-1587-5235	KAKENHI [25830142]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26120507, 16H01551]; Grants-in-Aid for Scientific Research [14J12344] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI Young Scientists grant (B) (no. 25830142) and Grant-in-Aid for Scientific Research on Innovative Areas (no. 26120507, 16H01551) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Chen RH, 1996, ONCOGENE, V12, P1493; CURRAN T, 1984, CELL, V36, P259; de Ronde W, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.048101; DUMONT GA, 1993, INT J ADAPT CONTROL, V7, P367, DOI 10.1002/acs.4480070506; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; HERRERA R, 1990, CELL GROWTH DIFFER, V1, P483; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Marmarelis VZ, 2004, NONLINEAR DYNAMIC MO; Mitsis GD, 2002, ANN BIOMED ENG, V30, P272, DOI 10.1114/1.1458591; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Ozaki Y., 2010, PLOS ONE, V5; Purves D., 2008, NEUROSCIENCE, VXvii, p[857, 944]; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Saito TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057037; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; WOLD H., 1966, MULTIVARIATE ANAL, P391, DOI DOI 10.1007/S00423-022-02505-9; Wold S., 1993, PLS PARTIAL LEAST SQ; Xu QS, 2001, J CHEMOMETR, V15, P135, DOI 10.1002/cem.605	30	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160548	10.1371/journal.pone.0160548	http://dx.doi.org/10.1371/journal.pone.0160548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513954	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100043
J	Magalhaes, LG; Marques, FB; da Fonseca, MB; Rogerio, KR; Graebin, CS; Andricopulo, AD				Magalhaes, Luma G.; Marques, Fernando B.; da Fonseca, Marina B.; Rogerio, Kamilla R.; Graebin, Cedric S.; Andricopulo, Adriano D.			Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; COLCHICINE SITE; P-GLYCOPROTEIN; IN-VITRO; MICROTUBULES; APOPTOSIS; AGENTS; PODOPHYLLOTOXIN; TARGET; CELLS	Microtubules play critical roles in vital cell processes, including cell growth, division, and migration. Microtubule-targeting small molecules are chemotherapeutic agents that are widely used in the treatment of cancer. Many of these compounds are structurally complex natural products (e.g., paclitaxel, vinblastine, and vincristine) with multiple stereogenic centers. Because of the scarcity of their natural sources and the difficulty of their partial or total synthesis, as well as problems related to their bioavailability, toxicity, and resistance, there is an urgent need for novel microtubule binding agents that are effective for treating cancer but do not have these disadvantages. In the present work, our lead discovery effort toward less structurally complex synthetic compounds led to the discovery of a series of acridinones inspired by the structure of podophyllotoxin, a natural product with important microtubule assembly inhibitory activity, as novel mechanism-based tubulin assembly inhibitors with potent anticancer properties and low toxicity. The compounds were evaluated in vitro by wound healing assays employing the metastatic and triple negative breast cancer cell line MDA-MB-231. Four compounds with IC50 values between 0.294 and 1.7 mu M were identified. These compounds showed selective cytotoxicity against MDA-MB-231 and DU-145 cancer cell lines and promoted cell cycle arrest in G(2)/M phase and apoptosis. Consistent with molecular modeling results, the acridinones inhibited tubulin assembly in in vitro polymerization assays with IC50 values between 0.9 and 13 mu M. Their binding to the colchicine-binding site of tubulin was confirmed through competitive assays.	[Magalhaes, Luma G.; Andricopulo, Adriano D.] Univ Sao Paulo, Lab Quim Med & Computac, Ctr Pesquisa & Inovacao Biodiversidade & Farmacos, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil; [Marques, Fernando B.; da Fonseca, Marina B.; Rogerio, Kamilla R.; Graebin, Cedric S.] Univ Fed Rural Rio de Janeiro, Dept Quim, Lab Diversidade Mol & Quim Med, BR-23897000 Seropedica, RJ, Brazil	Universidade de Sao Paulo; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Andricopulo, AD (corresponding author), Univ Sao Paulo, Lab Quim Med & Computac, Ctr Pesquisa & Inovacao Biodiversidade & Farmacos, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil.	aandrico@ifsc.usp.br	Andricopulo, Adriano D/B-7672-2012; Graebin, Cedric S/F-2009-2010	Andricopulo, Adriano D/0000-0002-0457-818X; Graebin, Cedric S/0000-0003-1410-1227; Rogerio, Kamilla/0000-0003-0555-9949; Brandao da Fonseca, Marina/0000-0003-1753-5979	State of Sao Paulo Research Foundation (FAPESP) [2013/07600-3 - CEPID-CIBFar]; National Council for Scientific and Technological Development (CNPq) [474879/2012-7 - Universal]; Coordination for the Improvement of Higher Education Personnel (CAPES); Carlos Chagas Filho Research Support Foundation of the State of Rio de Janeiro (FAPERJ) [E-26/111.474/2011, E-26/111.357/2014]	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Carlos Chagas Filho Research Support Foundation of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The work was supported by the following: The State of Sao Paulo Research Foundation (FAPESP, grant # 2013/07600-3 - CEPID-CIBFar); The National Council for Scientific and Technological Development (CNPq, grant # 474879/2012-7 - Universal); The Coordination for the Improvement of Higher Education Personnel (CAPES); and The Carlos Chagas Filho Research Support Foundation of the State of Rio de Janeiro (FAPERJ, grants # E-26/111.474/2011 and # E-26/111.357/2014).	ALBINI A, 1987, CANCER RES, V47, P3239; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bates SE, 2004, CLIN CANCER RES, V10, P4724, DOI 10.1158/1078-0432.CCR-0829-03; Bhattacharyya B, 2008, MED RES REV, V28, P155, DOI 10.1002/med.20097; BONNE D, 1985, J BIOL CHEM, V260, P2819; BURK RR, 1973, P NATL ACAD SCI USA, V70, P369, DOI 10.1073/pnas.70.2.369; Castedo M, 2004, ONCOGENE, V23, P4362, DOI 10.1038/sj.onc.1207572; Checchi PM, 2003, TRENDS PHARMACOL SCI, V24, P361, DOI 10.1016/S0165-6147(03)00161-5; CLARK PI, 1987, CLIN PHARMACOKINET, V12, P223, DOI 10.2165/00003088-198712040-00001; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HIMES RH, 1991, PHARMACOL THERAPEUT, V51, P257, DOI 10.1016/0163-7258(91)90081-V; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Joy ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088350; Kamal A, 2014, BIOORG MED CHEM LETT, V24, P3356, DOI 10.1016/j.bmcl.2014.05.096; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kremmidiotis G, 2010, MOL CANCER THER, V9, P1562, DOI 10.1158/1535-7163.MCT-09-0815; Li YJ, 2014, BIOORGAN MED CHEM, V22, P4312, DOI 10.1016/j.bmc.2014.05.017; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Magedov IV, 2011, J MED CHEM, V54, P4234, DOI 10.1021/jm200410r; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Mulligan JM, 2006, MOL PHARMACOL, V70, P60, DOI 10.1124/mol.105.021204; Negi AS, 2015, BIOORGAN MED CHEM, V23, P373, DOI 10.1016/j.bmc.2014.12.027; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Prota AE, 2014, J MOL BIOL, V426, P1848, DOI 10.1016/j.jmb.2014.02.005; Prota AE, 2013, SCIENCE, V339, P587, DOI 10.1126/science.1230582; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; SACKETT DL, 1993, PHARMACOL THERAPEUT, V59, P163, DOI 10.1016/0163-7258(93)90044-E; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Sparreboom A, 1997, P NATL ACAD SCI USA, V94, P2031, DOI 10.1073/pnas.94.5.2031; Srivastava RK, 1998, MOL CELL BIOL, V18, P3509, DOI 10.1128/MCB.18.6.3509; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Stierand K, 2010, ACS MED CHEM LETT, V1, P540, DOI 10.1021/ml100164p; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Tratrat C, 2002, ORG LETT, V4, P3187, DOI 10.1021/ol0200908; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VINDELOV LL, 1983, CYTOMETRY, V3, P332, DOI 10.1002/cyto.990030505; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Wade RH, 2009, MOL BIOTECHNOL, V43, P177, DOI 10.1007/s12033-009-9193-5; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Xi JL, 2013, MOL CANCER RES, V11, P856, DOI 10.1158/1541-7786.MCR-12-0177	50	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160842	10.1371/journal.pone.0160842	http://dx.doi.org/10.1371/journal.pone.0160842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508497	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400058
J	Huang, LY; Stuart, C; Takeda, K; D'Agnillo, F; Golding, B				Huang, Li-Yun; Stuart, Christine; Takeda, Kazuyo; D'Agnillo, Felice; Golding, Basil			Poly(I:C) Induces Human Lung Endothelial Barrier Dysfunction by Disrupting Tight Junction Expression of Claudin-5	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTORS; VASCULAR-PERMEABILITY; VIRUS-INFECTION; ACTIVATION; CELLS; PATHOGENESIS; INNATE; INFLAMMATION; RECOGNITION	Viral infections are often accompanied by pulmonary microvascular leakage and vascular endothelial dysfunction via mechanisms that are not completely defined. Here, we investigated the effect of the Toll-like receptor 3 (TLR3) ligand polyinosinic-polycytidylic acid [Poly(I:C)], a synthetic analog of viral double-stranded RNA (dsRNA) commonly used to simulate viral infections, on the barrier function and tight junction integrity of primary human lung microvascular endothelial cells. Poly(I: C) stimulated IL-6, IL-8, TNF alpha, and IFN beta production in conjunction with the activation of NF-kappa B and IRF3 confirming the Poly(I:C)-responsiveness of these cells. Poly(I:C) increased endothelial monolayer permeability with a corresponding dose-and time-dependent decrease in the expression of claudin-5, a transmembrane tight junction protein and reduction of CLDN5 mRNA levels. Immunofluorescence experiments revealed disappearance of membrane-associated claudin-5 and co-localization of cytoplasmic claudin-5 with lysosomal-associated membrane protein 1. Chloroquine and Bay11-7082, inhibitors of TLR3 and NF-kappa B signaling, respectively, protected against the loss of claudin-5. Together, these findings provide new insight on how dsRNA-activated signaling pathways may disrupt vascular endothelial function and contribute to vascular leakage pathologies.	[Huang, Li-Yun; Stuart, Christine; Golding, Basil] US FDA, Lab Plasma Derivat, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [D'Agnillo, Felice] US FDA, Lab Biochem & Vasc Biol, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Takeda, Kazuyo] US FDA, Microscopy & Imaging Core Facil, Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Golding, B (corresponding author), US FDA, Lab Plasma Derivat, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.; D'Agnillo, F (corresponding author), US FDA, Lab Biochem & Vasc Biol, Div Hematol Res & Review, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Felice.DAgnillo@fda.hhs.gov; Basil.Golding@fda.hhs.gov			CBER Targeted Funds for Influenza Research	CBER Targeted Funds for Influenza Research	This project was supported in part by CBER Targeted Funds for Influenza Research to B. Golding (2014-2015). This fund also supported the Research Fellowship Program appointment of CS at the Center for Biologics Evaluation and Research from the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this article have not been formally disseminated by the FDA and should not be construed to represent any agency determination or policy.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aoshi T, 2011, CURR OPIN VIROL, V1, P226, DOI 10.1016/j.coviro.2011.07.002; Armstrong SM, 2013, VIRULENCE, V4, P537, DOI 10.4161/viru.25779; Balint Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063776; Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Chattopadhyay S, 2014, J INTERF CYTOK RES, V34, P427, DOI 10.1089/jir.2014.0034; Chiang ET, 2006, J CLIN IMMUNOL, V26, P406, DOI 10.1007/s10875-006-9024-4; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; D'Agnillo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062576; Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006; Goddard LM, 2013, THROMB HAEMOSTASIS, V109, P407, DOI 10.1160/TH12-09-0678; Kasa A, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974448; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Lee N L S, 2014, Hong Kong Med J, V20 Suppl 6, P11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; MAJDE JA, 1991, MICROB PATHOGENESIS, V10, P105, DOI 10.1016/0882-4010(91)90071-H; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331; Patel MC, 2014, FUTURE VIROL, V9, P811, DOI 10.2217/fvl.14.70; Rezaee F, 2011, J ALLERGY CLIN IMMUN, V128, P1216, DOI 10.1016/j.jaci.2011.08.035; Ritter Mirko, 2005, J Inflamm (Lond), V2, P16, DOI 10.1186/1476-9255-2-16; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818	31	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160875	10.1371/journal.pone.0160875	http://dx.doi.org/10.1371/journal.pone.0160875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504984	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200071
J	Yamada, H; Kuro-o, M; Hara, K; Ueda, Y; Kusaka, I; Kakei, M; Ishikawa, S				Yamada, Hodaka; Kuro-o, Makoto; Hara, Kazuo; Ueda, Yuichiro; Kusaka, Ikuyo; Kakei, Masafumi; Ishikawa, San-e			The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; FRACTIONAL EXCRETION; VERTEBRAL FRACTURES; MINERAL METABOLISM; DIABETIC-PATIENTS; MORTALITY; FGF23; RISK; CKD; CALCIFICATION	Background Fibroblast growth factor 23 (FGF23) regulates mineral homeostasis. In developed renal dysfunction, FGF23 levels increase to maintain the phosphate excretion capacity. However, in diabetic patients with early-stage renal impairment, the FGF23 elevation is not very sensitive. We hypothesized that urinary phosphate (U-P)/serum FGF23 ratio would theoretically be an index that reflects the number of nephrons (nephron index). In this study, we determined whether the nephron index would be associated with renal function and vascular diseases in diabetic patients. Methods In total, 142 patients with diabetes mellitus were enrolled. The nephron index was calculated using the following formula: U-P (mg/day)/serum FGF23 (pg/ml). Results The mean age was 63 +/- 11 years and eGFR levels were 79.5 +/- 25.4 ml/min/1.73 m(2), respectively. Thirty patients had a medical history of macroangiopathy. The Nephron index was significantly decreased in subjects with macroangiopathy compared with those without macroangiopathy. A multivariate analysis of risk factors for macroangiopathy revealed that duration of diabetes, eGFR, and nephron index were significantly associated with a higher frequency of arteriosclerotic disease. Conclusion These findings suggest that a decrease in nephron index reflects early-stage renal impairment and is an independent risk factor of macroangiopathy in diabetic patients.	[Yamada, Hodaka; Hara, Kazuo; Ueda, Yuichiro; Kusaka, Ikuyo; Kakei, Masafumi] Jichi Med Univ, Saitama Med Ctr, Dept Med, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan; [Kuro-o, Makoto] Jichi Med Univ, Ctr Mol Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan; [Ishikawa, San-e] Int Univ Hlth & Welf Hosp, Div Endocrinol & Metab, 537-3 Iguchi, Nasushiobara, Tochigi 3292763, Japan	Jichi Medical University; Jichi Medical University; International University of Health & Welfare	Yamada, H (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Med, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	hyamada0510@jichi.ac.jp			Vehicle Racing Commemorative Foundation; Kidney Foundation, Japan [JKFB15-33]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; AMED-CREST, JST	Vehicle Racing Commemorative Foundation; Kidney Foundation, Japan(Kidney Foundation, Japan); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST, JST	M. K. is supported by research grants from AMED-CREST, JST, MEXT-Supported Program for the Strategic Research Foundation at Private Universities, and Vehicle Racing Commemorative Foundation. This research was supported by grant from The Kidney Foundation, Japan (JKFB15-33). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bech AP, 2015, J NEPHROL, V28, P477, DOI 10.1007/s40620-015-0178-0; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Craver L, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-221; Dominguez JR, 2013, J AM SOC NEPHROL, V24, P647, DOI 10.1681/ASN.2012090894; Garimella PS, 2014, ATHEROSCLEROSIS, V233, P91, DOI 10.1016/j.atherosclerosis.2013.12.015; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Isakova T, 2015, J AM SOC NEPHROL, V26, P2328, DOI 10.1681/ASN.2015020117; Isakova T, 2012, CURR OPIN NEPHROL HY, V21, P334, DOI 10.1097/MNH.0b013e328351a391; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Komaba H, 2012, NAT REV NEPHROL, V8, P484, DOI 10.1038/nrneph.2012.116; Kuro-o M, 2013, KIDNEY INT SUPPL, V3, P420, DOI 10.1038/kisup.2013.88; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; MacIsaac RJ, 2014, AM J KIDNEY DIS, V63, pS39, DOI 10.1053/j.ajkd.2013.10.048; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nakano C, 2012, BONE, V50, P1266, DOI 10.1016/j.bone.2012.02.634; Reyes-Garcia R, 2014, DIABETES CARE, V37, pE89, DOI 10.2337/dc13-2235; Scialla JJ, 2014, J AM SOC NEPHROL, V25, P349, DOI 10.1681/ASN.2013050465; Scialla JJ, 2013, KIDNEY INT, V83, P1159, DOI 10.1038/ki.2013.3; Silswal N, 2014, AM J PHYSIOL-ENDOC M, V307, pE426, DOI 10.1152/ajpendo.00264.2014; Tanaka H, 2009, BONE, V45, P949, DOI 10.1016/j.bone.2009.07.016; Yamamoto M, 2012, J CLIN ENDOCR METAB, V97, P1277, DOI 10.1210/jc.2011-2537; Yamamoto M, 2009, J BONE MINER RES, V24, P702, DOI 10.1359/JBMR.081207; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	28	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160782	10.1371/journal.pone.0160782	http://dx.doi.org/10.1371/journal.pone.0160782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504998	Green Submitted, gold, Green Published			2022-12-26	WOS:000381374200063
J	Jian, Z; Chen, YJ; Shimkunas, R; Jian, YW; Jaradeh, M; Chavez, K; Chiamvimonvat, N; Tardiff, JC; Izu, LT; Ross, RS; Ye, CI				Jian, Zhong; Chen, Yi-Je; Shimkunas, Rafael; Jian, Yuwen; Jaradeh, Mark; Chavez, Karen; Chiamvimonvat, Nipavan; Tardiff, Jil C.; Izu, Leighton T.; Ross, Robert S.; Ye Chen-Izu			In Vivo Cannulation Methods for Cardiomyocytes Isolation from Heart Disease Models	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CARDIAC TROPONIN-T; 2,3-BUTANEDIONE MONOXIME BDM; VENTRICULAR MYOCYTES; MUSCULAR-DYSTROPHY; MICE LACKING; GENE; MOUSE; CARDIOMYOPATHY; CONTRACTION	Isolation of high quality cardiomyocytes is critically important for achieving successful experiments in many cellular and molecular cardiology studies. Methods for isolating cardiomyocytes from the murine heart generally are time-sensitive and experience-dependent, and often fail to produce high quality cells. Major technical difficulties can be related to the surgical procedures needed to explant the heart and to cannulate the vessel to mount onto the Langendorff system before in vitro reperfusion can begin. During this period, transient hypoxia and ischemia may damage the heart, resulting in low yield and poor quality of cells, especially for heart disease models that have fragile cells. We have developed novel in vivo cannulation methods to minimize hypoxia and ischemia, and fine-tuned the entire protocol to produce high quality ventricular myocytes. The high cell quality has been confirmed using important structural and functional criteria such as morphology, t-tubule structure, action potential morphology, Ca2+ signaling, responsiveness to beta-adrenergic agonist, and ability to have robust contraction under mechanically loaded condition. Together these assessments show the preservation of the cardiac excitation-contraction machinery in cells isolated using this technique. The in vivo cannulation method enables consistent isolation of high-quality cardiomyocytes, even from heart disease models that were notoriously difficult for cell isolation using traditional methods.	[Jian, Zhong; Chen, Yi-Je; Shimkunas, Rafael; Jian, Yuwen; Jaradeh, Mark; Chavez, Karen; Izu, Leighton T.; Ye Chen-Izu] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Chen, Yi-Je] Univ Calif Davis, Microsurg Core Dept Pharmacol, Davis, CA 95616 USA; [Chiamvimonvat, Nipavan; Ye Chen-Izu] Univ Calif Davis, Dept Internal Med, Div Cardiol, Davis, CA 95616 USA; [Tardiff, Jil C.] Univ Arizona, Dept Med & Cellular & Mol Med, Tucson, AZ USA; [Ross, Robert S.] Univ Calif San Diego, Vet Adm Healthcare Syst, Cardiol Sect, San Diego, CA 92103 USA; [Shimkunas, Rafael; Ye Chen-Izu] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona; University of California System; University of California San Diego; University of California System; University of California Davis	Ye, CI (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.; Ye, CI (corresponding author), Univ Calif Davis, Dept Internal Med, Div Cardiol, Davis, CA 95616 USA.; Ye, CI (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	ychenizu@ucdavis.edu	Ross, Robert/ABE-1109-2020	Ross, Robert/0000-0003-2195-8982; Jaradeh, Mark/0000-0001-8916-7533; Chiamvimonvat, Nipavan/0000-0001-9499-8817; Jian, Zhong/0000-0003-1072-5788	National Institutes of Health [R01HL90880, R01HL123526, R01HL085727, R01HL085844, R01HL115933, R01HL127806]; American Heart Association [14GRNT20510041]; University of California startup fund; VA Merit Review Grant [I01 BX000576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137228, T32HL086350, R01HL085844, R01HL123526, R01HL127806] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001490, I01BX000576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of California startup fund; VA Merit Review Grant(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by 1. National Institutes of Health R01HL90880 (https://www.nih.gov/) to LTI and YC, 2. National Institutes of Health (https://www.nih.gov/) R01HL123526 to YC, 3. American Heart Association 14GRNT20510041 (http://www.heart.org/HEARTORG/) to YC, 4. University of California startup fund (www.ucdavis.edu) to YC, 5. National Institutes of Health (https://www.nih.gov/) R01HL085727 to NC, 6. National Institutes of Health (https://www.nih.gov/) R01HL085844 to NC, 7. The VA Merit Review Grant (http://www.research.va.gov/services/shared_docs/merit_review.cfm) I01 BX000576 to NC, 8. National Institutes of Health (https://www.nih.gov/) R01HL115933 to RSR, and 9. National Institutes of Health (https://www.nih.gov/) R01HL127806 to RSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; COULOMBE A, 1990, J MOL CELL CARDIOL, V22, P921, DOI 10.1016/0022-2828(90)90123-J; deAlmeida AC, 2010, JOURNAL OF VISUALIZE, DOI [10.3791/1729, DOI 10.3791/1729]; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Huang PL, 1999, BRAZ J MED BIOL RES, V32, P1353, DOI 10.1590/S0100-879X1999001100005; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Javadpour MM, 2003, J CLIN INVEST, V112, P768, DOI 10.1172/JC1200315967; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; LI T, 1985, J PHARMACOL EXP THER, V232, P688; LOPATIN AN, 1993, J PHARMACOL EXP THER, V265, P1011; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Neubauer S, 2000, MAGN RESON MATER PHY, V11, P73; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Pinz I, 2011, CELL BIOCHEM BIOPHYS, V61, P93, DOI 10.1007/s12013-011-9165-9; POWELL T, 1976, BIOCHEM BIOPH RES CO, V72, P327, DOI 10.1016/0006-291X(76)90997-9; QUAIFE RA, 1991, CIRCULATION, V83, P566, DOI 10.1161/01.CIR.83.2.566; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Starling RC, 1998, MOL CELL BIOCHEM, V180, P171, DOI 10.1023/A:1006876031121; Tangney JR, 2013, BIOPHYS J, V104, P1623, DOI 10.1016/j.bpj.2013.02.021; Tani M, 1996, AM J PHYSIOL-HEART C, V271, pH2515, DOI 10.1152/ajpheart.1996.271.6.H2515; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Verrecchia F, 1997, AM J PHYSIOL-CELL PH, V272, pC875, DOI 10.1152/ajpcell.1997.272.3.C875; Watanabe Y, 2001, BRIT J PHARMACOL, V132, P1317, DOI 10.1038/sj.bjp.0703926; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160605	10.1371/journal.pone.0160605	http://dx.doi.org/10.1371/journal.pone.0160605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500929	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500036
J	Miller, SJ; Rothstein, JD				Miller, Sean J.; Rothstein, Jeffrey D.			Astroglia in Thick Tissue with Super Resolution and Cellular Reconstruction	PLOS ONE			English	Article							SPINAL-CORD; ASTROCYTE; DISEASE; HETEROGENEITY; KIR4.1; MODEL; MICE	We utilized the recently published method of passive CLARITY to explore brain astrocytes for the first time with our optimized method. Astrocytes are the fundamental cells in the brain that act to maintain the synaptic activity of neurons, support metabolism of all neurons, and communicate through extensive networks throughout the CNS. They are the defining cell that differentiates lower organisms from humans. From a disease vantage point they are the principal cause of brain tumors and the propagator of neurodegenerative diseases like amyotrophic lateral sclerosis. New methods to study these cells is paramount. Our modified use of CLARITY provides a new way to study these brain cells. To reduce cost, speed up tissue clearing process, reduce human handling error, and to retrieve quantifiable data from single confocal and pseudo-super resolution microscopy we modified and optimized the original protocol.	[Miller, Sean J.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Miller, Sean J.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21218 USA; [Miller, Sean J.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Sch Med, Cellular & Mol Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Rothstein, JD (corresponding author), Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21218 USA.; Rothstein, JD (corresponding author), Johns Hopkins Univ, Sch Med, Cellular & Mol Med, Baltimore, MD 21218 USA.	jrothstein@jhmi.edu			NIH [NS085207, NS092067]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the NIH: NS085207 and NS092067 (JDR), and by the National Science Foundation (SJM).	Basso M, 2013, J BIOL CHEM, V288, P15699, DOI 10.1074/jbc.M112.425066; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Cabarrocas J, 2003, GLIA, V41, P81, DOI 10.1002/glia.10169; Garcia-Marques J, 2013, CEREB CORTEX, V23, P1463, DOI 10.1093/cercor/bhs134; Guo YS, 2010, FEBS LETT, V584, P1615, DOI 10.1016/j.febslet.2010.03.025; Haidet-Phillips AM, 2015, BRAIN RES, V1628, P343, DOI 10.1016/j.brainres.2015.06.035; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Kaiser M, 2006, J NEUROCHEM, V99, P900, DOI 10.1111/j.1471-4159.2006.04131.x; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Olsen ML, 2010, BRAIN, V133, P1013, DOI 10.1093/brain/awq049; Tong XP, 2014, NAT NEUROSCI, V17, P694, DOI 10.1038/nn.3691; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	18	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160391	10.1371/journal.pone.0160391	http://dx.doi.org/10.1371/journal.pone.0160391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494718	Green Published, Green Submitted, gold			2022-12-26	WOS:000381369500039
J	Zhao, G; Liu, LP; Peek, RM; Hao, XS; Polk, DB; Li, H; Yan, F				Zhao, Gang; Liu, Liping; Peek, Richard M., Jr.; Hao, Xishan; Polk, D. Brent; Li, Hui; Yan, Fang			Activation of Epidermal Growth Factor Receptor in Macrophages Mediates Feedback Inhibition of M2 Polarization and Gastrointestinal Tumor Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor receptor (EGFR); epithelial-mesenchymal transition (EMT); gastric cancer; macrophage; tumor microenvironment; HB-EGF; M2 polarization; STAT6; colonic tumor	EGFR; PROMOTE; CANCER; COLON; ESTABLISHMENT; RESISTANCE; RESPONSES; ADENOMAS; INVASION; MUTATION	EGF receptor (EGFR) in tumor cells serves as a tumor promoter. However, information about EGFR activation in macrophages in regulating M2 polarization and tumor development is limited. This study aimed to investigate the effects of EGFR activation in macrophages on M2 polarization and development of gastrointestinal tumors. IL-4, a cytokine to elicit M2 polarization, stimulated release of an EGFR ligand, HB-EGF, and transactivation and down-regulation of EGFR in Raw 264.7 cells and peritoneal macrophages from WT mice. Knockdown of HB-EGF in macrophages inhibited EGFR transactivation by IL-4. IL-4-stimulated STAT6 activation, Arg1 and YM1 gene expression, and HB-EGF production were further enhanced by inhibition of EGFR activity in Raw 264.7 cells using an EGFR kinase inhibitor and in peritoneal macrophages from Egfr(wa5) mice with kinase inactive EGFR and by knockdown of EGFR in peritoneal macrophages from Egfr(fl/fl) LysM-Cre mice with myeloid cell-specific EGFR deletion. Chitin induced a higher level of M2 polarization in peritoneal macrophages in Egfr(fl/fl) LysM-Cre mice than that in Egfr(fl/fl) mice. Accordingly, IL-4-conditioned medium stimulated growth and epithelial-to-mesenchymal transition in gastric epithelial and colonic tumor cells, which were suppressed by that from Raw 264.7 cells with HB-EGF knockdown but promoted by that from Egfr(wa5) and Egfr(fl/fl) LysM-Cre peritoneal macrophages. Clinical assessment revealed that the number of macrophages with EGFR expression became less, indicating decreased inhibitory effects on M2 polarization, in late stage of human gastric cancers. Thus, IL-4-stimulated HB-EGF-dependent transactivation of EGFR in macrophages may mediate inhibitory feedback for M2 polarization and HB-EGF production, thereby inhibiting gastrointestinal tumor growth.	[Zhao, Gang; Liu, Liping; Yan, Fang] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA; [Zhao, Gang; Hao, Xishan; Li, Hui] Tianjin Canc Inst, Dept Gastrointestinal Canc Biol, Natl Clin Canc Res Ctr, Tianjin 300060, Peoples R China; [Zhao, Gang; Hao, Xishan; Li, Hui] Tianjin Med Univ, Canc Inst & Hosp, Huanhuxi Rd, Tianjin 300060, Peoples R China; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37232 USA; [Peek, Richard M., Jr.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Div Gastroenterol, Nashville, TN 37232 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Dept Biochem & Mol Biol, Los Angeles, CA 90027 USA; [Polk, D. Brent] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90027 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA	Vanderbilt University; Tianjin Medical University; Tianjin Medical University; Vanderbilt University; Vanderbilt University; Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles	Li, H (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Huanhuxi Rd, Tianjin 300060, Peoples R China.; Polk, DB (corresponding author), Childrens Hosp Los Angeles, 4650 Sunset Blvd MS 126, Los Angeles, CA 90027 USA.; Yan, F (corresponding author), Vanderbilt Univ, Med Ctr, 2215 Garland Ave,MRB 4,Rm 1035, Nashville, TN 37232 USA.	dbpolk@chla.usc.edu; lihui@tjmuch.com; fang.yan@vanderbilt.edu	liu, li/HGC-0900-2022		National Institutes of Health [R01DK081134, R01DK56008, R01DK54993, P30DK058404]; National Natural Science Foundation of China [31471341]; NATIONAL CANCER INSTITUTE [R01CA077955, P01CA116087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054993, P30DK058404, R01DK081134, R01DK056008, R01DK058587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK081134 (to F. Y.) and R01DK56008 and R01DK54993 (to D. B. P.), and core services were performed through Vanderbilt University Medical Center's Digestive Disease Research Center supported by National Institutes of Health Grant P30DK058404. This work was also supported by National Natural Science Foundation of China Grant 31471341 (to H. L.) The authors declare no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Alferez D, 2008, MOL CANCER THER, V7, P590, DOI 10.1158/1535-7163.MCT-07-0433; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bucci M, 2000, BRIT J PHARMACOL, V131, P13, DOI 10.1038/sj.bjp.0703549; Burova E, 2007, FEBS LETT, V581, P1475, DOI 10.1016/j.febslet.2007.03.002; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gao P, 2013, CARDIOVASC RES, V97, P533, DOI 10.1093/cvr/cvs369; Goel GA, 2011, AM J GASTROENTEROL, V106, P719, DOI 10.1038/ajg.2011.51; Goldstein NS, 2001, CANCER, V92, P1331, DOI 10.1002/1097-0142(20010901)92:5<1331::AID-CNCR1455>3.0.CO;2-M; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Kawahara A, 2010, ONCOL REP, V24, P405, DOI 10.3892/or_00000873; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lu N, 2014, J IMMUNOL, V192, P1013, DOI 10.4049/jimmunol.1300133; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Nishimura M, 2009, MOL CELL BIOL, V29, P5529, DOI 10.1128/MCB.00375-09; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pander J, 2011, CLIN CANCER RES, V17, P5668, DOI 10.1158/1078-0432.CCR-11-0239; Patsialou A, 2009, CANCER RES, V69, P9498, DOI 10.1158/0008-5472.CAN-09-1868; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rigo A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-273; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Singhirunnusorn P, 2007, J BIOL CHEM, V282, P12698, DOI 10.1074/jbc.M608723200; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	46	18	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20462	20472		10.1074/jbc.M116.750182	http://dx.doi.org/10.1074/jbc.M116.750182			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27507810	hybrid, Green Published			2022-12-26	WOS:000384574800014
J	Yang, J; Song, W; Wei, QQ; Ou, RW; Cao, B; Liu, WL; Shao, N; Shang, HF				Yang, Jing; Song, Wei; Wei, Qianqian; Ou, Ruwei; Cao, Bei; Liu, Wanglin; Shao, Na; Shang, Hui-Fang			Screening for Cognitive Impairments in Primary Blepharospasm	PLOS ONE			English	Article							CRANIAL-CERVICAL DYSTONIA; MINI-MENTAL-STATE; REVISED ACE-R; DISEASE; DISORDERS; DEMENTIA; TOXIN; FMRI	Backgrounds Studies have reported that non-motor symptoms are an important component of primary dystonia. However, evidence supporting cognitive impairment in primary dystonia is limited and contradictory. Methods We applied the Chinese version of the Addenbrooke's Cognitive Examination-Revised and the Mini-Mental State Examination (MMSE) to screen for cognitive impairment in patients with primary blepharospasm. In addition, we investigated the relationship between performance on the Addenbrooke's Cognitive Examination-Revised and quality of life as measured by the Medical Outcomes Study 36-item Short-Form (SF36). Results The study included 68 primary blepharospasm patients and 68 controls matched by age, sex and education. The prevalence of cognitive deficits was 22.0% and 32.3% in primary blepharospasm patients group, as measured by the MMSE and the Addenbrooke's Cognitive Examination-Revised, respectively. Primary blepharospasm patents had a broad range of cognitive deficits, with the most frequently affected domains being visuospatial function (30.9%) and language (30.9%), followed by memory (27.9%), orientation/attention (26.4%) and verbal fluency (22.0%). Patients with cognitive deficits had lower total SF36 scores, especially in the subdomains of physical functioning, role-physical and social functioning, compared to those without cognitive deficits. Scores on the Addenbrooke's Cognitive Examination-Revised were significantly correlated with both the SF36 scores and the scores on the subdomains of physical functioning and social functioning. Conclusions Some patients with primary blepharospasm have cognitive deficits. Poor performance on the Addenbrooke's Cognitive Examination-Revised is related to poorer quality of life.	[Yang, Jing; Song, Wei; Wei, Qianqian; Ou, Ruwei; Cao, Bei; Liu, Wanglin; Shao, Na; Shang, Hui-Fang] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China	Sichuan University	Shang, HF (corresponding author), Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Sichuan, Peoples R China.	hfshang2002@163.com			National Science Fund of China [81371394, 81500971]	National Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was founded by the National Science Fund of China (Grant No. 81371394, 81500971).	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; Allam N, 2007, ACTA NEUROL SCAND, V116, P196, DOI 10.1111/j.1600-0404.2007.00862.x; Amaral-Carvalho V, 2012, COGN BEHAV NEUROL, V25, P72, DOI 10.1097/WNN.0b013e318259594b; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Fang R, 2014, DEMENT GERIATR COGN, V37, P223, DOI 10.1159/000353541; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Aleman GG, 2009, MOVEMENT DISORD, V24, P2112, DOI 10.1002/mds.22736; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hinse P, 1996, J NEUROL, V243, P29; Jahanshahi M, 2003, MOVEMENT DISORD, V18, P1470, DOI 10.1002/mds.10595; JANKOVIC J, 1987, NEUROLOGY, V37, P616, DOI 10.1212/WNL.37.4.616; Kawata KHD, 2012, DEMENT GER COGN D EX, V2, P29, DOI 10.1159/000336909; Kerrison JB, 2003, AM J OPHTHALMOL, V136, P846, DOI 10.1016/S0002-9394(03)00895-X; Komadina NC, 2011, DEMENT GERIATR COGN, V31, P349, DOI 10.1159/000328165; Laisney M, 2009, J NEUROL, V256, P1083, DOI 10.1007/s00415-009-5073-y; Larner AJ, 2014, INT PSYCHOGERIATR, V26, P555, DOI 10.1017/S1041610213002329; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Page D, 2007, MOVEMENT DISORD, V22, P341, DOI 10.1002/mds.21234; Pillon B, 2006, NEUROLOGY, V66, P1556, DOI 10.1212/01.wnl.0000216131.41563.24; Redondo-Verge L, 2001, REV NEUROLOGIA, V32, P82, DOI 10.33588/rn.3201.2000085; Rittman T, 2013, J NEUROL NEUROSUR PS, V84, P544, DOI 10.1136/jnnp-2012-303618; Romano R, 2014, PARKINSONISM RELAT D, V20, P162, DOI 10.1016/j.parkreldis.2013.10.008; Schmidt KE, 2003, NEUROLOGY, V60, P1738, DOI 10.1212/01.WNL.0000063306.67984.8C; Scott RB, 2003, MOVEMENT DISORD, V18, P539, DOI 10.1002/mds.10399; Stamelou M, 2012, BRAIN, V135, P1668, DOI 10.1093/brain/awr224; TAYLOR AE, 1991, CLIN NEUROPHARMACOL, V14, P62, DOI 10.1097/00002826-199102000-00005; van Tricht MJ, 2012, J NEUROL NEUROSUR PS, V83, P814, DOI 10.1136/jnnp-2011-301386; Dias FMV, 2009, ARQ NEURO-PSIQUIAT, V67, P12, DOI 10.1590/S0004-282X2009000100004; Walterfang M, 2014, MOVEMENT DISORD, V29, P694, DOI 10.1002/mds.25849; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yang J, 2013, J NEUROL, V260, P2754, DOI 10.1007/s00415-013-7042-8; Zoons E, 2011, NEUROIMAGE, V56, P1011, DOI 10.1016/j.neuroimage.2011.02.045	33	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160867	10.1371/journal.pone.0160867	http://dx.doi.org/10.1371/journal.pone.0160867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526026	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100025
J	Faksri, K; Tan, JH; Disratthakit, A; Xia, EY; Prammananan, T; Suriyaphol, P; Khor, CC; Teo, YY; Ong, RTH; Chaiprasert, A				Faksri, Kiatichai; Tan, Jun Hao; Disratthakit, Areeya; Xia, Eryu; Prammananan, Therdsak; Suriyaphol, Prapat; Khor, Chiea Chuen; Teo, Yik-Ying; Ong, Rick Twee-Hee; Chaiprasert, Angkana			Whole-Genome Sequencing Analysis of Serially Isolated Multi-Drug and Extensively Drug Resistant Mycobacterium tuberculosis from Thai Patients	PLOS ONE			English	Article							PREDICTION; STABILITY; SPOLIGOTYPES; KANAMYCIN; OUTBREAK; PATTERNS; GENES	Multi-drug and extensively drug-resistant tuberculosis (MDR and XDR-TB) are problems that threaten public health worldwide. Only some genetic markers associated with drug-resistant TB are known. Whole-genome sequencing (WGS) is a promising tool for distinguishing between re-infection and persistent infection in isolates taken at different times from a single patient, but has not yet been applied in MDR and XDR-TB. We aim to detect genetic markers associated with drug resistance and distinguish between reinfection and persistent infection from MDR and XDR-TB patients based on WGS analysis. Samples of Mycobacterium tuberculosis (n = 7), serially isolated from 2 MDR cases and 1 XDR-TB case, were retrieved from Siriraj Hospital, Bangkok. TheWGS analysis used an Illumina Miseq sequencer. In cases of persistent infection, MDR-TB isolates differed at an average of 2 SNPs across the span of 2-9 months whereas in the case of reinfection, isolates differed at 61 SNPs across 2 years. Known genetic markers associated with resistance were detected from strains susceptible to streptomycin (2/7 isolates), p-aminosalicylic acid (3/7 isolates) and fluoroquinolone drugs. Among fluoroquinolone drugs, ofloxacin had the highest phenotype-genotype concordance (6/7 isolates), whereas gatifloxcain had the lowest (3/7 isolates). A putative candidate SNP in Rv2477c associated with kanamycin and amikacin resistance was suggested for further validation. WGS provided comprehensive results regarding molecular epidemiology, distinguishing between persistent infection and reinfection in M/XDR-TB and potentially can be used for detection of novel mutations associated with drug resistance.	[Faksri, Kiatichai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Faksri, Kiatichai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand; [Tan, Jun Hao; Teo, Yik-Ying; Ong, Rick Twee-Hee] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Disratthakit, Areeya; Chaiprasert, Angkana] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand; [Xia, Eryu; Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Prammananan, Therdsak] Natl Sci & Technol Dev Agcy, Minist Sci & Technol, Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Suriyaphol, Prapat] Mahidol Univ, Siriraj Hosp, Bioinformat & Data Management Res Unit, Off Res & Dev,Fac Med, Bangkok, Thailand; [Khor, Chiea Chuen; Teo, Yik-Ying] Genome Inst Singapore, Singapore, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore, Singapore	Khon Kaen University; Khon Kaen University; National University of Singapore; Mahidol University; National University of Singapore; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Faksri, K (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Faksri, K (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Khon Kaen, Thailand.; Chaiprasert, A (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.	kiatichai@kku.ac.th; angkana.cha@mahidol.ac.th		Khor, Chiea Chuen/0000-0002-1128-4729; Faksri, Kiatichai/0000-0001-5022-4182	Faculty of Medicine, Siriraj Hospital, Mahidol University [R015833003]; JST/NSTDA [P-12-01777]; National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund [NUHSRO/2014/069/AF-New Idea/04]; Genome Institute of Singapore (GIS), A-STAR, Singapore	Faculty of Medicine, Siriraj Hospital, Mahidol University; JST/NSTDA; National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund(National University of Singapore); Genome Institute of Singapore (GIS), A-STAR, Singapore	This study was partially supported by Faculty of Medicine, Siriraj Hospital, Mahidol University grant No. R015833003, JST/NSTDA, grant no. P-12-01777, and the National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/069/AF-New Idea/04). The authors thank Genome Institute of Singapore (GIS), A-STAR, Singapore, for supporting of NGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partially supported by Faculty of Medicine, Siriraj Hospital, Mahidol University grant No. R015833003, JST/NSTDA grant No. P-12-01777 and the National University of Singapore Yong Loo Lin School of Medicine Aspiration Fund (NUHSRO/2014/069/AF-New Idea/04). We thanks for Genome Institute of Singapore (GIS), A-STAR, Singapore for supporting of NGS. We would like to acknowledge Prof. David Blair for editing the manuscript via Publication Clinic KKU. The author declared that they have no competing interests.	Andrews S., 2010, FASTQC QUALITY CONTR; Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Benavente ED, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0603-3; Blower TR, 2016, P NATL ACAD SCI USA, V113, P1706, DOI 10.1073/pnas.1525047113; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coll F, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0164-0; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; de Boer AS, 1999, J INFECT DIS, V180, P1238, DOI 10.1086/314979; Disratthakit A, 2015, INFECT GENET EVOL, V32, P432, DOI 10.1016/j.meegid.2015.03.038; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Mazandu GK, 2012, INT J MOL SCI, V13, P7283, DOI 10.3390/ijms13067283; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niemann S, 1999, J CLIN MICROBIOL, V37, P3078, DOI 10.1128/JCM.37.2.409-412.1999; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Regmi SM, 2015, MOL GENET GENOMICS, V290, P1933, DOI 10.1007/s00438-015-1048-0; Robertson D, 2007, TUBERCULOSIS, V87, P450, DOI 10.1016/j.tube.2007.05.015; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Salamon H, 2015, J INFECT DIS, V211, pS50, DOI 10.1093/infdis/jiu816; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Saunders NJ, 2011, J INFECTION, V62, P212, DOI 10.1016/j.jinf.2011.01.003; Savine E, 2002, J CLIN MICROBIOL, V40, P4561, DOI 10.1128/JCM.40.12.4561-4566.2002; Sharma D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139414; Sowajassatakul A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-165; Steiner A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-881; Stucki D, 2015, J INFECT DIS, V211, P1306, DOI 10.1093/infdis/jiu601; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vishnoi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-373; Walker TM, 2015, LANCET INFECT DIS; Wand ME, 2015, J ANTIMICROB CHEMOTH, V70, P2209, DOI 10.1093/jac/dkv097; WHO, 1998, INT J TUBERC LUNG D, V2, P71; Willby M, 2015, ANTIMICROB AGENTS CH, V59, P5427, DOI 10.1128/AAC.00662-15; Xia E, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0270-7; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	52	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160992	10.1371/journal.pone.0160992	http://dx.doi.org/10.1371/journal.pone.0160992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518818	Green Submitted, gold, Green Published			2022-12-26	WOS:000381382100032
J	Shin, JW; Park, SH; Kang, YG; Wu, Y; Choi, HJ; Shin, JW				Shin, Ji Won; Park, So Hee; Kang, Yun Gyeong; Wu, Yanru; Choi, Hyun Ju; Shin, Jung-Woog			Changes, and the Relevance Thereof, in Mitochondrial Morphology during Differentiation into Endothelial Cells	PLOS ONE			English	Article							SHEAR-STRESS; FISSION; DYNAMICS; FUSION	The roles of mitochondria in various physiological functions of vascular endothelial cells have been investigated extensively. Morphological studies in relation to physiological functions have been performed. However, there have been few reports of morphological investigations related to stem cell differentiation. This was the first morphological study of mitochondria in relation to endothelial differentiation and focused on quantitative analysis of changes in mitochondrial morphology, number, area, and length during differentiation of human mesenchymal stem cells (hMSCs) into endothelial-like cells. To induce differentiation, we engaged vascular endothelial growth factors and flow-induced shear stress. Cells were classified according to the expression of von Willebrand factor as hMSCs, differentiating cells, and almost fully differentiated cells. Based on imaging analysis, we investigated changes in mitochondrial number, area, and length. In addition, mitochondrial networks were quantified on a single-mitochondrion basis by introducing a branch form factor. The data indicated that the mitochondrial number, area per cell, and length were decreased with differentiation. The mitochondrial morphology became simpler with progression of differentiation. These findings could be explained in view of energy level during differentiation; a higher level of energy is needed during differentiation, with larger numbers of mitochondria with branches. Application of this method to differentiation into other lineages will explain the energy levels required to control stem cell differentiation.	[Shin, Ji Won; Park, So Hee; Kang, Yun Gyeong; Shin, Jung-Woog] Inje Univ, Dept Biomed Engn, Gimhae, Gyeongnam, South Korea; [Wu, Yanru; Shin, Jung-Woog] Inje Univ, Dept Hlth Sci & Technol, Gimhae, Gyeongnam, South Korea; [Choi, Hyun Ju] Gimhae Biomed Ctr, Res & Dev Team, Gimhae, Gyeongnam, South Korea; [Shin, Jung-Woog] Inje Univ, UHARC, Inst Aged Life Redesign, Cardiovasc & Metab Dis Ctr, Gimhae, Gyeongnam, South Korea	Inje University; Inje University; Inje University	Shin, JW (corresponding author), Inje Univ, Dept Biomed Engn, Gimhae, Gyeongnam, South Korea.; Shin, JW (corresponding author), Inje Univ, Dept Hlth Sci & Technol, Gimhae, Gyeongnam, South Korea.; Shin, JW (corresponding author), Inje Univ, UHARC, Inst Aged Life Redesign, Cardiovasc & Metab Dis Ctr, Gimhae, Gyeongnam, South Korea.	biomechshin@gmail.com			Priority Research Centers Program (Ministry of Education, Science and Technology) [20100020224]; Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea [NRF-2014H1C1A1066694]	Priority Research Centers Program (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea(Ministry of Education (MOE), Republic of Korea)	This research was supported by the grants of Priority Research Centers Program (20100020224, the Ministry of Education, Science and Technology) and the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (NRF-2014H1C1A1066694). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the grants of Priority Research Centers Program (20100020224, the Ministry of Education, Science and Technology) and the Human Resource Training Program for Regional Innovation and Creativity through the Ministry of Education and National Research Foundation of Korea (NRF-2014H1C1A1066694).	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Au HK, 2005, ANN NY ACAD SCI, V1042, P177, DOI 10.1196/annals.1338.020; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Colazzo F, 2014, GROWTH FACTORS, V32, P139, DOI 10.3109/08977194.2014.945642; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; De Palma C, 2010, CELL DEATH DIFFER, V17, P1684, DOI 10.1038/cdd.2010.48; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Naka K, 2011, INT J HEMATOL, V93, P434, DOI 10.1007/s12185-011-0793-z; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Sathananthan A H, 2000, Hum Reprod, V15 Suppl 2, P148; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; Westermann B, 2012, BBA-BIOENERGETICS, V1817, P1833, DOI 10.1016/j.bbabio.2012.02.033; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wilkerson DC, 2011, INT J BIOCHEM CELL B, V43, P1252, DOI 10.1016/j.biocel.2011.05.005; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yuan L, 2013, CELL MOL BIOENG, V6, P220, DOI 10.1007/s12195-013-0275-x	25	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161015	10.1371/journal.pone.0161015	http://dx.doi.org/10.1371/journal.pone.0161015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517609	gold, Green Published, Green Submitted			2022-12-26	WOS:000381382100037
J	Heulens, N; Korf, H; Mathyssen, C; Everaerts, S; De Smidt, E; Dooms, C; Yserbyt, J; Gysemans, C; Gayan-Ramirez, G; Mathieu, C; Janssens, W				Heulens, Nele; Korf, Hannelie; Mathyssen, Carolien; Everaerts, Stephanie; De Smidt, Elien; Dooms, Christophe; Yserbyt, Jonas; Gysemans, Conny; Gayan-Ramirez, Ghislaine; Mathieu, Chantal; Janssens, Wim			1,25-Dihydroxyvitamin D Modulates Antibacterial and Inflammatory Response in Human Cigarette Smoke-Exposed Macrophages	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VITAMIN-D DEFICIENCY; ANTIGEN EXPRESSION; HUMAN MONOCYTES; LUNG-FUNCTION; CUTTING EDGE; PHAGOCYTOSIS; D-3; INDUCTION; MECHANISM	Cigarette smoking is associated with increased inflammation and defective antibacterial responses in the airways. Interestingly, vitamin D has been shown to suppress inflammation and to improve antibacterial defense. However, it is currently unknown whether vitamin D may modulate inflammation and antibacterial defects in human cigarette smoke (CS)exposed airways. To explore these unresolved issues, alveolar macrophages obtained from non-smoking and smoking subjects as well as human cigarette smoke extract (CSE)treated THP-1 macrophages were stimulated with 1,25-dihydroxyvitamin D (1,25(OH)(2)D) to address inflammatory and antibacterial responses. Although basal levels of inflammatory cytokines and chemokines did not differ between non-smoking and smoking subjects, 1,25 (OH)(2)D did reduce levels of IL-6, TNF-alpha and MCP-1 in alveolar macrophages in response to LPS/IFN-gamma, although not statistically significant for TNF-alpha and IL-6 in smokers. CSE did not significantly alter vitamin D metabolism (expression levels of CYP24A1 or CYP27B1) in THP-1 macrophages. Furthermore, stimulation with 1,25(OH)(2)D reduced mRNA expression levels and/or protein levels of IL-8, TNF-alpha and MCP-1 in CSE-treated THP-1 macrophages. 1,25( OH)(2)D did not improve defects in phagocytosis of E. coli bacteria or the oxidative burst response in CSE-treated THP-1 macrophages or alveolar macrophages from smokers. However, 1,25(OH)(2)D significantly enhanced mRNA expression and/or protein levels of the antimicrobial peptide cathelicidin in alveolar macrophages and THP-1 macrophages, independently of CS exposure. In conclusion, our results provide the first evidence that vitamin D could be a new strategy for attenuating airway inflammation and improving antibacterial defense in CS-exposed airways.	[Heulens, Nele; Mathyssen, Carolien; Everaerts, Stephanie; Dooms, Christophe; Yserbyt, Jonas; Gayan-Ramirez, Ghislaine; Janssens, Wim] Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Resp Dis, Leuven, Belgium; [Korf, Hannelie; De Smidt, Elien; Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Clin & Expt Endocrinol, Leuven, Belgium	KU Leuven; KU Leuven	Janssens, W (corresponding author), Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Resp Dis, Leuven, Belgium.	wim.janssens@uzleuven.be	Everaerts, Stephanie/AAA-3205-2019; mathieu, chantal/ABD-5505-2021	mathieu, chantal/0000-0002-4055-5233; Gayan-Ramirez, Ghislaine/0000-0001-9652-7437; Janssens, Wim/0000-0003-1830-2982; gysemans, conny/0000-0003-3559-6089; Korf, Hannelie/0000-0003-3540-0138	FWO Vlaanderen [G.0B11.13]; Katholieke Universiteit Leuven [OT/11/088]; AstraZeneca chair	FWO Vlaanderen(FWO); Katholieke Universiteit Leuven(KU Leuven); AstraZeneca chair	This study was funded by FWO Vlaanderen (G.0B11.13) (www.fwo.be), Katholieke Universiteit Leuven (OT/11/088) (www.kuleuven.be) and AstraZeneca chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2014, THORAX, V69, P24, DOI 10.1136/thoraxjnl-2013-203682; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barnes PJ, 2014, CLIN CHEST MED, V35, P71, DOI 10.1016/j.ccm.2013.10.004; Bozinovski S, 2011, AM J RESP CELL MOL, V45, P229, DOI 10.1165/rcmb.2010-0272OC; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dockrell D, 2012, MUCOSAL IMMUNOLOGY A, P1; Dusso AS, 1997, J CLIN ENDOCR METAB, V82, P2222, DOI 10.1210/jc.82.7.2222; Golden GA, 2013, J BIOCHEM MOL TOXIC, V27, P77, DOI 10.1002/jbt.21467; GOLDMAN R, 1984, CANCER RES, V44, P11; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Heulens N, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0271-x; Heulens N, 2015, J PHARMACOL EXP THER, V353, P360, DOI 10.1124/jpet.115.223032; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; KLECH H, 1989, EUR RESPIR J, V2, P561; Korf H, 2012, IMMUNOBIOLOGY, V217, P1292, DOI 10.1016/j.imbio.2012.07.018; Lange NE, 2012, AM J RESP CRIT CARE, V186, P616, DOI 10.1164/rccm.201110-1868OC; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2015, LANCET RESP MED, V3, P120, DOI 10.1016/S2213-2600(14)70255-3; Matsunawa M, 2009, TOXICOL SCI, V109, P50, DOI 10.1093/toxsci/kfp044; Mehta H, 2008, INFLAMM RES, V57, P497, DOI 10.1007/s00011-008-8078-6; Mulligan JK, 2014, J ALLERGY CLIN IMMUN, V134, P342, DOI 10.1016/j.jaci.2014.01.039; ORTEGA E, 1994, COMP IMMUNOL MICROB, V17, P77, DOI 10.1016/0147-9571(94)90009-4; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Sly LM, 2001, J BIOL CHEM, V276, P35482, DOI 10.1074/jbc.M102876200; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Takano Y, 2011, STEROIDS, V76, P1305, DOI 10.1016/j.steroids.2011.06.009; Tokuda N, 1996, P SOC EXP BIOL MED, V211, P244, DOI 10.3181/00379727-211-43967; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; XU H, 1993, SCAND J IMMUNOL, V38, P535, DOI 10.1111/j.1365-3083.1993.tb03237.x; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	35	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160482	10.1371/journal.pone.0160482	http://dx.doi.org/10.1371/journal.pone.0160482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513734	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100040
J	Samango-Sprouse, C; Kirkizlar, E; Hall, MP; Lawson, P; Demko, Z; Zneimer, SM; Curnow, KJ; Gross, S; Gropman, A				Samango-Sprouse, Carole; Kirkizlar, Eser; Hall, Megan P.; Lawson, Patrick; Demko, Zachary; Zneimer, Susan M.; Curnow, Kirsten J.; Gross, Susan; Gropman, Andrea			Incidence of X and Y Chromosomal Aneuploidy in a Large Child Bearing Population	PLOS ONE			English	Article							KLINEFELTER-SYNDROME; ESTIMATED RATES; ABNORMALITIES; SPERM; PREVALENCE; INFERTILITY; FREQUENCIES; RISK; MEN; AGE	Background X&Y chromosomal aneuploidies are among the most common human whole-chromosomal copy number changes, but the population-based incidence and prevalence in the childbearing population is unclear. Methods This retrospective analysis of prospectively collected data leveraged a routine non-invasive prenatal test (NIPT) using parental genotyping to estimate the population-based incidence of X&Y chromosome variations in this population referred for NIPT (generally due to advanced maternal age). Results From 141,916 women and 29,336 men, 119 X&Y chromosomal abnormalities (prevalence: 1 in 1,439) were identified. Maternal findings include: 43 cases of 45, X (40 mosaic); 30 cases of 47, XXX (12 mosaic); 3 cases of 46, XX uniparental disomy; 2 cases of 46, XY/46, XX; 23 cases of mosaicism of unknown type; 2 cases of 47, XX, i(X)(q10). Paternal findings include: 2 cases of 47, XXY (1 mosaic); 10 cases of 47, XYY (1 mosaic); 4 partial Y deletions. Conclusions Single chromosome aneuploidy was present in one of every 1,439 individuals considered in this study, showing 47, XXX; 47, XX, i(X)(q10); 47, XYY; 47, XXY, partial Y deletions, and a high level of mosaicism for 45, X. This expands significantly our understanding of X&Y chromosomal variations and fertility issues, and is critical for families and adults affected by these disorders. This current and extensive information on fertility will be beneficial for genetic counseling on prenatal diagnoses as well as for newly diagnosed postnatal cases.	[Samango-Sprouse, Carole; Gropman, Andrea] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Kirkizlar, Eser; Hall, Megan P.; Demko, Zachary; Zneimer, Susan M.; Curnow, Kirsten J.; Gross, Susan] Natera Inc, San Carlos, CA USA; [Gropman, Andrea] Childrens Natl Med Ctr, Dept Neurol & Pediat, Washington, DC 20010 USA; [Samango-Sprouse, Carole; Lawson, Patrick] Focus Fdn, Davidsonville, MD USA	George Washington University; Children's National Health System	Samango-Sprouse, C (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.; Samango-Sprouse, C (corresponding author), Focus Fdn, Davidsonville, MD USA.	cssprouse@gwu.edu		/0000-0002-7300-5027; Samango-Sprouse, Carole/0000-0001-9941-0568; Lawson, Patrick/0000-0003-0256-2050	Natera, Inc.; Focus Foundation	Natera, Inc.; Focus Foundation	d Natera, Inc. provided support in the form of salaries for authors EK, MPH, ZD, SMZ, KJC, and SG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; We would like to send a special thanks to The Focus Foundation for supporting this study and contributing significant staff hours towards the creation of this manuscript.	Abramsky L, 1997, PRENATAL DIAG, V17, P363, DOI 10.1002/(SICI)1097-0223(199704)17:4<363::AID-PD79>3.0.CO;2-O; Aksglaede L, 2013, EUR J ENDOCRINOL, V168, pR67, DOI 10.1530/EJE-12-0934; Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491; BRATKOWSKA W, 1985, Acta Anthropogenetica, V9, P153; BUCKTON KE, 1980, ANN HUM GENET, V43, P227, DOI 10.1111/j.1469-1809.1980.tb01556.x; Dar P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.08.006; Foudila T, 1999, HUM REPROD, V14, P532, DOI 10.1093/humrep/14.2.532; Gekas J, 2001, HUM REPROD, V16, P82, DOI 10.1093/humrep/16.1.82; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; HOEGERMAN SF, 1995, LANCET, V346, P1095; Johnson DS, 2010, HUMAN REPROD; Johnson MD, 1998, FERTIL STERIL, V70, P397, DOI 10.1016/S0015-0282(98)00209-X; KELLY TE, 1986, J MED GENET, V23, P371, DOI 10.1136/jmg.23.4.371-b; KING CR, 1982, J MED GENET, V19, P467, DOI 10.1136/jmg.19.6.467; LINDEN MG, 1995, PEDIATRICS, V96, P672; Maruotti GM, 2013, J MATERN-FETAL NEO M, V26, P68, DOI 10.3109/14767058.2013.829701; Morris JK, 2008, EUR J HUM GENET, V16, P163, DOI 10.1038/sj.ejhg.5201956; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Olson SB, 1988, PREFERENTIAL PATERNA, P583; Pang MG, 2010, FERTIL STERIL, V94, P1012, DOI 10.1016/j.fertnstert.2009.04.043; Pergament E, 2014, OBSTET GYNECOL, V124, P210, DOI 10.1097/AOG.0000000000000363; Pfeffer J, 1999, FERTIL STERIL, V72, P472, DOI 10.1016/S0015-0282(99)00279-4; Ravel C, 2006, HUM REPROD, V21, P1484, DOI 10.1093/humrep/del024; Russell LM, 2007, CYTOGENET GENOME RES, V116, P181, DOI 10.1159/000098184; SCHREINEMACHERS DM, 1982, HUM GENET, V61, P318; Sloter E, 2004, FERTIL STERIL, V81, P925, DOI 10.1016/j.fertnstert.2003.07.043; Stochholm K, 2006, J CLIN ENDOCR METAB, V91, P3897, DOI 10.1210/jc.2006-0558; Sybert VP, 2004, NEW ENGL J MED, V351, P1227, DOI 10.1056/NEJMra030360; Tartaglia NR, 2012, J DEV BEHAV PEDIATR, V33, P309, DOI 10.1097/DBP.0b013e31824501c8; Tartaglia NR, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-8; Templado C, 2005, CYTOGENET GENOME RES, V111, P199, DOI 10.1159/000086890; Vegetti W, 2000, HUM REPROD, V15, P351, DOI 10.1093/humrep/15.2.351; VILLANUEVA AL, 1983, OBSTET GYNECOL, V62, pS70; Wosnitzer MS, 2013, AM J MED GENET C, V163C, P16, DOI 10.1002/ajmg.c.31350; Yoshida A, 1997, UROL INT, V58, P166, DOI 10.1159/000282975; You YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114600	38	20	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161045	10.1371/journal.pone.0161045	http://dx.doi.org/10.1371/journal.pone.0161045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512996	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100116
J	Xie, GY; Olson, DH; Blaustein, AR				Xie, Gisselle Yang; Olson, Deanna H.; Blaustein, Andrew R.			Projecting the Global Distribution of the Emerging Amphibian Fungal Pathogen, Batrachochytrium dendrobatidis, Based on IPCC Climate Futures	PLOS ONE			English	Article							CHYTRID FUNGUS; POPULATION DECLINES; RANAVIRUS INFECTION; DISEASE; CHYTRIDIOMYCOSIS; TEMPERATURE; ECOLOGY; TERRESTRIAL; RANGE; LIFE	Projected changes in climate conditions are emerging as significant risk factors to numerous species, affecting habitat conditions and community interactions. Projections suggest species range shifts in response to climate change modifying environmental suitability and is supported by observational evidence. Both pathogens and their hosts can shift ranges with climate change. We consider how climate change may influence the distribution of the emerging infectious amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), a pathogen associated with worldwide amphibian population losses. Using an expanded global Bd database and a novel modeling approach, we examined a broad set of climate metrics to model the Bd-climate niche globally and regionally, then project how climate change may influence Bd distributions. Previous research showed that Bd distribution is dependent on climatic variables, in particular temperature. We trained a machine-learning model (random forest) with the most comprehensive global compilation of Bd sampling records (similar to 5,000 site-level records, mid-2014 summary), including 13 climatic variables. We projected future Bd environmental suitability under IPCC scenarios. The learning model was trained with combined worldwide data (non-region specific) and also separately per region (region-specific). One goal of our study was to estimate of how Bd spatial risks may change under climate change based on the best available data. Our models supported differences in Bd-climate relationships among geographic regions. We projected that Bd ranges will shift into higher latitudes and altitudes due to increased environmental suitability in those regions under predicted climate change. Specifically, our model showed a broad expansion of areas environmentally suitable for establishment of Bd on amphibian hosts in the temperate zones of the Northern Hemisphere. Our projections are useful for the development of monitoring designs in these areas, especially for sensitive species and those vulnerable to multiple threats.	[Xie, Gisselle Yang; Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Olson, Deanna H.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA	Oregon State University; United States Department of Agriculture (USDA); United States Forest Service	Olson, DH (corresponding author), US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA.	dedeolson@fs.fed.us			Oregon State University; U.S. Forest Service, Pacific Northwest Research Station	Oregon State University; U.S. Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service)	This work was supported by Oregon State University, to GYX and ARB and the U.S. Forest Service, Pacific Northwest Research Station to DHO and GYX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Beniston M., 1996, CLIMATE CHANGE 1995, P191; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2007, BIOSCIENCE, V57, P437, DOI 10.1641/B570517; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Blaustein Andrew R., 2010, Diversity, V2, P281; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Bradley PW, 2015, CONSERV BIOL, V29, P1347, DOI 10.1111/cobi.12566; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Chestnut T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106790; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Conradie W, 2011, AFR ZOOL, V46, P95, DOI 10.3377/004.046.0122; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daszak P, 2004, HERPETOL J, V14, P201; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Gao XJ, 2008, GLOBAL PLANET CHANGE, V62, P195, DOI 10.1016/j.gloplacha.2008.02.002; GASCON C, 2007, AMPHIBIAN CONSERVATI; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Iverson LR, 2008, FOREST ECOL MANAG, V254, P390, DOI 10.1016/j.foreco.2007.07.023; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Kampichler C, 2010, ECOL INFORM, V5, P441, DOI 10.1016/j.ecoinf.2010.06.003; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Li XH, 2013, INTEGR ZOOL, V8, P124, DOI 10.1111/1749-4877.12000; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Ljungqvist FC, 2016, NATURE, V532, P94, DOI 10.1038/nature17418; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Marshall J., 2007, ATMOSPHERE OCEAN CLI; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel An, 2013, Proc Natl Acad Sci U S A, V110, P15325, DOI 10.1073/pnas.1307356110; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mitchell TD, 2003, CLIMATIC CHANGE, V60, P217, DOI 10.1023/A:1026035305597; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moss Richard, 2008, NEW SCENARIOS ANAL E; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; OLSON D. H., 2014, FROGLOG, V22, P17, DOI DOI 10.1371/JOURNAL; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Ostfeld RS, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0051; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Refsnider JM, 2015, G3-GENES GENOM GENET, V5, P2291, DOI 10.1534/g3.115.021808; Roedder Dennis, 2009, Diversity, V1, P52; Rodder D, 2010, DIS AQUAT ORGAN, V92, P201, DOI 10.3354/dao02197; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot022; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rojas S, 2005, DIS AQUAT ORGAN, V63, P95, DOI 10.3354/dao063095; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; United States Geological Survey, 2008, GLOB DIG EL MOD GTOP; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Xia JY, 2014, NAT GEOSCI, V7, P173, DOI [10.1038/NGEO2093, 10.1038/ngeo2093]	86	31	33	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160746	10.1371/journal.pone.0160746	http://dx.doi.org/10.1371/journal.pone.0160746			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513565	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100065
J	Domina, M; Cariccio, VL; Benfatto, S; Venza, M; Venza, I; Donnarumma, D; Bartolini, E; Borgogni, E; Bruttini, M; Santini, L; Midiri, A; Galbo, R; Romeo, L; Patane, F; Biondo, C; Norais, N; Masignani, V; Teti, G; Felici, F; Beninati, C				Domina, Maria; Cariccio, Veronica Lanza; Benfatto, Salvatore; Venza, Mario; Venza, Isabella; Donnarumma, Danilo; Bartolini, Erika; Borgogni, Erica; Bruttini, Marco; Santini, Laura; Midiri, Angelina; Galbo, Roberta; Romeo, Letizia; Patane, Francesco; Biondo, Carmelo; Norais, Nathalie; Masignani, Vega; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Epitope Mapping of a Monoclonal Antibody Directed against Neisserial Heparin Binding Antigen Using Next Generation Sequencing of Antigen-Specific Libraries	PLOS ONE			English	Article							SEROGROUP-B VACCINE; PROTEIN; MENINGITIDIS; REVEALS; SERA	We explore here the potential of a newly described technology, which is named PROFILER and is based on next generation sequencing of gene-specific lambda phage-displayed libraries, to rapidly and accurately map monoclonal antibody (mAb) epitopes. For this purpose, we used a novel mAb (designated 31E10/E7) directed against Neisserial Heparin-Binding Antigen (NHBA), a component of the anti-group B meningococcus Bexsero1 vaccine. An NHBA phage-displayed library was affinity-selected with mAb 31E10/E7, followed by massive sequencing of the inserts present in antibody-selected phage pools. Insert analysis identified an amino acid stretch (D91-A128) in the N-terminal domain, which was shared by all of the mAb-enriched fragments. Moreover, a recombinant fragment encompassing this sequence could recapitulate the immunoreactivity of the entire NHBA molecule against mAb 31E10/E7. These results were confirmed using a panel of overlapping recombinant fragments derived from the NHBA vaccine variant and a set of chemically synthetized peptides covering the 10 most frequent antigenic variants. Furthermore, hydrogen-deuterium exchange mass-spectrometry analysis of the NHBA-mAb 31E10/E7 complex was also compatible with mapping of the epitope to the D91-A128 region. Collectively, these results indicate that the PROFILER technology can reliably identify epitope-containing antigenic fragments and requires considerably less work, time and reagents than other epitope mapping methods.	[Domina, Maria; Cariccio, Veronica Lanza; Beninati, Concetta] Scylla Biotech Srl, Messina, Italy; [Benfatto, Salvatore; Midiri, Angelina; Romeo, Letizia; Biondo, Carmelo; Beninati, Concetta] Univ Messina, Dept Human Pathol, Messina, Italy; [Venza, Mario; Venza, Isabella; Patane, Francesco; Teti, Giuseppe] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Donnarumma, Danilo; Bartolini, Erika; Borgogni, Erica; Bruttini, Marco; Santini, Laura; Norais, Nathalie; Masignani, Vega] GSK Vaccines, Siena, Italy; [Bruttini, Marco] Univ Siena, Dept Life Sci, Siena, Italy; [Galbo, Roberta] Univ Messina, Dept Chem Biol & Pharmaceut Sci, Messina, Italy; [Teti, Giuseppe] Charybdis Vaccines Srl, Messina, Italy; [Felici, Franco] Univ Molise, Dept Biosci & Terr, Pesche, Isernia, Italy	University of Messina; University of Messina; GlaxoSmithKline; University of Siena; University of Messina; University of Molise	Teti, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.; Teti, G (corresponding author), Charybdis Vaccines Srl, Messina, Italy.	gteti@unime.it	Romeo, Letizia/Z-2735-2019; Bruttini, Marco/AHA-2769-2022; Patane, Francesco/AAW-9473-2021; Domina, Maria/K-7883-2016; Donnarumma, Danilo/AAH-1744-2021; Felici, Franco/H-5693-2012; Galbo, Roberta/AAI-1067-2021; GALBO, Roberta/AAR-8424-2021; Biondo, Carmelo/AAA-3391-2019; Romeo, Letizia/Z-4819-2019	Romeo, Letizia/0000-0002-7460-8815; Bruttini, Marco/0000-0003-1063-2522; Donnarumma, Danilo/0000-0001-9471-0254; Felici, Franco/0000-0003-2205-5195; GALBO, Roberta/0000-0002-2880-3871; Domina, Maria/0000-0002-0445-8356; BENINATI, Concetta/0000-0001-8305-1337; Midiri, Angelina/0000-0002-4128-9678; Benfatto, Salvatore/0000-0003-4439-3136	Scylla Biotech Srl; GSK Vaccines; Ministero dell'Universita e della Ricerca Scientifica of Italy [593]	Scylla Biotech Srl; GSK Vaccines; Ministero dell'Universita e della Ricerca Scientifica of Italy(Ministry of Education, Universities and Research (MIUR))	Scylla Biotech Srl and Charybdis Vaccines Srl, two spin-off companies of the University of Messina, provided support in the form laboratory reagents and consumables. Support in the form of salaries for authors was provided by Scylla Biotech Srl (MD and VLC) and GSK Vaccines (DD, EBa, EBo, MB, LS, VM). The specific roles of these authors are articulated in the 'author contributions' section. Work described here was supported by funds granted to Scylla Biotech Srl by the Ministero dell'Universita e della Ricerca Scientifica of Italy (Project n. 4/13 ex art. 11 D.M. n. 593). Funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work described here was supported in part by funds granted to Scylla Biotech Srl by the Ministero dell'Universita e della Ricerca Scientifica of Italy (Project n. 4/13 ex art. 11 D.M. n. 593). We thank Massimiliano Biagini for help in designing the peptide microarray slides.	Abad R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150721; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Birkenmeier G, 1997, FEBS LETT, V416, P193, DOI 10.1016/S0014-5793(97)01201-5; Bottger V, 2009, METHODS MOL BIOL, V524, P181, DOI 10.1007/978-1-59745-450-6_13; Bombaci M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006332; Domina M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114159; FELICI F, 1991, J MOL BIOL, V222, P301, DOI 10.1016/0022-2836(91)90213-P; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; Alonso MG, 2015, CLIN EXP ALLERGY, V45, P994, DOI 10.1111/cea.12474; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Granoff DM, 2013, PEDIATR INFECT DIS J, V32, P372, DOI 10.1097/INF.0b013e318282942f; Hager-Braun C, 2005, EXPERT REV PROTEOMIC, V2, P745, DOI 10.1586/14789450.2.5.745; Heinrich L, 2010, J IMMUNOL METHODS, V352, P13, DOI 10.1016/j.jim.2009.10.002; Hudson EP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00706; Lee HJ, 2016, VACCINE, V34, P1180, DOI 10.1016/j.vaccine.2016.01.033; Malito E, 2014, P NATL ACAD SCI USA, V111, P17128, DOI 10.1073/pnas.1419686111; Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110; Minenkova O, 2003, INT J CANCER, V106, P534, DOI 10.1002/ijc.11269; Panatto D, 2013, INDIAN J MED RES, V138, P835; Papasergi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075266; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Segal S, 2005, BRIT MED BULL, V72, P65, DOI 10.1093/bmb/ldh041; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Tsang RSW, 2015, CAN J INFECT DIS MED, V26, P299, DOI 10.1155/2015/393659; Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054; Wasko I, 2016, VACCINE, V34, P510, DOI 10.1016/j.vaccine.2015.11.070; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004	29	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160702	10.1371/journal.pone.0160702	http://dx.doi.org/10.1371/journal.pone.0160702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508302	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400046
J	Lin, JN; Lin, CL; Yang, CH; Lin, MC; Lai, CH; Lin, HH; Kao, CH				Lin, Jiun-Nong; Lin, Cheng-Li; Yang, Chi-Hui; Lin, Ming-Chia; Lai, Chung-Hsu; Lin, Hsi-Hsun; Kao, Chia-Hung			Risk of Nephrotic Syndrome following Enteroviral Infection in Children: A Nationwide Retrospective Cohort Study	PLOS ONE			English	Article							COXSACKIE-B VIRUSES; CELLULAR RECEPTORS; CLINICAL-FEATURES; DISEASE; COMMON; ADENOVIRUSES; VALIDATION; CHILDHOOD; PROTEIN; KIDNEY	Purpose Nephrotic syndrome is a common chronic illness encountered during childhood. Infections have been identified as a cause of nephrotic syndrome. The aim of this study was to evaluate the association between enteroviral infection and nephrotic syndrome. Methods A nationwide retrospective cohort study was conducted by analyzing data from the National Health Insurance Research Database in Taiwan. Children aged <18 years with enteroviral infection were enrolled. Non-enterovirus-infected children were randomly selected as the comparison cohort. The primary endpoint was the occurrence of nephrotic syndrome. Methods This study included 280,087 enterovirus-infected children and 280,085 non-enterovirus-infected children. The mean age of the enterovirus-infected children was 2.38 years, and 53.7% of these children were boys. The overall incidence densities of nephrotic syndrome for enterovirus-and non-enterovirus-infected children were 2.65 and 2.21 per 10,000 person-years, respectively. The enterovirus-infected cohort had a higher cumulative incidence of nephrotic syndrome than did the non-enterovirus-infected cohort (log-rank test, p = 0.01). Multivariable analyses revealed that children with enteroviral infection were significantly associated with an increased risk of nephrotic syndrome compared with those without enteroviral infection (adjusted hazard ratio, 1.20; 95% confidence interval, 1.04-1.39; p = 0.01), particularly in children infected with coxsackievirus. Subgroup analyses revealed that enterovirus-infected girls, children of blue-collar workers, and children without allergies had a higher risk of nephrotic syndrome than did children in the non-enterovirus-infected cohort. Conclusion This study revealed a significant association between enteroviral infection and nephrotic syndrome. Additional studies elucidating the role and pathogenesis of enterovirus in nephrotic syndrome are warranted.	[Lin, Jiun-Nong] I Shou Univ, E Da Hosp, Dept Crit Care Med, Kaohsiung, Taiwan; [Lin, Jiun-Nong] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Lin, Jiun-Nong; Lai, Chung-Hsu; Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Off Hlth Data, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Med, Taichung, Taiwan; [Yang, Chi-Hui] Meiho Univ, Gen Educ Ctr, Pingtung, Taiwan; [Lin, Ming-Chia] I Shou Univ, E Da Hosp, Dept Nucl Med, Kaohsiung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	E-Da Hospital; I Shou University; I Shou University; E-Da Hospital; I Shou University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; E-Da Hospital; I Shou University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abzug MJ, 2014, J INFECTION, V68, pS108, DOI 10.1016/j.jinf.2013.09.020; Andolino TP, 2015, PEDIATR REV, V36, P117, DOI 10.1542/pir.36-3-117; ARONSON MD, 1975, J INFECT DIS, V132, P303, DOI 10.1093/infdis/132.3.303; BAYATPOUR M, 1973, CAN MED ASSOC J, V109, P873; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bian X, 2016, DIABETES, V65, P285, DOI 10.2337/db15-0179; BURCH G, 1974, J UROLOGY, V112, P714, DOI 10.1016/S0022-5347(17)59835-3; BURCH GE, 1969, ANN INTERN MED, V71, P963, DOI 10.7326/0003-4819-71-5-963; Chang JW, 2012, J EPIDEMIOL, V22, P517, DOI 10.2188/jea.JE20120033; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheung W, 2004, PEDIATR NEPHROL, V19, P627, DOI 10.1007/s00467-004-1438-8; Conaldi PG, 1997, J VIROL, V71, P9180, DOI 10.1128/JVI.71.12.9180-9187.1997; Eddy AA, 2003, LANCET, V362, P629, DOI 10.1016/S0140-6736(03)14184-0; el Bakkali L, 2011, PEDIATR NEPHROL, V26, P1241, DOI 10.1007/s00467-011-1851-8; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Jacques J, 2008, J CLIN MICROBIOL, V46, P206, DOI 10.1128/JCM.01414-07; Korhonen L, 2013, CLIN EXP ALLERGY, V43, P625, DOI 10.1111/cea.12068; Lee TC, 2009, PEDIATR INFECT DIS J, V28, P904, DOI 10.1097/INF.0b013e3181a41d63; LIN CY, 1990, CHEST, V97, P1408, DOI 10.1378/chest.97.6.1408; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; MEADOW SR, 1981, ARCH DIS CHILD, V56, P517, DOI 10.1136/adc.56.7.517; Metz DK, 2014, J PAEDIAT CHILD HLTH; Midgley CM, 2015, LANCET RESP MED, V3, P879, DOI 10.1016/S2213-2600(15)00335-5; Nagai M, 2003, LAB INVEST, V83, P901, DOI 10.1097/01.LAB.0000073307.82991.CC; Nishimura Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00105; Pasch A, 2006, NEPHROL DIAL TRANSPL, V21, P1184, DOI 10.1093/ndt/gfl016; Puenpa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098888; Rhoades RE, 2011, VIROLOGY, V411, P288, DOI 10.1016/j.virol.2010.12.014; SHARPLES PM, 1985, ARCH DIS CHILD, V60, P1014, DOI 10.1136/adc.60.11.1014; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; SUN SC, 1971, J PATHOL, V104, P53, DOI 10.1002/path.1711040107; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Wei CC, 2015, J EPIDEMIOL, V25, P370, DOI 10.2188/jea.JE20140167; Wei CC, 2014, PEDIATR NEPHROL, V29, P2157, DOI 10.1007/s00467-014-2835-2; Witso E, 2006, J CLIN MICROBIOL, V44, P4095, DOI 10.1128/JCM.00653-06; Wong W, 2007, J PAEDIATR CHILD H, V43, P337, DOI 10.1111/j.1440-1754.2007.01077.x; Yu YB, 2012, THROMB HAEMOSTASIS, V108, P225, DOI 10.1160/TH12-01-0010; Zhao YL, 2016, ARCH VIROL, V161, P1705, DOI 10.1007/s00705-016-2792-0; Zhou HT, 2014, INT J INFECT DIS, V28, P1, DOI 10.1016/j.ijid.2014.04.031	40	6	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0161004	10.1371/journal.pone.0161004	http://dx.doi.org/10.1371/journal.pone.0161004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508414	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400075
J	Liu, J; Fu, RQ; Liu, RR; Zhao, GP; Zheng, MQ; Cui, HX; Li, QH; Song, J; Wang, J; Wen, J				Liu, Jie; Fu, Ruiqi; Liu, Ranran; Zhao, Guiping; Zheng, Maiqing; Cui, Huanxian; Li, Qinghe; Song, Jiao; Wang, Jie; Wen, Jie			Protein Profiles for Muscle Development and Intramuscular Fat Accumulation at Different Post-Hatching Ages in Chickens	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; HIGH-DENSITY-LIPOPROTEIN; SKELETAL-MUSCLE; PROTEOMIC ANALYSIS; CELL-ADHESION; MEAT QUALITY; STEM-CELLS; IGF-I; GROWTH; PREADIPOCYTES	Muscle development and growth influences the efficiency of poultry meat production, and is closely related to deposition of intramuscular fat (IMF), which is crucial in meat quality. To clarify the molecular mechanisms underlying muscle development and IMF deposition in chickens, protein expression profiles were examined in the breast muscle of Beijing-You chickens at ages 1, 56, 98 and 140 days, using isobaric tags for relative and absolute quantification (iTRAQ). Two hundred and four of 494 proteins were expressed differentially. The expression profile at day 1 differed greatly from those at day 56, 98 and 140. KEGG pathway analysis of differential protein expression from pair-wise comparisons (day 1 vs. 56; 56 vs. 98; 98 vs. 140), showed that the fatty acid degradation pathway was more active during the stage from day 1 to 56 than at other periods. This was consistent with the change in IMF content, which was highest at day 1 and declined dramatically thereafter. When muscle growth was most rapid (days 56-98), pathways involved in muscle development were dominant, including hypertrophic cardiomyopathy, dilated cardiomyopathy, cardiac muscle contraction, tight junctions and focal adhesion. In contrast with hatchlings, the fatty acid degradation pathway was downregulated from day 98 to 140, which was consistent with the period for IMF deposition following rapid muscle growth. Changes in some key specific proteins, including fast skeletal muscle troponin T isoform, aldehyde dehydrogenase 1A1 and apolipoprotein A1, were verified by Western blotting, and could be potential biomarkers for IMF deposition in chickens. Protein-protein interaction networks showed that ribosomerelated functional modules were clustered in all three stages. However, the functional module involved in the metabolic pathway was only clustered in the first stage (day 1 vs. 56). This study improves our understanding of the molecular mechanisms underlying muscle development and IMF deposition in chickens.	[Liu, Jie; Fu, Ruiqi; Liu, Ranran; Zhao, Guiping; Zheng, Maiqing; Cui, Huanxian; Li, Qinghe; Song, Jiao; Wang, Jie; Wen, Jie] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wen, J (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	wenjie@caas.cn		Zhao, Guiping/0000-0002-1510-6903; Wen, Jie/0000-0001-7460-4219	National Natural Science Foundation of China [31201797]; Agricultural Science and Technology Innovation Program [ASTIP-IAS04]; earmarked fund for modern agro-industry technology research system [CARS-42]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Innovation Program; earmarked fund for modern agro-industry technology research system	The research was supported by grants: the National Natural Science Foundation of China (31201797); the Agricultural Science and Technology Innovation Program (ASTIP-IAS04); the earmarked fund for modern agro-industry technology research system (CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang M-L, 2015, CIRCULATION J; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; BARDSLEY RG, 1992, BIOCHIMIE, V74, P267, DOI 10.1016/0300-9084(92)90125-X; Bjarnadottir SG, 2011, MEAT SCI, V89, P143, DOI 10.1016/j.meatsci.2011.04.002; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Cairns RFJ, 2014, ROLE ANNEXIN A6 HEPA; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chartrin P, 2007, ANIMAL, V1, P113, DOI 10.1017/S1751731107658029; Cleveland-Donovan K, 2010, ENDOCRINOLOGY, V151, P3752, DOI 10.1210/en.2010-0043; Cui HX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-213; Daszkiewicz T., 2005, POLISH J FOOD NUTR S, V14, P1; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; de Klerk E, 2015, NUCLEIC ACIDS RES; Deutsch DR, 2014, J PROTEOME RES, V13, P4363, DOI 10.1021/pr500550t; DING SH, 1994, BIOCHEM MOL BIOL INT, V32, P131; Doherty MK, 2004, PROTEOMICS, V4, P2082, DOI 10.1002/pmic.200300716; FORSBERG NE, 1989, J ANIM SCI, V67, P3313; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Furuya TK, 2013, GENET MOL RES, V12, P3495, DOI 10.4238/2013.February.28.7; Gilmore WS, 2004, BIOCHEM SOC T, V32, P1122, DOI 10.1042/BST0321122; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Goll DE, 1998, CAN J ANIM SCI, V78, P503, DOI 10.4141/A98-081; Grieve A. G., 2012, INT J CELL BIOL, DOI 10.1155/2012/852430; Harada A, 2014, NUCLEIC ACIDS RES; Holleboom AG, 2013, J LIPID RES, V54, P1964, DOI 10.1194/jlr.P028449; JIN JP, 2000, BASIC APPL MYOL, V10, P17; Juan AH, 2011, GENE DEV, V25, P789, DOI 10.1101/gad.2027911; Kalista S, 2012, ENDOCRINOLOGY, V153, P241, DOI 10.1210/en.2011-1687; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kim NK, 2011, J AGR FOOD CHEM, V59, P5657, DOI 10.1021/jf200217j; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lee DBN, 2004, AM J PHYSIOL-RENAL, V287, pF481, DOI 10.1152/ajprenal.00175.2003; Lee DM, 2012, GENES GENOM, V34, P125, DOI 10.1007/s13258-011-0075-4; Lefaucheur L, 2010, MEAT SCI, V84, P257, DOI 10.1016/j.meatsci.2009.05.004; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Liao BH, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0328-7; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Lo ASY, 2005, J CELL BIOCHEM, V94, P763, DOI 10.1002/jcb.20343; Lonergan SM, 2003, POULTRY SCI, V82, P1990, DOI 10.1093/ps/82.12.1990; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Maruyama K, 1997, FASEB J, V11, P341, DOI 10.1096/fasebj.11.5.9141500; Meroufel DN, 2015, INT J CLIN EXP PATHO, V8, P7358; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Patani N, 2011, ANTICANCER RES, V31, P4115; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje; Rajesh RV, 2010, COMP BIOCHEM PHYS D, V5, P234, DOI 10.1016/j.cbd.2010.06.004; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rong QWXXM, 2013, J ANIMAL PLANT SCI, V20, P3122; Saneyasu T, 2016, J POULTRY SCI; Seenundun S, 2010, EMBO J, V29, P1401, DOI 10.1038/emboj.2010.37; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Soler L, 2014, CURR PROTEIN PEPT SC, V15, P89, DOI 10.2174/1389203715666140221112956; Steelman CA, 2006, FASEB J, V20, P580, DOI 10.1096/fj.05-5125fje; Talmud PJ, 2002, HUMAN MOL; TARUGI P, 1989, J LIPID RES, V30, P9; Teltathum T, 2009, INT J BIOL SCI, V5, P679; Velez EJ, 2014, GEN COMP ENDOCR, V205, P296, DOI 10.1016/j.ygcen.2014.05.024; VIEIRA PM, 1995, J LIPID RES, V36, P601; Wang X, 2012, EFFECT INSULIN TNFA; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; Wei B, 2011, ARCH BIOCHEM BIOPHYS, V505, P144, DOI 10.1016/j.abb.2010.10.013; Wei H, 2016, NEUROSCIENCE, V312, P26, DOI 10.1016/j.neuroscience.2015.11.003; Woodhouse S, 2013, J CELL SCI, V126, P565, DOI 10.1242/jcs.114843; Xu YJ, 2012, J PROTEOMICS, V75, P2093, DOI 10.1016/j.jprot.2012.01.013; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zerehdaran S, 2004, POULTRY SCI, V83, P521, DOI 10.1093/ps/83.4.521; Zhang JZ, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0067-4; Zhang Q, 2014, BIOTECHNOL LETT, V36, P1225, DOI 10.1007/s10529-014-1489-2; Zhang Q, 2010, MEAT SCI, V86, P814, DOI 10.1016/j.meatsci.2010.07.002; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	75	21	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0159722	10.1371/journal.pone.0159722	http://dx.doi.org/10.1371/journal.pone.0159722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508388	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400011
J	Choi, JS; Kim, RO; Yoon, S; Kim, WK				Choi, Jin Soo; Kim, Ryeo-Ok; Yoon, Seokjoo; Kim, Woo-Keun			Developmental Toxicity of Zinc Oxide Nanoparticles to Zebrafish (Danio rerio): A Transcriptomic Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; ZNO NANOPARTICLES; BREAST-CANCER; LARVAL ZEBRAFISH; EXPOSURE; SIZE; IDENTIFICATION; EMBRYO; WATER; BAFF	Zinc oxide nanoparticles (ZnO NPs) are being utilized in an increasing number of fields and commercial applications. While their general toxicity and associated oxidative stress have been extensively studied, the toxicological pathways that they induce in developmental stages are still largely unknown. In this study, the developmental toxicity of ZnO NPs to embryonic/larval zebrafish was investigated. The transcriptional expression profiles induced by ZnO NPs were also investigated to ascertain novel genomic responses related to their specific toxicity pathway. Zebrafish embryos were exposed to 0.01, 0.1, 1, and 10 mg/L ZnO NPs for 96 h post-fertilization. The toxicity of ZnO NPs, based on their Zn concentration, was quite similar to that in embryonic/larval zebrafish exposed to corresponding ZnSO4 concentrations. Pericardial edema and yolk-sac edema were the principal malformations induced by ZnO NPs. Gene-expression profiling using microarrays demonstrated 689 genes that were differentially regulated (fold change > 1.5) following exposure to ZnO NPs (498 upregulated, 191 downregulated). Several genes that were differentially regulated following ZnO NP exposure shared similar biological pathways with those observed with ZnSO4 exposure, but six genes (aicda, cyb5d1, edar, intl2, ogfrl2 and tnfsf13b) associated with inflammation and the immune system responded specifically to ZnO NPs (either in the opposite direction or were unchanged in ZnSO4 exposure). Real-time reverse-transcription quantitative polymerase chain reaction confirmed that the responses of these genes to ZnO NPs were significantly different from their response to ZnSO4 exposure. ZnO NPs may affect genes related to inflammation and the immune system, resulting in yolk-sac edema and pericardia edema in embryonic/larval developmental stages. These results will assist in elucidating the mechanisms of toxicity of ZnO NPs during development of zebrafish.	[Choi, Jin Soo] Korea Inst Toxicol, Future Environm Res Ctr, Jinju 660844, South Korea; [Kim, Ryeo-Ok; Yoon, Seokjoo; Kim, Woo-Keun] Korea Inst Toxicol, Syst Toxicol Res Ctr, Daejeon 305343, South Korea	Korea Institute of Toxicology; Korea Institute of Toxicology	Kim, WK (corresponding author), Korea Inst Toxicol, Syst Toxicol Res Ctr, Daejeon 305343, South Korea.	wookkim@kitox.re.kr			Korea Institute of Toxicology; Korea Institute of Toxicology (Korea)	Korea Institute of Toxicology; Korea Institute of Toxicology (Korea)	This work was supported by Korea Institute of Toxicology (no grant numbers).; This work was supported by the Korea Institute of Toxicology (Korea).	Abdouni H, 2013, NUCLEIC ACIDS RES, V41, P5457, DOI 10.1093/nar/gkt212; Berry JP, 2007, COMP BIOCHEM PHYS C, V145, P61, DOI 10.1016/j.cbpc.2006.07.011; Brun NR, 2014, SCI TOTAL ENVIRON, V476, P657, DOI 10.1016/j.scitotenv.2014.01.053; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Charchar FJ, 2012, LANCET, V379, P915, DOI 10.1016/S0140-6736(11)61453-0; Chen DS, 2011, AQUAT TOXICOL, V105, P344, DOI 10.1016/j.aquatox.2011.07.005; Chen TH, 2014, J HAZARD MATER, V277, P134, DOI 10.1016/j.jhazmat.2013.12.030; Cheng F, 2009, MOL BIOL CELL, V20, P319, DOI 10.1091/mbc.E08-07-0681; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Donahue RN, 2011, J CANC THER, V2, P579; Duan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074606; Felix LC, 2013, ENVIRON SCI TECHNOL, V47, P6589, DOI 10.1021/es401403p; Griffitt RJ, 2013, AQUAT TOXICOL, V130, P192, DOI 10.1016/j.aquatox.2013.01.010; Hao LH, 2013, ECOTOX ENVIRON SAFE, V91, P52, DOI 10.1016/j.ecoenv.2013.01.007; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Ispas C, 2009, ENVIRON SCI TECHNOL, V43, P6349, DOI 10.1021/es9010543; Lin B, 2009, FISH SHELLFISH IMMUN, V26, P396, DOI 10.1016/j.fsi.2008.11.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Munoz A, 2011, MOL IMMUNOL, V48, P1073, DOI 10.1016/j.molimm.2011.01.015; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Ma HB, 2013, ENVIRON POLLUT, V172, P76, DOI 10.1016/j.envpol.2012.08.011; Mehinto AC, 2014, AQUAT TOXICOL, V152, P186, DOI 10.1016/j.aquatox.2014.04.004; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Mironava T, 2010, NANOTOXICOLOGY, V4, P120, DOI 10.3109/17435390903471463; Murdock RC, 2008, TOXICOL SCI, V101, P239, DOI 10.1093/toxsci/kfm240; OECD, 1995, GUID TEST CHEM, DOI [10.1787/9789264069787-en, DOI 10.1787/9789264203709-EN]; Pan Y, 2011, BEHAV BRAIN RES, V216, P66, DOI 10.1016/j.bbr.2010.07.017; Pandit NP, 2013, DEV COMP IMMUNOL, V39, P460, DOI 10.1016/j.dci.2013.01.004; Park JW, 2012, ENVIRON POLLUT, V167, P163, DOI 10.1016/j.envpol.2012.03.039; Pelekanou V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-76; Poynton HC, 2013, ENVIRON SCI TECHNOL, V47, P9453, DOI 10.1021/es401396t; Takano T, 2008, DEV COMP IMMUNOL, V32, P693, DOI 10.1016/j.dci.2007.10.008; Tuomela S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068415; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang Jiangxin, 2012, Methods Mol Biol, V926, P317, DOI 10.1007/978-1-62703-002-1_20; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warheit DB, 2006, TOXICOL SCI, V91, P227, DOI 10.1093/toxsci/kfj140; Xiong DW, 2011, SCI TOTAL ENVIRON, V409, P1444, DOI 10.1016/j.scitotenv.2011.01.015; Zagon IS, 2013, EXP BIOL MED, V238, P589, DOI 10.1177/1535370213489492; Zhang Y, 2008, WATER RES, V42, P2204, DOI 10.1016/j.watres.2007.11.036; Zhao Q, 2014, AM J CLIN PATHOL, V141, P226, DOI 10.1309/AJCP4JP8BZOMHEAW; Zhao XS, 2013, AQUAT TOXICOL, V136, P49, DOI 10.1016/j.aquatox.2013.03.019; Zhao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140499; Zhou H, 2014, ANAL BIOANAL CHEM, V406, P3689, DOI 10.1007/s00216-014-7773-0; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779; Zhu XS, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195103	46	51	53	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160763	10.1371/journal.pone.0160763	http://dx.doi.org/10.1371/journal.pone.0160763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504894	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200061
J	Nunez, JCB; Oleksiak, MF				Nunez, Joaquin C. B.; Oleksiak, Marjorie F.			A Cost-Effective Approach to Sequence Hundreds of Complete Mitochondrial Genomes	PLOS ONE			English	Article							FUNDULUS-HETEROCLITUS; NATURAL-POPULATIONS; GENETIC DIVERSITY; DNA; GENERATION; MICROARRAY; PURIFICATION; EXPRESSION; MUTATIONS; KILLIFISH	We present a cost-effective approach to sequence whole mitochondrial genomes for hundreds of individuals. Our approach uses small reaction volumes and unmodified (non-phosphorylated) barcoded adaptors to minimize reagent costs. We demonstrate our approach by sequencing 383 Fundulus sp. mitochondrial genomes (192 F. heteroclitus and 191 F. majalis). Prior to sequencing, we amplified the mitochondrial genomes using 4-5 custommade, overlapping primer pairs, and sequencing was performed on an Illumina HiSeq 2500 platform. After removing low quality and short sequences, 2.9 million and 2.8 million reads were generated for F. heteroclitus and F. majalis respectively. Individual genomes were assembled for each species by mapping barcoded reads to a reference genome. For F. majalis, the reference genome was built de novo. On average, individual consensus sequences had high coverage: 61-fold for F. heteroclitus and 57-fold for F. majalis. The approach discussed in this paper is optimized for sequencing mitochondrial genomes on an Illumina platform. However, with the proper modifications, this approach could be easily applied to other small genomes and sequencing platforms.	[Nunez, Joaquin C. B.; Oleksiak, Marjorie F.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Nunez, Joaquin C. B.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	University of Miami; Brown University	Oleksiak, MF (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	moleksiak@rsmas.miami.edu	Nunez, Joaquin C. B./L-5355-2015	Nunez, Joaquin C. B./0000-0002-3171-8918	National Science Foundation (NSF) [MCB-1158241, IOS-1147042]; Rosenstiel School of Marine and Atmospheric Science (RSMAS); NSF [DEB-1120512, DEB-1265282, DEB-1120013, DEB-1120263, DEB-1120333, DEB-1120398]; Direct For Biological Sciences [1158241] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Rosenstiel School of Marine and Atmospheric Science (RSMAS); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Science Foundation (NSF) grants MCB-1158241 and IOS-1147042 to MFO and the Rosenstiel School of Marine and Atmospheric Science (RSMAS) grants SURGE 2014 and SURGE 2015 to JCBN. Data analysis was supported by the NSF (collaborative research grants DEB-1120512, DEB-1265282, DEB-1120013, DEB-1120263, DEB-1120333, DEB-1120398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank D. L. Crawford for valuable comments on this manuscript, and to the Rosenstiel School of Marine and Atmospheric Science (RSMAS) undergraduate program for its support to JCBN through the Small Undergraduate Research Grant Experience (SURGE) grants 2014 and 2015. Data analysis was aided by reference to a draft F. heteroclitus genome, which was supported by funding from NSF (collaborative research grants DEB-1120512, DEB-1265282, DEB-1120013, DEB-1120263, DEB-1120333, DEB-1120398).	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 1983, POLYMORPHISM MICTOCH; Avise John C., 1994, pi; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baris TZ, 2016, AM J PHYSIOL-REG I, V311, pR157, DOI 10.1152/ajpregu.00008.2016; Baris TZ, 2016, AM J PHYSIOL-REG I, V310, pR185, DOI 10.1152/ajpregu.00421.2015; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Borgstrom E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019119; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Burnett KG, 2007, COMP BIOCHEM PHYS D, V2, P257, DOI 10.1016/j.cbd.2007.09.001; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Dayan DI, 2015, MOL ECOL, V24, P3345, DOI 10.1111/mec.13188; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Du X, 2016, AQUAT TOXICOL, V177, P44, DOI 10.1016/j.aquatox.2016.05.007; Du X, 2015, AQUAT TOXICOL, V165, P231, DOI 10.1016/j.aquatox.2015.06.009; DUGGINS CF, 1995, HEREDITY, V74, P117, DOI 10.1038/hdy.1995.18; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fangue NA, 2009, J EXP BIOL, V212, P514, DOI 10.1242/jeb.024034; Flight PA, 2011, MOL ECOL, V20, P4503, DOI 10.1111/j.1365-294X.2011.05290.x; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gemmell NJ, 2001, TRENDS ECOL EVOL, V16, P115, DOI 10.1016/S0169-5347(00)02087-5; Gherman A, 2007, PLOS GENET, V3, P1223, DOI 10.1371/journal.pgen.0030119; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Hancock-Hanser BL, 2013, MOL ECOL RESOUR, V13, P254, DOI 10.1111/1755-0998.12059; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; HAWKINS TL, 1994, NUCLEIC ACIDS RES, V22, P4543, DOI 10.1093/nar/22.21.4543; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Leveque M, 2007, EUR J HUM GENET, V15, P1145, DOI 10.1038/sj.ejhg.5201891; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Moschallski M, 2010, ELECTROPHORESIS, V31, P2655, DOI 10.1002/elps.201000097; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Narum SR, 2013, MOL ECOL, V22, P2841, DOI 10.1111/mec.12350; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Oleksiak MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-263; Picard M, 2011, J PHYSIOL-LONDON, V589, P4413, DOI 10.1113/jphysiol.2011.212712; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Skinner MA, 2005, WATER QUAL RES J CAN, V40, P288, DOI 10.2166/wqrj.2005.034; Smith AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq368; Smith MW, 1998, MOL MAR BIOL BIOTECH, V7, P79; Sosa MX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002737; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STONEKING M, 1994, J BIOENERG BIOMEMBR, V26, P251, DOI 10.1007/BF00763097; Tan G, 2015, SYST BIOL, V64, P778, DOI 10.1093/sysbio/syv033; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tilak MK, 2015, CONSERV GENET RESOUR, V7, P37, DOI 10.1007/s12686-014-0338-x; Wakeley J, 1997, GENETICS, V145, P847; Wang BA, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-180, 10.1186/1471-2164-15-467]; Whitehead A, 2010, EVOLUTION, V64, P2070, DOI 10.1111/j.1558-5646.2010.00957.x; Whitehead A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-11; Williams LM, 2011, MOL BIOL EVOL, V28, P1817, DOI 10.1093/molbev/msr004; Williams LM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-282	71	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160958	10.1371/journal.pone.0160958	http://dx.doi.org/10.1371/journal.pone.0160958			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505419	gold, Green Submitted, Green Published			2022-12-26	WOS:000381374200085
J	Chen, LF; Gong, YH; Cai, YL; Liu, W; Zhou, Y; Xiao, Y; Xu, ZY; Liu, Y; Lei, XY; Wang, GZ; Guo, MP; Ma, XL; Bian, YB				Chen, Lianfu; Gong, Yuhua; Cai, Yingli; Liu, Wei; Zhou, Yan; Xiao, Yang; Xu, Zhangyi; Liu, Yin; Lei, Xiaoyu; Wang, Gangzheng; Guo, Mengpei; Ma, Xiaolong; Bian, Yinbing			Genome Sequence of the Edible Cultivated Mushroom Lentinula edodes (Shiitake) Reveals Insights into Lignocellulose Degradation	PLOS ONE			English	Article							GENE PREDICTION; COG DATABASE; ANNOTATION; EVOLUTION; MECHANISMS; ALIGNMENT; IDENTIFICATION; EUKARYOTES; EXPRESSION; ALGORITHM	Lentinula edodes, one of the most popular, edible mushroom species with a high content of proteins and polysaccharides as well as unique aroma, is widely cultivated in many Asian countries, especially in China, Japan and Korea. As a white rot fungus with lignocellulose degradation ability, L. edodes has the potential for application in the utilization of agriculture straw resources. Here, we report its 41.8-Mb genome, encoding 14,889 predicted genes. Through a phylogenetic analysis with model species of fungi, the evolutionary divergence time of L. edodes and Gymnopus luxurians was estimated to be 39 MYA. The carbohydrate-active enzyme genes in L. edodes were compared with those of the other 25 fungal species, and 101 lignocellulolytic enzymes were identified in L. edodes, similar to other white rot fungi. Transcriptome analysis showed that the expression of genes encoding two cellulases and 16 transcription factor was up-regulated when mycelia were cultivated for 120 minutes in cellulose medium versus glucose medium. Our results will foster a better understanding of the molecular mechanism of lignocellulose degradation and provide the basis for partial replacement of wood sawdust with agricultural wastes in L. edodes cultivation.	[Chen, Lianfu; Gong, Yuhua; Cai, Yingli; Liu, Wei; Zhou, Yan; Xiao, Yang; Xu, Zhangyi; Wang, Gangzheng; Guo, Mengpei; Ma, Xiaolong; Bian, Yinbing] Huazhong Agr Univ, Plant Sci & Technol Coll, Inst Appl Mycol, Wuhan, Hubei, Peoples R China; [Chen, Lianfu; Gong, Yuhua; Cai, Yingli; Liu, Wei; Zhou, Yan; Xiao, Yang; Xu, Zhangyi; Wang, Gangzheng; Guo, Mengpei; Ma, Xiaolong; Bian, Yinbing] Huazhong Agr Univ, Minist Agr, Key Lab Agromicrobial Resource Comprehens Utiliza, Wuhan, Hubei, Peoples R China; [Liu, Yin; Lei, Xiaoyu] Huazhong Agr Univ, Food Sci & Technol Coll, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Bian, YB (corresponding author), Huazhong Agr Univ, Plant Sci & Technol Coll, Inst Appl Mycol, Wuhan, Hubei, Peoples R China.; Bian, YB (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Agromicrobial Resource Comprehens Utiliza, Wuhan, Hubei, Peoples R China.	bianyb.123@163.com	Liu, Wei/AAK-4323-2020; Gong, Yuhua/AAR-1896-2020	Wang, Gangzheng/0000-0001-8143-4983; Liu, Wei/0000-0001-7586-7117	National Key Technology Support Program in the 12th Five-Year Plan of China [2013BAD16B02]; National Science Foundation of China [31372117]; Science and Technology Plan of Hubei Province [2012DBA19001]	National Key Technology Support Program in the 12th Five-Year Plan of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Hubei Province	This work was financially supported by the National Key Technology Support Program in the 12th Five-Year Plan of China (Grant No. 2013BAD16B02), the National Science Foundation of China (Grant No. 31372117), and the Science and Technology Plan of Hubei Province (Grant No. 2012DBA19001).	Alananbeh KM, 2014, SAUDI J BIOL SCI, V21, P616, DOI 10.1016/j.sjbs.2014.08.001; Au CH, 2013, GENE, V1643; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bao DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058294; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castellano I., 2013, GAMMA GLUTAMYL TRANS; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chandra LC, 2011, FOOD CHEM TOXICOL, V49, P3074, DOI 10.1016/j.fct.2011.09.001; Chang S-T, 1999, INT J MED MUSHROOMS, V1; Chang ST, 1996, WORLD J MICROB BIOT, V12, P473, DOI 10.1007/BF00419460; Chang ST., 1987, MUSHROOM J TROP, V7, P31; Chen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058780; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Dayarian A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-345; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Gaitan-Hernandez R, 2004, ENG LIFE SCI, V4, P363, DOI 10.1002/elsc.200420042; Gaitan-Hernandez R, 2006, APPL MICROBIOL BIOT, V71, P432, DOI 10.1007/s00253-005-0241-1; Gaitan-Hernandez R, 2014, BRAZ J MICROBIOL, V45, P467, DOI 10.1590/S1517-83822014000200013; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Gong WB, 2014, FUNGAL BIOL-UK, V118, P295, DOI 10.1016/j.funbio.2014.01.001; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas Brian J, 2011, Mycology, V2, P118; Han MV, 2013, MOL BIOL EVOL, V30, P1987, DOI 10.1093/molbev/mst100; Hiraide M, 2004, J WOOD SCI, V50, P358, DOI 10.1007/s10086-003-0568-0; Humle T, 2001, MUSHROOM NEWS KENNET, V49, P14; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Korripally P, 2015, APPL ENVIRON MICROB, V81, P7802, DOI 10.1128/AEM.02064-15; Kues U, 2015, CURR OPIN BIOTECH, V33, P268, DOI 10.1016/j.copbio.2015.03.006; Kwan HS, 2012, NATURE PRECEDINGS; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu B., 2013, QUANT BIOL, P1308, DOI [10.48550/arXiv.1308.2012, DOI 10.48550/ARXIV.1308.2012]; Liu Y., 2015, SCI REPORTS; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Miao RenYun, 2014, Mycosystema, V33, P411; Mitchell A, 2014, INTERPROPROTEIN FAMI; Morales P., 1990, Micologia Neotropical Aplicada, V3, P13; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nadalin F, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S8; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pire D. G., 2001, Micologia Aplicada International, V13, P87; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rogers MF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r4; Sakamoto Y, 2005, CURR GENET, V48, P195, DOI 10.1007/s00294-005-0002-9; Sakamoto Y, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0151-2; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Shim D, 2016, J BIOTECHNOL, V223, P24, DOI 10.1016/j.jbiotec.2016.02.032; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Szeto CYY, 2008, MYCOL RES, V112, P108, DOI 10.1016/j.mycres.2007.08.024; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; Wong K-S, 2013, NOVEL LENTINULA EDOD; Wong KS, 2012, BIORESOURCE TECHNOL, V104, P157, DOI 10.1016/j.biortech.2011.10.097; Wu L, 2013, GENE, V531, P270, DOI 10.1016/j.gene.2013.08.090; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; YASUMOTO K, 1971, AGR BIOL CHEM TOKYO, V35, P2070, DOI 10.1080/00021369.1971.10860188; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Young-Jin P, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone, DOI 10.1371/journal.pone.]; Yu SH, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-12	85	132	162	4	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160336	10.1371/journal.pone.0160336	http://dx.doi.org/10.1371/journal.pone.0160336			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500531	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500019
J	Pierre, TGS; House, MJ; Bangma, SJ; Pang, WJ; Bathgate, A; Gan, EK; Ayonrinde, OT; Bhathal, PS; Clouston, A; Olynyk, JK; Adams, LA				Pierre, Tim G. St.; House, Michael J.; Bangma, Sander J.; Pang, Wenjie; Bathgate, Andrew; Gan, Eng K.; Ayonrinde, Oyekoya T.; Bhathal, Prithi S.; Clouston, Andrew; Olynyk, John K.; Adams, Leon A.			Stereological Analysis of Liver Biopsy Histology Sections as a Reference Standard for Validating Non-Invasive Liver Fat Fraction Measurements by MRI	PLOS ONE			English	Article							ATTENUATION PARAMETER CAP; DUAL-ECHO MRI; MAGNETIC-RESONANCE; HEPATIC STEATOSIS; UNITED-STATES; TRANSIENT ELASTOGRAPHY; DISEASE; QUANTIFICATION; SPECTROSCOPY; PREVALENCE	Background and Aims Validation of non-invasive methods of liver fat quantification requires a reference standard. However, using standard histopathology assessment of liver biopsies is problematical because of poor repeatability. We aimed to assess a stereological method of measuring volumetric liver fat fraction (VLFF) in liver biopsies and to use the method to validate a magnetic resonance imaging method for measurement of VLFF. Methods VLFFs were measured in 59 subjects (1) by three independent analysts using a stereological point counting technique combined with the Delesse principle on liver biopsy histological sections and (2) by three independent analysts using the HepaFat-Scan (R) technique on magnetic resonance images of the liver. Bland Altman statistics and intraclass correlation (IC) were used to assess the repeatability of each method and the bias between the methods of liver fat fraction measurement. Results Inter-analyst repeatability coefficients for the stereology and HepaFat-Scan (R) methods were 8.2 (95% CI 7.7-8.8)% and 2.4 (95% CI 2.2-2.5)% VLFF respectively. IC coefficients were 0.86 (95% CI 0.69-0.93) and 0.990 (95% CI 0.985-0.994) respectively. Small biases (<= 3.4%) were observable between two pairs of analysts using stereology while no significant biases were observable between any of the three pairs of analysts using HepaFat-Scan (R). A bias of 1.4 +/- 0.5% VLFF was observed between the HepaFat-Scan (R) method and the stereological method. Conclusions Repeatability of the stereological method is superior to the previously reported performance of assessment of hepatic steatosis by histopathologists and is a suitable reference standard for validating non-invasive methods of measurement of VLFF.	[Pierre, Tim G. St.; House, Michael J.] Univ Western Australia, Sch Phys, Crawley, WA, Australia; [Gan, Eng K.; Ayonrinde, Oyekoya T.; Olynyk, John K.; Adams, Leon A.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Gan, Eng K.; Ayonrinde, Oyekoya T.; Olynyk, John K.] Fremantle Hosp, Dept Gastroenterol, Fremantle, WA, Australia; [Adams, Leon A.] Sir Charles Gairdner Hosp, Liver Transplant Unit, Nedlands, WA, Australia; [House, Michael J.; Bangma, Sander J.; Pang, Wenjie; Bathgate, Andrew] Resonance Hlth Ltd, Claremont, WA, Australia; [Bhathal, Prithi S.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Ayonrinde, Oyekoya T.; Olynyk, John K.] Curtin Univ Technol, Fac Hlth Sci, Bentley, WA, Australia; [Clouston, Andrew] Univ Queensland, Ctr Liver Dis Res, Sch Med, Translat Res Inst, Woolloongabba, Qld, Australia; [Olynyk, John K.] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Melbourne; Curtin University; University of Queensland; Murdoch University	Pierre, TGS (corresponding author), Univ Western Australia, Sch Phys, Crawley, WA, Australia.	Tim.StPierre@uwa.edu.au	House, Michael J/B-6477-2008; Ayonrinde, Oyekoya/K-2337-2019; St Pierre, Timothy G/A-5509-2008	House, Michael J/0000-0002-1752-6274; Ayonrinde, Oyekoya/0000-0002-0598-151X; St Pierre, Timothy G/0000-0003-4682-4972; Olynyk, John/0000-0003-0417-3411	Resonance Health Ltd	Resonance Health Ltd	Resonance Health Ltd directly funded the cost of the MRI scans and the services of one pathologist who is not an author. Resonance Health Ltd provided support in the form of salaries for authors [SB, WP, AB], but did not have any additional role in the study design, analysis, or decision to publish. [WP] was involved in data collection (stereology and Hepafat-Scan (R)) and [SB, WP, AB] contributed to the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Artz NS, 2015, J MAGN RESON IMAGING, V42, P811, DOI 10.1002/jmri.24842; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bydder M, 2008, MAGN RESON IMAGING, V26, P347, DOI 10.1016/j.mri.2007.08.012; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Cowin GJ, 2008, J MAGN RESON IMAGING, V28, P937, DOI 10.1002/jmri.21542; d'Assignies G, 2011, EUR RADIOL, V21, P301, DOI 10.1007/s00330-010-1941-1; d'Assignies G, 2009, EUR RADIOL, V19, P2033, DOI 10.1007/s00330-009-1351-4; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Deng J, 2014, PEDIATR RADIOL, V44, P1379, DOI 10.1007/s00247-014-3024-y; El-Badry AM, 2009, ANN SURG, V250, P691, DOI 10.1097/SLA.0b013e3181bcd6dd; ELIAS H, 1971, PHYSIOL REV, V51, P158, DOI 10.1152/physrev.1971.51.1.158; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fischer MA, 2010, INVEST RADIOL, V45, P465, DOI 10.1097/RLI.0b013e3181da1343; Fishbein M, 2005, J CLIN GASTROENTEROL, V39, P619, DOI 10.1097/00004836-200508000-00012; Franzen LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370; Graif M, 2000, INVEST RADIOL, V35, P319, DOI 10.1097/00004424-200005000-00006; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1981, VIRCHOWS ARCH B, V37, P317, DOI 10.1007/BF02892580; HALLY AD, 1964, Q J MICROSC SCI, V105, P503; Hatta T, 2010, J GASTROENTEROL, V45, P1263, DOI 10.1007/s00535-010-0277-6; House MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059287; Idilman IS, 2014, SCAND J GASTROENTERO, V49, P617, DOI 10.3109/00365521.2014.894118; Kang BK, 2012, INVEST RADIOL, V47, P368, DOI 10.1097/RLI.0b013e31824baff3; Kang GH, 2011, J MAGN RESON IMAGING, V34, P928, DOI 10.1002/jmri.22701; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; KOCH MM, 1978, DIGESTION, V18, P162, DOI 10.1159/000198199; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Kuhn JP, 2011, INVEST RADIOL, V46, P783, DOI 10.1097/RLI.0b013e31822b124c; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee MJ, 2013, PATHOL RES PRACT, V209, P371, DOI 10.1016/j.prp.2013.04.001; Leporq B, 2013, EUR RADIOL, V23, P2175, DOI 10.1007/s00330-013-2826-x; Mazhar SM, 2009, CLIN GASTROENTEROL H, V7, P135, DOI 10.1016/j.cgh.2008.11.023; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Mennesson N, 2009, J COMPUT ASSIST TOMO, V33, P672, DOI 10.1097/RCT.0b013e318199d883; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Noureddin M, 2013, HEPATOLOGY, V58, P1930, DOI 10.1002/hep.26455; Pacifico L, 2011, WORLD J GASTROENTERO, V17, P3012, DOI 10.3748/wjg.v17.i25.3012; Parente DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112574; Permutt Z, 2012, ALIMENT PHARM THER, V36, P22, DOI 10.1111/j.1365-2036.2012.05121.x; Rinella ME, 2003, LIVER TRANSPLANT, V9, P851, DOI 10.1053/jlts.2003.50153; Schuchmann S, 2007, EUR J RADIOL, V62, P416, DOI 10.1016/j.ejrad.2006.12.009; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; St Pierre TG, 2004, NMR BIOMED, V17, P446, DOI 10.1002/nbm.905; Suzuki Y, 2013, RADIOL PHYS TECHNOL, V6, P142, DOI [10.1007/s12194-012-0180-3, 10.1007/s12194-012-0191-0]; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Welsh JA, 2013, J PEDIATR-US, V162, P496, DOI 10.1016/j.jpeds.2012.08.043; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zaitoun AM, 2001, J CLIN PATHOL, V54, P461, DOI 10.1136/jcp.54.6.461	53	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160789	10.1371/journal.pone.0160789	http://dx.doi.org/10.1371/journal.pone.0160789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501242	Green Published, gold			2022-12-26	WOS:000381373500053
J	Garthe, S; Schwemmer, P; Paiva, VH; Corman, AM; Fock, HO; Voigt, CC; Adler, S				Garthe, Stefan; Schwemmer, Philipp; Paiva, Vitor H.; Corman, Anna-Marie; Fock, Heino O.; Voigt, Christian C.; Adler, Sven			Terrestrial and Marine Foraging Strategies of an Opportunistic Seabird Species Breeding in the Wadden Sea	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; LARUS-FUSCUS; 1ST-PASSAGE TIME; FEEDING ECOLOGY; STABLE-ISOTOPES; FISHERIES; GULLS; DISCARDS; TRACKING; BLOOD	Lesser black-backed gulls Larus fuscus are considered to be mainly pelagic. We assessed the importance of different landscape elements (open sea, tidal flats and inland) by comparing marine and terrestrial foraging behaviours in lesser black-backed gulls breeding along the coast of the southern North Sea. We attached GPS data loggers to eight incubating birds and collected information on diet and habitat use. The loggers recorded data for 10-19 days to allow flight-path reconstruction. Lesser black-backed gulls foraged in both offshore and inland areas, but rarely on tidal flats. Targets and directions were similar among all eight individuals. Foraging trips (n = 108) lasted 0.5-26.4 h (mean 8.7 h), and ranges varied from 3.0-79.9 km (mean 30.9 km). The total distance travelled per foraging trip ranged from 7.5-333.6 km (mean 97.9 km). Trips out to sea were significantly more variable in all parameters than inland trips. Presence in inland areas was closely associated with daylight, whereas trips to sea occurred at day and night, but mostly at night. The most common items in pellets were grass (48%), insects (38%), fish (28%), litter (26%) and earthworms (20%). There was a significant relationship between the carbon and nitrogen isotope signals in blood and the proportional time each individual spent foraging at sea/land. On land, gulls preferentially foraged on bare ground, with significantly higher use of potato fields and significantly less use of grassland. The flight patterns of lesser black-backed gulls at sea overlapped with fishing-vessel distribution, including small beam trawlers fishing for shrimps in coastal waters close to the colony and large beam-trawlers fishing for flatfish at greater distances. Our data show that individuals made intensive use of the anthropogenic landscape and seascape, indicating that lesser black-backed gulls are not a predominantly marine species during the incubation period.	[Garthe, Stefan; Schwemmer, Philipp; Corman, Anna-Marie; Adler, Sven] Univ Kiel, Res & Technol Ctr FTZ, Hafentorn 1, D-25761 Busum, Germany; [Paiva, Vitor H.] Univ Coimbra, Inst Marine Res IMAR, P-3004517 Coimbra, Portugal; [Paiva, Vitor H.] Univ Coimbra, Marine & Environm Sci Ctr MARE, Dept Life Sci, P-3004517 Coimbra, Portugal; [Fock, Heino O.] Thunen Inst Sea Fisheries, Palmaille 9, D-22767 Hamburg, Germany; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Alfred Kowalke Str 17, D-10315 Berlin, Germany; [Adler, Sven] Swedish Univ Agr Sci, Umea, Sweden	University of Kiel; Universidade de Coimbra; Universidade de Coimbra; Johann Heinrich von Thunen Institute; Leibniz Institut fur Zoo und Wildtierforschung; Swedish University of Agricultural Sciences	Garthe, S (corresponding author), Univ Kiel, Res & Technol Ctr FTZ, Hafentorn 1, D-25761 Busum, Germany.	garthe@ftz-west.uni-kiel.de	Paiva, Vitor H./J-1092-2019; Adler, Sven/GLU-0860-2022; Paiva, Vitor Hugo/GRX-9179-2022	Paiva, Vitor H./0000-0001-6368-9579; Garthe, Stefan/0000-0003-0548-9346	Niedersachsische Wattenmeerstiftung (NWS) [04/09]	Niedersachsische Wattenmeerstiftung (NWS)	Grants were provided by the Niedersachsische Wattenmeerstiftung (NWS 04/09) to SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PJAL, 2010, ZOOLOGIA-CURITIBA, V27, P674, DOI 10.1590/S1984-46702010000500002; Barnett PR, 2004, AGR ECOSYST ENVIRON, V102, P49, DOI 10.1016/S0167-8809(03)00278-0; Barrett RT, 2007, ICES J MAR SCI, V64, P1675, DOI 10.1093/icesjms/fsm152; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Batschelet E, 1981, CIRCULAR STAT BIOL; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Butler SJ, 2004, IBIS, V146, P123, DOI 10.1111/j.1474-919X.2004.00352.x; Camphuysen CJ, 1995, ARDEA, V83, P365; Camphuysen CJ, 1993, SULA, V7, P81; Camphuysen KCJ, 2015, MAR BIOL, V162, P1417, DOI 10.1007/s00227-015-2678-9; Ceia FR, 2014, MAR ECOL PROG SER, V497, P273, DOI 10.3354/meps10586; Ceia FR, 2012, MAR BIOL, V159, P1581, DOI 10.1007/s00227-012-1946-1; Cherel Y, 2014, MAR ECOL PROG SER, V505, P267, DOI 10.3354/meps10795; Corman AM, 2016, ECOL EVOL, V6, P974, DOI 10.1002/ece3.1884; Coulson JC, 2008, BIRD STUDY, V55, P297, DOI 10.1080/00063650809461535; Cuendet G., 1983, P415; Faraway J, 2006, EXTENDING LINEAR MOD; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2011, ECOLOGY, V92, P228, DOI 10.1890/10-0818.1; Fock HO, 2008, MAR POLICY, V32, P728, DOI 10.1016/j.marpol.2007.12.010; Garthe S, 2004, J APPL ECOL, V41, P724, DOI 10.1111/j.0021-8901.2004.00918.x; Garthe S, 1997, ARCH FISH MAR RES, V45, P223; Garthe S, 1996, COLON WATERBIRD, V19, P232, DOI 10.2307/1521861; Glutz von Blotzheim U.N., 1982, HDB VOGEL MITTELEURO, V8; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kubetzki U, 2003, MAR BIOL, V143, P199, DOI 10.1007/s00227-003-1036-5; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; Lavoie RA, 2012, WATERBIRDS, V35, P402, DOI 10.1675/063.035.0305; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Quillfeldt P, 2008, MAR BIOL, V155, P593, DOI 10.1007/s00227-008-1048-2; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schneider DC, 2002, ECOSYSTEMS, V5, P736, DOI 10.1007/s10021-002-0156-y; Schwemmer H, 2013, ESTUAR COAST SHELF S, V119, P71, DOI 10.1016/j.ecss.2012.12.021; Schwemmer P, 2005, MAR ECOL PROG SER, V285, P245, DOI 10.3354/meps285245; Schwemmer P, 2008, ESTUAR COAST SHELF S, V77, P12, DOI 10.1016/j.ecss.2007.08.017; Schwemmer P, 2008, LANDSCAPE ECOL, V23, P355, DOI 10.1007/s10980-008-9194-y; Sommerfeld J, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2889-8; Sumner M, 2013, TRIP SPATIAL ANAL AN; Tiedemann R, 1997, J ORNITHOL, V138, P183, DOI 10.1007/BF01651622; Tyson C, 2015, ICES J MAR SCI, V72, P1882, DOI 10.1093/icesjms/fsv021; Ulleweit J, 2010, J APPL ICHTHYOL, V26, P54, DOI 10.1111/j.1439-0426.2010.01449.x; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Walter U, 1997, ARCH FISH MAR RES, V45, P61; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wilson RP, 2012, MAR ECOL PROG SER, V451, P245, DOI 10.3354/meps09608; Zydelis R, 2013, BIOL CONSERV, V162, P76, DOI 10.1016/j.biocon.2013.04.002	52	30	32	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159630	10.1371/journal.pone.0159630	http://dx.doi.org/10.1371/journal.pone.0159630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525661	gold, Green Submitted, Green Published			2022-12-26	WOS:000381471100008
J	Villa, P; Soriano, S; Grun, R; Marra, F; Nomade, S; Pereira, A; Boschian, G; Pollarolo, L; Fang, F; Bahain, JJ				Villa, Paola; Soriano, Sylvain; Grun, Rainer; Marra, Fabrizio; Nomade, Sebastien; Pereira, Alison; Boschian, Giovanni; Pollarolo, Luca; Fang, Fang; Bahain, Jean-Jacques			The Acheulian and Early Middle Paleolithic in Latium (Italy): Stability and Innovation	PLOS ONE			English	Article							TIBER RIVER; SEA-LEVEL; AGGRADATIONAL SECTIONS; AGE CONSTRAINTS; MONTI SABATINI; TOOTH ENAMEL; PLEISTOCENE; ROME; STRATIGRAPHY; 40AR/39AR	We present here the results of a technological and typological analysis of the Acheulian and early Middle Paleolithic assemblages from Torre in Pietra (Latium, Italy) together with comparisons with the Acheulian small tools of Castel di Guido. The assemblages were never chronometrically dated before. We have now 40Ar/39Ar dates and ESR-U-series dates, within a geomorphological framework, which support correlations to marine isotope stages. The Acheulian (previously correlated to MIS 9) is now dated to MIS 10 while the Middle Paleolithic is dated to MIS 7. Lithic analyses are preceded by taphonomic evaluations. The Levallois method of the Middle Paleolithic assemblage is an innovation characterized by the production of thin flake blanks without cortex. In contrast, the small tool blanks of the Acheulian were either pebbles or thick flakes with some cortex. They provided a relatively easy manual prehension. The choice of Levallois thin flake blanks in the Middle Paleolithic assemblage suggest that the new technology is most likely related to the emergence of hafting. Accordingly, the oldest direct evidence of hafting technology is from the site of Campitello Quarry in Tuscany (Central Italy) where birch-bark tar, found on the proximal part of two flint flakes, is dated to the end of MIS 7. Nevertheless, a peculiar feature of the Middle Paleolithic at Torre in Pietra is the continuous presence of small tool blanks on pebbles and cores and on thick flake albeit at a much lower frequency than in the older Acheulian industries. The adoption of the new technology is thus characterized by innovation combined with a degree of stability. The persistence of these habits in spite of the introduction of an innovative technique underlies the importance of cultural transmission and conformity in the behavior of Neandertals.	[Villa, Paola] Univ Colorado Museum, Boulder, CO 80309 USA; [Villa, Paola] Ist Italiano Paleontol Umana, Rome, Italy; [Villa, Paola; Pollarolo, Luca] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Soriano, Sylvain] Univ Paris Ouest, CNRS, ArScAn, AnTET, F-92023 Nanterre, France; [Grun, Rainer; Fang, Fang] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Grun, Rainer; Fang, Fang] Griffith Univ, Res Ctr Human Evolut, Nathan, Qld 4111, Australia; [Marra, Fabrizio] Ist Nazl Geofis & Vulcanol, I-00147 Rome, Italy; [Nomade, Sebastien; Pereira, Alison] UVSQ, Lab Sci Climat & Environm, CEA Saclay, UMR 8212, F-91198 Gif Sur Yvette, France; [Nomade, Sebastien; Pereira, Alison] Univ Paris Saclay, F-91198 Gif Sur Yvette, France; [Pereira, Alison; Bahain, Jean-Jacques] Museum Natl Hist Nat, UMR 7194, Dept Prehist, F-75013 Paris, France; [Pereira, Alison] Univ Ferrara, Sez Sci Preist & Antropol, Dipartimento Studi Umanistici, Ferrara, Italy; [Pereira, Alison] Ecole Francaise, Rome, Italy; [Boschian, Giovanni] Univ Pisa, Dipartimento Biol, I-56126 Pisa, Italy; [Pollarolo, Luca] Univ Geneva, Dept Genet & Evolut, Lab Archeol & Peuplement Afr, CH-1211 Geneva, Switzerland	University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Australian National University; Griffith University; Istituto Nazionale Geofisica e Vulcanologia (INGV); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Ferrara; University of Pisa; University of Geneva	Villa, P (corresponding author), Univ Colorado Museum, Boulder, CO 80309 USA.; Villa, P (corresponding author), Ist Italiano Paleontol Umana, Rome, Italy.; Villa, P (corresponding author), Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa.	villap@colorado.edu	MARRA, Fabrizio/AAB-9514-2019; Bahain, Jean-Jacques/AAB-8910-2019; Grun, Rainer/A-1437-2012	MARRA, Fabrizio/0000-0002-4881-9563; Grun, Rainer/0000-0003-1366-3674; Bahain, Jean-Jacques/0000-0002-1446-5568; POLLAROLO, LUCA/0000-0001-9449-5937; Soriano, Sylvain/0000-0002-4288-9763; Villa, Paola/0000-0002-9831-5443; BOSCHIAN, Giovanni/0000-0003-4324-6353; nomade, sebastien/0000-0001-7373-0571	National Science Foundation [BCS 1118143]; CNRS, UMR, ArScAn/AnTET, Nanterre	National Science Foundation(National Science Foundation (NSF)); CNRS, UMR, ArScAn/AnTET, Nanterre	This work is funded by the National Science Foundation, BCS 1118143, grant to PV, SS. CNRS, UMR 7041, ArScAn/AnTET, Nanterre, grant to SS.; Research at Torre in Pietra and on the Castel di Guido lithics was funded by National Science Foundation Grant BCS 1118143 to PV and SS and by a travel grant from CNRS, UMR 7041, ArSca/AnTET, Nanterre to SS. We thank the Pigorini Museum, the Italian Institute of Human Paleontology and the Dipartimento di Biologia of the University of Pisa for access to the Torre in Pietra and Castel di Guido collections and facilities during analysis. We are grateful to Anna Maria Moretti, Alfonsina Russo and Flavia Trucco of the Soprintendenza of Lazio and Etruria Meridionale for access to the Torre in Pietra archeological site, allowing us to clean the two preserved sections and take sediment samples for dating. Salvatore Milli and Maria Rita Palombo have provided us with very valuable information on the Torre in Pietra stratigraphy. Throughout our analysis we valued the very informative paper on the Torre in Pietra lithic assemblages by Marcello Piperno and Italo Biddittu. Fabio Parenti, President of the Italian Institute of Human Paleontology and Luciano Bruni very graciously allowed us complete access to the lithic material of Torre in Pietra and its transport from the town of Anagni to the Zoology Museum in Rome and keep it there for the duration of this study. We thank Francesco di Gennaro and Mario Mineo of the Pigorini Museum in Rome for permission to take photos of the materials and allowing us to use the skills of Fabio Naccari for photography. We thanks Luca Galletti for conceiving and making Fig D of the S1 File. Antonio Tagliacozzo of the Paleontology Section in the Pigorini Museum and Fabio Parenti provided us with faunal materials (teeth and bones) from Torre in Pietra for ESR-U-series dating. PV, SS and LP are particularly grateful to Mario Amore of the Pigorini Museum and the staff of the Zoology Museum in Rome for the good humor and quick access to the Museum facilities (including the indispensable coffee machines). We thank two anonymous reviewers for their insightful and helpful comments. We also wish to thank the University of Colorado Interlibrary Loan Service for their effcient and rapid deliveries and the University of Colorado Museum of Natural History for covering the publication cost.	Beyries S., 1983, BULL SOC PREHIST FR, V80, P275, DOI [DOI 10.3406/BSPF.1983.5455, 10.3406/bspf.1983.5455]; Biddittu I, 1984, I PRIMI ABITANTI DEU, P168; Bietti A., 2009, PERCUSSION ENCLUME I, P143; Boeda E, 2004, APPROCHES FONCTIONNE, P293; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI [10.3406/bspf.1993.9669, DOI 10.3406/BSPF.1993.9669]; Boeda E., 1994, CONCEPT LEVALLOIS VA; Boeda E., 1995, PALEO, P57, DOI [10.3406/pal.1995.1380, DOI 10.3406/PAL.1995.1380]; Boeda E, 1997, TECHNOGENESE SYSTEME; Boeda E., 1991, TECHNIQUES CULTURE, V17-18, P37, DOI DOI 10.4000/TC.685; Boeda E., 2001, IND OUTILS BIFACIAUX, P51; Boeda E., 2013, TECHNO LOGIQUE TECHN; BORDES F, 1968, OLD STONE AGE; Bordes F, 1971, MUNIBE, P5; Boschian G, 2015, QUATERN INT, V361, P288, DOI 10.1016/j.quaint.2014.04.030; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; Bourguignon L, 2008, SOC PALEOLITHIQUE GR, P41; Bradley B, 1986, STONE AGE PREHISTORY, P29; Cahen D., 1986, CHRONOSTRATIGRAPHIE, V26, P89; Caloi L., 1978, Quaternaria, V20, P315; Caloi L, 1998, QUATERN INT, V47-8, P77, DOI 10.1016/S1040-6182(97)00073-6; Childe VG, 1932, ANTIQUITY, V6, P185; Cioni R., 1993, B SOC GEOL ITAL, V112, P251; Cliquet D, 2001, IND OUTILS BIFACIAUX, P141; Conato V., 1980, QUATERNARIA, V22, P131; Connet N, 2014, LGV SEA GRANDE OCCUP, P215; DEINO A, 1990, J GEOPHYS RES-SOLID, V95, P8453, DOI 10.1029/JB095iB06p08453; Dutton A, 2009, NAT GEOSCI, V2, P355, DOI 10.1038/NGEO470; Duval M, 2016, QUAT GEOCHRONOL, V31, P19, DOI 10.1016/j.quageo.2015.09.007; EVERNDEN JF, 1965, CURR ANTHROPOL, V6, P343; Faivre JPh, 2009, FRACTURATION SPLIT T, P133, DOI DOI 10.4000/PALEO.1944; Florindo F, 2007, EARTH PLANET SC LETT, V256, P61, DOI 10.1016/j.epsl.2007.01.014; Folgado M, 2009, RIV SCI PREISTORICHE, V59, P49; Forestier H., 1993, PALEO, V5, P53, DOI [DOI 10.3406/PAL.1993.1104, 10.3406/pal.1993.1104]; Gliozzi E, 1997, RIV ITAL PALEONTOL S, V103, P369, DOI 10.13130/2039-4942/5299; Gran R., 2000, ANCIENT TL, V18, P1; Grant KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6076; Green HS, 1983, STUDIA PRAEHISTORICA, V3, P29; Grimaldi S., 1998, PALEO, V10, P109, DOI DOI 10.3406/PAL.1998.1132; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Guibert P, 2008, SOC PALEOLITHIQUE GR, P41; Harding P., 1987, HUMAN USES FLINT CHE, P115; Herisson D, 2012, PALEO, V23, P137, DOI DOI 10.4000/PALEO.2329; Jarry M, 2007, BOSSES 1 LAMAGDELAIN, P7; Jaubert J, 1990, CHASSEURS AUROCHS BO; Jaubert J., 1996, QUATERNARIA NOVA, V6, P313; Joris O., 2006, AXE AGE ACHEULIAN TO, P287; Karner DB, 1998, GEOL SOC AM BULL, V110, P748, DOI 10.1130/0016-7606(1998)110<0748:COFASW>2.3.CO;2; Karner DB, 1998, GEOL SOC AM BULL, V110, P740, DOI 10.1130/0016-7606(1998)110<0740:AAGORV>2.3.CO;2; Karner DB, 2001, J VOLCANOL GEOTH RES, V107, P185, DOI 10.1016/S0377-0273(00)00258-4; Karner DB, 2001, EARTH PLANET SC LETT, V188, P135, DOI 10.1016/S0012-821X(01)00325-9; Koehler H, 2008, BULL SOC PREHIST FR, V105, P709, DOI 10.3406/bspf.2008.13781; Kotsakis T., 2008, Memorie Descrittive della Carta Geologica d'Italia, V80, P115; Kuhn SL., 1995, MOUSTERIAN LITHIC TE, DOI [10.1515/9781400864034, DOI 10.1515/9781400864034]; Lai Pannocchia F, 1950, RIV SCI PREISTORICHE, V1950, P67; Lamotte A, 1999, B SOC PREHISTORIQUE, V96, P117; Lhomme V, 2007, ANTIQUITY, V81, P536, DOI 10.1017/S0003598X00095570; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Ludwig K.R, 2003, BERKELEY GEOCHRONOLO; Malatesta A., 1978, QUATERNARIA, V20, P237; Malatesta A., 1978, QUATERNARIA, V20, P537; Marcy J.-L., 1993, B SOCI T PR HISTORIQ, V90, P251; Marra F, 2016, EARTH PLANET SC LETT, V449, P105, DOI 10.1016/j.epsl.2016.05.037; Marra F, 2014, EARTH-SCI REV, V139, P104, DOI 10.1016/j.earscirev.2014.08.014; Marra F, 2014, QUATERNARY SCI REV, V94, P74, DOI 10.1016/j.quascirev.2014.04.010; Marra F, 1998, EARTH PLANET SC LETT, V159, P147, DOI 10.1016/S0012-821X(98)00071-5; Marra F., 1995, GEOLOGIA ROMA CTR ST, VVolume 50, P49; Marra F, 2015, QUATERNARY SCI REV, V129, P260, DOI 10.1016/j.quascirev.2015.10.027; Marra F, 2014, EARTH-SCI REV, V136, P1, DOI 10.1016/j.earscirev.2014.05.001; Marra F, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001543; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; Michel V., 2009, ARCHEOSCIENCES, V32, P51; Milli S, 2005, QUATERN INT, V126, P251, DOI 10.1016/j.quaint.2004.04.025; Milli S., 2008, GEOACTA SPECIAL PUBL, V1, P667; Milli S, 2001, POST SESS 1 INT C WO; Monnier J.-L., 1985, REV ARCHEOLOGIQUE OU, V2, P7; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Nicoud E, 2013, PARADOXE ACHEULEEN; Nomade S, 2014, 27 WORLD UISPP C BUR; Palombo M.R., 2004, GEOL ROMANA, V37, P135; Peretto C, 2015, QUAT INT IN PRESS; Perpere M, 1999, ANTHROPOLOGIE, V103, P43; Pike AWG, 2002, GEOCHIM COSMOCHIM AC, V66, P4273, DOI 10.1016/S0016-7037(02)00997-3; Piperno M, 1978, QUATERNARIA, V20, P441; Radmilli AM, 1996, SCAVI CASTEL GUIDO P; Roe DA, 1981, LOWER MIDDLE PALAEOL; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Sacca D., 2012, RIV SCI PREISTORICHE, VLXII, P13; Sacca D, 2012, QUATERN INT, V276, P27, DOI 10.1016/j.quaint.2012.03.055; Sambridge M, 2012, QUAT GEOCHRONOL, V9, P42, DOI 10.1016/j.quageo.2012.02.010; Santucci E, 2016, QUATERN INT, V406, P169, DOI 10.1016/j.quaint.2015.08.042; Shea JJ, 2015, LITHIC TECHNOL, V40, P231, DOI 10.1179/2051618515Y.0000000011; Shimelmitz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106293; Soressi M, 2002, THESIS, P1; Sorgi C., 1994, THESIS; Soriano S, 2000, THESIS, P10; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Tavoso A, 1986, PALEOLITHIQUE INFERI, V5; Teheux E, 2000, ARCHEOPAGES, V1, P30; Tuffreau A, 2008, ANTHROPOLOGIE, V112, P104, DOI 10.1016/j.anthro.2008.01.003; Turq A, 2010, QUATERN INT, V223, P383, DOI 10.1016/j.quaint.2010.03.012; Vallin L, 2006, PALEO, V18, P237, DOI DOI 10.4000/PALEO.347; VALLOIS H, 1956, AM J PHYS ANTHROPOL, V14, P319, DOI 10.1002/ajpa.1330140224; Villa P, 1983, TERRA AMATA MIDDLE P; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; White M, 2003, CURR ANTHROPOL, V44, P598, DOI 10.1086/377653; White M, 2006, J QUATERNARY SCI, V21, P525, DOI 10.1002/jqs.1034	106	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160516	10.1371/journal.pone.0160516	http://dx.doi.org/10.1371/journal.pone.0160516			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525705	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100016
J	Bharti, PK; Chandel, HS; Ahmad, A; Krishna, S; Udhayakumar, V; Singh, N				Bharti, Praveen Kumar; Chandel, Himanshu Singh; Ahmad, Amreen; Krishna, Sri; Udhayakumar, Venkatachalam; Singh, Neeru			Prevalence of pfhrp2 and/or pfhrp3 Gene Deletion in Plasmodium falciparum Population in Eight Highly Endemic States in India	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; SEQUENCE VARIATION; MALARIA; HRP2; CHLOROQUINE; PERFORMANCE; MANAGEMENT; DIVERSITY; SENEGAL; REGION	Background Plasmodium falciparum encoded histidine rich protein (HRP2) based malaria rapid diagnostic tests (RDTs) are used in India. Deletion of pfhrp2 and pfhrp3 genes contributes to false negative test results, and large numbers of such deletions have been reported from South America, highlighting the importance of surveillance to detect such deletions. Methods This is the first prospective field study carried out at 16 sites located in eight endemic states of India to assess the performance of PfHRP2 based RDT kits used in the national malaria control programme. In this study, microscopically confirmed P. falciparum but RDT negative samples were assessed for presence of pfhrp2, pfhrp3, and their flanking genes using PCR. Results Among 1521 microscopically positive P. falciparum samples screened, 50 were negative by HRP2 based RDT test. Molecular testing was carried out using these 50 RDT negative samples by assuming that 1471 RDT positive samples carried pfhrp2 gene. It was found that 2.4% (36/1521) and 1.8% (27/1521) of samples were negative for pfhrp2 and pfhrp3 genes, respectively. However, the frequency of pfhrp2 deletions varied between the sites ranging from 0-25% (2.4, 95% CI; 1.6-3.3). The frequency of both pfhrp2 and pfhrp3 gene deletion varied from 0-8% (1.6, 95% CI; 1.0-2.4). Conclusion This study provides evidence for low level presence of pfhrp2 and pfhrp3 deleted P. falciparum parasites in different endemic regions of India, and periodic surveillance is warranted for reliable use of PfHRP2 based RDTs.	[Bharti, Praveen Kumar; Chandel, Himanshu Singh; Ahmad, Amreen; Krishna, Sri; Singh, Neeru] NIRTH, Jabalpur 482003, Madhya Pradesh, India; [Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Malaria Branch, Ctr Global Hlth, Atlanta, GA 30333 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Centers for Disease Control & Prevention - USA	Singh, N (corresponding author), NIRTH, Jabalpur 482003, Madhya Pradesh, India.	neeru.singh@gmail.com			Indian Council of Medical Research, India	Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was funded by Indian Council of Medical Research, India.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; [Anonymous], 2015, PLOS ONE, DOI DOI 10.1371/journal.pone.0131576; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; Baker J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-129; Bharti PK, 2010, TROP MED INT HEALTH, V15, P33, DOI 10.1111/j.1365-3156.2009.02425.x; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Diagnosis and Treatment of Malaria, 2013, DIAGN TREATM MAL 201; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Hendriksen ICE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001297; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Jain V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115266; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Krishna S, 2015, EMERG INFECT DIS, V21, P1853, DOI 10.3201/eid2110.150678; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; National Vector Borne Diseases Control programme, 2014, MAL SIT IND 2014; Okoth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126805; Ramutton T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-276; Singh J., 1944, Indian Medical Gazette, V79, P102; Singh N, 1997, AM J TROP MED HYG, V56, P188, DOI 10.4269/ajtmh.1997.56.188; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058080; Singh N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-191; Sinha I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0900-3; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	30	94	94	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0157949	10.1371/journal.pone.0157949	http://dx.doi.org/10.1371/journal.pone.0157949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518538	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100002
J	Li, H; Zheng, HL; Li, LH; Shen, XG; Zang, WJ; Sun, YS				Li, Hui; Zheng, Huiling; Li, Lihui; Shen, Xingai; Zang, Wenjuan; Sun, Yongsen			The Effects of Matrix Metalloproteinase-9 on Dairy Goat Mastitis and Cell Survival of Goat Mammary Epithelial Cells	PLOS ONE			English	Article							BOVINE MASTITIS; GROWTH-FACTORS; SOMATIC-CELLS; UP-REGULATION; MMP-9; METALLOPROTEINASE-9; ANGIOGENESIS; REDUCTION; APOPTOSIS; MODEL	Matrix metalloproteinase-9 (MMP-9) is a zinc-dependent enzyme, and plays a crucial role in extracellular matrix degeneration, inflammation and tissue remodeling. However, the relationship between MMP-9 and somatic cell count (SCC) in goat milk and the role of MMP-9 in the regulation of mastitis are still unknown. In this study, we found MMP-9 was predominantly expressed in the spleen, intestine and mammary gland. The SCC in goat milk was positively correlated with MMP-9 expression, and staphylococcus aureus could markedly increase MMP-9 expression in goat mammary epithelial cells (GMEC) in dosage and time dependent manner. We also demonstrated that SB-3CT, an inhibitor of MMP-9, promoted apoptosis and inhibited proliferation in GMEC. Thus, MMP-9 may emerge as an easily measurable and sensitive parameter that reflects the number of somatic cells present in milk and a regulatory factor of apoptosis in GMEC.	[Li, Hui; Zheng, Huiling; Li, Lihui; Shen, Xingai; Zang, Wenjuan; Sun, Yongsen] Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zheng, HL (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	zhenghuiling@nwsuaf.edu.cn		Li, Hui/0000-0002-5604-0592	National Natural Science Foundation of China, China [31572368]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM3029]; National Natural Science Foundation of China [31572368]	National Natural Science Foundation of China, China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31572368), China, and the Natural Science Basic Research Plan in Shaanxi Province of China (No. 2016JM3029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 31572368), and the Natural Science Basic Research Plan in Shaanxi Province of China (No. 2016JM3029).	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Barkema HW, 1998, J DAIRY SCI, V81, P411, DOI 10.3168/jds.S0022-0302(98)75591-2; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergonier D, 2014, VET RES, V45, DOI 10.1186/s13567-014-0097-4; Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; Cortes-Reynosa P, 2008, MATRIX BIOL, V27, P220, DOI 10.1016/j.matbio.2007.11.003; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; d'Angelo F, 2007, J DAIRY SCI, V90, P3550, DOI 10.3168/jds.2007-0149; DULIN AM, 1983, J DAIRY SCI, V66, P2426, DOI 10.3168/jds.S0022-0302(83)82101-8; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Hampel D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149479; HARMON RJ, 1994, J DAIRY SCI, V77, P2103, DOI 10.3168/jds.S0022-0302(94)77153-8; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Krieglstein K, 2000, NAT NEUROSCI, V3, P1085, DOI 10.1038/80598; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Li H., 2015, TUMOR BIOL, P1; Li N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146071; Paape MJ, 1997, FLEMISH VET J, V66, P93; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Raulo SM, 2002, VET IMMUNOL IMMUNOP, V85, P137, DOI 10.1016/S0165-2427(01)00423-8; Schorr K, 1999, J MAMMARY GLAND BIOL, V4, P153, DOI 10.1023/A:1018773123899; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Shi HB, 2014, J DAIRY SCI, V97, P5437, DOI 10.3168/jds.2013-7863; Silanikove N, 2014, J DAIRY SCI, V97, P3449, DOI 10.3168/jds.2013-7334; Simonetti O, 2012, J ANTIMICROB CHEMOTH, V67, P191, DOI 10.1093/jac/dkr440; Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011; Vaillant C, 2003, MOL CELL NEUROSCI, V24, P395, DOI 10.1016/S1044-7431(03)00196-9; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang H, 2015, J DAIRY SCI, V98, P9001, DOI 10.3168/jds.2015-9418; Wang Zhen, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P1123; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Wellnitz O, 2004, VET IMMUNOL IMMUNOP, V101, P191, DOI 10.1016/j.vetimm.2004.04.019; Yu TC, 2011, VET IMMUNOL IMMUNOP, V144, P210, DOI 10.1016/j.vetimm.2011.09.006; Zhao X, 2008, J ANIM SCI, V86, P57, DOI 10.2527/jas.2007-0302; Zhao YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134797	40	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160989	10.1371/journal.pone.0160989	http://dx.doi.org/10.1371/journal.pone.0160989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518717	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100031
J	Aljohi, A; Matou-Nasri, S; Ahmed, N				Aljohi, Ali; Matou-Nasri, Sabine; Ahmed, Nessar			Antiglycation and Antioxidant Properties of Momordica charantia	PLOS ONE			English	Article							GLYCATION; EXTRACTS; PRODUCTS; PULP	The accumulation of advanced glycation endproducts (AGEs) and oxidative stress underlie the pathogenesis of diabetic complications. In many developing countries, diabetes treatment is unaffordable, and plants such as bitter gourd (or bitter melon; Momordica charantia) are used as traditional remedies because they exhibit hypoglycaemic properties. This study compared the antiglycation and antioxidant properties of aqueous extracts of M. charantia pulp (MCP), flesh (MCF) and charantin in vitro. Lysozyme was mixed with methylglyoxal and 0-15 mg/ml of M. charantia extracts in a pH 7.4 buffer and incubated at 37 degrees C for 3 days. Crosslinked AGEs were assessed using gel electrophoresis, and the carboxymethyllysine (CML) content was analyzed by enzyme-linked immunosorbent assays. The antioxidant activities of the extracts were evaluated using assays to assess DPPH (1,1-diphenyl-2picryl- hydrazyl) and hydroxyl radical scavenging activities, metal-chelating activity and reducing power of the extracts. The phenolic, flavonol and flavonoid content of the extracts were also determined. All extracts inhibited the formation of crosslinked AGEs and CML in a dose-dependent manner, with MCF being the most potent. The antioxidant activity of MCF was higher than that of MCP, but MCP showed the highest metal-chelating activity. MCF had the highest phenolic and flavonoid contents, whereas MCP had the highest flavonol content. M. charantia has hypoglycaemic effects, but this study shows that M. charantia extracts are also capable of preventing AGE formation in vitro. This activity may be due to the antioxidant properties, particularly the total phenolic content of the extracts. Thus, the use of M. charantia deserves more attention, as it may not only reduce hyperglycaemia but also protect against the build-up of tissue AGEs and reduce oxidative stress in patients with diabetes.	[Aljohi, Ali; Ahmed, Nessar] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England; [Matou-Nasri, Sabine] King Saud Bin Abdulaziz Univ Hlth Sci, Med Genom Res Dept, Minist Natl Guard Hlth Affairs, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia	Manchester Metropolitan University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs	Ahmed, N (corresponding author), Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England.	N.Ahmed@mmu.ac.uk						Muhammad SA, 2007, EUR J PHARMACOL, V561, P32, DOI 10.1016/j.ejphar.2007.01.041; Ahmed I, 2001, DIABETES RES CLIN PR, V51, P155, DOI 10.1016/S0168-8227(00)00224-2; Ahmed N, 2005, DIABETES RES CLIN PR, V67, P3, DOI 10.1016/j.diabres.2004.09.004; Baby Joseph, 2013, Asian Pacific Journal of Tropical Disease, V3, P93, DOI 10.1016/S2222-1808(13)60052-3; Boo HO, 2012, IND CROP PROD, V40, P129, DOI 10.1016/j.indcrop.2012.02.042; Bucala R, 2014, J CLIN INVEST, V124, P1887, DOI 10.1172/JCI75224; DYER DG, 1993, J CLIN INVEST, V91, P2463, DOI 10.1172/JCI116481; Elosta A, 2012, CURR DIABETES REV, V8, P92, DOI 10.2174/157339912799424528; Fernandes Nafisa P C, 2007, BMC Complement Altern Med, V7, P29, DOI 10.1186/1472-6882-7-29; Fujiwara Y, 2011, FREE RADICAL BIO MED, V50, P883, DOI 10.1016/j.freeradbiomed.2010.12.033; Ghous T, 2015, PAK J PHARM SCI, V28, P1217; Gogi MD, 2010, CROP PROT, V29, P884, DOI 10.1016/j.cropro.2010.03.014; Hsieh CL, 2005, J ETHNOPHARMACOL, V102, P357, DOI 10.1016/j.jep.2005.06.044; Kamata Katsuo, 2009, J Smooth Muscle Res, V45, P125; Keter LK, 2012, J ETHNOPHARMACOL, V139, P74, DOI 10.1016/j.jep.2011.10.014; Kislinger T, 2004, CURR MED CHEM, V11, P2185, DOI 10.2174/0929867043364649; Kubola J, 2008, FOOD CHEM, V110, P881, DOI 10.1016/j.foodchem.2008.02.076; Kuong Y, 2009, J MED PLANTS RES, V3, P894; Loizzo MR, 2012, J FOOD COMPOS ANAL, V25, P179, DOI 10.1016/j.jfca.2011.09.002; Mashilipa C, 2011, J MED FOOD, V14, P1647, DOI 10.1089/jmf.2011.0054; Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007; Price DL, 2001, J BIOL CHEM, V276, P48967, DOI 10.1074/jbc.M108196200; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Samak G, 2009, FOOD CHEM, V115, P631, DOI 10.1016/j.foodchem.2008.12.078; Sell DR, 2012, GERONTOLOGY, V58, P227, DOI 10.1159/000334668; Shan B, 2012, FOOD BIOPROD PROCESS, V90, P579, DOI 10.1016/j.fbp.2011.09.004; Singh Jaipaul, 2011, Open Med Chem J, V5, P70, DOI 10.2174/1874104501105010070; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Tang SY, 2004, FREE RADICAL BIO MED, V36, P1575, DOI 10.1016/j.freeradbiomed.2004.03.017; Trakoon-osot W., 2013, Journal of Pharmacy Research, V6, P859, DOI 10.1016/j.jopr.2013.08.007; Tsai SY, 2006, FOOD CHEM, V98, P670, DOI 10.1016/j.foodchem.2005.07.003; Tsuji-Naito K, 2009, FOOD CHEM, V116, P854, DOI 10.1016/j.foodchem.2009.03.042; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Virdi J, 2003, J ETHNOPHARMACOL, V88, P107, DOI 10.1016/S0378-8741(03)00184-3; Waheed Akbar, 2006, Pak J Pharm Sci, V19, P322	36	31	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159985	10.1371/journal.pone.0159985	http://dx.doi.org/10.1371/journal.pone.0159985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513747	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000381381100022
J	Busch, DS; McElhany, P				Busch, D. Shallin; McElhany, Paul			Estimates of the Direct Effect of Seawater pH on the Survival Rate of Species Groups in the California Current Ecosystem	PLOS ONE			English	Article							OCEAN ACIDIFICATION; POTENTIAL IMPACTS; CO2; RESPONSES; FUTURE; ADAPTATION; SYSTEM; OYSTER; FACE	Ocean acidification (OA) has the potential to restructure ecosystems due to variation in species sensitivity to the projected changes in ocean carbon chemistry. Ecological models can be forced with scenarios of OA to help scientists, managers, and other stakeholders understand how ecosystems might change. We present a novel methodology for developing estimates of species sensitivity to OA that are regionally specific, and applied the method to the California Current ecosystem. To do so, we built a database of all published literature on the sensitivity of temperate species to decreased pH. This database contains 393 papers on 285 species and 89 multi-species groups from temperate waters around the world. Research on urchins and oysters and on adult life stages dominates the literature. Almost a third of the temperate species studied to date occur in the California Current. However, most laboratory experiments use control pH conditions that are too high to represent average current chemistry conditions in the portion of the California Current water column where the majority of the species live. We developed estimates of sensitivity to OA for functional groups in the ecosystem, which can represent single species or taxonomically diverse groups of hundreds of species. We based these estimates on the amount of available evidence derived from published studies on species sensitivity, how well this evidence could inform species sensitivity in the California Current ecosystem, and the agreement of the available evidence for a species/species group. This approach is similar to that taken by the Intergovernmental Panel on Climate Change to characterize certainty when summarizing scientific findings. Most functional groups (26 of 34) responded negatively to OA conditions, but when uncertainty in sensitivity was considered, only 11 groups had relationships that were consistently negative. Thus, incorporating certainty about the sensitivity of species and functional groups to OA is an important part of developing robust scenarios for ecosystem projections.	[Busch, D. Shallin] Natl Marine Fisheries Serv, Ocean Acidificat Program, Off Ocean & Atmospher Res, NOAA, Seattle, WA 98115 USA; [Busch, D. Shallin] Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, NOAA, Seattle, WA 98112 USA; [McElhany, Paul] Natl Marine Fisheries Serv, Conservat Biol Div, NW Fisheries Sci Ctr, NOAA, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Busch, DS (corresponding author), Natl Marine Fisheries Serv, Ocean Acidificat Program, Off Ocean & Atmospher Res, NOAA, Seattle, WA 98115 USA.; Busch, DS (corresponding author), Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, NOAA, Seattle, WA 98112 USA.	Shallin.Busch@noaa.gov			National Oceanic and Atmospheric Administration's Northwest Fisheries Science Center; Ocean Acidification Program; Northwest Fisheries Science Center; NOAA Ocean Acidification Program	National Oceanic and Atmospheric Administration's Northwest Fisheries Science Center; Ocean Acidification Program; Northwest Fisheries Science Center; NOAA Ocean Acidification Program	DSB and PM were funded by the National Oceanic and Atmospheric Administration's Northwest Fisheries Science Center and Ocean Acidification Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Isaac Kaplan and Chris Harvey provided helpful comments to improve this manuscript. Funding for this project was provided by the NOAA Ocean Acidification Program and the Northwest Fisheries Science Center.	Ainsworth CH, 2011, ICES J MAR SCI, V68, P1217, DOI 10.1093/icesjms/fsr043; Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Barton A, 2015, OCEANOGRAPHY, V28, P146, DOI 10.5670/oceanog.2015.38; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; Bednarsek N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0123; Bednarsek N, 2012, NAT GEOSCI, V5, P881, DOI 10.1038/NGEO1635; Brand EJ, 2007, NOAA TECHNICAL MEMOR; Browman HI, 2016, ICES J MAR SCI, V73, P529, DOI 10.1093/icesjms/fsw010; Busch DS, 2015, OCEANOGRAPHY, V28, P30, DOI 10.5670/oceanog.2015.29; Busch DS, 2013, ICES J MAR SCI, V70, P823, DOI 10.1093/icesjms/fst061; Clarkson MO, 2015, SCIENCE, V348, P229, DOI 10.1126/science.aaa0193; Cooley SR, 2015, OCEANOGRAPHY, V28, P198, DOI 10.5670/oceanog.2015.42; Cornwall CE, ICES J MARI IN PRESS; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dupont S, 2014, J SHELLFISH RES, V33, P857, DOI 10.2983/035.033.0320; Dutkiewicz S, 2015, NAT CLIM CHANGE, V5, P1002, DOI [10.1038/NCLIMATE2722, 10.1038/nclimate2722]; Enochs IC, 2015, NAT CLIM CHANGE, V5, P1083, DOI 10.1038/NCLIMATE2758; Evans W, 2015, J GEOPHYS RES-OCEANS, V120, P1446, DOI 10.1002/2014JC010580; Fabricius KE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2479; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Feely RA, 2013, WASHINGTON BLUE RIBB; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Field CB, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P1; Fu FX, 2010, AQUAT MICROB ECOL, V59, P55, DOI 10.3354/ame01396; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Gattuso J-P, 2014, CLIMATE CHANGE 201 A; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Gruber N, 2012, SCIENCE, V337, P220, DOI 10.1126/science.1216773; Haigh R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117533; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Hodgson E, 2014, APPENDIX MANAGEMENT; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 201 A; Hofmann GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028983; Home P.J., 2010, NMFSNWFSC104 NOAA; Kaplan IC, 2014, UPDATE 2014 METHODOL; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kaplan IC, 2010, CAN J FISH AQUAT SCI, V67, P1968, DOI 10.1139/F10-118; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; McElhany P, 2013, MAR BIOL, V160, P1807, DOI 10.1007/s00227-012-2052-0; Meyer J, 2015, BIOGEOSCIENCES, V12, P1671, DOI 10.5194/bg-12-1671-2015; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Miller JJ, 2016, MAR BIOL, V163, P1; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; National Marine Fisheries Service, 2015, NOAA CURR FISH STAT, V2014; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Padilla-Gamino JL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0155; Pespeni MH, 2013, INTEGR COMP BIOL, V53, P857, DOI 10.1093/icb/ict094; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Reum JCP, 2016, ICES J MAR SCI, V73, P582, DOI 10.1093/icesjms/fsu231; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ross PM, 2011, WATER-SUI, V3, P1005, DOI 10.3390/w3041005; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; SCHINDLER DW, 1985, SCIENCE, V228, P1395, DOI 10.1126/science.228.4706.1395; Tatters AO, 2013, EVOLUTION, V67, P1879, DOI 10.1111/evo.12029; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Tukey JW, 1977, EXPLORATORY DATA ANA; Udovydchenkov IA, 2010, J ACOUST SOC AM, V128, pEL130, DOI 10.1121/1.3402284; Waldbusser GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128376; Wittmann AC, 2013, NAT CLIM CHANGE, V3, P995, DOI 10.1038/NCLIMATE1982	64	32	32	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160669	10.1371/journal.pone.0160669	http://dx.doi.org/10.1371/journal.pone.0160669			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513576	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100056
J	Jian, JW; Elumalai, P; Pitti, T; Wu, CY; Tsai, KC; Chang, JY; Peng, HP; Yang, AS				Jian, Jhih-Wei; Elumalai, Pavadai; Pitti, Thejkiran; Wu, Chih Yuan; Tsai, Keng-Chang; Chang, Jeng-Yih; Peng, Hung-Pin; Yang, An-Suei			Predicting Ligand Binding Sites on Protein Surfaces by 3-Dimensional Probability Density Distributions of Interacting Atoms	PLOS ONE			English	Article							POCKETS; IDENTIFICATION; DATABASE; ALGORITHM; SITEHOUND; CAVITIES; FINDSITE	Predicting ligand binding sites (LBSs) on protein structures, which are obtained either from experimental or computational methods, is a useful first step in functional annotation or structure-based drug design for the protein structures. In this work, the structure-based machine learning algorithm ISMBLab-LIG was developed to predict LBSs on protein surfaces with input attributes derived from the three-dimensional probability density maps of interacting atoms, which were reconstructed on the query protein surfaces and were relatively insensitive to local conformational variations of the tentative ligand binding sites. The prediction accuracy of the ISMBLab-LIG predictors is comparable to that of the best LBS predictors benchmarked on several well-established testing datasets. More importantly, the ISMBLab-LIG algorithm has substantial tolerance to the prediction uncertainties of computationally derived protein structure models. As such, the method is particularly useful for predicting LBSs not only on experimental protein structures without known LBS templates in the database but also on computationally predicted model protein structures with structural uncertainties in the tentative ligand binding sites.	[Jian, Jhih-Wei; Elumalai, Pavadai; Pitti, Thejkiran; Wu, Chih Yuan; Tsai, Keng-Chang; Chang, Jeng-Yih; Peng, Hung-Pin; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Jian, Jhih-Wei] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 11221, Taiwan; [Jian, Jhih-Wei; Pitti, Thejkiran] Acad Sinica, Inst Informat Sci, Bioinformat Program, Taiwan Int Grad Program, Taipei 115, Taiwan; [Pitti, Thejkiran] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Elumalai, Pavadai] Univ Cape Town, South African Med Res Council, Drug Discovery & Dev Res Unit, ZA-7701 Rondebosch, South Africa; [Tsai, Keng-Chang] Natl Res Inst Chinese Med, 155-1,Sec 2,Linong St, Taipei 11221, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Tsing Hua University; South African Medical Research Council; University of Cape Town; National Research Institute of Chinese Medicine	Yang, AS (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	yangas@gate.sinica.edu.tw	Pavadai, Elumalai/AAE-3232-2021	Yang, An-Suei/0000-0002-4699-873X; Tsai, Keng-Chang/0000-0001-8277-9174	Ministry of Science and Technology (MoST) in Taiwan [103-2622-B-001-001-CC2, 103-2325-B-001-023]; Academia Sinica [104-0210-01-09-02]	Ministry of Science and Technology (MoST) in Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	ASY received the funding [1] (103-2622-B-001-001-CC2 and 103-2325-B-001-023) from Ministry of Science and Technology (MoST) in Taiwan (https://www.most.gov.tw/) [2] 104-0210-01-09-02 from Academia Sinica (https://www.sinica.edu.tw/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amemiya T, 2012, NUCLEIC ACIDS RES, V40, pD554, DOI 10.1093/nar/gkr966; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Bray T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-379; Brylinski M, 2008, P NATL ACAD SCI USA, V105, P129, DOI 10.1073/pnas.0707684105; Brylinski M, 2010, J CHEM INF MODEL, V50, P1839, DOI 10.1021/ci100235n; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Cassarino TG, 2014, PROTEINS, V82, P154, DOI 10.1002/prot.24495; Chen CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037706; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Gao M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003302; Ghersi Dario, 2011, Journal of Structural and Functional Genomics, V12, P109, DOI 10.1007/s10969-011-9110-6; Ghersi D, 2009, BIOINFORMATICS, V25, P3185, DOI 10.1093/bioinformatics/btp562; Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Henrich S, 2010, J MOL RECOGNIT, V23, P209, DOI 10.1002/jmr.984; Hernandez M, 2009, NUCLEIC ACIDS RES, V37, pW413, DOI 10.1093/nar/gkp281; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Huang BD, 2009, OMICS, V13, P325, DOI 10.1089/omi.2009.0045; Kawabata T, 2007, PROTEINS, V68, P516, DOI 10.1002/prot.21283; Kawabata T, 2010, PROTEINS, V78, P1195, DOI 10.1002/prot.22639; Khazanov NA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003321; Laurie ATR, 2006, CURR PROTEIN PEPT SC, V7, P395; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Ngan CH, 2012, BIOINFORMATICS, V28, P286, DOI 10.1093/bioinformatics/btr651; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Puvanendrampillai D, 2003, BIOINFORMATICS, V19, P1856, DOI 10.1093/bioinformatics/btg243; Roche DB, 2010, BIOINFORMATICS, V26, P2920, DOI 10.1093/bioinformatics/btq543; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2012, STRUCTURE, V20, P987, DOI 10.1016/j.str.2012.03.009; Skolnick J, 2013, CURR OPIN STRUC BIOL, V23, P191, DOI 10.1016/j.sbi.2013.01.009; Skolnick J, 2009, BRIEF BIOINFORM, V10, P378, DOI 10.1093/bib/bbp017; Tsai KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040846; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xie ZR, 2015, METHODS MOL BIOL, V1215, P383, DOI 10.1007/978-1-4939-1465-4_17; Xie ZR, 2012, BIOINFORMATICS, V28, P1579, DOI 10.1093/bioinformatics/bts182; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yu CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033340; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	52	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160315	10.1371/journal.pone.0160315	http://dx.doi.org/10.1371/journal.pone.0160315			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513851	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100032
J	Kim, HS; Min, SI; Han, A; Choi, C; Min, SK; Ha, J				Kim, Hyun Soo; Min, Sang-il; Han, Ahram; Choi, Chanjoong; Min, Seung-Kee; Ha, Jongwon			Longitudinal Evaluation of Segmental Arterial Mediolysis in Splanchnic Arteries: Case Series and Systematic Review	PLOS ONE			English	Review							OF-THE-LITERATURE; SUPERIOR MESENTERIC-ARTERY; INTERNAL CAROTID-ARTERY; COLIC ARTERY; FOLLOW-UP; PANCREATICODUODENAL ARTERY; FIBROMUSCULAR DYSPLASIA; DISSECTING ANEURYSM; SPONTANEOUS RUPTURE; VISCERAL ARTERIES	Background Segmental arterial mediolysis (SAM) is a rare non-atherosclerotic, non-inflammatory vascular disorder varying widely in clinical course. The purpose of this study is to analyze detailing clinical and imaging manifestations over time in patients with SAM through a literature review and to suggest an optimal management strategy. Methods A retrospective review of eight consecutive patients diagnosed with SAM between January, 2000 and January, 2012 was conducted. All presented with acute-onset abdominal or flank pain. Clinical features, imaging studies, and laboratory findings served as grounds for diagnosis, having excluded more common conditions (ie, fibromuscular dysplasia, collagen vascular disorders, or arteritis). CT angiography was done initially and repeated periodically (Week 1, Month 3, then yearly). Treatment was conservative, utilizing endovascular intervention as warranted by CT diagnostics. In a related systematic review, all English literature from 1976 to 2015 was screened via the PubMed database, assessing patient demographics, affected arteries, clinical presentations, and treatment methods. Findings Ultimately, 25 arterial lesions identified in eight patients (median age, 62.8 years; range, 40-84 years) were monitored for a median period of 26 months (range, 15-57 months). At baseline, celiac axis (3/8, 37.5%), superior mesenteric (4/8, 50%), and common hepatic (2/8, 25%) arteries were involved, in addition to isolated lesions of right renal, splenic, right colic, middle colic, gastroduodenal, left gastric, right gastroepiploic, proper hepatic, right hepatic, and left hepatic arteries. Compared with prior publications, celiac axis and superior mesenteric artery were more commonly affected in cohort. Arterial dissections (n = 8), aneurysms (n = 5), stenoses or occlusions (n = 4), and a single pseudoaneurysm were documented. Despite careful conservative management, new splanchnic arterial lesions (n = 4) arose during follow-up. Considering the few available reports of new arterial lesions in the literature, newly developing pathology is a distinctive feature of our patients, four of whom eventually required endovascular interventions. Conclusions Careful clinical observation via periodic CT angiography is required in patients with SAM, checking for newly developing lesions. The natural history of SAM should be clarified in a larger patient population.	[Kim, Hyun Soo; Min, Sang-il; Han, Ahram; Choi, Chanjoong; Min, Seung-Kee; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea	Seoul National University (SNU)	Min, SI (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.	surgeonmsi@gmail.com		Choi, Chanjoong/0000-0002-7116-2619				Abdelrazeq Ayman S, 2008, Cardiovasc Intervent Radiol, V31 Suppl 2, pS108; Agarwal S, 2009, INDIAN J GASTROENTER, V28, P72, DOI 10.1007/s12664-009-0023-2; Alturkustani M, 2013, AM J FOREN MED PATH, V34, P98, DOI 10.1097/PAF.0b013e31828879e8; ARMAS OA, 1992, ARCH PATHOL LAB MED, V116, P531; Baker-Lepain JC, 2010, ARTHRIT CARE RES, V62, P1655, DOI 10.1002/acr.20294; Basso MC, 2005, PATHOL INT, V55, P632, DOI 10.1111/j.1440-1827.2005.01881.x; Chan RJ, 1998, ARTHRITIS RHEUM, V41, P935, DOI 10.1002/1529-0131(199805)41:5<935::AID-ART22>3.0.CO;2-N; Chino Osamu, 2004, Tokai J Exp Clin Med, V29, P155; Cooke DL, 2013, J NEUROINTERV SURG, V5, P478, DOI 10.1136/neurintsurg-2012-010323; Davran R, 2010, CARDIOVASC INTER RAD, V33, P601, DOI 10.1007/s00270-009-9651-2; Eifinger Frank, 2004, J Perinatol, V24, P461, DOI 10.1038/sj.jp.7211130; ESKENASYCOTTIER AC, 1994, CLIN NEUROPATHOL, V13, P329; Filippone EJ, 2011, AM J KIDNEY DIS, V58, P981, DOI 10.1053/j.ajkd.2011.05.031; Fujiwara Yushi, 2010, Osaka City Med J, V56, P47; Gahide G, 2011, KIDNEY INT, V80, P1002, DOI 10.1038/ki.2011.279; Galketiya K, 2016, ANZ J SURG, V86, P201, DOI 10.1111/ans.12654; Ha HK, 2000, RADIOGRAPHICS, V20, P779, DOI 10.1148/radiographics.20.3.g00mc02779; Hashimoto T, 2008, J VASC SURG, V48, P1338, DOI 10.1016/j.jvs.2008.05.056; Hatogai Ken, 2012, Nihon Shokakibyo Gakkai Zasshi, V109, P247; HERITZ DM, 1990, J VASC SURG, V12, P561, DOI 10.1067/mva.1990.24040; Hirakawa E, 2005, HISTOPATHOLOGY, V47, P544, DOI 10.1111/j.1365-2559.2005.02149.x; Hirokawa T, 2009, SURG TODAY, V39, P144, DOI 10.1007/s00595-008-3811-x; Horsley-Silva JL, 2014, J PANCREAS, V15, P72, DOI 10.6092/1590-8577/2036; Imai MA, 2005, PATHOL INT, V55, P290, DOI 10.1111/j.1440-1827.2005.01827.x; Inada K, 2007, PATHOL RES PRACT, V203, P771, DOI 10.1016/j.prp.2007.07.010; INAYAMA Y, 1992, ACTA PATHOL JAPON, V42, P201; Ito M R, 1995, Ryumachi, V35, P693; Ito Nobuhisa, 2012, J Med Case Rep, V6, P307, DOI 10.1186/1752-1947-6-307; Jibiki M, 2005, EUR J VASC ENDOVASC, V29, P213, DOI 10.1016/j.ejvs.2004.09.010; JUVONEN T, 1994, EUR J VASCULAR SURG, V8, P96, DOI 10.1016/S0950-821X(05)80128-8; Kalva SP, 2011, J VASC INTERV RADIOL, V22, P1380, DOI 10.1016/j.jvir.2011.07.001; Kato T, 1996, Cardiovasc Surg, V4, P644, DOI 10.1016/0967-2109(95)00145-X; Keuleers Siegmund, 2009, Eur J Intern Med, V20, pe9, DOI 10.1016/j.ejim.2008.07.035; Khan NU, 2009, J HEART LUNG TRANSPL, V28, P977, DOI 10.1016/j.healun.2009.05.013; Kidogawa Hideo, 2013, Nihon Shokakibyo Gakkai Zasshi, V110, P1831; Kimura Y, 2015, INTERACT CARDIOV TH, V21, P814, DOI 10.1093/icvts/ivv249; Lefevre G, 2014, MEDICINE, V93, P255, DOI 10.1097/MD.0000000000000088; Liao CY, 2017, GASTROENTEROL REP, V5, P244, DOI 10.1093/gastro/gov030; LIE JT, 1992, ARCH PATHOL LAB MED, V116, P238; Marshall L, 2015, ANZ J SURG, V85, P49, DOI 10.1111/ans.12304; Matsuda R, 2012, J NEUROSURG, V116, P948, DOI 10.3171/2012.1.JNS111967; Matsuda Y, 2015, WORLD J GASTROINT SU, V7, P78, DOI 10.4240/wjgs.v7.i5.78; Michael M, 2006, AM J ROENTGENOL, V187, P1463, DOI 10.2214/AJR.05.0281; Min SI, 2011, J VASC SURG, V54, P461, DOI 10.1016/j.jvs.2011.03.001; Mizutani Kosuke, 2008, Hinyokika Kiyo, V54, P489; Muller AM, 2006, PATHOLOGE, V27, P152, DOI 10.1007/s00292-006-0821-6; Nagashima Y, 1998, PATHOL RES PRACT, V194, P643, DOI 10.1016/S0344-0338(98)80101-5; Naitoh I, 2010, J PANCREAS, V11, P625; Nishimura Kengo, 2014, Ann Vasc Dis, V7, P328, DOI 10.3400/avd.cr.14-00058; Nishiyama Sayaka, 2004, J Clin Forensic Med, V11, P268, DOI 10.1016/j.jcfm.2004.04.010; Obara H, 2006, J VASC SURG, V43, P623, DOI 10.1016/j.jvs.2005.11.033; Obara H, 2011, J VASC SURG, V54, P1488, DOI 10.1016/j.jvs.2011.04.053; Ohta H, 2003, ACTA NEUROCHIR, V145, P805, DOI 10.1007/s00701-003-0079-1; Oki Takashi, 2011, Hinyokika Kiyo, V57, P611; Peters M, 1995, NEUROLOGY, V45, P2284, DOI 10.1212/WNL.45.12.2284; Phillips Courtney K, 2006, Rev Urol, V8, P36; Rengstorff DS, 2004, DIS COLON RECTUM, V47, P769, DOI 10.1007/s10350-003-0103-9; Ro A, 2010, CARDIOVASC PATHOL, V19, P248, DOI 10.1016/j.carpath.2009.02.002; Ro Ayako, 2008, Leg Med (Tokyo), V10, P101, DOI 10.1016/j.legalmed.2007.08.002; Rosenfelder NA, 2006, EUR J GASTROEN HEPAT, V18, P295, DOI 10.1097/00042737-200603000-00012; Ruderman I, 2015, NEPHROLOGY, V20, P224, DOI 10.1111/nep.12360; Ryan JM, 2000, J VASC INTERV RADIOL, V11, P865, DOI 10.1016/S1051-0443(07)61802-8; Sakano T, 1997, BRIT J RADIOL, V70, P656, DOI 10.1259/bjr.70.834.9227264; Sakata N, 2002, PATHOL RES PRACT, V198, P493, DOI 10.1078/0344-0338-00290; Shenouda M, 2014, ANN VASC SURG, V28, P269, DOI 10.1016/j.avsg.2013.03.003; Shimohira M, 2008, J ENDOVASC THER, V15, P493, DOI 10.1583/08-2384.1; SLAVIN RE, 1976, LAB INVEST, V35, P23; SLAVIN RE, 1995, MODERN PATHOL, V8, P287; SLAVIN RE, 1989, AM J SURG PATHOL, V13, P558, DOI 10.1097/00000478-198907000-00003; Slavin RE, 2007, INT J SURG PATHOL, V15, P121, DOI 10.1177/1066896906297684; Soga Y, 2009, PATHOL INT, V59, P197, DOI 10.1111/j.1440-1827.2009.02351.x; Soulen MC, 2004, J VASC INTERV RADIOL, V15, P763, DOI 10.1097/01.RVI.0000133543.32123.DC; STANLEY JC, 1975, ARCH SURG-CHICAGO, V110, P561; Tabassum A, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-26; Takagi C, 2003, INTERNAL MED, V42, P818, DOI 10.2169/internalmedicine.42.818; Takahashi Yuko, 2007, Nihon Rinsho Meneki Gakkai Kaishi, V30, P193; Tameo MN, 2011, J VASC SURG, V53, P1107, DOI 10.1016/j.jvs.2010.11.034; Tomonaga T, 2011, HEPATO-GASTROENTEROL, V58, P1912, DOI 10.5754/hge10177; Ushijima Tomoki, 2013, Ann Vasc Dis, V6, P198, DOI 10.3400/avd.cr.12.00094; Wang Janet-Jing-Ling, 1994, Journal of the Formosan Medical Association, V93, P715; Yamada M, 2004, J VASC SURG, V39, P246, DOI 10.1016/j.jvs.2003.07.022; Yamakawa H, 2005, CLIN NEUROL NEUROSUR, V107, P117, DOI 10.1016/j.clineuro.2004.01.007; Yamamoto T, 2014, J GASTROEN HEPATOL, V29, P1129, DOI 10.1111/jgh.12603; Yoo BR, 2012, J CLIN ULTRASOUND, V40, P255, DOI 10.1002/jcu.21906; Yoshida H, 2013, CLIN J GASTROENTEROL, V6, P447, DOI 10.1007/s12328-013-0433-7	85	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161182	10.1371/journal.pone.0161182	http://dx.doi.org/10.1371/journal.pone.0161182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513466	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100127
J	Kono, S; Yamamoto, H; Kushida, T; Hirano-Iwata, A; Niwano, M; Tanii, T				Kono, Sho; Yamamoto, Hideaki; Kushida, Takatoshi; Hirano-Iwata, Ayumi; Niwano, Michio; Tanii, Takashi			Live-Cell, Label-Free Identification of GABAergic and Non-GABAergic Neurons in Primary Cortical Cultures Using Micropatterned Surface	PLOS ONE			English	Article							NETWORKS; POLARITY; INHIBITION; APOPTOSIS; GROWTH; DEATH	Excitatory and inhibitory neurons have distinct roles in cortical dynamics. Here we present a novel method for identifying inhibitory GABAergic neurons from non-GABAergic neurons, which are mostly excitatory glutamatergic neurons, in primary cortical cultures. This was achieved using an asymmetrically designed micropattern that directs an axonal process to the longest pathway. In the current work, we first modified the micropattern geometry to improve cell viability and then studied the axon length from 2 to 7 days in vitro (DIV). The cell types of neurons were evaluated retrospectively based on immunoreactivity against GAD67, a marker for inhibitory GABAergic neurons. We found that axons of non-GABAergic neurons grow significantly longer than those of GABAergic neurons in the early stages of development. The optimal threshold for identifying GABAergic and non-GABAergic neurons was evaluated to be 110 mu m at 6 DIV. The method does not require any fluorescence labelling and can be carried out on live cells. The accuracy of identification was 98.2%. We confirmed that the high accuracy was due to the use of a micropattern, which standardized the development of cultured neurons. The method promises to be beneficial both for engineering neuronal networks in vitro and for basic cellular neuroscience research.	[Kono, Sho; Kushida, Takatoshi; Tanii, Takashi] Waseda Univ, Grad Sch Fundamental Sci & Engn, Tokyo, Japan; [Kono, Sho] JSPS, Tokyo, Japan; [Yamamoto, Hideaki] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan; [Hirano-Iwata, Ayumi] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi, Japan; [Niwano, Michio] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan	Waseda University; Japan Society for the Promotion of Science; Tohoku University; Tohoku University; Tohoku University	Tanii, T (corresponding author), Waseda Univ, Grad Sch Fundamental Sci & Engn, Tokyo, Japan.; Yamamoto, H (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi, Japan.	h-yamamoto@bme.tohoku.ac.jp; tanii@waseda.jp	Hirano-Iwata, Ayumi/T-3350-2019	Hirano-Iwata, Ayumi/0000-0002-3043-7698; Yamamoto, Hideaki/0000-0003-3362-5376	Japan Society for the Promotion of Science (JSPS) [26390035]; Asahi Glass Foundation;  [15K17449]; Grants-in-Aid for Scientific Research [15K17449] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Glass Foundation; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) (26390035), Grant-in-Aid for Young Scientists (B) (15K17449), and Grant-in-Aid for JSPS Fellows, and by a research grant from the Asahi Glass Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus CA, 2013, TRENDS CELL BIOL, V23, P305, DOI 10.1016/j.tcb.2013.02.001; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Brewer GJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00165; BRIGHT J, 1994, BIOSCIENCE REP, V14, P67; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Chang CL, 2014, J NEUROSCI, V34, P855, DOI 10.1523/JNEUROSCI.0229-13.2014; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Feinerman O, 2008, NAT PHYS, V4, P967, DOI 10.1038/nphys1099; Fricke R, 2011, BIOMATERIALS, V32, P2070, DOI 10.1016/j.biomaterials.2010.11.036; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hayashi K, 2003, J CELL SCI, V116, P4419, DOI 10.1242/jcs.00762; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kato-Negishi M, 2004, DEV BRAIN RES, V152, P99, DOI 10.1016/j.devbrainres.2004.05.013; Kawano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048034; Levy O, 2012, EUR J NEUROSCI, V35, P1753, DOI 10.1111/j.1460-9568.2012.08094.x; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; Offenhausser A, 2007, SOFT MATTER, V3, P290, DOI 10.1039/b607615g; RE F, 1994, J CELL BIOL, V127, P537, DOI 10.1083/jcb.127.2.537; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033623; Shein Idelson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014443; Stenger DA, 1998, J NEUROSCI METH, V82, P167, DOI 10.1016/S0165-0270(98)00047-8; Suzuki Ikurou, 2004, J Nanobiotechnology, V2, P7, DOI 10.1186/1477-3155-2-7; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tessadori J, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00099; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Toriyama M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.51; Vishwanathan A, 2011, LAB CHIP, V11, P1081, DOI [10.1039/c0lc00450b, 10.1039/c01c00450b]; Wheeler BC, 2010, P IEEE, V98, P398, DOI 10.1109/JPROC.2009.2039029; Wilson NR, 2007, J NEUROSCI, V27, P13581, DOI 10.1523/JNEUROSCI.3863-07.2007; Yamamoto H, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3610998; Yamamoto H, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.012407; Yamamoto H, 2012, J NEUROCHEM, V123, P904, DOI 10.1111/jnc.12001; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	39	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160987	10.1371/journal.pone.0160987	http://dx.doi.org/10.1371/journal.pone.0160987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513933	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100105
J	Krak, K; Vit, P; Belyayev, A; Douda, J; Hreusova, L; Mandak, B				Krak, Karol; Vit, Petr; Belyayev, Alexander; Douda, Jan; Hreusova, Lucia; Mandak, Bohumil			Allopolyploid Origin of Chenopodium album s. str. (Chenopodiaceae): A Molecular and Cytogenetic Insight	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; NATURAL-POPULATIONS; CONCERTED EVOLUTION; POLYPLOID FORMATION; CARDAMINE BRASSICACEAE; RECURRENT FORMATION; CHLOROPLAST GENOME; MULTIPLE ORIGINS; REYNOUTRIA TAXA; SEQUENCES	Reticulate evolution is characterized by occasional hybridization between two species, creating a network of closely related taxa below and at the species level. In the present research, we aimed to verify the hypothesis of the allopolyploid origin of hexaploid C. album s. str., identify its putative parents and estimate the frequency of allopolyploidization events. We sampled 122 individuals of the C. album aggregate, covering most of its distribution range in Eurasia. Our samples included putative progenitors of C. album s. str. of both ploidy levels, i.e. diploids (C. ficifolium, C. suecicum) and tetraploids (C. striatiforme, C. strictum). To fulfil these objectives, we analysed sequence variation in the nrDNA ITS region and the rpl32-trnL intergenic spacer of cpDNA and performed genomic in-situ hybridization (GISH). Our study confirms the allohexaploid origin of C. album s. str. Analysis of cpDNA revealed tetraploids as the maternal species. In most accessions of hexaploid C. album s. str., ITS sequences were completely or nearly completely homogenized towards the tetraploid maternal ribotype; a tetraploid species therefore served as one genome donor. GISH revealed a strong hybridization signal on the same eighteen chromosomes of C. album s. str. with both diploid species C. ficifolium and C. suecicum. The second genome donor was therefore a diploid species. Moreover, some individuals with completely unhomogenized ITS sequences were found. Thus, hexaploid individuals of C. album s. str. with ITS sequences homogenized to different degrees may represent hybrids of different ages. This proves the existence of at least two different allopolyploid lineages, indicating a polyphyletic origin of C. album s. str.	[Krak, Karol; Vit, Petr; Belyayev, Alexander; Douda, Jan; Hreusova, Lucia; Mandak, Bohumil] Czech Acad Sci, Inst Bot, Zamek 1, CZ-25243 Pruhonice, Czech Republic; [Krak, Karol; Vit, Petr; Douda, Jan; Hreusova, Lucia; Mandak, Bohumil] Czech Univ Life Sci Prague, Fac Environm Sci, Kamycka 129, CZ-16521 Prague 6, Suchdol, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Czech University of Life Sciences Prague	Krak, K (corresponding author), Czech Acad Sci, Inst Bot, Zamek 1, CZ-25243 Pruhonice, Czech Republic.; Krak, K (corresponding author), Czech Univ Life Sci Prague, Fac Environm Sci, Kamycka 129, CZ-16521 Prague 6, Suchdol, Czech Republic.	karol.krak@ibot.cas.cz	Belyayev, Alexander/G-1611-2014; Vit, Petr/J-3278-2014	Belyayev, Alexander/0000-0002-8933-6197; Vit, Petr/0000-0003-3997-928X; Krak, Karol/0000-0002-0340-2086; Douda, Jan/0000-0002-1205-364X; Mandak, Bohumil/0000-0002-9545-7497	Grant Agency of the Czech Republic [13-02290S];  [RVO 67985939]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); 	This study was supported by the Grant Agency of the Czech Republic (13-02290S) and as part of long-term research development project RVO 67985939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aellen P., 1960, ILLUSTRIERTE FLORA M, V3/2, P569; Aguilar JF, 1999, MOL ECOL, V8, P1341, DOI 10.1046/j.1365-294X.1999.00690.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Belyayev A, 2000, GENOME, V43, P1021, DOI 10.1139/gen-43-6-1021; Belyayev A, 2001, CHROMOSOME RES, V9, P129, DOI 10.1023/A:1009231019833; Bhargava A, 2006, GENET RESOUR CROP EV, V53, P1309, DOI 10.1007/s10722-005-3879-8; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cook LM, 1998, MOL ECOL, V7, P1293, DOI 10.1046/j.1365-294x.1998.00453.x; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Dvorak F., 1993, Feddes Repertorium, V104, P439, DOI 10.1002/fedr.19931040704; DVORAK F, 1992, Feddes Repertorium, V103, P153, DOI 10.1002/fedr.19921030302; DVORAK F, 1990, Feddes Repertorium, V101, P347, DOI 10.1002/fedr.19901010706; Dvorak F., 1994, Feddes Repertorium, V105, P113; DVORAK F, 1992, Feddes Repertorium, V103, P49; ELDER JF, 1995, Q REV BIOL, V70, P297, DOI 10.1086/419073; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Fuentes-Bazan S, 2012, WILLDENOWIA, V42, P5, DOI 10.3372/wi42.42101; Fuentes-Bazan S, 2012, MOL PHYLOGENET EVOL, V62, P359, DOI 10.1016/j.ympev.2011.10.006; Gangopadhyay G, 2002, GENET RESOUR CROP EV, V49, P503, DOI 10.1023/A:1020909128003; GIUSTI L, 1970, Darwiniana (San Isidro), V16, P98; Grozeva N, FLORA MEDITERRANEA, V16, P400; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRISON JSH, 1996, METHODS GENOME ANAL, P163; Hodac L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt HV, 2011, ANN BOT-LONDON, V108, P143, DOI 10.1093/aob/mcr118; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; Juttersonke B, 1989, FEDDES REPERT, V100, P1; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawatani T., 1956, JPN J GENET, V31, P15, DOI [10.1266/jjg.31.15, DOI 10.1266/JJG.31.15]; KAWATANI TOYOHIKO, 1950, JAPANESE JOUR GENETICS, V25, P177, DOI 10.1266/jjg.25.177; Keener C.S., 1970, SIDA, V3, P533; Koch MA, 2003, MOL BIOL EVOL, V20, P338, DOI 10.1093/molbev/msg046; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Kolano B, 2011, GENOME, V54, P710, DOI 10.1139/G11-035; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Lomonosova M. N., 1994, Botanicheskii Zhurnal (St. Petersburg), V79, P124; Lomonosova M. N., 2001, Botanicheskii Zhurnal (St. Petersburg), V86, P145; Lomonosova M. N., 2003, Botanicheskii Zhurnal (St. Petersburg), V88, P130; Lowe AJ, 1996, AM J BOT, V83, P1365, DOI 10.2307/2446125; Lysak MA, 2001, PLANT J, V28, P689, DOI 10.1046/j.1365-313x.2001.01194.x; Malinska H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-291; Mandak B, 2005, PLANT SYST EVOL, V253, P219, DOI 10.1007/s00606-005-0316-6; Mandak B, 2004, PRESLIA, V76, P15; Mandak B, 2003, ANN BOT-LONDON, V92, P265, DOI 10.1093/aob/mcg141; Mandak B, 2016, PERSPECT PLANT ECOL; Mandak B, 2012, FLORA, V207, P530, DOI 10.1016/j.flora.2012.03.010; Mason AS, 2015, TRENDS GENET, V31, P5, DOI 10.1016/j.tig.2014.09.011; Mavrodiev EV, 2015, NEW PHYTOL, V206, P1172, DOI 10.1111/nph.13227; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nylander JAA., 2004, BIOINFORMATICS; PALOMINO G, 1990, SOUTHWEST NAT, V35, P351; PIJNACKER LP, 1984, CAN J GENET CYTOL, V26, P415, DOI 10.1139/g84-067; Queiroz CD, 2011, MOL PHYLOGENET EVOL, V59, P293, DOI 10.1016/j.ympev.2011.01.013; Rahiminejad MR, 2004, PLANT SYST EVOL, V246, P77, DOI 10.1007/s00606-003-0108-9; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2007, HEREDITY, V98, P143, DOI 10.1038/sj.hdy.6800912; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Segraves KA, 1999, MOL ECOL, V8, P253, DOI 10.1046/j.1365-294X.1999.00562.x; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shimizu-Inatsugi R, 2009, MOL ECOL, V18, P4024, DOI 10.1111/j.1365-294X.2009.04329.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Storchova H, 2015, GENET RESOUR CROP EV, V62, P913, DOI 10.1007/s10722-014-0200-8; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang L, 2015, NORD J BOT, V33, P109, DOI 10.1111/j.1756-1051.2012.00108.x; THOMPSON JD, 1992, TRENDS ECOL EVOL, V7, P302, DOI 10.1016/0169-5347(92)90228-4; Uotila P., 1973, Annales Botanici Fennici, V10, P337; UOTILA P, 1972, Annales Botanici Fennici, V9, P29; Uotila P, 1978, ACTA BOT FENN, V108, P1; Uotila P., 2001, FLORA NORDICA, V2, P4; Uotila P., 1997, FLORA DES IRANISCHEN, V172, P24; Vit P, 2016, BOT J LIN S IN PRESS; Walsh BM, 2015, AM J BOT, V102, P533, DOI 10.3732/ajb.1400344; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhong XB, 1996, CHROMOSOME RES, V4, P24, DOI 10.1007/BF02254940; Zhu G.L., 2003, FLORA CHINA, V5, P351; Zozomova-Lihova J, 2014, NEW PHYTOL, V203, P1096, DOI 10.1111/nph.12873; Zozomova-Lihova J, 2014, ANN BOT-LONDON, V113, P817, DOI 10.1093/aob/mcu012	88	33	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161063	10.1371/journal.pone.0161063	http://dx.doi.org/10.1371/journal.pone.0161063			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513342	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100117
J	Robinson-Cohen, C; Newitt, R; Shen, DD; Rettie, AE; Kestenbaum, BR; Himmelfarb, J; Yeung, CK				Robinson-Cohen, Cassianne; Newitt, Richard; Shen, Danny D.; Rettie, Allan E.; Kestenbaum, Bryan R.; Himmelfarb, Jonathan; Yeung, Catherine K.			Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients	PLOS ONE			English	Article							FISH ODOR SYNDROME; MONOOXYGENASE 3; CARDIOVASCULAR OUTCOMES; CYSTATIN-C; GENE; POLYMORPHISMS; RISK; IDENTIFICATION; METABOLISM; MUTATIONS	Elevated levels of circulating pro-atherogenic uremic solutes, particularly trimethylamine N-oxide (TMAO), have been implicated in cardiovascular disease development in patients with chronic kidney disease (CKD). TMAO is generated from trimethylamine (TMA) via metabolism by hepatic flavin-containing monooxygenase isoform 3 (FMO3). We determined the functional effects of three common FMO3 variants at amino acids 158, 308, and 257 on TMAO concentrations in a prospective cohort study and evaluated associations of polymorphisms with CKD progression and mortality. Each additional minor allele at amino acid 158 was associated with a 0.38 mu g/mL higher circulating TMAO (p = 0.01) and with faster rates of annualized relative eGFR decline. Participants with 0, 1 and 2 variant alleles averaged an eGFR loss of 8%, 12%, and 14% per year, respectively (p-for trend = 0.05). Compared to participants with the homozygous reference allele, heterozygous and homozygous variant participants had a 2.0-fold (95% CI: 0.85, 4.6) and 2.2-fold (95% CI: 0.89, 5.48) higher risk of mortality, respectively (p-for-trend = 0.04). No associations with clinical outcomes were observed for allelic variants at amino acids 257 or 308. Understanding the contribution of genetic variation of FMO3 to disease progression and all-cause mortality can guide recommendations for diet modification or pharmacotherapy in CKD patients at increased risk of adverse outcomes.	[Robinson-Cohen, Cassianne; Newitt, Richard; Kestenbaum, Bryan R.; Himmelfarb, Jonathan; Yeung, Catherine K.] Univ Washington, Dept Med, Div Nephrol, Kidney Res Inst, Seattle, WA 98195 USA; [Shen, Danny D.; Yeung, Catherine K.] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA; [Rettie, Allan E.] Univ Washington, Sch Pharm, Dept Med Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Yeung, CK (corresponding author), Univ Washington, Dept Med, Div Nephrol, Kidney Res Inst, Seattle, WA 98195 USA.; Yeung, CK (corresponding author), Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA.	cathyy@u.washington.edu	Robinson-Cohen, Cassianne/ABB-4985-2021	Robinson-Cohen, Cassianne/0000-0003-4783-7046	Norman S. Coplon Extramural Grant Program by Satellite Healthcare; National Institutes of Health National Center for Advancing Translational Sciences [KL2 TR000421]	Norman S. Coplon Extramural Grant Program by Satellite Healthcare; National Institutes of Health National Center for Advancing Translational Sciences	These studies were supported by a grant from the Norman S. Coplon Extramural Grant Program by Satellite Healthcare, a not-for-profit renal care provider National Institute of Health (CKY), and the National Institutes of Health National Center for Advancing Translational Sciences Grant KL2 TR000421 (CKY). The authors also acknowledge The University of Washington Kidney Research Institute, supported by an unrestricted gift from the Northwest Kidney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman BR, 1999, MOL GENET METAB, V68, P24, DOI 10.1006/mgme.1999.2885; Allerston CK, 2007, PHARMACOGENET GENOM, V17, P827, DOI 10.1097/FPC.0b013e328256b198; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Bandyopadhyay A, 2012, NAT CHEM BIOL, V8, P238, DOI [10.1038/NCHEMBIO.768, 10.1038/nchembio.768]; BELL JD, 1991, BIOCHIM BIOPHYS ACTA, V1096, P101, DOI 10.1016/0925-4439(91)90046-C; Bushueva O, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/712169; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Dolan C, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-41; Echeverria D, 2010, J TOXICOL ENV HEAL A, V73, P1003, DOI 10.1080/15287390903566591; Kaysen GA, 2015, J RENAL NUTR, V25, P351, DOI 10.1053/j.jrn.2015.02.006; Koukouritaki SB, 2007, J PHARMACOL EXP THER, V320, P266, DOI 10.1124/jpet.106.112268; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mackay Richard J, 2011, Clin Biochem Rev, V32, P33; Mao M, 2009, PHARMACOGENOMICS, V10, P1447, DOI 10.2217/PGS.09.77; POULSEN LL, 1974, BIOCHEM PHARMACOL, V23, P3431, DOI 10.1016/0006-2952(74)90346-3; Robinson-Cohen C, 2012, J RENAL NUTR; Robinson-Cohen C, 2014, J AM SOC NEPHROL, V25, P399, DOI 10.1681/ASN.2013040392; Roshanravan B, 2012, AM J KIDNEY DIS, V60, P912, DOI 10.1053/j.ajkd.2012.05.017; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Shih DM, 2015, J LIPID RES, V56, P22, DOI 10.1194/jlr.M051680; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; TREACY E, 1995, J INHERIT METAB DIS, V18, P306, DOI 10.1007/BF00710420; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warrier M, 2015, CELL REP, V10, P326, DOI 10.1016/j.celrep.2014.12.036; Woods JS, 2014, NEUROTOXICOLOGY, V44, P288, DOI 10.1016/j.neuro.2014.07.010; Yeung CK, 2007, ARCH BIOCHEM BIOPHYS, V464, P251, DOI 10.1016/j.abb.2007.04.014; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang AQ, 1995, J INHERIT METAB DIS, V18, P669, DOI 10.1007/BF02436755; Zschocke J, 1999, LANCET, V354, P834	32	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161074	10.1371/journal.pone.0161074	http://dx.doi.org/10.1371/journal.pone.0161074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513517	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100118
J	Yuan, SY; Liu, J; Zhou, J; Lu, W; Zhou, HY; Long, LH; Hu, ZL; Ni, L; Wang, Y; Chen, JG; Wang, F				Yuan, Shi-Ying; Liu, Jue; Zhou, Jun; Lu, Wei; Zhou, Hai-Yun; Long, Li-Hong; Hu, Zhuang-Li; Ni, Lan; Wang, Yi; Chen, Jian-Guo; Wang, Fang			AMPK Mediates Glucocorticoids Stress-Induced Downregulation of the Glucocorticoid Receptor in Cultured Rat Prefrontal Cortical Astrocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEPRESSIVE-LIKE BEHAVIORS; HIPPOCAMPAL NEUROGENESIS; GENE-EXPRESSION; CORTEX; CORTICOSTERONE; TRANSCRIPTION; HYPOTHALAMUS; MECHANISM; RESPONSES	Chronic stress induces altered energy metabolism and plays important roles in the etiology of depression, in which the glucocorticoid negative feedback is disrupted due to imbalanced glucocorticoid receptor (GR) functions. The mechanism underlying the dysregulation of GR by chronic stress remains elusive. In this study, we investigated the role of AMP-activated protein kinase (AMPK), the key enzyme regulating cellular energy metabolism, and related signaling pathways in chronic stress-induced GR dysregulation. In cultured rat cortical astrocytes, glucocorticoid treatment decreased the level, which was accompanied by the decreased expression of liver kinase B1 (LKB1) and reduced phosphorylation of AMPK. Glucocorticoid-induced effects were attenuated by glucocorticoid-inducible kinase 1 (SGK1) inhibitor GSK650394, which also inhibited glucocorticoid induced phosphorylation of Forkhead box O3a (FOXO3a). Furthermore, glucocorticoid-induced down-regulation of GR was mimicked by the inhibition of AMPK and abolished by the AMPK activators or the histone deacetylase 5 (HDAC5) inhibitors. In line with the role of AMPK in GR expression, AMPK activator metformin reversed glucocorticoid-induced reduction of AMPK phosphorylation and GR expression as well as behavioral alteration of rats. Taken together, these results suggest that chronic stress activates SGK1 and suppresses the expression of LKB1 via inhibitory phosphorylation of FOXO3a. Downregulated LKB1 contributes to reduced activation of AMPK, leading to the dephosphorylation of HDAC5 and the suppression of transcription of GR.	[Yuan, Shi-Ying; Zhou, Jun; Lu, Wei; Zhou, Hai-Yun; Long, Li-Hong; Hu, Zhuang-Li; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pharmacol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Liu, Jue; Wang, Yi] Huazhong Univ Sci & Technol, Dept Pharm, Cent Hosp Wuhan, Tongji Med Coll, Wuhan, Peoples R China; [Long, Li-Hong; Hu, Zhuang-Li; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Minist Educ China, Key Lab Neurol Dis HUST, Wuhan, Hubei, Peoples R China; [Long, Li-Hong; Hu, Zhuang-Li; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan, Peoples R China; [Long, Li-Hong; Hu, Zhuang-Li; Ni, Lan; Chen, Jian-Guo; Wang, Fang] Huazhong Univ Sci & Technol, Inst Brain Res, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Ministry of Education, China; Huazhong University of Science & Technology	Wang, F (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pharmacol, Tongji Med Coll, Wuhan, Hubei, Peoples R China.; Wang, F (corresponding author), Minist Educ China, Key Lab Neurol Dis HUST, Wuhan, Hubei, Peoples R China.; Wang, F (corresponding author), Key Lab Drug Target Res & Pharmacodynam Evaluat H, Wuhan, Peoples R China.; Wang, F (corresponding author), Huazhong Univ Sci & Technol, Inst Brain Res, Wuhan, Peoples R China.	wangfangtj0322@163.com	wang, fang/GYD-4295-2022		National Basic Research Program of China (973 Program) [2013CB531303, 2014CB744601]; National Natural Science Foundation of China [81101003]; Chenguang Plan of Wuhan Municipal Science and Technology Bureau [2014070404010226]; National Major Scientific Instrument and Equipment Development Projects [2013YQ03092306]; PCSIRT [IRT13016]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chenguang Plan of Wuhan Municipal Science and Technology Bureau; National Major Scientific Instrument and Equipment Development Projects; PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the National Basic Research Program of China (973 Program, No. 2013CB531303 to J.-G. Chen, No. 2014CB744601 to F. Wang). It was supported by the National Natural Science Foundation of China (No. 81101003) and the Chenguang Plan of Wuhan Municipal Science and Technology Bureau to J. Liu (No. 2014070404010226). It was also supported by National Major Scientific Instrument and Equipment Development Projects (No. 2013YQ03092306) and PCSIRT (No. IRT13016) to J.G.C.	Anacker C, 2011, MOL PSYCHIATR, V16, P738, DOI 10.1038/mp.2011.26; Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Borsoi M, 2015, PHYSIOL BEHAV, V140, P79, DOI 10.1016/j.physbeh.2014.12.024; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Gadek-Michalska A, 2013, PHARMACOL REP, V65, P1163; Iio W, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-72; Johnson SA, 2006, BEHAV BRAIN RES, V168, P280, DOI 10.1016/j.bbr.2005.11.019; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karanth S, 1997, ENDOCRINOLOGY, V138, P3476, DOI 10.1210/en.138.8.3476; Kola B, 2006, TRENDS ENDOCRIN MET, V17, P205, DOI 10.1016/j.tem.2006.05.006; Kola B, 2008, J CLIN ENDOCR METAB, V93, P4969, DOI 10.1210/jc.2008-1297; Law YW, 2014, J AFFECT DISORDERS, V168, P254, DOI 10.1016/j.jad.2014.06.031; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Liu FD, 2012, AGE, V34, P157, DOI 10.1007/s11357-011-9214-8; Liu J, 2009, CELL MOL NEUROBIOL, V29, P317, DOI 10.1007/s10571-008-9323-9; Liu L, 2014, ENDOCRINOLOGY, V155, P2190, DOI 10.1210/en.2013-1632; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042166; Lussier AL, 2013, NEUROPHARMACOLOGY, V71, P174, DOI 10.1016/j.neuropharm.2013.04.012; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MOGUILEWSKY M, 1984, J STEROID BIOCHEM, V20, P271, DOI 10.1016/0022-4731(84)90216-4; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Pew T, 2008, ENDOCRINOLOGY, V149, P2637, DOI 10.1210/en.2007-1096; Puthanveetil P, 2013, CURR PHARM DESIGN, V19, P4818, DOI 10.2174/13816128113199990340; Sato H, 2008, J NEUROCHEM, V106, P805, DOI 10.1111/j.1471-4159.2008.05489.x; Seib LM, 2003, NEUROSCI LETT, V337, P29, DOI 10.1016/S0304-3940(02)01287-9; Spasic MR, 2009, NEUROSCIENTIST, V15, P309, DOI 10.1177/1073858408327805; Takano K, 2012, J PHARMACOL SCI, V120, P176, DOI 10.1254/jphs.12039FP; Unemura K, 2012, J PHARMACOL SCI, V119, P30, DOI 10.1254/jphs.12047FP; Viollet B, 2003, BIOCHEM SOC T, V31, P216, DOI 10.1042/bst0310216; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wu W, 2006, MOL ENDOCRINOL, V20, P2304, DOI 10.1210/me.2006-0131; Wu WN, 2013, MOL PHARMACOL, V84, P876, DOI 10.1124/mol.113.086744; Xia M, 2014, SCHIZOPHR RES; Yi CO, 2011, ANAT CELL BIOL, V44, P194, DOI 10.5115/acb.2011.44.3.194; Zhao JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199372; Zhu SH, 2014, BRAIN RES, V1576, P81, DOI 10.1016/j.brainres.2014.06.002	45	56	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159513	10.1371/journal.pone.0159513	http://dx.doi.org/10.1371/journal.pone.0159513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE5NI	27513844	Green Submitted, Green Published, gold			2022-12-26	WOS:000389654500001
J	Zimmerman, D; Goto, JJ; Krishnan, VV				Zimmerman, David; Goto, Joy J.; Krishnan, Viswanathan V.			Equilibrium Dynamics of beta-N-Methylamino-L-Alanine (BMAA) and Its Carbamate Adducts at Physiological Conditions	PLOS ONE			English	Article							2-DIMENSIONAL NMR-SPECTROSCOPY; NUCLEAR-MAGNETIC-RESONANCE; NEUTRAL AQUEOUS-SOLUTION; NEUROTOXIC AMINO-ACID; CARBON-DIOXIDE; MOTOR-NEURONS; RECEPTOR ACTIVATION; BICARBONATE; GUAM; ALS	Elevated incidences of Amyotrophic Lateral Sclerosis/Parkinsonism Dementia complex (ALS/PDC) is associated with beta-methylamino-L-alanine (BMAA), a non-protein amino acid. In particular, the native Chamorro people living in the island of Guam were exposed to BMAA by consuming a diet based on the cycad seeds. Carbamylated forms of BMAA are glutamate analogues. The mechanism of neurotoxicity of the BMAA is not completely understood, and BMAA acting as a glutamate receptor agonist may lead to excitotoxicity that interferes with glutamate transport systems. Though the interaction of BMAA with bicarbonate is known to produce carbamate adducts, here we demonstrate that BMAA and its primary and secondary adducts coexist in solution and undergoes a chemical exchange among them. Furthermore, we determined the rates of formation/cleavage of the carbamate adducts under equilibrium conditions using two-dimensional proton exchange NMR spectroscopy (EXSY). The coexistence of the multiple forms of BMAA at physiological conditions adds to the complexity of the mechanisms by which BMAA functions as a neurotoxin.	[Zimmerman, David; Goto, Joy J.; Krishnan, Viswanathan V.] Calif State Univ Fresno, Coll Sci & Math, Dept Chem, Fresno, CA 93740 USA; [Krishnan, Viswanathan V.] Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA	California State University System; California State University Fresno; University of California System; University of California Davis	Krishnan, VV (corresponding author), Calif State Univ Fresno, Coll Sci & Math, Dept Chem, Fresno, CA 93740 USA.; Krishnan, VV (corresponding author), Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA.	krish@csufresno.edu			National Science Foundation (NSF) [1059994]; National Science Foundation, Chemistry Graduate Scholarship Program (GRASP) (NSF-DUE) [1059994]; California State University, Fresno, College of Science & Mathematics, Graduate Fellowship	National Science Foundation (NSF)(National Science Foundation (NSF)); National Science Foundation, Chemistry Graduate Scholarship Program (GRASP) (NSF-DUE); California State University, Fresno, College of Science & Mathematics, Graduate Fellowship	DZ was supported in by a graduate fellowship by National Science Foundation (NSF Award # 1059994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DZ was supported by the National Science Foundation, Chemistry Graduate Scholarship Program (GRASP) (NSF-DUE Award # 1059994) and the California State University, Fresno, College of Science & Mathematics, Graduate Fellowship. The authors thank C. Cortney for critical reading of the manuscript.	Arif M, 2014, P NATL ACAD SCI USA, V111, P1144, DOI 10.1073/pnas.1322614111; ARNOLD A, 1953, J NERV MENT DIS, V117, P135, DOI 10.1097/00005053-195311720-00005; ARNOLD H, 1969, TETRAHEDRON LETT, P137; Aroua MK, 1997, J CHEM ENG DATA, V42, P692, DOI 10.1021/je970004s; Bartoschek S, 2000, EUR J BIOCHEM, V267, P3130, DOI 10.1046/j.1432-1327.2000.01331.x; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bradley WG, 2009, AMYOTROPH LATERAL SC, V10, P7, DOI 10.3109/17482960903286009; Brownson DM, 2002, J ETHNOPHARMACOL, V82, P159, DOI 10.1016/S0378-8741(02)00170-8; Castellano J.A., 1992, HDB DISPLAY TECHNOLO; Chen Y, 1996, INORG CHIM ACTA, V249, P239, DOI 10.1016/0020-1693(96)05092-X; Chiu AS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01482; Chiu AS, 2012, TOXICON, V60, P1159, DOI 10.1016/j.toxicon.2012.07.169; Chiu AS, 2011, INT J ENV RES PUB HE, V8, P3728, DOI 10.3390/ijerph8093728; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; DAVIS AJ, 1993, FEBS LETT, V329, P249, DOI 10.1016/0014-5793(93)80231-I; DAVIS AJ, 1993, BIOORG CHEM, V21, P309, DOI 10.1006/bioo.1993.1026; Dunlop RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075376; EWING SP, 1980, J AM CHEM SOC, V102, P3072, DOI 10.1021/ja00529a033; GIBBONS BH, 1963, J BIOL CHEM, V238, P3502; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; GUPTA RC, 1993, CHEM-BIOL INTERACT, V87, P295, DOI 10.1016/0009-2797(93)90057-6; Harned HS, 1941, J AM CHEM SOC, V63, P1706, DOI DOI 10.1021/JA01851A058; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kang X-H, 2013, INDUCED OXIDATIVE ST; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; Krishnan VV, 2012, CHEM PHYS LETT, V523, P124, DOI 10.1016/j.cplett.2011.11.058; KURLAND LT, 1954, NEUROLOGY, V4, P355, DOI 10.1212/WNL.4.5.355; LEITHAUSER MT, 1990, CARCINOGENESIS, V11, P463, DOI 10.1093/carcin/11.3.463; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; Lobner D, 2007, NEUROBIOL DIS, V25, P360, DOI 10.1016/j.nbd.2006.10.002; LORIMER GH, 1983, TRENDS BIOCHEM SCI, V8, P65, DOI 10.1016/0968-0004(83)90393-6; MARTIN RB, 1963, SCIENCE, V139, P1198, DOI 10.1126/science.139.3560.1198; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; MEIER BH, 1979, J AM CHEM SOC, V101, P6441, DOI 10.1021/ja00515a053; MORROW JS, 1974, J BIOL CHEM, V249, P7484; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; MYERS TG, 1990, J BIOL CHEM, V265, P10193; NUNN PB, 1991, SCIENCE, V251, P1619, DOI 10.1126/science.1859531; NUNN PB, 1989, J INORG BIOCHEM, V37, P175, DOI 10.1016/0162-0134(89)80040-6; NUNN PB, 1989, FEBS LETT, V251, P31, DOI 10.1016/0014-5793(89)81423-1; Nunn PB, 2009, AMYOTROPH LATERAL SC, V10, P26, DOI 10.3109/17482960903272975; OLNEY JW, 1990, SCIENCE, V248, P596, DOI 10.1126/science.2185543; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; PEREIRA MA, 1991, CANCER LETT, V57, P37, DOI 10.1016/0304-3835(91)90060-U; RANCE M, 1985, J MAGN RESON, V62, P497, DOI 10.1016/0022-2364(85)90218-5; Rao SD, 2006, EXP NEUROL, V201, P244, DOI 10.1016/j.expneurol.2006.04.017; RICHTER KE, 1989, BRAIN RES, V492, P385, DOI 10.1016/0006-8993(89)90925-6; Sanderson DJ, 2008, PROG BRAIN RES, V169, P159, DOI 10.1016/S0079-6123(07)00009-X; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; SHAO WP, 1995, BBA-PROTEIN STRUCT M, V1248, P177, DOI 10.1016/0167-4838(95)00015-M; Team RDC, 2009, R LANG ENV STAT COMP; VEGA A, 1967, PHYTOCHEMISTRY, V6, P759, DOI 10.1016/S0031-9422(00)86018-5; Wang XG, 2010, J PHYS CHEM A, V114, P1734, DOI 10.1021/jp909019u; WEISS JH, 1989, NEURON, V3, P321, DOI 10.1016/0896-6273(89)90256-0; WEISS JH, 1989, BRAIN RES, V497, P64, DOI 10.1016/0006-8993(89)90970-0; WEISS JH, 1988, SCIENCE, V241, P973, DOI 10.1126/science.3136549; WITTEBORT RJ, 1978, BIOPHYS J, V24, P765, DOI 10.1016/S0006-3495(78)85419-8	59	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160491	10.1371/journal.pone.0160491	http://dx.doi.org/10.1371/journal.pone.0160491			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513925	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100042
J	Mohammadi, N; Midiri, A; Mancuso, G; Patane, F; Venza, M; Venza, I; Passantino, A; Galbo, R; Teti, G; Beninati, C; Biondo, C				Mohammadi, Nastaran; Midiri, Angelina; Mancuso, Giuseppe; Patane, Francesco; Venza, Mario; Venza, Isabella; Passantino, Annamaria; Galbo, Roberta; Teti, Giuseppe; Beninati, Concetta; Biondo, Carmelo			Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1 beta Production during Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BACTERIAL RECOGNITION; IL-1-BETA PRODUCTION; HOST-RESISTANCE; MOUSE MODEL; DISEASE; INFLAMMASOME; ACTIVATION; INNATE; IMMUNITY	Previous studies have shown that the pro-inflammatory cytokine IL-1 beta has a crucial role in host defenses against group B streptococcus (GBS), a frequent human pathogen, by recruiting neutrophils to infection sites. We examined here the cell types and mechanisms involved in IL-1 beta production during infection. Using a GBS-induced peritonitis model in mice, we first found that a large proportion of exudate cells contain intracellular IL-1 beta by immunofluorescence. Of the IL-1 beta positive cells, 82 and 7% were neutrophils and macrophages, respectively, suggesting that the former cell type might significantly contribute to IL-1 beta production. Accordingly, depletion of neutrophils with anti-Ly6G antibodies resulted in a significant reduction in the levels of IL-1 beta, but not of TNF-alpha or IL-6. We next found that neutrophils are capable of releasing mature IL-1 beta and TNF-alpha directly in response to in vitro stimulation with GBS. The production of pro-IL-1 beta and TNF-alpha in these cells required the Toll-like receptor (TLR) adaptor MyD88 and the chaperone protein UNC93B1, which is involved in mobilization of a subfamily of TLRs to the endosomes. Moreover, pro-IL-1 beta processing and IL-1 beta release was triggered by GBS hemolysin and required components of the canonical inflammasome, including caspase-1, ASC and NLRP3. Collectively our findings indicate that neutrophils make a significant contribution to IL-1 beta production during GBS infection, thereby amplifying their own recruitment. These cells directly recognize GBS by means of endosomal TLRs and cytosolic sensors, leading to activation of the caspase-1 inflammasome.	[Mohammadi, Nastaran; Venza, Mario; Venza, Isabella; Teti, Giuseppe] Univ Messina, Dept Clin & Expt Med, I-98125 Messina, Italy; [Midiri, Angelina; Mancuso, Giuseppe; Patane, Francesco; Beninati, Concetta; Biondo, Carmelo] Univ Messina, Dept Human Pathol, I-98125 Messina, Italy; [Passantino, Annamaria] Univ Messina, Dept Vet Sci, I-98125 Messina, Italy; [Galbo, Roberta] Univ Messina, Dept Biol Chem & Environm Sci, I-98125 Messina, Italy; [Teti, Giuseppe] Charybdis Vaccines Srl, I-98125 Messina, Italy; [Beninati, Concetta] Scylla Biotech Srl, I-98125 Messina, Italy	University of Messina; University of Messina; University of Messina; University of Messina	Teti, G (corresponding author), Univ Messina, Dept Clin & Expt Med, I-98125 Messina, Italy.; Teti, G (corresponding author), Charybdis Vaccines Srl, I-98125 Messina, Italy.	gteti@unime.it	GALBO, Roberta/AAR-8424-2021; Patane, Francesco/AAW-9473-2021; Biondo, Carmelo/AAA-3391-2019	GALBO, Roberta/0000-0002-2880-3871; Midiri, Angelina/0000-0002-4128-9678; Passantino, Annamaria/0000-0003-1701-3636; Mancuso, Giuseppe/0000-0001-5454-3228; BENINATI, Concetta/0000-0001-8305-1337	Ministero dell'Universita e della Ricerca Scientifica of Italy [4/13 ex art. 11 D.M. n. 593]	Ministero dell'Universita e della Ricerca Scientifica of Italy(Ministry of Education, Universities and Research (MIUR))	Scylla Biotech Srl, a spin-off company of the University of Messina, provided support in the form laboratory reagents and consumables. C. Beninati and GT own Scylla Biotech Srl and Charybdis Vaccines. The specific roles of these authors are articulated in the 'author contributions' section. Scylla Biotech Srl and Charybdis Vaccines did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Work described here was supported by funds granted to Scylla Biotech Srl by the Ministero dell'Universita e della Ricerca Scientifica of Italy (Project n. 4/13 ex art. 11 D.M. n. 593).	Albanyan EA, 2000, INFECT IMMUN, V68, P2053, DOI 10.1128/IAI.68.4.2053-2060.2000; [Anonymous], 2004, NEOREVIEWS; Bakele M, 2014, J BIOL CHEM, V289, P5320, DOI 10.1074/jbc.M113.505636; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Biondo C, 2012, EUR REV MED PHARMACO, V16, P1506; Biondo C, 2014, MBIO, V5, DOI 10.1128/mBio.01428-14; Broz P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003144; Buscetta M, 2014, J BIOL CHEM, V289, P21003, DOI 10.1074/jbc.M114.553073; Cardaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036588; Cho JS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003047; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Croker BA, 2011, J IMMUNOL, V186, P1131, DOI 10.4049/jimmunol.1002702; Cusumano V, 1996, INFECT IMMUN, V64, P2941, DOI 10.1128/IAI.64.8.2941-2944.1996; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; ENGLE WA, 1988, J PEDIATR-US, V113, P747, DOI 10.1016/S0022-3476(88)80394-9; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; Gupta R, 2014, J BIOL CHEM, V289, P13701, DOI 10.1074/jbc.C114.548982; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Karmakar M, 2015, J IMMUNOL, V194, P1763, DOI 10.4049/jimmunol.1401624; Karmakar M, 2012, J IMMUNOL, V189, P4231, DOI 10.4049/jimmunol.1201447; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lin FYC, 2004, J INFECT DIS, V190, P928, DOI 10.1086/422756; Lin FYC, 2001, J INFECT DIS, V184, P1022, DOI 10.1086/323350; Mancuso G, 2002, J IMMUNOL, V169, P1401, DOI 10.4049/jimmunol.169.3.1401; Mancuso G, 1997, INFECT IMMUN, V65, P3731, DOI 10.1128/IAI.65.9.3731-3735.1997; MANCUSO G, 1994, INFECT IMMUN, V62, P4997, DOI 10.1128/IAI.62.11.4997-5002.1994; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Mocsai A, 1999, J IMMUNOL, V162, P1120; Papasergi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075266; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Rowe SJ, 2002, J IMMUNOL, V169, P6401, DOI 10.4049/jimmunol.169.11.6401; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Signorino G, 2014, INFECT IMMUN, V82, P5013, DOI 10.1128/IAI.02282-14; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; TETI G, 1993, INFECT IMMUN, V61, P227, DOI 10.1128/IAI.61.1.227-235.1993; TETI G, 1992, CIRC SHOCK, V38, P138; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	53	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160249	10.1371/journal.pone.0160249	http://dx.doi.org/10.1371/journal.pone.0160249			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509078	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400026
J	Orum, TV; Ferguson, N; Mihail, JD				Orum, Thomas V.; Ferguson, Nancy; Mihail, Jeanne D.			Saguaro (Carnegiea gigantea) Mortality and Population Regeneration in the Cactus Forest of Saguaro National Park: Seventy-Five Years and Counting	PLOS ONE			English	Article							SOUTHWESTERN UNITED-STATES; NORTHERN SONORAN DESERT; CLIMATIC VARIABILITY; LONG-TERM; TEMPERATURES; POLLINATION; TRENDS; NURSE	Annual census data spanning seventy-five years document mortality and regeneration in a population of saguaro cactus (Carnegiea gigantea) in the Cactus Forest of the Rincon Mountain District of Saguaro National Park near Tucson, AZ. On 6 four-hectare plots, each saguaro was censused and a methodical search for new saguaros was conducted annually each year from 1942 through 2016, with the exception of 1955. Regeneration has been episodic with 828 plants established from 1959 through 1993 compared with 34 plants established between 1942 and 1958 and only three plants established after 1993. The years preceding 1959 and following 1993, include some of the driest decades in centuries in southern Arizona. While woodcutting and cattle grazing are believed to be among the causes of decades of failed regeneration prior to 1958, neither of these factors contributed to the failed regeneration following 1993. The height structure of the population from 1942 to 2016 shifted dramatically from a population dominated by large saguaros (>5.4 m tall) in the first three decades of the study to a population dominated by small saguaros (<1.8 m tall) in the most recent two decades. Mortality is shown to be strongly age dependent. In the year following the 2011 catastrophic freeze, 21 of 59 plants older than 80 years died compared with zero deaths in 270 plants between the ages of 29 and 80 years. Saguaros under 40 years old, growing under small shrubs or in the open, have a lower probability of survival than better protected saguaros. Long-term population monitoring is essential to understanding the complex impacts of human and environmental factors on the population dynamics of long-lived species.	[Orum, Thomas V.; Ferguson, Nancy] Sweetwater Ctr, Tucson, AZ 85724 USA; [Mihail, Jeanne D.] Univ Missouri, Div Plant Sci, Columbia, MO USA	University of Missouri System; University of Missouri Columbia	Orum, TV (corresponding author), Sweetwater Ctr, Tucson, AZ 85724 USA.	torum@email.arizona.edu						ALCORN SM, 1961, SCIENCE, V133, P1594, DOI 10.1126/science.133.3464.1594; ALCORN SM, 1959, AM J BOT, V46, P526, DOI 10.2307/2439624; ALCORN SM, 1991, INT J SYST BACTERIOL, V41, P197, DOI 10.1099/00207713-41-2-197; ALCORN STANLEY M., 1962, PLANT DIS REPORTER, V46, P156; BETANCOURT JL, 1993, USDA ROCKY, V236, P42; Bowers J. E., 1980, Desert Plants, V2, P232; Bowers Janice E., 1988, SENSE PLACE LIFE WOR; BOYLE AM, 1949, PHYTOPATHOLOGY, V39, P1029; Conver J, 2013, SAGUAROS; Coppola K., 2007, ARIDUS, V19, P1; Dimmitt M., 2013, GROWING DESERT COLUM; Drezner TD, 2007, J ARID ENVIRON, V69, P554, DOI 10.1016/j.jaridenv.2006.11.003; Drezner TD, 2014, SOUTHWEST NAT, V59, P121, DOI 10.1894/N04-JB-39.1; Drezner TD, 2002, PHYS GEOGR, V23, P465, DOI 10.2747/0272-3646.23.6.465; Drezner TD, 2003, AM J BOT, V90, P911, DOI 10.3732/ajb.90.6.911; DREZNER TD, 2004, DESERT PLANTS, V20, P3; Gilbertson RL, 1975, MYCOTAXON, V2, P83; Gill LS, 1951, SCI MONOGRAPH SERIES, V17, P204; Hanson RT, 2006, HYDROGEOL J, V14, P1122, DOI 10.1007/s10040-006-0067-7; HASTINGS JR, 1961, J ARIZONA ACAD SCI, V2, P32; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lee EW, 2003, STAT METHODS SURVIVA, Vthird, DOI DOI 10.1002/0471458546; Lowe C. H., 1981, Desert Plants, V3, P83; McClaran MP, 2014, AGR FOREST METEOROL, V197, P40, DOI 10.1016/j.agrformet.2014.06.004; MCGREGOR SE, 1962, ECOLOGY, V43, P259, DOI 10.2307/1931981; Mielke JL, 1944, SCI MONOGRAPH SERIES, V17, P193; MILBRATH GM, 1972, PHYTOPATHOLOGY, V62, P739, DOI 10.1094/Phyto-62-739; NIERING WA, 1963, SCIENCE, V142, P15, DOI 10.1126/science.142.3588.15; NOBEL PS, 1980, BOT GAZ, V141, P188, DOI 10.1086/337142; PARKER KC, 1993, ANN ASSOC AM GEOGR, V83, P452, DOI 10.1111/j.1467-8306.1993.tb01945.x; Pierson EA, 2013, J ARID ENVIRON, V88, P57, DOI 10.1016/j.jaridenv.2012.08.008; Pierson EA, 1998, ECOLOGY, V79, P2676, DOI 10.1890/0012-9658(1998)079[2676:AYSOSC]2.0.CO;2; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Shreve F., 1910, PLANT WORLD, V13, P235; STEENBERGH W F, 1969, Ecology (Washington D C), V50, P825, DOI 10.2307/1933696; Steenbergh W. F., 1977, SCI MONOGRAPH SERIES, V8; Steenbergh W. F., 1983, SCI MONOGRAPH SERIES, V17; Swann DE, 2009, NPSSODNNRTR2007093; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; TURNER R M, 1969, Ecology (Washington D C), V50, P835, DOI 10.2307/1933697; Turner R. M., 2003, CHANGING MILE REVISI; TURNER RM, 1990, ECOLOGY, V71, P464, DOI 10.2307/1940301; TURNER RM, 1966, BOT GAZ, V127, P95, DOI 10.1086/336348; Weiss JL, 2009, J CLIMATE, V22, P5918, DOI 10.1175/2009JCLI2905.1	44	10	10	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160899	10.1371/journal.pone.0160899	http://dx.doi.org/10.1371/journal.pone.0160899			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505437	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200076
J	Arase, S; Watanabe, Y; Setoyama, H; Nagaoka, N; Kawai, M; Matsumoto, S				Arase, Sohei; Watanabe, Yohei; Setoyama, Hiromi; Nagaoka, Noriko; Kawai, Mitsuhisa; Matsumoto, Satoshi			Disturbance in the Mucosa-Associated Commensal Bacteria Is Associated with the Exacerbation of Chronic Colitis by Repeated Psychological Stress; Is That the New Target of Probiotics?	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; INFLAMMATORY-BOWEL-DISEASE; INTERFERON-GAMMA; GUT MICROBIOTA; RAT; RESPONSES; UROCORTIN; CELLS; BRAIN; MICE	Psychological stress can exacerbate inflammatory bowel disease. However, the mechanisms underlying how psychological stress affects gut inflammation remain unclear. Here, we focused on the relationship between changes in the microbial community of mucosaassociated commensal bacteria (MACB) and mucosal immune responses induced by chronic psychological stress in a murine model of ulcerative colitis. Furthermore, we examined the effect of probiotic treatment on exacerbated colitis and MACB composition changes induced by chronic psychological stress. Repeated water avoidance stress (rWAS) in B6-Tcra(-/-) mice severely exacerbated colitis, which was evaluated by both colorectal tissue weight and histological score of colitis. rWAS treatment increased mRNA expression of UCN2 and IFN-gamma in large intestinal lamina propria mononuclear cells (LI-LPMC). Interestingly, exacerbated colitis was associated with changes in the microbial community of MACB, specifically loss of bacterial species diversity and an increase in the component ratio of Clostridium, revealed by 16S rRNA gene amplicon analysis. Finally, the oral administration of a probiotic Lactobacillus strain was protective against the exacerbation of colitis and was associated with a change in the bacterial community of MACB in rWAS-exposed Tcra(-/-) mice. Taken together, these results suggested that loss of species diversity in MACB might play a key role in exacerbated colitis induced by chronic psychological stress. In addition, probiotic treatment may be used as a tool to preserve the diversity of bacterial species in MACB and alleviate gut inflammation induced by psychological stress.	[Arase, Sohei; Watanabe, Yohei; Setoyama, Hiromi; Nagaoka, Noriko; Kawai, Mitsuhisa; Matsumoto, Satoshi] Yakult Cent Inst, Kunitachi, Tokyo, Japan	Yakult Honsha Company, Limited	Arase, S (corresponding author), Yakult Cent Inst, Kunitachi, Tokyo, Japan.	sohei-arase@yakult.co.jp			Yakult Central Institute	Yakult Central Institute	This work was funded by the Yakult Central Institute (http://institute.yakult.co.jp/). The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2013, NEUROGASTROENT MOTIL, V25, pE515, DOI 10.1111/nmo.12154; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Baigent SM, 2001, PEPTIDES, V22, P809, DOI 10.1016/S0196-9781(01)00395-3; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Baroja ML, 2007, CLIN EXP IMMUNOL, V149, P470, DOI 10.1111/j.1365-2249.2007.03434.x; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; BONAZ B, 1994, BRAIN RES, V641, P21, DOI 10.1016/0006-8993(94)91810-4; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Borody T, 2015, POLSKIE ARCHIWUM MED; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dongarra ML, 2013, CURR ALLERGY ASTHM R, V13, P19, DOI 10.1007/s11882-012-0313-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Ferrier L, 2003, GASTROENTEROLOGY, V125, P795, DOI 10.1016/S0016-5085(03)01057-6; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Fukudo S, 2007, J GASTROENTEROL, V42, P48, DOI 10.1007/s00535-006-1942-7; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Gareau MG, 2007, AM J PHYSIOL-GASTR L, V293, pG198, DOI 10.1152/ajpgi.00392.2006; Hoffman JM, 2016, AM J PATHOL, V186, P134, DOI 10.1016/j.ajpath.2015.09.013; Julio-Pieper M, 2012, STRESS, V15, P218, DOI 10.3109/10253890.2011.607524; Kageyama K, 1999, ENDOCRINOLOGY, V140, P5651, DOI 10.1210/en.140.12.5651; Kawaguchi-Miyashita M, 2001, EUR J IMMUNOL, V31, P980, DOI 10.1002/1521-4141(200104)31:4<980::AID-IMMU980>3.0.CO;2-U; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Koda T, 2003, J NUTR SCI VITAMINOL, V49, P179, DOI 10.3177/jnsv.49.179; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; Koob GF, 1999, BRAIN RES, V848, P141, DOI 10.1016/S0006-8993(99)01991-5; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Leonard BE, 2005, EUR PSYCHIAT, V20, pS302, DOI 10.1016/S0924-9338(05)80180-4; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Galdeano CM, 2009, J DAIRY RES, V76, P446, DOI 10.1017/S0022029909990021; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Matsumoto S, 2005, CLIN EXP IMMUNOL, V140, P417, DOI 10.1111/j.1365-2249.2005.02790.x; Matsumoto S, 2001, DIGESTION, V64, P92, DOI 10.1159/000048846; Matsumoto Satoshi, 2000, Microbial Ecology in Health and Disease, V12, P102, DOI 10.1080/089106000435509; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Okuda Y, 2003, AM J PATHOL, V162, P263, DOI 10.1016/S0002-9440(10)63817-5; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Park JH, 2002, CELL IMMUNOL, V219, P22, DOI 10.1016/S0008-8749(02)00579-8; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Ray A, 2015, IMMUNOLOGY, V146, P359, DOI 10.1111/imm.12511; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Saitoh Y, 2015, SCIENCE, V347, P775, DOI 10.1126/science.1261833; Sakai F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105370; Sun YD, 2013, GASTROENTEROLOGY, V144, P1478, DOI 10.1053/j.gastro.2013.02.038; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; van der Waaij LA, 2004, EUR J GASTROEN HEPAT, V16, P669, DOI 10.1097/01.meg.0000108346.41221.19; Veerappan Ganesh R, 2012, Curr Gastroenterol Rep, V14, P324, DOI 10.1007/s11894-012-0265-5; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150559; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065760	64	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160736	10.1371/journal.pone.0160736	http://dx.doi.org/10.1371/journal.pone.0160736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IE	27500935	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500049
J	Blenkiron, C; Simonov, D; Muthukaruppan, A; Tsai, P; Dauros, P; Green, S; Hong, J; Print, CG; Swift, S; Phillips, AR				Blenkiron, Cherie; Simonov, Denis; Muthukaruppan, Anita; Tsai, Peter; Dauros, Priscila; Green, Sasha; Hong, Jiwon; Print, Cristin G.; Swift, Simon; Phillips, Anthony R.			Uropathogenic Escherichia coli Releases Extracellular Vesicles That Are Associated with RNA	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; SMALL NONCODING RNAS; ALPHA-HEMOLYSIN; STRAIN 536; BACTERIA; CELLS; COMMUNICATION; MICRORNAS; VIRULENCE; PATHWAYS	Background Bacterium-to-host signalling during infection is a complex process involving proteins, lipids and other diffusible signals that manipulate host cell biology for pathogen survival. Bacteria also release membrane vesicles (MV) that can carry a cargo of effector molecules directly into host cells. Supported by recent publications, we hypothesised that these MVs also associate with RNA, which may be directly involved in the modulation of the host response to infection. Methods and Results Using the uropathogenic Escherichia coli (UPEC) strain 536, we have isolated MVs and found they carry a range of RNA species. Density gradient centrifugation further fractionated and characterised the MV preparation and confirmed that the isolated RNA was associated with the highest particle and protein containing fractions. Using a new approach, RNA-sequencing of libraries derived from three different 'size' RNA populations (<50nt, 50-200nt and 200nt+) isolated from MVs has enabled us to now report the first example of a complete bacterial MV-RNA profile. These data show that MVs carry rRNA, tRNAs, other small RNAs as well as full-length protein coding mRNAs. Confocal microscopy visualised the delivery of lipid labelled MVs into cultured bladder epithelial cells and showed their RNA cargo labelled with 5-EU (5-ethynyl uridine), was transported into the host cell cytoplasm and nucleus. MV RNA uptake by the cells was confirmed by droplet digital RT-PCR of csrC. It was estimated that 1% of MV RNA cargo is delivered into cultured cells. Conclusions These data add to the growing evidence of pathogenic bacterial MV being associated a wide range of RNAs. It further raises the plausibility for MV-RNA-mediated cross-kingdom communication whereby they influence host cell function during the infection process.	[Blenkiron, Cherie; Simonov, Denis; Dauros, Priscila; Green, Sasha; Print, Cristin G.; Swift, Simon] Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand; [Blenkiron, Cherie; Simonov, Denis; Hong, Jiwon; Phillips, Anthony R.] Univ Auckland, Dept Surg, Auckland, New Zealand; [Muthukaruppan, Anita] Univ Auckland, Dept Obstet & Gynaecol, Auckland, New Zealand; [Tsai, Peter; Print, Cristin G.] Univ Auckland, Bioinformat Inst, Auckland, New Zealand; [Hong, Jiwon; Phillips, Anthony R.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Print, Cristin G.; Phillips, Anthony R.] Univ Auckland, Maurice Wilkins Ctr, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland	Blenkiron, C (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Auckland, New Zealand.; Blenkiron, C (corresponding author), Univ Auckland, Dept Surg, Auckland, New Zealand.	c.blenkiron@auckland.ac.nz	Swift, Simon/H-3072-2019; Hong, Jiwon/AHB-4913-2022; Blenkiron, Cherie/H-8468-2019	Swift, Simon/0000-0001-7352-1112; Hong, Jiwon/0000-0003-0936-3281; Blenkiron, Cherie/0000-0002-0217-3808; Simonov, Denis/0000-0001-9709-3554; Dauros Singorenko, Priscila/0000-0003-1314-7047; Print, Cristin/0000-0001-8345-7812; Muthukaruppan, Anitadevi/0000-0002-6330-1594; Tsai, Peter/0000-0002-9930-9029	Lottery Health Research (NZ); Health Research Council (NZ); Maurice Wilkins Centre for Biodiscovery (NZ); Maurice and Phyllis Paykel Trust (NZ); Johnson and Johnson	Lottery Health Research (NZ); Health Research Council (NZ)(Health Research Council of New Zealand); Maurice Wilkins Centre for Biodiscovery (NZ); Maurice and Phyllis Paykel Trust (NZ); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA)	This work was funded by grants received by the authors from the following. Lottery Health Research (NZ), Health Research Council (NZ), Maurice Wilkins Centre for Biodiscovery (NZ) and Maurice and Phyllis Paykel Trust (NZ). Scholarship for DS from Johnson and Johnson. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1987, CURRENT PROTOCOLS MO, DOI [10.1016/j.molbiopara.2013.03.003, DOI 10.1016/J.MOLBIOPARA.2013.03.003]; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Cossart P, 2014, FEBS LETT, V588, P2437, DOI 10.1016/j.febslet.2014.05.051; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dallo SF, 2012, THESCIENTIFICWORLDJO, V2012, DOI 10.1100/2012/128705; Deatherage BL, 2012, INFECT IMMUN, V80, P1948, DOI 10.1128/IAI.06014-11; Dhakal BK, 2012, CELL HOST MICROBE, V11, P58, DOI 10.1016/j.chom.2011.12.003; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Furuse Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106434; Galizi R, 2013, MOL BIOCHEM PARASIT, V188, P99, DOI 10.1016/j.molbiopara.2013.03.003; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; KNAPP S, 1986, J BACTERIOL, V168, P22, DOI 10.1128/jb.168.1.22-30.1986; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lasser C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu HJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2071; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Marquez V, 2002, BIOCHEM SOC T, V30, P133, DOI 10.1042/BST0300133; Miyazaki J, 2002, FEMS IMMUNOL MED MIC, V33, P23, DOI 10.1111/j.1574-695X.2002.tb00567.x; Nevo-Dinur K, 2012, TRENDS GENET, V28, P314, DOI 10.1016/j.tig.2012.03.008; Ryan RP, 2008, MICROBIOL-SGM, V154, P1845, DOI 10.1099/mic.0.2008/017871-0; Sjostrom AE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15329; Staedel C, 2013, CELL MICROBIOL, V15, P1496, DOI 10.1111/cmi.12159; Tree JJ, 2014, MOL CELL, V55, P199, DOI 10.1016/j.molcel.2014.05.006; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705	37	65	67	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160440	10.1371/journal.pone.0160440	http://dx.doi.org/10.1371/journal.pone.0160440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500956	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500024
J	Jiang, Y; Sverdlov, MS; Toth, PT; Huang, LS; Du, GW; Liu, YY; Natarajan, V; Minshall, RD				Jiang, Ying; Sverdlov, Maria S.; Toth, Peter T.; Huang, Long Shuang; Du, Guangwei; Liu, Yiyao; Natarajan, Viswanathan; Minshall, Richard D.			Phosphatidic Acid Produced by RalA-activated PLD2 Stimulates Caveolae-mediated Endocytosis and Trafficking in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caveolin; endocytosis; filamin; Ras protein; trafficking	PHOSPHOLIPASE-D; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; LIPID RAFTS; LYSOPHOSPHATIDIC ACID; ACTIN CYTOSKELETON; EXOCYST COMPLEX; PROTEIN; INSULIN; RECEPTOR	Caveolae are the primary route for internalization and transendothelial transport of macromolecules, such as insulin and albumin. Caveolae-mediated endocytosis is activated by Src-dependent caveolin-1 (Cav-1) phosphorylation and subsequent recruitment of dynamin-2 and filamin A (FilA), which facilitate vesicle fission and trafficking, respectively. Here, we tested the role of RalA and phospholipase D (PLD) signaling in the regulation of caveolae-mediated endocytosis and trafficking. The addition of albumin to human lung microvascular endothelial cells induced the activation of RalA within minutes, and siRNA-mediated down-regulation of RalA abolished fluorescent BSA uptake. Co-immunoprecipitation studies revealed that albumin induced the association between RalA, Cav-1, and FilA; however, RalA knockdown with siRNA did not affect FilA recruitment to Cav-1, suggesting that RalA was not required for FilA and Cav-1 complex formation. Rather, RalA probably facilitates caveolae-mediated endocytosis by activating downstream effectors. PLD2 was shown to be activated by RalA, and inhibition of PLD2 abolished Alexa-488-BSA uptake, indicating that phosphatidic acid (PA) generated by PLD2 may facilitate caveolae-mediated endocytosis. Furthermore, using a PA biosensor, GFP-PASS, we observed that BSA induced an increase in PA co-localization with Cav-1-RFP, which could be blocked by a dominant negative PLD2 mutant. Total internal reflection fluorescence microscopy studies of Cav-1-RFP also showed that fusion of caveolae with the basal plasma membrane was dependent on PLD2 activity. Thus, our results suggest that the small GTPase RalA plays an important role in promoting invagination and trafficking of caveolae, not by potentiating the association between Cav-1 and FilA but by stimulating PLD2-mediated generation of phosphatidic acid.	[Jiang, Ying; Liu, Yiyao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Sichuan, Peoples R China; [Jiang, Ying; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Coll Med, Chicago, IL 60612 USA; [Sverdlov, Maria S.; Toth, Peter T.; Huang, Long Shuang; Natarajan, Viswanathan; Minshall, Richard D.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Huang, Long Shuang; Natarajan, Viswanathan] Univ Illinois, Coll Med, Dept Med, Chicago, IL 60612 USA; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol, Houston, TX 77030 USA; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Pharmacol, Houston, TX 77030 USA	University of Electronic Science & Technology of China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Minshall, RD (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.; Minshall, RD (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.	rminsh@uic.edu	Huang, Longshuang/H-9553-2016	Toth, Peter/0000-0003-2168-0124; Liu, Yiyao/0000-0002-7222-739X; Du, Guangwei/0000-0003-4193-6975	National Institutes of Health [R01 HL071626, HL125356, P01 HL060678, P01HL98050, R01HL119478, T32 HL007692]; National Natural Science Foundation of China [11272083, 31470906]; China Scholarship Council (CSC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071626, T32HL007692, R01HL119478, P01HL098050, P01HL060678, R01HL125356] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council (CSC)(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL071626 and HL125356 (to R. D. M.), P01 HL060678 Project 4 and Core D (to R. D. M.), P01HL98050 (to V. N.), R01HL119478 (to G. D.), and T32 HL007692 (to M. S. S.); National Natural Science Foundation of China Grants 11272083 and 31470906; and the China Scholarship Council (CSC). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn S, 2002, J BIOL CHEM, V277, P26642, DOI 10.1074/jbc.M201499200; Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Balasubramanian N, 2010, CURR BIOL, V20, P75, DOI 10.1016/j.cub.2009.11.016; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Cullis DN, 2002, J BIOL CHEM, V277, P49158, DOI 10.1074/jbc.M206316200; Dobrinskikh E, 2014, AM J PHYSIOL-RENAL, V306, pF941, DOI 10.1152/ajprenal.00532.2013; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Gingras D, 1998, BIOCHEM BIOPH RES CO, V247, P888, DOI 10.1006/bbrc.1998.8885; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Hazelett CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039602; Hiroyama M, 2005, J CELL BIOCHEM, V95, P149, DOI 10.1002/jcb.20351; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Inoue M, 2006, MOL BIOL CELL, V17, P2303, DOI 10.1091/mbc.E06-01-0030; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Itach SBS, 2012, DEV BIOL, V362, P154, DOI 10.1016/j.ydbio.2011.12.002; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Lopez JA, 2008, J BIOL CHEM, V283, P17939, DOI 10.1074/jbc.M800321200; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Natarajan V, 1997, CHEM PHYS LIPIDS, V86, P65, DOI 10.1016/S0009-3084(97)02660-1; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Parinandi NL, 1999, ANTIOXID REDOX SIGN, V1, P193, DOI 10.1089/ars.1999.1.2-193; Parinandi NL, 2001, ARCH BIOCHEM BIOPHYS, V396, P231, DOI 10.1006/abbi.2001.2609; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Pleskot R, 2010, PLANT J, V62, P494, DOI 10.1111/j.1365-313X.2010.04168.x; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Rondaij MG, 2008, BLOOD, V112, P56, DOI 10.1182/blood-2007-07-099309; Ros-Baro A, 2001, P NATL ACAD SCI USA, V98, P12050, DOI 10.1073/pnas.211341698; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Schafer DA, 2000, TRAFFIC, V1, P892; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Sverdlov M, 2007, J CELL MOL MED, V11, P1239, DOI 10.1111/j.1582-4934.2007.00127.x; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Testerink C, 2011, J EXP BOT, V62, P2349, DOI 10.1093/jxb/err079; Yamaguchi A, 1997, J BIOL CHEM, V272, P31230, DOI 10.1074/jbc.272.50.31230; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zimnicka AM, 2016, MOL BIOL CELL, V27, P2090, DOI 10.1091/mbc.E15-11-0756	52	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20729	20738		10.1074/jbc.M116.752485	http://dx.doi.org/10.1074/jbc.M116.752485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27510034	Green Published, hybrid			2022-12-26	WOS:000384574800034
J	McCammon, KM; Panda, SP; Xia, CW; Kim, JJP; Moutinho, D; Kranendonk, M; Auchus, RJ; Lafer, EM; Ghosh, D; Martasek, P; Kar, R; Masters, BS; Roman, LJ				McCammon, Karen M.; Panda, Satya P.; Xia, Chuanwu; Kim, Jung-Ja P.; Moutinho, Daniela; Kranendonk, Michel; Auchus, Richard J.; Lafer, Eileen M.; Ghosh, Debashis; Martasek, Pavel; Kar, Rekha; Masters, Bettie Sue; Roman, Linda J.			Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; flavoprotein; membrane protein; protein crystallization; protein stability; reductase; POR deficiency; cytochrome P450 oxidoreductase; diflavin oxidoreductase	P450 OXIDOREDUCTASE DEFICIENCY; CONGENITAL ADRENAL-HYPERPLASIA; HEME OXYGENASE-1 ACTIVITY; ESCHERICHIA-COLI; DISORDERED STEROIDOGENESIS; LIMITED PROTEOLYSIS; STRUCTURAL BASIS; HUMAN AROMATASE; SYSTEM; MUTATIONS	Human NADPH-cytochrome P450 oxidoreductase (POR) gene mutations are associated with severe skeletal deformities and disordered steroidogenesis. The human POR mutation A287P presents with disordered sexual development and skeletal malformations. Difficult recombinant expression and purification of this POR mutant suggested that the protein was less stable than WT. The activities of cytochrome P450 17A1, 19A1, and 21A2, critical in steroidogenesis, were similar using our purified, full-length, unmodified A287P or WT POR, as were those of several xenobiotic-metabolizing cytochromes P450, indicating that the A287P protein is functionally competent in vitro, despite its functionally deficient phenotypic behavior in vivo. Differential scanning calorimetry and limited trypsinolysis studies revealed a relatively unstable A287P compared with WT protein, leading to the hypothesis that the syndrome observed in vivo results from altered POR protein stability. The crystal structures of the soluble domains of WT and A287P reveal only subtle differences between them, but these differences are consistent with the differential scanning calorimetry results as well as the differential susceptibility of A287P and WT observed with trypsinolysis. The relative in vivo stabilities of WT and A287P proteins were also examined in an osteoblast cell line by treatment with cycloheximide, a protein synthesis inhibitor, showing that the level of A287P protein post-inhibition is lower than WT and suggesting that A287P may be degraded at a higher rate. Current studies demonstrate that, unlike previously described mutations, A287P causes POR deficiency disorder due to conformational instability leading to proteolytic susceptibility in vivo, rather than through an inherent flavin-binding defect.	[McCammon, Karen M.; Panda, Satya P.; Lafer, Eileen M.; Kar, Rekha; Masters, Bettie Sue; Roman, Linda J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Moutinho, Daniela; Kranendonk, Michel] Univ Nova Lisboa, NOVA Med Sch FCM, Ctr Toxicogen & Human Hlth Tox Genet Oncol & Huma, Campo Martires Patria 130, P-1169056 Lisbon, Portugal; [Auchus, Richard J.] Univ Michigan, Div Metab Endocrinol & Diabet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ghosh, Debashis] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Martasek, Pavel] Charles Univ Prague, Dept Pediat, Fac Med 1, CR-11636 Prague 1, Czech Republic; [Martasek, Pavel] Gen Univ Hosp, Prague 11636 1, Czech Republic; [Moutinho, Daniela] Univ Santiago de Compostela, CIMUS, Ave Barcelona, Santiago De Compostela 15782, Spain	University of Texas System; University of Texas Health San Antonio; Medical College of Wisconsin; Universidade Nova de Lisboa; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Charles University Prague; General University Hospital Prague; Universidade de Santiago de Compostela	Roman, LJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.; Masters, BS (corresponding author), Duke Univ, Sch Med, Dept Biochem, Box 3711,307 Res Dr, Durham, NC 27710 USA.	bettie.sue.masters@duke.edu; roman@uthscsa.edu	Kranendonk, Michel/AAP-7609-2021; Martásek, Pavel/G-6622-2017; Kranendonk, Michel/H-8176-2013; Moutinho, Daniela/Y-7010-2019	Martásek, Pavel/0000-0001-6165-4444; Kranendonk, Michel/0000-0003-1362-0076; Lafer, Eileen/0000-0002-0493-6522; Moutinho, Daniela/0000-0002-8554-4765	University of Texas Health Science Center at San Antonio Institutional Mass Spectrometry Core Laboratory; Center for Macromolecular Interactions; Cancer Therapy and Research Center, National Institutes of Health, NCI [CA054174]; Texas State funds through University of Texas Health Science Center at San Antonio Office of the Vice President for Research; National Institutes of Health Shared Instrumentation Grant [S10RR025111]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097031, R01GM081568, R01GM086596] Funding Source: NIH RePORTER	University of Texas Health Science Center at San Antonio Institutional Mass Spectrometry Core Laboratory; Center for Macromolecular Interactions; Cancer Therapy and Research Center, National Institutes of Health, NCI; Texas State funds through University of Texas Health Science Center at San Antonio Office of the Vice President for Research; National Institutes of Health Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source beamlines SBC 19ID for their assistance in data collection and Jessica Lo and Egbuta Chinaza for performing the aromatase assays. We gratefully acknowledge the support of the University of Texas Health Science Center at San Antonio Institutional Mass Spectrometry Core Laboratory and Center for Macromolecular Interactions, both of which are supported in part by the Cancer Therapy and Research Center, National Institutes of Health, NCI P30 Award CA054174, and by Texas State funds provided through the University of Texas Health Science Center at San Antonio Office of the Vice President for Research. The Mass Spectrometry Laboratory is also supported in part by National Institutes of Health Shared Instrumentation Grant S10RR025111 (to S.T. Weintraub), and the expert technical assistance of Sammy Pardo is gratefully acknowledged. We also thank Dr. Verna Frasca of Malvern Instruments for invaluable advice and guidance, and Liping Wang for technical expertise in performing the DSC experiments. Thanks are also due to Dr. Neal C. Robinson for the careful reading and sage advice regarding interpretation of the DSC experiments.	Adachi M, 2006, AM J MED GENET A, V140A, P633, DOI 10.1002/ajmg.a.31112; Adachi M, 2004, AM J MED GENET A, V128A, P333, DOI 10.1002/ajmg.a.30169; Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Arnold U, 2005, BIOCATAL BIOTRANSFOR, V23, P159, DOI 10.1080/10242420500183287; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Duarte MP, 2005, MUTAGENESIS, V20, P199, DOI 10.1093/mutage/gei028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHER CW, 1992, FASEB J, V6, P759, DOI 10.1096/fasebj.6.2.1537466; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Fluck CE, 2010, BIOCHEM BIOPH RES CO, V401, P149, DOI 10.1016/j.bbrc.2010.09.035; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fukami M, 2005, J CLIN ENDOCR METAB, V90, P414, DOI 10.1210/jc.2004-0810; Ghosh D, 2010, J STEROID BIOCHEM, V118, P197, DOI 10.1016/j.jsbmb.2009.09.012; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Huber WJ, 2009, DRUG METAB DISPOS, V37, P857, DOI 10.1124/dmd.108.025023; ILAN Z, 1981, J BIOL CHEM, V256, P66; Jin Y, 2015, BIOCHEM J, V468, P25, DOI 10.1042/BJ20141410; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Kranendonk M, 1998, MUTAGENESIS, V13, P263, DOI 10.1093/mutage/13.3.263; Kranendonk M, 2008, ARCH BIOCHEM BIOPHYS, V475, P93, DOI 10.1016/j.abb.2008.04.014; Krone N, 2012, J CLIN ENDOCR METAB, V97, pE257, DOI 10.1210/jc.2011-0640; Lala P, 2004, J STEROID BIOCHEM, V88, P235, DOI 10.1016/j.jsbmb.2003.12.010; Makaji E, 2010, TOXICOL SCI, V113, P293, DOI 10.1093/toxsci/kfp255; Marohnic CC, 2006, J BIOL CHEM, V281, P35975, DOI 10.1074/jbc.M607095200; Marohnic CC, 2011, ARCH BIOCHEM BIOPHYS, V513, P42, DOI 10.1016/j.abb.2011.06.008; Marohnic CC, 2010, DRUG METAB DISPOS, V38, P332, DOI 10.1124/dmd.109.030445; McLaughlin LA, 2008, DRUG METAB DISPOS, V36, P1322, DOI 10.1124/dmd.108.021261; McPherson A., 1999, CRYSTALLIZATION BIOL; Moutinho D, 2012, DRUG METAB DISPOS, V40, P754, DOI 10.1124/dmd.111.042820; Mui B., 1993, LIPOSOME TECHNOLOGY, P55; Nicolo C, 2010, MOL CELL ENDOCRINOL, V321, P245, DOI 10.1016/j.mce.2010.02.024; ONO T, 1975, J BIOL CHEM, V250, P1571; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallan PS, 2015, J BIOL CHEM, V290, P13128, DOI 10.1074/jbc.M115.646307; Panda SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075638; Pandey AV, 2013, PHARMACOL THERAPEUT, V138, P229, DOI 10.1016/j.pharmthera.2013.01.010; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; Riddick DS, 2013, DRUG METAB DISPOS, V41, P12, DOI 10.1124/dmd.112.048991; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; STURA E A, 1990, Methods (Orlando), V1, P38, DOI 10.1016/S1046-2023(05)80145-8; Tomkova M, 2015, PHARMACOGENOMICS, V16, P205, DOI 10.2217/pgs.14.169; Tomkova M, 2012, PHARMACOGENOMICS, V13, P543, DOI [10.2217/PGS.12.21, 10.2217/pgs.12.21]; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wang YH, 2010, ENDOCRINOLOGY, V151, P1677, DOI 10.1210/en.2009-1247; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Yoshimoto FK, 2014, BIOCHEMISTRY-US, V53, P7531, DOI 10.1021/bi5011865; Yoshimoto FK, 2012, BIOCHEMISTRY-US, V51, P7064, DOI 10.1021/bi300895w	60	14	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20487	20502		10.1074/jbc.M116.716019	http://dx.doi.org/10.1074/jbc.M116.716019			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496950	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000384574800016
J	Hwang, SK; Koper, K; Satoh, H; Okita, TW				Hwang, Seon-Kap; Koper, Kaan; Satoh, Hikaru; Okita, Thomas W.			Rice Endosperm Starch Phosphorylase (Pho1) Assembles with Disproportionating Enzyme (Dpe1) to Form a Protein Complex That Enhances Synthesis of Malto-oligosaccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosyltransferase; metabolism; phosphorylase; protein complex; protein-protein interaction; D-enzyme; disproportionating enzyme; rice endosperm; starch phosphorylase; starch synthesis	ALPHA-GLUCAN PHOSPHORYLASE; SWEET-POTATO ROOTS; BIOSYNTHETIC-ENZYMES; BRANCHING ENZYME; CHLAMYDOMONAS-REINHARDTII; POLYACRYLAMIDE-GEL; MALTOSE METABOLISM; LOW-TEMPERATURE; SPINACH LEAVES; SYNTHASE I	Starch synthesis in cereal grain endosperm is dependent on the concerted actions of many enzymes. The starch plastidial phosphorylase (Pho1) plays an important role in the initiation of starch synthesis and in the maturation of starch granule in developing rice seeds. Prior evidence has suggested that the rice enzyme, OsPho1, may have a physical/functional interaction with other starch biosynthetic enzymes. Pulldown experiments showed that OsPho1 as well as OsPho1 devoid of its L80 region, a peptide unique to higher plant phosphorylases, captures disproportionating enzyme (OsDpe1). Interaction of the latter enzyme form with OsDpe1 indicates that the putative regulatory L80 is not responsible for multienzyme assembly. This heterotypic enzyme complex, determined at a molar ratio of 1:1, was validated by reciprocal co-immunoprecipitation studies of native seed proteins and by co-elution chromatographic and co-migration electrophoretic patterns of these enzymes in rice seed extracts. The OsPho1-OsDpe1 complex utilized a broader range of substrates for enhanced synthesis of larger maltooligosaccharides than each individual enzyme and significantly elevated the substrate affinities of OsPho1 at 30 degrees C. Moreover, the assembly with OsDpe1 enables OsPho1 to utilize products of transglycosylation reactions involving G1 and G3, sugars that it cannot catalyze directly.	[Hwang, Seon-Kap; Koper, Kaan; Okita, Thomas W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Satoh, Hikaru] Kyushu Univ, Fac Agr, Fukuoka 8128581, Japan	Washington State University; Kyushu University	Okita, TW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	okita@wsu.edu		Hwang, Paul/0000-0001-9552-5341; Okita, Tom/0000-0002-2246-0599	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-12ER20216]; USDA-NIFA (United States Department of Agriculture National Institute of Food and Agriculture) [WNP00590]; Agricultural Research Center, College of Agricultural, Human, and Natural Resource Sciences, Washington State University	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); USDA-NIFA (United States Department of Agriculture National Institute of Food and Agriculture); Agricultural Research Center, College of Agricultural, Human, and Natural Resource Sciences, Washington State University	This work was supported in part by DE-FG02-12ER20216 from the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy (to T. W. O, S.-K. H., and K. K.) and by project WNP00590, USDA-NIFA (United States Department of Agriculture National Institute of Food and Agriculture), and the Agricultural Research Center, College of Agricultural, Human, and Natural Resource Sciences, Washington State University. The authors declare that they have no conflicts of interest with the contents of this article.	Abe N, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-80; Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; Akdogan G., 2011, Journal of Applied Glycoscience, V58, P99, DOI 10.5458/jag.jag.JAG-2010_026; Chen HM, 2002, PHYSIOL PLANTARUM, V114, P506, DOI 10.1034/j.1399-3054.2002.1140402.x; Colleoni C, 1999, PLANT PHYSIOL, V120, P1005, DOI 10.1104/pp.120.4.1005; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Crofts AJ, 2010, PLANTA, V231, P1261, DOI 10.1007/s00425-010-1125-x; Crofts N, 2015, J EXP BOT, V66, P4469, DOI 10.1093/jxb/erv212; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Dong XB, 2015, PLANT PHYSIOL, V169, P2496, DOI 10.1104/pp.15.01411; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Grimaud F, 2008, J EXP BOT, V59, P3395, DOI 10.1093/jxb/ern198; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; Hwang SK, 2008, J BIOL CHEM, V283, P6640, DOI 10.1074/jbc.M707447200; Hwang SK, 2007, PHYTOCHEMISTRY, V68, P464, DOI 10.1016/j.phytochem.2006.11.027; Hwang SK, 2016, PLANTA, V243, P999, DOI 10.1007/s00425-015-2461-7; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Jiang HW, 2003, PHYTOCHEMISTRY, V63, P53, DOI 10.1016/S0031-9422(03)00005-0; KAKEFUDA G, 1989, PLANT PHYSIOL, V91, P136, DOI 10.1104/pp.91.1.136; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035336; Liu FS, 2012, BIOCHEM J, V448, P373, DOI 10.1042/BJ20120573; Liu FS, 2012, J EXP BOT, V63, P1167, DOI 10.1093/jxb/err341; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; Lloyd JR, 2004, PLANT PHYSIOL, V134, P1347, DOI 10.1104/pp.103.038026; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Lu Y, 2006, PLANT PHYSIOL, V142, P878, DOI 10.1104/pp.106.086850; Lutken H, 2010, PLANTA, V232, P1127, DOI 10.1007/s00425-010-1245-3; MORI H, 1993, J BIOL CHEM, V268, P5574; Nakamura Y, 2012, PLANT CELL PHYSIOL, V53, P869, DOI 10.1093/pcp/pcs030; NAKANO K, 1986, J BIOL CHEM, V261, P8230; O'Neill EC, 2014, CHEM SCI, V5, P341, DOI 10.1039/c3sc51829a; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; OKITA TW, 1979, PLANT PHYSIOL, V64, P187, DOI 10.1104/pp.64.2.187; OKITA TW, 1980, PLANT PHYSIOL, V66, P870, DOI 10.1104/pp.66.5.870; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHIMOMURA S, 1982, J BIOCHEM-TOKYO, V91, P703, DOI 10.1093/oxfordjournals.jbchem.a133743; Sorensen BK, 2002, ANAL BIOCHEM, V304, P33, DOI 10.1006/abio.2001.5604; Subasinghe RM, 2014, PLANT PHYSIOL BIOCH, V83, P168, DOI 10.1016/j.plaphy.2014.07.016; SUGANUMA T, 1991, CARBOHYD RES, V212, P201, DOI 10.1016/0008-6215(91)84057-L; Takaha T, 1996, J BIOL CHEM, V271, P2902, DOI 10.1074/jbc.271.6.2902; Takaha T, 1998, BIOCHEM BIOPH RES CO, V247, P493, DOI 10.1006/bbrc.1998.8817; Takaha T, 1998, PLANTA, V205, P445, DOI 10.1007/s004250050342; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1	48	40	44	4	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					19994	20007		10.1074/jbc.M116.735449	http://dx.doi.org/10.1074/jbc.M116.735449			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502283	Green Published, hybrid			2022-12-26	WOS:000383243100023
J	Kojima, S; Muramoto, K; Kusano, T				Kojima, Seiji; Muramoto, Koji; Kusano, Tomonobu			Outer Membrane Proteins Derived from Non-cyanobacterial Lineage Cover the Peptidoglycan of Cyanophora paradoxa Cyanelles and Serve as a Cyanelle Diffusion Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; cyanobacteria; Gram-negative bacteria; outer membrane; peptidoglycan; cyanelle; diffusion channel	SYNECHOCOCCUS PCC 6301; ESCHERICHIA-COLI; CELL-WALL; MUREIN-LIPOPROTEIN; SELENOMONAS-RUMINANTIUM; PSEUDOMONAS-AERUGINOSA; BUDDING BACTERIA; PORIN CHANNELS; ENVELOPE; DIVISION	The cyanelle is a primitive chloroplast that contains a peptidoglycan layer between its inner and outer membranes. Despite the fact that the envelope structure of the cyanelle is reminiscent of Gram-negative bacteria, the Cyanophora paradoxa genome appears to lack genes encoding homologs of putative peptidoglycan-associated outer membrane proteins and outer membrane channels. These are key components of Gram-negative bacterial membranes, maintaining structural stability and regulating permeability of outer membrane, respectively. Here, we discovered and characterized two dominant peptidoglycan-associated outer membrane proteins of the cyanelle (approximate to 2 x 10(6) molecules per cyanelle). We named these proteins CppF and CppS (cyanelle peptidoglycan-associated proteins). They are homologous to each other and function as a diffusion channel that allows the permeation of compounds with M-r <1,000 as revealed by permeability measurements using proteoliposomes reconstituted with purified CppS and CppF. Unexpectedly, amino acid sequence analysis revealed no evolutionary linkage to cyanobacteria, showing only a moderate similarity to cell surface proteins of bacteria belonging to Planctomycetes phylum. Our findings suggest that the C. paradoxa cyanelle adopted non-cyanobacterial lineage proteins as its main outer membrane components, providing a physical link with the underlying peptidoglycan layer and functioning as a diffusion route for various small substances across the outer membrane.	[Kojima, Seiji] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Kojima, Seiji; Muramoto, Koji; Kusano, Tomonobu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan	Tohoku University; Tohoku University	Kojima, S (corresponding author), Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Aoba Ku, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	skojima0801@gmail.com	Kojima, Seiji/I-8643-2017	Kojima, Seiji/0000-0002-2184-1592	Japan Society for the Promotion of Science [15K20860]; Agricultural Chemical Research Foundation [1-322]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agricultural Chemical Research Foundation(Agricultural Chemical Research Foundation, Japan)	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for Young Scientist (B) 15K20860 and by Agricultural Chemical Research Foundation Grant 1-322 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article.	AITKEN A, 1979, J GEN MICROBIOL, V112, P219, DOI 10.1099/00221287-112-2-219; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; Bhattacharya D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2931; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Dagan T, 2013, GENOME BIOL EVOL, V5, P31, DOI 10.1093/gbe/evs117; Dyson HJ, 2016, BIOPHYS J, V110, P1013, DOI 10.1016/j.bpj.2016.01.030; Engelhardt H, 1998, J STRUCT BIOL, V124, P276, DOI 10.1006/jsbi.1998.4070; Facchinelli F, 2013, PLANTA, V237, P637, DOI 10.1007/s00425-012-1819-3; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; FUNG J, 1978, J BACTERIOL, V133, P1467, DOI 10.1128/JB.133.3.1467-1471.1978; GEHRING KB, 1989, J BIOL CHEM, V264, P2810; HALL WT, 1963, J CELL BIOL, V19, P551, DOI 10.1083/jcb.19.3.551; Hansel A, 1998, CURR MICROBIOL, V36, P321, DOI 10.1007/s002849900316; Hansel A, 1998, BBA-GENE STRUCT EXPR, V1399, P31, DOI 10.1016/S0167-4781(98)00090-6; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Hirano T, 2016, PLANT CELL, V28, P1521, DOI 10.1105/tpc.16.00104; Huang F, 2004, MOL CELL PROTEOMICS, V3, P586, DOI 10.1074/mcp.M300137-MCP200; Huber C, 2005, MOL MICROBIOL, V55, P197, DOI 10.1111/j.1365-2958.2004.04351.x; Iino M, 2003, J PHYCOL, V39, P561, DOI 10.1046/j.1529-8817.2003.02132.x; JURGENS UJ, 1985, ARCH MICROBIOL, V142, P168, DOI 10.1007/BF00447062; Koike H, 2000, PHOTOSYNTH RES, V65, P207, DOI 10.1023/A:1010734912776; Koike H, 2007, PHOTOSYNTH RES, V93, P45, DOI 10.1007/s11120-007-9156-2; Kojima S, 2016, BIOSCI BIOTECH BIOCH, V80, P1954, DOI 10.1080/09168451.2016.1194185; Kojima S, 2011, J BACTERIOL, V193, P2347, DOI 10.1128/JB.00106-11; Kojima S, 2010, J BACTERIOL, V192, P5953, DOI 10.1128/JB.00417-10; KONIG E, 1984, ARCH MICROBIOL, V138, P200, DOI 10.1007/BF00402120; KOSKI P, 1987, ANAL BIOCHEM, V164, P261, DOI 10.1016/0003-2697(87)90395-2; Kowata H, 2016, J ANTIBIOT, V69, P863, DOI 10.1038/ja.2016.50; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; LIESACK W, 1986, ARCH MICROBIOL, V145, P361, DOI 10.1007/BF00470872; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Nicolaisen K, 2009, MOL MICROBIOL, V74, P58, DOI 10.1111/j.1365-2958.2009.06850.x; NIKAIDO H, 1983, J BACTERIOL, V153, P232, DOI 10.1128/JB.153.1.232-240.1983; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1991, J BIOL CHEM, V266, P770; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pfanzagl B, 1996, J BACTERIOL, V178, P332, DOI 10.1128/jb.178.2.332-339.1996; Qiu H, 2013, TRENDS PLANT SCI, V18, P680, DOI 10.1016/j.tplants.2013.09.007; Raven JA, 2003, EUR J PHYCOL, V38, P47, DOI 10.1080/0967026031000096245; Ribeiro ACF, 2006, DEFECT DIFFUS FORUM, V258-260, P305, DOI 10.4028/www.scientific.net/DDF.258-260.305; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; SUGAWARA E, 1992, J BIOL CHEM, V267, P2507; SUZUKI H, 1978, MOL GEN GENET, V167, P1; Takano H, 2010, BBA-GEN SUBJECTS, V1800, P144, DOI 10.1016/j.bbagen.2009.07.020; van Baren MJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2585-6; Voigt B, 2012, PROTEOMICS, V12, P1781, DOI 10.1002/pmic.201100512; WECKESSER J, 1988, METHOD ENZYMOL, V167, P173; YEM DW, 1978, J BACTERIOL, V133, P1419, DOI 10.1128/JB.133.3.1419-1426.1978; YOSHIMURA F, 1983, J BIOL CHEM, V258, P2308; Zhao GS, 2006, APPL MICROBIOL BIOT, V70, P464, DOI 10.1007/s00253-005-0079-6	56	7	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20198	20209		10.1074/jbc.M116.746131	http://dx.doi.org/10.1074/jbc.M116.746131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502278	Green Published, hybrid			2022-12-26	WOS:000383243100039
J	Gao, GW; Yang, J; Jing, XY; Huang, P; Hua, JL; Yue, D				Gao, Guangwei; Yang, Jian; Jing, Xiaoyuan; Huang, Pu; Hua, Juliang; Yue, Dong			Robust Face Recognition via Multi-Scale Patch-Based Matrix Regression	PLOS ONE			English	Article							COLLABORATIVE REPRESENTATION; SPARSE REPRESENTATION; IMAGE; ALGORITHM; SAMPLE	In many real-world applications such as smart card solutions, law enforcement, surveillance and access control, the limited training sample size is the most fundamental problem. By making use of the low-rank structural information of the reconstructed error image, the socalled nuclear norm-based matrix regression has been demonstrated to be effective for robust face recognition with continuous occlusions. However, the recognition performance of nuclear norm-based matrix regression degrades greatly in the face of the small sample size problem. An alternative solution to tackle this problem is performing matrix regression on each patch and then integrating the outputs from all patches. However, it is difficult to set an optimal patch size across different data-bases. To fully utilize the complementary information from different patch scales for the final decision, we propose a multi-scale patch-based matrix regression scheme based on which the ensemble of multi-scale outputs can be achieved optimally. Extensive experiments on benchmark face databases validate the effectiveness and robustness of our method, which outperforms several state-of-the-art patch-based face recognition algorithms.	[Gao, Guangwei; Yue, Dong] Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China; [Yang, Jian; Hua, Juliang] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China; [Jing, Xiaoyuan] Nanjing Univ Posts & Telecommun, Sch Automat, Nanjing 210023, Jiangsu, Peoples R China; [Huang, Pu] Nanjing Univ Posts & Telecommun, Sch Comp Sci & Technol, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Posts & Telecommunications; Nanjing University of Science & Technology; Nanjing University of Posts & Telecommunications; Nanjing University of Posts & Telecommunications	Gao, GW (corresponding author), Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China.	csggao@gmail.com			National Science Fund for Distinguished Young Scholars [61125305, 91420201, 61472187, 61233011, 61373063]; National Natural Science Foundation of China [61502245, 61503188, 61503195]; NUPTSF [NY214204, NY214165]; China Postdoctoral Science Foundation [2015M571786]; Natural Science Fund for Colleges and Universities in Jiangsu Province [15KJB520026]; Natural Science Foundation of Jiangsu Province [BK20150849, BK20150982]; Key Project of Chinese Ministry of Education [313030]; 973 Program [2014CB349303]; Fundamental Research Funds for the Central Universities [30920140121005]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13072]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NUPTSF; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Fund for Colleges and Universities in Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Project of Chinese Ministry of Education(Ministry of Education, China); 973 Program(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was partially supported by the National Science Fund for Distinguished Young Scholars under Grant Nos. 61125305, 91420201, 61472187, 61233011 and 61373063, the National Natural Science Foundation of China under Grant Nos. 61502245, 61503188 and 61503195, the NUPTSF under Grant Nos. NY214204 and NY214165, the China Postdoctoral Science Foundation No. 2015M571786, the Natural Science Fund for Colleges and Universities in Jiangsu Province No. 15KJB520026, the Natural Science Foundation of Jiangsu Province under Grant Nos. BK20150849 and BK20150982, the Key Project of Chinese Ministry of Education under Grant No. 313030, the 973 Program No. 2014CB349303, Fundamental Research Funds for the Central Universities No. 30920140121005, and Program for Changjiang Scholars and Innovative Research Team in University No. IRT13072.	Beveridge JR, 2001, 3 WORKSH EMP EV COMP, P1; Cai JF, 2010, SIAM J OPTIMIZ, V20, P1956, DOI 10.1137/080738970; Chen BJ, 2015, J MATH IMAGING VIS, V51, P124, DOI 10.1007/s10851-014-0511-6; Chen SC, 2004, PATTERN RECOGN, V37, P1553, DOI 10.1016/j.patcog.2003.12.010; Deng ZH, 2014, IEEE T CYBERNETICS, V44, P2585, DOI 10.1109/TCYB.2014.2311014; Gao GW, 2015, APPL SOFT COMPUT, V37, P48, DOI 10.1016/j.asoc.2015.07.034; Gao GW, 2014, NEUROCOMPUTING, V134, P92, DOI 10.1016/j.neucom.2012.12.059; Gu B, 2016, IEEE T NEUR NET LEAR, DOI [DOI 10.1109/TNNLS.2016.2527796, 10.1109/TNNLS.2016.2527796]; Gu B, 2017, IEEE T NEUR NET LEAR, V28, P1646, DOI 10.1109/TNNLS.2016.2544779; Gu B, 2015, IEEE T NEUR NET LEAR, V26, P1403, DOI 10.1109/TNNLS.2014.2342533; Gu B, 2015, NEURAL NETWORKS, V67, P140, DOI 10.1016/j.neunet.2015.03.013; Guillaumin M, 2009, IEEE I CONF COMP VIS, P498, DOI 10.1109/ICCV.2009.5459197; Guo ZH, 2016, IEEE T IMAGE PROCESS, V25, P687, DOI 10.1109/TIP.2015.2507408; He R, 2014, IEEE T PATTERN ANAL, V36, P261, DOI 10.1109/TPAMI.2013.102; Huang G. B., 2007, 0749 U MASS; Jain AK, 2004, IEEE T CIRC SYST VID, V14, P4, DOI 10.1109/TCSVT.2003.818349; Jiang JJ, 2014, IEEE T MULTIMEDIA, V16, P1268, DOI 10.1109/TMM.2014.2311320; Jiang YZ, 2015, IEEE T CYBERNETICS, V45, P548, DOI 10.1109/TCYB.2014.2330844; Juang CF, 2007, IEEE T SYST MAN CY A, V37, P1077, DOI 10.1109/TSMCA.2007.904579; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kumar R, 2011, IEEE I CONF COMP VIS, P2375, DOI 10.1109/ICCV.2011.6126520; Kumar R, 2009, PROC CVPR IEEE, P150, DOI 10.1109/CVPRW.2009.5206837; Lai ZH, 2014, IEEE T CIRC SYST VID, V24, P1651, DOI 10.1109/TCSVT.2014.2305495; Lai ZH, 2014, IEEE T NEUR NET LEAR, V25, P1942, DOI 10.1109/TNNLS.2013.2297381; Lee KC, 2005, IEEE T PATTERN ANAL, V27, P684, DOI 10.1109/TPAMI.2005.92; Lin D., 2006, 2006 IEEE COMP SOC C, P1355; Lin Z., 2013, J STRUCT BIOL, V181, P116, DOI [10.1016/j.jsb.2012.10.010, DOI 10.1016/J.JSB.2012.10.010]; Luo L, 2014, INT C PATT RECOG, P1834, DOI 10.1109/ICPR.2014.321; Martinez A., 1998, AR FACE DATABASE CVC; Naseem I, 2010, IEEE T PATTERN ANAL, V32, P2106, DOI 10.1109/TPAMI.2010.128; Ou WH, 2014, PATTERN RECOGN, V47, P1559, DOI 10.1016/j.patcog.2013.10.017; Qian JJ, 2015, PATTERN RECOGN, V48, P3145, DOI 10.1016/j.patcog.2015.04.017; Shawe-Taylor J., 1999, 4 EUR C COMP LEARN T; Shen CH, 2010, IEEE T PATTERN ANAL, V32, P2216, DOI 10.1109/TPAMI.2010.47; Su Y, 2009, IEEE T IMAGE PROCESS, V18, P1885, DOI 10.1109/TIP.2009.2021737; Tan XY, 2006, PATTERN RECOGN, V39, P1725, DOI 10.1016/j.patcog.2006.03.013; Tan XY, 2005, IEEE T NEURAL NETWOR, V16, P875, DOI 10.1109/TNN.2005.849817; Tawari A, 2013, IEEE T MULTIMEDIA, V15, P1543, DOI 10.1109/TMM.2013.2266635; Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Wolf L, 2011, IEEE T PATTERN ANAL, V33, P1978, DOI 10.1109/TPAMI.2010.230; Wong WK, 2015, IEEE T CYBERNETICS, V45, P2425, DOI 10.1109/TCYB.2014.2374452; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yang J, 2017, IEEE T PATTERN ANAL, V39, P156, DOI 10.1109/TPAMI.2016.2535218; Yang J, 2012, PATTERN RECOGN, V45, P1104, DOI 10.1016/j.patcog.2011.08.022; Yang M, 2015, NEUROCOMPUTING, V168, P70, DOI 10.1016/j.neucom.2015.06.013; Yang M, 2014, PATTERN RECOGN, V47, P535, DOI 10.1016/j.patcog.2013.08.003; Yang M, 2011, PROC CVPR IEEE, P625, DOI 10.1109/CVPR.2011.5995393; Yang WK, 2015, PATTERN RECOGN, V48, P20, DOI 10.1016/j.patcog.2014.07.009; Zhang FL, 2015, IEEE T IMAGE PROCESS, V24, P1956, DOI 10.1109/TIP.2015.2400213; Zhang L, 2011, IEEE I CONF COMP VIS, P471, DOI 10.1109/ICCV.2011.6126277; Zhu PF, 2012, LECT NOTES COMPUT SC, V7572, P822, DOI 10.1007/978-3-642-33718-5_59	52	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0159945	10.1371/journal.pone.0159945	http://dx.doi.org/10.1371/journal.pone.0159945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525734	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100009
J	Gao, L; Zhou, WB; Symmes, B; Freed, CR				Gao, Lu; Zhou, Wenbo; Symmes, Breanna; Freed, Curt R.			Re-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease	PLOS ONE			English	Article							PROTEIN HANDLING SYSTEMS; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; PC12 CELLS; IN-VITRO; NEURONAL CELLS; ACTIVATION; EXPRESSION; NURR1; GENE	Parkinson's disease is characterized by the death of dopaminergic neurons in the substantia nigra. To understand the molecular mechanisms of the disease, an in vitro model is important. In the 1990s, we used the SV40 large T antigen to immortalize dopaminergic neurons derived from Embryonic Day 14 rat mesencephalon. We selected a clone for its high expression of dopaminergic neuron markers such as tyrosine hydroxylase (TH), and we named it 1RB3AN27 (N27). Because the original N27 cell line has been passaged many times, the line has become a mixture of cell types with highly variable expression of TH. In the current study, we have performed multiple rounds of clonal cultures and have identified a dopaminergic cell clone expressing high levels of TH and the dopamine transporter (DAT). We have named this new clone N27-A. Nearly 100% of N27-A cells express TH, DAT and Tuj1. Western blots have confirmed that N27-A cells have three to four times the levels of TH and DAT compared to the previous mixed population in N27. Further analysis has shown that the new clone expresses the dopamine neuron transcription factors Nurr1, En1, FoxA2 and Pitx3. The N27-A cells express the vesicular monoamine transporter (VMAT2), but do not express dopamine-beta-hydroxylase (D beta H), the enzyme responsible for converting dopamine to norepinephrine. Functional analysis has shown that N27-A cells are more sensitive than N27 cells to neurotoxins taken up by the dopamine transporter such as 6-hydroxydopamine and 1-methyl-4-phenylpyridine (MPP+). The DAT inhibitor nomifensine can block MPP+ induced toxicity. The non-selective toxic effects of hydrogen peroxide were similar in both cell lines. The N27-A cells show dopamine release under basal and depolarization conditions. We conclude that the new N27-A clone of the immortalized rat dopaminergic cell line N27 should provide an improved in vitro model for Parkinson's disease research.	[Gao, Lu] Fudan Univ, Sch Basic Med Sci, Dept Human Anat & Histoembryol, Shanghai, Peoples R China; [Gao, Lu; Zhou, Wenbo; Symmes, Breanna; Freed, Curt R.] Univ Colorado, Sch Med, Gates Ctr Stem Cell Res & Regenerat Med, Neurosci Program,Div Clin Pharmacol & Toxicol,Dep, Aurora, CO 80045 USA; [Gao, Lu; Zhou, Wenbo; Symmes, Breanna; Freed, Curt R.] Univ Colorado, Sch Med, Gates Ctr Stem Cell Res & Regenerat Med, Neurosci Program,Div Clin Pharmacol & Toxicol,Dep, Aurora, CO 80045 USA; [Gao, Lu; Zhou, Wenbo; Symmes, Breanna; Freed, Curt R.] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO 80045 USA	Fudan University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhou, WB; Freed, CR (corresponding author), Univ Colorado, Sch Med, Gates Ctr Stem Cell Res & Regenerat Med, Neurosci Program,Div Clin Pharmacol & Toxicol,Dep, Aurora, CO 80045 USA.; Zhou, WB; Freed, CR (corresponding author), Univ Colorado, Sch Med, Gates Ctr Stem Cell Res & Regenerat Med, Neurosci Program,Div Clin Pharmacol & Toxicol,Dep, Aurora, CO 80045 USA.; Zhou, WB; Freed, CR (corresponding author), Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO 80045 USA.	Wenbo.zhou@ucdenver.edu; curt.freed@ucdenver.edu			Jerome A. Yavitz Charitable Foundation; Leopold Korn and Michael Korn Professorship in Parkinson's Disease [201020];  [SHFD201410]	Jerome A. Yavitz Charitable Foundation; Leopold Korn and Michael Korn Professorship in Parkinson's Disease; 	The study was supported by the Jerome A. Yavitz Charitable Foundation (2014-15) (to C.R.F.), the Leopold Korn and Michael Korn Professorship in Parkinson's Disease (201020) (to C.R.F.), and by the personal savings of C.R.F. Dr. Lu Gao was a visiting scholar from Fudan University, Shanghai, and was supported by the Chinese Minister of Education (SHFD201410).	Ahn TB, 2015, NEURAL REGEN RES, V10, P1113, DOI 10.4103/1673-5374.160106; Amiri E, 2016, CELL MOL NEUROBIOL, V36, P829, DOI 10.1007/s10571-015-0266-7; Bang SY, 2015, STEM CELLS DEV, V24, P520, DOI 10.1089/scd.2014.0218; Cantu D, 2011, J NEUROCHEM, V118, P79, DOI 10.1111/j.1471-4159.2011.07290.x; Charli A, 2016, NEUROTOXICOLOGY, V53, P302, DOI 10.1016/j.neuro.2015.06.007; Choi DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115954; Clarkson ED, 1998, P NATL ACAD SCI USA, V95, P1265, DOI 10.1073/pnas.95.3.1265; Connolly BS, 2014, JAMA-J AM MED ASSOC, V311, P1670, DOI 10.1001/jama.2014.3654; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Filograna R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136769; Hammond SL, 2015, NEUROSCI LETT, V607, P83, DOI 10.1016/j.neulet.2015.09.015; Harischandra DS, 2015, TOXICOL SCI, V143, P454, DOI 10.1093/toxsci/kfu247; Holmes S, 2013, ENDOCRINOLOGY, V154, P4281, DOI 10.1210/en.2013-1242; Hu SQ, 2015, J MOL NEUROSCI, V57, P561, DOI 10.1007/s12031-015-0638-y; Kabiraj P, 2015, PROTEIN J, V34, P349, DOI 10.1007/s10930-015-9629-7; Kim CH, 2015, P NATL ACAD SCI USA, V112, P8756, DOI 10.1073/pnas.1509742112; Kumaran R, 2015, HUM MOL GENET, V24, pR32, DOI 10.1093/hmg/ddv236; Latchoumycandane C, 2011, TOXICOL APPL PHARM, V256, P314, DOI 10.1016/j.taap.2011.07.021; Leiros M, 2015, NEUROSCIENCE, V305, P26, DOI 10.1016/j.neuroscience.2015.07.082; Li F, 2013, CELL MOL NEUROBIOL, V33, P907, DOI 10.1007/s10571-013-9957-0; Lim MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138460; Lopert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050683; Luk KC, 2013, J NEUROCHEM, V125, P932, DOI 10.1111/jnc.12160; Mullin S, 2013, MOL NEUROBIOL, V47, P587, DOI 10.1007/s12035-013-8394-x; Nordstrom U, 2015, NEUROBIOL DIS, V73, P70, DOI 10.1016/j.nbd.2014.09.012; Oh SM, 2015, EMBO MOL MED, V7, P510, DOI 10.15252/emmm.201404610; Park KH, 2016, NEUROPHARMACOLOGY, V101, P87, DOI 10.1016/j.neuropharm.2015.09.006; Pristera A, 2015, P NATL ACAD SCI USA, V112, pE4929, DOI 10.1073/pnas.1503911112; Ramalingam M, 2016, J CELL BIOCHEM, V117, P917, DOI 10.1002/jcb.25376; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Shao YT, 2015, TOXICOL MECH METHOD, V25, P637, DOI 10.3109/15376516.2015.1053654; Tian PX, 2015, INT J CLIN EXP PATHO, V8, P4863; Veenvliet JV, 2013, DEVELOPMENT, V140, P3373, DOI 10.1242/dev.094565; Volpicelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030661; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Xiong R, 2014, TOXICOL APPL PHARM, V280, P285, DOI 10.1016/j.taap.2014.08.014; Xiong R, 2013, CHEM-BIOL INTERACT, V204, P116, DOI 10.1016/j.cbi.2013.04.016; Zeng XS, 2015, MOL CELL BIOCHEM, V410, P239, DOI 10.1007/s11010-015-2557-1; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	42	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160847	10.1371/journal.pone.0160847	http://dx.doi.org/10.1371/journal.pone.0160847			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512998	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100080
J	Jacobs, CN; Merchant, W; Jendrassak, M; Limpasuvan, V; Gurka, R; Hackett, EE				Jacobs, Corrine N.; Merchant, Wilmot; Jendrassak, Marek; Limpasuvan, Varavut; Gurka, Roi; Hackett, Erin E.			Flow Scales of Influence on the Settling Velocities of Particles with Varying Characteristics	PLOS ONE			English	Article							HOMOGENEOUS ISOTROPIC TURBULENCE; HEAVY-PARTICLES; COHERENT STRUCTURES; SUSPENDED SEDIMENT; AEROSOL-PARTICLES; FIELDS; MOTION; SAND	The settling velocities of natural, synthetic, and industrial particles were measured in a grid turbulence facility using optical measurement techniques. Particle image velocimetry and 2D particle tracking were used to measure the instantaneous velocities of the flow and the particles' trajectories simultaneously. We find that for particles examined in this study (Rep =0.4-123), settling velocity is either enhanced or unchanged relative to stagnant flow for the range of investigated turbulence conditions. The smallest particles' normalized settling velocities exhibited the most consistent trends when plotted versus the Kolmogorov-based Stokes numbers suggesting that the dissipative scales influence their dynamics. In contrast, the mid-sized particles were better characterized with a Stokes number based on the integral time scale. The largest particles were largely unaffected by the flow conditions. Using proper orthogonal decomposition (POD), the flow pattern scales are compared to particle trajectory curvature to complement results obtained through dimensional analysis using Stokes numbers. The smallest particles are found to have trajectories with curvatures of similar scale as the small flow scales (higher POD modes) whilst mid-sized particle trajectories had curvatures that were similar to the larger flow patterns (lower POD modes). The curvature trajectories of the largest particles did not correspond to any particular flow pattern scale suggesting that their trajectories were more random. These results provide experimental evidence of the "fast tracking" theory of settling velocity enhancement in turbulence and demonstrate that particles align themselves with flow scales in proportion to their size.	[Jacobs, Corrine N.; Merchant, Wilmot; Jendrassak, Marek; Limpasuvan, Varavut; Gurka, Roi; Hackett, Erin E.] Coastal Carolina Univ, Sch Coastal & Marine Syst Sci, Conway, SC 29528 USA		Hackett, EE (corresponding author), Coastal Carolina Univ, Sch Coastal & Marine Syst Sci, Conway, SC 29528 USA.	ehackett@coastal.edu	Avidan, Corrine/X-8284-2019	Avidan, Corrine/0000-0001-8441-9017; Gurka, Roi/0000-0002-8907-6663	II-VI Foundation; Coastal Carolina University's Provost office	II-VI Foundation; Coastal Carolina University's Provost office	This work was supported by II-VI Foundation (Undergraduate Research Program), http://ii-vifoundation.com/, EEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Jenna Hill (Coastal Carolina University) for use of the laser diffraction size analyzer and Mr. James Sturgeon at Conbraco Inc. for donating the industrial particles. The support of Coastal Carolina University's Provost office through the Academic Enhancement Grant and the Kerns Palmetto Professor Endowment played an important role to this work.	Aliseda A, 2002, J FLUID MECH, V468, P77, DOI 10.1017/S0022112002001593; DIETRICH WE, 1982, WATER RESOUR RES, V18, P1615, DOI 10.1029/WR018i006p01615; FERNANDO HJS, 1993, PHYS FLUIDS A-FLUID, V5, P1849, DOI 10.1063/1.858808; Good GH, 2014, J FLUID MECH, V759, DOI 10.1017/jfm.2014.602; Gurka R, 2006, INT J HEAT FLUID FL, V27, P416, DOI 10.1016/j.ijheatfluidflow.2006.01.001; Ha HK, 2010, GEOSCI J, V14, P163, DOI 10.1007/s12303-010-0016-2; Kawanisi K, 2008, J HYDRAUL ENG-ASCE, V134, P261, DOI 10.1061/(ASCE)0733-9429(2008)134:2(261); Kolmogorov A, 1941, P USSR ACAD SCI, V3, P299; Lumley J., 1970, APPL MATH MECH-ENGL; Luo H, 2011, EXP MECH, V51, P1499, DOI 10.1007/s11340-011-9475-2; MAXEY MR, 1990, PHILOS T ROY SOC A, V333, P289, DOI 10.1098/rsta.1990.0162; MAXEY MR, 1986, J ATMOS SCI, V43, P1112, DOI 10.1175/1520-0469(1986)043<1112:GSOAPI>2.0.CO;2; MAXEY MR, 1987, J FLUID MECH, V174, P441, DOI 10.1017/S0022112087000193; McKenna SP, 2004, PHYS FLUIDS, V16, P3499, DOI 10.1063/1.1779671; Melling A, 1997, MEAS SCI TECHNOL, V8, P1406, DOI 10.1088/0957-0233/8/12/005; MURRAY SP, 1970, J GEOPHYS RES, V75, P1647, DOI 10.1029/JC075i009p01647; NIELSEN P, 1993, J SEDIMENT PETROL, V63, P835; NIELSEN P, 1984, J GEOPHYS RES-OCEANS, V89, P616, DOI 10.1029/JC089iC01p00616; Nielsen P., 1992, COASTAL BOTTOM BOUND, DOI 10.1142/1269; Pope S. B., 2000, TURBULENT FLOWS, DOI DOI 10.1017/CBO9780511840531; Rubey WW, 1933, AM J SCI, V25, P325; Scully ME, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003784; Shy SS, 1997, EXP THERM FLUID SCI, V14, P251, DOI 10.1016/S0894-1777(96)00111-2; SIROVICH L, 1987, Q APPL MATH, V45, P561, DOI 10.1090/qam/910462; Taylor ZJ, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4807074; TOOBY PF, 1977, J GEOPHYS RES-OC ATM, V82, P2096, DOI 10.1029/JC082i015p02096; WANG LP, 1993, J FLUID MECH, V256, P27, DOI 10.1017/S0022112093002708; Yang CY, 1998, J FLUID MECH, V371, P179, DOI 10.1017/S0022112098002328; Yang TS, 2005, J FLUID MECH, V526, P171, DOI 10.1017/S0022112004002861; Yang TS, 2003, PHYS FLUIDS, V15, P868, DOI 10.1063/1.1557526	30	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159645	10.1371/journal.pone.0159645	http://dx.doi.org/10.1371/journal.pone.0159645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513958	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100016
J	Khanom, R; Nguyen, CTK; Kayamori, K; Zhao, X; Morita, K; Miki, Y; Katsube, K; Yamaguchi, A; Sakamoto, K				Khanom, Rumana; Chi Thi Kim Nguyen; Kayamori, Kou; Zhao, Xin; Morita, Keiichi; Miki, Yoshio; Katsube, Ken-ichi; Yamaguchi, Akira; Sakamoto, Kei			Keratin 17 Is Induced in Oral Cancer and Facilitates Tumor Growth	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTERMEDIATE-FILAMENTS; MAMMALIAN TARGET; GENE-EXPRESSION; WOUND REPAIR; SKIN; MATURATION; KINASE; GLUT1; PROLIFERATION	Keratin subtypes are selectively expressed depending on the cell type. They not only provide structural support, but regulate the metabolic processes and signaling pathways that control the growth of the epithelium. KRT17 (keratin 17) is induced in the regenerative epithelium and acts on diverse signaling pathways. Here, we demonstrate that KRT17 is invariably and permanently induced in oral squamous cell carcinoma (OSCC), as revealed by immunohistochemistry and cDNA microarray analysis. Two representative OSCC cell lines; KRT17-weakly expressing Ca9-22 and KRT17-highly expressing HSC3 were used to establish KRT17-overexpressing Ca9-22 and KRT17-knockdown HSC3 cells. Analysis of these cells revealed that KRT17 promoted cell proliferation and migration by stimulating the Akt/mTOR pathway. KRT17 also upregulated the expression of SLC2A1 (solute carrier family 2 member 1/Glut1) and glucose uptake. To further investigate the effect of KRT17 on tumorigenesis, KRT17-knockout HSC3 cells were established and were transplanted to the cephalic skin of nude mice. The tumors that developed from KRT17-knockout HSC3 cells had a lower Ki-67 labeling index and were significantly smaller compared to the controls. These results indicate that KRT17 stimulates the Akt/mTOR pathway and glucose uptake, thereby facilitating tumor growth. We could not confirm the relationship between KRT17 and SFN (stratifin) in the cells examined in this study. However, our study reinforces the concept that the cellular properties of cancer are regulated by a series of molecules similar to those found in wound healing. In OSCC, KRT17 acts as a pathogenic keratin that facilitates tumor growth through the stimulation of multiple signaling pathways, highlighting the importance of KRT17 as a multifunctional promoter of tumorigenesis.	[Khanom, Rumana; Chi Thi Kim Nguyen; Kayamori, Kou; Zhao, Xin; Yamaguchi, Akira; Sakamoto, Kei] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan; [Morita, Keiichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Miki, Yoshio] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Genet, Tokyo, Japan; [Katsube, Ken-ichi] Tohto Coll Hlth Sci, Fac Human Care, Dept Nursing Sci, Saitama, Japan; [Yamaguchi, Akira] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan; [Khanom, Rumana; Miki, Yoshio; Yamaguchi, Akira] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Dental College; Tokyo Medical & Dental University (TMDU)	Sakamoto, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Pathol, Tokyo, Japan.	s-kei.mpa@tmd.ac.jp	Yamaguchi, Akira/AAX-9286-2020	Khanom, Rumana/0000-0002-6209-7763	Japan Society for the Promotion of Science [25462848, 25253098]; Grants-in-Aid for Scientific Research [25253098, 25462915] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 25462848 to KS) and a Grant-in-Aid for Scientific Research (A) (No. 25253098 to AY) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/j-grantsinaid/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Bianchi N, 2005, MOL CELL BIOL, V25, P7249, DOI 10.1128/MCB.25.16.7249-7259.2005; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hobbs RP, 2015, NAT GENET, V47, P933, DOI 10.1038/ng.3355; Kayamori K, 2010, AM J PATHOL, V176, P968, DOI 10.2353/ajpath.2010.090299; Khanom R, 2012, HISTOL HISTOPATHOL, V27, P949, DOI 10.14670/HH-27.949; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Loschke F, 2016, J INVEST DERMATOL, V136, P202, DOI 10.1038/JID.2015.403; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; McGowan K, 1998, Subcell Biochem, V31, P173; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Mikami T, 2015, VIRCHOWS ARCH, V466, P559, DOI 10.1007/s00428-015-1735-6; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Pedersen TX, 2003, ONCOGENE, V22, P3964, DOI 10.1038/sj.onc.1206614; QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Sakamoto K, 2012, LAB INVEST, V92, P688, DOI 10.1038/labinvest.2012.9; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Snijders AM, 2009, ONCOGENE, V28, P625, DOI 10.1038/onc.2008.421; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Tomioka H, 2006, J ORAL PATHOL MED, V35, P206, DOI 10.1111/j.1600-0714.2006.00410.x; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Vijayaraj P, 2009, J CELL BIOL, V187, P175, DOI 10.1083/jcb.200906094; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Xin Z, 2014, VIRCHOWS ARCH; Yan M, 2011, ORAL ONCOL, V47, P504, DOI 10.1016/j.oraloncology.2011.03.027; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	44	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161163	10.1371/journal.pone.0161163	http://dx.doi.org/10.1371/journal.pone.0161163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512993	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100125
J	Lee, G; Lee, J; Oh, H; Lee, S				Lee, GeonHui; Lee, JaeSeo; Oh, HyunJik; Lee, SangHoon			Reproducible Construction of Surface Tension-Mediated Honeycomb Concave Microwell Arrays for Engineering of 3D Microtissues with Minimal Cell Loss	PLOS ONE			English	Article							SPHEROID CULTURE; DIFFERENTIATION EFFICIENCY; LIVER; HEPATOCYTES; MODEL; FABRICATION; HYDROGEL	The creation of engineered 3D microtissues has attracted prodigious interest because of the fact that this microtissue structure is able to mimic in vivo environments. Such microtissues can be applied extensively in the fields of regenerative medicine and tissue engineering, as well as in drug and toxicity screening. Here, we develop a novel method of fabricating a large number of dense honeycomb concave microwells via surface tension-mediated self-construction. More specifically, in order to control the curvature and shape of the concavity in a precise and reproducible manner, a custom-made jig system was designed and fabricated. By applying a pre-set force using the jig system, the shape of the honeycomb concave well was precisely and uniformly controlled, despite the fact that wells were densely packed. The thin wall between the honeycomb wells enables the minimization of cell loss during the cell-seeding process. To evaluate the performance of the honeycomb microwell array, rat hepatocytes were seeded, and spheroids were successfully formed with uniform shape and size. Liver-specific functions such as albumin secretion and cytochrome P450 were subsequently analyzed. The proposed method of fabricating honeycomb concave wells is cost-effective, simple, and reproducible. The honeycomb well array can produce multiple spheroids with minimal cell loss, and can lead to significant contributions in tissue engineering and organ regeneration.	[Lee, GeonHui; Lee, JaeSeo; Lee, SangHoon] Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul, South Korea; [Oh, HyunJik; Lee, SangHoon] Korea Univ, Coll Hlth Sci, Sch Biomed Engn, Seoul, South Korea; [Lee, SangHoon] Korea Univ, Coll Hlth Sci, Dept Bioconvergence Engn, Seoul, South Korea; [Oh, HyunJik] MicroFIT R&BD Inst, Gyeonggi Do, South Korea	Korea University; Korea University; Korea University	Lee, S (corresponding author), Korea Univ, KU KIST Grad Sch Converging Sci & Technol, Seoul, South Korea.; Lee, S (corresponding author), Korea Univ, Coll Hlth Sci, Sch Biomed Engn, Seoul, South Korea.; Lee, S (corresponding author), Korea Univ, Coll Hlth Sci, Dept Bioconvergence Engn, Seoul, South Korea.	dbiomed@korea.ac.kr			National Research Foundation of Korea, Republic of Korea [NRF-2015R1A2A1A09004998]	National Research Foundation of Korea, Republic of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea (NRF-2015R1A2A1A09004998), Republic of Korea (http://www.nrf.re.kr/nrf_eng_cms/).	Chao SH, 2007, LAB CHIP, V7, P641, DOI 10.1039/b618269k; Choi YY, 2010, BIOMATERIALS, V31, P4296, DOI 10.1016/j.biomaterials.2010.01.115; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Fernandez JG, 2010, ADV MATER, V22, P2538, DOI 10.1002/adma.200903893; Fukuda J, 2005, TISSUE ENG, V11, P1254, DOI 10.1089/ten.2005.11.1254; Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Giang UBT, 2007, LAB CHIP, V7, P1660, DOI 10.1039/b714742b; Hwang JW, 2011, MACROMOL RES, V19, P1320, DOI 10.1007/s13233-012-1202-4; Jeong GS, 2013, ADV HEALTHC MATER, V2, P119, DOI 10.1002/adhm.201200070; Jeong GS, 2012, LAB CHIP, V12, P159, DOI 10.1039/c1lc20619b; Jun Y, 2013, BIOMATERIALS, V34, P8122, DOI 10.1016/j.biomaterials.2013.07.079; Jun Y, 2013, BIOMATERIALS, V34, P3784, DOI 10.1016/j.biomaterials.2013.02.010; Kwapiszewska K, 2014, LAB CHIP, V14, P2096, DOI 10.1039/c4lc00291a; Lee BR, 2012, BIOMATERIALS, V33, P837, DOI 10.1016/j.biomaterials.2011.10.014; Lee KH, 2011, LAB CHIP, V11, P1168, DOI [10.1039/c0lc00540a, 10.1039/c01c00540a]; Lee S-A, 2012, FUNCTIONAL 3D HUMAN, DOI [10.1371/journal.pone.0050723, DOI 10.1371/JOURNAL.PONE.0050723]; Lee SA, 2013, LAB CHIP, V13, P3529, DOI 10.1039/c3lc50197c; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Liu TQ, 2014, BIOMATERIALS, V35, P6060, DOI 10.1016/j.biomaterials.2014.04.047; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Moon SH, 2014, BIOMATERIALS, V35, P5987, DOI 10.1016/j.biomaterials.2014.04.001; Mori R, 2008, J BIOSCI BIOENG, V106, P237, DOI 10.1263/jbb.106.237; Morimoto Y, 2013, BIOMATER SCI-UK, V1, P257, DOI 10.1039/c2bm00117a; Nam K-H, 2014, J LAB AUTOMATION; No DY, 2014, BIOMATERIALS, V35, P8983, DOI 10.1016/j.biomaterials.2014.07.009; Otsuka H, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064217; Park JY, 2009, BIOMED MICRODEVICES, V11, P129, DOI 10.1007/s10544-008-9216-1; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Riccalton-Banks L, 2003, MOL CELL BIOCHEM, V248, P97, DOI 10.1023/A:1024184826728; Sakai Y, 2007, ACTA BIOMATER, V3, P1033, DOI 10.1016/j.actbio.2007.06.004; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632; Takayama K, 2013, BIOMATERIALS, V34, P1781, DOI 10.1016/j.biomaterials.2012.11.029; Timmins Nicholas E., 2004, Angiogenesis, V7, P97, DOI 10.1007/s10456-004-8911-7; Tsuda Y, 2009, MICR SYST 2009 MEMS; Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030; Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028; Xu YC, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3687399; Yeon SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073345; Yoshimoto K, 2009, LAB CHIP, V9, P1286, DOI 10.1039/b818610n; Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631	46	26	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161026	10.1371/journal.pone.0161026	http://dx.doi.org/10.1371/journal.pone.0161026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513567	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100110
J	Mohamed, MA; Eltamaly, AM; Alolah, AI				Mohamed, Mohamed A.; Eltamaly, Ali M.; Alolah, Abdulrahman I.			PSO-Based Smart Grid Application for Sizing and Optimization of Hybrid Renewable Energy Systems	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; OPTIMAL-DESIGN; ALGORITHMS; CAPACITY; STORAGE	This paper introduces an optimal sizing algorithm for a hybrid renewable energy system using smart grid load management application based on the available generation. This algorithm aims to maximize the system energy production and meet the load demand with minimum cost and highest reliability. This system is formed by photovoltaic array, wind turbines, storage batteries, and diesel generator as a backup source of energy. Demand profile shaping as one of the smart grid applications is introduced in this paper using load shifting-based load priority. Particle swarm optimization is used in this algorithm to determine the optimum size of the system components. The results obtained from this algorithm are compared with those from the iterative optimization technique to assess the adequacy of the proposed algorithm. The study in this paper is performed in some of the remote areas in Saudi Arabia and can be expanded to any similar regions around the world. Numerous valuable results are extracted from this study that could help researchers and decision makers.	[Mohamed, Mohamed A.; Alolah, Abdulrahman I.] King Saud Univ, Dept Elect Engn, Riyadh 11421, Saudi Arabia; [Mohamed, Mohamed A.] Menia Univ, Dept Elect Engn, Al Minya 61519, Egypt; [Eltamaly, Ali M.] King Saud Univ, Sustainable Energy Technol Ctr, Riyadh 11421, Saudi Arabia; [Eltamaly, Ali M.] Mansoura Univ, Dept Elect Engn, Mansoura 35516, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Minia University; King Saud University; Egyptian Knowledge Bank (EKB); Mansoura University	Mohamed, MA (corresponding author), King Saud Univ, Dept Elect Engn, Riyadh 11421, Saudi Arabia.; Mohamed, MA (corresponding author), Menia Univ, Dept Elect Engn, Al Minya 61519, Egypt.	dabdelaziz@ksu.edu.sa	Alolah, Abdulrahman I/C-7706-2015; Mohamed, Mohamed A./AAU-8668-2021; Eltamaly, Ali M/E-6486-2016; Mohamed, Mohamed A./AAD-3846-2021	Alolah, Abdulrahman I/0000-0003-2039-4679; Mohamed, Mohamed A./0000-0001-8700-0270; Eltamaly, Ali M/0000-0002-9831-7182; Mohamed, Mohamed A./0000-0001-8700-0270	College of Engineering Research Center at King Saud University in Riyadh, Saudi Arabia; Deanship of Scientific Research at King Saud University in Riyadh, Saudi Arabia	College of Engineering Research Center at King Saud University in Riyadh, Saudi Arabia; Deanship of Scientific Research at King Saud University in Riyadh, Saudi Arabia	The authors acknowledge the College of Engineering Research Center and Deanship of Scientific Research at King Saud University in Riyadh, Saudi Arabia, for the financial support to carry out the research work reported in this paper.	[Anonymous], 2010, 2010 18 IR C EL ENG; Ardakani AJ, 2008, ENERG BUILDINGS, V40, P2177, DOI 10.1016/j.enbuild.2008.06.010; Askarzadeh A, 2015, SOL ENERGY, V112, P383, DOI 10.1016/j.solener.2014.12.013; Bai Q., 2010, COMPUT INF SCI, DOI [10.5539/cis.v3n1p180, DOI 10.5539/CIS.V3N1P180]; Bashir M., 2012, 2012 11th International Conference on Environment and Electrical Engineering, P1081, DOI 10.1109/EEEIC.2012.6221541; Bashir M., 2012, 2012 11th International Conference on Environment and Electrical Engineering, P989, DOI 10.1109/EEEIC.2012.6221521; Boonbumroong U, 2011, SOL ENERGY, V85, P560, DOI 10.1016/j.solener.2010.12.027; Borowy BS, 1996, IEEE T ENERGY CONVER, V11, P367, DOI 10.1109/60.507648; Caron S, 2010, INT CONF SMART GRID, P391, DOI 10.1109/SMARTGRID.2010.5622073; Conejo AJ, 2010, IEEE T SMART GRID, V1, P236, DOI 10.1109/TSG.2010.2078843; Das S, 2008, STUD COMPUT INTELL, V116, P1, DOI 10.1007/978-3-540-78297-1_1; Datta M, 2009, IEEE T ENERGY CONVER, V24, P153, DOI 10.1109/TEC.2008.2008870; de Andrade CF, 2014, ENERG CONVERS MANAGE, V86, P801, DOI 10.1016/j.enconman.2014.06.046; Diaf S, 2008, ENERG POLICY, V36, P743, DOI 10.1016/j.enpol.2007.10.028; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Dufo-Lopez R, 2008, RENEW ENERG, V33, P2559, DOI 10.1016/j.renene.2008.02.027; Eltamaly AM, 2016, SOL ENERGY, V124, P26, DOI 10.1016/j.solener.2015.11.016; Eltamaly AM, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/637174; Erdinc O, 2012, RENEW SUST ENERG REV, V16, P1412, DOI 10.1016/j.rser.2011.11.011; Fadaee M, 2012, RENEW SUST ENERG REV, V16, P3364, DOI 10.1016/j.rser.2012.02.071; Flowers, 1997, SIZING WIND PHOTOVOL; Gao Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09295; Garcia RS, 2006, RENEW ENERG, V31, P2296, DOI 10.1016/j.renene.2005.11.003; Hakimi SM, 2009, RENEW ENERG, V34, P1855, DOI 10.1016/j.renene.2008.11.022; ISH TECHNOLOGY, POW EN TECHN; Kaabeche A., 2010, SMEE, V1, P205; Kaabeche A, 2014, SOL ENERGY, V103, P171, DOI 10.1016/j.solener.2014.02.017; Kaviani AK, 2009, RENEW ENERG, V34, P2380, DOI 10.1016/j.renene.2009.03.020; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Lee TY, 2009, IET RENEW POWER GEN, V3, P152, DOI 10.1049/iet-rpg:20070068; Mohamed MA, 2015, J RENEW SUSTAIN ENER, V7, DOI 10.1063/1.4938154; Mohammadi M, 2015, SAGE OPEN, V5, DOI [10.1109/PLASMA.2015.7179880, 10.1177/2158244015579726]; Mohsenian-Rad AH, 2010, IEEE T SMART GRID, V1, P120, DOI 10.1109/TSG.2010.2055903; Sharafi M, 2014, RENEW ENERG, V68, P67, DOI 10.1016/j.renene.2014.01.011; Sinha S, 2014, RENEW SUST ENERG REV, V32, P192, DOI 10.1016/j.rser.2014.01.035; Ucar A, 2009, APPL ENERG, V86, P1864, DOI 10.1016/j.apenergy.2008.12.016; Wang LF, 2007, 2007 IEEE SWARM INTELLIGENCE SYMPOSIUM, P250, DOI 10.1109/SIS.2007.367945; Wang LF, 2009, IEEE T ENERGY CONVER, V24, P163, DOI 10.1109/TEC.2008.2005280; Weitemeyer S, 2015, RENEW ENERG, V75, P14, DOI 10.1016/j.renene.2014.09.028; Yang HX, 2008, SOL ENERGY, V82, P354, DOI 10.1016/j.solener.2007.08.005; Yeh TH, 2008, IEEE T ENERGY CONVER, V23, P592, DOI 10.1109/TEC.2008.918626	41	63	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159702	10.1371/journal.pone.0159702	http://dx.doi.org/10.1371/journal.pone.0159702			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513000	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100017
J	Wu, XD; Li, GH				Wu, Xudong; Li, Guohui			Prevalent Accumulation of Non-Optimal Codons through Somatic Mutations in Human Cancers	PLOS ONE			English	Article							HUMAN GENETIC-DISEASE; HUMAN GENOME; PROTEINS; PREDICTION; RESOURCE; MODELS; RECONSTRUCTION; POLYMORPHISMS; SUBSTITUTION; METABOLISM	Cancer is characterized by uncontrolled cell growth, and the cause of different cancers is generally attributed to checkpoint dysregulation of cell proliferation and apoptosis. Recent studies have shown that non-optimal codons were preferentially adopted by genes to generate cell cycle-dependent oscillations in protein levels. This raises the intriguing question of how dynamic changes of codon usage modulate the cancer genome to cope with a noncontrolled proliferative cell cycle. In this study, we comprehensively analyzed the somatic mutations of codons in human cancers, and found that non-optimal codons tended to be accumulated through both synonymous and non-synonymous mutations compared with other types of genomic substitution. We further demonstrated that non-optimal codons were prevalently accumulated across different types of cancers, amino acids, and chromosomes, and genes with accumulation of non-optimal codons tended to be involved in protein interaction/signaling networks and encoded important enzymes in metabolic networks that played roles in cancer-related pathways. This study provides insights into the dynamics of codons in the cancer genome and demonstrates that accumulation of non-optimal codons may be an adaptive strategy for cancerous cells to win the competition with normal cells. This deeper interpretation of the patterns and the functional characterization of somatic mutations of codons will help to broaden the current understanding of the molecular basis of cancers.	[Wu, Xudong; Li, Guohui] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, 457 Zhongshan Rd, Dalian 116023, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Li, GH (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Lab Mol Modeling & Design, 457 Zhongshan Rd, Dalian 116023, Peoples R China.	ghli@dicp.ac.cn						Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; De Baets G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004374; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hsieh TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099395; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kulsum U, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-341; Kumar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129087; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu X, 2013, ACTA PHARMACOL SIN, V34, P805, DOI 10.1038/aps.2013.61; Makhoul CH, 2002, J BIOMOL STRUCT DYN, V20, P413, DOI 10.1080/07391102.2002.10506859; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mottaz A, 2010, BIOINFORMATICS, V26, P851, DOI 10.1093/bioinformatics/btq028; Olivier Magali, 2004, IARC Sci Publ, P247; Ostrow SL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004239; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pedersen SF, 2013, CANCER RES, V73, P1658, DOI 10.1158/0008-5472.CAN-12-4188; Peng L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13413; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Schaper E, 2014, MOL BIOL EVOL, V31, P1132, DOI 10.1093/molbev/msu062; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su M, 2014, CELL REP, V7, P376, DOI 10.1016/j.celrep.2014.03.011; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Vacic V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002709; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241; Wang E, 2013, CANCER LETT, V340, P261, DOI 10.1016/j.canlet.2012.11.050; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918; Wong KM, 2011, ANNU REV GENOM HUM G, V12, P407, DOI 10.1146/annurev-genom-082509-141532; Wu XD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-707; Wu XD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-244; Wu XD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-145; Xie T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142631; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2003, GENETICS, V165, P695; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Zhang JZ, 2012, ADV EXP MED BIOL, V751, P279, DOI 10.1007/978-1-4614-3567-9_13; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	69	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160463	10.1371/journal.pone.0160463	http://dx.doi.org/10.1371/journal.pone.0160463			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513638	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100039
J	Taylor, L; Brodermann, MH; McCaffary, D; Iqbal, AJ; Greaves, DR				Taylor, Lewis; Brodermann, Maximillian Hugo; McCaffary, David; Iqbal, Asif Jilani; Greaves, David R.			Netrin-1 Reduces Monocyte and Macrophage Chemotaxis towards the Complement Component C5a	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; RECEPTOR ANTAGONIST; CHEMOKINE RECEPTORS; CELL-MIGRATION; INFLAMMATION; ATHEROSCLEROSIS; IMMUNE; GENE; ECULIZUMAB; EXPRESSION	Netrin-1, acting at its cognate receptor UNC5b, has been previously demonstrated to inhibit CC chemokine-induced immune cell migration. In line with this, we found that netrin-1 was able to inhibit CCL2-induced migration of bone marrow derived macrophages (BMDMs). However, whether netrin-1 is capable of inhibiting chemotaxis to a broader range of chemoattractants remains largely unexplored. As our initial experiments demonstrated that RAW264.7 and BMDMs expressed high levels of C5a receptor 1 (C5aR1) on their surface, we aimed to determine the effect of netrin-1 exposure on monocyte/macrophage cell migration induced by C5a, a complement peptide that plays a major role in multiple inflammatory pathologies. Treatment of RAW264.7 macrophages, BMDMs and human monocytes with netrin-1 inhibited their chemotaxis towards C5a, as measured using two different real-time methods. This inhibitory effect was found to be dependent on netrin-1 receptor signalling, as an UNC5b blocking antibody was able to reverse netrin-1 inhibition of C5a induced BMDM migration. Treatment of BMDMs with netrin-1 had no effect on C5aR1 proximal signalling events, as surface C5aR1 expression, internalisation and intracellular Ca2+ release following C5aR1 ligation remained unaffected after netrin-1 exposure. We next examined receptor distal events that occur following C5aR1 activation, but found that netrin-1 was unable to inhibit C5a induced phosphorylation of ERK1/2, Akt and p38, pathways important for cellular migration. Furthermore, netrin-1 treatment had no effect on BMDM cytoskeletal rearrangement following C5a stimulation as determined by microscopy and real-time electrical impedance sensing. Taken together these data highlight that netrin-1 inhibits monocyte and macrophage cell migration, but that the mechanism behind this effect remains unresolved. Nevertheless, netrin-1 and its cognate receptors warrant further investigation as they may represent a potential avenue for the development of novel anti-inflammatory therapeutics.	[Taylor, Lewis; Brodermann, Maximillian Hugo; McCaffary, David; Iqbal, Asif Jilani; Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	University of Oxford	Greaves, DR (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England.	david.greaves@path.ox.ac.uk		Greaves, David/0000-0003-2856-9410; Iqbal, Asif/0000-0002-3224-3651	British Heart Foundation [RG/15/10/31485, FS/12/69/30008]; British Heart Foundation Centre of Research Excellence, Oxford [RE/13/1/30181]	British Heart Foundation(British Heart Foundation); British Heart Foundation Centre of Research Excellence, Oxford	This work was funded by a British Heart Foundation Programme Grant awarded to DRG (RG/15/10/31485), a British Heart Foundation Studentship awarded to LT (FS/12/69/30008) and the British Heart Foundation Centre of Research Excellence, Oxford (RE/13/1/30181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Allen WE, 1997, J CELL SCI, V110, P707; Arumugam TV, 2004, J HEPATOL, V40, P934, DOI 10.1016/j.jhep.2004.02.017; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; Chiou WF, 2004, INT IMMUNOPHARMACOL, V4, P1329, DOI 10.1016/j.intimp.2004.05.017; Costelloe EO, 1999, J LEUKOCYTE BIOL, V66, P172, DOI 10.1002/jlb.66.1.172; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; He ZS, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-86; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Iqbal AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058744; Jain U, 2013, BRIT J PHARMACOL, V168, P488, DOI 10.1111/j.1476-5381.2012.02183.x; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Joseph BB, 2013, AM J CARDIOVASC DIS, V3, P129; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Layne K, 2015, CARDIOVASC RES, V107, P410, DOI 10.1093/cvr/cvv201; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Mavroidis M, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0485-6; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Moore SW, 2007, ADV EXP MED BIOL, V621, P17, DOI 10.1007/978-0-387-76715-4_2; Moriconi A, 2014, P NATL ACAD SCI USA, V111, P16937, DOI 10.1073/pnas.1417365111; NICE NIfHaCE, 2016, NICE DRAFT GUID REC; Passacquale G, 2015, BRIT J PHARMACOL, V172, P3548, DOI 10.1111/bph.13144; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Ravasi T, 2002, J IMMUNOL, V168, P44, DOI 10.4049/jimmunol.168.1.44; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Staab EB, 2014, INT IMMUNOPHARMACOL, V21, P293, DOI 10.1016/j.intimp.2014.05.008; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Taylor L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10682; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Vorotnikov AV, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1528, DOI 10.1134/S0006297911130104; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160685	10.1371/journal.pone.0160685	http://dx.doi.org/10.1371/journal.pone.0160685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509208	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400045
J	Chen, SH; Byrne-Nash, RT; Cox, MM				Chen, Stefanie H.; Byrne-Nash, Rose T.; Cox, Michael M.			Escherichia coli RadD Protein Functionally Interacts with the Single-stranded DNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; DNA repair; protein-DNA interaction; protein-protein interaction; radiation biology; SSB; helicase	COMPLEX-FORMATION; SSB; REPLICATION; HELICASE; PURIFICATION; MECHANISM; RADIATION; RESIDUES; SUBUNITS; REPAIR	The bacterial single-stranded DNA binding protein (SSB) acts as an organizer of DNA repair complexes. The radD gene was recently identified as having an unspecified role in repair of radiation damage and, more specifically, DNA double-strand breaks. Purified RadD protein displays a DNA-independent ATPase activity. However, ATP hydrolytic rates are stimulated by SSB through its C terminus. The RadD and SSB proteins also directly interact in vivo in a yeast two-hybrid assay and in vitro through ammonium sulfate co-precipitation. Therefore, it is likely that the repair function of RadD is mediated through interaction with SSB at the site of damage.	[Chen, Stefanie H.; Byrne-Nash, Rose T.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, 433 Babcock Dr,Rm 337, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Chen, SH (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr,Rm 337, Madison, WI 53706 USA.	slchen3@wisc.edu		Nash, Rose/0000-0002-9706-5585; Chen, Stefanie/0000-0002-9550-971X	National Institutes of Health [GM032335]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM032335, R01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by the National Institutes of Health Grant GM032335 (to M. M. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antony E, 2013, J MOL BIOL, V425, P4802, DOI 10.1016/j.jmb.2013.08.021; Aramaki T, 2015, J BIOCHEM, V157, P529, DOI 10.1093/jb/mvv014; Baharoglu Z, 2014, NUCLEIC ACIDS RES, V42, P2366, DOI 10.1093/nar/gkt1259; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen SH, 2015, MOL MICROBIOL, V95, P754, DOI 10.1111/mmi.12885; Cooper DL, 2016, ELIFE, V5, DOI 10.7554/eLife.10807; Furukohri A, 2012, NUCLEIC ACIDS RES, V40, P6039, DOI 10.1093/nar/gks264; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; James P, 1996, GENETICS, V144, P1425; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; Lu D, 2011, NUCLEIC ACIDS RES, V39, P6536, DOI 10.1093/nar/gkr315; Lu D, 2009, BIOCHEMISTRY-US, V48, P6764, DOI 10.1021/bi900361r; Marceau Aimee H, 2012, Methods Mol Biol, V922, P151, DOI 10.1007/978-1-62703-032-8_9; Mawer JSP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004485; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Page AN, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.210187; Petzold C, 2015, J BIOL CHEM, V290, P14626, DOI 10.1074/jbc.M115.655134; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rudolph CJ, 2013, NATURE, V500, P608, DOI 10.1038/nature12312; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156	28	16	16	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20779	20786		10.1074/jbc.M116.736223	http://dx.doi.org/10.1074/jbc.M116.736223			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27519413	Green Published, hybrid			2022-12-26	WOS:000384574800038
J	Dew-Budd, K; Jarnigan, J; Reed, LK				Dew-Budd, Kelly; Jarnigan, Julie; Reed, Laura K.			Genetic and Sex-Specific Transgenerational Effects of a High Fat Diet in Drosophila melanogaster	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; METABOLIC STATE; REFERENCE PANEL; EGG SIZE; GENERATIONS; PHENOTYPES; GROWTH; FLIES; TRIACYLGLYCEROL; REPRODUCTION	An organism's phenotype is the product of its environment and genotype, but an ancestor's environment can also be a contributing factor. The recent increase in caloric intake and decrease in physical activity of developed nations' populations is contributing to deteriorating health and making the study of the longer term impacts of a changing lifestyle a priority. The dietary habits of ancestors have been shown to affect phenotype in several organisms, including humans, mice, and the fruit fly. Whether the ancestral dietary effect is purely environmental or if there is a genetic interaction with the environment passed down for multiple generations, has not been determined previously. Here we used the fruit fly, Drosophila melanogaster, to investigate the genetic, sex-specific, and environmental effects of a high fat diet for three generations' on pupal body weights across ten genotypes. We also tested for genotype-specific transgenerational effects on metabolic pools and egg size across three genotypes. We showed that there were substantial differences in transgenerational responses to ancestral diet between genotypes and sexes through both first and second descendant generations. Additionally, there were differences in phenotypes between maternally and paternally inherited dietary effects. We also found a treated organism's reaction to a high fat diet was not a consistent predictor of its untreated descendants' phenotype. The implication of these results is that, given our interest in understanding and preventing metabolic diseases like obesity, we need to consider the contribution of ancestral environmental experiences. However, we need to be cautious when drawing population-level generalization from small studies because transgenerational effects are likely to exhibit substantial sex and genotype specificity.	[Dew-Budd, Kelly; Jarnigan, Julie; Reed, Laura K.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Dew-Budd, Kelly] Univ Arizona, Sch Plant Sci, Tucson, AZ USA	University of Alabama System; University of Alabama Tuscaloosa; University of Arizona	Reed, LK (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	lreed1@ua.edu		Reed, Laura/0000-0002-4381-494X; Dew-Budd, Kelly/0000-0003-3791-2241	National Institutes of General Medical Sciences [R01GM098856]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098856] Funding Source: NIH RePORTER	National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant R01GM098856 from National Institutes of General Medical Sciences, [www.nigms.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Aldrich JC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005148; Azevedo RBR, 1997, AM NAT, V150, P250, DOI 10.1086/286065; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branco AT, 2014, GENETICS, V197, P147, DOI 10.1534/genetics.114.163170; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brookheart RT, 2016, MOL CELL ENDOCRINOL, V435, P20, DOI 10.1016/j.mce.2015.12.003; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buescher JL, 2013, DIS MODEL MECH, V6, P1123, DOI 10.1242/dmm.011924; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; CHURCH RB, 1966, J EXP ZOOL, V162, P337, DOI 10.1002/jez.1401620309; CLARK AG, 1988, GENETICS, V119, P595; Crill WD, 1996, EVOLUTION, V50, P1205, DOI [10.2307/2410661, 10.1111/j.1558-5646.1996.tb02361.x]; De Luca M, 2005, OBES RES, V13, P1596, DOI 10.1038/oby.2005.196; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Donkin I, 2016, CELL METAB, V23, P369, DOI 10.1016/j.cmet.2015.11.004; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Ho DH, 2010, J EXP BIOL, V213, P3, DOI 10.1242/jeb.019752; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Lecomte V, 2013, BIOESSAYS, V35, P787, DOI 10.1002/bies.201300051; Linder JE, 2009, FLY, V3, P143, DOI 10.4161/fly.8051; Macdonald SJ, 2007, GENETICS, V176, P1261, DOI 10.1534/genetics.106.069641; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Matzkin LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059530; McPherson NO, 2014, FERTIL STERIL, V101, P865, DOI 10.1016/j.fertnstert.2013.12.007; Nystrand M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1242; Paoloni-Giacobino A, 2014, VITAM HORM, V94, P211, DOI 10.1016/B978-0-12-800095-3.00008-0; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Prasad NG, 2003, EVOL ECOL RES, V5, P903; Reed LK, 2014, GENETICS, V197, P781, DOI 10.1534/genetics.114.163857; Reed LK, 2010, GENETICS, V185, P1009, DOI 10.1534/genetics.109.113571; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Schiffer M, 2013, J EXP BIOL, V216, P3790, DOI 10.1242/jeb.085126; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Somer RA, 2014, CURR OPIN GENET DEV, V27, P43, DOI 10.1016/j.gde.2014.03.008; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Stern S, 2014, J PHYSIOL-LONDON, V592, P2343, DOI 10.1113/jphysiol.2014.271445; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Valtonen TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031611; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Wei YC, 2015, HUM REPROD UPDATE, V21, P194, DOI 10.1093/humupd/dmu061; Williams S, 2015, G3-GENES GENOM GENET, V5, P2817, DOI 10.1534/g3.115.023564; Xia B, 2016, AGING-US, V8, P1115, DOI 10.18632/aging.100932; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhu JM, 2014, J NEUROSCI, V34, P2768, DOI 10.1523/JNEUROSCI.4402-13.2014	50	18	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160857	10.1371/journal.pone.0160857	http://dx.doi.org/10.1371/journal.pone.0160857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518304	gold, Green Published			2022-12-26	WOS:000381382100028
J	Yoon, SH; Kim, YH; Lee, YJ; Park, J; Kim, JW; Lee, HS; Kim, B				Yoon, Sung Hyun; Kim, Young Hoon; Lee, Yoon Jin; Park, Jihoon; Kim, Jin Won; Lee, Hye Seung; Kim, Bohyoung			Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment	PLOS ONE			English	Article							LEVEL; CHEMOTHERAPY; CARCINOMA; BIOMARKER	Background Image texture analysis is a noninvasive technique for quantifying intratumoral heterogeneity, with derived texture features reported to be closely related to the treatment outcome of tumors. Gastric cancer is one of the most common tumors and the third leading cause of cancer-related deaths worldwide. Although trastuzumab is associated with a survival gain among patients with human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer, optimal patient selection is challenging. The purpose of this study was to determine whether CT texture features of HER2-positive gastric cancer were related to the survival rate after trastuzumab treatment. Methods and Findings Patients diagnosed with HER2-positive advanced gastric cancer from February 2007 to August 2014 were retrospectively selected. Using in-house built software, histogram features (kurtosis and skewness) and gray-level co-occurrence matrices (GLCM) features (angular second moment [ASM], contrast, entropy, variance, and correlation) were derived from the CT images of HER2-positive advanced gastric cancer in 26 patients. All the patients were followed up for more than 6 months, with no confirmed deaths. The patients were dichotomized into a good and poor survival group based on cutoff points of overall survival of 12 months. A receiver-operating characteristics (ROC) analysis was performed to test the ability of each texture parameter to identify the good survival group. Kaplan-Meier curves for patients above and below each threshold were constructed. Using a threshold of >265.8480 for contrast, >488.3150 for variance, and <= 0.1319x10(-3). for correlation, all of the area under the ROC curves showed fair accuracy (>0.7). Kaplan-Meier analysis showed statistically significant survival difference between two groups according to optimal cutoff values of contrast, variance, correlation and ASM. However, as this study had a small number of patients, a further study with a larger population will be needed to validate the results. Conclusions Heterogeneous texture features on CT images were associated with better survival in patients with HER2-positive advanced gastric cancer who received trastuzumab-based treatment. Therefore, texture analysis shows potential to be a clinically useful imaging biomarker providing additional prognostic information for patient selection.	[Yoon, Sung Hyun; Kim, Young Hoon; Lee, Yoon Jin; Park, Jihoon] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Radiol,Inst Radiat Med,Med Res Ctr, Songnam, South Korea; [Kim, Jin Won] Seoul Natl Univ, Coll Med, Bundang Hosp, Div Hematol & Med Oncol,Dept Internal Med, Songnam, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Dept Pathol, Bundang Hosp, Songnam, South Korea; [Kim, Bohyoung] Hankuk Univ Foreign Studies, Div Biomed Engn, Yongin, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hankuk University Foreign Studies	Kim, YH (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Radiol,Inst Radiat Med,Med Res Ctr, Songnam, South Korea.	yhkrad@gmail.com	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986; Yoon, Sung Hyun/0000-0002-0547-7866				Bang YJ, 2010, LANCET, V376, P1302; BARALDI A, 1995, IEEE T GEOSCI REMOTE, V33, P293, DOI 10.1109/36.377929; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; De Cecco CN, 2015, INVEST RADIOL, V50, P239, DOI 10.1097/RLI.0000000000000116; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2012, QUANTITATIVE IMAGING; Ganeshan B, 2013, CANCER IMAGING, V13, P140, DOI 10.1102/1470-7330.2013.0015; Ganeshan B, 2013, RADIOLOGY, V266, P326, DOI 10.1148/radiol.12112428; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Gomez-Martin C, 2013, J CLIN ONCOL, V31, P4445, DOI 10.1200/JCO.2013.48.9070; Kleppe M, 2014, NAT MED, V20, P342, DOI 10.1038/nm.3522; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Menard S, 2001, ANN ONCOL, V12, P15, DOI 10.1023/A:1011151505425; Ng F, 2013, EUR J RADIOL, V82, P342, DOI 10.1016/j.ejrad.2012.10.023; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Oba K, 2013, EUR J CANCER, V49, P1565, DOI 10.1016/j.ejca.2012.12.016; Ock CY, 2015, CLIN CANCER RES, V21, P2520, DOI 10.1158/1078-0432.CCR-14-2659; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Valtorta E, 2015, MODERN PATHOL, V28, P1481, DOI 10.1038/modpathol.2015.98; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Waugh SA, 2016, EUR RADIOL, V26, P322, DOI 10.1007/s00330-015-3845-6; Woo J, 2015, GASTROENTEROL REP, V3, P316, DOI 10.1093/gastro/gov052; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Zhang HW, 2013, RADIOLOGY, V269, P801, DOI 10.1148/radiol.13130110	26	26	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161278	10.1371/journal.pone.0161278	http://dx.doi.org/10.1371/journal.pone.0161278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517841	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100067
J	Chang, YJ; Cheng, YW; Lin, RK; Huang, CC; Tzu, WTL; Ke, TW; Wei, PL				Chang, Yu-Jia; Cheng, Ya-Wen; Lin, Ruo-Kai; Huang, Chi-Chou; Chen, William Tzu-Liang; Ke, Tao-Wei; Wei, Po-Li			Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT)	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; TRANSCRIPTION FACTOR SNAIL; EPIDERMAL-GROWTH-FACTOR; MIGRATORY ABILITY; LIVER METASTASES; GENE-EXPRESSION; PROTEIN-C; EZRIN; LOCALIZATION; VIMENTIN	Background Treatment resistance and metastasis are the major causes of death among patients with colorectal cancer (CRC). Approximately 20% of surgically treated patients ultimately develop metastases during the follow-up period. Currently, the TNM system is the only available prognostic test. Therefore, the identification of new markers for CRC remains important. Thrombomodulin (TM), a glycoprotein, is involved in angiogenesis and has been linked to many malignant diseases. However, the function of TM in CRC remains unclear. Methods A total of 170 patients with CRC participated in this study. TM expression was analyzed via immunohistochemistry. Univariate (Kaplan-Meier) analysis was used to analyze patient outcomes, including overall survival (OS) and disease-free survival (DFS). TM expression was manipulated using shRNA or an overexpression system. Transwell migration assays, wound healing migration assays, and the xCELLigence biosensor system were used to detect cell proliferative and migratory capacities. Results TM expression in the tumor tissues significantly and positively correlated with the DFS and OS of non-metastatic patients with CRC (ps = 0.036 and 0.0218, respectively). Suppression of TM expression increased the proliferation and migration of DLD-1 cells. TM overexpression reduced the cells' proliferative and migratory capacities. Cyclooxygenase (COX)-2 expression was up-regulated following TM silencing. Furthermore, the association between the migration of colon cancer cells and the levels of TM and epithelial-to-mesenchymal transition (EMT) markers (fibronectin, vimentin and ezrin) was confirmed in HT29 and DLD-1 cells. Conclusions Our study demonstrates that patients with non-metastatic CRC display low TM expression in their tumors and exhibit reduced DFS and OS. The enhanced expression of mesenchymal markers and COX-2 may be involved in the mechanisms that underlie recurrence in patients with cancer displaying low TM expression.	[Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Cheng, Ya-Wen; Wei, Po-Li] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Lin, Ruo-Kai] Taipei Med Univ, Grad Inst Pharmacognosy, Taipei, Taiwan; [Huang, Chi-Chou] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Huang, Chi-Chou] Chung Shan Med Univ, Dept Surg, Taichung, Taiwan; [Chen, William Tzu-Liang; Ke, Tao-Wei] China Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taichung, Taiwan; [Ke, Tao-Wei] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wei, Po-Li] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Wei, PL (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.	poliwei@tmu.edu.tw			National Science Council [NSC101-2314-B-038-029-MY3, NSC101-2314-B-038-016-MY3]; Taipei Medical University and Taipei Medical University Hospital [TMU-TMUH-01-3]; Health and Welfare Surcharge of Tobacco Products [MOHW105-TDU-B-212-134001]	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Medical University and Taipei Medical University Hospital; Health and Welfare Surcharge of Tobacco Products	This work was supported by the National Science Council (NSC101-2314-B-038-029-MY3 and NSC101-2314-B-038-016-MY3), Taipei Medical University and Taipei Medical University Hospital (TMU-TMUH-01-3), and Health and Welfare Surcharge of Tobacco Products (MOHW105-TDU-B-212-134001).	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Binefa G, 2014, WORLD J GASTROENTERO, V20, P6786, DOI 10.3748/wjg.v20.i22.6786; Bocca C, 2012, MOL CARCINOGEN, V51, P783, DOI 10.1002/mc.20846; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang YJ, 2015, TUMOR BIOL, V36, P1859, DOI 10.1007/s13277-014-2788-x; Chang YWE, 2006, CANCER RES, V66, P11700, DOI 10.1158/0008-5472.CAN-06-1818; Chen LM, 2013, TUMOR BIOL, V34, P3743, DOI 10.1007/s13277-013-0958-x; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chiu ST, 2009, CARCINOGENESIS, V30, P1475, DOI 10.1093/carcin/bgp133; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Eckes B, 1998, J CELL SCI, V111, P1897; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; ESMON CT, 1982, J BIOL CHEM, V257, P7944; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gulubova M, 2006, ACTA HISTOCHEM, V108, P25, DOI 10.1016/j.acthis.2005.12.001; Hanly AM, 2006, BRIT J CANCER, V94, P1320, DOI 10.1038/sj.bjc.6603098; Hsu YY, 2012, FASEB J, V26, P3440, DOI 10.1096/fj.12-204917; Huang CY, 2015, TUMOUR BIOL; Huang MT, 2010, ANN SURG ONCOL, V17, P3379, DOI 10.1245/s10434-010-1163-4; Ivaska Johanna, 2011, Small GTPases, V2, P51; Kim SJ, 1997, ANTICANCER RES, V17, P2319; Kirane A, 2012, CARCINOGENESIS, V33, P1639, DOI 10.1093/carcin/bgs195; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LAGER DJ, 1995, AM J PATHOL, V146, P933; Leiphrakpam PD, 2014, CELL SIGNAL, V26, P868, DOI 10.1016/j.cellsig.2014.01.014; Liu PL, 2010, MOL CARCINOGEN, V49, P874, DOI 10.1002/mc.20663; MARUNO M, 1994, J NEURO-ONCOL, V19, P155, DOI 10.1007/BF01306457; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Ou JJ, 2014, CARCINOGENESIS, V35, P1661, DOI 10.1093/carcin/bgu090; RAIFE TJ, 1994, J CLIN INVEST, V93, P1846, DOI 10.1172/JCI117171; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Ruers T, 2002, EUR J CANCER, V38, P1023, DOI 10.1016/S0959-8049(02)00059-X; SATO N, 1992, J CELL SCI, V103, P131; Sierko E, 2010, THROMB RES, V125, pE71, DOI 10.1016/j.thromres.2009.09.011; Tai CJ, 2012, ANN SURG ONCOL, V19, P336, DOI 10.1245/s10434-011-1692-5; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Wang RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139232; Wei PL, 2013, J AGR FOOD CHEM, V61, P8191, DOI 10.1021/jf4009586; Wei PL, 2012, ANN SURG ONCOL, V19, pS572, DOI 10.1245/s10434-011-2055-y; Wei PL, 2011, ANN SURG ONCOL, V18, P1782, DOI 10.1245/s10434-010-1504-3; Wu CT, 2014, TUMOR BIOL, V35, P6047, DOI 10.1007/s13277-014-1801-8; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038	46	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160550	10.1371/journal.pone.0160550	http://dx.doi.org/10.1371/journal.pone.0160550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512995	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100044
J	Delport, JA; Strikwerda, A; Armstrong, A; Schaus, D; John, M				Delport, Johannes A.; Strikwerda, Arend; Armstrong, Amanda; Schaus, David; John, Michael			Quality of Care Is Improved by Rapid Short Incubation MALDI-ToF Identification from Blood Cultures as Measured by Reduced Length of Stay and Patient Outcomes as Part of a Multi-Disciplinary Approach to Bacteremia in Pediatric Patients	PLOS ONE			English	Article							PATHOGEN IDENTIFICATION	Sepsis has seen an incremental increase in cases of about 13% annually in the USA and accounts for approximately 4400 deaths among pediatric patients. Early identification of the specific pathogen allows the clinician to ensure that the antibiotic coverage is optimal, an intervention that has been shown to improve patient outcomes in sepsis. Our study's objective was to assess the impact of a rapid Bruker MALDI-T of identification protocol on pediatric sepsis cases by assessing various indicators. We assessed the quality of care by measuring the following indicators; time to identification of the pathogen, initiation of the most appropriate antibiotic, length of stay (LOS) in hospital and patient outcomes, using a retrospective review over three consecutive years. In total 92 pediatric patients, similar in age and gender distributions were assessed; 37 in 2012, 33 in 2013 and 22 in 2014. The introduction of MALDI-TOF identification in 2013 led to a significant decrease in time to identify a pathogen by 21.03 hours (p = 1.95E-05). A short incubation MALDI-TOF identification protocol in 2014 further reduced time to identification by 17.75 hours (p = 2.48E-3). Overall in 2014 this led to a trend to earlier optimization of antibiotics by 20.2 hours (p = 0.14) and a reduction in length of stay after the implementation of MALDI-ToF identification in 2013 of 3.07 days and a further reduction of 8.92 days after the introduction of the rapid short incubation identification protocol using MALDI-Tof in 2014 (P = 0.12). By evaluating the subgroup of patients where antibiotics were changed, our study confirmed that patients received appropriate therapy 48.8% (20.2 hours) earlier compared to conventional methods leading to a decrease in length of stay of 23.65 days after the implementation of MALDI-ToF identification and a further reduction of 9.82 days in 2014 compared to 2012 (p = 0.02). In 2014 outcomes between the patients needing a change in their antibiotic compared to the patients where the empirical therapy was considered to be optimal were similar with respect to length of stay; 13.04 and 10.93 days (p = 0.34). In the 2012 group there was a significant increase in the length of stay in the group needing change in excess of 30 days (p = 0.02) compared to the group where empirical therapy was considered to be optimal, this clearly showed an improvement in the quality of care received after the rapid identification was instituted in 2014. The 2012 group had a four times overall increased sepsis associated mortality risk compared to the 2014 group and when empirical antibiotics needed to be optimized this risk was 7 times compared to the 2014 group. We conclude that rapid identification of bacterial pathogens in pediatric blood cultures with a rapid incubation MALDI-TOF identification protocol plays an important role in improving quality of care as part of a multidisciplinary approach to pediatric bacteremia and sepsis.	[Delport, Johannes A.; Armstrong, Amanda; Schaus, David; John, Michael] London Hlth Sci Ctr, Div Microbiol Pathol & Lab Med, London, ON, Canada; [Delport, Johannes A.; Strikwerda, Arend; John, Michael] Univ Western Ontario, Schulich Sch Med & Dent, Clin Skills Bldg, London, ON, Canada; [Delport, Johannes A.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario)	Delport, JA (corresponding author), London Hlth Sci Ctr, Div Microbiol Pathol & Lab Med, London, ON, Canada.; Delport, JA (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Clin Skills Bldg, London, ON, Canada.; Delport, JA (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada.	johan.delport@LHSC.on.ca	Delport, Johan/N-2721-2013	Delport, Johan/0000-0002-8882-1756				Biondi E, 2013, PEDIATRICS, V132, P990, DOI 10.1542/peds.2013-1759; BRYAN CS, 1983, REV INFECT DIS, V5, P629; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z; Kohlmann R, 2015, INT J MED MICROBIOL, V305, P469, DOI 10.1016/j.ijmm.2015.04.004; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Verroken A, 2015, EUR J CLIN MICROBIOL, V34, P405, DOI 10.1007/s10096-014-2242-4; Watson RS, 2001, CRIT CARE MED, V29, pA8	10	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160618	10.1371/journal.pone.0160618	http://dx.doi.org/10.1371/journal.pone.0160618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513860	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100050
J	Kancherla, V; Garn, JV; Zakai, NA; Williamson, RS; Cashion, WT; Odewole, O; Judd, SE; Oakley, GP				Kancherla, Vijaya; Garn, Joshua V.; Zakai, Neil A.; Williamson, Rebecca S.; Cashion, Winn T.; Odewole, Oluwaseun; Judd, Suzanne E.; Oakley, Godfrey P., Jr.			Multivitamin Use and Serum Vitamin B12 Concentrations in Older-Adult Metformin Users in REGARDS, 2003-2007	PLOS ONE			English	Article							COBALAMIN DEFICIENCY; DIABETES-MELLITUS; B-12 DEFICIENCY; NATIONAL-HEALTH; TERM TREATMENT; ASSOCIATION; PREVALENCE; THERAPY; FOLATE; HOMOCYSTEINE	Metformin, an insulin-sensitizing drug, is a first line treatment for type 2 diabetes. Longterm use of metformin has been associated with subsequent reductions in vitamin B12 concentrations. The objective of our study was to determine whether metformin use is associated with lower serum vitamin B12 concentrations in older adults, and whether concurrent use of multivitamins modifies this association. We examined 2,510 participants aged 50 years and over, participating in the national population-based Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Multivariable linear and logistic regression models were used to assess associations between multivitamin use and serum vitamin B12 concentrations. We estimated adjusted odds ratios (aOR)s and confidence intervals (CI)s. Results were stratified by three metformin/diabetes sub-groups: 1) participants with diabetes who were metformin users; 2) participants with diabetes who were not metformin users; and 3) participants without diabetes. We found that diabetic metformin users had significantly lower geometric mean serum B12 concentrations (409 pmol/L) than the group with diabetes not taking metformin (485 pmol/L; P<0.01), and the group without diabetes (445 pmol/L; P = 0.02). The geometric mean serum B12 concentrations were greater for multivitamin users (509 pmol/L) compared to those who did not use multivitamins (376 pmol/L; p<0.01). Among the participants with diabetes who were on metformin therapy, multivitamin use was associated with geometric mean serum vitamin B12 concentrations that were 50% (or 161 pmol/L) higher, compared to those not using multivitamins. Among metformin users, multivitamin use was associated with lower prevalence of combined low and borderline vitamin B12 concentrations (aOR = 0.14; 95% CI = 0.04, 0.54) compared to those not using multivitamins. In conclusion, metformin use was associated with lower geometric mean serum vitamin B12 concentrations among diabetic older adults compared to their counterparts. Concurrent multivitamin use may potentially protect against low or borderline vitamin B12 concentrations in long-term metformin users. Additional research is needed to further examine this association as low or borderline vitamin B12 concentrations can be preventable, or treatable if detected at an early stage, in long-term metformin users.	[Kancherla, Vijaya; Garn, Joshua V.; Williamson, Rebecca S.; Cashion, Winn T.; Odewole, Oluwaseun; Oakley, Godfrey P., Jr.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Zakai, Neil A.] Univ Vermont Coll, Coll Med, Dept Med, Burlington, VT USA; [Zakai, Neil A.] Univ Vermont Coll, Coll Med, Dept Pathol, Burlington, VT USA; [Judd, Suzanne E.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL USA	Emory University; Rollins School Public Health; University of Vermont; University of Vermont; University of Alabama System; University of Alabama Birmingham	Oakley, GP (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	gpoakley@mindspring.com		Garn, Joshua/0000-0002-4360-466X	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01 NS041588]; Centers for Disease Control and Prevention [U48 DP001909]; National Institute of Neurological Disorders and Stroke; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The REGARDS research project is supported by a cooperative agreement U01 NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. Representatives of the funding agency have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. The authors thank the other investigators, the staff, and the participants of the REGARDS study for their valuable contributions. A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org. Additionally, this publication was supported by Cooperative Agreement Number U48 DP001909 from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres E, 2010, EXPERT OPIN PHARMACO, V11, P249, DOI 10.1517/14656560903456053; Aroda VR, 2016, J CLIN ENDOCR METAB, V101, P1754, DOI 10.1210/jc.2015-3754; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Bell DSH, 2010, SOUTH MED J, V103, P265, DOI 10.1097/SMJ.0b013e3181ce0e4d; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; CALLAGHAN TS, 1980, BRIT MED J, V280, P1214, DOI 10.1136/bmj.280.6225.1214; Carmel R, 2012, CURR OPIN GASTROEN, V28, P151, DOI 10.1097/MOG.0b013e3283505852; de Jager J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2181; Evatt ML, 2010, PUBLIC HEALTH NUTR, V13, P25, DOI 10.1017/S1368980009990279; Favrat B, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-2; Frank E, 2000, AM J CLIN NUTR, V72, P969; Herrmann W, 2008, DTSCH ARZTEBL INT, V105, P680, DOI 10.3238/arztebl.2008.0680; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ismail-Beigi F, 2012, NEW ENGL J MED, V366, P1319, DOI 10.1056/NEJMcp1013127; Kibirige D, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-17; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lam JR, 2013, JAMA-J AM MED ASSOC, V310, P2435, DOI 10.1001/jama.2013.280490; Leung S, 2010, CLIN BIOCHEM, V43, P759, DOI 10.1016/j.clinbiochem.2010.02.011; LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2; Liu KW, 2006, AGE AGEING, V35, P200, DOI 10.1093/ageing/afj042; Miller RG, 2012, DIABETES, V61, P2987, DOI 10.2337/db11-1625; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Niafar M, 2015, INTERN EMERG MED, V10, P93, DOI 10.1007/s11739-014-1157-5; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Pflipsen MC, 2009, J AM BOARD FAM MED, V22, P528, DOI 10.3122/jabfm.2009.05.090044; Pongchaidecha Manat, 2004, Journal of the Medical Association of Thailand, V87, P780; Rajan S, 2002, J AM GERIATR SOC, V50, P624, DOI 10.1046/j.1532-5415.2002.50155.x; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Sahin M, 2007, J DIABETES COMPLICAT, V21, P118, DOI 10.1016/j.jdiacomp.2005.10.005; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; Schneider ALC, 2012, AM J EPIDEMIOL, V176, P738, DOI 10.1093/aje/kws156; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Shelton RC, 2009, CANCER CAUSE CONTROL, V20, P1271, DOI 10.1007/s10552-009-9340-0; Solomon LR, 2007, BLOOD REV, V21, P113, DOI 10.1016/j.blre.2006.05.001; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food and Nutrition Board Institute of Medicine, 1998, DIET REF INT THIAM R; Ting RZW, 2006, ARCH INTERN MED, V166, P1975, DOI 10.1001/archinte.166.18.1975; TOMKIN GH, 1971, BMJ-BRIT MED J, V2, P685, DOI 10.1136/bmj.2.5763.685; Valdes-Ramos R, 2015, ENDOCR METAB IMMUNE, V15, P54, DOI 10.2174/1871530314666141111103217; Wile DJ, 2010, DIABETES CARE, V33, P156, DOI 10.2337/dc09-0606; Wulffele MG, 2003, J INTERN MED, V254, P455, DOI 10.1046/j.1365-2796.2003.01213.x; Yetley EA, 2011, AM J CLIN NUTR, V94, p313S, DOI 10.3945/ajcn.111.013243	45	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160802	10.1371/journal.pone.0160802	http://dx.doi.org/10.1371/journal.pone.0160802			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513580	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100074
J	Gomes, A; Reyes, EV; Garduno, LS; Rojas, R; Mesejo, GM; Del Rosario, E; Jose, L; Javier, C; Vaughan, C; Donastorg, Y; Hammer, S; Brudney, K; Taylor, BS				Gomes, Angelina; Reyes, Emily V.; Garduno, L. Sergio; Rojas, Rita; Mir Mesejo, Geraldine; Del Rosario, Eliza; Jose, Lina; Javier, Carmen; Vaughan, Catherine; Donastorg, Yeycy; Hammer, Scott; Brudney, Karen; Taylor, Barbara S.			Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV plus Hispanics Initiating Antiretroviral Therapy	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; BODY-MASS INDEX; INFECTED PATIENTS; METABOLIC SYNDROME; DATA-COLLECTION; WEIGHT-GAIN; PREVALENCE; ASSOCIATION; EVENTS; ADULTS	Background Cardiovascular disease (CVD) is a leading health threat for HIV+ patients on antiretroviral therapy (ART); cardiometabolic comorbidities are key predictors of risk. Data are limited on incidence of metabolic comorbidities in HIV+ individuals initiating ART in low and middle income countries (LMICs), particularly for Hispanics. We examined incidence of diabetes and obesity in a prospective cohort of those initiating ART in the Dominican Republic. Methods Participants >= 18 years, initiating ART <90 days prior to study enrollment, were examined for incidence of impaired fasting glucose (IFG), diabetes mellitus (DM), overweight, and obesity. Fasting plasma glucose (FPG) 100-125mg/dl defined IFG; FPG >= 126 mg/dl, diagnosis per medical record, or use of hypoglycemic medication defined DM. Overweight and obesity were BMI 25-30 and >= 30kg/m2, respectively. Dyslipidemia was total cholesterol >= 240mg/dl or use of lipid-lowering medication. Framingham risk equation was used to determine ten-year CVD risk at the end of observation. Results Of 153 initiating ART, 8 (6%) had DM and 23 (16%) had IFG at baseline, 6 developed DM (28/1000 person-years follow up [PYFU]) and 46 developed IFG (329/1000 PYFU). At baseline, 24 (18%) were obese and 36 (27%) were overweight, 15 became obese (69/1000 PYFU) and 22 became overweight (163/1000 PYFU). Median observation periods for the diabetes and obesity analyses were 23.5 months and 24.3 months, respectively. Increased CVD risk (>= 10% 10-year Framingham risk score) was present for 13% of the cohort; 79% of the cohort had >= 1 cardiometabolic comorbidity, 48% had >= 2, and 13% had all three. Conclusions In this Hispanic cohort in an LMIC, incidences of IFG/DM and overweight/obesity were similar to or higher than that found in high income countries, and cardiometabolic disorders affected three-quarters of those initiating ART. Care models incorporating cardiovascular risk reduction into HIV treatment programs are needed to prevent CVD-associated mortality in this vulnerable population.	[Gomes, Angelina; Vaughan, Catherine; Hammer, Scott; Brudney, Karen; Taylor, Barbara S.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Reyes, Emily V.; Rojas, Rita; Jose, Lina; Javier, Carmen] Inst Dermatol & Cirugia Piel Dr Humberto Bogaert, Unidad Tratamiento ITS & VIH, Santo Domingo, Dominican Rep; [Garduno, L. Sergio; Taylor, Barbara S.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Mir Mesejo, Geraldine; Del Rosario, Eliza] Profamilia, Dept Med, Santo Domingo, Dominican Rep; [Donastorg, Yeycy] Inst Dermatol & Cirugia Piel Dr Humberto Bogaert, Unidad Vacunas, Santo Domingo, Dominican Rep; [Gomes, Angelina] NYU, Dept Med, 550 1St Ave, New York, NY 10016 USA; [Reyes, Emily V.] Hosp Salvador B Gautier, Dept Infectol, Santo Domingo, Dominican Rep; [Garduno, L. Sergio] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA; [Rojas, Rita] Hosp Gen Plaza Salud, Dept Infectol, Santo Domingo, Dominican Rep; [Vaughan, Catherine] Cambridge Hlth Alliance, Cambridge, MA USA	Columbia University; University of Texas System; University of Texas Health San Antonio; PROFAMILIA; New York University; State University System of Florida; Florida State University; Harvard University; Cambridge Health Alliance	Taylor, BS (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.; Taylor, BS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	TaylorB4@uthscsa.edu		Rojas-Fermin, Rita/0000-0003-2569-6190	U.S. National Institute for Allergy and Infectious Diseases [K23AI081538]; University of Texas Health Science Center at San Antonio Institute for Integration of Medicine and Science's Clinical and Translational Science [8UL1TR000149]	U.S. National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas Health Science Center at San Antonio Institute for Integration of Medicine and Science's Clinical and Translational Science	U.S. National Institute for Allergy and Infectious Diseases K23AI081538 to BST https://www.niaid.nih.gov/Pages/default.aspx and University of Texas Health Science Center at San Antonio Institute for Integration of Medicine and Science's Clinical and Translational Science Award 8UL1TR000149 to BST https://iims.uthscsa.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2014, JAIDS-J ACQ IMM DEF, V67, pS27, DOI 10.1097/QAI.0000000000000256; Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; Armah KA, 2014, CLIN INFECT DIS, V58, P121, DOI 10.1093/cid/cit652; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Bonfanti P, 2007, JAIDS-J ACQ IMM DEF, V45, P426, DOI 10.1097/QAI.0b013e318074ef83; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Buchacz K, 2013, ANTIVIR THER, pe40, DOI [10.1097/QAI.0000000000000010, DOI 10.1097/QAI.0000000000000010]; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino Ralph B., CIRCULATION, V117, P743, DOI [10.1161/CIRCULATIONAHA.107.699579, DOI 10.1161/CIRCULATIONAHA.107.699579]; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Edward AO, 2013, N AM J MED SCI, V5, P680, DOI 10.4103/1947-2714.123251; Edwards-Jackson N, 2011, HIV MED, V12, P510, DOI 10.1111/j.1468-1293.2011.00916.x; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guehi C, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0094-y; Hodgson LM, 2001, AIDS, V15, P2341, DOI 10.1097/00002030-200111230-00024; Miranda JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054056; Jones CY, 2003, CLIN INFECT DIS, V37, pS69, DOI 10.1086/375889; Kim DJ, 2012, JAIDS-J ACQ IMM DEF, V61, P600, DOI 10.1097/QAI.0b013e31827303d5; Koethe JR, 2016, AIDS RES HUM RETROV, V32, P50, DOI 10.1089/aid.2015.0147; Krishnan S, 2012, JAIDS-J ACQ IMM DEF, V61, P381, DOI 10.1097/QAI.0b013e3182690e3c; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Law MG, 2006, HIV MED, V7, P218, DOI 10.1111/j.1468-1293.2006.00362.x; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Lo YC, 2009, HIV MED, V10, P302, DOI 10.1111/j.1468-1293.2008.00687.x; Mariz CD, 2011, CAD SAUDE PUBLICA, V27, P1997; Mave V, 2016, J INFECT DIS; Muyanja D, 2016, AIDS PATIENT CARE ST, V30, P4, DOI 10.1089/apc.2015.0213; Ndona MM, 2012, INT J GEN MED, V5, P983, DOI 10.2147/IJGM.S32167; Nery MW, 2013, SCI WORLD J, DOI 10.1155/2013/969281; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Pichardo R, 2012, REV ARCH DOMINICANOS; Riyaten P, 2015, JAIDS-J ACQ IMM DEF, V69, P453, DOI 10.1097/QAI.0000000000000647; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schargrodsky H, 2008, AM J MED, V121, P58, DOI 10.1016/j.amjmed.2007.08.038; Tate T, 2012, ANTIVIR THER, V17, P1281, DOI 10.3851/IMP2348; Taylor BS, 2014, JAIDS-J ACQ IMM DEF, V65, pE33, DOI 10.1097/QAI.0000000000000010; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c; Tzur F, 2015, ISR MED ASSOC J, V17, P620; UNAIDS, 2014, THE GAP REP; WHO, 2014, DOM REP NCD COUNTR P; Zha BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059514	52	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160797	10.1371/journal.pone.0160797	http://dx.doi.org/10.1371/journal.pone.0160797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508301	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400055
J	Krusemark, CJ; Tilmans, NP; Brown, PO; Harbury, PB				Krusemark, Casey J.; Tilmans, Nicolas P.; Brown, Patrick O.; Harbury, Pehr B.			Directed Chemical Evolution with an Outsized Genetic Code	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; LIBRARY TECHNOLOGY ELT; IN-VITRO SELECTION; SUBSTRATE-SPECIFICITY; SYNTHETIC ANTIBODIES; ORGANIC-SYNTHESIS; DNA; MOLECULES; LIGANDS; PHAGE	The first demonstration that macromolecules could be evolved in a test tube was reported twenty-five years ago. That breakthrough meant that billions of years of chance discovery and refinement could be compressed into a few weeks, and provided a powerful tool that now dominates all aspects of protein engineering. A challenge has been to extend this scientific advance into synthetic chemical space: to enable the directed evolution of abiotic molecules. The problem has been tackled in many ways. These include expanding the natural genetic code to include unnatural amino acids, engineering polyketide and polypeptide synthases to produce novel products, and tagging combinatorial chemistry libraries with DNA. Importantly, there is still no small-molecule analog of directed protein evolution, i.e. a substantiated approach for optimizing complex (>= 10 boolean AND 9 diversity) populations of synthetic small molecules over successive generations. We present a key advance towards this goal: a tool for genetically-programmed synthesis of small-molecule libraries from large chemical alphabets. The approach accommodates alphabets that are one to two orders of magnitude larger than any in Nature, and facilitates evolution within the chemical spaces they create. This is critical for small molecules, which are built up from numerous and highly varied chemical fragments. We report a proof-of-concept chemical evolution experiment utilizing an outsized genetic code, and demonstrate that fitness traits can be passed from an initial small-molecule population through to the great-grandchildren of that population. The results establish the practical feasibility of engineering synthetic small molecules through accelerated evolution.	[Krusemark, Casey J.; Tilmans, Nicolas P.; Brown, Patrick O.; Harbury, Pehr B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Krusemark, Casey J.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Brown, Patrick O.] Impossible Foods, Redwood City, CA 94063 USA	Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harbury, PB (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	harbury@stanford.edu		Tilmans, Nicolas/0000-0002-3553-5203	American Cancer Society; National Heart Blood and Lung Institute [U01 HL099997, PCBC 2011 Pilot 01]; NIH Office of the Director award [DP-OD000429-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099995, U01HL099997] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Heart Blood and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Office of the Director award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Cancer Society post-doctoral fellowship (to CJK), the National Heart Blood and Lung Institute award #U01 HL099997, PCBC 2011 Pilot 01 (to PBH), and the NIH Office of the Director award #DP-OD000429-01 (to PBH).	Arico-Muendel C, 2015, ANTIMICROB AGENTS CH, V59, P3450, DOI 10.1128/AAC.00070-15; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Boder ET, 2011, ANNU REV CHEM BIOMOL, V2, P53, DOI 10.1146/annurev-chembioeng-061010-114142; Bulaj G, 1998, BIOCHEMISTRY-US, V37, P8965, DOI 10.1021/bi973101r; CHAMBERS TC, 1994, BIOCHEM J, V299, P309, DOI 10.1042/bj2990309; Ciobanu M, 2011, CHEM COMMUN, V47, P9321, DOI 10.1039/c1cc13213j; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Deng HF, 2012, J MED CHEM, V55, P7061, DOI 10.1021/jm300449x; Dietrich JA, 2010, ANNU REV BIOCHEM, V79, P563, DOI 10.1146/annurev-biochem-062608-095938; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629; Gold L, 2012, COLD SPRING HARB PER, V4; Green KD, 2009, CHEMBIOCHEM, V10, P234, DOI 10.1002/cbic.200800393; Halpin DR, 2004, PLOS BIOL, V2, P1031, DOI 10.1371/journal.pbio.0020175; Halpin DR, 2004, PLOS BIOL, V2, P1022, DOI 10.1371/journal.pbio.0020174; Hansen MH, 2009, J AM CHEM SOC, V131, P1322, DOI 10.1021/ja808558a; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kollmann CS, 2014, BIOORGAN MED CHEM, V22, P2353, DOI 10.1016/j.bmc.2014.01.050; Kumar A, 2013, CRIT REV BIOTECHNOL, V33, P365, DOI 10.3109/07388551.2012.716810; Kwon SW, 2003, MOL CELL PROTEOMICS, V2, P242, DOI 10.1074/mcp.M300039-MCP200; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Mannocci L, 2008, P NATL ACAD SCI USA, V105, P17670, DOI 10.1073/pnas.0805130105; Matochko WL, 2014, NUCLEIC ACIDS RES, V42, P1784, DOI 10.1093/nar/gkt1104; Muller MM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003187; Munoz E, 2008, PROTEIN ENG DES SEL, V21, P311, DOI 10.1093/protein/gzn007; NEEDELS MC, 1993, P NATL ACAD SCI USA, V90, P10700, DOI 10.1073/pnas.90.22.10700; NIELSEN J, 1993, J AM CHEM SOC, V115, P9812, DOI 10.1021/ja00074a063; Packer MS, 2015, NAT REV GENET, V16, P379, DOI 10.1038/nrg3927; Peisajovich SG, 2007, NAT METHODS, V4, P991, DOI 10.1038/nmeth1207-991; Satz AL, 2015, BIOCONJUGATE CHEMIST; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SNYDER GH, 1981, BIOCHEMISTRY-US, V20, P6509, DOI 10.1021/bi00526a001; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; SUN IYC, 1980, J BIOL CHEM, V255, P742; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Weisinger RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032299; Weisinger RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028056; Winssinger N, 2002, P NATL ACAD SCI USA, V99, P11139, DOI 10.1073/pnas.172286899; Wrenn SJ, 2007, J AM CHEM SOC, V129, P13137, DOI 10.1021/ja073993a; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	46	20	20	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0154765	10.1371/journal.pone.0154765	http://dx.doi.org/10.1371/journal.pone.0154765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508294	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400001
J	Shenai, S; Ronacher, K; Malherbe, S; Stanley, K; Kriel, M; Winter, J; Peppard, T; Barry, CE; Wang, J; Dodd, LE; Via, LE; Barry, CE; Walzl, G; Alland, D				Shenai, Shubhada; Ronacher, Katharina; Malherbe, Stefanus; Stanley, Kim; Kriel, Magdalena; Winter, Jill; Peppard, Thomas; Barry, Charles E.; Wang, Jing; Dodd, Lori E.; Via, Laura E.; Barry, Clifton E., III; Walzl, Gerhard; Alland, David			Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPIN RESISTANCE; TREATMENT RESPONSE; CLINICAL-TRIALS; TIME; BIOMARKERS; RELAPSE; LIQUID; RISK	Introduction Biomarkers are needed to monitor tuberculosis (TB) treatment and predict treatment outcomes. We evaluated the Xpert MTB/RIF (Xpert) assay as a biomarker for TB treatment during and at the end of the 24 weeks therapy. Methods Sputum from 108 HIV-negative, culture-positive pulmonary TB patients was analyzed using Xpert at time points before and during anti-TB therapy. Results were compared against culture. Direct Xpert cycle-threshold (Ct), a change in the Ct (delta Ct), or a novel "percent closing of baseline Ct deficit" (percent closing) were evaluated as classifiers of same-day and end-of-treatment culture and therapeutic outcomes. Results Xpert was positive in 29/95 (30.5%) of subjects at week 24; and positive one year after treatment in 8/64 (12.5%) successfully-treated patients who remained free of tuberculosis. We identified a relationship between initial bacterial load measured by baseline Xpert Ct and time to culture conversion (hazard ratio 1.06, p = 0.0023), and to the likelihood of being among the 8 treatment failures at week 24 (AUC = 72.8%). Xpert Ct was even more strongly associated with culture conversion on the day the test was performed with AUCs 96.7%, 99.2%, 86.0% and 90.2%, at Day 7, Week 4, 8 and 24, respectively. Compared to baseline Ct measures alone, a combined measure of baseline Ct plus either Delta Ct or percent closing improved the classification of treatment failure status to a 75% sensitivity and 88.9% specificity. Conclusions Genome loads measured by Xpert provide a potentially-useful biomarker for classifying same day culture status and predicting response to therapy.	[Shenai, Shubhada; Alland, David] Rutgers Biomed & Hlth Sci, Rutgers New Jersey Med Sch, Div Infect Dis, 185 South Orange Ave, Newark, NJ 07103 USA; [Ronacher, Katharina; Malherbe, Stefanus; Stanley, Kim; Kriel, Magdalena; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, DST NRF Ctr Excellence Biomed TB Res, Cape Town, South Africa; [Ronacher, Katharina; Malherbe, Stefanus; Stanley, Kim; Kriel, Magdalena; Walzl, Gerhard] Univ Stellenbosch, Fac Med & Hlth Sci, MRC Ctr TB Res, Div Mol Biol & Human Genet,Dept Biomed Sci, Cape Town, South Africa; [Winter, Jill] Catalysis Fdn Hlth, Emeryville, CA 94608 USA; [Peppard, Thomas] Certara LP, Greater Detroit Area, Detroit, MI 48226 USA; [Barry, Charles E.] Brown Univ, Providence, RI 02912 USA; [Wang, Jing] Leidos Biomed Res Inc, Clin Monitoring Res Program, Clin Res Directorate, NCI Campus Frederick, Frederick, MD USA; [Dodd, Lori E.] NIAID, Biostat Res Branch, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Via, Laura E.; Barry, Clifton E., III] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7701 Rondebosch, South Africa; [Via, Laura E.; Barry, Clifton E., III] Univ Cape Town, Fac Hlth Sci, Dept Clin Lab Sci, ZA-7701 Rondebosch, South Africa	Rutgers State University New Brunswick; Rutgers State University Medical Center; National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University; Brown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; University of Cape Town	Alland, D (corresponding author), Rutgers Biomed & Hlth Sci, Rutgers New Jersey Med Sch, Div Infect Dis, 185 South Orange Ave, Newark, NJ 07103 USA.	allandda@njms.rutgers.edu	Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020; Ronacher, Katharina/N-9603-2016; Via, Laura/AAD-3917-2021; Walzl, Gerhard/N-6371-2016	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X; Ronacher, Katharina/0000-0002-6371-1462; Via, Laura/0000-0001-6074-9521; Peppard, Thomas/0000-0003-2052-4007; Walzl, Gerhard/0000-0003-2487-125X	Catalysis Foundation for Health; Intramural Research Program of the NIAID, National Institutes of Health; Intramural Research program of the NIAID, NIH [OPP51919]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001214, ZIAAI001067, ZIAAI001081] Funding Source: NIH RePORTER	Catalysis Foundation for Health; Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research program of the NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported the Catalysis Foundation for Health and by the Intramural Research Program of the NIAID, National Institutes of Health (CEB), by the Intramural Research program of the NIAID, NIH (CEB) Grant No - OPP51919, and with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all patients for participation in this study and the clinic and Laboratory staff from the Stellenbosch University, Cape Town, South Africa for technical assistance. This work was supported by the Catalysis Foundation for Health and by the Intramural Research Program of the NIAID, National Institutes of Health (CEB), by the Intramural Research program of the NIAID, NIH (CEB) Grant No-OPP51919, and with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, PUBLIC HEALTH MUCOBA; Banada PP, 2010, J CLIN MICROBIOL, V48, P3551, DOI 10.1128/JCM.01053-10; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chigutsa E, 2013, ANTIMICROB AGENTS CH, V57, P789, DOI 10.1128/AAC.01876-12; Connolly LE, 2007, PLOS MED, V4, P435, DOI 10.1371/journal.pmed.0040120; Epstein MD, 1998, CHEST, V113, P379, DOI 10.1378/chest.113.2.379; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hesseling AC, 2010, INT J TUBERC LUNG D, V14, P560; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Kayigire XA, 2013, J CLIN MICROBIOL, V51, P1894, DOI 10.1128/JCM.03290-12; Kurbatova EV, 2015, LANCET RESP MED, V3, P201, DOI 10.1016/S2213-2600(15)00036-3; McIntosh MW, 2002, BIOMETRICS, V58, P657, DOI 10.1111/j.0006-341X.2002.00657.x; Nicol MP, 2013, LANCET RESP MED, V1, P427, DOI 10.1016/S2213-2600(13)70133-4; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Phillips PPJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0565-y; Su WJ, 2011, EUR RESPIR J, V37, P376, DOI 10.1183/09031936.00007410; Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448; van Zyl-Smit RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028815; Robert S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125403; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; World Health Organization, 2013, DEFINITIONS REPORTIN	25	28	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160062	10.1371/journal.pone.0160062	http://dx.doi.org/10.1371/journal.pone.0160062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508390	Green Published, gold			2022-12-26	WOS:000381380400020
J	Kao, JH; Chen, CD; Li, ZRT; Chan, TC; Tung, TH; Chu, YH; Cheng, HY; Liu, JW; Shih, FY; Shu, PY; Lin, CC; Tsai, WH; Ku, CC; Ho, CK; King, CC				Kao, Jui-Hung; Chen, Chaur-Dong; Li, Zheng-Rong Tiger; Chan, Ta-Chien; Tung, Tsung-Hwa; Chu, Yin-Hsia; Cheng, Hau-Yuan; Liu, Jien-Wei; Shih, Fuh-Yuan; Shu, Pei-Yun; Lin, Chien-Chou; Tsai, Wu-Hsiung; Ku, Chia-Chi; Ho, Chi-Kung; King, Chwan-Chuen			The Critical Role of Early Dengue Surveillance and Limitations of Clinical Reporting - Implications for Non-Endemic Countries	PLOS ONE			English	Article							GLOBAL DISTRIBUTION; DIFFUSION PATTERNS; TAIWAN; POPULATION; DISEASE; ADULTS; KAOHSIUNG; OUTBREAKS; CHILDREN; VIRUSES	The increasing dengue burden and epidemic severity worldwide have highlighted the need to improve surveillance. In non-endemic areas such as Taiwan, where outbreaks start mostly with imported cases from Southeast Asia, a closer examination of surveillance dynamics to detect cases early is necessary. To evaluate problems with dengue surveillance and investigate the involvement of different factors at various epidemic stages, we investigated 632 laboratory-confirmed indigenous dengue cases in Kaohsiung City, Taiwan during 2009-2010. The estimated sensitivity of clinical surveillance was 82.4% (521/632). Initially, the modified serological surveillance (targeting only the contacts of laboratory-confirmed dengue cases) identified clinically unrecognized afebrile cases in younger patients who visited private clinics and accounted for 30.4% (35/115) of the early-stage cases. Multivariate regression indicated that hospital/medical center visits [Adjusted Odds Ratio (aOR): 11.6, 95% confidence interval (CI): 6.3-21.4], middle epidemic stage [aOR: 2.4 (1.2-4.7)], fever [aOR: 2.3 (2.3-12.9)], and musculo-articular pain [aOR: 1.9 (1.05-3.3)] were significantly associated with clinical reporting. However, cases with pruritus/rash [aOR: 0.47 (0.26-0.83)] and diarrhea [aOR: 0.47 (0.26-0.85)] were underreported. In conclusion, multiple factors contributed to dengue surveillance problems. To prevent a large-scale epidemic and minimize severe dengue cases, there is a need for integrated surveillance incorporating entomological, clinical, serological, and virological surveillance systems to detect early cases, followed by immediate prevention and control measures and continuous evaluation to ensure effectiveness. This effort will be particularly important for an arbovirus, such as Zika virus, with a high asymptomatic infection ratio. For dengue-non-endemic countries, we recommend serological surveillance be implemented in areas with high Aedes mosquito indices or many breeding sites. Syndromic surveillance, spatial analysis and monitoring changes in epidemiological characteristics using a geographical information system, as well as epidemic prediction models involving epidemiological, meteorological and environmental variables will be helpful for early risk communication to increase awareness.	[Kao, Jui-Hung] Natl Taiwan Univ, Coll Med, Dept Med, Taipei 100, Taiwan; [Chen, Chaur-Dong; Tsai, Wu-Hsiung; Ho, Chi-Kung] Kaohsiung City Govt, Dept Hlth, Kaohsiung 802, Taiwan; [Li, Zheng-Rong Tiger; Tung, Tsung-Hwa; King, Chwan-Chuen] NTU, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Chan, Ta-Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Cheng, Hau-Yuan] NTU Hosp, Dept Pediat, Taipei 100, Taiwan; [Liu, Jien-Wei] Chang Gung Univ Med Coll, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 833, Taiwan; [Shih, Fuh-Yuan] NTU Hosp, Dept Emergency Med, Taipei 100, Taiwan; [Shu, Pei-Yun; Lin, Chien-Chou] Taiwan Ctr Dis Control, Dept Hlth, Taipei 100, Taiwan; [Ho, Chi-Kung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung 807, Taiwan; [Ho, Chi-Kung] Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan; [Ku, Chia-Chi] NTU, Coll Med, Inst Immunol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University	Ho, CK (corresponding author), Kaohsiung City Govt, Dept Hlth, Kaohsiung 802, Taiwan.; King, CC (corresponding author), NTU, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan.; Ho, CK (corresponding author), Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung 807, Taiwan.; Ho, CK (corresponding author), Kaohsiung Med Univ Hosp, Dept Occupat & Environm Med, Kaohsiung 807, Taiwan.; Ku, CC (corresponding author), NTU, Coll Med, Inst Immunol, Taipei 100, Taiwan.	chiachiku@ntu.edu.tw; hochikung@yahoo.com; chwanchuen@gmail.com	Kao, Jui-Hung/H-2470-2012; Chu, Ying-Hsia/J-4738-2019	Kao, Jui-Hung/0000-0002-8236-9121; Chu, Ying-Hsia/0000-0002-8289-7418; KU, CHIA-CHI/0000-0002-5740-1505; Ho, Chi-Kung/0000-0001-8001-0601; SHIH, FUH-YUAN/0000-0002-7755-0110	Ministry of Science and Technology (MOST) in Taiwan [MOST104-2314-B002-025, NSC102-2621-M002-002, 101-2923-B-002-006-MY3, 102-2815-C-002-183-B]	Ministry of Science and Technology (MOST) in Taiwan(Ministry of Science and Technology, Taiwan)	The authors greatly appreciate financial support from the Ministry of Science and Technology (MOST) in Taiwan [formerly the National Science Council] Grant numbers MOST104-2314-B002-025, NSC102-2621-M002-002, 101-2923-B-002-006-MY3, and 102-2815-C-002-183-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968; Anez G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/678645; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Carvalho A, 2016, EXPERT REV VACCINES, V15, P539, DOI 10.1586/14760584.2016.1152187; Chang SF, 2012, J FORMOS MED ASSOC, V111, P297, DOI 10.1016/j.jfma.2011.12.001; Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070; Chu HJ, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-42; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hammond SN, 2005, AM J TROP MED HYG, V73, P1063; Hanna JN, 2006, AUST NZ J PUBL HEAL, V30, P220, DOI 10.1111/j.1467-842X.2006.tb00861.x; Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903; Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666; Jelinek T, 2009, EUROSURVEILLANCE B E, V14; Kan CC, 2008, AM J TROP MED HYG, V79, P344, DOI 10.4269/ajtmh.2008.79.344; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103/141662, 10.3201/eid2103.141662]; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Li Z-RT, 2012, IMPACT ENV FACTORS M; Lin CH, 2012, EMERG INFECT DIS, V18, P1603, DOI 10.3201/eid1810.111929; Lin CC, 2010, AM J TROP MED HYG, V82, P731, DOI 10.4269/ajtmh.2010.09-0549; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011; Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0; Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775; Shu PY, 2001, VACCINE, V19, P1753, DOI 10.1016/S0264-410X(00)00391-1; Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420; Tan HF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-11; Wen TH, 2012, ANN ASSOC AM GEOGR, V102, P1026, DOI 10.1080/00045608.2012.671130; Wen TH, 2010, INT J INFECT DIS, V14, pE334, DOI 10.1016/j.ijid.2009.06.006; WHO, 1997, DENG HAEM FEV DIAGN; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu HH, 2013, J MED ENTOMOL, V50, P261, DOI 10.1603/ME11263; Yap G, 2013, AM J TROP MED HYG, V88, P1065, DOI 10.4269/ajtmh.12-0150	36	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160230	10.1371/journal.pone.0160230	http://dx.doi.org/10.1371/journal.pone.0160230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501302	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500015
J	Pan, Y; Wang, S; Su, B; Zhou, F; Zhang, R; Xu, T; Zhang, R; Leventaki, V; Drakos, E; Liu, W; Claret, FX				Pan, Y.; Wang, S.; Su, B.; Zhou, F.; Zhang, R.; Xu, T.; Zhang, R.; Leventaki, V.; Drakos, E.; Liu, W.; Claret, F. X.			Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression	ONCOGENE			English	Article							DOMAIN-BINDING PROTEIN-1; NASOPHARYNGEAL CARCINOMA; SIGNAL TRANSDUCER; CONSTITUTIVE ACTIVATION; MOLECULAR TARGETS; DNA-DAMAGE; GROWTH; P27(KIP1); APOPTOSIS; RADIOTHERAPY	Our previous studies demonstrated that Jab1/Csn5 overexpression is correlated with low survival rates in cancer patients, including nasopharyngeal carcinoma (NPC), breast cancer and hepatocellular carcinoma, and contributes to NPC's resistance to radiotherapy and cisplatin by regulating DNA damage and repair pathways. However, the molecular mechanism by which Jab1/Csn5 expression is upregulated in NPCs has yet to be determined. In the present study, we identified the upstream regulator of Jab1/Csn5 expression and demonstrated its role in intrinsic resistance of NPC cells to treatment with cisplatin. Signal transducer and activator of transcription-3 (Stat3) expression correlates with and contributes to Jab1/Csn5 transcription. Consistently, silencing of Stat3 in tumors reduced Jab1/Csn5 expression, thereby sensitizing NPC cells to cisplatin-induced apoptosis both in vitro and in vivo. Mechanistically, Stat3 transcriptionally regulated Jab1/Csn5. Furthermore, high mRNA expression levels of Stat3 or Jab1 in colon cancer, breast cancer and glioblastoma are associated with significantly shorter survival times from the R2 online database. These findings identify a novel Stat3-Jab1/Csn5 signaling axis in cancer pathogenesis with therapeutic and prognostic relevance.	[Pan, Y.] Jiangnan Univ, Affiliated Hosp, Sch Med, Dept Pathol, Wuxi, Peoples R China; [Pan, Y.; Wang, S.; Su, B.; Zhang, R.; Xu, T.; Claret, F. X.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 7435 Fannin St Unit 950, Houston, TX 77030 USA; [Wang, S.] Guangdong Prov Hosp Chinese Med, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Zhou, F.] Wuhan Univ, Zhongnan Hosp, Dept Hematol, Wuhan, Peoples R China; [Zhang, R.] Sun Yat Sen Univ, Ctr Canc, Dept Endoscopy, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Leventaki, V.; Drakos, E.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Liu, W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Claret, F. X.] Univ Texas Houston, Grad Sch Biomed Sci, Experimental Therapeut Acad Program & Canc Biol P, Houston, TX USA; [Leventaki, V.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Drakos, E.] Univ Crete, Sch Med, Dept Pathol, Iraklion, Greece	Jiangnan University; University of Texas System; UTMD Anderson Cancer Center; Guangzhou University of Chinese Medicine; Wuhan University; State Key Lab Oncology South China; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; St Jude Children's Research Hospital; University of Crete	Claret, FX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, 7435 Fannin St Unit 950, Houston, TX 77030 USA.	fxclaret@mdanderson.org	Claret, Francois X/R-2104-2016; Wang, Sumei/V-2800-2019; Leventaki, Vasiliki/N-8175-2018	Claret, Francois X/0000-0003-4629-6495; Wang, Sumei/0000-0002-2011-4019; Zhou, Fuling/0000-0003-0982-0382; Pan, Yunbao/0000-0002-6311-2945	National Natural Science Foundation of China [81372816]; Fundamental Research Funds for the Central Universities [JUSRP115A31]; NIH [R01CA90853, P30CA016672]; University Cancer Foundation via the Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA090853] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Cancer Foundation via the Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Kwok-Wai Lo, The Chinese University of Hong Kong for providing EBV-positive NPC cell line C666.1. We thank Markeda Wade in the Department of Scientific Publications at MD Anderson Cancer Center for editing the manuscript. This study was supported by in part by grants from the National Natural Science Foundation of China (81372816), Fundamental Research Funds for the Central Universities (JUSRP115A31), NIH grant R01CA90853, University Cancer Foundation via the Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center and by the NIH award P30CA016672.	Adachi M, 2012, ORAL ONCOL, V48, P1220, DOI 10.1016/j.oraloncology.2012.06.006; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buettner R, 2002, CLIN CANCER RES, V8, P945; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Cheng SH, 2000, INT J RADIAT ONCOL, V48, P1323, DOI 10.1016/S0360-3016(00)00779-3; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Fletcher S, 2009, BIOCHEM CELL BIOL, V87, P825, DOI [10.1139/O09-044, 10.1139/o09-044]; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Hsiao JR, 2003, BRIT J CANCER, V89, P344, DOI 10.1038/sj.bjc.6601003; Ji T, 2013, CANCER LETT, V341, P231, DOI 10.1016/j.canlet.2013.08.022; Jing N, 2005, ANTI-CANCER DRUG, V16, P601, DOI 10.1097/00001813-200507000-00002; Kouvaraki MA, 2003, CANCER RES, V63, P2977; Kouvaraki MA, 2006, CANCER RES, V66, P8581, DOI 10.1158/0008-5472.CAN-06-0975; Liu YP, 2008, INT J MOL MED, V21, P153; Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625; Lui VWY, 2009, CARCINOGENESIS, V30, P2085, DOI 10.1093/carcin/bgp253; Lui VWY, 2009, INT J CANCER, V125, P1884, DOI 10.1002/ijc.24567; Niu G, 2002, ONCOGENE, V21, P7001, DOI 10.1038/sj.onc.1205859; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Ong YK, 2003, EUR J CANCER, V39, P1535, DOI 10.1016/S0959-8049(03)00310-1; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Pan Y, 2013, ONCOGENE, V32, P2756, DOI 10.1038/onc.2012.294; Pan YB, 2014, CANCER BIOL THER, V15, P256, DOI 10.4161/cbt.27823; Pan YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054565; Pan YB, 2012, CANCER LETT, V326, P155, DOI 10.1016/j.canlet.2012.07.033; Pan YB, 2012, CANCER RES, V72, P1890, DOI 10.1158/0008-5472.CAN-11-3472; Rassidakis GZ, 2003, CLIN CANCER RES, V9, P1121; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Schlessinger K, 2005, CANCER RES, V65, P5828, DOI 10.1158/0008-5472.CAN-05-0317; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Spano JP, 2003, EUR J CANCER, V39, P2121, DOI 10.1016/S0959-8049(03)00367-8; Steinman RA, 2003, ONCOGENE, V22, P3608, DOI 10.1038/sj.onc.1206523; Sui L, 2001, CLIN CANCER RES, V7, P4130; Vultur A, 2004, ONCOGENE, V23, P2600, DOI 10.1038/sj.onc.1207378; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Weerasinghe P, 2007, INT J ONCOL, V31, P129; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	43	41	41	0	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1069	1079		10.1038/onc.2016.271	http://dx.doi.org/10.1038/onc.2016.271			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27524414	Green Accepted			2022-12-26	WOS:000395371500005
J	Koppenol-Raab, M; Harwig, MC; Posey, AE; Egner, JM; MacKenzie, KR; Hill, RB				Koppenol-Raab, Marijke; Harwig, Megan Cleland; Posey, Ammon E.; Egner, John M.; MacKenzie, Kevin R.; Hill, R. Blake			A Targeted Mutation Identified through pK(a) Measurements Indicates a Postrecruitment Role for Fis1 in Yeast Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						confocal microscopy; mitochondria; nuclear magnetic resonance (NMR); protein assembly; protein-protein interaction; structural model; macromolecular machine; mitochondrial dynamics; pKa measurements; tetratricopeptide repeat (TPR) domains	PROTEIN-PROTEIN INTERACTIONS; WD REPEAT PROTEIN; SACCHAROMYCES-CEREVISIAE; MEMBRANE RECRUITMENT; RECOGNITION SITES; DRP1 RECRUITMENT; DIVISION; DYNAMICS; DNM1P; ADAPTER	The tail-anchored protein Fis1 is implicated as a passive tether in yeast mitochondrial fission. We probed the functional role of Fis1 Glu-78, whose elevated side chain pK(a) suggests participation in protein interactions. Fis1 binds partners Mdv1 or Dnm1 tightly, but mutation E78A weakens Fis1 interaction with Mdv1, alters mitochondrial morphology, and abolishes fission in a growth assay. In fis1 rescue experiments, Fis1-E78A causes a novel localization pattern in which Dnm1 uniformly coats the mitochondria. By contrast, Fis1-E78A at lower expression levels recruits Dnm1 into mitochondrial punctate structures but fails to support normal fission. Thus, Fis1 makes multiple interactions that support Dnm1 puncta formation and may be essential after this step, supporting a revised model for assembly of the mitochondrial fission machinery. The insights gained by mutating a residue with a perturbed pK(a) suggest that side chain pK(a) values inferred from routine NMR sample pH optimization could provide useful leads for functional investigations.	[Koppenol-Raab, Marijke; Posey, Ammon E.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Posey, Ammon E.] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Harwig, Megan Cleland; Egner, John M.; Hill, R. Blake] Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [MacKenzie, Kevin R.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Koppenol-Raab, Marijke] NIAID, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Posey, Ammon E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA	Johns Hopkins University; Johns Hopkins University; Medical College of Wisconsin; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Washington University (WUSTL)	Hill, RB (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rbhill@mcw.edu		Hill, Blake/0000-0001-6228-3905; Harwig, Megan/0000-0003-2140-5739	National Institutes of Health [R01 GM067180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM067180. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Bhar D, 2006, J BIOL CHEM, V281, P17312, DOI 10.1074/jbc.M513530200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Bui HT, 2012, J CELL BIOL, V199, P613, DOI 10.1083/jcb.201207079; Castaneda CA, 2009, PROTEINS, V77, P570, DOI 10.1002/prot.22470; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chan DC, 2007, NEW ENGL J MED, V356, P1707, DOI 10.1056/NEJMp078040; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; DuBoff B, 2013, TRENDS NEUROSCI, V36, P325, DOI 10.1016/j.tins.2013.03.002; Farrell D, 2010, PROTEINS, V78, P843, DOI 10.1002/prot.22611; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Guo Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053523; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; Hill RB, 2000, J AM CHEM SOC, V122, P746, DOI 10.1021/ja9919332; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Karren MA, 2005, J CELL BIOL, V171, P291, DOI 10.1083/jcb.200506158; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Lees JPB, 2012, J MOL BIOL, V423, P143, DOI 10.1016/j.jmb.2012.06.042; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Naylor K, 2006, J BIOL CHEM, V281, P2177, DOI 10.1074/jbc.M507943200; Norel R, 2001, PROTEIN SCI, V10, P2147, DOI 10.1110/ps.12901; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Otera Hidenori, 2011, Small GTPases, V2, P167; Palmer CS, 2013, J BIOL CHEM, V288, P27584, DOI 10.1074/jbc.M113.479873; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Picton LK, 2009, BIOCHEMISTRY-US, V48, P6598, DOI 10.1021/bi802221h; Pierce BD, 2009, YEAST, V26, P349, DOI 10.1002/yea.1667; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Rines Daniel R, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.top065482; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHALLER W, 1995, BIOCHEMISTRY-US, V34, P4714, DOI 10.1021/bi00014a028; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Shaw JD, 2003, TRAFFIC, V4, P479, DOI 10.1034/j.1600-0854.2003.t01-1-00106.x; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Suzuki M, 2005, J BIOL CHEM, V280, P21444, DOI 10.1074/jbc.M414092200; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; Tooley JE, 2011, ACTA CRYSTALLOGR F, V67, P1310, DOI 10.1107/S1744309111029368; Waltner JK, 2005, PROTEIN SCI, V14, P2478, DOI 10.1110/ps.051606305; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Wells RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021384; Whitworth K, 2014, TRAFFIC, V15, P43, DOI 10.1111/tra.12125; Wilkens SJ, 1998, J AM CHEM SOC, V120, P4806, DOI 10.1021/ja973489d; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zhang Y, 2012, J BIOL CHEM, V287, P9855, DOI 10.1074/jbc.M111.329359; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	72	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20329	20344		10.1074/jbc.M116.724005	http://dx.doi.org/10.1074/jbc.M116.724005			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496949	Green Published, hybrid			2022-12-26	WOS:000384574800005
J	Mitsuda, SH; Shimizu, N				Mitsuda, Sho-hei; Shimizu, Noriaki			Epigenetic Repeat-Induced Gene Silencing in the Chromosomal and Extrachromosomal Contexts in Human Cells	PLOS ONE			English	Article							HOMOGENEOUSLY STAINING REGIONS; REPLICATION INITIATION REGION; MAMMALIAN-CELLS; DOUBLE MINUTES; DNA METHYLATION; CANCER-CELLS; AMPLIFICATION; HETEROCHROMATIN; CHROMATIN; TRANSCRIPTION	A plasmid bearing both a replication initiation region and a matrix attachment region is spontaneously amplified in transfected mammalian cells and generates plasmid repeats in the extrachromosomal double minutes (DMs) or the chromosomal homogeneously staining region (HSR). Generally, the repeat sequences are subject to repeat-induced gene silencing, the mechanism of which remains to be elucidated. Previous research showed that gene expression from the same plasmid repeat was higher from repeats located at DMs than at the HSR, which may reflect the extrachromosomal environment of the DMs. In the current study, plasmid repeats in both DMs and HSR were associated with repressive histone modifications (H3K9me3, H3K9me2), and the levels of repressive chromatin markers were higher in HSR than in DMs. Inactive chromatin is known to spread to neighboring regions in chromosome arm. Here, we found that such spreading also occurs in extrachromosomal DMs. Higher levels of active histone modifications (H3K9Ac, H3K4me3, and H3K79me2) were detected at plasmid repeats in DMs than in HSR. The level of DNA CpG methylation was generally low in both DMs and HSR; however, there were some hypermethylated copies within the population of repeated sequences, and the frequency of such copies was higher in DMs than in HSR. Together, these data suggest a "DNA methylation-core and chromatin-spread" model for repeat-induced gene silencing. The unique histone modifications at the extrachromosomal context are discussed with regard to the model.	[Mitsuda, Sho-hei; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398521, Japan	Hiroshima University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima, Hiroshima 7398521, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23380203, 24658290, 26660293]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23380203) and a Grant-in-Aid for Challenging Exploratory Research (24658290, 26660293), both from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) to N.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Carey MF, 2009, CHROMATIN IMMUNOPECI, V2009; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Fu HQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003542; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Fukuma M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153338; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; Itoh N, 1998, J CELL SCI, V111, P3275; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; L'Abbate A, 2014, NUCLEIC ACIDS RES, V42, P9131, DOI 10.1093/nar/gku590; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; Nathanson DA, 2014, SCIENCE, V343, P72, DOI 10.1126/science.1241328; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shimizu N, 2009, CYTOGENET GENOME RES, V124, P312, DOI 10.1159/000218135; Shimizu N, 2001, EXP CELL RES, V268, P201, DOI 10.1006/excr.2001.5286; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Shimizu N, 2007, GENE CHROMOSOME CANC, V46, P865, DOI 10.1002/gcc.20473; Solovei I, 2000, GENE CHROMOSOME CANC, V29, P297, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1046>3.0.CO;2-H; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; Utani KI, 2007, MOL CANCER RES, V5, P695, DOI 10.1158/1541-7786.MCR-07-0031; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804; Wang FW, 2006, MOL CELL BIOL, V26, P4028, DOI 10.1128/MCB.02189-05; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Zhang WL, 2008, PLANT CELL, V20, P25, DOI 10.1105/tpc.107.057083	39	14	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161288	10.1371/journal.pone.0161288	http://dx.doi.org/10.1371/journal.pone.0161288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525955	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100052
J	Bernardina, GRD; Cerveri, P; Barros, RML; Marins, JCB; Silvatti, AP				Bernardina, Gustavo R. D.; Cerveri, Pietro; Barros, Ricardo M. L.; Marins, Joao C. B.; Silvatti, Amanda P.			Action Sport Cameras as an Instrument to Perform a 3D Underwater Motion Analysis	PLOS ONE			English	Article							KINEMATIC ANALYSIS; CALIBRATION; GAIT; ACCURACY; TRUNK; SOFTWARE; TRACKING; CAPTURE; SYSTEM	Action sport cameras (ASC) are currently adopted mainly for entertainment purposes but their uninterrupted technical improvements, in correspondence of cost decreases, are going to disclose them for three-dimensional (3D) motion analysis in sport gesture study and athletic performance evaluation quantitatively. Extending this technology to sport analysis however still requires a methodologic step-forward to making ASC a metric system, encompassing ad-hoc camera setup, image processing, feature tracking, calibration and 3D reconstruction. Despite traditional laboratory analysis, such requirements become an issue when coping with both indoor and outdoor motion acquisitions of athletes. In swimming analysis for example, the camera setup and the calibration protocol are particularly demanding since land and underwater cameras are mandatory. In particular, the underwater camera calibration can be an issue affecting the reconstruction accuracy. In this paper, the aim is to evaluate the feasibility of ASC for 3D underwater analysis by focusing on camera setup and data acquisition protocols. Two GoPro Hero3+ Black (frequency: 60Hz; image resolutions: 1280x720/1920x1080 pixels) were located underwater into a swimming pool, surveying a working volume of about 6m(3). A two-step custom calibration procedure, consisting in the acquisition of one static triad and one moving wand, carrying nine and one spherical passive markers, respectively, was implemented. After assessing camera parameters, a rigid bar, carrying two markers at known distance, was acquired in several positions within the working volume. The average error upon the reconstructed inter-marker distances was less than 2.5mm (1280x720) and 1.5mm (1920x1080). The results of this study demonstrate that the calibration of underwater ASC is feasible enabling quantitative kinematic measurements with accuracy comparable to traditional motion capture systems.	[Bernardina, Gustavo R. D.; Marins, Joao C. B.; Silvatti, Amanda P.] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Cerveri, Pietro] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [Barros, Ricardo M. L.] Univ Estadual Campinas, Fac Phys Educ, Sao Paulo, Brazil	Universidade Federal de Vicosa; Polytechnic University of Milan; Universidade Estadual de Campinas	Bernardina, GRD (corresponding author), Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil.	gustavordalla@gmail.com	de Barros, Ricardo Machado Leite/AAF-4555-2020; Barros, Ricardo M. L./G-6329-2010	de Barros, Ricardo Machado Leite/0000-0002-9554-1381; Barros, Ricardo M. L./0000-0002-9554-1381	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation) [00/1293-1, 2006/02403-1, 2009/09359-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Counsel of Technological and Scientific Development) [473729/2008-3, 304975/2009-5, 478120/2011-7, 234088/2014-1, 481391/2013-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Federal Agency for Support and Evaluation of Graduation Education) [2011/10-7, 08/2014]; Fundacao de Amparo a Pesquisa de Minas Gerais (Minas Gerais Research Foundation) [PEE-00596-14]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Counsel of Technological and Scientific Development); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Federal Agency for Support and Evaluation of Graduation Education); Fundacao de Amparo a Pesquisa de Minas Gerais (Minas Gerais Research Foundation)	RMLB received funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation) (www.fapesp.br) through Award Numbers 00/1293-1, 2006/02403-1, and 2009/09359-6. RMLB and APS received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (National Counsel of Technological and Scientific Development) (www.cnpq.br) through Award Numbers 473729/2008-3, 304975/2009-5, 478120/2011-7, 234088/2014-1, and 481391/2013-4. GRDB and this study received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brazilian Federal Agency for Support and Evaluation of Graduation Education) (www.capes.gov.br) through Award Numbers 2011/10-7 and 08/2014. APS received funding from Fundacao de Amparo a Pesquisa de Minas Gerais (Minas Gerais Research Foundation) (www.fapemig.br) through Award Number PEE-00596-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balletti C, 2014, SENSORS-BASEL, V14, P17471, DOI 10.3390/s140917471; Bates NA, 2013, J BIOMECH, V46, P1237, DOI 10.1016/j.jbiomech.2013.02.024; Begon M, 2015, MED ENG PHYS, V37, P1032, DOI 10.1016/j.medengphy.2015.08.001; Bernardina G.R.D., 2014, ISBS C P ARCH, P505; Ceccon S, 2013, J SPORT SCI, V31, P276, DOI 10.1080/02640414.2012.729134; Cerveri P, 2001, IEEE T EVOLUT COMPUT, V5, P271, DOI 10.1109/4235.930315; Cerveri P, 1998, J BIOMECH, V31, P935, DOI 10.1016/S0021-9290(98)00104-3; Ceseracciu E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087640; Ceseracciu E, 2011, J BIOMECH, V44, P2236, DOI 10.1016/j.jbiomech.2011.06.003; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Chong AK, 2011, PHOTOGRAMM REC, V26, P263, DOI 10.1111/j.1477-9730.2011.00638.x; de Jesus K, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/269264; Fantozzi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138105; Figueroa PJ, 2003, COMPUT METH PROG BIO, V72, P155, DOI 10.1016/S0169-2607(02)00122-0; Fujii K, 2014, EUR J SPORT SCI, V14, P538, DOI 10.1080/17461391.2013.876104; Garcia-Ramos A, 2015, EUR J SPORT SCI, V15, P687, DOI 10.1080/17461391.2015.1063699; Gefen A, 2000, J BIOMECH ENG-T ASME, V122, P630, DOI 10.1115/1.1318904; Gourgoulis V, 2008, J SCI MED SPORT, V11, P90, DOI 10.1016/j.jsams.2007.02.010; Joyce C, 2013, SPORT BIOMECH, V12, P108, DOI 10.1080/14763141.2012.728244; Klotz MCM, 2013, GAIT POSTURE, V38, P148, DOI 10.1016/j.gaitpost.2012.11.005; Kwon YH, 2000, P 18 INT S BIOM SPOR, P48; Magalhaes FA, 2013, J SPORT SCI MED, V12, P660; Maier MW, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-244; McDonnell L.K., 2012, P 30 INT C INT SOC B, V98, P316; Monnet T, 2014, SPORTS ENG, V17, P171, DOI 10.1007/s12283-014-0152-4; Olsen E, 2012, SENSORS-BASEL, V12, P8145, DOI 10.3390/s120608145; Pribanic T, 2008, P 26 INT C BIOM SPOR, P77; Safayi S, 2015, J NEUROL SCI, V358, P107, DOI 10.1016/j.jns.2015.08.031; Seminati E, 2015, SPORT BIOMECH, V14, P216, DOI 10.1080/14763141.2015.1052747; Shortis M, 2015, SENSORS-BASEL, V15, P30810, DOI 10.3390/s151229831; Silvatti AP, 2013, COMPUT METHOD BIOMEC, V16, P1240, DOI 10.1080/10255842.2012.664637; Silvatti AP, 2012, J SPORT SCI, V30, P1551, DOI 10.1080/02640414.2012.713976; Silvatti AP, 2012, J BIOMECH, V45, P1112, DOI 10.1016/j.jbiomech.2012.01.004; Sinclair J, 2013, SPORT BIOMECH, V12, P272, DOI 10.1080/14763141.2012.759614; Timmis MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115179; Vieira LHP, 2017, COMP M BIO BIO E-IV, V5, P221, DOI 10.1080/21681163.2015.1072055; Wahid F, 2016, CLIN BIOMECH, V32, P92, DOI 10.1016/j.clinbiomech.2015.12.012; Wang J, 2008, PATTERN RECOGN, V41, P607, DOI 10.1016/j.patcog.2007.06.012; Yanai T, 1996, J BIOMECH, V29, P673, DOI 10.1016/0021-9290(95)00123-9; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	40	18	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160490	10.1371/journal.pone.0160490	http://dx.doi.org/10.1371/journal.pone.0160490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513846	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100041
J	Higuchi-Takeuchi, M; Morisaki, K; Toyooka, K; Numata, K				Higuchi-Takeuchi, Mieko; Morisaki, Kumiko; Toyooka, Kiminori; Numata, Keiji			Synthesis of High-Molecular-Weight Polyhydroxyalkanoates by Marine Photosynthetic Purple Bacteria	PLOS ONE			English	Article							SP PCC 6803; RECOMBINANT ESCHERICHIA-COLI; RALSTONIA-EUTROPHA H16; REPRESSOR PROTEIN; BIOSYNTHESIS; POLY(3-HYDROXYALKANOATES); POLY(3-HYDROXYBUTYRATE); BIODEGRADABILITY; BIOTECHNOLOGY; DEGRADATION	Polyhydroxyalkanoate (PHA) is a biopolyester/bioplastic that is produced by a variety of microorganisms to store carbon and increase reducing redox potential. Photosynthetic bacteria convert carbon dioxide into organic compounds using light energy and are known to accumulate PHA. We analyzed PHAs synthesized by 3 purple sulfur bacteria and 9 purple non-sulfur bacteria strains. These 12 purple bacteria were cultured in nitrogen-limited medium containing acetate and/or sodium bicarbonate as carbon sources. PHA production in the purple sulfur bacteria was induced by nitrogen-limited conditions. Purple non-sulfur bacteria accumulated PHA even under normal growth conditions, and PHA production in 3 strains was enhanced by nitrogen-limited conditions. Gel permeation chromatography analysis revealed that 5 photosynthetic purple bacteria synthesized high-molecular-weight PHAs, which are useful for industrial applications. Quantitative reverse transcription polymerase chain reaction analysis revealed that mRNA levels of phaC and PhaZ genes were low under nitrogen-limited conditions, resulting in production of high-molecular-weight PHAs. We conclude that all 12 tested strains are able to synthesize PHA to some degree, and we identify 5 photosynthetic purple bacteria that accumulate high-molecular-weight PHA molecules. Furthermore, the photosynthetic purple bacteria synthesized PHA when they were cultured in seawater supplemented with acetate. The photosynthetic purple bacteria strains characterized in this study should be useful as host microorganisms for large-scale PHA production utilizing abundant marine resources and carbon dioxide.	[Higuchi-Takeuchi, Mieko; Morisaki, Kumiko; Numata, Keiji] RIKEN Ctr Sustainable Resource Sci, Biomass Engn Res Div, Enzyme Res Team, Wako, Saitama, Japan; [Toyooka, Kiminori] RIKEN Ctr Sustainable Resource Sci, Technol Platform Div, Mass Spectrometry & Microscopy Unit, Yokohama, Kanagawa, Japan	RIKEN; RIKEN	Numata, K (corresponding author), RIKEN Ctr Sustainable Resource Sci, Biomass Engn Res Div, Enzyme Res Team, Wako, Saitama, Japan.	keiji.numata@riken.jp	Numata, Keiji/H-9751-2012; Toyooka, Kiminori/B-5027-2011; Higuchi-Takeuchi, Mieko/L-8406-2017	Numata, Keiji/0000-0003-2199-7420; 	Japan Science and Technology Agency (JST); ImPACT Planned Serendipity; Grants-in-Aid for Scientific Research [16K00593] Funding Source: KAKEN	Japan Science and Technology Agency (JST); ImPACT Planned Serendipity; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Japan Science and Technology Agency (JST); ImPACT Planned Serendipity [http://www.jst.go.jp/impact/serendipity/en/index.html].	Abed RMM, 2009, J APPL MICROBIOL, V106, P1, DOI 10.1111/j.1365-2672.2008.03918.x; Akai M, 2011, J BIOL CHEM, V286, P25224, DOI 10.1074/jbc.M111.236380; Akiyama M, 2003, POLYM DEGRAD STABIL, V80, P183, DOI 10.1016/S0141-3910(02)00400-7; ANDERSON AJ, 1990, MICROBIOL REV, V54, P450, DOI 10.1128/MMBR.54.4.450-472.1990; Aoyagi Y, 2003, POLYM DEGRAD STABIL, V79, P209, DOI 10.1016/S0141-3910(02)00273-2; BRANDL H, 1989, INT J BIOL MACROMOL, V11, P49, DOI 10.1016/0141-8130(89)90040-8; BRANDL H, 1991, ARCH MICROBIOL, V155, P337; Bugnicourt E, 2014, EXPRESS POLYM LETT, V8, P791, DOI 10.3144/expresspolymlett.2014.82; Carlozzi P, 2001, J BIOTECHNOL, V88, P239, DOI 10.1016/S0168-1656(01)00280-2; Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c; Chowdhury WQ, 1996, APPL BIOCHEM BIOTECH, V57-8, P361, DOI 10.1007/BF02941714; Chuah JA, 2013, POLYM DEGRAD STABIL, V98, P331, DOI 10.1016/j.polymdegradstab.2012.09.008; Fuller RC, 1995, POLYESTERS PHOTOSYNT, P973, DOI [10.1007/0-306-47954-0_60, DOI 10.1007/0-306-47954-0_60]; Giovannoni S, 2007, NAT REV MICROBIOL, V5, P820, DOI 10.1038/nrmicro1752; HAHN SK, 1994, BIOTECHNOL BIOENG, V44, P256, DOI 10.1002/bit.260440215; Hooks DO, 2014, MOLECULES, V19, P8629, DOI 10.3390/molecules19068629; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Kusaka S, 1997, APPL MICROBIOL BIOT, V47, P140, DOI 10.1007/s002530050902; Kusaka S, 1999, INT J BIOL MACROMOL, V25, P87, DOI 10.1016/S0141-8130(99)00019-7; Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1; Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c; LIEBERGESELL M, 1991, ARCH MICROBIOL, V155, P415, DOI 10.1007/BF00244955; Lu JN, 2009, POLYM REV, V49, P226, DOI 10.1080/15583720903048243; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Maeda I, 2003, BIOTECHNOL BIOENG, V81, P474, DOI 10.1002/bit.10494; Masuda S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00577-13; McQualter RB, 2015, PLANT BIOTECHNOL J, V13, P700, DOI 10.1111/pbi.12298; Nagao N, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00388-15; Numata K, 2005, BIOMACROMOLECULES, V6, P2008, DOI 10.1021/bm0501151; Numata K, 2015, ACS SUSTAIN CHEM ENG, V3, P569, DOI 10.1021/acssuschemeng.5b00031; Numata K, 2015, BIOCHEMISTRY-US, V54, P1401, DOI 10.1021/bi501560b; Numata K, 2013, POLYM J, V45, P1094, DOI 10.1038/pj.2013.25; Numata K, 2012, MAR BIOTECHNOL, V14, P323, DOI 10.1007/s10126-011-9416-1; Numata K, 2009, MATERIALS, V2, P1104, DOI 10.3390/ma2031104; Osanai T, 2013, DNA RES, V20, P525, DOI 10.1093/dnares/dst028; Potter M, 2002, MICROBIOL-SGM, V148, P2413, DOI 10.1099/00221287-148-8-2413; Potter M, 2005, BIOMACROMOLECULES, V6, P552, DOI 10.1021/bm049401n; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; RAMSAY BA, 1990, APPL ENVIRON MICROB, V56, P2093, DOI 10.1128/AEM.56.7.2093-2098.1990; Saegusa H, 2001, J BACTERIOL, V183, P94, DOI 10.1128/JB.183.1.94-100.2001; SENIOR PJ, 1972, BIOCHEM J, V128, P1193, DOI 10.1042/bj1281193; Sim SJ, 1997, NAT BIOTECHNOL, V15, P63, DOI 10.1038/nbt0197-63; Suriyamongkol P, 2007, BIOTECHNOL ADV, V25, P148, DOI 10.1016/j.biotechadv.2006.11.007; Tomizawa S, 2010, APPL MICROBIOL BIOT, V87, P1427, DOI 10.1007/s00253-010-2601-8; Valappil SP, 2008, J APPL MICROBIOL, V104, P1624, DOI 10.1111/j.1365-2672.2007.03678.x; Yamada M, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-6; Yamashita K, 2006, BIOMACROMOLECULES, V7, P2449, DOI 10.1021/bm060442o	47	48	52	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160981	10.1371/journal.pone.0160981	http://dx.doi.org/10.1371/journal.pone.0160981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513570	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100101
J	Mayurasakorn, K; Niatsetskaya, ZV; Sosunov, SA; Williams, JJ; Zirpoli, H; Vlasakov, I; Deckelbaum, RJ; Ten, VS				Mayurasakorn, Korapat; Niatsetskaya, Zoya V.; Sosunov, Sergey A.; Williams, Jill J.; Zirpoli, Hylde; Vlasakov, Iliyan; Deckelbaum, Richard J.; Ten, Vadim S.			DHA but Not EPA Emulsions Preserve Neurological and Mitochondrial Function after Brain Hypoxia-Ischemia in Neonatal Mice	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; PERMEABILITY TRANSITION; EICOSAPENTAENOIC ACID; CELL-DEATH; INJURY; NEURODEGENERATION; NEUROPROTECTION; IDENTIFICATION; LIPIDS	Background and Purpose Treatment with triglyceride emulsions of docosahexaenoic acid (tri-DHA) protected neonatal mice against hypoxia-ischemia (HI) brain injury. The mechanism of this neuroprotection remains unclear. We hypothesized that administration of tri-DHA enriches HI-brains with DHA/DHA metabolites. This reduces Ca2+ -induced mitochondrial membrane permeabilization and attenuates brain injury. Methods 10-day-old C57BL/6J mice following HI-brain injury received tri-DHA, tri-EPA or vehicle. At 4-5 hours of reperfusion, mitochondrial fatty acid composition and Ca2+ buffering capacity were analyzed. At 24 hours and at 8-9 weeks of recovery, oxidative injury, neurofunctional and neuropathological outcomes were evaluated. In vitro, hyperoxia-induced mitochondrial generation of reactive oxygen species (ROS) and Ca2+ buffering capacity were measured in the presence or absence of DHA or EPA. Results Only post-treatment with tri-DHA reduced oxidative damage and improved short-and long-term neurological outcomes. This was associated with increased content of DHA in brain mitochondria and DHA-derived bioactive metabolites in cerebral tissue. After tri-DHA administration HI mitochondria were resistant to Ca2+-induced membrane permeabilization. In vitro, hyperoxia increased mitochondrial ROS production and reduced Ca2+ buffering capacity; DHA, but not EPA, significantly attenuated these effects of hyperoxia. Conclusions Post-treatment with tri-DHA resulted in significant accumulation of DHA and DHA derived bioactive metabolites in the HI-brain. This was associated with improved mitochondrial tolerance to Ca2+-induced permeabilization, reduced oxidative brain injury and permanent neuroprotection. Interaction of DHA with mitochondria alters ROS release and improves Ca2+ buffering capacity. This may account for neuroprotective action of post-HI administration of tri-DHA.	[Mayurasakorn, Korapat; Williams, Jill J.; Zirpoli, Hylde; Deckelbaum, Richard J.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Niatsetskaya, Zoya V.; Sosunov, Sergey A.; Deckelbaum, Richard J.; Ten, Vadim S.] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Vlasakov, Iliyan] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA; [Vlasakov, Iliyan] Harvard Med Sch, Boston, MA USA	Columbia University; Columbia University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Deckelbaum, RJ (corresponding author), Columbia Univ, Inst Human Nutr, New York, NY 10032 USA.; Deckelbaum, RJ; Ten, VS (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	rjd20@columbia.edu; vt82@columbia.edu		Mayurasakorn, Korapat/0000-0003-3816-6463	National Heart, Lung, and Blood Institute [R01 HL040404]; National Institute of Neurological Disorders and Stroke [NS 088197]; NIH at BWH [P01GM095467]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088197] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH at BWH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Heart, Lung, and Blood Institute, R01 HL040404 (RJD), [http://www.nhlbi.nih.gov/]; National Institute of Neurological Disorders and Stroke, NS 088197 (RJD and VST), by NIH Grant P01GM095467 at BWH, [http://www.ninds.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Aito H, 2002, PEDIATR RES, V52, P40, DOI 10.1023/01.PDR.0000016665.07813.0B; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Bazan NG, 2012, MOL NEUROBIOL, V46, P221, DOI 10.1007/s12035-012-8322-5; Berman DR, 2013, NEONATOLOGY, V104, P71, DOI 10.1159/000351011; Berman DR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.020; Callaway JK, 2001, CLIN EXP PHARMACOL P, V28, P913, DOI 10.1046/j.1440-1681.2001.03547.x; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Hong SH, 2014, J NEUROL SCI, V338, P135, DOI 10.1016/j.jns.2013.12.033; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Khairallah RJ, 2010, J PHARMACOL EXP THER, V335, P155, DOI 10.1124/jpet.110.170605; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; Kuroda S, 1996, ACTA PHYSIOL SCAND, V156, P149, DOI 10.1046/j.1365-201X.1996.449170000.x; LEPAGE G, 1986, J LIPID RES, V27, P114; Mayurasakorn K, 2011, CURR OPIN CLIN NUTR, V14, P158, DOI 10.1097/MCO.0b013e328342cba5; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; Norris PC, 2016, PROSTAGLANDINS LEUKO; Okabe N, 2011, J STROKE CEREBROVASC, V20, P188, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.016; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Sosunov SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120456; Stanley WC, 2012, CURR OPIN CLIN NUTR, V15, P122, DOI 10.1097/MCO.0b013e32834fdaf7; Ten VS, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/542976; Ten VS, 2004, STROKE, V35, P2183, DOI 10.1161/01.STR.0000137768.25203.df; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Thornton C, 2015, CLIN CHIM ACTA, V451, P35, DOI 10.1016/j.cca.2015.01.026; WILLERBRANDS AF, 1973, J MOL CELL CARDIOL, V5, P259, DOI 10.1016/0022-2828(73)90066-7; Williams JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056233; Winkler JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18972; Ying Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052998	33	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160870	10.1371/journal.pone.0160870	http://dx.doi.org/10.1371/journal.pone.0160870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513579	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100083
J	Grassi, MA; Rao, VR; Chen, SQ; Cao, DC; Gao, XY; Cleary, PA; Huang, RS; Paterson, AD; Natarajan, R; Rehman, J; Kern, TS				Grassi, Michael A.; Rao, Vidhya R.; Chen, Siquan; Cao, Dingcai; Gao, Xiaoyu; Cleary, Patricia A.; Huang, R. Stephanie; Paterson, Andrew D.; Natarajan, Rama; Rehman, Jalees; Kern, Timothy S.		DCCT EDIC Res Grp	Lymphoblastoid Cell Lines as a Tool to Study Inter-Individual Differences in the Response to Glucose	PLOS ONE			English	Article							GENE-EXPRESSION VARIATION; EARLY DIABETIC-RETINOPATHY; RETINAL ENDOTHELIAL-CELLS; GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR-ALPHA; POLYMORPHONUCLEAR LEUKOCYTES; PHARMACOGENOMIC DISCOVERY; HISTONE MODIFICATIONS; SKIN FIBROBLASTS; TWINS DISCORDANT	Background White blood cells have been shown in animal studies to play a central role in the pathogenesis of diabetic retinopathy. Lymphoblastoid cells are immortalized EBV-transformed primary B-cell leukocytes that have been extensively used as a model for conditions in which white blood cells play a primary role. The purpose of this study was to investigate whether lymphoblastoid cell lines, by retaining many of the key features of primary leukocytes, can be induced with glucose to demonstrate relevant biological responses to those found in diabetic retinopathy. Methods Lymphoblastoid cell lines were obtained from twenty-three human subjects. Differences between high and standard glucose conditions were assessed for expression, endothelial adhesion, and reactive oxygen species. Results Collectively, stimulation of the lymphoblastoid cell lines with high glucose demonstrated corresponding changes on molecular, cellular and functional levels. Lymphoblastoid cell lines up-regulated expression of a panel of genes associated with the leukocyte-mediated inflammation found in diabetic retinopathy that include: a cytokine (IL-1B fold change = 2.11, p-value = 0.02), an enzyme (PKCB fold change = 2.30, p-value = 0.01), transcription factors (NFKB-p50 fold change = 2.05, p-value = 0.01), (NFKB-p65 fold change = 2.82, p-value = 0.003), and an adhesion molecule (CD18 fold change = 2.59, 0.02). Protein expression of CD18 was also increased (p-value = 2.14x10(-5)). The lymphoblastoid cell lines demonstrated increased adhesiveness to endothelial cells (p = 1.28x10(-5)). Reactive oxygen species were increased (p = 2.56x10(-6)). Significant inter-individual variation among the lymphoblastoid cell lines in these responses was evident (F = 18.70, p < 0.0001). Conclusions Exposure of lymphoblastoid cell lines derived from different human subjects to high glucose demonstrated differential and heterogeneous gene expression, adhesion, and cellular effects that recapitulated features found in the diabetic state. Lymphoblastoid cells may represent a useful tool to guide an individualized understanding of the development and potential treatment of diabetic complications like retinopathy.	[Grassi, Michael A.; Rao, Vidhya R.; Cao, Dingcai] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA; [Chen, Siquan] Univ Illinois, Inst Genom & Syst Biol, Cellular Screening Ctr, Chicago, IL 60607 USA; [Gao, Xiaoyu; Cleary, Patricia A.] George Washington Univ, Biostat Ctr, Rockville, MD 20007 USA; [Huang, R. Stephanie] Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL 60637 USA; [Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Sickkids, Genet & Genome Biol Res Inst, Toronto, ON, Canada; [Natarajan, Rama] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, Duarte, CA USA; [Rehman, Jalees] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Kern, Timothy S.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Kern, Timothy S.] Vet Adm Med Ctr Res Serv 151, Cleveland, OH 44106 USA; [Rao, Vidhya R.] Loyola Univ, Med Ctr, Dept Mol Pharmacol & Therapeut, 2160 S 1st Ave, Maywood, IL 60153 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; George Washington University; University of Chicago; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); City of Hope; Beckman Research Institute of City of Hope; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Case Western Reserve University; Case Western Reserve University; Loyola University Chicago	Grassi, MA (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	grassim@uic.edu	Rao, Vidhya R/AAQ-2047-2020; Paterson, Andrew/AAQ-7511-2020; Rehman, Jalees/GVU-1981-2022; Rehman, Jalees/J-8258-2012; Paterson, Andrew D/A-4088-2011	Rao, Vidhya R/0000-0002-1465-2646; Paterson, Andrew/0000-0002-9169-118X; Rehman, Jalees/0000-0002-2787-9292; Rehman, Jalees/0000-0002-2787-9292; Paterson, Andrew D/0000-0002-9169-118X; Huang, R. Stephanie/0000-0002-9862-0368	NIDDK Diabetic Complications Consortium (DiaComp) [DK076169]; Search for Vision; National Eye Institute [R01 EY023644-01A1, EY001792]; Research to Prevent Blindness, Inc., New York, NY; Juvenile Diabetes Research Foundation [JDRF 17-2012-480]; National Institutes of Health [R01 DK065073]; NIH/NIGMS [K08GM089941, UO1GM61393]; Circle of Service Foundation; NIH/NCI [R21 CA139278]; University of Chicago Cancer Center Support Grant [P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; Conquer Cancer Foundation of American Society of Clinical Oncology; NIH/NCATS [UL1RR024999]; NIDDK, Division of Diabetes, Endocrinology, and Metabolic Diseases [U01 DK094176, U01 DK094157]; National Eye Institute, National Institute of Neurological Disorders and Stroke, the General Clinical Research Center Program; National Eye Institute, National Institute of Neurological Disorders and Stroke, Clinical Translational Science Center Awards Program; NATIONAL EYE INSTITUTE [R01EY023644, P30EY001792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK106917, U01DK094157, R01DK065073] Funding Source: NIH RePORTER	NIDDK Diabetic Complications Consortium (DiaComp); Search for Vision; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc., New York, NY(Research to Prevent Blindness (RPB)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Circle of Service Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Cancer Center Support Grant; Breast Cancer SPORE Career Development Award; Conquer Cancer Foundation of American Society of Clinical Oncology; NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK, Division of Diabetes, Endocrinology, and Metabolic Diseases; National Eye Institute, National Institute of Neurological Disorders and Stroke, the General Clinical Research Center Program; National Eye Institute, National Institute of Neurological Disorders and Stroke, Clinical Translational Science Center Awards Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge financial support for this research. Funding for this work was provided by: the NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org), grant DK076169 (MAG); Search for Vision (http://www.searchforvision.org/home.html)(MAG); National Eye Institute (https://nei.nih.gov/) R01 EY023644-01A1 (MAG); National Eye Institute Core Grant EY001792 for Vision Research; an unrestricted grant from Research to Prevent Blindness (http://www.rpbusa.org/rpb), Inc., New York, NY; the Juvenile Diabetes Research Foundation (http://jdrf.org/) (JDRF 17-2012-480) (RN); the National Institutes of Health R01 DK065073 (RN); RSH received support from NIH/NIGMS (http://www.nigms.nih.gov) grant K08GM089941, Circle of Service Foundation (http://www.cosfoundation.org/) Early Career Investigator award, NIH/NCI (http://www.cancer.gov/) grant R21 CA139278, NIH/NIGMS grant UO1GM61393, University of Chicago Cancer Center Support Grant (#P30 CA14599), Breast Cancer SPORE Career Development Award [CA125183], a Conquer Cancer Foundation of American Society of Clinical Oncology (http://www.asco.org/) Translational Research Professorship award In Memory of Merrill J. Egorin, MD (awarded to Dr. MJ Ratain) and a pilot grant from NIH/NCATS (https://ncats.nih.gov/) grant UL1RR024999. Funding for EDIC is provided by cooperative agreement grants (1982-1993, and 2012-2017) and contracts (1982-2012) with the NIDDK (http://www.niddk.nih.gov), Division of Diabetes, Endocrinology, and Metabolic Diseases (grant numbers U01 DK094176 and U01 DK094157), as well as the National Eye Institute, National Institute of Neurological Disorders and Stroke, the General Clinical Research Center Program (1993-2007), and the Clinical Translational Science Center Awards Program (2006-present). Industry contributors have had no role in the DCCT/EDIC study but have provided free or discounted supplies or equipment to support participants' adherence to the study: Abbott Diabetes Care (Alameda, CA), Animas (Westchester, PA), Bayer Diabetes Care (North America Headquarters, Tarrytown, NY), Becton Dickinson (Franklin Lakes, NJ), Eli Lilly (Indianapolis, IN), Extend Nutrition (St. Louis, MO), Insulet Corporation (Bedford, MA), Lifescan (Milpitas, CA), Medtronic Diabetes (Minneapolis, MN), Nipro Home Diagnostics (Ft. Lauderdale, FL), Nova Diabetes Care (Billerica, MA), Omron (Shelton, CT), Perrigo Diabetes Care (Allegan, MI), Roche Diabetes Care (Indianapolis, IN), and Sanofi-Aventis (Bridgewater, NJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis AP, 2008, SEMIN IMMUNOPATHOL, V30, P65, DOI 10.1007/s00281-008-0111-x; [Anonymous], 2001, RELATIVE QUANTITATIO; Arar NH, 2008, INVEST OPHTH VIS SCI, V49, P3839, DOI 10.1167/iovs.07-1633; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Babapoor-Farrokhran S, 2015, P NATL ACAD SCI USA, V112, pE3030, DOI 10.1073/pnas.1423765112; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Ben-Mahmud BM, 2004, DIABETES, V53, P2968, DOI 10.2337/diabetes.53.11.2968; BEVILACQUA MP, 1985, J CLIN INVEST, V76, P2003, DOI 10.1172/JCI112200; Bullaughey K, 2009, HUM MOL GENET, V18, P4296, DOI 10.1093/hmg/ddp382; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Calay ES, 2013, NAT MED, V19, P265, DOI 10.1038/nm.3114; Caliskan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107166; Caramori ML, 2015, J CLIN ENDOCR METAB, V100, pE883, DOI 10.1210/jc.2014-4467; Caramori ML, 2012, DIABETES, V61, P739, DOI 10.2337/db11-0617; DCCT Res Grp, 1986, DIABETES, V35, P530; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Dermitzakis ET, 2012, NAT REV GENET, V13, P215, DOI 10.1038/nrg3115; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Doganay S, 2002, EYE, V16, P163, DOI 10.1038/sj.eye.6700095; Donnelly R, 2004, BRIT J OPHTHALMOL, V88, P145, DOI 10.1136/bjo.88.1.145; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; FREEDMAN SF, 1992, EXP EYE RES, V55, P767, DOI 10.1016/0014-4835(92)90181-Q; Fu DX, 2014, J LIPID RES, V55, P860, DOI 10.1194/jlr.M045401; Fu YP, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/861291; Genuth S, 1999, DIABETES CARE, V22, P99; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Gibson G, 2008, NAT REV GENET, V9, P575, DOI 10.1038/nrg2383; Grassi MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087883; Grassi MA, 2012, INVEST OPHTH VIS SCI, V53, P2377, DOI 10.1167/iovs.11-8068; Grassi MA, 2011, HUM MOL GENET, V20, P2472, DOI 10.1093/hmg/ddr121; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Hietala K, 2008, DIABETES, V57, P2176, DOI 10.2337/db07-1495; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu Y, 2013, P NATL ACAD SCI USA, V110, P15401, DOI 10.1073/pnas.1307211110; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; Joussen AM, 2009, MOL VIS, V15, P1418; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Junaid MA, 2011, BIOCHEM BIOPH RES CO, V412, P688, DOI 10.1016/j.bbrc.2011.08.027; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kim SY, 2005, DIABETES, V54, P1534, DOI 10.2337/diabetes.54.5.1534; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Li Y, 2012, INVEST OPHTH VIS SCI, V53, P5520, DOI 10.1167/iovs.12-10010; Lutty GA, 1997, AM J PATHOL, V151, P707; McAuley AK, 2014, INVEST OPHTH VIS SCI, V55, P1666, DOI 10.1167/iovs.13-13559; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Miao F, 2014, DIABETES, V63, P1748, DOI 10.2337/db13-1251; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Moen EL, 2012, GENOME MED, V4, DOI 10.1186/gm391; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Nam HY, 2011, PHARMACOGENOMICS, V12, P907, DOI [10.2217/pgs.11.24, 10.2217/PGS.11.24]; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Patel Nishal, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P222; Paterson AD, 2012, J CARDIOVASC TRANSL, V5, P388, DOI 10.1007/s12265-012-9385-4; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Rao VR, 2010, INVEST OPHTH VIS SCI, V51, P5198, DOI 10.1167/iovs.09-5144; SCHRODER S, 1991, AM J PATHOL, V139, P81; Serra AM, 2012, AM J PATHOL, V181, P719, DOI 10.1016/j.ajpath.2012.04.009; Sheu WHH, 2013, HUM MOL GENET, V22, P3165, DOI 10.1093/hmg/ddt161; Shukla SJ, 2005, PHARMACOGENOMICS, V6, P303, DOI 10.1517/14622416.6.3.303; Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000; Sobrin L, 2011, INVEST OPHTH VIS SCI, V52, P7593, DOI 10.1167/iovs.11-7510; Song HP, 2007, GRAEF ARCH CLIN EXP, V245, P24, DOI 10.1007/s00417-006-0379-2; Stark AL, 2013, PHARMACOGENOMICS, V14, P447, DOI [10.2217/PGS.13.32, 10.2217/pgs.13.32]; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tang J, 2011, PROG RETIN EYE RES; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tian P, 2013, MOL VIS, V19, P2092; Veenstra AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078405; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wang AL, 2014, MOL VIS, V20, P1146; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Wheeler HE, 2012, PHARMACOGENOMICS, V13, P55, DOI [10.2217/PGS.11.121, 10.2217/pgs.11.121]; WIERUSZWYSOCKA B, 1987, J LEUKOCYTE BIOL, V42, P519, DOI 10.1002/jlb.42.5.519; Xu YH, 2010, INT IMMUNOPHARMACOL, V10, P1552, DOI 10.1016/j.intimp.2010.09.006; Zheng L, 2007, DIABETES, V56, P337, DOI 10.2337/db06-0789; 2006, OPHTHALMOLOGY, V113, P2221, DOI DOI 10.1016/J.OPHTHA.2006.07.032; 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.2353/AJPATH.2008.071070	94	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160504	10.1371/journal.pone.0160504	http://dx.doi.org/10.1371/journal.pone.0160504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509144	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400035
J	Iwasa, T; Amiya, E; Ando, J; Watanabe, M; Murasawa, T; Komuro, I				Iwasa, Takeshi; Amiya, Eisuke; Ando, Jiro; Watanabe, Masafumi; Murasawa, Takahide; Komuro, Issei			Different Contributions of Physical Activity on Arterial Stiffness between Diabetics and Non-Diabetics	PLOS ONE			English	Article							ANKLE VASCULAR INDEX; SERUM URIC-ACID; ENDOTHELIAL FUNCTION; HEART-ASSOCIATION; AMERICAN-COLLEGE; GLYCEMIC CONTROL; ATHEROSCLEROSIS; GUIDELINES; EXERCISE; MELLITUS	Background We compared the contribution of physical activity to the change in arterial stiffness between patients with and without diabetes in ischemic heart disease. Methods We studied 96 (diabetes) and 109 (without diabetes) patients with ischemic heart disease treated by percutaneous coronary intervention (PCI). Arterial stiffness was assessed by cardio-ankle vascular index (CAVI) at the first diagnosis of significant coronary ischemia and 6 months after PCI and optimal medical therapy. Physical activity was evaluated using the long form of the International Physical Activity Questionnaire (IPAQ). Results CAVI values increased more for diabetic patients than for non-diabetic. The IPAQ scores did not differ between the two groups. During follow-up, CAVI values did not significantly change in either group. In diabetic patients, the CAVI score for 48 patients did not change (NC-group) and 48 patients improved (Improved-group). Physical activity scores were 937.9 +/- 923.2 and 1524.6 +/- 1166.2 in the NC- and Improved-groups, respectively. IPAQ scores and uric acid levels significantly affect CAVI improvement after adjusting for age, sex, baseline CAVI, total cholesterol, and estimated glomerular filtration rate. Conclusion Determining factors influencing CAVI improvement during follow-up were significantly different between patients with and without diabetes. IPAQ scores and uric acid levels were significantly correlated with CAVI changes.	[Iwasa, Takeshi; Amiya, Eisuke; Ando, Jiro; Watanabe, Masafumi; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Murasawa, Takahide] Univ Tokyo, Dept Med Engn, Tokyo, Japan; [Iwasa, Takeshi] Natl Canc Ctr, Dept Gen Internal Med, Oncol Emergencies, Tokyo, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan	Ando, J (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	jando-kkr@umin.ac.jp	Amiya, Eisuke/O-4981-2019	Amiya, Eisuke/0000-0003-2810-8040				ARROLL B, 1992, J CLIN EPIDEMIOL, V45, P439, DOI 10.1016/0895-4356(92)90093-3; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Delaney JAC, 2013, ATHEROSCLEROSIS, V230, P278, DOI 10.1016/j.atherosclerosis.2013.07.045; Erdogan D, 2005, INT J CLIN PRACT, V59, P1276, DOI 10.1111/j.1742-1241.2005.00621.x; Fang ZY, 2002, AM HEART J, V143, P383, DOI 10.1067/mhj.2002.120780; Funck KL, 2016, AM J HYPERTENS, V29, P882, DOI 10.1093/ajh/hpv197; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Ibata J, 2013, J DIABETES INVEST, V4, P82, DOI 10.1111/j.2040-1124.2012.00229.x; Ishizaka N, 2007, ATHEROSCLEROSIS, V192, P131, DOI 10.1016/j.atherosclerosis.2006.04.016; Jennersjo P, 2012, DIABETIC MED, V29, P1119, DOI 10.1111/j.1464-5491.2012.03621.x; Kirk A, 2003, DIABETES CARE, V26, P1186, DOI 10.2337/diacare.26.4.1186; Manolis AJ, 2005, AM J HYPERTENS, V18, P18, DOI 10.1016/j.amjhyper.2004.08.014; Matsumae T, 2010, HYPERTENS RES, V33, P243, DOI 10.1038/hr.2009.219; Matsuo T, 2005, HEART VESSELS, V20, P8, DOI 10.1007/s00380-004-0793-5; Miller TD, 2002, CIRCULATION, V106, P189; Nakamura K, 2008, CIRC J, V72, P598; Pahkala K, 2011, CIRCULATION, V124, P1956, DOI 10.1161/CIRCULATIONAHA.111.043851; Sasaki JIH, 2008, DIABETES RES CLIN PR, V80, P265, DOI 10.1016/j.diabres.2007.12.016; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Smith SC, 2001, J AM COLL CARDIOL, V38, P1581, DOI 10.1016/S0735-1097(01)01682-5; Spinetti G, 2008, CARDIOVASC RES, V78, P265, DOI 10.1093/cvr/cvn039; Wang HY, 2013, J AM SOC HYPERTENS, V7, P426, DOI 10.1016/j.jash.2013.06.003; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Woolf K, 2008, J AM DIET ASSOC, V108, P948, DOI 10.1016/j.jada.2008.03.015	26	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160632	10.1371/journal.pone.0160632	http://dx.doi.org/10.1371/journal.pone.0160632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508936	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400041
J	Mitchell, A; Gopurenko, D				Mitchell, Andrew; Gopurenko, David			DNA Barcoding the Heliothinae (Lepidoptera: Noctuidae) of Australia and Utility of DNA Barcodes for Pest Identification in Helicoverpa and Relatives	PLOS ONE			English	Article							ARMIGERA HUBNER LEPIDOPTERA; PHYLOGENETICS; POPULATIONS; MORPHOLOGY	Helicoverpa and Heliothis species include some of the world's most significant crop pests, causing billions of dollars of losses globally. As such, a number are regulated quarantine species. For quarantine agencies, the most crucial issue is distinguishing native species from exotics, yet even this task is often not feasible because of poorly known local faunas and the difficulties of identifying closely related species, especially the immature stages. DNA barcoding is a scalable molecular diagnostic method that could provide the solution to this problem, however there has been no large-scale test of the efficacy of DNA barcodes for identifying the Heliothinae of any region of the world to date. This study fills that gap by DNA barcoding the entire heliothine moth fauna of Australia, bar one rare species, and comparing results with existing public domain resources. We find that DNA barcodes provide robust discrimination of all of the major pest species sampled, but poor discrimination of Australian Heliocheilus species, and we discuss ways to improve the use of DNA barcodes for identification of pests.	[Mitchell, Andrew] Australian Museum, Res Inst, Sydney, NSW, Australia; [Gopurenko, David] NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Gopurenko, David] Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia	Australian Museum; NSW Department of Primary Industries	Mitchell, A (corresponding author), Australian Museum, Res Inst, Sydney, NSW, Australia.	Andrew.Mitchell@austmus.gov.au	Gopurenko, David/H-3341-2014; Mitchell, Andrew/B-7018-2008	Gopurenko, David/0000-0003-2886-1614; Mitchell, Andrew/0000-0001-5022-5898	NSW BioFirst Initiative; Australian Museum Research Institute	NSW BioFirst Initiative; Australian Museum Research Institute	This work was supported by NSW BioFirst Initiative and Australian Museum Research Institute.	Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cleary AJ, 2006, AUST J ENTOMOL, V45, P10, DOI 10.1111/j.1440-6055.2006.00521.x; Frewin A., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138018; Gilligan TM, 2014, LEPINTERCEPT IDENTIF; Gilligan TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142912; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanner R, 2009, TECHNICAL REPORT; HARDWICK D. F., 1965, Memoirs of the Entomology Society of Canada; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Juen A, 2012, J PEST SCI, V85, P89, DOI 10.1007/s10340-011-0406-x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Li J, 2012, J BIOSAFETY, P04; Li QQ, 2011, MOL BIOL REP, V38, P5107, DOI 10.1007/s11033-010-0658-1; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; Matthews M, 1999, HELIOTHINE MOTHS AUS; Mitchell A, 2015, MOL ECOL RESOUR, V15, P1102, DOI 10.1111/1755-0998.12380; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; Orui Y, 2000, JPN J APPL ENTOMOL Z, V44, P73, DOI 10.1303/jjaez.2000.73; Perera OP, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev137; Pogue MG, 2013, ZOOTAXA, V3716, P157; Pogue MG, 2013, SYST ENTOMOL, V38, P523, DOI 10.1111/syen.12010; Poole RW, 1993, MISSISSIPPI AGR FORE, V185; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ranjith M. T., 2015, Entomon, V40, P125; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Sosa-Gomez DR, 2016, REV BRAS ENTOMOL, V60, P101, DOI 10.1016/j.rbe.2015.09.008; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x	37	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160895	10.1371/journal.pone.0160895	http://dx.doi.org/10.1371/journal.pone.0160895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509042	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400061
J	Wang, GQ; Tang, T; Wang, ZS; Liu, YY; Wang, L; Luo, PF; Xia, ZF				Wang, Guang-Qing; Tang, Tao; Wang, Zhong-Shan; Liu, Ying-Ying; Wang, Li; Luo, Peng-Fei; Xia, Zhao-Fan			Overexpression of Hypo-Phosphorylated I kappa B beta at Ser313 Protects the Heart against Sepsis	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; INDUCED AUTOPHAGY; SEPTIC SHOCK; PEST DOMAIN; CELL-DEATH; ACTIVATION; STRESS; CARDIOMYOCYTES; TRANSCRIPTION; ALPHA	I kappa B beta is an inhibitor of nuclear factor kappa B(NF-kappa B) and participates in the cardiac response to sepsis. However, the role of the hypo-phosphorylated form of I kappa B beta at Ser313, which can be detected during sepsis, is unknown. Here, we examined the effects of I kappa B beta with a mutation at Ser313 -> Ala313 on cardiac damage induced by sepsis. Transgenic (Tg) mice were generated to overexpress I kappa B beta, in which Ser-313 is replaced with alanine ubiquitously, in order to mimic the hypo-phosphorylated form of I kappa B beta. Survival analysis showed that Tg mice exhibited decreased inflammatory cytokine levels and decreased rates of mortality in comparison to wild type (WT) mice, after sepsis in a cecal-ligation and puncture model (CLP). Compared to WT septic mice, sepsis in Tg mice resulted in improved cardiac functions, lower levels of troponin I and decreased rates of cardiomyocyte apoptosis, compared to WT mice. The increased formation of autophagicvacuoles detected with electron microscopy demonstrated the enhancement of cardiac autophagy. This phenomenon was further confirmed by the differential expression of genes related to autophagy, such as LC3, Atg5, Beclin-1, and p62. The increased expression of Cathepsin L(Ctsl), a specific marker for mitochondrial stress response, may be associated with the beneficial effects of the hypo-phosphorylated form of I kappa B beta. Our observations suggest that the hypo-phosphorylated form of I kappa B beta at Ser313 is beneficial to the heart in sepsis through inhibition of apoptosisand enhancement of autophagy in mutated I kappa B beta transgenic mice.	[Wang, Guang-Qing; Wang, Zhong-Shan; Liu, Ying-Ying; Wang, Li; Luo, Peng-Fei; Xia, Zhao-Fan] Second Mil Med Univ, Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China; [Tang, Tao] PLA, Hosp 91528, Dept Surg, Shanghai, Peoples R China	Naval Medical University	Xia, ZF (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Burn Surg, Shanghai, Peoples R China.	xiazhaofan@163.com			National Natural Science Foundation of China [81120108015, 81071554, 81272085]; 973 Program [2012CB518100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was done with three grants (81120108015, 81071554, 81272085) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn). Dr. Zhao-Fan Xia received funding from the 973 Program 2012CB518100. XZF (grant 81120108015) and WGQ (grants 81071554 and 81272085) received the funding. XZF played a role in study design, decision to publish and preparation of the manuscript. WGQ played a role in study design, data analysis, decision to publish and preparation of the manuscript.	Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200; Chen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100631; Chu ZL, 1996, MOL CELL BIOL, V16, P5974; Cuenca J, 2007, AM J PATHOL, V171, P820, DOI 10.2353/ajpath.2007.061076; Dennemarker J, 2010, BIOL CHEM, V391, P913, DOI 10.1515/BC.2010.097; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Fan CG, 2004, J CLIN INVEST, V113, P746, DOI 10.1172/JCI200417337; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hsieh CH, 2011, ANN SURG, V253, P1190, DOI 10.1097/SLA.0b013e318214b67e; Kim KJ, 2014, IMMUNOLOGY, V143, P21, DOI 10.1111/imm.12283; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Landesberg G, 2012, EUR HEART J, V33, P895, DOI 10.1093/eurheartj/ehr351; Li WL, 2016, EXP THER MED, V11, P1259, DOI 10.3892/etm.2016.3054; Lin F, 2015, HUM MOL GENET, V24, P2899, DOI 10.1093/hmg/ddv052; McKinsey TA, 1997, J BIOL CHEM, V272, P22377, DOI 10.1074/jbc.272.36.22377; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nishida K, 2015, J MOL CELL CARDIOL, V78, P73, DOI 10.1016/j.yjmcc.2014.09.029; Niso-Santano M, 2012, AUTOPHAGY, V8, P268, DOI 10.4161/auto.8.2.18845; Nivon M, 2009, AUTOPHAGY, V5, P766, DOI 10.4161/auto.8788; Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008; Rao P, 2010, NATURE, V466, P1115, DOI 10.1038/nature09283; Scheibel M, 2010, J EXP MED, V207, P2621, DOI 10.1084/jem.20100864; Sheyin O, 2014, HEART LUNG, V44, P75, DOI 10.1016/j.hrtlng.2014.10.002; Shulak L, 2014, J VIROL, V88, P2927, DOI 10.1128/JVI.03406-13; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; Song XW, 2010, J CELL PHYSIOL, V225, P437, DOI 10.1002/jcp.22217; Sun M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000191; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Suzuki J, 2007, J AM COLL CARDIOL, V49, P491, DOI 10.1016/j.jacc.2006.10.043; Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839; Tang JR, 2013, J IMMUNOL, V190, P2913, DOI 10.4049/jimmunol.1202670; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Valovka T, 2011, BIOCHEM J, V434, P253, DOI 10.1042/BJ20101220; Wright CJ, 2012, J BIOL CHEM, V287, P6230, DOI 10.1074/jbc.M111.318246; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160860	10.1371/journal.pone.0160860	http://dx.doi.org/10.1371/journal.pone.0160860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508931	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400059
J	Ranwez, V				Ranwez, Vincent			Two Simple and Efficient Algorithms to Compute the SP-Score Objective Function of a Multiple Sequence Alignment	PLOS ONE			English	Article								Background Multiple sequence alignment (MSA) is a crucial step in many molecular analyses and many MSA tools have been developed. Most of them use a greedy approach to construct a first alignment that is then refined by optimizing the sum of pair score (SP-score). The SP-score estimation is thus a bottleneck for most MSA tools since it is repeatedly required and is time consuming. Results Given an alignment of n sequences and L sites, I introduce here optimized solutions reaching O(nL) time complexity for affine gap cost, instead of O(n(2)L), which are easy to implement.	[Ranwez, Vincent] Montpellier SupAgro, UMR AGAP, F-34060 Montpellier, France	Institut Agro; Montpellier SupAgro; Universite de Montpellier	Ranwez, V (corresponding author), Montpellier SupAgro, UMR AGAP, F-34060 Montpellier, France.	Vincent.ranwez@supagro.fr	ranwez, vincent/I-5490-2017	ranwez, vincent/0000-0002-9308-7541	French research agency: Agence Nationale de la Recherche [ANR-10-BINF-01-02]	French research agency: Agence Nationale de la Recherche(French National Research Agency (ANR))	This work has been supported by the French research agency: Agence Nationale de la Recherche (ANR-10-BINF-01-02 "Ancestrome") (http://www.agence-nationale-recherche.fr/).	ALTSCHUL SF, 1989, J THEOR BIOL, V138, P297, DOI 10.1016/S0022-5193(89)80196-1; Blackburne BP, 2013, MOL BIOL EVOL, V30, P642, DOI 10.1093/molbev/mss256; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Kececioglu JD, 1998, LECT NOTES COMPUT SC, V1448, P189, DOI 10.1007/BFb0030790; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Przybylski D, 2002, PROTEINS, V46, P197, DOI 10.1002/prot.10029; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Xiao-Dan Wang, 2015, Intelligent Computing Theories and Methodologies. 11th International Conference, ICIC 2015. Proceedings: LNCS 9225, P529, DOI 10.1007/978-3-319-22180-9_52	11	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160043	10.1371/journal.pone.0160043	http://dx.doi.org/10.1371/journal.pone.0160043			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505054	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200018
J	Zamir, M; Zaman, G; Alshomrani, AS				Zamir, Muhammad; Zaman, Gul; Alshomrani, Ali Saleh			Sensitivity Analysis and Optimal Control of Anthroponotic Cutaneous Leishmania	PLOS ONE			English	Article							MODELS; THRESHOLD; SANDFLIES; DISEASES; CLIMATE; HOSTS	This paper is focused on the transmission dynamics and optimal control of Anthroponotic Cutaneous Leishmania. The threshold condition R-0 for initial transmission of infection is obtained by next generation method. Biological sense of the threshold condition is investigated and discussed in detail. The sensitivity analysis of the reproduction number is presented and the most sensitive parameters are high lighted. On the basis of sensitivity analysis, some control strategies are introduced in the model. These strategies positively reduce the effect of the parameters with high sensitivity indices, on the initial transmission. Finally, an optimal control strategy is presented by taking into account the cost associated with control strategies. It is also shown that an optimal control exists for the proposed control problem. The goal of optimal control problem is to minimize, the cost associated with control strategies and the chances of infectious humans, exposed humans and vector population to become infected. Numerical simulations are carried out with the help of Runge-Kutta fourth order procedure.	[Zamir, Muhammad] Univ Sci & Technol, Dept Math, Bannu, Khyber Pakhtunk, Pakistan; [Zamir, Muhammad; Zaman, Gul] Univ Malakand Lower Dir, Dept Math, Khyber Pakhtunkhwa, Pakistan; [Alshomrani, Ali Saleh] King Abdulaziz Univ, Dept Math, Fac Sci, Jeddah, Saudi Arabia	University of Science & Technology Bannu; King Abdulaziz University	Zaman, G (corresponding author), Univ Malakand Lower Dir, Dept Math, Khyber Pakhtunkhwa, Pakistan.	gzaman@uom.edu.pk	ALSHOMRANI, ALI SALEH/Q-4236-2017	ALSHOMRANI, ALI SALEH/0000-0001-9222-8915	Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia	Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia	This work has been partially supported by the Department of Mathematics, Faculty of Science, King Abdul Aziz University, Jeddah, Saudi Arabia.	ANDERSON R M, 1991; Bacaer N, 2006, J MATH BIOL, V53, P421, DOI 10.1007/s00285-006-0015-0; Birkhoff G., 1989, ORDINARY DIFFERENTIA; Calzada JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053289; Chaves LF, 2009, ANN TROP MED PARASIT, V103, P221, DOI 10.1179/136485909X398267; Chaves LF, 2004, ACTA TROP, V92, P245, DOI 10.1016/j.actatropica.2004.08.004; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; Das P, 2007, J BIOL SYST, V15, P139, DOI 10.1142/S0218339007002155; DIEKMANN O, 1990, J MATH BIOL, V28, P365; ELmojtaba IM, 2010, NONLINEAR ANAL-REAL, V11, P2175, DOI 10.1016/j.nonrwa.2010.01.011; HACKBUSCH W, 1978, COMPUTING, V20, P229, DOI 10.1007/BF02251947; Harre JG, 2001, MED VET ENTOMOL, V15, P189, DOI 10.1046/j.1365-2915.2001.00278.x; HATI AK, 1991, INDIAN J MED RES-A, V93, P388; Kamien M.I., 1991, DYNAMICS OPTIMIZATIO; Kasap OE, 2006, J VECTOR ECOL, V31, P378, DOI 10.3376/1081-1710(2006)31[378:CDOTSF]2.0.CO;2; Kolaczinski J, 2004, T ROY SOC TROP MED H, V98, P373, DOI 10.1016/j.trstmh.2003.11.003; Lashari AA, 2012, NONLINEAR ANAL-REAL, V13, P203, DOI 10.1016/j.nonrwa.2011.07.026; Lukes D.L., 1982, DIFFERENTIAL EQUATIO, V162; Molina R, 2003, ANN TROP MED PARASIT, V97, P29, DOI 10.1179/000349803225002516; Ngoteya FN., 2015, APPL COMPUT MATH-BAK, V4, P363, DOI [10.11648/j.acm.20150405.15, DOI 10.11648/J.ACM.20150405.15]; Porrozzi R, 2004, AM J TROP MED HYG, V71, P297, DOI 10.4269/ajtmh.2004.71.297; Ribas LM, 2013, SCI WORLD J, DOI 10.1155/2013/810380; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; Safan M, 2006, J MATH BIOL, V53, P703, DOI 10.1007/s00285-006-0028-8; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Zaman G, 2008, BIOSYSTEMS, V93, P240, DOI 10.1016/j.biosystems.2008.05.004; Zaman G, 2009, BIOSYSTEMS, V98, P43, DOI 10.1016/j.biosystems.2009.05.006	27	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160513	10.1371/journal.pone.0160513	http://dx.doi.org/10.1371/journal.pone.0160513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505634	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200040
J	Grabmaier, U; Kania, G; Kreiner, J; Grabmeier, J; Uhl, A; Huber, BC; Lackermair, K; Herbach, N; Todica, A; Eriksson, U; Weckbach, LT; Brunner, S				Grabmaier, U.; Kania, G.; Kreiner, J.; Grabmeier, J.; Uhl, A.; Huber, B. C.; Lackermair, K.; Herbach, N.; Todica, A.; Eriksson, U.; Weckbach, L. T.; Brunner, S.			Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM)	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DILATED CARDIOMYOPATHY; DISEASE; INFLAMMATION; MANAGEMENT; THERAPY; GAMMA	Vascular cell adhesion molecule-1 (VCAM-1) is strongly upregulated in hearts of mice with coxsackie virus-induced as well as in patients with viral infection-triggered dilated cardiomyopathy. Nevertheless, the role of its soluble form as a biomarker in inflammatory heart diseases remains unclear. Therefore, we investigated whether plasma levels of soluble VCAM-1 (sVCAM-1) directly correlated with disease activity and progression of cardiac dysfunction in the mouse model of experimental autoimmune myocarditis (EAM). EAM was induced by immunization of BALB/c mice with heart-specific myosin-alpha heavy chain peptide together with complete Freund's adjuvant. ELISA revealed strong expression of cardiac VCAM-1 (cVCAM-1) throughout the course of EAM in immunized mice compared to control animals. Furthermore, sVCAM-1 was elevated in the plasma of immunized compared to control mice at acute and chronic stages of the disease. sVCAM-1 did not correlate with the degree of acute cardiac inflammation analyzed by histology or cardiac cytokine expression investigated by ELISA. Nevertheless, heart to body weight ratio correlated significantly with sVCAM-1 at chronic stages of EAM. Cardiac systolic dysfunction studied with positron emission tomography indicated a weak relationship with sVCAM-1 at the chronic stage of the disease. Our data provide evidence that plasma levels of sVCAM-1 are elevated throughout all stages of the disease but showed no strong correlation with the severity of EAM.	[Grabmaier, U.; Kreiner, J.; Grabmeier, J.; Uhl, A.; Huber, B. C.; Lackermair, K.; Weckbach, L. T.; Brunner, S.] Univ Munich, Dept Med 1, Munich, Germany; [Kania, G.] Univ Zurich Hosp, Div Rheumatol, Res Syst Autoimmune Dis, Zurich, Switzerland; [Weckbach, L. T.] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Herbach, N.] Univ Munich, Inst Vet Pathol, Munich, Germany; [Todica, A.] Univ Munich, Dept Nucl Med, Munich, Germany; [Eriksson, U.] Univ Zurich, Ctr Mol Cardiol, Cardioimmunol, Zurich, Switzerland	University of Munich; University of Zurich; University Zurich Hospital; University of Munich; University of Munich; University of Munich; University of Zurich	Grabmaier, U (corresponding author), Univ Munich, Dept Med 1, Munich, Germany.	Ulrich.Grabmaier@med.uni-muenchen.de	Kania, Gabriela/E-8715-2017	Kania, Gabriela/0000-0003-3788-4594; Huber, Bruno/0000-0002-1032-7686; Eriksson, Urs/0000-0003-1217-9696; Weckbach, Ludwig T/0000-0002-0981-2246	"Forderung fur Forschung und Lehre" - program of the LMU-Munich	"Forderung fur Forschung und Lehre" - program of the LMU-Munich	This work was funded by the "Forderung fur Forschung und Lehre" - program of the LMU-Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Blankenberg S, 2001, CIRCULATION, V104, P1336, DOI 10.1161/hc3701.095949; Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006; Bobbert P, 2011, EUR HEART J, V32, P1134, DOI 10.1093/eurheartj/ehq498; Brunner S, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0388-3; Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Eriksson U, 2003, CIRCULATION, V107, P320, DOI 10.1161/01.CIR.0000043802.38699.66; Eriksson U, 2001, J IMMUNOL, V167, P5464, DOI 10.4049/jimmunol.167.9.5464; Grabmaier U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094615; Gross L, 2016, EUR HEART J-CARD IMG, V17, P136, DOI 10.1093/ehjci/jev237; Kania G, 2013, CIRCULATION, V127, P2285, DOI 10.1161/CIRCULATIONAHA.112.000434; Kania G, 2009, CIRC RES, V105, P462, DOI 10.1161/CIRCRESAHA.109.196287; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; Lewis MJ, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-015-0896-7; Maisch B, 1995, EUR HEART J, V16, P173, DOI 10.1093/eurheartj/16.suppl_O.173; MASON JC, 1993, ARTHRITIS RHEUM, V36, P519, DOI 10.1002/art.1780360412; Schultheiss HP, 2011, EUR HEART J, V32, P2616, DOI 10.1093/eurheartj/ehr165; SPRONK PE, 1994, CLIN EXP IMMUNOL, V97, P439; Wu L, 2014, J EXP MED, V211, P1441, DOI 10.1084/jem.20132126; Yamashita T, 2011, CARDIOVASC RES, V91, P640, DOI 10.1093/cvr/cvr148; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001	23	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0158299	10.1371/journal.pone.0158299	http://dx.doi.org/10.1371/journal.pone.0158299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501319	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000381373500002
J	Zhao, X; Liu, XT; Zan, XY; Jin, G; Maes, JHR				Zhao, Xin; Liu, Xiaoting; Zan, Xiangyi; Jin, Ge; Maes, Joseph H. R.			Male Smokers' and Non-Smokers' Response Inhibition in Go/No-Go Tasks: Effect of Three Task Parameters	PLOS ONE			English	Article							CIGARETTE-SMOKING; COGNITIVE CONTROL; FAGERSTROM TEST; DYSFUNCTION; DEPENDENCE; BEHAVIOR; SAMPLE	Impaired response inhibition plays a major role in many addictive behaviors. However, in studies using go/no-go tasks, findings regarding the presence of response inhibition deficits in nicotine-dependent individuals are mixed. This might be due to differences between studies on a number of task parameters. Here we aimed to identify task conditions under which go/no-go task performance deficits can be observed in smokers and to characterize the nature of such deficits. Sixty-one male students (30 smokers, 31 non-smokers) performed a go/no-go task while independently manipulating three task parameters: (1) percentage no-go trials (50% or 25%), (2) stimulus presentation time (600 ms or 200 ms), and (3) nature of no-go stimuli (cigarette related or cigarette unrelated). Three measures, reaction time on go trials and percentage correct responses on go and no-go trials, served as performance indicators. Under 200-ms but not 600-ms stimulus presentation conditions, the smokers responded faster on go trials and made more errors on both go and no-go trials than the non-smokers did. These differences occurred irrespective of the percentage of no-go trials and nature of no-go stimuli. The accuracy differences disappeared after controlling for the response time differences, suggesting a strong speed-accuracy trade-off. This study contributes to unraveling the conditions under which smokers display impaired inhibition performance and helps to characterize the nature of this impairment. Under task conditions prompting fast responding, smokers are more prone to increase response speed and to make more errors than non-smokers.	[Zhao, Xin; Liu, Xiaoting] Northwest Normal Univ, Behav Rehabil Training Res Inst, Sch Psychol, Lanzhou 730070, Peoples R China; [Zan, Xiangyi] Lanzhou Univ, Hosp 2, Lanzhou 730070, Peoples R China; [Jin, Ge] Lanzhou City Univ, Coll Educ, Lanzhou 730070, Peoples R China; [Maes, Joseph H. R.] Radboud Univ Nijmegen, Ctr Cognit, Donders Inst Brain Cognit & Behav, POB 9104, NL-6500 HE Nijmegen, Netherlands	Northwest Normal University - China; Lanzhou University; Lanzhou City University; Radboud University Nijmegen	Maes, JHR (corresponding author), Radboud Univ Nijmegen, Ctr Cognit, Donders Inst Brain Cognit & Behav, POB 9104, NL-6500 HE Nijmegen, Netherlands.	r.maes@donders.ru.nl	Maes, J.H.R./D-2009-2010	Maes, J.H.R./0000-0002-4536-695X	National Natural Science Foundation of China [31300838]; National Natural Science Foundation of GanSu Province [1506RJZA248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of GanSu Province	This work was supported by The National Natural Science Foundation of China (31300838) and The National Natural Science Foundation of GanSu Province (1506RJZA248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Billieux J, 2010, DRUG ALCOHOL DEPEN, V112, P164, DOI 10.1016/j.drugalcdep.2010.06.006; Buzzell GA, 2014, NEUROSCI LETT, V563, P61, DOI 10.1016/j.neulet.2014.01.030; de Ruiter MB, 2012, DRUG ALCOHOL DEPEN, V121, P81, DOI 10.1016/j.drugalcdep.2011.08.010; Dinn WM, 2004, ADDICT BEHAV, V29, P107, DOI 10.1016/j.addbeh.2003.07.001; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Evans DE, 2009, GENES BRAIN BEHAV, V8, P86, DOI 10.1111/j.1601-183X.2008.00445.x; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; Hatsukami D, 1989, J Subst Abuse, V1, P407; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Huang CL, 2006, ADDICT BEHAV, V31, P2324, DOI 10.1016/j.addbeh.2006.02.024; Katz R, 2010, AM J GERIAT PSYCHIAT, V18, P1017, DOI 10.1097/JGP.0b013e3181d695f2; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Luijten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018898; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nestor L, 2011, NEUROIMAGE, V56, P2258, DOI 10.1016/j.neuroimage.2011.03.054; Powell J, 2002, BIOL PSYCHIAT, V51, P151, DOI 10.1016/S0006-3223(01)01208-2; Reynolds B, 2007, EXP CLIN PSYCHOPHARM, V15, P264, DOI 10.1037/1064-1297.15.3.264; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sammy C. K.-W., 2002, CHIN J CLINI PSYCHOL, P4; Seli P, 2013, FRONT PSYCHOL, V4, P1, DOI DOI 10.3389/FPSYG.2013; Smith JL, 2014, DRUG ALCOHOL DEPEN, V145, P1, DOI 10.1016/j.drugalcdep.2014.08.009; Spinella M, 2002, ADDICT BIOL, V7, P381, DOI 10.1080/1355621021000005964; Wright L, 2014, J ABNORM PSYCHOL, V123, P429, DOI 10.1037/a0036295; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x	26	8	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160595	10.1371/journal.pone.0160595	http://dx.doi.org/10.1371/journal.pone.0160595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IE	27500831	Green Submitted, Green Published, gold			2022-12-26	WOS:000381373500035
J	Apicella, M; Migliore, C; Capeloa, T; Menegon, S; Cargnelutti, M; Degiuli, M; Sapino, A; Sottile, A; Sarotto, I; Casorzo, L; Cassoni, P; De Simone, M; Comoglio, PM; Marsoni, S; Corso, S; Giordano, S				Apicella, M.; Migliore, C.; Capeloa, T.; Menegon, S.; Cargnelutti, M.; Degiuli, M.; Sapino, A.; Sottile, A.; Sarotto, I.; Casorzo, L.; Cassoni, P.; De Simone, M.; Comoglio, P. M.; Marsoni, S.; Corso, S.; Giordano, S.			Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort	ONCOGENE			English	Article							ACQUIRED-RESISTANCE; GENE AMPLIFICATION; LUNG-CANCER; ACTIVATION; MUTATIONS; ADENOCARCINOMA; SENSITIVITY; INHIBITORS; GEFITINIB; GROWTH	Amplification of the MET oncogene occurs in 2-4% of gastroesophageal cancers and defines a small and aggressive subset of tumors. Although in vitro studies have given very promising results, clinical trials with MET inhibitors have been disappointing, showing few and short lasting responses. The aim of the work was to exploit a MET-amplified patient-derived xenograft model to optimize anti-MET therapeutic strategies in gastroesophageal cancer. We found that despite the high MET amplification level ( 26 gene copies), in the absence of qualitative or quantitative alterations of EGFR, MET inhibitors induced only tumor growth inhibition, whereas dual MET/EGFR inhibition led to complete tumor regression. Importantly, the combo treatment completely prevented the onset of resistance, which quite rapidly appeared in tumors treated with MET monotherapy. We found that this secondary resistance was due to EGFR activation and could be overcome by dual MET/EGFR inhibition. Similar results were also obtained in a MET-addicted, established gastric cancer cell line. In vitro experiments performed on tumor-derived primary cells confirmed that MET inhibitors were not able to abrogate the activation of downstream transducers and that only the combined MET/EGFR treatment completely shut off the signaling. Previously reported cases, as well as those described here, showed only partial and transient sensitivity to anti-MET therapy. The finding that combined anti-MET/EGFR therapy-even in the absence of EGFR genetic alterations-induced complete and durable response, represents a proof of concept and guarantees further investigations, opening a new perspective of treatment for these patients.	[Apicella, M.; Migliore, C.; Corso, S.; Giordano, S.] Univ Torino, Dept Oncol, Candiolo, Italy; [Apicella, M.; Migliore, C.; Capeloa, T.; Menegon, S.; Cargnelutti, M.; Sapino, A.; Sottile, A.; Sarotto, I.; Casorzo, L.; De Simone, M.; Comoglio, P. M.; Marsoni, S.; Corso, S.; Giordano, S.] IRCCS, FPO, Candiolo Canc Inst, Candiolo, Italy; [Capeloa, T.] Univ Torino, Dept Clin & Biol Sci, Orbassano, Italy; [Degiuli, M.] Osped Molinette, Dept Surg, Turin, Italy; [Sapino, A.; Cassoni, P.] Univ Torino, Dept Med Sci, Turin, Italy	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Corso, S; Giordano, S (corresponding author), Univ Torino, IRCCS, FPO, Candiolo Canc Inst,Dept Oncol, Str Prov 142, I-10060 Turin, Italy.	simona.corso@unito.it; silvia.giordano@unito.it	Sapino, Anna/AGY-9901-2022; Giordano, Silvia/J-9858-2018; Sapino, Anna/J-4113-2018; Casorzo, Laura/AAB-7684-2020; Cassoni, Paola/I-8544-2018; sarotto, ivana/AAB-7797-2020	Sapino, Anna/0000-0003-3542-9571; Giordano, Silvia/0000-0003-1854-1086; Sapino, Anna/0000-0003-3542-9571; Casorzo, Laura/0000-0002-2509-7369; CORSO, Simona/0000-0002-5069-1503; Menegon, Silvia/0000-0002-5078-2464; Migliore, Cristina/0000-0003-3722-2814; Marsoni, Silvia/0000-0002-5361-7122; sottile, antonino/0000-0003-4252-3240; Comoglio, Paolo/0000-0002-7056-5328	Italian Association for Cancer Research (AIRC) [15464]; Fondazione Piemontese per la Ricerca sul Cancro (ONLUS) 5 X 1000 Fondi Ministero della Salute	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Piemontese per la Ricerca sul Cancro (ONLUS) 5 X 1000 Fondi Ministero della Salute	We thank all our colleagues for helpful scientific discussion; Drs Martinoglio, Porporato and Buscarino for technical support with RT-PCR and sequencing; Dr Perra for tumor microdissection; Dr Giove for support with immunohistochemistry; animal facility employees; Dr Natale for critical manuscript reading. SG and SC are EuroPDX Consortium members. This work was funded by the Italian Association for Cancer Research (AIRC); IG grant 15464 to SG and Fondazione Piemontese per la Ricerca sul Cancro (ONLUS) 5 X 1000 Fondi Ministero della Salute 2013.	Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Bang YJ, 2010, LANCET, V376, P1302; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2102er11; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Breindel JL, 2013, CANCER RES, V73, P5053, DOI 10.1158/0008-5472.CAN-12-3775; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Crew KD, 2004, SEMIN ONCOL, V31, P450, DOI 10.1053/j.seminoncol.2004.04.021; Cunningham D, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.16; Doi T., 2015, J CLIN ONCOL S3, V33; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Lee J, 2015, ONCOTARGET, V6, P28211, DOI 10.18632/oncotarget.4721; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Puri Neelu, 2008, J Carcinog, V7, P9; Qi J, 2011, CANCER RES, V71, P1081, DOI 10.1158/0008-5472.CAN-10-1623; Shah AM, 2015, J CLIN ONCOL, V33; Shah MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054014; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166	33	22	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1200	1210		10.1038/onc.2016.283	http://dx.doi.org/10.1038/onc.2016.283			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27524418				2022-12-26	WOS:000395861300004
J	Shapiro, BA; Vu, NT; Shultz, MD; Shultz, JC; Mietla, JA; Gouda, MM; Yacoub, A; Dent, P; Fisher, PB; Park, MA; Chalfant, CE				Shapiro, Brian A.; Vu, Ngoc T.; Shultz, Michael D.; Shultz, Jacqueline C.; Mietla, Jennifer A.; Gouda, Mazen M.; Yacoub, Adly; Dent, Paul; Fisher, Paul B.; Park, Margaret A.; Chalfant, Charles E.			Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKC Signaling Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cell death; cell signaling; RNA splicing; signal transduction; MDA-7; IL-24; Bcl-x; alternative splicing; non-small cell lung cancer	PROSTATE-CANCER CELLS; CHEMOTHERAPY-INDUCED APOPTOSIS; KINASE-C-DELTA; PROTEIN PHOSPHATASE-1; BREAST-CANCER; IN-VIVO; CARCINOMA-CELLS; ER STRESS; CASPASE 9; BCL-X(L)	Melanoma differentiation-associated gene 7 (MDA-7/IL-24) exhibits cytotoxic effects on tumor cells while sparing untransformed cells, and Bcl-x(L) is reported to efficiently block the induction of cell death by MDA-7/IL-24. The expression of Bcl-x(L) is regulated at the level of RNA splicing via alternative 5 splice site selection within exon 2 to produce either the pro-apoptotic Bcl-x(s) or the anti-apoptotic Bcl-x(L). Our laboratory previously reported that Bcl-x RNA splicing is dysregulated in a large percentage of human non-small cell lung cancer (NSCLC) tumors. Therefore, we investigated whether the alternative RNA splicing of Bcl-x pre-mRNA was modulated by MDA-7/IL-24, which would suggest that specific NSCLC tumors are valid targets for this cytokine therapy. Adenovirus-delivered MDA-7/IL-24 (Ad.mda-7) reduced the viability of NSCLC cells of varying oncogenotypes, which was preceded by a decrease in the ratio of Bcl-x(L)/Bcl-x(s) mRNA and Bcl-x(L) protein expression. Importantly, both the expression of Bcl-x(L) and the loss of cell viability were rescued in Ad.mda-7-treated cells incubated with Bcl-x(s) siRNA. In addition, NSCLC cells ectopically expressing Bcl-x(s) exhibited significantly reduced Bcl-x(L) expression, which was again restored by Bcl-x(s) siRNA, suggesting the existence of a novel mechanism by which Bcl-x(s) mRNA restrains the expression of Bcl-x(L). In additional mechanistic studies, inhibition of SRC and PKC completely ablated the ability of MDA-7/IL-24 to reduce the Bcl-x(L)/(s) mRNA ratio and cell viability. These findings show that Bcl-x(s) expression is an important mediator of MDA-7/IL-24-induced cytotoxicity requiring the SRC/PKC signaling axis in NSCLC cells.	[Shapiro, Brian A.; Shultz, Michael D.; Chalfant, Charles E.] Hunter Holmes McGuire Vet Adm Med Ctr, Richmond, VA 23249 USA; [Shapiro, Brian A.; Vu, Ngoc T.; Shultz, Jacqueline C.; Mietla, Jennifer A.; Gouda, Mazen M.; Dent, Paul; Park, Margaret A.; Chalfant, Charles E.] Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, Richmond, VA 23298 USA; [Yacoub, Adly] Virginia Commonwealth Univ, Sch Med, Dept Neurosurg, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Sch Med, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Dent, Paul; Fisher, Paul B.; Chalfant, Charles E.] Virginia Commonwealth Univ, Inst Mol Med, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Dent, Paul; Fisher, Paul B.; Park, Margaret A.; Chalfant, Charles E.] Virginia Commonwealth Univ, Massey Canc Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Johnson Ctr Crit Care & Pulm Res, Med Coll Virginia Campus, Richmond, VA 23298 USA	Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Fisher, PB (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1101 East Marshall St,POB 980033, Richmond, VA 23298 USA.; Park, MA; Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, 1101 East Marshall St,POB 980614, Richmond, VA 23298 USA.	paul.fisher@vcuhealth.org; margaret.park@vcuhealth.org; charles.chalfant@vcuhealth.org			National Institutes of Health, NCI Cancer Center Support Grant [P30 CA016059]; National Institutes of Health [NH1C06-RR17393]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD087198] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA104177, R01CA154314, R21CA201195, R01CA097318, P30CA016059, R01CA117950, R01CA127641, T32CA085159, R01CA192613] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017393] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	National Institutes of Health, NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Services and products in support of this project were generated by the VCU Massey Cancer Center Shared supported, in part, with funding from National Institutes of Health, NCI Cancer Center Support Grant P30 CA016059. National Institutes of Health Grant NH1C06-RR17393 was provided to Virginia Commonwealth University for renovation.	Ban J, 1998, BIOCHEM BIOPH RES CO, V248, P147, DOI 10.1006/bbrc.1998.8907; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; Boise LH, 1997, P NATL ACAD SCI USA, V94, P3759, DOI 10.1073/pnas.94.8.3759; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Boschelli DH, 2004, J MED CHEM, V47, P1599, DOI 10.1021/jm0499458; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chang WH, 2011, CANCER RES, V71, P383, DOI 10.1158/0008-5472.CAN-10-1037; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Coluccia AML, 2004, BLOOD, V103, P2787, DOI 10.1182/blood-2003-09-3144; DATTA R, 1995, CELL GROWTH DIFFER, V6, P363; de Graaf Katrin, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-7; Deng G, 1998, MOL MED, V4, P158, DOI 10.1007/BF03401913; DOLE MG, 1995, CANCER RES, V55, P2576; Eto K, 2011, MOL CELL BIOCHEM, V355, P217, DOI 10.1007/s11010-011-0857-7; FANG W, 1994, J IMMUNOL, V153, P4388; Finch A, 2006, CANCER CELL, V10, P113, DOI 10.1016/j.ccr.2006.06.017; Hamed HA, 2013, CANCER BIOL THER, V14, P1039, DOI 10.4161/cbt.26110; Hamed HA, 2010, CANCER BIOL THER, V9, P526, DOI 10.4161/cbt.9.7.11116; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Hyer ML, 2000, MOL THER, V2, P348, DOI 10.1006/mthe.2000.0139; Inoue S, 2005, MOL THER, V12, P707, DOI 10.1016/j.ymthe.2005.05.015; Jiang HP, 1995, ONCOGENE, V11, P2477; Johnson BW, 2000, J BIOL CHEM, V275, P31546, DOI 10.1074/jbc.M001363200; Johnson RM, 2015, J BIOL CHEM, V290, P25717, DOI 10.1074/jbc.M115.671206; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kontny E, 2000, J LEUKOCYTE BIOL, V67, P249, DOI 10.1002/jlb.67.2.249; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Larroque-Cardoso P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.47; Lebedeva IV, 2003, ONCOGENE, V22, P8758, DOI 10.1038/sj.onc.1206891; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Massiello A, 2004, J BIOL CHEM, V279, P15799, DOI 10.1074/jbc.M313950200; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Mercatante DR, 2001, J BIOL CHEM, V276, P16411, DOI 10.1074/jbc.M009256200; MEYN RE, 1995, ANTI-CANCER DRUG, V6, P443, DOI 10.1097/00001813-199506000-00013; MINN AJ, 1995, BLOOD, V86, P1903, DOI 10.1182/blood.V86.5.1903.bloodjournal8651903; Minn AJ, 1996, J BIOL CHEM, V271, P6306, DOI 10.1074/jbc.271.11.6306; Mitra RS, 2001, NEOPLASIA, V3, P437, DOI 10.1038/sj.neo.7900181; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Nekrutenko A, 2006, TRENDS GENET, V22, P645, DOI 10.1016/j.tig.2006.09.012; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Peterman EE, 2004, J CARDIOVASC PHARM, V43, P645, DOI 10.1097/00005344-200405000-00006; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Piazzi M, 2013, MOL CELL PROTEOMICS, V12, P2220, DOI 10.1074/mcp.M113.029686; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Saeki T, 2002, ONCOGENE, V21, P4558, DOI 10.1038/sj.onc.1205553; Saeki T, 2000, GENE THER, V7, P2051, DOI 10.1038/sj.gt.3301330; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Sauane M, 2010, J CELL PHYSIOL, V222, P546, DOI 10.1002/jcp.21969; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258; Shultz JC, 2012, MOL CANCER RES, V10, P660, DOI 10.1158/1541-7786.MCR-11-0363; Shultz JC, 2011, MOL CANCER RES, V9, P889, DOI 10.1158/1541-7786.MCR-11-0061; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Sieger KA, 2004, MOL THER, V9, P355, DOI 10.1016/j.ymthe.2003.11.014; Su ZZ, 2006, ONCOGENE, V25, P2339, DOI 10.1038/sj.onc.1209271; Su ZZ, 2005, ONCOGENE, V24, P7552, DOI 10.1038/sj.onc.1208911; SUMANTRAN VN, 1995, CANCER RES, V55, P2507; Tanuma N, 2008, J BIOL CHEM, V283, P35805, DOI 10.1074/jbc.M805468200; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; White MC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000984; Wiederrecht G J, 1995, Prog Cell Cycle Res, V1, P53; Yang XF, 1997, IMMUNITY, V7, P629, DOI 10.1016/S1074-7613(00)80384-2	72	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21669	21681		10.1074/jbc.M116.737569	http://dx.doi.org/10.1074/jbc.M116.737569			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27519412	Green Published, hybrid			2022-12-26	WOS:000385999200032
J	Hwang, J; Lee, JA; Pallas, DC				Hwang, Juyeon; Lee, Jocelyn A.; Pallas, David C.			Leucine Carboxyl Methyltransferase 1(LCMT-1) Methylates Protein Phosphatase 4(PP4) and Protein Phosphatase 6(PP6) and Differentially Regulates the Stable Formation of Different PP4 Holoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2A CATALYTIC SUBUNIT; DNA-DAMAGE CHECKPOINT; MIDDLE TUMOR-ANTIGEN; BOVINE BRAIN; DEPHOSPHORYLATES GAMMA-H2AX; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ALPHA4 PROTEIN; PP2A; ASSOCIATION	The protein phosphatase 2A (PP2A) subfamily of phosphatases, PP2A, PP4, and PP6, are multifunctional serine/threonine protein phosphatases involved in many cellular processes. Carboxyl methylation of the PP2A catalytic subunit (PP2Ac) C-terminal leucine is regulated by the opposing activities of leucine carboxyl methyltransferase 1 (LCMT-1) and protein phosphatase methylesterase 1 (PME-1) and regulates PP2A holoenzyme formation. The site of methylation on PP2Ac is conserved in the catalytic subunits of PP4 and PP6, and PP4 is also methylated on that site, but the identities of the methyltransferase enzyme for PP4 are not known. Whether PP6 is methylated is also not known. Here we use antibodies specific for the unmethylated phosphatases to show that PP6 is carboxyl-methylated and that LCMT-1 is the major methyltransferase for PP2A, PP4, and PP6 in mouse embryonic fibroblasts (MEFs). Analysis of PP2A and PP4 complexes by blue native polyacrylamide gel electrophoresis (BN-PAGE) indicates that PP4 holoenzyme complexes, like those of PP2A, are differentially regulated by LCMT-1, with the PP4 regulatory subunit 1 (PP4R1)-containing PP4 complex being the most dramatically affected by the LCMT-1 loss. MEFs derived from LCMT-1 knock-out mouse embryos have reduced levels of PP2A B regulatory subunit and PP4R1 relative to control MEFs, indicating that LCMT-1is important for maintaining normal levels of these subunits. Finally, LCMT-1 homozygous knock-out MEFs exhibited hyperphosphorylation of HDAC3, a reported target of the methylation-dependent PP4R1-PP4c complex. Collectively, our data suggest that LCMT-1 coordinately regulates the carboxyl methylation of PP2A-related phosphatases and, consequently, their holoenzyme assembly and function.	Emory Univ, Sch Med, Winship Canc Ctr, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Grad Program, Atlanta, GA 30322 USA	Emory University; Emory University	Pallas, DC (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	dpallas@emory.edu			National Institutes of Health [R01 CA57327, 5F31CA123640]; Emory University Research Committee; NATIONAL CANCER INSTITUTE [R01CA057327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Research Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 CA57327 (NCI). This work was also supported by an award from the Emory University Research Committee. Dr. David Pallas is entitled to royalties from the sale of products related to the research described in this paper by Millipore Inc., Santa Cruz Biotechnologies Inc., Invitrogen, and Novus Biologicals Inc. In addition, this same author serves as a consultant to Millipore. The terms of these arrangements have been reviewed and approved by Emory University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; \Supported by National Institutes of Health Predoctoral Fellowship Grant 5F31CA123640 (NCI).	Bartling B, 2005, LUNG CANCER-J IASLC, V49, P145, DOI 10.1016/j.lungcan.2005.02.006; Bastians H, 1996, J CELL SCI, V109, P2865; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CAMPBELL KS, 1995, J VIROL, V69, P3721, DOI 10.1128/JVI.69.6.3721-3728.1995; Chen GI, 2008, J BIOL CHEM, V283, P29273, DOI 10.1074/jbc.M803443200; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; FAVRE B, 1994, J BIOL CHEM, V269, P16311; Filali M, 1999, J CELL BIOCHEM, V73, P153, DOI 10.1002/(SICI)1097-4644(19990501)73:2<153::AID-JCB2>3.3.CO;2-Z; Gentry MS, 2005, EUKARYOT CELL, V4, P1029, DOI 10.1128/EC.4.6.1029-1040.2005; George RR, 2002, PROTEIN EXPRES PURIF, V26, P266, DOI 10.1016/S1046-5928(02)00540-5; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Hastie CJ, 2000, BIOCHEM J, V347, P845, DOI 10.1042/0264-6021:3470845; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kloeker S, 1997, BIOCHEM J, V327, P481, DOI 10.1042/bj3270481; Kloeker S, 1999, J BIOL CHEM, V274, P5339, DOI 10.1074/jbc.274.9.5339; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LEE J, 1993, J BIOL CHEM, V268, P19192; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; Lee J, 2014, BIOCHEM BIOPH RES CO, V452, P42, DOI 10.1016/j.bbrc.2014.08.045; Liby P, 2006, FOLIA BIOL-PRAGUE, V52, P21; Lillo C, 2014, PLANT CELL ENVIRON, V37, P2631, DOI 10.1111/pce.12364; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nanahoshi M, 1999, FEBS LETT, V446, P108, DOI 10.1016/S0014-5793(99)00189-1; Nanahoshi M, 1998, BIOCHEM BIOPH RES CO, V251, P520, DOI 10.1006/bbrc.1998.9493; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Rusin SF, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3138; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; TUROWSKI P, 1995, J CELL BIOL, V129, P397, DOI 10.1083/jcb.129.2.397; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Wandzioch E, 2014, CANCER RES, V74, P4295, DOI 10.1158/0008-5472.CAN-13-3130; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, BIOCHEM BIOPH RES CO, V203, P1710, DOI 10.1006/bbrc.1994.2383; XIE HY, 1993, J BIOL CHEM, V268, P13364; XIE HY, 1994, J BIOL CHEM, V269, P1981; Yoo SJS, 2008, J CELL BIOCHEM, V105, P290, DOI 10.1002/jcb.21830; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhong JN, 2011, CELL CYCLE, V10, P1411, DOI 10.4161/cc.10.9.15479	59	22	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21008	21019		10.1074/jbc.M116.739920	http://dx.doi.org/10.1074/jbc.M116.739920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27507813	Green Published, hybrid			2022-12-26	WOS:000385406200017
J	Zeng, FM; Sun, XL; Yang, BX; Shen, H; Liu, L				Zeng, Fanmin; Sun, Xueli; Yang, Bangxiang; Shen, Hong; Liu, Ling			The Theoretical Construction of a Classification of Clinical Somatic Symptoms in Psychosomatic Medicine Theory	PLOS ONE			English	Article							PSYCHOLOGICAL-RESEARCH; SOMATIZATION; PERSPECTIVES; ALEXITHYMIA; DEPRESSION; VALIDITY	Objective This article adopts the perspective of psychosomatic medicine to present and test a theoretical model of the classification of clinical somatic symptoms. The theoretical model consists of four dimensions: emotional somatic symptoms, biological somatic symptoms, imaginative somatic symptoms, and cognitive somatic symptoms. Method A clinical somatic symptom classification scale was developed according to the theoretical model. A total of 542 participants completed the clinical somatic symptoms classification scale. The data were analyzed using exploratory and confirmatory factor analyses. Results The results confirmed the theoretical model. The analyses found that the proposed theoretical structure of the scale was good, as indicated by factor loadings and fit indices, and that the scale had good reliability and construct validity. Conclusions Based on the interpretation of the clinical symptoms of psychosomatic medicine, the treatment of chronic non-infectious diseases includes at least three dimensions: the first is the etiological treatment, the second is the pathophysiological and pathopsychological dimension, and the third is symptomatic treatment. The unified psychosomatic point of view and diverse clinical thinking modes are aimed at identifying different classes of somatic symptoms and important prerequisites for the treatment of these symptoms. We registered the study with the Chinese Clinical Trial Registry and it was approved by the West China Hospital, Sichuan University ethics committee. Trial registration: The registration number is ChiCTR-OCS-14004632 (time: 2014-05-12).	[Zeng, Fanmin] Southwest Univ Nationalities, Coll Sociol & Psychol, Chengdu, Sichuan, Peoples R China; [Sun, Xueli] Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu, Sichuan, Peoples R China; [Yang, Bangxiang] Sichuan Univ, West China Hosp, Dept Pain Management, Chengdu, Sichuan, Peoples R China; [Shen, Hong] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Sichuan, Peoples R China; [Liu, Ling] Sichuan Univ, West China Hosp, Dept Digest Internal Med, Chengdu, Sichuan, Peoples R China	Southwest Minzu University; Sichuan University; Sichuan University; Sichuan University; Sichuan University	Sun, XL (corresponding author), Sichuan Univ, West China Hosp, Dept Psychiat, Chengdu, Sichuan, Peoples R China.	648488969@qq.com						ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; DEROGATIS LR, 1977, J CLIN PSYCHOL, V33, P981, DOI 10.1002/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0; Eizaguirre AE, 2004, PERS INDIV DIFFER, V36, P321, DOI 10.1016/S0191-8869(03)00099-0; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Fava GA, 2000, PSYCHOTHER PSYCHOSOM, V69, P184, DOI 10.1159/000012393; Fink P, 1996, J PSYCHOSOM RES, V40, P7, DOI 10.1016/0022-3999(95)00510-2; Haynes SN, 1995, PSYCHOL ASSESSMENT, V7, P238, DOI 10.1037/1040-3590.7.3.238; Hotopf M, 2004, PSYCHOL MED, V34, P195, DOI 10.1017/S003329170300151X; KATON W, 1982, AM J MED, V72, P127, DOI 10.1016/0002-9343(82)90599-X; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; LAWTON MP, 1959, J CONSULT PSYCHOL, V23, P352, DOI 10.1037/h0045248; Li T, 2010, OXFORD TXB PSYCHIAT; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Merskey H, 1996, PAIN, V67, P209, DOI 10.1016/0304-3959(96)03236-X; Ouyang QIN, 2010, CLIN DIAGNOSTICS, P7; Reed JF, 2000, COMPUT METH PROG BIO, V63, P43, DOI 10.1016/S0169-2607(00)00074-2; Rief W, 2010, PSYCHOSOM MED, V72, P648, DOI 10.1097/PSY.0b013e3181d73fce; Shorter E., 1992, PARALYSIS FATIGUE HI; Strain JJ, 1979, PSYCCRITIQUES, V24, P11; TAYLOR GJ, 1992, J PSYCHOSOM RES, V36, P417, DOI 10.1016/0022-3999(92)90002-J; Wang X, 1999, RATING SCALES MENTAL, P23; 孙学礼, 2013, [中华精神科杂志, Chinese Journal of Psychiatry], V46, P371	23	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161222	10.1371/journal.pone.0161222	http://dx.doi.org/10.1371/journal.pone.0161222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27525701	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100044
J	Musielak, TJ; Slane, D; Liebig, C; Bayer, M				Musielak, Thomas J.; Slane, Daniel; Liebig, Christian; Bayer, Martin			A Versatile Optical Clearing Protocol for Deep Tissue Imaging of Fluorescent Proteins in Arabidopsis thaliana	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; CONFOCAL MICROSCOPY; 2-PHOTON MICROSCOPY; PLANT REPRODUCTION; MOUSE-BRAIN; RECONSTRUCTION; EMBRYOS; ORGANS; AGENT	Confocal microscopy is widely used to visualize gene expression patterns and developmental processes in plants. However, the imaging of plant tissue can be challenging due to its opacity, which often makes previous immersion in a clearing agent necessary. Many commonly- used chemicals suffer either from their incompatibility with fluorescent proteins or their complex and lengthy application. 2,2'-thiodiethanol (TDE) has recently been described as a clearing agent with an emphasis on high resolution microscopy due to its potential to adjust the refractive index. Here, we evaluate the use of TDE-based clearing for confocal as well as two-photon microscopy in various Arabidopsis thaliana tissue types. We demonstrate that tissue fixation is a mandatory prerequisite for the use of TDE, in order to preserve tissue integrity and fluorescent protein activity. TDE concentrations between 50-70% are a good compromise for imaging of technically challenging tissue to achieve good clearing without affecting fluorescent protein activity. TDE-based clearing is simple and rapid to use and allows for a flexible experimental setup while facilitating high quality imaging.	[Musielak, Thomas J.; Slane, Daniel; Bayer, Martin] Max Planck Inst Dev Biol, Dept Cell Biol, Spemannstr 35, D-72076 Tubingen, Germany; [Liebig, Christian] Max Planck Inst Dev Biol, Light Microscopy Facil, Spemannstr 35, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society	Bayer, M (corresponding author), Max Planck Inst Dev Biol, Dept Cell Biol, Spemannstr 35, D-72076 Tubingen, Germany.	martin.bayer@tuebingen.mpg.de	Bayer, Martin/AAP-3372-2020	Bayer, Martin/0000-0001-5806-2253; Slane, Daniel/0000-0003-2948-8188	DFG [SFB1101/B01]; Max Planck Society	DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	DFG: SFB1101/B01 to MB http://www.dfg.de and Max Planck Society http://www.mpg.de.	Advani A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024695; Aoyagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116280; Appleton PL, 2009, J MICROSC-OXFORD, V234, P196, DOI 10.1111/j.1365-2818.2009.03163.x; Babu Y, 2013, PLANT PHYSIOL, V162, P1448, DOI 10.1104/pp.113.217166; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Costantini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep09808; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Enami K, 2009, PLANT CELL PHYSIOL, V50, P280, DOI 10.1093/pcp/pcn197; Feijo JA, 2004, PROTOPLASMA, V223, P1, DOI 10.1007/s00709-003-0026-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hasegawa J, 2016, PLANT CELL PHYSIOL, V57, P462, DOI 10.1093/pcp/pcw027; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kong J, 2015, CURR BIOL, V25, P225, DOI 10.1016/j.cub.2014.11.021; Kurihara D, 2015, DEVELOPMENT, V142, P4168, DOI 10.1242/dev.127613; Kurihara D, 2013, DEV GROWTH DIFFER, V55, P462, DOI 10.1111/dgd.12040; Littlejohn GR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00140; Littlejohn GR, 2010, NEW PHYTOL, V186, P1018, DOI 10.1111/j.1469-8137.2010.03244.x; McBryde MC, 1936, AM J BOT, V23, P686, DOI 10.2307/2436351; Musielak TJ, 2015, PLANT REPROD, V28, P161, DOI 10.1007/s00497-015-0267-1; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Palmer WM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13492; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Slane D, 2014, DEVELOPMENT, V141, P4831, DOI 10.1242/dev.116459; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; Staudt T, 2007, MICROSC RES TECHNIQ, V70, P1, DOI 10.1002/jemt.20396; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Timmers ACJ, 2016, J MICROSC-OXFORD, V263, P165, DOI 10.1111/jmi.12394; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Warner CA, 2014, PLANT PHYSIOL, V166, P1684, DOI 10.1104/pp.114.244673; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	34	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161107	10.1371/journal.pone.0161107	http://dx.doi.org/10.1371/journal.pone.0161107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517463	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100050
J	Navarro-Villaran, E; Tinoco, J; Jimenez, G; Pereira, S; Wang, JZ; Aliseda, S; Rodriguez-Hernandez, MA; Gonzalez, R; Marin-Gomez, LM; Gomez-Bravo, MA; Padillo, FJ; Alamo-Martinez, JM; Muntane, J				Navarro-Villaran, Elena; Tinoco, Jose; Jimenez, Granada; Pereira, Sheila; Wang, Jize; Aliseda, Sara; Rodriguez-Hernandez, Maria A.; Gonzalez, Raul; Marin-Gomez, Luis M.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Alamo-Martinez, Jose M.; Muntane, Jordi			Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-TRANSPLANTATION; CYCLOSPORINE-A; INCREASED SURVIVAL; CELLS; GROWTH; FK506; SIROLIMUS; IMMUNOSUPPRESSANT; RECURRENCE	Orthotopic liver transplantation (OLT) is the recommended treatment for patients at early stages of hepatocarcinoma (HCC) with potential portal hypertension and/ or bilirubinemia, but without vascular-associated diseases. The patients are receiving immunosuppressive therapy to reduce graft rejection, but differential side effects have been related to calcineurin and mTOR inhibitor administration regarding tumor recurrence and nephrotoxicity. The in vitro studies showed that Tacrolimus exerted a more potent pro-apoptotic effect than Everolimus (Huh 7>Hep 3B>HepG2), being sirolimus only active in Hep3B cell line. Tacrolimus and Everolimus exerted potent antiproliferative properties in Huh 7 and Hep3B in which cells Sirolimus was inactive. Interestingly, Tacrolimus-and Everolimus-dependent G(0)/ G(1) cell accumulation occurred as a consequence of drastic reduction in S, as well as in S and G(2+M) phases, respectively. The in vivo studies support data on the more effective antitumoral properties of Everolimus, eventual risk of pro-angiogenic tumoral properties and nephrotoxicity of Tacrolimus, and pro-proliferative properties of Sirolimus in tumors developed in nude mice.	[Navarro-Villaran, Elena; Pereira, Sheila; Aliseda, Sara; Rodriguez-Hernandez, Maria A.; Gonzalez, Raul] Univ Seville, Virgen del Rocio Virgen Macarena Univ Hosp, CSIC, Inst Biomed Seville IBIS, Seville, Spain; [Tinoco, Jose; Jimenez, Granada; Wang, Jize; Marin-Gomez, Luis M.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Alamo-Martinez, Jose M.; Muntane, Jordi] Univ Seville, Virgen del Rocio Virgen Macarena Univ Hosp, CSIC, IBIS,Dept Gen Surg, Seville, Spain; [Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Alamo-Martinez, Jose M.; Muntane, Jordi] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Muntane, J (corresponding author), Univ Seville, Virgen del Rocio Virgen Macarena Univ Hosp, CSIC, IBIS,Dept Gen Surg, Seville, Spain.; Muntane, J (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.	jmuntane-ibis@us.es	Navarro-Villarán, Elena/F-4699-2018; Padillo-Ruiz, Javier/AAF-9792-2021; Rodríguez-Hernández, Ángeles/K-9717-2015	Navarro-Villarán, Elena/0000-0003-0765-9089; Padillo-Ruiz, Javier/0000-0002-1220-0822; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; GOMEZ BRAVO, MIGUEL ANGEL/0000-0002-5155-3508	Instituto de Salud Carlos III [PI13/00021]; Consejeria de Innovacion, Ciencia y Empresa [CTS-6264]; Consejeria de Salud y Bienestar Social [PI13/00025]; Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Consejeria de Innovacion, Ciencia y Empresa; Consejeria de Salud y Bienestar Social; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund "A way to achieve Europe" ERDF(European Commission)	The authors thank the Instituto de Salud Carlos III (PI13/00021), Consejeria de Innovacion, Ciencia y Empresa (CTS-6264) and Consejeria de Salud y Bienestar Social (PI13/00025) for their financial support. The authors also thank the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) founded by Instituto de Salud Carlos III and co-financed by European Development Regional Fund "A way to achieve Europe" ERDF for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almawi WY, 2000, NEPHROL DIAL TRANSPL, V15, P1916, DOI 10.1093/ndt/15.12.1916; Baksh S, 2000, ONCOGENE, V19, P2820, DOI 10.1038/sj.onc.1203585; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cao Xiao-Wei, 2005, Hepatobiliary Pancreat Dis Int, V4, P269; Choi SJN, 2008, TRANSPL P, V40, P2734, DOI 10.1016/j.transproceed.2008.08.028; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; Dumont FJ, 2000, CURR MED CHEM, V7, P731, DOI 10.2174/0929867003374723; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Giordano A, 2008, CARDIOVASC RES, V79, P519, DOI 10.1093/cvr/cvn079; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Huynh H, 2012, ANGIOGENESIS, V15, P59, DOI 10.1007/s10456-011-9243-z; Huynh H, 2009, J CELL MOL MED, V13, P2673, DOI 10.1111/j.1582-4934.2009.00692.x; Huynh H, 2009, J CELL MOL MED, V13, P1371, DOI 10.1111/j.1582-4934.2008.00364.x; Kawahara T, 2016, MOL CARCINOGEN, V55, P161, DOI 10.1002/mc.22265; Khanna AK, 2003, BIOCHEM BIOPH RES CO, V303, P266, DOI 10.1016/S0006-291X(03)00340-1; Liu HY, 2012, ANTICANCER RES, V32, P1627; Massoud O, 2012, J HEPATOL, V56, P288, DOI 10.1016/j.jhep.2011.06.012; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; McAlister VC, 2006, AM J TRANSPLANT, V6, P1578, DOI 10.1111/j.1600-6143.2006.01360.x; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Neuhaus P, 2001, LIVER TRANSPLANT, V7, P473, DOI 10.1053/jlts.2001.24645; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Rodriguez-Peralvarez M, 2013, J HEPATOL, V59, P1193, DOI 10.1016/j.jhep.2013.07.012; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; Saunders PO, 2013, ONCOGENE, V32, P4789, DOI 10.1038/onc.2012.498; Schumacher G, 2005, WORLD J GASTROENTERO, V11, P1420; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siemann G, 1999, MOL PHARMACOL, V55, P1094, DOI 10.1124/mol.55.6.1094; Aguilar LT, 2009, TRANSPL P, V41, P2453, DOI 10.1016/j.transproceed.2009.05.012; Toso C, 2010, HEPATOLOGY, V51, P1237, DOI 10.1002/hep.23437; Vivarelli M, 2008, ANN SURG, V248, P857, DOI 10.1097/SLA.0b013e3181896278; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160979	10.1371/journal.pone.0160979	http://dx.doi.org/10.1371/journal.pone.0160979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518575	Green Published, gold, Green Submitted			2022-12-26	WOS:000381382100030
J	Yu, BQ; Lv, X; Su, LP; Li, JF; Yu, YY; Gu, QL; Yan, M; Zhu, ZG; Liu, BY				Yu, Beiqin; Lv, Xin; Su, Liping; Li, Jianfang; Yu, Yingyan; Gu, Qinlong; Yan, Min; Zhu, Zhenggang; Liu, Bingya			MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 1; CELL LUNG-CANCER; MICRORNA-148A SUPPRESSES; MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; PANCREATIC-CANCER; BREAST-CANCER; EXPRESSION; PROLIFERATION; CARCINOMA	MicroRNAs (miRNAs) have been widely accepted as a class of gene expression regulators which post-translationally regulate protein expression. These small noncoding RNAs have been proved closely involved in the modulation of various pathobiological processes in cancer. In this research, we demonstrated that miR-148a expression was significantly downregulated in gastric cancer tissues in comparison with the matched normal mucosal tissues, and its expression was statistically associated with lymph node metastasis. Ectopic expression of miR-148a inhibited tumor cell proliferation and migration in vitro, and inhibited tumor formation in vivo. Subsequently, we identified cholecystokinin B receptor (CCK-BR) as a direct target of miR-148a using western blot and luciferase activity assay. More importantly, siRNA-induced knockdown of CCK-BR elicited similar anti-oncogenic effects (decreased proliferation and migration) as those induced by enforced miR-148a expression. We also found that miR-148a-mediated anti-cancer effects are dependent on the inhibition of STAT3 and Akt activation, which subsequently regulates the pathways involved in cell proliferation and migration. Taken together, our results suggest that miR-148a serves as a tumor suppressor in human gastric carcinogenesis by targeting CCK-BR via inactivating STAT3 and Akt.	[Yu, Beiqin; Lv, Xin; Su, Liping; Li, Jianfang; Yu, Yingyan; Gu, Qinlong; Yan, Min; Zhu, Zhenggang; Liu, Bingya] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Sch Med, Shanghai, Peoples R China; [Lv, Xin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Vasc Surg, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, BY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms,Sch Med, Shanghai, Peoples R China.	liubingya@sjtu.edu.cn	Liu, Bingya/GMW-5655-2022	Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [81172324, 81272749, 91229106, 81372187]; Science and Technology Commission of Shanghai Municipality [12XD1403700, 13ZR1425600]; Key Projects in the National Science & Technology Pillar Program of China [2014BAI09B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Projects in the National Science & Technology Pillar Program of China	This study was supported by grants from National Natural Science Foundation of China (Nos. 81172324, 81272749, 91229106, 81372187), Science and Technology Commission of Shanghai Municipality (Nos. 12XD1403700, 13ZR1425600), Key Projects in the National Science & Technology Pillar Program of China (No. 2014BAI09B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahmad A, 2013, ANTI-CANCER AGENT ME, V13, P1014, DOI 10.2174/18715206113139990117; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bickenbach K, 2012, J GASTRIC CANCER, V12, P55, DOI 10.5230/jgc.2012.12.2.55; Borkowski R, 2015, CANCER RES, V75, P666, DOI 10.1158/0008-5472.CAN-14-1329; Braconi C, 2010, HEPATOLOGY, V51, P881, DOI 10.1002/hep.23381; Chen BL, 2013, CELL CYCLE, V12, P112, DOI 10.4161/cc.23030; Chen F, 2012, CANCER RES, V72, P379, DOI 10.1158/0008-5472.CAN-11-1982; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; Du W, 2013, ONCOGENE, V32, P3319, DOI 10.1038/onc.2012.359; Duan YT, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-127; Dun BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081702; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Huang SL, 2013, INT IMMUNOPHARMACOL, V17, P585, DOI 10.1016/j.intimp.2013.07.021; ITO M, 1993, J BIOL CHEM, V268, P18300; Jiang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096698; Jin GC, 2013, GASTROENTEROLOGY, V145, P820, DOI 10.1053/j.gastro.2013.07.034; Lin L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-879; Lin L, 2010, CANCER RES, V70, P2445, DOI 10.1158/0008-5472.CAN-09-2468; Liu RH, 2015, CLIN CANCER RES, V21, P854, DOI 10.1158/1078-0432.CCR-14-1740; Long XR, 2014, INT J ONCOL, V44, P1915, DOI 10.3892/ijo.2014.2373; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Pan LJ, 2014, EUR J MED RES, V19, DOI 10.1186/s40001-014-0068-2; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Rojanasakul Y, 2013, CELL CYCLE, V12, P202, DOI 10.4161/cc.23419; Sakamoto N, 2014, CANCER SCI, V105, P236, DOI 10.1111/cas.12330; SETHI T, 1993, CANCER RES, V53, P5208; Smith JP, 2012, CANCER BIOL THER, V13, P164, DOI 10.4161/cbt.13.3.18698; Song YX, 2012, INT J CANCER, V131, P1042, DOI 10.1002/ijc.26485; Tao SF, 2014, BIOCHEM BIOPH RES CO, V451, P74, DOI 10.1016/j.bbrc.2014.07.073; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wang SH, 2013, TUMOR BIOL, V34, P3705, DOI 10.1007/s13277-013-0954-1; Xia JZ, 2014, J CANCER RES CLIN, V140, P1451, DOI 10.1007/s00432-014-1649-8; Xu W, 2013, CANCER LETT, V332, P11, DOI 10.1016/j.canlet.2012.12.030; Yan J, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0879-6; Yu BQ, 2012, MOL MED REP, V6, P821, DOI 10.3892/mmr.2012.1006; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang JP, 2014, ONCOGENE, V33, P4069, DOI 10.1038/onc.2013.369; Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714; Zheng QZ, 2014, PROSTATE, V74, P1655, DOI 10.1002/pros.22883; Zhou JJ, 2010, MOL CELL BIOCHEM, V343, P133, DOI 10.1007/s11010-010-0507-5	44	50	52	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0158961	10.1371/journal.pone.0158961	http://dx.doi.org/10.1371/journal.pone.0158961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518872	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100005
J	Dias, M; Brochetta, C; Marchetti, A; Bodinier, R; Bruckert, F; Cosson, P				Dias, Marco; Brochetta, Cristiana; Marchetti, Anna; Bodinier, Romain; Bruckert, Franz; Cosson, Pierre			Role of SpdA in Cell Spreading and Phagocytosis in Dictyostelium	PLOS ONE			English	Article							SHEAR-FLOW; DISCOIDEUM CELLS; SOLID SUBSTRATE; ADHESION; CYTOKINESIS; MOTILITY	Dictyostelium discoideum is a widely used model to study molecular mechanisms controlling cell adhesion, cell spreading on a surface, and phagocytosis. In this study we isolated and characterize a new mutant created by insertion of a mutagenic vector in the heretofore uncharacterized spdA gene. SpdA-ins mutant cells produce an altered, slightly shortened version of the SpdA protein. They spread more efficiently than WT cells when allowed to adhere to a glass substrate, and phagocytose particles more efficiently. On the contrary, a functional spdA knockout mutant where a large segment of the gene was deleted phagocytosed less efficiently and spread less efficiently on a substrate. These phenotypes were highly dependent on the cellular density, and were most visible at high cell densities, where secreted quorum-sensing factors inhibiting cell motility, spreading and phagocytosis are most active. These results identify the involvement of SpdA in the control of cell spreading and phagocytosis. The underlying molecular mechanisms, as well as the exact link between SpdA and cell spreading, remain to be established.	[Dias, Marco; Brochetta, Cristiana; Marchetti, Anna; Bodinier, Romain; Cosson, Pierre] Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Geneva, Switzerland; [Bruckert, Franz] Univ Grenoble Alpes, Lab Mat & Genie Phys, UMR CNRS Grenoble INP5628, 3 Parvis Louis Neel,BP 257, Grenoble 1, France	University of Geneva; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Cosson, P (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, Fac Med, Geneva, Switzerland.	Pierre.Cosson@unige.ch			Swiss National Science Foundation [31003A-153326]; Doerenkamp-Zbinden Foundation; E. Naef Foundation (FENRIV)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Doerenkamp-Zbinden Foundation; E. Naef Foundation (FENRIV)	This work has been supported by the Swiss National Science Foundation (grant 31003A-153326, PC), the Doerenkamp-Zbinden Foundation, and the E. Naef Foundation (FENRIV). (Swiss National Science Foundation : http://www.snf.ch/; Doerenkamp-Zbinden Foundation : http://www.doerenkamp.ch; E. Naef Foundation : http://www.fondation-naef.com). MD was financed throughout his PhD by the Swiss National Science Foundation (grant 31003A-153326, PC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesley SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026024; Bruckert F, 2002, J MUSCLE RES CELL M, V23, P651, DOI 10.1023/A:1024407107588; Chamaraux F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.158102; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cornillon S, 2002, J CELL SCI, V115, P737; Cornillon S, 2008, EUKARYOT CELL, V7, P1600, DOI 10.1128/EC.00155-08; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; de Chassey B, 2001, GENE, V262, P115, DOI 10.1016/S0378-1119(00)00545-X; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; Dias M, 2013, J CELL SCI, V126, P756, DOI 10.1242/jcs.113951; Gebbie L, 2004, MOL BIOL CELL, V15, P3915, DOI 10.1091/mbc.E03-12-0908; Gole L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026901; Hochreiter-Hufford A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008748; KREITMEIER M, 1995, J CELL BIOL, V129, P179, DOI 10.1083/jcb.129.1.179; Kuspa Adam, 2006, V346, P201; Lelong E, 2011, CELL MICROBIOL, V13, P246, DOI 10.1111/j.1462-5822.2010.01532.x; Muller I, 2005, J BIOL CHEM, V280, P10435, DOI 10.1074/jbc.M411445200; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Pluddemann A, 2011, IMMUNOL REV, V240, P11, DOI 10.1111/j.1600-065X.2010.00989.x; Rosel D, 2012, J CELL SCI, V125, P37, DOI 10.1242/jcs.077040	23	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160376	10.1371/journal.pone.0160376	http://dx.doi.org/10.1371/journal.pone.0160376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512991	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100035
J	Louis, JM; Baber, JL; Ghirlando, R; Aniana, A; Bax, A; Roche, J				Louis, John M.; Baber, James L.; Ghirlando, Rodolfo; Aniana, Annie; Bax, Ad; Roche, Julien			Insights into the Conformation of the Membrane Proximal Regions Critical to the Trimerization of the HIV-1 gp41 Ectodomain Bound to Dodecyl Phosphocholine Micelles	PLOS ONE			English	Article							FUSION-ACTIVE CONFORMATION; ENVELOPE GLYCOPROTEIN; NEUTRALIZING ANTIBODY; PROTEIN GP41; SEDIMENTATION-VELOCITY; ATOMIC-STRUCTURE; MEDIATED FUSION; EXTERNAL REGION; VIRAL MEMBRANE; INTERMEDIATE	The transitioning of the ectodomain of gp41 from a pre-hairpin to a six-helix bundle conformation is a crucial aspect of virus-cell fusion. To gain insight into the intermediary steps of the fusion process we have studied the pH and dodecyl phosphocholine (DPC) micelle dependent trimer association of gp41 by systematic deletion analysis of an optimized construct termed 17-172 (residues 528 to 683 of Env) that spans the fusion peptide proximal region (FPPR) to the membrane proximal external region (MPER) of gp41, by sedimentation velocity and double electron-electron resonance (DEER) EPR spectroscopy. Trimerization at pH 7 requires the presence of both the FPPR and MPER regions. However, at pH 4, the protein completely dissociates to monomers. DEER measurements reveal a partial fraying of the C-terminal MPER residues in the 17-172 trimer while the other regions, including the FPPR, remain compact. In accordance, truncating nine C-terminal MPER residues (675-683) in the 17-172 construct does not shift the trimer-monomer equilibrium significantly. Thus, in the context of the gp41 ectodomain spanning residues 17-172, trimerization is clearly dependent on FPPR and MPER regions even when the terminal residues of MPER unravel. The antibody Z13e1, which spans both the 2F5 and 4E10 epitopes in MPER, binds to 17-172 with a K-d of 1 +/- 0.12 mu M. Accordingly, individual antibodies 2F5 and 4E10 also recognize the 17-172 trimer/DPC complex. We propose that binding of the C-terminal residues of MPER to the surface of the DPC micelles models a correct positioning of the trimeric transmembrane domain anchored in the viral membrane.	[Louis, John M.; Baber, James L.; Aniana, Annie; Bax, Ad; Roche, Julien] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Roche, Julien] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Iowa State University	Louis, JM; Roche, J (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.; Roche, J (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA USA.	johnl@niddk.nih.gov; julien.roche@nih.gov		Louis, John M/0000-0002-0052-1899	Intramural Research Program of the NIDDK; National Institutes of Health; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK029048, ZIADK033007] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the NIDDK, National Institutes of Health and the Intramural AIDS-Targeted Antiviral Program of the Office of the Director, NIH.	Baber JL, 2015, ANGEW CHEM INT EDIT, V54, P5336, DOI 10.1002/anie.201500640; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dai Z, 2015, BIOCHEMISTRY-US, V54, P1589, DOI 10.1021/bi501376f; Eggink D, 2010, CURR PHARM DESIGN, V16, P3716, DOI 10.2174/138161210794079218; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hildinger M, 2001, J VIROL, V75, P3038, DOI 10.1128/JVI.75.6.3038-3042.2001; Hollmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060302; Inagaki S, 2013, METHODS, V59, P287, DOI 10.1016/j.ymeth.2012.11.006; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2004, J MAGN RESON, V169, P1, DOI 10.1016/j.jmr.2004.03.024; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Kondo N, 2015, J BIOL CHEM, V290, P6558, DOI 10.1074/jbc.M114.623181; Korazim O, 2006, J MOL BIOL, V364, P1103, DOI 10.1016/j.jmb.2006.08.091; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lakomek NA, 2014, STRUCTURE, V22, P1311, DOI 10.1016/j.str.2014.06.016; Lakomek NA, 2013, ANGEW CHEM INT EDIT, V52, P3911, DOI 10.1002/anie.201207266; Lev N, 2009, BIOCHEMISTRY-US, V48, P3166, DOI 10.1021/bi802243j; Louis JM, 2015, BIOCHEMISTRY-US, V54, P6796, DOI 10.1021/acs.biochem.5b01021; Louis JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104683; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Melikyan GB, 2006, J VIROL, V80, P3249, DOI 10.1128/JVI.80.7.3249-3258.2006; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Ratnayake PU, 2015, BBA-BIOMEMBRANES, V1848, P289, DOI 10.1016/j.bbamem.2014.07.022; Reichart TM, 2016, ANGEW CHEM INT EDIT, V55, P2688, DOI 10.1002/anie.201508421; Roche J, 2015, J BIOMOL NMR, V61, P235, DOI 10.1007/s10858-015-9900-4; Roche J, 2014, P NATL ACAD SCI USA, V111, P3425, DOI 10.1073/pnas.1401397111; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Roux KH, 2007, CURR OPIN STRUC BIOL, V17, P244, DOI 10.1016/j.sbi.2007.03.008; Sackett K, 2002, BIOCHEMISTRY-US, V41, P4678, DOI 10.1021/bi0255322; Sackett K, 2011, EUR BIOPHYS J BIOPHY, V40, P489, DOI 10.1007/s00249-010-0662-3; Sackett K, 2010, J MOL BIOL, V397, P301, DOI 10.1016/j.jmb.2010.01.018; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Schuck P, 2004, BIOPHYS CHEM, V108, P187, DOI 10.1016/j.bpc.2003.10.016; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tamm LK, 2014, STRUCTURE, V22, P1225, DOI 10.1016/j.str.2014.08.010; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; von HT, 2013, PHYS CHEM CHEM PHYS, V15, P5854, DOI [10.1039/c3cp44462g, DOI 10.1039/C3CP44462G]; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0	55	10	10	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160597	10.1371/journal.pone.0160597	http://dx.doi.org/10.1371/journal.pone.0160597			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513582	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100047
J	Ruess, DA; Probst, M; Marjanovic, G; Wittel, UA; Hopt, UT; Keck, T; Bausch, D				Ruess, Dietrich A.; Probst, Moriz; Marjanovic, Goran; Wittel, Uwe A.; Hopt, Ulrich T.; Keck, Tobias; Bausch, Dirk			HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; TOLL-LIKE RECEPTORS; N-TERMINAL KINASE; RAT-LIVER; GENE-EXPRESSION; IN-VITRO; INDUCED HEPATOTOXICITY; MOLECULAR-MECHANISMS; HEMORRHAGIC-SHOCK; CELL-DEATH	Background Histone deacetylases (HDAC) catalyze N-terminal deacetylation of lysine-residues on histones and multiple nuclear and cytoplasmic proteins. In various animal models, such as trauma/hemorrhagic shock, ischemic stroke or myocardial infarction, HDAC inhibitor (HDACi) application is cyto- and organoprotective and promotes survival. HDACi reduce stress signaling, cell death and inflammation. Hepatic ischemia-reperfusion (I/R) injury during major liver resection or transplantation increases morbidity and mortality. Assuming protective properties, the aim of this study was to investigate the effect of the HDACi VPA and SAHA on warm hepatic I/R. Material and Methods Male Wistar-Kyoto rats (age: 6-8 weeks) were randomized to VPA, SAHA, vehicle control (pre-) treatment or sham-groups and underwent partial no-flow liver ischemia for 90 minutes with subsequent reperfusion for 6, 12, 24 and 60 hours. Injury and regeneration was quantified by serum AST and ALT levels, by macroscopic aspect and (immuno-) histology. HDACi treatment efficiency, impact on MAPK/SAPK-activation and Hippo-YAP signaling was determined by Western blot. Results Treatment with HDACi significantly enhanced hyperacetylation of Histone H3-K9 during I/R, indicative of adequate treatment efficiency. Liver injury, as measured by macroscopic aspect, serum transaminases and histology, was delayed, but not alleviated in VPA and SAHA treated animals. Importantly, tissue destruction was significantly more pronounced with VPA. SAPK-activation (p38 and JNK) was reduced by VPA and SAHA in the early (6h) reperfusion phase, but augmented later on (JNK, 24h). Regeneration appeared enhanced in SAHA and VPA treated animals and was dependent on Hippo-YAP signaling. Conclusions VPA and SAHA delay warm hepatic I/R injury at least in part through modulation of SAPK-activation. However, these HDACi fail to exert organoprotective effects, in this setting. For VPA, belated damage is even aggravated.	[Ruess, Dietrich A.; Probst, Moriz; Marjanovic, Goran; Wittel, Uwe A.; Hopt, Ulrich T.] Univ Hosp Freiburg, Dept Surg, Freiburg, Germany; [Keck, Tobias; Bausch, Dirk] Univ Hosp Schleswig Holstein, Dept Surg, Campus Lubeck, Lubeck, Germany	University of Freiburg; University of Kiel; Schleswig Holstein University Hospital	Ruess, DA (corresponding author), Univ Hosp Freiburg, Dept Surg, Freiburg, Germany.	dietrich.ruess@uniklinik-freiburg.de	Ruess, Dietrich A./J-6983-2019; Bausch, Dirk/AAX-7904-2020	Ruess, Dietrich A./0000-0003-4371-2246; Bausch, Dirk/0000-0001-6511-1535; Keck, Tobias/0000-0001-7651-6183	German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Basu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062478; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Butler LM, 2000, CANCER RES, V60, P5165; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Cao WS, 2008, J EXP MED, V205, P1491, DOI 10.1084/jem.20071728; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Chuang YF, 2014, BIOCHEM PHARMACOL, V88, P372, DOI 10.1016/j.bcp.2014.02.004; Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/417590; Czaja MJ, 2003, HEPATOLOGY, V37, P1405, DOI 10.1053/jhep.2003.50233; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Datta G, 2013, WORLD J GASTROENTERO, V19, P1683, DOI 10.3748/wjg.v19.i11.1683; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Eum HA, 2007, BIOCHEM BIOPH RES CO, V358, P500, DOI 10.1016/j.bbrc.2007.04.153; Evankovich J, 2010, J BIOL CHEM, V285, P39888, DOI 10.1074/jbc.M110.128348; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Farmer D. G., 2000, TRANSPLANT REV, V14, P106, DOI DOI 10.1053/TR.2000.4651; Finkelstein RA, 2010, J SURG RES, V163, P146, DOI 10.1016/j.jss.2010.04.024; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Gim SA, 2015, J SURG RES, V198, P228, DOI 10.1016/j.jss.2015.05.043; Gonzales ER, 2008, J TRAUMA, V65, P554, DOI 10.1097/TA.0b013e31818233ef; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Grijalva JL, 2014, AM J PHYSIOL-GASTR L, V307, pG196, DOI 10.1152/ajpgi.00077.2014; Gujral JS, 2001, HEPATOLOGY, V33, P397, DOI 10.1053/jhep.2001.22002; Hancock Wayne W, 2011, Handb Exp Pharmacol, V206, P103, DOI 10.1007/978-3-642-21631-2_6; Huang JS, 2013, HEPATOLOGY, V57, P1742, DOI 10.1002/hep.26206; Iannelli A, 2009, TRANSPL P, V41, P4099, DOI 10.1016/j.transproceed.2009.08.074; Jaeschke H, 1998, J Hepatobiliary Pancreat Surg, V5, P402; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jafarian I, 2013, TOXICOL MECH METHOD, V23, P617, DOI 10.3109/15376516.2013.821567; Jin G, 2011, SURGERY, V150, P429, DOI 10.1016/j.surg.2011.07.001; Jin J, 2014, FOOD CHEM TOXICOL, V73, P95, DOI 10.1016/j.fct.2014.08.009; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim M, 2012, ANN SURG, V255, P492, DOI 10.1097/SLA.0b013e3182441767; King LA, 2009, J HEPATO-BILIARY-PAN, V16, P763, DOI 10.1007/s00534-009-0155-x; Kobayashi M, 2002, SURGERY, V131, P344, DOI 10.1067/msy.2002.121097; Kochanek AR, 2012, J SURG RES, V176, P185, DOI 10.1016/j.jss.2011.06.007; Komulainen T, 2015, TOXICOLOGY, V331, P47, DOI 10.1016/j.tox.2015.03.001; Lee MH, 2007, TOXICOL APPL PHARM, V220, P45, DOI 10.1016/j.taap.2006.12.016; Leone A, 2014, TOXICOL APPL PHARM, V275, P189, DOI 10.1016/j.taap.2014.01.017; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Levine MH, 2015, AM J TRANSPLANT, V15, P965, DOI 10.1111/ajt.13106; Li J, 2001, MOL CELL BIOL, V21, P8213, DOI 10.1128/MCB.21.23.8213-8224.2001; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Nanau RM, 2013, CLIN BIOCHEM, V46, P1323, DOI 10.1016/j.clinbiochem.2013.06.012; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Pourahmad J, 2012, TOXICOL IN VITRO, V26, P545, DOI 10.1016/j.tiv.2012.01.020; Quesnelle KM, 2015, ARCH TOXICOL, V89, P651, DOI 10.1007/s00204-014-1437-x; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Shakespear MR, 2011, TRENDS IMMUNOL, V32, P335, DOI 10.1016/j.it.2011.04.001; Shinoda M, 2002, WOUND REPAIR REGEN, V10, P314, DOI 10.1046/j.1524-475X.2002.t01-1-10507.x; Sun J, 2014, INT J MOL SCI, V15, P21069, DOI 10.3390/ijms151121069; Sweet MJ, 2012, IMMUNOL CELL BIOL, V90, P14, DOI 10.1038/icb.2011.88; Theruvath TP, 2008, TRANSPLANTATION, V85, P1500, DOI 10.1097/TP.0b013e31816fefb5; Uehara T, 2005, J HEPATOL, V42, P850, DOI 10.1016/j.jhep.2005.01.030; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Xie M, 2014, CIRCULATION, V129, P1139, DOI 10.1161/CIRCULATIONAHA.113.002416; Xu QH, 2004, FREE RADICAL BIO MED, V36, P985, DOI 10.1016/j.freeradbiomed.2004.01.009; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469	69	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161233	10.1371/journal.pone.0161233	http://dx.doi.org/10.1371/journal.pone.0161233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513861	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100131
J	Wang, HB; Laskowitz, DT; Dodds, JA; Xie, GQ; Zhang, PH; Huang, YN; Wang, B; Wu, YF				Wang, Hai-Bo; Laskowitz, Daniel T.; Dodds, Jodi A.; Xie, Gao-Qiang; Zhang, Pu-Hong; Huang, Yi-Ning; Wang, Bo; Wu, Yang-Feng			Peak Systolic Velocity Measurements with Transcranial Doppler Ultrasound Is a Predictor of Incident Stroke among the General Population in China	PLOS ONE			English	Article							CEREBRAL-ARTERY STENOSIS; SICKLE-CELL-DISEASE; BLOOD-FLOW VELOCITY; RISK-FACTORS; INTRACRANIAL ATHEROSCLEROSIS; PRIMARY PREVENTION; PREVALENCE; ULTRASONOGRAPHY; ASSOCIATION; INFARCTION	Background and Objective It is necessary to develop an effective and low-cost screening tool for identifying Chinese people at high risk of stroke. Transcranial Doppler ultrasound (TCD) is a powerful predictor of stroke in the pediatric sickle cell disease population, as demonstrated in the STOP trial. Our study was conducted to determine the prediction value of peak systolic velocities as measured by TCD on subsequent stroke risk in a prospective cohort of the general population from Beijing, China. Methods In 2002, a prospective cohort study was conducted among 1392 residents from 11 villages of the Shijingshan district of Beijing, China. The cohort was scheduled for follow up with regard to incident stroke in 2005, 2007, and 2012 by a study team comprised of epidemiologists, nurses, and physicians. Univariate and multivariate Cox proportional hazard regression models were used to determine the factors associated with incident stroke. Results Participants identified by TCD criteria as having intracranial stenosis had a 3.6-fold greater risk of incident stroke (hazard ratio (HR) 3.57, 95% confidence interval (CI) 1.86-6.83, P < 0.01) than those without TCD evidence of intracranial stenosis. The association remained significant in multivariate analysis (HR 2.53, 95% CI 1.31-4.87) after adjusting for other risk factors or confounders. Older age, cigarette smoking, hypertension, and diabetes mellitus remained statistically significant as risk factors after controlling for other factors. Conclusions The study confirmed the screening value of TCD among the general population in urban China. Increasing the availability of TCD screening may help identify subjects as higher risk for stroke.	[Wang, Hai-Bo; Xie, Gao-Qiang; Wu, Yang-Feng] Peking Univ, Clin Res Inst, Xueyuan Rd 38, Beijing 100191, Peoples R China; [Laskowitz, Daniel T.; Dodds, Jodi A.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA; [Zhang, Pu-Hong; Wu, Yang-Feng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing 100191, Peoples R China; [Huang, Yi-Ning] Peking Univ, Hosp 1, Dept Neurol, Beijing 100034, Peoples R China; [Wang, Bo] Peking Union Med Hosp, Dept Neurol, Beijing 100730, Peoples R China; [Wu, Yang-Feng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China	Peking University; Duke University; Peking University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University	Wu, YF (corresponding author), Peking Univ, Clin Res Inst, Xueyuan Rd 38, Beijing 100191, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing 100191, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China.	wuyf@bjmu.edu.cn		Zhang, Puhong/0000-0003-4610-9848	People's Republic of China Ministry of Science and Technology; Ministry of Health [2001BA703B01, 2006BAI01A02]; People's Republic of China Ministry of Science and Technology; Ministry of Health [2001BA703B01, 2006BAI01A02]; FOGARTY INTERNATIONAL CENTER [D43TW008303] Funding Source: NIH RePORTER	People's Republic of China Ministry of Science and Technology; Ministry of Health; People's Republic of China Ministry of Science and Technology; Ministry of Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the People's Republic of China Ministry of Science and Technology and the Ministry of Health through the 10th and 11th National Five-Year Plan Projects (contracts 2001BA703B01 and 2006BAI01A02).	ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 1997, ANN NEUROL, V42, P699, DOI 10.1002/ana.410420505; Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Berkowitz AL, 2015, NEUROLOGY, V84, P2183, DOI 10.1212/WNL.0000000000001618; Feigin VL, 2015, NEUROL RES, V37, P378, DOI 10.1179/1743132815Y.0000000025; Gaciong Z, 2013, CURR HYPERTENS REP, V15, P559, DOI 10.1007/s11906-013-0401-0; Gao S, 2002, J NEUROIMAGING, V12, P213, DOI 10.1177/10528402012003001; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; Huang YN, 1997, NEUROLOGY, V48, P524, DOI 10.1212/WNL.48.2.524; Huang YL, 2014, NEUROLOGY, V82, P1153, DOI 10.1212/WNL.0000000000000268; Hwang CS, 2002, J NEUROIMAGING, V12, P124, DOI 10.1111/j.1552-6569.2002.tb00108.x; International Labour Organization, 1988, INT STAND CLASS OCC; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Liu CY, 2014, EUR REV MED PHARMACO, V18, P3368; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ni J, 2011, J NEUROL SCI, V301, P63, DOI 10.1016/j.jns.2010.10.029; Nishida M, 2007, CLIN CHIM ACTA, V384, P99, DOI 10.1016/j.cca.2007.06.009; ROTHMAN SM, 1986, ANN NEUROL, V20, P684, DOI 10.1002/ana.410200606; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sada S, 2014, NEUROL INDIA, V62, P510, DOI 10.4103/0028-3886.144443; Topcuoglu MA, 2012, J NEUROCHEM, V123, P39, DOI 10.1111/j.1471-4159.2012.07942.x; Tse LA, 2012, PUBLIC HEALTH, V126, P960, DOI 10.1016/j.puhe.2012.07.010; Vollmer WM, 2002, ANN EPIDEMIOL, V12, P295, DOI 10.1016/S1047-2797(01)00288-5; Wang L, 2014, CELL BIOCHEM BIOPHYS, V70, P823, DOI 10.1007/s12013-014-9986-4; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee; Xie GQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101527; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang P, 2006, J HUM HYPERTENS, V20, P742, DOI 10.1038/sj.jhh.1002068; Zhang PH, 2006, BRAIN RES BULL, V69, P282, DOI 10.1016/j.brainresbull.2005.12.008; Zhang S, 2013, EUR J NEUROL, V20, P1479, DOI 10.1111/ene.12210; Zhao JJ, 2013, J CLIN NEUROSCI, V20, P1427, DOI 10.1016/j.jocn.2013.01.012	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160967	10.1371/journal.pone.0160967	http://dx.doi.org/10.1371/journal.pone.0160967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513983	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100097
J	Yagyu, S; Iehara, T; Tanaka, S; Gotoh, T; Misawa-Furihata, A; Sugimoto, T; London, WB; Hogarty, MD; Teramukai, S; Nakagawara, A; Hiyama, E; Maris, JM; Hosoi, H				Yagyu, Shigeki; Iehara, Tomoko; Tanaka, Shiro; Gotoh, Takahiro; Misawa-Furihata, Akiko; Sugimoto, Tohru; London, Wendy B.; Hogarty, Michael D.; Teramukai, Satoshi; Nakagawara, Akira; Hiyama, Eiso; Maris, John M.; Hosoi, Hajime			Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma	PLOS ONE			English	Article							CHILDRENS-ONCOLOGY-GROUP; LOCALIZED NEUROBLASTOMA; SPONTANEOUS REGRESSION; CANCER PATIENTS; RISK GROUP; PROGNOSIS; INFANTS; DNA; STRATIFICATION; CLASSIFICATION	We previously developed a method for determining MYCN gene amplification status using cell-free DNA fragments released from cancer cells into the blood of patients with neuroblastoma (NB). Here, we analyzed the relationship between MYCN amplification (MNA) status and neuroblastoma prognosis. We screened serum samples from 151 patients with NB for MNA, using real-time quantitative PCR, and compared the results with MYCN status determined using paired tumor samples. We additionally investigated whether MNA status correlates with patient survival. When a cut-off value of 5 was used, serum-based MNA analysis was found to show good sensitivity (86%) and very high specificity (95%). The sensitivities for stage 1 and 2 might be acceptable, even though it is not as good as for stage 3 and 4 (67% for stage 1 and 2, 92% for stage 3, and 87% for stage 4). MNA status correlated with overall survival in our cohort of 82 patients, with survival data available (p < 0.01). The hazard ratio of MNA status was 4.98 in patients diagnosed at less than 18 months of age (95% confidence interval, 1.00-24.78), and 1.41 (95% confidence interval, 0.63-3.14) for those diagnosed at 18 months of age or older. Serum-based MNA analysis is rapid and non-invasive compared with tumor-based MNA analysis, and has potential to predict tumor MNA status. There is still a room to improve the sensitivity of the test for tumors of stages 1 and 2, nonetheless this assay might help to determine therapeutic strategies prior to tumor biopsy, especially for patients with a life-threatening condition, as well as for patients of less than 18 months of age whose risk-grouping and treatment allocation depends on their MNA status.	[Yagyu, Shigeki; Iehara, Tomoko; Gotoh, Takahiro; Misawa-Furihata, Akiko; Sugimoto, Tohru; Hosoi, Hajime] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan; [Tanaka, Shiro] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [London, Wendy B.] Harvard Med Sch, Dana Farber Canc Inst, Childrens Hosp Boston, Div Hematol Oncol, Boston, MA USA; [Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Hogarty, Michael D.; Maris, John M.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Hogarty, Michael D.; Maris, John M.] Univ Penn, Philadelphia, PA 19104 USA; [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biostat, Kyoto, Japan; [Nakagawara, Akira] Chiba Canc Ctr, Div Biochem & Innovat Canc Therapeut, Chiba, Japan; [Nakagawara, Akira] Saga Med Canc KOSEIKAN, Saga, Japan; [Hiyama, Eiso] Hiroshima Univ, Hiroshima Univ Hosp, Nat Sci Ctr Basic Res & Dev, Dept Pediat Surg, Hiroshima, Japan	Kyoto Prefectural University of Medicine; Kyoto University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Kyoto Prefectural University of Medicine; Chiba Cancer Center; Hiroshima University	Hosoi, H (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan.	hhosoi@koto.kpu-m.ac.jp	Hiyama, Eiso/A-2013-2019; Yagyu, Shigeki/H-9070-2019; 田中, 司朗/GON-6916-2022; Teramukai, Satoshi/I-2249-2019; London, Wendy/ABD-4624-2021; London, Wendy Beth/ABA-8948-2021	Hiyama, Eiso/0000-0001-9179-5037; Yagyu, Shigeki/0000-0003-4256-9783; 田中, 司朗/0000-0001-6817-5235; Teramukai, Satoshi/0000-0003-2184-0597; London, Wendy Beth/0000-0003-3571-6538	Japan Society for the Promotion of Science (JSPS) KAKENHI [25253095]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development (AMED); Kyoto-Funding for Innovation in Health-related RD Fields Grant [88]; Adaptable and Seamless Technology Transfer Program through Target-driven RD [AS221Z03404F]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kyoto-Funding for Innovation in Health-related RD Fields Grant; Adaptable and Seamless Technology Transfer Program through Target-driven RD	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI, Grant Number 25253095, (https://www.jsps.go.jp/english/e-grants/); the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and development (AMED), (http://www.amed.go.jp/en/); Kyoto-Funding for Innovation in Health-related R&D Fields Grant Number 88, (http://www.astem.or.jp/english/); Adaptable and Seamless Technology Transfer Program through Target-driven R&D, Grant Number AS221Z03404F, (http://www.jst.go.jp/tt/EN/univ-ip/a-step.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, CANCER RES, V65, P828; Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bagatell R, 2009, J CLIN ONCOL, V27, P365, DOI 10.1200/JCO.2008.17.9184; Banelli B, 2005, ONCOGENE, V24, P5619, DOI 10.1038/sj.onc.1208722; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Caren H, 2010, P NATL ACAD SCI USA, V107, P4323, DOI 10.1073/pnas.0910684107; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Combaret V, 2009, PEDIATR BLOOD CANCER, V53, P329, DOI 10.1002/pbc.22009; De Bernardi B, 2009, J CLIN ONCOL, V27, P1034, DOI 10.1200/JCO.2008.17.5877; Fritsch P, 2004, PEDIATR BLOOD CANCER, V43, P679, DOI 10.1002/pbc.20126; Gotoh T, 2005, J CLIN ONCOL, V23, P5205, DOI 10.1200/JCO.2005.02.014; Hero B, 2008, J CLIN ONCOL, V26, P1504, DOI 10.1200/JCO.2007.12.3349; Hiyama E, 2008, LANCET, V371, P1173, DOI 10.1016/S0140-6736(08)60523-1; Iehara T, 2006, BRIT J CANCER, V94, P1510, DOI 10.1038/sj.bjc.6603149; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; London WB, 2005, J CLIN ONCOL, V23, P6459, DOI 10.1200/JCO.2005.05.571; Nawroz H, 1996, NAT MED, V2, P1035, DOI 10.1038/nm0996-1035; Nuchtern JG, 2012, ANN SURG, V256, P573, DOI 10.1097/SLA.0b013e31826cbbbd; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Peuchmaur M, 2003, CANCER, V98, P2274, DOI 10.1002/cncr.11773; SAWADA T, 1990, Acta Paediatrica Japonica, V32, P725; SAWADA T, 1984, CANCER, V53, P2731, DOI 10.1002/1097-0142(19840615)53:12<2731::AID-CNCR2820531232>3.0.CO;2-D; SAWADA T, 1984, LANCET, V2, P271; Sawada T, 1994, Prog Clin Biol Res, V385, P371; SCHILLING FH, 1994, LANCET, V344, P1157, DOI 10.1016/S0140-6736(94)90665-3; Sozzi G, 2001, CANCER RES, V61, P4675; Woods WG, 1996, LANCET, V348, P1682, DOI 10.1016/S0140-6736(96)06020-5; Yagyu S, 2008, CLIN CANCER RES, V14, P7011, DOI 10.1158/1078-0432.CCR-08-1249; Yagyu S, 2011, CANCER LETT, V309, P185, DOI 10.1016/j.canlet.2011.05.032; Yamamoto K, 1998, J CLIN ONCOL, V16, P1265, DOI 10.1200/JCO.1998.16.4.1265; Yoneda A, 2001, MED PEDIATR ONCOL, V36, P160, DOI 10.1002/1096-911X(20010101)36:1<160::AID-MPO1039>3.0.CO;2-G	32	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161039	10.1371/journal.pone.0161039	http://dx.doi.org/10.1371/journal.pone.0161039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513929	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100114
J	Wang, DJ; Shen, YX; Li, YH; Huang, J				Wang, Dianjie; Shen, Youxin; Li, Yuhui; Huang, Jin			Rock Outcrops Redistribute Organic Carbon and Nutrients to Nearby Soil Patches in Three Karst Ecosystems in SW China	PLOS ONE			English	Article							STEM-FLOW; THROUGHFALL; CANOPY; FOREST	Emergent rock outcrops are common in terrestrial ecosystems. However, little research has been conducted regarding their surface function in redistributing organic carbon and nutrient fluxes to soils nearby. Water that fell on and ran off 10 individual rock outcrops was collected in three 100 x 100 m plots within a rock desertification ecosystem, an anthropogenic forest ecosystem, and a secondary forest ecosystem between June 2013 and June 2014 in Shilin, SW China. The concentrations of total organic carbon (TOC), total nitrogen (N), total phosphorus (P), and potassium (K) in the water samples were determined during three seasons, and the total amounts received by and flowing out from the outcrops were calculated. In all three ecosystems, TOC and N, P, and K were found throughout the year in both the water received by and delivered to nearby soil patches. Their concentrations and amounts were generally greater in forested ecosystems than in the rock desertification ecosystem. When rock outcrops constituted a high percentage (>= 30%) of the ground surface, the annual export of rock outcrop runoff contributed a large amount of organic carbon and N, P, and K nutrients to soil patches nearby by comparison to the amount soil patches received via atmospheric deposition. These contributions may increase the spatial heterogeneity of soil fertility within patches, as rock outcrops of different sizes, morphologies, and emergence ratios may surround each soil patch.	[Wang, Dianjie; Shen, Youxin] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Peoples R China; [Li, Yuhui] Yunnan Normal Univ, Kunming, Peoples R China; [Huang, Jin] Stone Forest Scen Area Adm, Shilin, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Normal University	Shen, YX (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Menglun, Peoples R China.	yxshen@xtbg.ac.cn	li, yuhui/Q-1730-2019		National Natural Science Foundation of China [41262013, 41371514];  [O7ZK101K02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	O7ZK101K02; http://www.pe.cas.cn/bszn/rcc/200905/t20090513_65052.html; and The National Natural Science Foundation of China (41262013, 41371514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK MR, 1985, J ECOL, V73, P625, DOI 10.2307/2260499; Budel B, 1999, EUR J PHYCOL, V34, P361, DOI 10.1080/09670269910001736422; Cao J, 2005, KARST ECOSYSTEM SW C; Chan YK, 2012, ENVIRON MICROBIOL, V14, P2272, DOI 10.1111/j.1462-2920.2012.02821.x; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Clark KL, 1998, J TROP ECOL, V14, P27, DOI 10.1017/S0266467498000030; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; EATON JS, 1973, J ECOL, V61, P495, DOI 10.2307/2259041; Elbert W, 2009, BIOGEOSCIENCES, V6, P6983, DOI [DOI 10.5194/BGD-6-6983-2009, 10.5194/bgd-6-6983-2009]; Elbert W, 2012, NAT GEOSCI, V5, P459, DOI 10.1038/ngeo1486; Ford D.C., 2007, KARST HYDROGEOLOGY G, DOI DOI 10.1002/9781118684986.CH6; GAMS I, 1993, ENVIRON GEOL, V21, P110, DOI 10.1007/BF00775293; GERSPER PL, 1971, ECOLOGY, V52, P691, DOI 10.2307/1934160; Goransson H, 2014, BIOGEOCHEMISTRY, V121, P329, DOI 10.1007/s10533-014-0031-x; Hartmann A, 2016, BIOGEOSCIENCES, V13, P159, DOI 10.5194/bg-13-159-2016; Huan ZQ, 2008, FOREST ECOL MANAG, V254, P46, DOI 10.1016/j.foreco.2007.07.021; Kidron GJ, 2012, J HYDROL, V420, P284, DOI 10.1016/j.jhydrol.2011.12.014; Lange J, 2003, HYDROL PROCESS, V17, P279, DOI 10.1002/hyp.1124; Li Chao, 2013, Acta Ecologica Sinica, V33, P2410; [李阳兵 Li Yangbing], 2004, [生态环境, Ecology and Environment], V13, P434; Li YB, 2004, ECTA PEDOLOGICA SINI, V41, P196; Lian Bin, 2010, Bulletin of Mineralogy, Petrology and Geochemistry, V29, P52; Liu C.Q., 2009, BIOGEOCHEMICAL PROCE; Mathers NJ, 2003, FOREST ECOL MANAG, V175, P467, DOI 10.1016/S0378-1127(02)00182-2; [沈有信 Shen Youxin], 2005, [广西植物, Guihaia], V25, P321; Song L, 1997, STONE FOREST TREASUR; STILING PD, 1996, ECOLOGY THEORIES APP; [田友萍 Tian Youping], 2002, [生态学报, Acta Ecologica Sinica], V22, P1793; [田友萍 Tian Youping], 2003, [中国岩溶, Carsologica Sinica], V22, P203; Tretiach M., 1995, GAZZ BOT ITAL, V129, P159; Wang DJ, 2016, ENVIRON SCI POLLUT R, V23, P8610, DOI 10.1007/s11356-016-6091-9; [王电杰 Wang Dianjie], 2015, [山地学报, Mountain Research], V33, P16; Wang MZ, 2005, STUDY ECOGEOLOGICAL; [徐海清 Xu Haiqing], 2006, [广西植物, Guihaia], V26, P43; Yuan D, 1994, KARST SCI CHINA; Yuan DX, 1988, SCI KARST ENV; Zhang F.M., 1997, STUDY LUNAN STONE FO; [张红波 Zhang Hongbo], 2012, [中国岩溶, Carsologica Sinica], V31, P289; Zhang Wei, 2006, Scientia Agricultura Sinica, V39, P1828; Zhou YY, 2004, KARST ECOSYSTEM SW C	40	20	23	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160773	10.1371/journal.pone.0160773	http://dx.doi.org/10.1371/journal.pone.0160773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509199	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400054
J	Burdam, FH; Hakimi, M; Thio, F; Kenangalem, E; Indrawanti, R; Noviyanti, R; Trianty, L; Marfurt, J; Handayuni, I; Soenarto, Y; Douglas, NM; Anstey, NM; Price, RN; Poespoprodjo, JR				Burdam, Faustina Helena; Hakimi, Mohammad; Thio, Franciscus; Kenangalem, Enny; Indrawanti, Ratni; Noviyanti, Rintis; Trianty, Leily; Marfurt, Jutta; Handayuni, Irene; Soenarto, Yati; Douglas, Nicholas M.; Anstey, Nicholas M.; Price, Ric N.; Poespoprodjo, Jeanne Rini			Asymptomatic Vivax and Falciparum Parasitaemia with Helminth Co-Infection: Major Risk Factors for Anaemia in Early Life	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; PLASMODIUM-FALCIPARUM; ASCARIS-LUMBRICOIDES; PRESCHOOL-CHILDREN; MALARIA; INFECTIONS; TRANSMISSION; INDONESIA; INFANCY; IMPACT	Background Anaemia in children under five years old is associated with poor health, growth and developmental outcomes. In Papua, Indonesia, where the burden of anaemia in infants is high, we conducted a community survey to assess the association between Plasmodium infection, helminth carriage and the risk of anaemia. Methods A cross sectional household survey was carried out between April and July 2013 in 16 villages in the District of Mimika using a multistage sampling procedure. A total of 629 children aged 1-59 months from 800 households were included in the study. Demographic, symptom and anthropometry data were recorded using a standardized questionnaire. Blood and stool samples were collected for examination. Results Of the 533 children with blood film examination, 8.8% (47) had P. vivax parasitaemia and 3.9% (21) had P. falciparum; the majority of children with malaria were asymptomatic (94.4%, 68/72). Soil transmitted helminth (STH) infection was present in 43% (105/269) of children assessed; those with STH were at significantly greater risk of P. vivax parasitaemia compared to those without STH (OR = 3.7 [95% CI 1.5-9.2], p = 0.004). Anaemia (Hb < 10 g/dl) was present in 24.5% (122/497) of children and associated with P. vivax parasitaemia (OR = 2.9 [95% CI, 1.7-4.9], p = 0.001), P. falciparum parasitaemia (OR = 4.3 [95% CI, 2.0-9.4], p < 0.001), hookworm carriage (OR = 2.6 [95% CI, 1.2-5.8], p = 0.026), Plasmodium-helminth coinfection (OR 4.0 [95% CI, 1.4-11.3], p = 0.008) and severe stunting (OR = 1.9 ([95% CI, 1.1-3.3], p = 0.012). Conclusions Asymptomatic P. vivax and P. falciparum infections and hookworm all contribute to risk of paediatric anaemia in coendemic areas and should be targeted with prevention and treatment programs. The relationship between helminth infections and the increased risk of P. vivax parasitaemia should be explored prospectively.	[Burdam, Faustina Helena; Kenangalem, Enny] Mimika Dist Hlth Author, Timika, Papua, Indonesia; [Thio, Franciscus; Kenangalem, Enny; Poespoprodjo, Jeanne Rini] Mimika Dist Hosp, Timika, Papua, Indonesia; [Burdam, Faustina Helena; Thio, Franciscus; Kenangalem, Enny; Poespoprodjo, Jeanne Rini] Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia; [Indrawanti, Ratni; Soenarto, Yati; Poespoprodjo, Jeanne Rini] Univ Gadjah Mada, Dr Sardjito Hosp, Fac Med, Dept Child Hlth, Yogyakarta, Indonesia; [Burdam, Faustina Helena; Hakimi, Mohammad] Univ Gadjah Mada, Fac Med, Dept Publ Hlth, Maternal & Child Hlth & Reprod Hlth, Yogyakarta, Indonesia; [Noviyanti, Rintis; Trianty, Leily] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Marfurt, Jutta; Handayuni, Irene; Douglas, Nicholas M.; Anstey, Nicholas M.; Price, Ric N.] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT, Australia; [Marfurt, Jutta; Handayuni, Irene; Douglas, Nicholas M.; Anstey, Nicholas M.; Price, Ric N.] Charles Darwin Univ, Darwin, NT, Australia; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Central General Hospital Dr. Sardjito; Gadjah Mada University; Gadjah Mada University; Eijkman Institute; Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Oxford	Poespoprodjo, JR (corresponding author), Mimika Dist Hosp, Timika, Papua, Indonesia.; Poespoprodjo, JR (corresponding author), Papuan Hlth & Community Dev Fdn, Timika Malaria Res Programme, Timika, Papua, Indonesia.; Poespoprodjo, JR (corresponding author), Univ Gadjah Mada, Dr Sardjito Hosp, Fac Med, Dept Child Hlth, Yogyakarta, Indonesia.	didot2266@yahoo.com	Poespoprodjo, Jeanne/AAF-1698-2020; Hakimi, Mohammad/GOV-6587-2022; Indrawanti, Ratni/GOP-2405-2022; Douglas, Nicholas/ABC-3052-2021	Poespoprodjo, Jeanne/0000-0003-1573-734X; Douglas, Nicholas/0000-0002-7214-4244; Noviyanti, Rintis/0000-0003-1383-3274; Price, Richard/0000-0003-2000-2874; Trianty, Leily/0000-0002-4368-476X	Wellcome Trust [091625, 099875]; DFAT (Australian Department of Foreign Affairs and Trade); NHMRC [1037304]	Wellcome Trust(Wellcome TrustEuropean Commission); DFAT (Australian Department of Foreign Affairs and Trade); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the Wellcome Trust (a Senior Fellowship in Clinical Science awarded to RNP - 091625 and Training Fellowships awarded to JRP - 099875). The Timika Research Facility and Papuan Health and Community Development Foundation were supported by DFAT (Australian Department of Foreign Affairs and Trade) and the NHMRC (Program Grant 1037304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanyie FA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-1; [Anonymous], 2005, GUIDELINES SAMPLING; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Brabin BJ, 2001, J NUTR, V131, P2; Brabin BJ, 2001, J NUTR, V131, p46S; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Carter RC, 2010, PEDIATRICS, V126, pE427, DOI 10.1542/peds.2009-2097; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; Degarege A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-291; DHO M, 2014, MIM DISTR HLTH OFF M; Douglas NM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001575; Douglas NM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-135; Ekiz C, 2005, HEMATOL J, V5, P579, DOI 10.1038/sj.thj.6200574; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Karyana M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-148; Kinung'hi SM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0864-5; LAWLESS JW, 1994, J NUTR, V124, P645, DOI 10.1093/jn/124.5.645; Le Hesran JY, 2004, T ROY SOC TROP MED H, V98, P397, DOI 10.1016/j.trstmh.2003.10.009; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maketa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0595-5; Melo GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011206; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; MOH I, IND DEM HLTH SURV 20; MOH I, NAT GUID MAL TREATM; MOH I, 2006, NAT GUID MAL TREATM; MURRAY J, 1978, AM J CLIN NUTR, V31, P1363, DOI 10.1093/ajcn/31.8.1363; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Nacher M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-259; Oppenheimer SJ, 2001, J NUTR, V131, p616S, DOI 10.1093/jn/131.2.616S; Poespoprodjo JR, 2011, J INFECT DIS, V204, P1613, DOI 10.1093/infdis/jir558; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Ratcliff A, 2007, LANCET, V369, P757, DOI 10.1016/S0140-6736(07)60160-3; Ratcliff A, 2007, T ROY SOC TROP MED H, V101, P351, DOI 10.1016/j.trstmh.2006.06.008; Research Facility T, 2010, RSMM HOSP MORB SURV; Righetti AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001889; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Senn N, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001195; Shapiro AE, 2005, T ROY SOC TROP MED H, V99, P18, DOI 10.1016/j.trstmh.2004.02.006; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Tarafder MR, 2010, INT J PARASITOL, V40, P399, DOI 10.1016/j.ijpara.2009.09.003; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P68, DOI 10.4269/ajtmh.2003.68.68; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; WHO, WHO CHILD GROWTH STA; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT	50	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160917	10.1371/journal.pone.0160917	http://dx.doi.org/10.1371/journal.pone.0160917			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504828	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200078
J	Carvalho, JT; Nolfi, S				Carvalho, Jonata Tyska; Nolfi, Stefano			Cognitive Offloading Does Not Prevent but Rather Promotes Cognitive Development	PLOS ONE			English	Article							MEMORY; INFORMATION; SEQUENCES; EVOLUTION; DYNAMICS	We investigate the relation between the development of reactive and cognitive capabilities. In particular we investigate whether the development of reactive capabilities prevents or promotes the development of cognitive capabilities in a population of evolving robots that have to solve a time-delay navigation task in a double T-Maze environment. Analysis of the experiments reveals that the evolving robots always select reactive strategies that rely on cognitive offloading, i.e., the possibility of acting so as to encode onto the relation between the agent and the environment the states that can be used later to regulate the agent's behavior. The discovery of these strategies does not prevent, but rather facilitates, the development of cognitive strategies that also rely on the extraction and use of internal states. Detailed analysis of the results obtained in the different experimental conditions provides evidence that helps clarify why, contrary to expectations, reactive and cognitive strategies tend to have synergetic relationships.	[Carvalho, Jonata Tyska; Nolfi, Stefano] CNR, Inst Cognit Sci & Technol, Via S Martino della Battaglia 44, I-00185 Rome, Italy; [Carvalho, Jonata Tyska] Fed Univ Rio Grande, Ctr Computat Sci C3, Av Italia,Km 8, BR-96203900 Rio Grande, Brazil	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Universidade Federal do Rio Grande	Carvalho, JT (corresponding author), CNR, Inst Cognit Sci & Technol, Via S Martino della Battaglia 44, I-00185 Rome, Italy.; Carvalho, JT (corresponding author), Fed Univ Rio Grande, Ctr Computat Sci C3, Av Italia,Km 8, BR-96203900 Rio Grande, Brazil.	jonatatyska@gmail.com; stefano.nolfi@istc.cnr.it	Tyska Carvalho, Jonata/GPG-3909-2022	Tyska Carvalho, Jonata/0000-0001-9020-2076	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [9052-13-5]; CAPES through the Brazilian program science without borders	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES through the Brazilian program science without borders	JTC has a PhD Scholarship provided by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (http://www.capes.gov.br), Grant number: 9052-13-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is partially funded by CAPES through the Brazilian program science without borders. We thank Giovanni Pezzulo and the anonymous reviewers for useful comments.	[Anonymous], 2007, BODY SHAPES WAY WE T; Antonelo E, 2008, IEEE INT CONF ROBOT, P911, DOI 10.1109/ROBOT.2008.4543321; Bakker B., 2003, P 2003 IEEE RSJ INT, V1, P430, DOI DOI 10.1109/IROS.2003.1250667; Beer R. D., 1996, From Animals to Animats 4. Proceedings of the Fourth International Conference on Simulation of Adaptive Behavior, P421; Beer Randall D., 1992, Adaptive Behavior, V1, P91, DOI 10.1177/105971239200100105; Beer RD, 2003, ADAPT BEHAV, V11, P209, DOI 10.1177/1059712303114001; Blynel J, 2003, LECT NOTES COMPUT SC, V2611, P593; Bonani M, 2010, IEEE INT C INT ROBOT, P4187, DOI 10.1109/IROS.2010.5649153; Chung JR, 2011, IEEE T AUTON MENT DE, V3, P257, DOI 10.1109/TAMD.2011.2132800; Clark A, 1999, TRENDS COGN SCI, V3, P345, DOI 10.1016/S1364-6613(99)01361-3; Clark A, 1998, BEING THERE PUTTING; de Greeff J, 2010, EVOLUTION OF COMMUNICATION AND LANGUAGE IN EMBODIED AGENTS, P179, DOI 10.1007/978-3-642-01250-1_11; Duarte M, 2015, J INTELL ROBOT SYST, V78, P463, DOI 10.1007/s10846-014-0086-x; Floreano D, 1996, IEEE T SYST MAN CY B, V26, P396, DOI 10.1109/3477.499791; Gigliotta O, 2008, ADAPT BEHAV, V16, P148, DOI 10.1177/1059712308089184; Gigliotta O, 2011, THEOR BIOSCI, V130, P259, DOI 10.1007/s12064-011-0128-x; Gilbert SJ, 2015, Q J EXP PSYCHOL, V68, P971, DOI 10.1080/17470218.2014.972963; Gilbert SJ, 2015, CONSCIOUS COGN, V33, P245, DOI 10.1016/j.concog.2015.01.006; Hartland C, 2009, IEEE C EVOL COMPUTAT, P2788, DOI 10.1109/CEC.2009.4983292; Jerde TE, 2003, J NEUROSCI, V23, P2383; Keijzer FA, 2002, COGNITIVE SYSTEMS RE, V3, P275; Lehman J., 2014, P 2014 ANN C GEN EV; Linaker F., 2001, INT JOINT C ART INT, P777; Maeda N, 2012, P 34 ANN M COGN SCI, P1954; Massera G., 2013, ADV ARTIFICIAL LIFE, V12, P538, DOI DOI 10.7551/978-0-262-31709-2-CH078; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; Nasr GE., 2002, P FLAIRS, P381; Nolfi S., HDB ROBOTIC IN PRESS; Ollion C, 2012, ARTIF LIFE, V13, P407; Paine RW, 2005, ADAPT BEHAV, V13, P211, DOI 10.1177/105971230501300303; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; PORT RF, 1995, MIND MOTION; Risko EF, 2015, CONSCIOUS COGN, V36, P61, DOI 10.1016/j.concog.2015.05.014; Rylatt RM, 2000, NEURAL PROCESS LETT, V12, P145, DOI 10.1023/A:1009645229062; Slocum AC, 2000, FROM ANIM ANIMAT, P430; Sperati V., 2008, SWARM ROBOTICS SWARM, V4, P73; Steward J., 2010, ENACTION NEW PARADIG; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Tversky B, 2011, TOP COGN SCI, V3, P499, DOI 10.1111/j.1756-8765.2010.01113.x; Varela F., 1991, EMBODIED MIND; VONHOFSTEN C, 1988, J EXP PSYCHOL HUMAN, V14, P610, DOI 10.1037/0096-1523.14.4.610; Wikenheiser AM, 2015, CURR OPIN NEUROBIOL, V32, P8, DOI 10.1016/j.conb.2014.10.002; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Ziemke T, 2002, ADAPT BEHAV, V10, P185, DOI 10.1177/1059712302010003003	45	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160679	10.1371/journal.pone.0160679	http://dx.doi.org/10.1371/journal.pone.0160679			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IK	27505162	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200056
J	Gusdal, AK; Josefsson, K; Adolfsson, ET; Martin, L				Gusdal, Annelie K.; Josefsson, Karin; Adolfsson, Eva Thors; Martin, Lene			Registered Nurses' Perceptions about the Situation of Family Caregivers to Patients with Heart Failure - A Focus Group Interview Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-PROMOTING CONVERSATIONS; SELF-CARE; EUROPEAN-SOCIETY; SOCIAL SUPPORT; SHARED CARE; TASK-FORCE; HIGH-RISK; MANAGEMENT; ASSOCIATION	Introduction Heart failure is a growing public health problem associated with poor quality of life and significant morbidity and mortality. The majority of heart failure care is provided by family caregivers, and is associated with caregiver burden and reduced quality of life. Research emphasizes that future nursing interventions should recognize the importance of involving family caregivers to achieve optimal outcomes. Aims The aims of this study are to explore registered nurses' perceptions about the situation of family caregivers to patients with heart failure, and registered nurses' interventions, in order to improve family caregivers' situation. Methods The study has a qualitative design with an inductive approach. Six focus group interviews were held with 23 registered nurses in three hospitals and three primary health care centres. Data were analysed using qualitative content analysis. Results Two content areas were identified by the a priori study aims. Four categories and nine subcategories emerged in the analysis process. The content area "Family caregivers' situation" includes two categories: "To be unburdened" and "To comprehend the heart failure condition and its consequences". The content area "Interventions to improve family caregivers' situation" includes two categories: "Individualized support and information" and "Bridging contact". Conclusions Registered nurses perceive family caregivers' situation as burdensome, characterized by worry and uncertainty. In the PHCCs, the continuity and security of an RN as a permanent health care contact was considered an important and sustainable intervention to better care for family caregivers' worry and uncertainty. In the nurse-led heart failure clinics in hospitals, registered nurses can provide family caregivers with the opportunity of involvement in their relative's health care and address congruence and relationship quality within the family through the use of "Shared care" and or Family-centred care. Registered nurses consider it necessary to have a coordinated individual care plan as a basis for collaboration between the county council and the municipality.	[Gusdal, Annelie K.; Josefsson, Karin; Martin, Lene] Malardalen Univ, Sch Hlth Care & Social Welf, Eskilstuna, Sweden; [Josefsson, Karin] Univ Boras, Fac Caring Sci Work Life & Social Welf, Boras, Sweden; [Adolfsson, Eva Thors] Uppsala Univ, Cty Council Vastmanland, Clin Res Ctr, Vasteras, Sweden; [Adolfsson, Eva Thors] Vastmanland Cty Hosp, Dept Primary Hlth Care, Vasteras, Sweden; [Martin, Lene] City Univ London, Sch Hlth Sci, London, England	Malardalen University; University of Boras; Uppsala University; Vasteras Central Hospital; City University London	Gusdal, AK (corresponding author), Malardalen Univ, Sch Hlth Care & Social Welf, Eskilstuna, Sweden.	annelie.gusdal@mdh.se						Agren S, 2012, J CARD FAIL, V18, P359, DOI 10.1016/j.cardfail.2012.01.014; Agren S, 2010, EUR J CARDIOVASC NUR, V9, P254, DOI 10.1016/j.ejcnurse.2010.03.001; Annema C, 2009, HEART LUNG, V38, P427, DOI 10.1016/j.hrtlng.2008.12.002; Arestedt K, 2013, EUR J CARDIOVASC NUR, V12, P69, DOI 10.1177/1474515111432997; Bell JM, 2009, BELIEFS AND ILLNESS; Benzein E., 2012, ATT MOTA FAMILJER IN; Benzein E., 2010, FAMILJEFOKUSERAD OMV; Benzein EG, 2008, NURS INQ, V15, P106, DOI 10.1111/j.1440-1800.2008.00401.x; Benzein EG, 2008, INT J PALLIAT NURS, V14, P439, DOI 10.12968/ijpn.2008.14.9.31124; Bidwell JT, 2015, RES NURS HLTH; Brinkmann S, 2009, DEN KVALITATIVA FORS; Buck HG, 2015, EUR J CARDIOVASC NUR, V14, P79, DOI 10.1177/1474515113518434; Clark AM, 2008, J ADV NURS, V61, P373, DOI 10.1111/j.1365-2648.2007.04527.x; Clark AM, 2014, HEART, V100, P716, DOI 10.1136/heartjnl-2013-304852; Duhamel F, 2007, CLIN NURSE SPEC, V21, P43, DOI 10.1097/00002800-200701000-00009; Gallagher R, 2011, J CARDIOVASC NURS, V26, P439, DOI 10.1097/JCN.0b013e31820984e1; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gusdal A.K., 2014, J CARDIOVASC NURS; Hartmann M, 2010, PSYCHOTHER PSYCHOSOM, V79, P136, DOI 10.1159/000286958; Holloway I, 2010, QUALITATIVE RES; Hooker SA, 2015, J CARDIOVASC NURS, V30, P52; Jaarsma T, 2014, CAN J CARDIOL, V30, P272, DOI 10.1016/j.cjca.2013.09.022; Kang XF, 2011, J CARDIOVASC NURS, V26, P386, DOI 10.1097/JCN.0b013e3182076a69; Kitko LA, 2014, CLIN NURS RES; Kosiborod M, 2007, CIRCULATION, V115, P1975, DOI 10.1161/CIRCULATIONAHA.106.670901; Krippendorff K., 2013, CONTENT ANALYSIS AN; Krueger R., 2015, FOCUS GROUPS; Lum HD, 2014, HEART LUNG, V43, P306, DOI 10.1016/j.hrtlng.2014.05.002; Luttik Marie Louise, 2005, Eur J Cardiovasc Nurs, V4, P11, DOI 10.1016/j.ejcnurse.2004.12.002; Martensson J, 2009, EUR J CARDIOVASC NUR, V8, P119, DOI 10.1016/j.ejcnurse.2008.10.002; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McDonagh TA, 2011, EUR J HEART FAIL, V13, P235, DOI 10.1093/eurjhf/hfq221; McLafferty I, 2004, J ADV NURS, V48, P187, DOI 10.1111/j.1365-2648.2004.03186.x; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Molloy GJ, 2005, EUR J HEART FAIL, V7, P592, DOI 10.1016/j.ejheart.2004.07.008; NVivo10, 2012, NVIVO SOFTWARE PROGR; Ostlund U, 2014, J FAM NURS, V20, P259, DOI 10.1177/1074840714542962; Pihl E, 2005, EUR J HEART FAIL, V7, P583, DOI 10.1016/j.ejheart.2004.07.016; Pihl Emma, 2010, Can J Cardiovasc Nurs, V20, P9; Pressler SJ, 2013, J CARDIOVASC NURS, V28, P417, DOI 10.1097/JCN.0b013e3182563877; Retrum JH, 2013, J CARDIOVASC NURS, V28, P129, DOI 10.1097/JCN.0b013e3182435f27; Roccaforte R, 2005, EUR J HEART FAIL, V7, P1133, DOI 10.1016/j.ejheart.2005.08.005; Roger VL, 2010, INT J ENV RES PUB HE, V7, P1807, DOI 10.3390/ijerph7041807; Salyer J, 2012, J CARDIOVASC NURS, V27, P384, DOI 10.1097/JCN.0b013e31823228cd; Sebern M, 2005, J ADV NURS, V52, P170, DOI 10.1111/j.1365-2648.2005.03580.x; Sebern MD, 2012, WESTERN J NURS RES, V34, P289, DOI 10.1177/0193945911399088; Sochalski J, 2009, HEALTH AFFAIR, V28, P179, DOI 10.1377/hlthaff.28.1.179; SoS Socialstyrelsen, 2008, HJARTSVIKT VETENSKAP; Stromberg A, 2003, EUR HEART J, V24, P1014, DOI 10.1016/S0195-668X(03)00112-X; Stromberg A, 2006, DIAGNOSTIK OCH BEHAN; Stromberg Anna, 2013, Curr Heart Fail Rep, V10, P270, DOI 10.1007/s11897-013-0146-8; SwedeHF, THE SWEDISH HEART FA; Takeda A, 2012, COCHRANE DB SYST REV, V9; Trivedi RB, 2012, J CARDIOVASC NURS, V27, P24, DOI 10.1097/JCN.0b013e3182129ce7; Voltelen B., 2016, THESIS; Whittingham K, 2013, PALLIATIVE MED, V27, P596, DOI 10.1177/0269216313477179; WMA World Medical Association, 2015, DECLARATION OF HELSI; Wright L. M., 2013, NURSES AND FAMILIES; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	60	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160302	10.1371/journal.pone.0160302	http://dx.doi.org/10.1371/journal.pone.0160302			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IK	27505287	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200030
J	Tian, B; Maidana, DE; Dib, B; Miller, JB; Bouzika, P; Miller, JW; Vavvas, DG; Lin, HJ				Tian, Bo; Maidana, Daniel E.; Dib, Bernard; Miller, John B.; Bouzika, Peggy; Miller, Joan W.; Vavvas, Demetrios G.; Lin, Haijiang			miR-17-3p Exacerbates Oxidative Damage in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							MITOCHONDRIAL SUPEROXIDE-DISMUTASE; GENE-EXPRESSION; DOWN-REGULATION; MOUSE MODEL; STRESS; THIOREDOXIN; ANTIOXIDANT; LIGHT; SOD2; PHAGOCYTOSIS	Oxidative stress has been shown to contribute to the development of age-related macular degeneration (AMD). MicroRNAs (miRNA) are small non-coding RNA molecules that function in RNA silencing and post-transcriptional regulation of gene expression. We showed miR-17-3p to be elevated in macular RPE cells from AMD patients and in ARPE-19 cells under oxidative stress. Transfection of miR-17-3p mimic in ARPE-19 induced cell death and exacerbated oxidative lethality that was alleviated by miR-17-3p inhibitor. The expression of antioxidant enzymes manganese superoxide dismutase (MnSOD) and thioredoxin reductase-2 (TrxR(2)) were suppressed by miR-17-3p mimic and reversed by miR-17-3p inhibitor. These results suggest miR-17-3p aggravates oxidative damage-induced cell death in human RPE cells, while miR-17-3p inhibitor acts as a potential protector against oxidative stress by regulating the expression of antioxidant enzymes.	[Tian, Bo; Maidana, Daniel E.; Dib, Bernard; Miller, John B.; Bouzika, Peggy; Miller, Joan W.; Vavvas, Demetrios G.; Lin, Haijiang] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Retina Serv, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA; [Tian, Bo] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou, Henan, Peoples R China	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Zhengzhou University	Vavvas, DG; Lin, HJ (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear Infirm, Retina Serv, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA.	Demetrios_Vavvas@meei.harvard.edu; Haijiang_Lin@meei.harvard.edu	Miller, John J/GZG-5663-2022	Lin, Haijiang/0000-0003-2931-468X; Vavvas, Demetrios/0000-0002-8622-6478; Dib, Bernard/0000-0001-8973-9503	NEI [R21EY023079-01A1, EY014104]; Yeatts Family Foundation; Loefflers Family Fund; Macula Society Research Grant award; Physician Scientist Award; research to prevent blindness foundation; Bayer Healthcare Global Ophthalmology Award; NATIONAL EYE INSTITUTE [P30EY014104, R21EY023079, R01EY025362] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Yeatts Family Foundation; Loefflers Family Fund; Macula Society Research Grant award; Physician Scientist Award; research to prevent blindness foundation(Research to Prevent Blindness (RPB)); Bayer Healthcare Global Ophthalmology Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by: NEI R21EY023079-01A1 (DGV); the Yeatts Family Foundation (DGV, JWM); the Loefflers Family Fund (DGV, JWM); the 2013 Macula Society Research Grant award (DGV); a Physician Scientist Award (DGV), an unrestricted grant (JWM) from the research to prevent blindness foundation; NEI grant EY014104 (Meei Core Grant); and Bayer Healthcare Global Ophthalmology Award (DEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by: NEI R21EY023079-01A1 (DGV); the Yeatts Family Foundation (DGV, JWM); the Loefflers Family Fund (DGV, JWM); the 2013 Macula Society Research Grant award (DGV); a Physician Scientist Award (DGV), an unrestricted grant (JWM) from the research to prevent blindness foundation; NEI grant EY014104 (Meei Core Grant); and Bayer Healthcare Global Ophthalmology Award (DEM). The authors would like to thank Kassandra Kosmidou for proofreading this manuscript.	AKEO K, 1988, CURR EYE RES, V7, P961, DOI 10.3109/02713688809015141; Alizadeh M, 2001, INVEST OPHTH VIS SCI, V42, P2706; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BECQUET F, 1994, EXP CELL RES, V212, P374, DOI 10.1006/excr.1994.1157; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Brunk UT, 1995, GERONTOLOGY, V41, P201; Chen JA, 2011, NEURON, V69, P721, DOI 10.1016/j.neuron.2011.01.014; Curti V, 2014, MOL NUTR FOOD RES, V58, P1776, DOI 10.1002/mnfr.201400007; DELVECCHIO PJ, 1991, CURR EYE RES, V10, P919, DOI 10.3109/02713689109020327; Dib B, 2015, BBA-MOL CELL RES, V1853, P2897, DOI 10.1016/j.bbamcr.2015.08.012; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; DOREY CK, 1990, CURR EYE RES, V9, P549, DOI 10.3109/02713689008999595; DOREY CK, 1989, INVEST OPHTH VIS SCI, V30, P1047; Du WW, 2015, J CELL SCI, V128, P293, DOI 10.1242/jcs.158360; Flores Lisa C, 2012, Longev Healthspan, V1, P4, DOI 10.1186/2046-2395-1-4; Fukui M, 2010, FREE RADICAL BIO MED, V48, P821, DOI 10.1016/j.freeradbiomed.2009.12.024; Garcia TY, 2015, INVEST OPHTH VIS SCI, V56, P7480, DOI 10.1167/iovs.15-17251; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Guo L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/168358; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Haque R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042542; He Yuan, 2010, J Ocul Biol Dis Infor, V3, P92, DOI 10.1007/s12177-011-9061-y; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Jiang X, 2011, CELL BIOCHEM FUNCT, V29, P164, DOI 10.1002/cbf.1728; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kasahara E, 2005, INVEST OPHTH VIS SCI, V46, P3426, DOI 10.1167/iovs.05-0344; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim Min-Ho, 2003, Korean J Ophthalmol, V17, P19; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kowaltowski AJ, 2004, FREE RADICAL BIO MED, V37, P1845, DOI 10.1016/j.freeradbiomed.2004.09.005; Kucera O, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/752506; Kutty RK, 2010, MOL VIS, V16, P1475; Lad EM, 2015, GRAEF ARCH CLIN EXP, V253, P1941, DOI 10.1007/s00417-015-3094-z; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P6308, DOI 10.1167/iovs.10-6632; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Liu T, 2013, DNA CELL BIOL, V32, P685, DOI 10.1089/dna.2013.2032; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Lukiw Walter J, 2012, Int J Biochem Mol Biol, V3, P105; Marazita MC, 2016, REDOX BIOL, V7, P78, DOI 10.1016/j.redox.2015.11.011; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Murad N, 2014, FEBS J, V281, P5251, DOI 10.1111/febs.13066; Myers CR, 2009, TOXICOLOGY, V257, P95, DOI 10.1016/j.tox.2008.12.013; NEWSOME DA, 1990, INVEST OPHTH VIS SCI, V31, P2508; Nishinaka Y, 2001, REDOX REP, V6, P289, DOI 10.1179/135100001101536427; OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Satoh J, 2015, BIOMARK INSIGHTS, V10, P21, DOI [10.4137/BMI.S25132, 10.4137/BMIMI.S25132]; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Sugano E, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/185825; Sugano E, 2013, CELL STRUCT FUNCT, V38, P81, DOI 10.1247/csf.12025; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Szemraj M, 2015, MED SCI MONITOR, V21, P2734, DOI 10.12659/MSM.893697; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Thomas M, 2013, INT J MOL SCI, V14, P12273, DOI 10.3390/ijms140612273; Tripanichkul W, 2007, BRAIN RES, V1164, P24, DOI 10.1016/j.brainres.2007.05.076; Vandenbroucke K, 2008, MOL BIOL EVOL, V25, P507, DOI 10.1093/molbev/msm276; Wang JCC, 2015, MOL VIS, V21, P264; WANG M, 1995, RES COMMUN MOL PATH, V89, P291; Weigel AL, 2003, FREE RADICAL BIO MED, V35, P465, DOI 10.1016/S0891-5849(03)00320-4; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1; Whitmore SS, 2015, PROG RETIN EYE RES, V45, P1, DOI 10.1016/j.preteyeres.2014.11.005; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011004; Yildirim SS, 2013, CELL BIOCHEM BIOPHYS, V67, P1397, DOI 10.1007/s12013-013-9672-y; Yin RT, 2013, J VASC RES, V50, P157, DOI 10.1159/000345697; Yokoyama T, 2006, EXP EYE RES, V83, P602, DOI 10.1016/j.exer.2006.02.016	75	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160887	10.1371/journal.pone.0160887	http://dx.doi.org/10.1371/journal.pone.0160887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505139	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200073
J	Ojo, KK; Ranade, RM; Zhang, ZS; Dranow, DM; Myers, JB; Choi, R; Hewitt, SN; Edwards, TE; Davies, DR; Lorimer, D; Boyle, SM; Barrett, LK; Buckner, FS; Fan, EK; Van Voorhis, WC				Ojo, Kayode K.; Ranade, Ranae M.; Zhang, Zhongsheng; Dranow, David M.; Myers, Janette B.; Choi, Ryan; Hewitt, Steve Nakazawa; Edwards, Thomas E.; Davies, Douglas R.; Lorimer, Donald; Boyle, Stephen M.; Barrett, Lynn K.; Buckner, Frederick S.; Fan, Erkang; Van Voorhis, Wesley C.			Brucella melitensis Methionyl-tRNA-Synthetase (MetRS), a Potential Drug Target for Brucellosis	PLOS ONE			English	Article							UREA-BASED INHIBITORS; RESISTANCE; OPTIMIZATION; DOXYCYCLINE; RIFAMPICIN; PROTEINS; SUIS; MAP	We investigated Brucella melitensis methionyl-tRNA-synthetase (BmMetRS) with molecular, structural and phenotypic methods to learn if BmMetRS is a promising target for brucellosis drug development. Recombinant BmMetRS was expressed, purified from wild type Brucella melitensis biovar Abortus 2308 strain ATCC/CRP #DD-156 and screened by a thermal melt assay against a focused library of one hundred previously classified methionyl-tRNA-synthetase inhibitors of the blood stage form of Trypanosoma brucei. Three compounds showed appreciable shift of denaturation temperature and were selected for further studies on inhibition of the recombinant enzyme activity and cell viability against wild type B. melitensis strain 16M. BmMetRS protein complexed with these three inhibitors resolved into three-dimensional crystal structures and was analyzed. All three selected methionyl-tRNA-synthetase compounds inhibit recombinant BmMetRS enzymatic functions in an aminoacylation assay at varying concentrations. Furthermore, growth inhibition of B. melitensis strain 16M by the compounds was shown. Inhibitor-BmMetRS crystal structure models were used to illustrate the molecular basis of the enzyme inhibition. Our current data suggests that BmMetRS is a promising target for brucellosis drug development. However, further studies are needed to optimize lead compound potency, efficacy and safety as well as determine the pharmacokinetics, optimal dosage, and duration for effective treatment.	[Ojo, Kayode K.; Ranade, Ranae M.; Myers, Janette B.; Choi, Ryan; Hewitt, Steve Nakazawa; Barrett, Lynn K.; Buckner, Frederick S.; Van Voorhis, Wesley C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Emerging & Reemerging Infect Dis, Seattle, WA USA; [Zhang, Zhongsheng; Fan, Erkang] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Dranow, David M.; Edwards, Thomas E.; Davies, Douglas R.; Lorimer, Donald] Beryllium, Bainbridge Isl, WA USA; [Boyle, Stephen M.] Virginia Polytech Inst & State Univ, Ctr Mol Med & Infect Dis, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Virginia Polytechnic Institute & State University	Ojo, KK; Van Voorhis, WC (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Ctr Emerging & Reemerging Infect Dis, Seattle, WA USA.	ojo67kk@u.washington.edu; wesley@uw.edu	Zhang, zs/GXN-3521-2022; Ojo, Kayode/AAB-2490-2019; Ojo, Kayode K/X-9307-2019; Buckner, Frederick/AAF-3938-2020	Ojo, Kayode K/0000-0002-2007-2170; Buckner, Frederick/0000-0001-7796-6477; Edwards, Thomas/0000-0002-0474-8003	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201200025C, R01AI097177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097177] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272201200025C and R01AI097177. The funders provided support in the form of salaries for authors RMR, ZZ, FSB and EF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Sekait M A, 2000, J Family Community Med, V7, P47; Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; [Anonymous], 2016, PERF STAND ANT SUSC; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; Braibant M, 2002, ANTIMICROB AGENTS CH, V46, P3050, DOI 10.1128/AAC.46.9.3050-3053.2002; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; COLMENERO JD, 1990, INFECTION, V18, P152, DOI 10.1007/BF01642103; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Critchley IA, 2009, J ANTIMICROB CHEMOTH, V63, P954, DOI 10.1093/jac/dkp041; Crowther GJ, 2009, J BIOMOL SCREEN, V14, P700, DOI 10.1177/1087057109335749; DELAROY YMD, 1986, J ANTIMICROB CHEMOTH, V18, P648, DOI 10.1093/jac/18.5.648; Deniziak MA, 2001, ACTA BIOCHIM POL, V48, P337; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRENCHICK PJ, 1985, AM J VET RES, V46, P332; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Green LS, 2009, ANTIMICROB AGENTS CH, V53, P86, DOI 10.1128/AAC.00275-08; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; HALL WH, 1990, REV INFECT DIS, V12, P1060; Jarvest RL, 2003, BIOORG MED CHEM LETT, V13, P665, DOI 10.1016/S0960-894X(02)01027-2; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Jennings GJ, 2007, T ROY SOC TROP MED H, V101, P707, DOI 10.1016/j.trstmh.2007.02.027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karabay O, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-18; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Kayode KO, 2011, MOL BIOCHEM PARASIT, V176, P98, DOI 10.1016/j.molbiopara.2010.12.009; Kim S, 2003, APPL MICROBIOL BIOT, V61, P278, DOI 10.1007/s00253-003-1243-5; Kim SY, 2006, BIOORG MED CHEM LETT, V16, P4898, DOI 10.1016/j.bmcl.2006.06.057; Koh CY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002775; Marianelli C, 2004, J CLIN MICROBIOL, V42, P5439, DOI 10.1128/JCM.42.12.5439-5443.2004; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Organization JFaAOWH, 1986, ORG JFAAOWH WHO; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pedro-Rosa L, 2015, J BIOMOL SCREEN, V20, P122, DOI 10.1177/1087057114548832; PLOMMET M, 1991, ZBL BAKT-INT J MED M, V275, P436; Ranade RM, 2015, ANTIMICROB AGENTS CH, V59, P7128, DOI 10.1128/AAC.01573-15; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Shibata S, 2012, J MED CHEM, V55, P6342, DOI 10.1021/jm300303e; Shibata S, 2011, ANTIMICROB AGENTS CH, V55, P1982, DOI 10.1128/AAC.01796-10; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Young EJ, 2005, BRUCELLA SPECIES	46	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160350	10.1371/journal.pone.0160350	http://dx.doi.org/10.1371/journal.pone.0160350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500735	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500021
J	Brito, NB; Llanos, JPS; Ferrer, MF; Garcia, JGO; Brito, ID; Castro, FPG; Castellanos, NC; Rodriguez, CXA; Abizanda, EP				Benitez Brito, Nestor; Suarez Llanos, Jose Pablo; Fuentes Ferrer, Manuel; Oliva Garcia, Jose Gregorio; Delgado Brito, Irina; Pereyra-Garcia Castro, Francisca; Caracena Castellanos, Nieves; Acevedo Rodriguez, Candelaria Xiomara; Palacio Abizanda, Enrique			Relationship between Mid-Upper Arm Circumference and Body Mass Index in Inpatients	PLOS ONE			English	Article							CALF CIRCUMFERENCE; WEIGHT-LOSS; MALNUTRITION; UNDERNUTRITION; MORTALITY; IMPACT; RISK; MNA	Introduction Nutritional screening is a fundamental aspect of the initial evaluation of the hospitalised patient. Body Mass Index (BMI) in association with other parameters is a good marker of malnutrition (<18.5 kg/m(2)), but it presents the handicap that the great majority of patients cannot be weighed and measured. For this reason it is necessary to find other indicators that can be measured in these patients. Objectives 1) Analyse the relationship between BMI and Mid-Upper Arm Circumference (MUAC); 2) establish a cut-off point of MUAC equivalent to BMI <18.5 kg/m(2). Materials and Methods The anthropometric data of patients hospitalised over the period 2004-2013 were retrospectively revised. The following variables were collected: weight, height, BMI, MUAC, sex and age. Results 1373 patients were evaluated, who presented a mean weight of: 65.04 +/- 15.51 kg; height: 1.66 +/- 0.09 m; BMI: 23.48 +/- 5.03 kg/m(2); MUAC: 26.95 +/- 4.50 cm; age: 56.24 +/- 16.77. MUAC correlates suitably to BMI by means of the following equation (simple linear regression): BMI = -0.042 + 0.873 x MUAC (cm) (R-2 = 0.609), with a Pearson r value of 0.78 (p<0.001). The area under the curve of MUAC for the diagnosis of malnutrition was 0.92 (95% CI: 0.90-0.94; p<0.001). The MUAC value <= 22.5 cm presented a sensitivity of 67.7%, specificity of 94.5%, and a correct classification of 90%. No significant statistical differences were found in the cut-off point of MUAC for the diagnosis of malnutrition based on sex (p = 0.115) and age (p = 0.694). Conclusions 1) MUAC correlates positively and significantly with BMI. 2) MUAC <= 22.5 cm correlates properly with a BMI of <18.5 kg/m(2), independent of the age or sex of the patient, although there are other alternatives. MUAC constitutes a useful tool as a marker of malnutrition, fundamentally in patients for whom weight and height cannot be determined.	[Benitez Brito, Nestor; Suarez Llanos, Jose Pablo; Oliva Garcia, Jose Gregorio; Delgado Brito, Irina; Pereyra-Garcia Castro, Francisca; Caracena Castellanos, Nieves; Acevedo Rodriguez, Candelaria Xiomara; Palacio Abizanda, Enrique] Hosp Univ Nuestra Senora Candelaria, Endocrinol & Nutr Dept, Ctra Rosario 145, Santa Cruz De Tenerife 38010, Spain; [Fuentes Ferrer, Manuel] Hosp Clin San Carlos, Preventit Med Dept, Calle Prof Martin Lagos S-N, Madrid 28040, Spain	Hospital Clinico San Carlos	Llanos, JPS (corresponding author), Hosp Univ Nuestra Senora Candelaria, Endocrinol & Nutr Dept, Ctra Rosario 145, Santa Cruz De Tenerife 38010, Spain.	psuarezllanos@gmail.com	Ferrer, Manuel Enrique Fuentes Ferrer ME Fuentes/L-1086-2017; Brito, Néstor Benítez/AAD-3568-2020	Ferrer, Manuel Enrique Fuentes Ferrer ME Fuentes/0000-0002-5177-1441; Brito, Néstor Benítez/0000-0001-6243-4099; suarez-llanos, jose pablo/0000-0002-7409-3196				Alvarez J, 2008, NUTR HOSP, V23, P536; Bickford G R, 1999, Clin Lab Manage Rev, V13, P357; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; Augusto CHC, 2011, NUTR CLIN DIET HOSP, V31, P22; Chakraborty R, 2011, RURAL REMOTE HEALTH, V11; Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7; de la Cruz AP, 2004, MED CLIN-BARCELONA, V123, P201, DOI 10.1157/13064413; Eriksen J, 2013, EUR J CLIN NUTR, V67, P607, DOI 10.1038/ejcn.2013.65; Gueresi P, 2014, EXP GERONTOL, V58, P230, DOI 10.1016/j.exger.2014.08.012; Guerrero-Segundo M, 2012, REV SANID MILIT MEX, V66, P17; Khadivzadeh T, 2002, East Mediterr Health J, V8, P612; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Leandro-Merhi VA, 2012, J NUTR HEALTH AGING, V16, P128, DOI 10.1007/s12603-011-0098-1; Ljungqvist O, 2009, NUTR HOSP, V24, P369; Mora Mendoza A, 2015, NUTR HOSP S4, V31, P1; Garcia JGO, 2013, NUTR HOSP, V28, P1286, DOI 10.3305/nh.2013.28.4.6479; Nguyen P, 2014, FOOD NUTR BULL, V35, P301, DOI 10.1177/156482651403500303; Powell-Tuck J, 2003, CLIN NUTR, V22, P307, DOI 10.1016/S0261-5614(03)00009-8; REILLY JJ, 1988, JPEN-PARENTER ENTER, V12, P371, DOI 10.1177/0148607188012004371; Sorensen J, 2008, CLIN NUTR, V27, P340, DOI 10.1016/j.clnu.2008.03.012; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; Llanos JPS, 2014, NUTR HOSP, V29, P1149, DOI 10.3305/nh.2014.29.5.7299; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; Tang AM, 2013, USE OF CUTOFFS FOR M; Tsai AC, 2011, BRIT J NUTR, V105, P275, DOI 10.1017/S0007114510003429; Vellas B, 1999, NUTRITION, V15, P116, DOI 10.1016/S0899-9007(98)00171-3	26	49	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160480	10.1371/journal.pone.0160480	http://dx.doi.org/10.1371/journal.pone.0160480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494612	gold, Green Published			2022-12-26	WOS:000381369500047
J	Pfister, JA; D'Mello, SR				Pfister, Jason A.; D'Mello, Santosh R.			Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cell death; Huntington's disease; neurodegeneration; neuron; neuroprotection; neuronal death; neuronal survival; nucleophosmin	CEREBELLAR GRANULE NEURONS; ACUTE MYELOID-LEUKEMIA; CELL-CYCLE REGULATION; NF-KAPPA-B; HUNTINGTONS-DISEASE; 3-NITROPROPIONIC ACID; POSTMITOTIC NEURONS; PROTEIN EXPRESSION; CENTROSOME DUPLICATION; INDEPENDENT MECHANISM	NPM1 (nucleophosmin 1) is a nucleolar phosphoprotein that regulates many cellular processes, including ribosome biogenesis, proliferation, and genomic integrity. Although its role in proliferating cell types and tissues has been extensively investigated, little is known about its function in neurons and in the brain where it is highly expressed. We report that NPM1 protein expression is increased selectively in the striatum in both the R6/2 transgenic and 3-nitropropionic acid-injected mouse models of Huntington's disease. Examination of the effect of ectopic expression on cultured neurons revealed that increasing NPM1 is toxic to otherwise healthy cerebellar granule and cortical neurons. Toxicity is dependent on its cytoplasmic localization and oligomerization status. Forced retention of NPM1 in the nucleus, as well as inhibiting its ability to oligomerize, not only neutralizes NPM1 toxicity but also renders it protective against apoptosis. Although not blocked by pharmacological inhibition of the pro-apoptotic molecules, JNK, glycogen synthase kinase 3 beta, or caspases, toxicity is blocked by compounds targeting cyclin-dependent kinases (CDKs), as well as by dominant-negative forms of CDK1 and CDK2 and the pan-CDK inhibitor, p21(Cip1/Waf1). Although induced in in vivo Huntington's disease models, NPM1 protein levels are unchanged in cultured cerebellar granule and cortical neurons induced to die by low potassium or homocysteic acid treatment, respectively. Moreover, and counterintuitively, knockdown of its expression or inhibition of endogenous NPM1 oligomerization in these cultured neurons is toxic. Taken together, our study suggests that although neurons need NPM1 for survival, an increase in its expression beyond physiological levels and its translocation to the cytoplasm leads to death through abortive cell cycle induction.	[Pfister, Jason A.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [D'Mello, Santosh R.] Southern Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA	University of Texas System; University of Texas Dallas; Southern Methodist University	D'Mello, SR (corresponding author), Southern Methodist Univ, Dept Biol Sci, Dedman Life Sci Bldg,6501 Airline Rd, Dallas, TX 75275 USA.	sdmello@smu.edu	D'Mello, Santosh/AAO-7192-2020; D'Mello, Santosh/AAM-3644-2020	D'Mello, Santosh/0000-0002-7652-1334; 	National Institutes of Health [R01 NS040408]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS040408 (to S. R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn JY, 2005, MOL CELL, V18, P435, DOI 10.1016/j.molcel.2005.04.010; Bardai FH, 2013, J NEUROSCI, V33, P11833, DOI 10.1523/JNEUROSCI.5831-12.2013; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bates GP, 1997, HUM MOL GENET, V6, P1633, DOI 10.1093/hmg/6.10.1633; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P289, DOI 10.1016/S0149-7634(96)00027-9; Borsello T, 2007, CURR PHARM DESIGN, V13, P1875; Brady SN, 2009, ONCOGENE, V28, P3209, DOI 10.1038/onc.2009.178; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; CHAN WY, 1989, BIOCHEMISTRY-US, V28, P1033, DOI 10.1021/bi00429a017; Chen HM, 2008, EUR J NEUROSCI, V28, P2003, DOI 10.1111/j.1460-9568.2008.06491.x; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Cisbani G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.121; D'Mello SR, 2005, CNS NEUROL DISORD-DR, V4, P3, DOI 10.2174/1568007053005118; D'MELLO SR, 1993, P NATL ACAD SCI USA, V90, P10989, DOI 10.1073/pnas.90.23.10989; Dastidar SG, 2012, J NEUROSCI, V32, P2846, DOI 10.1523/JNEUROSCI.5841-11.2012; Dastidar SG, 2011, J NEUROSCI, V31, P402, DOI 10.1523/JNEUROSCI.2897-10.2011; Duan-Porter WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115062; Erickson JD, 2013, CELL DEATH DIFFER, V20, P1435, DOI 10.1038/cdd.2013.107; Falini B, 2009, CURR OPIN ONCOL, V21, P573, DOI 10.1097/CCO.0b013e3283313dfa; Greene LA, 2007, BBA-MOL BASIS DIS, V1772, P392, DOI 10.1016/j.bbadis.2006.12.003; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Jian Y, 2009, ONCOGENE, V28, P4201, DOI 10.1038/onc.2009.275; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Koulich E, 2001, J NEUROCHEM, V76, P1188, DOI 10.1046/j.1471-4159.2001.00134.x; Lee J, 2014, BBA-MOL BASIS DIS, V1842, P785, DOI 10.1016/j.bbadis.2013.09.017; Lee SB, 2012, J CELL BIOL, V199, P65, DOI 10.1083/jcb.201205015; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Lim ACB, 2003, J ALZHEIMERS DIS, V5, P329, DOI 10.3233/JAD-2003-5409; Maezawa I, 2002, PATHOL INT, V52, P551, DOI 10.1046/j.1440-1827.2002.01398.x; Mallick S, 2014, J BIOL CHEM, V289, P35409, DOI 10.1074/jbc.M114.597575; Marquez-Lona EM, 2012, BIOCHEM BIOPH RES CO, V417, P514, DOI 10.1016/j.bbrc.2011.11.152; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Neef DW, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000291; Neve RL, 2006, PHARMACOL THERAPEUT, V111, P99, DOI 10.1016/j.pharmthera.2005.09.005; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2012, NUCLEIC ACIDS RES, V40, P4861, DOI 10.1093/nar/gks162; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Pfister JA, 2015, EXP BIOL MED, V240, P774, DOI 10.1177/1535370215579168; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Prinos Panagiotis, 2011, Int J Biochem Mol Biol, V2, P24; RATAN RR, 1994, J NEUROSCI, V14, P4385; Rau R, 2009, HEMATOL ONCOL, V27, P171, DOI 10.1002/hon.904; Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Verdaguer E, 2004, NEUROCHEM INT, V44, P251, DOI 10.1016/S0197-0186(03)00147-5; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Wang LL, 2010, J NEUROSCI RES, V88, P1970, DOI 10.1002/jnr.22352; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Yalcin A, 2003, J NEUROCHEM, V84, P397, DOI 10.1046/j.1471-4159.2003.01540.x; Ye KQ, 2005, CANCER BIOL THER, V4, P918, DOI 10.4161/cbt.4.9.2072; Yohe S, 2015, J CLIN MED, V4, P460, DOI 10.3390/jcm4030460; Yu Y, 2006, MOL CELL BIOL, V26, P3798, DOI 10.1128/MCB.26.10.3798-3809.2006; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	62	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20787	20797		10.1074/jbc.M116.723015	http://dx.doi.org/10.1074/jbc.M116.723015			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27510036	hybrid, Green Published			2022-12-26	WOS:000384574800039
J	Sun, YJ; Kaur, K; Kanayama, K; Morinaga, K; Park, S; Hokugo, A; Kozlowska, A; McBride, WH; Li, J; Jewett, A; Nishimura, I				Sun, Yujie; Kaur, Kawaljit; Kanayama, Keiichi; Morinaga, Kenzo; Park, Sil; Hokugo, Akishige; Kozlowska, Anna; McBride, William H.; Li, Jun; Jewett, Anahid; Nishimura, Ichiro			Plasticity of Myeloid Cells during Oral Barrier Wound Healing and the Development of Bisphosphonate-related Osteonecrosis of the Jaw	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; bone marrow; necrosis (necrotic death); neutrophil; wound healing	MEMORY T-CELLS; BONE-MARROW; IMMUNE-SYSTEM; IN-VIVO; NEUTROPHIL; INFLAMMATION; MACROPHAGES; DISEASE; INNATE; ZOLEDRONATE	Injury to the barrier tissue initiates a rapid distribution of myeloid immune cells from bone marrow, which guide sound wound healing. Bisphosphonates, a widely used anti-bone resorptive drug with minimal systemic side effects, have been linked to an abnormal wound healing in the oral barrier tissue leading to, in some cases, osteonecrosis of the jaw (ONJ). Here we report that the development of ONJ may involve abnormal phenotypic plasticity of Ly6G+/Gr1+ myeloid cells in the oral barrier tissue undergoing tooth extraction wound healing. A bolus intravenous zoledronate (ZOL) injection to female C57Bl/6 mice followed by maxillary first molar extraction resulted in the development of ONJ-like lesion during the second week of wound healing. The multiplex assay of dissociated oral barrier cells exhibited the secretion of cytokines and chemokines, which was significantly modulated in ZOL mice. Tooth extraction-induced distribution of Ly6G+/Gr1+ cells in the oral barrier tissue increased in ZOL mice at week 2. ONJ-like lesion in ZOL mice contained Ly6G+/Gr1+ cells with abnormal size and morphology as well as different flow cytometric staining intensity. When anti-Ly6G (Gr1) antibody was intraperitoneally injected for 5 days during the second week of tooth extraction, CD11b+GR1(hi) cells in bone marrow and Ly6G+ cells in the oral barrier tissue were depleted, and the development of ONJ-like lesion was significantly attenuated. This study suggests that local modulation of myeloid cell plasticity in the oral barrier tissue may provide the basis for pathogenesis and thus therapeutic as well as preventive strategy of ONJ.	[Sun, Yujie; Li, Jun] Capital Med Univ, Beijing Stomatol Hosp, Sch Stomatol, Dept Dent Implant Ctr, Beijing 100050, Peoples R China; [Sun, Yujie; Kaur, Kawaljit; Kanayama, Keiichi; Morinaga, Kenzo; Park, Sil; Hokugo, Akishige; Kozlowska, Anna; Jewett, Anahid; Nishimura, Ichiro] UCLA Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668, Los Angeles, CA 90095 USA; [Sun, Yujie; Park, Sil; Nishimura, Ichiro] UCLA Sch Dent, Div Adv Prosthodont, Los Angeles, CA 90095 USA; [Kaur, Kawaljit; Park, Sil; Kozlowska, Anna; Jewett, Anahid; Nishimura, Ichiro] UCLA Sch Dent, Div Oral Med & Biol, Los Angeles, CA 90095 USA; [Kanayama, Keiichi] Asahi Univ, Dept Periodontol, Sch Dent, Gifu 5010296, Japan; [Morinaga, Kenzo] Fukuoka Dent Coll, Dept Oral Rehabil, Fukuoka 8140175, Japan; [Hokugo, Akishige] Univ Calif Los Angeles, David Geffen Sch Med, Div Plast & Reconstruct Surg, Los Angeles, CA 90095 USA; [Kozlowska, Anna] Poznan Univ Med Sci, Dept Tumor Immunol, Chair Med Biotechnol, PL-61866 Poznan, Poland; [McBride, William H.] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol & Cellular Oncol, Los Angeles, CA 90095 USA	Capital Medical University; Asahi University; Fukuoka Dental College (FDC); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Poznan University of Medical Sciences; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, J (corresponding author), Capital Med Univ, Beijing Stomatol Hosp, Sch Stomatol, Dept Dent Implant Ctr, Beijing 100050, Peoples R China.; Jewett, A; Nishimura, I (corresponding author), UCLA Sch Dent, Weintraub Ctr Reconstruct Biotechnol, Box 951668, Los Angeles, CA 90095 USA.; Jewett, A (corresponding author), UCLA Sch Dent, Div Oral Med & Biol, Los Angeles, CA 90095 USA.	lijun3021@aliyun.com; ajewett@dentistry.ucla.edu; inishimura@dentistry.ucla.edu	Kozlowska, Anna Karolina/P-1620-2015; Kozlowska, Anna Karolina/AAC-7248-2019	Kozlowska, Anna Karolina/0000-0003-2465-217X; Kozlowska, Anna Karolina/0000-0003-2465-217X	National Institutes of Health from National Center for Research Resources Research Improvement Program Grant [C06 RR014529]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022552, R21DE023410] Funding Source: NIH RePORTER	National Institutes of Health from National Center for Research Resources Research Improvement Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the Tissue Procurement Core Laboratory, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA for histopathological and immunohistochemical specimen preparation. We also thank Jessica Cook, UCLA, for excellent technical assistance. This work was conducted in part in a facility supported by National Institutes of Health Grant C06 RR014529 from the National Center for Research Resources Research Improvement Program Grant.	Ali Naveid, 2015, Small GTPases, V6, P202, DOI 10.1080/21541248.2015.1085485; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Arora M, 2010, MUCOSAL IMMUNOL, V3, P578, DOI 10.1038/mi.2010.41; Ashhurst TM, 2014, CELL IMMUNOL, V291, P49, DOI 10.1016/j.cellimm.2014.07.002; Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Chiaramonte MG, 1999, J IMMUNOL, V162, P920; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Cortes-Vieyra R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1396106; Didierlaurent A, 2005, CELL MOL LIFE SCI, V62, P1285, DOI 10.1007/s00018-005-5032-4; Failli A, 2014, HUM VACC IMMUNOTHER, V10, P3375, DOI 10.4161/hv.29416; Favot CL, 2013, INT J ORAL MAX SURG, V42, P619, DOI 10.1016/j.ijom.2012.12.011; Fournier BM, 2012, MUCOSAL IMMUNOL, V5, P354, DOI 10.1038/mi.2012.24; Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gatzka M, 2015, J DTSCH DERMATOL GES, V13, P647, DOI 10.1111/ddg.12677; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; Hoefert S, 2015, CLIN ORAL INVEST, V19, P1307, DOI 10.1007/s00784-014-1358-3; Hokugo A, 2010, J BONE MINER RES, V25, P1337, DOI 10.1002/jbmr.23; Kagnoff MF, 2014, J CLIN INVEST, V124, P2841, DOI 10.1172/JCI75225; Kalyan S, 2014, CELL MOL LIFE SCI, V71, P2335, DOI 10.1007/s00018-013-1495-x; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Kuiper JWP, 2012, BRIT J PHARMACOL, V165, P532, DOI 10.1111/j.1476-5381.2011.01592.x; Lin A, 2010, CELL ADHES MIGR, V4, P396, DOI 10.4161/cam.4.3.11917; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Matsui T, 2015, INT IMMUNOL, V27, P269, DOI 10.1093/intimm/dxv013; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Omenetti S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00639; Park CO, 2015, NAT MED, V21, P688, DOI 10.1038/nm.3883; Park S, 2015, J BIOL CHEM, V290, P17349, DOI 10.1074/jbc.M115.652305; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Russell RGG, 2007, ANN NY ACAD SCI, V1117, P209, DOI 10.1196/annals.1402.089; Sagiv JY, 2015, CELL REP, V10, P562, DOI 10.1016/j.celrep.2014.12.039; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Scott DA, 2012, FRONT ORAL BIOL, V15, P56; Scumpia PO, 2010, J IMMUNOL, V184, P2247, DOI 10.4049/jimmunol.0903652; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Sheridan BS, 2011, NAT IMMUNOL, V12, P485, DOI 10.1038/ni.2029; Soumelis V, 2015, CURR OPIN IMMUNOL, V32, P42, DOI 10.1016/j.coi.2014.12.007; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Tseng HC, 2015, ONCOTARGET, V6, P20002, DOI 10.18632/oncotarget.4755; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Utreja A, 2013, Odontostomatol Trop, V36, P38; Wicks K, 2015, DIABETES, V64, P4184, DOI 10.2337/db14-1895; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831; Yamazaki T, 2012, INT J ORAL MAX SURG, V41, P1397, DOI 10.1016/j.ijom.2012.06.020	58	18	19	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20602	20616		10.1074/jbc.M116.735795	http://dx.doi.org/10.1074/jbc.M116.735795			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514746	hybrid, Green Published			2022-12-26	WOS:000384574800025
J	Boronat-Garcia, A; Palomero-Rivero, M; Guerra-Crespo, M; Millan-Aldaco, D; Drucker-Colin, R				Boronat-Garcia, Alejandra; Palomero-Rivero, Marcela; Guerra-Crespo, Magdalena; Millan-Aldaco, Diana; Drucker-Colin, Rene			Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; EMBRYONIC STEM-CELLS; NERVE GROWTH-FACTOR; DOPAMINE NEURONS; PROGENITOR CELLS; DIFFERENTIATION; MEDULLA; NGF; GENERATION; THERAPIES	Cell replacement therapy in Parkinson's disease (PD) aims at re-establishing dopamine neurotransmission in the striatum by grafting dopamine-releasing cells. Chromaffin cell (CC) grafts produce some transitory improvements of functional motor deficits in PD animal models, and have the advantage of allowing autologous transplantation. However, CC grafts have exhibited low survival, poor functional effects and dopamine release compared to other cell types. Recently, chromaffin progenitor-like cells were isolated from bovine and human adult adrenal medulla. Under low-attachment conditions, these cells aggregate and grow as spheres, named chromospheres. Here, we found that bovine-derived chromosphere- cell cultures exhibit a greater fraction of cells with a dopaminergic phenotype and higher dopamine release than CC. Chromospheres grafted in a rat model of PD survived in 57% of the total grafted animals. Behavioral tests showed that surviving chromosphere cells induce a reduction in motor alterations for at least 3 months after grafting. Finally, we found that compared with CC, chromosphere grafts survive more and produce more robust and consistent motor improvements. However, further experiments would be necessary to determine whether the functional benefits induced by chromosphere grafts can be improved, and also to elucidate the mechanisms underlying the functional effects of the grafts.	[Boronat-Garcia, Alejandra; Palomero-Rivero, Marcela; Guerra-Crespo, Magdalena; Millan-Aldaco, Diana; Drucker-Colin, Rene] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Circuito Exterior S-N,Ciudad Univ, Ciudad Mexico, Mexico	Universidad Nacional Autonoma de Mexico	Drucker-Colin, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Neuropatol Mol, Circuito Exterior S-N,Ciudad Univ, Ciudad Mexico, Mexico.	drucker@unam.mx			Direccion General Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT) [IN204612]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [179927]; Secretaria de Ciencia, Tecnologia e Innovacion (SECITI) [ICyTDF/170/2012-SECITI/014/2013]; CONACyT-Mexico	Direccion General Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Ciencia, Tecnologia e Innovacion (SECITI); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the following grants: Direccion General Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Inovacion Tecnologica (DGAPA-PAPIIT) [IN204612], Consejo Nacional de Ciencia y Tecnologia (CONACyT) [179927] and Secretaria de Ciencia, Tecnologia e Innovacion (SECITI) [ICyTDF/170/2012-SECITI/014/2013]. The funding source had not any involvement in the study design, in the collection, analysis and intepretation of data, in the writing or in any decision made for publication.; ABG received a PhD fellowship from CONACyT-Mexico. This work is part of the fulfillment of requirements for ABG's PhD degree in Biomedical Science from the Universidad Nacional Autonoma de Mexico. We thank the Posgrado en Ciencias Biomedicas and the Universidad Nacional Autonoma de Mexico.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Barker RA, 2015, NAT REV NEUROL, V11, P492, DOI 10.1038/nrneurol.2015.123; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; BING G, 1990, NEUROSCIENCE, V34, P687, DOI 10.1016/0306-4522(90)90175-4; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Bjorklund A, 2013, MOVEMENT DISORD, V28, P110, DOI 10.1002/mds.25343; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Chung KF, 2009, STEM CELLS, V27, P2602, DOI 10.1002/stem.180; Correia AS, 2008, FRONT NEUROSCI-SWITZ, V2, P26, DOI 10.3389/neuro.01.011.2008; CREESE I, 1977, SCIENCE, V197, P596, DOI 10.1126/science.877576; CUNNINGHAM LA, 1991, BRAIN RES, V561, P192, DOI 10.1016/0006-8993(91)91595-R; Date I, 1997, EXP NEUROL, V147, P10, DOI 10.1006/exnr.1997.6579; DRUCKERCOLIN R, 1991, J NEUROSCI METH, V39, P153, DOI 10.1016/0165-0270(91)90081-A; DRUCKERCOLIN R, 1994, MOL CELL NEUROSCI, V5, P485, DOI 10.1006/mcne.1994.1060; Dunnett SB, 1989, EXP BRAIN RES, V78, P343; Ehrhart-Bornstein M, 2010, CELL MOL NEUROBIOL, V30, P1417, DOI 10.1007/s10571-010-9571-3; Ehrhart-Bornstein M, 2008, ANN NY ACAD SCI, V1148, P112, DOI 10.1196/annals.1410.053; Fernandez Espejo Emilio, 2001, Journal of Neuroscience, V21, P9888; Fernandez-Espejo E, 2005, BRAIN RES REV, V49, P343, DOI 10.1016/j.brainresrev.2005.01.004; FIANDACA MS, 1988, EXP NEUROL, V102, P76, DOI 10.1016/0014-4886(88)90080-5; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; Galan-Rodriguez B, 2008, NEUROBIOL DIS, V29, P529, DOI 10.1016/j.nbd.2007.11.009; Garcia-Montes J, 2012, HEALTH, V4, P1153; Garcia-Montes JR, 2012, CNS NEUROL DISORD-DR, V11, P897, DOI 10.2174/1871527311201070897; Grealish S, 2014, CELL STEM CELL, V15, P653, DOI 10.1016/j.stem.2014.09.017; Grealish S, 2010, BRAIN, V133, P482, DOI 10.1093/brain/awp328; Huber K, 2009, AUTON NEUROSCI-BASIC, V151, P10, DOI 10.1016/j.autneu.2009.07.020; Jensen MB, 2012, J STEM CELL RES S10, P003; KELLY PH, 1975, BRAIN RES, V94, P507, DOI 10.1016/0006-8993(75)90233-4; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lanau F, 1997, J NEUROCHEM, V68, P804; Lindvall Olle, 2004, NeuroRx, V1, P382; Lindvall O, 2013, MOVEMENT DISORD, V28, P268, DOI 10.1002/mds.25378; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; MORIHISA JM, 1984, EXP NEUROL, V84, P643, DOI 10.1016/0014-4886(84)90211-5; NIIJIMA K, 1995, J NEUROSCI, V15, P1180; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Rath A, 2013, CELL TRANSPLANT, V22, P1281, DOI 10.3727/096368912X654984; Root DH, 2015, J NEUROSCI, V35, P3460, DOI 10.1523/JNEUROSCI.4525-13.2015; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Santana MM, 2012, STEM CELL TRANSL MED, V1, P783, DOI 10.5966/sctm.2012-0022; Saxena S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064454; STEMPLE DL, 1988, NEURON, V1, P517, DOI 10.1016/0896-6273(88)90182-1; STROMBERG I, 1985, EXP BRAIN RES, V60, P335; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Vukicevic V, 2015, MOL CELL ENDOCRINOL, V408, P178, DOI 10.1016/j.mce.2014.12.020; Vukicevic V, 2012, CELL TRANSPLANT, V21, P2471, DOI 10.3727/096368912X638874; Vukicevic V, 2012, J MOL NEUROSCI, V48, P420, DOI 10.1007/s12031-012-9746-0	55	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160854	10.1371/journal.pone.0160854	http://dx.doi.org/10.1371/journal.pone.0160854			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525967	Green Submitted, Green Published, gold			2022-12-26	WOS:000381471100024
J	O'Neill, S; Dierickx, S; Okebe, J; Dabira, E; Gryseels, C; d'Alessandro, U; Grietens, KP				O'Neill, Sarah; Dierickx, Susan; Okebe, Joseph; Dabira, Edgard; Gryseels, Charlotte; d'Alessandro, Umberto; Grietens, Koen Peeters			The Importance of Blood Is Infinite: Conceptions of Blood as Life Force, Rumours and Fear of Trial Participation in a Fulani Village in Rural Gambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MEDICAL-RESEARCH; CLINICAL-TRIAL; VACCINE TRIAL; VULNERABILITY; CHALLENGES; MALARIA; EXPERIENCES; COMMUNITY; POVERTY	Background Clinical trials require high levels of participation and low drop-out rates to be successful. However, collecting blood samples from individuals recruited into clinical trials can be challenging when there is reticence about blood-taking. In addition to concerns regarding the feasibility of medical research, fears of 'blood-stealing' and 'blood-selling' have ethical implications related to cultural sensitivity and informed consent. This study explores anxieties around blood-taking during a malaria treatment trial in the Gambia. Methods This case study is based on ethnographic research in one theoretically selected village due to the high reticence to screening for the clinical trial 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' carried out in the Gambia between 2013 and 2014. Data collection tools included in-depth interviews, participant observation, informal conversations and group discussions. Results In total only 176 of 411 habitants (42%) in the village accepted having a bloodspot taken to screen for malaria. Although trial recruitment was initially high in the village, some families refused screening when rumours started spreading that the trial team was taking too much blood. Concerns about 'loss of blood' were equated to loss of strength and lack of good food to replenish bodily forces. Families in the study village were concerned about the weakness of their body while they had to harvest their crops at the time of recruitment for the trial. Conclusion A common recommendation to prevent and avoid rumours against public health interventions and trials is the provision of full and consistent information during the consent procedure, which is assumed to lead to more accurate knowledge of the purpose of the intervention and increased trial participation. However, even when information provision is continuous, the emergence of rumours can be related to times of uncertainty and perceptions of vulnerability, which are often a reflection of structural inequalities and diverging value orientations between communities and public health institutions.	[O'Neill, Sarah; Dierickx, Susan; Gryseels, Charlotte; d'Alessandro, Umberto; Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium; [Dierickx, Susan; Gryseels, Charlotte] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Dierickx, Susan] Vrije Univ Brussels, RHEA, Ctr Expertise Gender Div & Intersect, Brussels, Belgium; [Okebe, Joseph; Dabira, Edgard; d'Alessandro, Umberto] Med Res Council Gambia, Fajara, Gambia; [Okebe, Joseph] Univ Antwerp, Antwerp, Belgium; [d'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium	Institute of Tropical Medicine (ITM); University of Amsterdam; Vrije Universiteit Brussel; University of London; London School of Hygiene & Tropical Medicine; University of Antwerp; University of London; London School of Hygiene & Tropical Medicine; Nagasaki University	O'Neill, S (corresponding author), Inst Trop Med, Dept Publ Hlth, Unit Med Anthropol, Antwerp, Belgium.	soneill@itg.be	Peeters Grietens, Koen/G-7028-2019; Okebe, Joseph/Y-1664-2019	Peeters Grietens, Koen/0000-0001-6570-9887; Okebe, Joseph/0000-0001-5466-1611; Gryseels, Charlotte/0000-0002-8963-4469; O'Neill, Sarah/0000-0001-8807-0991; Dierickx, Susan/0000-0003-3140-0771	Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust) [MR/K007203/1]; Institute of Social Cultural Anthropology at the University of Oxford, Oxford, UK; MRC [MC_EX_MR/J002364/1] Funding Source: UKRI; Medical Research Council [MC_EX_MR/J002364/1] Funding Source: researchfish	Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust); Institute of Social Cultural Anthropology at the University of Oxford, Oxford, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is part of the study 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the MRCG social science fieldworkers Fatou Y Manneh, Hejinkey Darboe and Michelle Demba for their assistance with data collection during fieldwork as well as for the transcription and translation of recorded interviews and discussions. We also thank the Prinogam trial fieldwork coordinator Matar Ceesay and team for good co-operation and assistance with fieldwork arrangements. This work is part of the study 'Primaquine's gametocytocidal efficacy in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine' (MR/K007203/1) funded by the Joint Global Health Trials Scheme (DFID/MRC/Wellcome Trust). The main author thanks the Institute of Social Cultural Anthropology at the University of Oxford, Oxford, UK for the visiting fellowship.	Alwang J., 2001, SOCIAL PROTECTION DI; [Anonymous], 2001, HDB ETHNOGRAPHY; Bannister-Tyrrell M, 2015, LANCET, V385, P420, DOI 10.1016/S0140-6736(14)62392-8; Baxter P, 2008, QUAL REP, V13, P544; Bernard R, 2006, RESEARCH METHODS IN; Brooks N., 2003, TYNDALL CENT CLIM CH, V38, P20; Cham M, 2000, MATERNAL MORTALITY G; Chapman RR, 2006, MED ANTHROPOL Q, V20, P487, DOI 10.1525/maq.2006.20.4.487; Clarke SE, 2003, TROP MED INT HEALTH, V8, P884, DOI 10.1046/j.1365-3156.2003.01095.x; Comaroff J, 1999, AM ETHNOL, V26, P279, DOI 10.1525/ae.1999.26.2.279; Comaroff J, 2000, PUBLIC CULTURE, V12, P291, DOI 10.1215/08992363-12-2-291; Dal-Re R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001149; Dierickx S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148627; Fairhead J, 2006, SOC SCI MED, V63, P1109, DOI 10.1016/j.socscimed.2006.02.018; Feldman-Savelsberg P, 2000, MED ANTHROPOL Q, V14, P159, DOI 10.1525/maq.2000.14.2.159; Fischer Frank, 2000, CITIZENS EXPERTS ENV; Geissler PW, 2006, TROP MED INT HEALTH, V11, P975, DOI 10.1111/j.1365-3156.2006.01682.x; Geissler PW, 2008, SOC SCI MED, V67, P696, DOI 10.1016/j.socscimed.2008.02.004; Gikonyo C, 2008, SOC SCI MED, V67, P708, DOI 10.1016/j.socscimed.2008.02.003; Graboyes M, 2010, DEV WORLD BIOETH, V10, P34, DOI 10.1111/j.1471-8847.2009.00274.x; Grietens KP, 2014, AM J TROP MED HYG, V91, P213, DOI 10.4269/ajtmh.13-0630; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; Jones COH, 2004, AM J TROP MED HYG, V71, P156, DOI 10.4269/ajtmh.2004.71.156; Kaler A, 2009, SOC SCI MED, V68, P1711, DOI 10.1016/j.socscimed.2009.01.038; Kamuya DM, 2013, DEV WORLD BIOETH, V13, P1, DOI 10.1111/dewb.12009; Kathy Charmaz, 2014, CONSTRUCTING GROUNDE, V2nd; Katz J, 1996, JAMA-J AM MED ASSOC, V276, P1662, DOI 10.1001/jama.276.20.1662; Khalil Susan S, 2007, BMC Med Ethics, V8, P9, DOI 10.1186/1472-6939-8-9; Kingori P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-556; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Leach M., 2007, VACCINE ANXIETIES; Leatherman T, 2005, ETHOS, V33, P46, DOI 10.1525/eth.2005.33.1.046; Lucia S, 2013, JRAI, P42; Madiega PA, 2013, DEV WORLD BIOETH, V13, P21, DOI 10.1111/dewb.12019; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-145; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (NCPHS), 1979, BELM REP ETH PRINC G; Nichter M, 2003, RISK CULTURE AND HEALTH INEQUALITY: SHIFTING PERCEPTIONS OF DANGER AND BLAME, P13; O'Neill S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0687-2; Oaks L, 2003, CULTURE HLTH INEQUAL; Okebe J, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0597-1; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Toe LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080800; Wiseman V, 2008, SOC SCI MED, V67, P487, DOI 10.1016/j.socscimed.2008.04.007; WMA General Assembly, 1964, WORLD MED ASS DECL H; Yin RK, 2003, DESIGN AND METHODS; Zainal Z., 2007, JURNAL KEMANUSIAAN, V5; Zarowsky C, 2013, GLOB HEALTH PROMOT, V20, P3, DOI 10.1177/1757975912470062	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160464	10.1371/journal.pone.0160464	http://dx.doi.org/10.1371/journal.pone.0160464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SL	27525652	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000381471100015
J	Samad, NA; Dagher-Kharrat, MB; Hidalgo, O; El Zein, R; Douaihy, B; Siljak-Yakovlev, S				Samad, Nour Abdel; Dagher-Kharrat, Magda Bou; Hidalgo, Oriane; El Zein, Rana; Douaihy, Bouchra; Siljak-Yakovlev, Sonja			Unlocking the Karyological and Cytogenetic Diversity of Iris from Lebanon: Oncocyclus Section Shows a Distinctive Profile and Relative Stasis during Its Continental Radiation	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; RIBOSOMAL DNA; EVOLUTION; ASTERACEAE; IRIDACEAE; KARYOTYPE; WHEAT; HETEROCHROMATIN	Despite being an important target of conservation concern and horticultural interest, Lebanese irises yet have a confusing taxonomic history and species' delimitation is often considered problematic, more especially among royal irises (Iris section Oncocyclus). Indeed, these irises of exceptionally large and spectacular flowers have radiated across Caucasus and eastern Mediterranean giving rise to a number of strict endemic taxa, many of them being considered under threat. Whilst efforts have mostly focused on clarifying the evolutionary relationships in the group based on morphological and molecular data, karyological and cytogenetic characters have been comparatively overlooked. In this study, we established for the first time the physical mapping of 35S rDNA loci and heterochromatin, and obtained karyo-morphological data for ten Lebanese Iris species belonging to four sections (Iris, Limniris, Oncocyclus and Scorpiris). Our results evidenced distinctive genomic profiles for each one of the sections, where Oncocyclus irises, while having the lowest chromosome numbers, exhibit both the highest number of 35S loci and CMA3+ sites. The continental radiation of royal irises has been accompanied by a relative karyological and cytogenetic stasis, even though some changes were observed regarding karyotype formula and asymmetry indexes. In addition to that, our results enabled taxonomic differentiation between I. germanica and I. mesopotamica-two taxa currently considered as synonyms-and highlighted the need for further studies on populations of I. persica and I. wallasiae in the Eastern Mediterranean Region.	[Samad, Nour Abdel; Dagher-Kharrat, Magda Bou; El Zein, Rana; Douaihy, Bouchra] Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, Lab Caracterisat Genom Plantes, Campus Sci & Technol, Mar Roukos Mkalles, Lebanon; [Samad, Nour Abdel; Siljak-Yakovlev, Sonja] Univ Paris 11, Univ Paris Saclay, Ecol Systemat Evolut, UMR 8079,AgroParisTech, Bat 360, F-91405 Orsay, France; [Hidalgo, Oriane] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England	Saint Joseph University Beirut; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Royal Botanic Gardens, Kew	Dagher-Kharrat, MB (corresponding author), Univ St Joseph, Fac Sci, Dept Sci Vie & Terre, Lab Caracterisat Genom Plantes, Campus Sci & Technol, Mar Roukos Mkalles, Lebanon.	magda.boudagher@usj.edu.lb	Kharrat, Magda Bou Dagher/E-8473-2017; Hidalgo, Oriane/F-5985-2013	Kharrat, Magda Bou Dagher/0000-0001-7969-1673; Hidalgo, Oriane/0000-0002-1547-8627; Douaihy, Bouchra/0000-0001-7600-3409	National Council for Scientific Research Lebanon [01-06-08]; Research Council of Saint Joseph University [FS-56]	National Council for Scientific Research Lebanon; Research Council of Saint Joseph University	This work was supported by the National Council for Scientific Research Lebanon under Grant [01-06-08] to MBK and the Research Council of Saint Joseph University under Grant FS-56 to MBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SP, 2000, AM J BOT, V87, P1578, DOI 10.2307/2656733; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; AVISHAI M, 1977, BOT GAZ, V138, P502, DOI 10.1086/336956; AVISHAI M, 1980, BOT GAZ, V141, P107, DOI 10.1086/337130; Avishai M, 1977, SPECIES RELATIONSHIP; Bareka P, 2012, PLANT SYST EVOL, V298, P421, DOI 10.1007/s00606-011-0555-7; Bogunic F, 2011, PLANT BIOLOGY, V13, P194, DOI 10.1111/j.1438-8677.2010.00326.x; Cerbah M, 1998, MOL BIOL EVOL, V15, P345, DOI 10.1093/oxfordjournals.molbev.a025931; CHAUDHARY SA, 1972, BOT NOTISER, V125, P497; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Cuadrado A, 1997, THEOR APPL GENET, V94, P347, DOI 10.1007/s001220050422; Dadejova M, 2007, NEW PHYTOL, V174, P658, DOI 10.1111/j.1469-8137.2007.02034.x; DAVIS AP, 1990, BOT J LINN SOC, V103, P281, DOI 10.1111/j.1095-8339.1990.tb00189.x; Dobigny G, 2004, SYST BIOL, V53, P470, DOI 10.1080/10635150490445698; Doronkin VM, 1987, IRIDACEAE JUSS NAUKA, P113; Garcia S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-95; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; GEBER G, 1988, PLANT SYST EVOL, V158, P97, DOI 10.1007/BF00936336; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; Glasgow K, 1997, IRISES PRACTICAL GAR; Goldblatt P, 1997, ANN MO BOT GARD, V84, P285, DOI 10.2307/2400005; Hall Tony, 2014, Curtis's Botanical Magazine, V31, P238, DOI 10.1111/curt.12080; Heslop-Harrison J. S., 1991, Technique, a Journal of Methods in Cell and Molecular Biology, V3, P109; Hidalgo O, 2007, BOT J LINN SOC, V153, P193, DOI 10.1111/j.1095-8339.2007.00598.x; Jang TS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-136; Kocyigit M, 2013, 5 BITK K YAL TURK; Kohlein F, 1987, IRIS; Kovarik A, 2005, GENETICS, V169, P931, DOI 10.1534/genetics.104.032839; LACADENA JR, 1984, THEOR APPL GENET, V67, P207, DOI 10.1007/BF00317037; Lavi R, 2015, NEW PHYTOL, V205, P369, DOI 10.1111/nph.12982; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lim KY, 2007, ANN BOT-LONDON, V100, P219, DOI 10.1093/aob/mcm116; Makarevitch I, 2003, INT J PLANT SCI, V164, P229, DOI 10.1086/346160; Martel E, 2004, PLANT SYST EVOL, V249, P139, DOI 10.1007/s00606-004-0191-6; Martinez J, 2010, PLANT SYST EVOL, V289, P223, DOI 10.1007/s00606-010-0345-7; Mathew B., 1989, IRIS; MITRA JYOTIRMAY, 1956, BOT GAZ, V117, P265, DOI 10.1086/335916; Monty A, 2006, CAN J BOT, V84, P1327, DOI 10.1139/B06-081; MOUTERDE P., 1966, NOUVELLE FLORE LIBAN; Mouterde P., 1983, NOUVELLE FLORE LIBAN; Muratovic E, 2010, ADV SCI LETT, V3, P180, DOI 10.1166/asl.2010.1116; Paszko B, 2006, PLANT SYST EVOL, V258, P39, DOI 10.1007/s00606-005-0389-2; Peruzzi L, 2013, COMP CYTOGENET, V7, P1, DOI 10.3897/CompCytogen.v7i1.4431; Pikaard CS, 2001, TRENDS GENET, V17, P675, DOI 10.1016/S0168-9525(01)02545-8; Rasoul TN, 1984, ORNAMENTAL BULBS; Rix M, 1997, GUIDE SPECIES IRISES, P62; Rodionenko G. I., 1987, GENUS IRIS L QUESTIO; Ruas CD, 2005, GENET MOL BIOL, V28, P129, DOI 10.1590/S1415-47572005000100023; Saad L, 2006, THESIS; Saad L, 2009, BOT J LINN SOC, V159, P123, DOI 10.1111/j.1095-8339.2008.00896.x; Sapir Y, 2005, PLANT BIOLOGY, V7, P417, DOI 10.1055/s-2005-837709; Sapir Y, 2002, ISR J PLANT SCI, V50, pS119, DOI 10.1560/DJXH-QX0M-5P0H-DLMW; Sapir Y, 2003, J NAT CONSERV, V11, P91, DOI 10.1078/1617-1381-00041; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; Siljak-Yakovlev S, 2002, THEOR APPL GENET, V104, P505, DOI 10.1007/s001220100755; Siljak-Yakovlev S, 2005, 17 INT BOT C VIENN, P384; SiljakYakovlev S, 1996, SEX PLANT REPROD, V9, P127, DOI 10.1007/BF02221391; Simonet M., 1934, ANN SCI NAT BOT ANN, V1016, P229; SIMONET MARC, 1932, BULL SOC BOT FRANCE, V78, P696; Souza G, 2015, PLANT SYST EVOL, V301, P2013, DOI 10.1007/s00606-015-1216-z; Stace CA, 2000, TAXON, V49, P451, DOI 10.2307/1224344; The Plant List, 2013, VERS 1 1 PUBL INT; Tohme G., 2011, LEBANESE SCI J, V12, P133; Tohme G., 2007, ILLUSTRATED FLORA LE; Tohme H, 2002, 1000 ONE FLOWERS LEB; Vereecken NJ, 2013, ANN BOT-LONDON, V111, P1155, DOI 10.1093/aob/mct081; Walter KS, 1998, 1997 IUCN RED LIST T; Watanabe K, 1999, J PLANT RES, V112, P145, DOI 10.1007/PL00013869; Watts S, 2013, ANN BOT-LONDON, V111, P395, DOI 10.1093/aob/mcs292; Weiss-Schneeweiss H, 2007, NEW PHYTOL, V174, P669, DOI 10.1111/j.1469-8137.2007.02019.x; West WA, 1967, ASI YB, P64; Wilson CA, 2004, MOL PHYLOGENET EVOL, V33, P402, DOI 10.1016/j.ympev.2004.06.013; Wilson CA, 2016, TAXON, V65, P35, DOI 10.12705/651.3; WU QG, 1985, BOT J LINN SOC, V90, P253, DOI 10.1111/j.1095-8339.1985.tb00385.x; ZARCO CR, 1986, TAXON, V35, P526, DOI 10.2307/1221906	77	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160816	10.1371/journal.pone.0160816	http://dx.doi.org/10.1371/journal.pone.0160816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525415	gold, Green Published, Green Submitted			2022-12-26	WOS:000381471100021
J	Chen, YG; Ma, TW; Chen, XY; Chen, ZD; Yang, CJ; Lin, CZ; Shan, LG				Chen, Yonggang; Ma, Tianwu; Chen, Xiaoyin; Chen, Zhende; Yang, Chunju; Lin, Chenzhi; Shan, Ligang			A New DEM Generalization Method Based on Watershed and Tree Structure	PLOS ONE			English	Article							GENERATION	The DEM generalization is the basis of multi- dimensional observation, the basis of expressing and analyzing the terrain. DEM is also the core of building the Multi- Scale Geographic Database. Thus, many researchers have studied both the theory and the method of DEM generalization. This paper proposed a new method of generalizing terrain, which extracts feature points based on the tree model construction which considering the nested relationship of watershed characteristics. The paper used the 5 m resolution DEM of the Jiuyuan gully watersheds in the Loess Plateau as the original data and extracted the feature points in every single watershed to reconstruct the DEM. The paper has achieved generalization from 1:10000 DEM to 1:50000 DEM by computing the best threshold. The best threshold is 0.06. In the last part of the paper, the height accuracy of the generalized DEM is analyzed by comparing it with some other classic methods, such as aggregation, resample, and VIP based on the original 1:50000 DEM. The outcome shows that the method performed well. The method can choose the best threshold according to the target generalization scale to decide the density of the feature points in the watershed. Meanwhile, this method can reserve the skeleton of the terrain, which can meet the needs of different levels of generalization. Additionally, through overlapped contour contrast, elevation statistical parameters and slope and aspect analysis, we found out that the W8D algorithm performed well and effectively in terrain representation.	[Chen, Yonggang; Ma, Tianwu; Chen, Xiaoyin; Yang, Chunju; Lin, Chenzhi; Shan, Ligang] Zhejiang Agr & Forestry Univ, Sch Environm & Resource Sci, Linan 311300, Zhejiang, Peoples R China; [Chen, Yonggang; Ma, Tianwu; Chen, Xiaoyin; Yang, Chunju] Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan 311300, Zhejiang, Peoples R China; [Chen, Zhende] Zhejiang Agr & Forestry Univ, Sch Informat Engn, Linan 311300, Zhejiang, Peoples R China	Zhejiang A&F University; Zhejiang A&F University	Chen, YG (corresponding author), Zhejiang Agr & Forestry Univ, Sch Environm & Resource Sci, Linan 311300, Zhejiang, Peoples R China.; Chen, YG (corresponding author), Zhejiang Prov Key Lab Carbon Cycling Forest Ecosy, Linan 311300, Zhejiang, Peoples R China.	cyg_gis@163.com	chen, xia/GYR-3948-2022; Ma, Tianwu/AAM-8641-2021	Ma, Tianwu/0000-0002-6199-9298	National Natural Science Foundation of China [41201408]; Zhejiang Province Ecological Public Welfare Program [2014C32119]; Zhejiang Province Natural Science Foundation of China [LY16D010009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Ecological Public Welfare Program; Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	Financial support for this research was provided by the National Natural Science Foundation of China (41201408), the Zhejiang Province Ecological Public Welfare Program (2014C32119) and the Zhejiang Province Natural Science Foundation of China (LY16D010009).	Band LE., 2000, T GIS, V4, P181, DOI 10.1111/1467-9671. 00048.; Chen CF, 2013, INT J GEOGR INF SCI, V27, P154, DOI 10.1080/13658816.2012.674136; Chen YM, 2012, COMPUT GEOSCI-UK, V48, P41, DOI 10.1016/j.cageo.2012.05.002; Chen Z-T, 1987, SYSTEMATIC SELECTION, P50; CRONIN T, 1995, COMPUT GEOSCI, V21, P609, DOI 10.1016/0098-3004(94)00100-9; De Floriani L., 1983, Eurographics '83. Proceedings of the International Conference and Exhibition, P333; Dong Youfu, 2013, Geomatics and Information Science of Wuhan University, V38, P353; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Evans IS, 2012, GEOMORPHOLOGY, V137, P94, DOI 10.1016/j.geomorph.2010.09.029; Fei LF, 2009, INT J GEOGR INF SCI, V23, P703, DOI 10.1080/13658810701703001; FREEMAN TG, 1991, COMPUT GEOSCI, V17, P413, DOI 10.1016/0098-3004(91)90048-I; Garland M, 1995, FAST POLYGONAL APPRO; Ge S., 2005, J MT SCI-ENGL, V2, P265, DOI DOI 10.1007/BF02973200; Heller M., 1990, TRIANGULATION ALGORI, P163; Jordan G, 2007, COMPUT GEOSCI-UK, V33, P573, DOI 10.1016/j.cageo.2006.08.010; LEE J, 1991, INT J GEOGR INF SYST, V5, P267, DOI 10.1080/02693799108927855; [刘学军 LIU Xuejun], 2007, [地理研究, Geographical Research], V26, P433; Lou S, 2013, MEASUREMENT, V46, P1002, DOI 10.1016/j.measurement.2012.09.015; Roubal J, 1985, AUTOMATED CONTOUR LA, P472; Shijie Z, 2013, RES WATERSHED HYPSOM; Soman KP, 2006, DATA MINING THEORY P; Taud H, 1999, COMPUT GEOSCI, V25, P775, DOI 10.1016/S0098-3004(99)00019-9; Vivoni ER, 2004, J HYDROL ENG, V9, P288, DOI 10.1061/(ASCE)1084-0699(2004)9:4(288); Whiteaker TL, 2007, INT J GEOGR INF SCI, V21, P341, DOI 10.1080/13658810600965255; Xiong LY, 2014, GEOMORPHOLOGY, V209, P18, DOI 10.1016/j.geomorph.2013.12.009; Zhou QM, 2011, ISPRS J PHOTOGRAMM, V66, P38, DOI 10.1016/j.isprsjprs.2010.08.005	26	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0159798	10.1371/journal.pone.0159798	http://dx.doi.org/10.1371/journal.pone.0159798			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517296	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100007
J	Faria, CP; Zanini, GM; Dias, GS; da Silva, S; Sousa, MD				Faria, Clarissa Perez; Zanini, Graziela Maria; Dias, Gisele Silva; da Silva, Sidnei; Sousa, Maria do Ceu			Molecular Characterization of Giardia lamblia: First Report of Assemblage B in Human Isolates from Rio de Janeiro (Brazil)	PLOS ONE			English	Article							DUODENALIS ASSEMBLAGE; SEQUENCE-ANALYSIS; IDENTIFICATION; INFECTIONS; CHILDREN; SAMPLES; CYSTS; LOCUS; PRESERVATION; GENOTYPES	Background Despite the high prevalence of giardiasis, the genetic characterization of Giardia lamblia has been poorly documented in Brazil and molecular epidemiology research has only been conducted in the last few years. The aim of this study was to determine the prevalence of different G. lamblia assemblages and detect mixed infections among patients with giardiasis. Methods and Principal Findings The cross-section survey was conducted among patients attending the FIOCRUZ in Rio de Janeiro. In order to discriminate the genetic assemblages/sub-assemblages, G. lamblia isolates were characterized by PCR-RFLP and qPCR using four loci genes (bg, gdh, tpi and orfC4). Of the 65 positive samples, 41 (63.1%) were successfully amplified by nested-PCR of bg and gdh genes. Among them, 16 were typed as sub-assemblage AII, 7 as BIII, 4 as BIV and 8 as a mixture of BIII and BIV. After the analysis by qPCR assay, a total of 55 (84.6%) samples were amplified using at least one locus: bg gene was amplified in 38 (58.5%) samples, gdh in 41 (63.1%), tpi in 39 (60%), and orfC4 in 39 (60%). Multilocus genotyping results showed that 29 (52.7%) samples belonged to Assemblage A and 26 (47.3%) samples belonged to Assemblage B. In 2011 and 2012, 20 (74.1%) samples belonged to Assemblage A and 7 (25.9%) belonged to Assemblage B. In subsequent years (2013-2015) there was a predominance of Assemblage B, 19 (67.9%) versus 9 (32.1%) Assemblage A. Conclusions This is the first time that Assemblage B of G. lamblia was reported in human clinical samples from Rio de Janeiro (Brazil) and is the first report about genetic characterization using four genes. The qPCR assemblage-specific showed no mixed infections by Assemblages A and B. A switch in genetic profile over the years was observed, firstly predominance of Assemblage A and lastly of Assemblage B.	[Faria, Clarissa Perez; Sousa, Maria do Ceu] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Faria, Clarissa Perez; Sousa, Maria do Ceu] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Faria, Clarissa Perez; Zanini, Graziela Maria; Dias, Gisele Silva; da Silva, Sidnei] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Parasitol Lab, Rio De Janeiro, Brazil	Universidade de Coimbra; Universidade de Coimbra; Fundacao Oswaldo Cruz	Sousa, MD (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.; Sousa, MD (corresponding author), Univ Coimbra, Fac Pharm, Coimbra, Portugal.	msousa@ff.uc.pt	FARIA, CLARISSA PEREZ/G-1148-2016; Sousa, Maria/HCI-9642-2022; Sousa, Maria do Céu/AGQ-8739-2022	FARIA, CLARISSA PEREZ/0000-0002-5311-1308; SOUSA, Maria do Ceu Rodrigues/0000-0003-4957-7831; Zanini, Graziela/0000-0003-4466-3124	FCT POCTI (FEDER); COMPETE [PEst-C/SAU/LA000172013-2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	FCT POCTI (FEDER)(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FCT POCTI (FEDER) and COMPETE (PEst-C/SAU/LA000172013-2014); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/gbe/evt197; Almeida A, 2010, APPL ENVIRON MICROB, V76, P1895, DOI 10.1128/AEM.02305-09; Appelbee AJ, 2003, VET PARASITOL, V112, P289, DOI 10.1016/S0304-4017(02)00422-3; Broglia A, 2013, PARASITOL RES, V112, P3449, DOI 10.1007/s00436-013-3524-y; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1; Colli CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118065; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8; Ramirez JD, 2015, INFECT GENET EVOL, V32, P208, DOI 10.1016/j.meegid.2015.03.015; De Carli G. A., 2001, PARASITOLOGIA CLIN S; Carvalho Thaís Batista de, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P269, DOI 10.1590/S0036-46652006000500006; de Oliveira AM, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/513978; Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489; FAUST E. C., 1938, American Journal of Tropical Medicine, V18, P169; Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Huey CS, 2013, INFECT GENET EVOL, V17, P269, DOI 10.1016/j.meegid.2013.04.013; IBGE, 2010, INF EST RIO JAN; Puebla LJ, 2014, INFECT GENET EVOL, V23, P7, DOI 10.1016/j.meegid.2014.01.007; Kohli Anita, 2008, Trans R Soc Trop Med Hyg, V102, P718, DOI 10.1016/j.trstmh.2008.03.002; Kuk S, 2012, MEM I OSWALDO CRUZ, V107, P965, DOI 10.1590/S0074-02762012000800001; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Mariano APM., 2015, INT J HLTH SCI, V3, P61, DOI 10.15640/ijhs.v3n1a4; Minetti C, 2015, J CLIN MICROBIOL, V53, P3133, DOI 10.1128/JCM.00715-15; Monis PT, 1999, MOL BIOL EVOL, V16, P1135, DOI 10.1093/oxfordjournals.molbev.a026204; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Castro EDR, 2015, REV INST MED TROP SP, V57, P27, DOI 10.1590/S0036-46652015000100004; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Santos CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-399; Santos CKS, 2012, T ROY SOC TROP MED H, V106, P473, DOI 10.1016/j.trstmh.2012.05.011; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Sommer MF, 2015, PARASITOL RES, V114, P2165, DOI 10.1007/s00436-015-4405-3; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Thompson RCA, 2015, INFECT GENET EVOL, V11, pS1567; Torres-Romero JC, 2014, MEM I OSWALDO CRUZ, V109, P388, DOI 10.1590/0074-0276140507; Van den Bossche D, 2015, J MICROBIOL METH, V110, P78, DOI 10.1016/j.mimet.2015.01.016; Volotao AC, 2007, ACTA TROP, V102, P10, DOI 10.1016/j.actatropica.2007.02.010; Wielinga CM, 2007, PARASITOLOGY, V134, P1795, DOI 10.1017/S0031182007003071; Wilke H, 2009, J MICROBIOL METH, V78, P292, DOI 10.1016/j.mimet.2009.06.018	43	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160762	10.1371/journal.pone.0160762	http://dx.doi.org/10.1371/journal.pone.0160762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517469	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100022
J	Heintz, TG; Eva, R; Fawcett, JW				Heintz, Tristan G.; Eva, Richard; Fawcett, James W.			Regional Regulation of Purkinje Cell Dendritic Spines by Integrins and Eph/Ephrins	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; SYNAPSE FORMATION; HIPPOCAMPAL-NEURONS; GLUTAMATE TRANSPORT; EPH RECEPTORS; MOUSE-BRAIN; EXPRESSION; PLASTICITY; KINASE	Climbing fibres and parallel fibres compete for dendritic space on Purkinje cells in the cerebellum. Normally, climbing fibres populate the proximal dendrites, where they suppress the multiple small spines typical of parallel fibres, leading to their replacement by the few large spines that contact climbing fibres. Previous work has shown that ephrins acting via EphA4 are a signal for this change in spine type and density. We have used an in vitro culture model in which to investigate the ephrin effect on Purkinje cell dendritic spines and the role of integrins in these changes. We found that integrins alpha 3, alpha 5 and alpha 4 are present in many of the dendritic spines of cultured Purkinje cells. pFAK, the main downstream signalling molecule from integrins, has a similar distribution, although the intenstity of pFAK staining and the percentage of pFAK+ spines was consistently higher in the proximal dendrites. Activating integrins with Mg2+ led to an increase in the intensity of pFAK staining and an increase in the proportion of pFAK+ spines in both the proximal and distal dendrites, but no change in spine length, density or morphology. Blocking integrin binding with an RGD- containing peptide led to a reduction in spine length, with more stubby spines on both proximal and distal dendrites. Treatment of the cultures with ephrinA3- Fc chimera suppressed dendritic spines specifically on the proximal dendrites and there was also a decrease of pFAK in spines on this domain. This effect was blocked by simultaneous activation of integrins with Mn2+. We conclude that Eph/ephrin signaling regulates proximal dendritic spines in Purkinje cells by inactivating integrin downstream signalling.	[Heintz, Tristan G.; Eva, Richard; Fawcett, James W.] Univ Cambridge, John van Geest Ctr Brain Repair, Robinson Way, Cambridge CB2 0PY, England	University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, John van Geest Ctr Brain Repair, Robinson Way, Cambridge CB2 0PY, England.	jf108@cam.ac.uk	Eva, Richard/J-7865-2017	Eva, Richard/0000-0003-0305-0452; Fawcett, James/0000-0002-7990-4568	MRC [G1000864]; ERC ECMNeuro; Christopher and Dana Reeve Foundation consortium; EU Marie Curie RTN Axregen; Medical Research Council [G1000864] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC ECMNeuro; Christopher and Dana Reeve Foundation consortium; EU Marie Curie RTN Axregen; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by MRC G1000864 (www.mrc.ac.uk), ERC ECMNeuro (https://erc.europa.eu), Christopher and Dana Reeve Foundation consortium (www.christopherreeve.org), and EU Marie Curie RTN Axregen (ec.europa.eu/research/mariecurieactions).	Babayan AH, 2012, J NEUROSCI, V32, P12854, DOI 10.1523/JNEUROSCI.2024-12.2012; Bi XN, 2001, J COMP NEUROL, V435, P184, DOI 10.1002/cne.1201; Bourgin C, 2007, J CELL BIOL, V178, P1295, DOI 10.1083/jcb.200610139; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019160; Cingolani LA, 2008, NEURON, V58, P749, DOI 10.1016/j.neuron.2008.04.011; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Greferath U, 2002, MECH DEVELOP, V119, pS231, DOI 10.1016/S0925-4773(03)00122-9; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kawaguchi SY, 2006, MOL CELL NEUROSCI, V31, P416, DOI 10.1016/j.mcn.2005.10.012; Kerrisk ME, 2014, PROG BRAIN RES, V214, P101, DOI 10.1016/B978-0-444-63486-3.00005-0; Kerrisk ME, 2013, J NEUROSCI, V33, P6742, DOI 10.1523/JNEUROSCI.0528-13.2013; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lee KJ, 2004, NEUROSCI LETT, V359, P21, DOI 10.1016/j.neulet.2004.01.071; Levy AD, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00116; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Martone ME, 1997, BRAIN RES, V771, P238, DOI 10.1016/S0006-8993(97)00792-0; McGeachie AB, 2011, NEUROSCI RES, V70, P24, DOI 10.1016/j.neures.2011.02.006; Migani P, 2007, BRAIN RES, V1182, P60, DOI 10.1016/j.brainres.2007.08.065; Moeller ML, 2006, J BIOL CHEM, V281, P1587, DOI 10.1074/jbc.M511756200; Murai KK, 2011, GLIA, V59, P1567, DOI 10.1002/glia.21226; Murai KK, 2004, NEUROSCIENTIST, V10, P304, DOI 10.1177/1073858403262221; Orlando C, 2012, J NEUROSCI, V32, P18009, DOI 10.1523/JNEUROSCI.2406-12.2012; Pozo K, 2012, P NATL ACAD SCI USA, V109, P1323, DOI 10.1073/pnas.1113736109; Saywell V, 2014, CEREBELLUM, V13, P307, DOI 10.1007/s12311-014-0548-5; Senkov O, 2014, PROG BRAIN RES, V214, P53, DOI 10.1016/B978-0-444-63486-3.00003-7; Shi Y, 2006, J NEUROSCI, V26, P1813, DOI 10.1523/JNEUROSCI.4091-05.2006; Su JM, 2012, CELL REP, V2, P223, DOI 10.1016/j.celrep.2012.07.001; Troca-Marin JA, 2010, MOL CELL NEUROSCI, V43, P308, DOI 10.1016/j.mcn.2009.12.004; Vitureira N, 2012, CURR OPIN NEUROBIOL, V22, P516, DOI 10.1016/j.conb.2011.09.006; Warren MS, 2012, J NEUROSCI, V32, P2824, DOI 10.1523/JNEUROSCI.3942-11.2012; Willson CA, 2006, J MOL HISTOL, V37, P369, DOI 10.1007/s10735-006-9067-0; Yu XZ, 2013, NEURON, V80, P64, DOI 10.1016/j.neuron.2013.07.014; Zhou L, 2012, J BIOL CHEM, V287, P9346, DOI 10.1074/jbc.M111.302802	39	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0158558	10.1371/journal.pone.0158558	http://dx.doi.org/10.1371/journal.pone.0158558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518800	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100004
J	Prakash, A; Cao, VB; Doublie, S				Prakash, Aishwarya; Cao, Vy Bao; Doublie, Sylvie			Phosphorylation Sites Identified in the NEIL1 DNA Glycosylase Are Potential Targets for the JNK1 Kinase	PLOS ONE			English	Article							BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE-DNA GLYCOSYLASE; C-TERMINAL DOMAIN; IN-VIVO; POSTTRANSLATIONAL MODIFICATIONS; MASS-SPECTROMETRY; PROTEIN-PHOSPHORYLATION; SIGNALING NETWORKS; ENDONUCLEASE-VIII; FAMILY KINASES	The NEIL1 DNA glycosylase is one of eleven mammalian DNA glycosylases that partake in the first step of the base excision repair (BER) pathway. NEIL1 recognizes and cleaves mainly oxidized pyrimidines from DNA. The past decade has witnessed the identification of an increasing number of post-translational modifications (PTMs) in BER enzymes including phosphorylation, acetylation, and sumoylation, which modulate enzyme function. In this work, we performed the first comprehensive analysis of phosphorylation sites in human NEIL1 expressed in human cells. Mass spectrometry (MS) analysis revealed phosphorylation at three serine residues: S207, S306, and a third novel site, S61. We expressed, purified, and characterized phosphomimetic (glutamate) and phosphoablating (alanine) mutants of the three phosphorylation sites in NEIL1 revealed by the MS analysis. All mutant enzymes were active and bound tightly to DNA, indicating that phosphorylation does not affect DNA binding and enzyme activity at these three serine sites. We also characterized phosphomimetic mutants of two other sites of phosphorylation, Y263 and S269, reported previously, and observed that mutation of Y263 to E yielded a completely inactive enzyme. Furthermore, based on sequence motifs and kinase prediction algorithms, we identified the c-Jun N-terminal kinase 1 (JNK1) as the kinase involved in the phosphorylation of NEIL1. JNK1, a member of the mitogen activated protein kinase (MAPK) family, was detected in NEIL1 immunoprecipitates, interacted with NEIL1 in vitro, and was able to phosphorylate the enzyme at residues S207, S306, and S61.	[Prakash, Aishwarya] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA; [Cao, Vy Bao; Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA	University of South Alabama; University of Vermont	Prakash, A (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, 1660 Springhill Ave, Mobile, AL 36604 USA.; Doublie, S (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Markey Ctr Mol Genet, Stafford Hall,95 Carrigan Dr, Burlington, VT 05405 USA.	aprakash@health.southalabama.edu; Sylvie.Doublie@uvm.edu		Doublie, Sylvie/0000-0002-6294-5304; Cao, Vy/0000-0003-4703-450X; Prakash, Aishwarya/0000-0003-1441-6237	National Cancer Institute at National Institutes of Health [P01 CA098993]; National Institute of Environmental Health Sciences at the National Institutes of Health [2-K99ES024417]; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103449]; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES024417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103449] Funding Source: NIH RePORTER	National Cancer Institute at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Cancer Institute at National Institutes of Health [P01 CA098993 to SD]; the National Institute of Environmental Health Sciences at the National Institutes of Health [2-K99ES024417 to AP]; and National Institute of General Medical Sciences of the National Institutes of Health Institutional Development Award (IDeA) grant [P20GM103449 to the Vermont Genetics Network (VGN)].; We would like to thank Drs. Robyn Maher and David Pederson for supplying us with the NEIL1-SBP construct, Dr. Scott Kathe for technical assistance with the affinity pull-down and biochemistry experiments, Drs. Cindy Burrows and Aaron Fleming (University of Utah) for the Sp- containing oligonucleotide, and Dr. Brian E. Eckenroth for critically reading the manuscript. We would also like to acknowledge Julia Ganister Fields, Bethany Ahlers, and Dr. YingWai Lam at the Vermont Genetics Network Proteomics Facility who performed the mass spectrometry analysis. The mass spectrometry work reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Akbari M, 2012, MUTAT RES-FUND MOL M, V736, P33, DOI 10.1016/j.mrfmmm.2011.06.006; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Bandaru V, 2004, ACTA CRYSTALLOGR D, V60, P1142, DOI 10.1107/S0907444904007929; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Cui J, 2007, ACTA PHARMACOL SIN, V28, P601, DOI 10.1111/j.1745-7254.2007.00579.x; Dantzer F, 2002, NUCLEIC ACIDS RES, V30, P2349, DOI 10.1093/nar/30.11.2349; Das A, 2004, J BIOL CHEM, V279, P47132, DOI 10.1074/jbc.M406224200; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Doublie S, 2004, P NATL ACAD SCI USA, V101, P10284, DOI 10.1073/pnas.0402051101; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Garcia BA, 2005, METHODS, V35, P256, DOI 10.1016/j.ymeth.2004.08.017; Grin IR, 2011, BIOCHEMISTRY-MOSCOW+, V76, P80, DOI 10.1134/S000629791101010X; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2013, J MOL BIOL, V425, P2359, DOI 10.1016/j.jmb.2013.03.030; Hegde PM, 2015, J BIOL CHEM, V290, P20919, DOI 10.1074/jbc.M115.642918; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Hu JP, 2005, NUCLEIC ACIDS RES, V33, P3271, DOI 10.1093/nar/gki636; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Imamura K, 2009, J BIOL CHEM, V284, P26174, DOI 10.1074/jbc.M109.021907; Jaruga P, 2010, BIOCHEMISTRY-US, V49, P1053, DOI 10.1021/bi902161f; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Kang LH, 2015, EXP EYE RES, V135, P102, DOI 10.1016/j.exer.2015.02.005; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Kornyushyna O, 2002, BIOCHEMISTRY-US, V41, P15304, DOI 10.1021/bi0264925; Kundu S, 2010, DNA REPAIR, V9, P1026, DOI 10.1016/j.dnarep.2010.07.002; Leandro GS, 2015, MUTAT RES-FUND MOL M, V776, P31, DOI 10.1016/j.mrfmmm.2014.12.011; Lillenes MS, 2011, MECH AGEING DEV, V132, P449, DOI 10.1016/j.mad.2011.08.002; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lundby A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1871; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Odell ID, 2010, DNA REPAIR, V9, P134, DOI 10.1016/j.dnarep.2009.11.005; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Onizuka K, 2012, CHEMBIOCHEM, V13, P1338, DOI 10.1002/cbic.201200139; Picco Vincent, 2013, Genes Cancer, V4, P360, DOI 10.1177/1947601913486347; Prakash A, 2012, PROG MOL BIOL TRANSL, V110, P71, DOI 10.1016/B978-0-12-387665-2.00004-3; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Safaei J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S6; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Sidorenko VS, 2009, FEBS J, V276, P5149, DOI 10.1111/j.1742-4658.2009.07212.x; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Tacoma R, 2016, J PROTEOMICS, V130, P200, DOI 10.1016/j.jprot.2015.09.024; Takesono A, 2002, J CELL SCI, V115, P3039; Vik ES, 2012, DNA REPAIR, V11, P766, DOI 10.1016/j.dnarep.2012.07.002; Wallace SS, 1998, RADIAT RES, V150, pS60, DOI 10.2307/3579809; Wallace SS, 2014, DNA REPAIR, V19, P14, DOI 10.1016/j.dnarep.2014.03.030; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Zhao XB, 2010, BIOCHEMISTRY-US, V49, P1658, DOI 10.1021/bi901852q; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	68	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0157860	10.1371/journal.pone.0157860	http://dx.doi.org/10.1371/journal.pone.0157860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518429	gold, Green Published, Green Submitted			2022-12-26	WOS:000381382100001
J	Balaguier, R; Madeleine, P; Vuillerme, N				Balaguier, Romain; Madeleine, Pascal; Vuillerme, Nicolas			Is One Trial Sufficient to Obtain Excellent Pressure Pain Threshold Reliability in the Low Back of Asymptomatic Individuals? A Test-Retest Study	PLOS ONE			English	Article							NORMAL MUSCLES; ALGOMETRY; SENSITIVITY; SUMMATION; SEX	The assessment of pressure pain threshold (PPT) provides a quantitative value related to the mechanical sensitivity to pain of deep structures. Although excellent reliability of PPT has been reported in numerous anatomical locations, its absolute and relative reliability in the lower back region remains to be determined. Because of the high prevalence of low back pain in the general population and because low back pain is one of the leading causes of disability in industrialized countries, assessing pressure pain thresholds over the low back is particularly of interest. The purpose of this study study was (1) to evaluate the intra- and inter-absolute and relative reliability of PPT within 14 locations covering the low back region of asymptomatic individuals and (2) to determine the number of trial required to ensure reliable PPT measurements. Fifteen asymptomatic subjects were included in this study. PPTs were assessed among 14 anatomical locations in the low back region over two sessions separated by one hour interval. For the two sessions, three PPT assessments were performed on each location. Reliability was assessed computing intraclass correlation coefficients (ICC), standard error of measurement (SEM) and minimum detectable change (MDC) for all possible combinations between trials and sessions. Bland-Altman plots were also generated to assess potential bias in the dataset. Relative reliability for both intra-and inter-session was almost perfect with ICC ranged from 0.85 to 0.99. With respect to the intra-session, no statistical difference was reported for ICCs and SEM regardless of the conducted comparisons between trials. Conversely, for inter-session, ICCs and SEM values were significantly larger when two consecutive PPT measurements were used for data analysis. No significant difference was observed for the comparison between two consecutive measurements and three measurements. Excellent relative and absolute reliabilities were reported for both intra-and inter-session. Reliable measurements can be equally achieved when using the mean of two or three consecutive PPT measurements, as usually proposed in the literature, or with only the first one. Although reliability was almost perfect regardless of the conducted comparison between PPT assessments, our results suggest using two consecutive measurements to obtain higher short term absolute reliability.	[Balaguier, Romain; Vuillerme, Nicolas] Univ Grenoble Alpes, EA AGEIS, Grenoble, France; [Balaguier, Romain; Madeleine, Pascal; Vuillerme, Nicolas] Aalborg Univ, Dept Hlth Sci & Technol, Phys Act & Human Performance Grp SMI, Aalborg, Denmark; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Aalborg University; Institut Universitaire de France	Vuillerme, N (corresponding author), Univ Grenoble Alpes, EA AGEIS, Grenoble, France.; Vuillerme, N (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Phys Act & Human Performance Grp SMI, Aalborg, Denmark.; Vuillerme, N (corresponding author), Inst Univ France, Paris, France.	nicolas.vuillerme@agim.eu	Madeleine, Pascal/AAD-3201-2021; Balaguier, Romain/ABD-8496-2020; VUILLERME, Nicolas/U-5767-2019	VUILLERME, Nicolas/0000-0003-3773-393X; Balaguier, Romain/0000-0001-6393-1556	French Ministry of Higher Education and Research; Blatand French-Danish scientific cooperation program (Institut Francais du Danemark); Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France); Aalborg University (Danemark)	French Ministry of Higher Education and Research; Blatand French-Danish scientific cooperation program (Institut Francais du Danemark); Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France); Aalborg University (Danemark)	This joint PhD project is financed by a grant from the French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The presented work is part of the joint PhD thesis of Romain Balaguier at Univ. Grenoble Alpes (France) and Aalborg University (Denmark), who was supported by a grant of the French Ministry of Higher Education and Research. This work is also part of a larger pluri-disciplinary project called 'EWS' (Ergonomics at Work and in Sports). EWS project has benefited from support from the Blatand French-Danish scientific cooperation program (Institut Francais du Danemark), the Direction des Relations Territoriales et Internationales from Univ. Grenoble Alpes (France) and Aalborg University (Danemark) we acknowledge gratefully. The authors would like to thank anonymous reviewers for helpful comments and suggestions.	Andersen CH, 2014, J OCCUP REHABIL, V24, P316, DOI 10.1007/s10926-013-9441-1; Andersen H, 2006, SOMATOSENS MOT RES, V23, P97, DOI 10.1080/08990220600856255; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Arendt-Nielsen L, 2009, J PAIN, V10, P556, DOI 10.1016/j.jpain.2009.02.002; Aweid O, 2014, KNEE SURG SPORT TR A, V22, P1549, DOI 10.1007/s00167-013-2558-0; Baker S J, 1997, Eur J Pain, V1, P229, DOI 10.1016/S1090-3801(97)90108-7; Binderup AT, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-234; Binderup AT, 2011, INT ARCH OCC ENV HEA, V84, P647, DOI 10.1007/s00420-011-0627-6; BONICA JJ, 1979, PAIN, V6, P247, DOI 10.1016/0304-3959(79)90046-0; Bruyneel A.-V., 2015, KINESITHERAPIE REV, V15, P74; Chesterton LS, 2007, CLIN J PAIN, V23, P760, DOI 10.1097/AJP.0b013e318154b6ae; Chiarotto A, 2016, PHYS THER, V96, P1620, DOI 10.2522/ptj.20150420; Downie AS, 2016, PAIN, V157, P225, DOI 10.1097/j.pain.0000000000000351; Dunn KM, 2006, AM J EPIDEMIOL, V163, P754, DOI 10.1093/aje/kwj100; Farasyn A., 2003, J BODYW MOV THER, V7, P53, DOI [10.1016/S1360-8592(02)00050-5, DOI 10.1016/S1360-8592(02)00050-5]; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Fingleton CP, 2014, J MANIP PHYSIOL THER, V37, P97, DOI 10.1016/j.jmpt.2013.12.006; FISCHER AA, 1987, PAIN, V30, P115, DOI 10.1016/0304-3959(87)90089-3; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; Ge HY, 2004, PAIN, V110, P72, DOI 10.1016/j.pain.2004.03.005; Graven-Nielsen T, 2012, ARTHRITIS RHEUM-US, V64, P2907, DOI 10.1002/art.34466; Harvill L.M., 1991, EDUC MEAS-ISSUES PRA, V10, P33, DOI [DOI 10.1111/J.1745-3992.1991.TB00195.X, 10.1111/j.1745-3992.1991.tb00195.x]; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Kongsted A, 2015, SPINE J, V15, P885, DOI 10.1016/j.spinee.2015.02.012; Koo TK, 2013, J MANIP PHYSIOL THER, V36, P84, DOI 10.1016/j.jmpt.2013.01.001; Lacourt TE, 2012, SCAND J PAIN, V3, P31, DOI 10.1016/j.sjpain.2011.10.003; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Madeleine P, 2014, J ORTHOP SPORT PHYS, V44, P587, DOI 10.2519/jospt.2014.5117; Mense S, 1992, MUSCLE PAIN UNDERSTA; Merboth MK, 2000, NURS CLIN N AM, V35, P375; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Montenegro MLLS, 2012, BRAZ J MED BIOL RES, V45, P578, DOI 10.1590/S0100-879X2012007500064; Mutlu EK, 2015, J PHYS THER SCI, V27, P1961, DOI 10.1589/jpts.27.1961; Nie H, 2006, EXP BRAIN RES, V170, P182, DOI 10.1007/s00221-005-0196-6; Nie HL, 2009, EUR J PAIN, V13, P592, DOI 10.1016/j.ejpain.2008.07.013; Nikolajsen L, 2011, J CHILD ORTHOP, V5, P173, DOI 10.1007/s11832-011-0336-4; Nussbaum EL, 1998, PHYS THER, V78, P160, DOI 10.1093/ptj/78.2.160; OHRBACH R, 1989, PAIN, V37, P257, DOI 10.1016/0304-3959(89)90189-9; Park G, 2011, ANN REHABIL MED-ARM, V35, P412, DOI 10.5535/arm.2011.35.3.412; Paungmali Aatit, 2012, Asian J Sports Med, V3, P8; Pinsault Nicolas, 2008, Physiotherapy Theory and Practice, V24, P380, DOI 10.1080/09593980701884824; Punnett L, 2004, J ELECTROMYOGR KINES, V14, P13, DOI 10.1016/j.jelekin.2003.09.015; Roren A, 2013, MANUAL THER, V18, P473, DOI 10.1016/j.math.2013.04.005; Schless SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131011; Soee ABL, 2013, J PAIN RES, V6, P103, DOI 10.2147/JPR.S38514; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vanderweeen L., 1996, Man Ther, V1, P258, DOI 10.1054/math.1996.0276; Waller R, 2015, SCAND J PAIN, V9, P38, DOI 10.1016/j.sjpain.2015.05.004; Walton D, 2011, J ORTHOP SPORT PHYS, V41, P644, DOI 10.2519/jospt.2011.3666; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Ylinen J, 2005, EUR J PAIN, V9, P673, DOI 10.1016/j.ejpain.2005.01.001; Ylinen J, 2007, AUST J PHYSIOTHER, V53, P207, DOI 10.1016/S0004-9514(07)70032-6	54	44	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160866	10.1371/journal.pone.0160866	http://dx.doi.org/10.1371/journal.pone.0160866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513474	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100082
J	Dagil, YA; Arbatsky, NP; Alkhazova, BI; L'vov, VL; Mazurov, DV; Pashenkov, MV				Dagil, Yulia A.; Arbatsky, Nikolai P.; Alkhazova, Biana I.; L'vov, Vyacheslav L.; Mazurov, Dmitriy V.; Pashenkov, Mikhail V.			The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue	PLOS ONE			English	Article							NOD1-ACTIVATING PEPTIDOGLYCAN AGONISTS; BACTERIAL PEPTIDOGLYCAN; MURAMYL DIPEPTIDE; ADJUVANT ACTIVITY; DENDRITIC CELLS; INNATE IMMUNITY; KAPPA-B; NOD2; BINDING; DOMAIN	Muropeptides are fragments of peptidoglycan that trigger innate immune responses by activating nucleotide-binding oligomerization domain (NOD) 1 and NOD2. Muropeptides from Gram-negative bacteria contain a meso-diaminopimelic acid (meso-DAP) residue in either a terminal or a non-terminal position. While the former ones are known to be recognized by NOD1, much less is known about recognition of muropeptides with non-terminal meso-DAP, which are most abundant moieties of Gram-negative peptidoglycans. Here, we developed a novel system to assess biological activity of muropeptides, based on CRISPR/Cas9-mediated knockout (KO) of NOD1 and NOD2 genes in modified HEK293T cells. Using NOD1/NOD2 knockout and overexpression systems, as well as human monocytes and macrophages, we refine the current view of muropeptide recognition. We show that NOD2 can recognize different natural muropeptides containing a meso-DAP residue (preferably in a non-terminal position), provided they are present at micromolar concentrations. NOD2 accepts muropeptides with long and branched peptide chains and requires an intact N-acetylmuramyl residue. Muropeptides with non-terminal meso-DAP can activate NOD1 as well, but, in this case, probably require peptidase pre-processing to expose the meso-DAP residue. Depending on NOD1/NOD2 ratio in specific cell types, meso-DAP-containing muropeptides can be recognized either primarily via NOD2 (in monocytes) or via NOD1 (in monocyte-derived macrophages and HEK293T-derived cells). The dual NOD1/NOD2 agonism of meso-DAP-containing muropeptides should be taken into account when assessing cellular responses to muropeptides and designing muropeptide immunostimulants and vaccine adjuvants.	[Dagil, Yulia A.; Arbatsky, Nikolai P.; Pashenkov, Mikhail V.] Fed Med Biol Agcy, Inst Immunol, Natl Res Ctr, Clin Immunol Lab, Moscow, Russia; [Alkhazova, Biana I.; L'vov, Vyacheslav L.] Fed Med Biol Agcy, Inst Immunol, Natl Res Ctr, Lab Preparat Biochem, Moscow, Russia; [Mazurov, Dmitriy V.] Fed Med Biol Agcy, Inst Immunol, Natl Res Ctr, Lab Immunochem, Moscow, Russia	NRC Institute of Immunology FMBA of Russia; NRC Institute of Immunology FMBA of Russia; NRC Institute of Immunology FMBA of Russia	Pashenkov, MV (corresponding author), Fed Med Biol Agcy, Inst Immunol, Natl Res Ctr, Clin Immunol Lab, Moscow, Russia.	mvpashenkov@yandex.ru	Pashenkov, Mikhail/AAU-8034-2020	Pashenkov, Mikhail/0000-0002-6995-1790; Lvov, Viacheslav/0000-0002-0609-8331	Russian Foundation for Basic Research [13-04-00753]; Corus Farm Ltd (Moscow, Russia)	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Corus Farm Ltd (Moscow, Russia)	This work was supported by the Russian Foundation for Basic Research (grant 13-04-00753) and Corus Farm Ltd (Moscow, Russia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1974, BIOCHEM BIOPH RES CO, V56, P561, DOI 10.1016/0006-291X(74)90640-8; Beranova-Giorgianni S, 1998, J MASS SPECTROM, V33, P1182, DOI 10.1002/(SICI)1096-9888(199812)33:12<1182::AID-JMS733>3.0.CO;2-Q; Berrington WR, 2010, EUR J IMMUNOL, V40, P3519, DOI 10.1002/eji.201040518; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Inohara N, 1999, J BIOL CHEM, V274, P14560, DOI 10.1074/jbc.274.21.14560; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Laroui H, 2011, J BIOL CHEM, V286, P31003, DOI 10.1074/jbc.M111.257501; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Magalhaes JG, 2005, EMBO REP, V6, P1201, DOI 10.1038/sj.embor.7400552; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mo JY, 2012, J BIOL CHEM, V287, P23057, DOI 10.1074/jbc.M112.344283; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Pandey AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000500; Pashenkov MV, 2010, INT IMMUNOPHARMACOL, V10, P875, DOI 10.1016/j.intimp.2010.04.025; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Rubino SJ, 2013, INNATE IMMUN-LONDON, V19, P493, DOI 10.1177/1753425912471691; Schertzer JD, 2011, DIABETES, V60, P2206, DOI 10.2337/db11-0004; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Tarasevich A, 2015, ACTA VIROL, V59, P247, DOI 10.4149/av_2015_03_247; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; van Heel DA, 2006, EUR J IMMUNOL, V36, P1629, DOI 10.1002/eji.200535636; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Watanabe T, 2010, J CLIN INVEST, V120, P1645, DOI 10.1172/JCI39481; Wolfert MA, 2007, INFECT IMMUN, V75, P706, DOI 10.1128/IAI.01597-06	34	18	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160784	10.1371/journal.pone.0160784	http://dx.doi.org/10.1371/journal.pone.0160784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513337	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100072
J	Linher-Melville, K; Nashed, MG; Ungard, RG; Haftchenary, S; Rosa, DA; Gunning, PT; Singh, G				Linher-Melville, Katja; Nashed, Mina G.; Ungard, Robert G.; Haftchenary, Sina; Rosa, David A.; Gunning, Patrick T.; Singh, Gurmit			Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity	PLOS ONE			English	Article							SIGNAL TRANSDUCER; CYSTINE/GLUTAMATE ANTIPORTER; ANTIESTROGEN RESISTANCE; GLUTAMATE RELEASE; MULTIPLE-MYELOMA; STAT3; GENE; TARGET; ACTIVATION; PROLACTIN	Pharmacologically targeting activated STAT3 and/or STAT5 has been an active area of cancer research. The cystine/glutamate antiporter, system x(c)(-), contributes to redox balance and export of intracellularly produced glutamate in response to up-regulated glutaminolysis in cancer cells. We have previously shown that blocking STAT3/5 using the small molecule inhibitor, SH-4-54, which targets the SH2 domains of both proteins, increases xCT expression, thereby increasing system x(c)(-) activity in human breast cancer cells. The current investigation demonstrates that chronic SH-4-54 administration, followed by clonal selection of treatment-resistant MDA-MB-231 and T47D breast cancer cells, elicits distinct subtype-dependent effects. xCT mRNA and protein levels, glutamate release, and cystine uptake are decreased relative to untreated passage-matched controls in triple-negative MDA-MB-231 cells, with the inverse occurring in estrogen-responsive T47D cells. This "ying-yang" effect is linked with a shifted balance between the phosphorylation status of STAT3 and STAT5, intracellular ROS levels, and STAT5 SUMOylation/de-SUMOylation. STAT5 emerged as a definitive negative regulator of xCT at the transcriptional level, while STAT3 activation is coupled with increased system x(c)(-) activity. We propose that careful classification of a patient's breast cancer subtype is central to effectively targeting STAT3/5 as a therapeutic means of treating breast cancer, particularly given that xCT is emerging as an important biomarker of aggressive cancers.	[Linher-Melville, Katja; Nashed, Mina G.; Ungard, Robert G.; Singh, Gurmit] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Haftchenary, Sina; Rosa, David A.; Gunning, Patrick T.] Univ Toronto, Dept Chem & Phys Sci, Mississauga, ON L5L 1C6, Canada	McMaster University; University of Toronto; University Toronto Mississauga	Singh, G (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada.	singhg@mcmaster.ca	Nashed, Mina/AAI-2573-2021	Nashed, Mina/0000-0001-9549-0863; Ungard, Robert/0000-0003-3444-6409	Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR) [111061]	Canadian Breast Cancer Foundation (CBCF); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The work of KLM was supported by a Canadian Breast Cancer Foundation (CBCF) fellowship, and GS is supported by an operating grant from the Canadian Institutes of Health Research (CIHR); Funded Reference Number 111061.	Alas S, 2003, CLIN CANCER RES, V9, P316; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Balza E, 2013, CARCINOGENESIS, V34, P620, DOI 10.1093/carcin/bgs360; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Bossis G, 2014, CELL REP, V7, P1815, DOI 10.1016/j.celrep.2014.05.016; Bourgeais Jerome, 2013, JAKSTAT, V2, pe25764, DOI 10.4161/jkst.25764; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Canbay E, 1997, BIOCHEM J, V324, P231, DOI 10.1042/bj3240231; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; DaSilva L, 1996, MOL CELL ENDOCRINOL, V117, P131, DOI 10.1016/0303-7207(95)03738-1; Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Driscoll JJ, 2010, BLOOD, V115, P2827, DOI 10.1182/blood-2009-03-211045; Fazzari J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08380; Feligioni M, 2013, NEUROMOL MED, V15, P707, DOI 10.1007/s12017-013-8266-6; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Frasor J, 2003, TRENDS ENDOCRIN MET, V14, P118, DOI 10.1016/S1043-2760(03)00030-4; Fukui H, 2011, INFLAMM BOWEL DIS, V17, P1177, DOI 10.1002/ibd.21473; Ginsberg M, 2007, MOL CELL BIOL, V27, P6300, DOI 10.1128/MCB.00613-07; Girardot M, 2015, ONCOGENE, V34, P1323, DOI 10.1038/onc.2014.60; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Haftchenary S, 2013, ACS MED CHEM LETT, V4, P1102, DOI 10.1021/ml4003138; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Y, 2005, CANCER RES, V65, P7446, DOI 10.1158/0008-5472.CAN-04-4267; Iiyama M, 2006, CELL SIGNAL, V18, P174, DOI 10.1016/j.cellsig.2005.04.002; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kanai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086790; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kramer Oliver H, 2012, JAKSTAT, V1, P203, DOI 10.4161/jkst.21232; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; LANDER E S, 1988, Genomics, V2, P231; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Linher-Melville K, 2015, MOL CELL BIOCH; Linher-Melville K, 2015, MOL CELL BIOCHEM, V405, P205, DOI 10.1007/s11010-015-2412-4; Linher-Melville K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-415; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Magne S, 2003, MOL CELL BIOL, V23, P8934, DOI 10.1128/MCB.23.24.8934-8945.2003; Makkinje A, 2012, J BIOL CHEM, V287, P27703, DOI 10.1074/jbc.M112.389981; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Nahta R, 2003, CLIN CANCER RES, V9, P5078; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Park-Sarge Ok-Kyong, 2008, V464, P255; Peng DF, 2012, GUT, V61, P1250, DOI 10.1136/gutjnl-2011-301078; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sattler M, 1999, BLOOD, V93, P2928; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Sung B, 2012, FREE RADICAL BIO MED, V53, P1977, DOI 10.1016/j.freeradbiomed.2012.08.012; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Nguyen TV, 2012, MOL CELL, V45, P210, DOI 10.1016/j.molcel.2011.12.026; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turei D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/737591; Ungard RG, 2014, PAIN, V155, P28, DOI 10.1016/j.pain.2013.08.030; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Xu Z, 2009, ANTIOXID REDOX SIGN, V11, P1453, DOI [10.1089/ars.2008.2182, 10.1089/ARS.2008.2182]; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhen AW, 2013, HEPATOLOGY, V58, P1315, DOI 10.1002/hep.26490	81	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161202	10.1371/journal.pone.0161202	http://dx.doi.org/10.1371/journal.pone.0161202			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513743	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100130
J	Nunvar, J; Kalferstova, L; Bloodworth, RAM; Kolar, M; Degrossi, J; Lubovich, S; Cardona, ST; Drevinek, P				Nunvar, Jaroslav; Kalferstova, Lucie; Bloodworth, Ruhi A. M.; Kolar, Michal; Degrossi, Jose; Lubovich, Silvina; Cardona, Silvia T.; Drevinek, Pavel			Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis	PLOS ONE			English	Article							QUORUM SENSING SYSTEMS; CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; SPONTANEOUS MUTATIONS; MOLECULAR-SPECTRUM; STRUCTURAL BASIS; CENOCEPACIA; GENOME; STRAIN; BIOSYNTHESIS	Several bacterial species from the Burkholderia cepacia complex (Bcc) are feared opportunistic pathogens that lead to debilitating lung infections with a high risk of developing fatal septicemia in cystic fibrosis (CF) patients. However, the pathogenic potential of other Bcc species is yet unknown. To elucidate clinical relevance of Burkholderia contaminans, a species frequently isolated from CF respiratory samples in Ibero-American countries, we aimed to identify its key virulence factors possibly linked with an unfavorable clinical outcome. We performed a genome-wide comparative analysis of two isolates of B. contaminans ST872 from sputum and blood culture of a female CF patient in Argentina. RNA-seq data showed significant changes in expression for quorum sensing-regulated virulence factors and motility and chemotaxis. Furthermore, we detected expression changes in a recently described low-oxygen-activated (lxa) locus which encodes stress-related proteins, and for two clusters responsible for the biosynthesis of antifungal and hemolytic compounds pyrrolnitrin and occidiofungin. Based on phenotypic assays that confirmed changes in motility and in proteolytic, hemolytic and antifungal activities, we were able to distinguish two phenotypes of B. contaminans that coexisted in the host and entered her bloodstream. Whole genome sequencing revealed that the sputum and bloodstream isolates (each representing a distinct phenotype) differed by over 1,400 mutations as a result of a mismatch repair-deficient hypermutable state of the sputum isolate. The inferred lack of purifying selection against nonsynonymous mutations and the high rate of pseudogenization in the derived isolate indicated limited evolutionary pressure during evolution in the nutrient-rich, stable CF sputum environment. The present study is the first to examine the genomic and transcriptomic differences between longitudinal isolates of B. contaminans. Detected activity of a number of putative virulence factors implies a genuine pathogenic nature of this novel Bcc species.	[Nunvar, Jaroslav; Kalferstova, Lucie; Drevinek, Pavel] Charles Univ Prague, Fac Med 2, Dept Med Microbiol, Prague, Czech Republic; [Nunvar, Jaroslav; Kalferstova, Lucie; Drevinek, Pavel] Motol Univ Hosp, Prague, Czech Republic; [Bloodworth, Ruhi A. M.; Cardona, Silvia T.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Kolar, Michal] Acad Sci Czech Republ, Lab Genom & Bioinformat, Inst Mol Genet, Prague, Czech Republic; [Degrossi, Jose] Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina; [Lubovich, Silvina] Hosp Ninos Dr Ricardo Gutierrez, Ctr Resp Dr A Alvarez, Buenos Aires, DF, Argentina	Charles University Prague; Motol University Hospital; University of Manitoba; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Drevinek, P (corresponding author), Charles Univ Prague, Fac Med 2, Dept Med Microbiol, Prague, Czech Republic.; Drevinek, P (corresponding author), Motol Univ Hosp, Prague, Czech Republic.	pavel.drevinek@lfmotol.cuni.cz	Kolář, Michal/A-3307-2012	Kolář, Michal/0000-0002-4593-1525; Cardona, Silvia/0000-0002-0629-8886	Ministry of Health of the Czech Republic [NT12405-5, 15-28017A]; Grant Agency of the Charles University [GAUK640214]; Academy of Sciences of the Czech Republic [RVO68378050]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Grant Agency of the Charles University; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	Ministry of Health of the Czech Republic, NT12405-5, www.iga.mzcr.cz; LK, PD, Ministry of Health of the Czech Republic, 15-28017A, www.azvcr.cz; PD, JN, Grant Agency of the Charles University, GAUK640214, www.cuni.cz/UK-33.html; LK, PD, and Academy of Sciences of the Czech Republic, RVO68378050, www.avcr.cz; MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Barth AL, 1996, J MED MICROBIOL, V45, P110, DOI 10.1099/00222615-45-2-110; BARTH AL, 1995, J CLIN MICROBIOL, V33, P2192, DOI 10.1128/JCM.33.8.2192-2194.1995; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blackburn L, 2004, J Cyst Fibros, V3, P133, DOI 10.1016/j.jcf.2004.03.007; Bloodworth RAM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00766-15; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Chapalain A, 2013, MICROBIOLOGYOPEN, V2, P226, DOI 10.1002/mbo3.67; Chen KC, 2013, APPL ENVIRON MICROB, V79, P2899, DOI 10.1128/AEM.00263-13; Coutinho CP, 2015, J MED MICROBIOL, V64, P927, DOI 10.1099/jmm.0.000094; Cunha MV, 2003, J CLIN MICROBIOL, V41, P4113, DOI 10.1128/JCM.41.9.4113-4120.2003; Dillon MM, 2015, GENETICS, V200, P935, DOI 10.1534/genetics.115.176834; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; El-Banna N, 1998, J APPL MICROBIOL, V85, P69; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gingues S, 2005, J BACTERIOL, V187, P8247, DOI 10.1128/JB.187.24.8247-8255.2005; Gomez-Escribano JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1652-8; Gu GY, 2011, APPL ENVIRON MICROB, V77, P6189, DOI 10.1128/AEM.00377-11; Gu GY, 2009, FEMS MICROBIOL LETT, V297, P54, DOI 10.1111/j.1574-6968.2009.01653.x; Gu GY, 2009, BIOCHEM BIOPH RES CO, V380, P328, DOI 10.1016/j.bbrc.2009.01.073; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Jorda-Vargas L, 2008, J CLIN MICROBIOL, V46, P1151, DOI 10.1128/JCM.01595-07; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kalferstova L, 2015, J CLIN MICROBIOL, V53, P1515, DOI 10.1128/JCM.03605-14; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; Lameignere E, 2010, GLYCOBIOLOGY, V20, P87, DOI 10.1093/glycob/cwp151; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee H, 2012, P NATL ACAD SCI USA, V109, pE2774, DOI 10.1073/pnas.1210309109; Lieberman TD, 2014, NAT GENET, V46, P82, DOI 10.1038/ng.2848; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lin ZJ, 2012, J NAT PROD, V75, P1518, DOI 10.1021/np300108u; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu SE, 2009, BIOCHEMISTRY-US, V48, P8312, DOI 10.1021/bi900814c; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000017; Martina P, 2014, INT J MED MICROBIOL, V304, P1182, DOI 10.1016/j.ijmm.2014.08.011; Martina P, 2013, J CLIN MICROBIOL, V51, P339, DOI 10.1128/JCM.02500-12; McKeon SA, 2011, J INFECT DIS, V203, P383, DOI 10.1093/infdis/jiq054; Medina-Pascual MJ, 2015, CLIN MICROBIOL INFEC, V21, P150, DOI 10.1016/j.cmi.2014.07.014; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; O'Grady EP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-441; O'Sullivan LA, 2007, ENVIRON MICROBIOL, V9, P1017, DOI 10.1111/j.1462-2920.2006.01228.x; Oliver A, 2010, CLIN MICROBIOL INFEC, V16, P798, DOI 10.1111/j.1469-0691.2010.03250.x; Oliver A, 2010, INT J MED MICROBIOL, V300, P563, DOI 10.1016/j.ijmm.2010.08.009; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Sass AM, 2013, ISME J, V7, P1568, DOI 10.1038/ismej.2013.36; Schmidt S, 2009, ENVIRON MICROBIOL, V11, P1422, DOI 10.1111/j.1462-2920.2009.01870.x; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Subramoni S, 2012, FUTURE MICROBIOL, V7, P1373, DOI [10.2217/FMB.12.118, 10.2217/fmb.12.118]; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomson ELS, 2012, VIRULENCE, V3, P286, DOI 10.4161/viru.19355; Turner KH, 2015, P NATL ACAD SCI USA, V112, P4110, DOI 10.1073/pnas.1419677112; Vanlaere E, 2009, INT J SYST EVOL MICR, V59, P102, DOI 10.1099/ijs.0.001123-0; Williams AB, 2014, DNA REPAIR, V24, P73, DOI 10.1016/j.dnarep.2014.09.009; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zlosnik JEA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106428	69	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160975	10.1371/journal.pone.0160975	http://dx.doi.org/10.1371/journal.pone.0160975			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27512997	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100098
J	Swain, CA; Smith, LC; Nash, D; Pulver, WP; Lazariu, V; Anderson, BJ; Warren, BL; Birkhead, GS; McNutt, LA				Swain, Carol-Ann; Smith, Lou C.; Nash, Denis; Pulver, Wendy P.; Lazariu, Victoria; Anderson, Bridget J.; Warren, Barbara L.; Birkhead, Guthrie S.; McNutt, Louise-Anne			Postpartum Loss to HIV Care and HIV Viral Suppression among Previously Diagnosed HIV-Infected Women with a Live Birth in New York State	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; LOW-INCOME; FOLLOW-UP; PROGRAM; TRANSMISSION; ENGAGEMENT; ADHERENCE; OUTCOMES; COHORT	Mother-to-child-transmission of HIV in the United States has been greatly reduced, with clear benefits for the child. However, little is known about factors that predict maternal loss to HIV care in the postpartum year. This retrospective cohort study included 980 HIV-positive women, diagnosed with HIV at least one year before pregnancy, who had a live birth during 2008-2010 in New York State. Women who did not meet the following criterion in the 12 months after the delivery-related hospital discharge were considered to be lost to HIV care: two or more laboratory tests (CD4 or HIV viral load), separated by at least 90 days. Adjusted relative risks (aRR) and 95% confidence intervals (CI) for predictors of postpartum loss to HIV care were identified with Poisson regression, solved using generalized estimating equations. Having an unsuppressed (>200 copies/mL) HIV viral load in the postpartum year was also evaluated. Overall, 24% of women were loss to HIV care during the postpartum year. Women with low participation in HIV care during preconception were more likely to be lost to HIV care during the postpartum year (aRR: 2.70; 95% CI: 2.09-3.49). In contrast, having a low birth weight infant was significantly associated with a decreased likelihood of loss to HIV care (aRR: 0.72; 95% CI: 0.53-0.98). While 75% of women were virally suppressed at the last viral load before delivery only 44% were continuously suppressed in the postpartum year; 12% had no viral load test reported in the postpartum year and 44% had at least one unsuppressed viral load test. Lack of engagement in preconception HIV-related health care predicts postpartum loss to HIV care for HIV-positive parturient women. Many women had poor viral control during the postpartum period, increasing the risk of disease progression and infectivity.	[Swain, Carol-Ann; Smith, Lou C.; Anderson, Bridget J.; Warren, Barbara L.] New York State Dept Hlth, AIDS Inst, Albany, NY 12237 USA; [Swain, Carol-Ann; Smith, Lou C.; Lazariu, Victoria; Birkhead, Guthrie S.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA; [Nash, Denis] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Pulver, Wendy P.] New York State Dept Hlth, Ctr Community Hlth, Albany, NY 12201 USA; [McNutt, Louise-Anne] SUNY Albany, Inst Hlth & Environm, Albany, NY 12222 USA; [Swain, Carol-Ann] New York State Dept Hlth, ESP, Corning Tower, Albany, NY 12237 USA	State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System	Swain, CA (corresponding author), New York State Dept Hlth, AIDS Inst, Albany, NY 12237 USA.; Swain, CA (corresponding author), SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA.; Swain, CA (corresponding author), New York State Dept Hlth, ESP, Corning Tower, Albany, NY 12237 USA.	carolann.swain@health.ny.gov	Birkhead, Guthrie/AAG-9058-2019; Nash, Denis/AFI-7485-2022	Birkhead, Guthrie/0000-0002-6511-6560; Swain, Carol-Ann/0000-0001-8451-2887; Nash, Denis/0000-0002-3280-5386	Centers for Disease Control and Prevention, National HIV Surveillance System [13-1302, U62PS003966]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention, National HIV Surveillance System; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Centers for Disease Control and Prevention 13-1302, National HIV Surveillance System U62PS003966. BJA is the principal investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2015, CLIN INFECT DIS; Birkhead G. S., 2010, J PUBLIC HEALTH MAN, V16, P481; Birkhead GS, 2000, AM J OBSTET GYNECOL, V183, P245, DOI 10.1067/mob.2000.105937; Birkhead GS, 2010, J PUBLIC HEALTH MAN, V16, P492, DOI 10.1097/PHH.0b013e3181ee9b11; DiBari JN, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/530769; Gardner L MG, 2015, C OPP INF RETR 2015; Hu YYW, 2012, AIDS PATIENT CARE ST, V26, P471, DOI 10.1089/apc.2011.0371; IBM, 2005, 2005 ASC SOFTW CORP; Irvine MK, 2015, CLIN INFECT DIS, V60, P298, DOI 10.1093/cid/ciu783; Lehrman S, 2002, AIDS CARE, V14, P751, DOI 10.1080/0954012021000031822; Little RJAaR D. B., 2002, STAT ANAL MISSING DA; Loftus H, 2015, INT J STD AIDS; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mellins CA, 2008, AIDS CARE, V20, P958, DOI 10.1080/09540120701767208; Miranda WP, 2015, ELIMINATING MOTHER C; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; New York State Department of Health, HIV STD HCV PREV REL; New York State Department of Health, 2003, GUID HLTH PROF NEWB; New York State Department of Health, HIV UN CAR PROGR; New York State Department of Health, ANN VIT STAT TABL TA; New York State Department of Health, 2012, HIV AIDS SURV ANN RE; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raghunathan T. E., 2002, IVEWARE IMPUTATION V; Raghunathans TE, 2001, SURV METHODOL, V27, P1; Rana AI, 2010, J WOMENS HEALTH, V19, P1863, DOI 10.1089/jwh.2009.1880; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Sabharwal CJ, 2014, J ACQUIR IMMUNE DEFI; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Siddiqui R, 2014, AIDS PATIENT CARE ST, V28, P248, DOI 10.1089/apc.2013.0321; Terzian AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029679; Torian LV, 2011, AIDS PATIENT CARE ST, V25, P79, DOI 10.1089/apc.2010.0151; United States Census Bureau/American FactFinder, 2011, 2006 2010 AM COMM SU; Weir S, 2011, WOMEN HEALTH ISS, V21, P277, DOI 10.1016/j.whi.2011.03.001; White House Office of AIDS Policy, 2010, NAT HIV AIDS STRAT; World Health Organization, RET HIV CAR PROGR DE; World Health Organization, PACK ESS SERV PREGN; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	39	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160775	10.1371/journal.pone.0160775	http://dx.doi.org/10.1371/journal.pone.0160775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KY	27513953	gold, Green Published, Green Submitted			2022-12-26	WOS:000381381100070
J	Weng, TY; Wang, CY; Hung, YH; Chen, WC; Chen, YL; Lai, MD				Weng, Tzu-Yang; Wang, Chih-Yang; Hung, Yu-Hsuan; Chen, Wei-Ching; Chen, Yi-Ling; Lai, Ming-Derg			Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PREDICTS POOR-PROGNOSIS; GENE-EXPRESSION; TUMOR-GROWTH; ENDOGENOUS INHIBITOR; IN-VITRO; THROMBOSPONDIN-1; ANGIOGENESIS; INFLAMMATION; SURVIVAL	Thrombospondin 1 and thrombospondin 2 (THBS1 and THBS2) share similar multifunctional domains, and are known to be antiangiogenic. However, the expression pattern of THBS1 and THBS2 is different, and the specific role of THBS2 in different subtypes of lung cancer remains largely unclear. To evaluate the significance of THBS1 and THBS2 in the development of lung cancer, the present study performed a microarray-based systematic-analysis to determine the transcript levels of thrombospondins and their relation to the prognosis in lung cancer. THBS1 was in general underexpressed in lung cancer; in contrast, mRNA levels of THBS2 were markedly overexpressed in a number of datasets of non-small cell lung carcinoma (NSCLC), including lung adenocarcinoma (AC) and squamous cell carcinoma. Similar expression pattern of THBS1 and THBS2 was verified in pulmonary AC cell lines with real-time PCR analysis. The survival of lung AC patients with high THBS2 mRNA expression levels was poorer than patients with low levels of expression of THBS2. In a microarray-based analysis, genes coexpressed with THBS1 or THBS2 were determined. Pulmonary AC patients with a high expression level of seven TSHB1-coexpressed genes (CCL5, CDH11, FYB, GZMK, LA-DQA1, PDE4DIP, and SELL) had better survival rates than those with a low expression level. Patients with a high expression of seven TSHB2-coexpressed genes (CHI3L1, COL5A2, COL11A1, FAP, MXRA5, THY1, and VCAN) had poor survival rates. Downregulation of VCAN and THBS2 with shRNA inhibited the cell proliferation in the A549 cell line. In summary, THBS1 functions as a tumor suppressor in lung adenocarcinoma. However, THBS2 may play a double-edged role in the progression of lung AC, i.e. anti-angiogenic and oncogenic function. Further study on the mechanism underlying the activity of THBS2 is warranted to have further implications for cancer diagnosis and treatment of pulmonary AC.	[Weng, Tzu-Yang; Wang, Chih-Yang; Hung, Yu-Hsuan; Chen, Wei-Ching; Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan; [Wang, Chih-Yang; Hung, Yu-Hsuan; Chen, Wei-Ching; Lai, Ming-Derg] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Weng, Tzu-Yang] Natl Cheng Kung Univ, Ctr Infect Dis & Signal Res, Tainan, Taiwan; [Chen, Yi-Ling] Chia Nan Univ Pharm & Sci, Dept Senior Citizen Serv Management, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chia Nan University of Pharmacy & Science	Lai, MD (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan, Taiwan.; Lai, MD (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan.	a1211207@mail.ncku.edu.tw	Chen, Yi/HIR-2608-2022; Lai, Ming-Derg/M-8028-2014	Wang, Chih-Yang/0000-0002-4137-5074	Ministry of Science and Technology, Taiwan [MOST 104-2325-B-006-004]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study is supported by the grant from Ministry of Science and Technology (MOST 104-2325-B-006-004), Taiwan to MD Lai.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Aguado BA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17566; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Bertin N, 1997, CANCER RES, V57, P396; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen ZJ, 2009, J INT MED RES, V37, P551, DOI 10.1177/147323000903700232; Chijiwa T, 2009, ONCOL REP, V22, P279, DOI 10.3892/or_00000435; Chong IW, 2006, ONCOL REP, V16, P981; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Collett, 1993, MODELLING SURVIVAL D; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Danielsen JMR, 2007, BRIT J HAEMATOL, V138, P756, DOI 10.1111/j.1365-2141.2007.06729.x; Fierro AC, 2008, CURR GENOMICS, V9, P525, DOI 10.2174/138920208786847935; Fleitas T, 2013, CLIN TRANSL ONCOL, V15, P897, DOI 10.1007/s12094-013-1020-6; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hawighorst T, 2001, EMBO J, V20, P2631, DOI 10.1093/emboj/20.11.2631; He Y, 2015, CANCER BIOMARK, V15, P645, DOI 10.3233/CBM-150504; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jefri M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1592-3; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kodama J, 2001, CLIN CANCER RES, V7, P2826; Lamy L, 2007, J IMMUNOL, V178, P5930, DOI 10.4049/jimmunol.178.9.5930; Lange-Asschenfeldt B, 2002, BLOOD, V99, P538, DOI 10.1182/blood.V99.2.538; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Liao YD, 2013, J CANCER RES CLIN, V139, P1523, DOI 10.1007/s00432-013-1471-8; Loges Sonja, 2010, Genes Cancer, V1, P12, DOI 10.1177/1947601909356574; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Marteau F, 2005, BLOOD, V106, P3860, DOI 10.1182/blood-2005-05-1843; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Naumnik W, 2015, ADV EXP MED BIOL, V833, P9, DOI 10.1007/5584_2014_78; Noh YH, 2003, J INVEST DERMATOL, V121, P1536, DOI 10.1046/j.1523-1747.2003.12643.x; Oshika Y, 1998, CLIN CANCER RES, V4, P1785; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Pirinen R, 2005, HUM PATHOL, V36, P44, DOI 10.1016/j.humpath.2004.10.010; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Stewart BW, WORLD CANC REPORT 20; Streit M, 1999, P NATL ACAD SCI USA, V96, P14888, DOI 10.1073/pnas.96.26.14888; Sun RC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-225; Tan BK, 2009, CARDIOVASC RES, V83, P566, DOI 10.1093/cvr/cvp131; Thom I, 2010, CANCER-AM CANCER SOC, V116, P4114, DOI 10.1002/cncr.25196; Thomas A, 2015, NAT REV CLIN ONCOL, V12, P511, DOI 10.1038/nrclinonc.2015.90; Tsai Ming-Ju, 2014, ISRN Biochem, V2014, P351959, DOI 10.1155/2014/351959; Verone-Boyle AR, 2016, ONCOTARGET, V7, P995, DOI 10.18632/oncotarget.6493; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Wood SL, 2014, CANCER TREAT REV, V40, P558, DOI 10.1016/j.ctrv.2013.10.001; Yamaguchi M, 2002, LUNG CANCER-J IASLC, V36, P143, DOI 10.1016/S0169-5002(01)00470-6; Yan XP, 2013, ONCOL REP, V30, P2733, DOI 10.3892/or.2013.2784; Zheng SQ, 2010, ANTICANCER RES, V30, P713	52	50	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161007	10.1371/journal.pone.0161007	http://dx.doi.org/10.1371/journal.pone.0161007			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513329	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100108
J	Biadgilign, S; Shumetie, A; Yesigat, H				Biadgilign, Sibhatu; Shumetie, Arega; Yesigat, Habtamu			Does Economic Growth Reduce Childhood Undernutrition in Ethiopia?	PLOS ONE			English	Article							NUTRITIONAL-STATUS; INTERVENTIONS; POVERTY; IMPACT	Background Policy discussions and debates in the last couple of decades emphasized efficiency of development policies for translating economic growth to development. One of the key aspects in this regard in the developing world is achieving improved nutrition through economic development. Nonetheless, there is a dearth of literature that empirically verifies the association between economic growth and reduction of childhood undernutrition in low-and middle-income countries. Thus, the aim of the study is to assess the interplay between economic growth and reduction of childhood undernutrition in Ethiopia. Methods The study used pooled data of three rounds (2000, 2005 and 2010) from the Demographic and Health Surveys (DHS) of Ethiopia. A multilevel mixed logistic regression model with robust standard errors was utilized in order to account for the hierarchical nature of the data. The dependent variables were stunting, underweight, and wasting in children in the household. The main independent variable was real per capita income (PCI) that was adjusted for purchasing power parity. This information was obtained from World Bank. Results A total of 32,610 children were included in the pooled analysis. Overall, 11,296 (46.7%) [46.0%-47.3%], 8,197(33.8%) [33.2%-34.4%] and 3,175(13.1%) [12.7%-13.5%] were stunted, underweight, and wasted, respectively. We found a strong correlation between prevalence of early childhood undernutrition outcomes and real per capita income (PCI). The proportions of stunting (r = -0.1207, p< 0.0001), wasting (r = -0.0338, p< 0.0001) and underweight (r = -0.1035, p< 0.0001) from the total children in the household were negatively correlated with the PCI. In the final model adjustment with all the covariates, economic growth substantially reduced stunting [beta = -0.0016, SE = 0.00013, p< 0.0001], underweight [beta = -0.0014, SE = 0.0002, p< 0.0001] and wasting [beta = -0.0008, SE = 0.0002, p< 0.0001] in Ethiopia over a decade. Conclusion Economic growth reduces child undernutrition in Ethiopia. This verifies the fact that the economic growth of the country accompanied with socio-economic development and improvement of the livelihood of the poor. Direct nutrition specific and nutrition sensitive interventions could also be recommended in order to have an impact on the massive reduction of childhood undernutrition in the country.	[Biadgilign, Sibhatu] Publ Hlth Nutr Res, Addis Ababa, Ethiopia; [Shumetie, Arega] Haramaya Univ Ethiopia, Dept Econ, Harar, Ethiopia; [Shumetie, Arega] Makerere Univ Uganda, Harar, Ethiopia; [Yesigat, Habtamu] Tech Univ Munich, Prod & Resource Econ, Freising Weihenstephan, Germany	Technical University of Munich	Biadgilign, S (corresponding author), Publ Hlth Nutr Res, Addis Ababa, Ethiopia.	sibhatu2010@gmail.com		Biadgilign, Sibhatu/0000-0002-7582-5977				ALDERMAN H, 1994, ECON DEV CULT CHANGE, V42, P485, DOI 10.1086/452099; Alderman H, 0105 CREDIT; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bryce J, 2008, LANCET, V371; Diao XS, 2010, WORLD DEV, V38, P1375, DOI 10.1016/j.worlddev.2009.06.011; Edmonds E, 2004, WELL DO IMPROVEMENTS; Federal Ministry of Health, 2008, PROGR IMPL MAN NAT N; FMoH/UNICEF/EU, 2016, SIT AN NUTR SECT ETH; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Harttgen K., 2012, 2012013 UNDP; Harttgen K, 2013, POPUL DEV REV, V39, P397, DOI 10.1111/j.1728-4457.2013.00609.x; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Ministry of Planning and Development, 2010, POV WELL BEING MOZ 3; O'Donnell O, 2009, J DEV ECON, V88, P45, DOI 10.1016/j.jdeveco.2008.01.004; Pauw K, 2011, FOOD POLICY, V36, P795, DOI 10.1016/j.foodpol.2011.09.002; Ranis G, 2000, WORLD DEV, V28, P197, DOI 10.1016/S0305-750X(99)00131-X; Ravallion M, 1996, WORLD BANK ECON REV, V10, P1, DOI 10.1093/wber/10.1.1; Ruel M, 2013, LANCET, V382; Sanchez PA, 2009, FOOD SECUR, V1, P37, DOI 10.1007/s12571-009-0011-5; Smith LC, 2002, ECON DEV CULT CHANGE, V51, P55, DOI 10.1086/345313; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; Suri T, 2011, WORLD DEV, V39, P506, DOI 10.1016/j.worlddev.2010.08.020; Thirtle C, 2003, WORLD DEV, V31, P1959, DOI 10.1016/j.worlddev.2003.07.001; UN, 2014, NUTR POST2015 SUST D; Vollmer S, 2014, LANCET GLOB HEALTH, V2, pE225, DOI 10.1016/S2214-109X(14)70025-7; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; World Bank, 2021, WORLD BANK IND	28	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160050	10.1371/journal.pone.0160050	http://dx.doi.org/10.1371/journal.pone.0160050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3KR	27508299	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400019
J	Reken, S; Sturtz, S; Kiefer, C; Bohler, YB; Wieseler, B				Reken, Stefanie; Sturtz, Sibylle; Kiefer, Corinna; Boehler, Yvonne-Beatrice; Wieseler, Beate			Assumptions of Mixed Treatment Comparisons in Health Technology Assessments - Challenges and Possible Steps for Practical Application	PLOS ONE			English	Article							TREATMENT COMPARISON METAANALYSIS; NETWORK-META-ANALYSIS; CARE DECISION-MAKING; ISPOR TASK-FORCE; INCONSISTENCY; HETEROGENEITY; REGRESSION; BIAS	The validity of mixed treatment comparisons (MTCs), also called network meta-analysis, relies on whether it is reasonable to accept the underlying assumptions on similarity, homogeneity, and consistency. The aim of this paper is to propose a practicable approach to addressing the underlying assumptions of MTCs. Using data from clinical studies of antidepressants included in a health technology assessment (HTA), we present a stepwise approach to dealing with challenges related to checking the above assumptions and to judging the robustness of the results of an MTC. At each step, studies that were dissimilar or contributed to substantial heterogeneity or inconsistency were excluded from the primary analysis. In a comparison of the MTC estimates from the consistent network with the MTC estimates from the homogeneous network including inconsistencies, few were affected by notable changes; that is, a change in effect size (factor 2), direction of effect or statistical significance. Considering the small proportion of studies excluded from the network due to inconsistency, as well as the number of notable changes, the MTC results were deemed sufficiently robust. In the absence of standard methods, our approach to checking assumptions in MTCs may inform other researchers in need of practical options, particularly in HTA.	[Reken, Stefanie; Boehler, Yvonne-Beatrice; Wieseler, Beate] Inst Qual & Efficiency Hlth Care, Dept Drug Assessment, Cologne, Germany; [Sturtz, Sibylle; Kiefer, Corinna] Inst Qual & Efficiency Hlth Care, Dept Med Biometry, Cologne, Germany; [Boehler, Yvonne-Beatrice] TH Koln Univ Appl Sci, Fac Appl Nat Sci, Leverkusen, Germany		Reken, S (corresponding author), Inst Qual & Efficiency Hlth Care, Dept Drug Assessment, Cologne, Germany.	stefanie.reken@iqwig.de		Wieseler, Beate/0000-0002-3519-754X				Ades AE, 2013, MED DECIS MAKING, V33, P679, DOI 10.1177/0272989X13485156; Ades AE, 2015, NETWORK METAANALYSIS; Biondi-Zoccai G, 2014, NETWORK METAANALYSIS; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cooper NJ, 2011, VALUE HEALTH, V14, P371, DOI 10.1016/j.jval.2010.09.001; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S., 2014, GENERALISED LINEAR M; Dias S, 2013, MED DECIS MAKING, V33, P618, DOI 10.1177/0272989X13485157; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Donegan S, 2013, RES SYNTH METHODS, V4, P291, DOI 10.1002/jrsm.1085; Fu R, 2010, CONDUCTING QUANTITAT, V55; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, 2013, KOST NUTZ BEW VENL F, V190, DOI 10.1016/j.jval.2011.01.011; Institute for Quality and Efficiency in Health Care, 2015, GEN METH VERS 4 2; Jansen JP, 2014, VALUE HEALTH, V17, P157, DOI 10.1016/j.jval.2014.01.004; Jansen JP, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-152; Jansen JP, 2012, J CLIN EPIDEMIOL, V65, P798, DOI 10.1016/j.jclinepi.2012.01.002; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Kiefer C, 2015, DTSCH ARZTEBL INT, V112, P803, DOI 10.3238/arztebl.2015.0803; Konig J, 2013, STAT MED, V32, P5414, DOI 10.1002/sim.6001; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lu GB, 2006, J AM STAT ASSOC, V101, P447, DOI 10.1198/016214505000001302; Mills EJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5195; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Schottker B, 2009, GMS HLTH TECHNOL ASS, V5, DOI [doi: 10.3205/ hta000071, DOI 10.3205/HTA000071]; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Sturtz S, 2012, RES SYNTH METHODS, V3, P300, DOI 10.1002/jrsm.1057; Thorlund K, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-2; Veroniki AA, 2013, INT J EPIDEMIOL, V42, P332, DOI 10.1093/ije/dys222	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160712	10.1371/journal.pone.0160712	http://dx.doi.org/10.1371/journal.pone.0160712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508415	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400048
J	Zibung, M; Zuber, C; Conzelmann, A				Zibung, Marc; Zuber, Claudia; Conzelmann, Achim			The Motor Subsystem as a Predictor of Success in Young Football Talents: A Person-Oriented Study	PLOS ONE			English	Article							MATCH PERFORMANCE; FIELD-TESTS; SOCCER; IDENTIFICATION; RELIABILITY; MATURITY; ELITE	Motor tests play a key role in talent selection in football. However, individual motor tests only focus on specific areas of a player's complex performance. To evaluate his or her overall performance during a game, the current study takes a holistic perspective and uses a person-oriented approach. In this approach, several factors are viewed together as a system, whose state is analysed longitudinally. Based on this idea, six motor tests were aggregated to form the Motor Function subsystem. 104 young, top-level, male football talents were tested three times (2011, 2012, 2013; Mage, t2011 = 12.26, SD = 0.29), and their overall level of performance was determined one year later (2014). The data were analysed using the LICUR method, a pattern-analytical procedure for person-oriented approaches. At all three measuring points, four patterns could be identified, which remained stable over time. One of the patterns found at the third measuring point identified more subsequently successful players than random selection would. This pattern is characterised by above-average, but not necessarily the best, performance on the tests. Developmental paths along structurally stable patterns that occur more often than predicted by chance indicate that the Motor Function subsystem is a viable means of forecasting in the age range of 12-15 years. Above-average, though not necessary outstanding, performance both on fitness and technical tests appears to be particularly promising. These findings underscore the view that a holistic perspective may be profitable in talent selection.	[Zibung, Marc; Zuber, Claudia; Conzelmann, Achim] Univ Bern, Inst Sport Sci, Bern, Switzerland	University of Bern	Zibung, M (corresponding author), Univ Bern, Inst Sport Sci, Bern, Switzerland.	marc.zibung@ispw.unibe.ch	Zuber, Claudia/AAF-9854-2019	Zuber, Claudia/0000-0002-0858-3963	Swiss Football Association	Swiss Football Association	Swiss Football Association (www.football.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Swiss Football Association is a non-profit organisation.	Abbott A, 2004, J SPORT SCI, V22, P395, DOI 10.1080/02640410410001675324; Abbott A, 2002, HIGH ABIL STUD, V13, P157, DOI 10.1080/1359813022000048798; Abbott A., 2002, TALENT IDENTIFICATIO; Abbott Angela, 2005, Nonlinear Dynamics Psychol Life Sci, V9, P61; Ali A, 2007, J SPORT SCI, V25, P1461, DOI 10.1080/02640410601150470; [Anonymous], 2002, SLEIPNER STAT PACKAG; Backhaus Klaus, 2008, MULTIVARIATE ANALYSE; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Bergman L. R., 2003, STUDYING INDIVIDUAL; Bergman LR, 2003, NEW DIR CHILD ADOLES, V101, P25, DOI 10.1002/cd.80; Bergman LR, 2010, Z PSYCHOL, V218, P155, DOI 10.1027/0044-3409/a000025; Bergman LR, 1997, DEV PSYCHOPATHOL, V9, P291, DOI 10.1017/S095457949700206X; Cairns R. B. Elder G. H. Costello E. J., 1996, DEVELOPMENTAL SCI, P1, DOI [10.1017/CBO9780511571114.002, DOI 10.1017/CBO9780511571114.002]; Castagna C, 2010, J STRENGTH COND RES, V24, P3227, DOI 10.1519/JSC.0b013e3181e72709; Castagna C, 2009, J STRENGTH COND RES, V23, P1954, DOI 10.1519/JSC.0b013e3181b7f743; Conzelmann A, 2001, SPORT PERS NLICHKEIT; Dardouri W, 2014, SCI SPORT, V29, P88, DOI 10.1016/j.scispo.2013.06.004; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Honer O, 2015, J SPORT SCI, V33, P145, DOI 10.1080/02640414.2014.928416; Lerner R.M., 2006, HDB CHILD PSYCHOL, P1, DOI DOI 10.1002/9780470147658.CHPSY0101; Lidor R, 2009, INT J SPORT EXERC PS, V7, P131, DOI 10.1080/1612197X.2009.9671896; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Meylan C, 2010, INT J SPORTS SCI COA, V5, P571, DOI 10.1260/1747-9541.5.4.571; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Pervin L.A., 1990, HDB PERSONALITY THEO, P193; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Reilly T., 2008, TALENT IDENTIFICATIO, P183; Reitzle M, 2013, EUR J DEV PSYCHOL, V10, P1, DOI 10.1080/17405629.2012.742848; Tabachnick B. G., 2013, USING MULTIVARIATE S; Trost K, 2008, J SOC ISSUES, V64, P157, DOI 10.1111/j.1540-4560.2008.00553.x; Waldron M, 2013, PEDIATR EXERC SCI, V25, P423, DOI 10.1123/pes.25.3.423; Wohlwill J. F., 1973, STUDY BEHAV DEV; Zibung M, 2013, EUR J SPORT SCI, V13, P452, DOI 10.1080/17461391.2012.749947; Zuber C, 2015, J SPORT SCI, V33, P160, DOI 10.1080/02640414.2014.928827	35	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0161049	10.1371/journal.pone.0161049	http://dx.doi.org/10.1371/journal.pone.0161049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508929	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400077
J	Ericsson, J; Husmark, T; Mathiesen, C; Sepahvand, B; Borck, O; Gunnarsson, L; Lydmark, P; Schroder, E				Ericsson, Jonas; Husmark, Teodor; Mathiesen, Christoffer; Sepahvand, Benjamin; Borck, Oyvind; Gunnarsson, Linda; Lydmark, Par; Schroder, Elsebeth			Involving High School Students in Computational Physics University Research: Theory Calculations of Toluene Adsorbed on Graphene	PLOS ONE			English	Article							ELECTRONIC-STRUCTURE; GRAPHITE; ADSORPTION; SURFACES; SOLVENTS	To increase public awareness of theoretical materials physics, a small group of high school students is invited to participate actively in a current research projects at Chalmers University of Technology. The Chalmers research group explores methods for filtrating hazardous and otherwise unwanted molecules from drinking water, for example by adsorption in active carbon filters. In this project, the students use graphene as an idealized model for active carbon, and estimate the energy of adsorption of the methylbenzene toluene on graphene with the help of the atomic-scale calculational method density functional theory. In this process the students develop an insight into applied quantum physics, a topic usually not taught at this educational level, and gain some experience with a couple of state-of-the-art calculational tools in materials research.	[Ericsson, Jonas; Husmark, Teodor; Mathiesen, Christoffer; Sepahvand, Benjamin; Gunnarsson, Linda; Lydmark, Par] Hulebacksgymnasiet, Idrottsvagen 2, SE-43580 Molnlycke, Sweden; [Borck, Oyvind] Randaberg Videregaende Skole, Grodemveien 70, NO-4070 Randaberg, Norway; [Schroder, Elsebeth] Chalmers Univ Technol, Microtechnol & Nanosci, MC2, SE-41296 Gothenburg, Sweden	Chalmers University of Technology	Schroder, E (corresponding author), Chalmers Univ Technol, Microtechnol & Nanosci, MC2, SE-41296 Gothenburg, Sweden.		Schröder, Elsebeth/A-2030-2011; Borck, Øyvind/J-1861-2015	Schröder, Elsebeth/0000-0003-4995-3585; Borck, Øyvind/0000-0003-3368-8975	Vetenskapsradet (VR); Knut och Alice Wallenbergs Stiftelse (KAW)	Vetenskapsradet (VR)(Swedish Research Council); Knut och Alice Wallenbergs Stiftelse (KAW)	This work was supported by Vetenskapsradet (VR, http://www.vr.se [grant number not used]) and Knut och Alice Wallenbergs Stiftelse (KAW, http://www.wallenberg.se/kaw [grant number not used]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson J, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764356; [Anonymous], 2016, OPEN SOURCE GRID BAS; [Anonymous], 2016, PYTHON BASED ATOMIC; Bahn SR, 2002, COMPUT SCI ENG, V4, P56, DOI 10.1109/5992.998641; Berland K, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066501; Berland K, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/13/135001; Chakarova-Kack SD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.146107; Chakarova-Kack SD, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155402; Corley C. R, 2013, HIST TEACHER, V46, P397; Dion M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.246401; Enkovaara J, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/25/253202; Keuskamp JA, 2013, METHODS ECOL EVOL, V4, P1070, DOI 10.1111/2041-210X.12097; Klomkliang N, 2012, IND ENG CHEM RES, V51, P5320, DOI 10.1021/ie300121p; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; Le D, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/42/424210; Londero E, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/42/424212; Marklinder I, 2015, BRIT FOOD J, V117, P1764, DOI 10.1108/BFJ-07-2014-0236; MONKENBUSCH M, 1981, BER BUNSEN PHYS CHEM, V85, P442, DOI 10.1002/bbpc.19810850520; Osborn J. M., 2009, BROADENING PARTICIPA, P41; Schroder E, ARXIV160705107; Schroder E, 2013, J NANOMATER, V2013, DOI 10.1155/2013/871706; Surwade SP, 2015, NAT NANOTECHNOL, V10, P459, DOI [10.1038/nnano.2015.37, 10.1038/NNANO.2015.37]; Thiel GP, 2015, PHYS TODAY, V68, P66, DOI 10.1063/PT.3.2828; Thonhauser T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.125112; Ulbricht H, 2006, CARBON, V44, P2931, DOI 10.1016/j.carbon.2006.05.040; White RF, 1997, LANCET, V349, P1239, DOI 10.1016/S0140-6736(96)07218-2	26	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159168	10.1371/journal.pone.0159168	http://dx.doi.org/10.1371/journal.pone.0159168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505418	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200003
J	Wand, S; Klages, M; Kirbach, C; Warszawska, J; Meybohm, P; Zacharowski, K; Koch, A				Wand, Saskia; Klages, Matthias; Kirbach, Christin; Warszawska, Joanna; Meybohm, Patrick; Zacharowski, Kai; Koch, Alexander			IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; DISSEMINATED INTRAVASCULAR COAGULATION; SEPTIC SHOCK; FAILURE; MODEL; THROMBELASTOGRAPHY; COAGULOPATHY; INFLAMMATION; HEMOSTASIS; ACTIVATION	Introduction Sepsis remains associated with a high mortality rate. Endotoxin has been shown to influence viscoelastic coagulation parameters, thus suggesting a link between endotoxin levels and the altered coagulation phenotype in septic patients. This study evaluated the effects of systemic polyspecific IgM-enriched immunoglobulin (IgM-IVIg) (Pentaglobin (R) [Biotest, Dreieich, Germany]) on endotoxin activity (EA), inflammatory markers, viscoelastic and conventional coagulation parameters. Methods Patients with severe sepsis were identified by daily screening in a tertiary, academic, surgical ICU. After the inclusion of 15 patients, the application of IgM-IVIg (5 mg/kg/d over three days) was integrated into the unit's standard operation procedure (SOP) to treat patients with severe sepsis, thereby generating "control" and "IgM-IVIg" groups. EA assays, thrombelastometry (ROTEM (R)) and impedance aggregometry (Multiplate (R)) were performed on whole blood. Furthermore, routine laboratory parameters were determined according to unit's standards. Results Data from 26 patients were included. On day 1, EA was significantly decreased in the IgM-IVIg group following 6 and 12 hours of treatment (0.51 +/- 0.06 vs. 0.26 +/- 0.07, p < 0.05 and 0.51 +/- 0.06 vs. 0.25 +/- 0.04, p < 0.05) and differed significantly compared with the control group following 6 hours of treatment (0.26 +/- 0.07 vs. 0.43 +/- 0.07, p < 0.05). The platelet count was significantly higher in the IgM-IVIg group following four days of IgM-IVIg treatment (200/nl +/- 43 vs. 87/nl +/- 20, p < 0.05). The fibrinogen concentration was significantly lower in the control group on day 2 (311 mg/dl +/- 37 vs. 475 mg/dl +/- 47 (p = 0.015)) and day 4 (307 mg/dl +/- 35 vs. 420 mg/dl +/- 16 (p = 0.017)). No differences in thrombelastometric or aggregometric measurements, or inflammatory markers (interleukin-6 (IL-6), leukocyte, lipopolysaccharide binding protein (LBP)) were observed. Conclusion Treatment with IgM-enriched immunoglobulin attenuates the EA levels in patients with severe sepsis and might have an effect on septic thrombocytopenia and fibrinogen depletion. Viscoelastic, aggregometric or inflammatory parameters were not influenced.	[Wand, Saskia; Klages, Matthias; Kirbach, Christin; Warszawska, Joanna; Meybohm, Patrick; Zacharowski, Kai; Koch, Alexander] Univ Hosp Frankfurt, Dept Anesthesia Intens Care Med & Pain Therapy, Frankfurt, Germany; [Wand, Saskia] Univ Hosp Gottingen, Clin Anaesthesiol, Gottingen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Gottingen	Wand, S (corresponding author), Univ Hosp Frankfurt, Dept Anesthesia Intens Care Med & Pain Therapy, Frankfurt, Germany.; Wand, S (corresponding author), Univ Hosp Gottingen, Clin Anaesthesiol, Gottingen, Germany.	saskia.wand@med.uni-goettingen.de	Meybohm, Patrick/K-4066-2017	Meybohm, Patrick/0000-0002-2666-8696; Zacharowski, Kai/0000-0002-0212-9110				Adamzik M, 2011, SHOCK, V35, P339, DOI 10.1097/SHK.0b013e318204bff6; Barratt-Due A, 2013, IMMUNOBIOLOGY, V218, P683, DOI 10.1016/j.imbio.2012.08.268; BEHRE G, 1992, ANTIMICROB AGENTS CH, V36, P2139, DOI 10.1128/AAC.36.10.2139; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brenner T, 2012, ACTA ANAESTH SCAND, V56, P1277, DOI 10.1111/j.1399-6576.2012.02750.x; Buda S, 2005, J CARDIOTHOR VASC AN, V19, P440, DOI 10.1053/j.jvca.2005.05.003; Capasso L, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-63; El-Nawawy A, 2005, J TROP PEDIATRICS, V51, P271, DOI 10.1093/tropej/fmi011; Flower RJ, 1979, BRIT J PHARMACOL, V66, p94p, DOI DOI 10.1186/1824-7288-39-63; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffmann JN, 2008, SHOCK, V29, P133, DOI 10.1097/shk.0b013e318123e5a6; Iba T, 2009, CRIT CARE, V13, DOI 10.1186/cc8210; ISHIKAWA A, 1979, RES EXP MED, V175, P233, DOI 10.1007/BF01851279; Kawai K, 2007, J GASTROENTEROL, V42, P450, DOI 10.1007/s00535-007-2027-y; Koch A, 2013, CRIT CARE, V17, DOI 10.1186/cc12892; Levi M, 2010, MINERVA ANESTESIOL, V76, P851; Levi M, 2001, J CRIT CARE, V16, P167, DOI 10.1053/jcrc.2001.30666; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Marshall JC, 2002, CRIT CARE, V6, P342, DOI 10.1186/cc1522; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; Moreau D, 2007, CHEST, V131, P1735, DOI 10.1378/chest.06-2233; NATANSON C, 1989, J EXP MED, V169, P823, DOI 10.1084/jem.169.3.823; Oesser S, 1999, RES EXP MED, V198, P325, DOI 10.1007/s004330050115; Puleo F, 2011, SEMIN RESP CRIT CARE, V32, P626, DOI 10.1055/s-0031-1287871; Rodriguez A, 2005, SHOCK, V23, P298, DOI 10.1097/01.shk.0000157302.69125.f8; SCHEDEL I, 1991, CRIT CARE MED, V19, P1104, DOI 10.1097/00003246-199109000-00003; Senzel L, 2009, CURR OPIN HEMATOL, V16, P329, DOI 10.1097/MOH.0b013e32832e9dc6; Sivula M, 2009, BLOOD COAGUL FIBRIN, V20, P419, DOI 10.1097/MBC.0b013e32832a76e1; Spiel AO, 2006, J THROMB HAEMOST, V4, P411, DOI 10.1111/j.1538-7836.2006.01715.x; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Vaishnavi C, 2013, INDIAN J MED MICROBI, V31, P334, DOI 10.4103/0255-0857.118870; Zacharowski K, 2006, THROMB HAEMOSTASIS, V95, P557, DOI 10.1160/TH05-06-0420	34	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160907	10.1371/journal.pone.0160907	http://dx.doi.org/10.1371/journal.pone.0160907			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504630	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200077
J	Mediero, A; Wilder, T; Ramkhelawon, B; Moore, KJ; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Ramkhelawon, Bhama; Moore, Kathryn J.; Cronstein, Bruce N.			Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis	FASEB JOURNAL			English	Article						K; BxN; rheumatoid arthritis; inflammation	INHIBITS LEUKOCYTE MIGRATION; ISCHEMIA-REPERFUSION INJURY; RHEUMATOID-ARTHRITIS; MACROPHAGE RETENTION; CYTOKINE PRODUCTION; KIDNEY; DISEASE; ATHEROSCLEROSIS; EXPRESSION; PROTECTS	Rheumatoid arthritis is an autoimmune disease that is characterized by chronic inflammation and destruction of joints. Netrin-1, a chemorepulsant, laminin-like matrix protein, promotes inflammation by preventing macrophage egress from inflamed sites and is required for osteoclast differentiation. We asked whether blockade of Netrin-1 or its receptors [Unc5b and DCC (deleted in colorectal carcinoma)] may be useful therapeutic targets for treatment of inflammatory arthritis. Arthritis was induced in 8-wk-old C57Bl/6 mice by intraperitoneal injection of K/BxN serum. Murine monoclonal antibodies against Netrin-1, Unc5b, or DCC (10 mu g/mouse) were injected weekly for 4 wk (n = 10). Paw swelling and thickness were assessed and following euthanasia 2-4 wk after serum transfer, paws were prepared for micro-computed tomography and histology. Paw inflammation was maximal 2 wk after injection. Anti-Netrin-1 or anti-Unc5b, but not anti-DCC, antibodies significantly reduced paw inflammation (clinical score: 9.8 +/- 0.8, 10.4 +/- 0.9, and 13.5 +/- 0.5, respectively vs. 16 +/- 0 for control; P < 0.001). Micro-computed tomography showed bony erosions in untreated or anti-DCC-treated mice, whereas there were no erosions in anti-Netrin-1/anti-Unc5b-treated-animals. Tartrate-resistant acid phosphatase staining demonstrated a marked decrease in osteoclasts in anti-Netrin-1/anti-Unc5b-treated animals. Immunofluorescence staining revealed a decrease in cathepsin K+ and CD68(+) cells in anti-Netrin-1/anti-Unc5b-treated animals. Blockade of Netrin-1/Unc5b by monoclonal antibodies prevents bone destruction and reduces the severity of K/BxN serum transfer-induced arthritis. Netrin-1 may be a novel therapeutic target for treatment of inflammatory bone destruction.Mediero, A., Wilder, T., Ramkhelawon, B., Moore, K. J., Cronstein, B. N. Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis.	[Mediero, Aranzazu] Univ Autonoma Madrid, Inst Invest Sanitaria, Bone & Joint Res Unit, Fdn Jimenez Diaz, Madrid, Spain; [Mediero, Aranzazu; Wilder, Tuere; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA; [Ramkhelawon, Bhama; Moore, Kathryn J.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA	Autonomous University of Madrid; Fundacion Jimenez Diaz; New York University; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Moore, Kathryn/ABE-6416-2020; Mediero, Aranzazu/AAA-8362-2020	Moore, Kathryn/0000-0003-2505-2547; Pintor, Jesus/0000-0002-9191-7679; Cronstein, Bruce/0000-0002-4295-7383; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR54897, AR046121]; NIH National Heart, Lung, and Blood Institute [RC1HL100815, K99 HL125667]; New York University (NYU) Health and Hospitals Corporation Clinical and Translational Science Institute [UL1TR000038]; NYU Caregiver Intervention Center (Support Grant 9NIH/National Cancer Institute (NCI)) [5 P30CA16087-310]; Celgene and Gilead Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL125667, RC1HL100815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054897, R01AR068593, P30AR046121, R01AR056672, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York University (NYU) Health and Hospitals Corporation Clinical and Translational Science Institute; NYU Caregiver Intervention Center (Support Grant 9NIH/National Cancer Institute (NCI)); Celgene and Gilead Pharmaceuticals(Bristol-Myers SquibbCelgene Corporation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR56672, AR54897, and AR046121) and NIH National Heart, Lung, and Blood Institute (Grants RC1HL100815 and K99 HL125667); New York University (NYU) Health and Hospitals Corporation Clinical and Translational Science Institute (Grant UL1TR000038); NYU Caregiver Intervention Center (Support Grant 9NIH/National Cancer Institute (NCI) 5 P30CA16087-310); and grants from Celgene and Gilead Pharmaceuticals. A.M. and B.N.C. have filed a patent on the use of adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). A.M., B.N.C., B.R., and K.J.M. have filed a patent on the use of antibodies against Netrin-1 for the treatment of bone diseases. T.W.declares no conflicts of interest.. B.N.C. holds patent numbers 5,932,558; 6,020,321; 6,555,545; 7,795,427; adenosine A<INF>1</INF>R and A<INF>2B</INF>R antagonists to treat fatty liver (pending); and adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). B.N.C. is a consultant for Bristol-Myers Squibb, AstraZeneca, Novartis, CanFite Biopharmaceuticals, Cypress Laboratories, Regeneron (Westat, Data and Safety Monitoring Board), Endocyte, Protalex, Allos, Savient, Gismo Therapeutics, Antares Pharmaceutical, Medivector, King Pharmaceutical, Celizome, Tap Pharmaceuticals, Prometheus Laboratories, Sepracor, Amgen, Combinatorx, Kyowa Hakka, Hoffman-LaRoche, and Avidimer Therapeutics. B.N.C. has stock in CanFite Biopharmaceuticals.	Aherne CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24957; Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Bresnihan B, 1999, J RHEUMATOL, V26, P717; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046201; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Han Y, 2012, INVEST OPHTH VIS SCI, V53, P1285, DOI 10.1167/iovs.11-8722; Hu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1778, DOI 10.1002/art.39116; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mediero A, 2016, ANN RHEUM DIS, V75, P1706, DOI 10.1136/annrheumdis-2015-207593; Mediero A, 2015, J BONE MINER RES, V30, P837, DOI 10.1002/jbmr.2421; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Monach Paul, 2007, V136, P269; Moore KJ, 2012, FUTUR CARDIOL, V8, P349, DOI [10.2217/FCA.12.30, 10.2217/fca.12.30]; Podjaski C, 2015, BRAIN, V138, P1598, DOI 10.1093/brain/awv092; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ramkhelawon B, 2013, ARTERIOSCL THROM VAS, V33, P1180, DOI 10.1161/ATVBAHA.112.301008; Ranganathan P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/525891; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Rao Y, 2002, GENE DEV, V16, P2973, DOI 10.1101/gad.1005802; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; Schubert T, 2009, INT J IMMUNOPATH PH, V22, P715, DOI 10.1177/039463200902200317; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Takagawa S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-40; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086	37	22	26	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3835	3844		10.1096/fj.201600615R	http://dx.doi.org/10.1096/fj.201600615R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27502509	Green Published			2022-12-26	WOS:000386474700017
J	Nazmi, AR; Lang, EJM; Bai, Y; Allison, TM; Othman, MH; Panjikar, S; Arcus, VL; Parker, EJ				Nazmi, Ali Reza; Lang, Eric J. M.; Bai, Yu; Allison, Timothy M.; Othman, Mohamad H.; Panjikar, Santosh; Arcus, Vickery L.; Parker, Emily J.			Interdomain Conformational Changes Provide Allosteric Regulation en Route to Chorismate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; Bacillus; crystal structure; inhibition mechanism; multifunctional enzyme; X-ray scattering; DAHPS; aromatic amino acid; chorismate mutase; shikimate	3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; MM3 FORCE-FIELD; AMINO-ACID BIOSYNTHESIS; ACTIVE-SITE RESIDUES; ESCHERICHIA-COLI; MOLECULAR-MECHANICS; PREPHENATE DEHYDROGENASE; SYNERGISTIC ALLOSTERY; MUTASE; PROTEIN	Multifunctional proteins play a variety of roles in metabolism. Here, we examine the catalytic function of the combined 3-deoxy-d-arabino heptulosonate-7-phosphate synthase (DAH7PS) and chorismate mutase (CM) from Geobacillus sp. DAH7PS operates at the start of the biosynthetic pathway for aromatic metabolites, whereas CM operates in a dedicated branch of the pathway for the biosynthesis of amino acids tyrosine and phenylalanine. In line with sequence predictions, the two catalytic functions are located in distinct domains, and these two activities can be separated and retain functionality. For the full-length protein, prephenate, the product of the CM reaction, acts as an allosteric inhibitor for the DAH7PS. The crystal structure of the full-length protein with prephenate bound and the accompanying small angle x-ray scattering data reveal the molecular mechanism of the allostery. Prephenate binding results in the tighter association between the dimeric CM domains and the tetrameric DAH7PS, occluding the active site and therefore disrupting DAH7PS function. Acquisition of a physical gating mechanism to control catalytic function through gene fusion appears to be a general mechanism for providing allostery for this enzyme.	[Nazmi, Ali Reza; Lang, Eric J. M.; Bai, Yu; Othman, Mohamad H.] Univ Canterbury, Biomol Interact Ctr, POB 4800, Christchurch 8140, New Zealand; [Nazmi, Ali Reza; Lang, Eric J. M.; Bai, Yu; Othman, Mohamad H.; Parker, Emily J.] Univ Canterbury, Dept Chem, POB 4800, Christchurch 8140, New Zealand; [Allison, Timothy M.] Univ Oxford, Dept Chem, South Parks Rd, Oxford OX1 5QY, England; [Panjikar, Santosh] Australian Synchrotron, Melbourne, Vic 3168, Australia; [Panjikar, Santosh] Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Clayton, Vic 3800, Australia; [Arcus, Vickery L.] Univ Waikato, Sch Sci, Hamilton 3240, New Zealand; [Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr, Biomol Interact Ctr, POB 4800, Christchurch 8140, New Zealand	University of Canterbury; University of Canterbury; University of Oxford; Monash University; University of Waikato; University of Canterbury	Parker, EJ (corresponding author), Univ Canterbury, Dept Chem, Private Bag 4800, Christchurch, New Zealand.	emily.parker@canterbury.ac.nz	Panjikar, Santosh/D-2709-2012; Lang, Eric J. M./N-3777-2019	Panjikar, Santosh/0000-0001-7429-3879; Lang, Eric J. M./0000-0002-3808-054X; Parker, Emily/0000-0002-9571-9987; Bai, Yu/0000-0002-5698-0023; Nazmi, Ali Reza/0000-0003-1262-5078	New Zealand Marsden Fund Grant [UOC1105]; Biomolecular Interaction Centre; University of Canterbury High Performance Computing	New Zealand Marsden Fund Grant(Royal Society of New ZealandMarsden Fund (NZ)); Biomolecular Interaction Centre; University of Canterbury High Performance Computing	This work was supported by New Zealand Marsden Fund Grant UOC1105, the Biomolecular Interaction Centre, and the University of Canterbury High Performance Computing. The authors declare that they have no conflicts of interest with the contents of this article.	ALLINGER NL, 1989, J AM CHEM SOC, V111, P8551, DOI 10.1021/ja00205a001; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Elleuche S, 2015, APPL MICROBIOL BIOT, V99, P1545, DOI 10.1007/s00253-014-6315-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hur S, 2002, P NATL ACAD SCI USA, V99, P1176, DOI 10.1073/pnas.022628599; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knaggs AR, 2003, NAT PROD REP, V20, P119, DOI 10.1039/b100399m; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Lang EJM, 2016, J AM CHEM SOC, V138, P2036, DOI 10.1021/jacs.5b13134; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Lassila JK, 2007, BIOCHEMISTRY-US, V46, P6883, DOI 10.1021/bi700215x; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Light SH, 2012, PROTEIN SCI, V21, P887, DOI 10.1002/pro.2075; LII JH, 1989, J AM CHEM SOC, V111, P8576, DOI 10.1021/ja00205a003; LII JH, 1989, J AM CHEM SOC, V111, P8566, DOI 10.1021/ja00205a002; Liu DR, 1996, J AM CHEM SOC, V118, P1789, DOI 10.1021/ja953151o; Lutke-Eversloh T, 2005, APPL ENVIRON MICROB, V71, P7224, DOI 10.1128/AEM.71.11.7224-7228.2005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; Schofield LR, 2004, PROTEIN EXPRES PURIF, V34, P17, DOI 10.1016/j.pep.2003.11.008; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Shumilin IA, 2002, J MOL BIOL, V320, P1147, DOI 10.1016/S0022-2836(02)00545-4; TURNBULL J, 1990, BIOCHEMISTRY-US, V29, P10245, DOI 10.1021/bi00496a014; Tzin V, 2009, PLANT J, V60, P156, DOI 10.1111/j.1365-313X.2009.03945.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vincent S, 2002, BIOORG MED CHEM LETT, V12, P929, DOI 10.1016/S0960-894X(02)00053-7; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Wu J, 2005, BIOCHEM J, V390, P583, DOI 10.1042/BJ20050294; Zhang S, 1998, J BIOL CHEM, V273, P6248, DOI 10.1074/jbc.273.11.6248; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	51	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21836	21847		10.1074/jbc.M116.741637	http://dx.doi.org/10.1074/jbc.M116.741637			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27502275	Green Published, hybrid			2022-12-26	WOS:000386332600001
J	Kubota, Y; Nomura, K; Katoh, Y; Yamashita, R; Kaneko, K; Furuyama, K				Kubota, Yoshiko; Nomura, Kazumi; Katoh, Yasutake; Yamashita, Rina; Kaneko, Kiriko; Furuyama, Kazumichi			Novel Mechanisms for Heme-dependent Degradation of ALAS1 Protein as a Component of Negative Feedback Regulation of Heme Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent protease; heme; mass spectrometry (MS); mitochondria; post-translational modification (PTM); protein degradation; 5-aminolevulinate synthase	DELTA-AMINOLEVULINATE SYNTHASE; 5-AMINOLEVULINATE SYNTHASE; LON PROTEASE; SIDEROBLASTIC ANEMIA; MITOCHONDRIAL; ENZYME; CELLS; MOTIF; RECOGNITION; GENE	In eukaryotic cells, heme production is tightly controlled by heme itself through negative feedback-mediated regulation of nonspecific 5-aminolevulinate synthase (ALAS1), which is a rate-limiting enzyme for heme biosynthesis. However, the mechanism driving the heme-dependent degradation of the ALAS1 protein in mitochondria is largely unknown. In the current study, we provide evidence that the mitochondrial ATP-dependent protease ClpXP, which is a heteromultimer of CLPX and CLPP, is involved in the heme-dependent degradation of ALAS1 in mitochondria. We found that ALAS1 forms a complex with ClpXP in a heme-dependent manner and that siRNA-mediated suppression of either CLPX or CLPP expression induced ALAS1 accumulation in the HepG2 human hepatic cell line. We also found that a specific heme-binding motif on ALAS1, located at the N-terminal end of the mature protein, is required for the heme-dependent formation of this protein complex. Moreover, hemin-mediated oxidative modification of ALAS1 resulted in the recruitment of LONP1, another ATP-dependent protease in the mitochondrial matrix, into the ALAS1 protein complex. Notably, the heme-binding site in the N-terminal region of the mature ALAS1 protein is also necessary for the heme-dependent oxidation of ALAS1. These results suggest that ALAS1 undergoes a conformational change following the association of heme to the heme-binding motif on this protein. This change in the structure of ALAS1 may enhance the formation of complexes between ALAS1 and ATP-dependent proteases in the mitochondria, thereby accelerating the degradation of ALAS1 protein to maintain appropriate intracellular heme levels.	[Kubota, Yoshiko; Nomura, Kazumi; Yamashita, Rina; Kaneko, Kiriko; Furuyama, Kazumichi] Iwate Med Univ, Dept Mol Biochem, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan; [Katoh, Yasutake] Tohoku Univ, Dept Integrat Genom, Tohoku Med Megabank Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan	Iwate Medical University; Tohoku University	Furuyama, K (corresponding author), Iwate Med Univ, Dept Mol Biochem, 2-1-1 Nishitokuta, Yahaba, Iwate 0283694, Japan.	furuyama@iwate-med.ac.jp		Furuyama, Kazumichi/0000-0002-1376-4080	Japan Society for the Promotion of Science [23590353]; Health Labor Sciences Research Grant from Ministry of Health Labor and Welfare in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grant from Ministry of Health Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grant-in-aid for Scientific Research (C) 23590353 from the Japan Society for the Promotion of Science and by a Health Labor Sciences Research Grant from the Ministry of Health Labor and Welfare in Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Furuyama K, 1997, BLOOD, V90, P822, DOI 10.1182/blood.V90.2.822.822_822_830; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Furuyama K, 2014, HANDB PORPHYR SCI, V27, P1; Garcia-Nafria J, 2010, PROTEIN SCI, V19, P987, DOI 10.1002/pro.376; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kadirvel S, 2012, EXP HEMATOL, V40, P477, DOI 10.1016/j.exphem.2012.01.013; Kang SG, 2002, J BIOL CHEM, V277, P21095, DOI 10.1074/jbc.M201642200; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lowth BR, 2012, J STRUCT BIOL, V179, P193, DOI 10.1016/j.jsb.2012.06.001; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; YAMAUCHI K, 1980, FEBS LETT, V115, P15, DOI 10.1016/0014-5793(80)80716-2	31	52	53	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20516	20529		10.1074/jbc.M116.719161	http://dx.doi.org/10.1074/jbc.M116.719161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27496948	Green Published, hybrid			2022-12-26	WOS:000384574800018
J	Birhanu, Z; Abebe, L; Sudhakar, M; Dissanayake, G; Yihdego, YYE; Alemayehu, G; Yewhalaw, D				Birhanu, Zewdie; Abebe, Lakew; Sudhakar, Morankar; Dissanayake, Gunawardena; Yihdego, Yemane Ye-ebiyo; Alemayehu, Guda; Yewhalaw, Delenasaw			Malaria Related Perceptions, Care Seeking after Onset of Fever and Anti-Malarial Drug Use in Malaria Endemic Settings of Southwest Ethiopia	PLOS ONE			English	Article							BEHAVIOR; TRANSMISSION; MANAGEMENT; CHILDREN; AREA	Background Prompt care seeking and appropriate use of anti-malarial drugs are critical components of malaria prevention and control. This study assessed malaria related perceptions, care seeking behavior and anti-malarial drug use in malaria endemic settings of Ethiopia. Methods Data were generated from a community based cross-sectional study conducted among 798 households during January 2014 as part of a larger household behavioral study in three malaria endemic districts of Jimma Zone, Southwest Ethiopia. Both quantitative and qualitative data were collected and analyzed using SPSS 17.0 and STATA 12.0. Results In this study, only 76.1% of the respondents associated malaria to mosquito bite, and incorrect beliefs and perceptions were noted. Despite moderate level of knowledge (estimated mean = 62.2, Std Err = 0.7, 95% CI: 60.6-63.8%), quite high favorable attitude (overall estimated mean = 91.5, Std Err = 0.6, 95% CI: 90.1-92.9%) were recorded towards malaria preventive measures. The mean attitude score for prompt care seeking, appropriate use of anti-malarial drugs, LLIN use and Indoor Residual Spray acceptance was 98.5 (Std Err = 0.4, 95% CI: 97.5-99.4), 92.7 (Std Err = 0.6 95% CI: 91.5-93.9), 88.8 (Std Err = 0.5, 95% CI: 85.5-92.1) and 86.5 (Std Err = 1.2, 95% CI: 83.9-89.1), respectively. The prevalence of fever was 2.9% (116/ 4107) and of the study participants with fever, 71.9%(95% CI: 65.5-78.3%) sought care and all of them consulted formal health care system. However, only 17 (19.8%) sought care within 24 hours after onset of fever. The frequency of care seeking was higher (77.8%, n = 21/27) and more prompt (28.6%, 6/21) for children under five as compared to old age groups despite it was not statistically significant (p > 0.05). However, higher median time of seeking first care was observed among Muslims and people who did not attend school (p < 0.05). Of those who used anti-malarial drugs, 9.1% indicated that they used it inappropriately through saving and/or sharing. Irregular availability of antimalarial drugs; irregular presence of frontline health workers and misconceptions were mentioned to contribute to delayed care seeking and irrational use of anti-malarial drugs. Conclusions Although care seeking behavior for febrile illness was quite high in this community, the habit of prompt care seeking was very limited. Thus, malaria prevention and control programs need to take into account local misconceptions and wrong perceptions, and health system factors to achieve optimal health seeking behavior in such malaria endemic settings.	[Birhanu, Zewdie; Abebe, Lakew; Sudhakar, Morankar] Jimma Univ, Dept Hlth Educ & Behav Sci, Coll Hlth Sci, Jimma, Ethiopia; [Dissanayake, Gunawardena; Alemayehu, Guda] US Agcy Int Dev, Presidents Malaria Initiat, Addis Ababa, Ethiopia; [Yihdego, Yemane Ye-ebiyo] Africa Indoor Residual Spraying, Abt Associates, Accra, Ghana; [Yewhalaw, Delenasaw] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Hlth Sci, Jimma, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia	Jimma University; United States Agency for International Development (USAID); ABT Associates; Jimma University; Jimma University	Birhanu, Z (corresponding author), Jimma Univ, Dept Hlth Educ & Behav Sci, Coll Hlth Sci, Jimma, Ethiopia.	zbkoricha@yahoo.com	Birhanu, Zewdie/L-5983-2019; Dissanayake, Gune/AAF-2238-2020	Dissanayake, Gune/0000-0002-6154-2642	United States Agency for International Development (USAID)/President's Malaria Initiative (PMI)-Ethiopia [AID-663-A-13-00010]; United States Agency for International Development (USAID)	United States Agency for International Development (USAID)/President's Malaria Initiative (PMI)-Ethiopia(United States Agency for International Development (USAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study received financial support from the United States Agency for International Development (USAID)/President's Malaria Initiative (PMI)-Ethiopia (website:https://www.usaid.gov/ethiopia) under cooperative agreement number AID-663-A-13-00010. USIAD staffs provided overall guidance and support during the whole course of the study. Disclaimer This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the view of USAID or the United States Government.	Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; [Anonymous], PRES MAL IN STRAT 20; [Anonymous], 2010, NAT STRAT PLAN MAL P; Birhanu Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2677-2; Budhathoki CB, 2009, J NEPAL HLTH RES COU, V6; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV PR; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-49; Deribew A., 2012, MALARIA J, V11, P11; Deribew A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-121; Ethiopian Health and Nutrition Research Institute, 2011, ETH NAT MAL IND SURV; Ethiopian Public Health Institute-Federal Ministry of Health, 2020, MAN LAB DIAGN MAL, V2; Federal Ministry of Health, 2007, HLTH EXT IMPL GUID; Federal Ministry of Health, 2010, HLTH SECT DEV PROGR; Federal Ministry of Health, 2014, HLTH HLTH REL IND; Federal Ministry of Health of Ethiopia, 2010, NAT STRAT PLAN MAL P; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Malik EM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-60; Ministry of Health, 2013, ANN PERF REP; Mota REM, 2009, AM J TROP MED HYG, V81, P935, DOI 10.4269/ajtmh.2009.08-0361; Njau JD, 2006, TROP MED INT HEALTH, V11, P299, DOI 10.1111/j.1365-3156.2006.01569.x; Nonvignon J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-188; Okeke T. A., 2008, Journal of Human Ecology, V24, P215; President's Malaria Initiative [Ethiopia], MAL OP PLAN FY 2015; Ramachandran L, 1995, HLTH ED NEW APPROACH; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-333; WHO, TEST TREAT TRACK IN; WHO, TREATM; WHO, GLOB PARTN MAL FREE; WHO, TRAIN MOD MAL CONTR; WHO/Roll Back Malaria Partnership, ACT INV DEF MAL 2016; WHO World Health Organization, ROLL BACK MAL STRAT; World Health Organization, WHO INF CONS FEV MAN; Yadav SP, 2010, J VECTOR DIS, V47, P235	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160234	10.1371/journal.pone.0160234	http://dx.doi.org/10.1371/journal.pone.0160234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517717	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100010
J	Haubrock, M; Hartmann, F; Wingender, E				Haubrock, Martin; Hartmann, Fabian; Wingender, Edgar			NF-Y Binding Site Architecture Defines a C-Fos Targeted Promoter Class	PLOS ONE			English	Article							PIONEER TRANSCRIPTION FACTORS; CHROMATIN ACCESSIBILITY; REPETITIVE ELEMENTS; CANCER CELLS; GENOME; GENE; SPECIFICITY; DISCOVERY; REGIONS; TOOL	ChIP-seq experiments detect the chromatin occupancy of known transcription factors in a genome-wide fashion. The comparisons of several species-specific ChIP-seq libraries done for different transcription factors have revealed a complex combinatorial and contextspecific co-localization behavior for the identified binding regions. In this study we have investigated human derived ChIP-seq data to identify common cis-regulatory principles for the human transcription factor c-Fos. We found that in four different cell lines, c-Fos targeted proximal and distal genomic intervals show prevalences for either AP-1 motifs or CCAAT boxes as known binding motifs for the transcription factor NF-Y, and thereby act in a mutually exclusive manner. For proximal regions of co-localized c-Fos and NF-YB binding, we gathered evidence that a characteristic configuration of repeating CCAAT motifs may be responsible for attracting c-Fos, probably provided by a nearby AP-1 bound enhancer. Our results suggest a novel regulatory function of NF-Y in gene-proximal regions. Specific CCAAT dimer repeats bound by the transcription factor NF-Y define this novel cis-regulatory module. Based on this behavior we propose a new enhancer promoter interaction model based on AP-1 motif defined enhancers which interact with CCAATbox characterized promoter regions.	[Haubrock, Martin; Hartmann, Fabian; Wingender, Edgar] Univ Gottingen, Univ Med Ctr Gottingen UMG, Inst Bioinformat, Goldschmidtstr 1, D-37077 Gottingen, Germany	University of Gottingen	Haubrock, M (corresponding author), Univ Gottingen, Univ Med Ctr Gottingen UMG, Inst Bioinformat, Goldschmidtstr 1, D-37077 Gottingen, Germany.	mhaubro@uni-goettingen.de		Wingender, Edgar/0000-0002-7729-8453	German Research Foundation; Open Access Publication Funds of the Gottingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the Gottingen University	The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Benatti P, 2016, BBA-MOL CELL RES, V1863, P673, DOI 10.1016/j.bbamcr.2015.12.019; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Coss D, 2004, J BIOL CHEM, V279, P152, DOI 10.1074/jbc.M304697200; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2016, NUCLEIC ACIDS RES, V44, P4684, DOI 10.1093/nar/gkw096; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Faniello MC, 1999, J BIOL CHEM, V274, P7623, DOI 10.1074/jbc.274.12.7623; Faniello MC, 2002, BIOCHEM J, V363, P53, DOI 10.1042/0264-6021:3630053; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Haubrock M, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S15; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hunt RW, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0412-4; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lok CN, 2002, BIOCHEM J, V368, P741, DOI 10.1042/BJ20020791; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercer TR, 2013, GENOME RES, V23, P1081, DOI 10.1101/gr.156612.113; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Preston GA, 2000, CELL DEATH DIFFER, V7, P215, DOI 10.1038/sj.cdd.4400637; R Development Core Team, 2008, R A LANGUAGE AND ENV; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Volkel S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005102; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wingender E, 2015, NUCLEIC ACIDS RES, V43, pD97, DOI 10.1093/nar/gku1064; Xie D, 2013, CELL, V155, P713, DOI 10.1016/j.cell.2013.09.043; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160803	10.1371/journal.pone.0160803	http://dx.doi.org/10.1371/journal.pone.0160803			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517874	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100025
J	Javaheri, B; Hopkinson, M; Poulet, B; Pollard, AS; Shefelbine, SJ; Chang, YM; Francis-West, P; Bou-Gharios, G; Pitsillides, AA				Javaheri, Behzad; Hopkinson, Mark; Poulet, Blandine; Pollard, Andrea S.; Shefelbine, Sandra J.; Chang, Yu-Mei; Francis-West, Philippa; Bou-Gharios, George; Pitsillides, Andrew A.			Deficiency and Also Transgenic Overexpression of Timp-3 Both Lead to Compromised Bone Mass and Architecture In Vivo	PLOS ONE			English	Article							HYPERTROPHIC CHONDROCYTES UNDERGO; HUMAN TISSUE INHIBITOR; OSTEOBLAST-LIKE CELLS; EXTRACELLULAR-MATRIX; METALLOPROTEINASES-3 TIMP-3; MESENCHYMAL PROGENITORS; IMAGE-ANALYSIS; LONG BONES; DIFFERENTIATION; MICE	Tissue inhibitor of metalloproteinases-3 (TIMP-3) regulates extracellular matrix via its inhibition of matrix metalloproteinases and membrane-bound sheddases. Timp-3 is expressed at multiple sites of extensive tissue remodelling. This extends to bone where its role, however, remains largely unresolved. In this study, we have used Micro-CT to assess bone mass and architecture, histological and histochemical evaluation to characterise the skeletal phenotype of Timp-3 KO mice and have complemented this by also examining similar indices in mice harbouring a Timp-3 transgene driven via a Col-2a-driven promoter to specifically target overexpression to chondrocytes. Our data show that Timp-3 deficiency compromises tibial bone mass and structure in both cortical and trabecular compartments, with corresponding increases in osteoclasts. Transgenic overexpression also generates defects in tibial structure predominantly in the cortical bone along the entire shaft without significant increases in osteoclasts. These alterations in cortical mass significantly compromise predicted tibial load-bearing resistance to torsion in both genotypes. Neither Timp-3 KO nor transgenic mouse growth plates are significantly affected. The impact of Timp-3 deficiency and of transgenic overexpression extends to produce modification in craniofacial bones of both endochondral and intramembranous origins. These data indicate that the levels of Timp-3 are crucial in the attainment of functionally-appropriate bone mass and architecture and that this arises from chondrogenic and osteogenic lineages.	[Javaheri, Behzad; Hopkinson, Mark; Pollard, Andrea S.; Chang, Yu-Mei; Pitsillides, Andrew A.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Poulet, Blandine; Bou-Gharios, George] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Shefelbine, Sandra J.] Northeastern Univ, Dept Mech & Ind Engn, Boston, MA 02115 USA; [Francis-West, Philippa] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London, England	University of London; University of London Royal Veterinary College; University of Liverpool; Northeastern University; University of London; King's College London	Javaheri, B (corresponding author), Royal Vet Coll, Dept Comparat Biomed Sci, London, England.	bjavaheri@rvc.ac.uk	Javaheri, Behzad/L-5997-2018; Javaheri, Behzad/AAF-1784-2019; Francis-West, Philippa/AAR-5607-2020	Javaheri, Behzad/0000-0001-7941-3104; Javaheri, Behzad/0000-0001-7941-3104; Pollard, Andrea/0000-0001-7215-738X; Poulet, Blandine/0000-0002-9224-5253; Bou-Gharios, George/0000-0002-9563-9418; Hopkinson, Mark/0000-0002-9508-8652	BBSRC [BB/I014608/1]; Arthritis Research UK [20413, 20581, 20039]; Biotechnology and Biological Sciences Research Council [BB/I014608/1] Funding Source: researchfish; Versus Arthritis [20039, 20859, 20581] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Versus Arthritis(Versus Arthritis)	This study was supported by funding from the BBSRC BB/I014608/1 and Arthritis Research UK 20413, 20581 and 20039.	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; BLAVIER L, 1995, J CELL SCI, V108, P3649; CANCEDDA FD, 1992, J CELL BIOL, V117, P427, DOI 10.1083/jcb.117.2.427; Carlos Fd, 2011, COMPUT TOMOGR, P169; Carlson B., 2004, HUMAN EMBRYOLOGY DEV, P527; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; D'Souza RN, 2010, TOP BONE BIOL, V6, P153, DOI 10.1007/978-1-84882-822-3_10; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Enishi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104638; GALOTTO M, 1994, J BONE MINER RES, V9, P1239; GENTILI C, 1993, J CELL BIOL, V122, P703, DOI 10.1083/jcb.122.3.703; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; HALL BK, 1988, AM SCI, V76, P174; Hanken J, 1993, SKULL DEV; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Horton W. A., 1990, GROWTH GENET HORM, V6, P1; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inada M, 2001, J BONE MINER RES, V16, pS149; Inada M, 2002, J BONE MINER RES S1, V16; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Javaheri B, 2015, BONE, V81, P277, DOI 10.1016/j.bone.2015.07.035; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KIRSCH T, 1992, DIFFERENTIATION, V52, P89, DOI 10.1111/j.1432-0436.1992.tb00503.x; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; MOSKALEWSKI S, 1989, DEVELOPMENT, V107, P473; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nagase H, 2008, THE CANC DEGRADOME, DOI [10.1007/978-0-387-69057-5_37, DOI 10.1007/978-0-387-69057-5_37]; Nah HD, 2000, J BONE MINER RES, V15, P522, DOI 10.1359/jbmr.2000.15.3.522; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; Olafsdottir H, 2007, J ANAT, V211, P37, DOI 10.1111/j.1469-7580.2007.00751.x; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Osteogenesis Gilbert S., DEV BIOL, V6; Park J, 2015, BIOL OPEN, V4, P608, DOI 10.1242/bio.201411031; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Sahebjam S, 2007, ARTHRITIS RHEUM, V56, P905, DOI 10.1002/art.22427; Schiltz C, 2008, J CELL BIOCHEM, V104, P1803, DOI 10.1002/jcb.21747; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serafini M, 2014, STEM CELL RES, V12, P659, DOI 10.1016/j.scr.2014.01.006; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; SILBERMANN M, 1983, ANAT REC, V206, P373, DOI 10.1002/ar.1092060404; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Suzuki H, 2003, BIOSCI BIOTECH BIOCH, V67, P1737, DOI 10.1271/bbb.67.1737; Tesson L, 2002, TRANSGENIC RES, V11, P43, DOI 10.1023/A:1013928600442; THESINGH CW, 1991, BONE MINER, V12, P25, DOI 10.1016/0169-6009(91)90119-K; Van't Hof R, 2013, BONE, V05, P210; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Yang G, 2014, CELL RES, V24, P1266, DOI 10.1038/cr.2014.111; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng Y, 1998, DEV DYNAM, V211, P228; Zhou X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004820	67	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0159657	10.1371/journal.pone.0159657	http://dx.doi.org/10.1371/journal.pone.0159657			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519049	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000381382100006
J	Park, J; Kobayashi, Y; Urayama, KY; Yamaura, H; Yatabe, Y; Hida, T				Park, Jangchul; Kobayashi, Yoshihisa; Urayama, Kevin Y.; Yamaura, Hidekazu; Yatabe, Yasushi; Hida, Toyoaki			Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naive Patients with Advanced Lung Adenocarcinoma	PLOS ONE			English	Article							PULMONARY ADENOCARCINOMA; NEGATIVE ALK; CANCER; CHEMOTHERAPY; CRIZOTINIB; GEFITINIB; SURVIVAL; FEATURES; REARRANGEMENTS; ONCOGENE	This study aimed to identify the computed tomography characteristics of treatment-naive patients with lung adenocarcinoma and known driver mutations in EGFR, KRAS, or ALK. Patients with advanced lung adenocarcinoma (stage IIIB-IV) and known mutations in EGFR, KRAS, or ALK were assessed. The radiological findings for the main tumor and intra-thoracic status were retrospectively analyzed in each group, and the groups' characteristics were compared. We identified 265 treatment-naIve patients with non-small-cell carcinoma, who had EGFR mutations (n = 159), KRAS mutations (n = 55), or ALK rearrangements (n = 51). Among the three groups, we evaluated only patients with stage IIIB-IV lung adenocarcinoma who had EGFR mutations (n = 126), KRAS mutations (n = 35), or ALK rearrangements (n = 47). We found that ground-glass opacity at the main tumor was significantly more common among EGFR-positive patients, compared to ALK-positive patients (p = 0.009). Lymphadenopathy was significantly more common among ALK-positive patients, compared to EGFR-positive patients (p = 0.003). Extranodal invasion was significantly more common among ALK-positive patients, compared to EGFR-positive patients and KRAS-positive patients (p = 0.001 and p = 0.049, respectively). Lymphangitis was significantly more common among ALK-positive patients, compared to EGFR-positive patients (p = 0.049). Pleural effusion was significantly less common among KRAS-positive patients, compared to EGFRpositive patients and ALK-positive patients (p = 0.046 and p = 0.026, respectively). Lung metastases were significantly more common among EGFR-positive patients, compared to KRAS-positive patients and ALK-positive patients (p = 0.007 and p = 0.04, respectively). In conclusion, EGFR mutations were associated with ground-glass opacity, KRAS-positive tumors were generally solid and less likely to metastasize to the lung and pleura, and ALK-positive tumors tended to present with lymphadenopathy, extranodal invasion, and lymphangitis. These mutation-specific imaging characteristics may be related to the biological differences between these cancers.	[Park, Jangchul; Hida, Toyoaki] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan; [Park, Jangchul] Nagoya East City Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan; [Kobayashi, Yoshihisa] Kinki Univ, Dept Thorac Surg, Fac Med, Osaka, Japan; [Urayama, Kevin Y.] Tokyo Med & Dent Univ, Dept Human Genet & Dis Div, Tokyo, Japan; [Yamaura, Hidekazu] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi, Japan; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan	Aichi Cancer Center; Kindai University (Kinki University); Tokyo Medical & Dental University (TMDU); Aichi Cancer Center	Park, J (corresponding author), Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi, Japan.; Park, J (corresponding author), Nagoya East City Med Ctr, Dept Resp Med, Nagoya, Aichi, Japan.	samasama75@gmail.com	YATABE, Yasushi/J-6461-2014	YATABE, Yasushi/0000-0003-1788-559X; Kobayashi, Yoshihisa/0000-0003-2057-408X	National Cancer Center Research and Development Fund [23-A-18]; Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan	National Cancer Center Research and Development Fund(National Cancer Center - Japan); Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan	This study was supported by the National Cancer Center Research and Development Fund (23-A-18) and Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Blons H, 2006, AM J SURG PATHOL, V30, P1309, DOI 10.1097/01.pas.0000213285.65907.31; Camidge DR, 2012, LANCET ONCOL, V13, P1011, DOI 10.1016/S1470-2045(12)70344-3; Choi H, 2013, LUNG CANCER, V79, P242, DOI 10.1016/j.lungcan.2012.11.021; Colen R, 2014, TRANSL ONCOL, V7, P556, DOI 10.1016/j.tranon.2014.07.007; Doebele RC, 2012, CANCER-AM CANCER SOC, V118, P4502, DOI 10.1002/cncr.27409; Enomoto Y, 2013, RESPIR INVESTIG, V51, P153, DOI 10.1016/j.resinv.2013.02.004; Fukui T, 2012, LUNG CANCER, V77, P319, DOI 10.1016/j.lungcan.2012.03.013; Halpenny DF, 2014, LUNG CANCER, V86, P190, DOI 10.1016/j.lungcan.2014.09.007; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hsu JS, 2014, J THORAC IMAG, V29, P357, DOI 10.1097/RTI.0000000000000116; Laack E, 2011, J THORAC ONCOL, V6, P199, DOI 10.1097/JTO.0b013e3181fb7cf1; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Paik PK, 2012, CANCER-AM CANCER SOC, V118, P5840, DOI 10.1002/cncr.27637; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park J, 2014, CANCER MED-US, V3, P118, DOI 10.1002/cam4.172; Ren SX, 2014, J THORAC ONCOL, V9, pE21, DOI 10.1097/JTO.0000000000000013; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sabri A, 2016, EUR RADIOL IN PRESS; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shin DY, 2014, J THORAC ONCOL, V9, P195, DOI 10.1097/JTO.0000000000000069; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Sun JM, 2012, J THORAC ONCOL, V7, pE36, DOI 10.1097/JTO.0b013e318274694e; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yano M, 2006, J THORAC ONCOL, V1, P413, DOI 10.1097/01243894-200606000-00006; Yatabe Y, 2006, J MOL DIAGN, V8, P335, DOI 10.2353/jmoldx.2006.050104; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	31	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161081	10.1371/journal.pone.0161081	http://dx.doi.org/10.1371/journal.pone.0161081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518729	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100045
J	Babai, MA; Arasteh, P; Hadibarhaghtalab, M; Naghizadeh, MM; Salehi, A; Askari, A; Homayounfar, R				Babai, Mohammad Ali; Arasteh, Peyman; Hadibarhaghtalab, Maryam; Naghizadeh, Mohammad Mehdi; Salehi, Alireza; Askari, Alireza; Homayounfar, Reza			Defining a BMI Cut-Off Point for the Iranian Population: The Shiraz Heart Study	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HIP RATIO; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; RISK-FACTORS; OBESITY; VALUES; DETERMINANTS; HYPERTENSION	In this study we evaluated and redefined the optimum body mass index (BMI) cut-off point for the Iranian population based on metabolic syndrome (MeS) risk factors. We further evaluated BMI cut-off points with and without waist circumference (WC) as a cofactor of risk and compared the differences. This study is part of the largest surveillance programs conducted in Shiraz, Iran, termed the Shiraz Heart study. Our study sample included subjects between the ages of 20 to 65 years old. After excluding pregnant women, those with missing data and those with comorbid disease, a total of 12283 made up the study population. The participants underwent a series of tests and evaluations by trained professionals in accordance with WHO recommendations. Hypertension, abnormal fasting blood sugar (FBS), triglyceride (TG) and high density lipoprotein cholesterol (HDL) (in the context of the definition of metabolic syndrome) were prevalent among 32.4%, 27.6%, 42.1 and 44.2% of our participants, respectively. Women displayed higher rates of overall obesity compared to men (based on the definition by the WHO as higher than 30 kg/m(2)). Regarding MeS, 38.9% of our population had the all symptoms of MeS which was more prevalent among women (41.5% vs. 36%). When excluding WC in the definition of MeS, results showed that males tend to show a higher rate of metabolic risk factors (19.2% vs. 15.6%). Results of multivariate analysis showed that parallel to an increase in BMI, the odds ratio (OR) for acquiring each component of the metabolic syndrome increased (OR = 1.178; CI: 1.166-1.190). By excluding WC, the previous OR decreased (OR = 1.105; CI: 1.093-1.118). Receiver Operating Characteristic (ROC) curve analysis showed that the optimum BMI cut-off point for predicting metabolic syndrome was 26.1 kg/m(2) and 26.2 kg/m(2) [Accuracy (Acc) = 69% and 61%, respectively)] for males and females, respectively. The overall BMI cut-off for both sexes was 26.2 kg/m(2) (Acc = 65%) with sensitivity and specificity of 69% and 62%, respectively. This cut-off had a positive predictive value of 54% and a negative predictive value of 76%. When we excluded waist circumference, the optimum BMI cut-off for acquiring metabolic risk factors in males decreased to 25.7 kg/m(2) (Acc = 67%) and increased for women to 27.05 kg/m(2) (Acc = 66%). Iranians are at higher risks of morbidity related to metabolic factors at a lower BMI cut-off and prompt action and preventive health policy are required to prevent and educate Iranians regarding diseases associated with obesity.	[Babai, Mohammad Ali] Shiraz Univ Med Sci, Cardiovasc Res Ctr, Shiraz, Iran; [Arasteh, Peyman; Hadibarhaghtalab, Maryam; Naghizadeh, Mohammad Mehdi; Askari, Alireza; Homayounfar, Reza] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran; [Arasteh, Peyman; Hadibarhaghtalab, Maryam; Salehi, Alireza] Shiraz Univ Med Sci, MPH Dept, Sch Med, Shiraz, Iran; [Salehi, Alireza] Shiraz Univ Med Sci, Res Ctr Tradit Med & Hist Med, Sch Med, Shiraz, Iran; [Homayounfar, Reza] Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Hadibarhaghtalab, M; Homayounfar, R (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.; Hadibarhaghtalab, M (corresponding author), Shiraz Univ Med Sci, MPH Dept, Sch Med, Shiraz, Iran.; Homayounfar, R (corresponding author), Shiraz Univ Med Sci, Ctr Hlth Policy Res, Shiraz, Iran.	Maryam_Hadibarhaghtalab@yahoo.com; r_homayounfar@yahoo.com	Homayounfar, R/L-8813-2017; Askari, Alireza/Z-2099-2019; Naghizadeh, Mohammad Mehdi/O-4889-2017; Salehi, Alireza/N-5720-2017	Homayounfar, R/0000-0001-5398-9519; Naghizadeh, Mohammad Mehdi/0000-0001-5562-103X; Salehi, Alireza/0000-0003-2750-8499; Arasteh, Peyman/0000-0001-6499-9093	Shiraz University of Medical Sciences	Shiraz University of Medical Sciences	This study was supported by the Shiraz University of Medical Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Shiraz University of Medical Sciences for their financial support of the study. We would also like to thank all the individuals who patiently participated in our study. This study is registered as a dissertation of Master of PublicHealth (MPH) courses by Dr. Maryam Hadibarhaghtalab.	Al-Lawati JA, 2008, PUBLIC HEALTH NUTR, V11, P102, DOI 10.1017/S1368980007000183; Almajwal AM, 2009, ANN SAUDI MED, V29, P437, DOI 10.4103/0256-4947.57165; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beauloye V, 2007, J CLIN ENDOCR METAB, V92, P3025, DOI 10.1210/jc.2007-0619; Canoy D, 2010, CURR ATHEROSCLER REP, V12, P125, DOI 10.1007/s11883-010-0092-9; Chang Y, 2012, INT J OBESITY, V36, P1187, DOI 10.1038/ijo.2011.247; de Koning L, 2007, EUR HEART J, V28, P850, DOI 10.1093/eurheartj/ehm026; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Dong XL, 2011, POSTGRAD MED J, V87, P251, DOI 10.1136/pgmj.2010.100453; Ervin R. B., 2009, NATL HLTH STAT REPOR, P1; Esteghamati A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-26; Famodu AA, 2009, CLIN HEMORHEOL MICRO, V43, P335, DOI 10.3233/CH-2009-1244; Freedman DS, 2012, OBESITY; Gregory CO, 2008, PUBLIC HEALTH NUTR, V11, P1037, DOI 10.1017/S1368980007001504; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180; He Y, 2007, DIABETES CARE, V30, P2128, DOI 10.2337/dc06-2402; Heshmat Ramin, 2010, Acta Med Indones, V42, P209; Jeppesen J, 2007, J AM COLL CARDIOL, V49, P2112, DOI 10.1016/j.jacc.2007.01.088; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Melmer A, 2013, OBESITY, V21, P775, DOI 10.1002/oby.20289; Nascimento H, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0022-7; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Wannamethee SG, 2010, DIABETOLOGIA, V53, P890, DOI 10.1007/s00125-010-1670-7; Worachartcheewan A, 2010, ACTA DIABETOL, V47, pS91, DOI 10.1007/s00592-009-0137-0; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zaher ZMM, 2009, ASIA PAC J CLIN NUTR, V18, P209; Zandieh A, 2012, ANN HUM BIOL, V39, P484, DOI 10.3109/03014460.2012.716860; Zeng Q, 2014, BRIT J NUTR, V112, P1735, DOI 10.1017/S0007114514002657	31	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160639	10.1371/journal.pone.0160639	http://dx.doi.org/10.1371/journal.pone.0160639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509026	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400042
J	Cira, EK; Paerl, HW; Wetz, MS				Cira, Emily K.; Paerl, Hans W.; Wetz, Michael S.			Effects of Nitrogen Availability and Form on Phytoplankton Growth in a Eutrophied Estuary (Neuse River Estuary, NC, USA)	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; NUTRIENT-LIMITATION; TAXONOMIC COMPOSITION; COMMUNITY COMPOSITION; ORGANIC NITROGEN; NORTH-CAROLINA; DINOFLAGELLATE; LIGHT; UREA; CHESAPEAKE	Nitrogen availability and form are important controls on estuarine phytoplankton growth. This study experimentally determined the influence of urea and nitrate additions on phytoplankton growth throughout the growing season (March 2012, June 2011, August 2011) in a temperate, eutrophied estuary (Neuse River Estuary, North Carolina, USA). Photopigments (chlorophyll a and diagnostic photopigments: peridinin, fucoxanthin, alloxanthin, zeaxanthin, chlorophyll b) and microscopy-based cell counts were used as indicators of phytoplankton growth. In March, the phytoplankton community was dominated by Gyrodinium instriatum and only fucoxanthin-based growth rates were stimulated by nitrogen addition. The limited response to nitrogen suggests other factors may control phytoplankton growth and community composition in early spring. In June, inorganic nitrogen concentrations were low and stimulatory effects of both nitrogen forms were observed for chlorophyll a- and diagnostic photopigment- based growth rates. In contrast, cell counts showed that only cryptophyte and dinoflagellate (Heterocapsa rotundata) growth were stimulated. Responses of other photopigments may have been due to an increase in pigment per cell or growth of plankton too small to be counted with the microscopic methods used. Despite high nitrate concentrations in August, growth rates were elevated in response to urea and/or nitrate addition for all photopigments except peridinin. However, this response was not observed in cell counts, again suggesting that pigment-based growth responses may not always be indicative of a true community and/or taxa-specific growth response. This highlights the need to employ targeted microscopy-based cell enumeration concurrent with pigment-based technology to facilitate a more complete understanding of phytoplankton dynamics in estuarine systems. These results are consistent with previous studies showing the seasonal importance of nitrogen availability in estuaries, and also reflect taxa-specific responses nitrogen availability. Finally, this study demonstrates that under nitrogen-limiting conditions, the phytoplankton community and its various taxa are capable of using both urea and nitrate to support growth.	[Cira, Emily K.] Texas A&M Univ, Dept Phys & Environm Sci, Corpus Christi, TX 77843 USA; [Paerl, Hans W.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC USA; [Wetz, Michael S.] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA	Texas A&M University System; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System	Cira, EK (corresponding author), Texas A&M Univ, Dept Phys & Environm Sci, Corpus Christi, TX 77843 USA.	ecira@islander.tamucc.edu		Cira, Emily/0000-0002-4148-1133	National Science Foundation [DEB1104598]; NC Dept. of Environment and Natural Resources; Lower Neuse Basin Association (Neuse River Estuary ModMon Program); Division Of Environmental Biology [1119704] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NC Dept. of Environment and Natural Resources; Lower Neuse Basin Association (Neuse River Estuary ModMon Program); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation [DEB1104598 to MSW and HWP; NSF.gov], the NC Dept. of Environment and Natural Resources (portal.ncdenr.org), and the Lower Neuse Basin Association (Neuse River Estuary ModMon Program; lnba.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; Altman JC, 2012, AQUAT ECOL, V46, P269, DOI 10.1007/s10452-012-9398-8; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Berg GM, 2003, AQUAT MICROB ECOL, V30, P263, DOI 10.3354/ame030263; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Burkholder JM, 2008, HARMFUL ALGAE, V8, P77, DOI 10.1016/j.hal.2008.08.010; Calbet A, 2011, HARMFUL ALGAE, V10, P654, DOI 10.1016/j.hal.2011.05.001; CARON DA, 1993, MICROBIAL ECOL, V25, P93, DOI 10.1007/BF00182132; CHRISTIAN RR, 1991, MAR ECOL PROG SER, V71, P259, DOI 10.3354/meps071259; Cloern JE, 2005, MAR ECOL PROG SER, V285, P11, DOI 10.3354/meps285011; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Egerton Todd A, 2014, Microorganisms, V2, P33; Fisher T. R., 1995, SCOPE, P301; FISHER TR, 1992, MAR ECOL PROG SER, V82, P51, DOI 10.3354/meps082051; FISHER TR, 1988, ESTUAR COAST SHELF S, V27, P61, DOI 10.1016/0272-7714(88)90032-7; Gaulke AK, 2010, ESTUAR COAST SHELF S, V90, P45, DOI 10.1016/j.ecss.2010.08.006; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; Goericke R, 1998, MAR ECOL PROG SER, V169, P97, DOI 10.3354/meps169097; Hall NS, 2008, ESTUAR COAST, V31, P402, DOI 10.1007/s12237-008-9035-x; Legrand C, 1998, AQUAT MICROB ECOL, V15, P65, DOI 10.3354/ame015065; Lewitus AJ, 2005, ESTUARIES, V28, P160, DOI 10.1007/BF02732761; Lewitus AJ, 1998, LIMNOL OCEANOGR, V43, P636, DOI 10.4319/lo.1998.43.4.0636; LEWITUS AJ, 1991, PLANT CELL PHYSIOL, V32, P791; Li J, 2012, HARMFUL ALGAE, V13, P112, DOI 10.1016/j.hal.2011.10.005; Llewellyn CA, 2000, MAR ECOL PROG SER, V193, P33, DOI 10.3354/meps193033; Loureiro S, 2009, J PLANKTON RES, V31, P399, DOI 10.1093/plankt/fbn122; LUND J. W. G., 1958, HYDROBIOLOGIA, V11, P143, DOI 10.1007/BF00007865; MALLIN MA, 1993, MAR ECOL PROG SER, V93, P199, DOI 10.3354/meps093199; Margalef R., 1969, IBP HDB, V12, P7; Moisander PH, 2002, MICROB ECOL, V43, P432, DOI 10.1007/s00248-001-1044-2; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Nagasoe S, 2010, HYDROBIOLOGIA, V651, P225, DOI 10.1007/s10750-010-0301-0; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Olsen PS, 2001, J COASTAL RES, V32, P115; Ornolfsdottir EB, 2004, J EXP MAR BIOL ECOL, V303, P197, DOI 10.1016/j.jembe.2003.11.016; Paerl HW, 2010, ESTUAR COAST, V33, P485, DOI 10.1007/s12237-009-9137-0; Paerl HW, 2003, BIOSCIENCE, V53, P953, DOI 10.1641/0006-3568(2003)053[0953:PPAIOE]2.0.CO;2; Paerl HW, 1997, LIMNOL OCEANOGR, V42, P1154, DOI 10.4319/lo.1997.42.5_part_2.1154; Paerl HW, 2004, ENVIRON SCI TECHNOL, V38, P3068, DOI 10.1021/es0352350; Paerl HW, 1998, MAR ECOL PROG SER, V166, P17, DOI 10.3354/meps166017; Peierls BL, 2010, AQUAT MICROB ECOL, V60, P139, DOI 10.3354/ame1415; Peierls BL, 2003, ESTUARIES, V26, P1329, DOI 10.1007/BF02803635; PENNOCK JR, 1994, MAR ECOL PROG SER, V111, P275, DOI 10.3354/meps111275; PENNOCK JR, 1985, ESTUAR COAST SHELF S, V21, P711, DOI 10.1016/0272-7714(85)90068-X; Pinckney JL, 1998, MAR BIOL, V131, P371, DOI 10.1007/s002270050330; Pinckney JL, 1999, J PHYCOL, V35, P1455, DOI 10.1046/j.1529-8817.1999.3561455.x; Place AR, 2012, HARMFUL ALGAE, V14, P179, DOI 10.1016/j.hal.2011.10.021; PRICE NM, 1988, LIMNOL OCEANOGR, V33, P528, DOI 10.4319/lo.1988.33.4.0528; Rizzo WM, 1996, ESTUARIES, V19, P475, DOI 10.2307/1352464; Rosser SMJH, 2001, HYDROL PROCESS, V15, P2579, DOI 10.1002/hyp.288; Rothenberger MB, 2009, LIMNOL OCEANOGR, V54, P2107, DOI 10.4319/lo.2009.54.6.2107; Rstudio Team, 2015, RSTUDIO INT DEV R; RUDEK J, 1991, MAR ECOL PROG SER, V75, P133, DOI 10.3354/meps075133; Schluter L, 2000, MAR ECOL PROG SER, V192, P49, DOI 10.3354/meps192049; Seitzinger SP, 1997, MAR ECOL PROG SER, V159, P1, DOI 10.3354/meps159001; SELLNER KG, 1991, ESTUAR COAST SHELF S, V32, P27, DOI 10.1016/0272-7714(91)90026-8; Sellner KG, 1997, MAR CHEM, V56, P193, DOI 10.1016/S0304-4203(96)00069-2; Seong KA, 2006, MAR ECOL PROG SER, V322, P85, DOI 10.3354/meps322085; Solomon CM, 2008, AQUAT MICROB ECOL, V52, P149, DOI 10.3354/ame01213; Solomon CM, 2010, AQUAT MICROB ECOL, V59, P67, DOI 10.3354/ame01390; Stow CA, 2001, WATER RES, V35, P1489, DOI 10.1016/S0043-1354(00)00402-4; Twomey LJ, 2005, HYDROBIOLOGIA, V533, P123, DOI 10.1007/s10750-004-2403-z; Uchida T, 1997, J PLANKTON RES, V19, P603, DOI 10.1093/plankt/19.5.603; Valdes-Weaver LM, 2006, LIMNOL OCEANOGR, V51, P1410, DOI 10.4319/lo.2006.51.3.1410; Wawrik B, 2009, APPL ENVIRON MICROB, V75, P6662, DOI 10.1128/AEM.01002-09; Wetz MS, 2011, AQUAT MICROB ECOL, V63, P133, DOI 10.3354/ame01488; Yoo YD, 2009, J EUKARYOT MICROBIOL, V56, P413, DOI 10.1111/j.1550-7408.2009.00421.x; Yuan XC, 2012, ESTUAR COAST, V35, P325, DOI 10.1007/s12237-011-9433-3	68	18	18	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160663	10.1371/journal.pone.0160663	http://dx.doi.org/10.1371/journal.pone.0160663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504970	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200053
J	Gasper, MA; Biswas, SP; Fisher, BS; Ehnert, SC; Sherman, DR; Sodora, DL				Gasper, Melanie A.; Biswas, Shameek P.; Fisher, Bridget S.; Ehnert, Stephanie C.; Sherman, David R.; Sodora, Donald L.			Nonpathogenic SIV and Pathogenic HIV Infections Associate with Disparate Innate Cytokine Signatures in Response to Mycobacterium bovis BCG	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; NATURAL-KILLER-CELLS; TUBERCULOSIS INFECTION; IMMUNE ACTIVATION; SOOTY MANGABEYS; IN-VIVO; INTERLEUKIN-12 PRODUCTION; FUNCTIONAL-RESPONSES; LATENT TUBERCULOSIS	Infections with mycobacteria, including Mycobacterium tuberculosis (Mtb) and Mycobacterium bovis (M. bovis) BCG, are a leading cause of morbidity and mortality for HIV-infected persons. In contrast to HIV, nonpathogenic SIV infections of sooty mangabeys are characterized by a lack of clinical disease including an absence of opportunistic infections. The goal of this study was to identify innate immune responses to M. bovis BCG maintained during nonpathogenic lentiviral infections through a comparison of functional responses during pathogenic HIV or nonpathogenic SIV infections. Monocytes were evaluated for their ability to express key anti-mycobacterial cytokines TNF-a and IL-12 following a six-hour ex vivo BCG exposure. While HIV-infection was associated with a decreased percentage of IL-12-producing monocytes, nonpathogenic SIV-infection was associated with an increased percentage of monocytes producing both cytokines. Gene expression analysis of PBMC following ex vivo BCG exposure identified differential expression of NK cell-related genes and several cytokines, including IFN-gamma and IL-23, between HIV-infected and control subjects. In contrast, SIV-infected and uninfected-control mangabeys exhibited no significant differences in gene expression after BCG exposure. Finally, differential gene expression patterns were identified between species, with mangabeys exhibiting lower IL-6 and higher IL-17 in response to BCG when compared to humans. Overall, this comparison of immune responses to M. bovis BCG identified unique immune signatures (involving cytokines IL-12, TNF-a, IL-23, IL-17, and IL-6) that are altered during HIV, but maintained or increased during nonpathogenic SIV infections. These unique cytokine and transcriptome signatures provide insight into the differential immune responses to Mycobacteria during pathogenic HIVinfection that may be associated with an increased incidence of mycobacterial coinfections.	[Gasper, Melanie A.] Univ Washington, Pathobiol Grad Program, Seattle, WA 98195 USA; [Gasper, Melanie A.; Biswas, Shameek P.; Fisher, Bridget S.; Sherman, David R.; Sodora, Donald L.] Seattle Biomed Res Inst, Ctr Infect Dis Res, Seattle, WA 98109 USA; [Ehnert, Stephanie C.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA	University of Washington; University of Washington Seattle; Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR)	Sodora, DL (corresponding author), Seattle Biomed Res Inst, Ctr Infect Dis Res, 4 Nickerson St, Seattle, WA 98109 USA.	don.sodora@CIDResearch.org		Biswas, Shameek/0000-0002-9372-1143	National Institute of Dental and Craniofacial Research grant [R01-DE023047]; National Institute of Allergy and Infectious Diseases [U19AI106761]; Viral Pathogenesis Training Grant [T32-AI0832030-1]; University of Washington Center For AIDS Research grant [AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI113173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023047] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Viral Pathogenesis Training Grant; University of Washington Center For AIDS Research grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research grant R01-DE023047 (DLS), National Institute of Allergy and Infectious Diseases supported this research through the following grants: U19AI106761 (DRS), the Viral Pathogenesis Training Grant T32-AI0832030-1 (MAG), and the University of Washington Center For AIDS Research grant AI027757. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S K, 2001, J Assoc Physicians India, V49, P799; Akahoshi M, 2003, HUM GENET, V112, P237, DOI 10.1007/s00439-002-0873-5; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aytekin C, 2011, J INVEST ALLERG CLIN, V21, P401; Bean AGD, 1999, J IMMUNOL, V162, P3504; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; BIGGS BA, 1995, J IMMUNOL, V154, P6132; Bosinger SE, 2011, CURR OPIN HIV AIDS, V6, P411, DOI 10.1097/COH.0b013e3283499cf6; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Brill KJ, 2001, INFECT IMMUN, V69, P1755, DOI 10.1128/IAI.69.3.1755-1765.2001; CHEHIMI J, 1994, J EXP MED, V179, P1361, DOI 10.1084/jem.179.4.1361; Cheynier R, 1998, NAT MED, V4, P421, DOI 10.1038/nm0498-421; Chougnet C, 1996, J INFECT DIS, V174, P46, DOI 10.1093/infdis/174.1.46; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Cozzi-Lepri A, 2011, AIDS, V25, P1207, DOI 10.1097/QAD.0b013e3283471f10; CROWE SM, 1994, J LEUKOCYTE BIOL, V56, P318, DOI 10.1002/jlb.56.3.318; DENIS M, 1994, AIDS RES HUM RETROV, V10, P1619, DOI 10.1089/aid.1994.10.1619; Esser R, 1996, BLOOD, V88, P3474, DOI 10.1182/blood.V88.9.3474.bloodjournal8893474; Estcourt C, 1997, CLIN IMMUNOL IMMUNOP, V83, P60, DOI 10.1006/clin.1996.4323; Estes JD, 2008, J IMMUNOL, V180, P6798, DOI 10.4049/jimmunol.180.10.6798; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Gardam MA, 2003, LANCET INFECT DIS, V3, P148, DOI 10.1016/S1473-3099(03)00545-0; Garg A, 2015, J INFECT DIS, V211, P755, DOI 10.1093/infdis/jiu523; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gopal R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004099; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Harrison TS, 1996, J IMMUNOL, V156, P4492; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Howell AL, 1997, INT J CLIN LAB RES, V27, P111, DOI 10.1007/BF02912444; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kalokhe AS, 2015, J INFECT DIS, V211, P635, DOI 10.1093/infdis/jiu505; Kaul D, 2003, J LAB CLIN MED, V141, P330, DOI 10.1016/S0022-2143(03)00006-4; Kedzierska K, 2000, J INFECT DIS, V181, P390, DOI 10.1086/315191; Kedzierska K, 2003, J CLIN VIROL, V26, P247, DOI 10.1016/S1386-6532(02)00123-3; Khader SA, 2011, J IMMUNOL, V187, P5402, DOI 10.4049/jimmunol.1101377; Kobayashi K, 1996, J INFECT DIS, V174, P564, DOI 10.1093/infdis/174.3.564; Kosub DA, 2008, J VIROL, V82, P1155, DOI 10.1128/JVI.01275-07; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Long R, 2003, CAN MED ASSOC J, V168, P1153; Martinez AN, 2013, J INFECT DIS, V207, P1253, DOI 10.1093/infdis/jit037; Mir KD, 2012, J VIROL, V86, P7605, DOI 10.1128/JVI.06813-11; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Portevin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068864; Portevin D, 2012, CELL MICROBIOL, V14, P1734, DOI 10.1111/j.1462-5822.2012.01834.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Singh PP, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-686; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Sundaravaradan V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003441; Team RC, 2013, R LANGUAGE ENV STAT; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Watkins MLV, 2008, CLIN VACCINE IMMUNOL, V15, P1666, DOI 10.1128/CVI.00202-08; Wonderlich ER, 2015, J IMMUNOL, V195, P3284, DOI 10.4049/jimmunol.1500683; Wonderlich ER, 2013, J IMMUNOL, V190, P2188, DOI 10.4049/jimmunol.1201645; Worobey M, 2010, SCIENCE, V329, P1487, DOI 10.1126/science.1193550; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhou DJ, 1999, J IMMUNOL, V162, P2204	59	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0158149	10.1371/journal.pone.0158149	http://dx.doi.org/10.1371/journal.pone.0158149			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505158	Green Submitted, gold, Green Published			2022-12-26	WOS:000381374200001
J	Potuckova, E; Zuna, J; Hovorkova, L; Starkova, J; Stary, J; Trka, J; Zaliova, M				Potuckova, Eliska; Zuna, Jan; Hovorkova, Lenka; Starkova, Julia; Stary, Jan; Trka, Jan; Zaliova, Marketa			Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR ERG; EXPRESSION; SUBTYPE; DOMAINS	Intragenic ERG deletions occur in 3-5% of B-cell precursor acute lymphoblastic leukemia, specifically in B-other subtype lacking the classifying genetic lesions. They represent the only genetic lesion described so far present in the majority of cases clustering into a subgroup of B-other subtype characterized by a unique gene expression profile, probably sharing a common, however, not yet fully described, biological background. We aimed to elucidate whether ERG deletions could drive the specific biology of this ERG-related leukemia subgroup through expression of aberrant or decreased expression of wild type ERG isoforms. We showed that leukemic cells with endogenous ERG deletion express an aberrant transcript translated into two proteins in transfected cell lines and that one of these proteins colocalizes with wild type ERG. However, we did not confirm expression of the proteins in acute lymphoblastic leukemia cases with endogenous ERG deletion. ERG deletions resulted in significantly lower expression of wild type ERG transcripts compared to B-other cases without ERG deletion. However, cases with subclonal ERG deletion, clustering to the same ERG deletion associated subgroup, presented similar levels of wild type ERG as cases without ERG deletion. In conclusion, our data suggest that neither the expression of aberrant proteins from internally deleted allele nor the reduced expression of wild type ERG seem to provide a plausible explanation of the specific biology of ERG-related leukemia subgroup.	[Potuckova, Eliska; Zuna, Jan; Hovorkova, Lenka; Starkova, Julia; Trka, Jan; Zaliova, Marketa] Charles Univ Prague, Fac Med 2, CLIP, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Potuckova, Eliska; Zuna, Jan; Hovorkova, Lenka; Starkova, Julia; Stary, Jan; Trka, Jan; Zaliova, Marketa] Univ Hosp Motol, Prague, Czech Republic; [Stary, Jan] Charles Univ Prague, Dept Paediat Haematol & Oncol, Fac Med 2, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague	Zaliova, M (corresponding author), Charles Univ Prague, Fac Med 2, CLIP, Dept Paediat Haematol & Oncol, Prague, Czech Republic.; Zaliova, M (corresponding author), Univ Hosp Motol, Prague, Czech Republic.	marketa.zaliova@lfmotol.cuni.cz	Stary, Jan/AAB-9635-2020; Trka, Jan/Y-4820-2019; Zuna, Jan/ABA-4620-2021	Starkova, Julia/0000-0002-2269-5849; Zuna, Jan/0000-0002-0887-3709	Grant Agency of the Czech Republic [GJ15-06049Y]; University Hospital Motol [00064203]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); University Hospital Motol	EP and MZ were supported by grant GJ15-06049Y from The Grant Agency of the Czech Republic. JZ, J. Stary and JT were supported by project 00064203 (University Hospital Motol). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bohne A, 2009, LEUKEMIA RES, V33, P817, DOI 10.1016/j.leukres.2008.11.012; Carmichael CL, 2012, P NATL ACAD SCI USA, V109, P15437, DOI 10.1073/pnas.1213454109; Carrere S, 1998, ONCOGENE, V16, P3261, DOI 10.1038/sj.onc.1201868; Clappier E, 2014, LEUKEMIA, V28, P70, DOI 10.1038/leu.2013.277; Figueroa ME, 2013, J CLIN INVEST, V123, P3099, DOI 10.1172/JCI66203; Ichikawa H, 1999, MOL CELL BIOL, V19, P7639; Kruse EA, 2009, P NATL ACAD SCI USA, V106, P13814, DOI 10.1073/pnas.0906556106; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Mullighan CG, 2007, BLOOD, V110, p212A, DOI 10.1182/blood.V110.11.691.691; Owczarek CM, 2004, GENE, V324, P65, DOI 10.1016/j.gene.2003.09.047; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Stankiewicz MJ, 2013, LEUKEMIA, V27, P1339, DOI 10.1038/leu.2013.33; Tsuzuki S, 2011, BLOOD, V117, P3858, DOI 10.1182/blood-2010-11-320515; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zaliova M, 2014, LEUKEMIA, V28, P182, DOI 10.1038/leu.2013.282	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160385	10.1371/journal.pone.0160385	http://dx.doi.org/10.1371/journal.pone.0160385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494621	Green Published, Green Submitted, gold			2022-12-26	WOS:000381369500038
J	Hexnerova, R; Krizkova, K; Fabry, M; Sieglova, I; Kedrova, K; Collinsova, M; Ullrichova, P; Srb, P; Williams, C; Crump, MP; Tosner, Z; Jiracek, J; Veverka, V; Zakova, L				Hexnerova, Rozalie; Krizkova, Kvetoslava; Fabry, Milan; Sieglova, Irena; Kedrova, Katerina; Collinsova, Michaela; Ullrichova, Pavlina; Srb, Pavel; Williams, Christopher; Crump, Matthew P.; Tosner, Zdenek; Jiracek, Jiri; Veverka, Vaclav; Zakova, Lenka			Probing Receptor Specificity by Sampling the Conformational Space of the Insulin-like Growth Factor II C-domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; IGF-II; LIGAND-BINDING; 3-DIMENSIONAL STRUCTURE; 6-PHOSPHATE RECEPTOR; PROTEIN INTERACTIONS; ECTODOMAIN REVEALS; TYROSINE RESIDUES; CRYSTAL-STRUCTURE; HYBRID RECEPTORS	Insulin and insulin-like growth factors I and II are closely related protein hormones. Their distinct evolution has resulted in different yet overlapping biological functions with insulin becoming a key regulator of metabolism, whereas insulin-like growth factors (IGF)-I/II are major growth factors. Insulin and IGFs cross-bind with different affinities to closely related insulin receptor isoforms A and B (IR-A and IR-B) and insulin-like growth factor type I receptor (IGF-1R). Identification of structural determinants in IGFs and insulin that trigger their specific signaling pathways is of increasing importance in designing receptor-specific analogs with potential therapeutic applications. Here, we developed a straightforward protocol for production of recombinant IGF-II and prepared six IGF-II analogs with IGF-I-like mutations. All modified molecules exhibit significantly reduced affinity toward IR-A, particularly the analogs with a Pro-Gln insertion in the C-domain. Moreover, one of the analogs has enhanced binding affinity for IGF-1R due to a synergistic effect of the Pro-Gln insertion and S29N point mutation. Consequently, this analog has almost a 10-fold higher IGF1R/IR-A binding specificity in comparison with native IGF-II. The established IGF-II purification protocol allowed for cost-effective isotope labeling required for a detailedNMRstructural characterization of IGF-II analogs that revealed a link between the altered binding behavior of selected analogs and conformational rearrangement of their C-domains.	[Hexnerova, Rozalie; Krizkova, Kvetoslava; Fabry, Milan; Sieglova, Irena; Kedrova, Katerina; Collinsova, Michaela; Srb, Pavel; Jiracek, Jiri; Veverka, Vaclav; Zakova, Lenka] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic; [Hexnerova, Rozalie; Krizkova, Kvetoslava; Kedrova, Katerina; Tosner, Zdenek] Charles Univ Prague, Fac Sci, Albertov 6, Prague 12843, Czech Republic; [Ullrichova, Pavlina] Univ Chem & Technol, Dept Analyt Chem, Tech 5, Prague 16628 6, Czech Republic; [Fabry, Milan] Acad Sci Czech Republic, Inst Mol Genet, Vvi, Videnska 1083, CR-14220 Prague 4, Czech Republic; [Williams, Christopher; Crump, Matthew P.] Univ Bristol, Sch Chem, Dept Organ & Biol Chem, Cantocks Close, Bristol BS8 1TS, Avon, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Bristol	Veverka, V; Zakova, L (corresponding author), Acad Sci Czech Republic, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	vaclav.veverka@uochb.cas.cz; zakova@uochb.cas.cz	Zakova, Lenka/A-7119-2008; Zakova, Lenka/Y-6234-2019; Tosner, Zdenek/G-6736-2014; Veverka, Vaclav/P-5251-2019; Wiliams, Christopher/P-4904-2015; Hexnerová, Rozálie/O-6968-2017; Mlčochová, Květoslava/L-6979-2017; Srb, Pavel/C-5202-2014; Jiracek, Jiri/Y-6703-2019; Fabry, Milan/G-3602-2014; Machackova, Katerina/G-5608-2014; Veverka, Vaclav/G-9174-2014; Jiracek, Jiri/A-7124-2008	Zakova, Lenka/0000-0001-6439-2574; Tosner, Zdenek/0000-0003-2741-9154; Veverka, Vaclav/0000-0003-3782-5279; Wiliams, Christopher/0000-0001-5806-9842; Hexnerová, Rozálie/0000-0002-3537-8439; Mlčochová, Květoslava/0000-0002-6226-8067; Srb, Pavel/0000-0002-4562-578X; Jiracek, Jiri/0000-0003-3848-2773; Machackova, Katerina/0000-0003-4980-9460; Veverka, Vaclav/0000-0003-3782-5279; Jiracek, Jiri/0000-0003-3848-2773; Crump, Matthew/0000-0002-7868-5818	Czech Science Foundation [15-19018S]; Medical Research Council [MR/K000179/1]; Ministry of Education of the Czech Republic Programs "NAVRAT" [LK11205]; NPU I [LO1304]; Charles University Grant Agency [227020]; Specific University Research (Ministry of Education of the Czech Republic) [20/2013, A1_FCHI_2014_003]; Research Project of the Academy of Sciences of the Czech Republic [RVO:61388963]; MRC [MR/K000179/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1237655] Funding Source: researchfish	Czech Science Foundation(Grant Agency of the Czech Republic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education of the Czech Republic Programs "NAVRAT"; NPU I; Charles University Grant Agency; Specific University Research (Ministry of Education of the Czech Republic); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Czech Science Foundation Grant 15-19018S, Medical Research Council Grant MR/K000179/1, Ministry of Education of the Czech Republic Programs "NAVRAT" LK11205 and "NPU I" LO1304, Charles University Grant Agency Grant 227020, Specific University Research (Ministry of Education of the Czech Republic Grant 20/2013, A1_FCHI_2014_003), and Research Project of the Academy of Sciences of the Czech Republic RVO:61388963. The authors declare that they have no conflicts of interest with the contents of this article.	Alberini CM, 2012, TRENDS NEUROSCI, V35, P274, DOI 10.1016/j.tins.2011.12.007; Alvino CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027488; Alvino CL, 2009, J BIOL CHEM, V284, P7656, DOI 10.1074/jbc.M808061200; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; Bedinger DH, 2015, MOL CELL ENDOCRINOL, V415, P143, DOI 10.1016/j.mce.2015.08.013; Belfiore A, 2011, ENDOCR-RELAT CANCER, V18, pR125, DOI 10.1530/ERC-11-0074; Boucher J, 2010, J BIOL CHEM, V285, P17235, DOI 10.1074/jbc.M110.118620; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Clemmons DR, 1998, MOL CELL ENDOCRINOL, V140, P19, DOI 10.1016/S0303-7207(98)00024-0; COOKE RM, 1991, BIOCHEMISTRY-US, V30, P5484, DOI 10.1021/bi00236a022; De, 2015, BIOESSAYS, V37, P389; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; DeWolf E, 1996, PROTEIN SCI, V5, P2193; Dynkevich Y, 2013, ENDOCR REV, V34, P798, DOI 10.1210/er.2012-1033; Esposito DL, 1997, ENDOCRINOLOGY, V138, P2979, DOI 10.1210/en.138.7.2979; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; FRANCIS GL, 1992, J MOL ENDOCRINOL, V8, P213, DOI 10.1677/jme.0.0080213; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gill R, 1999, PROTEIN ENG, V12, P297, DOI 10.1093/protein/12.4.297; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; GURSKY O, 1992, BIOPHYS J, V61, P604, DOI 10.1016/S0006-3495(92)81865-9; Harjes E, 2006, STRUCTURE, V14, P881, DOI 10.1016/j.str.2006.03.008; HASHIMOTO R, 1995, J BIOL CHEM, V270, P18013, DOI 10.1074/jbc.270.30.18013; Henderson ST, 2015, GROWTH HORM IGF RES, V25, P20, DOI 10.1016/j.ghir.2014.09.004; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING GL, 1982, J BIOL CHEM, V257, P869; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; Kosinova L, 2014, BIOCHEMISTRY-US, V53, P3392, DOI 10.1021/bi500073z; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Krizkova K, 2016, BIOCHEMISTRY-US, V55, P2903, DOI 10.1021/acs.biochem.6b00140; Laajoki LG, 2000, J BIOL CHEM, V275, P10009, DOI 10.1074/jbc.275.14.10009; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; LEE JS, 1994, AM J PHYSIOL, V266, pC319, DOI 10.1152/ajpcell.1994.266.2.C319; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; MALY P, 1988, J BIOL CHEM, V263, P7068; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2015, STRUCTURE, V23, P1271, DOI 10.1016/j.str.2015.04.016; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Morcavallo A, 2012, J BIOL CHEM, V287, P11422, DOI 10.1074/jbc.M111.252478; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; OConnor R, 1997, MOL CELL BIOL, V17, P427, DOI 10.1128/MCB.17.1.427; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; Pascual-Lucas M, 2014, EMBO MOL MED, V6, P1246, DOI 10.15252/emmm.201404228; Renshaw PS, 2004, J BIOMOL NMR, V30, P225, DOI 10.1023/B:JNMR.0000048852.40853.5c; Sacco A, 2009, ENDOCRINOLOGY, V150, P3594, DOI 10.1210/en.2009-0377; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SATO A, 1993, INT J PEPT PROT RES, V41, P433; SCHAEFER EM, 1990, J BIOL CHEM, V265, P13248; Schaffer ML, 2003, BIOCHEMISTRY-US, V42, P9324, DOI 10.1021/bi034386c; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Siddle Kenneth, 2012, Front Endocrinol (Lausanne), V3, P34, DOI 10.3389/fendo.2012.00034; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Siwanowicz I, 2005, STRUCTURE, V13, P155, DOI 10.1016/j.str.2004.11.009; Slaaby R, 2008, GROWTH HORM IGF RES, V18, P267, DOI 10.1016/j.ghir.2007.09.003; Slaaby R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07911; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; TERASAWA H, 1994, EMBO J, V13, P5590, DOI 10.1002/j.1460-2075.1994.tb06896.x; TORRES AM, 1995, J MOL BIOL, V248, P385, DOI 10.1006/jmbi.1995.0229; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1; Vikova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19431; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Williams C, 2007, STRUCTURE, V15, P1065, DOI 10.1016/j.str.2007.07.007; Williams C, 2012, SCIENCE, V338, P1209, DOI 10.1126/science.1228633; YAMAGUCHI Y, 1993, ENDOCRINOLOGY, V132, P1132, DOI 10.1210/en.132.3.1132; Yun CH, 2005, BIOCHEM BIOPH RES CO, V326, P52, DOI 10.1016/j.bbrc.2004.10.203; Zakova L, 2014, ACTA CRYSTALLOGR D, V70, P2765, DOI 10.1107/S1399004714017775; Zakova L, 2013, J BIOL CHEM, V288, P10230, DOI 10.1074/jbc.M112.448050; Zeslawski W, 2001, EMBO J, V20, P3638, DOI 10.1093/emboj/20.14.3638; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6; Ziegler AN, 2014, J BIOL CHEM, V289, P4626, DOI 10.1074/jbc.M113.537597	87	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21234	+		10.1074/jbc.M116.741041	http://dx.doi.org/10.1074/jbc.M116.741041			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27510031	hybrid, Green Published			2022-12-26	WOS:000385406200036
J	Rapanelli, M; Frick, LR; Horn, KD; Schwarcz, RC; Pogorelov, V; Nairn, AC; Pittenger, C				Rapanelli, Maximiliano; Frick, Luciana R.; Horn, Kyla D.; Schwarcz, Rivka C.; Pogorelov, Vladimir; Nairn, Angus C.; Pittenger, Christopher			The Histamine H3 Receptor Differentially Modulates Mitogen-activated Protein Kinase (MAPK) and Akt Signaling in Striatonigral and Striatopallidal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H-3 RECEPTOR; HISTIDINE-DECARBOXYLASE; TOURETTE SYNDROME; REPETITIVE BEHAVIOR; S6 PHOSPHORYLATION; DOPAMINE D-1; PATHWAYS; MICE; NEUROBIOLOGY; COCAINE	The basal ganglia have a central role in motor patterning, habits, motivated behaviors, and cognition as well as in numerous neuropsychiatric disorders. Receptors for histamine, especially the H3 receptor (H3R), are highly expressed in the striatum, the primary input nucleus of the basal ganglia, but their effects on this circuitry have been little explored. H3R interacts with dopamine (DA) receptors ex vivo; the nature and functional importance of these interactions in vivo remain obscure. We found H3R activation with the agonist R-(-)-alpha-methylhistamine to produce a unique time-and cell type-dependent profile of molecular signaling events in the striatum. H3 agonist treatment did not detectably alter extracellular DA levels or signaling through the cAMP/DARPP-32 signaling pathway in either D1- or D2-expressing striatal medium spiny neurons (MSNs). In D1-MSNs, H3 agonist treatment transiently activated MAPK signaling and phosphorylation of rpS6 and led to phosphorylation of GSK3 beta-Ser(9), a novel effect. Consequences of H3 activation in D2-MSNs were completely different. MAPK signaling was unchanged, and GSK3 beta-Ser(9) phosphorylation was reduced. At the behavioral level, two H3 agonists had no significant effect on locomotion or stereotypy, but they dramatically attenuated the locomotor activation produced by the D1 agonist SKF82958. H3 agonist co-administration blocked the activation of MAPK signaling and the phosphorylation of rpS6 produced by D1 activation in D1-MSNs, paralleling behavioral effects. In contrast, GSK3 beta-Ser(9) phosphorylation was seen only after H3 agonist treatment, with no interactive effects. H3R signaling has been neglected in models of basal ganglia function and has implications for a range of pathophysiologies.	[Rapanelli, Maximiliano; Frick, Luciana R.; Pogorelov, Vladimir; Nairn, Angus C.; Pittenger, Christopher] Yale Univ, Dept Psychiat, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Dept Psychol, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Ctr Child Study, New Haven, CT 06519 USA; [Horn, Kyla D.; Pittenger, Christopher] Yale Univ, Interdept Neurosci Program, New Haven, CT 06519 USA; [Schwarcz, Rivka C.] Yale Univ, Grad Program Cell Biol, New Haven, CT 06519 USA; [Pogorelov, Vladimir] Duke Univ, 469 Sands Bldg, Durham, NC 27710 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Duke University	Nairn, AC; Pittenger, C (corresponding author), 34 Pk St,3rd Floor, New Haven, CT 06519 USA.	angus.nairn@yale.edu; christopher.pittenger@yale.edu	rapanelli, maximiliano/P-3141-2016	rapanelli, maximiliano/0000-0001-7329-2364; Nairn, Angus/0000-0002-7075-0195; Pittenger, Christopher/0000-0003-2117-9321	Allison Family Foundation; Tourette Syndrome Association; National Institutes of Health [R01MH091861, DA10044, MH090963]; State of Connecticut through Ribicoff Research Facilities at the Connecticut Mental Health Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091861, P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	Allison Family Foundation; Tourette Syndrome Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut through Ribicoff Research Facilities at the Connecticut Mental Health Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Allison Family Foundation (to C. P.), the Tourette Syndrome Association (to L. F.), National Institutes of Health Grants R01MH091861 (to C. P.) and DA10044 and MH090963 (to A. C. N.), and the State of Connecticut through its support of the Ribicoff Research Facilities at the Connecticut Mental Health Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Banks ML, 2009, PHARMACOLOGY, V83, P164, DOI 10.1159/000191473; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; Bolam JP, 2016, NEUROPHARMACOLOGY, V106, P74, DOI 10.1016/j.neuropharm.2015.08.013; Bongers G, 2007, J NEUROCHEM, V103, P248, DOI 10.1111/j.1471-4159.2007.04752.x; Brabant C, 2010, PROG NEUROBIOL, V92, P421, DOI 10.1016/j.pneurobio.2010.07.002; Brabant C, 2009, PSYCHOPHARMACOLOGY, V202, P673, DOI 10.1007/s00213-008-1345-y; Calabresi P, 2014, NAT NEUROSCI, V17, P1022, DOI 10.1038/nn.3743; Casas-Terradellas E, 2008, BBA-MOL CELL RES, V1783, P2241, DOI 10.1016/j.bbamcr.2008.08.011; Chan CS, 2012, J NEUROSCI, V32, P9124, DOI 10.1523/JNEUROSCI.0229-12.2012; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Desai RI, 2005, PHARMACOL BIOCHEM BE, V81, P843, DOI 10.1016/j.pbb.2005.06.006; Ellenbroek BA, 2013, BRIT J PHARMACOL, V170, P46, DOI 10.1111/bph.12221; Ellender TJ, 2011, J NEUROSCI, V31, P15340, DOI 10.1523/JNEUROSCI.3144-11.2011; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Ferrada C, 2008, NEUROPHARMACOLOGY, V55, P190, DOI 10.1016/j.neuropharm.2008.05.008; Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Girault JA, 2012, ADV EXP MED BIOL, V970, P407, DOI 10.1007/978-3-7091-0932-8_18; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Greengard P, 2001, BIOSCIENCE REP, V21, P247, DOI 10.1023/A:1013205230142; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Karagiannidis I, 2013, J MED GENET, V50, P760, DOI 10.1136/jmedgenet-2013-101637; Krusong K, 2011, NEUROSCI LETT, V495, P110, DOI 10.1016/j.neulet.2011.03.050; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P356, DOI 10.1016/j.neubiorev.2010.02.005; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Macpherson T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01301; Mahmood D, 2012, PHARMACOL REP, V64, P191; Mariottini C, 2009, J NEUROCHEM, V110, P1469, DOI 10.1111/j.1471-4159.2009.06249.x; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Miller JS, 2010, BRAIN RES BULL, V82, P184, DOI 10.1016/j.brainresbull.2010.03.005; Moreno E, 2011, J BIOL CHEM, V286, P5846, DOI 10.1074/jbc.M110.161489; Moreno E, 2014, J NEUROSCI, V34, P3545, DOI 10.1523/JNEUROSCI.4147-13.2014; Morisset S, 2000, NATURE, V408, P860, DOI 10.1038/35048583; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Park HY, 2014, J NEUROSCI, V34, P11744, DOI 10.1523/JNEUROSCI.0864-14.2014; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Pende Mario, 2006, Bull Cancer, V93, pE39; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Rapanelli M, 2016, NEUROPHARMACOLOGY, V106, P85, DOI 10.1016/j.neuropharm.2015.08.019; Rapanelli M, 2014, EUR NEUROPSYCHOPHARM, V24, P1896, DOI 10.1016/j.euroneuro.2014.10.007; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; Schwartz JC, 2011, BRIT J PHARMACOL, V163, P713, DOI 10.1111/j.1476-5381.2011.01286.x; SHARP T, 1987, BRAIN RES, V401, P322, DOI 10.1016/0006-8993(87)91416-8; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Torrent A, 2005, MOL PHARMACOL, V67, P195, DOI 10.1124/mol.104.005652; Vanhanen J, 2015, PSYCHOPHARMACOLOGY, V232, P1143, DOI 10.1007/s00213-014-3751-7; Webb IC, 2009, J BIOL RHYTHM, V24, P465, DOI 10.1177/0748730409346657; Xu MY, 2015, NEUROSCI LETT, V595, P50, DOI 10.1016/j.neulet.2015.03.067	59	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21042	21052		10.1074/jbc.M116.731406	http://dx.doi.org/10.1074/jbc.M116.731406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27510032	hybrid, Green Published			2022-12-26	WOS:000385406200020
J	Billeskov, R; Tan, EV; Cang, M; Abalos, RM; Burgos, J; Pedersen, BV; Christensen, D; Agger, EM; Andersen, P				Billeskov, Rolf; Tan, Esterlina V.; Cang, Marjorie; Abalos, Rodolfo M.; Burgos, Jasmin; Pedersen, Bo Vestergaard; Christensen, Dennis; Agger, Else Marie; Andersen, Peter			Testing the H56 Vaccine Delivered in 4 Different Adjuvants as a BCG-Booster in a Non-Human Primate Model of Tuberculosis	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; T-CELL RESPONSES; MYCOBACTERIUM-TUBERCULOSIS; PROTECTIVE IMMUNITY; CYNOMOLGUS MACAQUES; INTERFERON-GAMMA; RHESUS MACAQUES; INFECTION; MEMORY; FREQUENCY	The search for new and improved tuberculosis (TB) vaccines has focused on IFN-gamma both for selecting antigens and for evaluating vaccine delivery strategies. The essential role of IFN-gamma in endogenous host protection is well established, but it is still uncertain whether this also holds true for vaccine protection. Here we evaluate the H56 fusion protein vaccine as a BCG booster in a non-human primate (NHP) model of TB that closely recapitulates human TB pathogenesis. To date, only a handful of novel adjuvants have been tested in the NHP model of TB, and therefore we administered H56 in 3 novel cationic liposome adjuvants of increasing immunogenicity (CAF01, CAF04, CAF05) and compared them to H56 in the IC31 (R) adjuvant previously reported to promote protection in this model. The individual clinical parameters monitored during infection (weight, ESR, X-ray) all correlated with survival, and boosting BCG with H56 in all adjuvants resulted in better survival rates compared to BCG alone. The adjuvants promoted IFN-gamma responses of increasing intensity as measured by ELISPOT in the peripheral blood, but the level of vaccine-specific IFN-gamma production did not correlate with or predict disease outcome. This study's main outcome underscores the importance of the choice of adjuvant for TB subunit vaccines, and secondly it highlights the need for better correlates of protection in preclinical models of TB.	[Billeskov, Rolf; Christensen, Dennis; Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark; [Billeskov, Rolf] NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tan, Esterlina V.; Cang, Marjorie; Abalos, Rodolfo M.; Burgos, Jasmin] Leonard Wood Mem LWM Ctr Leprosy Res, Cebu, Philippines; [Pedersen, Bo Vestergaard] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark	Statens Serum Institut; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Statens Serum Institut	Billeskov, R; Andersen, P (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark.; Billeskov, R (corresponding author), NCI, Vaccine Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	rob@ssi.dk; pa@ssi.dk	Christensen, Dennis/C-6378-2008	Christensen, Dennis/0000-0003-2382-8639; Andersen, Peter/0000-0002-5869-2551; Billeskov, Rolf/0000-0003-4533-7304	European Commission [FP7-HEALTH-2011.1.4-4-280873]; National Institutes of Health [AI 105422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105422] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The parts of this work that was performed at the SSI was funded by the European Commission [contract number FP7-HEALTH-2011.1.4-4-280873 (ADITEC)], and National Institutes of Health [grant number AI 105422]. The funders had no role in design of studies or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Andersen CAS, 2009, J IMMUNOL, V183, P2294, DOI 10.4049/jimmunol.0804091; Andersen CS, 2009, J IMMUNOL, V182, P424, DOI 10.4049/jimmunol.182.1.424; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Billeskov R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072185; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Hansen J, 2012, CANCER IMMUNOL IMMUN, V61, P893, DOI 10.1007/s00262-011-1156-6; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kaufmann SHE, 2014, LANCET RESP MED, V2, P301, DOI 10.1016/S2213-2600(14)70033-5; Kaushal D, 2012, J MED PRIMATOL, V41, P191, DOI 10.1111/j.1600-0684.2012.00536.x; Langermans JAM, 2001, P NATL ACAD SCI USA, V98, P11497, DOI 10.1073/pnas.201404898; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Lin PL, 2009, INFECT IMMUN, V77, P4631, DOI 10.1128/IAI.00592-09; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Logan KE, 2005, VACCINE, V23, P5526, DOI 10.1016/j.vaccine.2005.07.037; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; Nordly P, 2011, J CONTROL RELEASE, V150, P307, DOI 10.1016/j.jconrel.2010.11.021; Nordly P, 2011, EUR J PHARM BIOPHARM, V77, P89, DOI 10.1016/j.ejpb.2010.10.001; Nunes-Alves C, 2014, NAT REV MICROBIOL, V12, P289, DOI 10.1038/nrmicro3230; Orr MT, 2015, J INFECT DIS, V212, P495, DOI 10.1093/infdis/jiv055; Pena JC, 2015, INFECT IMMUN, V83, P852, DOI 10.1128/IAI.02850-14; Sakai S, 2014, J IMMUNOL, V192, P2965, DOI 10.4049/jimmunol.1400019; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sharpe SA, 2010, CLIN VACCINE IMMUNOL, V17, P1170, DOI 10.1128/CVI.00079-10; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Hoang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080579; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Walsh GP, 1996, NAT MED, V2, P430, DOI 10.1038/nm0496-430; Yu H, 2012, INFECT IMMUN, V80, P1510, DOI 10.1128/IAI.06338-11	43	24	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161217	10.1371/journal.pone.0161217	http://dx.doi.org/10.1371/journal.pone.0161217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525651	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100043
J	Bourgi, K; Brar, I; Baker-Genaw, K				Bourgi, Kassem; Brar, Indira; Baker-Genaw, Kimberly			Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan	PLOS ONE			English	Article							VIRUS-INFECTION; INTERVENTION; ADULTS; RACE	With recommended screening for hepatitis C among the 1945-1965 birth cohort and advent of novel highly effective therapies, little is known about health disparities in the Hepatitis C care cascade. Our objective was to evaluate hepatitis C screening rates and linkage to care, among patients who test positive, at our large integrated health system. We used electronic medical records to retrospectively identify patients, in the birth cohort, who were seen in 21 Internal Medicine clinics from July 2014 to June 2015. Patients previously screened for hepatitis C and those with established disease were excluded. We studied patients' sociodemographic and medical conditions along with provider-specific factors associated with likelihood of screening. Patients who tested positive for HCV antibody were reviewed to assess appropriate linkage to care and treatment. Of 40,561 patients who met inclusion criteria, 21.3% (8657) were screened, 1.3% (109) tested positive, and 30% (30/100) completed treatment. Multivariate logistic regression showed that African American race, male gender, electronic health engagement, residency teaching clinic visit, and having more than one clinic visit were associated with higher odds of screening. Patients had a significant decrease in the likelihood of screening with sequential interval increase in their Charlson comorbidity index. When evaluating hepatitis C treatment in patients who screened positive, electronic health engagement was associated with higher odds of treatment whereas Medicaid insurance was associated with significantly lower odds. This study shows that hepatitis C screening rates and linkage to care continue to be suboptimal with a significant impact of multiple sociodemographic and insurance factors. Electronic health engagement emerges as a tool in linking patients to the hepatitis C care cascade.	[Bourgi, Kassem; Baker-Genaw, Kimberly] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA; [Brar, Indira] Henry Ford Hosp, Div Infect Dis, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Bourgi, K (corresponding author), Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA.	kbourgi@aol.com	Bourgi, Kassem/I-8590-2017	Bourgi, Kassem/0000-0001-9734-7489	Gilead Sciences; Janssen Pharmaceutica; ViiV Healthcare	Gilead Sciences(Gilead Sciences); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV Healthcare	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Kassem Bourgi and Dr. Kimberly Baker-Genaw have no conflicts of interest. Dr. Indira Brar has served as a speaker, advisory board member and received research funding from Gilead Sciences. Dr. Brar has served as a speaker and received research funding from Janssen Pharmaceutica. She has also received research funding from ViiV Healthcare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Assoumou SA, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu009; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Benhamou PY, 2011, DIABETES METAB, V37, pS53, DOI 10.1016/S1262-3636(11)70966-1; Cahill JE, 2014, J NEURO-ONCOL, V117, P1, DOI 10.1007/s11060-013-1333-x; Celona AF, 2004, CLIN GASTROENTEROL H, V2, P459, DOI 10.1016/S1542-3565(04)00160-0; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Fleckenstein Jaquelyn, 2004, Curr Gastroenterol Rep, V6, P66, DOI 10.1007/s11894-004-0028-z; Forde KA, 2014, CLIN GASTROENTEROL H, V12, P738, DOI 10.1016/j.cgh.2013.06.006; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hirsch AA, 2014, JT COMM J QUAL PATIE, V40, P351, DOI 10.1016/S1553-7250(14)40046-1; Holmberg SD, 2013, NEW ENGL J MED, V368, P1859, DOI 10.1056/NEJMp1302973; Irizarry T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4255; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Klevens RM, 2009, EMERG INFECT DIS, V15, P1499, DOI 10.3201/eid1509.081050; Linas BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097317; Linas BP, 2014, AM J MED, V127, P398, DOI 10.1016/j.amjmed.2014.01.012; Lo Re V, 2015, HEPATOLOGY, V62, p1382A; Loy V, 2015, HEPATOLOGY, V62, p789A; Medland NA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20634; Melia MT, 2011, HEPATOLOGY, V54, P70, DOI 10.1002/hep.24358; Meyer JP, 2015, INT J DRUG POLICY, V26, P922, DOI 10.1016/j.drugpo.2015.05.002; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Pyrsopoulos Nikolaos, 2005, Clin Liver Dis, V9, P427, DOI 10.1016/j.cld.2005.05.005; Roblin DW, 2011, AM J MANAG CARE, V17, P548; Roumia M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-013-0451-6; Saab S, 2014, AM J GASTROENTEROL, V109, P1576, DOI 10.1038/ajg.2014.243; Sidlow R, 2015, J HEALTHC QUAL, V37, P319, DOI 10.1097/JHQ.0000000000000010; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Thomas B, 2011, ADV CHRONIC KIDNEY D, V18, P406, DOI 10.1053/j.ackd.2011.10.005; Trooskin SB, 2007, WORLD J GASTROENTERO, V13, P1074, DOI 10.3748/wjg.v13.i7.1074; Turner BJ, 2015, J HOSP MED, V10, P510, DOI 10.1002/jhm.2376; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669	40	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161241	10.1371/journal.pone.0161241	http://dx.doi.org/10.1371/journal.pone.0161241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525983	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100046
J	Campbell, ML				Campbell, Marnie L.			Burial Duration and Frequency Influences Resilience of Differing Propagule Types in a Subtidal Seagrass, Posidonia australis	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; CYMODOCEA-NODOSA; THALASSIA-TESTUDINUM; WESTERN-AUSTRALIA; SEDIMENT BURIAL; CLONAL INTEGRATION; GROWTH-RESPONSE; VERTICAL GROWTH; RESTORATION; IMPACT	Sedimentation that leads to periodic, and often prolonged, burial events is becomingmore common on the world's coastlines as human populations expand and create urbanised marine environments. Different seagrass species react differently to sediment burial but many species in the southern hemisphere are yet to be examined. How seagrasses react to burial has restoration implications. There is a need to critically assess seagrass transplant propagule responses to periodic (pulse) and prolonged (press) burial events before selecting the most appropriate species, transplant propagule, and transplant site. In my study, mesocosm experiments, coupled with field measurements were used to assess how sexual (seedlings) and vegetative (sprigs) propagules of Posidonia australis responded to pulse and press burial events. Seedlings were highly susceptible to burial (both pulse and press), with no survival at the end of the experimental period. In contrast, rhizome growth in vegetative propagules was stimulated by pulse burial, although press burial events resulted inmortality. The implication for Posidonia australis restoration efforts in areas where burial is periodic, was that vegetative propagules are optimal transplant units, in comparison to seedlings. Press burial however, renders a transplant site sub-optimal for both seedling and sprig transplants.	[Campbell, Marnie L.] Murdoch Univ, Sch Biol & Environm Sci, Perth, WA, Australia; [Campbell, Marnie L.] Univ Waikato, Environm Res Inst, Hamilton, Waikato, New Zealand	Murdoch University; University of Waikato	Campbell, ML (corresponding author), Murdoch Univ, Sch Biol & Environm Sci, Perth, WA, Australia.; Campbell, ML (corresponding author), Univ Waikato, Environm Res Inst, Hamilton, Waikato, New Zealand.	mcampbel@waikato.ac.nz		Campbell, Marnie/0000-0002-8716-0036	Cockburn Cement Limited; Great Barrier Reef Marine Park Authority	Cockburn Cement Limited; Great Barrier Reef Marine Park Authority	Cockburn Cement Limited and the Great Barrier Reef Marine Park Authority provided financial support for this research. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted in part from funding from Cockburn Cement Limited and the Great Barrier Reef Marine Park Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 2016, BIOSCIENCE, V66, P156, DOI 10.1093/biosci/biv171; Balestri E, 2014, RESTOR ECOL, V22, P240, DOI 10.1111/rec.12052; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Bos AR, 2007, ESTUAR COAST SHELF S, V74, P344, DOI 10.1016/j.ecss.2007.04.006; Cabaco S, 2008, ESTUAR COAST SHELF S, V79, P354, DOI 10.1016/j.ecss.2008.04.021; Cabaco S, 2007, J EXP MAR BIOL ECOL, V340, P204, DOI 10.1016/j.jembe.2006.09.003; Calumpong HP, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P425, DOI 10.1016/B978-044450891-1/50023-2; Campbell M.L., 2000, THESIS; Campbell ML, 2002, B MAR SCI, V71, P1405; Campbell ML, 2003, MAR POLLUT BULL, V46, P828, DOI 10.1016/S0025-326X(03)00093-6; Campbell ML, 2003, AQUAT BOT, V76, P175, DOI 10.1016/S0304-3770(03)00016-0; Campbell ML, 2010, SEAGRASS RESTORATION; Celdran D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130015; Cunha AH, 2012, RESTOR ECOL, V20, P427, DOI 10.1111/j.1526-100X.2012.00878.x; DENHARTOG C, 1994, AQUAT BOT, V47, P21, DOI 10.1016/0304-3770(94)90045-0; Do VT, 2012, MAR POLLUT BULL, V64, P2340, DOI 10.1016/j.marpolbul.2012.08.025; Duarte CM, 1997, MAR ECOL PROG SER, V147, P285, DOI 10.3354/meps147285; DUARTE CM, 1990, MAR ECOL PROG SER, V67, P97, DOI 10.3354/meps067097; DUARTE CM, 1990, MAR ECOL PROG SER, V65, P193, DOI 10.3354/meps065193; Fourqurean JW, 2004, B MAR SCI, V75, P239; GALLEGOS ME, 1993, MAR ECOL PROG SER, V95, P185, DOI 10.3354/meps095185; Glasby TM, 2015, AQUAT BOT, V120, P251, DOI 10.1016/j.aquabot.2014.09.003; Glasby TM, 1996, ENVIRON MONIT ASSESS, V42, P241, DOI 10.1007/BF00414371; Green MO, 2007, ESTUAR COAST SHELF S, V72, P553, DOI 10.1016/j.ecss.2006.11.006; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Han QY, 2012, MAR ECOL PROG SER, V449, P133, DOI 10.3354/meps09532; Harwell MC, 1999, AQUAT BOT, V64, P51, DOI 10.1016/S0304-3770(99)00008-X; HOCKING PJ, 1981, AQUAT BOT, V11, P245, DOI 10.1016/0304-3770(81)90064-4; HOCKING PJ, 1980, ANN BOT-LONDON, V45, P149, DOI 10.1093/oxfordjournals.aob.a085806; Ibarra-Obando SE, 2004, J EXP MAR BIOL ECOL, V301, P193, DOI 10.1016/j.jembe.2003.10.001; Jarvis JC, 2015, ESTUAR COAST, V38, P964, DOI 10.1007/s12237-014-9869-3; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Kennedy H., 2004, EUROPEAN SEAGRASSES, P54; Kirkman H, 1998, MAR POLLUT BULL, V37, P460; LITTLER MM, 1983, MAR ECOL PROG SER, V11, P129, DOI 10.3354/meps011129; Manzanera M, 2011, MAR ECOL PROG SER, V423, P47, DOI 10.3354/meps08970; MARBA N, 1994, MAR ECOL PROG SER, V107, P307, DOI 10.3354/meps107307; Marba N, 2003, AQUAT BOT, V77, P87, DOI 10.1016/S0304-3770(03)00079-2; MARBA N, 1994, LIMNOL OCEANOGR, V39, P126, DOI 10.4319/lo.1994.39.1.0126; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; MARBA N, 1994, AQUAT BOT, V47, P1, DOI 10.1016/0304-3770(94)90043-4; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2004, EUROPEAN SEAGRASSES, P11; Marion SR, 2010, RESTOR ECOL, V18, P549, DOI 10.1111/j.1526-100X.2010.00695.x; MEINESZ A, 1992, Marine Ecology, V13, P163, DOI 10.1111/j.1439-0485.1992.tb00347.x; MOLENAAR H, 1993, BOT MAR, V36, P481, DOI 10.1515/botm.1993.36.6.481; MOLENAAR H, 1992, Marine Ecology, V13, P175, DOI 10.1111/j.1439-0485.1992.tb00348.x; Munkes B, 2015, MAR POLLUT BULL, V100, P144, DOI 10.1016/j.marpolbul.2015.09.013; Nelson M. K., 1992, THESIS; Ooi JLS, 2011, CONT SHELF RES, V31, P1945, DOI 10.1016/j.csr.2011.09.005; Paling EI, 2003, RESTOR ECOL, V11, P56, DOI 10.1046/j.1526-100X.2003.00072.x; Paling EI, 2001, ECOL ENG, V16, P331, DOI 10.1016/S0925-8574(00)00119-1; Pimm SL, 1991, BALANCE NATURE ECOLO; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; Roca G, 2016, ECOL INDIC, V63, P310, DOI 10.1016/j.ecolind.2015.12.007; ROSE CD, 1994, BOT MAR, V37, P531, DOI 10.1515/botm.1994.37.6.531; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Short FT, 2002, MAR ECOL PROG SER, V227, P253, DOI 10.3354/meps227253; Statton J, 2013, RESTOR ECOL, V21, P250, DOI 10.1111/j.1526-100X.2012.00873.x; Suykerbuyk W, 2016, ECOSYSTEMS, V19, P296, DOI 10.1007/s10021-015-9932-3; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Terrados J, 1997, MAR ECOL PROG SER, V152, P295, DOI 10.3354/meps152295; THAYER GW, 1975, AM SCI, V63, P288; TOMASKO DA, 1992, ESTUARIES, V15, P214, DOI 10.2307/1352694; Tuya F, 2013, J EXP MAR BIOL ECOL, V439, P42, DOI 10.1016/j.jembe.2012.10.015; Valentine JF, 2000, MAR ECOL PROG SER, V200, P213, DOI 10.3354/meps200213; Valle M, 2015, AQUAT BOT, V127, P12, DOI 10.1016/j.aquabot.2015.07.002; van Katwijk MM, 2009, MAR POLLUT BULL, V58, P179, DOI 10.1016/j.marpolbul.2008.09.028; van Keulen M, 2003, RESTOR ECOL, V11, P50, DOI 10.1046/j.1526-100X.2003.00036.x; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zhang PZ, 2001, NATURE, V410, P891, DOI 10.1038/35073504	73	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161309	10.1371/journal.pone.0161309	http://dx.doi.org/10.1371/journal.pone.0161309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526020	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100053
J	Li, CQ; Jiang, XH; Luo, MJ; Feng, GY; Sun, QX; Chen, YP				Li, Chaoqian; Jiang, Xiaohong; Luo, Mingjie; Feng, Guangyi; Sun, Qixiang; Chen, Yiping			Mycobacterium vaccae Nebulization Can Protect against Asthma in Balb/c Mice by Regulating Th9 Expression	PLOS ONE			English	Article							DELTA-T-CELLS; BACILLUS-CALMETTE-GUERIN; AIRWAY INFLAMMATION; TGF-BETA; TUBERCULOSIS; INDUCTION; INFECTION; IMMUNITY; CD8(+); PHLEI	Asthma is a heterogeneous disease characterized by chronic airway inflammation. CD4(+) T-helper 9 (Th9) cells are closely linked to asthma, helping to regulate inflammation and immunity. Epidemiological studies showed that mycobacteria infections are negatively associated with asthma. Our previous research showed that inactivated Mycobacterium phlei nebulization alleviated the airway hyperresponsiveness and inflammation of asthma. However, the relationship between Th9 cells and mycobacteria remains unknown. Here, we evaluated the relationship between Mycobacterium vaccae nebulization and Th9 cells in asthmatic mice. Eighteen Balb/c mice were randomized into 3 groups of 6 mice each (normal control group, asthma control group, and nebulization asthma group [ Neb. group]). The Neb. group was nebulized with M. vaccae one month before establishment of the asthmatic model with ovalbumin (OVA) sensitization, and the normal and asthma control groups were nebulized with phosphate-buffered saline. The hyperresponsiveness of the mouse airways was assessed using a non-invasive lung function machine. Lung airway inflammation was evaluated by hematoxylin and eosin and periodic acid-Schiff staining. Cytokine interlukin-9 (IL-9) concentration and OVA-specific IgE in the bronchoalveolar lavage fluid were measured by enzyme-linked immunosorbent assays. The percentages of gamma delta TCR+ CD3(+), IL-9(+) CD3(+), IL-10(+) CD3(+) lymphocytes, and IL9(+)gamma delta T and IL-10(+)gamma delta T cells were detected by flow cytometry. The airway inflammation and concentration of IL-9 and OVA-specific IgE were significantly reduced in the Neb. group compared to the asthma control group. The Neb. group had lower airway hyperresponsiveness, percentages of gamma delta TCR+ CD3(+) and IL-9(+) CD3(+) lymphocytes, and IL9(+) gamma delta T cells, and higher percentages of IL-10(+) CD3(+) lymphocytes and IL-10(+)gamma delta T cells compared to the asthma control group. Thus, mouse bronchial asthma could be prevented by M. vaccae nebulization. The mechanism could involve M. vaccae-mediated effects on induction of IL-9 secretion and suppression of IL-10 secretion from gamma delta T cells. gamma delta T cells showed prominent IL-10 expression, indicating that they possibly belong to the Th9 family.	[Li, Chaoqian] Guangxi Med Coll, Dept Resp Med, Nanning, Guangxi, Peoples R China; [Li, Chaoqian; Jiang, Xiaohong] Guangxi Med Univ, Dept Geriatr Resp Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Luo, Mingjie; Feng, Guangyi] Guangxi Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanning, Guangxi, Peoples R China; [Sun, Qixiang] Guangxi Med Univ, Grad Sch, Nanning, Guangxi, Peoples R China; [Chen, Yiping] Guangxi Med Univ, Natl Affiliated Hosp, Dept Geriatr Dis, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Jiang, XH (corresponding author), Guangxi Med Univ, Dept Geriatr Resp Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	285999574@qq.com	Chen, Yi/HIR-2608-2022		Guangxi Health and Family Planning Commission Self-raised Funds, People's Republic of China [z2014030]	Guangxi Health and Family Planning Commission Self-raised Funds, People's Republic of China	This work was supported by Guangxi Health and Family Planning Commission Self-raised Funds, People's Republic of China (grant number z2014030), http://www.gxws.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borish L, 1996, J ALLERGY CLIN IMMUN, V97, P1288, DOI 10.1016/S0091-6749(96)70197-5; Cheng L, 2008, J NEUROIMMUNOL, V203, P3, DOI 10.1016/j.jneuroim.2008.06.007; Cook L, 2008, J IMMUNOL, V181, P309, DOI 10.4049/jimmunol.181.1.309; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Emoto M, 1999, EUR J IMMUNOL, V29, P650, DOI 10.1002/(SICI)1521-4141(199902)29:02<650::AID-IMMU650>3.0.CO;2-M; Fu CL, 2006, J GENE MED, V8, P1393, DOI 10.1002/jgm.974; Glanville N, 2013, MUCOSAL IMMUNOLOGY; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Kerzerho J, 2013, J ALLERGY CLIN IMMUN, V131, P1048, DOI 10.1016/j.jaci.2012.09.027; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Li Chaoqian, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P162; Lighter-Fisher J, 2012, PEDIAT ALLER IMM PUL, V25, P80, DOI 10.1089/ped.2012.0146; ONYEBUJOH PC, 1995, RESP MED, V89, P199, DOI 10.1016/0954-6111(95)90248-1; Rook GAW, 2007, IMMUNOBIOLOGY, V212, P461, DOI 10.1016/j.imbio.2007.03.003; Rook GAW, 2012, CLIN REV ALLERG IMMU, V42, P5, DOI 10.1007/s12016-011-8285-8; Samary CD, 2013, RESP PHYSIOL NEUROBI, V189, P614, DOI 10.1016/j.resp.2013.07.025; Schmitt E, 2014, TRENDS IMMUNOL, V35, P61, DOI 10.1016/j.it.2013.10.004; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Strioga MM, 2014, VACCINE, V32, P4015, DOI 10.1016/j.vaccine.2014.05.006; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; Xing JC, 2011, J ASTHMA, V48, P115, DOI 10.3109/02770903.2011.554944; Yang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023826; Zhang JH, 2012, IMMUNOTHERAPY-UK, V4, P383, DOI [10.2217/imt.12.25, 10.2217/IMT.12.25]; Zhang JH, 2012, J AEROSOL MED PULM D, V25, P96, DOI 10.1089/jamp.2011.0904; Zhao Y, 2011, J ASTHMA, V48, P429, DOI 10.3109/02770903.2011.570403; Zufferey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077334	28	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161164	10.1371/journal.pone.0161164	http://dx.doi.org/10.1371/journal.pone.0161164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518187	Green Published, gold, Green Submitted			2022-12-26	WOS:000381382100055
J	de Assis, JM; Santos, MO; de Assis, FM				de Assis, Juliana M.; Santos, Mikaelle O.; de Assis, Francisco M.			Auditory Stimuli Coding by Postsynaptic Potential and Local Field Potential Features	PLOS ONE			English	Article							MUTUAL INFORMATION	The relation between physical stimuli and neurophysiological responses, such as action potentials (spikes) and Local Field Potentials (LFP), has recently been experimented in order to explain how neurons encode auditory information. However, none of these experiments presented analyses with postsynaptic potentials (PSPs). In the present study, we have estimated information values between auditory stimuli and amplitudes/latencies of PSPs and LFPs in anesthetized rats in vivo. To obtain these values, a new method of information estimation was used. This method produced more accurate estimates than those obtained by using the traditional binning method; a fact that was corroborated by simulated data. The traditional binning method could not certainly impart such accuracy even when adjusted by quadratic extrapolation. We found that the information obtained from LFP amplitude variation was significantly greater than the information obtained from PSP amplitude variation. This confirms the fact that LFP reflects the action of many PSPs. Results have shown that the auditory cortex codes more information of stimuli frequency with slow oscillations in groups of neurons than it does with slow oscillations in neurons separately.	[de Assis, Juliana M.; Santos, Mikaelle O.; de Assis, Francisco M.] Univ Fed Campina Grande, Dept Elect Engn, Campina Grande, Paraiba, Brazil	Universidade Federal de Campina Grande	de Assis, JM; Santos, MO (corresponding author), Univ Fed Campina Grande, Dept Elect Engn, Campina Grande, Paraiba, Brazil.	juliana.assis@ee.ufcg.edu.br; mikaelle.santos@ee.ufcg.edu.br		ASSIS, FRANCISCO/0000-0002-8619-0874	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [302704/2013-2]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), JMA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/), MOS; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), contract number 302704/2013-2 (PQ), FMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Belitski A, 2010, J COMPUT NEUROSCI, V29, P533, DOI 10.1007/s10827-010-0230-y; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; DeWeese MR, 2011, WHOLE CELL RECORDING; Dimitrov AG, 2011, J COMPUT NEUROSCI, V30, P1, DOI 10.1007/s10827-011-0314-3; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; GERSTEIN GL, 1960, BIOPHYS J, V1, P15, DOI 10.1016/S0006-3495(60)86872-5; Grosse I., 2000, THESIS; Ince RAA, 2010, NEURAL NETWORKS, V23, P713, DOI 10.1016/j.neunet.2010.05.008; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Kandel E., 2007, BEST BRAIN SCI AM; Kandel E., 2000, PRINCIPLES NEURAL SC; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Lewen GD, 2001, NETWORK-COMP NEURAL, V12, P317, DOI 10.1088/0954-898X/12/3/305; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Logothetis NK, 2003, J NEUROSCI, V23, P3963; LOWRY R., 2012, CONCEPTS APPL INFERE; Lu S., 2001, THESIS; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pavao R, 2014, J NEUROSCI, V34, P8778, DOI 10.1523/JNEUROSCI.0908-14.2014; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; Schneidman E, 2003, J NEUROSCI, V23, P11539; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Singer W, 2009, COGN NEURODYNAMICS, V3, P189, DOI 10.1007/s11571-009-9087-z; Singh A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001035; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y; Thomas MC, 2006, ELEMENTS INFORM THEO; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366	38	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160089	10.1371/journal.pone.0160089	http://dx.doi.org/10.1371/journal.pone.0160089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513950	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100025
J	Nemudraya, AA; Makartsova, AA; Fomin, AS; Nushtaeva, AA; Koval, OA; Richter, VA; Kuligina, EV				Nemudraya, Anna A.; Makartsova, Anna A.; Fomin, Alexandr S.; Nushtaeva, Anna A.; Koval, Olga A.; Richter, Vladimir A.; Kuligina, Elena V.			Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; TARGETED DELIVERY; CLINICAL-APPLICATIONS; LUNG-CANCER; MICE MODELS; THERAPY; NANOPARTICLES; NANOMEDICINE; PERSPECTIVES; PENETRATION	A recombinant analogue of lactaptin (RL2), a new potential anticancer molecule, induces apoptosis in cultured tumor cells. The tumor suppression efficacy of RL2 was shown against mouse hepatoma-1 cells and MDA-MB-231 human breast adenocarcinoma cells. The RL2-based therapeutic drug lactaptin is distributed evenly throughout the organism, which reduces its antitumor efficacy. In the current study, we obtained a genetic construct that allows production of the recombinant fusion protein T3-RL2, consisting of RL2 and T3 peptide (YTYDPWLIFPAN), in E. coli cells. T3 peptide was selected from a phage peptide library as a result of two screenings: in vitro using MDA-MB-231 cell culture and in vivo using a mouse xenograft model of breast cancer MDA-MB-231. It was shown that the displayed peptide T3 provides binding and internalization of phage particles by MDA-MB-231 cells and their specific accumulation in MDA-MB-231 tumor tissue. In addition, based on the nucleotide sequences coding RL2 and the known tumor-targeting peptide iRGD, we obtained genetic constructs that provide synthesis of fusion proteins RL2-iRGD and RLiRGD-His. We studied the cytotoxic activity of fusion proteins T3-RL2, RL2-iRGD and RLiRGD-His in vitro using MDA-MB-231 and MCF-7 human adenocarcinoma cells. The in vitro results showed that the fusion proteins inhibit proliferation of both cell cultures, and their cytotoxic activity is higher than that of RL2. In vivo experiments on the study of the antitumor efficacy of the obtained fusion proteins demonstrated that T3-RL2 protein significantly inhibits MDA-MB-231 tumor growth in a xenograft model compared with RL2, while the antitumor effect of RL2-iRGD and RL-iRGD-His proteins is comparable to the effect of RL2.	[Nemudraya, Anna A.; Makartsova, Anna A.; Fomin, Alexandr S.; Nushtaeva, Anna A.; Koval, Olga A.; Richter, Vladimir A.; Kuligina, Elena V.] Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia; [Makartsova, Anna A.; Koval, Olga A.] Novosibirsk State Univ, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University	Nemudraya, AA (corresponding author), Inst Chem Biol & Fundamental Med SB RAS, Novosibirsk, Russia.	ann.vaskova@gmail.com	Fomin, Alexander/U-5928-2019; Nushtaeva, Anna/I-1547-2016; Fomin, Alexandr/AAP-6413-2020; Nemudraya, Anna/R-2847-2016	Nushtaeva, Anna/0000-0001-9367-807X; Kuligina, Elena/0000-0003-3145-1878; Nemudraia, Anna/0000-0002-4190-6306; Koval, Olga/0000-0001-7788-2249	Ministry of Education and Science of the Russian Federation [14.607.21.0063, RFMEFI60714X0063]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	The study was supported by the Ministry of Education and Science of the Russian Federation (http://xn-80abucjiibhv9a.xn-p1ai/) under the Federal Targeted Program "R&D in Priority Areas of Russian S&T Development", contract 14.607.21.0063 (project unique identifier RFMEFI60714X0063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arachchige MCM, 2015, J BIOTECHNOL, V202, P88, DOI 10.1016/j.jbiotec.2015.01.009; Barollo S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156044; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Bondarenko DA, 2015, RUSSIAN J BIOPHARM, V7, P40; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Cieslewicz M, 2013, P NATL ACAD SCI USA, V110, P15919, DOI 10.1073/pnas.1312197110; Inoue Kazushi, 2016, Biomark Cancer, V8, P25, DOI 10.4137/BIC.S38394; Irvin WJ, 2008, EUR J CANCER, V44, P2799, DOI 10.1016/j.ejca.2008.09.034; Judes G, 2016, CANCER LETT, V382, P77, DOI 10.1016/j.canlet.2016.03.001; Jung HK, 2016, J CONTROL RELEASE, V235, P259, DOI 10.1016/j.jconrel.2016.06.008; Koval OA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093921; Koval OA, 2012, BIOCHIMIE, V94, P2467, DOI 10.1016/j.biochi.2012.08.017; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Liu WQ, 2016, ONCOL LETT, V11, P3943, DOI 10.3892/ol.2016.4538; Millimouno FM, 2014, CANCER PREV RES, V7, P1081, DOI 10.1158/1940-6207.CAPR-14-0136; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Nekipelaya VV, 2008, DOKL BIOCHEM BIOPHYS, V419, P58, DOI 10.1134/S1607672908020038; Nemudraya AA, 2016, ACTA NATURAE, V8, P48, DOI 10.32607/20758251-2016-8-1-48-57; Palma G, 2015, ONCOTARGET, V6, P26560, DOI 10.18632/oncotarget.5306; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Qifan W, 2016, TUMOUR BIOL J INT SO; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Ruoslahti E, 2012, ADV MATER, V24, P3747, DOI 10.1002/adma.201200454; Semenov DV, 2010, PROTEIN J, V29, P174, DOI 10.1007/s10930-010-9237-5; Sha HZ, 2015, J CONTROL RELEASE, V200, P188, DOI 10.1016/j.jconrel.2014.12.039; Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje; Sugahara KN, 2015, MOL CANCER THER, V14, P120, DOI 10.1158/1535-7163.MCT-14-0366; Sugahara KN, 2010, SCIENCE, V328, P1031, DOI 10.1126/science.1183057; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Swanton C, 2009, BRIT J CANCER, V100, P1517, DOI 10.1038/sj.bjc.6605031; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Wicki A, 2015, J CONTROL RELEASE, V200, P138, DOI 10.1016/j.jconrel.2014.12.030; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Yang WH, 2006, ONCOL REP, V15, P113; Zhang HT, 2011, ANTI-CANCER DRUG, V22, P409, DOI 10.1097/CAD.0b013e328342050d	37	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160980	10.1371/journal.pone.0160980	http://dx.doi.org/10.1371/journal.pone.0160980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513518	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100100
J	Noutahi, E; Semeria, M; Lafond, M; Seguin, J; Boussau, B; Gueguen, L; El-Mabrouk, N; Tannier, E				Noutahi, Emmanuel; Semeria, Magali; Lafond, Manuel; Seguin, Jonathan; Boussau, Bastien; Gueguen, Laurent; El-Mabrouk, Nadia; Tannier, Eric			Efficient Gene Tree Correction Guided by Genome Evolution	PLOS ONE			English	Article							RECONCILIATION; REARRANGEMENT; DUPLICATIONS; ALGORITHM; DATABASES; INFERENCE; MODEL	Motivations Gene trees inferred solely from multiple alignments of homologous sequences often contain weakly supported and uncertain branches. Information for their full resolution may lie in the dependency between gene families and their genomic context. Integrative methods, using species tree information in addition to sequence information, often rely on a computationally intensive tree space search which forecloses an application to large genomic databases. Results We propose a new method, called ProfileNJ, that takes a gene tree with statistical supports on its branches, and corrects its weakly supported parts by using a combination of information from a species tree and a distance matrix. Its low running time enabled us to use it on the whole Ensembl Compara database, for which we propose an alternative, arguably more plausible set of gene trees. This allowed us to perform a genome-wide analysis of duplication and loss patterns on the history of 63 eukaryote species, and predict ancestral gene content and order for all ancestors along the phylogeny. Availability A web interface called RefineTree, including ProfileNJ as well as a other gene tree correction methods, which we also test on the Ensembl gene families, is available at: http://wwwens. iro.umontreal.ca/*adbit/polytomysolver.html. The code of ProfileNJ as well as the set of gene trees corrected by ProfileNJ from Ensembl Compara version 73 families are also made available.	[Noutahi, Emmanuel; Lafond, Manuel; Seguin, Jonathan; El-Mabrouk, Nadia] Univ Montreal, Dept Informat DIRO, Montreal, PQ H3C 3J7, Canada; [Semeria, Magali; Boussau, Bastien; Gueguen, Laurent; Tannier, Eric] Univ Lyon 1, LBBE, UMR CNRS 5558, F-69622 Villeurbanne, France; [Tannier, Eric] INRIA Grenoble Rhone Alpes, F-38334 Montbonnot St Martin, France	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Tannier, E (corresponding author), Univ Lyon 1, LBBE, UMR CNRS 5558, F-69622 Villeurbanne, France.; Tannier, E (corresponding author), INRIA Grenoble Rhone Alpes, F-38334 Montbonnot St Martin, France.	Eric.tannier@inria.fr		Boussau, Bastien/0000-0003-0776-4460	French Agence Nationale de la Recherche (ANR) [ANR-10-BINF-01-01]; Natural Sciences and Engineering Research Council of Canada (NSERC); "Fonds de recherche du Quebec Nature et technologies" (FRQNT) of Quebec	French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Fonds de recherche du Quebec Nature et technologies" (FRQNT) of Quebec	MS, LG, BB and ET were supported by the French Agence Nationale de la Recherche (ANR) Grant ANR-10-BINF-01-01 "Ancestrome". EN, ML, JS and NEM were supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), and the "Fonds de recherche du Quebec Nature et technologies" (FRQNT) of Quebec. Computations were made on the supercomputer "Briaree" from Universite de Montreal, managed by Calcul Quebec and Compute Canada.	Abby SS, 2012, P NATL ACAD SCI USA, V109, P4962, DOI 10.1073/pnas.1116871109; Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; Arvestad L., 2004, P 8 ANN INT C RES CO, P326, DOI DOI 10.1145/974614.974657; Berard S, 2012, BIOINFORMATICS, V28, pI382, DOI 10.1093/bioinformatics/bts374; Berglund-Sonnhammer AC, 2006, J MOL EVOL, V63, P240, DOI 10.1007/s00239-005-0096-1; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Chaudhary R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S11; Chauve C, 2013, COMPUT BIOL SER, V19, P47, DOI 10.1007/978-1-4471-5298-9_4; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cohen O, 2012, BIOINFORMATICS, V28, pI389, DOI 10.1093/bioinformatics/bts396; Datta RS, 2009, NUCLEIC ACIDS RES, V37, pW84, DOI 10.1093/nar/gkp373; Doroftei Andrea, 2011, Algorithms in Bioinformatics. Proceedings of the 11th International Workshop, WABI 2011, P76, DOI 10.1007/978-3-642-23038-7_8; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Gorecki P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S14; Gorecki P, 2011, LECT N BIOINFORMAT, V6674, P148, DOI 10.1007/978-3-642-21260-4_17; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Khan MA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-334; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Konrad A, 2011, GENOME BIOL EVOL, V3, P1197, DOI 10.1093/gbe/evr093; Lafond Manuel, 2012, Algorithms in Bioinformatics. Proceedings of the12th International Workshop, WABI 2012, P106, DOI 10.1007/978-3-642-33122-0_9; Lafond M, 2016, EFFICIENT NONBINARY; Lafond M, 2014, BIOINFORMATICS, V30, pI519, DOI 10.1093/bioinformatics/btu463; Lafond M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S5; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lucas JMEX, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-268; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mahmudi O, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S10; Manuch J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S19-S11; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Patterson M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S15-S4; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Pryszcz LP, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq953; RAMBAUT A, 2006, FIGTREE; Rasmussen MD, 2012, GENOME RES, V22, P755, DOI 10.1101/gr.123901.111; Rasmussen MD, 2011, MOL BIOL EVOL, V28, P273, DOI 10.1093/molbev/msq189; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schreiber F, 2013, NUCL ACIDS RES; Semple C., 2003, PHYLOGENETICS; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Sonnhammer ELL, 2014, BIOINFORMATICS, V30, P2993, DOI 10.1093/bioinformatics/btu492; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swenson KM, 2012, ALGORITHM MOL BIOL, V7, DOI 10.1186/1748-7188-7-31; Szollosi GJ, 2013, SYST BIOL, V62, P901, DOI 10.1093/sysbio/syt054; Nguyen TH, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-12; Thomas PD, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-312; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wu YC, 2013, SYST BIOL, V62, P110, DOI 10.1093/sysbio/sys076; Zheng Y, 2014, LECT N BIOINFORMAT, V8394, P418, DOI 10.1007/978-3-319-05269-4_33	56	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0159559	10.1371/journal.pone.0159559	http://dx.doi.org/10.1371/journal.pone.0159559			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513924	Green Published, gold			2022-12-26	WOS:000381381100015
J	Wu, FY; Fan, YY; Liang, L; Wang, C				Wu, Fengyuan; Fan, Yunyun; Liang, Li; Wang, Chao			Numerical Simulation of Dry Granular Flow Impacting a Rigid Wall Using the Discrete Element Method	PLOS ONE			English	Article							CFD-DEM; AVALANCHES; MOTION; SCALE; INCLINE; MASSES; CHUTE	This paper presents a clump model based on Discrete Element Method. The clump model was more close to the real particle than a spherical particle. Numerical simulations of several tests of dry granular flow impacting a rigid wall flowing in an inclined chute have been achieved. Five clump models with different sphericity have been used in the simulations. By comparing the simulation results with the experimental results of normal force on the rigid wall, a clump model with better sphericity was selected to complete the following numerical simulation analysis and discussion. The calculation results of normal force showed good agreement with the experimental results, which verify the effectiveness of the clump model. Then, total normal force and bending moment of the rigid wall and motion process of the granular flow were further analyzed. Finally, comparison analysis of the numerical simulations using the clump model with different grain composition was obtained. By observing normal force on the rigid wall and distribution of particle size at the front of the rigid wall at the final state, the effect of grain composition on the force of the rigid wall has been revealed. It mainly showed that, with the increase of the particle size, the peak force at the retaining wall also increase. The result can provide a basis for the research of relevant disaster and the design of protective structures.	[Wu, Fengyuan; Fan, Yunyun; Liang, Li; Wang, Chao] Northeastern Univ, Key Lab, Minist Educ Safe Min Deep Met Mines, Shenyang, Peoples R China	Northeastern University - China	Fan, YY (corresponding author), Northeastern Univ, Key Lab, Minist Educ Safe Min Deep Met Mines, Shenyang, Peoples R China.	yunyunfan@126.com			National Natural Science Foundation of China [41201007, 51474048]; Fundamental Research Funds for the Central Universities [N130401003, L1501009]; Opening fund of State Key Laboratory of Geohazard Prevention and Geoenvironment Protection of Chengdu University of Technology [Sklgp2012K010]; Research Fund for General Science Project of Department of Education of Liaoning Province [L2013103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Opening fund of State Key Laboratory of Geohazard Prevention and Geoenvironment Protection of Chengdu University of Technology; Research Fund for General Science Project of Department of Education of Liaoning Province	This study was supported by the National Natural Science Foundation of China (Grant No. 41201007, 51474048), the Fundamental Research Funds for the Central Universities (N130401003, L1501009), the Opening fund of State Key Laboratory of Geohazard Prevention and Geoenvironment Protection of Chengdu University of Technology (Grant No. Sklgp2012K010) and the Research Fund for General Science Project of Department of Education of Liaoning Province (Grant No. L2013103).; The authors would like to acknowledge the National Natural Science Foundation of China (Grant No. 41201007, 51474048), the Fundamental Research Funds for the Central Universities (N130401003, L1501009), the Opening Fund of State Key Laboratory of Geohazard Prevention and Geoenvironment Protection of Chengdu University of Technology (Grant No. Sklgp2012K010) and the Research Fund for General Science Project of Department of Education of Liaoning Province (Grant No. L2013103) for the financial support.	Albaba A, 2015, GRANUL MATTER, V17, P603, DOI 10.1007/s10035-015-0579-8; Ancey C, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.011304; Azanza E, 1999, J FLUID MECH, V400, P199, DOI 10.1017/S0022112099006461; Bi WT, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2405844; CHU T, 1995, CAN GEOTECH J, V32, P285, DOI 10.1139/t95-030; Domnik B, 2013, J NON-NEWTON FLUID, V201, P56, DOI 10.1016/j.jnnfm.2013.07.005; Dufresne A, 2012, EARTH SURF PROC LAND, V37, P1527, DOI 10.1002/esp.3296; Faug T, 2002, NAT HAZARD EARTH SYS, V2, P187, DOI 10.5194/nhess-2-187-2002; Hanes DM, 2000, POWDER TECHNOL, V109, P133, DOI 10.1016/S0032-5910(99)00232-6; HUTTER K, 1991, PHILOS T ROY SOC A, V334, P93, DOI 10.1098/rsta.1991.0004; Itasca Consulting Group. Inc, 2003, PFC3D PARTCL FLOW CO; Iverson RM, 2001, J GEOPHYS RES-SOL EA, V106, P537, DOI 10.1029/2000JB900329; Jajcevic D, 2013, CHEM ENG SCI, V98, P298, DOI 10.1016/j.ces.2013.05.014; Jiang YJ, 2013, ROCK MECH ROCK ENG, V46, P713, DOI 10.1007/s00603-012-0293-3; Keller S, 1998, ANN GLACIOL, V26, P259, DOI 10.3189/1998AoG26-1-259-264; Kishi N, 2002, P STRUCT SHOCK IMP 4, VIV, P351; Lanni C, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 2: LANDSLIDE PROCESSES, P537, DOI 10.1007/978-3-319-09057-3_89; Lee BJ, 2004, CONTINUUM SIMULATION; Lee SJ, 2015, INT J NUMER METH ENG, V104, P79, DOI 10.1002/nme.4923; Li TW, 2012, POWDER TECHNOL, V220, P138, DOI 10.1016/j.powtec.2011.09.020; Maione R, 2015, POWDER TECHNOL, V286, P732, DOI 10.1016/j.powtec.2015.09.011; Manzella I, 2009, ENG GEOL, V109, P146, DOI 10.1016/j.enggeo.2008.11.006; Manzella I., 2013, LANDSLIDE SCI PRACTI, V3, P247; Neuwirth J, 2013, CHEM ENG SCI, V86, P151, DOI 10.1016/j.ces.2012.07.005; Nikolopoulos EI, 2015, GEOMORPHOLOGY, V243, P40, DOI 10.1016/j.geomorph.2015.04.028; Pudasaini S. P, 2007, AVALANCHE DYNAMICS D; Pudasaini SP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2726885; Pudasaini SP, 2013, ENG GEOL, V157, P124, DOI 10.1016/j.enggeo.2013.01.012; Pudasaini SP, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2011JF002186; Pudasaini SP, 2003, J FLUID MECH, V495, P193, DOI 10.1017/S0022112003006141; SAVAGE SB, 1989, J FLUID MECH, V199, P177, DOI 10.1017/S0022112089000340; Shirsath SS, 2014, AICHE J, V60, P3424, DOI 10.1002/aic.14535; Tao H, 2010, CHEM ENG PROCESS, V49, P151, DOI 10.1016/j.cep.2010.01.006; Teufelsbauer H, 2011, ACTA GEOTECH, V6, P119, DOI 10.1007/s11440-011-0140-9; Teufelsbauer H, 2009, GRANUL MATTER, V11, P209, DOI 10.1007/s10035-009-0142-6; Utili S, 2015, ENG GEOL, V186, P3, DOI 10.1016/j.enggeo.2014.08.018; Valentino R, 2008, ROCK MECH ROCK ENG, V41, P153, DOI 10.1007/s00603-006-0126-3; Wachs A, 2009, COMPUT FLUIDS, V38, P1608, DOI 10.1016/j.compfluid.2009.01.005; Walther JH, 2009, ENG COMPUTATION, V26, P688, DOI 10.1108/02644400910975478; Zhou GGD, 2013, POWDER TECHNOL, V239, P115, DOI 10.1016/j.powtec.2013.01.057	40	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160756	10.1371/journal.pone.0160756	http://dx.doi.org/10.1371/journal.pone.0160756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513661	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100066
J	Liao, RK; Yang, PL; Wu, WY; Ren, SM				Liao, Renkuan; Yang, Peiling; Wu, Wenyong; Ren, Shumei			An Inverse Method to Estimate the Root Water Uptake Source-Sink Term in Soil Water Transport Equation under the Effect of Superabsorbent Polymer	PLOS ONE			English	Article							SUPER ABSORBENT POLYMER; RETENTION; MOVEMENT; CHINA; MODEL	The widespread use of superabsorbent polymers (SAPs) in arid regions improves the efficiency of local land and water use. However, SAPs' repeated absorption and release of water has periodic and unstable effects on both soil's physical and chemical properties and on the growth of plant roots, which complicates modeling of water movement in SAP-treated soils. In this paper, we proposea model of soil water movement for SAP-treated soils. The residence time of SAP in the soil and the duration of the experiment were considered as the same parameter t. This simplifies previously proposed models in which the residence time of SAP in the soil and the experiment's duration were considered as two independent parameters. Numerical testing was carried out on the inverse method of estimating the source/sink term of root water uptake in the model of soil water movement under the effect of SAP. The test results show that time interval, hydraulic parameters, test error, and instrument precision had a significant influence on the stability of the inverse method, while time step, layering of soil, and boundary conditions had relatively smaller effects. A comprehensive analysis of the method's stability, calculation, and accuracy suggests that the proposed inverse method applies if the following conditions are satisfied: the time interval is between 5 d and 17 d; the time step is between 1000 and 10000; the test error is >= 0.9; the instrument precision is <= 0.03; and the rate of soil surface evaporation is <= 0.6 mm/d.	[Liao, Renkuan; Wu, Wenyong] China Inst Water Resources & Hydropower Res, State Key Lab Simulat & Regulat Water Cycles Rive, Beijing, Peoples R China; [Yang, Peiling; Ren, Shumei] China Agr Univ, Coll Water Conservancy & Civil Engn, Beijing, Peoples R China	China Institute of Water Resources & Hydropower Research; China Agricultural University	Yang, PL (corresponding author), China Agr Univ, Coll Water Conservancy & Civil Engn, Beijing, Peoples R China.	yangpeiling@163.com	Wenyong, Wu/AAS-8159-2021		National Natural Science Foundation of China [51379210]; National Science and Technology Project [2015BAD20B03]; Beijing Science and Technology Plan [D151100004115002]; Key Team Project of State Key Laboratory of Simulation and Regulation of Water Cycles in River Basins [2016ZY05, ID0112B05201600000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Project; Beijing Science and Technology Plan; Key Team Project of State Key Laboratory of Simulation and Regulation of Water Cycles in River Basins	This work was financially supported by the National Natural Science Foundation of China (51379210), National Science and Technology Project (2015BAD20B03), Beijing Science and Technology Plan (D151100004115002), and Key Team Project of State Key Laboratory of Simulation and Regulation of Water Cycles in River Basins (2016ZY05, ID0112B05201600000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai W, 2010, SOIL USE MANAGE, V26, P253, DOI 10.1111/j.1475-2743.2010.00271.x; Dai CL, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39462; Draye X, 2010, J EXP BOT, V61, P2145, DOI 10.1093/jxb/erq077; GARDNER WR, 1991, IRRIGATION SCI, V12, P109, DOI 10.1007/BF00192281; Guilherme MR, 2015, EUR POLYM J, V72, P365, DOI 10.1016/j.eurpolymj.2015.04.017; Han Y. G., 2007, PRINCIPLE TYPICAL CH; Han YG, 2012, ENVIRONMENTAL EARTH, V69, P289; Han YG, 2010, ENVIRON EARTH SCI, V61, P1197, DOI 10.1007/s12665-009-0443-4; [韩玉国 Han Yuguo], 2013, [干旱地区农业研究, Agricultural Research in the Arid Areas], V31, P161; Javaux M, 2008, VADOSE ZONE J, V7, P1079, DOI 10.2136/vzj2007.0115; Lei Z.D., 1988, SOIL HYDRODYNAMICS; Lekakis EH, 2015, J HYDROL, V530, P431, DOI 10.1016/j.jhydrol.2015.09.070; Li HC, 1997, J HYDRAULIC ENG, V2, P68; Li HJ, 2015, WATER-SUI, V7, P2382, DOI 10.3390/w7052382; Liao R, 2015, T ASABE, V58, P1535; Liao RenKuan, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P1; Mudiyanselage TK, 2008, J POLYM SCI POL CHEM, V46, P1357, DOI 10.1002/pola.22476; Sadeghi M, 2008, J BIOACT COMPAT POL, V23, P381, DOI 10.1177/0883911508093504; Salimi H, 2010, J APPL POLYM SCI, V117, P3228, DOI 10.1002/app.32210; Shao AJ, 1996, HYDROGEOLOGY ENG GEO, V2, P5; Shi JC, 2007, SOIL SCI SOC AM J, V71, P26, DOI 10.2136/sssaj2005.0395; Soliman AM, 2013, CONSTR BUILD MATER, V41, P270, DOI 10.1016/j.conbuildmat.2012.12.008; Thakur VK, 2015, INT J BIOL MACROMOL, V72, P834, DOI 10.1016/j.ijbiomac.2014.09.044; Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P2637, DOI 10.1021/sc500634p; Thakur VK, 2014, J CLEAN PROD, V82, P1, DOI 10.1016/j.jclepro.2014.06.066; Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z; Williamson TN, 2014, SOIL SCI SOC AM J, V78, P1320, DOI 10.2136/sssaj2014.01.0045; Yang LX, 2014, ECOL ENG, V62, P27, DOI 10.1016/j.ecoleng.2013.10.019; Yu J, 2012, SOIL SCI SOC AM J, V76, P1758, DOI 10.2136/sssaj2011.0387; Yuge K, 2014, IRRIGATION SCI, V32, P159, DOI 10.1007/s00271-013-0413-1; Zhu XiangMing, 2010, Acta Pedologica Sinica, V47, P913; Zhu XM, 2010, AGR WATER MANAGE, V97, P291, DOI 10.1016/j.agwat.2009.09.020; Zhuang WenHua, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P265; Zuo Q, 2004, SOIL SCI, V169, P13, DOI 10.1097/01.ss.0000112018.97541.85; Zuo Q, 2002, SOIL SCI, V167, P561, DOI 10.1097/00010694-200209000-00001; Zuo Qiang, 2003, Transactions of the Chinese Society of Agricultural Engineering, V19, P28	36	9	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0159936	10.1371/journal.pone.0159936	http://dx.doi.org/10.1371/journal.pone.0159936			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505000	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200017
J	Fowler, DK; Stewart, S; Seredick, S; Eisen, JS; Stankunas, K; Washbourne, P				Fowler, Daniel K.; Stewart, Scott; Seredick, Steve; Eisen, Judith S.; Stankunas, Kryn; Washbourne, Philip			A MultiSite Gateway Toolkit for Rapid Cloning of Vertebrate Expression Constructs with Diverse Research Applications	PLOS ONE			English	Article							ORFEOME VERSION 1.1; RNA-POLYMERASE-II; LENTIVIRAL VECTORS; GENE-EXPRESSION; TRANSGENIC ZEBRAFISH; FLUORESCENT PROTEINS; MULTIPLE PROTEINS; HIGHLY EFFICIENT; PROMOTER; RESOURCE	Recombination-based cloning is a quick and efficient way to generate expression vectors. Recent advancements have provided powerful recombinant DNA methods for molecular manipulations. Here, we describe a novel collection of three-fragment MultiSite Gateway cloning system-compatible vectors providing expanded molecular tools for vertebrate research. The components of this toolkit encompass a broad range of uses such as fluorescent imaging, dual gene expression, RNA interference, tandem affinity purification, chemically-inducible dimerization and lentiviral production. We demonstrate examples highlighting the utility of this toolkit for producing multi-component vertebrate expression vectors with diverse primary research applications. The vectors presented here are compatible with other Gateway toolkits and collections, facilitating the rapid generation of a broad range of innovative DNA constructs for biological research.	[Fowler, Daniel K.; Stewart, Scott; Stankunas, Kryn] Univ Oregon, Dept Biol, Inst Mol Biol, Eugene, OR 97403 USA; [Fowler, Daniel K.; Seredick, Steve; Eisen, Judith S.; Washbourne, Philip] Univ Oregon, Dept Biol, Inst Neurosci, Eugene, OR 97403 USA; [Fowler, Daniel K.] Washington State Univ, Coll Vet Med, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Seredick, Steve] Zymeworks Inc, Vancouver, BC, Canada	University of Oregon; University of Oregon; Washington State University	Stankunas, K (corresponding author), Univ Oregon, Dept Biol, Inst Mol Biol, Eugene, OR 97403 USA.; Washbourne, P (corresponding author), Univ Oregon, Dept Biol, Inst Neurosci, Eugene, OR 97403 USA.	kryn@uoregon.edu; pwash@uoneuro.uoregon.edu			NIH grant from the National Institute of Neurological Disorders and Stroke [R01 NS065795, R01 NS023915]; NIH grant from the National Heart, Lung and Blood Institute [R01 HL115294]; NIH grant from the National Institue of Child Health and Development [T32 HD007348, P01 HD022486]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115294] Funding Source: NIH RePORTER	NIH grant from the National Institute of Neurological Disorders and Stroke; NIH grant from the National Heart, Lung and Blood Institute; NIH grant from the National Institue of Child Health and Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R01 NS065795 from the National Institute of Neurological Disorders and Stroke to PW, R01 NS023915 from the National Institute of Neurological Disorders and Stroke to JSE, R01 HL115294 from the National Heart, Lung and Blood Institute to KS, T32 HD007348 from the National Institue of Child Health and Development to DKF, and P01 HD022486 from the National Institue of Child Health and Development to PW and JSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092217; Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Barry SC, 2001, HUM GENE THER, V12, P1103, DOI 10.1089/104303401750214311; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Bechtel S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-399; Bernardos RL, 2006, GENE EXPR PATTERNS, V6, P1007, DOI 10.1016/j.modgep.2006.04.006; Boniface EJ, 2009, GENESIS, V47, P484, DOI 10.1002/dvg.20526; Brandner CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-321; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Cai D, 2013, NAT METHODS, V10, P540, DOI [10.1038/NMETH.2450, 10.1038/nmeth.2450]; Campbell LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051270; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; CARRAWAY KL, 1994, J BIOL CHEM, V269, P14303; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Curtin JA, 2008, GENE THER, V15, P384, DOI 10.1038/sj.gt.3303105; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Dehennaut V, 2015, O GLCNACYLATION EPIG, P85; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dolt KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062054; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Fowler DK, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1246; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Geiling B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076279; Gestwicki JE, 2007, COMB CHEM HIGH T SCR, V10, P667, DOI 10.2174/138620707782507296; Giacomotto J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8378; Giuraniuc CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064419; Grant IM, 2015, DEV BIOL, V408, P345, DOI 10.1016/j.ydbio.2015.09.004; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Hager S, 2008, HUM GENE THER, V19, P840, DOI 10.1089/hum.2007.165; Hans S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-5; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Estornell LH, 2009, PLANT BIOTECHNOL J, V7, P298, DOI 10.1111/j.1467-7652.2009.00402.x; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kameda H, 2008, NEUROSCI RES, V61, P79, DOI 10.1016/j.neures.2008.01.014; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kim KJ, 2004, PROTEIN SCI, V13, P1698, DOI 10.1110/ps.04644504; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Liu YP, 2010, RNA, V16, P1328, DOI 10.1261/rna.1887910; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Low K, 2010, GENE THER, V17, P577, DOI 10.1038/gt.2010.14; Love NR, 2011, DEVELOPMENT, V138, P5451, DOI 10.1242/dev.066498; Maier CJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-632; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; MERRIL CR, 1971, NATURE, V233, P398, DOI 10.1038/233398a0; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Molina GA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-62; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Osti D, 2006, J VIROL METHODS, V136, P93, DOI 10.1016/j.jviromet.2006.04.003; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Provost E, 2007, GENESIS, V45, P625, DOI 10.1002/dvg.20338; Putyrski M, 2012, FEBS LETT, V586, P2097, DOI 10.1016/j.febslet.2012.04.061; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Seredick SD, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-35; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Shearin HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077724; Sigl R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097764; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Stankunas K, 2007, CHEMBIOCHEM, V8, P1162, DOI 10.1002/cbic.200700087; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tallafuss A, 2010, EUR J NEUROSCI, V32, P198, DOI 10.1111/j.1460-9568.2010.07340.x; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tsang M, 2004, DEVELOPMENT, V131, P2769, DOI 10.1242/dev.01157; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Villemure JF, 2001, J MOL BIOL, V312, P963, DOI 10.1006/jmbi.2001.5015; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Weissman TA, 2015, GENETICS, V199, P293, DOI 10.1534/genetics.114.172510; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White MD, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00008; Wille T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123646; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Zeiser E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020082; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	110	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0159277	10.1371/journal.pone.0159277	http://dx.doi.org/10.1371/journal.pone.0159277			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500400	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500005
J	Gupta, P; Gayen, M; Smith, JT; Gaidamakova, EK; Matrosova, VY; Grichenko, O; Knollmann-Ritschel, B; Daly, MJ; Kiang, JG; Maheshwari, RK				Gupta, Paridhi; Gayen, Manoshi; Smith, Joan T.; Gaidamakova, Elena K.; Matrosova, Vera Y.; Grichenko, Olga; Knollmann-Ritschel, Barbara; Daly, Michael J.; Kiang, Juliann G.; Maheshwari, Radha K.			MDP: A Deinococcus Mn2+-Decapeptide Complex Protects Mice from Ionizing Radiation	PLOS ONE			English	Article							RADIOPROTECTIVE AGENTS; DAMAGE; AMIFOSTINE; THERAPY; INJURY; RADIOTHERAPY; EXPOSURE; TRENDS; DEATH; CELLS	The radioprotective capacity of a rationally-designed Mn2+-decapeptide complex (MDP), based on Mn antioxidants in the bacterium Deinococcus radiodurans, was investigated in a mouse model of radiation injury. MDP was previously reported to be extraordinarily radioprotective of proteins in the setting of vaccine development. The peptide-component (DEHGTAVMLK) of MDP applied here was selected from a group of synthetic peptides screened in vitro for their ability to protect cultured human cells and purified enzymes from extreme damage caused by ionizing radiation (IR). We show that the peptides accumulated in Jurkat T-cells and protected them from 100 Gy. MDP preserved the activity of T4 DNA ligase exposed to 60,000 Gy. In vivo, MDP was nontoxic and protected B6D2F1/J (female) mice from acute radiation syndrome. All irradiated mice treated with MDP survived exposure to 9.5 Gy (LD70/30) in comparison to the untreated mice, which displayed 63% lethality after 30 days. Our results show that MDP provides early protection of white blood cells, and attenuates IR-induced damage to bone marrow and hematopoietic stem cells via G-CSF and GM-CSF modulation. Moreover, MDP mediated the immunomodulation of several cytokine concentrations in serum including G-CSF, GM-CSF, IL-3 and IL-10 during early recovery. Our results present the necessary prelude for future efforts towards clinical application of MDP as a promising IR countermeasure. Further investigation of MDP as a pre-exposure prophylactic and post-exposure therapeutic in radiotherapy and radiation emergencies is warranted.	[Gupta, Paridhi; Gayen, Manoshi; Gaidamakova, Elena K.; Matrosova, Vera Y.; Grichenko, Olga; Knollmann-Ritschel, Barbara; Daly, Michael J.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Pathol, Bethesda, MD 20814 USA; [Gayen, Manoshi] Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India; [Smith, Joan T.; Kiang, Juliann G.] Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; Birla Institute of Technology & Science Pilani (BITS Pilani); United States Department of Defense	Gupta, P; Daly, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Dept Pathol, Bethesda, MD 20814 USA.	guptaparidhi@gmail.com; michael.daly@usuhs.edu	Gayen, Manoshi/ABE-5937-2021; Matrosova, Vera/AAX-4125-2020	gayen, manoshi/0000-0003-1997-4211	Defense Threat Reduction Agency (DTRA) [HT9404-12-1-0020]; Armed Forces Radiobiology Research Institute (AFRRI) [RAB32164]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Armed Forces Radiobiology Research Institute (AFRRI)	This study was supported by the funds received from Defense Threat Reduction Agency (DTRA) grant # HT9404-12-1-0020 to RKM, and Armed Forces Radiobiology Research Institute (AFRRI) intramural grant # RAB32164 to JGK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlett BS, 2014, REDOX REP, V19, P80, DOI 10.1179/1351000213Y.0000000078; Blumenthal DJ, 2014, HEALTH PHYS, V106, P516, DOI 10.1097/HP.0b013e3182a5f94f; Blumenthal DJ, 2014, PREHOSP DISASTER MED, V29, P80, DOI 10.1017/S1049023X1400003X; Braverman ER, 2014, INT J ENV RES PUB HE, V11, P4158, DOI 10.3390/ijerph110404158; Chen CH, 2015, HEALTH PHYS, V109, P242, DOI 10.1097/HP.0000000000000326; Christensen DM, 2014, EMERG MED CLIN N AM, V32, P245, DOI 10.1016/j.emc.2013.10.002; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Dadla A, 2015, J ONCOL PHARM PRACT, V21, P474, DOI 10.1177/1078155214542493; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Dorr H, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-126; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; EICHNER ER, 1979, AM J MED, V66, P311, DOI 10.1016/0002-9343(79)90554-0; Felice PA, 2014, PLAST RECONSTR SURG, V134, p551E, DOI 10.1097/PRS.0000000000000543; Gaidamakova EK, 2012, CELL HOST MICROBE, V12, P117, DOI 10.1016/j.chom.2012.05.011; Gu JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095968; Gudkov S. V., 2015, Biofizika, V60, P801; Heylmann D, 2014, BBA-REV CANCER, V1846, P121, DOI 10.1016/j.bbcan.2014.04.009; Huang EY, 2014, ONCOTARGET, V5, P9756, DOI 10.18632/oncotarget.2386; Jacob A, 2010, MOL MED, V16, P137, DOI 10.2119/molmed.2009.00154; Johnke RM, 2014, FUTURE ONCOL, V10, P2345, DOI 10.2217/fon.14.175; Kamran MZ, 2016, MED RES REV, V36, P461, DOI 10.1002/med.21386; Kang HC, 2014, RADIAT ONCOL J, V32, P156, DOI 10.3857/roj.2014.32.3.156; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/215858; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/481392; Kim JH, 2014, RADIAT ONCOL J, V32, P103, DOI 10.3857/roj.2014.32.3.103; Koerner JF, 2014, HEALTH PHYS, V106, P645, DOI 10.1097/HP.0000000000000053; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Liu M, 2016, CHEM REC, V16, P1772, DOI 10.1002/tcr.201600005; Lu XY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-36; Lucas J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107897; Mohle R, 2007, SEMIN HEMATOL, V44, P193, DOI 10.1053/j.seminhematol.2007.04.006; Pham MH, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.09.007; Prasanna PGS, 2015, RADIAT RES, V184, P235, DOI 10.1667/RR14186.1; Reeves G, 2014, HEALTH PHYS, V106, P699, DOI 10.1097/HP.0000000000000090; Reich-Slotky R, 2016, TRANSFUSION, V56, P893, DOI 10.1111/trf.13435; Scott BR, 2014, DOSE-RESPONSE, V12, P415, DOI 10.2203/dose-response.13-041.Scott; Seidensticker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112731; Sengupta S, 2015, INDIAN J DERMATOL, V60, P307, DOI 10.4103/0019-5154.156397; Sharp TE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00299; Singh VK, 2015, HEALTH PHYS, V108, P607, DOI 10.1097/HP.0000000000000279; Singh VK, 2014, RADIAT PROT DOSIM, V162, P83, DOI 10.1093/rpd/ncu223; Singh VK, 2015, CYTOKINE, V71, P22, DOI 10.1016/j.cyto.2014.08.003; Singh VK, 2014, EXPERT OPIN THER PAT, V24, P1229, DOI 10.1517/13543776.2014.964684; Sioshansi S, 2014, PRACT RADIAT ONCOL, V4, pE227, DOI 10.1016/j.prro.2014.01.001; Tsujiguchi T, 2016, J RADIAT RES, V57, P35, DOI 10.1093/jrr/rrv071; Vasin MV, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-414; Wilke C, 2016, RADIOTHER ONCOL, V118, P65, DOI 10.1016/j.radonc.2015.11.012	50	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160575	10.1371/journal.pone.0160575	http://dx.doi.org/10.1371/journal.pone.0160575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500529	gold, Green Published, Green Submitted			2022-12-26	WOS:000381373500032
J	Goetzl, EJ; Mustapic, M; Kapogiannis, D; Eitan, E; Lobach, IV; Goetzl, L; Schwartz, JB; Miller, BL				Goetzl, Edward J.; Mustapic, Maja; Kapogiannis, Dimitrios; Eitan, Erez; Lobach, Irina V.; Goetzl, Laura; Schwartz, Janice B.; Miller, Bruce L.			Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease	FASEB JOURNAL			English	Article						dementia; amyloid; tau; biomarkers	BETA-SECRETASE; TRANSCRIPTIONAL REGULATION; EXTRACELLULAR VESICLES; OXIDATIVE STRESS; CLINICAL-TRIALS; NERVOUS-SYSTEM; BLOOD EXOSOMES; ADAS-COG; A-BETA; NEURONS	Efficient intercellular transfer of RNAs, proteins, and lipids as protected exosomal cargo has been demonstrated in the CNS, but distinct physiologic and pathologic roles have not been well defined for this pathway. The capacity to isolate immunochemically human plasma neuron-derived exosomes (NDEs), containing neuron-specific cargo, has permitted characterization of CNS-derived exosomes in living humans. Constituents of the amyloid -peptide (A)42-generating system now are examined in 2 distinct sets of human neural cells by quantification in astrocyte-derived exosomes (ADEs) and NDEs, enriched separately from plasmas of patients with Alzheimer's disease (AD) or frontotemporal dementia (FTD) and matched cognitively normal controls. ADE levels of -site amyloid precursor protein-cleaving enzyme 1 (BACE-1), -secretase, soluble A42, soluble amyloid precursor protein (sAPP), sAPP, glial-derived neurotrophic factor (GDNF), P-T181-tau, and P-S396-tau were significantly (3- to 20-fold) higher than levels in NDEs for patients and controls. BACE-1 levels also were a mean of 7-fold higher in ADEs than in NDEs from cultured rat type-specific neural cells. Levels of BACE-1 and sAPP were significantly higher and of GDNF significantly lower in ADEs of patients with AD than in those of controls, but not significantly different in patients with FTD than in controls. Abundant proteins of the A42 peptide-generating system in ADEs may sustain levels in neurons. ADE cargo proteins may be useful for studies of mechanisms of cellular interactions and effects of BACE-1 inhibitors in AD.Goetzl, E. J., Mustapic, M., Kapogiannis, D., Eitan, E., Lobach, I. V., Goetzl, L., Schwartz, J. B., Miller, B. L. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lobach, Irina V.] Univ Calif San Francisco, Clin Translat Sci Inst, San Francisco, CA 94143 USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, Geriatr Res Ctr, San Francisco, CA USA; [Mustapic, Maja; Kapogiannis, Dimitrios; Eitan, Erez] NIA, Lab Neurosci, NIH, Baltimore, MD 21224 USA; [Goetzl, Laura] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Goetzl, EJ (corresponding author), Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Mustapic, Maja/AAV-3212-2020; Kapogiannis, Dimitrios/AAW-4934-2020; Schwartz, Janice/K-6354-2019	Kapogiannis, Dimitrios/0000-0003-2181-3118; Goetzl, Laura/0000-0003-4130-2809; Mustapic, Maja/0000-0003-0511-2047	Biomarkers Across Neurodegenerative Diseases 2 program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association; Alzheimer's Research UK; Weston Brain Institute; U.S. National Institues of Health (NIH) National Institute on Aging (NIA) Intramural Program; NIH/NIA [P30 AG028383]; NATIONAL INSTITUTE ON AGING [ZIAAG000975, P30AG028383] Funding Source: NIH RePORTER	Biomarkers Across Neurodegenerative Diseases 2 program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association(Alzheimer's Association); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Weston Brain Institute; U.S. National Institues of Health (NIH) National Institute on Aging (NIA) Intramural Program; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 program of the Michael J. Fox Foundation for Parkinson's Research, the Alzheimer's Association, Alzheimer's Research UK and the Weston Brain Institute, the U.S. National Institues of Health (NIH) National Institute on Aging (NIA) Intramural Program (to M.M., D.K. and E.E.), and NIH/NIA grant P30 AG028383 (to E.L.A.). The authors thank Judith H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. E.J.G. has filed a provisional patent application with the U.S. Patent Office for the methodology of immunochemical isolation and analytical applications of astrocyte-derived exosomes. The remaining authors declare no competing financial interests.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Alzheimer's Disease Neuroimaging Initiative, 2009, ANN NEUROL, V65, P403; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hartlage-Rubsamen M, 2003, GLIA, V41, P169, DOI 10.1002/glia.10178; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Irizarry MC, 2008, J ALZHEIMERS DIS, V14, P301; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kurkinen KMA, 2016, J CELL SCI, V129, P2224, DOI 10.1242/jcs.185215; Liao MC, 2016, J NEUROSCI, V36, P1730, DOI 10.1523/JNEUROSCI.2735-15.2016; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mei ZR, 2015, NEUROCHEM RES, V40, P829, DOI 10.1007/s11064-015-1533-1; Multhaup G, 2015, J BIOL CHEM, V290, P23515, DOI 10.1074/jbc.R115.677211; Natunen T, 2016, NEUROBIOL DIS, V85, P187, DOI 10.1016/j.nbd.2015.11.005; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rajendran L, 2014, J NEUROSCI, V34, P15482, DOI 10.1523/JNEUROSCI.3258-14.2014; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ruth L, 2000, ACTA CRYSTALLOGR D, V56, P524, DOI 10.1107/S090744490000007X; Santello M, 2009, NEUROSCIENCE, V158, P253, DOI 10.1016/j.neuroscience.2008.03.039; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; TIEU PT, 1995, HUM MUTAT, V6, P55, DOI 10.1002/humu.1380060111; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	39	189	190	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3853	3859		10.1096/fj.201600756R	http://dx.doi.org/10.1096/fj.201600756R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27511944	Green Published			2022-12-26	WOS:000386474700019
J	Higuchi, T; Todaka, H; Sugiyama, Y; Ono, M; Tamaki, N; Hatano, E; Takezaki, Y; Hanazaki, K; Miwa, T; Lai, S; Morisawa, K; Tsuda, M; Taniguchi, T; Sakamoto, S				Higuchi, Takuma; Todaka, Hiroshi; Sugiyama, Yasunori; Ono, Masafumi; Tamaki, Nobuyuki; Hatano, Etsuro; Takezaki, Yuka; Hanazaki, Kazuhiro; Miwa, Takeshi; Lai, Sylvia; Morisawa, Keiko; Tsuda, Masayuki; Taniguchi, Taketoshi; Sakamoto, Shuji			Suppression of MicroRNA-7 (miR-7) Biogenesis by Nuclear Factor 90-Nuclear Factor 45 Complex (NF90-NF45) Controls Cell Proliferation in Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; LUNG-CANCER; NEGATIVE REGULATOR; GENE-EXPRESSION; PROTEIN; RNA; MECHANISM; GLIOBLASTOMA; METASTASIS; INHIBITOR	MicroRNA-7 (miR-7) has been characterized as an anti-oncogenic microRNA (miRNA) in several cancers, including hepatocellular carcinoma (HCC). However, the mechanism for the regulation of miR-7 production in tumors remains unclear. Here, we identified nuclear factor 90 (NF90) and NF45 complex (NF90-NF45) as negative regulators of miR-7 processing in HCC. Expression of NF90 and NF45 was significantly elevated in primary HCC tissues compared with adjacent non-tumor tissues. To examine which miRNAs are controlled by NF90-NF45, we performed an miRNA microarray and quantitative RT-PCR analyses of HCC cell lines. Depletion of NF90 resulted in elevated levels of mature miR-7, whereas the expression of primary miR-7-1 (pri-miR-7-1) was decreased in cells following knockdown of NF90. Conversely, the levels of mature miR-7 were reduced in cells overexpressing NF90 and NF45, although primiR- 7-1 was accumulated in the same cells. Furthermore, NF90-NF45 was found to bind pri-miR-7-1 in vitro. These results suggest that NF90-NF45 inhibits the pri-miR-7-1 processing step through the binding of NF90-NF45 to pri-miR-7-1. We also found that levels of the EGF receptor, an oncogenic factor that is a direct target of miR-7, and phosphorylation of AKT were significantly decreased in HCC cell lines depleted of NF90 or NF45. Of note, knockdown of NF90 or NF45 caused a reduction in the proliferation rate ofHCCcells. Taken together, NF90-NF45 stimulates an elevation of EGF receptor levels via the suppression of miR-7 biogenesis, resulting in the promotion of cell proliferation in HCC.	[Higuchi, Takuma; Todaka, Hiroshi; Sugiyama, Yasunori; Miwa, Takeshi; Lai, Sylvia; Morisawa, Keiko; Taniguchi, Taketoshi; Sakamoto, Shuji] Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Kochi 7838505, Japan; [Ono, Masafumi] Kochi Med Sch, Ctr Sci Res, Dept Gastroenterol & Hepatol, Kochi 7838505, Japan; [Takezaki, Yuka; Hanazaki, Kazuhiro] Kochi Med Sch, Ctr Sci Res, Dept Surg, Kochi 7838505, Japan; [Tsuda, Masayuki] Kochi Med Sch, Ctr Sci Res, Div Lab Anim Sci, Kochi 7838505, Japan; [Tamaki, Nobuyuki; Hatano, Etsuro] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan	Kochi University; Kochi University; Kochi University; Kochi University; Kyoto University	Sakamoto, S (corresponding author), Kochi Univ, Kochi Med Sch, Ctr Sci Res, Mol Biol Lab, Oko Cho, Nankoku, Kochi 7838505, Japan.	sshuji@kochi-u.ac.jp	Hatano, Etsuro/AAX-2407-2020	Hatano, Etsuro/0000-0003-3407-1918	Japan Society for the Promotion of Science [12J10660, 25460371, 16K08590]; Grants-in-Aid for Scientific Research [16K08590, 26750372] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science Grant-in-aid for JSPS Fellows 12J10660 and Grants-in-aid for Scientific Research (C) 25460371 and 16K08590. The authors declare that they have no conflicts of interest with the contents of this article.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Jiang W, 2015, ONCOGENE, V34, P4460, DOI 10.1038/onc.2014.373; Kalinowski FC, 2014, INT J BIOCHEM CELL B, V54, P312, DOI 10.1016/j.biocel.2014.05.040; Kalinowski FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047067; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Normanno N, 2003, J CELL PHYSIOL, V194, P13, DOI 10.1002/jcp.10194; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Papp G, 2014, GENE CHROMOSOME CANC, V53, P168, DOI 10.1002/gcc.22128; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sakamoto S, 2001, J BIOL CHEM, V276, P37237, DOI 10.1074/jbc.M105543200; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shin S, 2012, BIOCHIMIE, V94, P1431, DOI 10.1016/j.biochi.2012.03.023; Song DM, 2002, BIOCHEMISTRY-US, V41, P929, DOI 10.1021/bi015669c; Srikantan S, 2012, CURR PROTEIN PEPT SC, V13, P372, DOI 10.2174/138920312801619394; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Todaka H, 2015, MOL CELL BIOL, V35, P2295, DOI 10.1128/MCB.01297-14; Tominaga-Yamanaka K, 2012, AGING-US, V4, P695, DOI 10.18632/aging.100497; Wang YL, 2013, MOL CELL BIOL, V33, P1233, DOI 10.1128/MCB.01604-12; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wu DG, 2011, CHINESE MED J-PEKING, V124, P2616, DOI 10.3760/cma.j.issn.0366-6999.2011.17.010; Wu L, 2012, J HUAZHONG U SCI-MED, V32, P601, DOI 10.1007/s11596-012-1004-8; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	51	53	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 30	2016	291	40					21074	21084		10.1074/jbc.M116.748210	http://dx.doi.org/10.1074/jbc.M116.748210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY8UG	27519414	Green Published, hybrid			2022-12-26	WOS:000385406200023
J	Petrvalska, O; Kosek, D; Kukacka, Z; Tosner, Z; Man, P; Vecer, J; Herman, P; Obsilova, V; Obsil, T				Petrvalska, Olivia; Kosek, Dalibor; Kukacka, Zdenek; Tosner, Zdenek; Man, Petr; Vecer, Jaroslav; Herman, Petr; Obsilova, Veronika; Obsil, Tomas			Structural Insight into the 14-3-3 Protein-dependent Inhibition of Protein Kinase ASK1 (Apoptosis Signal-regulating kinase 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; apoptosis signal-regulating kinase 1 (ASK1); fluorescence; nuclear magnetic resonance (NMR); protein cross-linking; small-angle x-ray scattering (SAXS)	SMALL-ANGLE SCATTERING; NEUTRAL TREHALASE NTH1; X-RAY-SCATTERING; CRYSTAL-STRUCTURE; FAMILY PROTEINS; LIGAND-BINDING; CELL-DEATH; ACTIVATION; COMPLEX; PHOSPHORYLATION	Apoptosis signal-regulating kinase 1 (ASK1, also known as MAP3K5), a member of the mitogen-activated protein kinase kinase kinase (MAP3K) family, regulates diverse physiological processes. The activity of ASK1 is triggered by various stress stimuli and is involved in the pathogenesis of cancer, neurodegeneration, inflammation, and diabetes. ASK1 forms a high molecular mass complex whose activity is, under non-stress conditions, suppressed through interaction with thioredoxin and the scaffolding protein 14-3-3. The 14-3-3 protein binds to the phosphorylated Ser-966 motif downstream of the ASK1 kinase domain. The role of 14-3-3 in the inhibition of ASK1 has yet to be elucidated. In this study we performed structural analysis of the complex between the ASK1 kinase domain phosphorylated at Ser-966 (pASK1-CD) and the 14-3-3 protein. Small angle x-ray scattering (SAXS) measurements and chemical cross-linking revealed that the pASK1-CD14-3-3 complex is dynamic and conformationally heterogeneous. In addition, structural analysis coupled with the results of phosphorus NMR and time-resolved tryptophan fluorescence measurements suggest that 14-3-3 interacts with the kinase domain of ASK1 in close proximity to its active site, thus indicating this interaction might block its accessibility and/or affect its conformation.	[Petrvalska, Olivia; Kosek, Dalibor; Tosner, Zdenek; Obsil, Tomas] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Man, Petr] Charles Univ Prague, Dept Biochem, Fac Sci, Prague 12843, Czech Republic; [Petrvalska, Olivia; Kosek, Dalibor; Obsilova, Veronika; Obsil, Tomas] Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic; [Kukacka, Zdenek; Man, Petr] Acad Sci Czech Republic, Inst Microbiol, Prague 14220, Czech Republic; [Vecer, Jaroslav; Herman, Petr] Charles Univ Prague, Inst Phys, Fac Math & Phys, Prague 12116, Czech Republic	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Obsil, T (corresponding author), Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 12843, Czech Republic.; Obsilova, V; Obsil, T (corresponding author), Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic.	veronika.obsilova@fgu.cas.cz; obsil@natur.cuni.cz	Man, Petr/H-2451-2014; Kukacka, Zdenek/J-8816-2014; Obsil, Tomas/B-7142-2012; Košek, Dalibor/AAD-4715-2021; Tosner, Zdenek/G-6736-2014; Petrvalska, Olivia/O-6572-2017; Herman, Petr/A-2626-2008; Obsilova, Veronika/B-7116-2012	Man, Petr/0000-0002-1485-2197; Kukacka, Zdenek/0000-0001-7569-843X; Obsil, Tomas/0000-0003-4602-1272; Tosner, Zdenek/0000-0003-2741-9154; Petrvalska, Olivia/0000-0002-9855-1913; Herman, Petr/0000-0001-6918-2576; Obsilova, Veronika/0000-0003-4887-0323	EU [CZ.1.05/1.1.00/02.0109]	EU(European Commission)	We thank Petr Novak for assistance with MS, Martin Dracinsky for assistance with NMR, and Daniel Steiner for critical reading of the manuscript. Access to the MS facility was enabled by the EU project CZ.1.05/1.1.00/02.0109 and by the Czech Infrastructure for Integrative Structural Biology (LM2015043).	BOCK JL, 1975, BIOCHEM BIOPH RES CO, V66, P24, DOI 10.1016/S0006-291X(75)80289-0; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Carter L, 2015, BIOPHYS J, V109, P793, DOI 10.1016/j.bpj.2015.06.065; Cockrell LM, 2010, ONCOGENE, V29, P822, DOI 10.1038/onc.2009.382; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Durand D, 2006, BIOCHEMISTRY-US, V45, P7185, DOI 10.1021/bi060274k; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Fujino G, 2007, MOL CELL BIOL, V27, P8152, DOI 10.1128/MCB.00227-07; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Goldman EH, 2004, J BIOL CHEM, V279, P10442, DOI 10.1074/jbc.M311129200; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hari SB, 2013, CHEM BIOL, V20, P806, DOI 10.1016/j.chembiol.2013.05.005; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson ML, 2008, METHOD CELL BIOL, V84, P781, DOI 10.1016/S0091-679X(07)84024-6; Kacirova M, 2015, J BIOL CHEM, V290, P16246, DOI 10.1074/jbc.M115.636563; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Klein DC, 2003, J NEUROENDOCRINOL, V15, P370, DOI 10.1046/j.1365-2826.2003.01000.x; Kleppe R, 2014, MOL CELL PROTEOMICS, V13, P2017, DOI 10.1074/mcp.M113.035709; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kopecka M, 2014, J BIOL CHEM, V289, P13948, DOI 10.1074/jbc.M113.544551; Kosek D, 2014, J BIOL CHEM, V289, P24463, DOI 10.1074/jbc.M114.583807; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LAKOWICZ JR, 1999, PRINCIPLES FLUORESCE, P129; Macakova E, 2013, BBA-GEN SUBJECTS, V1830, P4491, DOI 10.1016/j.bbagen.2013.05.025; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Raveh B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000295; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Shiizaki Shigeru, 2013, Advances in Biological Regulation, V53, P135, DOI 10.1016/j.jbior.2012.09.006; Silhan J, 2004, J BIOL CHEM, V279, P49113, DOI 10.1074/jbc.M408671200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vecer J, 2011, J FLUORESC, V21, P873, DOI 10.1007/s10895-009-0589-1; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; White A, 2007, P NATL ACAD SCI USA, V104, P6353, DOI 10.1073/pnas.0701679104; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	50	33	38	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20753	20765		10.1074/jbc.M116.724310	http://dx.doi.org/10.1074/jbc.M116.724310			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514745	Green Published, hybrid			2022-12-26	WOS:000384574800036
J	Leung, JM; Chen, V; Hollander, Z; Dai, D; Tebbutt, SJ; Aaron, SD; Vandemheen, KL; Rennard, SI; FitzGerald, JM; Woodruff, PG; Lazarus, SC; Connett, JE; Coxson, HO; Miller, B; Borchers, C; McManus, BM; Ng, RT; Sin, DD				Leung, Janice M.; Chen, Virginia; Hollander, Zsuzsanna; Dai, Darlene; Tebbutt, Scott J.; Aaron, Shawn D.; Vandemheen, Kathy L.; Rennard, Stephen I.; FitzGerald, J. Mark; Woodruff, Prescott G.; Lazarus, Stephen C.; Connett, John E.; Coxson, Harvey O.; Miller, Bruce; Borchers, Christoph; McManus, Bruce M.; Ng, Raymond T.; Sin, Don D.			COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; APOLIPOPROTEIN-A-IV; MYOCARDIAL-INFARCTION; PLASMA; DIAGNOSIS; RISK; HOSPITALIZATION; VERIFICATION; PROTEOMICS; TRIAL	Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) result in considerable morbidity and mortality. However, there are no objective biomarkers to diagnose AECOPD. Methods We used multiple reaction monitoring mass spectrometry to quantify 129 distinct proteins in plasma samples from patients with COPD. This analytical approach was first performed in a biomarker cohort of patients hospitalized with AECOPD (Cohort A, n = 72). Proteins differentially expressed between AECOPD and convalescent states were chosen using a false discovery rate <0.01 and fold change >1.2. Protein selection and classifier building were performed using an elastic net logistic regression model. The performance of the biomarker panel was then tested in two independent AECOPD cohorts (Cohort B, n = 37, and Cohort C, n = 109) using leave-pair-out cross-validation methods. Results Five proteins were identified distinguishing AECOPD and convalescent states in Cohort A. Biomarker scores derived from this model were significantly higher during AECOPD than in the convalescent state in the discovery cohort (p<0.001). The receiver operating characteristic cross-validation area under the curve (CV-AUC) statistic was 0.73 in Cohort A, while in the replication cohorts the CV-AUC was 0.77 for Cohort B and 0.79 for Cohort C. Conclusions A panel of five biomarkers shows promise in distinguishing AECOPD from convalescence and may provide the basis for a clinical blood test to diagnose AECOPD. Further validation in larger cohorts is necessary for future clinical translation.	[Leung, Janice M.; Tebbutt, Scott J.; Coxson, Harvey O.; McManus, Bruce M.; Sin, Don D.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Leung, Janice M.; Tebbutt, Scott J.; Sin, Don D.] St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada; [Chen, Virginia; Hollander, Zsuzsanna; Dai, Darlene; Tebbutt, Scott J.; McManus, Bruce M.; Ng, Raymond T.] St Pauls Hosp, PROOF Ctr Excellence, Vancouver, BC, Canada; [Aaron, Shawn D.; Vandemheen, Kathy L.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Div Pulm Crit Care Sleep & Allergy, Omaha, NE USA; [Rennard, Stephen I.] AstraZeneca, Cambridge, England; [FitzGerald, J. Mark] Vancouver Gen Hosp, Dept Med, Div Resp Med, Vancouver, BC, Canada; [FitzGerald, J. Mark] Inst Heart & Lung Hlth, Vancouver, BC, Canada; [Woodruff, Prescott G.; Lazarus, Stephen C.] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, Dept Med, San Francisco, CA 94143 USA; [Woodruff, Prescott G.; Lazarus, Stephen C.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Connett, John E.] Univ Minnesota, Minneapolis, MN USA; [Miller, Bruce] GlaxoSmithKline Res & Dev Ltd, King Of Prussia, PA USA; [Borchers, Christoph] Univ Victoria, Genome British Columbia Prote Ctr, Dept Biochem & Microbiol, Victoria, BC, Canada	St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; University of Ottawa; Ottawa Hospital Research Institute; University of Nebraska System; University of Nebraska Medical Center; University of British Columbia; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; GlaxoSmithKline; University of Victoria	Sin, DD (corresponding author), St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada.; Sin, DD (corresponding author), St Pauls Hosp, Div Resp Med, Dept Med, Vancouver, BC, Canada.	Don.Sin@hli.ubc.ca	Coxson, Harvey O/A-9861-2017; Sin, Don/AAC-2219-2021; BORCHERS, Christoph/U-5964-2019	Coxson, Harvey O/0000-0001-5750-9711; Tebbutt, Scott/0000-0002-7908-1581; Aaron, Shawn/0000-0002-4762-3542	Genome Canada; Genome British Columbia; Genome Quebec; Canadian Institutes of Health Research; PROOF Centre of Excellence; St. Paul's Hospital Foundation; Canadian Respiratory Research Network; National Heart, Lung, and Blood Institute's COPD Clinical Research Network [U10 HL074441, U10 HL074418, U10 HL074428, U10 HL074409, U10 HL074407, U10 HL074422, U10 HL074416, U10 HL074408, U10 HL074439, U10 HL0744231, U10 HL074424]; GlaxoSmithKline	Genome Canada(Genome Canada); Genome British Columbia; Genome Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PROOF Centre of Excellence; St. Paul's Hospital Foundation; Canadian Respiratory Research Network; National Heart, Lung, and Blood Institute's COPD Clinical Research Network; GlaxoSmithKline(GlaxoSmithKline)	Funding was provided by Genome Canada, Genome British Columbia, Genome Quebec, the Canadian Institutes of Health Research, PROOF Centre of Excellence, St. Paul's Hospital Foundation, the Canadian Respiratory Research Network, and the National Heart, Lung, and Blood Institute's COPD Clinical Research Network (Grants U10 HL074441, U10 HL074418, U10 HL074428, U10 HL074409, U10 HL074407, U10 HL074422, U10 HL074416, U10 HL074408, U10 HL074439, U10 HL0744231, and U10 HL074424). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. GlaxoSmithKline provided support in the form of salaries for author BM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aaron SD, 2013, THORAX, V68, P142, DOI 10.1136/thoraxjnl-2012-202432; Ademowo OS, 2016, ANN RHEUM DIS, V75, P234, DOI 10.1136/annrheumdis-2014-205417; Airola A, 2011, COMPUT STAT DATA AN, V55, P1828, DOI 10.1016/j.csda.2010.11.018; Alberio T, 2014, J PROTEOME RES, V13, P3554, DOI 10.1021/pr401142p; [Anonymous], 2012, NATURE METHODS, V10, P1; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen CD, 2014, J PROTEOME RES, V13, P2818, DOI 10.1021/pr4012377; Cohen RD, 1997, J CLIN INVEST, V99, P1906, DOI 10.1172/JCI119358; De Serres G, 2009, J CLIN VIROL, V46, P129, DOI 10.1016/j.jcv.2009.07.010; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; DVORIN E, 1986, J BIOL CHEM, V261, P5714; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hernandez B, 2014, PROTEOMICS, V14, P1587, DOI 10.1002/pmic.201300377; Hurst JR, 2006, AM J RESP CRIT CARE, V174, P867, DOI 10.1164/rccm.200604-506OC; Issaq HJ, 2008, EXPERT REV PROTEOMIC, V5, P761, DOI 10.1586/14789450.5.6.761; Leidy Nancy K, 2014, Ann Am Thorac Soc, V11, P316, DOI 10.1513/AnnalsATS.201309-305OC; Leidy NK, 2011, AM J RESP CRIT CARE, V183, P323, DOI 10.1164/rccm.201005-0762OC; McAllister DA, 2012, EUR RESPIR J, V39, P1097, DOI 10.1183/09031936.00124811; Meng DQ, 2014, RESP CARE, V59, P1542, DOI 10.4187/respcare.03046; Meng ZJ, 2011, J PROTEOMICS, V74, P2650, DOI 10.1016/j.jprot.2011.04.011; Nikolakopoulou S, 2014, COPD, V11, P46, DOI 10.3109/15412555.2013.829436; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Percy AJ, 2013, J PROTEOMICS, V95, P66, DOI 10.1016/j.jprot.2013.07.026; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Quon BS, 2016, THORAX, V71, P216, DOI 10.1136/thoraxjnl-2014-206710; Recalde D, 2004, ARTERIOSCL THROM VAS, V24, P756, DOI 10.1161/01.ATV.0000119353.03690.22; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Sin DD, 2015, AM J RESP CRIT CARE, DOI [10. 1164/marn.201505-0871PP, DOI 10.1164/MARN.201505-0871PP]; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soyseth V, 2013, HEART, V99, P122, DOI 10.1136/heartjnl-2012-302685; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; UTERMANN G, 1979, EUR J BIOCHEM, V99, P333, DOI 10.1111/j.1432-1033.1979.tb13261.x; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Woodruff PG, 2011, COPD, V8, P21, DOI 10.3109/15412555.2010.540273; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	12	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161129	10.1371/journal.pone.0161129	http://dx.doi.org/10.1371/journal.pone.0161129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525416	gold, Green Submitted, Green Published			2022-12-26	WOS:000381471100035
J	Munyaneza, JE; Mustafa, T; Fisher, TW; Sengoda, VG; Horton, DR				Munyaneza, Joseph E.; Mustafa, Tariq; Fisher, Tonja W.; Sengoda, Venkatesan G.; Horton, David R.			Assessing the Likelihood of Transmission of Candidatus Liberibacter solanacearum to Carrot by Potato Psyllid, Bactericera cockerelli (Hemiptera: Triozidae)	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; 1ST REPORT; ASSOCIATION; TOMATO; INOCULATION; PLANTS; ACQUISITION; HAPLOTYPES; HOMOPTERA; SYMPTOMS	Candidatus Liberibacter solanacearum' (Lso) is a phloem-limited bacterium that severely affects important Solanaceae and Apiaceae crops, including potato, tomato, pepper, tobacco, carrot and celery. This bacterium is transmitted to solanaceous species by potato psyllid, Bactericera cockerelli, and to Apiaceae by carrot psyllids, including Trioza apicalis and Bactericera trigonica. Five haplotypes of Lso have so far been described, two are associated with solanaceous species and potato psyllids, whereas the other three are associated with carrot and celery crops and carrot psyllids. Little is known about cross-transmission of Lso to carrot by potato psyllids or to potato by carrot psyllids. Thus, the present study assessed whether potato psyllid can transmit Lso to carrot and whether Lso haplotypes infecting solanaceous species can also infect carrot and lead to disease symptom development. In addition, the stylet probing behavior of potato psyllid on carrot was assessed using electropenetrography (EPG) technology to further elucidate potential Lso transmission to Apiaceae by this potato insect pest. Results showed that, while potato psyllids survived on carrot for several weeks when confined on the plants under controlled laboratory and field conditions, the insects generally failed to infect carrot plants with Lso. Only three of the 200 carrot plants assayed became infected with Lso and developed characteristic disease symptoms. Lso infection in the symptomatic carrot plants was confirmed by polymerase chain reaction assay and Lso in the carrots was determined to be of the haplotype B, which is associated with solanaceous species. EPG results further revealed that potato psyllids readily feed on carrot xylem but rarely probe into the phloem tissue, explaining why little to no Lso infection occurred during the controlled laboratory and field cage transmission trials. Results of our laboratory and field transmission studies, combined with our EPG results, suggest that the risk of Lso infection and spread between psyllid-infested solanaceous and Apiaceae crops is likely to be negligible under normal field conditions.	[Munyaneza, Joseph E.; Mustafa, Tariq; Fisher, Tonja W.; Sengoda, Venkatesan G.; Horton, David R.] USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA	United States Department of Agriculture (USDA)	Munyaneza, JE (corresponding author), USDA ARS, Yakima Agr Res Lab, Wapato, WA 98951 USA.	Joseph.Munyaneza@ars.usda.gov	Mustafa, Tariq/AAU-4194-2021	Mustafa, Tariq/0000-0002-6083-5806	United States Department of Agriculture (USDA)-Agricultural Research Service State Partnership Potato Research Program; Texas Department of Agriculture; USDA-National Institute of Food and Agriculture-Specialty Crop Research Initiative [2009-51181-20176]; USDA-ARS State Partnership Potato Research Program; USDA-NIFA-SCRI [2009-51181-20176]; ARS [ARS-0429561] Funding Source: Federal RePORTER	United States Department of Agriculture (USDA)-Agricultural Research Service State Partnership Potato Research Program; Texas Department of Agriculture; USDA-National Institute of Food and Agriculture-Specialty Crop Research Initiative; USDA-ARS State Partnership Potato Research Program; USDA-NIFA-SCRI; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Financial support for this work was partially provided by United States Department of Agriculture (USDA)-Agricultural Research Service State Partnership Potato Research Program, Texas Department of Agriculture, and USDA-National Institute of Food and Agriculture-Specialty Crop Research Initiative (Project #2009-51181-20176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kylie Swisher, Millie Heidt, Becky Cochran and Blaine Heilman for their invaluable technical support. Financial support for this work was partially provided by USDA-ARS State Partnership Potato Research Program, Texas Department of Agriculture, and USDA-NIFA-SCRI (Project #2009-51181-20176). The use of trade, firm, or corporation names in this publication is for information and convenience of the reader. Such use does not constitute an official endorsement or approval by the United States Department of Agriculture or the Agricultural Research Service of any product or service to the exclusion of others that may be suitable. USDA is an equal opportunity provider and employer.	Alfaro-Fernandez A, 2012, PLANT DIS, V96, P582, DOI 10.1094/PDIS-11-11-0918-PDN; Alfaro-Fernandez A, 2012, PLANT DIS, V96, P581, DOI 10.1094/PDIS-10-11-0878-PDN; Anonymous, 2013, Bulletin OEPP, V43, P197, DOI 10.1111/epp.12043; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Bertolini E., 2014, PLANT PATHOL, DOI 10.1111/ppa.12245; Buchman JL, 2012, AM J POTATO RES, V89, P159, DOI 10.1007/s12230-012-9238-3; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Burckhardt D, 2012, ZOOTAXA, P1; EPPO, 2012, EPPO REPORTING SERVI, V6, P4; Gbur EE, 2012, ACSESS PUBL, P1, DOI 10.2134/2012.generalized-linear-mixed-models; Goolsby JA, 2012, J ECON ENTOMOL, V105, P1268, DOI 10.1603/EC11435; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Loiseau M, 2014, PLANT DIS, V98, P839, DOI 10.1094/PDIS-08-13-0900-PDN; Martini X, 2013, FLA ENTOMOL, V96, P658, DOI 10.1653/024.096.0240; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2015, PLANT DIS, V99, P1269, DOI 10.1094/PDIS-02-15-0206-PDN; Munyaneza JE, 2012, PLANT DIS, V96, P453, DOI 10.1094/PDIS-10-11-0871; Munyaneza JE, 2012, PLANT DIS, V96, P454, DOI 10.1094/PDIS-10-11-0870; Munyaneza JE, 2010, PLANT DIS, V94, P639, DOI 10.1094/PDIS-94-5-0639A; Munyaneza JE, 2015, AM J POTATO RES, V92, P230, DOI 10.1007/s12230-015-9448-6; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2012, PLANT DIS, V96, P18, DOI 10.1094/PDIS-03-11-0185; Munyaneza JE, 2011, AM J POTATO RES, V88, P435, DOI 10.1007/s12230-011-9209-0; Munyaneza JE, 2010, SOUTHWEST ENTOMOL, V35, P471, DOI 10.3958/059.035.0335; Munyaneza JE, 2010, J ECON ENTOMOL, V103, P1060, DOI 10.1603/EC10027; Mustafa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138946; Nelson WR, 2013, J PLANT PATHOL, V95, P455; Nelson WR, 2013, EUR J PLANT PATHOL, V135, P633, DOI 10.1007/s10658-012-0121-3; Nelson WR, 2011, EUR J PLANT PATHOL, V130, P5, DOI 10.1007/s10658-010-9737-3; Nissinen AI, 2014, PLANT PATHOL, V63, P812, DOI 10.1111/ppa.12144; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Pearson CC, 2014, ANN ENTOMOL SOC AM, V107, P650, DOI 10.1603/AN13178; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; Sandanayaka WRM, 2014, ENTOMOL EXP APPL, V151, P170, DOI 10.1111/eea.12179; SAS Institute, 2012, SAS REL; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Sengoda VG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093475; Sengoda VG, 2013, J ECON ENTOMOL, V106, P1964, DOI 10.1603/EC13129; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Tahzima R, 2014, PLANT DIS, V98, P1426, DOI 10.1094/PDIS-05-14-0509-PDN; Teresani GR, 2014, PHYTOPATHOLOGY, V104, P804, DOI 10.1094/PHYTO-07-13-0182-R; Teulon D. A. J., 2009, New Zealand Plant Protection, V62, P136; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; ULLMAN DE, 1988, ENVIRON ENTOMOL, V17, P675, DOI 10.1093/ee/17.4.675; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; Wen AM, 2013, AM J POTATO RES, V90, P229, DOI 10.1007/s12230-012-9293-9; Zhang YP, 1998, J VIROL METHODS, V71, P45, DOI 10.1016/S0166-0934(97)00190-0	52	19	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161016	10.1371/journal.pone.0161016	http://dx.doi.org/10.1371/journal.pone.0161016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525703	Green Published, gold, Green Submitted			2022-12-26	WOS:000381471100030
J	Pomies, P; Blaquiere, M; Maury, J; Mercier, J; Gouzi, F; Hayot, M				Pomies, Pascal; Blaquiere, Marine; Maury, Jonathan; Mercier, Jacques; Gouzi, Fares; Hayot, Maurice			Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes	PLOS ONE			English	Article							MUSCLE ATROPHY; UP-REGULATION; COPD; EXPRESSION; ACTIVATION; RESISTANCE; MYOBLASTS; ATROGIN-1; CELLS; MURF1	Oxidative stress is thought to be one of the most important mechanisms implicated in the muscle wasting of chronic obstructive pulmonary disease (COPD) patients, but its role has never been demonstrated. We therefore assessed the effects of both pro-oxidant and antioxidant treatments on the oxidative stress levels and atrophic signaling pathway of cultured COPD myotubes. Treatment of cultured COPD myotubes with the pro-oxidant molecule H2O2 resulted in increased ROS production (P = 0.002) and protein carbonylation (P = 0.050), in association with a more pronounced atrophy of the myotubes, as reflected by a reduced diameter (P = 0.003), and the activated expression of atrophic markers MuRF1 and FoxO1 (P = 0.022 and P = 0.030, respectively). Conversely, the antioxidant molecule ascorbic acid induced a reduction in ROS production (P<0.001) and protein carbonylation (P = 0.019), and an increase in the myotube diameter (P<0.001) to a level similar to the diameter of healthy subject myotubes, in association with decreased expression levels of MuRF1, atrogin-1 and FoxO1 (P<0.001, P = 0.002 and P = 0.042, respectively). A significant negative correlation was observed between the variations in myotube diameter and the variations in the expression of MuRF1 after antioxidant treatment (P = 0.047). Moreover, ascorbic acid was able to prevent the H2O2-induced atrophy of COPD myotubes. Last, the proteasome inhibitor MG132 restored the basal atrophy level of the COPD myotubes and also suppressed the H2O2-induced myotube atrophy. These findings demonstrate for the first time the involvement of oxidative stress in the atrophy of COPD peripheral muscle cells in vitro, via the FoxO1/MuRF1/atrogin-1 signaling pathway of the ubiquitin/proteasome system.	[Pomies, Pascal; Blaquiere, Marine; Maury, Jonathan; Mercier, Jacques; Gouzi, Fares; Hayot, Maurice] Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR9214, Montpellier, France; [Blaquiere, Marine; Mercier, Jacques; Gouzi, Fares; Hayot, Maurice] CHRU Montpellier, Dept Clin Physiol, Montpellier, France; [Maury, Jonathan] Fontalvie 5 Sante Grp, Clin Souffle La Solane, Osseja, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Pomies, P (corresponding author), Univ Montpellier, PhyMedExp, INSERM U1046, CNRS UMR9214, Montpellier, France.	pascal.pomies@inserm.fr	Pomiès, Pascal/AAC-8037-2020	Pomiès, Pascal/0000-0002-5301-6087	Montpellier Hospital (Programme Hospitalier de Recherche Clinique Interregional AREB-1); CIFRE grant (Conventions Industrielles de Formation par la Recherche) from the Fontalvie Corporation; French ANRT (Association Nationale de la Recherche et de la Technologie)	Montpellier Hospital (Programme Hospitalier de Recherche Clinique Interregional AREB-1); CIFRE grant (Conventions Industrielles de Formation par la Recherche) from the Fontalvie Corporation; French ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR))	This study was supported by a grant from the Montpellier Hospital (Programme Hospitalier de Recherche Clinique Interregional AREB-1). JM was supported by a CIFRE grant (Conventions Industrielles de Formation par la Recherche) from the Fontalvie Corporation and the French ANRT (Association Nationale de la Recherche et de la Technologie). The funder provided support in the form of salaries for authors [JM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alamdari N, 2012, BIOCHEM BIOPH RES CO, V417, P528, DOI 10.1016/j.bbrc.2011.11.154; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Caron AZ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-185; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chen GQ, 2011, LIFE SCI, V89, P44, DOI 10.1016/j.lfs.2011.04.018; Couillard A, 2003, AM J RESP CRIT CARE, V167, P1664, DOI 10.1164/rccm.200209-1028OC; Dodd SL, 2010, MUSCLE NERVE, V41, P110, DOI 10.1002/mus.21526; Doucet M, 2007, AM J RESP CRIT CARE, V176, P261, DOI 10.1164/rccm.200605-704OC; Fabre O, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.104; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Gouzi F, 2013, EUR RESP J; Gouzi F, 2013, J APPL PHYSIOL, V115, P1796, DOI 10.1152/japplphysiol.00778.2013; Hayot M, 2011, MOL CELL ENDOCRINOL, V332, P38, DOI 10.1016/j.mce.2010.09.008; Hirasaka K, 2013, J NUTR SCI VITAMINOL, V59, P317, DOI 10.3177/jnsv.59.317; Koechlin C, 2004, AM J RESP CRIT CARE, V169, P1022, DOI 10.1164/rccm.200310-1465OC; Laviolette L, 2010, J MED FOOD, V13, P589, DOI 10.1089/jmf.2009.0142; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; McClung JM, 2009, AM J PHYSIOL-CELL PH, V296, pC363, DOI 10.1152/ajpcell.00497.2008; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Pomies P, 2015, J CELL MOL MED, V19, P175, DOI 10.1111/jcmm.12390; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rossman MJ, 2013, AM J PHYSIOL-REG I, V305, pR1163, DOI 10.1152/ajpregu.00360.2013; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seymour JM, 2010, EUR RESPIR J, V36, P81, DOI 10.1183/09031936.00104909; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Theriault ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-35; van Helvoort HAC, 2007, CHEST, V131, P439, DOI 10.1378/chest.06-1655; Wang DT, 2014, INT IMMUNOPHARMACOL, V19, P206, DOI 10.1016/j.intimp.2014.02.002; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5	32	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0160092	10.1371/journal.pone.0160092	http://dx.doi.org/10.1371/journal.pone.0160092			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27526027	Green Published, Green Submitted, gold			2022-12-26	WOS:000381471100011
J	Lagos, J; Couvin, D; Arata, L; Tognarelli, J; Aguayo, C; Leiva, T; Arias, F; Hormazabal, JC; Rastogi, N; Fernandez, J				Lagos, Jaime; Couvin, David; Arata, Loredana; Tognarelli, Javier; Aguayo, Carolina; Leiva, Tamara; Arias, Fabiola; Carlos Hormazabal, Juan; Rastogi, Nalin; Fernandez, Jorge			Analysis of Mycobacterium tuberculosis Genotypic Lineage Distribution in Chile and Neighboring Countries	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; DRUG-RESISTANCE; POPULATION-STRUCTURE; 1ST INSIGHT; SPOLIGOTYPES; STRAINS; COMPLEX; TOOLS; TRANSMISSION	Tuberculosis (TB), caused by the pathogen Mycobacterium tuberculosis (MTB), remains a disease of high importance to global public health. Studies into the population structure of MTB have become vital to monitoring possible outbreaks and also to develop strategies regarding disease control. Although Chile has a low incidence of MTB, the current rates of migration have the potential to change this scenario. We collected and analyzed a total of 458 M. tuberculosis isolates (1 isolate per patient) originating from all 15 regions of Chile. The isolates were genotyped using the spoligotyping method and the data obtained were analyzed and compared with the SITVIT2 database. A total of 169 different patterns were identified, of which, 119 patterns (408 strains) corresponded to Spoligotype International Types (SITs) and 50 patterns corresponded to orphan strains. The most abundantly represented SITs/lineages were: SIT53/T1 (11.57%), SIT33/LAM3 (9.6%), SIT42/LAM9 (9.39%), SIT50/H3 (5.9%), SIT37/T3 (5%); analysis of the spoligotyping minimum spanning tree as well as spoligoforest were suggestive of a recent expansion of SIT42, SIT50 and SIT37; all of which potentially evolved from SIT53. The most abundantly represented lineages were LAM (40.6%), T (34.1%) and Haarlem (13.5%). LAM was more prevalent in the Santiago (43.6%) and Concepcion (44.1%) isolates, rather than the Iquique (29.4%) strains. The proportion of X lineage was appreciably higher in Iquique and Concepcion (11.7% in both) as compared to Santiago (1.6%). Global analysis of MTB lineage distribution in Chile versus neighboring countries showed that evolutionary recent lineages (LAM, T and Haarlem) accounted together for 88.2% of isolates in Chile, a pattern which mirrored MTB lineage distribution in neighboring countries (n = 7378 isolates recorded in SITVIT2 database for Peru, Brazil, Paraguay, and Argentina; and published studies), highlighting epidemiological advantage of Euro-American lineages in this region. Finally, we also observed exclusive emergence of patterns SIT4014/X1 and SIT4015 (unknown lineage signature) that have hitherto been found exclusively in Chile, indicating that conditions specific to Chile, along with the unique genetic makeup of the Chilean population, might have allowed for a possible co-evolution leading to the success of these emerging genotypes.	[Lagos, Jaime; Arata, Loredana; Tognarelli, Javier; Aguayo, Carolina; Fernandez, Jorge] Publ Hlth Inst Chile, Subdept Mol Genet, Santiago, Chile; [Couvin, David; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Abymes, Guadeloupe, France; [Leiva, Tamara; Arias, Fabiola] Publ Hlth Inst Chile, Mycobacteria Lab, Santiago, Chile; [Carlos Hormazabal, Juan] Publ Hlth Inst Chile, Subdept Infect Dis, Santiago, Chile		Fernandez, J (corresponding author), Publ Hlth Inst Chile, Subdept Mol Genet, Santiago, Chile.; Rastogi, N (corresponding author), Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranat TB Reference Lab, Abymes, Guadeloupe, France.	nrastogi@pasteur-guadeloupe.fr; jfernand@ispch.cl	RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Couvin, David/0000-0002-7897-9023				Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Alvarez N, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01549-15; [Anonymous], 2014, TUB INF SIT CHIL 201; Araya P, 2011, REV MED CHILE, V139, P467, DOI /S0034-98872011000400008; Barnes PF, 2003, NEW ENGL J MED, P349; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Couvin D, 2014, EUROREFERENCE J REFE, V12, P36, DOI [10.1186/1471-2407-14-960, DOI 10.1186/1471-2407-14-960]; Couvin D, 2015, TUBERCULOSIS, V95, pS177, DOI 10.1016/j.tube.2015.02.023; Cronin WA, 2001, J CLIN MICROBIOL, V39, P3709, DOI 10.1128/JCM.39.10.3709-3711.2001; Costa ERD, 2013, J CLIN MICROBIOL, V51, P1071, DOI 10.1128/JCM.01511-12; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Ellson J, 2004, MATH VIS, P127; Balcells ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118007; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; de Viedma DG, 2011, ENFERM INFEC MICR CL, V29, P8, DOI 10.1016/S0213-005X(11)70012-X; Gomes HM, 2012, INFECT GENET EVOL, V12, P649, DOI 10.1016/j.meegid.2011.08.027; Gonzalo X, 2011, EMERG INFECT DIS, V17, P528, DOI 10.3201/eid1703.100394; Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; Machado LNC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107106; Mancilla E Marcos, 2006, Rev. chil. infectol., V23, P220; Meza P, 2014, REV CHIL INFECTOL, V31, P21, DOI 10.4067/S0716-10182014000100003; Millet J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/689852; Monteserin J, 2013, INFECT GENET EVOL, V17, P195, DOI 10.1016/j.meegid.2013.04.010; Realpe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109456; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Ritacco V, 2012, EMERG INFECT DIS, V18, P1802, DOI 10.3201/eid1811.120126; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; World Health Organization, 2013, WHO REPORT; Zumla A, 2013, NAT REV DRUG DISCOV, V12, P388, DOI 10.1038/nrd4001	40	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160434	10.1371/journal.pone.0160434	http://dx.doi.org/10.1371/journal.pone.0160434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27518286	gold, Green Submitted, Green Published			2022-12-26	WOS:000381382100014
J	Wang, DM; Mitchell, ES				Wang, Dongmei; Mitchell, Ellen S.			Cognition and Synaptic-Plasticity Related Changes in Aged Rats Supplemented with 8-and 10-Carbon Medium Chain Triglycerides	PLOS ONE			English	Article							SYNDROME PROTEIN UBE3A; ALZHEIMERS-DISEASE; FATTY-ACIDS; INSULIN-RECEPTOR; REGULATORY NETWORKS; IN-VITRO; BRAIN; METABOLISM; MEMORY; PHOSPHORYLATION	Brain glucose hypometabolism is a common feature of Alzheimer's disease (AD). Previous studies have shown that cognition is improved by providing AD patients with an alternate energy source: ketones derived from either ketogenic diet or supplementation with medium chain triglycerides (MCT). Recently, data on the neuroprotective capacity of MCT-derived medium chain fatty acids (MCFA) suggest 8-carbon and 10-carbon MCFA may have cognition- enhancing properties which are not related to ketone production. We investigated the effect of 8 week treatment with MCT8, MCT10 or sunflower oil supplementation (5% by weight of chow diet) in 21 month old Wistar rats. Both MCT diets increased ketones plasma similarly compared to control diet, but MCT diets did not increase ketones in the brain. Treatment with MCT10, but not MCT8, significantly improved novel object recognition memory compared to control diet, while social recognition increased in both MCT groups. MCT8 and MCT10 diets decreased weight compared to control diet, where MCFA plasma levels were higher in MCT10 groups than in MCT8 groups. Both MCT diets increased IRS-1 (612) phosphorylation and decreased S6K phosphorylation (240/244) but only MCT10 increased Akt phosphorylation (473). MCT8 supplementation increased synaptophysin, but not PSD95, in contrast MCT10 had no effect on either synaptic marker. Expression of Ube3a, which controls synaptic stability, was increased by both MCT diets. Cortex transcription via qPCR showed that immediate early genes related to synaptic plasticity (arc, plk3, junb, egr2, nr4a1) were downregulated by both MCT diets while MCT8 additionally down-regulated fosb and egr1 but upregulated grin1 and gba2. These results demonstrate that treatment of 8-and 10-carbon length MCTs in aged rats have slight differential effects on synaptic stability, protein synthesis and behavior that may be independent of brain ketone levels.	[Wang, Dongmei; Mitchell, Ellen S.] Nestle Inst Hlth Sci, Cognit Hlth & Aging, EPFL Innovat Pk,Bldg H, CH-1015 Lausanne, Switzerland	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Mitchell, ES (corresponding author), Nestle Inst Hlth Sci, Cognit Hlth & Aging, EPFL Innovat Pk,Bldg H, CH-1015 Lausanne, Switzerland.	esiobhanmitchell@gmail.com		Mitchell, Ellen/0000-0001-7851-6283	Nestle Institute of Health Sciences	Nestle Institute of Health Sciences(Nestle SA)	ESM and DW are employees of Nestle Institute of Health Sciences, a for-profit institution, and received support in the form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aacute Nchez-Andrade G, 2005, J REPROD DEVELOP, V51, p547 558; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bezprozvanny I, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-23; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Castellano CA, 2015, J ALZHEIMERS DIS, V43, P1343, DOI 10.3233/JAD-141074; Chang PS, 2015, J PHARMACOL EXP THER, V352, P43, DOI 10.1124/jpet.114.218768; CHEN KS, 1995, NEUROSCIENCE, V68, P19, DOI 10.1016/0306-4522(95)00099-5; Dong SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031211; Ebert D, 2003, J NEUROSCI, V23, P5928; Fletcher BR, 2014, NEUROBIOL LEARN MEM, V115, P58, DOI 10.1016/j.nlm.2014.08.007; Garelick MG, 2011, EXP GERONTOL, V46, P155, DOI 10.1016/j.exger.2010.08.030; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Henderson ST, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-137; Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Katche C, 2012, NEUROBIOL LEARN MEM, V98, P220, DOI 10.1016/j.nlm.2012.08.001; Koldamova R, 2014, NEUROBIOL DIS, V63, P107, DOI 10.1016/j.nbd.2013.11.005; Lai KO, 2015, J BIOL CHEM, V290, P14637, DOI 10.1074/jbc.M114.627117; Lindecke A, 2006, EUR J NEUROSCI, V24, P555, DOI 10.1111/j.1460-9568.2006.04909.x; Malapaka RRV, 2012, J BIOL CHEM, V287, P183, DOI 10.1074/jbc.M111.294785; Markham JA, 2007, PHYSIOL BEHAV, V92, P881, DOI 10.1016/j.physbeh.2007.06.020; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; Miao S, 2013, J NEUROSCI, V33, P327, DOI 10.1523/JNEUROSCI.2509-12.2013; ODLE J, 1991, J NUTR, V121, P605, DOI 10.1093/jn/121.5.605; Page KA, 2009, DIABETES, V58, P1237, DOI 10.2337/db08-1557; Pan YL, 2010, BRIT J NUTR, V103, P1746, DOI 10.1017/S0007114510000097; Pang T, 2014, ACTA PHARMACOL SIN, V35, P727, DOI 10.1038/aps.2013.199; Perluigi M, 2015, NEUROBIOL DIS; Pipatpiboon N, 2012, ENDOCRINOLOGY, V153, P329, DOI 10.1210/en.2011-1502; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Sekine S, 2013, J NUTR SCI VITAMINOL, V59, P123, DOI 10.3177/jnsv.59.123; Sharma A, 2014, AM J ALZHEIMERS DIS; Sohn BK, 2015, J KOREAN MED SCI, V30, P779, DOI 10.3346/jkms.2015.30.6.779; Taha AY, 2009, NEUROCHEM RES, V34, P1619, DOI 10.1007/s11064-009-9952-5; Talbot K, 2014, NEURODEGENER DIS MAN, V4, P31, DOI [10.2217/NMT.13.73, 10.2217/nmt.13.73]; Tetrick MA, 2010, COMPARATIVE MED, V60, P486; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Williams K, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00018; Xie JL, 2013, NAT CELL BIOL, V15, P1263, DOI 10.1038/ncb2877; Yonezawa T, 2013, CURR MED CHEM, V20, P3855; Zhao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049191	45	28	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0160159	10.1371/journal.pone.0160159	http://dx.doi.org/10.1371/journal.pone.0160159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517611	Green Published, gold			2022-12-26	WOS:000381382100009
J	Li, GW; Thabane, L; Delate, T; Witt, DM; Levine, MAH; Cheng, J; Holbrook, A				Li, Guowei; Thabane, Lehana; Delate, Thomas; Witt, Daniel M.; Levine, Mitchell A. H.; Cheng, Ji; Holbrook, Anne			Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case	PLOS ONE			English	Article							NET CLINICAL BENEFIT; BLEEDING RISK; ANTICOAGULATION THERAPY; STROKE PREVENTION; VALIDATION; SCORE; THROMBOEMBOLISM; STRATIFICATION; OUTCOMES; SCHEMES	Objectives To construct and validate a prediction model for individual combined benefit and harm outcomes (stroke with no major bleeding, major bleeding with no stroke, neither event, or both) in patients with atrial fibrillation (AF) with and without warfarin therapy. Methods Using the Kaiser Permanente Colorado databases, we included patients newly diagnosed with AF between January 1, 2005 and December 31, 2012 for model construction and validation. The primary outcome was a prediction model of composite of stroke or major bleeding using polytomous logistic regression (PLR) modelling. The secondary outcome was a prediction model of all-cause mortality using the Cox regression modelling. Results We included 9074 patients with 4537 and 4537 warfarin users and non-users, respectively. In the derivation cohort (n = 4632), there were 136 strokes (2.94%), 280 major bleedings (6.04%) and 1194 deaths (25.78%) occurred. In the prediction models, warfarin use was not significantly associated with risk of stroke, but increased the risk of major bleeding and decreased the risk of death. Both the PLR and Cox models were robust, internally and externally validated, and with acceptable model performances. Conclusions In this study, we introduce a new methodology for predicting individual combined benefit and harm outcomes associated with warfarin therapy for patients with AF. Should this approach be validated in other patient populations, it has potential advantages over existing risk stratification approaches as a patient-physician aid for shared decision-making	[Li, Guowei; Thabane, Lehana; Levine, Mitchell A. H.; Cheng, Ji; Holbrook, Anne] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Li, Guowei; Thabane, Lehana; Levine, Mitchell A. H.; Cheng, Ji; Holbrook, Anne] McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada; [Delate, Thomas] Kaiser Permanente Colorado Clin Pharm Res Team, Aurora, CO USA; [Delate, Thomas] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Denver, CO 80202 USA; [Witt, Daniel M.] Univ Utah, Dept Pharmacotherapy, Salt Lake City, UT USA; [Levine, Mitchell A. H.; Holbrook, Anne] McMaster Univ, Dept Med, Div Clin Pharmacol & Toxicol, Hamilton, ON, Canada	McMaster University; McGill University; McMaster University; Kaiser Permanente; University of Colorado System; University of Colorado Denver; Utah System of Higher Education; University of Utah; McMaster University	Thabane, L; Holbrook, A (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Thabane, L; Holbrook, A (corresponding author), McMaster Univ, St Josephs Hosp, Hamilton, ON, Canada.; Holbrook, A (corresponding author), McMaster Univ, Dept Med, Div Clin Pharmacol & Toxicol, Hamilton, ON, Canada.	thabanl@mcmaster.ca; Tom.Delate@kp.org; holbrook@mcmaster.ca	Li, Guowei/HCH-8923-2022		Father Sean O'Sullivan Research Award; Research Institute of St. Joseph's Healthcare Hamilton; doctoral award from China Scholarship Council (CSC); Kaiser Permanente Pharmacy Department	Father Sean O'Sullivan Research Award; Research Institute of St. Joseph's Healthcare Hamilton; doctoral award from China Scholarship Council (CSC); Kaiser Permanente Pharmacy Department	This work was supported by the Father Sean O'Sullivan Research Award to GL, the Research Institute of St. Joseph's Healthcare Hamilton, and a doctoral award from the China Scholarship Council (CSC). DMW and TD received research funding from the Kaiser Permanente Pharmacy Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Ansell J, 2010, HEMATOL-AM SOC HEMAT, P221, DOI 10.1182/asheducation-2010.1.221; Arepally Gowthami, 2010, Crit Pathw Cardiol, V9, P41, DOI 10.1097/HPC.0b013e3181d24562; Banerjee A, 2014, THROMB HAEMOSTASIS, V111, P549, DOI 10.1160/TH13-12-1033; BEGG CB, 1984, BIOMETRIKA, V71, P11, DOI 10.2307/2336391; Bilen K, 2013, EMERG MED J, V30, P650, DOI 10.1136/emermed-2012-201235; Brasier AR, 2012, AM J TROP MED HYG, V86, P341, DOI 10.4269/ajtmh.2012.11-0469; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chao TF, 2015, J AM COLL CARDIOL, V65, P635, DOI 10.1016/j.jacc.2014.11.046; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheong JY, 2012, HEPATO-GASTROENTEROL, V59, P2592, DOI 10.5754/hge10157; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; Donze J, 2012, AM J MED, V125, P1095, DOI 10.1016/j.amjmed.2012.04.005; Dzeshka MS, 2014, CLIN CARDIOL, V37, P634, DOI 10.1002/clc.22294; Efron B., 1994, INTRO BOOTSTRAP; Ferreira D, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-143; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Holbrook A, 2007, CAN MED ASSOC J, V176, P1583, DOI 10.1503/cmaj.060837; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Holbrook AM, 2013, J POPUL THER CLIN PH, V20, pE406; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Ince B, 2014, EXPERT REV CARDIOVAS, V12, P929, DOI 10.1586/14779072.2014.931225; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Kohavi R, 1995, STUDY CROSS VALIDATI, P1137; Levesque LE, 2010, BMJ-BRIT MED J, V340, P907; Li GW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009518; Lip GYH, 2013, CHEST, V144, P1839, DOI 10.1378/chest.13-1635; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lip GYH, 2011, AM J MED, V124, P111, DOI 10.1016/j.amjmed.2010.05.007; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; MCCRORY DC, 1995, ARCH INTERN MED, V155, P277, DOI 10.1001/archinte.155.3.277; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Minne L, 2012, METHOD INFORM MED, V51, P353, DOI 10.3414/ME11-02-0044; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Olson KL, 2014, AM J MANAG CARE, V20, pE27; Pereira J.L., 2008, THESIS U MARYLAND CO; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2013, J THROMB HAEMOST, V11, P1053, DOI 10.1111/jth.12239; Rockson SG, 2004, J AM COLL CARDIOL, V43, P929, DOI 10.1016/j.jacc.2003.11.028; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Wells G, 2012, SAFETY EFFECTIVENESS; WIJESINHA A, 1983, MED DECIS MAKING, V3, P133, DOI 10.1177/0272989X8300300202; Witt DM, 2009, BLOOD, V114, P952, DOI 10.1182/blood-2009-02-207928; Witt DM, 2005, CHEST, V127, P1515, DOI 10.1378/chest.127.5.1515; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160713	10.1371/journal.pone.0160713	http://dx.doi.org/10.1371/journal.pone.0160713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513986	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100061
J	Liu, HH; Tsai, TH; Lee, SS; Kuo, YH; Hsieh, TF				Liu, Hsin-Ho; Tsai, Tsung-Hsun; Lee, Shang-Sen; Kuo, Yu-Hung; Hsieh, Tengfu			Maximum Urine Flow Rate of Less than 15ml/Sec Increasing Risk of Urine Retention and Prostate Surgery among Patients with Alpha-1 Blockers: A 10-Year Follow Up Study	PLOS ONE			English	Article							SYMPTOMS; QUALITY; TAIWAN	Background The aim of this study was to determine the subsequent risk of acute urine retention and prostate surgery in patients receiving alpha-1 blockers treatment and having a maximum urinary flow rate of less than 15ml/sec. Methods We identified patients who were diagnosed with benign prostate hyperplasia (BPH) and had a maximum uroflow rate of less than 15ml/sec between 1 January, 2002 to 31 December, 2011 from Taiwan's National Health Insurance Research Database into study group (n = 303). The control cohort included four BPH/LUTS patients without 5ARI used for each study group, randomly selected from the same dataset (n = 1,212). Each patient was monitored to identify those who subsequently developed prostate surgery and acute urine retention. Results Prostate surgery and acute urine retention are detected in 5.9% of control group and 8.3% of study group during 10-year follow up. Compared with the control group, there was increase in the risk of prostate surgery and acute urine retention in the study group (HR = 1.83, 95% CI: 1.16 to 2.91) after adjusting for age, comorbidities, geographic region and socioeconomic status. Conclusions Maximum urine flow rate of less than 15ml/sec is a risk factor of urinary retention and subsequent prostate surgery in BPH patients receiving alpha-1 blocker therapy. This result can provide a reference for clinicians.	[Liu, Hsin-Ho; Tsai, Tsung-Hsun; Lee, Shang-Sen; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Gen Hosp, Dept Urol, Taichung, Taiwan; [Liu, Hsin-Ho; Tsai, Tsung-Hsun; Lee, Shang-Sen; Hsieh, Tengfu] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Kuo, Yu-Hung; Hsieh, Tengfu] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Gen Hosp, Dept Res, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital	Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Gen Hosp, Dept Urol, Taichung, Taiwan.; Hsieh, TF (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hsieh, TF (corresponding author), Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Gen Hosp, Dept Res, Taichung, Taiwan.	hdf95@yahoo.com.tw						Bartkowski DP, 2004, J UROLOGY, V172, P1980, DOI 10.1097/01.ju.0000140849.49348.62; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Dong YH, 2013, PHARMACOTHERAPY, V33, P126, DOI 10.1002/phar.1176; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Hollingsworth JM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4474; Hsieh TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119694; Lee SS, 2016, PROSTATE, V76, P41, DOI 10.1002/pros.23097; Lenherr SM, 2013, UROL CLIN N AM, V40, P545, DOI 10.1016/j.ucl.2013.07.001; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Liu CY HY, 2006, J HLTH MANAGE, P1; Lu CL, 2005, ALIMENT PHARM THER, V22, P739, DOI 10.1111/j.1365-2036.2005.02664.x; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Oelke M, 2012, NEUROUROL URODYNAM, V31, P322, DOI 10.1002/nau.22222; Panicker JN, 2015, LANCET NEUROL, V14, P720, DOI 10.1016/S1474-4422(15)00070-8; Porru D, 2001, EUR UROL, V40, P23, DOI 10.1159/000049874; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Schwinn DA, 2004, MAYO CLIN PROC, V79, P1423, DOI 10.4065/79.11.1423; SIROKY MB, 1990, UROL CLIN N AM, V17, P537; Tzeng YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133013	24	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160689	10.1371/journal.pone.0160689	http://dx.doi.org/10.1371/journal.pone.0160689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513673	Green Published, gold, Green Submitted			2022-12-26	WOS:000381381100057
J	Vanas, V; Haigl, B; Stockhammer, V; Sutterluty-Fall, H				Vanas, Vanita; Haigl, Barbara; Stockhammer, Verena; Sutterluety-Fall, Hedwig			MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; BREAST-CANCER; DOWN-REGULATION; EXPRESSION; MIR-21; METASTASIS; SPROUTY4; PATHWAY; MIGRATION; CHEMOSENSITIVITY	Osteosarcoma is the most common primary bone tumor and poor prognosis for osteosarcoma patients is mainly due to chemotherapy resistance. MicroRNAs are important to maintain pathophysiological mechanisms of cancer and influence cell sensitivity to chemotherapy. In this study, we tested the functions of microRNA-21 for malignant features as well as for drug resistance of osteosarcoma. We used Northern blot to measure microRNA-21 levels in osteosarcoma-derived cell lines. MicroRNA-21 activity was modulated by either expressing a sponge to decrease its activity in an osteosarcoma-derived cell line expressing high levels of microRNA-21 or by introducing pri-microRNA-21 in a cell line with low endogenous levels. Cell migration was determined in a scratch assay and cell proliferation was measured by performing growth curve analysis. Sensitivity of the cells towards chemotherapeutics was investigated by performing cell viability assays and calculating the IC50 values. While cell migration was unaffected by modulated microRNA-21 levels, microRNA-21 inhibition slowed proliferation and exogenously expressed microRNA-21 promoted this process. Modulated microRNA-21 activity failed to effect sensitivity of osteosarcoma-derived cell lines to doxorubicin or methotrexate. Contrarily, reduction of microRNA-21 activity resulted in enhanced resistance towards cisplatin while ectopic expression of microRNA-21 showed the opposite effect. Increased microRNA-21 levels repressed the expression of Sprouty2 and ectopic expression of Sprouty2 was able to largely rescue the observed effects of microRNA-21 in osteosarcoma. In summary, our data indicate that in osteosarcoma microRNA-21 expression is an important component for regulation of cell proliferation and for determining sensitivity to cisplatin.	[Vanas, Vanita; Haigl, Barbara; Sutterluety-Fall, Hedwig] Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria; [Stockhammer, Verena] Med Univ Vienna, Dept Orthopaed, Vienna, Austria; [Haigl, Barbara] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Stockhammer, Verena] Landesklinikum Mistelbach Ganserndorf, Dept Orthopaed, Mistelbach, Austria	Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna	Sutterluty-Fall, H (corresponding author), Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria.	hedwig.sutterluety@meduniwien.ac.at		Sutterluty-Fall, Hedwig/0000-0001-9249-9299	Fellinger Krebsforschung; Medizinisch-wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien [AP 12093]; Herzfelder'sche Familienstiftung	Fellinger Krebsforschung; Medizinisch-wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung	The study was supported by Fellinger Krebsforschung 2014, Medizinisch-wissenschaftlicher Fonds des Burgermeisters der Bundeshauptstadt Wien grant nr AP 12093, and Herzfelder'sche Familienstiftung 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison Daniel C., 2012, Sarcoma, V2012, P704872, DOI 10.1155/2012/704872; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Avissar M, 2009, CARCINOGENESIS, V30, P2059, DOI 10.1093/carcin/bgp277; Doriguzzi A, 2015, INT J BIOCHEM CELL B, V64, P220, DOI 10.1016/j.biocel.2015.04.017; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Folini M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-12; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Gao SQ, 2015, ACTA BIOMATER, V25, P184, DOI 10.1016/j.actbio.2015.07.020; Giunti L, 2015, AM J CANCER RES, V5, P231; Gorlick R, 2009, CANC TREAT, V152, P467, DOI 10.1007/978-1-4419-0284-9_27; Haigl B, 2014, INT J ONCOL, V44, P1325, DOI 10.3892/ijo.2014.2272; Haigl B, 2010, BIOL CHEM, V391, P813, DOI 10.1515/BC.2010.082; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Jazbutyte V, 2010, CURR DRUG TARGETS, V11, P926, DOI 10.2174/138945010791591403; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kral RM, 2014, CELL BIOCHEM FUNCT, V32, P96, DOI 10.1002/cbf.2976; Lim HJ, 2016, CRIT REV ONCOL HEMAT, V97, P118, DOI 10.1016/j.critrevonc.2015.08.001; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Mayer CE, 2010, CELL MOL LIFE SCI, V67, P3299, DOI 10.1007/s00018-010-0379-6; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Ottaviani G, 2009, CANCER TREAT RES, V152, P3, DOI 10.1007/978-1-4419-0284-9_1; Pink RC, 2015, GYNECOL ONCOL, V137, P143, DOI 10.1016/j.ygyno.2014.12.042; Rathmanner N, 2013, FEBS LETT, V587, P2597, DOI 10.1016/j.febslet.2013.06.040; Sahay D, 2015, ONCOTARGET, V6, P20604, DOI 10.18632/oncotarget.3774; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shi CZ, 2016, GUT, V65, P1470, DOI 10.1136/gutjnl-2014-308455; Silva G, 2016, MOL CARCINOGEN, V55, P525, DOI 10.1002/mc.22299; Singh M, 2015, ONCOTARGET, V6, P27461, DOI 10.18632/oncotarget.4742; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Tao J, 2011, ONCOL REP, V25, P1721, DOI 10.3892/or.2011.1245; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vanas V, 2014, TUMOR BIOL, V35, P4447, DOI 10.1007/s13277-013-1587-0; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wu ZY, 2011, MED ONCOL, V28, P1469, DOI 10.1007/s12032-010-9563-7; Yamamichi N, 2009, CLIN CANCER RES, V15, P4009, DOI 10.1158/1078-0432.CCR-08-3257; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang SM, 2013, TOXICOLOGY, V306, P162, DOI 10.1016/j.tox.2013.02.014; Yang Y, 2015, CANCER GENE THER, V22, P23, DOI 10.1038/cgt.2014.66; Yuan J, 2012, J INT MED RES, V40, P2090, DOI 10.1177/030006051204000606; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Ziyan W, 2016, IRISH J MED SCI, V185, P85, DOI 10.1007/s11845-014-1225-x	48	47	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0161023	10.1371/journal.pone.0161023	http://dx.doi.org/10.1371/journal.pone.0161023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513462	Green Submitted, gold, Green Published			2022-12-26	WOS:000381381100109
J	Wu, CJ; Huang, YW; Lin, YT; Ning, HC; Yang, TC				Wu, Chao-Jung; Huang, Yi-Wei; Lin, Yi-Tsung; Ning, Hsiao-Chen; Yang, Tsuey-Ching			Inactivation of SmeSyRy Two-Component Regulatory System Inversely Regulates the Expression of SmeYZ and SmeDEF Efflux Pumps in Stenotrophomonas maltophilia	PLOS ONE			English	Article							L2 BETA-LACTAMASES; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; GENE; CONTRIBUTES; TRANSPORTER; REPRESSOR; VIRULENCE; CLONING; EVGA	SmeYZ efflux pump is a critical pump responsible for aminoglycosides resistance, virulence-related characteristics (oxidative stress susceptibility, motility, and secreted protease activity), and virulence in Stenotrophomonas maltophilia. However, the regulatory circuit involved in SmeYZ expression is little known. A two-component regulatory system (TCS), smeRySy, transcribed divergently from the smeYZ operon is the first candidate to be considered. To assess the role of SmeRySy in smeYZ expression, the smeRySy isogenic deletion mutant, KJ Delta RSy, was constructed by gene replacement strategy. Inactivation of smeSyRy correlated with a higher susceptibility to aminoglycosides concomitant with an increased resistance to chloramphenicol, ciprofloxacin, tetracycline, and macrolides. To elucidate the underlying mechanism responsible for the antimicrobials susceptibility profiles, the SmeRySy regulon was firstly revealed by transcriptome analysis and further confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) and promoter transcription fusion constructs assay. The results demonstrate that inactivation of smeRySy decreased the expression of SmeYZ pump and increased the expression of SmeDEF pump, which underlies the Delta smeSyRy-mediated antimicrobials susceptibility profile. To elucidate the cognate relationship between SmeSy and SmeRy, a single mutant, KJ Delta Ry, was constructed and the complementation assay of KJ Delta RSy with smeRy were performed. The results support that SmeSy-SmeRy TCS is responsible for the regulation of smeYZ operon; whereas SmeSy may be cognate with another unidentified response regulator for the regulation of smeDEF operon. The impact of inverse expression of SmeYZ and SmeDEF pumps on physiological functions was evaluated by mutants construction, H2O2 susceptibility test, swimming, and secreted protease activity assay. The increased expression of SmeDEF pump in KJ Delta RSy may compensate, to some extents, the SmeYZ downexpression-mediated compromise with respect to its role in secreted protease activity.	[Wu, Chao-Jung; Huang, Yi-Wei; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Div Infect Dis, Dept Med, Taipei 112, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Ning, Hsiao-Chen] Chang Gung Mem Hosp, Linkou Branch, Dept Lab Med, Taoyuan, Taiwan; [Ning, Hsiao-Chen] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-023-MY3]; Professor Tsuei-Chu Mong Merit Scholarship [30219003]; High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan [NSC-102-2319-B-010-001]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Professor Tsuei-Chu Mong Merit Scholarship; High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan	This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 30219003 from Professor Tsuei-Chu Mong Merit Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the High-throughput Genome Analysis Core Facility of National Core Facility Program for Biotechnology, Taiwan (NSC-102-2319-B-010-001), for Illumina sequencing.	Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Bolhuis H, 1997, FEMS MICROBIOL REV, V21, P55, DOI 10.1016/S0168-6445(97)00051-X; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Chen CH, 2011, ANTIMICROB AGENTS CH, V55, P5826, DOI 10.1128/AAC.00317-11; CLSI, 2012, M100S22 CLSI; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Huang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111784; Lambert T, 1999, ANTIMICROB AGENTS CH, V43, P2366, DOI 10.1128/AAC.43.10.2366; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Li XZ, 2000, J ANTIMICROB CHEMOTH, V46, P885, DOI 10.1093/jac/46.6.885; Lin CW, 2008, LETT APPL MICROBIOL, V47, P393, DOI 10.1111/j.1472-765X.2008.02443.x; Lin CW, 2014, ANTIMICROB AGENTS CH, V58, P2405, DOI 10.1128/AAC.01974-13; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Lin YT, 2015, ANTIMICROB AGENTS CH, V59, P4067, DOI 10.1128/AAC.00372-15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Misra R, 2009, BBA-PROTEINS PROTEOM, V1794, P817, DOI 10.1016/j.bbapap.2009.02.017; Nishino K, 2001, J BACTERIOL, V183, P1455, DOI 10.1128/JB.183.4.1455-1458.2001; Nishino K, 2002, J BACTERIOL, V184, P2319, DOI 10.1128/JB.184.8.2319-2323.2002; Perron K, 2004, J BIOL CHEM, V279, P8761, DOI 10.1074/jbc.M312080200; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Saito K, 2003, J BACTERIOL, V185, P6195, DOI 10.1128/JB.185.20.6195-6198.2003; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08	31	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160943	10.1371/journal.pone.0160943	http://dx.doi.org/10.1371/journal.pone.0160943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513575	Green Submitted, Green Published, gold			2022-12-26	WOS:000381381100092
J	Sun, CF; Liu, Y				Sun, Changfeng; Liu, Yu			Climate Response of Tree Radial Growth at Different Timescales in the Qinling Mountains	PLOS ONE			English	Article							NORTHEASTERN TIBETAN PLATEAU; NORTH-CENTRAL CHINA; BALSAMEA L. MILL.; INNER-MONGOLIA; TEMPERATURE RECONSTRUCTION; PRECIPITATION RECORDS; PINUS-TABULAEFORMIS; GROWING-SEASON; EASTERN CHINA; EARLY SUMMER	The analysis of the tree radial growth response to climate is crucial for dendroclimatological research. However, the response relationships between tree-ring indices and climatic factors at different timescales are not yet clear. In this study, the tree-ring width of Huashan pine (Pinus armandii) from Huashan in the Qinling Mountains, north-central China, was used to explore the response differences of tree growth to climatic factors at daily, pentad (5 days), dekad (10 days) and monthly timescales. Correlation function and linear regression analysis were applied in this paper. The tree-ring width showed a more sensitive response to daily and pentad climatic factors. With the timescale decreasing, the absolute value of the maximum correlation coefficient between the tree-ring data and precipitation increases as well as temperature (mean, minimum and maximum temperature). Compared to the other three timescales, pentad was more suitable for analysing the response of tree growth to climate. Relative to the monthly climate data, the association between the tree-ring data and the pentad climate data was more remarkable and accurate, and the reconstruction function based on the pentad climate was also more reliable and stable. We found that the major climatic factor limiting Huashan pine growth was the precipitation of pentads 20-35 (from April 6 to June 24) rather than the well-known April-June precipitation. The pentad was also proved to be a better timescale for analysing the climate and tree growth in the western and eastern Qinling Mountains. The formation of the earlywood density of Chinese pine (Pinus tabulaeformis) from Shimenshan in western Qinling was mainly affected by the maximum temperature of pentads 28-32 (from May 16 to June 9). The maximum temperature of pentads 28-33 (from May 16 to June 14) was the major factor affecting the ring width of Chinese pine from Shirenshan in eastern Qinling.	[Sun, Changfeng; Liu, Yu] Xi An Jiao Tong Univ, Dept Earth & Environm Sci, Sch Human Settlements & Civil Engn, 28 Xianning West Rd, Xian 710049, Peoples R China; [Sun, Changfeng; Liu, Yu] Chinese Acad Sci, State Key Lab Loess & Quaternary Geol, Inst Earth Environm, 97 Yanxiang Rd, Xian 710061, Peoples R China	Xi'an Jiaotong University; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Liu, Y (corresponding author), Xi An Jiao Tong Univ, Dept Earth & Environm Sci, Sch Human Settlements & Civil Engn, 28 Xianning West Rd, Xian 710049, Peoples R China.; Liu, Y (corresponding author), Chinese Acad Sci, State Key Lab Loess & Quaternary Geol, Inst Earth Environm, 97 Yanxiang Rd, Xian 710061, Peoples R China.	liuyu@loess.llqg.ac.cn	Sun, Changfeng/X-2375-2019; Liu, Yu/AAA-6165-2019	Sun, Changfeng/0000-0001-8648-8120; liu, yu/0000-0002-1402-0737	Chinese Academy of Sciences [KZZD-EW-04-01]; State Key Laboratory of Loess and Quaternary Geology Foundation [SKLLQG1317]; Chinese Academy of Sciences [KZZD-EW-04-01]; State Key Laboratory of Loess and Quaternary Geology Foundation [SKLLQG1317]	Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Loess and Quaternary Geology Foundation; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Loess and Quaternary Geology Foundation	This study was supported by grants from the Chinese Academy of Sciences (KZZD-EW-04-01) and the State Key Laboratory of Loess and Quaternary Geology Foundation (SKLLQG1317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/ngeo1797, 10.1038/NGEO1797]; Bai Jie, 2010, Chinese Journal of Plant Ecology, V34, P1274, DOI 10.3773/j.issn.1005-264x.2010.11.004; Baxter S, 2014, J CLIMATE, V27, P7356, DOI 10.1175/JCLI-D-14-00105.1; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Chen F, 2015, THEORETICAL APPL CLI; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107501; Chen F, 2014, GEOCHRONOMETRIA, V41, P234, DOI 10.2478/s13386-013-0159-9; Chen XQ, 2005, GLOBAL CHANGE BIOL, V11, P1118, DOI 10.1111/j.1365-2486.2005.00974.x; Cook E.R., 2013, METHODS DENDROCHRONO; Cook E. R., 1985, TIME SERIES ANAL APP; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Deslauriers A, 2003, TREES-STRUCT FUNCT, V17, P477, DOI 10.1007/s00468-003-0260-4; Deslauriers A, 2008, TREE PHYSIOL, V28, P863, DOI 10.1093/treephys/28.6.863; Downes G, 1999, TREES-STRUCT FUNCT, V14, P102, DOI 10.1007/PL00009752; Drew DM, 2009, TREES-STRUCT FUNCT, V23, P585, DOI 10.1007/s00468-008-0303-y; Duan JP, 2012, CLIM DYNAM, V39, P919, DOI 10.1007/s00382-011-1232-9; Duchesne L, 2011, FOREST ECOL MANAG, V262, P863, DOI 10.1016/j.foreco.2011.05.027; Fang KY, 2012, CLIM DYNAM, V39, P1697, DOI 10.1007/s00382-012-1371-7; [封晓辉 Feng Xiaohui], 2012, [生态学报, Acta Ecologica Sinica], V32, P1450; Fritts H. C., 1976, TREE RINGS CLIMATE; Garfin GM, 2005, TREE-RING RES, V61, P59, DOI 10.3959/1536-1098-61.2.59; George SS, 2014, QUATERNARY SCI REV, V95, P132, DOI 10.1016/j.quascirev.2014.04.029; Gou XH, 2007, INT J CLIMATOL, V27, P1497, DOI 10.1002/joc.1480; Griffin D, 2013, GEOPHYS RES LETT, V40, P954, DOI 10.1002/grl.50184; Gutierrez E, 2011, TREES-STRUCT FUNCT, V25, P637, DOI 10.1007/s00468-011-0540-3; HUGHES MK, 1994, QUATERNARY RES, V42, P88, DOI 10.1006/qres.1994.1056; Kirdyanov A, 2003, TREES-STRUCT FUNCT, V17, P61, DOI 10.1007/s00468-002-0209-z; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI [10.1038/nclimate1936, 10.1038/NCLIMATE1936]; Liang EY, 2011, GLOBAL PLANET CHANGE, V77, P97, DOI 10.1016/j.gloplacha.2011.04.005; Liang EY, 2009, IAWA J, V30, P371, DOI 10.1163/22941932-90000225; [刘洪滨 Liu Hongbin], 2002, [第四纪研究, Quaternary Sciences], V22, P220; Liu WH, 2009, ADV ATMOS SCI, V26, P621, DOI 10.1007/s00376-009-9028-0; Liu Y, 2004, CHINESE SCI BULL, V49, P405, DOI 10.1360/03wd0409; Liu Y, 2003, CHINESE SCI BULL, V48, P1140, DOI 10.1360/02wd0455; Liu Yan, 2009, Proceedings of the CSEE, V29, P1; Liu Y, 2007, TREE-RING RES, V63, P3, DOI 10.3959/1536-1098-63.1.3; Liu Y, 2009, BOREAS, V38, P285, DOI 10.1111/j.1502-3885.2008.00065.x; Mendivelso HA, 2014, AGR FOREST METEOROL, V188, P13, DOI 10.1016/j.agrformet.2013.12.010; Naurzbaev MM, 2000, J GEOPHYS RES-ATMOS, V105, P7317, DOI 10.1029/1999JD901059; Qi ZH, 2015, GLOBAL CHANGE BIOL, V21, P816, DOI 10.1111/gcb.12703; Qian C, 2012, CHINESE SCI BULL, V57, P276, DOI 10.1007/s11434-011-4724-4; Rossi S, 2008, GLOBAL ECOL BIOGEOGR, V17, P696, DOI 10.1111/j.1466-8238.2008.00417.x; Rotzer T, 2004, INT J BIOMETEOROL, V48, P109, DOI 10.1007/s00484-003-0191-1; Seo JW, 2011, ENVIRON EXP BOT, V72, P422, DOI 10.1016/j.envexpbot.2011.01.003; Shao X, 2010, QUATERNARY SCI REV, V29, P2111, DOI 10.1016/j.quascirev.2010.05.005; Shao XM., 1994, J CHINESE GEOGRAPHY, V4, P88; Shi JF, 2012, CLIM RES, V53, P157, DOI 10.3354/cr01098; [史江峰 Shi Jiangfeng], 2009, [第四纪研究, Quaternary Sciences], V29, P831; Tadross MA, 2005, J CLIMATE, V18, P3356, DOI 10.1175/JCLI3423.1; [田沁花 TIAN Qinhua], 2009, [地理学报, Acta Geographica Sinica], V64, P879; Vaganov EA, 1999, NATURE, V400, P149, DOI 10.1038/22087; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Wang XZ, 2013, 24 SOLAR TERMS CHINA; Wilson R., 2002, DENDROCHRONOLOGIA, V20, P1; Wu XC, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024016; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Yang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057638; Yin XG, 1995, Q J APPL METEOROL, V6, P257; [袁玉江 Yuan Yujiang], 2005, [生态学报, Acta Ecologica Sinica], V25, P756; Zhang ZH, 2015, ECOL INDIC, V51, P107, DOI 10.1016/j.ecolind.2014.07.042; Zhao P, 2007, CLIM DYNAM, V28, P797, DOI 10.1007/s00382-006-0212-y; Zhu HF, 2008, CHINESE SCI BULL, V53, P3914, DOI 10.1007/s11434-008-0400-8	62	11	12	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160938	10.1371/journal.pone.0160938	http://dx.doi.org/10.1371/journal.pone.0160938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508933	Green Submitted, gold, Green Published			2022-12-26	WOS:000381380400068
J	Tschirhart, N; Sein, T; Nosten, F; Foster, AM				Tschirhart, Naomi; Sein, Tabitha; Nosten, Francois; Foster, Angel M.			Migrant and Refugee Patient Perspectives on Travel and Tuberculosis along the Thailand-Myanmar Border: A Qualitative Study	PLOS ONE			English	Article								Background The Thailand-Myanmar border separates two very different health systems. The healthcare system in eastern Myanmar remains underdeveloped as a result of decades of instability. Comparatively, Tak province, Thailand has more healthcare resources. In this Thai border province government hospitals and non-governmental organizations provide tuberculosis (TB) treatment to migrants and refugees. Objectives Our overall study aimed to explore accessibility of TB treatment, TB surveillance and health system responsiveness specific to migrant and refugee populations in Tak province. In this paper, we focus on the perspectives of migrant and refugee TB patients with respect to travel and treatment in Tak province. Methods In 2014 we conducted focus group discussions with 61 TB, Tuberculosis and Human Immunodeficiency Virus co-infection, and multidrug-resistant TB patients in Tak province. We analyzed the data for content and themes and documented individual travel trajectories. Results and Discussion Migrants are travelling with active TB within the country and between Thailand and Myanmar. Migrants primarily travelled to obtain treatment but two participants reported travelling home to seek family care in Myanmar before returning to Thailand for treatment. Travel, while expensive and arduous, is an adaptive strategy that migrants use to access healthcare. Conclusions Migrant's need for travel points to larger difficulties associated with healthcare access in the border region. Long distance travel with an infectious disease can be seen as an indicator that local healthcare is not available or affordable. These findings suggest that public health officials from both sides of the border should discuss the factors that contribute to travel with active TB and explore potential solutions to mitigate disease transmission in migrant populations.	[Tschirhart, Naomi; Foster, Angel M.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada; [Tschirhart, Naomi; Sein, Tabitha; Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	University of Ottawa; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Tschirhart, N (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada.; Tschirhart, N (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Bangkok, Thailand.	ntschirhart@gmail.com	Nosten, Francois/AAC-5509-2019	Nosten, Francois/0000-0002-7951-0745	International Development Research Centre (Canada) [107473-99906075-055]; Faculty of Graduate and Post-Graduate Studies at the University of Ottawa; Ministry of Health and Long-Term Care in Ontario (Canada); Wellcome Trust of Great Britain	International Development Research Centre (Canada); Faculty of Graduate and Post-Graduate Studies at the University of Ottawa; Ministry of Health and Long-Term Care in Ontario (Canada); Wellcome Trust of Great Britain(Wellcome Trust)	The authors received support for this project through a Doctoral Research Award # 107473-99906075-055 from the International Development Research Centre (Canada) http://www.idrc.ca, and a student mobility bursary research travel grant from the Faculty of Graduate and Post-Graduate Studies at the University of Ottawa (NT). AF's Endowed Chair is funded by the Ministry of Health and Long-Term Care in Ontario (Canada) and the authors appreciate the general support for her time that made this project possible. The Shoklo Malaria Research Unit is part of the Mahidol Oxford University Research Unit, supported by the Wellcome Trust of Great Britain. SMRU provided in kind support including logistical and transportation assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks to Shoklo Malaria Research Unit staff, especially Dr. Sein Sein Thi, Dr. Lei Lei Swe, Mr. Tip Ruchaitrakul and Ms. Wilasinee Gatenoi. Thank you to the International Organization for Migration, World Vision Thailand, the Tak Provincial Public Health Office, and Premiere Urgence-Aide Medicale Internationale for contributing to this project. Thank you to Tabitha Sein, Kyaw Ye Min, James Bond and Channarong Intahchomphoo for their help with translating, interpreting and transcribing. The study team also thanks all of the men and women who shared their experiences with us. NT completed this project as part of the requirements for her PhD degree in Population Health at the University of Ottawa. The conclusions and opinions expressed in this article are those of the authors and do not necessarily represent the views of the organizations with which the authors are affiliated or the funders. SMRU is part of the Mahidol Oxford University Research Unit supported by the Wellcome Trust of Great Britain.	Tomas BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082440; Davies A, 2006, EUROHEALTH, V16, P10; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; Guba EG., 1994, HDB QUALITATIVE RES, P105; Health Information Systems Working Group, 2015, LONG ROAD REC ETHN C; Hemhongsa P, 2008, TROP MED INT HEALTH, V13, P1288, DOI 10.1111/j.1365-3156.2008.02139.x; Iemrod K, 2015, PUBLIC HLTH J BURAPH, V10, P2; Jayachandran V, 2014, ANN TROP MED PUBLIC, V7, P124, DOI 10.4103/1755-6783.146402; Kamberelis G., 2005, SAGE HDB QUALITATIVE, P887; Mohr O., 2012, EUROSURVEILLANCE, V17, P1; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Shoklo Malaria Research Unit, 2014, TB FIELD; WHO, 2014, GLOB TUB REP 2014	13	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160222	10.1371/journal.pone.0160222	http://dx.doi.org/10.1371/journal.pone.0160222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509036	Green Published, Green Submitted, gold			2022-12-26	WOS:000381380400025
J	Locatelli, S; Harrigan, RJ; Clee, PRS; Mitchell, MW; McKean, KA; Smith, TB; Gonder, MK				Locatelli, Sabrina; Harrigan, Ryan J.; Clee, Paul R. Sesink; Mitchell, Matthew W.; McKean, Kurt A.; Smith, Thomas B.; Gonder, Mary Katherine			Why Are Nigeria-Cameroon Chimpanzees (Pan troglodytes ellioti) Free of SIVcpz Infection?	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; CROSS-SPECIES TRANSMISSION; PILIOCOLOBUS-BADIUS-BADIUS; SIMIAN FOAMY VIRUS; WILD CHIMPANZEES; GENETIC DIVERSITY; GREAT APE; SELECTIVE SWEEP; HIGH PREVALENCE; NATIONAL-PARK	Simian immunodeficiency virus (SIV) naturally infects two subspecies of chimpanzee: Pan troglodytes troglodytes from Central Africa (SIVcpzPtt) and P. t. schweinfurtii from East Africa (SIVcpzPts), but is absent in P. t. verus from West Africa and appears to be absent in P. t. ellioti inhabiting Nigeria and western Cameroon. One explanation for this pattern is that P. t. troglodytes and P. t schweinfurthii may have acquired SIVcpz after their divergence from P. t. verus and P. t. ellioti. However, all of the subspecies, except P. t. verus, still occasionally exchange migrants making the absence of SIVcpz in P. t. ellioti puzzling. Sampling of P. t. ellioti has been minimal to date, particularly along the banks of the Sanaga River, where its range abuts that of P. t. troglodytes. This study had three objectives. First, we extended the sampling of SIVcpz across the range of chimpanzees north of the Sanaga River to address whether under-sampling might account for the absence of evidence for SIVcpz infection in P. t. ellioti. Second, we investigated how environmental variation is associated with the spread and prevalence of SIVcpz in the two chimpanzee subspecies inhabiting Cameroon since environmental variation has been shown to contribute to their divergence from one another. Finally, we compared the prevalence and distribution of SIVcpz with that of Simian Foamy Virus (SFV) to examine the role of ecology and behavior in shaping the distribution of diseases in wild host populations. The dataset includes previously published results on SIVcpz infection and SFVcpz as well as newly collected data, and represents over 1000 chimpanzee fecal samples from 41 locations across Cameroon. Results revealed that none of the 181 P. t. ellioti fecal samples collected across the range of P. t. ellioti tested positive for SIVcpz. In addition, species distribution models suggest that environmental variation contributes to differences in the distribution and prevalence of SIVcpz and SFVcpz. The ecological niches of these two viruses are largely non-overlapping, although stronger statistical support for this conclusion will require more sampling. Overall this study demonstrates that SIVcpz infection is absent or very rare in P. t. ellioti, despite multiple opportunities for transmission. The reasons for its absence remain unclear, but might be explained by one or more factors, including environmental variation, viral competition, and/or local adaptation-all of which should be explored in greater detail through continued surveillance of this region.	[Locatelli, Sabrina] INSERM, Inst Rech Dev, Unite Mixte Int 233, U1175, F-34394 Montpellier, France; [Locatelli, Sabrina] Univ Montpellier, F-34394 Montpellier, France; [Locatelli, Sabrina; Clee, Paul R. Sesink; Mitchell, Matthew W.; McKean, Kurt A.; Gonder, Mary Katherine] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Harrigan, Ryan J.; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Ctr Trop Res, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Clee, Paul R. Sesink; Mitchell, Matthew W.; Gonder, Mary Katherine] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [McKean, Kurt A.] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Los Angeles; Drexel University; University of Hull	Locatelli, S (corresponding author), INSERM, Inst Rech Dev, Unite Mixte Int 233, U1175, F-34394 Montpellier, France.; Locatelli, S (corresponding author), Univ Montpellier, F-34394 Montpellier, France.; Locatelli, S (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.	sabrina.locatelli@ird.fr	Locatelli, Sabrina/I-5777-2019	Locatelli, Sabrina/0000-0002-1133-0561; Mitchell, Matthew/0000-0002-6947-0495	National Science Foundation [0755823, 1243524, PD-08-1269]; Drexel University; University at Albany - State University of New York; Zoological Society of San Diego; Ebo Forest Research Project; Wildlife Conservation Society; World Wildlife Fund; Division Of Mathematical Sciences [1513657] Funding Source: National Science Foundation; Office Of Internatl Science &Engineering [1243524] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Drexel University; University at Albany - State University of New York; Zoological Society of San Diego; Ebo Forest Research Project; Wildlife Conservation Society; World Wildlife Fund; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Science Foundation (awards 0755823, 1243524 to MKG and PD-08-1269 to RH) and funding from Drexel University and the University at Albany - State University of New York (to MKG). The authors thank the Zoological Society of San Diego, the Ebo Forest Research Project, the Wildlife Conservation Society, and the World Wildlife Fund for their support in Cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the government of Cameroon for permission to conduct this research. We thank the Zoological Society of San Diego, the Ebo Forest Research Project, the Wildlife Conservation Society and the World Wildlife Fund for their support in Cameroon. We thank Ying-Ying Li and Beatrice Hahn for providing samples and for carrying out SIV testing. Finally, we thank the editor William M. Switzer, Sebastien Calvignac-Spencer and another anonymous reviewer for their constructive comments on an earlier version of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Boesch C, 2000, CHIMPANZEES TAI FORE; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Chapman CA, 1994, BEHAV ECOL SOCIOBIOL, V1, P59; Choudhary A, 2013, VIRUSES-BASEL, V5, P1414, DOI 10.3390/v5061414; Clee PRS, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-014-0275-z; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; D'arc M, 2015, P NATL ACAD SCI USA, V112, pE1343, DOI 10.1073/pnas.1502022112; De Groot NG, 2008, MOL ECOL, V17, P2074, DOI 10.1111/j.1365-294X.2008.03716.x; de Groot NG, 2002, P NATL ACAD SCI USA, V99, P11748, DOI 10.1073/pnas.182420799; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, SPECIES DISTRIBUTION, P677; Etienne L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-4; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gagneux P, 1999, ANIM BEHAV, V57, P19, DOI 10.1006/anbe.1998.0972; Gifford RJ, 2012, TRENDS GENET, V28, P89, DOI 10.1016/j.tig.2011.11.003; Goldberg TL, 2009, J VIROL, V83, P11318, DOI 10.1128/JVI.02616-08; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Gonder MK, 1997, NATURE, V388, P337, DOI 10.1038/41005; Goodall J., 1986, CHIMPANZEES GOMBE PA; Hansen MC, 2000, INT J REMOTE SENS, V21, P1331, DOI 10.1080/014311600210209; Hey J, 2010, MOL BIOL EVOL, V27, P921, DOI 10.1093/molbev/msp298; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Leendertz SAJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-24; Leendertz SAJ, 2010, J VIROL, V84, P7427, DOI 10.1128/JVI.00697-10; Lehner B., 2008, EOS T AM GEOPHYS UN, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Li YY, 2012, J VIROL, V86, P10776, DOI 10.1128/JVI.01498-12; Linial M, 2000, TRENDS MICROBIOL, V8, P284, DOI 10.1016/S0966-842X(00)01763-7; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Locatelli S, 2012, AIDS, V26, P659, DOI 10.1097/QAD.0b013e328350fb68; MacFie S, 2009, MOL BIOL EVOL, V26, P719, DOI 10.1093/molbev/msp016; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Matsumoto-Oda A, 1998, INT J PRIMATOL, V19, P999, DOI 10.1023/A:1020322203166; MCGREW W, 1996, GREAT APE SOC; Mitani JC, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P102, DOI 10.1017/CBO9780511606397.011; Mitchard ETA, 2011, REMOTE SENS ENVIRON, V115, P2861, DOI 10.1016/j.rse.2010.02.022; Mitchell MW, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-014-0276-y; Morgan BJ, 2012, FOLIA PRIMATOL, V83, P329, DOI 10.1159/000339813; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Murray SM, 2006, J MED PRIMATOL, V35, P225, DOI 10.1111/j.1600-0684.2006.00171.x; Murray SM, 2008, J VIROL, V82, P5981, DOI 10.1128/JVI.00367-08; Nerrienet E, 2005, J VIROL, V79, P1312, DOI 10.1128/JVI.79.2.1312-1319.2005; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Novembre FJ, 1997, J VIROL, V71, P4086, DOI 10.1128/JVI.71.5.4086-4091.1997; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prince AM, 2002, AIDS RES HUM RETROV, V18, P657, DOI 10.1089/088922202760019356; Pruetz Jill D., 2009, Paleoanthropology, V2009, P252; Rudicell RS, 2011, J VIROL, V85, P9918, DOI 10.1128/JVI.05475-11; Rudicell RS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001116; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Sommer V, 2004, FOLIA PRIMATOL, V75, P295, DOI 10.1159/000080208; Stenbak CR, 2014, J VIROL, V88, P982, DOI 10.1128/JVI.03154-13; Stumpf R, 2007, PRIMATES PERSPECTIVE, P321; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Terio KA, 2011, J ZOO WILDLIFE MED, V42, P597, DOI 10.1638/2010-0237.1; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377; Wooding S, 2005, AM J HUM GENET, V76, P291, DOI 10.1086/427927; Worobey M, 2010, SCIENCE, V329, P1487, DOI 10.1126/science.1193550; Wrangham RW, 1996, GREAT APE SOC, P81	79	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160788	10.1371/journal.pone.0160788	http://dx.doi.org/10.1371/journal.pone.0160788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505066	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200064
J	Lyu, ZC; Qin, N; Tyasi, TL; Zhu, HY; Liu, DH; Yuan, SG; Xu, RF				Lyu, Zhichao; Qin, Ning; Tyasi, Thobela Louis; Zhu, Hongyan; Liu, Dehui; Yuan, Shuguo; Xu, Rifu			The Hippo/MST Pathway Member SAV1 Plays a Suppressive Role in Development of the Prehierarchical Follicles in Hen Ovary	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; GRANULOSA-CELL PROLIFERATION; ACUTE REGULATORY PROTEIN; PROMOTES APOPTOSIS; SIGNALING PATHWAY; STEM-CELLS; CYCLIN D2; STIMULATING-HORMONE; FORKHEAD L2; YAP	The Hippo/MST signaling pathway is a critical player in controlling cell proliferation, self-renewal, differentiation, and apoptosis of most tissues and organs in diverse species. Previous studies have shown that Salvador homolog 1 (SAV1), a scaffolding protein which functions in the signaling system is expressed in mammalian ovaries and play a vital role in governing the follicle development. But the exact biological effects of chicken SAV1 in prehierarchical follicle development remain poorly understood. In the present study, we demonstrated that the SAV1 protein is predominantly expressed in the oocytes and undifferentiated granulosa cells in the various sized prehierarchical follicles of hen ovary, and the endogenous expression level of SAV1 mRNA appears down-regulated from the primordial follicles to the largest preovulatory follicles (F2-F1) by immunohistochemistry and real-time RT-PCR, respectively. Moreover, we found the intracellular SAV1 physically interacts with each of the pathway members, including STK4/MST1, STK3/MST2, LATS1 and MOB2 using western blotting. And SAV1 significantly promotes the phosphorylation of LATS1 induced by the kinase of STK4 or STK3 in vitro. Furthermore, SAV1 knockdown by small interfering RNA (siRNA) significantly increased proliferation of granulosa cells from the prehierarchical follicles (6-8 mm in diameter) by BrdU-incorporation assay, in which the expression levels of GDF9, StAR and FSHR mRNA was notably enhanced. Meanwhile, these findings were consolidated by the data of SAV1 overexpression. Taken together, the present results revealed that SAV1 can inhibit proliferation of the granulosa cells whereby the expression levels of GDF9, StAR and FSHR mRNA were negatively regulated. Accordingly, SAV1, as a member of the hippo/MST signaling pathway plays a suppressive role in ovarian follicle development by promoting phosphorylation and activity of the downstream LATS1, may consequently lead to prevention of the follicle selection during ovary development.	[Lyu, Zhichao; Qin, Ning; Tyasi, Thobela Louis; Zhu, Hongyan; Liu, Dehui; Xu, Rifu] Jilin Agr Univ, Dept Anim Genet Breeding & Reprod, Coll Anim Sci & Technol, Changchun 130118, Jilin, Peoples R China; [Yuan, Shuguo] Jilin Grain Grp Agr & Livestock Co Ltd, Changchun 130062, Jilin, Peoples R China	Jilin Agricultural University	Xu, RF (corresponding author), Jilin Agr Univ, Dept Anim Genet Breeding & Reprod, Coll Anim Sci & Technol, Changchun 130118, Jilin, Peoples R China.	poultryxu@jlau.edu.cn	Tyasi, Thobela Louis/AAH-8974-2021	Tyasi, Thobela Louis/0000-0002-3519-7806	National Natural Science Funds [31272431]; National High Technology Research and Development Program of China (863 Program) [2011AA100305]; Key Project of Education Department of Jilin Province [2013-47]; Jilin Grain Group Agriculture and Livestock Co., Ltd.; China Agriculture Research System [CARS-42]; Jilin Provincial Agriculture Research System	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key Project of Education Department of Jilin Province; Jilin Grain Group Agriculture and Livestock Co., Ltd.; China Agriculture Research System; Jilin Provincial Agriculture Research System	Funding provided by National Natural Science Funds (No. 31272431): https://isisn.nsfc.gov.cn/egrantweb/. This funder had a role in study design. National High Technology Research and Development Program of China (863 Program) (No. 2011AA100305): http://program.most.gov.cn/. This funder had a role in data collection and analysis. China Agriculture Research System (No. CARS-42): http://119.253.58.231/. This funder had a role in study design, data collection and analysis. This funder had a role in decision to publish. Jilin Provincial Agriculture Research System and the Key Project of Education Department of Jilin Province (No. 2013-47): http://www.jlxm.gov.cn/. This funder had a role in preparation of the manuscript. Jilin Grain Group Agriculture and Livestock Co., Ltd., provided support in the form of salaries for authors [SGY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Bentsi-Barnes IK, 2010, FERTIL STERIL, V94, P353, DOI 10.1016/j.fertnstert.2009.09.050; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheng Y, 2015, FASEB J, V29, P2423, DOI 10.1096/fj.14-267856; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Han YY, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105106; Hao J, 2014, J CELL PHYSIOL, V229, P266, DOI 10.1002/jcp.24455; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Johnson AL, 2015, POULTRY SCI, V94, P781, DOI 10.3382/ps/peu008; Johnson PA, 2005, BIOL REPROD, V72, P1095, DOI 10.1095/biolreprod.104.036822; Karpowicz P, 2010, DEVELOPMENT, V137, P4135, DOI 10.1242/dev.060483; Kawamura K, 2013, P NATL ACAD SCI USA, V110, P17474, DOI 10.1073/pnas.1312830110; Kodaka M, 2015, CELL MOL LIFE SCI, V72, P285, DOI 10.1007/s00018-014-1742-9; Kuo FT, 2012, REPRODUCTION, V144, P485, DOI 10.1530/REP-11-0259; Kuo FT, 2009, CELL SIGNAL, V21, P1935, DOI 10.1016/j.cellsig.2009.09.001; Lange AW, 2015, J MOL CELL BIOL, V7, P35, DOI 10.1093/jmcb/mju046; Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63; Li J, 2015, CELL PHYSIOL BIOCHEM, V36, P1712, DOI 10.1159/000430144; Li T, 2012, J MED GENET, V49, P254, DOI 10.1136/jmedgenet-2011-100727; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Lu WD, 2002, SPSS WINDOWS STAT AN, P124; Lun YZ, 2014, MOL MED REP, V9, P720, DOI 10.3892/mmr.2013.1813; Matsuura K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-523; Muniz LC, 2006, BIOL REPROD, V75, P279, DOI 10.1095/biolreprod.105.049486; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Park BH, 2011, BMB REP, V44, P584, DOI 10.5483/BMBRep.2011.44.9.584; Pisarska MD, 2010, AM J PHYSIOL-ENDOC M, V299, pE101, DOI 10.1152/ajpendo.00534.2009; Qin N, 2015, POULTRY SCI, V94, P2235, DOI 10.3382/ps/pev185; Qin N, 2015, POULTRY SCI, V94, P88, DOI 10.3382/ps/peu023; Qin N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141062; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Sarikaya DP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004962; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Stepinska U, 1996, J EXP ZOOL, V276, P19, DOI 10.1002/(SICI)1097-010X(19960901)276:1&lt;19::AID-JEZ3&gt;3.0.CO;2-8; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson WE, 1999, J HISTOCHEM CYTOCHEM, V47, P769, DOI 10.1177/002215549904700606; Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818; Woods DC, 2005, BIOL REPROD, V72, P643, DOI 10.1095/biolreprod.104.033902; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xiang C, 2015, CELL PHYSIOL BIOCHEM, V35, P957, DOI 10.1159/000369752; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108	55	24	25	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160896	10.1371/journal.pone.0160896	http://dx.doi.org/10.1371/journal.pone.0160896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505353	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200075
J	Gracia, MI; Sanchez, J; Millan, C; Casabuena, O; Vesseur, P; Martin, A; Garcia-Pena, FJ; Medel, P				Isabel Gracia, Marta; Sanchez, Jaime; Millan, Carlos; Casabuena, Oscar; Vesseur, Peter; Martin, Angel; Javier Garcia-Pena, Francisco; Medel, Pedro			Effect of Feed Form and Whole Grain Feeding on Gastrointestinal Weight and the Prevalence of Campylobacter jejuni in Broilers Orally Infected	PLOS ONE			English	Article							DIGESTIVE-TRACT; PARTICLE-SIZE; CHICKEN DIETS; MICROBIAL COMPOSITION; WHEAT; PERFORMANCE; COLONIZATION; POULTRY; IDENTIFICATION; CONTAMINATION	Two independent trials were carried out to evaluate the effect of feed form, whole wheat (WW) and oat hulls (OH) addition on gastrointestinal (GIT) weight and Campylobacter jejuni colonization in orally infected birds. In Trial 1, there were six treatments factorially arranged with two feed forms (mash vs pellets), and three levels of WW from 1-21/22-42d:0/0, 7.5/15%, 15/30%. Broilers were allocated in cages (3 birds/cage, 12 cages/treatment). In Trial 2, there were three treatments: a mash diet, a mash diet including WW(7.5% from 1-21 and 15% from 22-42d), and a third treatment including also 5% OH. Broilers were allocated in floor pens (1 pen with 30 birds/treatment). At 14d, all broilers in Trial 1 or 3 broilers/pen in Trial 2 were orally challenged with 1.5 x 10(5) cfu of C. jejuni ST-45 /. In Trial 1, birds fed pelleted diets consumed 13.5% more feed, gained 31% more weight, and presented 12.9% better feed conversion for the whole trial (P<0.05). Pelleting decreased the relative weight of GIT and gizzard and increased the relative weight of proventriculus (P<0.05). Mash diets decreased pH in the gizzard (P<0.05). Inclusion of WW decreased the relative weight of proventriculus, increased gizzard weight, and reduced pH in the gizzard (P<0.05). At 21d of age, mash tended to reduce C. jejuni compared to pellets (7.85 vs 8.27 log(10)cfu/g; P = 0.091) and WW inclusion at 7.5/15% reduced C. jejuni colonization when compared to lower and higher inclusion (P<0.05). In Trial 2, birds fed T3 (WW+OH) showed 1.38 log(10)cfu/g less than birds fed Control diet (P<0.05). In conclusion, despite of the clear morphological changes in the GIT derived of FF andWWinclusion, no clear reductions in C. jejuni populations in the ceca were observed. However, WW and OH inclusion to mash diets significantly reduced cecal C. jejuni colonization at 42 days.	[Isabel Gracia, Marta; Sanchez, Jaime; Millan, Carlos; Casabuena, Oscar; Medel, Pedro] Imasde Agroalimentaria SL, Madrid, Spain; [Vesseur, Peter] NEPLUVI, Houten, Netherlands; [Martin, Angel] PROPOLLO, Madrid, Spain; [Javier Garcia-Pena, Francisco] MAGRAMA, Lab Sanidad Anim Algete, Madrid, Spain		Gracia, MI (corresponding author), Imasde Agroalimentaria SL, Madrid, Spain.	mgracia@e-imasde.com			European Union's Seventh Framework Programme [605835]	European Union's Seventh Framework Programme(European Commission)	This work has been done within the project CAMPYBRO, which has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 605835.; This work has been done within the project CAMPYBRO, which has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 605835. We thank Jorge Garcia Palomares from Alta Morana Soc. Coop. for his help in the manufacturing of the experimental diets and Silvia Porras for analytical assistance.	Amerah AM, 2007, WORLD POULTRY SCI J, V63, P439, DOI 10.1017/S0043933907001560; Amerah AM, 2008, ANIM FEED SCI TECH, V147, P326, DOI 10.1016/j.anifeedsci.2008.01.014; [Anonymous], 2010, GUID CAR US AGR AN R; AOAC International, 1995, OFFICIAL METHODS ANA; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Bennett CD, 2002, POULTRY SCI, V81, P995, DOI 10.1093/ps/81.7.995; Bennett CD, 1995, CAN J ANIM SCI, V75, P611, DOI 10.4141/cjas95-090; Bjerrum L, 2005, AVIAN DIS, V49, P9, DOI 10.1637/7223-061504R; CHOI JH, 1986, POULTRY SCI, V65, P594, DOI 10.3382/ps.0650594; Cumming R. B., 1994, Proceedings 9th European poultry conference, Glasgow, UK, 7-12 August 1994: Volume 2., P219; Cumming RB, 1984, P POULTR HUSB RES FD, P68; de Blas C, 2010, GUIDELINES SPANISH F; EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2016.4419; Engberg RM, 2004, POULTRY SCI, V83, P925, DOI 10.1093/ps/83.6.925; Engberg RM, 2002, BRIT POULTRY SCI, V43, P569, DOI 10.1080/0007166022000004480; FORBES JM, 1995, WORLD POULTRY SCI J, V51, P149, DOI 10.1079/WPS19950010; Fravalo P, 2009, J FOOD PROTECT, V72, P1836, DOI 10.4315/0362-028X-72.9.1836; Frikha M, 2009, POULTRY SCI, V88, P994, DOI 10.3382/ps.2008-00480; Gabriel I, 2008, ANIM FEED SCI TECH, V142, P144, DOI 10.1016/j.anifeedsci.2007.06.036; Gabriel I, 2003, POULTRY SCI, V82, P1668, DOI 10.1093/ps/82.11.1668; Gabriel I, 2003, BRIT POULTRY SCI, V44, P283, DOI 10.1080/0007166031000096470; Hariharan H, 2004, VET MED-CZECH, V49, P441, DOI 10.17221/5736-VETMED; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Hetland H, 2003, BRIT POULTRY SCI, V44, P275, DOI 10.1080/0007166031000124595; Hetland H, 2002, BRIT POULTRY SCI, V43, P416, DOI 10.1080/00071660120103693; Hill K.J., 1971, P25; Huang DS, 2006, POULTRY SCI, V85, P831, DOI 10.1093/ps/85.5.831; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Jensen LS, 2000, ASIAN AUSTRAL J ANIM, V13, P35; Jones GPD, 2001, BRIT POULTRY SCI, V42, P477, DOI 10.1080/00071660120070587; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Luber P, 2006, APPL ENVIRON MICROB, V72, P66, DOI 10.1128/AEM.72.1.66-70.2006; Mateos GG, 2012, J APPL POULTRY RES, V21, P156, DOI 10.3382/japr.2011-00477; Moen B, 2012, J APPL MICROBIOL, V113, P1176, DOI 10.1111/j.1365-2672.2012.05404.x; Nauta M, 2009, INT J FOOD MICROBIOL, V129, P107, DOI 10.1016/j.ijfoodmicro.2008.12.001; Plavnik I, 2002, ANIM FEED SCI TECH, V96, P229, DOI 10.1016/S0377-8401(01)00321-2; ROCHE M, 1981, REPROD NUTR DEV, V21, P781, DOI 10.1051/rnd:19810611; Rosenquist H, 2006, INT J FOOD MICROBIOL, V108, P226, DOI 10.1016/j.ijfoodmicro.2005.12.007; Santos FBO, 2008, POULTRY SCI, V87, P405, DOI 10.3382/ps.2006-00417; SHANE SM, 1992, AVIAN PATHOL, V21, P189, DOI 10.1080/03079459208418836; Singh Y, 2014, ANIM FEED SCI TECH, V190, P1, DOI 10.1016/j.anifeedsci.2014.01.010; Skanseng B, 2013, AGRICULTURE-BASEL, V3, P741, DOI 10.3390/agriculture3040741; STERN NJ, 1988, AVIAN DIS, V32, P330, DOI 10.2307/1590822; Svihus B, 2004, BRIT POULTRY SCI, V45, P55, DOI 10.1080/00071660410001668860; Svihus B, 2011, WORLD POULTRY SCI J, V67, P207, DOI 10.1017/S0043933911000249; Svihus B, 2014, J APPL POULTRY RES, V23, P306, DOI 10.3382/japr.2014-00937; Taylor RD, 2004, BRIT POULTRY SCI, V45, P247, DOI 10.1080/00071660410001715858; Taylor RD, 2004, BRIT POULTRY SCI, V45, P237, DOI 10.1080/00071660410001715849; van Gerwe T, 2009, APPL ENVIRON MICROB, V75, P625, DOI 10.1128/AEM.01912-08; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002	50	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160858	10.1371/journal.pone.0160858	http://dx.doi.org/10.1371/journal.pone.0160858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500730	Green Submitted, gold, Green Published			2022-12-26	WOS:000381373500060
J	Wang, XF; Buechler, NL; Martin, A; Wells, J; Yoza, B; McCall, CE; Vachharajani, V				Wang, Xianfeng; Buechler, Nancy L.; Martin, Ayana; Wells, Jonathan; Yoza, Barbara; McCall, Charles E.; Vachharajani, Vidula			Sirtuin-2 Regulates Sepsis Inflammation in ob/ob Mice	PLOS ONE			English	Article							ENDOTHELIAL-CELL-ADHESION; FATTY-ACID OXIDATION; MICROVASCULAR DYSFUNCTION; ENDOTOXIN TOLERANCE; OBESE MICE; SIRT1; METABOLISM; IMMUNOSUPPRESSION; RESVERATROL; DEACETYLASE	Objective Obesity increases morbidity and resource utilization in sepsis patients. Sepsis transitions from early/hyper-inflammatory to late/hypo-inflammatory phase. Majority of sepsis-mortality occurs during the late sepsis; no therapies exist to treat late sepsis. In lean mice, we have shown that sirtuins (SIRTs) modulate this transition. Here, we investigated the role of sirtuins, especially the adipose-tissue abundant SIRT-2 on transition from early to late sepsis in obese with sepsis. Methods Sepsis was induced using cecal ligation and puncture (CLP) in ob/ob mice. We measured microvascular inflammation in response to lipopolysaccharide/normal saline re-stimulation as a "second-hit" (marker of immune function) at different time points to track phases of sepsis in ob/ob mice. We determined SIRT-2 expression during different phases of sepsis. We studied the effect of SIRT-2 inhibition during the hypo-inflammatory phase on immune function and 7-day survival. We used a RAW264.7 (RAW) cell model of sepsis for mechanistic studies. We confirmed key findings in diet induced obese (DIO) mice with sepsis. Results We observed that the ob/ob-septic mice showed an enhanced early inflammation and a persistent and prolonged hypo-inflammatory phase when compared to WT mice. Unlike WT mice that showed increased SIRT1 expression, we found that SIRT2 levels were increased in ob/ob mice during hypo-inflammation. SIRT-2 inhibition in ob/ob mice during the hypoinflammatory phase of sepsis reversed the repressed microvascular inflammation in vivo via activation of endothelial cells and circulating leukocytes and significantly improved survival. We confirmed the key finding of the role of SIRT2 during hypo-inflammatory phase of sepsis in this project in DIO-sepsis mice. Mechanistically, in the sepsis cell model, SIRT-2 expression modulated inflammatory response by deacetylation of NF kappa Bp65. Conclusion SIRT-2 regulates microvascular inflammation in obese mice with sepsis and may provide a novel treatment target for obesity with sepsis.	[Wang, Xianfeng; Buechler, Nancy L.; Vachharajani, Vidula] Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27101 USA; [Martin, Ayana; Yoza, Barbara; McCall, Charles E.; Vachharajani, Vidula] Wake Forest Sch Med, Dept Med, Winston Salem, NC 27101 USA; [Wells, Jonathan; Yoza, Barbara] Wake Forest Sch Med, Dept Surg, Winston Salem, NC USA	Wake Forest University; Wake Forest University; Wake Forest University	Vachharajani, V (corresponding author), Wake Forest Sch Med, Dept Anesthesiol, Winston Salem, NC 27101 USA.; Vachharajani, V (corresponding author), Wake Forest Sch Med, Dept Med, Winston Salem, NC 27101 USA.	vachhar@wakehealth.edu	Wang, Xianfeng/O-4463-2019; Vachharajani, Vidula/AAX-3640-2021	Wang, Xianfeng/0000-0002-3775-1102; Vachharajani, Vidula/0000-0002-0892-7084	National Institute of General Medical Sciences [R01GM099807, R01GM102497]; National Institute of Allergy and Infectious Diseases [R01AI065791]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099807, R01GM102497] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of General Medical Sciences, R01GM099807; National Institute of Allergy and Infectious Diseases, R01AI065791; and National Institute of General Medical Sciences, R01GM102497.	Akinnusi ME, 2008, CRIT CARE MED, V36, P151, DOI 10.1097/01.CCM.0000297885.60037.6E; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Cavaillon JM, 2005, J ENDOTOXIN RES, V11, P311, DOI 10.1179/096805105X58733; Chopra V, 2012, CELL REP, V2, P1492, DOI 10.1016/j.celrep.2012.11.001; Eppihimer MJ, 1997, AM J PHYSIOL-HEART C, V273, pH1903, DOI 10.1152/ajpheart.1997.273.4.H1903; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Gillette TG, 2006, EMBO J, V25, P2529, DOI 10.1038/sj.emboj.7601120; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hsu A, 2007, CLIN EXP IMMUNOL, V150, P332, DOI 10.1111/j.1365-2249.2007.03491.x; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Jung U, 1998, J CLIN INVEST, V102, P1526, DOI 10.1172/JCI119893; Kochanek Kenneth D, 2015, Natl Vital Stat Rep, V63, P1; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Liu TF, 2015, J BIOL CHEM, V290, P396, DOI 10.1074/jbc.M114.566349; Liu TF, 2012, J LEUKOCYTE BIOL, V92, P499, DOI 10.1189/jlb.0212078; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103573; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Poulsen MM, 2013, ANN NY ACAD SCI, V1290, P74, DOI 10.1111/nyas.12141; Prescott HC, 2014, CRIT CARE MED; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Singer G, 2009, SHOCK, V31, P275, DOI 10.1097/SHK.0b013e3181834ab3; Tailor A, 2003, ARTERIOSCL THROM VAS, V23, P675, DOI 10.1161/01.ATV.0000056742.97580.79; Trivedi V, 2015, J CRIT CARE, V30, P518, DOI 10.1016/j.jcrc.2014.12.007; Vachharajani V, 2006, MICROCIRCULATION, V13, P477, DOI 10.1080/10739680600777599; Vachharajani V, 2014, EXPERT REV CLIN IMMU, V10, P1141, DOI 10.1586/1744666X.2014.943192; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Vachharjani V, 2005, MICROCIRCULATION, V12, P183, DOI 10.1080/10739680590904982; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; VIRCA GD, 1989, J BIOL CHEM, V264, P21951; Wang XF, 2015, OBESITY, V23, P1209, DOI 10.1002/oby.21086; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Winnik S, 2015, EUR HEART J; Wood KA, 2004, PHARMACOECONOMICS, V22, P895, DOI 10.2165/00019053-200422140-00001; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoza B, 1998, PROG CLIN BIOL RES, V397, P209	47	42	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160431	10.1371/journal.pone.0160431	http://dx.doi.org/10.1371/journal.pone.0160431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500833	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500022
J	Azimi, P; Benzel, EC				Azimi, Parisa; Benzel, Edward C.			Cut-Off Value for Pain Sensitivity Questionnaire in Predicting Surgical Success in Patients with Lumbar Disc Herniation	PLOS ONE			English	Article							LOW-BACK-PAIN; SURGERY; OUTCOMES	Various factors related to predict surgical success were studied; however, a standard cut-off point for the Pain Sensitivity Questionnaire (PSQ) measure has not yet been established for a favorable surgical outcome for lumbar disc herniation (LDH). This study was to find the optimal cut-off point on the PSQ to distinguish surgical success in patients with LDH. A total of 154 patients with LDH consecutively referred to our clinic were enrolled into this prospective study between February 2011 and January 2014. All participants completed the PSQ. Patients completed the Oswestry Disability Index (ODI) score before surgery, and at 2 years after surgery. Surgical success was defined as a 13-point improvement from the baseline ODI scores. The cut-off value for PSQ was determined by the receiver-operating characteristic curve (ROC). The mean age of patients was 49.3 +/- 9.6 years, and there were 80 women. The mean time for follow-up assessment was 31 +/- 5months (range 24-35). Post-surgical success was 79.9% (n = 123) at 2 years follow up. The mean score for the total PSQ, PSQ-minor, and PSQ-moderate were 6.0 (SD = 1.6), 5.4 (SD = 1.9) and 6.5 ( SD = 1.7), respectively. Total PSQ score was also significantly correlated with the total scores of the ODI. The optimal total PSQ cut-off point was determined as > 5.2 to predict surgical success in LDH patients, with 80.0% sensitivity and 75.6% specificity (AUC-0.814, 95% CI 0.703-0.926). This study showed that the PSQ could be considered a parameter for predicting surgical success in patients with LDH, and can be useful in clinical practice.	[Azimi, Parisa] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran; [Benzel, Edward C.] Cleveland Clin Fdn, Dept Neurosurg, Cleveland, OH 44195 USA	Shahid Beheshti University Medical Sciences; Cleveland Clinic Foundation	Azimi, P (corresponding author), Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Tehran, Iran.	parisa.azimi@gmail.com	Sciences, Functional Neurosurgery Research Center Shahid Beheshti University of Medical/AAN-2817-2020					Azimi P, 2015, ASIAN SPINE J; Azimi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154114; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Cheung KMC, 2010, SPINE J, V10, P958, DOI 10.1016/j.spinee.2010.09.011; Clauw DJ, 1999, SPINE, V24; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Dai F, 2010, SPINE J, V10, P949, DOI 10.1016/j.spinee.2010.07.387; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finneson B E, 1979, Spine (Phila Pa 1976), V4, P141, DOI 10.1097/00007632-197903000-00008; Garg Bhavuk, 2011, J Orthop Surg (Hong Kong), V19, P30; HOSMER DW, 2000, WILEY PS TX, P1; Jacobsen LM, 2012, EUR J PAIN, V16, P1064, DOI 10.1002/j.1532-2149.2011.00102.x; JUNGE A, 1995, SPINE, V20, P460, DOI 10.1097/00007632-199502001-00009; Kim HJ, 2015, SPINE, V40, P193, DOI 10.1097/BRS.0000000000000699; Kim HJ, 2014, PAIN PRACT, V14, P745, DOI 10.1111/papr.12123; Kleinstueck FS, 2011, EUR SPINE J, V20, P1166, DOI 10.1007/s00586-010-1670-9; Mousavi SJ, 2006, SPINE, V31, pE454, DOI 10.1097/01.brs.0000222141.61424.f7; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Ruscheweyh R, 2009, PAIN, V146, P65, DOI 10.1016/j.pain.2009.06.020; Sellers AB, 2013, REGION ANESTH PAIN M, V38, P508, DOI 10.1097/AAP.0000000000000007; Silverplats K, 2010, EUR SPINE J, V19, P1459, DOI 10.1007/s00586-010-1433-7; Tschugg A, 2015, J WOMENS HEALTH, V24, P771, DOI 10.1089/jwh.2014.5108	23	15	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160541	10.1371/journal.pone.0160541	http://dx.doi.org/10.1371/journal.pone.0160541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494617	Green Published, gold, Green Submitted			2022-12-26	WOS:000381369500056
J	Kanageswaran, N; Nagel, M; Scholz, P; Mohrhardt, J; Gisselmann, G; Hatt, H				Kanageswaran, Ninthujah; Nagel, Maximilian; Scholz, Paul; Mohrhardt, Julia; Gisselmann, Guenter; Hatt, Hanns			Modulatory Effects of Sex Steroids Progesterone and Estradiol on Odorant Evoked Responses in Olfactory Receptor Neurons	PLOS ONE			English	Article							SENSORY NEURONS; MEMBRANE COMPONENT-1; REPLACEMENT THERAPY; SOCIAL RECOGNITION; ESTROUS-CYCLE; FEMALE RATS; MPR-ALPHA; BINDING; PROTEIN; SYSTEM	The influence of the sex steroid hormones progesterone and estradiol on physiology and behavior during menstrual cycles and pregnancy is well known. Several studies indicate that olfactory performance changes with cyclically fluctuating steroid hormone levels in females. Knowledge of the exact mechanisms behind how female sex steroids modulate olfactory signaling is limited. A number of different known genomic and non-genomic actions that are mediated by progesterone and estradiol via interactions with different receptors may be responsible for this modulation. Next generation sequencing-based RNA-Seq transcriptome data from the murine olfactory epithelium OE) and olfactory receptor neurons ORNs) revealed the expression of several membrane progestin receptors and the estradiol receptor Gpr30. These receptors are known to mediate rapid non-genomic effects through interactions with G proteins. RT-PCR and immunohistochemical staining results provide evidence for progestin and estradiol receptors in the ORNs. These data support the hypothesis that steroid hormones are capable of modulating the odorant-evoked activity of ORNs. Here, we validated this hypothesis through the investigation of steroid hormone effects by submerged electro-olfactogram and whole cell patch-clamp recordings of ORNs. For the first time, we demonstrate that the sex steroid hormones progesterone and estradiol decrease odorant-evoked signals in the OE and ORNs of mice at low nanomolar concentrations. Thus, both of these sex steroids can rapidly modulate the odor responsiveness of ORNs through membrane progestin receptors and the estradiol receptor Gpr30.	[Kanageswaran, Ninthujah; Nagel, Maximilian; Scholz, Paul; Mohrhardt, Julia; Gisselmann, Guenter; Hatt, Hanns] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Nagel, Maximilian] Rhein Westfal TH Aachen, Dept Chemosensat, Biol 2, Aachen, Germany	Ruhr University Bochum; RWTH Aachen University	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany.	Guenter.Gisselmann@rub.de			DFG [Sonderforschungsbereich 642]; Ruhr-Universitat Bochum	DFG(German Research Foundation (DFG)); Ruhr-Universitat Bochum	Hanns Hatt was funded by the DFG-Sonderforschungsbereich 642 "GTP- and ATP dependent membrane processes". The authors acknowledge support by the Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Albertazzi P, 2002, CLIMACTERIC, V5, P302; Bali N, 2012, ENDOCRINOLOGY, V153, P759, DOI 10.1210/en.2011-1699; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; Baumgart S, 2014, J CELL SCI, V127, P2518, DOI 10.1242/jcs.144220; Bi Gang, 1999, Shengli Xuebao, V51, P603; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Caruso S, 2001, HUM REPROD, V16, P2288, DOI 10.1093/humrep/16.11.2288; Chen JJ, 2014, STEROIDS, V81, P9, DOI 10.1016/j.steroids.2013.11.011; Cherian S, 2014, NEUROSCIENCE, V269, P43, DOI 10.1016/j.neuroscience.2014.03.011; Coiret G, 2005, FEBS LETT, V579, P2995, DOI 10.1016/j.febslet.2005.02.085; Dey S, 2015, CELL, V161, P1334, DOI 10.1016/j.cell.2015.04.052; Doty RL, 2008, BRAIN RES, V1214, P35, DOI 10.1016/j.brainres.2008.04.017; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; ELIASSON M, 1975, PHYSIOL BEHAV, V14, P705, DOI 10.1016/0031-9384(75)90061-X; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; GILBERT AN, 1991, PSYCHOSOM MED, V53, P693, DOI 10.1097/00006842-199111000-00009; Guerriero G, 2009, ANN NY ACAD SCI, V1163, P407, DOI 10.1111/j.1749-6632.2009.04438.x; Guo XZ, 2001, CELL RES, V11, P321, DOI 10.1038/sj.cr.7290103; Hammes SR, 2011, ENDOCRINOLOGY, V152, P4489, DOI 10.1210/en.2011-1470; Horvath TL, 1999, J NEUROENDOCRINOL, V11, P77; Hughes LF, 2002, CLIMACTERIC, V5, P140, DOI 10.1080/713605233; Kaluka D, 2015, BIOCHEMISTRY-US, V54, P1638, DOI 10.1021/bi501177e; Kanageswaran N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0113170; Kumar K. Ramesh, 1999, Indian Journal of Experimental Biology, V37, P317; Lee DY, 2002, LIFE SCI, V70, P2047, DOI 10.1016/S0024-3205(01)01534-X; Loch D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075716; Maruska KP, 2010, BEHAV BRAIN RES, V213, P208, DOI 10.1016/j.bbr.2010.04.058; Meyer C, 1998, STEROIDS, V63, P111, DOI 10.1016/S0039-128X(97)00143-8; Moffatt CA, 2003, BRAIN RES REV, V43, P192, DOI 10.1016/S0165-0173(03)00208-X; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; Morrill GA, 2013, STEROIDS, V78, P1233, DOI 10.1016/j.steroids.2013.08.006; Moussatche P, 2012, BIOCHEM SOC T, V40, P200, DOI 10.1042/BST20110638; Nathan BP, 2012, EXP NEUROL, V237, P1, DOI 10.1016/j.expneurol.2012.06.001; Negroni J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045266; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; NUMAN M, 1984, BEHAV NEUROSCI, V98, P712, DOI 10.1037/0735-7044.98.4.712; Oka Y, 2004, CHEM SENSES, V29, P815, DOI 10.1093/chemse/bjh247; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; Peluso JJ, 2009, J CLIN ENDOCR METAB, V94, P2644, DOI 10.1210/jc.2009-0147; Petersen SL, 2013, J NEUROENDOCRINOL, V25, P991, DOI 10.1111/jne.12060; Petersen SL, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00164; Pierman S, 2008, HORM BEHAV, V54, P98, DOI 10.1016/j.yhbeh.2008.02.001; Pierman S, 2006, BEHAV BRAIN RES, V174, P64, DOI 10.1016/j.bbr.2006.07.002; PIETRAS RJ, 1974, PHYSIOL BEHAV, V12, P475, DOI 10.1016/0031-9384(74)90125-5; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Tran QK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089669; Rettew JA, 2010, MOL CELL ENDOCRINOL, V328, P87, DOI 10.1016/j.mce.2010.07.017; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; Savigner A, 2009, J NEUROPHYSIOL, V101, P2898, DOI 10.1152/jn.91169.2008; SCHREIBER JR, 1983, CONTRACEPTION, V28, P77, DOI 10.1016/S0010-7824(83)80008-0; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith JL, 2008, STEROIDS, V73, P1160, DOI 10.1016/j.steroids.2008.05.003; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; ter Horst J, 2012, CELL MOL NEUROBIOL, V32, P725, DOI 10.1007/s10571-011-9774-2; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Thomas P, 2007, ENDOCRINOLOGY, V148, P705, DOI 10.1210/en.2006-0974; Thomas P, 2012, NEUROENDOCRINOLOGY, V96, P162, DOI 10.1159/000339822; Tubbs C, 2009, ENDOCRINOLOGY, V150, P473, DOI 10.1210/en.2008-0512; Vicini E, 2006, J CELL PHYSIOL, V206, P238, DOI 10.1002/jcp.20454; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; Wesson DW, 2006, HORM BEHAV, V49, P580, DOI 10.1016/j.yhbeh.2005.12.013	64	20	20	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0159640	10.1371/journal.pone.0159640	http://dx.doi.org/10.1371/journal.pone.0159640			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494699	Green Published, gold, Green Submitted			2022-12-26	WOS:000381369500012
J	Svenningsen, K; Veno, MT; Henningsen, K; Mallien, AS; Jensen, L; Christensen, T; Kjems, J; Vollmayr, B; Wiborg, O				Svenningsen, Katrine; Veno, Morten T.; Henningsen, Kim; Mallien, Anne S.; Jensen, Line; Christensen, Trine; Kjems, Jorgen; Vollmayr, Barbara; Wiborg, Ove			MicroRNA Profiling in the Medial and Lateral Habenula of Rats Exposed to the Learned Helplessness Paradigm: Candidate Biomarkers for Susceptibility and Resilience to Inescapable Shock	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; REGION-SPECIFIC CHANGES; STRESS RESILIENCE; GENE-EXPRESSION; ANTIDEPRESSANT TREATMENT; MOOD DISORDERS; MODEL; BRAIN; RESISTANCE; BEHAVIOR	Depression is a highly heterogeneous disorder presumably caused by a combination of several factors ultimately causing the pathological condition. The genetic liability model of depression is likely to be of polygenic heterogeneity. miRNAs can regulate multiple genes simultaneously and therefore are candidates that align with this model. The habenula has been linked to depression in both clinical and animal studies, shifting interest towards this region as a neural substrate in depression. The goal of the present study was to search for alterations in miRNA expression levels in the medial and lateral habenula of rats exposed to the learned helplessness (LH) rat model of depression. Ten miRNAs showed significant alterations associating with their response to the LH paradigm. Of these, six and four miR-NAs were significantly regulated in the MHb and LHb, respectively. In the MHb we identified miR-490, miR-291a-3p, MiR-467a, miR-216a, miR-18b, and miR-302a. In the LHb miR-543, miR-367, miR-467c, and miR-760-5p were significantly regulated. A target gene analysis showed that several of the target genes are involved in MAPK signaling, neutrophin signaling, and ErbB signaling, indicating that neurotransmission is affected in the habenula as a consequence of exposure to the LH paradigm.	[Svenningsen, Katrine; Henningsen, Kim; Jensen, Line; Christensen, Trine; Wiborg, Ove] Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark; [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Veno, Morten T.; Kjems, Jorgen] Aarhus Univ, Interdisciplinary Nanosci Ctr, Aarhus, Denmark; [Mallien, Anne S.; Vollmayr, Barbara] Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, Med Fac Mannheim, Mannheim, Germany; [Svenningsen, Katrine] Hosp Southern Jutland, Mol Diagnost & Clin Hlth Res Unit, Aabenraa, Denmark	Aarhus University; Aarhus University; Aarhus University; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Wiborg, O (corresponding author), Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark.	ove.wiborg@clin.au.dk	Kjems, Jorgen/I-3490-2016	Kjems, Jorgen/0000-0003-4128-9317; Veno, Morten/0000-0002-4754-5193	Lundbeck Foundation [R77-A7085]	Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Lundbeck Foundation (R77-A7085). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bergstrom A, 2008, BRAIN RES, V1196, P41, DOI 10.1016/j.brainres.2007.12.025; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Bisgaard CF, 2012, J PSYCHOPHARMACOL, V26, P1569, DOI 10.1177/0269881112460110; Bousman CA, 2014, AM J MED GENET B, V165, P62, DOI 10.1002/ajmg.b.32206; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Buttenschon HN, 2015, J AFFECT DISORDERS, V183, P287, DOI 10.1016/j.jad.2015.05.027; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024; Christensen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080666; Czeh B, 2016, PROG NEURO-PSYCHOPH, V64, P293, DOI 10.1016/j.pnpbp.2015.04.004; Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gaska M, 2012, PSYCHOPHARMACOLOGY, V223, P281, DOI 10.1007/s00213-012-2714-0; GROENEWEGEN HJ, 1986, J COMP NEUROL, V249, P65, DOI 10.1002/cne.902490107; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hassel B, 2010, EPILEPSIA, V51, P1714, DOI 10.1111/j.1528-1167.2010.02545.x; Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428; Hoyer C, 2012, NEUROPSYCHOBIOLOGY, V65, P147, DOI 10.1159/000335243; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Ladanyi A, 2006, CYTOM PART A, V69A, P947, DOI 10.1002/cyto.a.20322; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Mann JJ, 1999, NEUROPSYCHOPHARMACOL, V21, pS99, DOI 10.1038/sj.npp.1395364; O'Connor RM, 2012, MOL PSYCHIATR, V17, P359, DOI 10.1038/mp.2011.162; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Organization WH, 2012, DEPRESSION FACT SHEE; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Richter SH, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-41; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Savitz JB, 2013, MOL PSYCHIATR, V18, P523, DOI 10.1038/mp.2013.43; Savitz JB, 2011, BIOL PSYCHIAT, V69, P336, DOI 10.1016/j.biopsych.2010.09.027; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6; Tian WM, 2012, PSYCHIAT GENET, V22, P161, DOI 10.1097/YPG.0b013e3283539550; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Vollmayr B, 2013, CELL TISSUE RES, V354, P171, DOI 10.1007/s00441-013-1654-2; Wiborg O, 1999, PHARMACOL TOXICOL, V84, P88, DOI 10.1111/j.1600-0773.1999.tb00879.x; Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0160318	10.1371/journal.pone.0160318	http://dx.doi.org/10.1371/journal.pone.0160318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494716	gold, Green Published, Green Submitted			2022-12-26	WOS:000381369500030
J	Kuo, HC; Wang, CL; Yang, KD; Lo, MH; Hsieh, KS; Li, SC; Huang, YH				Kuo, Ho-Chang; Wang, Chih-Lu; Yang, Kuender D.; Lo, Mao-Hung; Hsieh, Kai-Sheng; Li, Sung-Chou; Huang, Ying-Hsien			Plasma Prostaglandin E-2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; TREATMENT FAILURE; EXPRESSION; LIGAND; ASSOCIATION; INHIBITION; MECHANISMS; MACROPHAGE; INDUCTION	Background A form of systemic vasculitis, Kawasaki disease (KD) occurs most frequently in children under the age of five years old. Previous studies have found that Prostaglandin E-2 (PGE(2)) correlates with KD, although the related mechanisms are still unknown. CD40L may also be a marker of vasculitis in KD, so this study focuses on PGE(2) and CD40L expression in KD. Materials and Methods This study consisted of a total of 144 KD patients, whose intravenous immunoglobulin (IVIG)/coronary arterial lesion (CAL) formation resistance was evaluated. PGE(2) levels were evaluated in vitro to study the effect of CD40L on CD4+ T lymphocytes. Results PGE(2) levels significantly increased after IVIG treatment (p<0.05), especially in patients who responded to initial IVIG treatment (p = 0.004) and for patients without CAL formation (p = 0.016). Furthermore, an in vitro study revealed that IVIG acted as a trigger for PGE(2) expression in the acute-stage mononuclear cells of KD patients. According to our findings, both IVIG and PGE(2) can impede surface CD40L expressions on CD4+ T lymphocytes (p<0.05). Conclusions The results of this study are among the first to find that plasma PGE(2) is correlated with the prevention of IVIG resistance and CAL formation through CD40L in KD.	[Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Li, Sung-Chou; Huang, Ying-Hsien] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Kuo, Ho-Chang; Lo, Mao-Hung; Hsieh, Kai-Sheng; Huang, Ying-Hsien] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Wang, Chih-Lu] Po Jen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Yang, Kuender D.] Mackay Mem Hosp, Mackay Med Sch, Inst Biomed Sci, Taipei, Taiwan; [Yang, Kuender D.] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Li, Sung-Chou] Kaohsiung Chang Gung Mem Hosp, Dept Med Res, Genom & Prote Core Lab, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Mackay Memorial Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital	Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.; Huang, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Huang, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan.	yhhuang123@yahoo.com.tw	Kuo, Ho-Chang/AAQ-6644-2020; Li, Sung-Chou/AGZ-8626-2022	Kuo, Ho-Chang/0000-0002-3295-2984; Li, Sung-Chou/0000-0002-3016-9718; Huang, Ying-Hsien/0000-0002-7127-0046; Hsieh, Kai-Sheng/0000-0002-0294-9872	Ministry of Science and Technology of Taiwan [MOST 105-2314-B-182 -050 -MY3, MOST 102-2314-B-182-053-MY3, MOST 103-2410-H-264-004]; Chang Gung Memorial Hospital in Taiwan [CMRPG8A0481, CMRPG8E0061, CMRPG8C1082, CMRPG8B0212, CMRPG8D1561, CORPG8F0011, CMRPG8D0521]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital in Taiwan(Chang Gung Memorial Hospital)	This study was supported by funding provided by the following grants: MOST 105-2314-B-182 -050 -MY3, MOST 102-2314-B-182-053-MY3, and MOST 103-2410-H-264-004 from the Ministry of Science and Technology of Taiwan and CMRPG8A0481, CMRPG8E0061, CMRPG8C1082, CMRPG8B0212, CMRPG8D1561, CORPG8F0011, and CMRPG8D0521 from Chang Gung Memorial Hospital in Taiwan. These institutes had no influence over the collection, analysis, or interpretation of the data or on the preparation of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1990, Kurume Medical Journal, V37, P203; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; CAROSELLA ED, 1989, CELL IMMUNOL, V121, P261, DOI 10.1016/0008-8749(89)90024-5; Chizzolini C, 2009, IMMUNOL CELL BIOL, V87, P510, DOI 10.1038/icb.2009.56; Daniels LB, 2012, CURR OPIN CARDIOL, V27, P572, DOI 10.1097/HCO.0b013e3283588f06; Dogan Omer Faruk, 2007, Heart Surg Forum, V10, pE70, DOI 10.1532/HSF98.20061151; Gomez I, 2013, PROSTAG LEUKOTR ESS, V89, P55, DOI 10.1016/j.plefa.2013.04.004; Guo MMH, 2015, ALLERGY, V70, P310, DOI 10.1111/all.12558; Hassan GS, 2012, IMMUNOBIOLOGY, V217, P521, DOI 10.1016/j.imbio.2011.03.010; Jia S, 2010, CLIN EXP IMMUNOL, V162, P131, DOI 10.1111/j.1365-2249.2010.04236.x; Jing H, 2004, J BIOL CHEM, V279, P55176, DOI 10.1074/jbc.M409816200; Kajimoto M, 2009, INFLAMM RES, V58, P224, DOI 10.1007/s00011-008-8138-y; KATO H, 1979, PEDIATRICS, V63, P175; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, J MED GENET, V48, P467, DOI 10.1136/jmg.2010.086611; Ko TM, 2015, CIRC RES, V116, P876, DOI 10.1161/CIRCRESAHA.116.305834; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144603; Kuo HC, 2012, SCI WORLD J, DOI 10.1100/2012/520865; Kuo HC, 2012, J CLIN IMMUNOL, V32, P746, DOI 10.1007/s10875-012-9668-1; Kuo HC, 2011, ACTA PHARMACOL SIN, V32, P1193, DOI 10.1038/aps.2011.93; Kuo HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017370; Kuo HC, 2011, J HUM GENET, V56, P161, DOI 10.1038/jhg.2010.154; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; LEE T, 1988, PROSTAG LEUKOTR ESS, V31, P53, DOI 10.1016/0952-3278(88)90076-2; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117; Maddur MS, 2014, IMMUNOL RES, V60, P320, DOI 10.1007/s12026-014-8580-6; Maddur MS, 2013, J CLIN IMMUNOL, V33, pS62, DOI 10.1007/s10875-012-9752-6; Maddur MS, 2011, J ALLERGY CLIN IMMUN, V127, P823, DOI 10.1016/j.jaci.2010.12.1102; Muller C, 2015, CANCER IMMUNOL IMMUN, V64, P1175, DOI 10.1007/s00262-015-1723-3; Na YR, 2015, EUR J IMMUNOL, V45, P2661, DOI 10.1002/eji.201545471; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Onouchi Y, 2004, EUR J HUM GENET, V12, P1062, DOI 10.1038/sj.ejhg.5201266; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Saha A, 2014, J IMMUNOL, V193, P2330, DOI 10.4049/jimmunol.1400399; Sasai K, 1988, Arerugi, V37, P952; SCHROR K, 1993, EUR HEART J, V14, P34; Shah SV, 2011, CLIN J AM SOC NEPHRO, V6, P2329, DOI 10.2215/CJN.08340811; Shibata T, 2011, J VISION, V11, DOI 10.1167/11.8.11; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Splawski JB, 1996, J IMMUNOL, V156, P119; Tiao MM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/942172; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Wang CL, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.2.e140; Weiss G, 1999, CLIN EXP IMMUNOL, V116, P435; Wiedeman AE, 2013, ARTHRITIS RHEUM-US, V65, P2713, DOI 10.1002/art.38082; Wiemer AJ, 2011, J IMMUNOL, V187, P3663, DOI 10.4049/jimmunol.1100103; Yamakawa R, 1998, J AM COLL CARDIOL, V31, P1074, DOI 10.1016/S0735-1097(98)00033-3	53	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2016	11	8							e0161265	10.1371/journal.pone.0161265	http://dx.doi.org/10.1371/journal.pone.0161265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SL	27525421	Green Submitted, gold, Green Published			2022-12-26	WOS:000381471100049
J	Guo, W; Zheng, WY; Wang, M; Li, XH; Ma, Y; Dai, HY				Guo, Wei; Zheng, Wenyan; Wang, Mei; Li, Xiaohong; Ma, Yue; Dai, Hongyan			Genome Sequences of Three Apple chlorotic leaf spot virus Isolates from Hawthorns in China	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; PEACH PRUNUS-PERSICA; COAT PROTEIN; TRICHOVIRUS	The genome sequences of Apple chlorotic leaf spot virus (ACLSV) isolates from three accessions of hawthorns (Crataegus pinnatifida) grown at Shenyang Agricultural University were determined using Illumina RNA-seq. To confirm the assembly data from the de novo sequencing, two ACLSV genomic sequences (SY01 and SY02) were sequenced using the Sanger method. The SY01 and SY02 sequences obtained with the Sanger method showed 99.5% and 99.7% nucleotide identity with the transcriptome data, respectively. The genome sequences of the hawthorn isolates SY01, SY02 and SY03 (GenBank accession nos. KM207212, KU870524 and KU870525, respectively) consisted of 7,543, 7,561 and 7,545 nucleotides, respectively, excluding poly-adenylated tails. Sequence analysis revealed that these hawthorn isolates shared an overall nucleotide identity of 82.8-92.1% and showed the highest identity of 90.3% for isolate YH (GenBank accession no. KC935955) from pear and the lowest identity of 67.7% for isolate TaTao5 (GenBank accession no. EU223295) from peach. Hawthorn isolate sequences were similar to those of 'B6 type' ACLSV. The relationship between ACLSV isolates largely depends upon the host species. This represents the first comparative study of the genome sequences of ACLSV isolates from hawthorns.	[Guo, Wei; Zheng, Wenyan; Wang, Mei; Ma, Yue; Dai, Hongyan] Shenyang Agr Univ, Coll Hort, 120 Dongling Rd, Shenyang 110866, Liaoning, Peoples R China; [Li, Xiaohong] Eastern Liaoning Univ, Coll Agron, 325 Wenhua Rd, Dandong 118003, Liaoning, Peoples R China	Shenyang Agricultural University; Liaodong University	Dai, HY (corresponding author), Shenyang Agr Univ, Coll Hort, 120 Dongling Rd, Shenyang 110866, Liaoning, Peoples R China.	daihy1970@163.com	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022		National Natural Science Foundation of China [31470678]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (grant no. 31470678). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2004, J PLANT PATHOL, V86, P117; Bejerman N, 2016, ARCH VIROL, V161, P2029, DOI 10.1007/s00705-016-2854-3; Chen SY, 2014, ARCH VIROL, V159, P1431, DOI 10.1007/s00705-013-1927-9; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Dai HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072910; Dhir S, 2013, J PHYTOPATHOL, V161, P704, DOI 10.1111/jph.12121; GERMAN S, 1990, VIROLOGY, V179, P104, DOI 10.1016/0042-6822(90)90279-Z; GermanRetana S, 1997, ARCH VIROL, V142, P833, DOI 10.1007/s007050050122; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Jelkmann W, 1996, PHYTOPATHOLOGY, V86, P101; Khalifa ME, 2016, VIRUS RES, V219, P51, DOI 10.1016/j.virusres.2015.11.001; Kinard GR, 1996, PLANT DIS, V80, P616, DOI 10.1094/PD-80-0616; [李科 Li Ke], 2015, [中国农业科学, Scientia Agricultura Sinica], V48, P2857; Lim S, 2015, VIRUS GENES, V51, P260, DOI 10.1007/s11262-015-1225-6; Liu MY, 2016, ARCH VIROL, V161, P677, DOI 10.1007/s00705-015-2691-9; Marini DB, 2008, ARCH VIROL, V153, P1003, DOI 10.1007/s00705-008-0076-z; MARTELLI GP, 1994, ARCH VIROL, V134, P451, DOI 10.1007/BF01310583; Nemeth M., 1986, VIRUSES MYCOPLASMA R; Niu FQ, 2012, ARCH VIROL, V157, P783, DOI 10.1007/s00705-011-1195-5; SATO K, 1993, J GEN VIROL, V74, P1927, DOI 10.1099/0022-1317-74-9-1927; Song YS, 2011, EUR J PLANT PATHOL, V130, P183, DOI 10.1007/s10658-011-9744-z; Yaegashi H, 2007, J GEN VIROL, V88, P2611, DOI 10.1099/vir.0.82984-0; Yanase H, 1979, JPN J PHYTOPATHOL, V45, P369, DOI [10.3186/jjphytopath.45.369, DOI 10.3186/JJPHYTOPATH.45.369]; Yoshikawa N, 1988, PLANT PATHOL, P241; Zhu H, 2014, CAN J PLANT PATHOL, V36, P396, DOI 10.1080/07060661.2014.927399	25	9	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161099	10.1371/journal.pone.0161099	http://dx.doi.org/10.1371/journal.pone.0161099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27519059	Green Submitted, Green Published, gold			2022-12-26	WOS:000381382100048
J	Mendy, VL; Vargas, R; El-sadek, L				Mendy, Vincent L.; Vargas, Rodolfo; El-sadek, Lamees			Trends in Heart Disease Mortality among Mississippi Adults over Three Decades, 1980-2013	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; UNITED-STATES; YOUNG-ADULTS; DISPARITIES; DEATHS; STROKE; HEALTH; US; DECREASE; DECLINE	Heart disease (HD) remains the leading cause of death among Mississippians; however, despite the importance of the condition, trends in HD mortality in Mississippi have not been adequately explored. This study examined trends in HD mortality among adults in Mississippi from 1980 through 2013 and further examined these trends by race and sex. We used data from Mississippi Vital Statistics (1980-2013) to calculate age-adjusted HD mortality rates for Mississippians age 25 or older. Cases were identified using underlying cause of death codes from the International Classification of Diseases, Ninth Revision (ICD-9: 390398, 402, 404-429) and Tenth Revision (ICD-10), including I00-I09, I11, I13, and I20-I51. Joinpoint software was used to calculate the average annual percent change in HD mortality rates for the overall population and by race and sex. Overall, the age-adjusted HD mortality rate among Mississippi adults decreased by 36.5% between 1980 and 2013, with an average annual percent change of -1.60% (95% CI -2.00 to -1.30). This trend varied across subgroups: HD mortality rates experienced an average annual change of -1.34% (95% CI -1.98 to -0.69) for black adults; -1.60% (95% CI -1.74 to -1.46) for white adults; -1.30% (95% CI -1.50 to -1.10) for all women, and -1.90% (95% -2.20 to -1.50) for all men. From 1980 to 2013, there was a continuous decrease in HD mortality among adult Mississippians. However, the magnitude of this reduction differed by race and sex.	[Mendy, Vincent L.; Vargas, Rodolfo; El-sadek, Lamees] Mississippi Dept Hlth, Off Hlth Data & Res, Jackson, MS 39216 USA		Mendy, VL (corresponding author), Mississippi Dept Hlth, Off Hlth Data & Res, Jackson, MS 39216 USA.	vincent.mendy@msdh.ms.gov			CDC [5U50DP003088-04]	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by CDC grant no. 5U50DP003088-04.	Agarwal R, 2010, PREV CHRONIC DIS, V7; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Berg J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-9; Capewell S, 2012, NUTR METAB CARDIOVAS, V22, P307, DOI 10.1016/j.numecd.2012.01.005; Cayuela A, 2004, ANN ONCOL, V15; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P649; Christian AH, 2007, J WOMENS HEALTH, V16, P68, DOI 10.1089/jwh.2006.M072; Cohen J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-283; Conrad Z, 2016, CIRCULATION, V133; Cooper R, 2000, CIRCULATION, V102, P3137; Davis AM, 2007, MED CARE RES REV, V64, p29S, DOI 10.1177/1077558707305416; Edwards BK, 2014, CANCER-AM CANCER SOC, V120, P1290, DOI 10.1002/cncr.28509; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; Gerber Y, 2006, CIRCULATION, V113, P2285, DOI 10.1161/CIRCULATIONAHA.105.590463; Harriss LR, 2011, AUST NZ J PUBL HEAL, V35, P466, DOI 10.1111/j.1753-6405.2011.00739.x; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Hong YL, 2013, CIRCULATION, V128; Horner RD, 2009, AM J PUBLIC HEALTH, V99, P1996, DOI 10.2105/AJPH.2008.148221; Marmot M, 2015, LANCET, V386, P2442, DOI 10.1016/S0140-6736(15)00150-6; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mendy VL, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140481; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2012, INT J CARDIOL, V158, P193, DOI 10.1016/j.ijcard.2011.01.016; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Qiu D, 2009, INT J CANCER, V124, P443, DOI 10.1002/ijc.23911; Ritchey MD, 2014, JAMA-J AM MED ASSOC, V312, P2037, DOI 10.1001/jama.2014.11344; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; Rooks RN, 2008, J AGING HEALTH, V20, P599, DOI 10.1177/0898264308321023; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Unal B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1135; Vaughan AS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002567; Wexelman BA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120288	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161194	10.1371/journal.pone.0161194	http://dx.doi.org/10.1371/journal.pone.0161194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3LI	27518895	Green Submitted, gold, Green Published			2022-12-26	WOS:000381382100061
J	Yano, S; Moseley, K; Fu, XW; Azen, C				Yano, Shoji; Moseley, Kathryn; Fu, Xiaowei; Azen, Colleen			Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters	PLOS ONE			English	Article							TYROSINE; HYPERPHENYLALANINEMIA; DYSFUNCTION; CHILDREN	Background Phenylketonuria (PKU) is due to a defective hepatic enzyme, phenylalanine (Phe) hydroxylase. Transport of the precursor amino acids from blood into the brain for serotonin and dopamine synthesis is reported to be inhibited by high blood Phe concentrations. Deficiencies of serotonin and dopamine are involved in neurocognitive dysfunction in PKU. Objective (1) To evaluate the effects of sapropterin (BH4) and concurrent use of large neutral amino acids (LNAA) on the peripheral biomarkers, melatonin and dopamine with the hypothesis they reflect brain serotonin and dopamine metabolism. (2) To evaluate synergistic effects with BH4 and LNAA. (3) To determine the effects of blood Phe concentrations on the peripheral biomarkers concentrations. Methods Nine adults with PKU completed our study consisting of four 4-week phases: (1) LNAA supplementation, (2) Washout, (3) BH4 therapy, and (4) LNAA with BH4 therapy. An overnight protocol measured plasma amino acids, serum melatonin, and 6-sulfatoxymelatonin and dopamine in first void urine after each phase. Results (1) Three out of nine subjects responded to BH4. A significant increase of serum melatonin levels was observed in BH4 responders with decreased blood Phe concentration. No significant change in melatonin, dopamine or Phe levels was observed with BH4 in the subjects as a whole. (2) Synergistic effects with BH4 and LNAA were observed in serum melatonin in BH4 responders. (3) The relationship between serum melatonin and Phe showed a significant negative slope (p = 0.0005) with a trend toward differing slopes among individual subjects (p = 0.066). There was also a negative association overall between blood Phe and urine 6-sulfatoxymelatonin and dopamine (P = 0.040 and 0.047). Conclusion Blood Phe concentrations affected peripheral monoamine neurotransmitter biomarker concentrations differently in each individual with PKU. Melatonin levels increased with BH4 therapy only when blood Phe decreased. Monitoring peripheral neurotransmitter metabolites may assist in optimizing individualized treatment in PKU.	[Yano, Shoji; Moseley, Kathryn] Univ Southern Calif, Keck Sch Med, LAC USC Med Ctr, Genet Div,Dept Pediat, Los Angeles, CA 90033 USA; [Fu, Xiaowei] Univ Southern Calif, Keck Sch Med, Dept Pathol, Childrens Hosp Los Angeles, Los Angeles, CA USA; [Azen, Colleen] Univ Southern Calif, Keck Sch Med, Clin & Translat Sci Inst, Los Angeles, CA USA	Los Angeles County+USC Medical Center; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Yano, S (corresponding author), Univ Southern Calif, Keck Sch Med, LAC USC Med Ctr, Genet Div,Dept Pediat, Los Angeles, CA 90033 USA.	syano@usc.edu	Yano, Shoji/AAG-2771-2021	Yano, Shoji/0000-0001-5565-9572	BioMarin Pharmaceutical Inc.; NIH/NCRR SC-CTSI Grant [UL1 RR031986]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001855] Funding Source: NIH RePORTER	BioMarin Pharmaceutical Inc.; NIH/NCRR SC-CTSI Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This investigator sponsored research study was funded by BioMarin Pharmaceutical Inc. and was supported in part by NIH/NCRR SC-CTSI Grant Number UL1 RR031986. PheBloc tablets were donated by Applied Nutrition (Nutricia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burlina AB, 2000, J INHERIT METAB DIS, V23, P313, DOI 10.1023/A:1005694122277; Burton B, 2015, MOL GENET METAB, V114, P415, DOI 10.1016/j.ymgme.2014.11.011; BUTLER IJ, 1981, J PEDIATR-US, V98, P729, DOI 10.1016/S0022-3476(81)80832-3; Chonjnacki C, 2011, WORLD J GASTROENTERO, V17, P2646, DOI [10.3748/wig.v17.i21.2646, DOI 10.3748/WIG.V17.I21.2646]; de Groot MJ, 2010, MOL GENET METAB, V99, pS86, DOI 10.1016/j.ymgme.2009.10.016; Hsing AW, 2010, CANCER EPIDEM BIOMAR, V19, P932, DOI 10.1158/1055-9965.EPI-10-0004; KAUFMAN S, 1982, PEDIATRICS, V70, P376; KETTLER R, 1974, NATURE, V249, P476, DOI 10.1038/249476a0; LENKE RR, 1980, NEW ENGL J MED, V303, P1202, DOI 10.1056/NEJM198011203032104; LYKKELUND C, 1988, EUR J PEDIATR, V148, P238, DOI 10.1007/BF00441411; Manti F, 2016, MOL GENET METAB, V117, P12, DOI 10.1016/j.ymgme.2015.11.006; Nardecchia F, 2015, MOL GENET METAB, V115, P84, DOI 10.1016/j.ymgme.2015.04.003; Nielsen J. B., 1988, Brain Dysfunction, V1, P51; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; Sharman R, 2010, J INHERIT METAB DIS, V33, pS417, DOI 10.1007/s10545-010-9211-6; van Spronsen FJ, 2009, J INHERIT METAB DIS, V32, P46, DOI 10.1007/s10545-008-0946-2; vanSpronsen FJ, 1996, AM J CLIN NUTR, V64, P916, DOI 10.1093/ajcn/64.6.916; Vockley J, 2014, GENET MED, V16, P188, DOI 10.1038/gim.2013.157; Yano S, 2014, J PEDIATR-US, V165, P184, DOI 10.1016/j.jpeds.2014.03.061; Yano S, 2013, J PEDIATR-US, V162, P999, DOI 10.1016/j.jpeds.2012.10.015	21	14	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160892	10.1371/journal.pone.0160892	http://dx.doi.org/10.1371/journal.pone.0160892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513937	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100087
J	Ajjampur, SSR; Png, CW; Chia, WN; Zhang, YL; Tan, KSW				Ajjampur, Sitara S. R.; Png, Chin Wen; Chia, Wan Ni; Zhang, Yongliang; Tan, Kevin S. W.			Ex Vivo and In Vivo Mice Models to Study Blastocystis spp. Adhesion, Colonization and Pathology: Closer to Proving Koch's Postulates	PLOS ONE			English	Article							CYSTEINE PROTEASES; ENTAMOEBA-HISTOLYTICA; INTESTINAL PARASITE; HOMINIS INFECTION; MUCIN DYNAMICS; SUBTYPES; BARRIER; MUCUS; CELL; IDENTIFICATION	Blastocystis spp. are widely prevalent extra cellular, non-motile anerobic protists that inhabit the gastrointestinal tract. Although Blastocystis spp. have been associated with gastrointestinal symptoms, irritable bowel syndrome and urticaria, their clinical significance has remained controversial. We established an ex vivo mouse explant model to characterize adhesion in the context of tissue architecture and presence of the mucin layer. Using confocal microscopy with tissue whole mounts and two axenic isolates of Blastocystis spp., subtype 7 with notable differences in adhesion to intestinal epithelial cells (IEC), isolate B (ST7-B) and isolate H (more adhesive, ST7-H), we showed that adhesion is both isolate dependent and tissue trophic. The more adhesive isolate, ST7-H was found to bind preferentially to the colon tissue than caecum and terminal ileum. Both isolates were also found to have mucinolytic effects. We then adapted a DSS colitis mouse model as a susceptible model to study colonization and acute infection by intra-caecal inoculation of trophic Blastocystis spp. cells. We found that the more adhesive isolate ST7-H was also a better colonizer with more mice shedding parasites and for a longer duration than ST7-B. Adhesion and colonization was also associated with increased virulence as ST7-H infected mice showed greater tissue damage than ST7-B. Both the ex vivo and in vivo models used in this study showed that Blastocystis spp. remain luminal and predominantly associated with mucin. This was further confirmed using colonic loop experiments. We were also successfully able to re-infect a second batch of mice with ST7-H isolates obtained from fecal cultures and demonstrated similar histopathological findings and tissue damage thereby coming closer to proving Koch's postulates for this parasite.	[Ajjampur, Sitara S. R.; Png, Chin Wen; Chia, Wan Ni; Zhang, Yongliang; Tan, Kevin S. W.] Natl Univ Singapore, Dept Microbiol & Immunol, Lab Mol & Cellular Parasitol, 5 Sci Dr 2, Singapore 117545, Singapore	National University of Singapore	Tan, KSW (corresponding author), Natl Univ Singapore, Dept Microbiol & Immunol, Lab Mol & Cellular Parasitol, 5 Sci Dr 2, Singapore 117545, Singapore.	kevin_tan@nuhs.edu.sg		Ajjampur, Sitara/0000-0003-3419-6577	National Medical Research Council (KSWT SA WNC)	National Medical Research Council (KSWT SA WNC)	This work was supported by National Medical Research Council (KSWT SA WNC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsalam AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084372; Abdulsalam AM, 2012, PARASITOLOGY, V139, P1014, DOI 10.1017/S0031182012000340; Alfellani MA, 2013, ACTA TROP, V126, P11, DOI 10.1016/j.actatropica.2012.12.011; Andersen LO, 2016, J CLIN MICROBIOL, V54, P524, DOI 10.1128/JCM.02520-15; Anuar TS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-40; Audebert C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25255; Bansal D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000551; Chen XQ, 1997, PARASITOL RES, V83, P313, DOI 10.1007/s004360050255; Cotton JA, 2015, PATHOGENS, V4, P764, DOI 10.3390/pathogens4040764; Coyle CM, 2012, CLIN INFECT DIS, V54, P105, DOI 10.1093/cid/cir810; Casero RD, 2015, ACTA TROP, V148, P156, DOI 10.1016/j.actatropica.2015.05.004; Ramirez JD, 2014, INFECT GENET EVOL, V22, P223, DOI 10.1016/j.meegid.2013.07.020; El Safadi D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-164; Jimenez-Gonzalez DE, 2012, PARASITOL RES, V110, P1269, DOI 10.1007/s00436-011-2626-7; Fayer R, 2014, PARASITOL RES, V113, P1465, DOI 10.1007/s00436-014-3787-y; Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245; Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470; Hasnain SZ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001856; Herbinger KH, 2011, INFECTION, V39, P527, DOI 10.1007/s15010-011-0155-z; HO LC, 1993, PARASITOL RES, V79, P614, DOI 10.1007/BF00932249; Iguchi A, 2007, PARASITOL INT, V56, P107, DOI 10.1016/j.parint.2006.12.004; Iguchi A, 2009, PARASITOL RES, V105, P135, DOI 10.1007/s00436-009-1373-5; Jantermtor S, 2013, PARASITOL RES, V112, P1781, DOI 10.1007/s00436-012-3218-x; Jarry A, 2015, MUCOSAL IMMUNOL, V8, P572, DOI 10.1038/mi.2014.89; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001; Laodim P, 2012, FOODBORNE PATHOG DIS, V9, P1077, DOI 10.1089/fpd.2012.1177; Laparra JM, 2009, LETT APPL MICROBIOL, V49, P695, DOI 10.1111/j.1472-765X.2009.02729.x; Lennon G, 2014, GUT MICROBES, V5, P277, DOI 10.4161/gmic.28793; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Lim MX, 2014, INFECT IMMUN, V82, P4789, DOI 10.1128/IAI.02279-14; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mirza H, 2012, CELL MICROBIOL, V14, P1474, DOI 10.1111/j.1462-5822.2012.01814.x; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; Moe KT, 1999, PARASITOL RES, V85, P103, DOI 10.1007/s004360050517; Naughton J, 2014, GUT MICROBES, V5, P48, DOI 10.4161/gmic.26680; Osman M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004496; Png CW, 2016, ONCOGENE, V35, P206, DOI 10.1038/onc.2015.74; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Puthia MK, 2006, INFECT IMMUN, V74, P4114, DOI 10.1128/IAI.00328-06; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Roberts T, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-17; Santin M, 2011, PARASITOL RES, V109, P205, DOI 10.1007/s00436-010-2244-9; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; Tan KSW, 2008, CLIN MICROBIOL REV, V21, P639, DOI 10.1128/CMR.00022-08; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135; Verma R, 2013, AM J MED SCI, V346, P80, DOI 10.1097/MAJ.0b013e3182801478; Wang WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103962; Wawrzyniak I, 2013, THER ADV INFECT DIS, V1, P167, DOI 10.1177/2049936113504754; Wawrzyniak I, 2012, PARASITOL INT, V61, P437, DOI 10.1016/j.parint.2012.02.007; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064; Wu ZH, 2014, BIG DATA RES, V1, P1, DOI 10.1016/j.bdr.2014.08.0022214; Wu ZN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002885; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x	59	19	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160458	10.1371/journal.pone.0160458	http://dx.doi.org/10.1371/journal.pone.0160458			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508942	Green Submitted, Green Published, gold			2022-12-26	WOS:000381380400032
J	Espinosa-Gongora, C; Larsen, N; Schonning, K; Fredholm, M; Guardabassi, L				Espinosa-Gongora, Carmen; Larsen, Niels; Schonning, Kristian; Fredholm, Merete; Guardabassi, Luca			Differential Analysis of the Nasal Microbiome of Pig Carriers or Non-Carriers of Staphylococcus aureus	PLOS ONE			English	Article							SP-NOV; COLONIZATION; IMPACT	Staphylococcus aureus is presently regarded as an emerging zoonotic agent due to the spread of specific methicillin-resistant S. aureus (MRSA) clones in pig farms. Studying the microbiota can be useful for the identification of bacteria that antagonize such opportunistic veterinary and zoonotic pathogen in animal carriers. The aim of this study was to determine whether the nasal microbiome of pig S. aureus carriers differs from that of non-carriers. The V3-V5 region of the 16S rRNA gene was sequenced from nasal swabs of 44 S. aureus carriers and 56 non-carriers using the 454 GS FLX titanium system. Carriers and non-carriers were selected on the basis of quantitative longitudinal data on S. aureus carriage in 600 pigs sampled at 20 Danish herds included in two previous studies in Denmark. Raw sequences were analysed with the BION meta package and the resulting abundance matrix was analysed using the DESeq2 package in R to identify operational taxonomic units (OTUs) with differential abundance between S. aureus carriers and non-carriers. Twenty OTUs were significantly associated to non-carriers, including species with known probiotic potential and antimicrobial effect such as lactic acid-producing isolates described among Leuconostoc spp. and some members of the Lachnospiraceae family, which is known for butyrate production. Further 5 OTUs were significantly associated to carriage, including known pathogenic bacteria such as Pasteurella multocida and Klebsiella spp. Our results show that the nasal microbiome of pigs that are not colonized with S. aureus harbours several species/taxa that are significantly less abundant in pig carriers, suggesting that the nasal microbiota may play a role in the individual predisposition to S. aureus nasal carriage in pigs. Further research is warranted to isolate these bacteria and assess their possible antagonistic effect on S. aureus for the pursuit of new strategies to control MRSA in pig farming.	[Espinosa-Gongora, Carmen; Guardabassi, Luca] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Larsen, Niels] Danish Genome Inst, Aarhus, Denmark; [Schonning, Kristian] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Schonning, Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Frederiksberg C, Denmark; [Guardabassi, Luca] Ross Univ, Sch Vet Med, Dept Biomed Sci, Basseterre, St Kitts & Nevi; [Espinosa-Gongora, Carmen] Danish Tech Univ, Natl Vet Inst, Frederiksberg C, Denmark	University of Copenhagen; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; Technical University of Denmark	Espinosa-Gongora, C; Guardabassi, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.; Guardabassi, L (corresponding author), Ross Univ, Sch Vet Med, Dept Biomed Sci, Basseterre, St Kitts & Nevi.; Espinosa-Gongora, C (corresponding author), Danish Tech Univ, Natl Vet Inst, Frederiksberg C, Denmark.	cesg@vet.dtu.dk; LGuardabassi@rossvet.edu.kn		Guardabassi, Luca/0000-0002-2389-5084; Espinosa-Gongora, Carmen/0000-0002-9536-0548	Danish Council for Independent Research, Technology and Production Science, E-grant [060202775]; Danish Council for Independent Research, Technology, and Production Science, Project PIG STAPH-the Role of Porcine Immunity and Genetics in Staphylococcus aureus Colonization (E-grant) [060202775]; University of Copenhagen research center for Control of antibiotic resistance (UC-Care); University of Copenhagen research centre for Control of antibiotic resistance (UC-Care)	Danish Council for Independent Research, Technology and Production Science, E-grant; Danish Council for Independent Research, Technology, and Production Science, Project PIG STAPH-the Role of Porcine Immunity and Genetics in Staphylococcus aureus Colonization (E-grant); University of Copenhagen research center for Control of antibiotic resistance (UC-Care); University of Copenhagen research centre for Control of antibiotic resistance (UC-Care)	The work was supported by the following: Danish Council for Independent Research, Technology and Production Science, E-grant number 060202775, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-council-1/the-danish-council-for-independent-research-technology-and-production-sciences; and University of Copenhagen research center for Control of antibiotic resistance (UC-Care), www.uc-care.ku.dk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Danish Council for Independent Research, Technology, and Production Science, Project PIG STAPH-the Role of Porcine Immunity and Genetics in Staphylococcus aureus Colonization (E-grant nr. 060202775), and by the University of Copenhagen research centre for Control of antibiotic resistance (UC-Care).	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Al Atrouni A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00049; [Anonymous], 2015, DANMAP 2014 USE ANTI; Bassiouni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123216; Benmechernene Z, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/418132; Blajman JE, 2014, BRIT POULTRY SCI, V55, P483, DOI 10.1080/00071668.2014.931930; Brousseau JP, 2015, J ANIM SCI, V93, P5313, DOI 10.2527/jas.2015-9190; Cakici F, 2015, WORLD J MICROB BIOT, V31, P59, DOI 10.1007/s11274-014-1764-3; Choi EB, 2014, ALLERGY, V69, P517, DOI 10.1111/all.12374; Chow SK, 2014, J CLIN MICROBIOL, V52, P854, DOI 10.1128/JCM.03076-13; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Collins MD, 1999, INT J SYST BACTERIOL, V49, P1247, DOI 10.1099/00207713-49-3-1247; Cremers AJH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-44; Dorado-Garcia A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135826; El-Jeni R, 2016, CAN J MICROBIOL, V62, P60, DOI 10.1139/cjm-2015-0481; Espinosa-Gongora C., 2013, Pig Journal, V68, P13; Espinosa-Gongora C, 2015, APPL ENVIRON MICROB, V81, P1251, DOI 10.1128/AEM.03392-14; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Ghareeb K, 2012, POULTRY SCI, V91, P1825, DOI 10.3382/ps.2012-02168; Giotis E. S., 2011, Pig Journal, V65, P35; Grontvedt C, 2015, 4 ASM ESCMID C METH; Guardabassi L, 2013, J GLOB ANTIMICROB RE, V1, P55, DOI 10.1016/j.jgar.2013.03.011; Gulden E, 2015, CLIN IMMUNOL; Hou CL, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0014-3; Hoyles L, 2014, LACTIC ACID BACTERIA: BIODIVERSITY AND TAXONOMY, P91; Huffnagle GB, 2015, CLIN IMMUNOL, V159, P177, DOI 10.1016/j.clim.2015.05.022; Huntley MA, 2013, BIOINFORMATICS, V29, P3220, DOI 10.1093/bioinformatics/btt551; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Kaspar U., 2015, ENVIRON MICROBIOL; Kodjo A, 1997, INT J SYST BACTERIOL, V47, P115, DOI 10.1099/00207713-47-1-115; Kolde R., 2015, PHEATMAP PRETTY HEAT; Kuehn JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061959; LaClaire L, 2000, ANTIMICROB AGENTS CH, V44, P2130, DOI 10.1128/AAC.44.8.2130-2132.2000; Larsen N, 2016, BION META 16S UNPUB; Liu CM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400216; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lowe BA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-20; Mach N, 2015, ENV MICROBIOL REP, V7, P554, DOI 10.1111/1758-2229.12285; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Ongradi J, 2014, ACTA MICROBIOL IMM H, V61, P79, DOI 10.1556/AMicr.61.2014.1.8; Peterson SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152493; R Core Team, 2013, R LANG ENV STAT COMP; Ramakrishnan VR, 2015, J ALLERGY CLIN IMMUN, V136, P334, DOI 10.1016/j.jaci.2015.02.008; Sanz Y, 2014, ADV EXP MED BIOL, V817, P291, DOI 10.1007/978-1-4939-0897-4_14; Skallerup P, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0599-y; Slifierz MJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0512-7; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weese JS, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-69; Wlodarska M, 2015, CELL HOST MICROBE, V17, P577, DOI 10.1016/j.chom.2015.04.008; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108	53	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160331	10.1371/journal.pone.0160331	http://dx.doi.org/10.1371/journal.pone.0160331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27509169	Green Published, gold, Green Submitted			2022-12-26	WOS:000381380400027
J	Mims, MC; Hauser, L; Goldberg, CS; Olden, JD				Mims, Meryl C.; Hauser, Lorenz; Goldberg, Caren S.; Olden, Julian D.			Genetic Differentiation, Isolation-by-Distance, and Metapopulation Dynamics of the Arizona Treefrog (Hyla wrightorum) in an Isolated Portion of Its Range	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SOFTWARE; CONTEMPORARY; PROGRAM; CHYTRIDIOMYCOSIS; SUBDIVISION; EXTINCTIONS; PROJECTIONS; INFERENCE; DECLINES	Population attributes such as diversity, connectivity, and structure are important components of understanding species persistence and vulnerability to extinction. Hyla wrightorum, the Arizona treefrog, is native to the southwestern United States and Mexico, and an isolated group of populations exists in the Huachuca Mountains and Canelo Hills (HMCH) of southeastern Arizona, USA. Due to concerns about declining observations of the species within the isolated HMCH portion of its range, the HMCH group is currently a candidate for federal protection under the U.S. Endangered Species Act. We present results of a genetic study examining population diversity, structure, and connectivity within the HMCH region. We sampled DNA from H. wrightorum larvae and adults from ten distinct locations, 8 of which were breeding sites and 4 of which were previously undescribed localities for the species. We developed and genotyped 17 polymorphic microsatellite loci and quantified genetic diversity, population differentiation, and landscape influences on population genetic structure. We found evidence of larger than expected effective population sizes, significant genetic differentiation between populations, and evidence of distance being the primary driver of genetic structure of populations with some influence of slope and canopy cover. We found little evidence of recent genetic bottlenecks, and individual-based analyses indicate admixture between populations despite significant genetic differentiation. These patterns may indicate that the breeding sites within the Huachuca Mountains constitute a metapopulation. We suggest that the HMCH region may contain larger and more connected breeding populations than previously understood, but the dynamics of this system and the limited geographic extent of the HMCH group justify current concern for the persistence of the species in this region. Efforts to ensure availability of high-quality breeding habitats and control for local threats such as effects of invasive predators may be critical to the persistence of these unique populations of H. wrightorum.	[Mims, Meryl C.; Hauser, Lorenz; Olden, Julian D.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Goldberg, Caren S.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Mims, Meryl C.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA	University of Washington; University of Washington Seattle; Washington State University; United States Department of the Interior; United States Geological Survey	Mims, MC (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.; Mims, MC (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA.	mmims@usgs.gov	Olden, Julian D/A-8535-2010; Goldberg, Caren S/B-4075-2015; Hauser, Lorenz/E-4365-2010	Olden, Julian/0000-0003-2143-1187	Hall Conservation Genetics Graduate Research Award at the University of Washington's College of the Environment; U.S. Army Award [W9214A-14-P-0048]	Hall Conservation Genetics Graduate Research Award at the University of Washington's College of the Environment; U.S. Army Award	Funding for this research was provided by the Hall Conservation Genetics Graduate Research Award at the University of Washington's College of the Environment and through the U.S. Army Award Number W9214A-14-P-0048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to extend our sincerest gratitude to the following funding sources and people for making this work possible. Funding for this research was provided by the Hall Conservation Genetics Graduate Research Award at the University of Washington's College of the Environment and by the U.S. Army Award Number W9214A-14-P-0048. Debbie Brewer (US Army, Fort Huachuca), Sheridan Stone (US Army, Fort Huachuca), John Kraft (US Forest Service), and Tom Jones (Arizona Game and Fish Department) all provided logistical and planning support for this work. Katherine Strickler, Kody Cochrell, Trevor Eakes, and Jessica Hale assisted in fieldwork and sampling.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allendorf F., 2007, CONSERVATION GENETIC; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Chan LM, 2009, MOL ECOL, V18, P3185, DOI 10.1111/j.1365-294X.2009.04273.x; Collins JP, 1994, I92014 IIPAM AR GAM; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2013, CONSERV GENET, V14, P263, DOI 10.1007/s10592-012-0396-0; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Duellman WE, 2001, HYLID FROGS MIDDLE A; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fish U.S. and Wildlife, 2013, US FISH WILDL SERV S; Game Arizona and Department Fish, 2006, RAN SUB UNPUB; Gergus EWA, 2004, COPEIA, P758; Gergus EWA, 2000, 196047 AR GAM FISH D; Gervasi SS, 2013, THESIS; Gilbert KJ, 2015, EVOLUTION, V69, P2154, DOI 10.1111/evo.12713; Goldberg Caren S., 2003, Herpetological Review, V34, P220; Goldberg CS, 2010, MOL ECOL RESOUR, V10, P304, DOI 10.1111/j.1755-0998.2009.02755.x; Hale JR, 2015, HYDROBIOLOGIA, V746, P313, DOI 10.1007/s10750-014-2024-0; Halekoh U., 2012, PBKRTEST PARAMETRIC; Hedrick P, 2005, EVOLUTION, V59, P1596; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Holleley CE, 2014, CONSERV GENET, V15, P23, DOI 10.1007/s10592-013-0518-3; Holycross A.T., 2006, FIELD GUIDE AMPHIBIA; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jones Thomas R., 2010, Herpetological Review, V41, P473; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MANTEL N, 1967, CANCER RES, V27, P209; Marsh DM, 2001, CONSERV BIOL, V15, P40, DOI 10.1046/j.1523-1739.2001.00129.x; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Mims MC, 2015, ECOLOGY, V96, P1371, DOI 10.1890/14-0490.1; Palstra FP, 2007, MOL ECOL, V16, P4504, DOI 10.1111/j.1365-294X.2007.03541.x; Phillipsen IC, 2013, ECOGRAPHY, V36, P731, DOI 10.1111/j.1600-0587.2012.00002.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROSEN PC, 1998, ENV EC LEGAL ISSUES, P180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Seager R, 2013, NAT CLIM CHANGE, V3, P482, DOI [10.1038/nclimate1787, 10.1038/NCLIMATE1787]; SLATKIN M, 1995, GENETICS, V139, P457; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Spear SF, 2012, ECOL APPL, V22, P856, DOI 10.1890/11-0627.1; Sredl MJ, 2000, AQUATIC HERPETOFAUNA; Sredl MJ, 2003, UNDERSTANDING MITIGA; Stebbins R.C, 2003, W REPTILES AMPHIBIAN; Storfer A, 2014, CONSERV GENET, V15, P137, DOI 10.1007/s10592-013-0526-3; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2011, GENETICS, V189, P633, DOI 10.1534/genetics.111.132233; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wright S, 1943, GENETICS, V28, P114; ZWEIFEL RICHARD G., 1961, AMER MUS NOVITATES, V2056, P1	74	18	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160655	10.1371/journal.pone.0160655	http://dx.doi.org/10.1371/journal.pone.0160655			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504892	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200052
J	Hao, JH; Gu, FY; Zhu, J; Lu, SW; Liu, YF; Li, YF; Chen, WZ; Wang, LP; Fan, S; Xian, CJ				Hao, Jinghong; Gu, Fengying; Zhu, Jie; Lu, Shaowei; Liu, Yifei; Li, Yunfei; Chen, Weizhi; Wang, Liping; Fan, Shuangxi; Xian, Cory J.			Low Night Temperature Affects the Phloem Ultrastructure of Lateral Branches and Raffinose Family Oligosaccharide (RFO) Accumulation in RFO-Transporting Plant Melon (Cucumismelo L.) during Fruit Expansion	PLOS ONE			English	Article							SYNTHASE GENE; LEAVES; EXPRESSION; MITOCHONDRIA; STRESS; IMPACT; CELL	Due to the importance and complexity of photo assimilate transport in raffinose family oligosaccharide (RFO)-transporting plants such as melon, it is important to study the features of the transport structure (phloem) particularly of the lateral branches connecting the source leaves and the sink fruits, and its responses to environmental challenges. Currently, it is unclear to what extents the cold environmental temperature stress would alter the phloem ultrastructure and RFO accumulation in RFO-transporting plants. In this study, we firstly utilized electron microscopy to investigate the changes in the phloem ultrastructure of lateral branches and RFO accumulation in melons after being subjected to low night temperatures (12 degrees C and 9 degrees C). The results demonstrated that exposure to 9 degrees C and 12 degrees C altered the ultrastructure of the phloem, with the effect of 9 degrees C being more obvious. The most obvious change was the appearance of plasma membrane invaginations in 99% companion cells and intermediary cells. In addition, phloem parenchyma cells contained chloroplasts with increased amounts of starch grains, sparse cytoplasm and reduced numbers of mitochondria. In the intermediary cells, the volume of cytoplasm was reduced by 50%, and the central vacuole was present. Moreover, the treatment at 9 degrees C during the night led to RFO accumulation in the vascular bundles of the lateral branches and fruit carpopodiums. These ultrastructural changes of the transport structure (phloem) following the treatment at 9 degrees C represented adaptive responses of melons to low temperature stresses. Future studies are required to examine whether these responses may affect phloem transport.	[Hao, Jinghong; Fan, Shuangxi] Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab New Tech Agr Applicat, Beijing 102206, Peoples R China; [Gu, Fengying; Zhu, Jie] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China; [Lu, Shaowei] Chinese Acad Agr Engn, Inst Protected Hort, Beijing 100125, Peoples R China; [Liu, Yifei; Chen, Weizhi] Shenyang Agr Univ, Coll Hort, Key Lab Protected Hort, Educ Minist & Liaoning Prov, Shenyang 110866, Peoples R China; [Li, Yunfei] Beijing Agr Technol Extens Ctr, Beijing 100029, Peoples R China; [Wang, Liping; Xian, Cory J.] Univ South Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	Beijing University of Agriculture; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Engineering; Shenyang Agricultural University; University of South Australia	Fan, S (corresponding author), Beijing Agr Univ, Coll Plant Sci & Technol, Beijing Key Lab New Tech Agr Applicat, Beijing 102206, Peoples R China.; Xian, CJ (corresponding author), Univ South Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	fsx20@163.com; cory.xian@unisa.edu.au	Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845; /0000-0001-9355-1167	Young Scientists Fund of the National Natural Science Foundation of China [31201641]; Science and Technology Committee of Beijing [Z131105000413]; National Natural Science Foundation of China [31372057]; open projects in Beijing Key Laboratory of New Technology in Agricultural Application-Function analysis of auxin respond factor for regulating fruit setting in melon [kf2016025]; Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship Award; NHMRC Senior Research Fellowship	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Beijing; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open projects in Beijing Key Laboratory of New Technology in Agricultural Application-Function analysis of auxin respond factor for regulating fruit setting in melon; Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship Award(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China (grant no. 31201641), the Science and Technology Committee of Beijing (Z131105000413), the National Natural Science Foundation of China (grant no. 31372057), and the 2016 open projects in Beijing Key Laboratory of New Technology in Agricultural Application-Function analysis of auxin respond factor for regulating fruit setting in melon (kf2016025). LW is supported by Australian National Health and Medical Research Council (NHMRC) Postgraduate Scholarship Award, and CJX is supported by NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict CR, 2011, IND CROP PROD, V33, P89, DOI 10.1016/j.indcrop.2010.09.005; Cheng JT, 2015, PLANT SCI, V237, P46, DOI 10.1016/j.plantsci.2015.05.006; Dalby SJ, 2013, MITOCHONDRION, V13, P647, DOI 10.1016/j.mito.2013.09.001; Dumlao MR, 2012, PHOTOSYNTH RES, V113, P181, DOI 10.1007/s11120-012-9762-5; GAMALEI YV, 1994, PLANTA, V194, P443, DOI 10.1007/BF00714455; Gil L, 2012, J PLANT PHYSIOL, V169, P965, DOI 10.1016/j.jplph.2012.02.019; Gould N, 2004, FUNCT PLANT BIOL, V31, P987, DOI 10.1071/FP04058; Hao JH, 2014, RUSS J PLANT PHYSL+, V61, P178, DOI 10.1134/S1021443714020058; Hao JH, 2010, J HORTIC SCI BIOTECH, V85, P260, DOI 10.1080/14620316.2010.11512665; Haritatos E, 1996, PLANTA, V198, P614, DOI 10.1007/BF00262649; Hayashi Y, 2014, ATLAS PLANT CELL STR, P89; Hubeau M, 2015, TRENDS PLANT SCI, V20, P676, DOI 10.1016/j.tplants.2015.07.008; Isayenkov SV, 2014, CYTOL GENET+, V48, P127, DOI 10.3103/S0095452714020042; Li TianLai, 2009, Acta Horticulturae Sinica, V36, P421; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Lutz C, 2007, PROTOPLASMA, V231, P183, DOI 10.1007/s00709-007-0249-8; McGarry RC, 2013, TRENDS PLANT SCI, V18, P198, DOI 10.1016/j.tplants.2013.01.004; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; Palma F, 2014, PLANT SCI, V217, P78, DOI 10.1016/j.plantsci.2013.12.004; Popov VN, 2013, RUSS J PLANT PHYSL+, V60, P221, DOI 10.1134/S1021443713020167; Reunov AA, 2009, ZYGOTE, V17, P1, DOI 10.1017/S0967199408004851; Reynolds ES, 1963, CELL BIOL, V17, P208, DOI DOI 10.1083/JCB.17.1.208; Sui XL, 2012, J PLANT PHYSIOL, V169, P1883, DOI 10.1016/j.jplph.2012.07.019; Turgeon R, 2007, P NATL ACAD SCI USA, V104, P19619; Ukolova I, 2012, BBA-BIOENERGETICS, V1817, pS75, DOI 10.1016/j.bbabio.2012.06.446; van Bel AJE, 2003, PLANT PHYSIOL, V131, P1509, DOI 10.1104/pp.102.022822; Van Bel AJE, 2003, PLANT CELL ENVIRON, V26, P125, DOI 10.1046/j.1365-3040.2003.00963.x; Veliz CG, 2014, J CEREAL SCI, V60, P433, DOI 10.1016/j.jcs.2014.04.008; Venzhik Yu V, 2012, Dokl Biol Sci, V445, P230, DOI 10.1134/S0012496612040047; Wang DH, 2012, J PLANT PHYSIOL, V169, P1838, DOI 10.1016/j.jplph.2012.07.015; Wu JY, 2011, ENV EXPT BOT, V78, P70	31	7	10	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160909	10.1371/journal.pone.0160909	http://dx.doi.org/10.1371/journal.pone.0160909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501301	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000381373500067
J	Kumar, A; Corey, C; Scott, I; Shiva, S; D'Cunha, J				Kumar, Ajay; Corey, Catherine; Scott, Iain; Shiva, Sruti; D'Cunha, Jonathan			Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NF-KAPPA-B; LYSINE ACETYLATION; PROTEIN ACETYLATION; DNA-DAMAGE; TRIPTOLIDE; APOPTOSIS; P53; PATHWAYS; DEATH; INHIBITION	Minnelide/Triptolide (TL) has recently emerged as a potent anticancer drug in non-small cell lung cancer (NSCLC). However, the precise mechanism of its action remains ambiguous. In this study, we elucidated the molecular basis for TL-induced cell death in context to p53 status. Cell death was attributed to dysfunction of mitochondrial bioenergetics in p53-deficient cells, which was characterized by decreased mitochondrial respiration, steady-state ATP level and membrane potential, but augmented reactive oxygen species (ROS). Increased ROS production resulted in oxidative stress in TL-treated cells. This was exhibited by elevated nuclear levels of a redox-sensitive transcriptional factor, NF-E2-related factor-2 (NRF2), along with diminished cellular glutathione (GSH) content. We further demonstrated that in the absence of p53, TL blunted the expression of mitochondrial SIRT3 triggering increased acetylation of NDUAF9 and succinate dehydrogenase, components of complexes I and II of the electron transport chain (ETC). TL-mediated hyperacetylation of complexes I and II proteins and these complexes displayed decreased enzymatic activities. We also provide the evidence that P53 regulate steady-state level of SIRT3 through Proteasome-Pathway. Finally, forced overexpression of Sirt3, but not deacetylase-deficient mutant of Sirt3 (H243Y), restored the deleterious effect of TL on p53-deficient cells by rescuing mitochondrial bioenergetics. On contrary, Sirt3 deficiency in the background of wildtype p53 triggered TL-induced mitochondrial impairment that echoed TL effect in p53-deficeint cells. These findings illustrate a novel mechanism by which TL exerts its potent effects on mitochondrial function and ultimately the viability of NSCLC tumor.	[Kumar, Ajay; D'Cunha, Jonathan] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA 15260 USA; [Corey, Catherine; Scott, Iain; Shiva, Sruti] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA USA; [Shiva, Sruti] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	D'Cunha, J (corresponding author), Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA 15260 USA.	Dcunhaj@upmc.edu			NHLBI NIH HHS [K22 HL116728] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL116728] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Antonoff MB, 2010, J SURG RES, V163, P72, DOI 10.1016/j.jss.2010.04.047; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Borja-Cacho D, 2010, J GASTROINTEST SURG, V14, P252, DOI 10.1007/s11605-009-1065-6; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Choi YW, 2014, CANCER LETT, V346, P300, DOI 10.1016/j.canlet.2014.01.015; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Ding XL, 2015, MOL MED REP, V12, P4508, DOI 10.3892/mmr.2015.3960; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, DOI [10.1016/j. freeradbiomed.2015.04.036, DOI 10.1016/J.FREERADBI0MED.2015.04.036]; Haran M, 2014, MITOCHONDRION, V19, P3, DOI 10.1016/j.mito.2014.09.007; Hofer A, 2014, EXP GERONTOL, V56, P202, DOI 10.1016/j.exger.2014.03.006; Holley AK, 2010, MITOCHONDRION, V10, P649, DOI 10.1016/j.mito.2010.06.003; Hoyle GW, 2010, AM J PHYSIOL-LUNG C, V298, pL830, DOI 10.1152/ajplung.00014.2010; Hu R, 2008, MOL BIOL CELL, V19, P4602, DOI 10.1091/mbc.E07-11-1137; Indo HP, 2015, J CLIN BIOCHEM NUTR, V56, P1, DOI 10.3164/jcbn.14-42; Iwahara T, 2012, MOL CELL BIOL, V32, P5022, DOI 10.1128/MCB.00822-12; Iwasa T, 2008, CLIN CANCER RES, V14, P6496, DOI 10.1158/1078-0432.CCR-08-0468; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Ji LL, 2014, INT J CLIN EXP PATHO, V7, P1124; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Krosch TCK, 2013, AM J SURG, V205, P387, DOI 10.1016/j.amjsurg.2013.01.008; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kumar A, 2011, ARTERIOSCL THROM VAS, V31, P133, DOI 10.1161/ATVBAHA.110.215061; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P7194, DOI 10.1021/ja00775a078; Li J., 2014, J ENG SCI TECHNOL, V7, P9, DOI DOI 10.1371/J0URNAL.P0NE.0100685; Li JJ, 2011, ONCOL REP, V25, P979, DOI 10.3892/or.2011.1158; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lin YC, 2014, FORENSIC SCI INT-GEN, V9, P12, DOI 10.1016/j.fsigen.2013.10.006; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lu Y, 2012, J CELL BIOCHEM, V113, P1022, DOI 10.1002/jcb.23434; Manzl C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.470; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Moon EJ, 2015, FREE RADICAL BIO MED, V79, P292, DOI 10.1016/j.freeradbiomed.2014.11.009; Mujumdar N, 2010, GASTROENTEROLOGY, V139, P598, DOI 10.1053/j.gastro.2010.04.046; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Park JH, 2016, FEBS LETT, V590, P924, DOI 10.1002/1873-3468.12061; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Reno T. A., 2015, ANN THORAC SURG, DOI [10.1016/j.athorasur.2015.05.074, DOI 10.1016/J.ATHORASUR.2015.05.074]; Rousalova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077411; Ryan KM, 2000, NATURE, V404, P892, DOI 10.1038/35009130; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sun H, 2012, ANTI-CANCER DRUG, V23, P1039, DOI 10.1097/CAD.0b013e32835679b8; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Vaitheesvaran B, 2015, METABOLOMICS, V11, P787, DOI 10.1007/s11306-014-0760-9; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Wang X, 2014, MOL MED REP, V10, P447, DOI 10.3892/mmr.2014.2191; Webster BR, 2013, J CELL SCI, V126, P4843, DOI 10.1242/jcs.131300; Wei D, 2014, INFLAMMATION, V37, P1307, DOI 10.1007/s10753-014-9858-5; WEI YS, 1991, ACTA PHARM SINIC, V12, P406; Weir Heather J M, 2013, Genes Cancer, V4, P118, DOI 10.1177/1947601913476949; Wu PP, 2011, ONCOL REP, V25, P551, DOI 10.3892/or.2010.1080; Yang HH, 2011, CLIN LUNG CANCER, V12, P166, DOI 10.1016/j.cllc.2011.03.012; Yang YJ, 2011, GENE, V488, P46, DOI 10.1016/j.gene.2011.07.029; Zhou J, 2014, TOXICOL LETT, V230, P454, DOI 10.1016/j.toxlet.2014.08.017	63	23	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160783	10.1371/journal.pone.0160783	http://dx.doi.org/10.1371/journal.pone.0160783			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27501149	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500052
J	Singhal, A; Tien, YY; Hsia, RY				Singhal, Astha; Tien, Yu-Yu; Hsia, Renee Y.			Racial-Ethnic Disparities in Opioid Prescriptions at Emergency Department Visits for Conditions Commonly Associated with Prescription Drug Abuse	PLOS ONE			English	Article							SEEKING BEHAVIOR; CHRONIC PAIN; CARE; TRENDS; US; BURDEN	Prescription drug abuse is a growing problem nationally. In an effort to curb this problem, emergency physicians might rely on subjective cues such as race-ethnicity, often unknowingly, when prescribing opioids for pain-related complaints, especially for conditions that are often associated with drug-seeking behavior. Previous studies that examined racial-ethnic disparities in opioid dispensing at emergency departments (EDs) did not differentiate between prescriptions at discharge and drug administration in the ED. We examined racialethnic disparities in opioid prescription at ED visits for pain-related complaints often associated with drug-seeking behavior and contrasted them with conditions objectively associated with pain. We hypothesized a priori that racial-ethnic disparities will be present among opioid prescriptions for conditions associated with non-medical use, but not for objective pain-related conditions. Using data from the National Hospital Ambulatory Medical Care Survey for 5 years (2007-2011), the odds of opioid prescription during ED visits made by non-elderly adults aged 18-65 for 'non-definitive' conditions (toothache, back pain and abdominal pain) or 'definitive' conditions (long-bone fracture and kidney stones) were modeled. Opioid prescription at discharge and opioid administration at the ED were the primary outcomes. We found significant racial-ethnic disparities, with non-Hispanic Blacks being less likely (adjusted odds ratio ranging from 0.56-0.67, p-value < 0.05) to receive opioid prescription at discharge during ED visits for back pain and abdominal pain, but not for toothache, fractures and kidney stones, compared to non-Hispanic whites after adjusting for other covariates. Differential prescription of opioids by race-ethnicity could lead to widening of existing disparities in health, and may have implications for disproportionate burden of opioid abuse among whites. The findings have important implications for medical provider education to include sensitization exercises towards their inherent biases, to enable them to consciously avoid these biases from defining their practice behavior.	[Singhal, Astha] Boston Univ, Sch Dent Med, Hlth Policy & Hlth Serv Res, Boston, MA 02215 USA; [Tien, Yu-Yu] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Boston University; University of Iowa; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hsia, RY (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.; Hsia, RY (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	renee.hsia@ucsf.edu		Singhal, Astha/0000-0001-9191-6978				[Anonymous], 2014, ED Manag, V26, P5; Barry CL, 2016, ADDICTION, V111, P85, DOI 10.1111/add.13077; Bijur P, 2008, AM J EMERG MED, V26, P270, DOI 10.1016/j.ajem.2007.05.010; Billings J, 2013, HEALTH AFFAIR, V32, P2099, DOI 10.1377/hlthaff.2012.1276; Boccuzzi J, 2015, J AM DENT ASSOC, V146, P655, DOI 10.1016/j.adaj.2015.07.008; Burgess DJ, 2011, J GEN INTERN MED, V26, P828, DOI 10.1007/s11606-011-1748-z; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevention, 1999, VIT SIGNS OV PRESCR; CENTERS FOR DISEASE CONTROL AND PREVENTION, 2013, MMWR-MORBID MORTAL W; Cepeda MS, 2014, CLIN J PAIN, V30, P1051, DOI 10.1097/AJP.0000000000000067; Compton WM, 2015, PREV MED, V80, P5, DOI 10.1016/j.ypmed.2015.04.003; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Gilson AM, 2009, PAIN MED, V10, pS89, DOI 10.1111/j.1526-4637.2009.00668.x; Grover CA, 2012, WEST J EMERG MED, V13, P416, DOI 10.5811/westjem.2012.4.11600; Han B, 2015, JAMA-J AM MED ASSOC, V314, P1468, DOI 10.1001/jama.2015.11859; Hansen J., 2011, REPORT TO THE SUBCOM; Hawkins SC, 2008, J EMERG MED, V34, P125, DOI 10.1016/j.jemermed.2007.07.001; Hupp JR, 2014, AM J EMERG MED, V32, P480, DOI 10.1016/j.ajem.2014.01.056; International Pain Summit Of The International Association For The Study Of Pain, 2011, J Pain Palliat Care Pharmacother, V25, P29, DOI 10.3109/15360288.2010.547560; Jones CM, 2013, JAMA-J AM MED ASSOC, V309, P657, DOI 10.1001/jama.2013.272; Kea B, 2014, ACAD EMERG MED, V21, P946, DOI 10.1111/acem.12425; King NB, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2014.301966; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Lee HH, 2012, AM J PUBLIC HEALTH, V102, pe77, DOI DOI 10.2105/AJPH.2012; Levy B, 2015, AM J PREV MED, V49, P409, DOI 10.1016/j.amepre.2015.02.020; Lewis CW, 2015, J AM DENT ASSOC, V146, P295, DOI 10.1016/j.adaj.2015.01.013; Mazer-Amirshahi M, 2014, ACAD EMERG MED, V21, P236, DOI 10.1111/acem.12328; McCaig LF, 2012, ANN EMERG MED, V60, P716, DOI 10.1016/j.annemergmed.2012.07.010; McCracken LM, 2012, J PAIN, V13, P32, DOI 10.1016/j.jpain.2011.09.007; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; Moskowitz D, 2011, J GEN INTERN MED, V26, P846, DOI 10.1007/s11606-011-1672-2; National Center for Health Statistics, 2011, AMB CAR DRUG DAT SYS; Nelson LS, 2015, JAMA-J AM MED ASSOC, V314, P1453, DOI 10.1001/jama.2015.12397; Okunseri C, 2014, J PUBLIC HEALTH DENT, V74, P283, DOI 10.1111/jphd.12055; Ondler C, 2014, AM J EMERG MED, V32, P1215, DOI 10.1016/j.ajem.2014.07.013; Pew Childrens Dental Campaign, 2012, PEW CHILDR DENT CAMP; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; Rupp T, 2004, ANN EMERG MED, V43, P494, DOI 10.1016/j.annemergmed.2003.11.019; Shah AA, 2015, MED CARE, V53, P1000, DOI 10.1097/MLR.0000000000000444; Speiser AM, 2015, J AM DENT ASSOC, V146, P655, DOI 10.1016/j.adaj.2015.07.009; Sullivan MD, 2013, PAIN, V154, pS94, DOI 10.1016/j.pain.2013.09.009; Tamayo-Sarver JH, 2003, AM J PUBLIC HEALTH, V93, P2067, DOI 10.2105/AJPH.93.12.2067; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; Todd KH, 2007, J PAIN, V8, P460, DOI 10.1016/j.jpain.2006.12.005; Wall T, 2012, J PUBLIC HEALTH DENT, V72, P216, DOI 10.1111/j.1752-7325.2012.00339.x; Weiner SG, 2015, J EMERG MED, V48, P424, DOI 10.1016/j.jemermed.2014.11.008; Weiner SG, 2013, ANN EMERG MED, V62, P281, DOI 10.1016/j.annemergmed.2013.05.025	47	156	156	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0159224	10.1371/journal.pone.0159224	http://dx.doi.org/10.1371/journal.pone.0159224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IE	27501459	Green Published, gold			2022-12-26	WOS:000381373500004
J	Yang, G; Gong, Y; Wang, Q; Wang, L; Zhang, X				Yang, G.; Gong, Y.; Wang, Q.; Wang, L.; Zhang, X.			miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation	ONCOGENE			English	Article							MICRORNA EXPRESSION; TUMOR SUPPRESSION; PROTEIN LIGASE; PROTEASOME; BREAST; SIGNATURE; FAMILY; GENES; MDM2	During tumourigenesis, p53 functions as 'the guardian of the genome' because p53-dependent apoptosis strongly regulates the fate of cancer cells. Therefore, p53 regulation must be sensitive and accurate. p53 activity is regulated through its ubiquitination and deubiquitination. However, the role of microRNA in ubiquitin-mediated p53 degradation has not been previously studied. Our previous studies indicated that miR-100 is required for apoptosis. In the current study, the mechanism of p53 protein ubiquitination mediated by miR-100 was characterized. An analysis of primary tumour samples from gastric cancer patients showed a significant correlation between miR-100 upregulation and primary human gastric tumourigenesis and progression. The in vivo and in vitro data indicated that miR-100 antagonism specifically induced the apoptosis of poorly differentiated gastric cancer cells but not non-cancerous gastric cells, indicating that miR-100 has a crucial role in regulating the progression of gastric tumours. In the regulation of p53-dependent apoptosis, miR-100 antagonism inhibited ubiquitin-mediated p53 protein degradation by activating RNF144B, an E3 ubiquitination ligase. Consequently, the miR-100-RNF144B-pirh2-p53-dependent pathway was initiated. Our findings highlight a novel mechanism of ubiquitin-mediated p53 protein degradation in apoptosis.	[Yang, G.; Gong, Y.; Zhang, X.] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, 388 Yuhangtang Rd, Hangzhou 310004, Zhejiang, Peoples R China; [Yang, G.; Gong, Y.; Zhang, X.] Zhejiang Univ, Coll Life Sci, 388 Yuhangtang Rd, Hangzhou 310004, Zhejiang, Peoples R China; [Wang, Q.; Wang, L.] Bengbu Med Coll, Affiliated Hosp 1, Dept Gastroenterol, Bengbu, Peoples R China	Zhejiang University; Zhejiang University; Bengbu Medical College	Zhang, X (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, 388 Yuhangtang Rd, Hangzhou 310004, Zhejiang, Peoples R China.; Zhang, X (corresponding author), Zhejiang Univ, Coll Life Sci, 388 Yuhangtang Rd, Hangzhou 310004, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	National Natural Science Foundation of China [41276152, 31430089]; National Program on the Key Basic Research Project [2015CB755903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on the Key Basic Research Project	This work was supported by the National Natural Science Foundation of China (41276152, 31430089) and the National Program on the Key Basic Research Project (2015CB755903).	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Allende-Vega N, 2010, SEMIN CANCER BIOL, V20, P29, DOI 10.1016/j.semcancer.2009.10.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Cairo S, 2010, P NATL ACAD SCI USA, V107, P20471, DOI 10.1073/pnas.1009009107; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen D, 2009, EMBO REP, V10, P166, DOI 10.1038/embor.2008.231; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Conforti F, 2013, ONCOGENE, V32, P4758, DOI 10.1038/onc.2012.497; Deng YB, 2008, NAT REV CANCER, V8, P450, DOI 10.1038/nrc2393; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Feki A, 2004, CRIT REV ONCOL HEMAT, V52, P103, DOI 10.1016/j.critrevonc.2004.07.002; Gong Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep11650; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P265, DOI 10.1016/j.urolonc.2009.02.002; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu W, 2009, CHINESE MED J-PEKING, V122, P2405, DOI 10.3760/cma.j.issn.0366-6999.2009.20.002; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Mercer J, 2007, MUTAT RES-FUND MOL M, V621, P75, DOI 10.1016/j.mrfmmm.2007.02.011; Motegi A, 2009, CANCER LETT, V283, P1, DOI 10.1016/j.canlet.2008.12.030; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Shi W, 2010, INT J CANCER, V126, P2036, DOI 10.1002/ijc.24880; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tsvetkov P, 2011, J BIOL CHEM, V286, P8839, DOI 10.1074/jbc.M110.193276; Wang XJ, 2011, CELL CYCLE, V10, P4225, DOI 10.4161/cc.10.24.18662; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	44	26	27	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1023	1037		10.1038/onc.2016.270	http://dx.doi.org/10.1038/onc.2016.270			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27524417				2022-12-26	WOS:000395371500001
J	Deniz, M; Kaufmann, J; Stahl, A; Gundelach, T; Janni, W; Hoffmann, I; Keimling, M; Hampp, S; Ihle, M; Wiesmuller, L				Deniz, Miriam; Kaufmann, Julia; Stahl, Andreea; Gundelach, Theresa; Janni, Wolfgang; Hoffmann, Isabell; Keimling, Marlen; Hampp, Stephanie; Ihle, Michaela; Wiesmueller, Lisa			In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis	FASEB JOURNAL			English	Article						aging; chemotherapy; epithelial-mesenchymal transition; PARP inhibition	EPITHELIAL-MESENCHYMAL TRANSITION; HOMOLOGOUS RECOMBINATION; HEREDITARY BREAST; POLY(ADP-RIBOSE) POLYMERASE; OVARIAN-CANCER; HIGH-GRADE; BRCA1; SUSCEPTIBILITY; MUTATIONS; PREDICTION	Dysfunction of homologous recombination is a common denominator of changes associated with breast cancer-predisposing mutations. In our previous work, we identified a functional signature in peripheral blood lymphocytes from women who were predisposed that indicated a shift from homologous recombination to alternative, error-prone DNA double-strand break (DSB) repair pathways. To capture both hereditary and nonhereditary factors, we newly established a protocol for isolation and ex vivo analysis of epithelial cells, epithelial-mesenchymal transition cells (EMTs), and fibroblasts from breast cancer specimens (147 patients). By applying a fluorescence-based test system, we analyzed the error-prone DSB repair pathway microhomology-mediated end joining in these tumor-derived cell types and peripheral blood lymphocytes. In parallel, we investigated DNA lesion processing by quantitative immunofluorescence microscopy of histone H2AX phosphorylated on Ser139 focus after radiomimetic treatment. Our study reveals elevated histone H2AX phosphorylated on Ser139 damage removal in epithelial cells, not EMTs, and poly(ADP-ribose)polymerase inhibitor sensitivities, which suggested a DSB repair pathway shift with increasing patient age. Of interest, we found elevated microhomology-mediated end joining in EMTs, not epithelial cells, from patients who received a treatment recommendation of adjuvant chemotherapy, that is, those with high-risk tumors. Our discoveries of altered DSB repair activities in cells may serve as a method to further classify breast cancer to predict responsiveness to adjuvant chemotherapy and/or therapeutics that target DSB repair-dysfunctional tumors.Deniz, M., Kaufmann, J., Stahl, A., Gundelach, T., Janni, W., Hoffmann, I., Keimling, M., Hampp, S., Ihle, M., Wiesmuller, L. In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis.	[Deniz, Miriam; Kaufmann, Julia; Stahl, Andreea; Gundelach, Theresa; Janni, Wolfgang; Keimling, Marlen; Hampp, Stephanie; Ihle, Michaela; Wiesmueller, Lisa] Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany; [Hoffmann, Isabell] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, Univ Med Ctr, Mainz, Germany	Ulm University; Johannes Gutenberg University of Mainz	Wiesmuller, L (corresponding author), Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany.	lisa.wiesmueller@uni-ulm.de			Federal Ministry of Education and Research (BMBF; Bonn, Germany) (BRENDA) [012P0505]; Deutsche Forchungsgemeinschaft (DFG) Graduate School of Molecular Medicine at Ulm University (Ulm, Germany) [110388]	Federal Ministry of Education and Research (BMBF; Bonn, Germany) (BRENDA)(Federal Ministry of Education & Research (BMBF)); Deutsche Forchungsgemeinschaft (DFG) Graduate School of Molecular Medicine at Ulm University (Ulm, Germany)(German Research Foundation (DFG))	This work was supported by grants from Federal Ministry of Education and Research (BMBF; Bonn, Germany) (BRENDA #012P0505), the Deutsche Forchungsgemeinschaft (DFG) Graduate School of Molecular Medicine at Ulm University (Ulm, Germany; Ph.D. fellowship to S.H.), and the Deutsche Krebshilfe (#110388). The authors thank Rolf Kreienberg, Karin Koretz, and Peter Moller (Institute of Pathology, Ulm University) for the continuous support of our molecular oncological studies; Harald Binder and Maria Blettner (Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes-Gutenberg-University of Mainz) for sharing their expertise regarding statistical evaluation of the data; and Ralf Hass (Department of Gynecology, Medical School Hannover, Hannover, Germany) for sharing reagents and technical advice during the initial phase of primary epithelial cell culture establishment.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Asakawa H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2486; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bae YK, 2015, J BREAST CANCER, V18, P256, DOI 10.4048/jbc.2015.18.3.256; Bai F, 2014, CANCER RES, V74, P6161, DOI 10.1158/0008-5472.CAN-14-1119; Baldeyron C, 2002, ONCOGENE, V21, P1401, DOI 10.1038/sj.onc.1205200; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Bohringer M, 2013, ONCOGENE, V32, P5458, DOI 10.1038/onc.2013.38; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Easton Douglas F, 2015, N Engl J Med, V372, P2243, DOI 10.1056/NEJMsr1501341; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; Ireno IC, 2014, CARCINOGENESIS, V35, P2273, DOI 10.1093/carcin/bgu160; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Keimling M, 2012, FASEB J, V26, P2094, DOI 10.1096/fj.11-200790; Keimling M, 2011, FASEB J, V25, P3849, DOI 10.1096/fj.11-185546; Keimling M, 2009, CARCINOGENESIS, V30, P1260, DOI 10.1093/carcin/bgp117; Larsen MJ, 2014, BREAST CANCER-BASIC, V8, P145, DOI 10.4137/BCBCR.S18715; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056591; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meindl A, 2011, DTSCH ARZTEBL INT, V108, P323, DOI 10.3238/arztebl.2011.0323; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; Minafra L, 2014, ANTICANCER RES, V34, P2173; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Naipal KAT, 2014, CLIN CANCER RES, V20, P4816, DOI 10.1158/1078-0432.CCR-14-0571; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Obermeier K, 2016, ONCOGENE, V35, P3796, DOI 10.1038/onc.2015.448; Ossovskaya Valeria, 2011, Genes Cancer, V2, P870, DOI 10.1177/1947601911432496; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Reis JS, 2006, J CLIN PATHOL, V59, P225, DOI 10.1136/jcp.2005.028324; Ribeiro E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066243; Rothfuss A, 2000, CANCER RES, V60, P390; Sharma PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121083; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vaidya A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004511; Walsh CS, 2015, GYNECOL ONCOL, V137, P343, DOI 10.1016/j.ygyno.2015.02.017; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Willers H, 2009, MOL CANCER RES, V7, P1304, DOI 10.1158/1541-7786.MCR-09-0149; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zubeldia-Plazaola A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00032	71	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3786	3799		10.1096/fj.201600453R	http://dx.doi.org/10.1096/fj.201600453R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27494941				2022-12-26	WOS:000386474700013
J	Dolezal, M; Hadravova, R; Kozisek, M; Bednarova, L; Langerova, H; Ruml, T; Rumlova, M				Dolezal, Michal; Hadravova, Romana; Kozisek, Milan; Bednarova, Lucie; Langerova, Hana; Ruml, Tomas; Rumlova, Michaela			Functional and Structural Characterization of Novel Type of Linker Connecting Capsid and Nucleocapsid Protein Domains in Murine Leukemia Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circular dichroism (CD); electron microscopy (EM); nuclear magnetic resonance (NMR); retrovirus; virus assembly; capsid protein (CA); charged assembly helix (CAH); murine leukemia virus (MLV); single alpha-helix (SAH); spacer peptide (SP)	HUMAN-IMMUNODEFICIENCY-VIRUS; PFIZER MONKEY VIRUS; CIRCULAR-DICHROISM SPECTRA; SINGLE ALPHA-HELICES; SPACER PEPTIDE; IN-VITRO; CRYOELECTRON MICROSCOPY; SECONDARY STRUCTURE; POTENTIAL ROLE; NMR	The assembly of immature retroviral particles is initiated in the cytoplasm by the binding of the structural polyprotein precursor Gag with viral genomic RNA. The protein interactions necessary for assembly are mediated predominantly by the capsid (CA) and nucleocapsid (NC) domains, which have conserved structures. In contrast, the structural arrangement of the CA-NC connecting region differs between retroviral species. In HIV-1 and Rous sarcoma virus, this region forms a rod-like structure that separates the CA and NC domains, whereas in Mason-Pfizer monkey virus, this region is densely packed, thus holding the CA and NC domains in close proximity. Interestingly, the sequence connecting the CA and NC domains in gammaretroviruses, such as murine leukemia virus (MLV), is unique. The sequence is called a charged assembly helix (CAH) due to a high number of positively and negatively charged residues. Although both computational and deletion analyses suggested that the MLV CAH forms a helical conformation, no structural or biochemical data supporting this hypothesis have been published. Using an in vitro assembly assay, alanine scanning mutagenesis, and biophysical techniques (circular dichroism, NMR, microcalorimetry, and electrophoretic mobility shift assay), we have characterized the structure and function of the MLV CAH. We provide experimental evidence that the MLV CAH belongs to a group of charged, E(R/K)-rich, single -helices. This is the first single -helix motif identified in viral proteins.	[Dolezal, Michal; Hadravova, Romana; Kozisek, Milan; Bednarova, Lucie; Rumlova, Michaela] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Flemingovo Namesti 2, Prague 16610 6, Czech Republic; [Langerova, Hana; Ruml, Tomas] Univ Chem & Technol, Dept Biochem & Microbiol, Tech 3, Prague 16628 6, Czech Republic; [Rumlova, Michaela] Univ Chem & Technol, Dept Biotechnol, Tech 5, Prague 16628 6, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Chemistry & Technology, Prague; University of Chemistry & Technology, Prague	Rumlova, M (corresponding author), Univ Chem & Technol, Dept Biotechnol, Tech 5, Prague 16628 6, Czech Republic.	michaela.rumlova@vscht.cz	Bednarova, Lucie/E-7622-2012; Ruml, Tomas/R-2543-2017; Rumlova, Michaela/G-9142-2018; Dolezal, Michal/G-5895-2014; Kozisek, Milan/D-4234-2013	Ruml, Tomas/0000-0002-5698-4366; Rumlova, Michaela/0000-0002-5645-8227; Dolezal, Michal/0000-0001-8814-7805; Kozisek, Milan/0000-0002-9476-3409	Grant Agency of the Czech Republic [14-15326S]; "National Program of Sustainability I" (NPU I) [LO 1302]; "Operational Programme Prague - Competitiveness" [CZ.2.16/3.1.00/24503]; NPU I LO1601 Grant [MSMT-43760/ 2015]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); "National Program of Sustainability I" (NPU I); "Operational Programme Prague - Competitiveness"; NPU I LO1601 Grant	This work was supported by the Grant Agency of the Czech Republic Grant 14-15326S (to M. R.), by "National Program of Sustainability I" (NPU I) projects LO 1302, by the "Operational Programme Prague - Competitiveness" (Grant CZ.2.16/3.1.00/24503), and by NPU I LO1601 Grant MSMT-43760/ 2015. The authors declare that they have no conflicts of interest with the contents of this article.	Accola MA, 1998, J VIROL, V72, P2072, DOI 10.1128/JVI.72.3.2072-2078.1998; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Baker EG, 2015, NAT CHEM BIOL, V11, P221, DOI 10.1038/nchembio.1739; Bharat TAM, 2014, P NATL ACAD SCI USA, V111, P8233, DOI 10.1073/pnas.1401455111; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Bohmova K, 2010, J VIROL, V84, P1977, DOI 10.1128/JVI.02022-09; Bowzard JB, 2001, J VIROL, V75, P6850, DOI 10.1128/JVI.75.15.6850-6856.2001; Bush DL, 2014, J VIROL, V88, P5617, DOI 10.1128/JVI.02659-13; Cheslock SR, 2003, J VIROL, V77, P7058, DOI 10.1128/JVI.77.12.7058-7066.2003; Datta SAK, 2011, J VIROL, V85, P4111, DOI 10.1128/JVI.00006-11; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; England MR, 2014, J VIROL, V88, P7170, DOI 10.1128/JVI.00309-14; Fuzik T, 2016, J VIROL, V90, P4593, DOI 10.1128/JVI.03197-15; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hadravova R, 2012, J VIROL, V86, P1297, DOI 10.1128/JVI.05564-11; Han Y, 2013, J AM CHEM SOC, V135, P17793, DOI 10.1021/ja406907h; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Keller PW, 2008, J VIROL, V82, P6788, DOI 10.1128/JVI.00213-08; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; KRAUSSLICH HG, 1995, J VIROL, V69, P3407; Machara A, 2016, J MED CHEM, V59, P545, DOI 10.1021/acs.jmedchem.5b01089; Melamed D, 2004, J VIROL, V78, P9675, DOI 10.1128/JVI.78.18.9675-9688.2004; Morellet N, 2005, PROTEIN SCI, V14, P375, DOI 10.1110/ps.041087605; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; PETTIT SC, 1994, J VIROL, V68, P8017, DOI 10.1128/JVI.68.12.8017-8027.1994; Rumlova M, 2003, VIROLOGY, V310, P310, DOI 10.1016/S0042-6822(03)00128-4; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Strohalmova-Bohmova K, 2014, J VIROL, V88, P14148, DOI 10.1128/JVI.02286-14; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Wang MQ, 2003, J VIROL, V77, P3339, DOI 10.1128/JVI.77.5.3339-3344.2003; Wiegers K, 1998, J VIROL, V72, P2846, DOI 10.1128/JVI.72.4.2846-2854.1998; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Wright ER, 2007, EMBO J, V26, P2218, DOI 10.1038/sj.emboj.7601664; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106	45	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20630	20642		10.1074/jbc.M116.746461	http://dx.doi.org/10.1074/jbc.M116.746461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27514744	Green Published, hybrid			2022-12-26	WOS:000384574800027
J	Ejby, M; Fredslund, F; Andersen, JM; Zagar, AV; Henriksen, JR; Andersen, TL; Svensson, B; Slotboom, DJ; Abou Hachem, M				Ejby, Morten; Fredslund, Folmer; Andersen, Joakim Mark; Zagar, Andreja Vujicic; Henriksen, Jonas Rosager; Andersen, Thomas Lars; Svensson, Birte; Slotboom, Dirk Jan; Abou Hachem, Maher			An ATP Binding Cassette Transporter Mediates the Uptake of alpha-(1,6)-Linked Dietary Oligosaccharides in Bifidobacterium and Correlates with Competitive Growth on These Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; carbohydrate-binding protein; crystal structure; probiotic; surface plasmon resonance (SPR); Bifidobacterium; gut microbiota; isomalto-oligosaccharide; oligosaccharide uptake; raffinose	GUT MICROBIOTA; STREPTOCOCCUS-MUTANS; ALPHA-GALACTOSIDASE; STRUCTURAL BASIS; MODEL; DIVERSITY; MICROORGANISMS; PERFORMANCE; METABOLISM; RAFFINOSE	The molecular details and impact of oligosaccharide uptake by distinct human gut microbiota (HGM) are currently not well understood. Non-digestible dietary galacto- and gluco--(1,6)-oligosaccharides from legumes and starch, respectively, are preferentially fermented by mainly bifidobacteria and lactobacilli in the human gut. Here we show that the solute binding protein (BlG16BP) associated with an ATP binding cassette (ABC) transporter from the probiotic Bifidobacterium animalis subsp. lactis Bl-04 binds -(1,6)-linked glucosides and galactosides of varying size, linkage, and monosaccharide composition with preference for the trisaccharides raffinose and panose. This preference is also reflected in the -(1,6)-galactoside uptake profile of the bacterium. Structures of BlG16BP in complex with raffinose and panose revealed the basis for the remarkable ligand binding plasticity of BlG16BP, which recognizes the non-reducing -(1,6)-diglycoside in its ligands. BlG16BP homologues occur predominantly in bifidobacteria and a few Firmicutes but lack in other HGMs. Among seven bifidobacterial taxa, only those possessing this transporter displayed growth on -(1,6)-glycosides. Competition assays revealed that the dominant HGM commensal Bacteroides ovatus was out-competed by B. animalis subsp. lactis Bl-04 in mixed cultures growing on raffinose, the preferred ligand for the BlG16BP. By comparison, B. ovatus mono-cultures grew very efficiently on this trisaccharide. These findings suggest that the ABC-mediated uptake of raffinose provides an important competitive advantage, particularly against dominant Bacteroides that lack glycan-specific ABC-transporters. This novel insight highlights the role of glycan transport in defining the metabolic specialization of gut bacteria.	[Ejby, Morten; Andersen, Joakim Mark; Svensson, Birte; Abou Hachem, Maher] Tech Univ Denmark, Prot Glycosci & Biotechnol, Dept Bioengn, Bldg 375, DK-2800 Lyngby, Denmark; [Henriksen, Jonas Rosager] Tech Univ Denmark, Dept Chem, Kemitorvet Bldg 206, DK-2800 Lyngby, Denmark; [Andersen, Thomas Lars] Tech Univ Denmark, Dept Microtechnol & Nanotechnol, Prod Storvet Bldg 423, DK-2800 Lyngby, Denmark; [Fredslund, Folmer] Lund Univ, MAX Lab 4, MaxLab, Ole Romers Vag 1, S-22100 Lund, Sweden; [Zagar, Andreja Vujicic; Slotboom, Dirk Jan] Univ Groningen, Inst Biomol Sci & Biotechnol, Membrane Enzymol, Nijenborgh 4, NL-9747 AG Groningen, Netherlands	Technical University of Denmark; Technical University of Denmark; Technical University of Denmark; Lund University; University of Groningen	Abou Hachem, M (corresponding author), Tech Univ Denmark, Prot Glycosci & Biotechnol, Dept Bioengn, Bldg 375, DK-2800 Lyngby, Denmark.	maha@bio.dtu.dk	Fredslund, Folmer/ABH-5821-2020; Abou Hachem, Maher/M-4772-2019	Fredslund, Folmer/0000-0003-0881-1927; Abou Hachem, Maher/0000-0001-8250-1842; Svensson, Birte/0000-0002-2993-8196; Henriksen, Jonas Rosager/0000-0001-9154-6639; Andresen, Thomas Lars/0000-0002-1048-127X; Ejby, Morten/0000-0003-2099-3591; Andersen, Joakim/0000-0001-8902-8162	Danish Strategic Research Council; FoSu committee; Danish Research Council for Independent Research Natural Sciences [4002-00297]; Biacore T100 instrument; Carlsberg Foundation [2011-01-0598]; Technical University of Denmark; European Research Council; EDICT program; Netherlands Organisation for Scientific Research (NWO)	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); FoSu committee; Danish Research Council for Independent Research Natural Sciences; Biacore T100 instrument; Carlsberg Foundation(Carlsberg Foundation); Technical University of Denmark; European Research Council(European Research Council (ERC)European Commission); EDICT program; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Danish Strategic Research Council, the FoSu committee to the project "Gene discovery and molecular interactions in pre/probiotics systems, Focus on carbohydrate prebiotics"; Danish Research Council for Independent Research Natural Sciences (Grant 4002-00297) and the Biacore T100 instrument; the Carlsberg Foundation for isothermal titration calorimetry equipment (2011-01-0598); Ph.D. stipends from the Technical University of Denmark (to M.E. and J.M.A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Research Council starting grant (to D. J. S.), the EDICT program, and the Netherlands Organisation for Scientific Research (NWO).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-312; Andersen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044409; Andersen KE, 2005, J AGR FOOD CHEM, V53, P5809, DOI 10.1021/jf040471v; Ao ZH, 2007, J AGR FOOD CHEM, V55, P4540, DOI 10.1021/jf063123x; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Brown K, 2012, NUTRIENTS, V4, P1552, DOI [10.3390/nu4081095, 10.3390/nu4111552]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ejby M, 2013, MOL MICROBIOL, V90, P1100, DOI 10.1111/mmi.12419; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gilad O, 2010, APPL ENVIRON MICROB, V76, P7285, DOI 10.1128/AEM.00738-10; Goffin D, 2011, CRIT REV FOOD SCI, V51, P394, DOI 10.1080/10408391003628955; Goh YJ, 2015, ANNU REV FOOD SCI T, V6, P137, DOI 10.1146/annurev-food-022814-015706; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishizuka S, 2009, MOL NUTR FOOD RES, V53, pS62, DOI 10.1002/mnfr.200800041; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106; Makelainen H, 2009, LETT APPL MICROBIOL, V49, P666, DOI 10.1111/j.1472-765X.2009.02698.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oldham ML, 2013, P NATL ACAD SCI USA, V110, P18132, DOI 10.1073/pnas.1311407110; Overmars L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-209; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Rosenow C, 1999, GENOME RES, V9, P1189, DOI 10.1101/gr.9.12.1189; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Studts JM, 1999, PROTEIN EXPRES PURIF, V16, P109, DOI 10.1006/prep.1999.1067; Suzuki R, 2008, J BIOL CHEM, V283, P13165, DOI 10.1074/jbc.M709777200; Swennen K, 2006, CRIT REV FOOD SCI, V46, P459, DOI 10.1080/10408390500215746; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; van den Broek LAM, 2003, APPL MICROBIOL BIOT, V61, P55, DOI 10.1007/s00253-002-1179-1; van Zanten GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047212; Ventura M, 2007, INT J FOOD MICROBIOL, V120, P2, DOI 10.1016/j.ijfoodmicro.2007.06.011; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42	56	35	36	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 16	2016	291	38					20220	20231		10.1074/jbc.M116.746529	http://dx.doi.org/10.1074/jbc.M116.746529			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EO	27502277	Green Published, hybrid			2022-12-26	WOS:000383243100041
J	Navarro-Retamal, C; Caballero, J				Navarro-Retamal, Carlos; Caballero, Julio			Flavonoids as CDK1 Inhibitors: Insights in Their Binding Orientations and Structure-Activity Relationship	PLOS ONE			English	Article							CELL-CYCLE; CDK1/CYCLIN-B INHIBITORS; CRYSTAL-STRUCTURE; KINASE; DOCKING; IDENTIFICATION; ACTIVATION; QUERCETIN; 3-KINASE; DESIGN	In the last years, the interactions of flavonoids with protein kinases (PKs) have been described by using crystallographic experiments. Interestingly, different orientations have been found for one flavonoid inside different PKs and different chemical substitutions lead to different orientations of the flavonoid scaffold inside one PK. Accordingly, orientation predictions of novel analogues could help to the design of flavonoids with high PK inhibitory activities. With this in mind, we studied the binding modes of 37 flavonoids (flavones and chalcones) inside the cyclin-dependent PK CDK1 using docking experiments. We found that the compounds under study adopted two different orientations into the active site of CDK1 (orientations I and II in the manuscript). In addition, quantitative structure-activity relationship (QSAR) models using CoMFA and CoMSIA methodologies were constructed to explain the trend of the CDK1 inhibitory activities for the studied flavonoids. Templatebased and docking-based alignments were used. Models developed starting from dockingbased alignment were applied for describing the whole dataset and compounds with orientation I. Adequate R-2 and Q(2) values were obtained by each method; interestingly, only hydrophobic and hydrogen bond donor fields describe the differential potency of the flavonoids as CDK1 inhibitors for both defined alignments and subsets. Our current application of docking and QSAR together reveals important elements to be drawn for the design of novel flavonoids with increased PK inhibitory activities.	[Navarro-Retamal, Carlos; Caballero, Julio] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile	Universidad de Talca	Caballero, J (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile.	jcaballero@utalca.cl	Caballero, Julio/G-3654-2014	Caballero, Julio/0000-0003-0182-1444; Navarro-Retamal, Carlos/0000-0001-9581-0206	Government of Chile	Government of Chile	CNR thanks the Government of Chile for a PhD fellowship awarded through CONICYT.	Abdul-Hay SO, 2013, J MED CHEM, V56, P2246, DOI 10.1021/jm301280p; Amaning K, 2013, BIOORG MED CHEM LETT, V23, P3620, DOI 10.1016/j.bmcl.2013.04.003; [Anonymous], 1699, SYBYL X 1 2; Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Boam T, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.585; Brown NR, 2015, NAT COMMUN, P6; BUSH BL, 1993, J COMPUT AID MOL DES, V7, P587, DOI 10.1007/BF00124364; Caballero J, 2011, CHEM BIOL DRUG DES, V78, P631, DOI 10.1111/j.1747-0285.2011.01186.x; Caporuscio F, 2011, J MED CHEM, V54, P4006, DOI 10.1021/jm2000689; Chin YW, 2013, BIOORG MED CHEM LETT, V23, P1768, DOI 10.1016/j.bmcl.2013.01.049; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Durdagi S, 2011, J CHEM INF MODEL, V51, P463, DOI 10.1021/ci100409y; FAVREAU LV, 1995, J BIOL CHEM, V270, P24468, DOI 10.1074/jbc.270.41.24468; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Holder S, 2007, MOL CANCER THER, V6, P163, DOI 10.1158/1535-7163.MCT-06-0397; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Kim K, 2015, ORG LETT, V17, P2550, DOI 10.1021/acs.orglett.5b01138; Kong ANT, 2000, ARCH PHARM RES, V23, P1, DOI 10.1007/BF02976458; Liu T, 2007, BIOORG MED CHEM LETT, V17, P278, DOI 10.1016/j.bmcl.2006.07.088; Lolli G, 2012, BIOCHEMISTRY-US, V51, P6097, DOI 10.1021/bi300531c; Lu HS, 2005, J MED CHEM, V48, P737, DOI 10.1021/jm049353p; MATTER WF, 1992, BIOCHEM BIOPH RES CO, V186, P624, DOI 10.1016/0006-291X(92)90792-J; Mena-Ulecia K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142774; Osguthorpe DJ, 2012, CHEM BIOL DRUG DES, V80, P182, DOI 10.1111/j.1747-0285.2012.01396.x; Palakurti R, 2013, MOL INFORM, V32, P385, DOI 10.1002/minf.201200169; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Quesada-Romero L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102212; Quesada-Romero L, 2014, MOL DIVERS, V18, P149, DOI 10.1007/s11030-013-9483-5; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Satyanarayana A, 2008, DEVELOPMENT, V135, P3389, DOI 10.1242/dev.024919; Schroeter H, 2002, NEUROBIOL AGING, V23, P861, DOI 10.1016/S0197-4580(02)00075-1; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Spencer JPE, 2003, J BIOL CHEM, V278, P34783, DOI 10.1074/jbc.M305063200; Srinivas NR, 2015, PHYTOTHER RES, V29, P1679, DOI 10.1002/ptr.5447; Turati F, 2015, BRIT J NUTR, V113, pS102, DOI 10.1017/S0007114515000148; Vidak M, 2015, MOLECULES, V20, P19406, DOI 10.3390/molecules201019406; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wendt B, 2014, J COMPUT AID MOL DES, V28, P803, DOI 10.1007/s10822-014-9761-z; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Wu D, 2011, J CHEM INF MODEL, V51, P1634, DOI 10.1021/ci2000659; Yokoyama T, 2015, J MED CHEM, V58, P7400, DOI 10.1021/acs.jmedchem.5b00893; Yoo J, 2011, J COMPUT AID MOL DES, V25, P555, DOI 10.1007/s10822-011-9441-1; Zhang SX, 2008, BIOORGAN MED CHEM, V16, P7127, DOI 10.1016/j.bmc.2008.06.055	48	11	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2016	11	8							e0161111	10.1371/journal.pone.0161111	http://dx.doi.org/10.1371/journal.pone.0161111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3LI	27517610	Green Published, Green Submitted, gold			2022-12-26	WOS:000381382100051
J	Dehghan, F; Soori, R; Dehghan, P; Gholami, K; Muniandy, S; Azarbayjani, MA; Yusof, A				Dehghan, Firouzeh; Soori, Rahman; Dehghan, Parvin; Gholami, Khadijeh; Muniandy, Sekaran; Azarbayjani, Mohammad Ali; Yusof, Ashril			Changes in Knee Laxity and Relaxin Receptor Isoforms Expression (RXFP1/RXFP2) in the Knee throughout Estrous Cycle Phases in Rodents	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; ORAL-CONTRACEPTIVE USE; MECHANICAL-PROPERTIES; MENSTRUAL-CYCLE; JOINT LAXITY; RXFP2 EXPRESSION; PATELLAR TENDON; PASSIVE RANGE; PROGESTERONE; PREGNANCY	The changes in knee laxity and relaxin receptor expression at different phases of rodent estrous cycle are not known. Here, changes in the parameter were investigated in rats at different phases of the estrous cycle. Estrous cycle phases of intact female rats were determined by cytological examination of the vaginal smear. Following phase identification, blood was collected for serum hormone analyses. Knee passive range of motion (ROM) was determined by using a digital miniature goniometer. The animals were then sacrificed and patellar tendon, collateral ligaments and hamstring muscles were harvested for relaxin/insulin-like family peptide receptor 1 and 2 (RXFP1/RXFP2) analyses. Knee passive ROM was the highest at proestrus followed by diestrus and the lowest at estrus. Estrogen level was the highest at proestrus while progesterone and relaxin levels were the highest at diestrus. A strong correlation was observed between relaxin and progesterone levels. At proestrus, expression of RXFP1 and RXFP2 proteins and mRNAs were the highest at proestrus followed by diestrus and estrus. The finding shows that higher level of progesterone and relaxin in diestrus might be responsible for higher laxity of knee joint in rats.	[Dehghan, Firouzeh; Soori, Rahman] Univ Tehran, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran, Iran; [Dehghan, Parvin] Babol Univ Med Sci, Babol Sar, Iran; [Gholami, Khadijeh] Univ Malaya, Fac Med, Dept Physiol, Kuala Lumpur 50603, Malaysia; [Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Azarbayjani, Mohammad Ali] Islamic Azad Univ, Cent Tehran Branch, Dept Phys Educ & Sports Sci, Tehran, Iran; [Dehghan, Firouzeh; Yusof, Ashril] Univ Malaya, Sports Ctr, Dept Exercise Sci, Kuala Lumpur 50603, Malaysia	University of Tehran; Babol University of Medical Sciences; Universiti Malaya; Universiti Malaya; Islamic Azad University; Universiti Malaya	Dehghan, F (corresponding author), Univ Tehran, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran, Iran.; Dehghan, F (corresponding author), Univ Malaya, Sports Ctr, Dept Exercise Sci, Kuala Lumpur 50603, Malaysia.	fir_dhn@yahoo.com	Gholami, Shadi/ABD-5582-2020; YUSOF, ASHRIL/B-8252-2010; Soori, Rahman/AAM-8873-2020; MUNIANDY, SEKARAN/B-5345-2010; Gholami, Shadi/A-5560-2013; Azarbayjani, Mohammad Ali/AGW-7332-2022; Amin Marashi, Seyed Mahmoud/G-1287-2017	Gholami, Shadi/0000-0003-1429-118X; YUSOF, ASHRIL/0000-0002-8117-6440; Soori, Rahman/0000-0002-4661-7204; MUNIANDY, SEKARAN/0000-0003-1310-3634; Gholami, Shadi/0000-0003-1429-118X; Azarbayjani, Mohammad Ali/0000-0002-3502-7487; Amin Marashi, Seyed Mahmoud/0000-0003-2703-1715	High Impact Research grant (HIR) from the University of Malaya, Kuala Lumpur, Malaysia [UM.C/HIR/MOHE/MED/11]	High Impact Research grant (HIR) from the University of Malaya, Kuala Lumpur, Malaysia	This work was supported by High Impact Research grant (HIR; grant UM.C/HIR/MOHE/MED/11) from the University of Malaya, Kuala Lumpur, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldabe D, 2012, EUR SPINE J, V21, P1769, DOI 10.1007/s00586-012-2162-x; Beynnon BD, 2006, AM J SPORT MED, V34, P757, DOI 10.1177/0363546505282624; Beynnon BD, 2005, AM J SPORT MED, V33, P1298, DOI 10.1177/0363546505275149; Chabay RW., 2015, MATTER INTERACTIONS, V4th edn; Dehghan F, 2015, ENVIRON TOXICOL PHAR, V40, P785, DOI 10.1016/j.etap.2015.09.004; Dehghan F, 2014, INT J MOL SCI, V15, P4619, DOI 10.3390/ijms15034619; Dehghan F, 2014, INT J MED SCI, V11, P180, DOI 10.7150/ijms.6283; Deie M, 2002, INT ORTHOP, V26, P154, DOI 10.1007/s00264-001-0326-0; Dragoo JL, 2011, AM J SPORT MED, V39, P2175, DOI 10.1177/0363546511413378; Dragoo JL, 2009, KNEE, V16, P69, DOI 10.1016/j.knee.2008.09.005; Dragoo JL, 2003, AM J SPORT MED, V31, P577, DOI 10.1177/03635465030310041701; Faryniarz DA, 2006, IN VITRO CELL DEV-AN, V42, P176, DOI 10.1290/0512089.1; FIELDS PA, 1985, BIOL REPROD, V32, P1169, DOI 10.1095/biolreprod32.5.1169; Flecknell P., 2009, LAB ANIMAL ANAESTHES; Garber JC, 2010, GUIDE CARE USE LAB A; Hansen M, 2009, J APPL PHYSIOL, V106, P1435, DOI 10.1152/japplphysiol.90933.2008; Hansen M, 2013, J APPL PHYSIOL, V114, P998, DOI 10.1152/japplphysiol.01255.2012; Hart DA, 2000, J ORTHOPAED RES, V18, P462, DOI 10.1002/jor.1100180320; Hashem G, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1978; Hewett TE, 2000, SPORTS MED, V29, P313, DOI 10.2165/00007256-200029050-00003; Hewett TE, 2007, AM J SPORT MED, V35, P659, DOI 10.1177/0363546506295699; Hofmann-Lehmann R, 2002, AIDS RES HUM RETROV, V18, P627, DOI 10.1089/088922202760019329; Karageanes SJ, 2000, CLIN J SPORT MED, V10, P162, DOI 10.1097/00042752-200007000-00003; Lee H, 2014, EUR J APPL PHYSIOL, V114, P285, DOI 10.1007/s00421-013-2771-z; Madan MS, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.06.014; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Martineau PA, 2004, CLIN J SPORT MED, V14, P281, DOI 10.1097/00042752-200409000-00006; Naqvi T, 2005, ARTHRITIS RES THER, V7, pR1, DOI 10.1186/ar1451; Ohtera K, 2002, J APPL PHYSIOL, V92, P1494, DOI 10.1152/japplphysiol.00614.2001; Park SK, 2009, BRIT J SPORT MED, V43, P174, DOI 10.1136/bjsm.2008.049270; Park SK, 2009, AM J SPORT MED, V37, P588, DOI 10.1177/0363546508326713; Pokorny MJ, 2000, J ORTHOP SPORT PHYS, V30, P683, DOI 10.2519/jospt.2000.30.11.683; RAJABI M, 1991, ENDOCRINOLOGY, V128, P863, DOI 10.1210/endo-128-2-863; Romani W, 2003, J WOMEN HEALTH GEN-B, V12, P287, DOI 10.1089/154099903321667627; Schauberger CW, 1996, AM J OBSTET GYNECOL, V174, P667, DOI 10.1016/S0002-9378(96)70447-7; Sherwood O, 1992, OXFORD REV REPROD, V15, P143; Shultz SJ, 2004, MED SCI SPORT EXER, V36, P1165, DOI 10.1249/01.MSS.0000132270.43579.1A; Shultz SJ, 2005, J SPORT MED PHYS FIT, V45, P594; Staley K, 2005, NAT NEUROSCI, V8, P697, DOI 10.1038/nn0605-697; Strickland SM, 2003, AM J SPORT MED, V31, P210, DOI 10.1177/03635465030310020901; Thornton GM, 2007, ASME 2007 SUMM BIOEN; Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warden SJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1034, DOI 10.1152/ajpendo.00367.2005; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Woodhouse E, 2007, KNEE SURG SPORT TR A, V15, P453, DOI 10.1007/s00167-006-0237-0; Zazulak BT, 2006, SPORTS MED, V36, P847, DOI 10.2165/00007256-200636100-00004	47	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160984	10.1371/journal.pone.0160984	http://dx.doi.org/10.1371/journal.pone.0160984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513858	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100104
J	Wu, XJ; Ren, GP; Gunning, WT; Weaver, DA; Kalinoski, AL; Khuder, SA; Huntley, JF				Wu, Xiaojun; Ren, Guoping; Gunning, William T., III; Weaver, David A.; Kalinoski, Andrea L.; Khuder, Sadik A.; Huntley, Jason F.			FmvB: A Francisella tularensis Magnesium-Responsive Outer Membrane Protein that Plays a Role in Virulence	PLOS ONE			English	Article							INTRACELLULAR SURVIVAL; SALMONELLA-TYPHIMURIUM; IRON ACQUISITION; TULAREMIA VACCINE; ESCHERICHIA-COLI; FERROUS IRON; TRANSPORT; BACTERIAL; CELLS; IDENTIFICATION	Francisella tularensis is the causative agent of the lethal disease tularemia. Despite decades of research, little is understood about why F. tularensis is so virulent. Bacterial outer membrane proteins (OMPs) are involved in various virulence processes, including protein secretion, host cell attachment, and intracellular survival. Many pathogenic bacteria require metals for intracellular survival and OMPs often play important roles in metal uptake. Previous studies identified three F. tularensis OMPs that play roles in iron acquisition. In this study, we examined two previously uncharacterized proteins, FTT0267 (named fmvA, for Francisella metal and virulence) and FTT0602c (fmvB), which are homologs of the previously studied F. tularensis iron acquisition genes and are predicted OMPs. To study the potential roles of FmvA and FmvB in metal acquisition and virulence, we first examined fmvA and fmvB expression following pulmonary infection of mice, finding that fmvB was upregulated up to 5-fold during F. tularensis infection of mice. Despite sequence homology to previously-characterized iron-acquisition genes, FmvA and FmvB do not appear to be involved iron uptake, as neither fmvA nor fmvB were upregulated in iron-limiting media and neither Delta fmvA nor Delta fmvB exhibited growth defects in iron limitation. However, when other metals were examined in this study, magnesium-limitation significantly induced fmvB expression, Delta fmvB was found to express significantly higher levels of lipopolysaccharide (LPS) in magnesium-limiting medium, and increased numbers of surface protrusions were observed on Delta fmvB in magnesium-limiting medium, compared to wild-type F. tularensis grown in magnesium-limiting medium. RNA sequencing analysis of Delta fmvB revealed the potential mechanism for increased LPS expression, as LPS synthesis genes kdtA and wbtA were significantly upregulated in Delta fmvB, compared with wild-type F. tularensis. To provide further evidence for the potential role of FmvB in magnesium uptake, we demonstrated that FmvB was outer membrane-localized. Finally, Delta fmvB was found to be attenuated in mice and cytokine analyses revealed that Delta fmvB- infected mice produced lower levels of pro-inflammatory cytokines, including GM-CSF, IL-3, and IL-10, compared with mice infected with wild-type F. tularensis. Taken together, although the function of FmvA remains unknown, FmvB appears to play a role in magnesium uptake and F. tularensis virulence. These results may provide new insights into the importance of magnesium for intracellular pathogens.	[Wu, Xiaojun; Ren, Guoping; Huntley, Jason F.] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gunning, William T., III] Univ Toledo, Coll Med & Life Sci, Dept Pathol & Elect Microscopy Facil, 2801 W Bancroft St, Toledo, OH 43606 USA; [Weaver, David A.; Kalinoski, Andrea L.] Univ Toledo, Coll Med & Life Sci, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA; [Weaver, David A.; Kalinoski, Andrea L.] Univ Toledo, Coll Med & Life Sci, Adv Microscopy & Imaging Ctr, 2801 W Bancroft St, Toledo, OH 43606 USA; [Khuder, Sadik A.] Univ Toledo, Coll Med & Life Sci, Dept Med, 2801 W Bancroft St, Toledo, OH 43606 USA; [Ren, Guoping] New England Biolabs Inc, Ipswich, MA USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; New England Biolabs	Huntley, JF (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Jason.Huntley@UToledo.edu	Huntley, Jason F/N-3848-2015	Huntley, Jason F/0000-0002-0501-6103	National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID-NIH) [R01 AI093351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093351] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID-NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01 AI093351 from the National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID-NIH) to J.F.H.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; Avican K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004600; Bandara AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019003; Beceiro A, 2013, CLIN MICROBIOL REV, V26, P185, DOI 10.1128/CMR.00059-12; Ben Nasr A, 2006, J LEUKOCYTE BIOL, V80, P774, DOI 10.1189/jlb.1205755; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Bigelow H, 2006, NUCLEIC ACIDS RES, V34, pW186, DOI 10.1093/nar/gkl262; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Caza M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00080; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chen HD, 2013, ANNU REV MICROBIOL, V67, P83, DOI 10.1146/annurev-micro-092412-155751; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Cleverley RM, 2015, BBA-BIOMEMBRANES, V1848, P2206, DOI 10.1016/j.bbamem.2015.06.002; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Diaz-Ochoa VE, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00002; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; EVANS ME, 1994, OLD HER U M, V5, P150; EVANS ME, 1990, J INFECT DIS, V162, P148, DOI 10.1093/infdis/162.1.148; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Freeman TC, 2012, BIOINFORMATICS, V28, P2425, DOI 10.1093/bioinformatics/bts478; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Garrow AG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-56; Geier H, 2011, INFECT IMMUN, V79, P2204, DOI 10.1128/IAI.01382-10; Ghafari M, 2015, BRAIN STRUCT FUNCT, V220, P2209, DOI 10.1007/s00429-014-0779-8; Groisman EA, 2013, ANNU REV GENET, V47, P625, DOI 10.1146/annurev-genet-051313-051025; HANCOCK REW, 1984, ANNU REV MICROBIOL, V38, P237, DOI 10.1146/annurev.mi.38.100184.001321; Hantke K, 1997, J BACTERIOL, V179, P6201, DOI 10.1128/jb.179.19.6201-6204.1997; HMIEL SP, 1989, J BACTERIOL, V171, P4742, DOI 10.1128/jb.171.9.4742-4751.1989; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Horzempa J, 2011, J INFECT DIS, V204, P51, DOI 10.1093/infdis/jir221; Hotchkiss RS, 2015, SCIENCE, V347, P1201, DOI 10.1126/science.aaa8334; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Huntley JF, 2010, J VIS EXP, V40; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Krocova Z, 2008, MICROB PATHOGENESIS, V45, P79, DOI 10.1016/j.micpath.2008.01.010; Kucharska I, 2015, STRUCTURE, V23, P2234, DOI 10.1016/j.str.2015.10.009; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kumar P, 2012, INFECT IMMUN, V80, P657, DOI 10.1128/IAI.05208-11; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x; Leon-Sicairos N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/476534; Lindgren H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119143; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Lo KYS, 2013, J MICROBIOL METH, V93, P153, DOI 10.1016/j.mimet.2013.03.004; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12; MOBLEY HLT, 2016, PATHOGENS, V5; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Porcheron G, 2013, FRONT CELL INFECT MI, V3, P90, DOI [DOI 10.3389/FCIMB.2013.00090, 10.3389/fcimb.2013.00090]; Price CA, 1982, CENTRIFUGATION DENSI, DOI [10.1016/C2013-0-11329-3, DOI 10.1016/C2013-0-11329-3]; Ramakrishnan G, 2008, J BACTERIOL, V190, P5353, DOI 10.1128/JB.00181-08; Ramakrishnan G, 2014, MICROBIOL-SGM, V160, P446, DOI 10.1099/mic.0.072835-0; Ramakrishnan G, 2012, J BIOL CHEM, V287, P25191, DOI 10.1074/jbc.M112.371856; Rasmussen JA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00338; Ren G, 2014, MOL MICROBIOL, V94, P926, DOI 10.1111/mmi.12808; Robertson GT, 2013, INFECT IMMUN, V81, P4026, DOI 10.1128/IAI.00595-13; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Rowe HM, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00094; Salomonsson E, 2009, INFECT IMMUN, V77, P3424, DOI 10.1128/IAI.00196-09; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Sen B, 2010, INFECT IMMUN, V78, P4276, DOI 10.1128/IAI.00503-10; Sjostedt A, 2003, CURR OPIN MICROBIOL, V6, P66, DOI 10.1016/S1369-5274(03)00002-X; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Straskova A, 2009, J PROTEOME RES, V8, P5336, DOI 10.1021/pr900570b; SUZUKI T, 1994, MOL MICROBIOL, V11, P31, DOI 10.1111/j.1365-2958.1994.tb00287.x; Szafranska AK, 2014, MBIO, V5, DOI 10.1128/mBio.01775-14; Titball RW, 2003, TRENDS MICROBIOL, V11, P118, DOI 10.1016/S0966-842X(03)00020-9; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2012, PATHOGENS, V1, P12, DOI 10.3390/pathogens1010012; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Wang XY, 2007, P NATL ACAD SCI USA, V104, P4136, DOI 10.1073/pnas.0611606104; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Wu HJ, 2008, CURR OPIN CHEM BIOL, V12, P93, DOI 10.1016/j.cbpa.2008.01.023; Wu Xiaojun, 2015, Bio Protoc, V5, pe1500; Xie F, 2016, VET MICROBIOL, V183, P1, DOI 10.1016/j.vetmic.2015.11.021; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yue WW, 2003, J MOL BIOL, V332, P353, DOI 10.1016/S0022-2836(03)00855-6	88	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160977	10.1371/journal.pone.0160977	http://dx.doi.org/10.1371/journal.pone.0160977			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513341	Green Published, Green Submitted, gold			2022-12-26	WOS:000381381100099
J	Yang, MY; Yang, CW; Ni, HJ; Zhao, YC; Li, M				Yang, Mingyuan; Yang, Changwei; Ni, Haijian; Zhao, Yuechao; Li, Ming			The Relationship between T1 Sagittal Angle and Sagittal Balance: A Retrospective Study of 119 Healthy Volunteers	PLOS ONE			English	Article							ADOLESCENT IDIOPATHIC SCOLIOSIS; MINUS THORACIC KYPHOSIS; CLINICAL-OUTCOMES; RADIOGRAPHIC PARAMETERS; SURGICAL-TREATMENT; PELVIC ANGLE; ALIGNMENT; SPINE; INCLINATION; PREDICTOR	T1 sagittal angle has been reported to be used as a parameter for assessing sagittal balance and cervical lordosis. However, no study has been performed to explore the relationship between T1 sagittal angle and sagittal balance, and whether T1 sagittal angle could be used for osteotomy guidelines remains unknown. The aim of our study is to explore the relationship between T1 sagittal angle and sagittal balance, determine the predictors for T1 sagittal angle, and determine whether T1 sagittal angle could be used for osteotomy guidelines to restore sagittal balance. Medical records of healthy volunteers in our outpatient clinic from January 2014 to August 2015 were reviewed, and their standing full-spine lateral radiographs were evaluated. Demographic and radiological parameters were collected and analyzed, including age, gender, T1 sagittal angle, maxTK, maxLL, SS, PT, and PI. Correlation coefficients between T1 sagittal angle and other spinopelvic parameters were determined. In addition, multiple regression analysis was performed to establish predictive radiographic parameters for T1 sagittal angle as the primary contributors. A total of 119 healthy volunteers were recruited in our study with a mean age of 34.7 years. It was found that T1 sagittal angle was correlated with maxTK with very good significance (r = 0.697, P < 0.001), maxLL with weak significance (r = 0.206, P = 0.024), SS with weak significance (r = 0.237, P = 0.009), PI with very weak significance (r = 0.189, P = 0.039), SVA with moderate significance (r = 0.445, P < 0.001), TPA with weak significance (r = 0.207, P = 0.023), and T1SPI with weak significance (r = 0.309, P = 0.001). The result of multiple regression analysis showed that T1 sagittal angle could be predicted by using the following regression equation: T1 sagittal angle = 0.6 * maxTK-0.2 * maxLL + 8. In the healthy population, T1 sagittal angle could be considered as a useful parameter for sagittal balance; however, it could not be thoroughly replaced for SVA. maxTK was the primary contributor to T1 sagittal angle. According to this equation, we could restore sagittal balance by surgically changing thoracic kyphosis and lumbar lordosis, which could serve as a guideline for osteotomy.	[Yang, Mingyuan; Yang, Changwei; Ni, Haijian; Li, Ming] Second Mil Med Univ, Dept Orthoped, Changhai Hosp, Shanghai, Peoples R China; [Zhao, Yuechao] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Yang, CW; Li, M (corresponding author), Second Mil Med Univ, Dept Orthoped, Changhai Hosp, Shanghai, Peoples R China.	changwei_y@qq.com; limingch@21cn.com						Akbar M, 2011, ORTHOPADE, V40, P661, DOI 10.1007/s00132-011-1814-6; Baghdadi YMK, 2014, SPINE, V39, pE166, DOI 10.1097/BRS.0000000000000073; Barrey C., 2011, EUR SPINE J, V20, P1, DOI 10.1007/s00586-011-1930-3; Benlidayi IC, 2015, AGING CLIN EXP RES, V27, P297, DOI 10.1007/s40520-014-0274-3; Berjano P, 2015, EUR SPINE J, V24, pS433, DOI 10.1007/s00586-015-3930-1; Bodin A, 2015, EUR SPINE J, V24, pS72, DOI 10.1007/s00586-014-3651-x; Etemadifar M, 2016, EUR SPINE J, V25, P2580, DOI 10.1007/s00586-015-4234-1; Fechtenbaum J, 2016, OSTEOPOROSIS INT, V27, P559, DOI 10.1007/s00198-015-3283-y; Hikata T, 2015, J NEUROSURG-SPINE, V23, P451, DOI 10.3171/2015.1.SPINE14642; Jang JS, 2007, SPINE, V32, P3081, DOI 10.1097/BRS.0b013e31815cde71; Jean L, 2014, EUR SPINE J, V23, P1394, DOI 10.1007/s00586-014-3207-0; Knott PT, 2010, SPINE J, V10, P994, DOI 10.1016/j.spinee.2010.08.031; La Maida GA, 2013, EUR SPINE J, V22, pS859, DOI 10.1007/s00586-013-3018-8; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P558, DOI 10.1007/s00586-011-1939-7; Le Huec JC, 2015, INT ORTHOP, V39, P87, DOI 10.1007/s00264-014-2516-6; Lee JH, 2015, EUR SPINE J; Lee SH, 2012, J SPINAL DISORD TECH, V25, pE41, DOI 10.1097/BSD.0b013e3182396301; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Mac-Thiong Jean-Marc, 2011, Eur Spine J, V20 Suppl 5, P572, DOI 10.1007/s00586-011-1923-2; Pesenti S, 2016, EUR SPINE J, V25, P424, DOI 10.1007/s00586-015-4244-z; Protopsaltis T, 2014, J BONE JOINT SURG AM, V96A, P1631, DOI 10.2106/JBJS.M.01459; Qiao J, 2014, SPINE, V39, P2103, DOI 10.1097/BRS.0000000000000635; Schwab F, 2012, SPINE, V37, P1077, DOI 10.1097/BRS.0b013e31823e15e2; Tang JA, 2012, NEUROSURGERY, V71, P662, DOI 10.1227/NEU.0b013e31826100c9; Upasani VV, 2007, SPINE, V32, P1355, DOI 10.1097/BRS.0b013e318059321d; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; Wiedenhofer B, 2011, ORTHOPADE, V40, P672, DOI 10.1007/s00132-011-1795-5; Yagi M, 2014, SPINE, V39, pE521, DOI 10.1097/BRS.0000000000000226; Yang CW, 2016, SPINE, V41, P399, DOI 10.1097/BRS.0000000000001231; Yang CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001198; Yang MY, 2016, SPINE, V41, pE359, DOI 10.1097/BRS.0000000000001258; Zheng GQ, 2014, SPINE, V39, P1055, DOI 10.1097/BRS.0000000000000346	33	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2016	11	8							e0160957	10.1371/journal.pone.0160957	http://dx.doi.org/10.1371/journal.pone.0160957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KY	27513865	gold, Green Submitted, Green Published			2022-12-26	WOS:000381381100095
J	Coquereau, L; Jolivet, A; Hegaret, H; Chauvaud, L				Coquereau, Laura; Jolivet, Aurelie; Hegaret, Helene; Chauvaud, Laurent			Short-Term Behavioural Responses of the Great Scallop Pecten maximus Exposed to the Toxic Alga Alexandrium minutum Measured by Accelerometry and Passive Acoustics	PLOS ONE			English	Article							OYSTER CRASSOSTREA-GIGAS; DYNAMIC BODY ACCELERATION; CLAM CORBICULA-FLUMINEA; HETEROCAPSA-CIRCULARISQUAMA; SOUND PRODUCTION; VALVE ACTIVITY; DINOFLAGELLATE; ACCUMULATION; HABITAT; URANIUM	Harmful algal blooms produced by toxic dinoflagellates have increased worldwide, impacting human health, the environment, and fisheries. Due to their potential sensitivity (e.g., environmental changes), bivalves through their valve movements can be monitored to detect harmful algal blooms. Methods that measure valve activity require bivalve-attached sensors and usually connected cables to data transfers, leading to stress animals and limit the use to sessile species. As a non-intrusive and continuously deployable tool, passive acoustics could be an effective approach to detecting harmful algal blooms in real time based on animal sound production. This study aimed to detect reaction changes in the valve movements of adult Pecten maximus exposed to the toxic dinoflagellate Alexandrium minutum using both accelerometry and passive acoustic methods. Scallops were experimentally exposed to three ecologically relevant concentrations of A. minutum for 2 hours. The number of each type of valve movement and their sound intensity, opening duration, and valve-opening amplitude were measured. Four behaviours were identified: closures, expulsion, displacement, and swimming. The response of P. maximus to A. minutum occurred rapidly at a high concentration. The valve activity of P. maximus was different when exposed to high concentrations (500 000 cells L-1) of A. minutum compared to the non-toxic dinoflagellate Heterocapsa triquetra; the number of valve movements increased, especially closure and expulsion, which were detected acoustically. Thus, this study demonstrates the potential for acoustics and sound production changes in the detection of harmful algal blooms. However, field trials and longer duration experiments are required to provide further evidence for the use of acoustics as a monitoring tool in the natural environment where several factors may interfere with valve behaviours.	[Coquereau, Laura; Jolivet, Aurelie; Hegaret, Helene; Chauvaud, Laurent] Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin, LIA BeBEST,UMR 6539, Rue Dumont DUrville, F-29280 Plouzane, France; [Jolivet, Aurelie] TBM Environm Somme, 115 Rue Claude Chappe,Technopole Brest Iroise, F-29280 Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Coquereau, L (corresponding author), Univ Bretagne Occidentale, Inst Univ Europeen Mer, Lab Sci Environm Marin, LIA BeBEST,UMR 6539, Rue Dumont DUrville, F-29280 Plouzane, France.	laura.coquereau@univ-brest.fr	Hegaret, Helene/B-7206-2008	Hegaret, Helene/0000-0003-4639-9013; Jolivet, Aurelie/0000-0001-5415-3326	ANR program "MER CALME" (ANR Project) [12-ASTR-0021-03]; Universite de Bretagne Occidentale President grant	ANR program "MER CALME" (ANR Project)(French National Research Agency (ANR)); Universite de Bretagne Occidentale President grant	This work was supported by ANR program "MER CALME" (ANR Project-12-ASTR-0021-03), Universite de Bretagne Occidentale President grants for the PhD thesis of Laura Coquereau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Basti L, 2009, AQUACULTURE, V291, P41, DOI 10.1016/j.aquaculture.2009.02.029; Botero CA, 2009, CURR BIOL, V19, P1151, DOI 10.1016/j.cub.2009.04.061; Bougrier S, 2003, AQUAT LIVING RESOUR, V16, P347, DOI 10.1016/S0990-7440(03)00080-9; Bougrier S., 2001, HARMFUL ALGAL BLOOMS, P407; Bricelj V, 1996, HARMFUL TOXIC ALGAL, P405; Bricelj V. Monica, 1998, Reviews in Fisheries Science, V6, P315, DOI 10.1080/10641269891314294; BRICELJ VM, 1991, MAR ECOL PROG SER, V74, P33, DOI 10.3354/meps074033; Chapelle A, 2008, UNDERSTANDING PREDIC; Chapelle Annie, 2015, Harmful Algae News, V51, P4; Coquereau L, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2902-2; Dharmaraj S., 1982, PROC S COAST AQ, V2, P627; Di Iorio L, 2012, J EXP MAR BIOL ECOL, V432, P9, DOI 10.1016/j.jembe.2012.07.010; DOHERTY FG, 1987, HYDROBIOLOGIA, V153, P159, DOI 10.1007/BF00006647; Frank DM, 2008, MAR FRESHW BEHAV PHY, V41, P1, DOI 10.1080/10236240801896207; GAINEY L F JR, 1988, Journal of Shellfish Research, V7, P623; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Haberkorn H, 2011, MAR POLLUT BULL, V62, P1191, DOI 10.1016/j.marpolbul.2011.03.034; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Indeck KL, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150337; Krause B, 2016, BIOL CONSERV, V195, P245, DOI 10.1016/j.biocon.2016.01.013; Lassus P, 2004, AQUAT LIVING RESOUR, V17, P207, DOI 10.1051/alr:2004012; Lassus P., 1994, Natural Toxins, V2, P329, DOI 10.1002/nt.2620020513; Lassus P, 1999, J SHELLFISH RES, V18, P211; Lillis A, 2014, MAR ECOL PROG SER, V505, P1, DOI 10.3354/meps10805; Lindholm T, 1999, HYDROBIOLOGIA, V393, P245, DOI 10.1023/A:1003563022422; Litaker RW, 2002, MAR ECOL PROG SER, V232, P45, DOI 10.3354/meps232045; Markich SJ, 2000, AQUAT TOXICOL, V51, P155, DOI 10.1016/S0166-445X(00)00114-4; May SP, 2010, HARMFUL ALGAE, V9, P281, DOI 10.1016/j.hal.2009.11.005; Nagai K, 2006, AQUACULTURE, V255, P395, DOI 10.1016/j.aquaculture.2005.12.018; Nedelec SL, 2015, MAR ECOL PROG SER, V524, P125, DOI 10.3354/meps11175; OSHIMA Y, 1995, J AOAC INT, V78, P528; Parvulescu A., 1964, MARINE BIOACOUSTICS, V1, P87; Parvulescu A., 1967, MARINE BIOACOUSTICS, P7, DOI DOI 10.3354/MEPS331243.; Piercy JJB, 2014, MAR ECOL PROG SER, V516, P35, DOI 10.3354/meps10986; Radford CA, 2014, MAR ECOL PROG SER, V505, P19, DOI 10.3354/meps10782; Raffin, 1998, ESPECES PHYTOPLANCTO; Rajagopal S, 1997, WATER RES, V31, P3187, DOI 10.1016/S0043-1354(97)00163-2; Ramsdell J. S., 2005, HARMFUL ALGAL RES RE; Robson AA, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150679; Robson AA, 2014, AQUAT BIOL, V21, P121, DOI 10.3354/ab00574; Schroders J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123629; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; SHUMWAY SE, 1985, J EXP MAR BIOL ECOL, V91, P77, DOI 10.1016/0022-0981(85)90222-9; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; THOMAS GE, 1971, MAR BIOL, V10, P87, DOI 10.1007/BF02026771; Tran D, 2005, ENVIRON TOXICOL CHEM, V24, P2278, DOI 10.1897/05-016R.1; Tran D, 2003, ENVIRON TOXICOL CHEM, V22, P914, DOI [10.1897/1551-5028(2003)022&lt;0914:EOPALO&gt;2.0.CO;2, 10.1002/etc.5620220432]; Tran D, 2015, AQUAT TOXICOL, V158, P41, DOI 10.1016/j.aquatox.2014.10.023; Tran D, 2010, AQUACULTURE, V298, P338, DOI 10.1016/j.aquaculture.2009.10.030; Watanabe M, 2002, WATER SCI TECHNOL, V46, P419, DOI 10.2166/wst.2002.0772	53	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2016	11	8							e0160935	10.1371/journal.pone.0160935	http://dx.doi.org/10.1371/journal.pone.0160935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3KR	27508498	gold, Green Published, Green Submitted			2022-12-26	WOS:000381380400067
J	Andrukhov, O; Andrukhova, O; Ozdemir, B; Haririan, H; Muller-Kern, M; Moritz, A; Rausch-Fan, X				Andrukhov, Oleh; Andrukhova, Olena; Ozdemir, Burcu; Haririan, Hady; Mueller-Kern, Michael; Moritz, Andreas; Rausch-Fan, Xiaohui			Soluble CD14 Enhances the Response of Periodontal Ligament Stem Cells to P. gingivalis Lipopolysaccharide	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; PORPHYROMONAS-GINGIVALIS; RECEPTOR 4; LPS; SCD14; DIFFERENTIATION; INTERLEUKIN-6; ACTIVATION; CHEMOKINES; EXPRESSION	Periodontal ligament stem cells (PDLSCs) are lacking membrane CD14, which is an important component of lipopolysaccharide (LPS) signaling through toll-like receptor (TLR) 4. In the present study we investigated the effect of soluble CD14 on the response of human PDLSCs to LPS of Porphyromonas (P.) gingivalis. Human PDLSCs (hPDLSCs) were stimulated with P. gingivalis LPS in the presence or in the absence of soluble CD14 (sCD14) and the production of interleukin (IL)-6, chemokine C-X-C motif ligand 8 (CXCL8), and chemokine C-C motif ligand 2 (CCL2) was measured. The response to P. gingivalis LPS was compared with that to TLR4 agonist Escherichia coli LPS and TLR2-agonist Pam3CSK4. The response of hPDLSCs to both P. gingivalis LPS and E. coli LPS was significantly enhanced by sCD14. In the absence of sCD14, no significant difference in the hPDLSCs response to two kinds of LPS was observed. These responses were significantly lower compared to that to Pam3CSK4. In the presence of sCD14, the response of hPdLSCs to P. gingivalis LPS was markedly higher than that to E. coli LPS and comparable with that to Pam3CSK4. The response of hPdLSCs to bacterial LPS is strongly augmented by sCD14. Local levels of sCD14 could be an important factor for modulation of the host response against periodontal pathogens.	[Andrukhov, Oleh; Ozdemir, Burcu; Haririan, Hady; Mueller-Kern, Michael; Moritz, Andreas; Rausch-Fan, Xiaohui] Med Univ Vienna, Univ Clin Dent, Div Conservat Dent & Periodontol, Vienna, Austria; [Andrukhova, Olena] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Ozdemir, Burcu] Gazi Univ, Fac Dent, Dept Periodontol, Ankara, Turkey	Medical University of Vienna; University of Veterinary Medicine Vienna; Gazi University	Andrukhov, O; Rausch-Fan, X (corresponding author), Med Univ Vienna, Univ Clin Dent, Div Conservat Dent & Periodontol, Vienna, Austria.	oleh.andrukhov@meduniwien.ac.at; xiaohui.rausch-fan@meduniwien.ac.at	Andrukhov, Oleh/H-9851-2018; Haririan, Hady/AAE-8581-2020	Andrukhov, Oleh/0000-0002-0485-2142; Rausch-Fan, Xiaohui/0000-0002-8010-1914; OZDEMIR, BURCU/0000-0003-0356-7769; Haririan, Hady/0000-0003-0783-609X	Medical University of Vienna	Medical University of Vienna	The study was supported by Authors Institution (Medical University of Vienna). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Alt E, 2011, BIOL CELL, V103, P197, DOI 10.1042/BC20100117; Andrukhov O, 2014, ACTA ODONTOL SCAND, V72, P337, DOI 10.3109/00016357.2013.834535; ARCEO N, 1991, J PERIODONTOL, V62, P499, DOI 10.1902/jop.1991.62.8.499; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Chang J, 2005, J DENT RES, V84, P994, DOI 10.1177/154405910508401105; Chang PC, 2013, J PERIODONTAL RES, V48, P184, DOI 10.1111/j.1600-0765.2012.01519.x; Chatzivasileiou K, 2015, J CELL MOL MED, V19, P2067, DOI 10.1111/jcmm.12613; Chatzivasileiou K, 2013, J CELL MOL MED, V17, P766, DOI 10.1111/jcmm.12058; Choi S, 2013, INT J ORAL SCI, V5, P7, DOI 10.1038/ijos.2013.19; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Good DW, 2012, J BIOL CHEM, V287, P20208, DOI 10.1074/jbc.M111.336255; Hasturk H, 2015, PERIODONTOL 2000, V69, P255, DOI 10.1111/prd.12105; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Isaza-Guzman DM, 2008, ORAL DIS, V14, P450, DOI 10.1111/j.1601-0825.2007.01400.x; Jeyaseelan S, 2005, INFECT IMMUN, V73, P1754, DOI 10.1128/IAI.73.3.1754-1763.2005; Jin L, 2001, J PERIODONTOL, V72, P634, DOI 10.1902/jop.2001.72.5.634; Jonsson D, 2011, J PERIODONTAL RES, V46, P153, DOI 10.1111/j.1600-0765.2010.01331.x; Kato H, 2014, ARCH ORAL BIOL, V59, P167, DOI 10.1016/j.archoralbio.2013.11.008; Kim D, 2014, MOL IMMUNOL, V57, P210, DOI 10.1016/j.molimm.2013.09.009; Kinane DF, 2001, PERIODONTOL 2000, V25, P8, DOI 10.1034/j.1600-0757.2001.22250102.x; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Kocgozlu L, 2009, J DENT RES, V88, P741, DOI 10.1177/0022034509341166; KUMADA H, 1995, J BACTERIOL, V177, P2098, DOI 10.1128/jb.177.8.2098-2106.1995; Li CH, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt456; Liu DY, 2012, J CLIN PERIODONTOL, V39, P1174, DOI 10.1111/jcpe.12009; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; Nicu EA, 2009, INNATE IMMUN, V15, P121, DOI 10.1177/1753425908101577; Ozdemir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107407; Pilz GA, 2011, CYTOM PART A, V79A, P635, DOI 10.1002/cyto.a.21073; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Racz GZ, 2014, J PHYSIOL PHARMACOL, V65, P327; Raunio T, 2009, ORAL DIS, V15, P484, DOI 10.1111/j.1601-0825.2009.01573.x; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Silva TA, 2007, J DENT RES, V86, P306, DOI 10.1177/154405910708600403; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tang HN, 2016, J CLIN PERIODONTOL, V43, P72, DOI 10.1111/jcpe.12501; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; Van Peer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00222; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhou X, 2015, J DENT RES; Zhu WJ, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/972313	52	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160848	10.1371/journal.pone.0160848	http://dx.doi.org/10.1371/journal.pone.0160848			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504628	Green Published, gold, Green Submitted			2022-12-26	WOS:000381374200068
J	dos Santos, EA; de Almeida, AAF; Ahnert, D; Branco, MCD; Valle, RR; Baligar, VC				dos Santos, Emerson Alves; Furtado de Almeida, Alex-Alan; Ahnert, Dario; da Silva Branco, Marcia Christina; Valle, Raul Rene; Baligar, Virupax C.			Diallel Analysis and Growth Parameters as Selection Tools for Drought Tolerance in Young Theobroma cacao Plants	PLOS ONE			English	Article							MULTIVARIATE GENETIC-DIVERGENCE; WATER-USE EFFICIENCY; YIELD COMPONENTS; RESPONSES; PHOTOSYNTHESIS; ALLOCATION; DEFICITS; CLONES; ROOTS; MODEL	This study aimed to estimate the combining ability, of T. cacao genotypes preselected for drought tolerance through diallel crosses. The experiment was conducted under greenhouse conditions at the Cacao Research Center (CEPEC), Ilheus, Bahia, Brazil, in a completely randomized block design, in an experimental arrangement 21 x 2 [21 complete diallel crosses and two water regimes (control and stressed)]. In the control, soil moisture was kept close to field capacity, with predawn leaf water potential (psi(WL)) ranging from -0.1 to -0.5 MPa. In the drought regime, the soil moisture was reduced gradually by decreasing the amount of water application until psi(WL) reached -2.0 to -2.5 MPa. Significant differences (p < 0.05) were observed for most morphological attributes analyzed regarding progenies, water regime and their interactions. The results of the joint diallel analysis revealed significant effects between general combining ability (GCA) x water regimes and between specific combining ability (SCA) x water regimes. The SCA 6 genetic material showed high general combining ability for growth variables regardless of the water regime. In general, the water deficit influenced the production of biomass in most of the evaluated T. cacao crosses, except for SCA-6 x IMC-67, Catongo x SCA, MOC-01 x Catongo, Catongo x IMC-67 and RB-40 x Catongo. Multivariate analysis showed that stem diameter (CD), total leaf area (TLA), leaf dry biomass (LDB), stem dry biomass (SDB), root dry biomass (RDB), total dry biomass (TDB), root length (RL), root volume (RV), root diameter (RD) < 1 mm and 1 <(RD) < 2 mm were the most important growth parameters in the separation of T. cacao genotypes in to tolerant and intolerant to soil water deficit.	[dos Santos, Emerson Alves; Furtado de Almeida, Alex-Alan; Ahnert, Dario; da Silva Branco, Marcia Christina] Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare de Andrade,Rod Jorge Amado, BR-45662900 Ilheus, BA, Brazil; [Valle, Raul Rene] Comissao Execut Plano Lavoura Cacaueira CEPEC CEP, Ctr Pesquisas Cacau, Rod Jorge Amado,Km 22, BR-45650000 Ilheus, BA, Brazil; [Baligar, Virupax C.] USDA ARS, Beltsville, MD 20705 USA	Universidade Estadual de Santa Cruz; United States Department of Agriculture (USDA)	de Almeida, AAF (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Campus Soane Nazare de Andrade,Rod Jorge Amado, BR-45662900 Ilheus, BA, Brazil.	alexalan@uesc.br		Baligar, Virupax/0000-0002-6441-4638; da Silva Branco, Marcia Christina/0000-0001-9998-713X	ARS [ARS-0426238] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		ABOHAMED S, 1983, NEW PHYTOL, V95, P9, DOI 10.1111/j.1469-8137.1983.tb03463.x; Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; Almeida A-AF, 2002, VULNERABILITY OF AGR, V14, P35; Arevalo AR, 1975, PROCEEDINGS OF THE 5, P78; Bae H, 2008, PLANT PHYSIOL BIOCH, V46, P174, DOI 10.1016/j.plaphy.2007.10.014; BALASIMHA D, 1988, INDIAN J AGR SCI, V58, P213; BALASIMHA D, 1991, AGR FOREST METEOROL, V55, P15, DOI 10.1016/0168-1923(91)90019-M; Ballester C, 2011, AGR WATER MANAGE, V98, P1027, DOI 10.1016/j.agwat.2011.01.011; Bartley BGD, 2005, THE GENETIC DIVERSIT; Belsky JM, 2003, AGR HUM VALUES, V20, P277, DOI 10.1023/A:1026100714149; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Carr MKV, 2011, EXP AGR, V47, P653, DOI 10.1017/S0014479711000421; Chapin III FS, 1993, AM NAT, V142, P79; Cruz C.D., 2004, MODELOS BIOMETRICOS, V3rd; DaMatta Fábio Murilo, 2004, Braz. J. Plant Physiol., V16, P1, DOI 10.1590/S1677-04202004000100001; DaMatta FM, 2003, PLANT SCI, V164, P111, DOI 10.1016/S0168-9452(02)00342-4; Davies WJ, 2003, ECOL STU AN, V168, P173; de Almeida A.-A. F., 2002, AGROTROPICA, V14, P35; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P425, DOI 10.1590/S1677-04202007000400011; Dias LAD, 1997, EUPHYTICA, V93, P181, DOI 10.1023/A:1002991915978; Dias LAD, 2003, BRAZ ARCH BIOL TECHN, V46, P339, DOI 10.1590/S1516-89132003000300005; Dias LAD, 1997, BRAZ J GENET, V20, P63; DIAS LAS, 1995, THEOR APPL GENET, V90, P534, DOI 10.1007/BF00222000; Dias LAS, 1997, AGROTROPICA, V9; Efombagn IBM, 2008, TREE GENET GENOMES, V4, P821, DOI 10.1007/s11295-008-0155-z; Efombagn MIB, 2006, AFR J BIOTECHNOL, V5, P1441; Efombagn MIB, 2009, J PLANT BREEDING CRO, V1, P258, DOI DOI 10.5897/JPBCS.9000105; FAGERIA NK, 2012, THE ROLE OF PLANT RO; Frimpong E, 2005, CULTIVO E BENEFICIAM; Frimpong E, 1996, PROCEEDINGS OF THE 1, P24; Gao HJ, 2009, SCI HORTIC-AMSTERDAM, V119, P147, DOI 10.1016/j.scienta.2008.07.034; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Hadley P, 1996, PROCEEDINGS OF THE M, P194; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hunt R, 1990, BASIC GROWTH ANALYSI; Jaramillo G, 2005, CROP SCI, V45, P1058, DOI 10.2135/cropsci2004.0314; JOLY RJ, 1989, ANN BOT-LONDON, V64, P1; Kozlowski T. T., 1976, Water deficits and plant growth. Volume 4. Soil water measurement, plant responses, and breeding for drought resistance. [Kozlowski, T.T. (Editor)]., P191; KUMMEROW J, 1982, PLANT SOIL, V65, P193, DOI 10.1007/BF02374650; LAMBERS H, 1992, ADV ECOL RES, V23, P187, DOI 10.1016/S0065-2504(08)60148-8; Li CY, 2003, FOREST ECOL MANAG, V179, P377, DOI 10.1016/S0378-1127(02)00552-2; Li CY, 2000, AUST J PLANT PHYSIOL, V27, P231; Lynch M, 1998, GENETICS AND ANALYSI; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; Merchant A, 2007, ANN BOT-LONDON, V100, P1507, DOI 10.1093/aob/mcm234; Moroni MT, 2003, FOREST ECOL MANAG, V177, P399, DOI 10.1016/S0378-1127(02)00410-3; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; Muller B, 2011, J EXP BOT, V62, P1715, DOI 10.1093/jxb/erq438; ORCHARD JE, 1988, 10TH INTERNATIONAL COCOA RESEARCH CONFERENCE, P193; Ortuno MF, 2004, PLANT SCI, V167, P275, DOI 10.1016/j.plantsci.2004.03.023; Osorio J, 1998, TREE PHYSIOL, V18, P363; Padi FK, 2013, PLANT BREEDING, V132, P229, DOI 10.1111/pbr.12039; Pinto EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105127; Rada F., 2005, Rev. Fac. Agron., V22, P112; RAZI IM, 1992, ASIAN JOURNAL OF PLA, V6, P709; SALE PJM, 1970, J HORTIC SCI BIOTECH, V45, P99, DOI 10.1080/00221589.1970.11514337; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; Seyed YS, 2012, WATER STRESS IN PLAN, P300; Silva W, 2001, ACTA SCIENTIARUM MAR, V23, P1205; Silva W. S. da, 1998, Agrotropica, V10, P31; Skirycz A, 2010, CURR OPIN BIOTECH, V21, P197, DOI 10.1016/j.copbio.2010.03.002; Software R, 2014, SOFTWARE R; Souza Júnior José Olimpio de, 2008, Rev. Bras. Ciênc. Solo, V32, P2367; Vellini ALTT, 2008, REV ARVORE, V32, P651, DOI 10.1590/S0100-67622008000400006; Yan WK, 2002, CROP SCI, V42, P11, DOI 10.2135/cropsci2002.0011; Yin CY, 2005, ENVIRON EXP BOT, V53, P315, DOI 10.1016/j.envexpbot.2004.04.007; Yin CY, 2005, PHYSIOL PLANTARUM, V123, P445, DOI 10.1111/j.1399-3054.2005.00477.x; Zuidema PA, 2005, AGR SYST, V84, P195, DOI 10.1016/j.agsy.2004.06.015	68	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160647	10.1371/journal.pone.0160647	http://dx.doi.org/10.1371/journal.pone.0160647			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504627	Green Published, Green Submitted, gold			2022-12-26	WOS:000381374200050
J	Ji, L; Jia, XP; Chiu, ASF; Xu, M				Ji, Ling; Jia, Xiaoping; Chiu, Anthony S. F.; Xu, Ming			Global Electricity Trade Network: Structures and Implications	PLOS ONE			English	Article							POWER GRID VULNERABILITY; TRANSMISSION; CENTRALITY; EVOLUTION; PATTERNS	Nations increasingly trade electricity, and understanding the structure of the global power grid can help identify nations that are critical for its reliability. This study examines the global grid as a network with nations as nodes and international electricity trade as links. We analyze the structure of the global electricity trade network and find that the network consists of four sub-networks, and provide a detailed analysis of the largest network, Eurasia. Russia, China, Ukraine, and Azerbaijan have high betweenness measures in the Eurasian sub-network, indicating the degrees of centrality of the positions they hold. The analysis reveals that the Eurasian sub-network consists of seven communities based on the network structure. We find that the communities do not fully align with geographical proximity, and that the present international electricity trade in the Eurasian sub-network causes an approximately 11 million additional tons of CO2 emissions.	[Ji, Ling] Beijing Univ Technol, Sch Econ & Management, Beijing, Peoples R China; [Jia, Xiaoping] Qingdao Univ Sci & Technol, Sch Environm & Safety Engn, Qingdao, Peoples R China; [Chiu, Anthony S. F.] De La Salle Univ, Dept Ind Engn, Manila, Philippines; [Xu, Ming] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Xu, Ming] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA; [Xu, Ming] Tongji Univ, Sustainable Dev & New Type Urbanizat Think Tank, Shanghai 200092, Peoples R China	Beijing University of Technology; Qingdao University of Science & Technology; De La Salle University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tongji University	Xu, M (corresponding author), Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA.; Xu, M (corresponding author), Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA.; Xu, M (corresponding author), Tongji Univ, Sustainable Dev & New Type Urbanizat Think Tank, Shanghai 200092, Peoples R China.	mingxu@umich.edu	Chiu, Shun Fung/ABA-4570-2020; Xu, Ming/F-3653-2010	Xu, Ming/0000-0002-7106-8390; Chiu, Anthony Shun Fung/0000-0003-2411-7302	China Postdoctoral Science Foundation [2015M580034]; Beijing Postdoctoral Research Foundation	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Beijing Postdoctoral Research Foundation(China Postdoctoral Science Foundation)	Ling Ji thanks the support from China Postdoctoral Science Foundation (Grant No. 2015M580034) and Beijing Postdoctoral Research Foundation. The author additionally thanks the Dow Sustainability Fellows Program for their support.; Ling Ji thanks the support from China Postdoctoral Science Foundation (Grand No. 2015M580034) and Beijing Postdoctoral Research Foundation. The authors appreciate Dr. Sai Liang for valuable suggestion, and gratefully acknowledge useful comments from the reviewers.	Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Blochl F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046127; Dai YY, 2014, PHYSICA A, V395, P405, DOI 10.1016/j.physa.2013.10.029; Dalin C, 2012, P NATL ACAD SCI USA, V109, P5989, DOI 10.1073/pnas.1203176109; Daly EM, 2009, IEEE T MOBILE COMPUT, V8, P606, DOI 10.1109/TMC.2008.161; Derrible S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040575; Derrible S, 2010, TRANSPORTATION, V37, P275, DOI 10.1007/s11116-009-9227-7; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Edenhofer Ottmar, 2011, P NATL ACAD SCI USA, V108, P8903; Fronczak A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056113; Geng JB, 2014, APPL ENERG, V132, P23, DOI 10.1016/j.apenergy.2014.06.064; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Girvan M, 2003, PHYS REV E, V2; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Helm D, 2014, ENERG POLICY, V64, P29, DOI 10.1016/j.enpol.2013.05.063; Huppmann D, 2015, EUR J OPER RES, V247, P191, DOI 10.1016/j.ejor.2015.05.056; IEA, 2013, CO2 EM FUEL COMB HIG; IEA (International Energy Agency), 2019, KEY WORLD EN STAT; Jamasb T, 2000, BENCHMARKING REGULAT, P1; Ruiz-Mendoza BJ, 2010, ENERG POLICY, V38, P6755, DOI 10.1016/j.enpol.2010.06.046; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Ji Q, 2014, ENERG CONVERS MANAGE, V85, P856, DOI 10.1016/j.enconman.2013.12.072; Jin WX, 2015, PHYSICA A, V427, P302, DOI 10.1016/j.physa.2015.02.035; Liang S, 2016, PHYSICA A, V452, P311, DOI 10.1016/j.physa.2016.01.090; Liang S, 2016, ENVIRON SCI TECHNOL, V50, P1330, DOI 10.1021/acs.est.5b04855; Liang S, 2015, J IND ECOL, V19, P307, DOI 10.1111/jiec.12242; Lin XW, 2014, ENVIRON SCI TECHNOL, V48, P5439, DOI 10.1021/es500471d; Misa TJ, 2010, COMMUN ACM, V53, P41, DOI 10.1145/1787234.1787249; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Ouyang M, 2014, PHYSICA A, V403, P45, DOI 10.1016/j.physa.2014.01.070; Saracco F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10595; Sauvage J, 2013, CROSS BORDER TRADE E, P2; Torriti J, 2014, ENERGY, V77, P635, DOI 10.1016/j.energy.2014.09.057; Vidmer A, 2015, PHYSICA A, V436, P188, DOI 10.1016/j.physa.2015.05.057; Xu M, 2011, ADV COMPLEX SYST, V14, P649, DOI 10.1142/S0219525911003335; Zhang HY, 2014, ENERG POLICY, V73, P312, DOI 10.1016/j.enpol.2014.06.020; Zhao XF, 2010, ENERG POLICY, V38, P6293, DOI 10.1016/j.enpol.2010.06.019; Zhu Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126699	42	9	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160869	10.1371/journal.pone.0160869	http://dx.doi.org/10.1371/journal.pone.0160869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT3IK	27504825	gold, Green Published, Green Submitted			2022-12-26	WOS:000381374200069
J	Vital, ACP; Guerrero, A; Monteschio, JD; Valero, MV; Carvalho, CB; de Abreu, BA; Madrona, GS; do Prado, IN				Pelaes Vital, Ana Carolina; Guerrero, Ana; Monteschio, Jessica de Oliveira; Valero, Maribel Velandia; Carvalho, Camila Barbosa; de Abreu Filho, Benicio Alves; Madrona, Grasiele Scaramal; do Prado, Ivanor Nunes			Effect of Edible and Active Coating (with Rosemary and Oregano Essential Oils) on Beef Characteristics and Consumer Acceptability	PLOS ONE			English	Article							SHELF-LIFE; ANTIOXIDANT ACTIVITY; MODIFIED ATMOSPHERE; PROTEIN OXIDATION; COLOR STABILITY; REFRIGERATED STORAGE; LONGISSIMUS-DORSI; PACKAGING SYSTEMS; LIPID OXIDATION; CHILL STORAGE	The effects of an alginate-based edible coating containing natural antioxidants (rosemary and oregano essential oils) on lipid oxidation, color preservation, water losses, texture and pH of beef steaks during 14 days of display were studied. The essential oil, edible coating and beef antioxidant activities, and beef consumer acceptability were also investigated. The edible coatings decreased lipid oxidation of the meat compared to the control. The coating with oregano was most effective (46.81% decrease in lipid oxidation) and also showed the highest antioxidant activity. The coatings significantly decreased color losses, water losses and shear force compared to the control. The coatings had a significant effect on consumer perception of odor, flavor and overall acceptance of the beef. In particular, the oregano coating showed significantly high values (approximately 7 in a 9-point scale). Active edible coatings containing natural antioxidants could improve meat product stability and therefore have potential use in the food industry.	[Pelaes Vital, Ana Carolina; Carvalho, Camila Barbosa] Univ Estadual Maringa, Food Sci Postgrad Program, Maringa, Parana, Brazil; [Guerrero, Ana; Monteschio, Jessica de Oliveira; Valero, Maribel Velandia; do Prado, Ivanor Nunes] Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil; [de Abreu Filho, Benicio Alves] Univ Estadual Maringa, Basic Hlth Sci Dept, Maringa, Parana, Brazil; [Madrona, Grasiele Scaramal] Univ Estadual Maringa, Dept Food Engn, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	do Prado, IN (corresponding author), Univ Estadual Maringa, Dept Anim Sci, Maringa, Parana, Brazil.	inprado@uem.br	Vital, Ana Carolina/AAE-1715-2022; Monteschio, jéssica/D-6498-2018; Guerrero, Ana/A-7272-2017; Abreu Filho, Benicio Alves/B-7322-2019	Monteschio, jéssica/0000-0003-1331-3260; Guerrero, Ana/0000-0001-6420-6364; Valero, Maribel Velandia/0000-0002-3015-7012; Abreu Filho, Benicio Alves/0000-0002-3271-808X; Vital, Ana Carolina/0000-0002-6033-6898	Coordination for the Improvement of High Education Personnel Foundation (CAPES)	Coordination for the Improvement of High Education Personnel Foundation (CAPES)	The authors thank the Coordination for the Improvement of High Education Personnel Foundation (CAPES) for their scholarship support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Fani A, 2015, FOOD HYDROCOLLOID, V47, P168, DOI 10.1016/j.foodhyd.2015.01.032; Alparslan Y, 2016, LWT-FOOD SCI TECHNOL, V72, P457, DOI 10.1016/j.lwt.2016.04.066; Amorati R, 2013, J AGR FOOD CHEM, V61, P10835, DOI 10.1021/jf403496k; Artes F, 2007, FOOD SCI TECHNOL INT, V13, P177, DOI 10.1177/1082013207079610; Asensio CM, 2011, J FOOD SCI, V76, pS445, DOI 10.1111/j.1750-3841.2011.02332.x; Asoodeh A, 2012, FOOD CHEM, V131, P291, DOI 10.1016/j.foodchem.2011.08.039; Atares L, 2016, TRENDS FOOD SCI TECH, V48, P51, DOI 10.1016/j.tifs.2015.12.001; Azarakhsh N, 2014, POSTHARVEST BIOL TEC, V88, P1, DOI 10.1016/j.postharvbio.2013.09.004; Barbosa-Pereira L, 2013, FOOD CONTROL, V31, P236, DOI 10.1016/j.foodcont.2012.09.036; Bazargani-Gilani B, 2015, INNOV FOOD SCI EMERG, V29, P280, DOI 10.1016/j.ifset.2015.04.007; Cardoso GP, 2016, MEAT SCI, V114, P85, DOI 10.1016/j.meatsci.2015.12.012; Choi WS, 2016, LWT-FOOD SCI TECHNOL, V70, P213, DOI 10.1016/j.lwt.2016.02.036; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; dos Santos PR, 2015, FOOD PACKAGING SHELF, V4, P10, DOI 10.1016/j.fpsl.2015.03.002; Fabra MJ, 2009, BIOMACROMOLECULES, V10, P1500, DOI 10.1021/bm900098p; Faustman C, 2010, MEAT SCI, V86, P86, DOI 10.1016/j.meatsci.2010.04.025; Fernandez-Pan I, 2014, FOOD CONTROL, V36, P69, DOI 10.1016/j.foodcont.2013.07.032; Foti MC, 2007, J PHARM PHARMACOL, V59, P1673, DOI 10.1211/jpp.59.12.0010; Furnols MFI, 2008, MEAT SCI, V80, P1013, DOI 10.1016/j.meatsci.2008.04.018; Galus S, 2016, FOOD HYDROCOLLOID, V52, P78, DOI 10.1016/j.foodhyd.2015.06.013; Guerreiro AC, 2015, POSTHARVEST BIOL TEC, V100, P226, DOI 10.1016/j.postharvbio.2014.09.002; Guerrero A, 2014, J SENS STUD, V29, P201, DOI 10.1111/joss.12095; Guerrero A, 2016, ANIMAL PROD IN PRESS; Guo, 2016, FOOD SCI HUM WELL, V5, P39, DOI [10.1016/j.fshw.2015.11.003, DOI 10.1016/J.FSHW.2015.11.003]; IBGE, 2015, CONT NAC TRIM; Insausti K, 1999, MEAT SCI, V53, P241, DOI 10.1016/S0309-1740(99)00063-7; Kumar Y, 2015, COMPR REV FOOD SCI F, V14, P796, DOI 10.1111/1541-4337.12156; Lagerstedt A, 2011, MEAT SCI, V87, P101, DOI 10.1016/j.meatsci.2010.08.010; Lavieri N, 2014, MEAT SCI, V97, P534, DOI 10.1016/j.meatsci.2014.02.014; Li WD, 2009, CENT EUR J BIOL, V4, P499, DOI 10.2478/s11535-009-0041-1; Lopacka J, 2016, MEAT SCI, V119, P147, DOI 10.1016/j.meatsci.2016.04.034; Lorenzo JM, 2014, LWT-FOOD SCI TECHNOL, V59, P181, DOI 10.1016/j.lwt.2014.04.061; Lu F, 2009, J SCI FOOD AGR, V89, P848, DOI 10.1002/jsfa.3523; Lund MN, 2007, MEAT SCI, V77, P295, DOI 10.1016/j.meatsci.2007.03.016; Lund MN, 2011, MOL NUTR FOOD RES, V55, P83, DOI 10.1002/mnfr.201000453; MACDOUGALL DB, 1982, FOOD CHEM, V9, P75, DOI 10.1016/0308-8146(82)90070-X; MACFIE HJH, 1990, NUTR REV, V48, P87, DOI [10.1111/j.1745-459X.1989.tb00463.x, 10.1111/j.1753-4887.1990.tb02910.x]; Maisuthisakul P, 2007, FOOD CHEM, V100, P1409, DOI 10.1016/j.foodchem.2005.11.032; Mancini RA, 2005, MEAT SCI, V71, P100, DOI 10.1016/j.meatsci.2005.03.003; Maqsood S, 2011, FOOD CHEM, V124, P875, DOI 10.1016/j.foodchem.2010.07.011; Matumoto-Pintro PT, 2011, INT DAIRY J, V21, P21, DOI 10.1016/j.idairyj.2010.07.003; Mohan A, 2016, FOOD BIOSCI, V15, P72, DOI 10.1016/j.fbio.2016.05.006; Nieto G, 2013, MEAT SCI, V95, P177, DOI 10.1016/j.meatsci.2013.05.016; Olmedo R, 2008, INT J FOOD SCI TECH, V43, P1935, DOI 10.1111/j.1365-2621.2008.01796.x; Olmedo RH, 2013, LWT-FOOD SCI TECHNOL, V53, P409, DOI 10.1016/j.lwt.2013.04.007; Pouzo LB, 2016, MEAT SCI, V111, P1, DOI 10.1016/j.meatsci.2015.07.026; Prado IN, 2015, ANIMAL, V9, P1423, DOI 10.1017/S1751731115000580; Raeisi M, 2015, LWT-FOOD SCI TECHNOL, V64, P898, DOI 10.1016/j.lwt.2015.06.010; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reverdy C, 2010, FOOD QUAL PREFER, V21, P794, DOI 10.1016/j.foodqual.2010.03.008; Ruiz-Navajas Y, 2013, FOOD CONTROL, V30, P386, DOI 10.1016/j.foodcont.2012.07.052; Schlesier K, 2002, FREE RADICAL RES, V36, P177, DOI 10.1080/10715760290006411; Shahidi F, 2010, CHEM SOC REV, V39, P4067, DOI 10.1039/b922183m; Soladoye OP, 2015, COMPR REV FOOD SCI F, V14, P106, DOI 10.1111/1541-4337.12127; Song YL, 2011, FOOD CONTROL, V22, P608, DOI 10.1016/j.foodcont.2010.10.012; Souza FN, 2011, VET IMMUNOL IMMUNOP, V143, P162, DOI 10.1016/j.vetimm.2011.05.028; Sun T, 2007, FOOD CHEM, V105, P101, DOI 10.1016/j.foodchem.2007.03.048; Tanzadehpanah H, 2012, FOOD RES INT, V49, P105, DOI 10.1016/j.foodres.2012.08.022; Turgut SS, 2016, MEAT SCI, V116, P126, DOI 10.1016/j.meatsci.2016.02.011; Volpe MG, 2015, LWT-FOOD SCI TECHNOL, V60, P615, DOI 10.1016/j.lwt.2014.08.048; Wyness L., 2013, NUTR CLIMATE CHANGE, P1; Zhang LH, 2016, LWT-FOOD SCI TECHNOL, V70, P155, DOI 10.1016/j.lwt.2016.02.046; Zhu QY, 2002, J AGR FOOD CHEM, V50, P6929, DOI 10.1021/jf0206163	63	85	88	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160535	10.1371/journal.pone.0160535	http://dx.doi.org/10.1371/journal.pone.0160535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27504957	Green Submitted, Green Published, gold			2022-12-26	WOS:000381374200043
J	Wang, XX; Huang, XY; Sachse, D; Ding, WH; Xue, JT				Wang, Xinxin; Huang, Xianyu; Sachse, Dirk; Ding, Weihua; Xue, Jiantao			Molecular Paleoclimate Reconstructions over the Last 9 ka from a Peat Sequence in South China	PLOS ONE			English	Article							N-ALKANE DISTRIBUTIONS; EAST-ASIAN MONSOON; LACUSTRINE SEDIMENTARY SEQUENCE; INTERTROPICAL CONVERGENCE ZONE; WESTERN NANLING MOUNTAINS; NORTH-ATLANTIC CLIMATE; DELTA-D VALUES; SUMMER MONSOON; ISOTOPIC COMPOSITION; HYDROGEN ISOTOPES	To achieve a better understanding of Holocene climate change in the monsoon regions of China, we investigated the molecular distributions and carbon and hydrogen isotope compositions delta C-13 and delta D values) of long-chain n-alkanes in a peat core from the Shiwangutian SWGT) peatland, south China over the last 9 ka. By comparisons with other climate records, we found that the delta C-13 values of the long-chain n-alkanes can be a proxy for humidity, while the dD values of the long-chain n-alkanes primarily recorded the moisture source dD signal during 9-1.8 ka BP and responded to the dry climate during 1.8-0.3 ka BP. Together with the average chain length ACL) and the carbon preference index CPI) data, the climate evolution over last 9 ka in the SWGT peatland can be divided into three stages. During the first stage 9-5 ka BP), the delta C-13 values were depleted and CPI and Paq values were low, while ACL values were high. They reveal a period of warm and wet climate, which is regarded as the Holocene optimum. The second stage 5-1.8 ka BP) witnessed a shift to relatively cool and dry climate, as indicated by the more positive delta C-13 values and lower ACL values. During the third stage 1.8-0.3 ka BP), the delta C-13, delta D, CPI and Paq values showed marked increase and ACL values varied greatly, implying an abrupt change to cold and dry conditions. This climate pattern corresponds to the broad decline in Asian monsoon intensity through the latter part of the Holocene. Our results do not support a later Holocene optimum in south China as suggested by previous studies.	[Wang, Xinxin; Huang, Xianyu; Ding, Weihua; Xue, Jiantao] China Univ Geosci, Sch Earth Sci, Lab Crit Zone Evolut, Wuhan, Peoples R China; [Huang, Xianyu] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan, Peoples R China; [Sachse, Dirk] Univ Potsdam, Inst Earth & Environm Sci, Potsdam, Germany; [Sachse, Dirk] GFZ German Res Ctr Geosci, Organ Surface Geochem Lab, Sect Geomorphol 5 1, Potsdam, Germany	China University of Geosciences; China University of Geosciences; University of Potsdam; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Huang, XY (corresponding author), China Univ Geosci, Sch Earth Sci, Lab Crit Zone Evolut, Wuhan, Peoples R China.; Huang, XY (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan, Peoples R China.	xianyu.huang@gmail.com	Sachse, Dirk/D-3410-2012; Huang, Xianyu/N-9729-2019	Sachse, Dirk/0000-0003-4207-0309; Huang, Xianyu/0000-0001-6175-9158; Wang, Xinxin/0000-0002-3097-5728	NSFC [41472308, 41330103]; 111 Project [B08030]; fundamental research funds for the central universities [CUG150618]	NSFC(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities)	This work was supported by NSFC (41472308, 41330103), the 111 Project (grant B08030), and the fundamental research funds for the central universities (CUG150618). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2000, QUATERNARY SCI REV, V19, P743, DOI 10.1016/S0277-3791(99)00031-1; Baas M, 2000, ORG GEOCHEM, V31, P535, DOI 10.1016/S0146-6380(00)00037-1; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; Bush RT, 2015, ORG GEOCHEM, V79, P65, DOI 10.1016/j.orggeochem.2014.12.003; Bush RT, 2013, GEOCHIM COSMOCHIM AC, V117, P161, DOI 10.1016/j.gca.2013.04.016; Castaneda IS, 2007, GEOLOGY, V35, P823, DOI 10.1130/G23916A.1; Chikaraishi Y, 2003, PHYTOCHEMISTRY, V63, P361, DOI 10.1016/S0031-9422(02)00749-5; COLLISTER JW, 1994, ORG GEOCHEM, V21, P619, DOI 10.1016/0146-6380(94)90008-6; Contreras-Rosales LA, 2014, QUATERNARY SCI REV, V102, P133, DOI 10.1016/j.quascirev.2014.08.010; CRANWELL PA, 1987, ORG GEOCHEM, V11, P513, DOI 10.1016/0146-6380(87)90007-6; Duan WH, 2016, GEOCHIM COSMOCHIM AC, V183, P250, DOI 10.1016/j.gca.2016.03.037; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; FANG JQ, 1991, QUATERNARY RES, V36, P37, DOI 10.1016/0033-5894(91)90016-X; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Feakins SJ, 2010, GEOCHIM COSMOCHIM AC, V74, P2128, DOI 10.1016/j.gca.2010.01.016; Ficken KJ, 2000, ORG GEOCHEM, V31, P745, DOI 10.1016/S0146-6380(00)00081-4; Freeman K.H., 2014, TREATISE GEOCHEMISTR, P395, DOI [10.1016/B978-0-08-095975-7.01028-7, DOI 10.1016/B978-0-08-095975-7.01028-7]; GAGOSIAN RB, 1986, ORG GEOCHEM, V10, P661, DOI 10.1016/S0146-6380(86)80002-X; GELPI E, 1970, PHYTOCHEMISTRY, V9, P603, DOI 10.1016/S0031-9422(00)85700-3; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; He YX, 2015, QUATERNARY RES, V84, P255, DOI 10.1016/j.yqres.2015.06.004; Hong YT, 2003, EARTH PLANET SC LETT, V211, P371, DOI 10.1016/S0012-821X(03)00207-3; [黄咸雨 Huang Xianyu], 2016, [第四纪研究, Quaternary Sciences], V36, P666; Huang XY, 2015, GEOCHIM COSMOCHIM AC, V154, P212, DOI 10.1016/j.gca.2015.01.031; Huang XY, 2013, GEOCHIM COSMOCHIM AC, V123, P106, DOI 10.1016/j.gca.2013.09.017; Huang XY, 2013, HOLOCENE, V23, P1123, DOI 10.1177/0959683613483617; Jia GD, 2015, QUATERNARY SCI REV, V111, P51, DOI 10.1016/j.quascirev.2015.01.002; Kahmen A, 2013, GEOCHIM COSMOCHIM AC, V111, P39, DOI 10.1016/j.gca.2012.09.003; Kuechler RR, 2013, QUATERNARY SCI REV, V82, P56, DOI 10.1016/j.quascirev.2013.10.013; Leider A, 2013, GEOCHIM COSMOCHIM AC, V117, P16, DOI 10.1016/j.gca.2013.04.018; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; Newberry SL, 2015, GEOCHIM COSMOCHIM AC, V165, P75, DOI 10.1016/j.gca.2015.05.001; Nichols JE., 2010, MIRES PEAT, V7, P1; Nichols J, 2010, GEOCHIM COSMOCHIM AC, V74, P1407, DOI 10.1016/j.gca.2009.11.012; Nichols JE, 2006, ORG GEOCHEM, V37, P1505, DOI 10.1016/j.orggeochem.2006.06.020; Nott CJ, 2000, ORG GEOCHEM, V31, P231, DOI 10.1016/S0146-6380(99)00153-9; Pancost RD, 2002, ORG GEOCHEM, V33, P675, DOI 10.1016/S0146-6380(02)00048-7; Porter J.E., 1994, QUATERNARY SCI, V1, P24; POYNTER JG, 1989, NATO ADV SCI I C-MAT, V282, P435; Rach O, 2014, NAT GEOSCI, V7, P109, DOI [10.1038/ngeo2053, 10.1038/NGEO2053]; Rao ZG, 2016, EARTH PLANET SC LETT, V446, P68, DOI 10.1016/j.epsl.2016.04.027; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Sachse D, 2012, ANNU REV EARTH PL SC, V40, P221, DOI 10.1146/annurev-earth-042711-105535; Sarkar S, 2015, QUATERNARY SCI REV, V123, P144, DOI 10.1016/j.quascirev.2015.06.020; Schellekens J, 2015, GEOCHIM COSMOCHIM AC, V150, P74, DOI 10.1016/j.gca.2014.12.003; Schmidt F, 2014, GLOBAL PLANET CHANGE, V112, P92, DOI 10.1016/j.gloplacha.2013.11.004; Seki O, 2011, GEOLOGY, V39, P875, DOI 10.1130/G32117.1; Seki O, 2009, ORG GEOCHEM, V40, P671, DOI 10.1016/j.orggeochem.2009.03.007; Shi Y F, 1992, SCI CHINA, V12, P1300, DOI DOI 10.1360/ZB1992-22-12-1300; Strong D, 2013, QUATERNARY SCI REV, V78, P65, DOI 10.1016/j.quascirev.2013.07.034; Vogts A, 2012, ORG GEOCHEM, V47, P109, DOI 10.1016/j.orggeochem.2012.03.011; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Wu WX, 2004, QUATERN INT, V117, P153, DOI 10.1016/S1040-6182(03)00125-3; [吴夏 Wu Xia], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P182; Xie SC, 2004, GEOCHIM COSMOCHIM AC, V68, P2849, DOI 10.1016/j.gca.2003.08.025; Xie SC, 2013, GEOLOGY, V41, P827, DOI 10.1130/G34318.1; Yamamoto S, 2010, CHEM GEOL, V277, P261, DOI 10.1016/j.chemgeo.2010.08.009; Yamamoto S, 2010, ORG GEOCHEM, V41, P491, DOI 10.1016/j.orggeochem.2010.01.006; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Yue YF, 2012, PALAEOGEOGR PALAEOCL, V365, P115, DOI 10.1016/j.palaeo.2012.09.018; Zhang JW, 2011, QUATERNARY SCI REV, V30, P1973, DOI 10.1016/j.quascirev.2011.04.023; Zhao Y, 2009, EARTH-SCI REV, V97, P242, DOI 10.1016/j.earscirev.2009.10.007; Zheng YH, 2015, ORG GEOCHEM, V87, P86, DOI 10.1016/j.orggeochem.2015.07.012; Zheng YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5631; Zheng YH, 2011, ORG GEOCHEM, V42, P25, DOI 10.1016/j.orggeochem.2010.10.003; Zheng YH, 2009, CHINESE SCI BULL, V54, P1065, DOI 10.1007/s11434-008-0563-3; Zhong W, 2015, QUATERNARY RES, V84, P246, DOI 10.1016/j.yqres.2015.06.002; Zhong W, 2015, HOLOCENE, V25, P1330, DOI 10.1177/0959683615584206; Zhong W, 2010, J QUATERNARY SCI, V25, P975, DOI 10.1002/jqs.1384; Zhou WJ, 2007, RADIOCARBON, V49, P865, DOI 10.1017/S0033822200042739; Zhou WJ, 2010, EARTH PLANET SC LETT, V294, P37, DOI 10.1016/j.epsl.2010.02.035; Zhou WJ, 2005, ORG GEOCHEM, V36, P1272, DOI 10.1016/j.orggeochem.2005.04.005	74	11	14	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2016	11	8							e0160934	10.1371/journal.pone.0160934	http://dx.doi.org/10.1371/journal.pone.0160934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IK	27505008	Green Published, gold			2022-12-26	WOS:000381374200081
J	Calderon-Patron, JM; Goyenechea, I; Ortiz-Pulido, R; Castillo-Ceron, J; Manriquez, N; Ramirez-Bautista, A; Rojas-Martinez, AE; Sanchez-Rojas, G; Zuria, I; Moreno, CE				Calderon-Patron, Jaime M.; Goyenechea, Irene; Ortiz-Pulido, Raul; Castillo-Ceron, Jesus; Manriquez, Norma; Ramirez-Bautista, Aurelio; Rojas-Martinez, Alberto E.; Sanchez-Rojas, Gerardo; Zuria, Iriana; Moreno, Claudia E.			Beta Diversity in a Highly Heterogeneous Area: Disentangling Species and Taxonomic Dissimilarity for Terrestrial Vertebrates	PLOS ONE			English	Article							ECOREGIONS; SIMILARITY; CONSERVATION; NESTEDNESS; TURNOVER; DRIVERS	Quantifying differences in species composition among communities provides important information related to the distribution, conservation and management of biodiversity, especially when two components are recognized: dissimilarity due to turnover, and dissimilarity due to richness differences. The ecoregions in central Mexico, within the Mexican Transition Zone, have outstanding environmental heterogeneity and harbor huge biological richness, besides differences in the origin of the biota. Therefore, biodiversity studies in this area require the use of complementary measures to achieve appropriate information that may help in the design of conservation strategies. In this work we analyze the dissimilarity of terrestrial vertebrates, and the components of turnover and richness differences, among six ecoregions in the state of Hidalgo, central Mexico. We follow two approaches: one based on species level dissimilarity, and the second on taxonomic dissimilarity. We used databases from the project "Biodiversity in the state of Hidalgo". Our results indicate that species dissimilarity is higher than taxonomic dissimilarity, and that turnover contributes more than richness differences, both for species and taxonomic total dissimilarity. Moreover, total dissimilarity, turnover dissimilarity and the dissimilarity due to richness differences were positively related in the four vertebrate groups. Reptiles had the highest values of dissimilarity, followed by mammals, amphibians and birds. For reptiles, birds, and mammals, species turnover was the most important component, while richness differences had a higher contribution for amphibians. The highest values of dissimilarity occurred between environmentally contrasting ecoregions (i.e., tropical and temperate forests), which suggests that environmental heterogeneity and differences in the origin of biotas are key factors driving beta diversity of terrestrial vertebrates among ecoregions in this complex area.	[Calderon-Patron, Jaime M.; Goyenechea, Irene; Ortiz-Pulido, Raul; Castillo-Ceron, Jesus; Manriquez, Norma; Ramirez-Bautista, Aurelio; Rojas-Martinez, Alberto E.; Sanchez-Rojas, Gerardo; Zuria, Iriana; Moreno, Claudia E.] Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Pachuca, Hidalgo, Mexico; [Calderon-Patron, Jaime M.] Univ Autonoma Queretaro, Fac Ciencias Nat, Lab Zool, Juriquilla, Queretaro, Mexico	Universidad Autonoma del Estado de Hidalgo; Universidad Autonoma de Queretaro	Moreno, CE (corresponding author), Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Pachuca, Hidalgo, Mexico.	cmoreno@uaeh.edu.mx	Sanchez-Rojas, Gerardo/AAI-8312-2021; Moreno, Claudia E./B-2733-2013; Zuria, Iriana/A-8490-2018; Sanchez-Rojas, Gerardo/C-3068-2008; Goyenechea, Irene/AAR-7074-2021; Ortiz-Pulido, Raul/E-2671-2013; Moreno, Claudia/GRJ-1036-2022; Sanchez-Rojas, Gerardo/AAG-6616-2021	Moreno, Claudia E./0000-0002-9584-2619; Zuria, Iriana/0000-0002-0004-3540; Sanchez-Rojas, Gerardo/0000-0003-1994-8611; Ortiz-Pulido, Raul/0000-0001-9898-5386; Sanchez-Rojas, Gerardo/0000-0003-1994-8611; Calderon-Patron, Jaime Manuel/0000-0002-5426-1228	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexican National Council of Science and Technology) through projects Fomix Hidalgo "Diversidad biologica del estado de Hidalgo" (Biological diversity of the state of Hidalgo) [43761, 95828, 191908]; CONACYT Basic Science Project "Evaluacion de la diversidad de especies mediante el analisis e integracion de elementos ecologicos, funcionales y evolutivos" [222632]	Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexican National Council of Science and Technology) through projects Fomix Hidalgo "Diversidad biologica del estado de Hidalgo" (Biological diversity of the state of Hidalgo); CONACYT Basic Science Project "Evaluacion de la diversidad de especies mediante el analisis e integracion de elementos ecologicos, funcionales y evolutivos"	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexican National Council of Science and Technology) through projects Fomix Hidalgo "Diversidad biologica del estado de Hidalgo" (Biological diversity of the state of Hidalgo), first, second and third stages awarded to IG (grant numbers 43761, 95828, and 191908). Manuscript writing and data analysis were also supported by the CONACYT Basic Science Project 222632 "Evaluacion de la diversidad de especies mediante el analisis e integracion de elementos ecologicos, funcionales y evolutivos" awarded to CEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeler DG, 2013, DIVERS DISTRIB, V19, P772, DOI 10.1111/ddi.12029; Mejenes-López Sol de Mayo Araucana, 2010, Therya, V1, P161, DOI 10.12933/therya-10-19; Bacaro G, 2007, J VEG SCI, V18, P793, DOI 10.1111/j.1654-1103.2007.tb02595.x; Baselga A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127913; Baselga A, 2015, METHODS ECOL EVOL, V6, P1069, DOI 10.1111/2041-210X.12388; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Calderon-Patron JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082905; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Carvalho JC, 2011, DIVERS DISTRIB, V17, P225, DOI 10.1111/j.1472-4642.2010.00731.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Londono-Murcia MC, 2010, ENVIRON CONSERV, V37, P116, DOI 10.1017/S0376892910000391; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chiu CH, 2014, ECOL MONOGR, V84, P21, DOI 10.1890/12-0960.1; CONABIO, 2011, CAT AUT TAX ANF AMPH; CONABIO, 2012, CAT AUT TAX REPT REP; da Silva F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109642; Diserud OH, 2007, BIOL LETTERS, V3, P20, DOI 10.1098/rsbl.2006.0553; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Duarte LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105043; Environmental Systems Research Institute, 2013, ARCGIS DESKT HELP VE; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hintsche S, PHYLOGENIE LEBEWESEN; Izsak C, 2001, MAR ECOL PROG SER, V215, P69, DOI 10.3354/meps215069; Jost Lou, 2011, P66; Koleff P., 2008, CAPITAL NATURAL ME X; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Martinez-Morales MA, 2007, AVIFAUNAS ESTATALES; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Morrone J.J., 2001, THESIS; Morrone JJ, 2015, J ZOOL SYST EVOL RES, V53, P249, DOI 10.1111/jzs.12098; Nipperess DA, 2010, J VEG SCI, V21, P809, DOI 10.1111/j.1654-1103.2010.01192.x; Ochoa-Ochoa LM, 2014, REV MEX BIODIVERS, V85, P918, DOI 10.7550/rmb.38737; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Otazo-Sanchez EM, 2013, PROGRAMA ESTATAL ACC; Pool TK, 2014, DIVERS DISTRIB, V20, P1235, DOI 10.1111/ddi.12231; Qian H, 2009, J SYST EVOL, V47, P509, DOI 10.1111/j.1759-6831.2009.00043.x; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; RAMIREZ-BAUTIsTA A., 2014, ANFIBIOS REPTILES HI; Ramirez-Pulido Jose, 2014, Special Publications Museum of Texas Tech University, V63, P1; Rodríguez Pilar, 2003, Acta Zool. Mex, P241; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Si XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127692; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563	54	14	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160438	10.1371/journal.pone.0160438	http://dx.doi.org/10.1371/journal.pone.0160438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500934	Green Published, Green Submitted, gold			2022-12-26	WOS:000381373500023
J	Cowan, DB; Yao, RA; Akurathi, V; Snay, ER; Thedsanamoorthy, JK; Zurakowski, D; Ericsson, M; Friehs, I; Wu, YT; Levitsky, S; del Nido, PJ; Packard, AB; McCully, JD				Cowan, Douglas B.; Yao, Rouan; Akurathi, Vamsidhar; Snay, Erin R.; Thedsanamoorthy, Jerusha K.; Zurakowski, David; Ericsson, Maria; Friehs, Ingeborg; Wu, Yaotang; Levitsky, Sidney; del Nido, Pedro J.; Packard, Alan B.; McCully, James D.			Intracoronary Delivery of Mitochondria to the Ischemic Heart for Cardioprotection	PLOS ONE			English	Article							REPERFUSION; INJURY; TRANSPLANTATION; CHANNELS; PROTECTS; NECROSIS; CALCIUM	We have previously shown that transplantation of autologously derived, respiration-competent mitochondria by direct injection into the heart following transient ischemia and reperfusion enhances cell viability and contractile function. To increase the therapeutic potential of this approach, we investigated whether exogenous mitochondria can be effectively delivered through the coronary vasculature to protect the ischemic myocardium and studied the fate of these transplanted organelles in the heart. Langendorff-perfused rabbit hearts were subjected to 30 minutes of ischemia and then reperfused for 10 minutes. Mitochondria were labeled with F-18-rhodamine 6G and iron oxide nanoparticles. The labeled mitochondria were either directly injected into the ischemic region or delivered by vascular perfusion through the coronary arteries at the onset of reperfusion. These hearts were used for positron emission tomography, microcomputed tomography, and magnetic resonance imaging with subsequent microscopic analyses of tissue sections to confirm the uptake and distribution of exogenous mitochondria. Injected mitochondria were localized near the site of delivery; while, vascular perfusion of mitochondria resulted in rapid and extensive dispersal throughout the heart. Both injected and perfused mitochondria were observed in interstitial spaces and were associated with blood vessels and cardiomyocytes. To determine the efficacy of vascular perfusion of mitochondria, an additional group of rabbit hearts were subjected to 30 minutes of regional ischemia and reperfused for 120 minutes. Immediately following regional ischemia, the hearts received unlabeled, autologous mitochondria delivered through the coronary arteries. Autologous mitochondria perfused through the coronary vasculature significantly decreased infarct size and significantly enhanced post-ischemic myocardial function. In conclusion, the delivery of mitochondria through the coronary arteries resulted in their rapid integration and widespread distribution throughout the heart and provided cardioprotection from ischemia-reperfusion injury.	[Cowan, Douglas B.; Yao, Rouan; Thedsanamoorthy, Jerusha K.; Zurakowski, David] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Cowan, Douglas B.; Yao, Rouan; Akurathi, Vamsidhar; Snay, Erin R.; Thedsanamoorthy, Jerusha K.; Zurakowski, David; Friehs, Ingeborg; Wu, Yaotang; Levitsky, Sidney; del Nido, Pedro J.; Packard, Alan B.; McCully, James D.] Harvard Med Sch, Boston, MA 02115 USA; [Akurathi, Vamsidhar; Snay, Erin R.; Wu, Yaotang; Packard, Alan B.] Boston Childrens Hosp, Dept Radiol, Boston, MA USA; [Zurakowski, David; Friehs, Ingeborg; del Nido, Pedro J.; McCully, James D.] Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA; [Ericsson, Maria] Harvard Med Sch, Dept Cell Biol, Boston, MA USA; [Levitsky, Sidney] Beth Israel Deaconess Med Ctr, Dept Cardiothorac Surg, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Cowan, DB (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.; Cowan, DB; McCully, JD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; McCully, JD (corresponding author), Boston Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA.	douglas.cowan@childrens.harvard.edu; james.mccully@childrens.harvard.edu		Cowan, Douglas/0000-0002-6309-2737	Anesthesia Foundation; Cardiac Conduction Fund; Cardiac Surgery Foundation of Boston Children's Hospital; Richard A. and Susan F. Smith President's Innovation Award; Sidman Family Foundation; National Institutes of Health [HL108107, HL103642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108107] Funding Source: NIH RePORTER	Anesthesia Foundation; Cardiac Conduction Fund; Cardiac Surgery Foundation of Boston Children's Hospital; Richard A. and Susan F. Smith President's Innovation Award; Sidman Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Anesthesia Foundation, the Cardiac Conduction Fund and Cardiac Surgery Foundation of Boston Children's Hospital, The Richard A. and Susan F. Smith President's Innovation Award, Michael B. Klein and Family, The Sidman Family Foundation, and the National Institutes of Health (HL108107 [ABP] and HL103642 [JDM]). The authors attest they had full freedom to explore the data and analyze the results independent from any sponsor and that they had sole authority to make the final decision to submit the material for publication.	Bartholoma MD, 2015, NUCL MED BIOL, V42, P796, DOI 10.1016/j.nucmedbio.2015.06.008; Bartholoma MD, 2013, NUCL MED BIOL, V40, P1043, DOI 10.1016/j.nucmedbio.2013.07.006; Choi YH, 2006, AM J PATHOL, V169, P72, DOI 10.2353/ajpath.2006.051163; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; Jakobs S, 2014, CURR OPIN CHEM BIOL, V20, P9, DOI 10.1016/j.cbpa.2014.03.019; Kornfeld OS, 2015, CIRC RES, V116, P1783, DOI 10.1161/CIRCRESAHA.116.305432; Lesnefsky EJ, 2004, AM J PHYSIOL-HEART C, V287, pH258, DOI 10.1152/ajpheart.00348.2003; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; McCully JD, 2007, ANN THORAC SURG, V83, P1102, DOI 10.1016/j.athoracsur.2006.10.059; McCully JD, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0095-4; McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008; McCully JD, 2004, AM J PHYSIOL-HEART C, V286, pH1923, DOI 10.1152/ajpheart.00935.2003; McCully JD, 2003, ANN THORAC SURG, V75, pS667, DOI 10.1016/S0003-4975(02)04689-1; McCully JD, 2002, ANN THORAC SURG, V74, P2138, DOI 10.1016/S0003-4975(02)04348-5; Ozcan C, 2001, J THORAC CARDIOV SUR, V121, P298, DOI 10.1067/mtc.2001.111421; Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478; Pacak CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108695; Preble JM, 2014, JOVE-J VIS EXP, DOI 10.3791/51682; Rousou AJ, 2004, AM J PHYSIOL-HEART C, V287, pH1967, DOI 10.1152/ajpheart.00338.2004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tansey EE, 2006, ANN THORAC SURG, V82, P1472, DOI 10.1016/j.athoracsur.2006.04.061; Wakiyama H, 2002, EUR J CARDIO-THORAC, V21, P424, DOI 10.1016/S1010-7940(01)01156-3	23	104	113	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2016	11	8							e0160889	10.1371/journal.pone.0160889	http://dx.doi.org/10.1371/journal.pone.0160889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3IE	27500955	Green Published, gold, Green Submitted			2022-12-26	WOS:000381373500063
J	Dinov, ID; Heavner, B; Tang, M; Glusman, G; Chard, K; Darcy, M; Madduri, R; Pa, J; Spino, C; Kesselman, C; Foster, I; Deutsch, EW; Price, ND; Van Horn, JD; Ames, J; Clark, K; Hood, L; Hampstead, BM; Dauer, W; Toga, AW				Dinov, Ivo D.; Heavner, Ben; Tang, Ming; Glusman, Gustavo; Chard, Kyle; Darcy, Mike; Madduri, Ravi; Pa, Judy; Spino, Cathie; Kesselman, Carl; Foster, Ian; Deutsch, Eric W.; Price, Nathan D.; Van Horn, John D.; Ames, Joseph; Clark, Kristi; Hood, Leroy; Hampstead, Benjamin M.; Dauer, William; Toga, Arthur W.			Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations	PLOS ONE			English	Article							MULTIPLE IMPUTATION; CLASSIFICATION; GENE; ALGORITHMS; MECHANISMS; DIAGNOSIS; MODELS	Background A unique archive of Big Data on Parkinson's Disease is collected, managed and disseminated by the Parkinson's Progression Markers Initiative (PPMI). The integration of such complex and heterogeneous Big Data from multiple sources offers unparalleled opportunities to study the early stages of prevalent neurodegenerative processes, track their progression and quickly identify the efficacies of alternative treatments. Many previous human and animal studies have examined the relationship of Parkinson's disease (PD) risk to trauma, genetics, environment, co-morbidities, or life style. The defining characteristics of Big Data-large size, incongruency, incompleteness, complexity, multiplicity of scales, and heterogeneity of information-generating sources-all pose challenges to the classical techniques for data management, processing, visualization and interpretation. We propose, implement, test and validate complementary model-based and model-free approaches for PD classification and prediction. To explore PD risk using Big Data methodology, we jointly processed complex PPMI imaging, genetics, clinical and demographic data. Methods and Findings Collective representation of the multi-source data facilitates the aggregation and harmonization of complex data elements. This enables joint modeling of the complete data, leading to the development of Big Data analytics, predictive synthesis, and statistical validation. Using heterogeneous PPMI data, we developed a comprehensive protocol for end-to-end data characterization, manipulation, processing, cleaning, analysis and validation. Specifically, we (i) introduce methods for rebalancing imbalanced cohorts, (ii) utilize a wide spectrum of classification methods to generate consistent and powerful phenotypic predictions, and (iii) generate reproducible machine-learning based classification that enables the reporting of model parameters and diagnostic forecasting based on new data. We evaluated several complementary model-based predictive approaches, which failed to generate accurate and reliable diagnostic predictions. However, the results of several machine-learning based classification methods indicated significant power to predict Parkinson's disease in the PPMI subjects (consistent accuracy, sensitivity, and specificity exceeding 96%, confirmed using statistical n-fold cross-validation). Clinical (e.g., Unified Parkinson's Disease Rating Scale (UPDRS) scores), demographic (e.g., age), genetics (e.g., rs34637584, chr12), and derived neuroimaging biomarker (e.g., cerebellum shape index) data all contributed to the predictive analytics and diagnostic forecasting. Conclusions Model-free Big Data machine learning-based classification methods (e.g., adaptive boosting, support vector machines) can outperform model-based techniques in terms of predictive precision and reliability (e.g., forecasting patient diagnosis). We observed that statistical rebalancing of cohort sizes yields better discrimination of group differences, specifically for predictive analytics based on heterogeneous and incomplete PPMI data. UPDRS scores play a critical role in predicting diagnosis, which is expected based on the clinical definition of Parkinson's disease. Even without longitudinal UPDRS data, however, the accuracy of model-free machine learning based classification is over 80%. The methods, software and protocols developed here are openly shared and can be employed to study other neurodegenerative disorders (e.g., Alzheimer's, Huntington's, amyotrophic lateral sclerosis), as well as for other predictive Big Data analytics applications.	[Dinov, Ivo D.; Tang, Ming] Univ Michigan, Michigan Inst Data Sci, Sch Nursing, Stat Online Computat Resource, Ann Arbor, MI USA; [Heavner, Ben; Glusman, Gustavo; Deutsch, Eric W.; Price, Nathan D.; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Darcy, Mike; Kesselman, Carl] Univ Southern Calif, Inst Informat Sci, Los Angeles, CA USA; [Chard, Kyle; Madduri, Ravi; Foster, Ian] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Chard, Kyle; Madduri, Ravi; Foster, Ian] Argonne Natl Lab, Chicago, IL USA; [Dinov, Ivo D.; Pa, Judy; Van Horn, John D.; Ames, Joseph; Clark, Kristi; Toga, Arthur W.] Univ Southern Calif, Stevens Neuroimaging & Informat Inst, Los Angeles, CA USA; [Hampstead, Benjamin M.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Hampstead, Benjamin M.] Univ Michigan, Michigan Alzheimers Dis Ctr, Ann Arbor, MI 48109 USA; [Hampstead, Benjamin M.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Dinov, Ivo D.; Spino, Cathie; Dauer, William] Univ Michigan, Udall Ctr Excellence Parkinsons Dis Res, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Institute for Systems Biology (ISB); University of Southern California; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Dinov, ID (corresponding author), Univ Michigan, Michigan Inst Data Sci, Sch Nursing, Stat Online Computat Resource, Ann Arbor, MI USA.	statistics@umich.edu	Deutsch, Eric/AAF-5912-2020; Foster, Ian/GNH-1877-2022; D'Arcy, Michel/D-4848-2016	Foster, Ian/0000-0003-2129-5269; Van Horn, John Darrell/0000-0003-1537-0816; Heavner, Benjamin/0000-0003-2898-9044; D'Arcy, Michel/0000-0003-2280-917X; Kesselman, Carl/0000-0003-0917-1562; Price, Nathan/0000-0002-4157-0267; Dauer, William/0000-0003-1775-7504	NSF [1023115, 1022560, 1022636, 0089377, 9652870, 0442992, 0442630, 0333672, 0716055]; NIH [P20 NR015331, P50 NS091856, P30 DK089503, U54 EB020406]; Michael J. Fox Foundation for Parkinson's Research; Abbvie; Avid; Biogen Idec; Bristol-Meyers Squibb; Covance; GE Health care; Genentech; GlaxoSmithKline; Lilly; Lundback; Merck; Meso Scale Discovery; Pfizer; Piramal; Roche; Servier; UCB; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922, U54EB020406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS091856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P20NR015331] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; Abbvie(AbbVie); Avid; Biogen Idec(Biogen); Bristol-Meyers Squibb(Bristol-Myers Squibb); Covance; GE Health care(General ElectricGE Healthcare); Genentech(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Lundback; Merck(Merck & Company); Meso Scale Discovery; Pfizer(Pfizer); Piramal; Roche(Roche Holding); Servier(Servier); UCB(UCB Pharma SA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was partially supported by NSF grants 1023115, 1022560, 1022636, 0089377, 9652870, 0442992, 0442630, 0333672, 0716055, and by NIH grants P20 NR015331, P50 NS091856, P30 DK089503 and U54 EB020406. Many colleagues part of the Big Data Discovery Science (BDDS) community and the Michigan Institute for Data Science (MIDAS) provided contributions including ideas, pilot testing, improvement suggestions and other assistance in the development and validation of these methods.; Some of the data used in the preparation of this article were obtained from the Parkinson's Progression Markers Initiative (PPMI) database (www.ppmi-info.org/data). For up-to-date information on the study, visit www.ppmi-info.org. PPMI-a public-private partnership-is funded by the Michael J. Fox Foundation for Parkinson's Research and funding partners, including Abbvie, Avid, Biogen Idec, Bristol-Meyers Squibb, Covance, GE Health care, Genentech, GlaxoSmithKline, Lilly, Lundback, Merck, Meso Scale Discovery, Pfizer, Piramal, Roche, Servier, and UCB (www.ppmi-info.org/fundingpartners).	Archibald R, 2007, IEEE GEOSCI REMOTE S, V4, P674, DOI 10.1109/LGRS.2007.905116; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cerasa A, 2014, PARKINSONISM RELAT D, V20, P1209, DOI 10.1016/j.parkreldis.2014.09.001; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Checkoway H, 2010, IARC SCIENTIFIC PUBL, P407; Chen HL, 2013, EXPERT SYST APPL, V40, P263, DOI 10.1016/j.eswa.2012.07.014; Christou N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019178; Clarke R, 2008, NAT REV CANCER, V8, P37, DOI 10.1038/nrc2294; Cookson MR, 2016, J NEUROCHEMISTRY; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Crawley MJ, 2007, MIXED EFFECTS MODELS, P681; Cuinlan JR, 2002, HDB DATA MINING KNOW; Dauer W, 2010, MOVEMENT DISORD, V25, pS40, DOI 10.1002/mds.22717; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; Dinov I., 2006, J STAT SOFTW, V16, P1; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Dinov ID, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00041; Dinov ID, 2014, BRAIN IMAGING BEHAV, V8, P311, DOI 10.1007/s11682-013-9248-x; Dinov Ivo D, 2009, Front Neuroinform, V3, P22, DOI 10.3389/neuro.11.022.2009; Duda R., 2012, PATTERN CLASSIFICATI; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gagnon JF, 2002, NEUROLOGY, V59, P585, DOI 10.1212/WNL.59.4.585; Garraux G, 2013, NEUROIMAGE-CLIN, V2, P883, DOI 10.1016/j.nicl.2013.06.004; Geerts H, 2014, FUTURE MED CHEM, V6, P1757, DOI 10.4155/FMC.14.97; Gelman A, 2014, BAYESIAN DATA ANAL, P284; Goldman SM, 2014, ANNU REV PHARMACOL, V54, P141, DOI 10.1146/annurev-pharmtox-011613-135937; GOLUB GH, 1979, TECHNOMETRICS, V21, P215, DOI 10.1080/00401706.1979.10489751; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hazan H, 2012, EL EL ENG ISR IEEEI; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hirschauer TJ, 2015, J MED SYST, V39, DOI 10.1007/s10916-015-0353-9; Husain Syed S, 2015, J Big Data, V2; Ishigami N, 2012, MOVEMENT DISORD, V27, P851, DOI 10.1002/mds.24994; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jahanshahi M, 2010, BRAIN, V133, P727, DOI 10.1093/brain/awq012; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jorgenson AK, 2012, J WORLD SYST RES, V18, P103, DOI 10.5195/JWSR.2012.483; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kohonen T., 1995, LEARNING VECTOR QUAN; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lane P, 2008, PHARM STAT, V7, P93, DOI 10.1002/pst.267; Lau YS, 2011, EUR J NEUROSCI, V33, P1264, DOI 10.1111/j.1460-9568.2011.07626.x; Lavrac N, 1999, RULE EVALUATION MEAS; Lawrence DB, 2012, THE ECONOMIC VALUE O; Li H, 2014, 2014 NINTH INTERNATI; Maciejewski R, 2011, IEEE T VIS COMPUT GR, V17, P440, DOI 10.1109/TVCG.2010.82; Manning CD, 2008, INTRO INFORM RETRIEV; Marras Connie, 2014, Arch Phys Med Rehabil, V95, pS238, DOI 10.1016/j.apmr.2013.08.298; McCulloch C., 2000, GEN LINEAR MODELS; Meda SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031913; Mehta P, 2014, MMWR SURVEILL SUMM, V63, P1; Mollick E, 2006, IEEE ANN HIST COMPUT, V28, P62, DOI 10.1109/MAHC.2006.45; Morales-Briceno H, 2015, CLIN GENET, V87, P259, DOI 10.1111/cge.12400; Muller MLTM, 2015, MOVEMENT DISORD, V30, P269, DOI 10.1002/mds.26061; Nalls MA, 2014, NATURE GENETICS; Nalls MA, 2015, MOVEMENT DISORDERS; Nalls MA, 2015, LANCET NEUROLOGY; Nalls MA, 2015, LANCET NEUROL, V14, P1002, DOI 10.1016/S1474-4422(15)00178-7; Nalls MA, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.07.028; Nombela C, 2011, FRONT NEUROL, V2; Olgiati S, 2015, PARKINSONISM RELAT D, V21, P981, DOI 10.1016/j.parkreldis.2015.06.005; Ormerod RJ, 2010, J OPER RES SOC, V61, P1207, DOI 10.1057/jors.2009.96; Patawari A, 2015, DATA INTEGRATION LIF; Pickles A., 1998, GEN ESTIMATING EQUAT; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Ramentol E, 2012, KNOWL INF SYST, V33, P245, DOI 10.1007/s10115-011-0465-6; Ratsch G, 2001, MACH LEARN, V42, P287, DOI 10.1023/A:1007618119488; Ravid R, 2012, FEBS J, V279, P1167, DOI 10.1111/j.1742-4658.2012.08518.x; Ray Chaudhuri Kallol, 2013, PLoS One, V8, pe57221, DOI 10.1371/journal.pone.0057221; Rubin DB., 2004, MULTIPLE IMPUTATION; Sarkiss CA, 2015, CLIN NEUROL NEUROSUR, V134, P122, DOI 10.1016/j.clineuro.2015.04.022; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Singh G, 2015, IFAC PAPERSONLINE, V48, P918, DOI 10.1016/j.ifacol.2015.09.087; Skalak D. B, 1994, P 11 INT C MACH LEAR, P293, DOI DOI 10.1016/B978-1-55860-335-6.50043-X; Su YS, 2011, J STAT SOFTW, V45, P1; Svedberg M, 2012, AMYLOID IMAGING PET; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wahid F, 2015, IEEE J BIOMED HEALTH, V19, P1794, DOI 10.1109/JBHI.2015.2450232; Walter C, 2005, SCI AM, V293, P32, DOI 10.1038/scientificamerican0805-32; West M., 1996, BAYESIAN FORECASTING; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	87	68	68	9	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2016	11	8							e0157077	10.1371/journal.pone.0157077	http://dx.doi.org/10.1371/journal.pone.0157077			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT3GR	27494614	gold, Green Submitted, Green Published			2022-12-26	WOS:000381369500002
